data_2lj4_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2lj4 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.575 ' HA ' ' O ' ' A' ' 80' ' ' PHE . 69.0 mmtt . . . . . 0 N--CA 1.453 -0.284 0 CA-C-O 121.434 0.635 . . . . 1.6899999999999999 111.365 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.618 ' HB3' ' CE1' ' A' ' 80' ' ' PHE . 2.3 tt -137.02 158.31 44.74 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 114.748 -1.115 . . . . 1.79 108.032 -176.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.543 ' H ' HD21 ' A' ' 8' ' ' LEU . 72.2 ttt180 -132.18 130.93 41.71 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 108.928 -0.767 . . . . 1.3700000000000001 108.928 172.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -145.96 154.83 42.34 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.394 -0.523 . . . . 1.0700000000000001 111.886 -175.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.497 ' HA ' ' HA ' ' A' ' 76' ' ' ASP . . . -114.86 137.04 52.43 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.901 -0.591 . . . . 1.04 109.823 177.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 32.4 p-80 -139.69 151.42 45.89 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.06 0.457 . . . . 0.34000000000000002 111.538 -172.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.61 ' O ' ' HA ' ' A' ' 112' ' ' HIS . 5.5 tt -119.08 144.51 46.55 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 108.336 -0.986 . . . . 1.0600000000000001 108.336 177.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.569 HD11 ' NE2' ' A' ' 112' ' ' HIS . 27.0 tp -130.4 120.97 25.07 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.724 0.297 . . . . 1.0800000000000001 111.061 -177.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 57.3 t -109.04 133.9 52.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 116.108 -0.496 . . . . 1.01 109.693 176.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.435 ' HE3' HD23 ' A' ' 14' ' ' LEU . 32.7 mmtp -106.03 151.22 24.93 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.274 -0.639 . . . . 1.22 109.274 176.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.401 ' HB3' ' HB1' ' A' ' 40' ' ' ALA . 46.6 p90 -142.61 162.23 36.02 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.707 0.289 . . . . 0.29999999999999999 110.859 -178.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.443 ' HB3' ' C ' ' A' ' 33' ' ' ALA . 28.7 p -50.59 110.78 0.45 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.93 -0.577 . . . . 1.6000000000000001 111.194 179.297 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 94.75 8.33 59.47 Favored Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.458 -0.877 . . . . 0.53000000000000003 113.36 177.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.473 ' C ' ' H ' ' A' ' 22' ' ' ASN . 88.5 p -90.83 46.84 1.36 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 117.841 0.82 . . . . 1.28 110.51 -178.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 70.8 ttt180 70.87 -35.55 0.33 Allowed 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 123.53 0.732 . . . . 4.1600000000000001 111.511 -178.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.473 ' H ' ' C ' ' A' ' 20' ' ' SER . 49.4 m-80 -140.52 96.86 7.6 Favored Pre-proline 0 C--N 1.326 -0.434 0 N-CA-C 109.623 -0.51 . . . . 1.77 109.623 179.526 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.514 ' C ' HG23 ' A' ' 32' ' ' THR . 87.4 Cg_endo -83.35 51.67 3.66 Favored 'Trans proline' 0 CA--C 1.536 0.618 0 C-N-CA 122.585 2.19 . . . . 1.71 113.133 -176.141 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.46 ' N ' HG23 ' A' ' 32' ' ' THR . 42.7 t -147.6 113.11 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 123.265 0.626 . . . . 1.1599999999999999 109.332 177.136 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.435 ' HB3' ' HB2' ' A' ' 16' ' ' LYS . 21.5 p -104.36 158.07 16.71 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.946 -0.115 . . . . 1.4299999999999999 110.728 178.405 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.532 ' HB2' ' HA ' ' A' ' 67' ' ' ASP . 0.0 OUTLIER -63.37 -13.78 43.1 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-O 121.551 0.691 . . . . 3.1200000000000001 110.033 172.313 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.485 ' CG ' ' HD2' ' A' ' 65' ' ' ARG . 0.1 OUTLIER -87.87 -13.81 41.04 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.92 -1.036 . . . . 2.25 110.827 -177.432 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 20.7 p -118.84 -35.22 3.73 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.326 0.584 . . . . 1.1299999999999999 110.511 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 79.4 -42.67 2.42 Favored Glycine 0 N--CA 1.452 -0.262 0 CA-C-N 115.083 -0.962 . . . . 0.81999999999999995 112.852 176.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -94.27 -67.98 0.83 Allowed 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 110.118 -0.327 . . . . 2.1000000000000001 110.118 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.2 m -153.63 146.59 24.48 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.075 -0.512 . . . . 1.3300000000000001 110.304 178.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.514 HG23 ' C ' ' A' ' 23' ' ' PRO . 9.9 t -112.8 33.79 4.79 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 122.545 1.164 . . . . 1.02 108.589 175.264 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.443 ' C ' ' HB3' ' A' ' 18' ' ' SER . . . -80.67 -4.55 54.7 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 114.165 -1.38 . . . . 1.1299999999999999 111.712 -175.074 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -95.26 -21.42 18.45 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.97 0.415 . . . . 2.21 111.007 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.434 HG13 ' OG1' ' A' ' 32' ' ' THR . 0.2 OUTLIER -99.18 136.54 29.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.052 -0.522 . . . . 1.1100000000000001 110.052 179.822 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 56.1 p -95.48 -178.4 4.41 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.329 -0.396 . . . . 1.2 110.325 -174.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.427 ' O ' HG13 ' A' ' 41' ' ' ILE . 6.6 p90 -65.17 -27.98 69.08 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.102 -0.703 . . . . 2.21 109.102 176.041 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -72.1 -49.2 38.13 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 115.89 -0.596 . . . . 0.95999999999999996 110.064 177.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.415 ' HB2' HG23 ' A' ' 35' ' ' VAL . 49.1 m-20 -65.12 -30.55 71.49 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-O 121.339 0.59 . . . . 0.91000000000000003 110.041 179.422 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.401 ' HB1' ' HB3' ' A' ' 17' ' ' PHE . . . -70.4 -46.47 63.91 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.184 -0.916 . . . . 1.03 110.427 177.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.493 ' O ' ' HB2' ' A' ' 45' ' ' GLN . 70.4 mt -63.33 -36.83 77.67 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.383 0 N-CA-C 109.726 -0.472 . . . . 1.0800000000000001 109.726 175.537 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.449 ' O ' ' HG3' ' A' ' 46' ' ' LYS . 79.5 tttt -59.16 -31.8 69.31 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.66 -0.7 . . . . 2.8399999999999999 110.169 177.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 53.1 tt0 -88.12 -46.84 8.96 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.635 -0.711 . . . . 1.02 110.149 -176.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.463 HD13 HG12 ' A' ' 113' ' ' ILE . 33.5 tp -60.19 -37.52 80.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.12 -0.491 . . . . 1.02 109.854 -179.302 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.493 ' HB2' ' O ' ' A' ' 41' ' ' ILE . 1.6 mm-40 -68.06 -21.35 65.0 Favored 'General case' 0 C--O 1.226 -0.175 0 CA-C-N 115.936 -0.575 . . . . 0.87 112.123 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.449 ' HG3' ' O ' ' A' ' 42' ' ' LYS . 68.4 mttm -82.43 -44.87 15.53 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.853 -0.339 . . . . 1.98 110.262 178.335 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.409 ' O ' HG13 ' A' ' 51' ' ' ILE . 43.9 m95 -67.8 -44.44 77.32 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.999 -0.28 . . . . 0.60999999999999999 110.618 177.097 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 32.4 t -61.15 -26.94 68.04 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.883 -0.414 . . . . 0.88 109.883 175.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.448 ' HB2' ' O ' ' A' ' 45' ' ' GLN . 3.9 tt0 -73.0 -56.62 4.87 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 116.152 -0.476 . . . . 0.55000000000000004 109.844 175.319 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.489 ' HB3' HG21 ' A' ' 56' ' ' VAL . 87.0 mtt180 -59.86 -41.97 92.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.84 -0.618 . . . . 0.47999999999999998 111.882 -176.179 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.474 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 98.0 mt -59.23 -34.76 54.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.101 0.476 . . . . 1.04 110.157 176.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -82.22 -37.91 25.31 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.559 -0.746 . . . . 1.0600000000000001 111.87 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.46 ' OG ' ' HA ' ' A' ' 50' ' ' ARG . 46.3 p -78.92 -29.55 44.26 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 111.99 0.367 . . . . 0.34999999999999998 111.99 -176.008 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 107.38 13.1 21.8 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.541 -0.838 . . . . 0.33000000000000002 112.667 179.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.453 ' HB2' ' HB3' ' A' ' 50' ' ' ARG . 33.5 mt-10 -73.99 -44.85 53.24 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.858 0.361 . . . . 0.65000000000000002 110.239 177.518 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.489 HG21 ' HB3' ' A' ' 50' ' ' ARG . 14.2 m -138.86 158.34 29.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 109.355 -0.609 . . . . 1.05 109.355 172.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 55.1 p -84.53 164.91 18.47 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.68 -0.489 . . . . 1.3100000000000001 109.68 176.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -57.95 -41.04 81.99 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.224 -0.658 . . . . 0.25 109.224 178.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -56.56 -53.28 59.41 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.898 -1.046 . . . . 1.72 111.381 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 30.6 mm-40 -56.54 -45.48 81.15 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 120.965 0.412 . . . . 2.0899999999999999 111.161 -178.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -68.1 -49.83 58.71 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.192 -0.458 . . . . 1.0700000000000001 111.121 -179.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.33 -53.74 54.74 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.236 0.458 . . . . 1.0600000000000001 112.236 -174.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.573 ' HA ' ' O ' ' A' ' 71' ' ' TYR . 74.7 m -51.63 -24.53 5.63 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 113.35 0.87 . . . . 1.52 113.35 -176.532 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -104.59 -48.1 3.89 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.564 0.697 . . . . 0.60999999999999999 110.457 -179.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.485 ' HD2' ' CG ' ' A' ' 27' ' ' ARG . 18.5 mmt180 -87.41 -41.37 13.62 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.993 -1.003 . . . . 0.95999999999999996 113.443 -168.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.493 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 58.5 p -64.77 125.43 24.76 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.049 0.452 . . . . 1.0600000000000001 111.301 -175.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.532 ' HA ' ' HB2' ' A' ' 26' ' ' ARG . 24.8 t70 -75.96 -17.76 59.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.69 -0.686 . . . . 2.2799999999999998 111.342 177.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . 0.431 ' O ' ' HD1' ' A' ' 71' ' ' TYR . 41.2 t -77.48 157.43 30.45 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.317 0.579 . . . . 2.0499999999999998 110.21 -178.536 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -57.11 -17.79 24.77 Favored Glycine 0 C--N 1.329 0.181 0 CA-C-N 114.482 -1.235 . . . . 0.29999999999999999 114.269 -170.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 51.1 p -69.38 -5.61 24.63 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 111.891 0.33 . . . . 0.46999999999999997 111.891 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.573 ' O ' ' HA ' ' A' ' 63' ' ' SER . 34.6 p90 -56.02 -33.58 65.03 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.014 0.435 . . . . 0.94999999999999996 109.988 175.033 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -94.45 4.82 53.37 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.119 0.485 . . . . 1.1100000000000001 110.911 -177.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.0 m -114.44 -15.99 12.0 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.002 -0.545 . . . . 0.70999999999999996 110.905 -177.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 101.7 19.57 15.23 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.861 -0.685 . . . . 0.67000000000000004 111.641 -176.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 85.8 -27.87 5.2 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 121.193 -0.527 . . . . 0.42999999999999999 112.656 178.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.497 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 7.6 p-10 -86.41 140.86 29.6 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-O 121.776 0.798 . . . . 1.6499999999999999 111.333 -175.275 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.3 mp -102.09 175.57 5.49 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 114.422 -1.263 . . . . 1.6899999999999999 109.84 177.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -86.49 -156.53 28.64 Favored Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 120.842 -0.694 . . . . 0.45000000000000001 111.413 177.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.543 ' HA ' ' O ' ' A' ' 8' ' ' LEU . 99.3 m-85 -85.29 136.96 33.27 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.022 0.439 . . . . 4.7400000000000002 110.52 179.337 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.618 ' CE1' ' HB3' ' A' ' 8' ' ' LEU . 13.8 p90 -137.96 166.34 24.3 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.655 -0.702 . . . . 1.6499999999999999 109.21 -179.604 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.502 ' O ' ' HB2' ' A' ' 84' ' ' GLU . 15.5 m -90.02 133.12 35.01 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 108.931 -0.766 . . . . 1.6899999999999999 108.931 176.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 20.0 m -53.02 121.42 7.36 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.828 0.347 . . . . 1.55 110.834 -178.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 104.86 1.09 42.4 Favored Glycine 0 CA--C 1.519 0.324 0 C-N-CA 120.964 -0.636 . . . . 0.79000000000000004 112.237 -176.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.502 ' HB2' ' O ' ' A' ' 81' ' ' SER . 28.5 tt0 -82.78 -3.79 57.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.777 0.322 . . . . 1.5800000000000001 111.609 -175.519 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 26.5 mmt -107.94 -144.97 0.39 Allowed 'General case' 0 N--CA 1.438 -1.035 0 N-CA-C 109.451 -0.574 . . . . 1.1299999999999999 109.451 -175.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -93.54 154.52 17.83 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 115.369 -0.832 . . . . 1.8899999999999999 109.089 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 22.3 tptm -53.94 -57.1 19.31 Favored Pre-proline 0 C--N 1.321 -0.671 0 N-CA-C 112.07 0.396 . . . . 2.7400000000000002 112.07 -178.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -74.0 -22.1 17.56 Favored 'Trans proline' 0 C--N 1.356 0.962 0 C-N-CA 121.506 1.47 . . . . 0.29999999999999999 111.661 -176.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.603 ' O ' HG21 ' A' ' 93' ' ' VAL . 23.8 t80 -72.8 -56.45 5.22 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.293 -0.867 . . . . 0.28000000000000003 109.608 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -64.48 -34.83 79.12 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.812 -0.631 . . . . 2.1200000000000001 109.654 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.45 ' HA ' ' NE ' ' A' ' 94' ' ' ARG . 9.9 t70 -52.35 -36.69 54.17 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.74 -0.664 . . . . 0.60999999999999999 111.091 175.029 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.541 ' O ' ' HG ' ' A' ' 96' ' ' LEU . . . -81.98 -35.34 29.06 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.937 -0.574 . . . . 1.1000000000000001 110.883 179.424 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.603 HG21 ' O ' ' A' ' 89' ' ' PHE . 14.7 t -64.17 -42.76 96.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.201 0.524 . . . . 1.1200000000000001 110.585 -177.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.45 ' NE ' ' HA ' ' A' ' 91' ' ' ASP . 39.4 ptt180 -70.86 -18.41 62.7 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.022 -0.535 . . . . 3.1800000000000002 110.583 177.415 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -88.66 2.6 52.94 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.921 -0.581 . . . . 1.0800000000000001 111.415 -174.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.579 ' HB2' ' HB2' ' A' ' 100' ' ' ASP . 0.8 OUTLIER -137.98 153.53 49.42 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.132 -0.485 . . . . 1.1200000000000001 110.64 177.621 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.674 ' HG2' ' H ' ' A' ' 98' ' ' ILE . 39.8 tttp -102.7 -179.18 3.89 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 109.18 -0.674 . . . . 2.1299999999999999 109.18 176.413 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.674 ' H ' ' HG2' ' A' ' 97' ' ' LYS . 9.2 mt -51.49 122.4 2.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 120.891 0.377 . . . . 1.6200000000000001 111.309 178.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 93.12 -2.12 71.23 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.9 -0.667 . . . . 0.46000000000000002 113.271 178.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.579 ' HB2' ' HB2' ' A' ' 96' ' ' LEU . 45.7 m-20 -100.19 141.98 32.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 117.423 0.611 . . . . 0.46000000000000002 110.657 -179.474 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 11.8 mt -111.55 147.02 15.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.954 -0.566 . . . . 1.0800000000000001 110.0 -179.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 91.3 p -92.19 152.45 42.58 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 116.419 -0.355 . . . . 1.45 110.953 -177.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -68.25 160.15 50.17 Favored 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 122.335 2.023 . . . . 0.40999999999999998 111.095 172.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.479 HG13 ' HG2' ' A' ' 45' ' ' GLN . 25.6 mm -43.1 107.95 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 O-C-N 123.889 0.743 . . . . 1.04 112.115 178.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 1.8 p -113.31 121.78 66.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.991 -0.549 . . . . 1.6599999999999999 109.983 177.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -85.41 155.44 21.28 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.97 0.414 . . . . 0.55000000000000004 110.4 179.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.404 ' OG1' ' HD2' ' A' ' 112' ' ' HIS . 4.4 p -135.85 -171.17 2.79 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.695 -0.684 . . . . 1.05 110.929 -178.306 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -56.37 -42.69 78.28 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.122 -0.49 . . . . 2.1600000000000001 111.672 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.425 ' O ' ' HD3' ' A' ' 16' ' ' LYS . 5.4 t -113.58 -0.38 14.38 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 112.593 0.59 . . . . 1.0900000000000001 112.593 -170.146 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 166.25 -126.86 1.52 Allowed Glycine 0 N--CA 1.436 -1.31 0 C-N-CA 119.198 -1.477 . . . . 0.39000000000000001 113.31 171.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.493 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 7.4 mp -125.79 149.08 48.88 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 114.767 -0.717 . . . . 1.0600000000000001 111.135 -168.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . 0.61 ' HA ' ' O ' ' A' ' 13' ' ' LEU . 78.4 m-70 -144.05 150.08 37.64 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.21 0.529 . . . . 0.25 111.854 178.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.463 HG12 HD13 ' A' ' 44' ' ' LEU . 2.5 pt -132.7 140.7 46.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 107.577 -1.268 . . . . 1.03 107.577 159.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 2.7 mp -130.43 145.17 35.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 C-N-CA 120.813 -0.355 . . . . 1.0600000000000001 110.643 -176.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.429 ' HG2' ' HB2' ' A' ' 11' ' ' ALA . 43.3 pttt -127.74 141.5 51.57 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.725 -0.842 . . . . 1.29 108.725 173.047 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . 0.537 ' HB2' ' CD1' ' A' ' 96' ' ' LEU . 55.1 ttt180 -83.72 129.06 34.95 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.212 0.53 . . . . 2.6800000000000002 111.097 -178.033 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -97.02 -34.51 11.15 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.137 -0.938 . . . . 1.54 110.105 -179.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.882 0 CA-C-O 118.647 -0.692 . . . . 1.1499999999999999 109.958 178.562 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 10.3 tptt . . . . . 0 N--CA 1.45 -0.441 0 CA-C-O 121.703 0.763 . . . . 1.6899999999999999 111.419 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.582 HD22 ' N ' ' A' ' 9' ' ' ARG . 2.1 tt -113.93 157.6 22.2 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 114.25 -1.341 . . . . 1.79 107.898 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.582 ' N ' HD22 ' A' ' 8' ' ' LEU . 63.2 ttt180 -141.0 130.32 23.66 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 109.164 -0.68 . . . . 1.3700000000000001 109.164 173.336 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -147.19 152.5 38.5 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 120.251 -0.58 . . . . 1.0700000000000001 112.15 -178.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -103.97 134.08 47.86 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.311 -0.858 . . . . 1.04 109.019 176.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 29.1 p-80 -135.13 148.05 49.66 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.101 0.477 . . . . 0.34000000000000002 111.851 -172.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.553 HD22 ' N ' ' A' ' 14' ' ' LEU . 5.2 tt -115.0 147.97 39.41 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.518 -0.919 . . . . 1.0600000000000001 108.518 177.457 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.553 ' N ' HD22 ' A' ' 13' ' ' LEU . 18.1 tp -131.65 130.24 41.83 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 110.35 -0.241 . . . . 1.0800000000000001 110.35 -177.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.412 HG21 HD11 ' A' ' 44' ' ' LEU . 56.5 t -119.7 133.63 65.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 109.827 -0.435 . . . . 1.01 109.827 174.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.439 ' CB ' HG22 ' A' ' 32' ' ' THR . 33.4 mmtp -104.96 154.91 19.47 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.066 -0.516 . . . . 1.22 110.503 178.145 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.405 ' HB3' ' HB3' ' A' ' 40' ' ' ALA . 50.4 p90 -149.64 161.62 41.83 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.633 -0.712 . . . . 0.29999999999999999 109.523 -178.057 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.46 ' HB3' ' C ' ' A' ' 33' ' ' ALA . 38.1 p -54.59 110.16 0.6 Allowed 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.147 0.499 . . . . 1.6000000000000001 110.5 177.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 108.84 9.47 26.4 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.918 -0.658 . . . . 0.53000000000000003 112.356 -176.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.491 ' C ' ' H ' ' A' ' 22' ' ' ASN . 42.5 p -88.06 26.69 1.32 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 117.095 0.448 . . . . 1.28 111.81 -175.537 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.424 ' HB2' ' O ' ' A' ' 20' ' ' SER . 83.2 mtt180 72.5 -20.04 0.28 Allowed 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.173 0.589 . . . . 4.1600000000000001 111.459 -178.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.491 ' H ' ' C ' ' A' ' 20' ' ' SER . 7.4 p30 -155.08 107.31 2.28 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-O 121.47 0.653 . . . . 1.77 109.345 171.182 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.428 ' C ' HG21 ' A' ' 32' ' ' THR . 87.5 Cg_endo -81.77 58.81 6.92 Favored 'Trans proline' 0 CA--C 1.534 0.49 0 C-N-CA 122.824 2.35 . . . . 1.71 113.47 -171.289 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.423 ' N ' HG21 ' A' ' 32' ' ' THR . 63.9 t -140.22 121.91 15.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 122.6 0.36 . . . . 1.1599999999999999 110.138 178.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.424 ' HG ' ' CG ' ' A' ' 67' ' ' ASP . 28.3 t -103.06 149.55 24.47 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 109.235 -0.654 . . . . 1.4299999999999999 109.235 179.452 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.554 ' HB2' ' HA ' ' A' ' 67' ' ' ASP . 2.1 mpt_? -77.38 -14.55 59.69 Favored 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 108.443 -0.947 . . . . 3.1200000000000001 108.443 173.089 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.436 ' HG2' ' HD3' ' A' ' 65' ' ' ARG . 1.9 tmm_? -76.41 -35.51 58.54 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 114.575 -1.193 . . . . 2.25 109.558 175.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 44.2 p -97.62 -34.19 11.04 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 121.273 0.558 . . . . 1.1299999999999999 110.595 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 75.37 -10.41 11.43 Favored Glycine 0 N--CA 1.452 -0.269 0 CA-C-N 115.492 -0.776 . . . . 0.81999999999999995 113.032 178.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -115.93 -71.36 0.74 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.886 0.374 . . . . 2.1000000000000001 109.995 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.2 p -152.51 154.83 36.26 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.031 -0.531 . . . . 1.3300000000000001 110.679 179.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.439 HG22 ' CB ' ' A' ' 16' ' ' LYS . 8.8 t -123.01 34.9 5.01 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 122.147 0.975 . . . . 1.02 109.712 175.332 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.46 ' C ' ' HB3' ' A' ' 18' ' ' SER . . . -79.6 -5.57 55.29 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.181 -0.918 . . . . 1.1299999999999999 112.309 -174.392 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -97.68 -25.27 15.16 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.083 0.468 . . . . 2.21 111.159 -179.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.437 HG22 ' HB2' ' A' ' 39' ' ' ASP . 0.3 OUTLIER -93.5 137.68 22.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 116.128 -0.487 . . . . 1.1100000000000001 110.174 -177.074 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 56.8 p -98.17 -178.29 4.0 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.442 -0.577 . . . . 1.2 109.442 -178.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.522 ' O ' HG13 ' A' ' 41' ' ' ILE . 0.2 OUTLIER -66.18 -24.27 66.61 Favored 'General case' 0 C--O 1.219 -0.518 0 C-N-CA 119.291 -0.963 . . . . 2.21 110.013 173.522 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -70.01 -45.7 66.67 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.887 -0.412 . . . . 0.95999999999999996 109.887 175.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.437 ' HB2' HG22 ' A' ' 35' ' ' VAL . 26.3 m-20 -69.01 -30.96 69.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.503 0.668 . . . . 0.91000000000000003 109.758 177.334 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.405 ' HB3' ' HB3' ' A' ' 17' ' ' PHE . . . -73.3 -42.26 62.59 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.139 -0.937 . . . . 1.03 110.863 179.15 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.522 HG13 ' O ' ' A' ' 37' ' ' TYR . 69.4 mt -63.54 -35.89 74.29 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.299 0 N-CA-C 109.494 -0.558 . . . . 1.0800000000000001 109.494 174.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 20.3 ttpt -62.96 -23.62 67.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.363 0.601 . . . . 2.8399999999999999 109.896 178.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.489 ' HG3' ' CD1' ' A' ' 47' ' ' TRP . 2.2 tp10 -87.67 -56.95 3.13 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.09 -0.959 . . . . 1.02 109.378 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.483 HD13 HG12 ' A' ' 113' ' ' ILE . 31.9 tp -59.24 -36.8 76.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.088 -0.96 . . . . 1.02 110.82 -174.213 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.574 ' O ' ' HB2' ' A' ' 49' ' ' GLN . 0.0 OUTLIER -67.07 -29.76 69.63 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 116.159 -0.473 . . . . 0.87 112.25 -177.407 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 44.5 mttp -78.29 -42.76 29.91 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.814 0.34 . . . . 1.98 110.316 178.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.489 ' CD1' ' HG3' ' A' ' 43' ' ' GLU . 49.4 m95 -66.81 -44.45 81.15 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.384 -0.371 . . . . 0.60999999999999999 111.364 178.226 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.445 ' HB3' HG23 ' A' ' 113' ' ' ILE . 88.9 p -64.7 -32.17 73.72 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 110.017 -0.364 . . . . 0.88 110.017 176.245 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.574 ' HB2' ' O ' ' A' ' 45' ' ' GLN . 11.0 tt0 -66.13 -49.81 66.16 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.1 -0.5 . . . . 0.55000000000000004 110.274 177.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.503 ' HB3' HG23 ' A' ' 56' ' ' VAL . 87.9 mtt180 -64.14 -44.49 91.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.755 -0.657 . . . . 0.47999999999999998 111.272 -179.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.413 HG13 ' O ' ' A' ' 47' ' ' TRP . 88.3 mt -59.84 -39.35 79.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.362 -0.381 . . . . 1.04 110.654 177.085 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.27 -36.21 68.94 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.232 -0.44 . . . . 1.0600000000000001 111.863 -179.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 24.6 p -85.19 -30.32 24.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.896 0.379 . . . . 0.34999999999999998 111.474 -177.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 108.91 11.34 22.86 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.62 -0.8 . . . . 0.33000000000000002 112.742 178.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.451 ' OE1' ' HG2' ' A' ' 50' ' ' ARG . 46.9 mt-10 -62.56 -49.51 74.99 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.612 -0.514 . . . . 0.65000000000000002 109.612 175.319 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.503 HG23 ' HB3' ' A' ' 50' ' ' ARG . 14.6 m -132.16 155.28 41.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.591 -0.731 . . . . 1.05 109.359 173.586 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.1 m -83.29 160.43 21.71 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 109.236 -0.653 . . . . 1.3100000000000001 109.236 178.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -54.93 -44.11 73.96 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.619 -0.512 . . . . 0.25 109.619 -179.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.55 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 39.9 mt-10 -59.15 -43.41 92.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.12 -0.945 . . . . 1.72 111.8 -179.178 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 -61.62 -49.05 78.14 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 120.964 0.411 . . . . 2.0899999999999999 110.519 -177.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -67.53 -50.16 59.97 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.926 -0.579 . . . . 1.0700000000000001 110.902 -178.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -58.6 -51.97 67.67 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.573 0.583 . . . . 1.0600000000000001 112.573 -174.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.575 ' HA ' ' O ' ' A' ' 71' ' ' TYR . 23.9 m -51.32 -27.26 9.13 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.736 0.643 . . . . 1.52 112.736 -177.559 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -102.68 -44.67 5.24 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.533 0.683 . . . . 0.60999999999999999 110.654 -178.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.436 ' HD3' ' HG2' ' A' ' 27' ' ' ARG . 25.3 mmt180 -94.6 -35.91 12.02 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 114.2 1.185 . . . . 0.95999999999999996 114.2 -169.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.507 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 33.7 p -66.7 128.13 35.07 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.9 0.381 . . . . 1.0600000000000001 110.797 -177.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.554 ' HA ' ' HB2' ' A' ' 26' ' ' ARG . 40.0 m-20 -90.92 5.54 48.22 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.701 -0.681 . . . . 2.2799999999999998 111.644 -177.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . 0.473 ' O ' ' HD1' ' A' ' 71' ' ' TYR . 36.1 t -88.22 170.0 11.39 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.67 -0.493 . . . . 2.0499999999999998 109.67 174.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -63.56 -19.02 62.06 Favored Glycine 0 N--CA 1.454 -0.142 0 C-N-CA 121.08 -0.581 . . . . 0.29999999999999999 111.962 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 55.3 p -65.93 -6.92 13.94 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 112.532 0.567 . . . . 0.46999999999999997 112.532 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.575 ' O ' ' HA ' ' A' ' 63' ' ' SER . 20.0 p90 -60.68 -23.16 64.62 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.216 0.532 . . . . 0.94999999999999996 109.747 176.171 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -89.28 -1.48 58.08 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.188 -0.46 . . . . 1.1100000000000001 111.055 179.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.5 m -126.17 6.94 7.15 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.91 0.386 . . . . 0.70999999999999996 110.998 -179.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.55 ' O ' ' HA ' ' A' ' 59' ' ' GLU . . . 73.37 30.39 62.59 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.634 -0.793 . . . . 0.67000000000000004 112.195 -177.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 85.45 -22.21 11.3 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 121.12 -0.562 . . . . 0.42999999999999999 111.801 -179.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -64.32 134.67 55.13 Favored 'General case' 0 CA--C 1.508 -0.663 0 CA-C-N 115.203 -0.498 . . . . 1.6499999999999999 111.49 -176.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.6 mp -117.52 158.18 25.0 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 115.685 -0.689 . . . . 1.6899999999999999 109.334 169.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -78.63 -150.05 4.83 Favored Glycine 0 C--N 1.308 -0.977 0 CA-C-N 115.023 -0.989 . . . . 0.45000000000000001 112.72 -179.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -88.52 144.82 26.1 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.203 0.525 . . . . 4.7400000000000002 111.697 -178.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -158.3 153.63 25.82 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.123 -0.944 . . . . 1.6499999999999999 108.803 -177.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 29.3 m -82.39 133.64 35.22 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.115 -0.698 . . . . 1.6899999999999999 109.115 178.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 4.5 p -49.98 121.14 5.02 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.997 -0.547 . . . . 1.55 111.514 -178.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 114.49 -17.18 18.86 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.847 -0.692 . . . . 0.79000000000000004 112.938 -178.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 65.6 mt-10 -83.55 46.71 1.18 Allowed 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 117.092 0.446 . . . . 1.5800000000000001 111.486 -176.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 25.7 mmt -137.68 -122.59 0.14 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.053 0.454 . . . . 1.1299999999999999 110.482 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 54.9 mtt -125.34 149.59 47.97 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.163 -1.051 . . . . 1.8899999999999999 108.163 176.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 16.3 tppt? -54.12 -52.76 65.71 Favored Pre-proline 0 C--N 1.32 -0.715 0 N-CA-C 112.423 0.527 . . . . 2.7400000000000002 112.423 -174.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.406 ' HG2' HG23 ' A' ' 107' ' ' THR . 74.0 Cg_endo -75.42 -23.62 12.95 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 121.336 1.357 . . . . 0.29999999999999999 112.136 -176.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.57 ' O ' HG22 ' A' ' 93' ' ' VAL . 45.3 t80 -74.34 -55.39 6.06 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.396 -0.82 . . . . 0.28000000000000003 109.868 179.354 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -64.75 -34.33 78.07 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.614 -0.721 . . . . 2.1200000000000001 110.087 -178.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.489 ' HA ' ' NE ' ' A' ' 94' ' ' ARG . 19.2 t70 -53.44 -35.94 61.03 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.929 -0.578 . . . . 0.60999999999999999 110.753 175.13 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.482 ' O ' ' HG ' ' A' ' 96' ' ' LEU . . . -80.4 -36.19 34.15 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.341 -0.391 . . . . 1.1000000000000001 110.957 178.511 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.57 HG22 ' O ' ' A' ' 89' ' ' PHE . 15.4 t -64.27 -41.67 93.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.275 0.559 . . . . 1.1200000000000001 110.693 -177.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.489 ' NE ' ' HA ' ' A' ' 91' ' ' ASP . 36.4 ptt180 -76.1 -12.21 60.07 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.833 -0.621 . . . . 3.1800000000000002 110.449 178.194 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -97.32 21.16 10.42 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.085 -0.507 . . . . 1.0800000000000001 111.314 -174.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.498 ' HB2' ' HB2' ' A' ' 100' ' ' ASP . 0.4 OUTLIER -152.32 156.35 39.44 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.86 -0.609 . . . . 1.1200000000000001 110.604 175.074 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.486 ' HG3' ' H ' ' A' ' 98' ' ' ILE . 50.8 tptt -99.01 175.92 5.75 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.502 -0.772 . . . . 2.1299999999999999 108.96 179.603 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.486 ' H ' ' HG3' ' A' ' 97' ' ' LYS . 67.3 mt -57.19 117.66 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 120.887 0.375 . . . . 1.6200000000000001 110.752 178.184 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 96.37 9.09 57.1 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.821 -0.704 . . . . 0.46000000000000002 112.748 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.498 ' HB2' ' HB2' ' A' ' 96' ' ' LEU . 21.7 m-20 -110.83 141.62 43.95 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 110.001 -0.37 . . . . 0.46000000000000002 110.001 176.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 12.3 mt -111.8 149.94 14.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.212 -0.449 . . . . 1.0800000000000001 110.002 -177.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 99.6 p -95.04 143.36 25.97 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 116.619 -0.264 . . . . 1.45 110.525 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -66.65 164.79 27.7 Favored 'Trans proline' 0 N--CA 1.461 -0.41 0 C-N-CA 122.319 2.013 . . . . 0.40999999999999998 110.93 171.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.432 HG23 HD22 ' A' ' 44' ' ' LEU . 20.2 mm -39.48 113.34 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 O-C-N 123.817 0.698 . . . . 1.04 112.571 -179.08 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 1.8 p -121.37 121.62 65.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.949 -0.568 . . . . 1.6599999999999999 110.121 175.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . 0.43 ' HG2' ' CD1' ' A' ' 111' ' ' LEU . 49.2 mt-30 -85.09 156.58 21.01 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.059 0.457 . . . . 0.55000000000000004 110.394 178.428 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.406 HG23 ' HG2' ' A' ' 88' ' ' PRO . 3.0 p -130.24 -172.49 2.8 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.684 -0.689 . . . . 1.05 110.212 179.042 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -60.96 -36.36 79.18 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.574 0.226 . . . . 2.1600000000000001 110.693 177.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.432 ' OG ' ' HE2' ' A' ' 16' ' ' LYS . 23.3 t -91.51 -61.37 1.66 Allowed 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 120.89 -0.324 . . . . 1.0900000000000001 110.657 -178.554 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -150.67 -130.93 1.78 Allowed Glycine 0 N--CA 1.442 -0.901 0 C-N-CA 119.287 -1.435 . . . . 0.39000000000000001 113.635 -174.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.463 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 7.4 mp -116.48 148.7 40.52 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.332 -0.434 . . . . 1.0600000000000001 111.392 -171.511 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . 0.51 ' HA ' ' O ' ' A' ' 13' ' ' LEU . 86.4 m-70 -144.09 151.88 40.2 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.267 0.556 . . . . 0.25 112.398 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.483 HG12 HD13 ' A' ' 44' ' ' LEU . 3.4 pt -133.21 136.26 55.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 107.484 -1.302 . . . . 1.03 107.484 159.273 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 2.8 mp -127.48 144.3 37.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 C-N-CA 120.753 -0.379 . . . . 1.0600000000000001 110.478 -176.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 41.3 pttt -125.76 140.81 52.37 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.773 -0.825 . . . . 1.29 108.773 172.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . 0.47 ' HB2' ' CD1' ' A' ' 96' ' ' LEU . 59.2 ttt180 -87.36 134.47 33.57 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.072 0.463 . . . . 2.6800000000000002 111.384 -177.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 6.7 mp -112.1 -24.06 10.1 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.568 -0.742 . . . . 1.54 111.187 -178.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.243 0.744 0 CA-C-O 118.019 -0.991 . . . . 1.1499999999999999 109.697 176.62 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 10.9 tptt . . . . . 0 N--CA 1.452 -0.346 0 CA-C-O 121.297 0.57 . . . . 1.6899999999999999 109.91 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.534 HD23 ' H ' ' A' ' 9' ' ' ARG . 0.3 OUTLIER -128.21 168.51 15.34 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 114.962 -1.017 . . . . 1.79 109.808 -171.807 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.534 ' H ' HD23 ' A' ' 8' ' ' LEU . 70.1 ttt180 -145.64 125.03 13.07 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.064 -0.717 . . . . 1.3700000000000001 109.064 174.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.52 ' N ' ' HZ ' ' A' ' 80' ' ' PHE . . . -145.93 160.57 41.64 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.353 -0.539 . . . . 1.0700000000000001 112.003 -177.726 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.551 ' HA ' ' HA ' ' A' ' 76' ' ' ASP . . . -106.65 131.66 53.53 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.282 -0.872 . . . . 1.04 109.573 178.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 22.5 p-80 -133.54 140.1 46.99 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.995 0.426 . . . . 0.34000000000000002 111.115 -173.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.68 ' O ' ' HA ' ' A' ' 112' ' ' HIS . 5.9 tt -113.24 137.54 51.32 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.852 -0.796 . . . . 1.0600000000000001 108.852 179.195 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.602 ' HA ' ' O ' ' A' ' 111' ' ' LEU . 23.2 tp -120.8 122.43 40.3 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.892 0.377 . . . . 1.0800000000000001 111.364 -178.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.46 HG21 HD12 ' A' ' 44' ' ' LEU . 57.7 t -108.04 137.69 38.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 109.059 -0.719 . . . . 1.01 109.059 171.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.602 ' HE2' ' OG ' ' A' ' 109' ' ' SER . 28.6 mmtp -105.22 164.33 11.91 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.806 -0.442 . . . . 1.22 109.806 178.616 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 42.9 p90 -155.55 160.57 40.62 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.418 -0.586 . . . . 0.29999999999999999 109.418 -177.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.428 ' HB3' ' C ' ' A' ' 33' ' ' ALA . 54.2 p -58.09 110.3 0.91 Allowed 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.483 -0.326 . . . . 1.6000000000000001 110.557 178.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 105.51 10.16 31.8 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.475 -0.869 . . . . 0.53000000000000003 113.15 -178.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.518 ' C ' ' H ' ' A' ' 22' ' ' ASN . 49.8 p -77.44 37.21 0.21 Allowed 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 117.639 0.719 . . . . 1.28 112.11 -174.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 60.6 ttt180 68.31 -36.17 0.31 Allowed 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.621 0.769 . . . . 4.1600000000000001 111.065 -176.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.518 ' H ' ' C ' ' A' ' 20' ' ' SER . 8.6 p30 -154.68 119.01 2.58 Favored Pre-proline 0 C--N 1.319 -0.731 0 N-CA-C 107.757 -1.201 . . . . 1.77 107.757 171.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -81.99 -151.72 0.04 OUTLIER 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 122.528 2.152 . . . . 1.71 111.885 -174.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.576 ' N ' HG23 ' A' ' 32' ' ' THR . 48.0 t 64.06 111.17 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 123.329 0.652 . . . . 1.1599999999999999 111.588 -175.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.473 ' HB3' ' HB2' ' A' ' 16' ' ' LYS . 35.7 p -103.93 152.92 21.4 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.377 -0.374 . . . . 1.4299999999999999 110.115 177.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.561 ' HG2' ' HA ' ' A' ' 67' ' ' ASP . 3.8 mmp_? -65.34 -12.01 47.68 Favored 'General case' 0 N--CA 1.462 0.159 0 N-CA-C 109.522 -0.547 . . . . 3.1200000000000001 109.522 172.256 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.534 ' HG3' ' CD ' ' A' ' 65' ' ' ARG . 31.5 ttp180 -67.79 -55.82 11.57 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.377 -0.828 . . . . 2.25 110.01 177.115 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 31.8 p -87.83 -34.11 18.35 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 121.446 0.641 . . . . 1.1299999999999999 110.63 -176.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 70.12 16.89 73.37 Favored Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 115.292 -0.867 . . . . 0.81999999999999995 111.962 -179.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -144.79 -68.41 0.31 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.582 0.229 . . . . 2.1000000000000001 110.548 -178.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.8 p -150.14 147.19 27.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.967 0.413 . . . . 1.3300000000000001 111.61 179.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.576 HG23 ' N ' ' A' ' 24' ' ' VAL . 9.6 t -127.51 16.16 7.06 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.67 0.748 . . . . 1.02 109.943 174.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.428 ' C ' ' HB3' ' A' ' 18' ' ' SER . . . -67.77 -4.34 12.16 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.126 -0.943 . . . . 1.1299999999999999 112.973 -178.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -95.07 -25.5 16.43 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.091 0.472 . . . . 2.21 110.968 -179.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.471 HG22 ' HB2' ' A' ' 39' ' ' ASP . 0.2 OUTLIER -95.6 135.06 30.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.097 -0.501 . . . . 1.1100000000000001 110.277 -178.364 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 63.4 p -93.36 178.22 5.79 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 109.548 -0.538 . . . . 1.2 109.548 -176.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.492 ' O ' HG13 ' A' ' 41' ' ' ILE . 0.1 OUTLIER -67.05 -22.25 65.87 Favored 'General case' 0 C--O 1.22 -0.463 0 C-N-CA 118.809 -1.156 . . . . 2.21 110.12 174.045 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -71.86 -46.97 56.1 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.975 -0.38 . . . . 0.95999999999999996 109.975 175.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.471 ' HB2' HG22 ' A' ' 35' ' ' VAL . 24.9 m-20 -64.19 -35.72 81.71 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.612 0.72 . . . . 0.91000000000000003 109.636 175.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.83 -47.4 66.12 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.888 -1.051 . . . . 1.03 110.788 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.492 HG13 ' O ' ' A' ' 37' ' ' TYR . 60.9 mt -63.02 -35.47 71.75 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.388 0 N-CA-C 110.001 -0.37 . . . . 1.0800000000000001 110.001 176.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.468 ' O ' ' HG3' ' A' ' 46' ' ' LYS . 27.8 ttpt -61.63 -28.69 69.55 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 121.3 0.572 . . . . 2.8399999999999999 109.695 179.424 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -88.6 -48.48 7.53 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.392 -0.822 . . . . 1.02 110.352 -177.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.463 HD11 HG12 ' A' ' 113' ' ' ILE . 29.3 tp -59.57 -36.99 77.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.002 -0.545 . . . . 1.02 110.366 -178.529 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.453 HE21 ' HA ' ' A' ' 45' ' ' GLN . 0.0 OUTLIER -67.97 -21.48 65.07 Favored 'General case' 0 N--CA 1.462 0.134 0 N-CA-C 112.114 0.413 . . . . 0.87 112.114 -179.042 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.468 ' HG3' ' O ' ' A' ' 42' ' ' LYS . 67.8 mttm -82.97 -44.62 15.08 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.929 -0.397 . . . . 1.98 109.929 177.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 43.2 m95 -65.63 -45.38 83.25 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.299 -0.409 . . . . 0.60999999999999999 111.181 177.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.441 ' HB3' HG21 ' A' ' 113' ' ' ILE . 97.1 p -65.24 -20.4 66.41 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.885 -0.413 . . . . 0.88 109.885 178.191 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -76.34 -56.6 4.49 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 109.541 -0.54 . . . . 0.55000000000000004 109.541 173.693 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.507 ' HB3' HG22 ' A' ' 56' ' ' VAL . 92.5 mtt180 -59.88 -43.09 94.93 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.724 -0.671 . . . . 0.47999999999999998 111.808 -176.443 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.46 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 95.3 mt -60.46 -33.64 55.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 120.985 0.421 . . . . 1.04 110.57 177.279 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -81.42 -38.75 25.99 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.102 -0.499 . . . . 1.0600000000000001 111.317 -179.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 26.7 p -75.99 -29.56 58.25 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.002 0.429 . . . . 0.34999999999999998 111.135 -178.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 106.33 6.54 36.09 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.869 -0.682 . . . . 0.33000000000000002 111.962 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.454 ' HB2' ' HB3' ' A' ' 50' ' ' ARG . 43.2 mt-10 -63.44 -45.65 89.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.809 0.338 . . . . 0.65000000000000002 110.376 178.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.507 HG22 ' HB3' ' A' ' 50' ' ' ARG . 12.7 m -136.73 155.9 34.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 109.562 -0.533 . . . . 1.05 109.562 172.548 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 13.0 m -83.28 159.61 21.88 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.431 -0.581 . . . . 1.3100000000000001 109.431 178.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -56.23 -40.68 74.47 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.544 -0.539 . . . . 0.25 109.544 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -52.12 -50.15 62.25 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.342 -0.844 . . . . 1.72 111.493 178.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -62.18 -46.76 87.52 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.852 -0.613 . . . . 2.0899999999999999 111.392 -173.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -71.1 -40.86 71.26 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.79 0.329 . . . . 1.0700000000000001 111.066 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -64.64 -45.92 84.75 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.445 -0.343 . . . . 1.0600000000000001 111.777 -176.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.48 ' HA ' ' O ' ' A' ' 71' ' ' TYR . 41.9 t -56.63 -27.43 58.35 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 112.658 0.614 . . . . 1.52 112.658 -177.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.471 ' O ' ' HA ' ' A' ' 27' ' ' ARG . 36.4 mt-30 -104.92 -48.58 3.71 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.378 0.609 . . . . 0.60999999999999999 110.632 -176.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.534 ' CD ' ' HG3' ' A' ' 27' ' ' ARG . 21.5 mmt180 -88.66 -41.75 12.43 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.134 -0.939 . . . . 0.95999999999999996 113.174 -169.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.5 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 22.8 t -60.62 122.25 14.23 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.701 0.286 . . . . 1.0600000000000001 111.189 -177.561 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.561 ' HA ' ' HG2' ' A' ' 26' ' ' ARG . 31.6 t70 -80.18 -7.61 59.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.382 0.61 . . . . 2.2799999999999998 110.639 176.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . 0.492 ' SG ' ' HE1' ' A' ' 112' ' ' HIS . 1.5 m -76.83 160.71 29.03 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.293 0.568 . . . . 2.0499999999999998 110.082 177.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -67.77 -11.53 60.53 Favored Glycine 0 N--CA 1.45 -0.423 0 CA-C-N 114.785 -1.098 . . . . 0.29999999999999999 112.554 -172.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 76.5 p -75.01 -5.69 45.38 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 111.518 0.192 . . . . 0.46999999999999997 111.518 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.48 ' O ' ' HA ' ' A' ' 63' ' ' SER . 16.8 p90 -54.91 -37.86 66.9 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.156 0.503 . . . . 0.94999999999999996 110.027 175.143 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -95.37 7.54 45.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.146 -0.479 . . . . 1.1100000000000001 110.591 -178.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.9 m -113.54 -14.82 12.64 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.959 -0.564 . . . . 0.70999999999999996 110.998 -177.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 103.5 14.39 25.78 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.775 -0.726 . . . . 0.67000000000000004 112.235 -177.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 88.49 -31.18 4.96 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.995 -0.621 . . . . 0.42999999999999999 112.428 179.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.551 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 8.5 p-10 -85.06 144.61 28.14 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-O 121.579 0.704 . . . . 1.6499999999999999 111.099 -176.217 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.524 ' O ' ' HG3' ' A' ' 9' ' ' ARG . 0.7 OUTLIER -106.4 176.98 4.99 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 114.631 -1.168 . . . . 1.6899999999999999 109.979 177.54 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -90.42 -125.4 3.02 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.928 -0.653 . . . . 0.45000000000000001 113.006 -176.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 34.3 p90 -98.3 136.32 38.64 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.128 0.489 . . . . 4.7400000000000002 110.96 -177.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.52 ' HZ ' ' N ' ' A' ' 10' ' ' ALA . 5.9 p90 -159.44 144.83 15.8 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.053 -0.721 . . . . 1.6499999999999999 109.053 179.09 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.0 p -94.02 154.51 17.61 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 120.994 0.426 . . . . 1.6899999999999999 110.497 -177.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 15.2 m -64.85 111.43 2.81 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.951 -0.568 . . . . 1.55 110.117 179.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.563 ' H ' ' HG3' ' A' ' 90' ' ' GLU . . . 113.46 5.18 22.96 Favored Glycine 0 N--CA 1.447 -0.578 0 CA-C-N 115.601 -0.727 . . . . 0.79000000000000004 111.454 -174.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -111.77 32.84 5.15 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 121.493 0.664 . . . . 1.5800000000000001 110.366 -177.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 22.1 mmt -137.41 -122.02 0.14 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.068 -0.515 . . . . 1.1299999999999999 110.277 179.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 63.8 mtt -121.1 155.1 35.18 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.293 -1.002 . . . . 1.8899999999999999 108.293 174.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.421 ' HB2' ' HD3' ' A' ' 88' ' ' PRO . 29.9 mmmt -53.15 -58.11 13.77 Favored Pre-proline 0 C--N 1.322 -0.598 0 N-CA-C 112.393 0.516 . . . . 2.7400000000000002 112.393 -177.396 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.421 ' HD3' ' HB2' ' A' ' 87' ' ' LYS . 77.1 Cg_endo -75.61 -23.7 12.58 Favored 'Trans proline' 0 C--N 1.354 0.838 0 C-N-CA 121.516 1.477 . . . . 0.29999999999999999 111.931 -175.47 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.608 ' O ' HG21 ' A' ' 93' ' ' VAL . 52.7 t80 -71.64 -56.15 6.38 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.472 -0.786 . . . . 0.28000000000000003 109.762 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.563 ' HG3' ' H ' ' A' ' 83' ' ' GLY . 4.6 tm-20 -67.08 -37.19 83.55 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.647 -0.706 . . . . 2.1200000000000001 110.192 -179.026 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -51.98 -36.01 48.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.687 -0.688 . . . . 0.60999999999999999 110.491 174.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.513 ' O ' ' HG ' ' A' ' 96' ' ' LEU . . . -79.63 -32.95 41.78 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.998 -0.546 . . . . 1.1000000000000001 111.419 178.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.608 HG21 ' O ' ' A' ' 89' ' ' PHE . 25.9 t -67.4 -39.74 83.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.564 0.697 . . . . 1.1200000000000001 110.121 -176.247 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.452 ' C ' ' HD2' ' A' ' 94' ' ' ARG . 0.2 OUTLIER -84.04 -8.0 59.24 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.421 -0.809 . . . . 3.1800000000000002 110.841 179.644 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -88.35 0.77 55.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.296 -0.411 . . . . 1.0800000000000001 111.067 -177.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.545 ' HB2' ' HB2' ' A' ' 100' ' ' ASP . 0.6 OUTLIER -139.36 157.29 46.13 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.1 -0.5 . . . . 1.1200000000000001 110.625 179.446 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.571 ' HG2' ' H ' ' A' ' 98' ' ' ILE . 10.7 tttt -102.53 -175.0 2.7 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.161 -0.681 . . . . 2.1299999999999999 109.161 176.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.571 ' H ' ' HG2' ' A' ' 97' ' ' LYS . 1.3 mp -54.67 120.34 2.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 C-N-CA 123.087 0.555 . . . . 1.6200000000000001 110.584 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 93.18 1.21 67.13 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.812 -0.709 . . . . 0.46000000000000002 113.078 176.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.545 ' HB2' ' HB2' ' A' ' 96' ' ' LEU . 33.4 m-20 -102.17 139.63 37.53 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 117.006 0.403 . . . . 0.46000000000000002 110.411 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 11.9 mt -111.3 148.92 14.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.01 -0.541 . . . . 1.0800000000000001 110.239 -178.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 97.7 p -93.3 158.67 36.71 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 116.404 -0.362 . . . . 1.45 110.725 -178.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -71.42 170.0 19.49 Favored 'Trans proline' 0 C--O 1.234 0.285 0 C-N-CA 122.475 2.117 . . . . 0.40999999999999998 111.518 172.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 19.5 mm -47.33 112.12 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 O-C-N 123.399 0.437 . . . . 1.04 111.911 175.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 58.9 t -116.75 122.65 70.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.155 -0.475 . . . . 1.6599999999999999 110.201 176.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -85.78 149.35 25.33 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.032 0.444 . . . . 0.55000000000000004 110.102 176.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 8.1 p -127.77 -172.24 2.63 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.797 -0.638 . . . . 1.05 111.018 -177.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -52.26 -40.75 62.13 Favored 'General case' 0 CA--C 1.518 -0.277 0 O-C-N 123.418 0.449 . . . . 2.1600000000000001 111.276 176.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.602 ' OG ' ' HE2' ' A' ' 16' ' ' LYS . 8.8 t -100.3 -60.53 1.51 Allowed 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 120.196 -0.601 . . . . 1.0900000000000001 111.323 -178.324 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -146.03 -137.13 3.02 Favored Glycine 0 N--CA 1.44 -1.034 0 C-N-CA 118.673 -1.727 . . . . 0.39000000000000001 113.733 -172.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.602 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 6.9 mp -109.65 143.16 39.79 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 114.87 -0.665 . . . . 1.0600000000000001 111.164 -170.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . 0.68 ' HA ' ' O ' ' A' ' 13' ' ' LEU . 85.6 m-70 -143.21 138.49 29.72 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.6 0.593 . . . . 0.25 112.6 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.463 HG12 HD11 ' A' ' 44' ' ' LEU . 3.9 pt -120.96 138.86 50.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 107.753 -1.203 . . . . 1.03 107.753 161.068 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 2.9 mp -129.43 143.09 42.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 C-N-CA 120.807 -0.357 . . . . 1.0600000000000001 110.48 -175.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.48 ' HG2' ' HB3' ' A' ' 11' ' ' ALA . 48.8 pttt -127.51 138.57 52.96 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.187 -0.671 . . . . 1.29 109.187 173.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . 0.485 ' HB2' ' CD1' ' A' ' 96' ' ' LEU . 70.4 ttt180 -84.22 128.38 34.53 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.051 0.453 . . . . 2.6800000000000002 111.545 -175.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.401 HD21 ' HB1' ' A' ' 11' ' ' ALA . 1.2 mm? -95.12 -45.46 7.2 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.613 -0.721 . . . . 1.54 109.999 176.57 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.892 0 CA-C-O 118.58 -0.724 . . . . 1.1499999999999999 110.379 -179.97 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 43.2 mmtm . . . . . 0 N--CA 1.453 -0.292 0 CA-C-O 121.343 0.592 . . . . 1.6899999999999999 111.305 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.527 HD22 ' H ' ' A' ' 9' ' ' ARG . 1.3 tt -124.8 165.82 17.32 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 107.413 -1.329 . . . . 1.79 107.413 178.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.527 ' H ' HD22 ' A' ' 8' ' ' LEU . 65.9 ttt180 -143.78 127.68 17.35 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 118.11 0.414 . . . . 1.3700000000000001 110.097 177.21 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -150.11 151.5 33.26 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.03 0.443 . . . . 1.0700000000000001 111.772 -179.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.408 ' N ' HD22 ' A' ' 117' ' ' LEU . . . -102.0 138.04 39.49 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.64 -0.709 . . . . 1.04 109.114 176.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 33.5 p-80 -138.08 153.34 49.31 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 120.564 -0.454 . . . . 0.34000000000000002 111.842 -171.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.559 HD21 ' N ' ' A' ' 14' ' ' LEU . 5.2 tt -120.69 145.44 47.46 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.508 -0.923 . . . . 1.0600000000000001 108.508 176.116 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.585 ' O ' ' HA ' ' A' ' 66' ' ' SER . 31.2 tp -131.0 118.2 20.27 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.59 0.233 . . . . 1.0800000000000001 110.962 -177.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.455 HG23 HD13 ' A' ' 44' ' ' LEU . 58.5 t -104.72 133.17 49.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 N-CA-C 109.607 -0.516 . . . . 1.01 109.607 176.182 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.455 ' HE3' HD23 ' A' ' 14' ' ' LEU . 32.2 mmtp -105.53 138.26 42.01 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.998 -0.547 . . . . 1.22 109.881 177.496 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.516 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 40.0 p90 -131.1 163.28 28.0 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.845 -0.616 . . . . 0.29999999999999999 109.344 178.46 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 43.8 p -53.16 109.5 0.43 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.109 0.481 . . . . 1.6000000000000001 110.269 176.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 108.07 7.94 30.23 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.637 -0.792 . . . . 0.53000000000000003 113.132 -177.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.748 ' HB3' ' O ' ' A' ' 109' ' ' SER . 74.5 m -84.46 38.76 0.7 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 117.042 0.421 . . . . 1.28 111.749 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 32.3 ttt85 72.86 -34.0 0.28 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.306 0.643 . . . . 4.1600000000000001 110.944 179.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.473 ' H ' ' C ' ' A' ' 20' ' ' SER . 6.3 p30 -145.08 111.51 4.75 Favored Pre-proline 0 C--N 1.325 -0.482 0 N-CA-C 109.175 -0.676 . . . . 1.77 109.175 171.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.441 ' C ' HG22 ' A' ' 32' ' ' THR . 91.8 Cg_endo -82.62 59.8 7.0 Favored 'Trans proline' 0 CA--C 1.533 0.467 0 C-N-CA 122.92 2.413 . . . . 1.71 113.889 -173.19 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.437 ' N ' HG22 ' A' ' 32' ' ' THR . 43.9 t -145.99 120.81 2.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 109.385 -0.598 . . . . 1.1599999999999999 109.385 175.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 37.7 t -104.73 152.19 22.83 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 110.299 -0.26 . . . . 1.4299999999999999 110.299 178.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.57 ' HG2' ' HA ' ' A' ' 67' ' ' ASP . 5.5 mmp_? -67.72 -9.81 47.04 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.275 0.559 . . . . 3.1200000000000001 109.764 171.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.548 ' HG3' ' CD ' ' A' ' 65' ' ' ARG . 13.8 ttp180 -76.36 -35.86 58.49 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.369 -0.832 . . . . 2.25 109.78 177.618 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 64.1 p -105.07 -35.44 7.63 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.896 -0.593 . . . . 1.1299999999999999 111.048 -175.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 84.75 -39.49 2.95 Favored Glycine 0 N--CA 1.451 -0.343 0 CA-C-N 115.683 -0.69 . . . . 0.81999999999999995 112.817 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.449 ' CG ' ' H ' ' A' ' 31' ' ' SER . 8.7 p-10 -91.72 -65.59 1.0 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.747 0.273 . . . . 2.1000000000000001 110.874 -178.032 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.449 ' H ' ' CG ' ' A' ' 30' ' ' ASP . 11.6 p -155.53 157.79 37.43 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.618 0.247 . . . . 1.3300000000000001 110.465 178.702 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.441 HG22 ' C ' ' A' ' 23' ' ' PRO . 13.4 t -121.76 34.44 5.18 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 122.308 1.051 . . . . 1.02 109.148 173.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -79.31 -5.99 55.71 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.853 -1.067 . . . . 1.1299999999999999 112.146 -173.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -98.1 -24.92 15.11 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.887 0.375 . . . . 2.21 111.156 -178.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.433 HG11 ' OG1' ' A' ' 32' ' ' THR . 0.3 OUTLIER -91.43 135.73 26.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 120.975 0.417 . . . . 1.1100000000000001 109.916 -178.795 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 65.7 p -94.5 179.03 5.41 Favored 'General case' 0 CA--C 1.513 -0.476 0 N-CA-C 109.583 -0.525 . . . . 1.2 109.583 -175.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.552 ' O ' HG13 ' A' ' 41' ' ' ILE . 8.1 p90 -64.82 -26.26 68.26 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 119.803 -0.759 . . . . 2.21 109.31 176.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -74.83 -44.35 49.73 Favored 'General case' 0 C--N 1.334 -0.087 0 CA-C-N 116.205 -0.452 . . . . 0.95999999999999996 110.629 177.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.422 ' HB2' HG22 ' A' ' 35' ' ' VAL . 45.7 m-20 -64.68 -32.64 74.4 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.642 0.734 . . . . 0.91000000000000003 109.435 177.001 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.516 ' HB2' ' HB3' ' A' ' 17' ' ' PHE . . . -71.07 -38.6 72.45 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.77 -1.104 . . . . 1.03 110.645 178.362 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.552 HG13 ' O ' ' A' ' 37' ' ' TYR . 77.2 mt -65.09 -36.83 78.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.486 -0.561 . . . . 1.0800000000000001 109.486 173.213 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.466 ' HB3' ' HZ1' ' A' ' 42' ' ' LYS . 9.2 mtpm? -65.53 -17.78 64.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.249 0.547 . . . . 2.8399999999999999 110.774 176.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.521 ' HG3' ' CD1' ' A' ' 47' ' ' TRP . 3.8 tp10 -87.69 -61.22 1.77 Allowed 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.978 -0.749 . . . . 1.02 108.978 175.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.473 HD12 HG12 ' A' ' 113' ' ' ILE . 20.9 tp -58.95 -38.12 78.3 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 114.84 -1.073 . . . . 1.02 111.572 -173.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.532 ' HB2' ' O ' ' A' ' 41' ' ' ILE . 3.8 mm-40 -68.8 -29.7 68.12 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 112.276 0.473 . . . . 0.87 112.276 -177.048 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 64.4 mttm -81.58 -38.44 26.1 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 120.501 -0.48 . . . . 1.98 110.223 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.521 ' CD1' ' HG3' ' A' ' 43' ' ' GLU . 35.4 m95 -67.48 -46.54 72.68 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.198 -0.455 . . . . 0.60999999999999999 111.536 175.462 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.477 ' HB3' HG23 ' A' ' 113' ' ' ILE . 94.3 p -63.77 -30.06 71.2 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.848 -0.427 . . . . 0.88 109.848 177.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.427 ' HB2' ' O ' ' A' ' 45' ' ' GLN . 11.9 tt0 -65.29 -53.55 42.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.907 -0.588 . . . . 0.55000000000000004 110.529 174.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.5 ' HB3' HG22 ' A' ' 56' ' ' VAL . 99.4 mtt180 -66.04 -39.49 90.2 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.04 -0.527 . . . . 0.47999999999999998 111.769 -176.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.46 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 99.3 mt -62.45 -34.31 63.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.207 0.527 . . . . 1.04 110.236 176.001 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -77.65 -34.98 52.95 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.891 -0.595 . . . . 1.0600000000000001 111.55 179.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.412 ' OG ' ' HA ' ' A' ' 50' ' ' ARG . 33.1 p -82.04 -29.28 32.01 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.963 0.411 . . . . 0.34999999999999998 111.067 -179.053 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 103.65 9.28 38.33 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 121.027 -0.606 . . . . 0.33000000000000002 112.112 179.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -65.13 -45.14 86.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.158 0.504 . . . . 0.65000000000000002 110.019 177.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.5 HG22 ' HB3' ' A' ' 50' ' ' ARG . 11.3 m -135.02 154.78 36.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 109.141 -0.689 . . . . 1.05 109.141 171.115 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 26.1 m -88.2 160.95 17.5 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.676 -0.491 . . . . 1.3100000000000001 109.676 179.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -53.18 -44.69 68.09 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.125 0.488 . . . . 0.25 110.12 -178.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.648 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 44.1 mt-10 -59.32 -32.45 70.08 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.286 -0.87 . . . . 1.72 112.328 -178.293 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -72.95 -51.74 17.26 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.822 0.344 . . . . 2.0899999999999999 110.921 -177.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -65.76 -42.69 90.58 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.216 -0.447 . . . . 1.0700000000000001 111.029 -178.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.8 -53.38 58.65 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.182 -0.463 . . . . 1.0600000000000001 112.079 -175.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.443 ' HA ' ' O ' ' A' ' 71' ' ' TYR . 23.8 t -53.47 -25.49 16.5 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.665 0.617 . . . . 1.52 112.665 -175.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -102.9 -43.01 5.65 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.406 0.622 . . . . 0.60999999999999999 110.567 -176.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.548 ' CD ' ' HG3' ' A' ' 27' ' ' ARG . 17.3 mmt180 -93.72 -42.36 9.19 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 113.858 1.058 . . . . 0.95999999999999996 113.858 -171.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.585 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 54.6 p -65.92 129.84 41.18 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.625 -0.43 . . . . 1.0600000000000001 110.884 -176.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.57 ' HA ' ' HG2' ' A' ' 26' ' ' ARG . 30.1 t70 -85.18 -12.08 53.52 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.294 0.568 . . . . 2.2799999999999998 111.453 179.59 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . 0.458 ' O ' ' HD1' ' A' ' 71' ' ' TYR . 51.2 t -76.18 157.86 32.27 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.459 -0.571 . . . . 2.0499999999999998 109.459 179.413 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -56.89 -17.02 20.33 Favored Glycine 0 C--N 1.33 0.228 0 CA-C-N 115.189 -0.914 . . . . 0.29999999999999999 113.09 -174.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.409 ' HB2' ' HA2' ' A' ' 75' ' ' GLY . 57.3 p -63.21 -12.88 31.64 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 111.885 0.328 . . . . 0.46999999999999997 111.885 176.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.458 ' HD1' ' O ' ' A' ' 68' ' ' CYS . 27.3 p90 -57.84 -28.77 64.4 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.996 0.427 . . . . 0.94999999999999996 110.198 176.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -88.84 -1.75 58.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.307 0.575 . . . . 1.1100000000000001 110.365 -178.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 5.3 m -125.38 8.17 7.78 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.554 -0.748 . . . . 0.70999999999999996 110.562 -177.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.648 ' O ' ' HA ' ' A' ' 59' ' ' GLU . . . 73.05 29.72 64.3 Favored Glycine 0 CA--C 1.52 0.371 0 CA-C-N 116.041 -0.527 . . . . 0.67000000000000004 113.118 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.409 ' HA2' ' HB2' ' A' ' 70' ' ' SER . . . 81.22 -21.16 6.16 Favored Glycine 0 C--O 1.233 0.088 0 C-N-CA 120.94 -0.648 . . . . 0.42999999999999999 112.236 178.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -71.01 132.15 44.72 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 122.853 0.461 . . . . 1.6499999999999999 110.772 -175.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.401 HD21 ' HE2' ' A' ' 85' ' ' MET . 3.5 mp -116.02 158.98 22.29 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 121.26 0.552 . . . . 1.6899999999999999 109.885 173.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -86.1 -148.36 11.54 Favored Glycine 0 C--N 1.308 -0.99 0 CA-C-N 114.623 -1.171 . . . . 0.45000000000000001 112.347 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -80.26 135.46 36.25 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.314 0.578 . . . . 4.7400000000000002 111.462 -179.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -148.02 141.3 25.16 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.249 -0.887 . . . . 1.6499999999999999 109.898 177.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 48.2 m -66.7 129.44 39.87 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 120.813 0.34 . . . . 1.6899999999999999 110.201 177.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.4 p -52.25 116.21 2.11 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.779 -0.646 . . . . 1.55 111.216 178.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 114.31 -5.89 23.24 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.967 -0.635 . . . . 0.79000000000000004 112.12 -177.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -91.21 34.27 0.94 Allowed 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 121.158 0.504 . . . . 1.5800000000000001 110.885 -179.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.401 ' HE2' HD21 ' A' ' 77' ' ' LEU . 25.3 mmt -131.05 -123.16 0.21 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.908 0.385 . . . . 1.1299999999999999 110.411 179.307 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 65.0 mtt -122.92 157.79 31.82 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.665 -0.865 . . . . 1.8899999999999999 108.665 174.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.479 ' HB3' ' HD3' ' A' ' 88' ' ' PRO . 45.1 tttm -54.39 -55.6 35.58 Favored Pre-proline 0 C--N 1.321 -0.633 0 N-CA-C 112.223 0.453 . . . . 2.7400000000000002 112.223 -174.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.479 ' HD3' ' HB3' ' A' ' 87' ' ' LYS . 91.8 Cg_endo -77.51 -24.06 9.36 Favored 'Trans proline' 0 C--N 1.357 0.986 0 C-N-CA 121.655 1.57 . . . . 0.29999999999999999 111.97 -176.314 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.576 ' O ' HG22 ' A' ' 93' ' ' VAL . 14.7 t80 -67.94 -55.52 12.45 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.672 -0.695 . . . . 0.28000000000000003 109.162 177.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.408 ' OE2' ' HD2' ' A' ' 94' ' ' ARG . 1.2 tm-20 -63.05 -34.99 78.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.282 -0.872 . . . . 2.1200000000000001 109.859 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.631 ' HA ' ' CZ ' ' A' ' 94' ' ' ARG . 14.7 t70 -51.34 -41.66 60.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.312 -0.858 . . . . 0.60999999999999999 111.365 175.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.617 ' O ' ' HG ' ' A' ' 96' ' ' LEU . . . -77.84 -29.72 50.65 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.274 -0.421 . . . . 1.1000000000000001 111.318 -179.213 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.576 HG22 ' O ' ' A' ' 89' ' ' PHE . 41.1 t -63.1 -49.36 83.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.281 -0.418 . . . . 1.1200000000000001 111.661 -173.497 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.631 ' CZ ' ' HA ' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -83.47 -2.81 56.77 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.17 -0.612 . . . . 3.1800000000000002 110.551 -179.233 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -86.2 -16.86 36.44 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.299 -0.41 . . . . 1.0800000000000001 111.219 -178.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.617 ' HG ' ' O ' ' A' ' 92' ' ' ALA . 0.6 OUTLIER -119.21 147.04 44.68 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.243 -0.435 . . . . 1.1200000000000001 110.829 -179.519 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.516 ' HA ' ' NH2' ' A' ' 116' ' ' ARG . 22.5 tptm -82.34 163.13 21.95 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.495 -0.558 . . . . 2.1299999999999999 109.495 177.182 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.46 HD12 ' H ' ' A' ' 98' ' ' ILE . 1.3 mp -38.05 118.09 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 O-C-N 123.369 0.418 . . . . 1.6200000000000001 110.644 169.276 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 94.71 -6.36 70.31 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.823 -0.703 . . . . 0.46000000000000002 113.699 176.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.54 ' HB2' ' HB2' ' A' ' 96' ' ' LEU . 44.8 m-20 -94.59 141.89 28.07 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 117.453 0.627 . . . . 0.46000000000000002 110.419 178.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 9.9 mt -110.26 148.76 13.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.095 -0.502 . . . . 1.0800000000000001 110.212 -178.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 88.5 p -93.85 146.46 31.75 Favored Pre-proline 0 C--N 1.319 -0.718 0 CA-C-N 116.315 -0.402 . . . . 1.45 110.615 -179.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -68.8 163.27 37.93 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 122.213 1.942 . . . . 0.40999999999999998 110.821 171.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.476 HG13 ' HG2' ' A' ' 45' ' ' GLN . 22.6 mm -39.86 109.86 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 O-C-N 123.774 0.672 . . . . 1.04 112.639 -178.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.0 p -115.35 120.5 64.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.991 -0.55 . . . . 1.6599999999999999 109.774 175.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -85.56 152.09 23.42 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.267 0.556 . . . . 0.55000000000000004 110.934 -179.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 14.6 p -131.74 -173.61 3.18 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.293 -0.867 . . . . 1.05 110.076 178.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -72.3 -22.24 61.22 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.534 0.207 . . . . 2.1600000000000001 111.457 178.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.748 ' O ' ' HB3' ' A' ' 20' ' ' SER . 7.8 t -110.23 -6.35 15.07 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.348 -0.541 . . . . 1.0900000000000001 112.021 -176.336 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 157.14 -131.91 3.07 Favored Glycine 0 N--CA 1.436 -1.327 0 C-N-CA 119.902 -1.142 . . . . 0.39000000000000001 112.545 169.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.43 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 5.0 mp -118.17 143.17 46.72 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 114.925 -0.637 . . . . 1.0600000000000001 111.192 -171.494 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . 0.567 ' NE2' HD12 ' A' ' 14' ' ' LEU . 86.9 m-70 -139.28 150.04 44.98 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.695 0.628 . . . . 0.25 112.695 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.477 HG23 ' HB3' ' A' ' 48' ' ' SER . 2.6 pt -132.31 140.17 48.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 107.615 -1.254 . . . . 1.03 107.615 159.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 2.7 mp -131.9 147.58 32.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 C-N-CA 120.948 -0.301 . . . . 1.0600000000000001 110.327 -176.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 35.9 pttt -130.08 139.13 50.99 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.557 -0.905 . . . . 1.29 108.557 172.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . 0.516 ' NH2' ' HA ' ' A' ' 97' ' ' LYS . 5.9 ttp180 -80.85 132.34 35.46 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.241 -0.584 . . . . 2.6800000000000002 110.967 -179.136 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.408 HD22 ' N ' ' A' ' 11' ' ' ALA . 3.6 mm? -96.18 -40.52 9.15 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.197 -0.911 . . . . 1.54 109.716 177.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.79 0 CA-C-O 118.347 -0.835 . . . . 1.1499999999999999 110.015 -179.733 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 66.9 mmtt . . . . . 0 C--O 1.232 0.162 0 CA-C-O 121.365 0.602 . . . . 1.6899999999999999 110.731 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.484 HD12 ' CD ' ' A' ' 116' ' ' ARG . 15.6 tp -116.7 173.4 6.65 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.007 -0.997 . . . . 1.79 109.385 -178.319 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.449 ' H ' ' HG ' ' A' ' 8' ' ' LEU . 65.3 ttt180 -146.26 126.56 13.94 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.802 -0.444 . . . . 1.3700000000000001 109.802 178.37 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.443 ' N ' ' HZ ' ' A' ' 80' ' ' PHE . . . -146.56 155.02 42.18 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.085 0.469 . . . . 1.0700000000000001 111.638 -179.477 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -106.05 140.7 38.64 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.519 -0.764 . . . . 1.04 109.401 177.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 50.6 p-80 -139.29 150.45 45.44 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.003 0.43 . . . . 0.34000000000000002 111.341 -173.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.572 ' O ' ' HA ' ' A' ' 112' ' ' HIS . 5.2 tt -118.28 142.75 47.18 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.233 -1.025 . . . . 1.0600000000000001 108.233 176.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.584 HD12 ' NE2' ' A' ' 112' ' ' HIS . 26.6 tp -127.82 121.82 31.09 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.597 0.236 . . . . 1.0800000000000001 110.715 -176.413 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.434 HG22 HD12 ' A' ' 44' ' ' LEU . 97.4 t -112.01 136.61 47.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 116.133 -0.485 . . . . 1.01 109.727 176.032 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.539 ' HE2' ' OG ' ' A' ' 109' ' ' SER . 32.5 mmtp -108.82 164.79 12.07 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.104 -0.498 . . . . 1.22 109.976 177.636 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.486 ' HB3' ' HB1' ' A' ' 40' ' ' ALA . 49.8 p90 -158.65 163.14 37.17 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.992 -0.549 . . . . 0.29999999999999999 110.141 -176.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.49 ' HB3' ' C ' ' A' ' 33' ' ' ALA . 35.8 p -54.13 109.51 0.49 Allowed 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 120.983 0.42 . . . . 1.6000000000000001 110.715 177.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 103.27 9.82 37.95 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.463 -0.875 . . . . 0.53000000000000003 112.841 -178.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.442 ' C ' ' H ' ' A' ' 22' ' ' ASN . 73.5 p -90.12 40.17 0.99 Allowed 'General case' 0 C--O 1.234 0.264 0 CA-C-N 117.338 0.569 . . . . 1.28 111.296 -175.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 50.1 ttt180 75.38 -34.2 0.25 Allowed 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 123.534 0.733 . . . . 4.1600000000000001 110.662 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.442 ' H ' ' C ' ' A' ' 20' ' ' SER . 5.7 p30 -149.6 118.55 3.81 Favored Pre-proline 0 C--N 1.323 -0.55 0 N-CA-C 109.321 -0.622 . . . . 1.77 109.321 173.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.544 ' O ' ' HA ' ' A' ' 31' ' ' SER . 66.2 Cg_endo -86.29 53.33 3.06 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 122.792 2.328 . . . . 1.71 113.353 -172.434 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.488 HG13 ' O ' ' A' ' 30' ' ' ASP . 81.7 t -143.32 121.12 6.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 109.242 -0.651 . . . . 1.1599999999999999 109.242 178.155 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 44.5 t -103.88 152.34 22.06 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.739 -0.467 . . . . 1.4299999999999999 109.739 177.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.62 ' CB ' ' HA ' ' A' ' 67' ' ' ASP . 9.2 tpt180 -73.72 -9.89 59.12 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.241 -0.651 . . . . 3.1200000000000001 109.241 174.038 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.564 ' HG3' ' HD3' ' A' ' 65' ' ' ARG . 13.9 ttp180 -79.94 -38.27 32.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.306 -0.861 . . . . 2.25 109.737 174.057 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 69.9 p -93.74 -34.14 13.34 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.661 -0.699 . . . . 1.1299999999999999 111.09 -175.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 81.83 -39.24 2.55 Favored Glycine 0 N--CA 1.451 -0.361 0 CA-C-N 115.238 -0.892 . . . . 0.81999999999999995 111.428 -177.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.488 ' O ' HG13 ' A' ' 24' ' ' VAL . 31.2 m-20 -107.45 -139.18 0.37 Allowed 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 108.408 -0.96 . . . . 2.1000000000000001 108.408 175.211 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.544 ' HA ' ' O ' ' A' ' 23' ' ' PRO . 2.7 p -75.27 135.11 40.96 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-O 121.27 0.557 . . . . 1.3300000000000001 111.763 -172.438 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.518 HG23 ' C ' ' A' ' 23' ' ' PRO . 12.3 t -106.79 31.26 5.42 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 107.689 -1.226 . . . . 1.02 107.689 168.353 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.49 ' C ' ' HB3' ' A' ' 18' ' ' SER . . . -82.32 -5.14 58.38 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 114.085 -1.416 . . . . 1.1299999999999999 112.178 -172.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -97.22 -22.77 16.51 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 120.938 0.399 . . . . 2.21 110.906 178.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.464 HG22 ' HB2' ' A' ' 39' ' ' ASP . 0.2 OUTLIER -90.4 136.3 24.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 109.574 -0.528 . . . . 1.1100000000000001 109.574 179.148 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 71.6 p -94.31 178.42 5.63 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.954 -0.388 . . . . 1.2 109.954 -176.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.452 ' O ' HG13 ' A' ' 41' ' ' ILE . 7.8 p90 -64.83 -26.24 68.25 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.003 -0.74 . . . . 2.21 109.003 174.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -71.04 -50.97 28.21 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 115.892 -0.594 . . . . 0.95999999999999996 109.896 176.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.464 ' HB2' HG22 ' A' ' 35' ' ' VAL . 11.6 m-20 -59.04 -37.99 78.29 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-O 121.439 0.638 . . . . 0.91000000000000003 109.711 177.199 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.486 ' HB1' ' HB3' ' A' ' 17' ' ' PHE . . . -67.26 -45.68 75.94 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.821 -1.081 . . . . 1.03 110.7 -178.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.476 ' CG1' HD22 ' A' ' 111' ' ' LEU . 68.8 mt -63.05 -36.83 77.5 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 CA-C-N 116.261 -0.427 . . . . 1.0800000000000001 109.986 176.051 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.409 ' HA ' ' HD2' ' A' ' 42' ' ' LYS . 11.1 mmmm -68.55 -17.83 64.23 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 116.107 -0.497 . . . . 2.8399999999999999 110.982 179.567 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.436 ' HG3' ' CD1' ' A' ' 47' ' ' TRP . 1.6 tt0 -88.56 -54.67 4.06 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.8 -0.636 . . . . 1.02 109.666 175.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.478 HD11 HG12 ' A' ' 113' ' ' ILE . 32.4 tp -58.69 -37.19 75.52 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.629 -0.714 . . . . 1.02 110.888 -176.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.436 ' HA ' HD12 ' A' ' 104' ' ' ILE . 3.1 mm-40 -63.77 -40.39 96.57 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.969 0.359 . . . . 0.87 111.969 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -70.5 -41.62 72.42 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 120.919 -0.313 . . . . 1.98 110.969 -177.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.436 ' CD1' ' HG3' ' A' ' 43' ' ' GLU . 39.3 m95 -66.76 -46.1 76.41 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.915 -0.314 . . . . 0.60999999999999999 110.621 176.472 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 33.0 t -57.91 -38.96 76.81 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.676 -0.49 . . . . 0.88 109.676 175.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -61.06 -52.04 66.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.683 -0.69 . . . . 0.55000000000000004 110.888 176.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.518 ' HB3' HG22 ' A' ' 56' ' ' VAL . 87.0 mtt180 -65.75 -41.18 92.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.812 -0.631 . . . . 0.47999999999999998 111.547 -176.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.423 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 96.7 mt -60.49 -38.24 77.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.146 0.498 . . . . 1.04 110.249 175.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.32 -35.24 71.17 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.837 -0.62 . . . . 1.0600000000000001 111.708 178.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 28.2 p -83.97 -31.15 25.7 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.827 0.346 . . . . 0.34999999999999998 111.594 -177.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 107.1 5.25 35.28 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.717 -0.754 . . . . 0.33000000000000002 111.819 -178.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.435 ' HB2' ' HB3' ' A' ' 50' ' ' ARG . 38.8 mt-10 -60.01 -53.18 60.9 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.829 -0.434 . . . . 0.65000000000000002 109.829 176.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.518 HG22 ' HB3' ' A' ' 50' ' ' ARG . 15.8 m -129.81 150.84 35.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 109.292 -0.633 . . . . 1.05 109.292 173.095 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.5 m -80.79 158.39 25.46 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.451 -0.574 . . . . 1.3100000000000001 109.451 179.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.43 ' CD2' ' HD3' ' A' ' 115' ' ' LYS . 2.2 t80 -52.75 -44.15 66.27 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.587 -0.523 . . . . 0.25 109.587 179.494 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.468 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 48.1 mt-10 -56.06 -45.22 79.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.135 -0.939 . . . . 1.72 112.002 179.468 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 34.2 mm-40 -63.85 -47.59 80.13 Favored 'General case' 0 CA--C 1.522 -0.132 0 CA-C-O 120.983 0.42 . . . . 2.0899999999999999 110.808 -175.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -67.76 -46.22 72.68 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.203 -0.453 . . . . 1.0700000000000001 110.767 -179.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.12 -52.63 64.52 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.344 -0.389 . . . . 1.0600000000000001 112.002 -176.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.458 ' HA ' ' O ' ' A' ' 71' ' ' TYR . 33.0 t -51.9 -25.49 8.15 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.856 0.687 . . . . 1.52 112.856 -177.131 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -102.18 -44.63 5.38 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.535 0.683 . . . . 0.60999999999999999 110.456 -179.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.564 ' HD3' ' HG3' ' A' ' 27' ' ' ARG . 21.5 mmt180 -93.64 -39.53 10.76 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 114.334 1.235 . . . . 0.95999999999999996 114.334 -169.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.418 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 59.7 p -63.23 123.75 19.44 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.118 0.485 . . . . 1.0600000000000001 111.059 -176.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.62 ' HA ' ' CB ' ' A' ' 26' ' ' ARG . 17.2 t70 -71.82 -18.8 62.06 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.441 -0.799 . . . . 2.2799999999999998 111.268 177.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 46.6 t -77.1 157.36 31.08 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.54 0.686 . . . . 2.0499999999999998 110.808 -178.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -58.63 -16.47 30.09 Favored Glycine 0 N--CA 1.453 -0.181 0 CA-C-N 114.388 -1.278 . . . . 0.29999999999999999 113.922 -174.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.448 ' HB2' ' CA ' ' A' ' 75' ' ' GLY . 2.6 p -66.17 -4.1 6.94 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 112.287 0.477 . . . . 0.46999999999999997 112.287 176.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.458 ' O ' ' HA ' ' A' ' 63' ' ' SER . 33.0 p90 -56.68 -27.99 59.9 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.112 0.482 . . . . 0.94999999999999996 110.069 175.541 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -92.12 -0.25 57.45 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.387 0.613 . . . . 1.1100000000000001 110.389 -179.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.2 m -124.72 9.32 8.27 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.647 -0.706 . . . . 0.70999999999999996 110.796 -175.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.468 ' O ' ' HA ' ' A' ' 59' ' ' GLU . . . 73.42 31.0 61.56 Favored Glycine 0 CA--C 1.519 0.335 0 C-N-CA 120.884 -0.674 . . . . 0.67000000000000004 112.738 -178.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.448 ' CA ' ' HB2' ' A' ' 70' ' ' SER . . . 76.78 3.09 78.95 Favored Glycine 0 C--O 1.227 -0.325 0 C-N-CA 121.081 -0.58 . . . . 0.42999999999999999 112.217 179.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -97.92 144.35 27.56 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 110.283 -0.266 . . . . 1.6499999999999999 110.283 -168.266 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.7 mp -120.39 171.45 8.52 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.129 -0.487 . . . . 1.6899999999999999 110.276 178.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -91.03 -148.6 21.78 Favored Glycine 0 C--N 1.317 -0.514 0 CA-C-N 115.783 -0.644 . . . . 0.45000000000000001 112.22 -178.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 99.8 m-85 -88.13 123.22 32.58 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.222 0.534 . . . . 4.7400000000000002 110.556 178.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.443 ' HZ ' ' N ' ' A' ' 10' ' ' ALA . 1.6 p90 -134.61 147.13 50.14 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.567 -0.742 . . . . 1.6499999999999999 110.085 -178.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 21.8 m -80.87 124.08 28.81 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 109.926 -0.398 . . . . 1.6899999999999999 109.926 179.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 24.6 m -54.25 119.1 4.69 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.99 -0.55 . . . . 1.55 110.925 -179.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 114.71 13.03 9.78 Favored Glycine 0 N--CA 1.443 -0.883 0 CA-C-N 115.627 -0.715 . . . . 0.79000000000000004 111.794 -178.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -116.56 7.45 13.67 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 111.521 0.193 . . . . 1.5800000000000001 111.521 179.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 24.9 mmt -99.06 -105.44 0.21 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.157 0.503 . . . . 1.1299999999999999 110.807 -179.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 68.9 mtm -142.18 147.38 36.5 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 107.904 -1.147 . . . . 1.8899999999999999 107.904 176.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -48.45 -54.81 22.84 Favored Pre-proline 0 CA--C 1.539 0.552 0 N-CA-C 113.0 0.741 . . . . 2.7400000000000002 113.0 -173.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.421 ' HG2' HG23 ' A' ' 107' ' ' THR . 71.8 Cg_endo -75.43 -27.49 9.29 Favored 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 121.401 1.4 . . . . 0.29999999999999999 111.739 -175.533 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.631 ' O ' HG21 ' A' ' 93' ' ' VAL . 42.4 t80 -72.35 -56.26 5.77 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.23 -0.896 . . . . 0.28000000000000003 109.984 -179.258 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -61.8 -38.28 87.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.462 -0.79 . . . . 2.1200000000000001 110.441 -177.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -60.65 -31.59 70.8 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.454 -0.794 . . . . 0.60999999999999999 110.502 178.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.496 ' O ' ' HG ' ' A' ' 96' ' ' LEU . . . -81.06 -25.98 36.67 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.037 -0.529 . . . . 1.1000000000000001 110.72 178.275 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.631 HG21 ' O ' ' A' ' 89' ' ' PHE . 25.7 t -70.95 -36.05 62.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.421 0.629 . . . . 1.1200000000000001 110.124 -178.465 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.51 ' C ' ' HD2' ' A' ' 94' ' ' ARG . 5.5 ppt_? -85.74 -16.47 38.84 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.679 -0.691 . . . . 3.1800000000000002 110.622 179.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -76.09 -17.07 59.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.012 -0.54 . . . . 1.0800000000000001 111.187 -176.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.561 ' HB2' ' HB2' ' A' ' 100' ' ' ASP . 0.9 OUTLIER -119.61 151.92 37.89 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.143 -0.481 . . . . 1.1200000000000001 110.736 179.443 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.437 ' HA ' ' NH2' ' A' ' 116' ' ' ARG . 23.5 tptm -92.57 167.46 11.91 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.053 -0.721 . . . . 2.1299999999999999 109.053 178.325 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.436 ' HA ' ' HG2' ' A' ' 116' ' ' ARG . 58.8 mt -46.25 115.97 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.851 0.358 . . . . 1.6200000000000001 111.301 173.507 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 100.46 -2.06 56.02 Favored Glycine 0 CA--C 1.521 0.428 0 C-N-CA 120.715 -0.755 . . . . 0.46000000000000002 113.528 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.561 ' HB2' ' HB2' ' A' ' 96' ' ' LEU . 68.1 m-20 -104.53 152.43 22.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 117.412 0.606 . . . . 0.46000000000000002 110.692 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 9.5 mt -121.8 149.11 25.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-O 120.988 0.423 . . . . 1.0800000000000001 110.873 -177.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.423 ' HG ' ' CD2' ' A' ' 96' ' ' LEU . 70.4 m -96.48 150.41 37.03 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 115.896 -0.593 . . . . 1.45 110.491 177.176 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.417 ' O ' HG22 ' A' ' 105' ' ' VAL . 73.5 Cg_endo -74.71 177.91 7.85 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.558 2.172 . . . . 0.40999999999999998 111.188 173.373 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.436 HD12 ' HA ' ' A' ' 45' ' ' GLN . 22.8 mm -44.62 108.28 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 O-C-N 123.501 0.501 . . . . 1.04 112.169 178.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.417 HG22 ' O ' ' A' ' 103' ' ' PRO . 69.6 t -110.98 115.19 49.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.919 -0.582 . . . . 1.6599999999999999 109.59 174.429 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -84.68 147.78 26.75 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.287 0.565 . . . . 0.55000000000000004 110.285 178.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.421 HG23 ' HG2' ' A' ' 88' ' ' PRO . 10.0 p -123.31 -172.81 2.59 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.445 -0.798 . . . . 1.05 110.297 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -64.82 -37.8 88.82 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.63 0.252 . . . . 2.1600000000000001 110.472 178.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.539 ' OG ' ' HE2' ' A' ' 16' ' ' LYS . 9.2 t -86.48 -61.61 1.7 Allowed 'General case' 0 C--O 1.222 -0.391 0 C-N-CA 120.918 -0.313 . . . . 1.0900000000000001 110.419 179.264 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -152.81 -131.04 1.6 Allowed Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 119.163 -1.494 . . . . 0.39000000000000001 113.605 -174.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.476 HD22 ' CG1' ' A' ' 41' ' ' ILE . 6.6 mp -116.03 145.96 42.55 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.425 -0.388 . . . . 1.0600000000000001 111.71 -169.486 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . 0.584 ' NE2' HD12 ' A' ' 14' ' ' LEU . 84.5 m-70 -144.87 142.04 29.59 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.101 0.477 . . . . 0.25 112.274 179.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.478 HG12 HD11 ' A' ' 44' ' ' LEU . 2.8 pt -123.47 140.55 46.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 107.707 -1.22 . . . . 1.03 107.707 159.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 2.6 mp -132.57 150.32 33.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 C-N-CA 120.731 -0.387 . . . . 1.0600000000000001 110.485 -175.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.464 ' HE3' HD21 ' A' ' 117' ' ' LEU . 7.1 pttp -136.24 141.95 43.99 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.494 -0.928 . . . . 1.29 108.494 173.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . 0.484 ' CD ' HD12 ' A' ' 8' ' ' LEU . 5.5 ttp180 -84.36 132.26 34.62 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.477 -0.489 . . . . 2.6800000000000002 110.826 179.374 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.464 HD21 ' HE3' ' A' ' 115' ' ' LYS . 4.1 mm? -99.76 -35.4 9.81 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.21 -0.905 . . . . 1.54 110.281 -178.372 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.893 0 CA-C-O 118.411 -0.804 . . . . 1.1499999999999999 110.165 179.97 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.505 ' HA ' ' O ' ' A' ' 80' ' ' PHE . 42.4 mmtm . . . . . 0 N--CA 1.453 -0.315 0 CA-C-O 121.241 0.544 . . . . 1.6899999999999999 111.258 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.585 ' O ' ' HA ' ' A' ' 79' ' ' PHE . 12.0 tp -118.65 169.8 9.5 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.349 -0.982 . . . . 1.79 108.349 176.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.4 ' HG3' ' O ' ' A' ' 77' ' ' LEU . 56.2 ttt180 -142.79 134.32 26.44 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 117.799 0.272 . . . . 1.3700000000000001 110.301 177.05 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.652 ' O ' ' HB2' ' A' ' 77' ' ' LEU . . . -155.69 154.24 31.23 Favored 'General case' 0 C--O 1.222 -0.364 0 C-N-CA 120.086 -0.646 . . . . 1.0700000000000001 112.063 -177.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.461 ' HB2' ' HG2' ' A' ' 115' ' ' LYS . . . -102.16 132.23 48.19 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.216 -0.661 . . . . 1.04 109.216 178.243 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 12.4 p-80 -133.19 148.77 52.06 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.178 0.513 . . . . 0.34000000000000002 111.768 -172.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.564 HD23 ' N ' ' A' ' 14' ' ' LEU . 5.2 tt -121.4 146.91 46.4 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.41 -0.959 . . . . 1.0600000000000001 108.41 177.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.564 ' N ' HD23 ' A' ' 13' ' ' LEU . 23.4 tp -131.34 132.86 44.78 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 110.091 -0.337 . . . . 1.0800000000000001 110.091 -178.337 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.415 HG21 HD12 ' A' ' 44' ' ' LEU . 58.4 t -123.2 130.67 74.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 O-C-N 123.353 0.408 . . . . 1.01 109.942 175.575 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.458 ' HE3' HD21 ' A' ' 14' ' ' LEU . 33.6 mmtp -104.44 152.44 22.33 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.903 -0.59 . . . . 1.22 110.025 177.073 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.486 ' HB3' ' HB1' ' A' ' 40' ' ' ALA . 42.7 p90 -143.23 162.94 34.3 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.006 -0.543 . . . . 0.29999999999999999 110.477 -177.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 32.6 p -51.84 112.84 0.84 Allowed 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.103 0.478 . . . . 1.6000000000000001 110.892 178.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 97.79 8.51 55.65 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.582 -0.818 . . . . 0.53000000000000003 113.141 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.601 ' HB2' ' O ' ' A' ' 109' ' ' SER . 80.3 p -88.68 45.59 1.3 Allowed 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 117.366 0.583 . . . . 1.28 110.893 -175.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.48 ' HB3' ' O ' ' A' ' 20' ' ' SER . 76.8 ttt180 75.8 -32.5 0.21 Allowed 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 123.175 0.59 . . . . 4.1600000000000001 110.93 -179.021 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.44 ' H ' ' C ' ' A' ' 20' ' ' SER . 3.5 p30 -153.31 109.0 2.61 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-O 121.09 0.471 . . . . 1.77 110.291 174.729 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.417 ' C ' HG23 ' A' ' 32' ' ' THR . 11.3 Cg_exo -73.69 52.86 2.6 Favored 'Trans proline' 0 CA--C 1.534 0.481 0 C-N-CA 123.236 2.624 . . . . 1.71 113.401 -179.338 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.418 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 83.9 t -141.84 116.88 5.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 109.722 -0.473 . . . . 1.1599999999999999 109.722 176.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.509 ' HB2' ' OD1' ' A' ' 67' ' ' ASP . 6.4 p -103.85 151.52 23.0 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 116.535 -0.302 . . . . 1.4299999999999999 110.308 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.665 ' CB ' ' HA ' ' A' ' 67' ' ' ASP . 3.3 tpp180 -69.33 -20.65 63.87 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 108.028 -1.101 . . . . 3.1200000000000001 108.028 173.041 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.433 ' CG ' ' HA ' ' A' ' 65' ' ' ARG . 2.7 tmm_? -69.43 -37.41 77.39 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 114.27 -1.332 . . . . 2.25 110.472 179.002 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 81.1 p -99.29 -36.37 9.65 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.498 0.666 . . . . 1.1299999999999999 110.803 179.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 72.57 -3.84 23.65 Favored Glycine 0 N--CA 1.451 -0.33 0 CA-C-N 115.203 -0.908 . . . . 0.81999999999999995 112.338 -176.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -113.78 -79.22 0.58 Allowed 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.605 -0.517 . . . . 2.1000000000000001 109.605 179.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.418 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 20.2 m -153.77 153.26 31.86 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.73 -0.668 . . . . 1.3300000000000001 109.82 176.296 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.425 ' OG1' HG13 ' A' ' 35' ' ' VAL . 10.2 t -117.52 30.66 7.16 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 122.286 1.041 . . . . 1.02 109.307 177.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -77.03 -5.94 50.72 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.711 -1.131 . . . . 1.1299999999999999 112.514 -176.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -95.74 -25.37 16.11 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.183 0.516 . . . . 2.21 110.651 -179.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.425 HG13 ' OG1' ' A' ' 32' ' ' THR . 0.2 OUTLIER -95.78 134.68 32.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.943 -0.571 . . . . 1.1100000000000001 110.293 -178.886 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 64.7 p -93.0 179.93 5.29 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.181 -0.463 . . . . 1.2 109.873 -175.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.471 ' O ' HG13 ' A' ' 41' ' ' ILE . 9.3 p90 -64.36 -28.47 69.72 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 119.934 -0.707 . . . . 2.21 109.142 175.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -72.13 -48.98 39.69 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 115.968 -0.56 . . . . 0.95999999999999996 110.345 177.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 43.4 m-20 -64.91 -28.78 69.77 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.189 0.518 . . . . 0.91000000000000003 110.161 178.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.486 ' HB1' ' HB3' ' A' ' 17' ' ' PHE . . . -71.36 -43.01 67.74 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.483 -0.78 . . . . 1.03 110.513 176.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.471 HG13 ' O ' ' A' ' 37' ' ' TYR . 87.1 mt -62.8 -35.95 73.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.477 -0.564 . . . . 1.0800000000000001 109.477 174.044 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 35.2 tttm -62.44 -24.52 67.47 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.402 -0.817 . . . . 2.8399999999999999 110.857 176.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.414 ' HG3' ' CD1' ' A' ' 47' ' ' TRP . 0.7 OUTLIER -87.28 -52.47 5.38 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.115 -0.698 . . . . 1.02 109.115 178.845 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.477 HD11 HG12 ' A' ' 113' ' ' ILE . 32.3 tp -63.46 -37.7 88.28 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.202 -0.908 . . . . 1.02 110.695 -173.465 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.46 HE21 ' HA ' ' A' ' 45' ' ' GLN . 0.0 OUTLIER -65.93 -30.7 71.33 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-N 116.152 -0.477 . . . . 0.87 112.133 -176.903 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -74.73 -44.18 51.22 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.941 0.4 . . . . 1.98 110.104 179.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.414 ' CD1' ' HG3' ' A' ' 43' ' ' GLU . 49.2 m95 -67.22 -44.51 79.33 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.205 -0.452 . . . . 0.60999999999999999 111.115 178.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.477 ' HB3' HG22 ' A' ' 113' ' ' ILE . 97.8 p -66.43 -22.29 66.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.83 0.348 . . . . 0.88 110.203 177.147 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.412 ' HB2' ' O ' ' A' ' 45' ' ' GLN . 10.0 tt0 -73.97 -56.95 4.33 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 116.013 -0.54 . . . . 0.55000000000000004 109.986 173.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.518 ' HB3' HG21 ' A' ' 56' ' ' VAL . 96.6 mtt180 -61.85 -41.37 97.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.556 -0.747 . . . . 0.47999999999999998 111.499 -175.102 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.421 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 97.5 mt -60.59 -36.31 69.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.006 0.431 . . . . 1.04 110.434 176.309 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -76.76 -42.7 39.98 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.078 -0.51 . . . . 1.0600000000000001 111.441 179.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 35.3 p -74.4 -29.63 61.6 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.916 0.389 . . . . 0.34999999999999998 111.294 -176.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 107.86 1.44 34.25 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.824 -0.703 . . . . 0.33000000000000002 112.366 -179.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.447 ' HB2' ' HB3' ' A' ' 50' ' ' ARG . 39.0 mt-10 -59.5 -44.41 93.12 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 121.047 0.451 . . . . 0.65000000000000002 110.513 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.518 HG21 ' HB3' ' A' ' 50' ' ' ARG . 13.0 m -137.8 157.55 33.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 109.401 -0.592 . . . . 1.05 109.401 172.16 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 14.5 m -86.43 160.26 19.09 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.348 -0.612 . . . . 1.3100000000000001 109.348 178.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -55.23 -44.25 75.28 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.024 0.44 . . . . 0.25 109.976 -177.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.603 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 50.8 mt-10 -60.54 -35.19 75.42 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.372 -0.831 . . . . 1.72 111.893 -178.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -62.39 -52.9 61.74 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-O 121.055 0.455 . . . . 2.0899999999999999 110.378 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -69.81 -46.32 65.94 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.605 -0.725 . . . . 1.0700000000000001 111.399 -175.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.92 -52.32 65.91 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.439 0.533 . . . . 1.0600000000000001 112.439 -173.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.481 ' HA ' ' O ' ' A' ' 71' ' ' TYR . 67.0 m -51.18 -21.97 2.32 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.993 0.738 . . . . 1.52 112.993 -179.606 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -103.75 -46.53 4.49 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.584 0.707 . . . . 0.60999999999999999 110.148 179.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.433 ' HA ' ' CG ' ' A' ' 27' ' ' ARG . 36.7 mmt-85 -95.63 -36.3 11.28 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 114.271 1.212 . . . . 0.95999999999999996 114.271 -169.097 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.451 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 54.3 p -63.87 114.84 4.32 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.274 0.559 . . . . 1.0600000000000001 110.279 -177.596 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.665 ' HA ' ' CB ' ' A' ' 26' ' ' ARG . 74.6 m-20 -75.57 -9.51 58.64 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.484 -0.78 . . . . 2.2799999999999998 111.632 -177.393 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 36.0 t -85.56 160.74 19.57 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.755 -0.657 . . . . 2.0499999999999998 110.163 178.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -56.28 -18.88 22.76 Favored Glycine 0 CA--C 1.518 0.237 0 CA-C-N 114.465 -1.243 . . . . 0.29999999999999999 114.378 -173.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 60.5 p -65.19 -7.23 11.79 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 112.502 0.556 . . . . 0.46999999999999997 112.502 177.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.481 ' O ' ' HA ' ' A' ' 63' ' ' SER . 32.0 p90 -52.5 -36.56 55.5 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 120.994 0.426 . . . . 0.94999999999999996 110.325 176.713 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -81.06 -1.25 43.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.002 0.429 . . . . 1.1100000000000001 111.039 -177.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 7.7 m -125.01 8.12 8.02 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.103 -0.499 . . . . 0.70999999999999996 110.501 -178.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.603 ' O ' ' HA ' ' A' ' 59' ' ' GLU . . . 75.14 26.24 66.86 Favored Glycine 0 C--O 1.226 -0.35 0 C-N-CA 121.014 -0.612 . . . . 0.67000000000000004 112.622 -179.508 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.49 -20.37 6.18 Favored Glycine 0 N--CA 1.454 -0.149 0 C-N-CA 121.012 -0.613 . . . . 0.42999999999999999 111.937 -179.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.407 ' H ' ' C ' ' A' ' 74' ' ' GLY . 9.3 t70 -68.43 128.6 37.18 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.179 -0.511 . . . . 1.6499999999999999 110.537 -177.359 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.652 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 19.4 mt -108.24 157.53 18.26 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 116.076 -0.511 . . . . 1.6899999999999999 110.065 176.562 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -87.82 -165.31 41.16 Favored Glycine 0 N--CA 1.443 -0.847 0 CA-C-N 115.478 -0.783 . . . . 0.45000000000000001 111.232 174.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.585 ' HA ' ' O ' ' A' ' 8' ' ' LEU . 75.4 m-85 -71.67 133.05 45.4 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.287 0.565 . . . . 4.7400000000000002 111.609 -178.046 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.505 ' O ' ' HA ' ' A' ' 7' ' ' LYS . 21.0 p90 -133.96 160.3 38.12 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.366 -0.834 . . . . 1.6499999999999999 109.399 178.628 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 12.1 m -79.75 123.57 27.81 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 109.032 -0.729 . . . . 1.6899999999999999 109.032 175.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 33.1 m -52.73 117.43 2.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.14 -0.482 . . . . 1.55 110.675 -178.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 113.97 -6.18 23.78 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.734 -0.746 . . . . 0.79000000000000004 112.425 -177.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -97.99 48.18 1.01 Allowed 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.453 0.644 . . . . 1.5800000000000001 110.435 179.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 25.3 mmt -135.58 -101.22 0.22 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.101 -0.5 . . . . 1.1299999999999999 110.502 177.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' MET . . . . . 0.479 ' HB2' ' HB3' ' A' ' 89' ' ' PHE . 48.4 mtt -145.8 149.71 34.85 Favored 'General case' 0 CA--C 1.513 -0.464 0 N-CA-C 107.79 -1.189 . . . . 1.8899999999999999 107.79 177.256 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.425 ' HB3' ' HD3' ' A' ' 88' ' ' PRO . 27.2 ttpp -53.38 -54.79 41.39 Favored Pre-proline 0 C--N 1.322 -0.605 0 N-CA-C 112.134 0.42 . . . . 2.7400000000000002 112.134 -174.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.425 ' HD3' ' HB3' ' A' ' 87' ' ' LYS . 83.4 Cg_endo -76.45 -27.82 7.43 Favored 'Trans proline' 0 C--N 1.356 0.97 0 C-N-CA 121.6 1.533 . . . . 0.29999999999999999 112.061 -176.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.637 ' O ' HG21 ' A' ' 93' ' ' VAL . 34.3 t80 -68.55 -56.59 7.78 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.248 -0.887 . . . . 0.28000000000000003 109.999 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -65.08 -37.08 86.38 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.398 -0.819 . . . . 2.1200000000000001 109.661 -177.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -52.75 -36.02 57.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.173 -0.921 . . . . 0.60999999999999999 110.995 174.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -83.77 -27.32 28.96 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.112 -0.494 . . . . 1.1000000000000001 111.207 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.637 HG21 ' O ' ' A' ' 89' ' ' PHE . 21.8 t -69.92 -48.17 65.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.243 0.544 . . . . 1.1200000000000001 109.947 -177.187 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -73.2 -6.81 48.31 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.446 -0.797 . . . . 3.1800000000000002 110.784 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -82.94 -20.51 35.14 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.865 -0.607 . . . . 1.0800000000000001 110.222 177.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.634 HD23 ' OG ' ' A' ' 102' ' ' SER . 0.8 OUTLIER -89.22 146.33 24.83 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-N 116.198 -0.456 . . . . 1.1200000000000001 109.912 -179.895 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 55.2 tptt -86.49 166.08 15.76 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 106.684 -1.599 . . . . 2.1299999999999999 106.684 163.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 51.8 mt -55.24 115.32 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 120.77 0.319 . . . . 1.6200000000000001 110.368 179.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 102.64 10.94 36.7 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.51 -0.852 . . . . 0.46000000000000002 113.559 -178.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.614 ' HB2' ' HB3' ' A' ' 96' ' ' LEU . 8.9 m-20 -108.08 149.1 28.88 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 117.896 0.848 . . . . 0.46000000000000002 110.462 -179.434 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 16.2 mt -116.14 144.84 22.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 121.066 0.46 . . . . 1.0800000000000001 110.671 -178.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.634 ' OG ' HD23 ' A' ' 96' ' ' LEU . 19.7 m -90.86 148.91 39.3 Favored Pre-proline 0 C--N 1.321 -0.657 0 CA-C-N 115.801 -0.636 . . . . 1.45 110.534 -179.459 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.69 176.2 10.3 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 122.642 2.228 . . . . 0.40999999999999998 111.195 172.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.421 HG22 HD22 ' A' ' 44' ' ' LEU . 19.6 mm -50.11 100.2 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 O-C-N 123.475 0.484 . . . . 1.04 112.133 178.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.6 p -107.75 119.59 57.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.101 0.477 . . . . 1.6599999999999999 110.21 176.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -85.99 149.86 24.89 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.935 0.398 . . . . 0.55000000000000004 110.73 -179.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 3.9 p -126.26 -172.33 2.6 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.601 -0.727 . . . . 1.05 111.122 -178.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -61.03 -34.84 75.47 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.556 0.217 . . . . 2.1600000000000001 111.527 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.601 ' O ' ' HB2' ' A' ' 20' ' ' SER . 6.8 t -97.5 -60.76 1.51 Allowed 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.55 -0.46 . . . . 1.0900000000000001 110.544 179.458 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -146.59 -133.42 2.46 Favored Glycine 0 N--CA 1.441 -0.986 0 C-N-CA 119.015 -1.564 . . . . 0.39000000000000001 113.877 -173.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.484 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 5.9 mp -114.58 148.08 38.55 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.06 -0.57 . . . . 1.0600000000000001 111.407 -169.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . 0.554 ' NE2' HD11 ' A' ' 14' ' ' LEU . 80.7 m-70 -144.2 151.82 40.01 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.316 0.579 . . . . 0.25 112.268 179.073 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.477 HG12 HD11 ' A' ' 44' ' ' LEU . 3.9 pt -134.35 143.91 36.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 107.774 -1.195 . . . . 1.03 107.774 159.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -133.22 138.19 51.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 C-N-CA 120.829 -0.348 . . . . 1.0600000000000001 110.665 -176.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.461 ' HG2' ' HB2' ' A' ' 11' ' ' ALA . 50.4 pttt -121.83 135.08 54.9 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.416 -0.587 . . . . 1.29 109.416 172.111 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 68.5 ttt180 -84.78 123.0 29.92 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.837 0.351 . . . . 2.6800000000000002 111.064 -175.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -93.15 -32.59 14.36 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.025 -0.534 . . . . 1.54 110.843 179.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.955 0 CA-C-O 118.569 -0.729 . . . . 1.1499999999999999 110.156 179.514 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 40.1 mmtm . . . . . 0 N--CA 1.454 -0.247 0 CA-C-O 121.546 0.688 . . . . 1.6899999999999999 111.039 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.554 HD23 ' H ' ' A' ' 9' ' ' ARG . 2.1 tt -115.19 158.71 21.88 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 114.651 -1.158 . . . . 1.79 108.178 179.282 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.554 ' H ' HD23 ' A' ' 8' ' ' LEU . 48.8 ttt180 -137.53 130.8 30.83 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 108.61 -0.885 . . . . 1.3700000000000001 108.61 175.153 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -144.78 155.47 43.54 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.244 -0.583 . . . . 1.0700000000000001 112.419 -178.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.568 ' HA ' ' HA ' ' A' ' 76' ' ' ASP . . . -109.67 133.6 52.94 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-N 115.421 -0.808 . . . . 1.04 109.538 176.225 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 37.9 p-80 -139.52 143.51 37.46 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.97 0.414 . . . . 0.34000000000000002 111.365 -172.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.657 ' O ' ' HA ' ' A' ' 112' ' ' HIS . 6.1 tt -111.82 134.84 53.13 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.536 -0.913 . . . . 1.0600000000000001 108.536 177.159 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.533 HD11 ' NE2' ' A' ' 112' ' ' HIS . 24.4 tp -117.36 122.34 43.6 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.811 0.339 . . . . 1.0800000000000001 111.224 -178.187 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.434 HG23 HD11 ' A' ' 44' ' ' LEU . 70.5 t -108.57 134.05 51.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 109.786 -0.45 . . . . 1.01 109.786 174.242 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.461 ' HE2' ' OG ' ' A' ' 109' ' ' SER . 31.3 mmtp -106.43 149.54 26.94 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.431 -0.581 . . . . 1.22 109.431 176.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.419 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 49.6 p90 -138.68 161.32 37.46 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.721 0.296 . . . . 0.29999999999999999 110.749 -179.027 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.511 ' HB3' ' HA ' ' A' ' 33' ' ' ALA . 59.8 p -52.62 109.8 0.44 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.849 -0.614 . . . . 1.6000000000000001 111.094 -179.173 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 97.8 9.46 54.4 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.63 -0.795 . . . . 0.53000000000000003 113.769 177.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.473 ' C ' ' H ' ' A' ' 22' ' ' ASN . 88.9 p -91.6 48.67 1.49 Allowed 'General case' 0 C--O 1.235 0.321 0 CA-C-N 118.293 1.047 . . . . 1.28 110.903 -177.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 71.27 -34.46 0.3 Allowed 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.531 0.732 . . . . 4.1600000000000001 111.537 -178.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.473 ' H ' ' C ' ' A' ' 20' ' ' SER . 41.5 m-80 -142.99 91.1 7.25 Favored Pre-proline 0 C--N 1.328 -0.367 0 N-CA-C 110.387 -0.227 . . . . 1.77 110.387 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.424 ' C ' HG22 ' A' ' 32' ' ' THR . 16.7 Cg_exo -73.99 54.81 3.24 Favored 'Trans proline' 0 CA--C 1.534 0.523 0 C-N-CA 123.408 2.739 . . . . 1.71 113.07 179.435 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.451 ' N ' HG22 ' A' ' 32' ' ' THR . 64.4 t -146.83 117.67 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 109.302 -0.629 . . . . 1.1599999999999999 109.302 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 42.1 t -106.45 151.74 24.55 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 110.344 -0.243 . . . . 1.4299999999999999 110.344 178.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.561 ' HB2' ' HA ' ' A' ' 67' ' ' ASP . 7.5 mpt_? -65.61 -14.71 61.71 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.994 0.426 . . . . 3.1200000000000001 109.894 170.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.5 ' HG3' ' CD ' ' A' ' 65' ' ' ARG . 23.9 ttp180 -66.86 -38.94 87.29 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.404 -0.817 . . . . 2.25 109.471 177.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 33.2 p -105.42 -35.14 7.6 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-O 121.433 0.635 . . . . 1.1299999999999999 110.979 -176.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 72.92 8.15 72.48 Favored Glycine 0 N--CA 1.451 -0.325 0 CA-C-N 115.419 -0.81 . . . . 0.81999999999999995 112.054 -178.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -131.03 -70.07 0.61 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.964 0.412 . . . . 2.1000000000000001 110.312 -178.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 11.0 p -154.54 157.65 38.63 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.16 -0.473 . . . . 1.3300000000000001 110.584 177.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.484 ' OG1' HG12 ' A' ' 35' ' ' VAL . 10.1 t -125.11 28.0 6.51 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 122.082 0.944 . . . . 1.02 109.66 172.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.511 ' HA ' ' HB3' ' A' ' 18' ' ' SER . . . -69.27 -5.53 23.6 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 114.979 -1.009 . . . . 1.1299999999999999 111.893 178.636 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -85.57 -25.18 26.88 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.833 -0.621 . . . . 2.21 110.754 -178.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.484 HG12 ' OG1' ' A' ' 32' ' ' THR . 0.2 OUTLIER -109.75 135.16 49.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.647 -0.706 . . . . 1.1100000000000001 110.47 -175.547 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 41.7 p -92.19 178.73 5.77 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 109.743 -0.466 . . . . 1.2 109.743 -178.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.515 ' O ' HG13 ' A' ' 41' ' ' ILE . 18.6 p90 -62.16 -29.63 70.48 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 119.885 -0.726 . . . . 2.21 109.57 177.336 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -72.39 -48.36 42.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.12 -0.491 . . . . 0.95999999999999996 110.446 177.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -64.22 -29.04 70.16 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.317 0.579 . . . . 0.91000000000000003 109.705 178.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.419 ' HB2' ' HB3' ' A' ' 17' ' ' PHE . . . -72.62 -46.34 54.59 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.09 -0.959 . . . . 1.03 110.696 177.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.515 HG13 ' O ' ' A' ' 37' ' ' TYR . 97.0 mt -62.41 -38.13 80.51 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 N-CA-C 109.635 -0.506 . . . . 1.0800000000000001 109.635 175.483 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.458 ' O ' ' HG3' ' A' ' 46' ' ' LYS . 82.6 tttt -60.87 -29.68 69.69 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.455 -0.793 . . . . 2.8399999999999999 110.162 178.216 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -87.62 -47.53 8.62 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.687 -0.688 . . . . 1.02 110.091 -177.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.466 HD13 HG12 ' A' ' 113' ' ' ILE . 35.5 tp -58.67 -38.57 78.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.896 -0.593 . . . . 1.02 109.743 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.435 ' HG2' HG13 ' A' ' 104' ' ' ILE . 2.5 mm-40 -62.63 -35.96 81.26 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.94 -0.573 . . . . 0.87 112.165 178.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.458 ' HG3' ' O ' ' A' ' 42' ' ' LYS . 68.8 mttm -70.78 -45.81 64.04 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.741 0.305 . . . . 1.98 110.77 -178.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 51.0 m95 -67.9 -44.34 77.2 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.98 -0.288 . . . . 0.60999999999999999 110.468 177.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 40.9 t -57.03 -33.5 67.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.024 0.44 . . . . 0.88 110.219 174.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.404 ' HB2' ' O ' ' A' ' 45' ' ' GLN . 12.1 tt0 -68.03 -54.38 18.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 0.55000000000000004 110.294 177.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.51 ' HB3' HG22 ' A' ' 56' ' ' VAL . 87.6 mtt180 -60.23 -45.24 93.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.96 -0.564 . . . . 0.47999999999999998 111.594 -178.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 97.2 mt -59.42 -40.69 82.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 120.997 0.427 . . . . 1.04 110.727 177.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.49 -38.42 71.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.152 -0.476 . . . . 1.0600000000000001 111.615 -179.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 58.1 p -78.22 -30.78 48.98 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.055 0.455 . . . . 0.34999999999999998 110.947 -179.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 106.68 3.0 37.32 Favored Glycine 0 N--CA 1.445 -0.725 0 N-CA-C 111.574 -0.61 . . . . 0.33000000000000002 111.574 -179.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.405 ' HB3' ' HB3' ' A' ' 50' ' ' ARG . 5.6 tt0 -55.57 -46.68 77.18 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 122.803 0.441 . . . . 0.65000000000000002 110.784 177.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.51 HG22 ' HB3' ' A' ' 50' ' ' ARG . 11.9 m -134.78 155.33 38.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 109.472 -0.566 . . . . 1.05 109.472 170.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.5 m -77.8 155.8 30.88 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.266 -0.642 . . . . 1.3100000000000001 109.266 178.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -54.3 -40.01 67.52 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.184 -0.673 . . . . 0.25 109.184 177.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -57.94 -44.8 87.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.892 -1.049 . . . . 1.72 111.671 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -64.11 -45.68 87.52 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.863 0.363 . . . . 2.0899999999999999 111.11 -175.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -70.56 -43.66 69.02 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.42 -0.354 . . . . 1.0700000000000001 110.896 -179.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.84 -46.02 89.85 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.248 0.462 . . . . 1.0600000000000001 112.248 -175.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.511 ' HA ' ' O ' ' A' ' 71' ' ' TYR . 21.7 m -59.2 -19.73 47.93 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 112.907 0.706 . . . . 1.52 112.907 -177.138 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.4 ' O ' ' HA ' ' A' ' 27' ' ' ARG . 35.7 mt-30 -110.69 -45.65 3.47 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.48 0.657 . . . . 0.60999999999999999 110.988 -178.182 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.5 ' CD ' ' HG3' ' A' ' 27' ' ' ARG . 25.6 mmt180 -92.35 -38.43 12.04 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 114.929 -1.032 . . . . 0.95999999999999996 113.278 -170.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.422 ' HB2' ' HG ' ' A' ' 13' ' ' LEU . 21.6 t -63.31 124.62 21.7 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.028 0.442 . . . . 1.0600000000000001 110.889 -178.624 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.561 ' HA ' ' HB2' ' A' ' 26' ' ' ARG . 22.8 t70 -80.99 -10.49 59.7 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.741 -0.663 . . . . 2.2799999999999998 111.11 177.644 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 48.3 t -80.24 158.59 26.16 Favored 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 120.132 -0.627 . . . . 2.0499999999999998 109.608 179.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -60.3 -12.06 23.0 Favored Glycine 0 N--CA 1.454 -0.108 0 CA-C-N 115.014 -0.994 . . . . 0.29999999999999999 113.122 -174.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 70.5 p -69.6 -10.15 57.01 Favored 'General case' 0 N--CA 1.448 -0.565 0 O-C-N 123.052 -0.087 . . . . 0.46999999999999997 110.984 176.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.511 ' O ' ' HA ' ' A' ' 63' ' ' SER . 12.8 p90 -57.42 -31.01 65.43 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 109.617 -0.512 . . . . 0.94999999999999996 109.617 174.013 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -95.35 2.63 54.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.141 0.496 . . . . 1.1100000000000001 110.626 179.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 5.0 m -116.37 -2.03 12.17 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.913 -0.585 . . . . 0.70999999999999996 111.284 -175.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 86.11 20.01 56.16 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.722 -0.751 . . . . 0.67000000000000004 112.233 -177.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 86.34 -29.34 4.84 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 121.092 -0.575 . . . . 0.42999999999999999 112.639 178.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.568 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 8.1 p-10 -89.41 144.93 25.68 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-O 121.573 0.702 . . . . 1.6499999999999999 111.397 -175.538 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.418 ' O ' ' HG3' ' A' ' 9' ' ' ARG . 1.7 mp -106.34 175.74 5.4 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 114.635 -1.166 . . . . 1.6899999999999999 110.131 178.612 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -82.76 -147.18 6.67 Favored Glycine 0 C--N 1.317 -0.509 0 C-N-CA 121.033 -0.604 . . . . 0.45000000000000001 112.497 179.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -99.16 124.19 44.01 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.109 0.48 . . . . 4.7400000000000002 110.807 -178.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -134.36 138.5 44.94 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.46 -0.791 . . . . 1.6499999999999999 110.425 -177.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 18.6 m -68.06 129.67 40.62 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.703 -0.481 . . . . 1.6899999999999999 109.703 177.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 17.8 m -49.47 121.47 5.11 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.8 -0.636 . . . . 1.55 111.832 -174.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 111.09 3.21 28.02 Favored Glycine 0 N--CA 1.452 -0.289 0 CA-C-N 115.847 -0.615 . . . . 0.79000000000000004 112.148 -177.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -91.7 26.31 2.4 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.945 0.402 . . . . 1.5800000000000001 111.304 -175.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.408 ' HE1' HD23 ' A' ' 77' ' ' LEU . 26.5 mmt -122.13 -131.78 0.28 Allowed 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 109.687 -0.486 . . . . 1.1299999999999999 109.687 179.59 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 5.1 mpp? -91.97 -93.3 0.14 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.939 0.4 . . . . 1.8899999999999999 109.931 177.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.45 ' H ' ' HD2' ' A' ' 88' ' ' PRO . 27.8 ttpp -163.58 -56.43 0.01 OUTLIER Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 115.852 -0.613 . . . . 2.7400000000000002 110.026 175.262 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.45 ' HD2' ' H ' ' A' ' 87' ' ' LYS . 60.5 Cg_endo -70.14 -30.0 21.16 Favored 'Trans proline' 0 C--N 1.359 1.097 0 C-N-CA 121.923 1.749 . . . . 0.29999999999999999 111.096 178.373 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.633 ' O ' HG22 ' A' ' 93' ' ' VAL . 20.1 t80 -61.66 -56.44 19.76 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.631 -1.168 . . . . 0.28000000000000003 109.762 176.468 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.8 tm-20 -64.36 -36.85 85.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.493 -0.776 . . . . 2.1200000000000001 110.165 -179.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -53.54 -33.52 54.89 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.354 -0.839 . . . . 0.60999999999999999 110.964 175.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.436 ' O ' ' HG ' ' A' ' 96' ' ' LEU . . . -84.35 -34.36 23.67 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.359 -0.382 . . . . 1.1000000000000001 111.298 177.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.633 HG22 ' O ' ' A' ' 89' ' ' PHE . 35.7 t -62.72 -44.52 99.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-O 121.417 0.627 . . . . 1.1200000000000001 110.596 -177.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 38.3 ptt180 -73.47 -11.29 60.41 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.612 -0.722 . . . . 3.1800000000000002 110.748 178.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -96.86 14.64 24.61 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.328 -0.396 . . . . 1.0800000000000001 111.815 -173.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.5 ' HB2' ' HB2' ' A' ' 100' ' ' ASP . 0.5 OUTLIER -148.17 155.75 41.77 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.022 0.439 . . . . 1.1200000000000001 110.857 177.395 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.573 ' HA ' ' NH2' ' A' ' 116' ' ' ARG . 23.8 tptm -92.25 162.73 14.18 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.789 -0.641 . . . . 2.1299999999999999 109.517 179.294 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.486 ' HA ' ' HG2' ' A' ' 116' ' ' ARG . 66.2 mt -42.63 114.33 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.974 0.416 . . . . 1.6200000000000001 111.241 171.52 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 103.3 -8.87 53.31 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.804 -0.712 . . . . 0.46000000000000002 113.449 178.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.5 ' HB2' ' HB2' ' A' ' 96' ' ' LEU . 18.4 m-20 -97.24 135.82 38.62 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 117.23 0.515 . . . . 0.46000000000000002 110.383 179.121 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.436 HG12 ' HB3' ' A' ' 115' ' ' LYS . 8.3 mt -103.98 149.72 7.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.946 -0.57 . . . . 1.0800000000000001 109.902 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 93.4 p -91.46 159.62 38.57 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 116.095 -0.502 . . . . 1.45 110.914 -177.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -71.22 166.55 28.88 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 122.383 2.055 . . . . 0.40999999999999998 111.342 170.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.435 HG13 ' HG2' ' A' ' 45' ' ' GLN . 25.7 mm -47.57 112.7 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 O-C-N 123.547 0.53 . . . . 1.04 111.793 176.629 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 1.9 p -118.47 124.8 73.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.154 -0.475 . . . . 1.6599999999999999 109.961 175.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -85.51 151.32 24.04 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.0 0.429 . . . . 0.55000000000000004 110.285 178.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 10.9 p -131.3 -172.21 2.79 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.942 -0.572 . . . . 1.05 110.855 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -55.5 -48.16 75.06 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.893 -0.594 . . . . 2.1600000000000001 111.928 -179.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.461 ' OG ' ' HE2' ' A' ' 16' ' ' LYS . 4.8 t -106.98 -3.93 19.58 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.791 0.663 . . . . 1.0900000000000001 112.791 -172.306 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 172.68 -128.59 1.56 Allowed Glycine 0 N--CA 1.439 -1.15 0 C-N-CA 118.984 -1.579 . . . . 0.39000000000000001 113.615 173.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.487 HD23 ' CG1' ' A' ' 41' ' ' ILE . 7.4 mp -126.4 151.0 48.26 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 114.976 -0.612 . . . . 1.0600000000000001 110.961 -170.2 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . 0.657 ' HA ' ' O ' ' A' ' 13' ' ' LEU . 84.7 m-70 -146.48 149.99 34.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.378 0.608 . . . . 0.25 112.53 178.309 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.466 HG12 HD13 ' A' ' 44' ' ' LEU . 2.9 pt -128.07 137.43 57.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 107.351 -1.351 . . . . 1.03 107.351 158.39 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 2.6 mp -130.57 144.02 39.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 C-N-CA 120.736 -0.386 . . . . 1.0600000000000001 110.85 -175.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.436 ' HB3' HG12 ' A' ' 101' ' ' ILE . 39.2 pttt -127.2 142.19 51.55 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.655 -0.868 . . . . 1.29 108.655 172.428 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . 0.573 ' NH2' ' HA ' ' A' ' 97' ' ' LYS . 3.1 ttp180 -79.81 134.77 36.36 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.295 0.569 . . . . 2.6800000000000002 111.095 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -102.66 -32.42 9.88 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.144 -0.935 . . . . 1.54 109.922 178.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.569 ' OXT' ' HD2' ' A' ' 116' ' ' ARG . . . . . . . . 0 C--O 1.246 0.888 0 CA-C-O 118.368 -0.825 . . . . 1.1499999999999999 110.401 178.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.439 ' HD2' ' HB3' ' A' ' 79' ' ' PHE . 60.1 mmtt . . . . . 0 N--CA 1.454 -0.241 0 CA-C-O 121.359 0.6 . . . . 1.6899999999999999 110.798 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.587 HD21 ' H ' ' A' ' 9' ' ' ARG . 1.3 tt -114.9 161.23 18.54 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 108.162 -1.051 . . . . 1.79 108.162 178.139 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.587 ' H ' HD21 ' A' ' 8' ' ' LEU . 48.2 ttt180 -141.45 128.61 20.91 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.082 -0.71 . . . . 1.3700000000000001 109.082 175.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.464 ' O ' ' HB2' ' A' ' 77' ' ' LEU . . . -146.97 158.74 44.01 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 119.97 -0.692 . . . . 1.0700000000000001 112.143 -178.459 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.44 ' HA ' ' HA ' ' A' ' 76' ' ' ASP . . . -106.73 135.75 47.73 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.641 -0.708 . . . . 1.04 109.177 177.521 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 10.1 p-80 -138.71 140.12 38.64 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 120.37 -0.532 . . . . 0.34000000000000002 111.463 -171.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.544 ' O ' ' HA ' ' A' ' 112' ' ' HIS . 7.0 tt -111.71 143.28 42.88 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.493 -0.929 . . . . 1.0600000000000001 108.493 175.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.573 HD13 ' NE2' ' A' ' 112' ' ' HIS . 23.9 tp -129.61 120.4 25.19 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.768 0.318 . . . . 1.0800000000000001 111.097 -177.028 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.422 HG23 HD13 ' A' ' 44' ' ' LEU . 37.5 t -106.98 132.39 54.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 109.379 -0.6 . . . . 1.01 109.379 175.456 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.646 ' HE2' ' OG ' ' A' ' 109' ' ' SER . 31.7 mmtp -106.21 154.37 20.81 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.837 -0.431 . . . . 1.22 109.837 177.61 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -149.19 160.95 42.92 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.056 -0.52 . . . . 0.29999999999999999 110.353 -176.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 5.6 t -54.27 109.49 0.49 Allowed 'General case' 0 N--CA 1.432 -1.327 0 CA-C-N 116.392 -0.367 . . . . 1.6000000000000001 110.071 174.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 105.74 9.61 32.45 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.502 -0.856 . . . . 0.53000000000000003 112.759 -178.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.477 ' HB2' ' O ' ' A' ' 109' ' ' SER . 78.3 p -95.03 39.44 1.11 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 117.258 0.529 . . . . 1.28 111.202 -176.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.417 ' HB3' ' O ' ' A' ' 20' ' ' SER . 54.8 ttt180 74.77 -34.29 0.26 Allowed 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.286 0.634 . . . . 4.1600000000000001 111.045 179.399 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.428 ' H ' ' C ' ' A' ' 20' ' ' SER . 6.3 p30 -151.06 114.07 3.12 Favored Pre-proline 0 C--N 1.324 -0.521 0 N-CA-C 109.265 -0.643 . . . . 1.77 109.265 172.296 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.439 ' C ' HG23 ' A' ' 32' ' ' THR . 89.9 Cg_endo -83.61 64.12 7.42 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 122.594 2.196 . . . . 1.71 112.88 -172.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.469 ' N ' HG23 ' A' ' 32' ' ' THR . 47.0 t -147.9 116.17 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 C-N-CA 122.855 0.462 . . . . 1.1599999999999999 109.851 179.406 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.42 ' HB3' ' HB2' ' A' ' 16' ' ' LYS . 28.7 p -105.63 158.47 16.68 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 110.585 -0.154 . . . . 1.4299999999999999 110.585 175.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.572 ' HB2' ' HA ' ' A' ' 67' ' ' ASP . 5.6 mpt_? -71.05 -4.0 22.68 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.111 0.481 . . . . 3.1200000000000001 110.216 171.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.56 ' HG3' ' CD ' ' A' ' 65' ' ' ARG . 22.0 ttp180 -76.26 -40.1 52.73 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.706 -0.679 . . . . 2.25 109.362 175.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 59.8 p -103.19 -35.8 8.34 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.707 -0.679 . . . . 1.1299999999999999 111.035 -176.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 80.95 -28.31 2.89 Favored Glycine 0 CA--C 1.52 0.365 0 CA-C-N 115.963 -0.562 . . . . 0.81999999999999995 112.21 -179.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -98.48 -71.21 0.7 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.839 0.352 . . . . 2.1000000000000001 110.64 -178.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 44.7 m -154.11 156.7 37.74 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.109 -0.496 . . . . 1.3300000000000001 110.212 177.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.469 HG23 ' N ' ' A' ' 24' ' ' VAL . 8.9 t -123.22 35.5 4.85 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 122.29 1.043 . . . . 1.02 109.695 178.285 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -77.67 -4.58 46.83 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.833 -1.076 . . . . 1.1299999999999999 111.528 -176.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -96.76 1.21 50.58 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.798 -0.637 . . . . 2.21 110.747 -178.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.445 HG11 ' OG1' ' A' ' 32' ' ' THR . 0.2 OUTLIER -129.46 134.75 63.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.685 -0.689 . . . . 1.1100000000000001 109.787 -179.955 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 41.2 p -96.49 -176.19 3.55 Favored 'General case' 0 CA--C 1.513 -0.468 0 N-CA-C 109.487 -0.56 . . . . 1.2 109.487 -178.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.547 ' O ' HG13 ' A' ' 41' ' ' ILE . 0.2 OUTLIER -67.93 -22.8 65.04 Favored 'General case' 0 C--O 1.219 -0.532 0 C-N-CA 118.883 -1.127 . . . . 2.21 110.036 173.583 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -68.82 -49.3 59.6 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.761 -0.459 . . . . 0.95999999999999996 109.761 174.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.408 ' HB2' HG21 ' A' ' 35' ' ' VAL . 8.4 m-20 -66.54 -32.44 73.79 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.368 0.604 . . . . 0.91000000000000003 109.967 177.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.85 -40.91 68.7 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.272 -0.876 . . . . 1.03 110.832 179.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.547 HG13 ' O ' ' A' ' 37' ' ' TYR . 61.8 mt -62.3 -34.67 65.35 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.312 0 N-CA-C 109.316 -0.624 . . . . 1.0800000000000001 109.316 173.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.429 ' O ' ' HG3' ' A' ' 46' ' ' LYS . 19.7 mtpt -65.34 -21.28 66.68 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 116.336 -0.393 . . . . 2.8399999999999999 111.085 176.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.431 ' HG3' ' CD1' ' A' ' 47' ' ' TRP . 1.6 tp10 -87.85 -57.61 2.87 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.34 -0.615 . . . . 1.02 109.34 178.187 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.487 HD12 HG12 ' A' ' 113' ' ' ILE . 23.8 tp -57.93 -38.89 76.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 114.965 -1.016 . . . . 1.02 111.101 -175.722 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.521 ' HB2' ' O ' ' A' ' 41' ' ' ILE . 3.6 mm-40 -66.22 -28.66 68.91 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 112.047 0.388 . . . . 0.87 112.047 -178.425 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.429 ' HG3' ' O ' ' A' ' 42' ' ' LYS . 66.4 mttm -77.56 -45.02 26.6 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.986 -0.376 . . . . 1.98 109.986 178.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.431 ' CD1' ' HG3' ' A' ' 43' ' ' GLU . 58.2 m95 -66.11 -45.5 80.94 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.249 -0.432 . . . . 0.60999999999999999 111.695 177.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.479 ' HB3' HG21 ' A' ' 113' ' ' ILE . 96.0 p -65.22 -23.82 67.18 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.957 0.408 . . . . 0.88 109.989 177.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.466 ' HB2' ' O ' ' A' ' 45' ' ' GLN . 10.1 tt0 -73.3 -56.68 4.75 Favored 'General case' 0 C--O 1.223 -0.337 0 CA-C-N 116.094 -0.503 . . . . 0.55000000000000004 109.776 173.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.514 ' HB3' HG22 ' A' ' 56' ' ' VAL . 92.4 mtt180 -61.1 -41.7 97.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.77 -0.65 . . . . 0.47999999999999998 111.81 -176.136 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.487 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 98.2 mt -60.7 -36.42 70.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.367 -0.378 . . . . 1.04 110.496 176.437 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -77.64 -36.95 51.0 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.243 -0.435 . . . . 1.0600000000000001 111.692 178.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.456 ' OG ' ' HA ' ' A' ' 50' ' ' ARG . 67.9 p -79.09 -29.8 43.5 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 111.76 0.282 . . . . 0.34999999999999998 111.76 -175.347 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 109.15 1.37 31.54 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.671 -0.776 . . . . 0.33000000000000002 112.318 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.435 ' HB2' ' HB3' ' A' ' 50' ' ' ARG . 43.5 mt-10 -61.97 -50.97 69.97 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.882 0.372 . . . . 0.65000000000000002 110.509 178.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.514 HG22 ' HB3' ' A' ' 50' ' ' ARG . 16.2 m -134.8 152.4 32.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 109.564 -0.532 . . . . 1.05 109.564 174.285 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 19.5 m -82.39 160.15 22.85 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.542 -0.54 . . . . 1.3100000000000001 109.542 178.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.41 ' HA ' ' CD1' ' A' ' 51' ' ' ILE . 2.6 t80 -54.95 -39.8 69.3 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.412 0.625 . . . . 0.25 109.74 -178.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -55.79 -45.56 78.17 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.541 -1.209 . . . . 1.72 111.351 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.45 ' O ' ' HG3' ' A' ' 64' ' ' GLN . 3.9 mm-40 -65.64 -47.83 74.24 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.964 -0.562 . . . . 2.0899999999999999 111.177 -173.154 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -67.25 -38.44 85.15 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.369 -0.378 . . . . 1.0700000000000001 110.845 -179.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.37 -53.18 58.73 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.131 -0.486 . . . . 1.0600000000000001 111.331 -178.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.565 ' HA ' ' O ' ' A' ' 71' ' ' TYR . 47.6 m -51.58 -29.56 17.68 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.892 0.701 . . . . 1.52 112.892 -177.337 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.45 ' HG3' ' O ' ' A' ' 60' ' ' GLU . 19.1 mt-30 -97.33 -50.48 4.53 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.738 0.78 . . . . 0.60999999999999999 110.708 -177.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.56 ' CD ' ' HG3' ' A' ' 27' ' ' ARG . 19.1 mmt180 -93.57 -40.26 10.39 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 114.55 -1.205 . . . . 0.95999999999999996 113.386 -166.18 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.508 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 38.7 p -63.84 121.52 14.23 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.106 0.479 . . . . 1.0600000000000001 111.177 -174.029 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.572 ' HA ' ' HB2' ' A' ' 26' ' ' ARG . 31.5 t70 -74.66 -15.08 60.82 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.571 -0.741 . . . . 2.2799999999999998 110.813 177.13 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . 0.504 ' SG ' ' HB2' ' A' ' 66' ' ' SER . 5.2 p -77.57 150.34 34.74 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.94 -0.573 . . . . 2.0499999999999998 110.556 -179.505 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -53.82 -18.04 7.83 Favored Glycine 0 C--N 1.329 0.176 0 CA-C-N 114.823 -1.08 . . . . 0.29999999999999999 114.742 -171.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 77.9 p -73.06 0.32 11.78 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 117.293 0.546 . . . . 0.46999999999999997 111.907 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.565 ' O ' ' HA ' ' A' ' 63' ' ' SER . 54.8 p90 -52.97 -41.27 64.41 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.767 0.318 . . . . 0.94999999999999996 110.295 174.045 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -95.14 2.68 55.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.045 0.45 . . . . 1.1100000000000001 110.983 -179.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 5.3 m -103.37 -6.78 21.59 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.076 -0.511 . . . . 0.70999999999999996 110.735 -178.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 90.61 19.85 42.95 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.891 -0.671 . . . . 0.67000000000000004 112.181 -177.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 84.7 -31.83 3.53 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 121.044 -0.598 . . . . 0.42999999999999999 112.697 179.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.44 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 6.9 p-10 -83.04 145.2 29.43 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-O 121.672 0.749 . . . . 1.6499999999999999 111.224 -176.031 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.464 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 16.6 mt -105.43 175.74 5.4 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 114.399 -1.273 . . . . 1.6899999999999999 110.388 179.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -87.43 -152.38 22.95 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 121.234 -0.508 . . . . 0.45000000000000001 112.014 177.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.439 ' HB3' ' HD2' ' A' ' 7' ' ' LYS . 91.6 m-85 -96.16 124.11 40.04 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.27 0.557 . . . . 4.7400000000000002 110.988 179.498 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.407 ' HE2' ' CB ' ' A' ' 77' ' ' LEU . 1.0 OUTLIER -134.44 160.2 38.72 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.491 -0.777 . . . . 1.6499999999999999 110.45 -176.214 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 40.8 p -89.22 126.59 35.55 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 109.598 -0.519 . . . . 1.6899999999999999 109.598 178.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 17.2 m -56.57 122.67 12.55 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.305 -0.407 . . . . 1.55 111.093 -178.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 113.23 6.85 21.81 Favored Glycine 0 N--CA 1.445 -0.708 0 N-CA-C 111.533 -0.627 . . . . 0.79000000000000004 111.533 -179.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -112.82 10.55 19.15 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.135 0.493 . . . . 1.5800000000000001 110.446 -178.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 23.6 mmt -99.17 -108.8 0.19 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.027 0.441 . . . . 1.1299999999999999 110.642 178.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 56.7 mtt -134.69 150.5 50.63 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 107.88 -1.155 . . . . 1.8899999999999999 107.88 175.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -54.05 -53.19 61.27 Favored Pre-proline 0 C--N 1.32 -0.697 0 N-CA-C 112.518 0.562 . . . . 2.7400000000000002 112.518 -175.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.406 ' HG2' HG23 ' A' ' 107' ' ' THR . 64.2 Cg_endo -75.16 -25.18 11.87 Favored 'Trans proline' 0 C--N 1.355 0.902 0 C-N-CA 121.561 1.507 . . . . 0.29999999999999999 112.152 -177.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.505 ' O ' HG23 ' A' ' 93' ' ' VAL . 27.0 t80 -72.88 -55.78 6.14 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.475 -0.784 . . . . 0.28000000000000003 109.723 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -60.41 -36.19 77.56 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.263 -0.88 . . . . 2.1200000000000001 110.214 -179.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.557 ' HA ' ' CZ ' ' A' ' 94' ' ' ARG . 26.6 t70 -56.38 -32.97 65.28 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.613 -0.721 . . . . 0.60999999999999999 111.117 177.69 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.474 ' O ' ' HG ' ' A' ' 96' ' ' LEU . . . -82.79 -26.98 31.28 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.381 -0.372 . . . . 1.1000000000000001 111.037 179.114 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.505 HG23 ' O ' ' A' ' 89' ' ' PHE . 28.0 t -67.36 -45.38 85.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.47 -0.332 . . . . 1.1200000000000001 111.666 -174.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.557 ' CZ ' ' HA ' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -83.32 -2.49 55.83 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.239 -0.584 . . . . 3.1800000000000002 110.408 178.262 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -86.5 -2.77 58.75 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.18 0.514 . . . . 1.0800000000000001 110.339 179.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.588 ' HB2' ' HB2' ' A' ' 100' ' ' ASP . 0.7 OUTLIER -136.26 153.61 51.14 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.614 -0.721 . . . . 1.1200000000000001 110.128 176.785 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.556 ' HG3' ' H ' ' A' ' 98' ' ' ILE . 20.2 tptm -102.42 179.17 4.38 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.128 -0.693 . . . . 2.1299999999999999 109.128 179.197 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.556 ' H ' ' HG3' ' A' ' 97' ' ' LYS . 65.3 mt -54.81 116.05 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.011 0.434 . . . . 1.6200000000000001 111.197 179.588 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 104.45 -6.18 45.31 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 121.016 -0.612 . . . . 0.46000000000000002 112.975 179.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.588 ' HB2' ' HB2' ' A' ' 96' ' ' LEU . 31.0 m-20 -98.14 138.86 34.81 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.906 0.353 . . . . 0.46000000000000002 110.886 -178.253 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 11.2 mt -108.56 147.62 13.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 109.385 -0.598 . . . . 1.0800000000000001 109.385 178.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 88.3 p -91.4 158.11 41.35 Favored Pre-proline 0 C--N 1.321 -0.658 0 CA-C-O 120.667 0.27 . . . . 1.45 110.571 -179.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -74.99 175.87 10.66 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.272 1.982 . . . . 0.40999999999999998 110.94 170.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.443 HG23 HD23 ' A' ' 44' ' ' LEU . 21.1 mm -49.0 112.8 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.898 0.38 . . . . 1.04 111.58 176.23 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.4 p -119.24 120.82 64.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.093 0.473 . . . . 1.6599999999999999 110.078 174.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -85.14 145.25 27.71 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 121.269 0.556 . . . . 0.55000000000000004 109.995 177.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.406 HG23 ' HG2' ' A' ' 88' ' ' PRO . 8.2 p -120.6 -171.93 2.27 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.349 -0.841 . . . . 1.05 110.886 -176.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -54.69 -45.4 73.97 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.811 -0.631 . . . . 2.1600000000000001 110.723 176.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.646 ' OG ' ' HE2' ' A' ' 16' ' ' LYS . 15.0 t -93.59 -60.81 1.68 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.921 -0.581 . . . . 1.0900000000000001 111.078 -177.21 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -144.95 -134.85 2.8 Favored Glycine 0 N--CA 1.442 -0.929 0 C-N-CA 118.865 -1.636 . . . . 0.39000000000000001 113.448 -172.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.435 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 6.8 mp -113.19 146.33 39.47 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.204 -0.498 . . . . 1.0600000000000001 111.116 -172.499 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . 0.573 ' NE2' HD13 ' A' ' 14' ' ' LEU . 77.9 m-70 -143.23 152.67 41.99 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.459 0.647 . . . . 0.25 112.484 179.35 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.487 HG12 HD12 ' A' ' 44' ' ' LEU . 3.6 pt -131.55 137.42 55.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 107.372 -1.344 . . . . 1.03 107.372 157.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 2.4 mp -127.57 144.17 38.32 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 C-N-CA 120.781 -0.368 . . . . 1.0600000000000001 110.247 -176.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.44 ' HG2' ' HB1' ' A' ' 11' ' ' ALA . 52.0 pttt -127.94 137.25 52.2 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.041 -0.726 . . . . 1.29 109.041 173.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . 0.514 ' HB2' ' CD1' ' A' ' 96' ' ' LEU . 65.2 ttt180 -85.49 126.61 33.97 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 120.989 0.424 . . . . 2.6800000000000002 111.358 -175.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.405 HD23 ' HB2' ' A' ' 11' ' ' ALA . 0.7 OUTLIER -97.26 -33.56 11.42 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.594 -0.73 . . . . 1.54 110.625 178.268 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.936 0 CA-C-O 118.736 -0.65 . . . . 1.1499999999999999 110.662 -179.64 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt . . . . . 0 N--CA 1.454 -0.247 0 CA-C-O 121.162 0.506 . . . . 1.6899999999999999 111.315 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.51 HD11 ' CD ' ' A' ' 116' ' ' ARG . 15.3 tp -132.18 171.97 12.99 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.022 -0.99 . . . . 1.79 108.779 -179.673 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 68.2 ttt180 -145.26 132.15 20.17 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 110.178 -0.304 . . . . 1.3700000000000001 110.178 175.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -148.51 160.31 43.2 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.329 0.585 . . . . 1.0700000000000001 112.421 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.419 ' HB3' HD21 ' A' ' 117' ' ' LEU . . . -107.47 138.96 42.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.239 -0.892 . . . . 1.04 109.129 176.489 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 20.0 p-80 -139.5 141.68 37.32 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.016 0.436 . . . . 0.34000000000000002 111.341 -172.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.582 ' O ' ' HA ' ' A' ' 112' ' ' HIS . 7.1 tt -113.47 138.39 50.18 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.549 -0.908 . . . . 1.0600000000000001 108.549 177.226 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.553 HD12 ' NE2' ' A' ' 112' ' ' HIS . 16.6 tp -121.2 137.5 54.65 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.697 0.284 . . . . 1.0800000000000001 111.501 -179.046 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 43.8 t -119.66 126.47 75.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.854 -0.612 . . . . 1.01 109.721 172.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.493 ' HE3' HD22 ' A' ' 14' ' ' LEU . 28.5 mmtp -103.31 154.82 18.97 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.982 -0.554 . . . . 1.22 109.821 177.171 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -151.67 162.32 41.19 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.133 -0.485 . . . . 0.29999999999999999 110.127 -176.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.432 ' CB ' ' HA ' ' A' ' 33' ' ' ALA . 4.1 t -47.25 110.01 0.26 Allowed 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 122.949 0.499 . . . . 1.6000000000000001 111.484 177.302 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 93.74 10.47 58.92 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.323 -0.941 . . . . 0.53000000000000003 113.588 177.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.515 ' C ' ' H ' ' A' ' 22' ' ' ASN . 83.4 p -81.84 46.98 1.04 Allowed 'General case' 0 C--O 1.234 0.252 0 CA-C-N 117.684 0.742 . . . . 1.28 111.326 -175.058 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 27.1 ttt180 69.32 -36.29 0.33 Allowed 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.805 0.842 . . . . 4.1600000000000001 111.115 -179.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.515 ' H ' ' C ' ' A' ' 20' ' ' SER . 57.5 m-80 -150.92 104.86 3.01 Favored Pre-proline 0 C--N 1.323 -0.576 0 N-CA-C 108.711 -0.848 . . . . 1.77 108.711 174.703 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_exo -64.04 -163.05 0.05 OUTLIER 'Trans proline' 0 CA--C 1.536 0.597 0 C-N-CA 123.172 2.581 . . . . 1.71 112.879 177.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.556 ' N ' HG23 ' A' ' 32' ' ' THR . 40.0 t 66.74 119.84 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-O 121.651 0.739 . . . . 1.1599999999999999 111.596 -175.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.7 t -102.0 152.3 21.11 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 115.357 -0.838 . . . . 1.4299999999999999 109.319 -179.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.663 ' CB ' ' HA ' ' A' ' 67' ' ' ASP . 8.6 tpp180 -79.91 -11.41 59.81 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.263 -1.014 . . . . 3.1200000000000001 108.263 175.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.542 ' HG3' ' HD3' ' A' ' 65' ' ' ARG . 17.2 ttp180 -80.68 -43.65 20.02 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 114.75 -1.113 . . . . 2.25 109.285 173.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 32.3 p -91.05 -33.77 15.37 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 116.038 -0.528 . . . . 1.1299999999999999 111.058 -175.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 81.78 -35.39 2.5 Favored Glycine 0 N--CA 1.452 -0.244 0 CA-C-N 116.089 -0.505 . . . . 0.81999999999999995 113.154 176.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 -99.52 -64.19 1.06 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.757 0.313 . . . . 2.1000000000000001 110.615 -175.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.1 p -154.08 150.49 28.26 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.308 -0.405 . . . . 1.3300000000000001 111.608 -178.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.556 HG23 ' N ' ' A' ' 24' ' ' VAL . 8.9 t -124.73 14.92 8.7 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.905 0.859 . . . . 1.02 110.095 176.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.432 ' HA ' ' CB ' ' A' ' 18' ' ' SER . . . -63.67 -4.42 3.0 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.447 -0.797 . . . . 1.1299999999999999 113.019 177.033 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 52.3 m-20 -89.88 -25.09 21.17 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.873 0.368 . . . . 2.21 110.538 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.449 HG13 ' OG1' ' A' ' 32' ' ' THR . 0.2 OUTLIER -102.29 139.22 23.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.989 -0.55 . . . . 1.1100000000000001 110.081 -178.568 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 25.3 p -100.02 -178.62 3.9 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 116.107 -0.497 . . . . 1.2 110.395 -175.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.497 ' O ' HG13 ' A' ' 41' ' ' ILE . 11.6 p90 -62.95 -30.78 71.83 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.517 -0.473 . . . . 2.21 109.872 177.223 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -72.66 -45.32 59.53 Favored 'General case' 0 CA--C 1.52 -0.173 0 CA-C-N 116.418 -0.355 . . . . 0.95999999999999996 110.545 179.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -67.35 -28.17 67.74 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-O 121.167 0.508 . . . . 0.91000000000000003 110.345 176.389 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -69.34 -43.93 72.66 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.376 -0.829 . . . . 1.03 110.337 175.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.497 HG13 ' O ' ' A' ' 37' ' ' TYR . 97.9 mt -62.65 -38.39 81.45 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.412 0 N-CA-C 109.529 -0.545 . . . . 1.0800000000000001 109.529 173.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 3.5 ttpm? -61.16 -25.99 67.39 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.342 -0.844 . . . . 2.8399999999999999 109.919 179.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.476 ' HG3' ' CD1' ' A' ' 47' ' ' TRP . 3.1 tp10 -87.99 -51.68 5.68 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.605 -0.725 . . . . 1.02 109.927 -178.444 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.476 ' CD2' ' HB3' ' A' ' 111' ' ' LEU . 33.0 tp -61.26 -37.85 84.6 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.421 -0.808 . . . . 1.02 110.573 -175.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.529 ' O ' ' HB2' ' A' ' 49' ' ' GLN . 4.7 mm-40 -65.27 -26.57 68.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.19 -0.459 . . . . 0.87 112.077 -178.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -81.29 -45.24 16.51 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.911 0.386 . . . . 1.98 110.41 178.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.476 ' CD1' ' HG3' ' A' ' 43' ' ' GLU . 42.9 m95 -65.36 -46.35 80.52 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.474 -0.33 . . . . 0.60999999999999999 111.556 177.617 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.457 ' HB3' HG22 ' A' ' 113' ' ' ILE . 83.8 p -65.27 -22.49 66.86 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.11 0.481 . . . . 0.88 110.16 177.393 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.529 ' HB2' ' O ' ' A' ' 45' ' ' GLN . 11.2 tt0 -72.09 -56.9 4.81 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 115.762 -0.654 . . . . 0.55000000000000004 109.753 174.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.527 ' HB3' HG22 ' A' ' 56' ' ' VAL . 97.0 mtt180 -61.42 -41.82 97.77 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.574 -0.739 . . . . 0.47999999999999998 111.611 -176.462 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.507 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 92.3 mt -62.05 -35.17 67.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.212 -0.449 . . . . 1.04 110.738 177.368 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -79.59 -36.83 37.52 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.098 -0.501 . . . . 1.0600000000000001 111.615 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 47.8 p -79.39 -29.78 42.2 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.794 0.33 . . . . 0.34999999999999998 111.591 -175.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 108.63 5.89 31.27 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.6 -0.81 . . . . 0.33000000000000002 112.142 -179.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.422 ' HB2' ' HB3' ' A' ' 50' ' ' ARG . 37.1 mt-10 -65.3 -47.89 75.02 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.931 0.396 . . . . 0.65000000000000002 110.117 178.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.527 HG22 ' HB3' ' A' ' 50' ' ' ARG . 14.5 m -136.53 156.44 35.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 109.679 -0.489 . . . . 1.05 109.679 172.241 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.7 m -81.01 161.54 24.2 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.696 -0.483 . . . . 1.3100000000000001 109.696 177.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -57.66 -42.53 83.69 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.025 -0.731 . . . . 0.25 109.025 177.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.46 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 38.6 mt-10 -57.47 -41.16 80.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.891 -1.05 . . . . 1.72 111.649 179.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -66.51 -45.72 78.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.128 0.49 . . . . 2.0899999999999999 110.637 -178.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -71.09 -46.06 62.52 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.077 -0.511 . . . . 1.0700000000000001 111.267 -179.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.69 -50.48 73.7 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.58 0.585 . . . . 1.0600000000000001 112.58 -174.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.584 ' HA ' ' O ' ' A' ' 71' ' ' TYR . 67.5 m -55.83 -25.0 39.76 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 113.132 0.79 . . . . 1.52 113.132 -177.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -105.85 -44.57 4.6 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.275 0.56 . . . . 0.60999999999999999 111.152 -177.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.542 ' HD3' ' HG3' ' A' ' 27' ' ' ARG . 22.6 mmt180 -96.69 -36.59 10.63 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 114.015 1.117 . . . . 0.95999999999999996 114.015 -169.144 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.494 ' HB2' ' HG ' ' A' ' 13' ' ' LEU . 31.7 t -62.48 119.54 9.34 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.977 0.418 . . . . 1.0600000000000001 110.623 -178.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.663 ' HA ' ' CB ' ' A' ' 26' ' ' ARG . 68.6 m-20 -79.05 -4.9 52.47 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.729 -0.669 . . . . 2.2799999999999998 110.749 179.149 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 1.4 m -81.04 161.27 24.27 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.503 0.668 . . . . 2.0499999999999998 110.888 173.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -63.2 -17.64 59.47 Favored Glycine 0 CA--C 1.516 0.149 0 CA-C-N 114.328 -1.306 . . . . 0.29999999999999999 114.119 -173.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.496 ' HB2' ' CA ' ' A' ' 75' ' ' GLY . 2.3 p -67.01 -6.69 18.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 117.207 0.503 . . . . 0.46999999999999997 112.283 177.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.584 ' O ' ' HA ' ' A' ' 63' ' ' SER . 35.2 p90 -52.03 -33.51 38.92 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.136 0.494 . . . . 0.94999999999999996 110.396 174.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -92.36 1.57 57.15 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.058 0.456 . . . . 1.1100000000000001 110.991 -176.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.6 m -115.58 -21.9 9.5 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.147 0.499 . . . . 0.70999999999999996 110.709 -178.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.46 ' O ' ' HA ' ' A' ' 59' ' ' GLU . . . 108.04 15.7 14.0 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.906 -0.664 . . . . 0.67000000000000004 112.02 -175.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.496 ' CA ' ' HB2' ' A' ' 70' ' ' SER . . . 96.65 -9.2 66.43 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.803 -0.713 . . . . 0.42999999999999999 112.885 178.195 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -95.54 145.32 25.3 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.633 0.73 . . . . 1.6499999999999999 111.559 -169.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.459 HD22 ' HE2' ' A' ' 85' ' ' MET . 0.8 OUTLIER -111.96 172.51 6.86 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 114.54 -1.209 . . . . 1.6899999999999999 108.89 171.32 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -92.22 -145.71 16.65 Favored Glycine 0 C--N 1.311 -0.829 0 C-N-CA 120.65 -0.786 . . . . 0.45000000000000001 111.905 -178.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -84.37 140.02 31.86 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.915 -0.402 . . . . 4.7400000000000002 109.915 177.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -152.98 155.6 37.26 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.836 -0.62 . . . . 1.6499999999999999 110.028 -178.241 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 50.5 m -79.74 139.58 37.25 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.463 -0.335 . . . . 1.6899999999999999 110.695 -178.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 33.6 m -61.13 112.87 2.28 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.263 0.554 . . . . 1.55 110.317 179.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 113.82 -11.36 22.99 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.901 -0.666 . . . . 0.79000000000000004 112.023 -177.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -84.93 41.2 0.85 Allowed 'General case' 0 C--O 1.233 0.23 0 CA-C-O 121.657 0.741 . . . . 1.5800000000000001 110.475 -177.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.459 ' HE2' HD22 ' A' ' 77' ' ' LEU . 24.3 mmt -136.82 -127.41 0.14 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.797 -0.638 . . . . 1.1299999999999999 109.342 177.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 63.6 mtt -119.16 153.62 34.59 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 108.133 -1.062 . . . . 1.8899999999999999 108.133 175.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.412 ' HB3' ' HD3' ' A' ' 88' ' ' PRO . 88.4 tttt -52.29 -55.13 34.42 Favored Pre-proline 0 CA--C 1.539 0.526 0 N-CA-C 112.38 0.511 . . . . 2.7400000000000002 112.38 -175.445 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.412 ' HD3' ' HB3' ' A' ' 87' ' ' LYS . 73.4 Cg_endo -74.59 -26.76 11.48 Favored 'Trans proline' 0 C--N 1.357 0.982 0 C-N-CA 121.656 1.57 . . . . 0.29999999999999999 111.976 -176.543 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.606 ' O ' HG21 ' A' ' 93' ' ' VAL . 32.1 t80 -68.31 -56.16 9.57 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.496 -0.774 . . . . 0.28000000000000003 109.416 179.298 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -65.38 -35.17 80.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.72 -0.673 . . . . 2.1200000000000001 109.721 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.582 ' HA ' ' NE ' ' A' ' 94' ' ' ARG . 23.0 t70 -53.79 -33.55 56.31 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.432 -0.804 . . . . 0.60999999999999999 110.978 175.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.551 ' O ' ' HG ' ' A' ' 96' ' ' LEU . . . -84.2 -37.74 21.46 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.408 -0.36 . . . . 1.1000000000000001 111.132 178.571 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.606 HG21 ' O ' ' A' ' 89' ' ' PHE . 15.2 t -61.96 -44.17 98.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-O 121.447 0.641 . . . . 1.1200000000000001 110.723 -177.189 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.582 ' NE ' ' HA ' ' A' ' 91' ' ' ASP . 26.4 ptt180 -74.14 -16.66 60.99 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.606 -0.725 . . . . 3.1800000000000002 110.607 178.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -93.68 12.96 23.67 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.982 -0.554 . . . . 1.0800000000000001 111.51 -174.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.551 ' HG ' ' O ' ' A' ' 92' ' ' ALA . 0.7 OUTLIER -142.14 150.75 41.52 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.152 -0.476 . . . . 1.1200000000000001 110.432 175.396 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.567 ' HA ' ' NH2' ' A' ' 116' ' ' ARG . 23.1 tptm -91.87 164.74 13.56 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.285 -0.635 . . . . 2.1299999999999999 109.285 177.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.44 ' N ' ' HG3' ' A' ' 97' ' ' LYS . 75.7 mt -41.83 115.94 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 123.458 0.474 . . . . 1.6200000000000001 111.38 172.138 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 101.99 -8.07 55.51 Favored Glycine 0 N--CA 1.45 -0.427 0 CA-C-N 115.701 -0.681 . . . . 0.46000000000000002 113.421 177.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.509 ' HB2' ' HB2' ' A' ' 96' ' ' LEU . 40.7 m-20 -99.06 141.22 32.09 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 117.16 0.48 . . . . 0.46000000000000002 110.979 -179.428 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 8.3 mt -106.73 148.67 10.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.016 -0.538 . . . . 1.0800000000000001 110.218 179.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 89.1 p -89.79 150.93 44.88 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 116.245 -0.434 . . . . 1.45 110.671 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -69.88 164.61 34.01 Favored 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 122.379 2.053 . . . . 0.40999999999999998 111.041 171.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.449 HG23 HD21 ' A' ' 44' ' ' LEU . 24.9 mm -40.7 110.94 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 O-C-N 123.75 0.656 . . . . 1.04 112.506 179.577 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.1 p -119.07 123.51 71.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.183 -0.462 . . . . 1.6599999999999999 110.085 175.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -85.73 149.32 25.37 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.098 0.475 . . . . 0.55000000000000004 109.938 177.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 4.4 p -126.56 -172.03 2.54 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.768 -0.651 . . . . 1.05 110.936 -176.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -52.2 -44.36 64.68 Favored 'General case' 0 C--N 1.331 -0.238 0 O-C-N 123.508 0.505 . . . . 2.1600000000000001 110.993 177.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.491 ' O ' ' HB2' ' A' ' 20' ' ' SER . 4.4 m -92.35 -61.14 1.67 Allowed 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 120.05 -0.66 . . . . 1.0900000000000001 112.084 178.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -149.07 -128.35 1.68 Allowed Glycine 0 N--CA 1.438 -1.231 0 C-N-CA 118.749 -1.691 . . . . 0.39000000000000001 113.413 -170.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.476 ' HB3' ' CD2' ' A' ' 44' ' ' LEU . 8.9 mp -116.08 148.88 39.79 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.604 -0.298 . . . . 1.0600000000000001 111.53 -170.572 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . 0.582 ' HA ' ' O ' ' A' ' 13' ' ' LEU . 69.3 m-70 -145.51 150.92 37.32 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.215 0.531 . . . . 0.25 112.023 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.467 HG12 HD11 ' A' ' 44' ' ' LEU . 5.2 pt -130.17 133.87 63.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 107.669 -1.234 . . . . 1.03 107.669 159.659 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 2.8 mp -124.72 144.66 33.9 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 N-CA-C 110.07 -0.345 . . . . 1.0600000000000001 110.07 -176.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.412 ' HA ' ' O ' ' A' ' 100' ' ' ASP . 46.0 pttt -130.42 138.12 50.17 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.932 -0.766 . . . . 1.29 108.932 174.261 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . 0.567 ' NH2' ' HA ' ' A' ' 97' ' ' LYS . 3.6 ttp180 -82.62 135.47 35.05 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.474 -0.49 . . . . 2.6800000000000002 111.236 -177.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.419 HD21 ' HB3' ' A' ' 11' ' ' ALA . 0.3 OUTLIER -102.28 -30.65 10.96 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.69 -0.687 . . . . 1.54 110.974 177.714 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.453 ' O ' ' HD2' ' A' ' 116' ' ' ARG . . . . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.649 -0.691 . . . . 1.1499999999999999 110.689 -178.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 69.3 mmtt . . . . . 0 CA--C 1.518 -0.271 0 CA-C-O 121.527 0.68 . . . . 1.6899999999999999 111.487 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.622 ' O ' ' HA ' ' A' ' 79' ' ' PHE . 3.2 tt -154.61 151.45 28.83 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.01 -1.107 . . . . 1.79 108.01 -176.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.563 ' N ' HD22 ' A' ' 8' ' ' LEU . 65.1 ttt180 -135.05 131.64 37.27 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 108.722 -0.844 . . . . 1.3700000000000001 108.722 173.476 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -148.99 150.9 33.63 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 120.066 -0.653 . . . . 1.0700000000000001 112.337 -175.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -104.42 133.39 49.38 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.318 -0.855 . . . . 1.04 109.057 178.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 26.0 p-80 -135.88 154.66 51.08 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.105 0.479 . . . . 0.34000000000000002 111.714 -172.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.544 HD23 ' N ' ' A' ' 14' ' ' LEU . 5.8 tt -123.93 148.98 46.44 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.538 -0.912 . . . . 1.0600000000000001 108.538 177.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.551 ' HA ' ' O ' ' A' ' 111' ' ' LEU . 24.5 tp -131.21 135.75 47.67 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 110.346 -0.242 . . . . 1.0800000000000001 110.346 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.408 HG21 HD11 ' A' ' 44' ' ' LEU . 57.4 t -121.17 128.98 76.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 N-CA-C 109.619 -0.511 . . . . 1.01 109.619 172.566 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.48 ' HE3' HD21 ' A' ' 14' ' ' LEU . 12.6 mmtp -103.57 148.48 25.94 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.996 -0.547 . . . . 1.22 109.777 178.115 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.471 ' HB3' ' HB1' ' A' ' 40' ' ' ALA . 53.6 p90 -143.75 162.62 35.54 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.144 -0.48 . . . . 0.29999999999999999 110.685 -178.442 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.42 ' HB3' ' HA ' ' A' ' 33' ' ' ALA . 19.7 p -49.46 112.25 0.61 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.144 -0.48 . . . . 1.6000000000000001 111.509 178.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 95.89 8.6 57.97 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.681 -0.771 . . . . 0.53000000000000003 113.56 178.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.45 ' C ' ' H ' ' A' ' 22' ' ' ASN . 77.3 p -91.11 43.3 1.14 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 117.59 0.695 . . . . 1.28 111.002 -177.672 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 74.5 ttt180 73.45 -32.79 0.25 Allowed 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.4 0.68 . . . . 4.1600000000000001 111.418 177.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.45 ' H ' ' C ' ' A' ' 20' ' ' SER . 43.7 m-80 -135.55 100.74 11.16 Favored Pre-proline 0 C--N 1.324 -0.527 0 N-CA-C 109.209 -0.663 . . . . 1.77 109.209 175.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.587 ' C ' HG21 ' A' ' 32' ' ' THR . 92.7 Cg_endo -82.69 41.35 1.1 Allowed 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.372 2.048 . . . . 1.71 112.756 -175.636 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.408 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 89.5 t -141.54 116.88 5.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 108.626 -0.879 . . . . 1.1599999999999999 108.626 177.529 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.545 ' HB2' ' OD1' ' A' ' 67' ' ' ASP . 19.7 p -103.57 154.85 19.04 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 110.286 -0.265 . . . . 1.4299999999999999 110.286 -177.487 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.432 ' CG ' ' HA ' ' A' ' 67' ' ' ASP . 35.2 mmt180 -69.03 -22.97 64.02 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 108.661 -0.866 . . . . 3.1200000000000001 108.661 173.352 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.421 ' HG3' ' HD2' ' A' ' 65' ' ' ARG . 5.3 tmm_? -70.74 -32.85 70.17 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 114.351 -1.295 . . . . 2.25 110.421 -179.209 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 75.4 p -100.04 -35.3 9.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.426 0.632 . . . . 1.1299999999999999 110.795 178.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 65.65 18.26 65.74 Favored Glycine 0 N--CA 1.453 -0.201 0 CA-C-N 114.877 -1.056 . . . . 0.81999999999999995 112.304 -178.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -141.95 -72.0 0.33 Allowed 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.769 -0.456 . . . . 2.1000000000000001 109.769 -179.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.408 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 6.2 p -155.2 148.74 25.2 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.885 -0.598 . . . . 1.3300000000000001 110.115 173.265 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.587 HG21 ' C ' ' A' ' 23' ' ' PRO . 14.5 t -113.42 22.69 13.94 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.939 0.876 . . . . 1.02 109.217 178.01 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.42 ' HA ' ' HB3' ' A' ' 18' ' ' SER . . . -72.58 -6.49 44.44 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.904 -1.044 . . . . 1.1299999999999999 111.719 -177.538 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -96.22 -24.0 16.45 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.108 0.48 . . . . 2.21 111.118 -178.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.453 HG21 ' HB2' ' A' ' 39' ' ' ASP . 0.2 OUTLIER -96.77 135.1 32.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.279 -0.419 . . . . 1.1100000000000001 109.972 179.531 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 59.6 p -96.31 -179.34 4.61 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.348 -0.387 . . . . 1.2 109.957 -175.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.412 ' O ' HG13 ' A' ' 41' ' ' ILE . 4.3 p90 -64.62 -27.22 68.79 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.967 -0.753 . . . . 2.21 108.967 175.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -74.13 -43.31 57.97 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 116.004 -0.544 . . . . 0.95999999999999996 110.412 178.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.453 ' HB2' HG21 ' A' ' 35' ' ' VAL . 19.4 m-20 -65.36 -33.63 76.41 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.523 0.677 . . . . 0.91000000000000003 109.934 175.602 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.471 ' HB1' ' HB3' ' A' ' 17' ' ' PHE . . . -70.79 -46.53 62.69 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.789 -1.096 . . . . 1.03 110.707 -179.631 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.412 HG13 ' O ' ' A' ' 37' ' ' TYR . 68.7 mt -63.18 -36.43 75.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 110.09 -0.337 . . . . 1.0800000000000001 110.09 176.471 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -64.3 -25.18 67.93 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.29 0.567 . . . . 2.8399999999999999 110.021 178.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.459 ' HG3' ' CD1' ' A' ' 47' ' ' TRP . 5.8 tp10 -84.87 -52.32 6.1 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.433 -0.803 . . . . 1.02 109.024 -178.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.485 HD13 HG12 ' A' ' 113' ' ' ILE . 30.9 tp -62.72 -37.57 87.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.045 -0.98 . . . . 1.02 110.535 -175.008 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.452 HE21 ' HA ' ' A' ' 45' ' ' GLN . 0.0 OUTLIER -67.18 -28.93 68.5 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 112.304 0.483 . . . . 0.87 112.304 -177.882 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -78.35 -43.39 27.81 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.636 -0.426 . . . . 1.98 110.131 178.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.459 ' CD1' ' HG3' ' A' ' 43' ' ' GLU . 49.3 m95 -64.48 -47.14 80.09 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 111.974 0.361 . . . . 0.60999999999999999 111.974 176.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.442 ' HB3' HG22 ' A' ' 113' ' ' ILE . 88.7 p -63.99 -25.58 68.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.987 0.422 . . . . 0.88 110.15 177.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.442 ' HB2' ' O ' ' A' ' 45' ' ' GLN . 14.2 tt0 -71.97 -56.13 6.22 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.994 -0.548 . . . . 0.55000000000000004 110.071 175.09 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.508 ' HB3' HG23 ' A' ' 56' ' ' VAL . 97.2 mtt180 -61.12 -41.93 97.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.935 -0.575 . . . . 0.47999999999999998 111.646 -176.443 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.468 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 93.9 mt -60.66 -36.82 73.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 120.976 0.417 . . . . 1.04 110.458 177.224 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -77.99 -37.37 47.39 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.01 -0.541 . . . . 1.0600000000000001 111.426 -179.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 55.4 p -78.69 -29.19 45.39 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.843 0.354 . . . . 0.34999999999999998 111.488 -177.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 106.28 9.56 31.37 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.764 -0.732 . . . . 0.33000000000000002 112.318 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.448 ' HB2' ' HB3' ' A' ' 50' ' ' ARG . 45.4 mt-10 -67.47 -45.11 76.87 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.895 0.379 . . . . 0.65000000000000002 110.348 178.473 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.508 HG23 ' HB3' ' A' ' 50' ' ' ARG . 11.5 m -135.95 154.78 34.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 109.088 -0.708 . . . . 1.05 109.088 171.493 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.5 m -85.65 159.0 19.94 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.191 -0.67 . . . . 1.3100000000000001 109.191 177.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -53.94 -46.97 71.72 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.938 0.399 . . . . 0.25 109.972 -177.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.546 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 48.8 mt-10 -61.58 -26.44 67.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.533 -0.758 . . . . 1.72 112.46 -179.061 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 53.8 mm-40 -72.92 -50.91 20.78 Favored 'General case' 0 CA--C 1.519 -0.223 0 C-N-CA 120.516 -0.473 . . . . 2.0899999999999999 110.358 178.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -67.95 -47.34 68.92 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.185 -0.461 . . . . 1.0700000000000001 111.127 -177.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -57.39 -53.62 56.04 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.217 0.451 . . . . 1.0600000000000001 112.217 -174.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.532 ' HA ' ' O ' ' A' ' 71' ' ' TYR . 23.5 m -52.3 -18.15 1.45 Allowed 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 113.614 0.968 . . . . 1.52 113.614 -178.227 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -110.41 -43.89 3.81 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-O 121.577 0.703 . . . . 0.60999999999999999 110.309 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.428 ' HG3' ' CE2' ' A' ' 47' ' ' TRP . 15.5 mmt180 -96.34 -36.86 10.72 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 114.212 1.19 . . . . 0.95999999999999996 114.212 -170.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.443 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 52.6 p -63.37 116.0 5.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.263 0.554 . . . . 1.0600000000000001 110.362 -176.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.545 ' OD1' ' HB2' ' A' ' 25' ' ' SER . 57.3 m-20 -84.71 9.68 13.3 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.536 -0.756 . . . . 2.2799999999999998 111.123 -177.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 1.1 m -80.95 -177.33 6.36 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.666 -0.697 . . . . 2.0499999999999998 110.294 170.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -76.09 -21.0 76.92 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.358 -0.925 . . . . 0.29999999999999999 111.699 175.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 71.2 p -65.84 0.46 1.77 Allowed 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 113.227 0.825 . . . . 0.46999999999999997 113.227 -178.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.532 ' O ' ' HA ' ' A' ' 63' ' ' SER . 27.7 p90 -62.94 -22.6 66.9 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 118.361 0.528 . . . . 0.94999999999999996 109.928 176.384 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -94.24 -2.94 51.58 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.382 0.61 . . . . 1.1100000000000001 110.087 177.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.6 m -115.49 1.01 13.54 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.296 -0.865 . . . . 0.70999999999999996 110.596 -175.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.546 ' O ' ' HA ' ' A' ' 59' ' ' GLU . . . 72.9 21.84 79.52 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.935 -0.65 . . . . 0.67000000000000004 111.998 -176.434 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 86.28 -20.58 21.04 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 121.026 -0.606 . . . . 0.42999999999999999 112.099 -177.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -69.93 132.04 45.34 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-N 115.553 -0.323 . . . . 1.6499999999999999 110.984 -176.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.489 ' O ' ' HG3' ' A' ' 9' ' ' ARG . 2.9 mp -118.17 161.82 19.24 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.248 0.547 . . . . 1.6899999999999999 110.283 174.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -85.71 -165.46 40.6 Favored Glycine 0 C--N 1.31 -0.913 0 CA-C-N 114.899 -1.046 . . . . 0.45000000000000001 112.834 -178.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.622 ' HA ' ' O ' ' A' ' 8' ' ' LEU . 85.0 m-85 -73.91 142.97 45.94 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.271 0.558 . . . . 4.7400000000000002 112.221 -176.301 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.528 ' CE1' ' HB3' ' A' ' 8' ' ' LEU . 2.3 p90 -149.69 167.93 25.03 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.964 -1.016 . . . . 1.6499999999999999 108.787 176.336 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 37.3 m -96.63 122.46 39.57 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 108.478 -0.934 . . . . 1.6899999999999999 108.478 170.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 4.6 p -47.14 123.05 4.97 Favored 'General case' 0 C--N 1.329 -0.306 0 O-C-N 123.662 0.602 . . . . 1.55 111.409 -179.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 114.49 17.78 6.91 Favored Glycine 0 N--CA 1.445 -0.766 0 N-CA-C 110.911 -0.875 . . . . 0.79000000000000004 110.911 -174.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -115.09 -17.02 11.54 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 120.587 0.232 . . . . 1.5800000000000001 111.173 -178.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 26.4 mmt -86.22 -92.37 0.09 Allowed 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.315 -0.554 . . . . 1.1299999999999999 110.895 -173.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' MET . . . . . 0.491 ' HB2' ' CB ' ' A' ' 89' ' ' PHE . 45.6 mtt -144.22 155.34 43.84 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 107.228 -1.397 . . . . 1.8899999999999999 107.228 177.06 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp -57.95 -53.54 64.72 Favored Pre-proline 0 C--N 1.317 -0.847 0 C-N-CA 120.274 -0.57 . . . . 2.7400000000000002 112.059 -176.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.457 ' HG2' HG22 ' A' ' 107' ' ' THR . 73.4 Cg_endo -74.81 -30.12 7.85 Favored 'Trans proline' 0 C--N 1.356 0.962 0 C-N-CA 121.736 1.624 . . . . 0.29999999999999999 111.855 -179.315 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.612 ' O ' HG22 ' A' ' 93' ' ' VAL . 11.2 t80 -61.97 -56.14 22.19 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.561 -0.745 . . . . 0.28000000000000003 109.181 176.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.15 -33.32 74.28 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.284 -0.871 . . . . 2.1200000000000001 110.5 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -60.55 -32.58 71.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.676 -0.693 . . . . 0.60999999999999999 110.581 178.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.427 ' O ' ' HG ' ' A' ' 96' ' ' LEU . . . -83.86 -31.18 25.9 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.0 -0.545 . . . . 1.1000000000000001 111.055 178.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.612 HG22 ' O ' ' A' ' 89' ' ' PHE . 20.2 t -68.8 -38.48 78.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.404 0.621 . . . . 1.1200000000000001 109.781 -176.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.45 ' C ' ' HD2' ' A' ' 94' ' ' ARG . 2.8 ppt_? -79.44 -1.31 36.75 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.522 -0.763 . . . . 3.1800000000000002 110.61 178.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -103.6 9.94 37.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 1.0800000000000001 111.285 -177.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.521 ' HB2' ' HB2' ' A' ' 100' ' ' ASP . 1.0 OUTLIER -145.96 146.26 30.96 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.354 -0.385 . . . . 1.1200000000000001 110.965 179.51 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.413 ' HG3' ' N ' ' A' ' 98' ' ' ILE . 56.6 tptt -91.01 168.98 11.26 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.773 -0.825 . . . . 2.1299999999999999 108.773 177.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.431 ' HA ' ' HG2' ' A' ' 116' ' ' ARG . 72.0 mt -45.43 116.94 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.111 0.481 . . . . 1.6200000000000001 111.234 173.593 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 103.47 -11.8 54.3 Favored Glycine 0 N--CA 1.449 -0.438 0 CA-C-N 115.54 -0.755 . . . . 0.46000000000000002 113.115 178.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.521 ' HB2' ' HB2' ' A' ' 96' ' ' LEU . 14.6 m-20 -93.96 144.28 25.6 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 117.191 0.496 . . . . 0.46000000000000002 110.716 -179.594 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 10.0 mt -112.62 147.93 16.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.756 -0.656 . . . . 1.0800000000000001 109.67 -179.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 91.4 p -89.89 157.41 46.11 Favored Pre-proline 0 C--N 1.319 -0.733 0 CA-C-N 116.356 -0.384 . . . . 1.45 110.365 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -74.23 173.82 13.53 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 122.267 1.978 . . . . 0.40999999999999998 111.132 171.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.44 HG23 HD23 ' A' ' 44' ' ' LEU . 21.9 mm -46.51 113.4 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-O 121.133 0.492 . . . . 1.04 112.019 176.266 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 93.4 t -111.72 117.77 55.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.91 -0.586 . . . . 1.6599999999999999 109.831 174.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -86.04 137.97 32.3 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.107 0.48 . . . . 0.55000000000000004 110.278 177.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.457 HG22 ' HG2' ' A' ' 88' ' ' PRO . 20.1 p -123.77 -172.23 2.49 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.664 -0.698 . . . . 1.05 110.21 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -66.67 -44.24 82.38 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.664 0.269 . . . . 2.1600000000000001 110.996 178.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 5.3 t -95.63 -1.41 50.3 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.302 0.482 . . . . 1.0900000000000001 112.302 -173.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 157.67 -124.68 1.44 Allowed Glycine 0 N--CA 1.437 -1.277 0 C-N-CA 119.775 -1.202 . . . . 0.39000000000000001 112.995 170.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.551 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 6.6 mp -127.9 145.66 50.88 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.112 -0.544 . . . . 1.0600000000000001 110.807 -170.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . 0.54 ' NE2' HD11 ' A' ' 14' ' ' LEU . 80.8 m-70 -143.95 143.06 31.07 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.486 0.551 . . . . 0.25 112.486 -178.276 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.485 HG12 HD13 ' A' ' 44' ' ' LEU . 3.9 pt -127.07 141.55 45.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 107.884 -1.154 . . . . 1.03 107.884 161.113 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 2.8 mp -132.35 148.47 31.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 C-N-CA 120.976 -0.29 . . . . 1.0600000000000001 110.396 -175.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 44.9 pttt -131.62 139.32 49.11 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.016 -0.735 . . . . 1.29 109.016 172.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . 0.431 ' HG2' ' HA ' ' A' ' 98' ' ' ILE . 5.9 ttp180 -84.1 136.48 33.99 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.104 0.478 . . . . 2.6800000000000002 111.494 -178.507 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -107.09 -27.96 10.28 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.295 -0.866 . . . . 1.54 110.743 177.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.868 0 CA-C-O 118.291 -0.862 . . . . 1.1499999999999999 110.452 179.691 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt . . . . . 0 N--CA 1.45 -0.442 0 CA-C-O 121.859 0.838 . . . . 1.6899999999999999 111.532 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.521 HD22 ' H ' ' A' ' 9' ' ' ARG . 2.4 tt -119.53 159.92 23.4 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 114.242 -1.345 . . . . 1.79 107.883 179.805 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.521 ' H ' HD22 ' A' ' 8' ' ' LEU . 63.2 ttt180 -140.46 127.07 20.26 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 108.869 -0.789 . . . . 1.3700000000000001 108.869 175.759 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.426 ' N ' ' HZ ' ' A' ' 80' ' ' PHE . . . -141.09 154.1 45.76 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 120.31 -0.556 . . . . 1.0700000000000001 112.231 -179.453 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.465 ' HA ' ' HA ' ' A' ' 76' ' ' ASP . . . -104.46 134.81 47.04 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.334 -0.848 . . . . 1.04 108.922 174.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 16.7 p-80 -141.59 138.51 32.67 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.969 0.414 . . . . 0.34000000000000002 111.125 -171.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.555 ' O ' ' HA ' ' A' ' 112' ' ' HIS . 6.0 tt -109.43 137.31 47.48 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.326 -0.99 . . . . 1.0600000000000001 108.326 177.378 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.587 HD12 ' NE2' ' A' ' 112' ' ' HIS . 17.4 tp -120.23 135.03 55.12 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.615 -0.266 . . . . 1.0800000000000001 110.837 -176.515 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.423 HG23 HD12 ' A' ' 44' ' ' LEU . 83.4 t -121.89 133.62 67.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 109.854 -0.424 . . . . 1.01 109.854 174.293 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.518 ' HE3' HD22 ' A' ' 14' ' ' LEU . 32.7 mmtp -104.76 149.75 25.35 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.917 -0.583 . . . . 1.22 110.495 177.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.525 ' HB3' ' HB3' ' A' ' 40' ' ' ALA . 49.9 p90 -145.4 163.04 35.85 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.702 -0.681 . . . . 0.29999999999999999 109.674 179.456 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.446 ' HB3' ' HA ' ' A' ' 33' ' ' ALA . 29.9 p -51.67 109.35 0.35 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.923 0.392 . . . . 1.6000000000000001 110.425 176.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 109.93 9.28 24.7 Favored Glycine 0 CA--C 1.523 0.585 0 C-N-CA 120.625 -0.798 . . . . 0.53000000000000003 112.795 -176.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.516 ' C ' ' H ' ' A' ' 22' ' ' ASN . 75.4 m -90.2 34.24 0.87 Allowed 'General case' 0 C--O 1.235 0.3 0 N-CA-C 112.359 0.503 . . . . 1.28 112.359 -177.599 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.451 ' HB3' ' O ' ' A' ' 20' ' ' SER . 20.8 ttt85 72.94 -30.33 0.21 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 122.925 0.49 . . . . 4.1600000000000001 110.917 -179.686 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.516 ' H ' ' C ' ' A' ' 20' ' ' SER . 6.1 p30 -146.96 114.54 4.29 Favored Pre-proline 0 C--N 1.322 -0.618 0 N-CA-C 108.843 -0.799 . . . . 1.77 108.843 172.34 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.448 ' C ' HG21 ' A' ' 32' ' ' THR . 93.6 Cg_endo -86.21 52.5 2.91 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 122.573 2.182 . . . . 1.71 113.403 -173.009 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 61.0 t -142.53 119.78 6.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 109.342 -0.614 . . . . 1.1599999999999999 109.342 177.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.447 ' HB3' ' HB2' ' A' ' 16' ' ' LYS . 13.5 p -103.83 156.08 18.11 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 121.211 -0.196 . . . . 1.4299999999999999 110.886 -179.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.63 ' HB2' ' HA ' ' A' ' 67' ' ' ASP . 1.7 mpt_? -69.82 -16.99 63.37 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 109.155 -0.683 . . . . 3.1200000000000001 109.155 173.443 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.463 ' HG2' ' HA ' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -82.42 -25.5 33.62 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.896 -1.047 . . . . 2.25 111.008 -178.629 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 73.3 p -105.33 -36.05 7.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.244 0.545 . . . . 1.1299999999999999 110.934 178.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 76.27 -21.63 2.24 Favored Glycine 0 CA--C 1.52 0.395 0 CA-C-N 115.308 -0.86 . . . . 0.81999999999999995 112.983 -179.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -101.76 -76.15 0.58 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.119 0.485 . . . . 2.1000000000000001 110.043 -179.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 21.4 m -154.75 151.47 28.73 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.804 -0.635 . . . . 1.3300000000000001 109.885 175.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.448 HG21 ' C ' ' A' ' 23' ' ' PRO . 12.4 t -113.8 23.0 13.46 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 122.181 0.991 . . . . 1.02 109.145 177.478 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.446 ' HA ' ' HB3' ' A' ' 18' ' ' SER . . . -71.71 -5.6 35.07 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.715 -1.129 . . . . 1.1299999999999999 111.401 -178.555 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -99.09 -15.24 19.07 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.602 -0.726 . . . . 2.21 110.688 -175.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -105.57 138.44 30.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.93 -0.577 . . . . 1.1100000000000001 109.704 179.772 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 62.4 p -94.77 -179.48 4.87 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.395 -0.366 . . . . 1.2 110.014 -175.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.519 ' O ' HG13 ' A' ' 41' ' ' ILE . 15.4 p90 -63.65 -28.35 69.85 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 119.986 -0.686 . . . . 2.21 109.223 176.302 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -75.11 -44.66 45.92 Favored 'General case' 0 CA--C 1.522 -0.132 0 CA-C-N 116.182 -0.463 . . . . 0.95999999999999996 110.682 178.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -62.87 -33.29 74.98 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.479 0.656 . . . . 0.91000000000000003 109.639 176.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.525 ' HB3' ' HB3' ' A' ' 17' ' ' PHE . . . -68.6 -44.64 73.91 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.944 -1.026 . . . . 1.03 110.671 178.269 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.519 HG13 ' O ' ' A' ' 37' ' ' TYR . 90.2 mt -63.28 -35.04 70.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 109.612 -0.514 . . . . 1.0800000000000001 109.612 175.023 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.421 ' HA ' ' HD2' ' A' ' 42' ' ' LYS . 23.5 mmmt -64.67 -21.29 66.7 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.072 -0.513 . . . . 2.8399999999999999 111.06 176.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.402 ' HG3' ' CD1' ' A' ' 47' ' ' TRP . 2.0 tp10 -88.57 -57.46 2.91 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.881 -0.6 . . . . 1.02 109.561 178.04 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.493 HD11 HG12 ' A' ' 113' ' ' ILE . 27.7 tp -58.8 -36.78 75.02 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.404 -0.816 . . . . 1.02 111.469 -175.302 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.524 ' O ' ' HB2' ' A' ' 49' ' ' GLN . 4.8 mm-40 -66.45 -26.5 67.24 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 112.23 0.456 . . . . 0.87 112.23 -177.397 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.404 ' HE3' ' O ' ' A' ' 42' ' ' LYS . 96.7 mttt -78.88 -45.52 20.46 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.101 0.476 . . . . 1.98 109.832 178.08 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.402 ' CD1' ' HG3' ' A' ' 43' ' ' GLU . 24.3 m95 -67.21 -43.52 81.85 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.799 -0.637 . . . . 0.60999999999999999 111.554 -178.095 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.474 ' HB3' HG22 ' A' ' 113' ' ' ILE . 97.2 p -67.18 -27.75 67.53 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 120.935 0.397 . . . . 0.88 109.969 177.211 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.524 ' HB2' ' O ' ' A' ' 45' ' ' GLN . 8.9 tt0 -67.58 -52.94 32.61 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 115.933 -0.576 . . . . 0.55000000000000004 109.638 175.611 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.479 ' HB3' HG21 ' A' ' 56' ' ' VAL . 91.6 mtt180 -60.97 -42.35 98.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.705 -0.68 . . . . 0.47999999999999998 111.556 -178.51 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.432 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 78.4 mt -60.29 -40.74 84.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.94 0.4 . . . . 1.04 110.744 177.354 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.4 -39.0 65.42 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.941 -0.572 . . . . 1.0600000000000001 111.979 179.035 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 74.7 p -79.75 -29.37 40.48 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 111.809 0.3 . . . . 0.34999999999999998 111.809 -175.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 109.11 4.27 31.18 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.599 -0.81 . . . . 0.33000000000000002 112.898 179.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.436 ' HB2' ' HB3' ' A' ' 50' ' ' ARG . 46.7 mt-10 -62.05 -47.01 86.59 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.089 0.471 . . . . 0.65000000000000002 110.084 177.443 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.479 HG21 ' HB3' ' A' ' 50' ' ' ARG . 10.2 m -134.9 159.0 41.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.821 -0.627 . . . . 1.05 109.378 171.743 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 19.7 m -92.98 161.96 14.25 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 109.562 -0.533 . . . . 1.3100000000000001 109.562 177.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -54.19 -48.19 71.26 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.728 0.299 . . . . 0.25 110.452 -175.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.451 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 43.6 mt-10 -56.4 -40.36 74.51 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.739 -0.664 . . . . 1.72 111.948 179.469 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -63.82 -50.25 69.67 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.0 0.429 . . . . 2.0899999999999999 110.738 -178.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -68.91 -46.5 68.14 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.877 -0.602 . . . . 1.0700000000000001 111.132 -177.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.405 ' O ' ' HB3' ' A' ' 66' ' ' SER . . . -60.12 -46.28 90.15 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.648 0.61 . . . . 1.0600000000000001 112.648 -173.304 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.483 ' HA ' ' HA ' ' A' ' 71' ' ' TYR . 20.4 m -57.75 -20.36 34.39 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.781 0.66 . . . . 1.52 112.781 -178.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -110.72 -46.58 3.35 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.521 0.677 . . . . 0.60999999999999999 110.726 -178.331 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.463 ' HA ' ' HG2' ' A' ' 27' ' ' ARG . 18.8 mmt180 -90.17 -37.65 14.03 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.963 -1.017 . . . . 0.95999999999999996 113.174 -170.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.447 ' O ' ' HB3' ' A' ' 71' ' ' TYR . 42.7 t -64.36 115.71 5.36 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.243 0.544 . . . . 1.0600000000000001 110.953 -177.57 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.63 ' HA ' ' HB2' ' A' ' 26' ' ' ARG . 44.5 m-20 -82.28 10.16 7.49 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.416 -0.811 . . . . 2.2799999999999998 111.024 179.589 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . 0.479 ' O ' ' HD1' ' A' ' 71' ' ' TYR . 49.6 t -93.34 166.34 12.34 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.07 -0.513 . . . . 2.0499999999999998 109.728 172.458 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -56.19 -26.83 50.94 Favored Glycine 0 CA--C 1.519 0.293 0 O-C-N 123.41 0.444 . . . . 0.29999999999999999 113.315 -177.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.521 ' HB2' ' CA ' ' A' ' 75' ' ' GLY . 2.6 p -61.83 -8.26 4.68 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 112.849 0.685 . . . . 0.46999999999999997 112.849 -179.565 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.483 ' HA ' ' HA ' ' A' ' 63' ' ' SER . 15.5 p90 -59.46 -29.73 68.01 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 108.979 -0.749 . . . . 0.94999999999999996 108.979 174.112 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -95.33 8.59 42.69 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.741 -0.663 . . . . 1.1100000000000001 111.045 179.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 5.0 m -125.29 -20.87 4.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.626 -0.261 . . . . 0.70999999999999996 111.435 -177.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.451 ' O ' ' HA ' ' A' ' 59' ' ' GLU . . . 109.42 15.95 11.74 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.624 -0.798 . . . . 0.67000000000000004 112.343 -177.602 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.521 ' CA ' ' HB2' ' A' ' 70' ' ' SER . . . 89.63 -12.99 65.33 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.75 -0.738 . . . . 0.42999999999999999 113.04 177.701 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.465 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 10.6 p-10 -106.35 144.56 32.86 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.507 0.67 . . . . 1.6499999999999999 111.372 -171.266 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -105.74 174.48 5.86 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.756 -1.111 . . . . 1.6899999999999999 109.725 176.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -90.63 -143.75 11.34 Favored Glycine 0 C--N 1.315 -0.614 0 C-N-CA 121.019 -0.61 . . . . 0.45000000000000001 112.232 -179.15 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -88.31 123.77 33.23 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.018 0.437 . . . . 4.7400000000000002 110.621 178.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.426 ' HZ ' ' N ' ' A' ' 10' ' ' ALA . 2.3 p90 -137.82 146.45 43.51 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.887 -0.597 . . . . 1.6499999999999999 110.351 -179.515 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 36.6 m -76.19 137.88 40.31 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 120.829 0.347 . . . . 1.6899999999999999 110.096 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 16.7 m -63.92 118.99 9.2 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.984 -0.553 . . . . 1.55 111.332 -175.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 114.49 -5.34 23.06 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.986 -0.626 . . . . 0.79000000000000004 112.387 -178.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -104.24 59.96 0.72 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.255 0.55 . . . . 1.5800000000000001 110.682 -179.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 23.0 mmt -144.03 -97.46 0.11 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.031 0.443 . . . . 1.1299999999999999 110.453 177.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 63.6 mtt -146.32 151.04 36.88 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.015 -1.106 . . . . 1.8899999999999999 108.015 173.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.405 ' HB3' ' HD3' ' A' ' 88' ' ' PRO . 23.1 tptm -52.98 -53.16 58.31 Favored Pre-proline 0 C--N 1.319 -0.738 0 N-CA-C 112.445 0.535 . . . . 2.7400000000000002 112.445 -176.231 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.405 ' HD3' ' HB3' ' A' ' 87' ' ' LYS . 75.6 Cg_endo -77.77 -26.04 7.23 Favored 'Trans proline' 0 C--N 1.356 0.938 0 C-N-CA 121.734 1.623 . . . . 0.29999999999999999 112.587 -176.501 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.542 ' O ' HG21 ' A' ' 93' ' ' VAL . 43.6 t80 -73.26 -55.24 6.7 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.805 -0.634 . . . . 0.28000000000000003 109.824 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -64.27 -35.12 79.81 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.241 -0.891 . . . . 2.1200000000000001 110.022 -178.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.561 ' HA ' ' CZ ' ' A' ' 94' ' ' ARG . 15.6 t70 -50.16 -40.85 47.92 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.735 -0.666 . . . . 0.60999999999999999 110.795 175.107 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.586 ' O ' ' HG ' ' A' ' 96' ' ' LEU . . . -78.24 -30.74 48.84 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.098 -0.501 . . . . 1.1000000000000001 111.184 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.542 HG21 ' O ' ' A' ' 89' ' ' PHE . 26.3 t -63.39 -47.74 90.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.676 -0.238 . . . . 1.1200000000000001 111.244 -174.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.561 ' CZ ' ' HA ' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -83.75 -4.92 59.02 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.247 -0.581 . . . . 3.1800000000000002 110.582 -179.476 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.27 -20.68 40.4 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.057 0.456 . . . . 1.0800000000000001 110.906 -179.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.586 ' HG ' ' O ' ' A' ' 92' ' ' ALA . 0.7 OUTLIER -121.02 147.37 45.59 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.969 -0.559 . . . . 1.1200000000000001 110.441 -179.909 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.412 ' HG3' ' N ' ' A' ' 98' ' ' ILE . 51.3 tptt -90.19 172.67 8.63 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.438 -0.578 . . . . 2.1299999999999999 109.438 -179.519 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.415 ' HA ' ' HG2' ' A' ' 116' ' ' ARG . 71.4 mt -48.26 113.67 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.934 0.397 . . . . 1.6200000000000001 111.377 176.233 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 101.78 -3.69 52.94 Favored Glycine 0 CA--C 1.522 0.481 0 C-N-CA 120.939 -0.648 . . . . 0.46000000000000002 113.913 178.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.552 ' HB2' ' HB2' ' A' ' 96' ' ' LEU . 26.1 m-20 -99.15 142.47 30.6 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 117.599 0.7 . . . . 0.46000000000000002 110.353 178.565 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 8.9 mt -109.69 152.32 11.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.428 -0.351 . . . . 1.0800000000000001 110.307 -178.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 4.7 p -101.35 148.34 35.04 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-O 121.007 0.432 . . . . 1.45 111.555 -178.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -68.94 159.85 52.23 Favored 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.697 2.265 . . . . 0.40999999999999998 111.145 171.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.452 HG21 HD21 ' A' ' 44' ' ' LEU . 22.1 mm -39.26 112.19 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 O-C-N 123.823 0.702 . . . . 1.04 112.557 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 1.9 p -116.37 128.1 73.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.813 -0.63 . . . . 1.6599999999999999 110.128 175.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -90.53 138.37 31.61 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 121.247 0.546 . . . . 0.55000000000000004 110.15 178.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.403 HG22 ' HG2' ' A' ' 88' ' ' PRO . 11.5 p -116.35 -175.91 2.85 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.577 -0.738 . . . . 1.05 110.68 -177.316 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -57.99 -42.21 84.66 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 123.287 0.367 . . . . 2.1600000000000001 111.009 179.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.437 ' OG ' ' HE2' ' A' ' 16' ' ' LYS . 24.5 t -85.16 -61.38 1.78 Allowed 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 116.493 -0.321 . . . . 1.0900000000000001 110.56 179.394 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -154.39 -128.68 1.22 Allowed Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 119.399 -1.381 . . . . 0.39000000000000001 113.39 -174.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.407 ' HB3' HD22 ' A' ' 44' ' ' LEU . 5.8 mp -112.35 145.43 40.08 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 122.379 0.272 . . . . 1.0600000000000001 111.676 -171.795 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . 0.587 ' NE2' HD12 ' A' ' 14' ' ' LEU . 76.5 m-70 -142.2 153.36 43.95 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 112.947 0.721 . . . . 0.25 112.947 178.001 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.493 HG12 HD11 ' A' ' 44' ' ' LEU . 4.3 pt -131.38 134.74 60.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 114.347 -1.297 . . . . 1.03 107.684 159.67 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.4 HD11 ' HB2' ' A' ' 92' ' ' ALA . 1.5 mp -128.14 146.22 34.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 C-N-CA 120.734 -0.386 . . . . 1.0600000000000001 110.905 -176.126 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 37.2 pttt -129.5 141.06 51.08 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.346 -0.983 . . . . 1.29 108.346 170.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . 0.483 ' HD3' HD21 ' A' ' 8' ' ' LEU . 4.7 ttp180 -82.22 134.9 35.32 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.255 -0.578 . . . . 2.6800000000000002 110.857 -179.189 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -103.07 -35.1 8.64 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.191 -0.913 . . . . 1.54 110.286 -179.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.937 0 CA-C-O 118.555 -0.736 . . . . 1.1499999999999999 110.485 -179.607 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.475 ' HA ' ' O ' ' A' ' 80' ' ' PHE . 73.2 mmtt . . . . . 0 N--CA 1.449 -0.477 0 CA-C-O 121.748 0.785 . . . . 1.6899999999999999 110.415 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.647 ' HB3' ' CE1' ' A' ' 80' ' ' PHE . 2.8 tt -100.62 155.5 17.84 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 113.878 -1.51 . . . . 1.79 108.489 -178.044 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.54 ' N ' HD23 ' A' ' 8' ' ' LEU . 71.8 ttt180 -132.65 127.97 36.03 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 108.674 -0.861 . . . . 1.3700000000000001 108.674 170.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -146.4 153.8 40.89 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.258 -0.577 . . . . 1.0700000000000001 112.095 -175.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -106.16 136.66 45.47 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.382 -0.826 . . . . 1.04 109.417 178.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 35.7 p-80 -137.15 149.48 47.32 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.917 0.389 . . . . 0.34000000000000002 111.321 -173.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.677 ' O ' ' HA ' ' A' ' 112' ' ' HIS . 5.2 tt -123.09 131.75 53.82 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.818 -0.808 . . . . 1.0600000000000001 108.818 179.293 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.596 HD11 ' NE2' ' A' ' 112' ' ' HIS . 25.6 tp -116.57 123.51 47.53 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.493 -0.321 . . . . 1.0800000000000001 110.767 -177.531 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.455 HG21 HD12 ' A' ' 44' ' ' LEU . 63.3 t -110.84 134.04 54.42 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 N-CA-C 109.349 -0.611 . . . . 1.01 109.349 173.522 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.493 ' HE2' ' OG ' ' A' ' 109' ' ' SER . 30.4 mmtp -105.91 154.3 20.76 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.492 -0.558 . . . . 1.22 109.492 178.703 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.435 ' HB3' ' HB3' ' A' ' 40' ' ' ALA . 48.9 p90 -146.53 160.57 41.96 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.801 0.334 . . . . 0.29999999999999999 110.954 -177.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.3 t -52.56 112.21 0.78 Allowed 'General case' 0 N--CA 1.435 -1.193 0 CA-C-N 115.997 -0.547 . . . . 1.6000000000000001 111.323 178.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 100.46 2.86 55.52 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.605 -0.807 . . . . 0.53000000000000003 113.205 177.033 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.448 ' C ' ' H ' ' A' ' 22' ' ' ASN . 91.3 p -90.19 40.15 1.0 Allowed 'General case' 0 C--O 1.234 0.277 0 CA-C-N 117.62 0.71 . . . . 1.28 111.086 -176.109 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.407 ' CZ ' ' HB2' ' A' ' 108' ' ' ASP . 96.3 mtt180 72.2 -32.85 0.25 Allowed 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.36 0.664 . . . . 4.1600000000000001 111.771 178.291 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.448 ' H ' ' C ' ' A' ' 20' ' ' SER . 52.5 m-80 -136.99 93.11 13.64 Favored Pre-proline 0 C--N 1.326 -0.453 0 N-CA-C 109.308 -0.627 . . . . 1.77 109.308 175.802 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.579 ' C ' HG23 ' A' ' 32' ' ' THR . 95.5 Cg_endo -83.69 51.72 3.57 Favored 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 122.546 2.164 . . . . 1.71 113.233 -174.51 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.471 ' N ' HG23 ' A' ' 32' ' ' THR . 61.2 t -144.89 118.56 2.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 109.323 -0.621 . . . . 1.1599999999999999 109.323 177.133 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 23.5 p -105.18 153.07 22.05 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 110.503 -0.184 . . . . 1.4299999999999999 110.503 178.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.574 ' HB2' ' HA ' ' A' ' 67' ' ' ASP . 7.4 mpt_? -66.2 -10.22 39.55 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.007 0.432 . . . . 3.1200000000000001 110.565 173.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.57 ' HG3' ' CD ' ' A' ' 65' ' ' ARG . 17.6 ttp180 -75.59 -41.12 55.37 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.812 -0.631 . . . . 2.25 109.506 176.288 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.407 ' C ' ' H ' ' A' ' 30' ' ' ASP . 40.0 p -95.79 -35.41 11.53 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.234 -0.894 . . . . 1.1299999999999999 111.231 -175.122 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 78.03 -35.07 1.69 Allowed Glycine 0 CA--C 1.518 0.244 0 CA-C-N 115.341 -0.845 . . . . 0.81999999999999995 112.637 178.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.407 ' H ' ' C ' ' A' ' 28' ' ' THR . 17.2 t70 -94.88 -69.39 0.75 Allowed 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 110.177 -0.305 . . . . 2.1000000000000001 110.177 -179.71 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 10.1 p -154.83 150.46 27.52 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.094 0.474 . . . . 1.3300000000000001 111.043 176.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.579 HG23 ' C ' ' A' ' 23' ' ' PRO . 13.8 t -113.44 30.26 7.36 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 122.349 1.071 . . . . 1.02 108.891 177.5 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.24 -3.47 49.32 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.475 -1.239 . . . . 1.1299999999999999 112.031 -175.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -92.87 -24.61 18.41 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.482 0.658 . . . . 2.21 109.979 177.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -98.02 135.93 30.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.284 -0.871 . . . . 1.1100000000000001 110.281 -179.458 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 34.0 p -96.19 -179.53 4.7 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.094 -0.503 . . . . 1.2 109.769 -176.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.545 ' O ' HG13 ' A' ' 41' ' ' ILE . 0.1 OUTLIER -64.87 -23.63 67.29 Favored 'General case' 0 C--O 1.222 -0.348 0 C-N-CA 119.04 -1.064 . . . . 2.21 110.026 173.505 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.454 ' N ' ' HD1' ' A' ' 37' ' ' TYR . 34.4 mt-10 -70.89 -46.93 61.71 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.649 -0.5 . . . . 0.95999999999999996 109.649 176.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -70.76 -28.88 65.01 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.066 0.46 . . . . 0.91000000000000003 110.404 176.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.435 ' HB3' ' HB3' ' A' ' 17' ' ' PHE . . . -66.32 -45.65 79.56 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.728 -0.669 . . . . 1.03 109.825 175.157 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.545 HG13 ' O ' ' A' ' 37' ' ' TYR . 72.9 mt -64.98 -38.41 82.72 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.382 0 CA-C-N 116.064 -0.517 . . . . 1.0800000000000001 109.7 174.101 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.423 ' O ' ' HG3' ' A' ' 46' ' ' LYS . 3.6 ttpm? -64.78 -20.94 66.64 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.863 -0.608 . . . . 2.8399999999999999 110.233 179.652 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.408 ' HG3' ' CD1' ' A' ' 47' ' ' TRP . 1.7 tp10 -88.29 -56.85 3.15 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.305 -0.628 . . . . 1.02 109.305 176.569 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.539 HD22 ' HB3' ' A' ' 111' ' ' LEU . 19.5 tp -58.92 -35.9 73.83 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.03 -0.986 . . . . 1.02 110.895 -174.479 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.445 ' HG2' HG13 ' A' ' 104' ' ' ILE . 4.6 mm-40 -64.42 -39.57 94.09 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-N 116.391 -0.368 . . . . 0.87 111.962 -178.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.458 ' O ' ' HG3' ' A' ' 50' ' ' ARG . 60.7 mttm -70.09 -43.77 70.43 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 110.122 -0.325 . . . . 1.98 110.122 -178.576 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.44 ' NE1' ' HG3' ' A' ' 65' ' ' ARG . 64.6 m95 -65.79 -46.38 78.93 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.479 -0.328 . . . . 0.60999999999999999 111.454 175.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 36.5 t -57.96 -34.0 69.45 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.755 -0.461 . . . . 0.88 109.755 176.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 -66.75 -56.84 8.71 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 115.907 -0.588 . . . . 0.55000000000000004 110.555 175.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.529 ' HB3' HG22 ' A' ' 56' ' ' VAL . 93.6 mtt180 -61.21 -42.12 98.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.676 -0.693 . . . . 0.47999999999999998 111.368 -175.634 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.43 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 98.2 mt -60.71 -39.43 81.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 120.96 0.409 . . . . 1.04 110.506 176.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.26 -39.92 65.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.979 -0.555 . . . . 1.0600000000000001 111.663 -179.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 55.8 p -78.61 -30.5 46.56 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.931 0.396 . . . . 0.34999999999999998 111.547 -177.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 107.61 9.25 29.2 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.727 -0.749 . . . . 0.33000000000000002 112.057 -178.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.496 ' HB2' ' HB3' ' A' ' 50' ' ' ARG . 43.1 mt-10 -64.9 -44.26 90.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.115 0.483 . . . . 0.65000000000000002 110.102 177.683 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.529 HG22 ' HB3' ' A' ' 50' ' ' ARG . 22.3 m -138.16 153.69 27.2 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.451 0 CA-C-N 115.791 -0.64 . . . . 1.05 109.456 173.767 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.6 m -77.39 157.89 30.36 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 109.327 -0.62 . . . . 1.3100000000000001 109.327 175.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -54.76 -41.28 70.28 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.171 -0.678 . . . . 0.25 109.171 177.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.479 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 41.0 mt-10 -56.0 -46.6 78.7 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.785 -1.098 . . . . 1.72 112.197 178.775 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -60.91 -44.73 96.77 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 120.936 0.398 . . . . 2.0899999999999999 111.019 -176.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -71.72 -43.72 65.4 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.346 -0.388 . . . . 1.0700000000000001 111.001 -178.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.68 -53.05 60.38 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.185 0.439 . . . . 1.0600000000000001 112.185 -175.005 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.495 ' HA ' ' O ' ' A' ' 71' ' ' TYR . 71.9 m -51.76 -27.8 13.24 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 113.121 0.785 . . . . 1.52 113.121 -177.61 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -100.03 -44.67 5.93 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.603 0.716 . . . . 0.60999999999999999 110.616 -177.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.57 ' CD ' ' HG3' ' A' ' 27' ' ' ARG . 17.4 mmt180 -94.41 -43.48 8.35 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.873 -1.058 . . . . 0.95999999999999996 113.576 -170.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.542 ' HB2' ' SG ' ' A' ' 68' ' ' CYS . 19.3 p -62.73 127.65 32.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.145 0.497 . . . . 1.0600000000000001 111.557 -173.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.574 ' HA ' ' HB2' ' A' ' 26' ' ' ARG . 27.0 t70 -81.68 -11.08 59.21 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.421 -0.809 . . . . 2.2799999999999998 110.616 176.694 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . 0.542 ' SG ' ' HB2' ' A' ' 66' ' ' SER . 5.1 p -75.77 150.19 37.82 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.017 -0.538 . . . . 2.0499999999999998 110.12 179.657 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -54.88 -21.66 24.16 Favored Glycine 0 N--CA 1.452 -0.247 0 CA-C-N 114.665 -1.152 . . . . 0.29999999999999999 113.757 -172.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.449 ' HB2' ' CA ' ' A' ' 75' ' ' GLY . 1.5 p -67.99 -2.44 7.63 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 112.635 0.606 . . . . 0.46999999999999997 112.635 177.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.495 ' O ' ' HA ' ' A' ' 63' ' ' SER . 33.1 p90 -55.13 -24.27 25.24 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 118.038 0.381 . . . . 0.94999999999999996 110.421 174.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -87.65 -8.94 55.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.857 0.36 . . . . 1.1100000000000001 111.115 -178.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 16.0 m -126.18 14.95 7.84 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.367 -0.379 . . . . 0.70999999999999996 111.28 -177.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.479 ' O ' ' HA ' ' A' ' 59' ' ' GLU . . . 74.86 33.48 55.21 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.745 -0.74 . . . . 0.67000000000000004 113.133 178.445 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.449 ' CA ' ' HB2' ' A' ' 70' ' ' SER . . . 77.88 5.07 86.46 Favored Glycine 0 C--O 1.228 -0.236 0 C-N-CA 120.811 -0.709 . . . . 0.42999999999999999 112.867 176.385 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -92.21 141.17 28.86 Favored 'General case' 0 C--N 1.322 -0.629 0 O-C-N 122.844 -0.209 . . . . 1.6499999999999999 110.448 -172.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -120.38 169.87 9.89 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.322 0.582 . . . . 1.6899999999999999 110.582 176.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -89.04 -158.8 34.62 Favored Glycine 0 C--N 1.314 -0.691 0 CA-C-N 115.025 -0.989 . . . . 0.45000000000000001 112.078 177.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.592 ' HA ' ' O ' ' A' ' 8' ' ' LEU . 96.7 m-85 -84.57 151.7 24.36 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.083 0.468 . . . . 4.7400000000000002 111.677 -178.495 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.647 ' CE1' ' HB3' ' A' ' 8' ' ' LEU . 2.5 p90 -157.87 160.36 37.59 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.492 -0.929 . . . . 1.6499999999999999 108.492 178.683 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 23.6 m -85.44 138.78 32.02 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 109.162 -0.681 . . . . 1.6899999999999999 109.162 177.067 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 14.7 m -59.71 112.24 1.74 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.159 0.504 . . . . 1.55 110.811 -174.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 114.53 12.91 10.07 Favored Glycine 0 N--CA 1.446 -0.647 0 CA-C-N 115.47 -0.786 . . . . 0.79000000000000004 112.184 -174.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -117.02 57.8 0.78 Allowed 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 121.069 0.462 . . . . 1.5800000000000001 110.377 177.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 22.5 mmt -146.42 -100.16 0.09 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.084 -0.507 . . . . 1.1299999999999999 110.512 178.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' MET . . . . . 0.422 ' HB2' ' HB3' ' A' ' 89' ' ' PHE . 61.4 mtt -142.99 155.77 44.73 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 108.17 -1.048 . . . . 1.8899999999999999 108.17 175.228 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.408 ' HB3' ' HD3' ' A' ' 88' ' ' PRO . 63.9 tttp -55.06 -57.75 18.16 Favored Pre-proline 0 C--N 1.321 -0.653 0 N-CA-C 112.448 0.536 . . . . 2.7400000000000002 112.448 -177.082 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.408 ' HD3' ' HB3' ' A' ' 87' ' ' LYS . 76.6 Cg_endo -75.35 -29.08 8.06 Favored 'Trans proline' 0 C--N 1.355 0.88 0 C-N-CA 121.643 1.562 . . . . 0.29999999999999999 111.908 -175.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.628 ' O ' HG21 ' A' ' 93' ' ' VAL . 38.5 t80 -68.12 -56.55 8.42 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.111 -0.949 . . . . 0.28000000000000003 109.942 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -65.24 -34.51 78.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.661 -0.7 . . . . 2.1200000000000001 109.855 -178.067 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -55.33 -34.67 64.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.636 -0.711 . . . . 0.60999999999999999 110.755 175.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.425 ' O ' ' HG ' ' A' ' 96' ' ' LEU . . . -83.74 -26.65 29.54 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.136 -0.484 . . . . 1.1000000000000001 110.951 179.05 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.628 HG21 ' O ' ' A' ' 89' ' ' PHE . 18.4 t -74.03 -38.17 48.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.157 0.503 . . . . 1.1200000000000001 110.186 -178.14 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.504 ' C ' ' HD2' ' A' ' 94' ' ' ARG . 6.5 ppt_? -76.32 -12.0 60.0 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.085 -0.507 . . . . 3.1800000000000002 110.261 178.055 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.07 -4.5 59.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.846 -0.615 . . . . 1.0800000000000001 111.254 -176.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.594 ' HB2' ' HB2' ' A' ' 100' ' ' ASP . 1.2 pp -132.79 151.91 51.9 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.173 0.511 . . . . 1.1200000000000001 111.167 179.192 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.563 ' HG3' ' H ' ' A' ' 98' ' ' ILE . 19.4 tptm -102.62 -178.48 3.69 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.688 -0.856 . . . . 2.1299999999999999 108.688 176.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.563 ' H ' ' HG3' ' A' ' 97' ' ' LYS . 65.9 mt -54.3 118.36 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 120.853 0.359 . . . . 1.6200000000000001 111.025 179.28 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 95.61 10.23 56.91 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.728 -0.749 . . . . 0.46000000000000002 113.14 178.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.594 ' HB2' ' HB2' ' A' ' 96' ' ' LEU . 27.0 m-20 -111.41 146.81 36.51 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 117.441 0.621 . . . . 0.46000000000000002 110.271 177.285 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 15.8 mt -120.17 148.89 23.01 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-N 116.455 -0.339 . . . . 1.0800000000000001 110.432 -178.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.442 ' HG ' ' CD2' ' A' ' 96' ' ' LEU . 38.3 m -96.78 151.08 37.63 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 116.234 -0.439 . . . . 1.45 111.206 179.026 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -74.17 176.94 8.9 Favored 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 122.583 2.189 . . . . 0.40999999999999998 111.432 172.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.445 HG13 ' HG2' ' A' ' 45' ' ' GLN . 22.5 mm -49.24 110.72 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 N-CA-C 112.775 0.657 . . . . 1.04 112.775 -178.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 55.0 t -109.75 115.71 50.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.886 -0.597 . . . . 1.6599999999999999 109.901 173.178 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 12.9 mt-30 -84.93 141.72 30.17 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.842 -0.429 . . . . 0.55000000000000004 109.842 177.396 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 16.6 p -123.55 -172.47 2.53 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.784 -0.644 . . . . 1.05 110.491 -179.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . 0.407 ' HB2' ' CZ ' ' A' ' 21' ' ' ARG . 6.9 p-10 -66.57 -35.53 80.44 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.617 0.246 . . . . 2.1600000000000001 111.253 -178.11 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.493 ' OG ' ' HE2' ' A' ' 16' ' ' LYS . 4.6 t -106.24 -9.73 16.73 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 120.287 -0.565 . . . . 1.0900000000000001 112.291 -174.359 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 172.18 -126.2 1.25 Allowed Glycine 0 N--CA 1.438 -1.177 0 C-N-CA 119.216 -1.469 . . . . 0.39000000000000001 112.967 173.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.539 ' HB3' HD22 ' A' ' 44' ' ' LEU . 6.0 mp -130.78 149.42 52.43 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 115.045 -0.578 . . . . 1.0600000000000001 110.906 -171.488 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . 0.677 ' HA ' ' O ' ' A' ' 13' ' ' LEU . 82.0 m-70 -146.97 136.04 22.45 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.098 0.407 . . . . 0.25 112.098 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.464 HG12 HD11 ' A' ' 44' ' ' LEU . 2.1 pt -119.13 140.03 44.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 107.972 -1.121 . . . . 1.03 107.972 160.362 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 2.5 mp -130.93 148.12 33.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 C-N-CA 120.923 -0.311 . . . . 1.0600000000000001 110.532 -175.141 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 54.3 pttt -134.61 144.25 47.79 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.113 -0.699 . . . . 1.29 109.113 174.209 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . 0.517 ' HB2' ' CD1' ' A' ' 96' ' ' LEU . 67.4 ttt180 -91.0 132.57 35.91 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.196 0.522 . . . . 2.6800000000000002 111.583 -177.391 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -101.96 -35.53 8.94 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.116 -0.947 . . . . 1.54 110.781 179.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.945 -0.55 . . . . 1.1499999999999999 109.841 179.191 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 13.6 tptt . . . . . 0 N--CA 1.453 -0.316 0 CA-C-O 121.709 0.766 . . . . 1.6899999999999999 110.871 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.553 HD22 ' N ' ' A' ' 9' ' ' ARG . 2.4 tt -136.55 157.02 47.76 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 114.522 -1.217 . . . . 1.79 108.176 -178.052 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.553 ' N ' HD22 ' A' ' 8' ' ' LEU . 77.2 ttt180 -140.82 127.72 20.55 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 107.907 -1.146 . . . . 1.3700000000000001 107.907 173.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -140.95 157.88 44.73 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 120.037 -0.665 . . . . 1.0700000000000001 112.496 -176.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.542 ' HA ' ' HA ' ' A' ' 76' ' ' ASP . . . -109.81 136.46 49.09 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.195 -0.912 . . . . 1.04 109.599 177.094 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 11.2 p-80 -136.77 139.65 41.98 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.79 -0.364 . . . . 0.34000000000000002 110.949 -172.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.618 ' O ' ' HA ' ' A' ' 112' ' ' HIS . 6.6 tt -111.42 142.37 43.77 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.161 -1.052 . . . . 1.0600000000000001 108.161 176.002 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.531 HD12 ' NE2' ' A' ' 112' ' ' HIS . 22.1 tp -128.95 133.54 47.86 Favored 'General case' 0 C--N 1.323 -0.575 0 O-C-N 123.043 0.214 . . . . 1.0800000000000001 110.441 -176.336 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.423 HG23 HD12 ' A' ' 44' ' ' LEU . 53.5 t -119.07 133.53 65.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 O-C-N 123.589 0.556 . . . . 1.01 109.978 175.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.421 ' HE3' HD21 ' A' ' 14' ' ' LEU . 34.2 mmtp -103.65 158.31 16.46 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.802 -0.635 . . . . 1.22 109.727 176.349 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.448 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 42.1 p90 -158.51 161.27 37.35 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.118 -0.492 . . . . 0.29999999999999999 109.693 -177.049 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.1 t -50.84 108.69 0.25 Allowed 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 110.005 -0.369 . . . . 1.6000000000000001 110.005 173.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 109.68 9.85 24.17 Favored Glycine 0 N--CA 1.446 -0.7 0 C-N-CA 120.323 -0.942 . . . . 0.53000000000000003 112.975 -177.18 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.456 ' C ' ' H ' ' A' ' 22' ' ' ASN . 50.6 p -85.32 21.82 1.64 Allowed 'General case' 0 C--O 1.236 0.352 0 CA-C-N 117.938 0.869 . . . . 1.28 111.726 -176.732 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.45 ' NH1' ' HB3' ' A' ' 108' ' ' ASP . 97.3 mtt180 72.6 -34.98 0.31 Allowed 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.786 0.835 . . . . 4.1600000000000001 110.833 -178.832 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.456 ' H ' ' C ' ' A' ' 20' ' ' SER . 7.0 p30 -146.66 104.71 3.96 Favored Pre-proline 0 C--N 1.32 -0.686 0 N-CA-C 108.578 -0.897 . . . . 1.77 108.578 168.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -66.03 -156.7 0.03 OUTLIER 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 123.674 2.916 . . . . 1.71 113.2 -178.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.535 ' N ' HG23 ' A' ' 32' ' ' THR . 47.6 t 64.99 112.97 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-N 115.494 -0.775 . . . . 1.1599999999999999 111.165 -175.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 19.1 p -103.36 152.18 21.87 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.352 -0.385 . . . . 1.4299999999999999 110.015 178.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.533 ' CG ' ' HA ' ' A' ' 67' ' ' ASP . 38.5 mmt180 -67.58 -20.38 65.37 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 108.727 -0.842 . . . . 3.1200000000000001 108.727 173.193 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.448 ' HG2' ' HD3' ' A' ' 65' ' ' ARG . 4.8 tmm_? -71.73 -36.22 70.41 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 114.621 -1.172 . . . . 2.25 110.791 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 69.3 p -97.67 -35.76 10.47 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.522 0.677 . . . . 1.1299999999999999 110.421 178.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 73.35 -6.7 14.4 Favored Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 114.718 -1.128 . . . . 0.81999999999999995 112.655 -178.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -121.68 -72.29 0.69 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.757 0.313 . . . . 2.1000000000000001 110.357 -178.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.6 m -147.8 146.26 29.08 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-O 121.0 0.429 . . . . 1.3300000000000001 111.21 -178.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.535 HG23 ' N ' ' A' ' 24' ' ' VAL . 14.6 t -125.48 11.82 8.03 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.8 0.81 . . . . 1.02 109.49 174.58 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -68.94 -4.34 16.25 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.241 -0.89 . . . . 1.1299999999999999 112.289 179.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -96.55 -23.86 16.33 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.037 0.446 . . . . 2.21 110.694 177.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.463 HG22 ' HB2' ' A' ' 39' ' ' ASP . 0.4 OUTLIER -93.85 136.34 25.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 109.389 -0.597 . . . . 1.1100000000000001 109.389 177.505 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 75.0 p -95.0 179.99 5.03 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.359 -0.382 . . . . 1.2 110.081 -174.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.501 ' O ' HG13 ' A' ' 41' ' ' ILE . 11.3 p90 -63.42 -28.13 69.77 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.262 -0.644 . . . . 2.21 109.262 175.372 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -73.74 -44.77 55.34 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.905 -0.589 . . . . 0.95999999999999996 110.362 178.186 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.463 ' HB2' HG22 ' A' ' 35' ' ' VAL . 43.9 m-20 -65.81 -32.42 73.94 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.484 0.659 . . . . 0.91000000000000003 109.693 176.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.448 ' HB2' ' HB3' ' A' ' 17' ' ' PHE . . . -68.4 -43.88 76.27 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.976 -1.011 . . . . 1.03 110.416 178.254 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.501 HG13 ' O ' ' A' ' 37' ' ' TYR . 95.1 mt -62.6 -37.82 79.93 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.409 0 N-CA-C 109.667 -0.494 . . . . 1.0800000000000001 109.667 174.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 55.9 tttp -65.94 -23.11 66.54 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 121.381 0.61 . . . . 2.8399999999999999 109.997 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -87.84 -50.27 6.56 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.33 -0.85 . . . . 1.02 109.549 -179.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.48 HD11 HG12 ' A' ' 113' ' ' ILE . 35.4 tp -62.61 -38.08 88.78 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.588 -0.733 . . . . 1.02 110.41 -178.05 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.479 ' HG2' HG13 ' A' ' 104' ' ' ILE . 5.0 mm-40 -61.09 -31.35 71.03 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 115.957 -0.565 . . . . 0.87 112.399 -179.595 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -80.24 -40.85 26.22 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.631 -0.428 . . . . 1.98 110.606 -179.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.425 ' O ' HG13 ' A' ' 51' ' ' ILE . 57.5 m95 -66.66 -45.32 79.31 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.139 0.422 . . . . 0.60999999999999999 112.139 177.036 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.481 ' HB3' HG23 ' A' ' 113' ' ' ILE . 93.4 p -63.99 -30.5 71.57 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.758 -0.46 . . . . 0.88 109.758 176.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.476 ' HB2' ' O ' ' A' ' 45' ' ' GLN . 15.1 tt0 -65.16 -53.34 46.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.503 -0.772 . . . . 0.55000000000000004 110.381 175.402 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.523 ' HB3' HG22 ' A' ' 56' ' ' VAL . 97.1 mtt180 -65.39 -41.48 93.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.996 -0.547 . . . . 0.47999999999999998 111.657 -177.07 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.474 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 84.6 mt -61.25 -33.93 58.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.09 0.471 . . . . 1.04 110.691 176.629 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -77.81 -41.91 35.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 1.0600000000000001 111.205 179.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 52.9 p -76.13 -29.81 57.96 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.252 -0.431 . . . . 0.34999999999999998 111.569 -176.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 103.21 9.99 37.64 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.78 -0.724 . . . . 0.33000000000000002 112.234 -179.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.406 ' HB2' ' HB3' ' A' ' 50' ' ' ARG . 39.2 mt-10 -64.51 -43.58 93.64 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.583 -0.525 . . . . 0.65000000000000002 109.583 176.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.523 HG22 ' HB3' ' A' ' 50' ' ' ARG . 11.7 m -138.49 149.79 24.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 108.968 -0.753 . . . . 1.05 108.968 170.12 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 12.0 m -81.69 162.08 23.14 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 109.468 -0.567 . . . . 1.3100000000000001 109.468 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -55.01 -43.44 73.63 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.843 -0.429 . . . . 0.25 109.843 -178.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -58.04 -46.32 85.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.537 -0.756 . . . . 1.72 111.443 179.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 41.4 mm-40 -59.4 -48.36 81.94 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-O 121.119 0.485 . . . . 2.0899999999999999 110.822 -178.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -68.78 -49.96 54.27 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.924 -0.58 . . . . 1.0700000000000001 110.866 -179.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.403 ' HA ' ' HB3' ' A' ' 66' ' ' SER . . . -58.45 -55.37 35.97 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.629 0.603 . . . . 1.0600000000000001 112.629 -173.229 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.475 ' HA ' ' HA ' ' A' ' 71' ' ' TYR . 28.4 t -52.27 -28.01 17.21 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.684 0.624 . . . . 1.52 112.684 -175.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -100.01 -46.74 5.24 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.528 0.68 . . . . 0.60999999999999999 110.426 -179.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.448 ' HD3' ' HG2' ' A' ' 27' ' ' ARG . 31.3 mmt180 -94.21 -36.91 11.81 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.758 -1.11 . . . . 0.95999999999999996 113.944 -168.603 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.533 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 24.7 p -67.89 123.72 21.37 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.642 -0.423 . . . . 1.0600000000000001 110.651 -178.065 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.533 ' HA ' ' CG ' ' A' ' 26' ' ' ARG . 25.1 m-20 -83.77 -5.93 59.31 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.826 -0.625 . . . . 2.2799999999999998 110.676 179.5 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . 0.511 ' SG ' ' HB2' ' A' ' 66' ' ' SER . 6.4 p -78.86 156.73 28.54 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.494 -0.776 . . . . 2.0499999999999998 110.215 175.413 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -54.83 -20.33 18.45 Favored Glycine 0 C--N 1.331 0.284 0 CA-C-N 114.959 -1.018 . . . . 0.29999999999999999 114.501 -171.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.52 ' HB2' ' CA ' ' A' ' 75' ' ' GLY . 1.3 p -70.08 -1.49 10.08 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.675 0.62 . . . . 0.46999999999999997 112.675 179.422 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.475 ' HA ' ' HA ' ' A' ' 63' ' ' SER . 41.6 p90 -56.55 -33.6 66.27 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 109.54 -0.541 . . . . 0.94999999999999996 109.54 173.671 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -95.29 8.32 43.48 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.021 -0.536 . . . . 1.1100000000000001 111.158 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 11.0 m -122.59 -20.16 6.08 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.698 0.285 . . . . 0.70999999999999996 111.605 -176.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 107.57 14.85 16.75 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.74 -0.743 . . . . 0.67000000000000004 112.226 -178.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.52 ' CA ' ' HB2' ' A' ' 70' ' ' SER . . . 92.99 -19.73 50.25 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.69 -0.767 . . . . 0.42999999999999999 112.904 178.449 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.542 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 7.6 p-10 -98.36 144.71 27.46 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.584 0.706 . . . . 1.6499999999999999 111.492 -171.758 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -100.35 175.72 5.61 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.504 -1.225 . . . . 1.6899999999999999 109.341 174.65 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -85.43 -148.0 10.13 Favored Glycine 0 C--N 1.315 -0.634 0 C-N-CA 120.709 -0.758 . . . . 0.45000000000000001 111.981 -179.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -91.85 139.44 30.66 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.931 0.396 . . . . 4.7400000000000002 110.16 178.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -152.14 174.03 14.22 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.992 -0.549 . . . . 1.6499999999999999 109.746 -177.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 13.9 p -95.57 135.4 37.28 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.333 0.587 . . . . 1.6899999999999999 110.942 179.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 13.2 m -63.83 128.11 34.35 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.483 -0.78 . . . . 1.55 110.585 -178.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 103.25 0.82 47.64 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.659 -0.782 . . . . 0.79000000000000004 112.395 -179.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -117.76 62.84 0.75 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.222 0.534 . . . . 1.5800000000000001 111.152 -179.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 21.0 mmt -139.49 -123.9 0.12 Allowed 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.066 -0.716 . . . . 1.1299999999999999 109.066 173.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' MET . . . . . 0.405 ' HB2' ' CB ' ' A' ' 89' ' ' PHE . 19.9 mmt -110.68 151.54 27.59 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.263 -1.014 . . . . 1.8899999999999999 108.263 173.191 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 24.5 ttmm -55.55 -51.72 77.8 Favored Pre-proline 0 C--N 1.319 -0.754 0 N-CA-C 112.379 0.511 . . . . 2.7400000000000002 112.379 -174.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -78.3 -22.9 9.27 Favored 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 121.474 1.449 . . . . 0.29999999999999999 111.72 -178.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.571 ' O ' HG22 ' A' ' 93' ' ' VAL . 33.1 t80 -70.89 -55.75 7.77 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.157 -0.929 . . . . 0.28000000000000003 109.718 179.682 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -65.81 -34.83 79.08 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.606 -0.725 . . . . 2.1200000000000001 109.99 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.506 ' HA ' ' NE ' ' A' ' 94' ' ' ARG . 15.6 t70 -51.25 -35.83 39.06 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.492 -0.776 . . . . 0.60999999999999999 110.7 173.68 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.565 ' O ' ' HG ' ' A' ' 96' ' ' LEU . . . -82.44 -37.15 25.85 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.072 -0.513 . . . . 1.1000000000000001 111.032 179.111 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.571 HG22 ' O ' ' A' ' 89' ' ' PHE . 15.2 t -62.75 -40.97 90.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-O 121.229 0.538 . . . . 1.1200000000000001 110.597 -177.168 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.506 ' NE ' ' HA ' ' A' ' 91' ' ' ASP . 37.7 ptt180 -74.8 -15.41 60.75 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.822 -0.626 . . . . 3.1800000000000002 110.566 178.26 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -95.64 14.42 23.06 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.026 -0.533 . . . . 1.0800000000000001 111.169 -174.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.583 ' HB2' ' HB2' ' A' ' 100' ' ' ASP . 1.4 pp -149.74 152.71 35.71 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.83 -0.623 . . . . 1.1200000000000001 110.307 177.005 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.434 ' HG3' ' H ' ' A' ' 98' ' ' ILE . 21.7 tptm -102.22 175.63 5.46 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.132 -0.692 . . . . 2.1299999999999999 109.132 179.536 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.436 ' HA ' ' HG2' ' A' ' 116' ' ' ARG . 70.7 mt -46.24 114.56 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.196 0.522 . . . . 1.6200000000000001 111.579 176.049 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 102.1 -15.96 56.06 Favored Glycine 0 CA--C 1.522 0.48 0 CA-C-N 115.649 -0.705 . . . . 0.46000000000000002 113.562 178.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.583 ' HB2' ' HB2' ' A' ' 96' ' ' LEU . 53.9 m-20 -89.08 141.19 28.71 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 117.346 0.573 . . . . 0.46000000000000002 110.348 -177.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 8.9 mt -112.68 147.99 16.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.18 -0.464 . . . . 1.0800000000000001 110.462 -176.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 99.3 p -89.65 160.1 42.26 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 116.256 -0.429 . . . . 1.45 110.643 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -74.23 176.36 9.7 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.324 2.016 . . . . 0.40999999999999998 111.196 171.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.479 HG13 ' HG2' ' A' ' 45' ' ' GLN . 23.9 mm -50.47 106.38 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 O-C-N 123.217 0.323 . . . . 1.04 111.541 174.78 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.4 p -112.92 123.02 68.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 109.794 -0.447 . . . . 1.6599999999999999 109.794 175.084 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -86.19 151.38 23.69 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.14 0.495 . . . . 0.55000000000000004 110.563 -179.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 6.8 p -126.78 -172.72 2.7 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.51 -0.768 . . . . 1.05 109.984 178.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . 0.45 ' HB3' ' NH1' ' A' ' 21' ' ' ARG . 36.3 m-20 -62.36 -46.73 87.35 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.746 0.307 . . . . 2.1600000000000001 110.501 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 22.5 t -80.07 -59.43 2.72 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.836 -0.346 . . . . 1.0900000000000001 110.796 -178.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -152.05 -130.4 1.6 Allowed Glycine 0 N--CA 1.443 -0.884 0 C-N-CA 119.075 -1.536 . . . . 0.39000000000000001 113.649 -175.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.515 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 6.1 mp -116.56 147.79 41.49 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.283 -0.459 . . . . 1.0600000000000001 111.372 -170.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . 0.618 ' HA ' ' O ' ' A' ' 13' ' ' LEU . 82.0 m-70 -143.48 152.96 42.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.419 0.628 . . . . 0.25 112.484 179.454 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.481 HG23 ' HB3' ' A' ' 48' ' ' SER . 3.6 pt -133.42 138.17 51.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 107.604 -1.258 . . . . 1.03 107.604 159.579 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 2.8 mp -128.42 147.52 32.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 C-N-CA 120.768 -0.373 . . . . 1.0600000000000001 110.386 -175.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.417 ' HG2' ' HB3' ' A' ' 11' ' ' ALA . 33.4 pttt -132.11 144.63 50.85 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.664 -0.865 . . . . 1.29 108.664 172.437 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . 0.438 ' HD3' HD21 ' A' ' 8' ' ' LEU . 5.5 ttp180 -82.79 135.03 35.09 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.302 0.572 . . . . 2.6800000000000002 110.902 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -101.83 -38.33 7.89 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.996 -1.002 . . . . 1.54 109.768 -179.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.036 0 CA-C-N 115.544 -0.753 . . . . 1.1499999999999999 109.735 179.862 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt . . . . . 0 N--CA 1.454 -0.248 0 CA-C-O 121.47 0.653 . . . . 1.6899999999999999 110.657 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.408 ' HG ' ' H ' ' A' ' 9' ' ' ARG . 11.4 tp -103.73 175.34 5.51 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 114.665 -1.152 . . . . 1.79 109.953 -174.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.442 ' HG2' ' HB2' ' A' ' 117' ' ' LEU . 53.8 ttt180 -146.08 132.49 19.65 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.567 -0.531 . . . . 1.3700000000000001 109.567 177.323 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.539 ' N ' ' HZ ' ' A' ' 80' ' ' PHE . . . -149.3 154.43 39.0 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.054 0.454 . . . . 1.0700000000000001 111.69 -179.149 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.406 ' HB1' ' HG2' ' A' ' 115' ' ' LYS . . . -101.83 131.85 47.93 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.517 -0.765 . . . . 1.04 108.95 175.413 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 29.6 p-80 -133.01 146.69 51.99 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.029 0.443 . . . . 0.34000000000000002 111.719 -172.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.55 HD21 ' N ' ' A' ' 14' ' ' LEU . 5.7 tt -117.46 144.65 44.81 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.478 -0.934 . . . . 1.0600000000000001 108.478 177.407 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.596 HD12 ' NE2' ' A' ' 112' ' ' HIS . 26.0 tp -131.03 119.91 22.69 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.64 0.257 . . . . 1.0800000000000001 110.675 -177.391 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.416 ' CG2' HD12 ' A' ' 44' ' ' LEU . 61.2 t -108.12 129.37 62.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 109.776 -0.453 . . . . 1.01 109.776 176.771 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.458 ' HE3' HD22 ' A' ' 14' ' ' LEU . 31.5 mmtp -105.87 149.99 26.04 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.089 -0.505 . . . . 1.22 110.022 178.68 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.479 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 43.1 p90 -145.88 162.54 37.5 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.331 -0.395 . . . . 0.29999999999999999 110.863 -176.451 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.46 ' HB3' ' C ' ' A' ' 33' ' ' ALA . 34.9 p -51.87 113.18 0.93 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.037 -0.529 . . . . 1.6000000000000001 111.129 177.272 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 95.5 8.58 58.41 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.587 -0.816 . . . . 0.53000000000000003 113.536 178.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.605 ' HB2' ' O ' ' A' ' 109' ' ' SER . 80.4 p -86.7 33.5 0.65 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 117.264 0.532 . . . . 1.28 110.921 -177.557 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.422 ' HB3' ' O ' ' A' ' 20' ' ' SER . 66.8 ttt180 71.25 -34.82 0.31 Allowed 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.245 0.618 . . . . 4.1600000000000001 111.122 -176.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.497 ' H ' ' C ' ' A' ' 20' ' ' SER . 33.2 m-80 -133.63 91.77 25.04 Favored Pre-proline 0 C--N 1.327 -0.398 0 N-CA-C 109.245 -0.65 . . . . 1.77 109.245 176.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.511 ' C ' HG22 ' A' ' 32' ' ' THR . 72.7 Cg_endo -80.47 57.72 6.65 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 122.258 1.972 . . . . 1.71 112.774 -176.308 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.515 ' N ' HG22 ' A' ' 32' ' ' THR . 48.5 t -143.7 118.67 4.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 109.418 -0.586 . . . . 1.1599999999999999 109.418 178.074 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 40.2 t -104.85 150.34 24.92 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 110.037 -0.357 . . . . 1.4299999999999999 110.037 178.095 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.534 ' HG2' ' HA ' ' A' ' 67' ' ' ASP . 5.2 mmp_? -66.07 -8.35 22.9 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.727 0.299 . . . . 3.1200000000000001 110.823 173.176 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.442 ' HD2' ' HD2' ' A' ' 65' ' ' ARG . 50.5 mtp180 -69.26 -50.68 44.77 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 121.555 0.693 . . . . 2.25 110.018 172.38 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.416 ' C ' ' H ' ' A' ' 30' ' ' ASP . 39.8 p -94.66 -33.62 12.9 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 115.154 -0.93 . . . . 1.1299999999999999 110.837 -172.73 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 80.31 -32.56 2.3 Favored Glycine 0 N--CA 1.451 -0.308 0 CA-C-N 115.813 -0.63 . . . . 0.81999999999999995 112.042 -178.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.416 ' H ' ' C ' ' A' ' 28' ' ' THR . 19.1 t70 -92.56 -69.85 0.72 Allowed 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 122.576 0.35 . . . . 2.1000000000000001 110.717 -177.663 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.5 p -154.79 155.56 34.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.602 -0.272 . . . . 1.3300000000000001 110.922 177.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.515 HG22 ' N ' ' A' ' 24' ' ' VAL . 8.9 t -118.82 34.87 5.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 122.309 1.052 . . . . 1.02 109.388 177.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.46 ' C ' ' HB3' ' A' ' 18' ' ' SER . . . -76.58 -5.25 46.93 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.695 -1.139 . . . . 1.1299999999999999 112.901 -173.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -94.8 -24.75 16.93 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.032 0.444 . . . . 2.21 110.848 -179.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.477 HG13 ' OG1' ' A' ' 32' ' ' THR . 0.2 OUTLIER -95.72 135.89 28.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.941 -0.572 . . . . 1.1100000000000001 109.816 179.87 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 67.0 p -96.34 178.42 5.37 Favored 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 109.952 -0.388 . . . . 1.2 109.952 -175.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.456 ' O ' HG13 ' A' ' 41' ' ' ILE . 13.3 p90 -63.99 -27.89 69.44 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.224 -0.658 . . . . 2.21 109.224 176.467 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -70.73 -47.17 61.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.779 -0.646 . . . . 0.95999999999999996 110.204 177.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.446 ' HB2' HG21 ' A' ' 35' ' ' VAL . 47.1 m-20 -67.87 -29.59 68.75 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.401 0.62 . . . . 0.91000000000000003 109.752 178.233 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.479 ' HB2' ' HB3' ' A' ' 17' ' ' PHE . . . -70.35 -43.96 69.11 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.007 -0.997 . . . . 1.03 110.583 177.499 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.456 HG13 ' O ' ' A' ' 37' ' ' TYR . 80.0 mt -62.24 -37.35 78.34 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 N-CA-C 109.549 -0.537 . . . . 1.0800000000000001 109.549 173.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -62.19 -25.46 67.79 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.784 -0.644 . . . . 2.8399999999999999 110.174 177.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -84.82 -53.41 5.35 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.477 -0.783 . . . . 1.02 109.405 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.486 HD11 HG12 ' A' ' 113' ' ' ILE . 23.9 tp -62.01 -36.27 81.02 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.145 -0.934 . . . . 1.02 110.587 -175.031 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.527 ' O ' ' HB2' ' A' ' 49' ' ' GLN . 0.0 OUTLIER -68.53 -24.71 64.67 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 112.348 0.499 . . . . 0.87 112.348 -177.909 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -80.43 -45.69 17.19 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.95 -0.389 . . . . 1.98 109.95 178.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.426 ' NE1' ' HG3' ' A' ' 65' ' ' ARG . 52.9 m95 -65.69 -46.55 78.62 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.138 -0.483 . . . . 0.60999999999999999 111.207 177.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.451 ' HB3' HG23 ' A' ' 113' ' ' ILE . 92.2 p -64.01 -24.26 67.65 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.807 0.337 . . . . 0.88 110.166 178.469 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.527 ' HB2' ' O ' ' A' ' 45' ' ' GLN . 10.9 tt0 -73.28 -56.67 4.76 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-N 116.11 -0.496 . . . . 0.55000000000000004 110.034 175.284 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.531 ' HB3' HG21 ' A' ' 56' ' ' VAL . 97.0 mtt180 -60.79 -42.4 97.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.473 -0.785 . . . . 0.47999999999999998 111.401 -177.041 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.42 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 98.0 mt -62.07 -40.17 86.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 120.823 0.344 . . . . 1.04 110.613 177.648 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.39 -44.65 74.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.234 -0.439 . . . . 1.0600000000000001 111.373 -178.395 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 32.3 p -77.39 -31.02 53.95 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.842 0.354 . . . . 0.34999999999999998 111.38 -177.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 109.19 10.23 24.41 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.658 -0.782 . . . . 0.33000000000000002 112.548 179.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.46 ' HB2' ' HB3' ' A' ' 50' ' ' ARG . 45.5 mt-10 -60.17 -46.93 88.02 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.211 0.529 . . . . 0.65000000000000002 109.867 175.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.531 HG21 ' HB3' ' A' ' 50' ' ' ARG . 11.1 m -133.24 158.83 43.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.714 -0.676 . . . . 1.05 109.315 172.096 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 17.8 m -85.95 155.22 20.99 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 109.247 -0.649 . . . . 1.3100000000000001 109.247 178.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -52.39 -42.63 64.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.301 0.572 . . . . 0.25 109.783 -177.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.516 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 39.2 mt-10 -55.08 -41.73 71.9 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.811 -1.086 . . . . 1.72 112.044 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -65.94 -47.2 75.47 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-O 120.712 0.291 . . . . 2.0899999999999999 111.112 -174.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -69.48 -43.31 73.45 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.343 -0.39 . . . . 1.0700000000000001 110.784 -178.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.66 -51.3 69.97 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.105 -0.498 . . . . 1.0600000000000001 111.813 -176.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.568 ' HA ' ' O ' ' A' ' 71' ' ' TYR . 40.4 m -51.26 -27.44 9.21 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.939 0.718 . . . . 1.52 112.939 -177.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -98.55 -46.7 5.64 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.893 0.854 . . . . 0.60999999999999999 110.936 -179.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.442 ' HD2' ' HD2' ' A' ' 27' ' ' ARG . 37.4 mmt180 -94.97 -37.26 11.23 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 114.398 -1.274 . . . . 0.95999999999999996 113.713 -166.133 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.433 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 60.0 p -65.64 117.5 8.18 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.305 -0.558 . . . . 1.0600000000000001 110.065 -178.35 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.534 ' HA ' ' HG2' ' A' ' 26' ' ' ARG . 24.0 t70 -73.84 -15.82 61.15 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.345 0.593 . . . . 2.2799999999999998 111.089 179.33 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 46.2 t -77.37 160.84 28.49 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.307 0.575 . . . . 2.0499999999999998 109.939 179.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -57.1 -18.0 25.55 Favored Glycine 0 C--N 1.328 0.134 0 CA-C-N 114.691 -1.14 . . . . 0.29999999999999999 114.425 -170.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.499 ' HB2' ' CA ' ' A' ' 75' ' ' GLY . 3.0 p -70.28 -0.11 7.42 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.861 0.689 . . . . 0.46999999999999997 112.861 179.198 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.568 ' O ' ' HA ' ' A' ' 63' ' ' SER . 39.2 p90 -60.29 -27.57 67.4 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 118.395 0.543 . . . . 0.94999999999999996 109.973 175.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -94.43 5.37 52.01 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.246 0.545 . . . . 1.1100000000000001 110.223 178.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.5 m -124.67 0.63 8.15 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.666 -0.697 . . . . 0.70999999999999996 111.005 -176.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.516 ' O ' ' HA ' ' A' ' 59' ' ' GLU . . . 75.2 29.62 60.1 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.724 -0.75 . . . . 0.67000000000000004 112.316 -177.388 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.499 ' CA ' ' HB2' ' A' ' 70' ' ' SER . . . 84.4 -3.59 85.98 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 121.01 -0.614 . . . . 0.42999999999999999 112.317 179.622 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -84.57 140.8 31.15 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.667 0.27 . . . . 1.6499999999999999 111.56 -169.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -120.94 163.17 18.65 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.775 -0.648 . . . . 1.6899999999999999 110.493 172.118 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -79.01 -117.05 0.23 Allowed Glycine 0 C--N 1.31 -0.891 0 CA-C-N 114.964 -1.016 . . . . 0.45000000000000001 113.44 -177.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 37.0 p90 -116.15 141.06 48.63 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.864 0.364 . . . . 4.7400000000000002 110.95 -176.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.539 ' HZ ' ' N ' ' A' ' 10' ' ' ALA . 3.5 p90 -158.23 129.56 6.56 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.084 -0.507 . . . . 1.6499999999999999 111.014 -178.482 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 82.2 p -74.31 155.33 38.32 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.308 -0.627 . . . . 1.6899999999999999 109.308 178.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 9.3 m -59.77 114.38 2.74 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.144 -0.48 . . . . 1.55 110.346 -178.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 114.05 1.49 23.81 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.685 -0.769 . . . . 0.79000000000000004 112.509 -176.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -90.84 15.22 11.69 Favored 'General case' 0 C--N 1.33 -0.281 0 O-C-N 122.593 -0.357 . . . . 1.5800000000000001 111.5 178.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 26.2 mmt -126.84 -126.99 0.23 Allowed 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 121.116 0.484 . . . . 1.1299999999999999 111.147 -176.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 54.7 mtt -123.19 149.26 44.87 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.09 -1.078 . . . . 1.8899999999999999 108.09 179.005 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 64.6 tttp -49.82 -54.98 26.61 Favored Pre-proline 0 CA--C 1.541 0.618 0 N-CA-C 112.52 0.563 . . . . 2.7400000000000002 112.52 -175.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -76.02 -22.47 13.06 Favored 'Trans proline' 0 C--N 1.356 0.965 0 C-N-CA 121.798 1.665 . . . . 0.29999999999999999 112.321 -176.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.618 ' O ' HG23 ' A' ' 93' ' ' VAL . 38.7 t80 -73.3 -56.22 5.37 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.402 -0.817 . . . . 0.28000000000000003 109.504 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -63.87 -33.55 75.94 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.595 -0.729 . . . . 2.1200000000000001 109.77 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.581 ' HA ' ' NE ' ' A' ' 94' ' ' ARG . 18.7 t70 -52.47 -37.74 57.78 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.237 -0.892 . . . . 0.60999999999999999 111.104 175.093 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.574 ' O ' ' HG ' ' A' ' 96' ' ' LEU . . . -81.76 -36.55 28.4 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.428 -0.351 . . . . 1.1000000000000001 110.895 178.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.618 HG23 ' O ' ' A' ' 89' ' ' PHE . 11.5 t -63.6 -41.25 91.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.267 0.556 . . . . 1.1200000000000001 110.699 -177.207 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.581 ' NE ' ' HA ' ' A' ' 91' ' ' ASP . 30.7 ptt180 -76.57 -18.55 58.6 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.776 -0.647 . . . . 3.1800000000000002 110.52 178.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -82.95 -5.91 59.25 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.923 -0.58 . . . . 1.0800000000000001 111.441 -172.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.574 ' HG ' ' O ' ' A' ' 92' ' ' ALA . 0.5 OUTLIER -133.45 160.51 37.19 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.18 0.514 . . . . 1.1200000000000001 111.244 -179.591 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.637 ' HG2' ' H ' ' A' ' 98' ' ' ILE . 33.6 tttp -102.33 178.42 4.6 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 115.656 -0.702 . . . . 2.1299999999999999 109.461 178.099 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.637 ' H ' ' HG2' ' A' ' 97' ' ' LYS . 8.2 mt -53.36 119.34 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.265 -0.425 . . . . 1.6200000000000001 111.138 178.346 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 102.1 -10.04 56.67 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.821 -0.704 . . . . 0.46000000000000002 113.057 178.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.559 ' HB2' ' HB2' ' A' ' 96' ' ' LEU . 61.5 m-20 -97.82 139.92 32.96 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 117.1 0.45 . . . . 0.46000000000000002 110.407 -177.774 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.434 HG12 ' HB3' ' A' ' 115' ' ' LYS . 9.5 mt -111.2 151.69 13.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.082 -0.508 . . . . 1.0800000000000001 110.499 -177.282 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.448 ' HG ' HD23 ' A' ' 96' ' ' LEU . 10.8 m -86.37 156.74 56.63 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 115.965 -0.561 . . . . 1.45 110.887 -178.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -75.99 176.49 9.96 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 122.477 2.118 . . . . 0.40999999999999998 110.183 166.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.405 HG13 ' HG2' ' A' ' 45' ' ' GLN . 22.8 mm -52.05 108.45 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 CA-C-O 121.052 0.454 . . . . 1.04 111.732 177.628 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 76.2 t -108.33 115.64 49.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.049 -0.523 . . . . 1.6599999999999999 110.004 175.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -85.9 140.77 30.09 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 121.195 0.521 . . . . 0.55000000000000004 110.235 177.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 8.4 p -118.37 -172.2 2.22 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.488 -0.778 . . . . 1.05 110.817 -177.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -63.41 -37.58 87.84 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.545 0.212 . . . . 2.1600000000000001 111.027 179.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.605 ' O ' ' HB2' ' A' ' 20' ' ' SER . 8.4 t -92.9 -61.37 1.6 Allowed 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.786 -0.366 . . . . 1.0900000000000001 110.478 179.241 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -145.63 -130.68 2.22 Favored Glycine 0 N--CA 1.443 -0.892 0 C-N-CA 119.026 -1.559 . . . . 0.39000000000000001 113.795 -173.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.44 HD23 ' CG1' ' A' ' 41' ' ' ILE . 6.7 mp -118.54 146.35 44.63 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.289 -0.455 . . . . 1.0600000000000001 111.139 -171.786 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . 0.596 ' NE2' HD12 ' A' ' 14' ' ' LEU . 80.6 m-70 -144.35 142.5 30.42 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.066 0.46 . . . . 0.25 112.061 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.486 HG12 HD11 ' A' ' 44' ' ' LEU . 3.4 pt -125.77 136.22 61.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 107.771 -1.196 . . . . 1.03 107.771 159.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 3.1 mp -128.58 141.23 47.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 C-N-CA 120.891 -0.324 . . . . 1.0600000000000001 110.372 -176.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.434 ' HB3' HG12 ' A' ' 101' ' ' ILE . 38.8 pttt -124.69 139.05 54.21 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.927 -0.768 . . . . 1.29 108.927 172.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 52.6 ttt180 -80.45 129.18 34.35 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.956 0.408 . . . . 2.6800000000000002 111.153 -176.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.442 ' HB2' ' HG2' ' A' ' 9' ' ' ARG . 3.5 mm? -100.99 -30.67 11.5 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.608 -0.724 . . . . 1.54 110.575 -177.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.992 0 CA-C-O 118.467 -0.777 . . . . 1.1499999999999999 110.012 178.612 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 40.6 mmtm . . . . . 0 N--CA 1.454 -0.272 0 CA-C-O 121.342 0.591 . . . . 1.6899999999999999 110.693 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 10.5 tp -120.21 172.61 7.66 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.182 -0.917 . . . . 1.79 109.133 -179.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.409 ' HG2' ' HB2' ' A' ' 117' ' ' LEU . 69.0 ttt180 -147.63 127.38 13.43 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.385 -0.598 . . . . 1.3700000000000001 109.385 177.793 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.556 ' O ' ' HB2' ' A' ' 77' ' ' LEU . . . -146.76 150.15 34.77 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.265 -0.574 . . . . 1.0700000000000001 112.181 -177.484 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.425 ' N ' HD22 ' A' ' 117' ' ' LEU . . . -103.01 134.41 46.5 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.065 -0.717 . . . . 1.04 109.065 176.052 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . 0.416 ' CE1' HD13 ' A' ' 77' ' ' LEU . 37.2 p-80 -136.18 151.32 49.61 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.098 0.475 . . . . 0.34000000000000002 112.05 -172.058 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.561 ' O ' ' HA ' ' A' ' 112' ' ' HIS . 4.7 tt -119.34 144.5 46.82 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.49 -0.929 . . . . 1.0600000000000001 108.49 175.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.585 HD12 ' NE2' ' A' ' 112' ' ' HIS . 28.9 tp -131.65 123.91 28.81 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.531 0.205 . . . . 1.0800000000000001 111.033 -176.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.403 HG23 HD12 ' A' ' 44' ' ' LEU . 71.1 t -113.82 138.03 44.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 109.87 -0.419 . . . . 1.01 109.87 176.052 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.475 ' HE3' HD23 ' A' ' 14' ' ' LEU . 34.0 mmtp -111.29 158.8 18.59 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.876 -0.416 . . . . 1.22 109.876 177.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.426 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 38.4 p90 -149.03 162.58 39.64 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.427 -0.351 . . . . 0.29999999999999999 110.306 -175.542 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.468 ' HB3' ' C ' ' A' ' 33' ' ' ALA . 35.5 p -52.18 109.61 0.4 Allowed 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 120.929 0.395 . . . . 1.6000000000000001 110.55 176.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 101.93 9.08 43.69 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.484 -0.865 . . . . 0.53000000000000003 112.947 -179.085 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.512 ' C ' ' H ' ' A' ' 22' ' ' ASN . 80.9 p -84.08 34.26 0.5 Allowed 'General case' 0 C--O 1.232 0.18 0 CA-C-N 117.29 0.545 . . . . 1.28 111.223 -178.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.439 ' HB2' ' O ' ' A' ' 20' ' ' SER . 89.9 mtt180 73.03 -28.61 0.19 Allowed 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.521 0.728 . . . . 4.1600000000000001 110.895 -177.17 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.512 ' H ' ' C ' ' A' ' 20' ' ' SER . 3.0 p30 -150.07 104.39 3.17 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 115.919 -0.582 . . . . 1.77 110.175 172.425 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.428 ' C ' HG23 ' A' ' 32' ' ' THR . 6.8 Cg_exo -75.3 57.95 4.92 Favored 'Trans proline' 0 CA--C 1.532 0.403 0 C-N-CA 123.448 2.766 . . . . 1.71 113.368 -178.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.418 ' N ' HG23 ' A' ' 32' ' ' THR . 40.3 t -148.48 110.81 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 109.867 -0.42 . . . . 1.1599999999999999 109.867 176.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.463 ' HB3' ' HB2' ' A' ' 16' ' ' LYS . 17.1 p -104.41 154.57 19.69 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.831 -0.168 . . . . 1.4299999999999999 110.689 177.094 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.64 ' HB2' ' HA ' ' A' ' 67' ' ' ASP . 1.2 mpt_? -62.2 -13.6 29.32 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.031 0.443 . . . . 3.1200000000000001 110.503 171.764 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.475 ' HG2' ' HA ' ' A' ' 65' ' ' ARG . 0.4 OUTLIER -80.59 -21.67 41.39 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.81 -0.632 . . . . 2.25 110.346 -179.689 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.419 ' C ' ' H ' ' A' ' 30' ' ' ASP . 36.3 p -115.35 -34.89 4.8 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.999 -0.546 . . . . 1.1299999999999999 110.79 -177.622 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 76.53 -33.11 1.38 Allowed Glycine 0 CA--C 1.517 0.207 0 CA-C-N 115.252 -0.886 . . . . 0.81999999999999995 113.065 176.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.419 ' H ' ' C ' ' A' ' 28' ' ' THR . 16.0 t70 -99.59 -69.13 0.78 Allowed 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 110.124 -0.324 . . . . 2.1000000000000001 110.124 -178.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 42.9 m -154.57 152.76 30.42 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.095 -0.502 . . . . 1.3300000000000001 110.495 175.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.428 HG23 ' C ' ' A' ' 23' ' ' PRO . 10.5 t -119.4 30.88 6.87 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 122.17 0.986 . . . . 1.02 108.903 175.743 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.468 ' C ' ' HB3' ' A' ' 18' ' ' SER . . . -79.96 -5.39 55.57 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 114.898 -1.046 . . . . 1.1299999999999999 111.364 -177.516 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -88.46 -25.68 22.49 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.413 0.625 . . . . 2.21 110.244 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -100.14 137.48 27.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.442 -0.799 . . . . 1.1100000000000001 109.895 -178.434 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 59.6 p -94.88 178.35 5.6 Favored 'General case' 0 CA--C 1.512 -0.487 0 N-CA-C 109.708 -0.478 . . . . 1.2 109.708 -176.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.47 ' O ' HG13 ' A' ' 41' ' ' ILE . 10.1 p90 -63.11 -29.23 70.63 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.009 -0.676 . . . . 2.21 109.561 177.436 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -72.96 -44.13 61.48 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.058 -0.519 . . . . 0.95999999999999996 110.539 178.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 39.7 m-20 -69.72 -27.12 64.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.299 0.571 . . . . 0.91000000000000003 109.89 177.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.426 ' HB2' ' HB3' ' A' ' 17' ' ' PHE . . . -73.37 -45.75 53.08 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.303 -0.862 . . . . 1.03 110.683 176.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.478 ' CG1' HD22 ' A' ' 111' ' ' LEU . 80.5 mt -61.81 -36.39 73.43 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.369 0 N-CA-C 109.619 -0.512 . . . . 1.0800000000000001 109.619 175.246 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -57.78 -32.05 67.15 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 115.561 -0.745 . . . . 2.8399999999999999 110.468 176.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -87.37 -46.18 9.88 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.605 -0.725 . . . . 1.02 109.904 -175.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.461 HD11 HG12 ' A' ' 113' ' ' ILE . 34.6 tp -62.16 -37.41 85.11 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.019 -0.537 . . . . 1.02 110.123 -178.551 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.51 ' O ' ' HB2' ' A' ' 49' ' ' GLN . 0.0 OUTLIER -64.72 -30.93 71.95 Favored 'General case' 0 C--O 1.225 -0.211 0 CA-C-N 116.271 -0.422 . . . . 0.87 111.779 179.581 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 59.4 mttm -72.08 -44.3 63.49 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.119 0.485 . . . . 1.98 110.503 179.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 25.5 m95 -71.54 -43.34 66.59 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.088 -0.506 . . . . 0.60999999999999999 111.414 -179.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.422 ' HB3' HG21 ' A' ' 113' ' ' ILE . 93.6 p -65.04 -22.95 67.06 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.903 -0.406 . . . . 0.88 109.903 175.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.51 ' HB2' ' O ' ' A' ' 45' ' ' GLN . 14.7 tt0 -71.55 -54.31 10.91 Favored 'General case' 0 C--O 1.224 -0.252 0 CA-C-N 116.047 -0.524 . . . . 0.55000000000000004 109.764 174.574 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.513 ' HB3' HG21 ' A' ' 56' ' ' VAL . 89.1 mtt180 -62.37 -41.69 98.83 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.903 -0.589 . . . . 0.47999999999999998 111.788 -177.59 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.43 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 82.1 mt -59.92 -40.01 81.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 120.998 0.427 . . . . 1.04 110.425 176.49 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.9 -41.26 64.79 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.012 -0.54 . . . . 1.0600000000000001 111.523 179.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 66.5 p -76.13 -29.43 57.81 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.829 0.347 . . . . 0.34999999999999998 111.505 -176.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 107.06 4.49 35.76 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.615 -0.802 . . . . 0.33000000000000002 112.271 178.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.469 ' OE1' ' HG2' ' A' ' 50' ' ' ARG . 46.3 mt-10 -61.05 -49.69 76.36 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.134 0.492 . . . . 0.65000000000000002 110.176 178.221 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.513 HG21 ' HB3' ' A' ' 50' ' ' ARG . 15.8 m -131.49 154.62 40.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.695 -0.684 . . . . 1.05 109.268 173.193 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 22.8 p -85.41 165.76 16.94 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 109.554 -0.536 . . . . 1.3100000000000001 109.554 177.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -57.38 -41.9 81.11 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.978 -0.378 . . . . 0.25 109.978 -177.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.577 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 42.0 mt-10 -59.23 -46.56 88.15 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.76 -0.654 . . . . 1.72 111.623 -179.179 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -60.53 -44.61 95.87 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-O 120.92 0.391 . . . . 2.0899999999999999 111.0 -178.018 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -70.76 -49.57 45.29 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.246 -0.434 . . . . 1.0700000000000001 111.084 -178.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.41 -51.86 68.08 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.332 0.493 . . . . 1.0600000000000001 112.332 -174.424 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.508 ' HA ' ' O ' ' A' ' 71' ' ' TYR . 52.8 m -51.12 -24.09 3.75 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 113.041 0.756 . . . . 1.52 113.041 -178.083 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -104.18 -44.94 4.85 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.493 0.663 . . . . 0.60999999999999999 110.494 -179.018 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.475 ' HA ' ' HG2' ' A' ' 27' ' ' ARG . 16.3 mmt180 -90.81 -42.73 10.49 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 113.848 1.055 . . . . 0.95999999999999996 113.848 -170.353 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.409 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 72.7 p -64.3 124.89 22.9 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.044 0.449 . . . . 1.0600000000000001 111.28 -175.305 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.64 ' HA ' ' HB2' ' A' ' 26' ' ' ARG . 25.7 t70 -76.6 -16.05 59.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.543 -0.753 . . . . 2.2799999999999998 111.475 178.204 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 52.6 t -78.05 155.79 30.44 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.201 0.524 . . . . 2.0499999999999998 110.15 -179.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -57.12 -18.1 26.1 Favored Glycine 0 N--CA 1.454 -0.138 0 CA-C-N 114.631 -1.168 . . . . 0.29999999999999999 113.638 -173.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 63.0 p -64.77 -7.7 12.04 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 112.035 0.383 . . . . 0.46999999999999997 112.035 176.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.508 ' O ' ' HA ' ' A' ' 63' ' ' SER . 25.2 p90 -57.88 -22.92 50.69 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.868 0.366 . . . . 0.94999999999999996 110.297 175.724 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -90.77 -0.23 57.64 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.06 0.457 . . . . 1.1100000000000001 110.674 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 16.3 m -126.34 14.38 7.72 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.888 -0.596 . . . . 0.70999999999999996 110.577 178.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.577 ' O ' ' HA ' ' A' ' 59' ' ' GLU . . . 70.75 27.33 72.56 Favored Glycine 0 CA--C 1.519 0.325 0 C-N-CA 120.839 -0.696 . . . . 0.67000000000000004 112.718 -178.708 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 82.3 -17.85 16.69 Favored Glycine 0 N--CA 1.454 -0.167 0 C-N-CA 121.034 -0.603 . . . . 0.42999999999999999 112.473 179.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -70.96 135.16 47.73 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-O 120.883 0.373 . . . . 1.6499999999999999 110.594 -176.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.556 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 19.2 mt -111.36 158.43 19.07 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.933 -0.576 . . . . 1.6899999999999999 110.291 176.408 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -81.84 -137.37 2.4 Favored Glycine 0 C--N 1.317 -0.507 0 CA-C-N 115.673 -0.694 . . . . 0.45000000000000001 112.625 179.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 38.1 p90 -98.43 135.57 39.82 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.189 0.519 . . . . 4.7400000000000002 110.626 -177.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.435 ' HZ ' ' N ' ' A' ' 10' ' ' ALA . 2.0 p90 -151.5 164.6 36.44 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.921 -0.581 . . . . 1.6499999999999999 110.21 -178.572 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 13.2 m -89.54 120.42 30.83 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 109.788 -0.449 . . . . 1.6899999999999999 109.788 178.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.5 p -55.36 118.85 4.79 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.932 -0.576 . . . . 1.55 110.909 178.468 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 114.43 5.92 20.47 Favored Glycine 0 N--CA 1.447 -0.572 0 N-CA-C 111.538 -0.625 . . . . 0.79000000000000004 111.538 -176.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -105.04 -6.19 20.22 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.83 0.347 . . . . 1.5800000000000001 110.803 -177.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 26.0 mmt -86.14 -97.48 0.07 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.252 0.549 . . . . 1.1299999999999999 110.873 -175.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 55.9 mtt -145.16 150.96 37.68 Favored 'General case' 0 CA--C 1.507 -0.694 0 N-CA-C 107.187 -1.412 . . . . 1.8899999999999999 107.187 176.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -55.85 -52.63 70.76 Favored Pre-proline 0 C--N 1.318 -0.797 0 CA-C-N 118.188 0.449 . . . . 2.7400000000000002 112.115 -174.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -74.03 -31.34 8.04 Favored 'Trans proline' 0 C--N 1.358 1.033 0 C-N-CA 121.466 1.444 . . . . 0.29999999999999999 111.891 -177.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.618 ' O ' HG21 ' A' ' 93' ' ' VAL . 29.7 t80 -65.74 -55.73 15.78 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.62 -0.718 . . . . 0.28000000000000003 109.481 177.018 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -64.52 -34.6 78.6 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.338 -0.846 . . . . 2.1200000000000001 110.461 -177.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -56.99 -36.54 70.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.824 -0.625 . . . . 0.60999999999999999 110.516 175.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.44 ' O ' ' HG ' ' A' ' 96' ' ' LEU . . . -78.97 -28.26 43.54 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.192 -0.458 . . . . 1.1000000000000001 110.981 178.356 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.618 HG21 ' O ' ' A' ' 89' ' ' PHE . 17.2 t -71.42 -36.48 61.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 121.267 0.556 . . . . 1.1200000000000001 110.14 -177.55 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.509 ' C ' ' HD2' ' A' ' 94' ' ' ARG . 6.1 ppt_? -82.66 -9.23 59.47 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.918 -0.583 . . . . 3.1800000000000002 110.446 179.008 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.35 -2.66 58.78 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.989 -0.551 . . . . 1.0800000000000001 110.955 -177.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.523 ' HB2' ' HB2' ' A' ' 100' ' ' ASP . 0.7 OUTLIER -135.87 152.9 51.5 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.896 -0.593 . . . . 1.1200000000000001 110.442 178.906 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.613 ' HG2' ' H ' ' A' ' 98' ' ' ILE . 47.0 tttt -102.88 -174.13 2.48 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.634 -0.506 . . . . 2.1299999999999999 109.634 176.64 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.613 ' H ' ' HG2' ' A' ' 97' ' ' LYS . 10.4 mt -57.54 116.08 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 121.061 0.458 . . . . 1.6200000000000001 111.692 -176.387 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 98.23 3.83 57.62 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.813 -0.708 . . . . 0.46000000000000002 113.239 179.326 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.523 ' HB2' ' HB2' ' A' ' 96' ' ' LEU . 7.7 m-20 -104.67 141.76 35.87 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 117.196 0.498 . . . . 0.46000000000000002 110.811 178.719 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 8.3 mt -111.84 146.58 16.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.774 -0.648 . . . . 1.0800000000000001 109.737 -178.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 88.1 p -93.35 155.46 40.9 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 116.374 -0.376 . . . . 1.45 110.292 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -74.23 175.54 10.81 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 122.125 1.883 . . . . 0.40999999999999998 111.131 171.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.43 HG13 ' HG2' ' A' ' 45' ' ' GLN . 20.3 mm -48.99 108.48 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 O-C-N 123.459 0.474 . . . . 1.04 112.144 177.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.4 p -115.84 120.08 63.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 120.91 0.386 . . . . 1.6599999999999999 110.125 175.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -85.42 152.45 23.21 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.141 0.496 . . . . 0.55000000000000004 110.964 -179.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 4.3 p -126.27 -172.51 2.64 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.434 -0.803 . . . . 1.05 110.237 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -60.78 -38.46 85.4 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.83 0.348 . . . . 2.1600000000000001 110.642 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.455 ' O ' ' HB2' ' A' ' 20' ' ' SER . 16.2 t -90.95 -60.63 1.86 Allowed 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 120.867 -0.333 . . . . 1.0900000000000001 110.694 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -150.55 -130.85 1.79 Allowed Glycine 0 N--CA 1.441 -1.019 0 C-N-CA 119.057 -1.544 . . . . 0.39000000000000001 114.084 -173.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.513 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 6.7 mp -116.07 146.2 42.39 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.184 -0.508 . . . . 1.0600000000000001 111.844 -168.012 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . 0.585 ' NE2' HD12 ' A' ' 14' ' ' LEU . 85.0 m-70 -141.99 150.0 40.78 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.578 0.584 . . . . 0.25 112.578 178.422 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.461 HG12 HD11 ' A' ' 44' ' ' LEU . 3.3 pt -132.42 138.21 52.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 107.446 -1.316 . . . . 1.03 107.446 159.379 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 2.2 mp -129.69 145.74 35.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 C-N-CA 120.755 -0.378 . . . . 1.0600000000000001 110.641 -175.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.426 ' HA ' ' O ' ' A' ' 100' ' ' ASP . 42.0 pttt -126.64 139.01 53.49 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.796 -0.816 . . . . 1.29 108.796 171.365 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . 0.451 ' HD3' ' HA ' ' A' ' 97' ' ' LYS . 60.7 ttt180 -83.63 125.12 31.5 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.174 0.512 . . . . 2.6800000000000002 110.86 -178.087 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.425 HD22 ' N ' ' A' ' 11' ' ' ALA . 4.2 mm? -93.06 -31.96 14.65 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.487 -0.779 . . . . 1.54 110.247 -179.114 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.865 0 CA-C-N 115.54 -0.755 . . . . 1.1499999999999999 109.962 179.747 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.42 ' HG3' ' HB2' ' A' ' 79' ' ' PHE . 10.8 mptt . . . . . 0 N--CA 1.45 -0.459 0 CA-C-O 121.838 0.827 . . . . 1.6899999999999999 110.82 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.57 HD22 ' H ' ' A' ' 9' ' ' ARG . 1.8 tt -116.01 159.53 21.51 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 114.2 -1.364 . . . . 1.79 108.001 -178.512 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.57 ' H ' HD22 ' A' ' 8' ' ' LEU . 79.0 ttt180 -136.28 127.85 28.75 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.431 -0.581 . . . . 1.3700000000000001 109.431 174.274 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.484 ' N ' ' HZ ' ' A' ' 80' ' ' PHE . . . -150.05 152.17 34.41 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.093 0.473 . . . . 1.0700000000000001 111.714 -179.244 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -101.87 136.78 41.12 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.458 -0.792 . . . . 1.04 109.527 177.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 37.4 p-80 -136.45 149.1 48.07 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.964 0.412 . . . . 0.34000000000000002 111.286 -173.327 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.555 ' O ' ' HA ' ' A' ' 112' ' ' HIS . 6.2 tt -118.37 149.46 41.16 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.836 -0.802 . . . . 1.0600000000000001 108.836 177.275 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.563 ' O ' ' HA ' ' A' ' 66' ' ' SER . 29.6 tp -130.84 124.61 31.65 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.611 0.243 . . . . 1.0800000000000001 111.052 -179.228 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.415 HG21 HD13 ' A' ' 44' ' ' LEU . 85.1 t -111.34 138.03 41.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 109.405 -0.591 . . . . 1.01 109.405 173.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.471 ' HB2' ' HB2' ' A' ' 25' ' ' SER . 24.9 mmtp -105.72 162.07 13.85 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.157 -0.474 . . . . 1.22 110.491 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.44 ' HB3' ' HB3' ' A' ' 40' ' ' ALA . 51.5 p90 -158.86 161.6 36.87 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.053 -0.521 . . . . 0.29999999999999999 109.92 179.48 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.486 ' HB3' ' C ' ' A' ' 33' ' ' ALA . 21.5 p -53.35 109.97 0.5 Allowed 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.347 -0.388 . . . . 1.6000000000000001 111.026 178.576 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 104.46 10.36 33.71 Favored Glycine 0 N--CA 1.443 -0.86 0 C-N-CA 120.229 -0.986 . . . . 0.53000000000000003 113.371 178.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.658 ' HB2' ' O ' ' A' ' 109' ' ' SER . 39.8 p -81.49 46.24 0.94 Allowed 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 117.855 0.828 . . . . 1.28 111.577 -174.065 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 56.2 ttt180 68.95 -37.01 0.35 Allowed 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.905 0.882 . . . . 4.1600000000000001 111.355 -177.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.515 ' H ' ' C ' ' A' ' 20' ' ' SER . 8.1 p30 -155.01 126.48 3.67 Favored Pre-proline 0 C--N 1.316 -0.866 0 N-CA-C 107.67 -1.233 . . . . 1.77 107.67 175.565 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -82.39 -156.11 0.07 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 122.302 2.001 . . . . 1.71 111.784 -175.106 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.591 ' N ' HG22 ' A' ' 32' ' ' THR . 57.5 t 60.07 114.12 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 123.423 0.689 . . . . 1.1599999999999999 111.692 -173.738 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.471 ' HB2' ' HB2' ' A' ' 16' ' ' LYS . 29.8 t -103.4 159.82 15.24 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.815 -0.63 . . . . 1.4299999999999999 109.722 177.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.586 ' HB2' ' HA ' ' A' ' 67' ' ' ASP . 5.5 mpt_? -75.33 -12.73 60.33 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 109.018 -0.734 . . . . 3.1200000000000001 109.018 169.498 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.425 ' HG2' ' HD3' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -72.52 -49.75 30.67 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.249 -0.887 . . . . 2.25 109.195 174.066 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.412 ' C ' ' H ' ' A' ' 30' ' ' ASP . 55.6 p -85.39 -34.05 21.84 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.468 -0.787 . . . . 1.1299999999999999 111.249 -177.511 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 80.7 -34.73 2.29 Favored Glycine 0 C--N 1.322 -0.216 0 CA-C-N 115.314 -0.857 . . . . 0.81999999999999995 111.395 -176.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.561 ' O ' ' HA ' ' A' ' 24' ' ' VAL . 4.4 m-20 -114.56 -135.27 0.35 Allowed 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 108.349 -0.982 . . . . 2.1000000000000001 108.349 173.025 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -70.82 142.03 51.3 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 112.703 0.631 . . . . 1.3300000000000001 112.703 -171.261 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.591 HG22 ' N ' ' A' ' 24' ' ' VAL . 8.9 t -124.25 14.51 9.01 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.337 -0.847 . . . . 1.02 109.461 175.219 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.486 ' C ' ' HB3' ' A' ' 18' ' ' SER . . . -68.75 -4.35 15.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.302 -0.863 . . . . 1.1299999999999999 111.565 177.587 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -88.73 -24.95 22.55 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.99 -0.55 . . . . 2.21 110.802 -178.053 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.557 HG22 ' HB3' ' A' ' 39' ' ' ASP . 0.1 OUTLIER -100.58 141.55 17.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.088 -0.505 . . . . 1.1100000000000001 110.211 -179.126 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 40.7 p -98.1 174.75 6.38 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 110.212 -0.292 . . . . 1.2 110.212 -176.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.519 ' O ' HG13 ' A' ' 41' ' ' ILE . 11.5 p90 -63.94 -26.85 68.77 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.101 -0.64 . . . . 2.21 109.507 177.713 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -71.04 -46.14 62.57 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.06 -0.518 . . . . 0.95999999999999996 110.526 178.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.557 ' HB3' HG22 ' A' ' 35' ' ' VAL . 2.7 t70 -70.0 -31.22 68.79 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.473 0.654 . . . . 0.91000000000000003 109.695 178.15 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.44 ' HB3' ' HB3' ' A' ' 17' ' ' PHE . . . -66.64 -41.97 87.43 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.232 -0.895 . . . . 1.03 110.347 175.658 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.519 HG13 ' O ' ' A' ' 37' ' ' TYR . 78.1 mt -64.63 -33.13 61.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 109.516 -0.549 . . . . 1.0800000000000001 109.516 173.517 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.513 ' HB3' ' O ' ' A' ' 39' ' ' ASP . 3.9 ttpm? -60.75 -28.32 68.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.298 0.571 . . . . 2.8399999999999999 109.993 176.212 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.437 ' HG3' ' CD1' ' A' ' 47' ' ' TRP . 6.2 tp10 -84.92 -52.88 5.69 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.403 -0.817 . . . . 1.02 109.487 -178.635 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.486 HD12 HG12 ' A' ' 113' ' ' ILE . 22.8 tp -64.61 -34.15 77.61 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.329 -0.851 . . . . 1.02 110.762 -174.267 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.503 ' O ' ' HB2' ' A' ' 49' ' ' GLN . 4.7 mm-40 -70.41 -19.63 62.98 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.353 -0.385 . . . . 0.87 111.892 -178.481 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.43 ' HG3' ' O ' ' A' ' 42' ' ' LYS . 67.9 mttm -84.25 -46.95 11.29 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.741 -0.466 . . . . 1.98 109.741 175.489 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.452 ' NE1' ' HG3' ' A' ' 65' ' ' ARG . 44.0 m95 -63.61 -48.05 78.9 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.144 -0.48 . . . . 0.60999999999999999 111.821 179.782 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.446 ' HB3' HG21 ' A' ' 113' ' ' ILE . 98.5 p -64.81 -20.53 66.44 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.507 -0.477 . . . . 0.88 110.023 177.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.503 ' HB2' ' O ' ' A' ' 45' ' ' GLN . 11.8 tt0 -77.52 -54.72 6.08 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.183 -0.462 . . . . 0.55000000000000004 110.014 175.771 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.497 ' HB3' HG21 ' A' ' 56' ' ' VAL . 97.9 mtt180 -63.21 -41.5 99.15 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.637 -0.711 . . . . 0.47999999999999998 111.435 -176.627 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.474 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 98.3 mt -61.12 -33.59 56.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.159 0.504 . . . . 1.04 110.48 176.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -79.75 -35.55 38.57 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.907 -0.588 . . . . 1.0600000000000001 111.444 -179.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 31.1 p -82.35 -28.98 31.23 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.811 0.338 . . . . 0.34999999999999998 111.602 -176.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 107.98 3.77 33.9 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.762 -0.732 . . . . 0.33000000000000002 112.375 179.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.441 ' HB2' ' HB3' ' A' ' 50' ' ' ARG . 36.8 mt-10 -61.79 -48.16 81.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.075 0.464 . . . . 0.65000000000000002 110.258 178.435 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.497 HG21 ' HB3' ' A' ' 50' ' ' ARG . 15.6 m -135.32 156.22 38.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 109.31 -0.626 . . . . 1.05 109.31 172.242 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.574 ' OG ' ' HG3' ' A' ' 60' ' ' GLU . 77.7 p -83.79 165.49 18.79 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.795 -0.446 . . . . 1.3100000000000001 109.795 178.035 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -57.7 -41.01 80.83 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.516 -0.55 . . . . 0.25 109.516 179.172 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.485 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 43.8 mt-10 -62.24 -41.35 98.34 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.062 -0.972 . . . . 1.72 111.962 -178.122 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.574 ' HG3' ' OG ' ' A' ' 57' ' ' SER . 41.2 mt-10 -60.76 -49.24 78.28 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.021 0.439 . . . . 2.0899999999999999 110.859 -179.659 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.14 -50.61 63.38 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.926 -0.579 . . . . 1.0700000000000001 111.073 -178.257 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -58.86 -52.1 67.19 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.351 0.5 . . . . 1.0600000000000001 112.351 -174.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.546 ' HA ' ' O ' ' A' ' 71' ' ' TYR . 20.2 m -51.5 -24.23 4.92 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 113.122 0.786 . . . . 1.52 113.122 -176.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -105.49 -44.12 4.78 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.583 0.706 . . . . 0.60999999999999999 110.615 -179.15 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.452 ' HG3' ' NE1' ' A' ' 47' ' ' TRP . 38.7 mmt-85 -90.92 -41.88 10.9 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 113.882 1.067 . . . . 0.95999999999999996 113.882 -170.131 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.563 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 75.9 p -64.17 122.7 17.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.055 0.455 . . . . 1.0600000000000001 111.615 -174.314 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.586 ' HA ' ' HB2' ' A' ' 26' ' ' ARG . 28.6 t70 -76.55 -9.33 58.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.618 -0.719 . . . . 2.2799999999999998 110.827 175.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . 0.428 ' SG ' HD22 ' A' ' 14' ' ' LEU . 4.1 m -77.13 163.43 26.6 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.897 -0.592 . . . . 2.0499999999999998 110.267 175.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -65.9 -16.28 63.71 Favored Glycine 0 CA--C 1.512 -0.142 0 CA-C-N 114.912 -1.04 . . . . 0.29999999999999999 113.203 -173.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.51 ' HB2' ' CA ' ' A' ' 75' ' ' GLY . 3.6 p -68.96 0.56 4.34 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 112.426 0.528 . . . . 0.46999999999999997 112.426 177.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.546 ' O ' ' HA ' ' A' ' 63' ' ' SER . 34.5 p90 -58.33 -26.47 63.14 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.137 0.494 . . . . 0.94999999999999996 110.154 175.515 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -95.29 -6.99 40.07 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.162 0.505 . . . . 1.1100000000000001 110.585 178.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.8 m -110.67 -0.02 17.31 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.835 -0.62 . . . . 0.70999999999999996 111.066 -175.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.485 ' O ' ' HA ' ' A' ' 59' ' ' GLU . . . 77.79 27.64 58.37 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.852 -0.689 . . . . 0.67000000000000004 112.218 -177.086 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.51 ' CA ' ' HB2' ' A' ' 70' ' ' SER . . . 81.94 -1.2 87.24 Favored Glycine 0 C--O 1.226 -0.373 0 C-N-CA 120.873 -0.679 . . . . 0.42999999999999999 111.85 -178.264 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -92.15 136.07 33.48 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 120.962 0.41 . . . . 1.6499999999999999 111.436 -169.215 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.6 mp -115.75 158.08 23.38 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.709 -0.678 . . . . 1.6899999999999999 109.548 172.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -85.35 -127.2 1.77 Allowed Glycine 0 C--N 1.308 -1.001 0 CA-C-N 114.944 -1.025 . . . . 0.45000000000000001 112.255 -179.118 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.42 ' HB2' ' HG3' ' A' ' 7' ' ' LYS . 46.4 p90 -92.67 147.31 22.98 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.83 0.348 . . . . 4.7400000000000002 110.734 -177.694 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.484 ' HZ ' ' N ' ' A' ' 10' ' ' ALA . 2.3 p90 -163.59 147.25 10.32 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.098 -0.501 . . . . 1.6499999999999999 110.499 179.056 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 17.5 m -76.08 135.03 39.89 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.13 -0.486 . . . . 1.6899999999999999 110.577 179.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 16.0 m -61.03 114.64 3.21 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.939 -0.573 . . . . 1.55 110.024 177.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 112.58 -8.08 26.18 Favored Glycine 0 N--CA 1.447 -0.606 0 CA-C-N 115.79 -0.641 . . . . 0.79000000000000004 111.895 -177.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -101.14 47.01 0.92 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.655 0.741 . . . . 1.5800000000000001 110.371 -177.296 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 21.6 mmt -135.82 -127.21 0.15 Allowed 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.87 -0.789 . . . . 1.1299999999999999 108.87 176.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 59.9 mtt -113.45 149.85 33.65 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.438 -0.949 . . . . 1.8899999999999999 108.438 174.028 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -53.3 -54.37 45.85 Favored Pre-proline 0 C--N 1.321 -0.646 0 N-CA-C 112.647 0.61 . . . . 2.7400000000000002 112.647 -174.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -74.61 -31.22 7.1 Favored 'Trans proline' 0 C--N 1.355 0.89 0 C-N-CA 121.387 1.391 . . . . 0.29999999999999999 111.667 -176.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.598 ' O ' HG21 ' A' ' 93' ' ' VAL . 42.9 t80 -66.03 -56.06 13.47 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.113 -0.949 . . . . 0.28000000000000003 110.099 179.309 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -64.61 -37.96 89.37 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.598 -0.728 . . . . 2.1200000000000001 110.218 -177.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.409 ' HA ' ' HD2' ' A' ' 94' ' ' ARG . 35.2 t70 -59.46 -26.93 65.64 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.874 -0.603 . . . . 0.60999999999999999 110.7 177.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -85.59 -21.39 28.52 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.495 -0.32 . . . . 1.1000000000000001 111.408 176.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.598 HG21 ' O ' ' A' ' 89' ' ' PHE . 44.8 t -74.83 -47.9 35.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 121.253 0.549 . . . . 1.1200000000000001 110.567 -173.737 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.409 ' HD2' ' HA ' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -78.49 1.79 21.18 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.195 -0.457 . . . . 3.1800000000000002 111.028 176.888 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -92.68 0.44 57.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.973 0.416 . . . . 1.0800000000000001 110.758 -179.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.538 ' HB2' ' HB2' ' A' ' 100' ' ' ASP . 0.4 OUTLIER -137.28 160.37 39.22 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.968 -0.56 . . . . 1.1200000000000001 110.627 177.876 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.498 ' HG3' ' H ' ' A' ' 98' ' ' ILE . 50.8 tptt -102.21 175.83 5.39 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.246 -0.65 . . . . 2.1299999999999999 109.246 179.433 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.498 ' H ' ' HG3' ' A' ' 97' ' ' LYS . 63.0 mt -57.71 114.66 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 120.97 0.414 . . . . 1.6200000000000001 110.725 177.797 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 104.76 -0.49 42.14 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.802 -0.714 . . . . 0.46000000000000002 112.528 -179.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.538 ' HB2' ' HB2' ' A' ' 96' ' ' LEU . 24.6 m-20 -105.17 137.45 42.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.797 0.298 . . . . 0.46000000000000002 110.522 179.732 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 12.7 mt -108.94 148.77 12.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.986 -0.552 . . . . 1.0800000000000001 109.902 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 95.7 p -91.28 156.05 43.95 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-N 116.469 -0.332 . . . . 1.45 110.539 -179.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -69.69 174.08 9.97 Favored 'Trans proline' 0 C--O 1.233 0.271 0 C-N-CA 122.478 2.118 . . . . 0.40999999999999998 111.245 171.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.434 HG22 HD22 ' A' ' 44' ' ' LEU . 26.1 mm -51.67 100.78 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 O-C-N 123.314 0.383 . . . . 1.04 111.447 176.025 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.5 p -104.76 118.34 51.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.2 0.524 . . . . 1.6599999999999999 109.868 175.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -85.23 146.96 26.82 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.214 0.531 . . . . 0.55000000000000004 110.674 -179.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 18.5 p -124.49 -172.38 2.55 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.395 -0.82 . . . . 1.05 109.76 179.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -73.46 -29.43 62.53 Favored 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 120.967 -0.293 . . . . 2.1600000000000001 110.81 178.085 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.658 ' O ' ' HB2' ' A' ' 20' ' ' SER . 8.4 t -101.3 -9.31 21.33 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.1 0.407 . . . . 1.0900000000000001 112.1 -175.377 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 160.66 -127.47 1.78 Allowed Glycine 0 N--CA 1.437 -1.293 0 C-N-CA 119.871 -1.157 . . . . 0.39000000000000001 112.638 170.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.51 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 6.1 mp -120.9 144.11 48.6 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 114.981 -0.61 . . . . 1.0600000000000001 110.846 -172.36 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . 0.555 ' HA ' ' O ' ' A' ' 13' ' ' LEU . 72.9 m-70 -143.06 151.72 41.09 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.262 0.553 . . . . 0.25 112.044 -179.773 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.486 HG12 HD12 ' A' ' 44' ' ' LEU . 2.8 pt -134.64 141.36 43.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 107.658 -1.238 . . . . 1.03 107.658 161.126 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 1.8 mp -129.98 143.31 41.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 C-N-CA 120.773 -0.371 . . . . 1.0600000000000001 110.62 -176.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.402 ' HA ' ' O ' ' A' ' 100' ' ' ASP . 43.8 pttt -125.14 138.17 54.16 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.63 -0.878 . . . . 1.29 108.63 172.136 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . 0.417 ' HB2' ' CD1' ' A' ' 96' ' ' LEU . 61.3 ttt180 -85.64 136.39 33.39 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.079 0.466 . . . . 2.6800000000000002 111.268 -177.079 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 6.6 mp -115.25 -24.29 8.54 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.62 -0.718 . . . . 1.54 111.508 -178.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.774 0 CA-C-O 118.22 -0.895 . . . . 1.1499999999999999 109.882 175.718 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 24.3 tptt . . . . . 0 N--CA 1.451 -0.421 0 CA-C-O 121.281 0.563 . . . . 1.6899999999999999 110.004 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.659 HD23 ' N ' ' A' ' 9' ' ' ARG . 2.9 tt -139.29 155.92 47.4 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 115.065 -0.97 . . . . 1.79 108.467 -177.449 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.659 ' N ' HD23 ' A' ' 8' ' ' LEU . 44.3 ttt180 -139.56 128.48 23.52 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 108.199 -1.038 . . . . 1.3700000000000001 108.199 173.422 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.418 ' O ' ' HB2' ' A' ' 77' ' ' LEU . . . -146.04 148.71 32.98 Favored 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 120.402 -0.519 . . . . 1.0700000000000001 111.983 -177.106 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -102.44 137.15 41.07 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.428 -0.806 . . . . 1.04 109.264 176.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 23.1 p-80 -137.37 152.68 49.95 Favored 'General case' 0 C--N 1.323 -0.587 0 C-N-CA 120.418 -0.513 . . . . 0.34000000000000002 111.872 -172.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.573 HD23 ' N ' ' A' ' 14' ' ' LEU . 5.4 tt -121.1 148.3 44.37 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.467 -0.938 . . . . 1.0600000000000001 108.467 177.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.573 ' N ' HD23 ' A' ' 13' ' ' LEU . 27.4 tp -131.23 130.96 43.58 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 110.378 -0.23 . . . . 1.0800000000000001 110.378 -179.355 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.41 ' CG2' HD12 ' A' ' 44' ' ' LEU . 63.6 t -120.83 129.22 75.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 109.518 -0.549 . . . . 1.01 109.518 173.241 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.6 ' HE2' ' OG ' ' A' ' 109' ' ' SER . 32.1 mmtp -104.58 158.33 16.57 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.214 -0.448 . . . . 1.22 110.504 178.336 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -150.68 162.13 41.28 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.954 -0.566 . . . . 0.29999999999999999 110.125 -175.07 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.448 ' HB3' ' C ' ' A' ' 33' ' ' ALA . 45.8 p -55.0 111.42 0.83 Allowed 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 110.117 -0.327 . . . . 1.6000000000000001 110.117 175.209 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 104.24 9.84 35.47 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.074 -1.06 . . . . 0.53000000000000003 112.394 -177.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.493 ' C ' ' H ' ' A' ' 22' ' ' ASN . 79.5 p -92.98 24.21 3.82 Favored 'General case' 0 N--CA 1.453 -0.308 0 O-C-N 122.376 -0.485 . . . . 1.28 110.791 -177.541 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 60.3 mtt180 71.79 -33.39 0.27 Allowed 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 123.225 0.61 . . . . 4.1600000000000001 111.406 -178.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.493 ' H ' ' C ' ' A' ' 20' ' ' SER . 38.5 m-80 -127.8 89.05 51.77 Favored Pre-proline 0 C--N 1.324 -0.541 0 N-CA-C 109.109 -0.7 . . . . 1.77 109.109 176.336 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.533 ' C ' HG22 ' A' ' 32' ' ' THR . 90.5 Cg_endo -79.84 45.46 1.96 Allowed 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 122.678 2.252 . . . . 1.71 112.82 -173.522 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 60.7 t -141.53 115.14 4.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 108.68 -0.859 . . . . 1.1599999999999999 108.68 178.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.459 ' HB2' ' OD1' ' A' ' 67' ' ' ASP . 15.9 p -100.84 158.35 16.04 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 110.173 -0.306 . . . . 1.4299999999999999 110.173 -178.04 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.448 ' HG2' ' HA ' ' A' ' 67' ' ' ASP . 18.3 mmm180 -72.97 -17.24 61.49 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 108.362 -0.977 . . . . 3.1200000000000001 108.362 172.122 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 13.2 ttp180 -65.83 -48.64 70.97 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 114.463 -1.244 . . . . 2.25 110.054 177.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 33.3 p -96.35 -34.49 11.55 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.153 0.501 . . . . 1.1299999999999999 110.765 -178.078 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 85.91 -31.37 4.01 Favored Glycine 0 N--CA 1.45 -0.381 0 CA-C-N 115.752 -0.658 . . . . 0.81999999999999995 113.148 -179.375 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -101.24 -61.23 1.4 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.973 0.386 . . . . 2.1000000000000001 111.424 -178.128 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 10.3 p -154.77 149.62 26.68 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.986 0.422 . . . . 1.3300000000000001 111.674 178.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.533 HG22 ' C ' ' A' ' 23' ' ' PRO . 12.6 t -116.86 27.31 9.23 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 122.305 1.05 . . . . 1.02 108.733 173.2 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.448 ' C ' ' HB3' ' A' ' 18' ' ' SER . . . -75.83 -4.43 40.68 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.598 -1.183 . . . . 1.1299999999999999 112.162 -175.213 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -97.94 -19.8 17.84 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.943 0.401 . . . . 2.21 110.632 -178.263 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.459 HG23 ' HB2' ' A' ' 39' ' ' ASP . 0.2 OUTLIER -101.85 137.85 28.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 116.062 -0.517 . . . . 1.1100000000000001 110.36 -178.667 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 61.8 p -96.91 177.9 5.47 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 109.531 -0.544 . . . . 1.2 109.531 -178.257 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.415 ' O ' HG13 ' A' ' 41' ' ' ILE . 0.1 OUTLIER -68.39 -21.26 64.7 Favored 'General case' 0 C--O 1.217 -0.616 0 C-N-CA 118.72 -1.192 . . . . 2.21 110.288 174.26 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -72.41 -41.98 65.63 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.931 -0.396 . . . . 0.95999999999999996 109.931 175.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.459 ' HB2' HG23 ' A' ' 35' ' ' VAL . 23.9 m-20 -71.04 -35.17 71.88 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.404 0.621 . . . . 0.91000000000000003 109.853 175.035 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.99 -48.25 66.29 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.098 -0.955 . . . . 1.03 110.613 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.437 ' CG1' HD21 ' A' ' 111' ' ' LEU . 69.8 mt -62.15 -36.83 76.44 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.462 0 N-CA-C 109.833 -0.432 . . . . 1.0800000000000001 109.833 175.661 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 59.6 tttp -59.86 -29.09 68.07 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.832 -0.622 . . . . 2.8399999999999999 109.891 178.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -88.91 -49.54 6.73 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.461 -0.791 . . . . 1.02 110.473 -178.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.453 HD11 HG12 ' A' ' 113' ' ' ILE . 33.9 tp -58.73 -36.42 74.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.969 -0.56 . . . . 1.02 110.039 -177.503 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.444 ' HG2' HG13 ' A' ' 104' ' ' ILE . 0.0 OUTLIER -66.92 -23.56 65.99 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-N 115.954 -0.566 . . . . 0.87 112.078 -179.692 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -85.01 -40.29 17.05 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 110.196 -0.298 . . . . 1.98 110.196 179.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.421 ' O ' HG13 ' A' ' 51' ' ' ILE . 36.8 m95 -66.46 -47.87 71.73 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.96 -0.296 . . . . 0.60999999999999999 111.293 174.829 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 88.6 p -62.75 -28.24 69.83 Favored 'General case' 0 C--N 1.333 -0.128 0 C-N-CA 120.719 -0.392 . . . . 0.88 110.062 177.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.443 ' HB2' ' O ' ' A' ' 45' ' ' GLN . 11.4 tt0 -66.74 -57.17 7.64 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.925 -0.58 . . . . 0.55000000000000004 110.323 173.774 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.508 ' HB3' HG23 ' A' ' 56' ' ' VAL . 86.2 mtt180 -61.14 -42.14 98.01 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.943 -0.571 . . . . 0.47999999999999998 111.58 -176.437 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.48 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 92.4 mt -61.51 -36.63 74.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 120.929 0.395 . . . . 1.04 110.43 177.479 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -77.46 -35.45 53.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.068 -0.515 . . . . 1.0600000000000001 111.684 -179.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 51.1 p -80.49 -30.34 37.33 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.893 0.377 . . . . 0.34999999999999998 111.481 -177.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 108.55 4.43 32.37 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.76 -0.733 . . . . 0.33000000000000002 112.218 -179.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.416 ' HB2' ' HB3' ' A' ' 50' ' ' ARG . 40.0 mt-10 -61.49 -48.7 79.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.007 0.432 . . . . 0.65000000000000002 110.104 178.039 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.508 HG23 ' HB3' ' A' ' 50' ' ' ARG . 13.6 m -133.77 157.45 42.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 109.354 -0.61 . . . . 1.05 109.354 171.824 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 49.6 m -85.93 160.02 19.5 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 109.471 -0.566 . . . . 1.3100000000000001 109.471 177.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -53.66 -43.92 69.2 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.272 0.558 . . . . 0.25 109.948 -177.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.581 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 2.8 mp0 -56.96 -39.13 74.01 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.845 -1.071 . . . . 1.72 111.916 -178.307 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 31.5 mm-40 -65.39 -48.94 71.14 Favored 'General case' 0 CA--C 1.521 -0.16 0 CA-C-O 120.836 0.35 . . . . 2.0899999999999999 111.118 -177.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -68.94 -42.72 76.33 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.386 -0.37 . . . . 1.0700000000000001 111.108 -177.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.11 -53.82 52.22 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.331 -0.395 . . . . 1.0600000000000001 112.051 -175.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.53 ' HA ' ' O ' ' A' ' 71' ' ' TYR . 16.0 m -51.56 -21.8 2.79 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 113.149 0.796 . . . . 1.52 113.149 -177.342 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -104.99 -46.71 4.2 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.519 0.676 . . . . 0.60999999999999999 110.473 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 21.2 mmt180 -94.8 -36.11 11.81 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.745 -1.116 . . . . 0.95999999999999996 113.99 -168.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.462 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 54.4 p -63.23 116.81 5.79 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.031 0.443 . . . . 1.0600000000000001 110.479 -177.684 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.459 ' OD1' ' HB2' ' A' ' 25' ' ' SER . 48.5 m-20 -82.15 0.72 39.6 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.772 -0.649 . . . . 2.2799999999999998 111.251 -178.657 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . 0.443 ' O ' ' HD1' ' A' ' 71' ' ' TYR . 1.7 m -78.42 173.67 12.1 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.869 -0.605 . . . . 2.0499999999999998 109.978 172.159 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -69.28 -16.54 71.32 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.706 -0.759 . . . . 0.29999999999999999 112.026 179.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 67.2 p -65.98 -5.51 9.74 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 112.576 0.584 . . . . 0.46999999999999997 112.576 -179.046 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.53 ' O ' ' HA ' ' A' ' 63' ' ' SER . 30.4 p90 -60.36 -25.76 66.1 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.005 0.431 . . . . 0.94999999999999996 110.33 177.78 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -94.36 -2.58 51.85 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.239 0.542 . . . . 1.1100000000000001 110.448 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 7.0 m -116.84 9.36 13.85 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.832 -0.622 . . . . 0.70999999999999996 110.748 -178.1 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.581 ' O ' ' HA ' ' A' ' 59' ' ' GLU . . . 68.27 28.51 73.27 Favored Glycine 0 C--O 1.227 -0.288 0 C-N-CA 120.915 -0.66 . . . . 0.67000000000000004 112.039 -177.435 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 83.29 -21.2 8.78 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 121.145 -0.55 . . . . 0.42999999999999999 112.282 -178.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -72.68 136.81 45.7 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.787 0.327 . . . . 1.6499999999999999 111.192 -173.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.418 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 2.6 mp -116.17 166.79 11.62 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.955 -0.566 . . . . 1.6899999999999999 110.027 174.665 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -81.24 -148.52 6.16 Favored Glycine 0 C--N 1.314 -0.669 0 CA-C-N 115.393 -0.821 . . . . 0.45000000000000001 113.138 -177.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -99.33 143.92 29.03 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.993 0.425 . . . . 4.7400000000000002 110.864 -179.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -157.31 175.23 14.29 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.856 -0.611 . . . . 1.6499999999999999 109.815 -174.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 16.2 m -104.17 139.52 39.11 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.876 -0.787 . . . . 1.6899999999999999 108.876 175.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 48.0 m -61.96 126.96 29.18 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.076 0.465 . . . . 1.55 110.812 -179.375 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 114.74 -4.25 22.87 Favored Glycine 0 N--CA 1.443 -0.898 0 CA-C-N 115.392 -0.822 . . . . 0.79000000000000004 111.276 -176.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -95.85 6.99 47.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.699 0.285 . . . . 1.5800000000000001 111.363 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 25.0 mmt -104.16 -122.6 0.21 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.047 0.451 . . . . 1.1299999999999999 110.572 179.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 54.8 mtt -123.69 152.15 42.36 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 107.919 -1.141 . . . . 1.8899999999999999 107.919 175.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm -53.17 -53.99 49.64 Favored Pre-proline 0 C--N 1.319 -0.721 0 N-CA-C 112.249 0.463 . . . . 2.7400000000000002 112.249 -175.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.05 -30.68 10.54 Favored 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 121.457 1.438 . . . . 0.29999999999999999 111.836 -177.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.625 ' O ' HG22 ' A' ' 93' ' ' VAL . 26.3 t80 -67.36 -56.48 9.53 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.247 -0.888 . . . . 0.28000000000000003 109.885 179.742 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -62.19 -35.32 78.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.535 -0.757 . . . . 2.1200000000000001 110.449 -178.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -61.12 -30.47 70.39 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.362 -0.836 . . . . 0.60999999999999999 110.905 178.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.47 ' O ' ' HG ' ' A' ' 96' ' ' LEU . . . -83.35 -26.84 30.16 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.851 0.357 . . . . 1.1000000000000001 110.659 178.001 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.625 HG22 ' O ' ' A' ' 89' ' ' PHE . 27.4 t -70.43 -37.62 71.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.255 0.55 . . . . 1.1200000000000001 110.165 -176.633 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.478 ' C ' ' HD2' ' A' ' 94' ' ' ARG . 6.2 ppt_? -78.92 -13.68 59.66 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.882 -0.599 . . . . 3.1800000000000002 110.735 178.657 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -84.23 -11.04 57.15 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.185 0.517 . . . . 1.0800000000000001 110.963 -175.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.53 ' HB2' ' HB2' ' A' ' 100' ' ' ASP . 0.9 OUTLIER -127.64 145.18 50.97 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.828 -0.624 . . . . 1.1200000000000001 110.761 179.713 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.431 ' HG3' ' H ' ' A' ' 98' ' ' ILE . 20.7 tptm -92.95 173.12 7.91 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 109.021 -0.733 . . . . 2.1299999999999999 109.021 178.754 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.434 ' HA ' ' HG2' ' A' ' 116' ' ' ARG . 72.1 mt -45.76 115.96 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.913 0.387 . . . . 1.6200000000000001 111.649 176.393 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 106.16 -12.27 44.47 Favored Glycine 0 CA--C 1.521 0.45 0 C-N-CA 120.946 -0.645 . . . . 0.46000000000000002 113.736 177.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.53 ' HB2' ' HB2' ' A' ' 96' ' ' LEU . 15.7 m-20 -97.95 148.98 22.91 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 117.566 0.683 . . . . 0.46000000000000002 111.144 -178.005 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 13.0 mt -115.83 149.08 18.15 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-N 115.951 -0.568 . . . . 1.0800000000000001 110.872 -174.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.474 ' HG ' HD22 ' A' ' 96' ' ' LEU . 5.9 m -81.72 151.18 67.59 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 115.953 -0.567 . . . . 1.45 110.806 -178.333 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -73.75 165.22 32.8 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 122.2 1.934 . . . . 0.40999999999999998 109.989 166.221 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.444 HG13 ' HG2' ' A' ' 45' ' ' GLN . 20.1 mm -46.47 108.54 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 O-C-N 123.32 0.387 . . . . 1.04 111.956 178.292 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.3 p -115.32 117.59 56.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.193 -0.458 . . . . 1.6599999999999999 110.157 176.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 16.8 mt-30 -85.25 147.24 26.67 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.055 0.455 . . . . 0.55000000000000004 110.07 178.105 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 8.8 p -121.38 -172.46 2.42 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.421 -0.808 . . . . 1.05 110.389 -177.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -59.86 -35.27 74.44 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.589 0.233 . . . . 2.1600000000000001 110.78 178.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.6 ' OG ' ' HE2' ' A' ' 16' ' ' LYS . 6.4 t -96.78 -60.93 1.49 Allowed 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.69 -0.404 . . . . 1.0900000000000001 110.884 -179.713 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -147.72 -135.02 2.57 Favored Glycine 0 N--CA 1.443 -0.884 0 C-N-CA 118.9 -1.619 . . . . 0.39000000000000001 113.733 -173.321 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.535 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 7.7 mp -113.83 146.34 40.11 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 114.962 -0.619 . . . . 1.0600000000000001 111.232 -170.643 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . 0.55 ' HA ' ' O ' ' A' ' 13' ' ' LEU . 77.0 m-70 -144.16 150.14 37.58 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.144 0.497 . . . . 0.25 111.902 179.659 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.453 HG12 HD11 ' A' ' 44' ' ' LEU . 2.1 pt -134.57 137.58 51.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 107.715 -1.217 . . . . 1.03 107.715 160.651 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.406 ' H ' ' HB2' ' A' ' 102' ' ' SER . 2.1 mp -128.1 145.96 34.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 C-N-CA 121.035 -0.266 . . . . 1.0600000000000001 110.735 -174.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 47.4 pttt -127.84 139.86 52.38 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.733 -0.84 . . . . 1.29 108.733 172.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . 0.466 ' HD3' HD22 ' A' ' 8' ' ' LEU . 4.7 ttp180 -83.11 133.92 35.03 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.12 -0.632 . . . . 2.6800000000000002 110.868 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -103.04 -36.0 8.33 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.87 -1.059 . . . . 1.54 109.729 -178.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.855 0 CA-C-O 117.992 -1.004 . . . . 1.1499999999999999 109.569 178.848 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt . . . . . 0 N--CA 1.453 -0.289 0 CA-C-O 121.281 0.562 . . . . 1.6899999999999999 109.95 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.555 HD22 ' H ' ' A' ' 9' ' ' ARG . 0.4 OUTLIER -124.04 164.37 19.52 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.046 -0.979 . . . . 1.79 109.529 -174.63 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.555 ' H ' HD22 ' A' ' 8' ' ' LEU . 58.4 ttt180 -145.35 128.85 17.0 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.395 -0.594 . . . . 1.3700000000000001 109.395 175.539 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.473 ' N ' ' HZ ' ' A' ' 80' ' ' PHE . . . -146.35 153.74 40.86 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.12 0.486 . . . . 1.0700000000000001 112.036 -179.456 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -106.81 133.03 52.1 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.457 -0.792 . . . . 1.04 109.089 176.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 38.0 p-80 -137.06 155.65 49.39 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.366 0.506 . . . . 0.34000000000000002 112.366 -170.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.57 HD21 ' N ' ' A' ' 14' ' ' LEU . 5.3 tt -123.13 147.25 46.99 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.694 -0.854 . . . . 1.0600000000000001 108.694 176.377 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.57 ' N ' HD21 ' A' ' 13' ' ' LEU . 23.6 tp -131.64 124.4 29.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.486 0.184 . . . . 1.0800000000000001 111.126 -178.677 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.41 HG21 HD11 ' A' ' 44' ' ' LEU . 58.9 t -112.85 142.03 26.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 109.787 -0.449 . . . . 1.01 109.787 175.577 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.406 ' HE3' HD22 ' A' ' 14' ' ' LEU . 31.2 mmtp -114.39 156.36 24.62 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.789 -0.448 . . . . 1.22 109.789 178.306 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -149.96 162.74 39.77 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.513 -0.312 . . . . 0.29999999999999999 110.26 -176.087 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.466 ' HB3' ' C ' ' A' ' 33' ' ' ALA . 54.0 p -52.06 112.88 0.86 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.786 0.327 . . . . 1.6000000000000001 111.111 179.046 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.402 ' C ' ' H ' ' A' ' 21' ' ' ARG . . . 99.63 10.37 47.34 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.327 -0.939 . . . . 0.53000000000000003 113.007 179.547 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.559 ' C ' ' H ' ' A' ' 22' ' ' ASN . 33.0 p -76.29 23.07 0.15 Allowed 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 117.459 0.63 . . . . 1.28 112.462 -174.438 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.402 ' H ' ' C ' ' A' ' 19' ' ' GLY . 86.1 mtt180 69.55 -35.28 0.31 Allowed 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.708 0.803 . . . . 4.1600000000000001 110.355 -175.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.559 ' H ' ' C ' ' A' ' 20' ' ' SER . 13.2 m-80 -140.13 102.25 6.85 Favored Pre-proline 0 N--CA 1.445 -0.717 0 N-CA-C 108.08 -1.082 . . . . 1.77 108.08 174.046 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -68.31 -159.27 0.05 OUTLIER 'Trans proline' 0 CA--C 1.531 0.371 0 C-N-CA 122.894 2.396 . . . . 1.71 111.821 179.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.506 ' N ' HG23 ' A' ' 32' ' ' THR . 16.5 t 62.25 107.16 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-N 115.487 -0.779 . . . . 1.1599999999999999 111.976 178.202 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.401 ' HB3' ' HB2' ' A' ' 16' ' ' LYS . 59.3 p -103.72 155.88 18.24 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.644 -0.502 . . . . 1.4299999999999999 109.644 175.425 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.52 ' HB2' ' HA ' ' A' ' 67' ' ' ASP . 4.7 mpt_? -66.33 -7.85 21.54 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.123 0.487 . . . . 3.1200000000000001 110.486 174.509 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.431 ' HG2' ' HD3' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -85.54 -27.23 25.71 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.421 -0.808 . . . . 2.25 110.237 178.887 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 26.8 p -108.31 -35.53 6.5 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.873 -0.603 . . . . 1.1299999999999999 111.193 -176.005 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 80.41 -33.98 2.26 Favored Glycine 0 CA--C 1.519 0.304 0 CA-C-N 115.443 -0.799 . . . . 0.81999999999999995 113.483 175.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.433 ' O ' HG22 ' A' ' 24' ' ' VAL . 15.0 t70 -105.13 -66.19 0.99 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.911 0.355 . . . . 2.1000000000000001 110.635 179.44 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 19.2 m -152.3 150.89 30.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.111 0.481 . . . . 1.3300000000000001 111.155 -179.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.506 HG23 ' N ' ' A' ' 24' ' ' VAL . 8.9 t -123.62 19.03 9.56 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 122.005 0.907 . . . . 1.02 109.347 178.012 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.466 ' C ' ' HB3' ' A' ' 18' ' ' SER . . . -67.35 -5.26 13.61 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.066 -0.97 . . . . 1.1299999999999999 112.364 177.449 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -92.39 -24.34 18.91 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.889 0.376 . . . . 2.21 111.111 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.449 HG12 ' OG1' ' A' ' 32' ' ' THR . 0.2 OUTLIER -101.78 137.15 30.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 116.138 -0.483 . . . . 1.1100000000000001 109.965 -179.573 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 77.1 p -94.04 177.48 5.96 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 116.289 -0.414 . . . . 1.2 110.054 -173.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.535 ' O ' HG13 ' A' ' 41' ' ' ILE . 15.4 p90 -63.37 -30.53 71.65 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 119.917 -0.713 . . . . 2.21 109.435 176.408 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -69.46 -47.78 62.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.081 -0.509 . . . . 0.95999999999999996 110.595 178.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 39.5 m-20 -70.38 -27.84 64.63 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.98 -0.555 . . . . 0.91000000000000003 110.26 179.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -74.31 -39.06 63.12 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.495 -0.775 . . . . 1.03 110.329 177.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.535 HG13 ' O ' ' A' ' 37' ' ' TYR . 80.6 mt -64.46 -36.71 78.05 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 109.524 -0.547 . . . . 1.0800000000000001 109.524 174.133 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.457 ' O ' ' HG3' ' A' ' 46' ' ' LYS . 26.3 mtpp -64.12 -25.0 67.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.942 0.401 . . . . 2.8399999999999999 110.485 175.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.433 ' HG3' ' NE1' ' A' ' 47' ' ' TRP . 6.9 tt0 -83.88 -51.76 6.92 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.892 -0.595 . . . . 1.02 109.823 -179.188 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.483 HD13 HG12 ' A' ' 113' ' ' ILE . 34.0 tp -60.69 -38.76 86.07 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.786 -0.643 . . . . 1.02 110.479 -179.744 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.476 ' O ' ' HB2' ' A' ' 49' ' ' GLN . 5.0 mm-40 -61.51 -38.28 86.8 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.189 -0.459 . . . . 0.87 112.146 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.457 ' HG3' ' O ' ' A' ' 42' ' ' LYS . 68.3 mttm -72.78 -38.68 67.19 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.672 0.273 . . . . 1.98 111.083 -177.723 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.449 ' O ' HG13 ' A' ' 51' ' ' ILE . 9.8 m95 -70.83 -45.85 63.81 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.885 -0.326 . . . . 0.60999999999999999 110.863 178.06 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.417 ' HB3' HG23 ' A' ' 113' ' ' ILE . 89.1 p -64.36 -28.3 69.61 Favored 'General case' 0 CA--C 1.528 0.122 0 N-CA-C 110.073 -0.343 . . . . 0.88 110.073 177.356 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.476 ' HB2' ' O ' ' A' ' 45' ' ' GLN . 12.5 tt0 -64.68 -52.05 59.3 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 116.018 -0.537 . . . . 0.55000000000000004 109.952 175.368 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.576 ' HB3' HG23 ' A' ' 56' ' ' VAL . 84.4 mtt180 -61.05 -46.73 89.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.548 -0.751 . . . . 0.47999999999999998 111.205 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.453 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 85.3 mt -56.69 -43.67 79.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.291 -0.413 . . . . 1.04 110.872 177.185 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.68 -42.62 81.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.117 -0.492 . . . . 1.0600000000000001 111.927 -179.339 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 51.3 p -77.7 -30.39 51.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.934 0.397 . . . . 0.34999999999999998 111.367 -177.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 108.68 8.96 27.6 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.564 -0.827 . . . . 0.33000000000000002 112.242 179.006 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.492 ' OE1' ' HG2' ' A' ' 50' ' ' ARG . 48.6 mt-10 -60.84 -49.37 77.77 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.096 0.475 . . . . 0.65000000000000002 109.913 176.657 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.576 HG23 ' HB3' ' A' ' 50' ' ' ARG . 31.4 m -134.44 154.68 37.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.719 -0.673 . . . . 1.05 109.41 173.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.416 ' OG ' ' HG2' ' A' ' 60' ' ' GLU . 19.8 p -79.44 161.83 25.86 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 110.042 -0.355 . . . . 1.3100000000000001 110.042 176.569 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -55.04 -38.4 67.92 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.377 0.608 . . . . 0.25 109.548 178.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -59.2 -43.45 92.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.885 -1.052 . . . . 1.72 111.828 -179.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.416 ' HG2' ' OG ' ' A' ' 57' ' ' SER . 12.1 mm-40 -64.48 -42.09 96.1 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-O 121.016 0.436 . . . . 2.0899999999999999 110.85 -178.589 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.427 ' O ' ' HG2' ' A' ' 65' ' ' ARG . . . -70.01 -55.85 8.51 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.896 -0.593 . . . . 1.0700000000000001 110.455 179.611 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -54.63 -52.96 60.61 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.513 0.56 . . . . 1.0600000000000001 112.513 -174.041 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.492 ' HA ' ' O ' ' A' ' 71' ' ' TYR . 20.8 t -52.0 -27.95 15.26 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.695 0.628 . . . . 1.52 112.695 -175.633 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -105.28 -44.19 4.81 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.492 0.663 . . . . 0.60999999999999999 110.894 -177.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.431 ' HD3' ' HG2' ' A' ' 27' ' ' ARG . 16.6 mmt180 -83.59 -44.4 14.64 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.944 -1.026 . . . . 0.95999999999999996 113.114 -171.852 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.411 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 77.6 p -65.21 120.04 11.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.128 0.49 . . . . 1.0600000000000001 111.429 -173.753 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.52 ' HA ' ' HB2' ' A' ' 26' ' ' ARG . 19.6 t70 -70.81 -16.9 62.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.48 -0.782 . . . . 2.2799999999999998 110.885 177.132 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . 0.476 ' O ' ' HD2' ' A' ' 71' ' ' TYR . 53.7 t -77.99 154.96 31.05 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.259 0.552 . . . . 2.0499999999999998 109.931 178.815 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -58.94 -12.37 14.83 Favored Glycine 0 C--O 1.234 0.148 0 CA-C-N 114.66 -1.155 . . . . 0.29999999999999999 113.714 -173.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 52.3 p -64.72 -8.07 13.29 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 111.771 0.285 . . . . 0.46999999999999997 111.771 176.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.492 ' O ' ' HA ' ' A' ' 63' ' ' SER . 51.1 p90 -57.59 -25.38 59.95 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.932 0.396 . . . . 0.94999999999999996 110.596 176.631 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -93.98 3.35 55.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.058 0.456 . . . . 1.1100000000000001 111.035 -179.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 9.0 m -126.78 14.42 7.47 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.099 -0.5 . . . . 0.70999999999999996 110.772 179.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 67.97 24.7 74.44 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 121.063 -0.589 . . . . 0.67000000000000004 112.54 -178.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 86.91 -17.2 42.57 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 121.16 -0.543 . . . . 0.42999999999999999 112.219 -179.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -74.55 136.79 42.12 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.733 0.302 . . . . 1.6499999999999999 110.682 -176.01 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.4 ' O ' ' HG3' ' A' ' 9' ' ' ARG . 2.4 mp -113.46 157.88 21.39 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 116.248 -0.433 . . . . 1.6899999999999999 110.055 173.218 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -76.19 -107.03 0.13 Allowed Glycine 0 C--N 1.309 -0.953 0 CA-C-N 115.226 -0.897 . . . . 0.45000000000000001 113.504 -175.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 9.1 p90 -120.87 149.0 43.28 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.716 0.293 . . . . 4.7400000000000002 110.796 -178.12 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.473 ' HZ ' ' N ' ' A' ' 10' ' ' ALA . 3.8 p90 -166.27 161.32 16.66 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.547 -0.538 . . . . 1.6499999999999999 109.547 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 73.0 p -105.11 125.45 50.99 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 109.292 -0.632 . . . . 1.6899999999999999 109.292 176.337 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 11.0 p -44.69 122.09 3.0 Favored 'General case' 0 C--O 1.234 0.288 0 O-C-N 123.79 0.681 . . . . 1.55 111.618 -178.048 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 114.42 10.46 13.22 Favored Glycine 0 N--CA 1.446 -0.655 0 CA-C-N 115.824 -0.626 . . . . 0.79000000000000004 111.662 -177.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -109.23 -5.48 15.9 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 111.481 0.178 . . . . 1.5800000000000001 111.481 179.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 26.2 mmt -95.15 -105.05 0.15 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.285 0.564 . . . . 1.1299999999999999 111.085 -175.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' MET . . . . . 0.434 ' HB2' ' HB3' ' A' ' 89' ' ' PHE . 44.1 mtt -138.12 148.81 45.33 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 107.381 -1.34 . . . . 1.8899999999999999 107.381 177.789 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 64.6 tttp -51.16 -54.55 36.75 Favored Pre-proline 0 C--N 1.32 -0.685 0 N-CA-C 112.472 0.545 . . . . 2.7400000000000002 112.472 -175.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.456 ' HG2' HG23 ' A' ' 107' ' ' THR . 86.5 Cg_endo -75.67 -29.7 6.96 Favored 'Trans proline' 0 C--N 1.356 0.965 0 C-N-CA 121.664 1.576 . . . . 0.29999999999999999 111.997 -177.557 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.58 ' O ' HG21 ' A' ' 93' ' ' VAL . 12.4 t80 -66.32 -56.42 11.23 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.722 -0.672 . . . . 0.28000000000000003 109.428 178.466 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.532 ' O ' ' HD3' ' A' ' 94' ' ' ARG . 4.2 tp10 -61.4 -36.14 79.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.16 -0.927 . . . . 2.1200000000000001 109.812 -179.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.756 ' HA ' ' NE ' ' A' ' 94' ' ' ARG . 27.2 t70 -54.44 -43.73 71.85 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 115.155 -0.929 . . . . 0.60999999999999999 110.77 177.529 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.667 ' O ' ' HG ' ' A' ' 96' ' ' LEU . . . -71.5 -34.4 70.09 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.022 -0.536 . . . . 1.1000000000000001 110.765 179.617 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.58 HG21 ' O ' ' A' ' 89' ' ' PHE . 28.4 t -60.86 -49.53 84.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.406 -0.361 . . . . 1.1200000000000001 111.219 -176.06 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.756 ' NE ' ' HA ' ' A' ' 91' ' ' ASP . 0.1 OUTLIER -75.91 -16.66 59.99 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.516 -0.474 . . . . 3.1800000000000002 110.479 179.463 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -78.34 -13.51 59.82 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.065 -0.516 . . . . 1.0800000000000001 111.439 -176.032 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.667 ' HG ' ' O ' ' A' ' 92' ' ' ALA . 0.4 OUTLIER -123.21 159.6 28.34 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.174 0.511 . . . . 1.1200000000000001 111.137 178.052 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.498 ' HE3' HD12 ' A' ' 98' ' ' ILE . 54.5 tptt -102.27 176.78 5.07 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.321 -0.854 . . . . 2.1299999999999999 109.321 178.769 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.498 HD12 ' HE3' ' A' ' 97' ' ' LYS . 1.1 mp -47.43 119.97 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 C-N-CA 123.423 0.689 . . . . 1.6200000000000001 111.298 178.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 92.92 -10.53 73.75 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 121.002 -0.618 . . . . 0.46000000000000002 113.071 176.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.541 ' HB2' ' HB2' ' A' ' 96' ' ' LEU . 23.1 m-20 -85.64 131.68 34.3 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 117.115 0.457 . . . . 0.46000000000000002 110.301 -178.418 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 8.7 mt -104.52 143.64 15.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.073 -0.512 . . . . 1.0800000000000001 109.779 179.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 89.2 p -88.22 148.49 42.86 Favored Pre-proline 0 C--N 1.318 -0.799 0 CA-C-N 116.341 -0.39 . . . . 1.45 110.402 -178.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -70.1 163.73 37.47 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 122.032 1.821 . . . . 0.40999999999999998 110.615 170.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.461 HG13 ' HG2' ' A' ' 45' ' ' GLN . 21.5 mm -39.64 100.33 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 N-CA-C 112.959 0.726 . . . . 1.04 112.959 179.318 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 1.8 p -104.69 118.13 51.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.979 -0.555 . . . . 1.6599999999999999 109.798 175.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -85.8 145.52 27.18 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.266 0.555 . . . . 0.55000000000000004 110.801 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.456 HG23 ' HG2' ' A' ' 88' ' ' PRO . 6.1 p -117.28 -172.82 2.29 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.309 -0.86 . . . . 1.05 110.161 179.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -65.63 -35.39 80.67 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 121.011 -0.275 . . . . 2.1600000000000001 110.363 177.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.405 ' O ' ' HB2' ' A' ' 20' ' ' SER . 4.8 t -92.33 -60.96 1.71 Allowed 'General case' 0 N--CA 1.443 -0.778 0 C-N-CA 120.254 -0.578 . . . . 1.0900000000000001 110.606 -179.125 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -145.03 -131.98 2.44 Favored Glycine 0 N--CA 1.44 -1.077 0 C-N-CA 119.015 -1.564 . . . . 0.39000000000000001 113.793 -174.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.481 HD23 ' CG1' ' A' ' 41' ' ' ILE . 6.0 mp -121.53 147.99 45.08 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 114.917 -0.641 . . . . 1.0600000000000001 111.08 -170.57 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . 0.515 ' HA ' ' O ' ' A' ' 13' ' ' LEU . 85.4 m-70 -143.25 148.97 37.25 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.313 0.577 . . . . 0.25 112.254 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.483 HG12 HD13 ' A' ' 44' ' ' LEU . 2.5 pt -131.05 135.04 60.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 107.491 -1.3 . . . . 1.03 107.491 160.055 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 3.0 mp -130.2 142.79 42.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 C-N-CA 120.866 -0.334 . . . . 1.0600000000000001 110.439 -175.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.457 ' HA ' ' O ' ' A' ' 100' ' ' ASP . 40.9 pttt -123.21 139.18 54.32 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.622 -0.881 . . . . 1.29 108.622 172.359 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . 0.499 ' HB2' ' CD1' ' A' ' 96' ' ' LEU . 57.1 ttt180 -83.74 131.74 34.9 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.155 0.502 . . . . 2.6800000000000002 111.052 -177.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.437 ' HB2' ' HG2' ' A' ' 9' ' ' ARG . 4.3 mm? -98.9 -41.11 7.75 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.259 -0.882 . . . . 1.54 109.832 179.004 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.899 0 CA-C-O 118.622 -0.704 . . . . 1.1499999999999999 110.409 179.341 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.507 ' HA ' ' O ' ' A' ' 80' ' ' PHE . 73.1 mmtt . . . . . 0 N--CA 1.452 -0.346 0 CA-C-O 121.304 0.573 . . . . 1.6899999999999999 111.034 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.598 ' HB3' ' CE1' ' A' ' 80' ' ' PHE . 3.2 tt -140.58 154.19 46.39 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 114.921 -1.036 . . . . 1.79 108.284 -177.256 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.537 ' N ' HD21 ' A' ' 8' ' ' LEU . 26.5 ttt180 -133.64 132.93 41.34 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.348 -0.982 . . . . 1.3700000000000001 108.348 172.494 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -147.06 150.44 35.07 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.459 -0.496 . . . . 1.0700000000000001 111.975 -174.094 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.588 ' HA ' ' HA ' ' A' ' 76' ' ' ASP . . . -108.45 133.74 52.2 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-N 115.698 -0.683 . . . . 1.04 109.8 177.544 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 45.8 p-80 -138.73 145.09 39.84 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 120.93 0.395 . . . . 0.34000000000000002 111.108 -172.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.568 ' O ' ' HA ' ' A' ' 112' ' ' HIS . 6.6 tt -112.82 142.92 44.91 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.251 -1.018 . . . . 1.0600000000000001 108.251 176.339 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.613 HD13 ' NE2' ' A' ' 112' ' ' HIS . 29.3 tp -128.97 118.41 22.56 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.739 0.304 . . . . 1.0800000000000001 111.021 -175.763 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.402 HG23 HD12 ' A' ' 44' ' ' LEU . 46.3 t -107.88 134.19 50.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 109.501 -0.555 . . . . 1.01 109.501 176.348 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.473 ' HZ2' ' HB2' ' A' ' 22' ' ' ASN . 32.7 mmtp -109.45 152.41 25.43 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.754 -0.462 . . . . 1.22 109.754 178.309 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.438 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 47.0 p90 -143.37 162.51 35.55 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.515 -0.311 . . . . 0.29999999999999999 110.533 -176.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 19.9 p -52.08 113.44 1.02 Allowed 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.276 -0.42 . . . . 1.6000000000000001 111.14 177.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 95.29 10.04 57.45 Favored Glycine 0 C--N 1.334 0.429 0 C-N-CA 120.761 -0.733 . . . . 0.53000000000000003 113.318 179.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.65 ' HB2' ' O ' ' A' ' 109' ' ' SER . 85.6 p -90.0 35.05 0.84 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 117.368 0.584 . . . . 1.28 111.523 -175.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.456 ' HB3' ' O ' ' A' ' 20' ' ' SER . 73.7 ttt180 71.82 -34.26 0.29 Allowed 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 120.995 0.426 . . . . 4.1600000000000001 111.16 -179.092 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.493 ' H ' ' C ' ' A' ' 20' ' ' SER . 45.7 m-80 -132.81 93.59 23.4 Favored Pre-proline 0 C--N 1.327 -0.385 0 N-CA-C 109.409 -0.589 . . . . 1.77 109.409 176.069 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.579 ' C ' HG23 ' A' ' 32' ' ' THR . 95.4 Cg_endo -80.83 49.16 3.14 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 122.507 2.138 . . . . 1.71 112.959 -176.326 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.424 ' N ' HG23 ' A' ' 32' ' ' THR . 47.3 t -147.26 117.0 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 N-CA-C 108.759 -0.83 . . . . 1.1599999999999999 108.759 178.052 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 41.2 t -105.89 154.23 20.85 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 110.203 -0.295 . . . . 1.4299999999999999 110.203 177.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.594 ' HB2' ' HA ' ' A' ' 67' ' ' ASP . 6.6 mpt_? -69.01 -5.27 20.7 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.087 0.47 . . . . 3.1200000000000001 110.422 171.363 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.582 ' HG3' ' CD ' ' A' ' 65' ' ' ARG . 18.3 ttp180 -78.21 -29.58 48.41 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.654 -0.703 . . . . 2.25 109.623 175.822 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 71.6 p -115.28 -33.78 5.2 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.753 -0.658 . . . . 1.1299999999999999 111.454 -174.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 81.55 -36.39 2.44 Favored Glycine 0 CA--C 1.52 0.371 0 CA-C-N 115.977 -0.556 . . . . 0.81999999999999995 112.905 178.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -95.03 -65.99 0.94 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.801 0.334 . . . . 2.1000000000000001 110.625 -178.059 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 13.7 p -153.94 156.26 37.16 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.949 0.404 . . . . 1.3300000000000001 110.932 178.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.579 HG23 ' C ' ' A' ' 23' ' ' PRO . 14.8 t -120.07 28.63 7.96 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 122.076 0.941 . . . . 1.02 109.146 174.054 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -75.78 -5.7 47.09 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.92 -1.036 . . . . 1.1299999999999999 111.422 -178.085 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -93.82 -25.72 17.24 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.902 -0.59 . . . . 2.21 111.095 -179.042 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.463 HG12 ' OG1' ' A' ' 32' ' ' THR . 0.2 OUTLIER -98.61 138.77 22.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 116.135 -0.484 . . . . 1.1100000000000001 109.76 -178.663 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 72.8 p -94.76 176.77 6.14 Favored 'General case' 0 CA--C 1.513 -0.474 0 N-CA-C 109.84 -0.43 . . . . 1.2 109.84 -174.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.461 ' O ' HG13 ' A' ' 41' ' ' ILE . 4.1 p90 -63.88 -27.17 68.97 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 119.897 -0.721 . . . . 2.21 109.099 175.534 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -72.75 -46.78 51.66 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.956 -0.565 . . . . 0.95999999999999996 110.301 178.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.438 ' HB2' HG21 ' A' ' 35' ' ' VAL . 42.1 m-20 -64.68 -33.52 76.14 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 121.375 0.607 . . . . 0.91000000000000003 109.633 177.108 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.438 ' HB2' ' HB3' ' A' ' 17' ' ' PHE . . . -68.8 -45.73 70.52 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.985 -1.007 . . . . 1.03 110.64 179.311 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.465 ' CG1' HD23 ' A' ' 111' ' ' LEU . 70.1 mt -62.55 -37.68 79.51 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.345 0 N-CA-C 109.704 -0.48 . . . . 1.0800000000000001 109.704 174.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.445 ' O ' ' HG3' ' A' ' 46' ' ' LYS . 27.8 ttpt -63.73 -22.88 67.13 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.902 -0.59 . . . . 2.8399999999999999 110.126 179.343 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.42 ' HG3' ' CD1' ' A' ' 47' ' ' TRP . 8.7 tp10 -85.45 -54.52 4.52 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.662 -0.699 . . . . 1.02 109.309 179.506 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.465 HD11 HG12 ' A' ' 113' ' ' ILE . 29.6 tp -59.81 -36.25 76.38 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.859 -1.064 . . . . 1.02 110.55 -174.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.426 ' HA ' HD11 ' A' ' 104' ' ' ILE . 3.9 mm-40 -64.2 -35.82 82.04 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.811 -0.632 . . . . 0.87 112.265 -179.353 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.445 ' HG3' ' O ' ' A' ' 42' ' ' LYS . 95.0 mttt -70.62 -47.42 60.16 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.153 0.501 . . . . 1.98 109.801 178.582 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.486 ' NE1' ' HG3' ' A' ' 65' ' ' ARG . 51.3 m95 -61.9 -47.59 84.27 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.8 -0.636 . . . . 0.60999999999999999 111.687 179.199 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.492 ' HB3' HG23 ' A' ' 113' ' ' ILE . 97.5 p -64.32 -22.71 67.04 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.954 0.407 . . . . 0.88 110.15 178.251 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -74.17 -57.37 4.0 Favored 'General case' 0 C--O 1.224 -0.261 0 CA-C-N 116.1 -0.5 . . . . 0.55000000000000004 110.063 174.083 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.535 ' HB3' HG21 ' A' ' 56' ' ' VAL . 96.9 mtt180 -61.6 -42.58 99.08 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.624 -0.716 . . . . 0.47999999999999998 111.46 -174.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 98.3 mt -60.39 -35.59 63.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.003 -0.544 . . . . 1.04 110.739 177.123 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -79.73 -41.32 26.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.086 -0.506 . . . . 1.0600000000000001 111.32 -179.002 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 58.3 p -74.6 -29.96 61.51 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.21 -0.45 . . . . 0.34999999999999998 111.641 -176.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 107.73 4.87 34.1 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.749 -0.738 . . . . 0.33000000000000002 112.14 -178.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.414 ' HB2' ' HB3' ' A' ' 50' ' ' ARG . 38.3 mt-10 -61.92 -47.23 85.85 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.847 0.356 . . . . 0.65000000000000002 110.049 178.443 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.535 HG21 ' HB3' ' A' ' 50' ' ' ARG . 14.3 m -136.57 165.26 29.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.963 -0.562 . . . . 1.05 109.652 172.212 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 54.5 p -86.15 165.7 16.36 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.945 -0.391 . . . . 1.3100000000000001 109.945 176.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -58.89 -39.4 81.35 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.248 -0.649 . . . . 0.25 109.248 176.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -54.35 -54.88 34.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.633 -1.167 . . . . 1.72 111.959 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -56.59 -44.29 80.91 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.09 -0.505 . . . . 2.0899999999999999 111.621 -176.009 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -68.83 -45.9 69.95 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.798 0.332 . . . . 1.0700000000000001 110.816 -179.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.44 -53.52 55.41 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.119 -0.491 . . . . 1.0600000000000001 111.957 -175.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.409 ' HA ' ' O ' ' A' ' 71' ' ' TYR . 50.0 m -53.33 -21.33 5.5 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 113.293 0.849 . . . . 1.52 113.293 -176.42 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -105.22 -46.1 4.32 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.439 0.637 . . . . 0.60999999999999999 110.718 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.582 ' CD ' ' HG3' ' A' ' 27' ' ' ARG . 24.7 mmt180 -93.97 -42.92 8.79 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 114.855 -1.066 . . . . 0.95999999999999996 113.65 -168.806 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.476 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 80.2 p -64.33 121.77 15.1 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.994 0.426 . . . . 1.0600000000000001 111.437 -174.38 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.594 ' HA ' ' HB2' ' A' ' 26' ' ' ARG . 25.0 t70 -73.63 -17.24 61.19 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.66 -0.7 . . . . 2.2799999999999998 111.568 178.624 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . 0.418 ' O ' ' HD1' ' A' ' 71' ' ' TYR . 52.2 t -76.91 155.87 32.49 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.178 0.513 . . . . 2.0499999999999998 109.926 -179.145 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -58.82 -12.44 14.6 Favored Glycine 0 N--CA 1.454 -0.112 0 CA-C-N 114.81 -1.087 . . . . 0.29999999999999999 113.621 -173.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.414 ' HB3' ' CD1' ' A' ' 77' ' ' LEU . 52.7 p -70.14 -7.82 44.72 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 116.579 0.19 . . . . 0.46999999999999997 111.207 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.418 ' HD1' ' O ' ' A' ' 68' ' ' CYS . 35.0 p90 -56.08 -29.62 60.81 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.861 0.362 . . . . 0.94999999999999996 110.21 175.723 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -90.45 2.85 55.27 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.372 -0.377 . . . . 1.1100000000000001 111.673 -174.063 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 30.0 m -125.39 -15.16 6.25 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.762 0.315 . . . . 0.70999999999999996 111.447 -179.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 107.22 24.14 6.66 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.524 -0.846 . . . . 0.67000000000000004 112.507 -179.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 91.34 -27.57 9.27 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.796 -0.716 . . . . 0.42999999999999999 113.063 176.124 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.588 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 7.5 p-10 -79.89 141.56 36.01 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-O 121.561 0.696 . . . . 1.6499999999999999 111.204 -176.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.414 ' CD1' ' HB3' ' A' ' 70' ' ' SER . 0.6 OUTLIER -106.13 176.0 5.31 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 114.755 -1.111 . . . . 1.6899999999999999 109.604 177.187 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -83.88 -150.28 10.51 Favored Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 120.871 -0.68 . . . . 0.45000000000000001 111.856 178.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.433 ' HA ' ' O ' ' A' ' 8' ' ' LEU . 21.3 p90 -94.15 145.91 24.36 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.101 0.477 . . . . 4.7400000000000002 111.214 -178.481 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.598 ' CE1' ' HB3' ' A' ' 8' ' ' LEU . 2.6 p90 -152.16 172.18 16.77 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.315 -0.995 . . . . 1.6499999999999999 108.315 179.031 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 89.0 p -103.71 142.27 34.63 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 109.139 -0.689 . . . . 1.6899999999999999 109.139 174.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 10.1 m -52.38 122.76 9.37 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.704 -0.68 . . . . 1.55 111.615 -173.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 114.69 -12.7 20.64 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.892 -0.67 . . . . 0.79000000000000004 112.998 179.371 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -90.59 45.19 1.24 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 117.013 0.406 . . . . 1.5800000000000001 111.665 -177.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.403 ' HE3' HD21 ' A' ' 77' ' ' LEU . 26.2 mmt -137.66 -108.28 0.19 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.043 0.449 . . . . 1.1299999999999999 110.297 178.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 59.5 mtt -140.26 150.68 44.38 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.278 -1.008 . . . . 1.8899999999999999 108.278 176.034 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -50.38 -54.27 36.44 Favored Pre-proline 0 C--N 1.322 -0.589 0 N-CA-C 112.682 0.623 . . . . 2.7400000000000002 112.682 -175.478 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -76.23 -27.45 8.09 Favored 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 121.63 1.553 . . . . 0.29999999999999999 112.036 -176.402 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.618 ' O ' HG21 ' A' ' 93' ' ' VAL . 24.2 t80 -70.06 -55.86 8.42 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.214 -0.903 . . . . 0.28000000000000003 109.719 -179.422 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -66.24 -34.78 78.78 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.392 -0.822 . . . . 2.1200000000000001 110.246 -177.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.482 ' HA ' ' NE ' ' A' ' 94' ' ' ARG . 19.6 t70 -54.64 -36.24 64.32 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.63 -0.713 . . . . 0.60999999999999999 110.86 175.021 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.565 ' O ' ' HG ' ' A' ' 96' ' ' LEU . . . -80.79 -35.47 33.07 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.213 -0.448 . . . . 1.1000000000000001 110.958 179.172 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.618 HG21 ' O ' ' A' ' 89' ' ' PHE . 21.0 t -62.12 -44.55 99.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.303 0.573 . . . . 1.1200000000000001 110.625 -178.178 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.482 ' NE ' ' HA ' ' A' ' 91' ' ' ASP . 38.1 ptt180 -73.87 -12.73 60.76 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.714 -0.676 . . . . 3.1800000000000002 110.564 179.279 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -95.11 6.16 49.83 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.067 -0.515 . . . . 1.0800000000000001 111.689 -173.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.565 ' HG ' ' O ' ' A' ' 92' ' ' ALA . 0.7 OUTLIER -141.26 146.87 37.36 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.425 -0.352 . . . . 1.1200000000000001 110.719 177.226 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.431 ' HG3' ' N ' ' A' ' 98' ' ' ILE . 55.2 tptt -88.89 168.95 12.0 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.372 -0.603 . . . . 2.1299999999999999 109.372 178.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.431 ' N ' ' HG3' ' A' ' 97' ' ' LYS . 70.7 mt -45.54 115.96 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 121.137 0.494 . . . . 1.6200000000000001 111.649 175.737 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 99.63 -4.62 58.1 Favored Glycine 0 N--CA 1.45 -0.416 0 CA-C-N 115.779 -0.646 . . . . 0.46000000000000002 113.324 177.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.493 ' HB2' ' HB2' ' A' ' 96' ' ' LEU . 66.4 m-20 -100.22 144.57 29.09 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 117.099 0.449 . . . . 0.46000000000000002 110.331 179.511 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 8.8 mt -116.03 147.95 19.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.19 -0.459 . . . . 1.0800000000000001 110.562 -174.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 92.5 p -92.5 155.54 42.13 Favored Pre-proline 0 C--N 1.322 -0.588 0 CA-C-N 116.041 -0.527 . . . . 1.45 110.612 -179.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -71.64 171.63 15.98 Favored 'Trans proline' 0 C--O 1.235 0.345 0 C-N-CA 122.323 2.016 . . . . 0.40999999999999998 111.393 171.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.426 HD11 ' HA ' ' A' ' 45' ' ' GLN . 22.7 mm -47.62 112.68 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 O-C-N 123.381 0.426 . . . . 1.04 111.986 178.514 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.1 p -117.59 118.67 59.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.004 0.431 . . . . 1.6599999999999999 110.258 176.257 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -85.44 141.65 29.8 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.2 0.524 . . . . 0.55000000000000004 110.373 178.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 7.5 p -115.94 -172.52 2.18 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.461 -0.791 . . . . 1.05 110.637 -178.263 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -58.21 -42.64 86.64 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.903 0.383 . . . . 2.1600000000000001 110.374 178.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.65 ' O ' ' HB2' ' A' ' 20' ' ' SER . 7.8 t -90.68 -61.62 1.63 Allowed 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 116.112 -0.494 . . . . 1.0900000000000001 110.652 -178.476 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -146.62 -133.14 2.42 Favored Glycine 0 N--CA 1.442 -0.941 0 C-N-CA 118.946 -1.597 . . . . 0.39000000000000001 113.499 -172.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.465 HD23 ' CG1' ' A' ' 41' ' ' ILE . 7.6 mp -115.58 145.92 42.23 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.199 -0.501 . . . . 1.0600000000000001 111.408 -170.625 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . 0.613 ' NE2' HD13 ' A' ' 14' ' ' LEU . 75.4 m-70 -142.06 152.2 43.1 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.392 0.615 . . . . 0.25 112.374 178.611 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.492 HG23 ' HB3' ' A' ' 48' ' ' SER . 2.8 pt -134.01 140.73 45.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 107.317 -1.364 . . . . 1.03 107.317 158.388 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 2.2 mp -130.76 148.33 33.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 C-N-CA 120.656 -0.418 . . . . 1.0600000000000001 110.657 -175.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.409 ' HG2' ' HB3' ' A' ' 11' ' ' ALA . 35.6 pttt -132.41 141.3 48.8 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.451 -0.944 . . . . 1.29 108.451 171.459 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . 0.429 ' HD3' HD23 ' A' ' 8' ' ' LEU . 5.6 ttp180 -81.47 135.72 35.63 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.198 0.523 . . . . 2.6800000000000002 110.768 -178.77 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -104.75 -31.87 9.13 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.258 -0.883 . . . . 1.54 110.561 -178.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.915 0 CA-C-O 118.445 -0.788 . . . . 1.1499999999999999 110.579 179.88 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.617 ' HA ' ' O ' ' A' ' 80' ' ' PHE . 5.9 mptt . . . . . 0 C--O 1.232 0.166 0 CA-C-O 121.566 0.698 . . . . 1.6899999999999999 111.707 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.617 ' O ' ' HA ' ' A' ' 79' ' ' PHE . 1.5 tt -117.59 160.75 20.75 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 114.494 -1.23 . . . . 1.79 107.886 178.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.565 ' H ' HD22 ' A' ' 8' ' ' LEU . 70.4 ttt180 -131.24 132.17 44.43 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 109.42 -0.585 . . . . 1.3700000000000001 109.42 172.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -150.45 150.27 31.11 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.933 0.397 . . . . 1.0700000000000001 111.824 -175.404 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -108.54 136.04 48.8 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.732 -0.667 . . . . 1.04 109.51 177.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 35.9 p-80 -138.83 157.24 46.42 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.088 0.471 . . . . 0.34000000000000002 111.852 -171.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.57 ' O ' ' HA ' ' A' ' 112' ' ' HIS . 4.8 tt -124.34 146.92 48.54 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.584 -0.895 . . . . 1.0600000000000001 108.584 176.786 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.556 ' N ' HD22 ' A' ' 13' ' ' LEU . 28.7 tp -131.51 120.66 23.26 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.512 0.196 . . . . 1.0800000000000001 111.028 -178.217 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.435 HG23 HD13 ' A' ' 44' ' ' LEU . 65.2 t -109.32 138.91 34.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 109.874 -0.417 . . . . 1.01 109.874 176.417 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.49 ' HE2' ' OG ' ' A' ' 109' ' ' SER . 33.8 mmtp -112.04 154.4 25.42 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.731 -0.47 . . . . 1.22 109.731 176.804 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.473 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 41.4 p90 -144.26 162.53 36.15 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.267 -0.424 . . . . 0.29999999999999999 110.351 -176.054 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.462 ' HB3' ' HA ' ' A' ' 33' ' ' ALA . 29.0 p -53.44 108.12 0.31 Allowed 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.046 0.45 . . . . 1.6000000000000001 110.699 179.144 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 101.32 7.95 48.05 Favored Glycine 0 CA--C 1.522 0.502 0 C-N-CA 120.823 -0.704 . . . . 0.53000000000000003 113.208 -179.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.628 ' HB2' ' O ' ' A' ' 109' ' ' SER . 89.5 p -85.03 49.44 1.74 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 117.33 0.565 . . . . 1.28 111.156 -177.862 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 71.66 -32.99 0.26 Allowed 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.631 0.772 . . . . 4.1600000000000001 110.954 -177.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.512 ' H ' ' C ' ' A' ' 20' ' ' SER . 4.8 p30 -151.97 118.04 3.12 Favored Pre-proline 0 C--N 1.321 -0.673 0 N-CA-C 109.095 -0.706 . . . . 1.77 109.095 174.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.512 ' C ' HG21 ' A' ' 32' ' ' THR . 95.0 Cg_endo -85.39 55.8 4.12 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.52 2.147 . . . . 1.71 113.135 -175.735 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.443 ' N ' HG21 ' A' ' 32' ' ' THR . 25.5 t -146.21 116.4 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 109.577 -0.527 . . . . 1.1599999999999999 109.577 176.197 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.429 ' HB3' ' HB2' ' A' ' 16' ' ' LYS . 66.3 p -104.1 159.24 15.84 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.926 -0.398 . . . . 1.4299999999999999 109.926 175.679 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.486 ' HG2' ' HA ' ' A' ' 67' ' ' ASP . 6.3 mmp_? -71.48 -7.17 45.74 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.397 0.618 . . . . 3.1200000000000001 109.691 172.066 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.477 ' CG ' ' HD2' ' A' ' 65' ' ' ARG . 3.7 tmm_? -81.06 -36.18 30.81 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.279 -0.873 . . . . 2.25 110.054 178.779 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.446 ' HG1' ' C ' ' A' ' 31' ' ' SER . 61.8 p -101.71 -34.81 9.32 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.296 0.57 . . . . 1.1299999999999999 110.789 179.805 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 85.67 -43.85 3.29 Favored Glycine 0 N--CA 1.45 -0.383 0 CA-C-N 115.738 -0.665 . . . . 0.81999999999999995 112.986 177.241 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -93.0 -63.77 1.18 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.764 0.316 . . . . 2.1000000000000001 110.248 -177.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.446 ' C ' ' HG1' ' A' ' 28' ' ' THR . 19.8 m -153.12 151.67 30.42 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.365 -0.38 . . . . 1.3300000000000001 110.652 176.216 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.512 HG21 ' C ' ' A' ' 23' ' ' PRO . 12.1 t -115.09 34.36 4.9 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 122.19 0.995 . . . . 1.02 108.915 176.234 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.462 ' HA ' ' HB3' ' A' ' 18' ' ' SER . . . -80.49 -6.09 57.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 114.946 -1.025 . . . . 1.1299999999999999 112.102 -172.563 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -94.13 -23.83 17.79 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.38 0.609 . . . . 2.21 110.528 -178.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.423 HG13 ' OG1' ' A' ' 32' ' ' THR . 0.2 OUTLIER -98.19 135.78 31.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.702 -0.681 . . . . 1.1100000000000001 110.103 -179.135 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 71.0 p -95.83 179.46 5.1 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.024 -0.535 . . . . 1.2 109.95 -175.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.514 ' O ' HG13 ' A' ' 41' ' ' ILE . 13.6 p90 -62.92 -31.11 72.12 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.006 -0.678 . . . . 2.21 109.468 176.335 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -71.89 -46.34 58.09 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-N 116.044 -0.525 . . . . 0.95999999999999996 110.596 178.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -67.25 -27.78 67.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.245 0.545 . . . . 0.91000000000000003 109.87 177.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.473 ' HB2' ' HB3' ' A' ' 17' ' ' PHE . . . -71.07 -43.05 68.57 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.513 -0.767 . . . . 1.03 110.366 176.48 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.514 HG13 ' O ' ' A' ' 37' ' ' TYR . 86.5 mt -64.78 -37.08 79.24 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.414 0 N-CA-C 109.494 -0.558 . . . . 1.0800000000000001 109.494 174.358 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.404 ' O ' ' HG3' ' A' ' 46' ' ' LYS . 62.2 tttp -61.49 -28.25 69.17 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.599 -0.728 . . . . 2.8399999999999999 110.209 177.522 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 58.8 tt0 -88.08 -48.23 7.9 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.663 -0.699 . . . . 1.02 110.082 -178.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.485 HD12 HG12 ' A' ' 113' ' ' ILE . 32.2 tp -61.15 -36.58 80.17 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.871 -0.604 . . . . 1.02 110.021 -179.256 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.438 ' O ' ' HB2' ' A' ' 49' ' ' GLN . 4.4 mm-40 -64.08 -36.21 83.26 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-N 115.96 -0.564 . . . . 0.87 111.97 178.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.404 ' HG3' ' O ' ' A' ' 42' ' ' LYS . 98.1 mttt -69.23 -46.3 67.71 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.843 -0.343 . . . . 1.98 110.461 179.653 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.408 ' O ' HG13 ' A' ' 51' ' ' ILE . 54.0 m95 -66.0 -46.14 79.06 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.475 -0.33 . . . . 0.60999999999999999 111.188 177.55 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 44.7 t -57.77 -35.27 70.53 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.881 -0.414 . . . . 0.88 109.881 175.006 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.438 ' HB2' ' O ' ' A' ' 45' ' ' GLN . 13.0 tt0 -65.6 -55.98 14.69 Favored 'General case' 0 C--O 1.225 -0.233 0 CA-C-N 115.915 -0.584 . . . . 0.55000000000000004 110.488 176.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.509 ' HB3' HG22 ' A' ' 56' ' ' VAL . 93.5 mtt180 -62.15 -42.31 99.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.097 -0.501 . . . . 0.47999999999999998 111.609 -176.235 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.418 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 98.3 mt -60.24 -35.21 60.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.012 0.434 . . . . 1.04 110.657 176.474 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -79.99 -38.89 31.22 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.943 -0.571 . . . . 1.0600000000000001 111.542 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 65.2 p -76.68 -29.99 56.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.72 0.295 . . . . 0.34999999999999998 111.456 -176.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 106.38 10.31 29.67 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.539 -0.839 . . . . 0.33000000000000002 112.141 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.415 ' HB2' ' HB3' ' A' ' 50' ' ' ARG . 41.4 mt-10 -67.1 -52.16 45.36 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.047 0.451 . . . . 0.65000000000000002 110.011 176.696 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.509 HG22 ' HB3' ' A' ' 50' ' ' ARG . 15.8 m -132.04 156.06 42.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.925 -0.58 . . . . 1.05 109.748 175.145 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 50.5 m -86.27 159.34 19.47 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.575 -0.528 . . . . 1.3100000000000001 109.575 178.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -52.41 -43.44 64.81 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.027 0.442 . . . . 0.25 110.249 -176.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.584 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 39.9 mt-10 -56.82 -43.49 81.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.236 -0.893 . . . . 1.72 112.105 -179.013 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -60.86 -46.34 90.95 Favored 'General case' 0 CA--C 1.521 -0.141 0 CA-C-O 120.958 0.408 . . . . 2.0899999999999999 110.587 -177.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -69.15 -51.1 41.64 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.048 -0.523 . . . . 1.0700000000000001 110.921 -179.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.78 -52.11 66.86 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.741 0.645 . . . . 1.0600000000000001 112.741 -173.231 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.519 ' HA ' ' O ' ' A' ' 71' ' ' TYR . 20.4 m -51.5 -25.47 6.64 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 112.859 0.688 . . . . 1.52 112.859 -176.726 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -105.36 -46.25 4.26 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.63 0.728 . . . . 0.60999999999999999 110.673 -177.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.477 ' HD2' ' CG ' ' A' ' 27' ' ' ARG . 27.8 mmt180 -88.26 -41.03 13.19 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.872 -1.058 . . . . 0.95999999999999996 113.54 -169.813 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.474 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 59.6 p -64.79 127.2 30.58 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.68 -0.408 . . . . 1.0600000000000001 111.14 -176.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.486 ' HA ' ' HG2' ' A' ' 26' ' ' ARG . 33.6 t70 -80.15 -10.84 59.78 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.424 0.631 . . . . 2.2799999999999998 111.157 179.091 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 44.8 t -77.56 163.04 26.64 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.94 -0.573 . . . . 2.0499999999999998 109.688 179.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -61.26 -16.45 49.09 Favored Glycine 0 N--CA 1.454 -0.146 0 CA-C-N 115.642 -0.708 . . . . 0.29999999999999999 112.598 -176.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 61.8 p -65.51 -7.63 15.41 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 112.021 0.378 . . . . 0.46999999999999997 112.021 177.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.519 ' O ' ' HA ' ' A' ' 63' ' ' SER . 14.1 p90 -60.96 -23.64 65.48 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 109.479 -0.563 . . . . 0.94999999999999996 109.479 175.466 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -95.09 5.97 50.37 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.084 0.469 . . . . 1.1100000000000001 110.613 178.003 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 6.2 m -126.02 3.24 7.26 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.097 -0.501 . . . . 0.70999999999999996 110.823 -179.084 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.584 ' O ' ' HA ' ' A' ' 59' ' ' GLU . . . 73.16 25.43 73.34 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.812 -0.708 . . . . 0.67000000000000004 112.047 -175.731 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 83.66 -20.31 12.22 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 121.202 -0.523 . . . . 0.42999999999999999 111.809 -177.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -73.36 133.13 43.72 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.294 -0.453 . . . . 1.6499999999999999 110.672 -175.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.441 HD22 ' HE2' ' A' ' 85' ' ' MET . 2.5 mp -115.78 164.1 14.87 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-O 121.307 0.575 . . . . 1.6899999999999999 110.009 175.05 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -82.5 -154.95 15.97 Favored Glycine 0 C--N 1.305 -1.169 0 CA-C-N 114.964 -1.016 . . . . 0.45000000000000001 111.808 176.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.617 ' HA ' ' O ' ' A' ' 8' ' ' LEU . 93.3 m-85 -84.17 147.77 27.12 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.037 0.446 . . . . 4.7400000000000002 110.933 -179.478 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.617 ' O ' ' HA ' ' A' ' 7' ' ' LYS . 14.9 p90 -147.8 165.63 29.99 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.647 -0.871 . . . . 1.6499999999999999 108.647 -177.237 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -90.5 149.98 21.97 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 109.645 -0.502 . . . . 1.6899999999999999 109.645 -178.498 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.6 p -58.77 111.7 1.37 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.838 0.351 . . . . 1.55 110.629 177.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 99.64 18.11 24.14 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.672 -0.775 . . . . 0.79000000000000004 112.514 -177.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -101.08 18.07 20.74 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.061 0.458 . . . . 1.5800000000000001 110.98 -178.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.441 ' HE2' HD22 ' A' ' 77' ' ' LEU . 26.3 mmt -124.51 -105.31 0.35 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.885 0.374 . . . . 1.1299999999999999 111.057 -177.045 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 82.7 mmm -141.26 152.6 44.66 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.133 -1.062 . . . . 1.8899999999999999 108.133 175.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.409 ' HB3' ' HD3' ' A' ' 88' ' ' PRO . 23.8 ttmm -50.77 -56.39 19.63 Favored Pre-proline 0 C--N 1.321 -0.642 0 N-CA-C 112.701 0.63 . . . . 2.7400000000000002 112.701 -175.707 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.409 ' HD3' ' HB3' ' A' ' 87' ' ' LYS . 85.1 Cg_endo -77.44 -27.85 6.05 Favored 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 121.48 1.453 . . . . 0.29999999999999999 111.928 -176.163 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.671 ' O ' HG21 ' A' ' 93' ' ' VAL . 14.5 t80 -67.98 -56.81 7.6 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.187 -0.915 . . . . 0.28000000000000003 109.854 -179.325 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -65.25 -38.21 89.62 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.502 -0.772 . . . . 2.1200000000000001 110.143 -178.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -57.03 -34.28 68.05 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.475 -0.784 . . . . 0.60999999999999999 110.617 177.17 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -78.91 -26.84 43.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 1.1000000000000001 110.707 177.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.671 HG21 ' O ' ' A' ' 89' ' ' PHE . 35.5 t -72.28 -36.94 57.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.332 0.587 . . . . 1.1200000000000001 109.977 -178.577 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.437 ' C ' ' HD2' ' A' ' 94' ' ' ARG . 2.0 ppt_? -83.08 -2.74 56.17 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.844 -0.617 . . . . 3.1800000000000002 110.246 179.237 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -97.43 9.69 41.7 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.093 -0.503 . . . . 1.0800000000000001 111.339 -177.386 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.487 ' HB2' ' HB2' ' A' ' 100' ' ' ASP . 0.4 OUTLIER -144.24 151.11 38.99 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.31 0.576 . . . . 1.1200000000000001 111.461 178.684 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.496 ' HG3' ' N ' ' A' ' 98' ' ' ILE . 22.5 tptm -91.34 172.25 8.66 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.253 -0.885 . . . . 2.1299999999999999 109.402 177.011 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.496 ' N ' ' HG3' ' A' ' 97' ' ' LYS . 1.3 mp -46.73 120.59 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 C-N-CA 123.344 0.658 . . . . 1.6200000000000001 110.85 176.689 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 97.72 -9.37 64.16 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.761 -0.733 . . . . 0.46000000000000002 113.28 176.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.487 ' HB2' ' HB2' ' A' ' 96' ' ' LEU . 12.1 m-20 -93.11 141.84 27.96 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 117.133 0.466 . . . . 0.46000000000000002 111.055 -177.802 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 9.4 mt -111.4 146.15 16.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.707 -0.679 . . . . 1.0800000000000001 109.668 -179.141 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 97.8 p -89.42 152.45 47.5 Favored Pre-proline 0 C--N 1.319 -0.755 0 CA-C-N 116.361 -0.382 . . . . 1.45 110.422 -179.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -69.18 166.79 25.68 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 122.35 2.033 . . . . 0.40999999999999998 111.111 171.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.438 HG13 ' HG2' ' A' ' 45' ' ' GLN . 29.0 mm -46.07 105.09 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 O-C-N 123.562 0.539 . . . . 1.04 112.05 178.693 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.0 p -111.52 121.18 63.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.253 -0.43 . . . . 1.6599999999999999 110.196 177.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -85.57 156.47 20.72 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.228 0.537 . . . . 0.55000000000000004 110.92 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 2.8 p -130.09 -173.17 2.97 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.383 -0.826 . . . . 1.05 110.019 177.357 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -56.51 -49.1 75.73 Favored 'General case' 0 C--N 1.328 -0.341 0 O-C-N 123.213 0.32 . . . . 2.1600000000000001 110.887 177.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.628 ' O ' ' HB2' ' A' ' 20' ' ' SER . 8.3 t -84.14 -60.69 2.02 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 116.212 -0.449 . . . . 1.0900000000000001 110.638 -177.139 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -146.76 -132.71 2.36 Favored Glycine 0 N--CA 1.441 -1.004 0 C-N-CA 118.921 -1.609 . . . . 0.39000000000000001 113.982 -173.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.507 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 6.8 mp -118.77 150.41 39.85 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.964 -0.618 . . . . 1.0600000000000001 111.377 -169.543 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . 0.57 ' HA ' ' O ' ' A' ' 13' ' ' LEU . 85.3 m-70 -144.58 150.15 36.99 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.205 0.526 . . . . 0.25 111.995 179.625 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.485 HG12 HD12 ' A' ' 44' ' ' LEU . 1.4 pt -134.25 137.02 52.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 107.514 -1.291 . . . . 1.03 107.514 160.27 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 2.8 mp -130.53 144.77 36.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 C-N-CA 120.87 -0.332 . . . . 1.0600000000000001 110.826 -175.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.447 ' HA ' ' O ' ' A' ' 100' ' ' ASP . 43.2 pttt -126.18 142.53 51.49 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.116 -0.698 . . . . 1.29 109.116 173.229 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . 0.442 ' HB2' ' CD1' ' A' ' 96' ' ' LEU . 68.4 ttt180 -84.8 129.03 34.88 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.282 0.563 . . . . 2.6800000000000002 111.338 -178.309 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -97.34 -39.53 9.17 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.187 -0.915 . . . . 1.54 110.4 -179.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.243 0.712 0 CA-C-O 118.374 -0.822 . . . . 1.1499999999999999 110.305 -179.332 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 94.8 mmm . . . . . 0 N--CA 1.481 1.117 0 N-CA-C 110.216 -0.29 . . . . 7.54 110.216 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 32.0 t 63.86 89.25 0.09 Allowed 'General case' 0 C--N 1.331 -0.2 0 O-C-N 123.634 0.583 . . . . 3.0899999999999999 110.849 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -85.94 -21.08 28.1 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.047 -0.524 . . . . 2.7999999999999998 109.958 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.575 ' HA ' ' O ' ' A' ' 80' ' ' PHE . 69.0 mmtt -77.48 134.6 38.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.434 0.635 . . . . 1.6899999999999999 111.365 -177.485 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.618 ' HB3' ' CE1' ' A' ' 80' ' ' PHE . 2.3 tt -137.02 158.31 44.74 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 114.748 -1.115 . . . . 1.79 108.032 -176.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.543 ' H ' HD21 ' A' ' 8' ' ' LEU . 72.2 ttt180 -132.18 130.93 41.71 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 108.928 -0.767 . . . . 1.3700000000000001 108.928 172.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -145.96 154.83 42.34 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.394 -0.523 . . . . 1.0700000000000001 111.886 -175.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.497 ' HA ' ' HA ' ' A' ' 76' ' ' ASP . . . -114.86 137.04 52.43 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.901 -0.591 . . . . 1.04 109.823 177.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 32.4 p-80 -139.69 151.42 45.89 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.06 0.457 . . . . 0.34000000000000002 111.538 -172.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.61 ' O ' ' HA ' ' A' ' 112' ' ' HIS . 5.5 tt -119.08 144.51 46.55 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 108.336 -0.986 . . . . 1.0600000000000001 108.336 177.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.569 HD11 ' NE2' ' A' ' 112' ' ' HIS . 27.0 tp -130.4 120.97 25.07 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.724 0.297 . . . . 1.0800000000000001 111.061 -177.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 57.3 t -109.04 133.9 52.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 116.108 -0.496 . . . . 1.01 109.693 176.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.435 ' HE3' HD23 ' A' ' 14' ' ' LEU . 32.7 mmtp -106.03 151.22 24.93 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.274 -0.639 . . . . 1.22 109.274 176.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.401 ' HB3' ' HB1' ' A' ' 40' ' ' ALA . 46.6 p90 -142.61 162.23 36.02 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.707 0.289 . . . . 0.29999999999999999 110.859 -178.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.443 ' HB3' ' C ' ' A' ' 33' ' ' ALA . 28.7 p -50.59 110.78 0.45 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.93 -0.577 . . . . 1.6000000000000001 111.194 179.297 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 94.75 8.33 59.47 Favored Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.458 -0.877 . . . . 0.53000000000000003 113.36 177.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.473 ' C ' ' H ' ' A' ' 22' ' ' ASN . 88.5 p -90.83 46.84 1.36 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 117.841 0.82 . . . . 1.28 110.51 -178.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 70.8 ttt180 70.87 -35.55 0.33 Allowed 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 123.53 0.732 . . . . 4.1600000000000001 111.511 -178.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.473 ' H ' ' C ' ' A' ' 20' ' ' SER . 49.4 m-80 -140.52 96.86 7.6 Favored Pre-proline 0 C--N 1.326 -0.434 0 N-CA-C 109.623 -0.51 . . . . 1.77 109.623 179.526 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.514 ' C ' HG23 ' A' ' 32' ' ' THR . 87.4 Cg_endo -83.35 51.67 3.66 Favored 'Trans proline' 0 CA--C 1.536 0.618 0 C-N-CA 122.585 2.19 . . . . 1.71 113.133 -176.141 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.46 ' N ' HG23 ' A' ' 32' ' ' THR . 42.7 t -147.6 113.11 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 123.265 0.626 . . . . 1.1599999999999999 109.332 177.136 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.435 ' HB3' ' HB2' ' A' ' 16' ' ' LYS . 21.5 p -104.36 158.07 16.71 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.946 -0.115 . . . . 1.4299999999999999 110.728 178.405 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.532 ' HB2' ' HA ' ' A' ' 67' ' ' ASP . 0.0 OUTLIER -63.37 -13.78 43.1 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-O 121.551 0.691 . . . . 3.1200000000000001 110.033 172.313 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.485 ' CG ' ' HD2' ' A' ' 65' ' ' ARG . 0.1 OUTLIER -87.87 -13.81 41.04 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.92 -1.036 . . . . 2.25 110.827 -177.432 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 20.7 p -118.84 -35.22 3.73 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.326 0.584 . . . . 1.1299999999999999 110.511 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 79.4 -42.67 2.42 Favored Glycine 0 N--CA 1.452 -0.262 0 CA-C-N 115.083 -0.962 . . . . 0.81999999999999995 112.852 176.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -94.27 -67.98 0.83 Allowed 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 110.118 -0.327 . . . . 2.1000000000000001 110.118 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.2 m -153.63 146.59 24.48 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.075 -0.512 . . . . 1.3300000000000001 110.304 178.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.514 HG23 ' C ' ' A' ' 23' ' ' PRO . 9.9 t -112.8 33.79 4.79 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 122.545 1.164 . . . . 1.02 108.589 175.264 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.443 ' C ' ' HB3' ' A' ' 18' ' ' SER . . . -80.67 -4.55 54.7 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 114.165 -1.38 . . . . 1.1299999999999999 111.712 -175.074 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -95.26 -21.42 18.45 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.97 0.415 . . . . 2.21 111.007 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.434 HG13 ' OG1' ' A' ' 32' ' ' THR . 0.2 OUTLIER -99.18 136.54 29.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.052 -0.522 . . . . 1.1100000000000001 110.052 179.822 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 56.1 p -95.48 -178.4 4.41 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.329 -0.396 . . . . 1.2 110.325 -174.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.427 ' O ' HG13 ' A' ' 41' ' ' ILE . 6.6 p90 -65.17 -27.98 69.08 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.102 -0.703 . . . . 2.21 109.102 176.041 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -72.1 -49.2 38.13 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 115.89 -0.596 . . . . 0.95999999999999996 110.064 177.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.415 ' HB2' HG23 ' A' ' 35' ' ' VAL . 49.1 m-20 -65.12 -30.55 71.49 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-O 121.339 0.59 . . . . 0.91000000000000003 110.041 179.422 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.401 ' HB1' ' HB3' ' A' ' 17' ' ' PHE . . . -70.4 -46.47 63.91 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.184 -0.916 . . . . 1.03 110.427 177.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.493 ' O ' ' HB2' ' A' ' 45' ' ' GLN . 70.4 mt -63.33 -36.83 77.67 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.383 0 N-CA-C 109.726 -0.472 . . . . 1.0800000000000001 109.726 175.537 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.449 ' O ' ' HG3' ' A' ' 46' ' ' LYS . 79.5 tttt -59.16 -31.8 69.31 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.66 -0.7 . . . . 2.8399999999999999 110.169 177.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 53.1 tt0 -88.12 -46.84 8.96 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.635 -0.711 . . . . 1.02 110.149 -176.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.463 HD13 HG12 ' A' ' 113' ' ' ILE . 33.5 tp -60.19 -37.52 80.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.12 -0.491 . . . . 1.02 109.854 -179.302 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.493 ' HB2' ' O ' ' A' ' 41' ' ' ILE . 1.6 mm-40 -68.06 -21.35 65.0 Favored 'General case' 0 C--O 1.226 -0.175 0 CA-C-N 115.936 -0.575 . . . . 0.87 112.123 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.449 ' HG3' ' O ' ' A' ' 42' ' ' LYS . 68.4 mttm -82.43 -44.87 15.53 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.853 -0.339 . . . . 1.98 110.262 178.335 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.409 ' O ' HG13 ' A' ' 51' ' ' ILE . 43.9 m95 -67.8 -44.44 77.32 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.999 -0.28 . . . . 0.60999999999999999 110.618 177.097 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 32.4 t -61.15 -26.94 68.04 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.883 -0.414 . . . . 0.88 109.883 175.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.448 ' HB2' ' O ' ' A' ' 45' ' ' GLN . 3.9 tt0 -73.0 -56.62 4.87 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 116.152 -0.476 . . . . 0.55000000000000004 109.844 175.319 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.489 ' HB3' HG21 ' A' ' 56' ' ' VAL . 87.0 mtt180 -59.86 -41.97 92.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.84 -0.618 . . . . 0.47999999999999998 111.882 -176.179 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.474 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 98.0 mt -59.23 -34.76 54.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.101 0.476 . . . . 1.04 110.157 176.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -82.22 -37.91 25.31 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.559 -0.746 . . . . 1.0600000000000001 111.87 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.46 ' OG ' ' HA ' ' A' ' 50' ' ' ARG . 46.3 p -78.92 -29.55 44.26 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 111.99 0.367 . . . . 0.34999999999999998 111.99 -176.008 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 107.38 13.1 21.8 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.541 -0.838 . . . . 0.33000000000000002 112.667 179.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.453 ' HB2' ' HB3' ' A' ' 50' ' ' ARG . 33.5 mt-10 -73.99 -44.85 53.24 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.858 0.361 . . . . 0.65000000000000002 110.239 177.518 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.489 HG21 ' HB3' ' A' ' 50' ' ' ARG . 14.2 m -138.86 158.34 29.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 109.355 -0.609 . . . . 1.05 109.355 172.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 55.1 p -84.53 164.91 18.47 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.68 -0.489 . . . . 1.3100000000000001 109.68 176.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -57.95 -41.04 81.99 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.224 -0.658 . . . . 0.25 109.224 178.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -56.56 -53.28 59.41 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.898 -1.046 . . . . 1.72 111.381 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 30.6 mm-40 -56.54 -45.48 81.15 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 120.965 0.412 . . . . 2.0899999999999999 111.161 -178.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -68.1 -49.83 58.71 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.192 -0.458 . . . . 1.0700000000000001 111.121 -179.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.33 -53.74 54.74 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.236 0.458 . . . . 1.0600000000000001 112.236 -174.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.573 ' HA ' ' O ' ' A' ' 71' ' ' TYR . 74.7 m -51.63 -24.53 5.63 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 113.35 0.87 . . . . 1.52 113.35 -176.532 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -104.59 -48.1 3.89 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.564 0.697 . . . . 0.60999999999999999 110.457 -179.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.485 ' HD2' ' CG ' ' A' ' 27' ' ' ARG . 18.5 mmt180 -87.41 -41.37 13.62 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.993 -1.003 . . . . 0.95999999999999996 113.443 -168.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.493 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 58.5 p -64.77 125.43 24.76 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.049 0.452 . . . . 1.0600000000000001 111.301 -175.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.532 ' HA ' ' HB2' ' A' ' 26' ' ' ARG . 24.8 t70 -75.96 -17.76 59.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.69 -0.686 . . . . 2.2799999999999998 111.342 177.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.431 ' O ' ' HD1' ' A' ' 71' ' ' TYR . 41.2 t -77.48 157.43 30.45 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.317 0.579 . . . . 2.0499999999999998 110.21 -178.536 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -57.11 -17.79 24.77 Favored Glycine 0 C--N 1.329 0.181 0 CA-C-N 114.482 -1.235 . . . . 0.29999999999999999 114.269 -170.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 51.1 p -69.38 -5.61 24.63 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 111.891 0.33 . . . . 0.46999999999999997 111.891 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.573 ' O ' ' HA ' ' A' ' 63' ' ' SER . 34.6 p90 -56.02 -33.58 65.03 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.014 0.435 . . . . 0.94999999999999996 109.988 175.033 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -94.45 4.82 53.37 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.119 0.485 . . . . 1.1100000000000001 110.911 -177.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.0 m -114.44 -15.99 12.0 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.002 -0.545 . . . . 0.70999999999999996 110.905 -177.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 101.7 19.57 15.23 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.861 -0.685 . . . . 0.67000000000000004 111.641 -176.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 85.8 -27.87 5.2 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 121.193 -0.527 . . . . 0.42999999999999999 112.656 178.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.497 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 7.6 p-10 -86.41 140.86 29.6 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-O 121.776 0.798 . . . . 1.6499999999999999 111.333 -175.275 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.3 mp -102.09 175.57 5.49 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 114.422 -1.263 . . . . 1.6899999999999999 109.84 177.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -86.49 -156.53 28.64 Favored Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 120.842 -0.694 . . . . 0.45000000000000001 111.413 177.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.543 ' HA ' ' O ' ' A' ' 8' ' ' LEU . 99.3 m-85 -85.29 136.96 33.27 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.022 0.439 . . . . 4.7400000000000002 110.52 179.337 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.618 ' CE1' ' HB3' ' A' ' 8' ' ' LEU . 13.8 p90 -137.96 166.34 24.3 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.655 -0.702 . . . . 1.6499999999999999 109.21 -179.604 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.502 ' O ' ' HB2' ' A' ' 84' ' ' GLU . 15.5 m -90.02 133.12 35.01 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 108.931 -0.766 . . . . 1.6899999999999999 108.931 176.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 20.0 m -53.02 121.42 7.36 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.828 0.347 . . . . 1.55 110.834 -178.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 104.86 1.09 42.4 Favored Glycine 0 CA--C 1.519 0.324 0 C-N-CA 120.964 -0.636 . . . . 0.79000000000000004 112.237 -176.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.502 ' HB2' ' O ' ' A' ' 81' ' ' SER . 28.5 tt0 -82.78 -3.79 57.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.777 0.322 . . . . 1.5800000000000001 111.609 -175.519 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 26.5 mmt -107.94 -144.97 0.39 Allowed 'General case' 0 N--CA 1.438 -1.035 0 N-CA-C 109.451 -0.574 . . . . 1.1299999999999999 109.451 -175.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -93.54 154.52 17.83 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 115.369 -0.832 . . . . 1.8899999999999999 109.089 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 22.3 tptm -53.94 -57.1 19.31 Favored Pre-proline 0 C--N 1.321 -0.671 0 N-CA-C 112.07 0.396 . . . . 2.7400000000000002 112.07 -178.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -74.0 -22.1 17.56 Favored 'Trans proline' 0 C--N 1.356 0.962 0 C-N-CA 121.506 1.47 . . . . 0.29999999999999999 111.661 -176.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.603 ' O ' HG21 ' A' ' 93' ' ' VAL . 23.8 t80 -72.8 -56.45 5.22 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.293 -0.867 . . . . 0.28000000000000003 109.608 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -64.48 -34.83 79.12 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.812 -0.631 . . . . 2.1200000000000001 109.654 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.45 ' HA ' ' NE ' ' A' ' 94' ' ' ARG . 9.9 t70 -52.35 -36.69 54.17 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.74 -0.664 . . . . 0.60999999999999999 111.091 175.029 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.541 ' O ' ' HG ' ' A' ' 96' ' ' LEU . . . -81.98 -35.34 29.06 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.937 -0.574 . . . . 1.1000000000000001 110.883 179.424 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.603 HG21 ' O ' ' A' ' 89' ' ' PHE . 14.7 t -64.17 -42.76 96.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.201 0.524 . . . . 1.1200000000000001 110.585 -177.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.45 ' NE ' ' HA ' ' A' ' 91' ' ' ASP . 39.4 ptt180 -70.86 -18.41 62.7 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.022 -0.535 . . . . 3.1800000000000002 110.583 177.415 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -88.66 2.6 52.94 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.921 -0.581 . . . . 1.0800000000000001 111.415 -174.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.579 ' HB2' ' HB2' ' A' ' 100' ' ' ASP . 0.8 OUTLIER -137.98 153.53 49.42 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.132 -0.485 . . . . 1.1200000000000001 110.64 177.621 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.674 ' HG2' ' H ' ' A' ' 98' ' ' ILE . 39.8 tttp -102.7 -179.18 3.89 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 109.18 -0.674 . . . . 2.1299999999999999 109.18 176.413 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.674 ' H ' ' HG2' ' A' ' 97' ' ' LYS . 9.2 mt -51.49 122.4 2.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 120.891 0.377 . . . . 1.6200000000000001 111.309 178.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 93.12 -2.12 71.23 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.9 -0.667 . . . . 0.46000000000000002 113.271 178.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.579 ' HB2' ' HB2' ' A' ' 96' ' ' LEU . 45.7 m-20 -100.19 141.98 32.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 117.423 0.611 . . . . 0.46000000000000002 110.657 -179.474 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 11.8 mt -111.55 147.02 15.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.954 -0.566 . . . . 1.0800000000000001 110.0 -179.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 91.3 p -92.19 152.45 42.58 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 116.419 -0.355 . . . . 1.45 110.953 -177.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -68.25 160.15 50.17 Favored 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 122.335 2.023 . . . . 0.40999999999999998 111.095 172.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.479 HG13 ' HG2' ' A' ' 45' ' ' GLN . 25.6 mm -43.1 107.95 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 O-C-N 123.889 0.743 . . . . 1.04 112.115 178.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 1.8 p -113.31 121.78 66.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.991 -0.549 . . . . 1.6599999999999999 109.983 177.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -85.41 155.44 21.28 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.97 0.414 . . . . 0.55000000000000004 110.4 179.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.404 ' OG1' ' HD2' ' A' ' 112' ' ' HIS . 4.4 p -135.85 -171.17 2.79 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.695 -0.684 . . . . 1.05 110.929 -178.306 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -56.37 -42.69 78.28 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.122 -0.49 . . . . 2.1600000000000001 111.672 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.425 ' O ' ' HD3' ' A' ' 16' ' ' LYS . 5.4 t -113.58 -0.38 14.38 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 112.593 0.59 . . . . 1.0900000000000001 112.593 -170.146 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 166.25 -126.86 1.52 Allowed Glycine 0 N--CA 1.436 -1.31 0 C-N-CA 119.198 -1.477 . . . . 0.39000000000000001 113.31 171.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.493 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 7.4 mp -125.79 149.08 48.88 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 114.767 -0.717 . . . . 1.0600000000000001 111.135 -168.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . 0.61 ' HA ' ' O ' ' A' ' 13' ' ' LEU . 78.4 m-70 -144.05 150.08 37.64 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.21 0.529 . . . . 0.25 111.854 178.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.463 HG12 HD13 ' A' ' 44' ' ' LEU . 2.5 pt -132.7 140.7 46.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 107.577 -1.268 . . . . 1.03 107.577 159.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 2.7 mp -130.43 145.17 35.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 C-N-CA 120.813 -0.355 . . . . 1.0600000000000001 110.643 -176.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.429 ' HG2' ' HB2' ' A' ' 11' ' ' ALA . 43.3 pttt -127.74 141.5 51.57 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.725 -0.842 . . . . 1.29 108.725 173.047 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . 0.537 ' HB2' ' CD1' ' A' ' 96' ' ' LEU . 55.1 ttt180 -83.72 129.06 34.95 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.212 0.53 . . . . 2.6800000000000002 111.097 -178.033 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -97.02 -34.51 11.15 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.137 -0.938 . . . . 1.54 110.105 -179.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.882 0 CA-C-O 118.647 -0.692 . . . . 1.1499999999999999 109.958 178.562 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 92.9 mtp . . . . . 0 N--CA 1.483 1.183 0 CA-C-O 120.661 0.267 . . . . 7.54 110.793 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 35.9 t -153.38 131.73 12.04 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.778 0.323 . . . . 3.0899999999999999 110.479 -178.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -101.31 -9.0 21.59 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.142 0.496 . . . . 2.7999999999999998 110.028 178.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 10.3 tptt -83.74 122.05 28.13 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 121.703 0.763 . . . . 1.6899999999999999 111.419 -175.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.582 HD22 ' N ' ' A' ' 9' ' ' ARG . 2.1 tt -113.93 157.6 22.2 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 114.25 -1.341 . . . . 1.79 107.898 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.582 ' N ' HD22 ' A' ' 8' ' ' LEU . 63.2 ttt180 -141.0 130.32 23.66 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 109.164 -0.68 . . . . 1.3700000000000001 109.164 173.336 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -147.19 152.5 38.5 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 120.251 -0.58 . . . . 1.0700000000000001 112.15 -178.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -103.97 134.08 47.86 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.311 -0.858 . . . . 1.04 109.019 176.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 29.1 p-80 -135.13 148.05 49.66 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.101 0.477 . . . . 0.34000000000000002 111.851 -172.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.553 HD22 ' N ' ' A' ' 14' ' ' LEU . 5.2 tt -115.0 147.97 39.41 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.518 -0.919 . . . . 1.0600000000000001 108.518 177.457 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.553 ' N ' HD22 ' A' ' 13' ' ' LEU . 18.1 tp -131.65 130.24 41.83 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 110.35 -0.241 . . . . 1.0800000000000001 110.35 -177.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.412 HG21 HD11 ' A' ' 44' ' ' LEU . 56.5 t -119.7 133.63 65.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 109.827 -0.435 . . . . 1.01 109.827 174.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.439 ' CB ' HG22 ' A' ' 32' ' ' THR . 33.4 mmtp -104.96 154.91 19.47 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.066 -0.516 . . . . 1.22 110.503 178.145 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.405 ' HB3' ' HB3' ' A' ' 40' ' ' ALA . 50.4 p90 -149.64 161.62 41.83 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.633 -0.712 . . . . 0.29999999999999999 109.523 -178.057 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.46 ' HB3' ' C ' ' A' ' 33' ' ' ALA . 38.1 p -54.59 110.16 0.6 Allowed 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.147 0.499 . . . . 1.6000000000000001 110.5 177.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 108.84 9.47 26.4 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.918 -0.658 . . . . 0.53000000000000003 112.356 -176.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.491 ' C ' ' H ' ' A' ' 22' ' ' ASN . 42.5 p -88.06 26.69 1.32 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 117.095 0.448 . . . . 1.28 111.81 -175.537 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.424 ' HB2' ' O ' ' A' ' 20' ' ' SER . 83.2 mtt180 72.5 -20.04 0.28 Allowed 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.173 0.589 . . . . 4.1600000000000001 111.459 -178.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.491 ' H ' ' C ' ' A' ' 20' ' ' SER . 7.4 p30 -155.08 107.31 2.28 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-O 121.47 0.653 . . . . 1.77 109.345 171.182 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.428 ' C ' HG21 ' A' ' 32' ' ' THR . 87.5 Cg_endo -81.77 58.81 6.92 Favored 'Trans proline' 0 CA--C 1.534 0.49 0 C-N-CA 122.824 2.35 . . . . 1.71 113.47 -171.289 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.423 ' N ' HG21 ' A' ' 32' ' ' THR . 63.9 t -140.22 121.91 15.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 122.6 0.36 . . . . 1.1599999999999999 110.138 178.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.424 ' HG ' ' CG ' ' A' ' 67' ' ' ASP . 28.3 t -103.06 149.55 24.47 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 109.235 -0.654 . . . . 1.4299999999999999 109.235 179.452 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.554 ' HB2' ' HA ' ' A' ' 67' ' ' ASP . 2.1 mpt_? -77.38 -14.55 59.69 Favored 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 108.443 -0.947 . . . . 3.1200000000000001 108.443 173.089 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.436 ' HG2' ' HD3' ' A' ' 65' ' ' ARG . 1.9 tmm_? -76.41 -35.51 58.54 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 114.575 -1.193 . . . . 2.25 109.558 175.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 44.2 p -97.62 -34.19 11.04 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 121.273 0.558 . . . . 1.1299999999999999 110.595 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 75.37 -10.41 11.43 Favored Glycine 0 N--CA 1.452 -0.269 0 CA-C-N 115.492 -0.776 . . . . 0.81999999999999995 113.032 178.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -115.93 -71.36 0.74 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.886 0.374 . . . . 2.1000000000000001 109.995 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.2 p -152.51 154.83 36.26 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.031 -0.531 . . . . 1.3300000000000001 110.679 179.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.439 HG22 ' CB ' ' A' ' 16' ' ' LYS . 8.8 t -123.01 34.9 5.01 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 122.147 0.975 . . . . 1.02 109.712 175.332 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.46 ' C ' ' HB3' ' A' ' 18' ' ' SER . . . -79.6 -5.57 55.29 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.181 -0.918 . . . . 1.1299999999999999 112.309 -174.392 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -97.68 -25.27 15.16 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.083 0.468 . . . . 2.21 111.159 -179.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.437 HG22 ' HB2' ' A' ' 39' ' ' ASP . 0.3 OUTLIER -93.5 137.68 22.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 116.128 -0.487 . . . . 1.1100000000000001 110.174 -177.074 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 56.8 p -98.17 -178.29 4.0 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.442 -0.577 . . . . 1.2 109.442 -178.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.522 ' O ' HG13 ' A' ' 41' ' ' ILE . 0.2 OUTLIER -66.18 -24.27 66.61 Favored 'General case' 0 C--O 1.219 -0.518 0 C-N-CA 119.291 -0.963 . . . . 2.21 110.013 173.522 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -70.01 -45.7 66.67 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.887 -0.412 . . . . 0.95999999999999996 109.887 175.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.437 ' HB2' HG22 ' A' ' 35' ' ' VAL . 26.3 m-20 -69.01 -30.96 69.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.503 0.668 . . . . 0.91000000000000003 109.758 177.334 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.405 ' HB3' ' HB3' ' A' ' 17' ' ' PHE . . . -73.3 -42.26 62.59 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.139 -0.937 . . . . 1.03 110.863 179.15 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.522 HG13 ' O ' ' A' ' 37' ' ' TYR . 69.4 mt -63.54 -35.89 74.29 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.299 0 N-CA-C 109.494 -0.558 . . . . 1.0800000000000001 109.494 174.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 20.3 ttpt -62.96 -23.62 67.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.363 0.601 . . . . 2.8399999999999999 109.896 178.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.489 ' HG3' ' CD1' ' A' ' 47' ' ' TRP . 2.2 tp10 -87.67 -56.95 3.13 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.09 -0.959 . . . . 1.02 109.378 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.483 HD13 HG12 ' A' ' 113' ' ' ILE . 31.9 tp -59.24 -36.8 76.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.088 -0.96 . . . . 1.02 110.82 -174.213 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.574 ' O ' ' HB2' ' A' ' 49' ' ' GLN . 0.0 OUTLIER -67.07 -29.76 69.63 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 116.159 -0.473 . . . . 0.87 112.25 -177.407 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 44.5 mttp -78.29 -42.76 29.91 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.814 0.34 . . . . 1.98 110.316 178.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.489 ' CD1' ' HG3' ' A' ' 43' ' ' GLU . 49.4 m95 -66.81 -44.45 81.15 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.384 -0.371 . . . . 0.60999999999999999 111.364 178.226 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.445 ' HB3' HG23 ' A' ' 113' ' ' ILE . 88.9 p -64.7 -32.17 73.72 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 110.017 -0.364 . . . . 0.88 110.017 176.245 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.574 ' HB2' ' O ' ' A' ' 45' ' ' GLN . 11.0 tt0 -66.13 -49.81 66.16 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.1 -0.5 . . . . 0.55000000000000004 110.274 177.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.503 ' HB3' HG23 ' A' ' 56' ' ' VAL . 87.9 mtt180 -64.14 -44.49 91.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.755 -0.657 . . . . 0.47999999999999998 111.272 -179.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.413 HG13 ' O ' ' A' ' 47' ' ' TRP . 88.3 mt -59.84 -39.35 79.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.362 -0.381 . . . . 1.04 110.654 177.085 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.27 -36.21 68.94 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.232 -0.44 . . . . 1.0600000000000001 111.863 -179.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 24.6 p -85.19 -30.32 24.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.896 0.379 . . . . 0.34999999999999998 111.474 -177.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 108.91 11.34 22.86 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.62 -0.8 . . . . 0.33000000000000002 112.742 178.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.451 ' OE1' ' HG2' ' A' ' 50' ' ' ARG . 46.9 mt-10 -62.56 -49.51 74.99 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.612 -0.514 . . . . 0.65000000000000002 109.612 175.319 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.503 HG23 ' HB3' ' A' ' 50' ' ' ARG . 14.6 m -132.16 155.28 41.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.591 -0.731 . . . . 1.05 109.359 173.586 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.1 m -83.29 160.43 21.71 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 109.236 -0.653 . . . . 1.3100000000000001 109.236 178.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -54.93 -44.11 73.96 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.619 -0.512 . . . . 0.25 109.619 -179.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.55 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 39.9 mt-10 -59.15 -43.41 92.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.12 -0.945 . . . . 1.72 111.8 -179.178 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 -61.62 -49.05 78.14 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 120.964 0.411 . . . . 2.0899999999999999 110.519 -177.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -67.53 -50.16 59.97 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.926 -0.579 . . . . 1.0700000000000001 110.902 -178.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -58.6 -51.97 67.67 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.573 0.583 . . . . 1.0600000000000001 112.573 -174.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.575 ' HA ' ' O ' ' A' ' 71' ' ' TYR . 23.9 m -51.32 -27.26 9.13 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.736 0.643 . . . . 1.52 112.736 -177.559 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -102.68 -44.67 5.24 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.533 0.683 . . . . 0.60999999999999999 110.654 -178.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.436 ' HD3' ' HG2' ' A' ' 27' ' ' ARG . 25.3 mmt180 -94.6 -35.91 12.02 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 114.2 1.185 . . . . 0.95999999999999996 114.2 -169.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.507 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 33.7 p -66.7 128.13 35.07 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.9 0.381 . . . . 1.0600000000000001 110.797 -177.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.554 ' HA ' ' HB2' ' A' ' 26' ' ' ARG . 40.0 m-20 -90.92 5.54 48.22 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.701 -0.681 . . . . 2.2799999999999998 111.644 -177.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.473 ' O ' ' HD1' ' A' ' 71' ' ' TYR . 36.1 t -88.22 170.0 11.39 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.67 -0.493 . . . . 2.0499999999999998 109.67 174.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -63.56 -19.02 62.06 Favored Glycine 0 N--CA 1.454 -0.142 0 C-N-CA 121.08 -0.581 . . . . 0.29999999999999999 111.962 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 55.3 p -65.93 -6.92 13.94 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 112.532 0.567 . . . . 0.46999999999999997 112.532 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.575 ' O ' ' HA ' ' A' ' 63' ' ' SER . 20.0 p90 -60.68 -23.16 64.62 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.216 0.532 . . . . 0.94999999999999996 109.747 176.171 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -89.28 -1.48 58.08 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.188 -0.46 . . . . 1.1100000000000001 111.055 179.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.5 m -126.17 6.94 7.15 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.91 0.386 . . . . 0.70999999999999996 110.998 -179.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.55 ' O ' ' HA ' ' A' ' 59' ' ' GLU . . . 73.37 30.39 62.59 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.634 -0.793 . . . . 0.67000000000000004 112.195 -177.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 85.45 -22.21 11.3 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 121.12 -0.562 . . . . 0.42999999999999999 111.801 -179.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -64.32 134.67 55.13 Favored 'General case' 0 CA--C 1.508 -0.663 0 CA-C-N 115.203 -0.498 . . . . 1.6499999999999999 111.49 -176.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.6 mp -117.52 158.18 25.0 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 115.685 -0.689 . . . . 1.6899999999999999 109.334 169.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -78.63 -150.05 4.83 Favored Glycine 0 C--N 1.308 -0.977 0 CA-C-N 115.023 -0.989 . . . . 0.45000000000000001 112.72 -179.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -88.52 144.82 26.1 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.203 0.525 . . . . 4.7400000000000002 111.697 -178.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -158.3 153.63 25.82 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.123 -0.944 . . . . 1.6499999999999999 108.803 -177.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 29.3 m -82.39 133.64 35.22 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.115 -0.698 . . . . 1.6899999999999999 109.115 178.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 4.5 p -49.98 121.14 5.02 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.997 -0.547 . . . . 1.55 111.514 -178.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 114.49 -17.18 18.86 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.847 -0.692 . . . . 0.79000000000000004 112.938 -178.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 65.6 mt-10 -83.55 46.71 1.18 Allowed 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 117.092 0.446 . . . . 1.5800000000000001 111.486 -176.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 25.7 mmt -137.68 -122.59 0.14 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.053 0.454 . . . . 1.1299999999999999 110.482 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 54.9 mtt -125.34 149.59 47.97 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.163 -1.051 . . . . 1.8899999999999999 108.163 176.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 16.3 tppt? -54.12 -52.76 65.71 Favored Pre-proline 0 C--N 1.32 -0.715 0 N-CA-C 112.423 0.527 . . . . 2.7400000000000002 112.423 -174.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.406 ' HG2' HG23 ' A' ' 107' ' ' THR . 74.0 Cg_endo -75.42 -23.62 12.95 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 121.336 1.357 . . . . 0.29999999999999999 112.136 -176.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.57 ' O ' HG22 ' A' ' 93' ' ' VAL . 45.3 t80 -74.34 -55.39 6.06 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.396 -0.82 . . . . 0.28000000000000003 109.868 179.354 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -64.75 -34.33 78.07 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.614 -0.721 . . . . 2.1200000000000001 110.087 -178.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.489 ' HA ' ' NE ' ' A' ' 94' ' ' ARG . 19.2 t70 -53.44 -35.94 61.03 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.929 -0.578 . . . . 0.60999999999999999 110.753 175.13 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.482 ' O ' ' HG ' ' A' ' 96' ' ' LEU . . . -80.4 -36.19 34.15 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.341 -0.391 . . . . 1.1000000000000001 110.957 178.511 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.57 HG22 ' O ' ' A' ' 89' ' ' PHE . 15.4 t -64.27 -41.67 93.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.275 0.559 . . . . 1.1200000000000001 110.693 -177.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.489 ' NE ' ' HA ' ' A' ' 91' ' ' ASP . 36.4 ptt180 -76.1 -12.21 60.07 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.833 -0.621 . . . . 3.1800000000000002 110.449 178.194 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -97.32 21.16 10.42 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.085 -0.507 . . . . 1.0800000000000001 111.314 -174.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.498 ' HB2' ' HB2' ' A' ' 100' ' ' ASP . 0.4 OUTLIER -152.32 156.35 39.44 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.86 -0.609 . . . . 1.1200000000000001 110.604 175.074 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.486 ' HG3' ' H ' ' A' ' 98' ' ' ILE . 50.8 tptt -99.01 175.92 5.75 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.502 -0.772 . . . . 2.1299999999999999 108.96 179.603 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.486 ' H ' ' HG3' ' A' ' 97' ' ' LYS . 67.3 mt -57.19 117.66 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 120.887 0.375 . . . . 1.6200000000000001 110.752 178.184 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 96.37 9.09 57.1 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.821 -0.704 . . . . 0.46000000000000002 112.748 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.498 ' HB2' ' HB2' ' A' ' 96' ' ' LEU . 21.7 m-20 -110.83 141.62 43.95 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 110.001 -0.37 . . . . 0.46000000000000002 110.001 176.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 12.3 mt -111.8 149.94 14.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.212 -0.449 . . . . 1.0800000000000001 110.002 -177.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 99.6 p -95.04 143.36 25.97 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 116.619 -0.264 . . . . 1.45 110.525 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -66.65 164.79 27.7 Favored 'Trans proline' 0 N--CA 1.461 -0.41 0 C-N-CA 122.319 2.013 . . . . 0.40999999999999998 110.93 171.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.432 HG23 HD22 ' A' ' 44' ' ' LEU . 20.2 mm -39.48 113.34 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 O-C-N 123.817 0.698 . . . . 1.04 112.571 -179.08 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 1.8 p -121.37 121.62 65.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.949 -0.568 . . . . 1.6599999999999999 110.121 175.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . 0.43 ' HG2' ' CD1' ' A' ' 111' ' ' LEU . 49.2 mt-30 -85.09 156.58 21.01 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.059 0.457 . . . . 0.55000000000000004 110.394 178.428 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.406 HG23 ' HG2' ' A' ' 88' ' ' PRO . 3.0 p -130.24 -172.49 2.8 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.684 -0.689 . . . . 1.05 110.212 179.042 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -60.96 -36.36 79.18 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.574 0.226 . . . . 2.1600000000000001 110.693 177.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.432 ' OG ' ' HE2' ' A' ' 16' ' ' LYS . 23.3 t -91.51 -61.37 1.66 Allowed 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 120.89 -0.324 . . . . 1.0900000000000001 110.657 -178.554 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -150.67 -130.93 1.78 Allowed Glycine 0 N--CA 1.442 -0.901 0 C-N-CA 119.287 -1.435 . . . . 0.39000000000000001 113.635 -174.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.463 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 7.4 mp -116.48 148.7 40.52 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.332 -0.434 . . . . 1.0600000000000001 111.392 -171.511 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . 0.51 ' HA ' ' O ' ' A' ' 13' ' ' LEU . 86.4 m-70 -144.09 151.88 40.2 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.267 0.556 . . . . 0.25 112.398 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.483 HG12 HD13 ' A' ' 44' ' ' LEU . 3.4 pt -133.21 136.26 55.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 107.484 -1.302 . . . . 1.03 107.484 159.273 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 2.8 mp -127.48 144.3 37.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 C-N-CA 120.753 -0.379 . . . . 1.0600000000000001 110.478 -176.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 41.3 pttt -125.76 140.81 52.37 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.773 -0.825 . . . . 1.29 108.773 172.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . 0.47 ' HB2' ' CD1' ' A' ' 96' ' ' LEU . 59.2 ttt180 -87.36 134.47 33.57 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.072 0.463 . . . . 2.6800000000000002 111.384 -177.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 6.7 mp -112.1 -24.06 10.1 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.568 -0.742 . . . . 1.54 111.187 -178.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.243 0.744 0 CA-C-O 118.019 -0.991 . . . . 1.1499999999999999 109.697 176.62 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 26.7 ptt? . . . . . 0 N--CA 1.484 1.24 0 CA-C-O 120.527 0.203 . . . . 7.54 111.148 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 13.5 p -144.83 -80.37 0.17 Allowed 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 120.738 0.304 . . . . 3.0899999999999999 110.664 178.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.495 ' O ' ' HA ' ' A' ' 81' ' ' SER . 12.2 pt-20 -149.22 5.43 0.64 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.136 -0.484 . . . . 2.7999999999999998 111.018 177.507 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 10.9 tptt -84.61 131.62 34.59 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 121.297 0.57 . . . . 1.6899999999999999 109.91 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.534 HD23 ' H ' ' A' ' 9' ' ' ARG . 0.3 OUTLIER -128.21 168.51 15.34 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 114.962 -1.017 . . . . 1.79 109.808 -171.807 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.534 ' H ' HD23 ' A' ' 8' ' ' LEU . 70.1 ttt180 -145.64 125.03 13.07 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.064 -0.717 . . . . 1.3700000000000001 109.064 174.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.52 ' N ' ' HZ ' ' A' ' 80' ' ' PHE . . . -145.93 160.57 41.64 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.353 -0.539 . . . . 1.0700000000000001 112.003 -177.726 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.551 ' HA ' ' HA ' ' A' ' 76' ' ' ASP . . . -106.65 131.66 53.53 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.282 -0.872 . . . . 1.04 109.573 178.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 22.5 p-80 -133.54 140.1 46.99 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.995 0.426 . . . . 0.34000000000000002 111.115 -173.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.68 ' O ' ' HA ' ' A' ' 112' ' ' HIS . 5.9 tt -113.24 137.54 51.32 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.852 -0.796 . . . . 1.0600000000000001 108.852 179.195 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.602 ' HA ' ' O ' ' A' ' 111' ' ' LEU . 23.2 tp -120.8 122.43 40.3 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.892 0.377 . . . . 1.0800000000000001 111.364 -178.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.46 HG21 HD12 ' A' ' 44' ' ' LEU . 57.7 t -108.04 137.69 38.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 109.059 -0.719 . . . . 1.01 109.059 171.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.602 ' HE2' ' OG ' ' A' ' 109' ' ' SER . 28.6 mmtp -105.22 164.33 11.91 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.806 -0.442 . . . . 1.22 109.806 178.616 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 42.9 p90 -155.55 160.57 40.62 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.418 -0.586 . . . . 0.29999999999999999 109.418 -177.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.428 ' HB3' ' C ' ' A' ' 33' ' ' ALA . 54.2 p -58.09 110.3 0.91 Allowed 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.483 -0.326 . . . . 1.6000000000000001 110.557 178.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 105.51 10.16 31.8 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.475 -0.869 . . . . 0.53000000000000003 113.15 -178.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.518 ' C ' ' H ' ' A' ' 22' ' ' ASN . 49.8 p -77.44 37.21 0.21 Allowed 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 117.639 0.719 . . . . 1.28 112.11 -174.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 60.6 ttt180 68.31 -36.17 0.31 Allowed 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.621 0.769 . . . . 4.1600000000000001 111.065 -176.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.518 ' H ' ' C ' ' A' ' 20' ' ' SER . 8.6 p30 -154.68 119.01 2.58 Favored Pre-proline 0 C--N 1.319 -0.731 0 N-CA-C 107.757 -1.201 . . . . 1.77 107.757 171.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -81.99 -151.72 0.04 OUTLIER 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 122.528 2.152 . . . . 1.71 111.885 -174.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.576 ' N ' HG23 ' A' ' 32' ' ' THR . 48.0 t 64.06 111.17 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 123.329 0.652 . . . . 1.1599999999999999 111.588 -175.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.473 ' HB3' ' HB2' ' A' ' 16' ' ' LYS . 35.7 p -103.93 152.92 21.4 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.377 -0.374 . . . . 1.4299999999999999 110.115 177.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.561 ' HG2' ' HA ' ' A' ' 67' ' ' ASP . 3.8 mmp_? -65.34 -12.01 47.68 Favored 'General case' 0 N--CA 1.462 0.159 0 N-CA-C 109.522 -0.547 . . . . 3.1200000000000001 109.522 172.256 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.534 ' HG3' ' CD ' ' A' ' 65' ' ' ARG . 31.5 ttp180 -67.79 -55.82 11.57 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.377 -0.828 . . . . 2.25 110.01 177.115 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 31.8 p -87.83 -34.11 18.35 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 121.446 0.641 . . . . 1.1299999999999999 110.63 -176.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 70.12 16.89 73.37 Favored Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 115.292 -0.867 . . . . 0.81999999999999995 111.962 -179.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -144.79 -68.41 0.31 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.582 0.229 . . . . 2.1000000000000001 110.548 -178.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.8 p -150.14 147.19 27.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.967 0.413 . . . . 1.3300000000000001 111.61 179.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.576 HG23 ' N ' ' A' ' 24' ' ' VAL . 9.6 t -127.51 16.16 7.06 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.67 0.748 . . . . 1.02 109.943 174.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.428 ' C ' ' HB3' ' A' ' 18' ' ' SER . . . -67.77 -4.34 12.16 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.126 -0.943 . . . . 1.1299999999999999 112.973 -178.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -95.07 -25.5 16.43 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.091 0.472 . . . . 2.21 110.968 -179.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.471 HG22 ' HB2' ' A' ' 39' ' ' ASP . 0.2 OUTLIER -95.6 135.06 30.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.097 -0.501 . . . . 1.1100000000000001 110.277 -178.364 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 63.4 p -93.36 178.22 5.79 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 109.548 -0.538 . . . . 1.2 109.548 -176.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.492 ' O ' HG13 ' A' ' 41' ' ' ILE . 0.1 OUTLIER -67.05 -22.25 65.87 Favored 'General case' 0 C--O 1.22 -0.463 0 C-N-CA 118.809 -1.156 . . . . 2.21 110.12 174.045 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -71.86 -46.97 56.1 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.975 -0.38 . . . . 0.95999999999999996 109.975 175.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.471 ' HB2' HG22 ' A' ' 35' ' ' VAL . 24.9 m-20 -64.19 -35.72 81.71 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.612 0.72 . . . . 0.91000000000000003 109.636 175.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.83 -47.4 66.12 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.888 -1.051 . . . . 1.03 110.788 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.492 HG13 ' O ' ' A' ' 37' ' ' TYR . 60.9 mt -63.02 -35.47 71.75 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.388 0 N-CA-C 110.001 -0.37 . . . . 1.0800000000000001 110.001 176.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.468 ' O ' ' HG3' ' A' ' 46' ' ' LYS . 27.8 ttpt -61.63 -28.69 69.55 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 121.3 0.572 . . . . 2.8399999999999999 109.695 179.424 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -88.6 -48.48 7.53 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.392 -0.822 . . . . 1.02 110.352 -177.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.463 HD11 HG12 ' A' ' 113' ' ' ILE . 29.3 tp -59.57 -36.99 77.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.002 -0.545 . . . . 1.02 110.366 -178.529 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.453 HE21 ' HA ' ' A' ' 45' ' ' GLN . 0.0 OUTLIER -67.97 -21.48 65.07 Favored 'General case' 0 N--CA 1.462 0.134 0 N-CA-C 112.114 0.413 . . . . 0.87 112.114 -179.042 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.468 ' HG3' ' O ' ' A' ' 42' ' ' LYS . 67.8 mttm -82.97 -44.62 15.08 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.929 -0.397 . . . . 1.98 109.929 177.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 43.2 m95 -65.63 -45.38 83.25 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.299 -0.409 . . . . 0.60999999999999999 111.181 177.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.441 ' HB3' HG21 ' A' ' 113' ' ' ILE . 97.1 p -65.24 -20.4 66.41 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.885 -0.413 . . . . 0.88 109.885 178.191 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -76.34 -56.6 4.49 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 109.541 -0.54 . . . . 0.55000000000000004 109.541 173.693 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.507 ' HB3' HG22 ' A' ' 56' ' ' VAL . 92.5 mtt180 -59.88 -43.09 94.93 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.724 -0.671 . . . . 0.47999999999999998 111.808 -176.443 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.46 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 95.3 mt -60.46 -33.64 55.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 120.985 0.421 . . . . 1.04 110.57 177.279 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -81.42 -38.75 25.99 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.102 -0.499 . . . . 1.0600000000000001 111.317 -179.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 26.7 p -75.99 -29.56 58.25 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.002 0.429 . . . . 0.34999999999999998 111.135 -178.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 106.33 6.54 36.09 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.869 -0.682 . . . . 0.33000000000000002 111.962 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.454 ' HB2' ' HB3' ' A' ' 50' ' ' ARG . 43.2 mt-10 -63.44 -45.65 89.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.809 0.338 . . . . 0.65000000000000002 110.376 178.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.507 HG22 ' HB3' ' A' ' 50' ' ' ARG . 12.7 m -136.73 155.9 34.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 109.562 -0.533 . . . . 1.05 109.562 172.548 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 13.0 m -83.28 159.61 21.88 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.431 -0.581 . . . . 1.3100000000000001 109.431 178.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -56.23 -40.68 74.47 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.544 -0.539 . . . . 0.25 109.544 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -52.12 -50.15 62.25 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.342 -0.844 . . . . 1.72 111.493 178.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -62.18 -46.76 87.52 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.852 -0.613 . . . . 2.0899999999999999 111.392 -173.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -71.1 -40.86 71.26 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.79 0.329 . . . . 1.0700000000000001 111.066 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -64.64 -45.92 84.75 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.445 -0.343 . . . . 1.0600000000000001 111.777 -176.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.48 ' HA ' ' O ' ' A' ' 71' ' ' TYR . 41.9 t -56.63 -27.43 58.35 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 112.658 0.614 . . . . 1.52 112.658 -177.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.471 ' O ' ' HA ' ' A' ' 27' ' ' ARG . 36.4 mt-30 -104.92 -48.58 3.71 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.378 0.609 . . . . 0.60999999999999999 110.632 -176.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.534 ' CD ' ' HG3' ' A' ' 27' ' ' ARG . 21.5 mmt180 -88.66 -41.75 12.43 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.134 -0.939 . . . . 0.95999999999999996 113.174 -169.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.5 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 22.8 t -60.62 122.25 14.23 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.701 0.286 . . . . 1.0600000000000001 111.189 -177.561 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.561 ' HA ' ' HG2' ' A' ' 26' ' ' ARG . 31.6 t70 -80.18 -7.61 59.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.382 0.61 . . . . 2.2799999999999998 110.639 176.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.492 ' SG ' ' HE1' ' A' ' 112' ' ' HIS . 1.5 m -76.83 160.71 29.03 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.293 0.568 . . . . 2.0499999999999998 110.082 177.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -67.77 -11.53 60.53 Favored Glycine 0 N--CA 1.45 -0.423 0 CA-C-N 114.785 -1.098 . . . . 0.29999999999999999 112.554 -172.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 76.5 p -75.01 -5.69 45.38 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 111.518 0.192 . . . . 0.46999999999999997 111.518 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.48 ' O ' ' HA ' ' A' ' 63' ' ' SER . 16.8 p90 -54.91 -37.86 66.9 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.156 0.503 . . . . 0.94999999999999996 110.027 175.143 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -95.37 7.54 45.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.146 -0.479 . . . . 1.1100000000000001 110.591 -178.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.9 m -113.54 -14.82 12.64 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.959 -0.564 . . . . 0.70999999999999996 110.998 -177.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 103.5 14.39 25.78 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.775 -0.726 . . . . 0.67000000000000004 112.235 -177.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 88.49 -31.18 4.96 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.995 -0.621 . . . . 0.42999999999999999 112.428 179.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.551 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 8.5 p-10 -85.06 144.61 28.14 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-O 121.579 0.704 . . . . 1.6499999999999999 111.099 -176.217 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.524 ' O ' ' HG3' ' A' ' 9' ' ' ARG . 0.7 OUTLIER -106.4 176.98 4.99 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 114.631 -1.168 . . . . 1.6899999999999999 109.979 177.54 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -90.42 -125.4 3.02 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.928 -0.653 . . . . 0.45000000000000001 113.006 -176.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 34.3 p90 -98.3 136.32 38.64 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.128 0.489 . . . . 4.7400000000000002 110.96 -177.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.52 ' HZ ' ' N ' ' A' ' 10' ' ' ALA . 5.9 p90 -159.44 144.83 15.8 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.053 -0.721 . . . . 1.6499999999999999 109.053 179.09 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.495 ' HA ' ' O ' ' A' ' 6' ' ' GLU . 4.0 p -94.02 154.51 17.61 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 120.994 0.426 . . . . 1.6899999999999999 110.497 -177.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 15.2 m -64.85 111.43 2.81 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.951 -0.568 . . . . 1.55 110.117 179.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.563 ' H ' ' HG3' ' A' ' 90' ' ' GLU . . . 113.46 5.18 22.96 Favored Glycine 0 N--CA 1.447 -0.578 0 CA-C-N 115.601 -0.727 . . . . 0.79000000000000004 111.454 -174.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -111.77 32.84 5.15 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 121.493 0.664 . . . . 1.5800000000000001 110.366 -177.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 22.1 mmt -137.41 -122.02 0.14 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.068 -0.515 . . . . 1.1299999999999999 110.277 179.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 63.8 mtt -121.1 155.1 35.18 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.293 -1.002 . . . . 1.8899999999999999 108.293 174.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.421 ' HB2' ' HD3' ' A' ' 88' ' ' PRO . 29.9 mmmt -53.15 -58.11 13.77 Favored Pre-proline 0 C--N 1.322 -0.598 0 N-CA-C 112.393 0.516 . . . . 2.7400000000000002 112.393 -177.396 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.421 ' HD3' ' HB2' ' A' ' 87' ' ' LYS . 77.1 Cg_endo -75.61 -23.7 12.58 Favored 'Trans proline' 0 C--N 1.354 0.838 0 C-N-CA 121.516 1.477 . . . . 0.29999999999999999 111.931 -175.47 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.608 ' O ' HG21 ' A' ' 93' ' ' VAL . 52.7 t80 -71.64 -56.15 6.38 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.472 -0.786 . . . . 0.28000000000000003 109.762 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.563 ' HG3' ' H ' ' A' ' 83' ' ' GLY . 4.6 tm-20 -67.08 -37.19 83.55 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.647 -0.706 . . . . 2.1200000000000001 110.192 -179.026 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -51.98 -36.01 48.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.687 -0.688 . . . . 0.60999999999999999 110.491 174.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.513 ' O ' ' HG ' ' A' ' 96' ' ' LEU . . . -79.63 -32.95 41.78 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.998 -0.546 . . . . 1.1000000000000001 111.419 178.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.608 HG21 ' O ' ' A' ' 89' ' ' PHE . 25.9 t -67.4 -39.74 83.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.564 0.697 . . . . 1.1200000000000001 110.121 -176.247 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.452 ' C ' ' HD2' ' A' ' 94' ' ' ARG . 0.2 OUTLIER -84.04 -8.0 59.24 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.421 -0.809 . . . . 3.1800000000000002 110.841 179.644 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -88.35 0.77 55.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.296 -0.411 . . . . 1.0800000000000001 111.067 -177.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.545 ' HB2' ' HB2' ' A' ' 100' ' ' ASP . 0.6 OUTLIER -139.36 157.29 46.13 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.1 -0.5 . . . . 1.1200000000000001 110.625 179.446 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.571 ' HG2' ' H ' ' A' ' 98' ' ' ILE . 10.7 tttt -102.53 -175.0 2.7 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.161 -0.681 . . . . 2.1299999999999999 109.161 176.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.571 ' H ' ' HG2' ' A' ' 97' ' ' LYS . 1.3 mp -54.67 120.34 2.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 C-N-CA 123.087 0.555 . . . . 1.6200000000000001 110.584 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 93.18 1.21 67.13 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.812 -0.709 . . . . 0.46000000000000002 113.078 176.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.545 ' HB2' ' HB2' ' A' ' 96' ' ' LEU . 33.4 m-20 -102.17 139.63 37.53 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 117.006 0.403 . . . . 0.46000000000000002 110.411 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 11.9 mt -111.3 148.92 14.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.01 -0.541 . . . . 1.0800000000000001 110.239 -178.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 97.7 p -93.3 158.67 36.71 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 116.404 -0.362 . . . . 1.45 110.725 -178.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -71.42 170.0 19.49 Favored 'Trans proline' 0 C--O 1.234 0.285 0 C-N-CA 122.475 2.117 . . . . 0.40999999999999998 111.518 172.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 19.5 mm -47.33 112.12 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 O-C-N 123.399 0.437 . . . . 1.04 111.911 175.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 58.9 t -116.75 122.65 70.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.155 -0.475 . . . . 1.6599999999999999 110.201 176.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -85.78 149.35 25.33 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.032 0.444 . . . . 0.55000000000000004 110.102 176.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 8.1 p -127.77 -172.24 2.63 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.797 -0.638 . . . . 1.05 111.018 -177.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -52.26 -40.75 62.13 Favored 'General case' 0 CA--C 1.518 -0.277 0 O-C-N 123.418 0.449 . . . . 2.1600000000000001 111.276 176.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.602 ' OG ' ' HE2' ' A' ' 16' ' ' LYS . 8.8 t -100.3 -60.53 1.51 Allowed 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 120.196 -0.601 . . . . 1.0900000000000001 111.323 -178.324 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -146.03 -137.13 3.02 Favored Glycine 0 N--CA 1.44 -1.034 0 C-N-CA 118.673 -1.727 . . . . 0.39000000000000001 113.733 -172.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.602 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 6.9 mp -109.65 143.16 39.79 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 114.87 -0.665 . . . . 1.0600000000000001 111.164 -170.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . 0.68 ' HA ' ' O ' ' A' ' 13' ' ' LEU . 85.6 m-70 -143.21 138.49 29.72 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.6 0.593 . . . . 0.25 112.6 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.463 HG12 HD11 ' A' ' 44' ' ' LEU . 3.9 pt -120.96 138.86 50.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 107.753 -1.203 . . . . 1.03 107.753 161.068 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 2.9 mp -129.43 143.09 42.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 C-N-CA 120.807 -0.357 . . . . 1.0600000000000001 110.48 -175.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.48 ' HG2' ' HB3' ' A' ' 11' ' ' ALA . 48.8 pttt -127.51 138.57 52.96 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.187 -0.671 . . . . 1.29 109.187 173.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . 0.485 ' HB2' ' CD1' ' A' ' 96' ' ' LEU . 70.4 ttt180 -84.22 128.38 34.53 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.051 0.453 . . . . 2.6800000000000002 111.545 -175.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.401 HD21 ' HB1' ' A' ' 11' ' ' ALA . 1.2 mm? -95.12 -45.46 7.2 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.613 -0.721 . . . . 1.54 109.999 176.57 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.892 0 CA-C-O 118.58 -0.724 . . . . 1.1499999999999999 110.379 -179.97 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 22.7 ptm . . . . . 0 N--CA 1.482 1.17 0 CA-C-O 121.471 0.653 . . . . 7.54 110.839 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 12.2 p -78.53 -53.51 7.14 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.087 -0.506 . . . . 3.0899999999999999 110.383 179.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -98.29 -18.84 18.15 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.079 -0.51 . . . . 2.7999999999999998 110.038 177.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 43.2 mmtm -76.21 131.28 39.22 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.789 -0.641 . . . . 1.6899999999999999 111.305 -177.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.527 HD22 ' H ' ' A' ' 9' ' ' ARG . 1.3 tt -124.8 165.82 17.32 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 107.413 -1.329 . . . . 1.79 107.413 178.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.527 ' H ' HD22 ' A' ' 8' ' ' LEU . 65.9 ttt180 -143.78 127.68 17.35 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 118.11 0.414 . . . . 1.3700000000000001 110.097 177.21 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -150.11 151.5 33.26 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.03 0.443 . . . . 1.0700000000000001 111.772 -179.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.408 ' N ' HD22 ' A' ' 117' ' ' LEU . . . -102.0 138.04 39.49 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.64 -0.709 . . . . 1.04 109.114 176.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 33.5 p-80 -138.08 153.34 49.31 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 120.564 -0.454 . . . . 0.34000000000000002 111.842 -171.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.559 HD21 ' N ' ' A' ' 14' ' ' LEU . 5.2 tt -120.69 145.44 47.46 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.508 -0.923 . . . . 1.0600000000000001 108.508 176.116 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.585 ' O ' ' HA ' ' A' ' 66' ' ' SER . 31.2 tp -131.0 118.2 20.27 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.59 0.233 . . . . 1.0800000000000001 110.962 -177.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.455 HG23 HD13 ' A' ' 44' ' ' LEU . 58.5 t -104.72 133.17 49.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 N-CA-C 109.607 -0.516 . . . . 1.01 109.607 176.182 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.455 ' HE3' HD23 ' A' ' 14' ' ' LEU . 32.2 mmtp -105.53 138.26 42.01 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.998 -0.547 . . . . 1.22 109.881 177.496 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.516 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 40.0 p90 -131.1 163.28 28.0 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.845 -0.616 . . . . 0.29999999999999999 109.344 178.46 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 43.8 p -53.16 109.5 0.43 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.109 0.481 . . . . 1.6000000000000001 110.269 176.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 108.07 7.94 30.23 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.637 -0.792 . . . . 0.53000000000000003 113.132 -177.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.748 ' HB3' ' O ' ' A' ' 109' ' ' SER . 74.5 m -84.46 38.76 0.7 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 117.042 0.421 . . . . 1.28 111.749 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 32.3 ttt85 72.86 -34.0 0.28 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.306 0.643 . . . . 4.1600000000000001 110.944 179.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.473 ' H ' ' C ' ' A' ' 20' ' ' SER . 6.3 p30 -145.08 111.51 4.75 Favored Pre-proline 0 C--N 1.325 -0.482 0 N-CA-C 109.175 -0.676 . . . . 1.77 109.175 171.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.441 ' C ' HG22 ' A' ' 32' ' ' THR . 91.8 Cg_endo -82.62 59.8 7.0 Favored 'Trans proline' 0 CA--C 1.533 0.467 0 C-N-CA 122.92 2.413 . . . . 1.71 113.889 -173.19 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.437 ' N ' HG22 ' A' ' 32' ' ' THR . 43.9 t -145.99 120.81 2.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 109.385 -0.598 . . . . 1.1599999999999999 109.385 175.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 37.7 t -104.73 152.19 22.83 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 110.299 -0.26 . . . . 1.4299999999999999 110.299 178.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.57 ' HG2' ' HA ' ' A' ' 67' ' ' ASP . 5.5 mmp_? -67.72 -9.81 47.04 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.275 0.559 . . . . 3.1200000000000001 109.764 171.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.548 ' HG3' ' CD ' ' A' ' 65' ' ' ARG . 13.8 ttp180 -76.36 -35.86 58.49 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.369 -0.832 . . . . 2.25 109.78 177.618 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 64.1 p -105.07 -35.44 7.63 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.896 -0.593 . . . . 1.1299999999999999 111.048 -175.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 84.75 -39.49 2.95 Favored Glycine 0 N--CA 1.451 -0.343 0 CA-C-N 115.683 -0.69 . . . . 0.81999999999999995 112.817 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.449 ' CG ' ' H ' ' A' ' 31' ' ' SER . 8.7 p-10 -91.72 -65.59 1.0 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.747 0.273 . . . . 2.1000000000000001 110.874 -178.032 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.449 ' H ' ' CG ' ' A' ' 30' ' ' ASP . 11.6 p -155.53 157.79 37.43 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.618 0.247 . . . . 1.3300000000000001 110.465 178.702 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.441 HG22 ' C ' ' A' ' 23' ' ' PRO . 13.4 t -121.76 34.44 5.18 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 122.308 1.051 . . . . 1.02 109.148 173.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -79.31 -5.99 55.71 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.853 -1.067 . . . . 1.1299999999999999 112.146 -173.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -98.1 -24.92 15.11 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.887 0.375 . . . . 2.21 111.156 -178.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.433 HG11 ' OG1' ' A' ' 32' ' ' THR . 0.3 OUTLIER -91.43 135.73 26.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 120.975 0.417 . . . . 1.1100000000000001 109.916 -178.795 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 65.7 p -94.5 179.03 5.41 Favored 'General case' 0 CA--C 1.513 -0.476 0 N-CA-C 109.583 -0.525 . . . . 1.2 109.583 -175.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.552 ' O ' HG13 ' A' ' 41' ' ' ILE . 8.1 p90 -64.82 -26.26 68.26 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 119.803 -0.759 . . . . 2.21 109.31 176.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -74.83 -44.35 49.73 Favored 'General case' 0 C--N 1.334 -0.087 0 CA-C-N 116.205 -0.452 . . . . 0.95999999999999996 110.629 177.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.422 ' HB2' HG22 ' A' ' 35' ' ' VAL . 45.7 m-20 -64.68 -32.64 74.4 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.642 0.734 . . . . 0.91000000000000003 109.435 177.001 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.516 ' HB2' ' HB3' ' A' ' 17' ' ' PHE . . . -71.07 -38.6 72.45 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.77 -1.104 . . . . 1.03 110.645 178.362 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.552 HG13 ' O ' ' A' ' 37' ' ' TYR . 77.2 mt -65.09 -36.83 78.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.486 -0.561 . . . . 1.0800000000000001 109.486 173.213 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.466 ' HB3' ' HZ1' ' A' ' 42' ' ' LYS . 9.2 mtpm? -65.53 -17.78 64.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.249 0.547 . . . . 2.8399999999999999 110.774 176.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.521 ' HG3' ' CD1' ' A' ' 47' ' ' TRP . 3.8 tp10 -87.69 -61.22 1.77 Allowed 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.978 -0.749 . . . . 1.02 108.978 175.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.473 HD12 HG12 ' A' ' 113' ' ' ILE . 20.9 tp -58.95 -38.12 78.3 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 114.84 -1.073 . . . . 1.02 111.572 -173.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.532 ' HB2' ' O ' ' A' ' 41' ' ' ILE . 3.8 mm-40 -68.8 -29.7 68.12 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 112.276 0.473 . . . . 0.87 112.276 -177.048 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 64.4 mttm -81.58 -38.44 26.1 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 120.501 -0.48 . . . . 1.98 110.223 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.521 ' CD1' ' HG3' ' A' ' 43' ' ' GLU . 35.4 m95 -67.48 -46.54 72.68 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.198 -0.455 . . . . 0.60999999999999999 111.536 175.462 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.477 ' HB3' HG23 ' A' ' 113' ' ' ILE . 94.3 p -63.77 -30.06 71.2 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.848 -0.427 . . . . 0.88 109.848 177.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.427 ' HB2' ' O ' ' A' ' 45' ' ' GLN . 11.9 tt0 -65.29 -53.55 42.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.907 -0.588 . . . . 0.55000000000000004 110.529 174.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.5 ' HB3' HG22 ' A' ' 56' ' ' VAL . 99.4 mtt180 -66.04 -39.49 90.2 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.04 -0.527 . . . . 0.47999999999999998 111.769 -176.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.46 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 99.3 mt -62.45 -34.31 63.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.207 0.527 . . . . 1.04 110.236 176.001 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -77.65 -34.98 52.95 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.891 -0.595 . . . . 1.0600000000000001 111.55 179.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.412 ' OG ' ' HA ' ' A' ' 50' ' ' ARG . 33.1 p -82.04 -29.28 32.01 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.963 0.411 . . . . 0.34999999999999998 111.067 -179.053 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 103.65 9.28 38.33 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 121.027 -0.606 . . . . 0.33000000000000002 112.112 179.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -65.13 -45.14 86.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.158 0.504 . . . . 0.65000000000000002 110.019 177.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.5 HG22 ' HB3' ' A' ' 50' ' ' ARG . 11.3 m -135.02 154.78 36.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 109.141 -0.689 . . . . 1.05 109.141 171.115 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 26.1 m -88.2 160.95 17.5 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.676 -0.491 . . . . 1.3100000000000001 109.676 179.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -53.18 -44.69 68.09 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.125 0.488 . . . . 0.25 110.12 -178.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.648 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 44.1 mt-10 -59.32 -32.45 70.08 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.286 -0.87 . . . . 1.72 112.328 -178.293 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -72.95 -51.74 17.26 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.822 0.344 . . . . 2.0899999999999999 110.921 -177.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -65.76 -42.69 90.58 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.216 -0.447 . . . . 1.0700000000000001 111.029 -178.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.8 -53.38 58.65 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.182 -0.463 . . . . 1.0600000000000001 112.079 -175.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.443 ' HA ' ' O ' ' A' ' 71' ' ' TYR . 23.8 t -53.47 -25.49 16.5 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.665 0.617 . . . . 1.52 112.665 -175.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -102.9 -43.01 5.65 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.406 0.622 . . . . 0.60999999999999999 110.567 -176.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.548 ' CD ' ' HG3' ' A' ' 27' ' ' ARG . 17.3 mmt180 -93.72 -42.36 9.19 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 113.858 1.058 . . . . 0.95999999999999996 113.858 -171.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.585 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 54.6 p -65.92 129.84 41.18 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.625 -0.43 . . . . 1.0600000000000001 110.884 -176.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.57 ' HA ' ' HG2' ' A' ' 26' ' ' ARG . 30.1 t70 -85.18 -12.08 53.52 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.294 0.568 . . . . 2.2799999999999998 111.453 179.59 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.458 ' O ' ' HD1' ' A' ' 71' ' ' TYR . 51.2 t -76.18 157.86 32.27 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.459 -0.571 . . . . 2.0499999999999998 109.459 179.413 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -56.89 -17.02 20.33 Favored Glycine 0 C--N 1.33 0.228 0 CA-C-N 115.189 -0.914 . . . . 0.29999999999999999 113.09 -174.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.409 ' HB2' ' HA2' ' A' ' 75' ' ' GLY . 57.3 p -63.21 -12.88 31.64 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 111.885 0.328 . . . . 0.46999999999999997 111.885 176.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.458 ' HD1' ' O ' ' A' ' 68' ' ' CYS . 27.3 p90 -57.84 -28.77 64.4 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.996 0.427 . . . . 0.94999999999999996 110.198 176.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -88.84 -1.75 58.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.307 0.575 . . . . 1.1100000000000001 110.365 -178.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 5.3 m -125.38 8.17 7.78 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.554 -0.748 . . . . 0.70999999999999996 110.562 -177.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.648 ' O ' ' HA ' ' A' ' 59' ' ' GLU . . . 73.05 29.72 64.3 Favored Glycine 0 CA--C 1.52 0.371 0 CA-C-N 116.041 -0.527 . . . . 0.67000000000000004 113.118 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.409 ' HA2' ' HB2' ' A' ' 70' ' ' SER . . . 81.22 -21.16 6.16 Favored Glycine 0 C--O 1.233 0.088 0 C-N-CA 120.94 -0.648 . . . . 0.42999999999999999 112.236 178.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -71.01 132.15 44.72 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 122.853 0.461 . . . . 1.6499999999999999 110.772 -175.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.401 HD21 ' HE2' ' A' ' 85' ' ' MET . 3.5 mp -116.02 158.98 22.29 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 121.26 0.552 . . . . 1.6899999999999999 109.885 173.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -86.1 -148.36 11.54 Favored Glycine 0 C--N 1.308 -0.99 0 CA-C-N 114.623 -1.171 . . . . 0.45000000000000001 112.347 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -80.26 135.46 36.25 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.314 0.578 . . . . 4.7400000000000002 111.462 -179.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -148.02 141.3 25.16 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.249 -0.887 . . . . 1.6499999999999999 109.898 177.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 48.2 m -66.7 129.44 39.87 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 120.813 0.34 . . . . 1.6899999999999999 110.201 177.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.4 p -52.25 116.21 2.11 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.779 -0.646 . . . . 1.55 111.216 178.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 114.31 -5.89 23.24 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.967 -0.635 . . . . 0.79000000000000004 112.12 -177.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -91.21 34.27 0.94 Allowed 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 121.158 0.504 . . . . 1.5800000000000001 110.885 -179.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.401 ' HE2' HD21 ' A' ' 77' ' ' LEU . 25.3 mmt -131.05 -123.16 0.21 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.908 0.385 . . . . 1.1299999999999999 110.411 179.307 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 65.0 mtt -122.92 157.79 31.82 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.665 -0.865 . . . . 1.8899999999999999 108.665 174.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.479 ' HB3' ' HD3' ' A' ' 88' ' ' PRO . 45.1 tttm -54.39 -55.6 35.58 Favored Pre-proline 0 C--N 1.321 -0.633 0 N-CA-C 112.223 0.453 . . . . 2.7400000000000002 112.223 -174.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.479 ' HD3' ' HB3' ' A' ' 87' ' ' LYS . 91.8 Cg_endo -77.51 -24.06 9.36 Favored 'Trans proline' 0 C--N 1.357 0.986 0 C-N-CA 121.655 1.57 . . . . 0.29999999999999999 111.97 -176.314 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.576 ' O ' HG22 ' A' ' 93' ' ' VAL . 14.7 t80 -67.94 -55.52 12.45 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.672 -0.695 . . . . 0.28000000000000003 109.162 177.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.408 ' OE2' ' HD2' ' A' ' 94' ' ' ARG . 1.2 tm-20 -63.05 -34.99 78.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.282 -0.872 . . . . 2.1200000000000001 109.859 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.631 ' HA ' ' CZ ' ' A' ' 94' ' ' ARG . 14.7 t70 -51.34 -41.66 60.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.312 -0.858 . . . . 0.60999999999999999 111.365 175.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.617 ' O ' ' HG ' ' A' ' 96' ' ' LEU . . . -77.84 -29.72 50.65 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.274 -0.421 . . . . 1.1000000000000001 111.318 -179.213 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.576 HG22 ' O ' ' A' ' 89' ' ' PHE . 41.1 t -63.1 -49.36 83.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.281 -0.418 . . . . 1.1200000000000001 111.661 -173.497 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.631 ' CZ ' ' HA ' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -83.47 -2.81 56.77 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.17 -0.612 . . . . 3.1800000000000002 110.551 -179.233 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -86.2 -16.86 36.44 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.299 -0.41 . . . . 1.0800000000000001 111.219 -178.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.617 ' HG ' ' O ' ' A' ' 92' ' ' ALA . 0.6 OUTLIER -119.21 147.04 44.68 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.243 -0.435 . . . . 1.1200000000000001 110.829 -179.519 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.516 ' HA ' ' NH2' ' A' ' 116' ' ' ARG . 22.5 tptm -82.34 163.13 21.95 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.495 -0.558 . . . . 2.1299999999999999 109.495 177.182 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.46 HD12 ' H ' ' A' ' 98' ' ' ILE . 1.3 mp -38.05 118.09 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 O-C-N 123.369 0.418 . . . . 1.6200000000000001 110.644 169.276 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 94.71 -6.36 70.31 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.823 -0.703 . . . . 0.46000000000000002 113.699 176.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.54 ' HB2' ' HB2' ' A' ' 96' ' ' LEU . 44.8 m-20 -94.59 141.89 28.07 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 117.453 0.627 . . . . 0.46000000000000002 110.419 178.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 9.9 mt -110.26 148.76 13.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.095 -0.502 . . . . 1.0800000000000001 110.212 -178.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 88.5 p -93.85 146.46 31.75 Favored Pre-proline 0 C--N 1.319 -0.718 0 CA-C-N 116.315 -0.402 . . . . 1.45 110.615 -179.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -68.8 163.27 37.93 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 122.213 1.942 . . . . 0.40999999999999998 110.821 171.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.476 HG13 ' HG2' ' A' ' 45' ' ' GLN . 22.6 mm -39.86 109.86 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 O-C-N 123.774 0.672 . . . . 1.04 112.639 -178.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.0 p -115.35 120.5 64.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.991 -0.55 . . . . 1.6599999999999999 109.774 175.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -85.56 152.09 23.42 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.267 0.556 . . . . 0.55000000000000004 110.934 -179.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 14.6 p -131.74 -173.61 3.18 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.293 -0.867 . . . . 1.05 110.076 178.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -72.3 -22.24 61.22 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.534 0.207 . . . . 2.1600000000000001 111.457 178.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.748 ' O ' ' HB3' ' A' ' 20' ' ' SER . 7.8 t -110.23 -6.35 15.07 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.348 -0.541 . . . . 1.0900000000000001 112.021 -176.336 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 157.14 -131.91 3.07 Favored Glycine 0 N--CA 1.436 -1.327 0 C-N-CA 119.902 -1.142 . . . . 0.39000000000000001 112.545 169.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.43 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 5.0 mp -118.17 143.17 46.72 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 114.925 -0.637 . . . . 1.0600000000000001 111.192 -171.494 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . 0.567 ' NE2' HD12 ' A' ' 14' ' ' LEU . 86.9 m-70 -139.28 150.04 44.98 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.695 0.628 . . . . 0.25 112.695 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.477 HG23 ' HB3' ' A' ' 48' ' ' SER . 2.6 pt -132.31 140.17 48.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 107.615 -1.254 . . . . 1.03 107.615 159.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 2.7 mp -131.9 147.58 32.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 C-N-CA 120.948 -0.301 . . . . 1.0600000000000001 110.327 -176.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 35.9 pttt -130.08 139.13 50.99 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.557 -0.905 . . . . 1.29 108.557 172.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . 0.516 ' NH2' ' HA ' ' A' ' 97' ' ' LYS . 5.9 ttp180 -80.85 132.34 35.46 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.241 -0.584 . . . . 2.6800000000000002 110.967 -179.136 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.408 HD22 ' N ' ' A' ' 11' ' ' ALA . 3.6 mm? -96.18 -40.52 9.15 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.197 -0.911 . . . . 1.54 109.716 177.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.79 0 CA-C-O 118.347 -0.835 . . . . 1.1499999999999999 110.015 -179.733 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 12.0 tpt . . . . . 0 N--CA 1.48 1.061 0 N-CA-C 109.712 -0.477 . . . . 7.54 109.712 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 9.3 p -55.04 -75.96 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 112.249 0.463 . . . . 3.0899999999999999 112.249 -175.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.452 ' O ' ' HA ' ' A' ' 81' ' ' SER . 12.8 pt-20 -94.77 -25.12 16.8 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.992 -0.283 . . . . 2.7999999999999998 110.66 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 66.9 mmtt -74.28 108.76 7.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.365 0.602 . . . . 1.6899999999999999 110.731 177.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.484 HD12 ' CD ' ' A' ' 116' ' ' ARG . 15.6 tp -116.7 173.4 6.65 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.007 -0.997 . . . . 1.79 109.385 -178.319 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.449 ' H ' ' HG ' ' A' ' 8' ' ' LEU . 65.3 ttt180 -146.26 126.56 13.94 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.802 -0.444 . . . . 1.3700000000000001 109.802 178.37 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.443 ' N ' ' HZ ' ' A' ' 80' ' ' PHE . . . -146.56 155.02 42.18 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.085 0.469 . . . . 1.0700000000000001 111.638 -179.477 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -106.05 140.7 38.64 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.519 -0.764 . . . . 1.04 109.401 177.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 50.6 p-80 -139.29 150.45 45.44 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.003 0.43 . . . . 0.34000000000000002 111.341 -173.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.572 ' O ' ' HA ' ' A' ' 112' ' ' HIS . 5.2 tt -118.28 142.75 47.18 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.233 -1.025 . . . . 1.0600000000000001 108.233 176.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.584 HD12 ' NE2' ' A' ' 112' ' ' HIS . 26.6 tp -127.82 121.82 31.09 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.597 0.236 . . . . 1.0800000000000001 110.715 -176.413 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.434 HG22 HD12 ' A' ' 44' ' ' LEU . 97.4 t -112.01 136.61 47.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 116.133 -0.485 . . . . 1.01 109.727 176.032 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.539 ' HE2' ' OG ' ' A' ' 109' ' ' SER . 32.5 mmtp -108.82 164.79 12.07 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.104 -0.498 . . . . 1.22 109.976 177.636 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.486 ' HB3' ' HB1' ' A' ' 40' ' ' ALA . 49.8 p90 -158.65 163.14 37.17 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.992 -0.549 . . . . 0.29999999999999999 110.141 -176.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.49 ' HB3' ' C ' ' A' ' 33' ' ' ALA . 35.8 p -54.13 109.51 0.49 Allowed 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 120.983 0.42 . . . . 1.6000000000000001 110.715 177.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 103.27 9.82 37.95 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.463 -0.875 . . . . 0.53000000000000003 112.841 -178.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.442 ' C ' ' H ' ' A' ' 22' ' ' ASN . 73.5 p -90.12 40.17 0.99 Allowed 'General case' 0 C--O 1.234 0.264 0 CA-C-N 117.338 0.569 . . . . 1.28 111.296 -175.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 50.1 ttt180 75.38 -34.2 0.25 Allowed 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 123.534 0.733 . . . . 4.1600000000000001 110.662 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.442 ' H ' ' C ' ' A' ' 20' ' ' SER . 5.7 p30 -149.6 118.55 3.81 Favored Pre-proline 0 C--N 1.323 -0.55 0 N-CA-C 109.321 -0.622 . . . . 1.77 109.321 173.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.544 ' O ' ' HA ' ' A' ' 31' ' ' SER . 66.2 Cg_endo -86.29 53.33 3.06 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 122.792 2.328 . . . . 1.71 113.353 -172.434 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.488 HG13 ' O ' ' A' ' 30' ' ' ASP . 81.7 t -143.32 121.12 6.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 109.242 -0.651 . . . . 1.1599999999999999 109.242 178.155 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 44.5 t -103.88 152.34 22.06 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.739 -0.467 . . . . 1.4299999999999999 109.739 177.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.62 ' CB ' ' HA ' ' A' ' 67' ' ' ASP . 9.2 tpt180 -73.72 -9.89 59.12 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.241 -0.651 . . . . 3.1200000000000001 109.241 174.038 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.564 ' HG3' ' HD3' ' A' ' 65' ' ' ARG . 13.9 ttp180 -79.94 -38.27 32.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.306 -0.861 . . . . 2.25 109.737 174.057 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 69.9 p -93.74 -34.14 13.34 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.661 -0.699 . . . . 1.1299999999999999 111.09 -175.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 81.83 -39.24 2.55 Favored Glycine 0 N--CA 1.451 -0.361 0 CA-C-N 115.238 -0.892 . . . . 0.81999999999999995 111.428 -177.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.488 ' O ' HG13 ' A' ' 24' ' ' VAL . 31.2 m-20 -107.45 -139.18 0.37 Allowed 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 108.408 -0.96 . . . . 2.1000000000000001 108.408 175.211 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.544 ' HA ' ' O ' ' A' ' 23' ' ' PRO . 2.7 p -75.27 135.11 40.96 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-O 121.27 0.557 . . . . 1.3300000000000001 111.763 -172.438 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.518 HG23 ' C ' ' A' ' 23' ' ' PRO . 12.3 t -106.79 31.26 5.42 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 107.689 -1.226 . . . . 1.02 107.689 168.353 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.49 ' C ' ' HB3' ' A' ' 18' ' ' SER . . . -82.32 -5.14 58.38 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 114.085 -1.416 . . . . 1.1299999999999999 112.178 -172.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -97.22 -22.77 16.51 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 120.938 0.399 . . . . 2.21 110.906 178.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.464 HG22 ' HB2' ' A' ' 39' ' ' ASP . 0.2 OUTLIER -90.4 136.3 24.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 109.574 -0.528 . . . . 1.1100000000000001 109.574 179.148 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 71.6 p -94.31 178.42 5.63 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.954 -0.388 . . . . 1.2 109.954 -176.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.452 ' O ' HG13 ' A' ' 41' ' ' ILE . 7.8 p90 -64.83 -26.24 68.25 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.003 -0.74 . . . . 2.21 109.003 174.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -71.04 -50.97 28.21 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 115.892 -0.594 . . . . 0.95999999999999996 109.896 176.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.464 ' HB2' HG22 ' A' ' 35' ' ' VAL . 11.6 m-20 -59.04 -37.99 78.29 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-O 121.439 0.638 . . . . 0.91000000000000003 109.711 177.199 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.486 ' HB1' ' HB3' ' A' ' 17' ' ' PHE . . . -67.26 -45.68 75.94 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.821 -1.081 . . . . 1.03 110.7 -178.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.476 ' CG1' HD22 ' A' ' 111' ' ' LEU . 68.8 mt -63.05 -36.83 77.5 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 CA-C-N 116.261 -0.427 . . . . 1.0800000000000001 109.986 176.051 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.409 ' HA ' ' HD2' ' A' ' 42' ' ' LYS . 11.1 mmmm -68.55 -17.83 64.23 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 116.107 -0.497 . . . . 2.8399999999999999 110.982 179.567 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.436 ' HG3' ' CD1' ' A' ' 47' ' ' TRP . 1.6 tt0 -88.56 -54.67 4.06 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.8 -0.636 . . . . 1.02 109.666 175.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.478 HD11 HG12 ' A' ' 113' ' ' ILE . 32.4 tp -58.69 -37.19 75.52 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.629 -0.714 . . . . 1.02 110.888 -176.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.436 ' HA ' HD12 ' A' ' 104' ' ' ILE . 3.1 mm-40 -63.77 -40.39 96.57 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.969 0.359 . . . . 0.87 111.969 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -70.5 -41.62 72.42 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 120.919 -0.313 . . . . 1.98 110.969 -177.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.436 ' CD1' ' HG3' ' A' ' 43' ' ' GLU . 39.3 m95 -66.76 -46.1 76.41 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.915 -0.314 . . . . 0.60999999999999999 110.621 176.472 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 33.0 t -57.91 -38.96 76.81 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.676 -0.49 . . . . 0.88 109.676 175.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -61.06 -52.04 66.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.683 -0.69 . . . . 0.55000000000000004 110.888 176.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.518 ' HB3' HG22 ' A' ' 56' ' ' VAL . 87.0 mtt180 -65.75 -41.18 92.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.812 -0.631 . . . . 0.47999999999999998 111.547 -176.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.423 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 96.7 mt -60.49 -38.24 77.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.146 0.498 . . . . 1.04 110.249 175.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.32 -35.24 71.17 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.837 -0.62 . . . . 1.0600000000000001 111.708 178.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 28.2 p -83.97 -31.15 25.7 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.827 0.346 . . . . 0.34999999999999998 111.594 -177.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 107.1 5.25 35.28 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.717 -0.754 . . . . 0.33000000000000002 111.819 -178.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.435 ' HB2' ' HB3' ' A' ' 50' ' ' ARG . 38.8 mt-10 -60.01 -53.18 60.9 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.829 -0.434 . . . . 0.65000000000000002 109.829 176.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.518 HG22 ' HB3' ' A' ' 50' ' ' ARG . 15.8 m -129.81 150.84 35.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 109.292 -0.633 . . . . 1.05 109.292 173.095 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.5 m -80.79 158.39 25.46 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.451 -0.574 . . . . 1.3100000000000001 109.451 179.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.43 ' CD2' ' HD3' ' A' ' 115' ' ' LYS . 2.2 t80 -52.75 -44.15 66.27 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.587 -0.523 . . . . 0.25 109.587 179.494 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.468 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 48.1 mt-10 -56.06 -45.22 79.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.135 -0.939 . . . . 1.72 112.002 179.468 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 34.2 mm-40 -63.85 -47.59 80.13 Favored 'General case' 0 CA--C 1.522 -0.132 0 CA-C-O 120.983 0.42 . . . . 2.0899999999999999 110.808 -175.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -67.76 -46.22 72.68 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.203 -0.453 . . . . 1.0700000000000001 110.767 -179.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.12 -52.63 64.52 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.344 -0.389 . . . . 1.0600000000000001 112.002 -176.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.458 ' HA ' ' O ' ' A' ' 71' ' ' TYR . 33.0 t -51.9 -25.49 8.15 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.856 0.687 . . . . 1.52 112.856 -177.131 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -102.18 -44.63 5.38 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.535 0.683 . . . . 0.60999999999999999 110.456 -179.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.564 ' HD3' ' HG3' ' A' ' 27' ' ' ARG . 21.5 mmt180 -93.64 -39.53 10.76 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 114.334 1.235 . . . . 0.95999999999999996 114.334 -169.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.418 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 59.7 p -63.23 123.75 19.44 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.118 0.485 . . . . 1.0600000000000001 111.059 -176.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.62 ' HA ' ' CB ' ' A' ' 26' ' ' ARG . 17.2 t70 -71.82 -18.8 62.06 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.441 -0.799 . . . . 2.2799999999999998 111.268 177.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 46.6 t -77.1 157.36 31.08 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.54 0.686 . . . . 2.0499999999999998 110.808 -178.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -58.63 -16.47 30.09 Favored Glycine 0 N--CA 1.453 -0.181 0 CA-C-N 114.388 -1.278 . . . . 0.29999999999999999 113.922 -174.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.448 ' HB2' ' CA ' ' A' ' 75' ' ' GLY . 2.6 p -66.17 -4.1 6.94 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 112.287 0.477 . . . . 0.46999999999999997 112.287 176.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.458 ' O ' ' HA ' ' A' ' 63' ' ' SER . 33.0 p90 -56.68 -27.99 59.9 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.112 0.482 . . . . 0.94999999999999996 110.069 175.541 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -92.12 -0.25 57.45 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.387 0.613 . . . . 1.1100000000000001 110.389 -179.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.2 m -124.72 9.32 8.27 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.647 -0.706 . . . . 0.70999999999999996 110.796 -175.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.468 ' O ' ' HA ' ' A' ' 59' ' ' GLU . . . 73.42 31.0 61.56 Favored Glycine 0 CA--C 1.519 0.335 0 C-N-CA 120.884 -0.674 . . . . 0.67000000000000004 112.738 -178.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.448 ' CA ' ' HB2' ' A' ' 70' ' ' SER . . . 76.78 3.09 78.95 Favored Glycine 0 C--O 1.227 -0.325 0 C-N-CA 121.081 -0.58 . . . . 0.42999999999999999 112.217 179.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -97.92 144.35 27.56 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 110.283 -0.266 . . . . 1.6499999999999999 110.283 -168.266 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.7 mp -120.39 171.45 8.52 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.129 -0.487 . . . . 1.6899999999999999 110.276 178.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -91.03 -148.6 21.78 Favored Glycine 0 C--N 1.317 -0.514 0 CA-C-N 115.783 -0.644 . . . . 0.45000000000000001 112.22 -178.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 99.8 m-85 -88.13 123.22 32.58 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.222 0.534 . . . . 4.7400000000000002 110.556 178.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.443 ' HZ ' ' N ' ' A' ' 10' ' ' ALA . 1.6 p90 -134.61 147.13 50.14 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.567 -0.742 . . . . 1.6499999999999999 110.085 -178.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.452 ' HA ' ' O ' ' A' ' 6' ' ' GLU . 21.8 m -80.87 124.08 28.81 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 109.926 -0.398 . . . . 1.6899999999999999 109.926 179.162 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 24.6 m -54.25 119.1 4.69 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.99 -0.55 . . . . 1.55 110.925 -179.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 114.71 13.03 9.78 Favored Glycine 0 N--CA 1.443 -0.883 0 CA-C-N 115.627 -0.715 . . . . 0.79000000000000004 111.794 -178.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -116.56 7.45 13.67 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 111.521 0.193 . . . . 1.5800000000000001 111.521 179.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 24.9 mmt -99.06 -105.44 0.21 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.157 0.503 . . . . 1.1299999999999999 110.807 -179.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 68.9 mtm -142.18 147.38 36.5 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 107.904 -1.147 . . . . 1.8899999999999999 107.904 176.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -48.45 -54.81 22.84 Favored Pre-proline 0 CA--C 1.539 0.552 0 N-CA-C 113.0 0.741 . . . . 2.7400000000000002 113.0 -173.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.421 ' HG2' HG23 ' A' ' 107' ' ' THR . 71.8 Cg_endo -75.43 -27.49 9.29 Favored 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 121.401 1.4 . . . . 0.29999999999999999 111.739 -175.533 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.631 ' O ' HG21 ' A' ' 93' ' ' VAL . 42.4 t80 -72.35 -56.26 5.77 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.23 -0.896 . . . . 0.28000000000000003 109.984 -179.258 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -61.8 -38.28 87.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.462 -0.79 . . . . 2.1200000000000001 110.441 -177.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -60.65 -31.59 70.8 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.454 -0.794 . . . . 0.60999999999999999 110.502 178.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.496 ' O ' ' HG ' ' A' ' 96' ' ' LEU . . . -81.06 -25.98 36.67 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.037 -0.529 . . . . 1.1000000000000001 110.72 178.275 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.631 HG21 ' O ' ' A' ' 89' ' ' PHE . 25.7 t -70.95 -36.05 62.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.421 0.629 . . . . 1.1200000000000001 110.124 -178.465 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.51 ' C ' ' HD2' ' A' ' 94' ' ' ARG . 5.5 ppt_? -85.74 -16.47 38.84 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.679 -0.691 . . . . 3.1800000000000002 110.622 179.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -76.09 -17.07 59.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.012 -0.54 . . . . 1.0800000000000001 111.187 -176.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.561 ' HB2' ' HB2' ' A' ' 100' ' ' ASP . 0.9 OUTLIER -119.61 151.92 37.89 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.143 -0.481 . . . . 1.1200000000000001 110.736 179.443 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.437 ' HA ' ' NH2' ' A' ' 116' ' ' ARG . 23.5 tptm -92.57 167.46 11.91 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.053 -0.721 . . . . 2.1299999999999999 109.053 178.325 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.436 ' HA ' ' HG2' ' A' ' 116' ' ' ARG . 58.8 mt -46.25 115.97 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.851 0.358 . . . . 1.6200000000000001 111.301 173.507 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 100.46 -2.06 56.02 Favored Glycine 0 CA--C 1.521 0.428 0 C-N-CA 120.715 -0.755 . . . . 0.46000000000000002 113.528 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.561 ' HB2' ' HB2' ' A' ' 96' ' ' LEU . 68.1 m-20 -104.53 152.43 22.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 117.412 0.606 . . . . 0.46000000000000002 110.692 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 9.5 mt -121.8 149.11 25.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-O 120.988 0.423 . . . . 1.0800000000000001 110.873 -177.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.423 ' HG ' ' CD2' ' A' ' 96' ' ' LEU . 70.4 m -96.48 150.41 37.03 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 115.896 -0.593 . . . . 1.45 110.491 177.176 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.417 ' O ' HG22 ' A' ' 105' ' ' VAL . 73.5 Cg_endo -74.71 177.91 7.85 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.558 2.172 . . . . 0.40999999999999998 111.188 173.373 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.436 HD12 ' HA ' ' A' ' 45' ' ' GLN . 22.8 mm -44.62 108.28 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 O-C-N 123.501 0.501 . . . . 1.04 112.169 178.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.417 HG22 ' O ' ' A' ' 103' ' ' PRO . 69.6 t -110.98 115.19 49.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.919 -0.582 . . . . 1.6599999999999999 109.59 174.429 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -84.68 147.78 26.75 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.287 0.565 . . . . 0.55000000000000004 110.285 178.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.421 HG23 ' HG2' ' A' ' 88' ' ' PRO . 10.0 p -123.31 -172.81 2.59 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.445 -0.798 . . . . 1.05 110.297 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -64.82 -37.8 88.82 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.63 0.252 . . . . 2.1600000000000001 110.472 178.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.539 ' OG ' ' HE2' ' A' ' 16' ' ' LYS . 9.2 t -86.48 -61.61 1.7 Allowed 'General case' 0 C--O 1.222 -0.391 0 C-N-CA 120.918 -0.313 . . . . 1.0900000000000001 110.419 179.264 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -152.81 -131.04 1.6 Allowed Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 119.163 -1.494 . . . . 0.39000000000000001 113.605 -174.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.476 HD22 ' CG1' ' A' ' 41' ' ' ILE . 6.6 mp -116.03 145.96 42.55 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.425 -0.388 . . . . 1.0600000000000001 111.71 -169.486 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . 0.584 ' NE2' HD12 ' A' ' 14' ' ' LEU . 84.5 m-70 -144.87 142.04 29.59 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.101 0.477 . . . . 0.25 112.274 179.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.478 HG12 HD11 ' A' ' 44' ' ' LEU . 2.8 pt -123.47 140.55 46.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 107.707 -1.22 . . . . 1.03 107.707 159.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 2.6 mp -132.57 150.32 33.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 C-N-CA 120.731 -0.387 . . . . 1.0600000000000001 110.485 -175.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.464 ' HE3' HD21 ' A' ' 117' ' ' LEU . 7.1 pttp -136.24 141.95 43.99 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.494 -0.928 . . . . 1.29 108.494 173.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . 0.484 ' CD ' HD12 ' A' ' 8' ' ' LEU . 5.5 ttp180 -84.36 132.26 34.62 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.477 -0.489 . . . . 2.6800000000000002 110.826 179.374 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.464 HD21 ' HE3' ' A' ' 115' ' ' LYS . 4.1 mm? -99.76 -35.4 9.81 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.21 -0.905 . . . . 1.54 110.281 -178.372 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.893 0 CA-C-O 118.411 -0.804 . . . . 1.1499999999999999 110.165 179.97 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 61.9 mtt . . . . . 0 N--CA 1.483 1.219 0 CA-C-O 121.07 0.462 . . . . 7.54 110.838 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 16.0 p -158.51 172.32 18.53 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.963 -0.562 . . . . 3.0899999999999999 109.821 178.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -147.46 -17.59 0.38 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.502 -0.317 . . . . 2.7999999999999998 110.652 178.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.505 ' HA ' ' O ' ' A' ' 80' ' ' PHE . 42.4 mmtm -76.41 115.54 16.25 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.241 0.544 . . . . 1.6899999999999999 111.258 -178.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.585 ' O ' ' HA ' ' A' ' 79' ' ' PHE . 12.0 tp -118.65 169.8 9.5 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.349 -0.982 . . . . 1.79 108.349 176.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.4 ' HG3' ' O ' ' A' ' 77' ' ' LEU . 56.2 ttt180 -142.79 134.32 26.44 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 117.799 0.272 . . . . 1.3700000000000001 110.301 177.05 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.652 ' O ' ' HB2' ' A' ' 77' ' ' LEU . . . -155.69 154.24 31.23 Favored 'General case' 0 C--O 1.222 -0.364 0 C-N-CA 120.086 -0.646 . . . . 1.0700000000000001 112.063 -177.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.461 ' HB2' ' HG2' ' A' ' 115' ' ' LYS . . . -102.16 132.23 48.19 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.216 -0.661 . . . . 1.04 109.216 178.243 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 12.4 p-80 -133.19 148.77 52.06 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.178 0.513 . . . . 0.34000000000000002 111.768 -172.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.564 HD23 ' N ' ' A' ' 14' ' ' LEU . 5.2 tt -121.4 146.91 46.4 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.41 -0.959 . . . . 1.0600000000000001 108.41 177.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.564 ' N ' HD23 ' A' ' 13' ' ' LEU . 23.4 tp -131.34 132.86 44.78 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 110.091 -0.337 . . . . 1.0800000000000001 110.091 -178.337 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.415 HG21 HD12 ' A' ' 44' ' ' LEU . 58.4 t -123.2 130.67 74.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 O-C-N 123.353 0.408 . . . . 1.01 109.942 175.575 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.458 ' HE3' HD21 ' A' ' 14' ' ' LEU . 33.6 mmtp -104.44 152.44 22.33 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.903 -0.59 . . . . 1.22 110.025 177.073 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.486 ' HB3' ' HB1' ' A' ' 40' ' ' ALA . 42.7 p90 -143.23 162.94 34.3 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.006 -0.543 . . . . 0.29999999999999999 110.477 -177.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 32.6 p -51.84 112.84 0.84 Allowed 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.103 0.478 . . . . 1.6000000000000001 110.892 178.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 97.79 8.51 55.65 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.582 -0.818 . . . . 0.53000000000000003 113.141 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.601 ' HB2' ' O ' ' A' ' 109' ' ' SER . 80.3 p -88.68 45.59 1.3 Allowed 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 117.366 0.583 . . . . 1.28 110.893 -175.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.48 ' HB3' ' O ' ' A' ' 20' ' ' SER . 76.8 ttt180 75.8 -32.5 0.21 Allowed 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 123.175 0.59 . . . . 4.1600000000000001 110.93 -179.021 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.44 ' H ' ' C ' ' A' ' 20' ' ' SER . 3.5 p30 -153.31 109.0 2.61 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-O 121.09 0.471 . . . . 1.77 110.291 174.729 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.417 ' C ' HG23 ' A' ' 32' ' ' THR . 11.3 Cg_exo -73.69 52.86 2.6 Favored 'Trans proline' 0 CA--C 1.534 0.481 0 C-N-CA 123.236 2.624 . . . . 1.71 113.401 -179.338 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.418 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 83.9 t -141.84 116.88 5.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 109.722 -0.473 . . . . 1.1599999999999999 109.722 176.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.509 ' HB2' ' OD1' ' A' ' 67' ' ' ASP . 6.4 p -103.85 151.52 23.0 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 116.535 -0.302 . . . . 1.4299999999999999 110.308 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.665 ' CB ' ' HA ' ' A' ' 67' ' ' ASP . 3.3 tpp180 -69.33 -20.65 63.87 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 108.028 -1.101 . . . . 3.1200000000000001 108.028 173.041 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.433 ' CG ' ' HA ' ' A' ' 65' ' ' ARG . 2.7 tmm_? -69.43 -37.41 77.39 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 114.27 -1.332 . . . . 2.25 110.472 179.002 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 81.1 p -99.29 -36.37 9.65 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.498 0.666 . . . . 1.1299999999999999 110.803 179.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 72.57 -3.84 23.65 Favored Glycine 0 N--CA 1.451 -0.33 0 CA-C-N 115.203 -0.908 . . . . 0.81999999999999995 112.338 -176.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -113.78 -79.22 0.58 Allowed 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.605 -0.517 . . . . 2.1000000000000001 109.605 179.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.418 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 20.2 m -153.77 153.26 31.86 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.73 -0.668 . . . . 1.3300000000000001 109.82 176.296 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.425 ' OG1' HG13 ' A' ' 35' ' ' VAL . 10.2 t -117.52 30.66 7.16 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 122.286 1.041 . . . . 1.02 109.307 177.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -77.03 -5.94 50.72 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.711 -1.131 . . . . 1.1299999999999999 112.514 -176.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -95.74 -25.37 16.11 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.183 0.516 . . . . 2.21 110.651 -179.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.425 HG13 ' OG1' ' A' ' 32' ' ' THR . 0.2 OUTLIER -95.78 134.68 32.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.943 -0.571 . . . . 1.1100000000000001 110.293 -178.886 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 64.7 p -93.0 179.93 5.29 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.181 -0.463 . . . . 1.2 109.873 -175.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.471 ' O ' HG13 ' A' ' 41' ' ' ILE . 9.3 p90 -64.36 -28.47 69.72 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 119.934 -0.707 . . . . 2.21 109.142 175.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -72.13 -48.98 39.69 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 115.968 -0.56 . . . . 0.95999999999999996 110.345 177.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 43.4 m-20 -64.91 -28.78 69.77 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.189 0.518 . . . . 0.91000000000000003 110.161 178.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.486 ' HB1' ' HB3' ' A' ' 17' ' ' PHE . . . -71.36 -43.01 67.74 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.483 -0.78 . . . . 1.03 110.513 176.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.471 HG13 ' O ' ' A' ' 37' ' ' TYR . 87.1 mt -62.8 -35.95 73.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.477 -0.564 . . . . 1.0800000000000001 109.477 174.044 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 35.2 tttm -62.44 -24.52 67.47 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.402 -0.817 . . . . 2.8399999999999999 110.857 176.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.414 ' HG3' ' CD1' ' A' ' 47' ' ' TRP . 0.7 OUTLIER -87.28 -52.47 5.38 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.115 -0.698 . . . . 1.02 109.115 178.845 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.477 HD11 HG12 ' A' ' 113' ' ' ILE . 32.3 tp -63.46 -37.7 88.28 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.202 -0.908 . . . . 1.02 110.695 -173.465 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.46 HE21 ' HA ' ' A' ' 45' ' ' GLN . 0.0 OUTLIER -65.93 -30.7 71.33 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-N 116.152 -0.477 . . . . 0.87 112.133 -176.903 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -74.73 -44.18 51.22 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.941 0.4 . . . . 1.98 110.104 179.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.414 ' CD1' ' HG3' ' A' ' 43' ' ' GLU . 49.2 m95 -67.22 -44.51 79.33 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.205 -0.452 . . . . 0.60999999999999999 111.115 178.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.477 ' HB3' HG22 ' A' ' 113' ' ' ILE . 97.8 p -66.43 -22.29 66.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.83 0.348 . . . . 0.88 110.203 177.147 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.412 ' HB2' ' O ' ' A' ' 45' ' ' GLN . 10.0 tt0 -73.97 -56.95 4.33 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 116.013 -0.54 . . . . 0.55000000000000004 109.986 173.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.518 ' HB3' HG21 ' A' ' 56' ' ' VAL . 96.6 mtt180 -61.85 -41.37 97.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.556 -0.747 . . . . 0.47999999999999998 111.499 -175.102 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.421 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 97.5 mt -60.59 -36.31 69.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.006 0.431 . . . . 1.04 110.434 176.309 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -76.76 -42.7 39.98 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.078 -0.51 . . . . 1.0600000000000001 111.441 179.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 35.3 p -74.4 -29.63 61.6 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.916 0.389 . . . . 0.34999999999999998 111.294 -176.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 107.86 1.44 34.25 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.824 -0.703 . . . . 0.33000000000000002 112.366 -179.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.447 ' HB2' ' HB3' ' A' ' 50' ' ' ARG . 39.0 mt-10 -59.5 -44.41 93.12 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 121.047 0.451 . . . . 0.65000000000000002 110.513 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.518 HG21 ' HB3' ' A' ' 50' ' ' ARG . 13.0 m -137.8 157.55 33.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 109.401 -0.592 . . . . 1.05 109.401 172.16 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 14.5 m -86.43 160.26 19.09 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.348 -0.612 . . . . 1.3100000000000001 109.348 178.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -55.23 -44.25 75.28 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.024 0.44 . . . . 0.25 109.976 -177.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.603 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 50.8 mt-10 -60.54 -35.19 75.42 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.372 -0.831 . . . . 1.72 111.893 -178.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -62.39 -52.9 61.74 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-O 121.055 0.455 . . . . 2.0899999999999999 110.378 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -69.81 -46.32 65.94 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.605 -0.725 . . . . 1.0700000000000001 111.399 -175.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.92 -52.32 65.91 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.439 0.533 . . . . 1.0600000000000001 112.439 -173.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.481 ' HA ' ' O ' ' A' ' 71' ' ' TYR . 67.0 m -51.18 -21.97 2.32 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.993 0.738 . . . . 1.52 112.993 -179.606 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -103.75 -46.53 4.49 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.584 0.707 . . . . 0.60999999999999999 110.148 179.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.433 ' HA ' ' CG ' ' A' ' 27' ' ' ARG . 36.7 mmt-85 -95.63 -36.3 11.28 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 114.271 1.212 . . . . 0.95999999999999996 114.271 -169.097 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.451 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 54.3 p -63.87 114.84 4.32 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.274 0.559 . . . . 1.0600000000000001 110.279 -177.596 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.665 ' HA ' ' CB ' ' A' ' 26' ' ' ARG . 74.6 m-20 -75.57 -9.51 58.64 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.484 -0.78 . . . . 2.2799999999999998 111.632 -177.393 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 36.0 t -85.56 160.74 19.57 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.755 -0.657 . . . . 2.0499999999999998 110.163 178.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -56.28 -18.88 22.76 Favored Glycine 0 CA--C 1.518 0.237 0 CA-C-N 114.465 -1.243 . . . . 0.29999999999999999 114.378 -173.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 60.5 p -65.19 -7.23 11.79 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 112.502 0.556 . . . . 0.46999999999999997 112.502 177.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.481 ' O ' ' HA ' ' A' ' 63' ' ' SER . 32.0 p90 -52.5 -36.56 55.5 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 120.994 0.426 . . . . 0.94999999999999996 110.325 176.713 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -81.06 -1.25 43.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.002 0.429 . . . . 1.1100000000000001 111.039 -177.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 7.7 m -125.01 8.12 8.02 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.103 -0.499 . . . . 0.70999999999999996 110.501 -178.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.603 ' O ' ' HA ' ' A' ' 59' ' ' GLU . . . 75.14 26.24 66.86 Favored Glycine 0 C--O 1.226 -0.35 0 C-N-CA 121.014 -0.612 . . . . 0.67000000000000004 112.622 -179.508 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.49 -20.37 6.18 Favored Glycine 0 N--CA 1.454 -0.149 0 C-N-CA 121.012 -0.613 . . . . 0.42999999999999999 111.937 -179.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.407 ' H ' ' C ' ' A' ' 74' ' ' GLY . 9.3 t70 -68.43 128.6 37.18 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.179 -0.511 . . . . 1.6499999999999999 110.537 -177.359 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.652 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 19.4 mt -108.24 157.53 18.26 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 116.076 -0.511 . . . . 1.6899999999999999 110.065 176.562 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -87.82 -165.31 41.16 Favored Glycine 0 N--CA 1.443 -0.847 0 CA-C-N 115.478 -0.783 . . . . 0.45000000000000001 111.232 174.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.585 ' HA ' ' O ' ' A' ' 8' ' ' LEU . 75.4 m-85 -71.67 133.05 45.4 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.287 0.565 . . . . 4.7400000000000002 111.609 -178.046 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.505 ' O ' ' HA ' ' A' ' 7' ' ' LYS . 21.0 p90 -133.96 160.3 38.12 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.366 -0.834 . . . . 1.6499999999999999 109.399 178.628 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 12.1 m -79.75 123.57 27.81 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 109.032 -0.729 . . . . 1.6899999999999999 109.032 175.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 33.1 m -52.73 117.43 2.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.14 -0.482 . . . . 1.55 110.675 -178.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 113.97 -6.18 23.78 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.734 -0.746 . . . . 0.79000000000000004 112.425 -177.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -97.99 48.18 1.01 Allowed 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.453 0.644 . . . . 1.5800000000000001 110.435 179.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 25.3 mmt -135.58 -101.22 0.22 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.101 -0.5 . . . . 1.1299999999999999 110.502 177.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' MET . . . . . 0.479 ' HB2' ' HB3' ' A' ' 89' ' ' PHE . 48.4 mtt -145.8 149.71 34.85 Favored 'General case' 0 CA--C 1.513 -0.464 0 N-CA-C 107.79 -1.189 . . . . 1.8899999999999999 107.79 177.256 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.425 ' HB3' ' HD3' ' A' ' 88' ' ' PRO . 27.2 ttpp -53.38 -54.79 41.39 Favored Pre-proline 0 C--N 1.322 -0.605 0 N-CA-C 112.134 0.42 . . . . 2.7400000000000002 112.134 -174.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.425 ' HD3' ' HB3' ' A' ' 87' ' ' LYS . 83.4 Cg_endo -76.45 -27.82 7.43 Favored 'Trans proline' 0 C--N 1.356 0.97 0 C-N-CA 121.6 1.533 . . . . 0.29999999999999999 112.061 -176.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.637 ' O ' HG21 ' A' ' 93' ' ' VAL . 34.3 t80 -68.55 -56.59 7.78 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.248 -0.887 . . . . 0.28000000000000003 109.999 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -65.08 -37.08 86.38 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.398 -0.819 . . . . 2.1200000000000001 109.661 -177.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -52.75 -36.02 57.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.173 -0.921 . . . . 0.60999999999999999 110.995 174.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -83.77 -27.32 28.96 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.112 -0.494 . . . . 1.1000000000000001 111.207 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.637 HG21 ' O ' ' A' ' 89' ' ' PHE . 21.8 t -69.92 -48.17 65.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.243 0.544 . . . . 1.1200000000000001 109.947 -177.187 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -73.2 -6.81 48.31 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.446 -0.797 . . . . 3.1800000000000002 110.784 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -82.94 -20.51 35.14 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.865 -0.607 . . . . 1.0800000000000001 110.222 177.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.634 HD23 ' OG ' ' A' ' 102' ' ' SER . 0.8 OUTLIER -89.22 146.33 24.83 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-N 116.198 -0.456 . . . . 1.1200000000000001 109.912 -179.895 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 55.2 tptt -86.49 166.08 15.76 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 106.684 -1.599 . . . . 2.1299999999999999 106.684 163.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 51.8 mt -55.24 115.32 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 120.77 0.319 . . . . 1.6200000000000001 110.368 179.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 102.64 10.94 36.7 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.51 -0.852 . . . . 0.46000000000000002 113.559 -178.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.614 ' HB2' ' HB3' ' A' ' 96' ' ' LEU . 8.9 m-20 -108.08 149.1 28.88 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 117.896 0.848 . . . . 0.46000000000000002 110.462 -179.434 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 16.2 mt -116.14 144.84 22.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 121.066 0.46 . . . . 1.0800000000000001 110.671 -178.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.634 ' OG ' HD23 ' A' ' 96' ' ' LEU . 19.7 m -90.86 148.91 39.3 Favored Pre-proline 0 C--N 1.321 -0.657 0 CA-C-N 115.801 -0.636 . . . . 1.45 110.534 -179.459 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.69 176.2 10.3 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 122.642 2.228 . . . . 0.40999999999999998 111.195 172.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.421 HG22 HD22 ' A' ' 44' ' ' LEU . 19.6 mm -50.11 100.2 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 O-C-N 123.475 0.484 . . . . 1.04 112.133 178.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.6 p -107.75 119.59 57.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.101 0.477 . . . . 1.6599999999999999 110.21 176.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -85.99 149.86 24.89 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.935 0.398 . . . . 0.55000000000000004 110.73 -179.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 3.9 p -126.26 -172.33 2.6 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.601 -0.727 . . . . 1.05 111.122 -178.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -61.03 -34.84 75.47 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.556 0.217 . . . . 2.1600000000000001 111.527 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.601 ' O ' ' HB2' ' A' ' 20' ' ' SER . 6.8 t -97.5 -60.76 1.51 Allowed 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.55 -0.46 . . . . 1.0900000000000001 110.544 179.458 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -146.59 -133.42 2.46 Favored Glycine 0 N--CA 1.441 -0.986 0 C-N-CA 119.015 -1.564 . . . . 0.39000000000000001 113.877 -173.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.484 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 5.9 mp -114.58 148.08 38.55 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.06 -0.57 . . . . 1.0600000000000001 111.407 -169.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . 0.554 ' NE2' HD11 ' A' ' 14' ' ' LEU . 80.7 m-70 -144.2 151.82 40.01 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.316 0.579 . . . . 0.25 112.268 179.073 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.477 HG12 HD11 ' A' ' 44' ' ' LEU . 3.9 pt -134.35 143.91 36.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 107.774 -1.195 . . . . 1.03 107.774 159.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -133.22 138.19 51.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 C-N-CA 120.829 -0.348 . . . . 1.0600000000000001 110.665 -176.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.461 ' HG2' ' HB2' ' A' ' 11' ' ' ALA . 50.4 pttt -121.83 135.08 54.9 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.416 -0.587 . . . . 1.29 109.416 172.111 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 68.5 ttt180 -84.78 123.0 29.92 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.837 0.351 . . . . 2.6800000000000002 111.064 -175.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -93.15 -32.59 14.36 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.025 -0.534 . . . . 1.54 110.843 179.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.955 0 CA-C-O 118.569 -0.729 . . . . 1.1499999999999999 110.156 179.514 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.9 mpt? . . . . . 0 N--CA 1.48 1.061 0 CA-C-O 121.013 0.435 . . . . 7.54 110.193 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 35.9 m -151.36 153.18 34.25 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.872 -0.604 . . . . 3.0899999999999999 110.486 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.554 ' O ' ' HA ' ' A' ' 81' ' ' SER . 12.9 pt-20 -101.77 -26.87 13.32 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.68 -0.691 . . . . 2.7999999999999998 109.778 177.603 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 40.1 mmtm -75.19 115.74 15.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.546 0.688 . . . . 1.6899999999999999 111.039 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.554 HD23 ' H ' ' A' ' 9' ' ' ARG . 2.1 tt -115.19 158.71 21.88 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 114.651 -1.158 . . . . 1.79 108.178 179.282 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.554 ' H ' HD23 ' A' ' 8' ' ' LEU . 48.8 ttt180 -137.53 130.8 30.83 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 108.61 -0.885 . . . . 1.3700000000000001 108.61 175.153 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -144.78 155.47 43.54 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.244 -0.583 . . . . 1.0700000000000001 112.419 -178.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.568 ' HA ' ' HA ' ' A' ' 76' ' ' ASP . . . -109.67 133.6 52.94 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-N 115.421 -0.808 . . . . 1.04 109.538 176.225 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 37.9 p-80 -139.52 143.51 37.46 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.97 0.414 . . . . 0.34000000000000002 111.365 -172.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.657 ' O ' ' HA ' ' A' ' 112' ' ' HIS . 6.1 tt -111.82 134.84 53.13 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.536 -0.913 . . . . 1.0600000000000001 108.536 177.159 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.533 HD11 ' NE2' ' A' ' 112' ' ' HIS . 24.4 tp -117.36 122.34 43.6 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.811 0.339 . . . . 1.0800000000000001 111.224 -178.187 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.434 HG23 HD11 ' A' ' 44' ' ' LEU . 70.5 t -108.57 134.05 51.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 109.786 -0.45 . . . . 1.01 109.786 174.242 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.461 ' HE2' ' OG ' ' A' ' 109' ' ' SER . 31.3 mmtp -106.43 149.54 26.94 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.431 -0.581 . . . . 1.22 109.431 176.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.419 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 49.6 p90 -138.68 161.32 37.46 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.721 0.296 . . . . 0.29999999999999999 110.749 -179.027 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.511 ' HB3' ' HA ' ' A' ' 33' ' ' ALA . 59.8 p -52.62 109.8 0.44 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.849 -0.614 . . . . 1.6000000000000001 111.094 -179.173 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 97.8 9.46 54.4 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.63 -0.795 . . . . 0.53000000000000003 113.769 177.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.473 ' C ' ' H ' ' A' ' 22' ' ' ASN . 88.9 p -91.6 48.67 1.49 Allowed 'General case' 0 C--O 1.235 0.321 0 CA-C-N 118.293 1.047 . . . . 1.28 110.903 -177.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 71.27 -34.46 0.3 Allowed 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.531 0.732 . . . . 4.1600000000000001 111.537 -178.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.473 ' H ' ' C ' ' A' ' 20' ' ' SER . 41.5 m-80 -142.99 91.1 7.25 Favored Pre-proline 0 C--N 1.328 -0.367 0 N-CA-C 110.387 -0.227 . . . . 1.77 110.387 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.424 ' C ' HG22 ' A' ' 32' ' ' THR . 16.7 Cg_exo -73.99 54.81 3.24 Favored 'Trans proline' 0 CA--C 1.534 0.523 0 C-N-CA 123.408 2.739 . . . . 1.71 113.07 179.435 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.451 ' N ' HG22 ' A' ' 32' ' ' THR . 64.4 t -146.83 117.67 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 109.302 -0.629 . . . . 1.1599999999999999 109.302 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 42.1 t -106.45 151.74 24.55 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 110.344 -0.243 . . . . 1.4299999999999999 110.344 178.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.561 ' HB2' ' HA ' ' A' ' 67' ' ' ASP . 7.5 mpt_? -65.61 -14.71 61.71 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.994 0.426 . . . . 3.1200000000000001 109.894 170.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.5 ' HG3' ' CD ' ' A' ' 65' ' ' ARG . 23.9 ttp180 -66.86 -38.94 87.29 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.404 -0.817 . . . . 2.25 109.471 177.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 33.2 p -105.42 -35.14 7.6 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-O 121.433 0.635 . . . . 1.1299999999999999 110.979 -176.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 72.92 8.15 72.48 Favored Glycine 0 N--CA 1.451 -0.325 0 CA-C-N 115.419 -0.81 . . . . 0.81999999999999995 112.054 -178.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -131.03 -70.07 0.61 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.964 0.412 . . . . 2.1000000000000001 110.312 -178.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 11.0 p -154.54 157.65 38.63 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.16 -0.473 . . . . 1.3300000000000001 110.584 177.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.484 ' OG1' HG12 ' A' ' 35' ' ' VAL . 10.1 t -125.11 28.0 6.51 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 122.082 0.944 . . . . 1.02 109.66 172.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.511 ' HA ' ' HB3' ' A' ' 18' ' ' SER . . . -69.27 -5.53 23.6 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 114.979 -1.009 . . . . 1.1299999999999999 111.893 178.636 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -85.57 -25.18 26.88 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.833 -0.621 . . . . 2.21 110.754 -178.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.484 HG12 ' OG1' ' A' ' 32' ' ' THR . 0.2 OUTLIER -109.75 135.16 49.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.647 -0.706 . . . . 1.1100000000000001 110.47 -175.547 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 41.7 p -92.19 178.73 5.77 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 109.743 -0.466 . . . . 1.2 109.743 -178.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.515 ' O ' HG13 ' A' ' 41' ' ' ILE . 18.6 p90 -62.16 -29.63 70.48 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 119.885 -0.726 . . . . 2.21 109.57 177.336 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -72.39 -48.36 42.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.12 -0.491 . . . . 0.95999999999999996 110.446 177.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -64.22 -29.04 70.16 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.317 0.579 . . . . 0.91000000000000003 109.705 178.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.419 ' HB2' ' HB3' ' A' ' 17' ' ' PHE . . . -72.62 -46.34 54.59 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.09 -0.959 . . . . 1.03 110.696 177.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.515 HG13 ' O ' ' A' ' 37' ' ' TYR . 97.0 mt -62.41 -38.13 80.51 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 N-CA-C 109.635 -0.506 . . . . 1.0800000000000001 109.635 175.483 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.458 ' O ' ' HG3' ' A' ' 46' ' ' LYS . 82.6 tttt -60.87 -29.68 69.69 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.455 -0.793 . . . . 2.8399999999999999 110.162 178.216 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -87.62 -47.53 8.62 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.687 -0.688 . . . . 1.02 110.091 -177.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.466 HD13 HG12 ' A' ' 113' ' ' ILE . 35.5 tp -58.67 -38.57 78.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.896 -0.593 . . . . 1.02 109.743 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.435 ' HG2' HG13 ' A' ' 104' ' ' ILE . 2.5 mm-40 -62.63 -35.96 81.26 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.94 -0.573 . . . . 0.87 112.165 178.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.458 ' HG3' ' O ' ' A' ' 42' ' ' LYS . 68.8 mttm -70.78 -45.81 64.04 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.741 0.305 . . . . 1.98 110.77 -178.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 51.0 m95 -67.9 -44.34 77.2 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.98 -0.288 . . . . 0.60999999999999999 110.468 177.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 40.9 t -57.03 -33.5 67.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.024 0.44 . . . . 0.88 110.219 174.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.404 ' HB2' ' O ' ' A' ' 45' ' ' GLN . 12.1 tt0 -68.03 -54.38 18.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 0.55000000000000004 110.294 177.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.51 ' HB3' HG22 ' A' ' 56' ' ' VAL . 87.6 mtt180 -60.23 -45.24 93.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.96 -0.564 . . . . 0.47999999999999998 111.594 -178.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 97.2 mt -59.42 -40.69 82.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 120.997 0.427 . . . . 1.04 110.727 177.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.49 -38.42 71.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.152 -0.476 . . . . 1.0600000000000001 111.615 -179.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 58.1 p -78.22 -30.78 48.98 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.055 0.455 . . . . 0.34999999999999998 110.947 -179.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 106.68 3.0 37.32 Favored Glycine 0 N--CA 1.445 -0.725 0 N-CA-C 111.574 -0.61 . . . . 0.33000000000000002 111.574 -179.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.405 ' HB3' ' HB3' ' A' ' 50' ' ' ARG . 5.6 tt0 -55.57 -46.68 77.18 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 122.803 0.441 . . . . 0.65000000000000002 110.784 177.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.51 HG22 ' HB3' ' A' ' 50' ' ' ARG . 11.9 m -134.78 155.33 38.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 109.472 -0.566 . . . . 1.05 109.472 170.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.5 m -77.8 155.8 30.88 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.266 -0.642 . . . . 1.3100000000000001 109.266 178.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -54.3 -40.01 67.52 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.184 -0.673 . . . . 0.25 109.184 177.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -57.94 -44.8 87.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.892 -1.049 . . . . 1.72 111.671 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -64.11 -45.68 87.52 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.863 0.363 . . . . 2.0899999999999999 111.11 -175.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -70.56 -43.66 69.02 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.42 -0.354 . . . . 1.0700000000000001 110.896 -179.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.84 -46.02 89.85 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.248 0.462 . . . . 1.0600000000000001 112.248 -175.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.511 ' HA ' ' O ' ' A' ' 71' ' ' TYR . 21.7 m -59.2 -19.73 47.93 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 112.907 0.706 . . . . 1.52 112.907 -177.138 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.4 ' O ' ' HA ' ' A' ' 27' ' ' ARG . 35.7 mt-30 -110.69 -45.65 3.47 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.48 0.657 . . . . 0.60999999999999999 110.988 -178.182 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.5 ' CD ' ' HG3' ' A' ' 27' ' ' ARG . 25.6 mmt180 -92.35 -38.43 12.04 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 114.929 -1.032 . . . . 0.95999999999999996 113.278 -170.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.422 ' HB2' ' HG ' ' A' ' 13' ' ' LEU . 21.6 t -63.31 124.62 21.7 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.028 0.442 . . . . 1.0600000000000001 110.889 -178.624 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.561 ' HA ' ' HB2' ' A' ' 26' ' ' ARG . 22.8 t70 -80.99 -10.49 59.7 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.741 -0.663 . . . . 2.2799999999999998 111.11 177.644 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 48.3 t -80.24 158.59 26.16 Favored 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 120.132 -0.627 . . . . 2.0499999999999998 109.608 179.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -60.3 -12.06 23.0 Favored Glycine 0 N--CA 1.454 -0.108 0 CA-C-N 115.014 -0.994 . . . . 0.29999999999999999 113.122 -174.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 70.5 p -69.6 -10.15 57.01 Favored 'General case' 0 N--CA 1.448 -0.565 0 O-C-N 123.052 -0.087 . . . . 0.46999999999999997 110.984 176.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.511 ' O ' ' HA ' ' A' ' 63' ' ' SER . 12.8 p90 -57.42 -31.01 65.43 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 109.617 -0.512 . . . . 0.94999999999999996 109.617 174.013 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -95.35 2.63 54.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.141 0.496 . . . . 1.1100000000000001 110.626 179.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 5.0 m -116.37 -2.03 12.17 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.913 -0.585 . . . . 0.70999999999999996 111.284 -175.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 86.11 20.01 56.16 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.722 -0.751 . . . . 0.67000000000000004 112.233 -177.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 86.34 -29.34 4.84 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 121.092 -0.575 . . . . 0.42999999999999999 112.639 178.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.568 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 8.1 p-10 -89.41 144.93 25.68 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-O 121.573 0.702 . . . . 1.6499999999999999 111.397 -175.538 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.418 ' O ' ' HG3' ' A' ' 9' ' ' ARG . 1.7 mp -106.34 175.74 5.4 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 114.635 -1.166 . . . . 1.6899999999999999 110.131 178.612 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -82.76 -147.18 6.67 Favored Glycine 0 C--N 1.317 -0.509 0 C-N-CA 121.033 -0.604 . . . . 0.45000000000000001 112.497 179.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -99.16 124.19 44.01 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.109 0.48 . . . . 4.7400000000000002 110.807 -178.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -134.36 138.5 44.94 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.46 -0.791 . . . . 1.6499999999999999 110.425 -177.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.554 ' HA ' ' O ' ' A' ' 6' ' ' GLU . 18.6 m -68.06 129.67 40.62 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.703 -0.481 . . . . 1.6899999999999999 109.703 177.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 17.8 m -49.47 121.47 5.11 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.8 -0.636 . . . . 1.55 111.832 -174.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 111.09 3.21 28.02 Favored Glycine 0 N--CA 1.452 -0.289 0 CA-C-N 115.847 -0.615 . . . . 0.79000000000000004 112.148 -177.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -91.7 26.31 2.4 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.945 0.402 . . . . 1.5800000000000001 111.304 -175.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.408 ' HE1' HD23 ' A' ' 77' ' ' LEU . 26.5 mmt -122.13 -131.78 0.28 Allowed 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 109.687 -0.486 . . . . 1.1299999999999999 109.687 179.59 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 5.1 mpp? -91.97 -93.3 0.14 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.939 0.4 . . . . 1.8899999999999999 109.931 177.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.45 ' H ' ' HD2' ' A' ' 88' ' ' PRO . 27.8 ttpp -163.58 -56.43 0.01 OUTLIER Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 115.852 -0.613 . . . . 2.7400000000000002 110.026 175.262 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.45 ' HD2' ' H ' ' A' ' 87' ' ' LYS . 60.5 Cg_endo -70.14 -30.0 21.16 Favored 'Trans proline' 0 C--N 1.359 1.097 0 C-N-CA 121.923 1.749 . . . . 0.29999999999999999 111.096 178.373 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.633 ' O ' HG22 ' A' ' 93' ' ' VAL . 20.1 t80 -61.66 -56.44 19.76 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.631 -1.168 . . . . 0.28000000000000003 109.762 176.468 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.8 tm-20 -64.36 -36.85 85.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.493 -0.776 . . . . 2.1200000000000001 110.165 -179.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -53.54 -33.52 54.89 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.354 -0.839 . . . . 0.60999999999999999 110.964 175.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.436 ' O ' ' HG ' ' A' ' 96' ' ' LEU . . . -84.35 -34.36 23.67 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.359 -0.382 . . . . 1.1000000000000001 111.298 177.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.633 HG22 ' O ' ' A' ' 89' ' ' PHE . 35.7 t -62.72 -44.52 99.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-O 121.417 0.627 . . . . 1.1200000000000001 110.596 -177.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 38.3 ptt180 -73.47 -11.29 60.41 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.612 -0.722 . . . . 3.1800000000000002 110.748 178.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -96.86 14.64 24.61 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.328 -0.396 . . . . 1.0800000000000001 111.815 -173.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.5 ' HB2' ' HB2' ' A' ' 100' ' ' ASP . 0.5 OUTLIER -148.17 155.75 41.77 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.022 0.439 . . . . 1.1200000000000001 110.857 177.395 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.573 ' HA ' ' NH2' ' A' ' 116' ' ' ARG . 23.8 tptm -92.25 162.73 14.18 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.789 -0.641 . . . . 2.1299999999999999 109.517 179.294 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.486 ' HA ' ' HG2' ' A' ' 116' ' ' ARG . 66.2 mt -42.63 114.33 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.974 0.416 . . . . 1.6200000000000001 111.241 171.52 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 103.3 -8.87 53.31 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.804 -0.712 . . . . 0.46000000000000002 113.449 178.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.5 ' HB2' ' HB2' ' A' ' 96' ' ' LEU . 18.4 m-20 -97.24 135.82 38.62 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 117.23 0.515 . . . . 0.46000000000000002 110.383 179.121 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.436 HG12 ' HB3' ' A' ' 115' ' ' LYS . 8.3 mt -103.98 149.72 7.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.946 -0.57 . . . . 1.0800000000000001 109.902 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 93.4 p -91.46 159.62 38.57 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 116.095 -0.502 . . . . 1.45 110.914 -177.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -71.22 166.55 28.88 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 122.383 2.055 . . . . 0.40999999999999998 111.342 170.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.435 HG13 ' HG2' ' A' ' 45' ' ' GLN . 25.7 mm -47.57 112.7 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 O-C-N 123.547 0.53 . . . . 1.04 111.793 176.629 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 1.9 p -118.47 124.8 73.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.154 -0.475 . . . . 1.6599999999999999 109.961 175.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -85.51 151.32 24.04 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.0 0.429 . . . . 0.55000000000000004 110.285 178.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 10.9 p -131.3 -172.21 2.79 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.942 -0.572 . . . . 1.05 110.855 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -55.5 -48.16 75.06 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.893 -0.594 . . . . 2.1600000000000001 111.928 -179.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.461 ' OG ' ' HE2' ' A' ' 16' ' ' LYS . 4.8 t -106.98 -3.93 19.58 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.791 0.663 . . . . 1.0900000000000001 112.791 -172.306 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 172.68 -128.59 1.56 Allowed Glycine 0 N--CA 1.439 -1.15 0 C-N-CA 118.984 -1.579 . . . . 0.39000000000000001 113.615 173.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.487 HD23 ' CG1' ' A' ' 41' ' ' ILE . 7.4 mp -126.4 151.0 48.26 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 114.976 -0.612 . . . . 1.0600000000000001 110.961 -170.2 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . 0.657 ' HA ' ' O ' ' A' ' 13' ' ' LEU . 84.7 m-70 -146.48 149.99 34.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.378 0.608 . . . . 0.25 112.53 178.309 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.466 HG12 HD13 ' A' ' 44' ' ' LEU . 2.9 pt -128.07 137.43 57.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 107.351 -1.351 . . . . 1.03 107.351 158.39 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 2.6 mp -130.57 144.02 39.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 C-N-CA 120.736 -0.386 . . . . 1.0600000000000001 110.85 -175.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.436 ' HB3' HG12 ' A' ' 101' ' ' ILE . 39.2 pttt -127.2 142.19 51.55 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.655 -0.868 . . . . 1.29 108.655 172.428 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . 0.573 ' NH2' ' HA ' ' A' ' 97' ' ' LYS . 3.1 ttp180 -79.81 134.77 36.36 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.295 0.569 . . . . 2.6800000000000002 111.095 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -102.66 -32.42 9.88 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.144 -0.935 . . . . 1.54 109.922 178.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.569 ' OXT' ' HD2' ' A' ' 116' ' ' ARG . . . . . . . . 0 C--O 1.246 0.888 0 CA-C-O 118.368 -0.825 . . . . 1.1499999999999999 110.401 178.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 24.0 ttt . . . . . 0 N--CA 1.48 1.064 0 CA-C-O 120.901 0.382 . . . . 7.54 110.906 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 2.5 p -75.21 -33.3 61.38 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.151 -0.477 . . . . 3.0899999999999999 112.079 -174.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -86.26 98.13 10.78 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.834 0.349 . . . . 2.7999999999999998 110.594 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.439 ' HD2' ' HB3' ' A' ' 79' ' ' PHE . 60.1 mmtt -142.12 113.78 7.89 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.359 0.6 . . . . 1.6899999999999999 110.798 178.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.587 HD21 ' H ' ' A' ' 9' ' ' ARG . 1.3 tt -114.9 161.23 18.54 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 108.162 -1.051 . . . . 1.79 108.162 178.139 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.587 ' H ' HD21 ' A' ' 8' ' ' LEU . 48.2 ttt180 -141.45 128.61 20.91 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.082 -0.71 . . . . 1.3700000000000001 109.082 175.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.464 ' O ' ' HB2' ' A' ' 77' ' ' LEU . . . -146.97 158.74 44.01 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 119.97 -0.692 . . . . 1.0700000000000001 112.143 -178.459 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.44 ' HA ' ' HA ' ' A' ' 76' ' ' ASP . . . -106.73 135.75 47.73 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.641 -0.708 . . . . 1.04 109.177 177.521 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 10.1 p-80 -138.71 140.12 38.64 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 120.37 -0.532 . . . . 0.34000000000000002 111.463 -171.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.544 ' O ' ' HA ' ' A' ' 112' ' ' HIS . 7.0 tt -111.71 143.28 42.88 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.493 -0.929 . . . . 1.0600000000000001 108.493 175.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.573 HD13 ' NE2' ' A' ' 112' ' ' HIS . 23.9 tp -129.61 120.4 25.19 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.768 0.318 . . . . 1.0800000000000001 111.097 -177.028 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.422 HG23 HD13 ' A' ' 44' ' ' LEU . 37.5 t -106.98 132.39 54.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 109.379 -0.6 . . . . 1.01 109.379 175.456 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.646 ' HE2' ' OG ' ' A' ' 109' ' ' SER . 31.7 mmtp -106.21 154.37 20.81 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.837 -0.431 . . . . 1.22 109.837 177.61 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -149.19 160.95 42.92 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.056 -0.52 . . . . 0.29999999999999999 110.353 -176.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 5.6 t -54.27 109.49 0.49 Allowed 'General case' 0 N--CA 1.432 -1.327 0 CA-C-N 116.392 -0.367 . . . . 1.6000000000000001 110.071 174.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 105.74 9.61 32.45 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.502 -0.856 . . . . 0.53000000000000003 112.759 -178.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.477 ' HB2' ' O ' ' A' ' 109' ' ' SER . 78.3 p -95.03 39.44 1.11 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 117.258 0.529 . . . . 1.28 111.202 -176.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.417 ' HB3' ' O ' ' A' ' 20' ' ' SER . 54.8 ttt180 74.77 -34.29 0.26 Allowed 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.286 0.634 . . . . 4.1600000000000001 111.045 179.399 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.428 ' H ' ' C ' ' A' ' 20' ' ' SER . 6.3 p30 -151.06 114.07 3.12 Favored Pre-proline 0 C--N 1.324 -0.521 0 N-CA-C 109.265 -0.643 . . . . 1.77 109.265 172.296 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.439 ' C ' HG23 ' A' ' 32' ' ' THR . 89.9 Cg_endo -83.61 64.12 7.42 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 122.594 2.196 . . . . 1.71 112.88 -172.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.469 ' N ' HG23 ' A' ' 32' ' ' THR . 47.0 t -147.9 116.17 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 C-N-CA 122.855 0.462 . . . . 1.1599999999999999 109.851 179.406 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.42 ' HB3' ' HB2' ' A' ' 16' ' ' LYS . 28.7 p -105.63 158.47 16.68 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 110.585 -0.154 . . . . 1.4299999999999999 110.585 175.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.572 ' HB2' ' HA ' ' A' ' 67' ' ' ASP . 5.6 mpt_? -71.05 -4.0 22.68 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.111 0.481 . . . . 3.1200000000000001 110.216 171.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.56 ' HG3' ' CD ' ' A' ' 65' ' ' ARG . 22.0 ttp180 -76.26 -40.1 52.73 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.706 -0.679 . . . . 2.25 109.362 175.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 59.8 p -103.19 -35.8 8.34 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.707 -0.679 . . . . 1.1299999999999999 111.035 -176.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 80.95 -28.31 2.89 Favored Glycine 0 CA--C 1.52 0.365 0 CA-C-N 115.963 -0.562 . . . . 0.81999999999999995 112.21 -179.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -98.48 -71.21 0.7 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.839 0.352 . . . . 2.1000000000000001 110.64 -178.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 44.7 m -154.11 156.7 37.74 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.109 -0.496 . . . . 1.3300000000000001 110.212 177.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.469 HG23 ' N ' ' A' ' 24' ' ' VAL . 8.9 t -123.22 35.5 4.85 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 122.29 1.043 . . . . 1.02 109.695 178.285 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -77.67 -4.58 46.83 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.833 -1.076 . . . . 1.1299999999999999 111.528 -176.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -96.76 1.21 50.58 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.798 -0.637 . . . . 2.21 110.747 -178.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.445 HG11 ' OG1' ' A' ' 32' ' ' THR . 0.2 OUTLIER -129.46 134.75 63.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.685 -0.689 . . . . 1.1100000000000001 109.787 -179.955 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 41.2 p -96.49 -176.19 3.55 Favored 'General case' 0 CA--C 1.513 -0.468 0 N-CA-C 109.487 -0.56 . . . . 1.2 109.487 -178.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.547 ' O ' HG13 ' A' ' 41' ' ' ILE . 0.2 OUTLIER -67.93 -22.8 65.04 Favored 'General case' 0 C--O 1.219 -0.532 0 C-N-CA 118.883 -1.127 . . . . 2.21 110.036 173.583 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -68.82 -49.3 59.6 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.761 -0.459 . . . . 0.95999999999999996 109.761 174.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.408 ' HB2' HG21 ' A' ' 35' ' ' VAL . 8.4 m-20 -66.54 -32.44 73.79 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.368 0.604 . . . . 0.91000000000000003 109.967 177.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.85 -40.91 68.7 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.272 -0.876 . . . . 1.03 110.832 179.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.547 HG13 ' O ' ' A' ' 37' ' ' TYR . 61.8 mt -62.3 -34.67 65.35 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.312 0 N-CA-C 109.316 -0.624 . . . . 1.0800000000000001 109.316 173.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.429 ' O ' ' HG3' ' A' ' 46' ' ' LYS . 19.7 mtpt -65.34 -21.28 66.68 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 116.336 -0.393 . . . . 2.8399999999999999 111.085 176.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.431 ' HG3' ' CD1' ' A' ' 47' ' ' TRP . 1.6 tp10 -87.85 -57.61 2.87 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.34 -0.615 . . . . 1.02 109.34 178.187 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.487 HD12 HG12 ' A' ' 113' ' ' ILE . 23.8 tp -57.93 -38.89 76.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 114.965 -1.016 . . . . 1.02 111.101 -175.722 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.521 ' HB2' ' O ' ' A' ' 41' ' ' ILE . 3.6 mm-40 -66.22 -28.66 68.91 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 112.047 0.388 . . . . 0.87 112.047 -178.425 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.429 ' HG3' ' O ' ' A' ' 42' ' ' LYS . 66.4 mttm -77.56 -45.02 26.6 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.986 -0.376 . . . . 1.98 109.986 178.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.431 ' CD1' ' HG3' ' A' ' 43' ' ' GLU . 58.2 m95 -66.11 -45.5 80.94 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.249 -0.432 . . . . 0.60999999999999999 111.695 177.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.479 ' HB3' HG21 ' A' ' 113' ' ' ILE . 96.0 p -65.22 -23.82 67.18 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.957 0.408 . . . . 0.88 109.989 177.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.466 ' HB2' ' O ' ' A' ' 45' ' ' GLN . 10.1 tt0 -73.3 -56.68 4.75 Favored 'General case' 0 C--O 1.223 -0.337 0 CA-C-N 116.094 -0.503 . . . . 0.55000000000000004 109.776 173.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.514 ' HB3' HG22 ' A' ' 56' ' ' VAL . 92.4 mtt180 -61.1 -41.7 97.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.77 -0.65 . . . . 0.47999999999999998 111.81 -176.136 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.487 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 98.2 mt -60.7 -36.42 70.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.367 -0.378 . . . . 1.04 110.496 176.437 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -77.64 -36.95 51.0 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.243 -0.435 . . . . 1.0600000000000001 111.692 178.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.456 ' OG ' ' HA ' ' A' ' 50' ' ' ARG . 67.9 p -79.09 -29.8 43.5 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 111.76 0.282 . . . . 0.34999999999999998 111.76 -175.347 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 109.15 1.37 31.54 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.671 -0.776 . . . . 0.33000000000000002 112.318 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.435 ' HB2' ' HB3' ' A' ' 50' ' ' ARG . 43.5 mt-10 -61.97 -50.97 69.97 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.882 0.372 . . . . 0.65000000000000002 110.509 178.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.514 HG22 ' HB3' ' A' ' 50' ' ' ARG . 16.2 m -134.8 152.4 32.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 109.564 -0.532 . . . . 1.05 109.564 174.285 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 19.5 m -82.39 160.15 22.85 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.542 -0.54 . . . . 1.3100000000000001 109.542 178.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.41 ' HA ' ' CD1' ' A' ' 51' ' ' ILE . 2.6 t80 -54.95 -39.8 69.3 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.412 0.625 . . . . 0.25 109.74 -178.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -55.79 -45.56 78.17 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.541 -1.209 . . . . 1.72 111.351 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.45 ' O ' ' HG3' ' A' ' 64' ' ' GLN . 3.9 mm-40 -65.64 -47.83 74.24 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.964 -0.562 . . . . 2.0899999999999999 111.177 -173.154 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -67.25 -38.44 85.15 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.369 -0.378 . . . . 1.0700000000000001 110.845 -179.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.37 -53.18 58.73 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.131 -0.486 . . . . 1.0600000000000001 111.331 -178.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.565 ' HA ' ' O ' ' A' ' 71' ' ' TYR . 47.6 m -51.58 -29.56 17.68 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.892 0.701 . . . . 1.52 112.892 -177.337 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.45 ' HG3' ' O ' ' A' ' 60' ' ' GLU . 19.1 mt-30 -97.33 -50.48 4.53 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.738 0.78 . . . . 0.60999999999999999 110.708 -177.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.56 ' CD ' ' HG3' ' A' ' 27' ' ' ARG . 19.1 mmt180 -93.57 -40.26 10.39 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 114.55 -1.205 . . . . 0.95999999999999996 113.386 -166.18 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.508 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 38.7 p -63.84 121.52 14.23 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.106 0.479 . . . . 1.0600000000000001 111.177 -174.029 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.572 ' HA ' ' HB2' ' A' ' 26' ' ' ARG . 31.5 t70 -74.66 -15.08 60.82 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.571 -0.741 . . . . 2.2799999999999998 110.813 177.13 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.504 ' SG ' ' HB2' ' A' ' 66' ' ' SER . 5.2 p -77.57 150.34 34.74 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.94 -0.573 . . . . 2.0499999999999998 110.556 -179.505 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -53.82 -18.04 7.83 Favored Glycine 0 C--N 1.329 0.176 0 CA-C-N 114.823 -1.08 . . . . 0.29999999999999999 114.742 -171.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 77.9 p -73.06 0.32 11.78 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 117.293 0.546 . . . . 0.46999999999999997 111.907 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.565 ' O ' ' HA ' ' A' ' 63' ' ' SER . 54.8 p90 -52.97 -41.27 64.41 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.767 0.318 . . . . 0.94999999999999996 110.295 174.045 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -95.14 2.68 55.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.045 0.45 . . . . 1.1100000000000001 110.983 -179.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 5.3 m -103.37 -6.78 21.59 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.076 -0.511 . . . . 0.70999999999999996 110.735 -178.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 90.61 19.85 42.95 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.891 -0.671 . . . . 0.67000000000000004 112.181 -177.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 84.7 -31.83 3.53 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 121.044 -0.598 . . . . 0.42999999999999999 112.697 179.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.44 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 6.9 p-10 -83.04 145.2 29.43 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-O 121.672 0.749 . . . . 1.6499999999999999 111.224 -176.031 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.464 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 16.6 mt -105.43 175.74 5.4 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 114.399 -1.273 . . . . 1.6899999999999999 110.388 179.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -87.43 -152.38 22.95 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 121.234 -0.508 . . . . 0.45000000000000001 112.014 177.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.439 ' HB3' ' HD2' ' A' ' 7' ' ' LYS . 91.6 m-85 -96.16 124.11 40.04 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.27 0.557 . . . . 4.7400000000000002 110.988 179.498 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.407 ' HE2' ' CB ' ' A' ' 77' ' ' LEU . 1.0 OUTLIER -134.44 160.2 38.72 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.491 -0.777 . . . . 1.6499999999999999 110.45 -176.214 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 40.8 p -89.22 126.59 35.55 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 109.598 -0.519 . . . . 1.6899999999999999 109.598 178.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 17.2 m -56.57 122.67 12.55 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.305 -0.407 . . . . 1.55 111.093 -178.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 113.23 6.85 21.81 Favored Glycine 0 N--CA 1.445 -0.708 0 N-CA-C 111.533 -0.627 . . . . 0.79000000000000004 111.533 -179.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -112.82 10.55 19.15 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.135 0.493 . . . . 1.5800000000000001 110.446 -178.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 23.6 mmt -99.17 -108.8 0.19 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.027 0.441 . . . . 1.1299999999999999 110.642 178.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 56.7 mtt -134.69 150.5 50.63 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 107.88 -1.155 . . . . 1.8899999999999999 107.88 175.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -54.05 -53.19 61.27 Favored Pre-proline 0 C--N 1.32 -0.697 0 N-CA-C 112.518 0.562 . . . . 2.7400000000000002 112.518 -175.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.406 ' HG2' HG23 ' A' ' 107' ' ' THR . 64.2 Cg_endo -75.16 -25.18 11.87 Favored 'Trans proline' 0 C--N 1.355 0.902 0 C-N-CA 121.561 1.507 . . . . 0.29999999999999999 112.152 -177.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.505 ' O ' HG23 ' A' ' 93' ' ' VAL . 27.0 t80 -72.88 -55.78 6.14 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.475 -0.784 . . . . 0.28000000000000003 109.723 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -60.41 -36.19 77.56 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.263 -0.88 . . . . 2.1200000000000001 110.214 -179.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.557 ' HA ' ' CZ ' ' A' ' 94' ' ' ARG . 26.6 t70 -56.38 -32.97 65.28 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.613 -0.721 . . . . 0.60999999999999999 111.117 177.69 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.474 ' O ' ' HG ' ' A' ' 96' ' ' LEU . . . -82.79 -26.98 31.28 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.381 -0.372 . . . . 1.1000000000000001 111.037 179.114 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.505 HG23 ' O ' ' A' ' 89' ' ' PHE . 28.0 t -67.36 -45.38 85.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.47 -0.332 . . . . 1.1200000000000001 111.666 -174.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.557 ' CZ ' ' HA ' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -83.32 -2.49 55.83 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.239 -0.584 . . . . 3.1800000000000002 110.408 178.262 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -86.5 -2.77 58.75 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.18 0.514 . . . . 1.0800000000000001 110.339 179.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.588 ' HB2' ' HB2' ' A' ' 100' ' ' ASP . 0.7 OUTLIER -136.26 153.61 51.14 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.614 -0.721 . . . . 1.1200000000000001 110.128 176.785 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.556 ' HG3' ' H ' ' A' ' 98' ' ' ILE . 20.2 tptm -102.42 179.17 4.38 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.128 -0.693 . . . . 2.1299999999999999 109.128 179.197 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.556 ' H ' ' HG3' ' A' ' 97' ' ' LYS . 65.3 mt -54.81 116.05 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.011 0.434 . . . . 1.6200000000000001 111.197 179.588 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 104.45 -6.18 45.31 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 121.016 -0.612 . . . . 0.46000000000000002 112.975 179.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.588 ' HB2' ' HB2' ' A' ' 96' ' ' LEU . 31.0 m-20 -98.14 138.86 34.81 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.906 0.353 . . . . 0.46000000000000002 110.886 -178.253 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 11.2 mt -108.56 147.62 13.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 109.385 -0.598 . . . . 1.0800000000000001 109.385 178.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 88.3 p -91.4 158.11 41.35 Favored Pre-proline 0 C--N 1.321 -0.658 0 CA-C-O 120.667 0.27 . . . . 1.45 110.571 -179.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -74.99 175.87 10.66 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.272 1.982 . . . . 0.40999999999999998 110.94 170.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.443 HG23 HD23 ' A' ' 44' ' ' LEU . 21.1 mm -49.0 112.8 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.898 0.38 . . . . 1.04 111.58 176.23 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.4 p -119.24 120.82 64.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.093 0.473 . . . . 1.6599999999999999 110.078 174.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -85.14 145.25 27.71 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 121.269 0.556 . . . . 0.55000000000000004 109.995 177.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.406 HG23 ' HG2' ' A' ' 88' ' ' PRO . 8.2 p -120.6 -171.93 2.27 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.349 -0.841 . . . . 1.05 110.886 -176.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -54.69 -45.4 73.97 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.811 -0.631 . . . . 2.1600000000000001 110.723 176.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.646 ' OG ' ' HE2' ' A' ' 16' ' ' LYS . 15.0 t -93.59 -60.81 1.68 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.921 -0.581 . . . . 1.0900000000000001 111.078 -177.21 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -144.95 -134.85 2.8 Favored Glycine 0 N--CA 1.442 -0.929 0 C-N-CA 118.865 -1.636 . . . . 0.39000000000000001 113.448 -172.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.435 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 6.8 mp -113.19 146.33 39.47 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.204 -0.498 . . . . 1.0600000000000001 111.116 -172.499 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . 0.573 ' NE2' HD13 ' A' ' 14' ' ' LEU . 77.9 m-70 -143.23 152.67 41.99 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.459 0.647 . . . . 0.25 112.484 179.35 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.487 HG12 HD12 ' A' ' 44' ' ' LEU . 3.6 pt -131.55 137.42 55.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 107.372 -1.344 . . . . 1.03 107.372 157.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 2.4 mp -127.57 144.17 38.32 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 C-N-CA 120.781 -0.368 . . . . 1.0600000000000001 110.247 -176.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.44 ' HG2' ' HB1' ' A' ' 11' ' ' ALA . 52.0 pttt -127.94 137.25 52.2 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.041 -0.726 . . . . 1.29 109.041 173.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . 0.514 ' HB2' ' CD1' ' A' ' 96' ' ' LEU . 65.2 ttt180 -85.49 126.61 33.97 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 120.989 0.424 . . . . 2.6800000000000002 111.358 -175.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.405 HD23 ' HB2' ' A' ' 11' ' ' ALA . 0.7 OUTLIER -97.26 -33.56 11.42 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.594 -0.73 . . . . 1.54 110.625 178.268 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.936 0 CA-C-O 118.736 -0.65 . . . . 1.1499999999999999 110.662 -179.64 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 25.4 ptt? . . . . . 0 N--CA 1.478 0.938 0 CA-C-O 120.975 0.417 . . . . 7.54 110.355 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 39.8 t -111.89 -44.42 3.46 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.212 -0.449 . . . . 3.0899999999999999 111.078 -178.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -77.07 -11.77 59.85 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.457 -0.338 . . . . 2.7999999999999998 110.872 -177.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -82.44 130.52 35.12 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.162 0.506 . . . . 1.6899999999999999 111.315 -175.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.51 HD11 ' CD ' ' A' ' 116' ' ' ARG . 15.3 tp -132.18 171.97 12.99 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.022 -0.99 . . . . 1.79 108.779 -179.673 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 68.2 ttt180 -145.26 132.15 20.17 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 110.178 -0.304 . . . . 1.3700000000000001 110.178 175.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -148.51 160.31 43.2 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.329 0.585 . . . . 1.0700000000000001 112.421 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.419 ' HB3' HD21 ' A' ' 117' ' ' LEU . . . -107.47 138.96 42.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.239 -0.892 . . . . 1.04 109.129 176.489 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 20.0 p-80 -139.5 141.68 37.32 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.016 0.436 . . . . 0.34000000000000002 111.341 -172.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.582 ' O ' ' HA ' ' A' ' 112' ' ' HIS . 7.1 tt -113.47 138.39 50.18 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.549 -0.908 . . . . 1.0600000000000001 108.549 177.226 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.553 HD12 ' NE2' ' A' ' 112' ' ' HIS . 16.6 tp -121.2 137.5 54.65 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.697 0.284 . . . . 1.0800000000000001 111.501 -179.046 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 43.8 t -119.66 126.47 75.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.854 -0.612 . . . . 1.01 109.721 172.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.493 ' HE3' HD22 ' A' ' 14' ' ' LEU . 28.5 mmtp -103.31 154.82 18.97 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.982 -0.554 . . . . 1.22 109.821 177.171 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -151.67 162.32 41.19 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.133 -0.485 . . . . 0.29999999999999999 110.127 -176.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.432 ' CB ' ' HA ' ' A' ' 33' ' ' ALA . 4.1 t -47.25 110.01 0.26 Allowed 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 122.949 0.499 . . . . 1.6000000000000001 111.484 177.302 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 93.74 10.47 58.92 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.323 -0.941 . . . . 0.53000000000000003 113.588 177.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.515 ' C ' ' H ' ' A' ' 22' ' ' ASN . 83.4 p -81.84 46.98 1.04 Allowed 'General case' 0 C--O 1.234 0.252 0 CA-C-N 117.684 0.742 . . . . 1.28 111.326 -175.058 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 27.1 ttt180 69.32 -36.29 0.33 Allowed 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.805 0.842 . . . . 4.1600000000000001 111.115 -179.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.515 ' H ' ' C ' ' A' ' 20' ' ' SER . 57.5 m-80 -150.92 104.86 3.01 Favored Pre-proline 0 C--N 1.323 -0.576 0 N-CA-C 108.711 -0.848 . . . . 1.77 108.711 174.703 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_exo -64.04 -163.05 0.05 OUTLIER 'Trans proline' 0 CA--C 1.536 0.597 0 C-N-CA 123.172 2.581 . . . . 1.71 112.879 177.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.556 ' N ' HG23 ' A' ' 32' ' ' THR . 40.0 t 66.74 119.84 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-O 121.651 0.739 . . . . 1.1599999999999999 111.596 -175.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.7 t -102.0 152.3 21.11 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 115.357 -0.838 . . . . 1.4299999999999999 109.319 -179.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.663 ' CB ' ' HA ' ' A' ' 67' ' ' ASP . 8.6 tpp180 -79.91 -11.41 59.81 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.263 -1.014 . . . . 3.1200000000000001 108.263 175.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.542 ' HG3' ' HD3' ' A' ' 65' ' ' ARG . 17.2 ttp180 -80.68 -43.65 20.02 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 114.75 -1.113 . . . . 2.25 109.285 173.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 32.3 p -91.05 -33.77 15.37 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 116.038 -0.528 . . . . 1.1299999999999999 111.058 -175.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 81.78 -35.39 2.5 Favored Glycine 0 N--CA 1.452 -0.244 0 CA-C-N 116.089 -0.505 . . . . 0.81999999999999995 113.154 176.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 -99.52 -64.19 1.06 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.757 0.313 . . . . 2.1000000000000001 110.615 -175.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.1 p -154.08 150.49 28.26 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.308 -0.405 . . . . 1.3300000000000001 111.608 -178.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.556 HG23 ' N ' ' A' ' 24' ' ' VAL . 8.9 t -124.73 14.92 8.7 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.905 0.859 . . . . 1.02 110.095 176.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.432 ' HA ' ' CB ' ' A' ' 18' ' ' SER . . . -63.67 -4.42 3.0 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.447 -0.797 . . . . 1.1299999999999999 113.019 177.033 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 52.3 m-20 -89.88 -25.09 21.17 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.873 0.368 . . . . 2.21 110.538 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.449 HG13 ' OG1' ' A' ' 32' ' ' THR . 0.2 OUTLIER -102.29 139.22 23.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.989 -0.55 . . . . 1.1100000000000001 110.081 -178.568 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 25.3 p -100.02 -178.62 3.9 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 116.107 -0.497 . . . . 1.2 110.395 -175.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.497 ' O ' HG13 ' A' ' 41' ' ' ILE . 11.6 p90 -62.95 -30.78 71.83 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.517 -0.473 . . . . 2.21 109.872 177.223 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -72.66 -45.32 59.53 Favored 'General case' 0 CA--C 1.52 -0.173 0 CA-C-N 116.418 -0.355 . . . . 0.95999999999999996 110.545 179.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -67.35 -28.17 67.74 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-O 121.167 0.508 . . . . 0.91000000000000003 110.345 176.389 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -69.34 -43.93 72.66 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.376 -0.829 . . . . 1.03 110.337 175.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.497 HG13 ' O ' ' A' ' 37' ' ' TYR . 97.9 mt -62.65 -38.39 81.45 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.412 0 N-CA-C 109.529 -0.545 . . . . 1.0800000000000001 109.529 173.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 3.5 ttpm? -61.16 -25.99 67.39 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.342 -0.844 . . . . 2.8399999999999999 109.919 179.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.476 ' HG3' ' CD1' ' A' ' 47' ' ' TRP . 3.1 tp10 -87.99 -51.68 5.68 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.605 -0.725 . . . . 1.02 109.927 -178.444 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.476 ' CD2' ' HB3' ' A' ' 111' ' ' LEU . 33.0 tp -61.26 -37.85 84.6 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.421 -0.808 . . . . 1.02 110.573 -175.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.529 ' O ' ' HB2' ' A' ' 49' ' ' GLN . 4.7 mm-40 -65.27 -26.57 68.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.19 -0.459 . . . . 0.87 112.077 -178.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -81.29 -45.24 16.51 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.911 0.386 . . . . 1.98 110.41 178.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.476 ' CD1' ' HG3' ' A' ' 43' ' ' GLU . 42.9 m95 -65.36 -46.35 80.52 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.474 -0.33 . . . . 0.60999999999999999 111.556 177.617 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.457 ' HB3' HG22 ' A' ' 113' ' ' ILE . 83.8 p -65.27 -22.49 66.86 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.11 0.481 . . . . 0.88 110.16 177.393 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.529 ' HB2' ' O ' ' A' ' 45' ' ' GLN . 11.2 tt0 -72.09 -56.9 4.81 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 115.762 -0.654 . . . . 0.55000000000000004 109.753 174.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.527 ' HB3' HG22 ' A' ' 56' ' ' VAL . 97.0 mtt180 -61.42 -41.82 97.77 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.574 -0.739 . . . . 0.47999999999999998 111.611 -176.462 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.507 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 92.3 mt -62.05 -35.17 67.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.212 -0.449 . . . . 1.04 110.738 177.368 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -79.59 -36.83 37.52 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.098 -0.501 . . . . 1.0600000000000001 111.615 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 47.8 p -79.39 -29.78 42.2 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.794 0.33 . . . . 0.34999999999999998 111.591 -175.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 108.63 5.89 31.27 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.6 -0.81 . . . . 0.33000000000000002 112.142 -179.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.422 ' HB2' ' HB3' ' A' ' 50' ' ' ARG . 37.1 mt-10 -65.3 -47.89 75.02 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.931 0.396 . . . . 0.65000000000000002 110.117 178.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.527 HG22 ' HB3' ' A' ' 50' ' ' ARG . 14.5 m -136.53 156.44 35.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 109.679 -0.489 . . . . 1.05 109.679 172.241 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.7 m -81.01 161.54 24.2 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.696 -0.483 . . . . 1.3100000000000001 109.696 177.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -57.66 -42.53 83.69 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.025 -0.731 . . . . 0.25 109.025 177.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.46 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 38.6 mt-10 -57.47 -41.16 80.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.891 -1.05 . . . . 1.72 111.649 179.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -66.51 -45.72 78.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.128 0.49 . . . . 2.0899999999999999 110.637 -178.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -71.09 -46.06 62.52 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.077 -0.511 . . . . 1.0700000000000001 111.267 -179.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.69 -50.48 73.7 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.58 0.585 . . . . 1.0600000000000001 112.58 -174.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.584 ' HA ' ' O ' ' A' ' 71' ' ' TYR . 67.5 m -55.83 -25.0 39.76 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 113.132 0.79 . . . . 1.52 113.132 -177.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -105.85 -44.57 4.6 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.275 0.56 . . . . 0.60999999999999999 111.152 -177.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.542 ' HD3' ' HG3' ' A' ' 27' ' ' ARG . 22.6 mmt180 -96.69 -36.59 10.63 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 114.015 1.117 . . . . 0.95999999999999996 114.015 -169.144 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.494 ' HB2' ' HG ' ' A' ' 13' ' ' LEU . 31.7 t -62.48 119.54 9.34 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.977 0.418 . . . . 1.0600000000000001 110.623 -178.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.663 ' HA ' ' CB ' ' A' ' 26' ' ' ARG . 68.6 m-20 -79.05 -4.9 52.47 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.729 -0.669 . . . . 2.2799999999999998 110.749 179.149 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 1.4 m -81.04 161.27 24.27 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.503 0.668 . . . . 2.0499999999999998 110.888 173.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -63.2 -17.64 59.47 Favored Glycine 0 CA--C 1.516 0.149 0 CA-C-N 114.328 -1.306 . . . . 0.29999999999999999 114.119 -173.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.496 ' HB2' ' CA ' ' A' ' 75' ' ' GLY . 2.3 p -67.01 -6.69 18.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 117.207 0.503 . . . . 0.46999999999999997 112.283 177.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.584 ' O ' ' HA ' ' A' ' 63' ' ' SER . 35.2 p90 -52.03 -33.51 38.92 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.136 0.494 . . . . 0.94999999999999996 110.396 174.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -92.36 1.57 57.15 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.058 0.456 . . . . 1.1100000000000001 110.991 -176.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.6 m -115.58 -21.9 9.5 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.147 0.499 . . . . 0.70999999999999996 110.709 -178.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.46 ' O ' ' HA ' ' A' ' 59' ' ' GLU . . . 108.04 15.7 14.0 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.906 -0.664 . . . . 0.67000000000000004 112.02 -175.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.496 ' CA ' ' HB2' ' A' ' 70' ' ' SER . . . 96.65 -9.2 66.43 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.803 -0.713 . . . . 0.42999999999999999 112.885 178.195 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -95.54 145.32 25.3 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.633 0.73 . . . . 1.6499999999999999 111.559 -169.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.459 HD22 ' HE2' ' A' ' 85' ' ' MET . 0.8 OUTLIER -111.96 172.51 6.86 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 114.54 -1.209 . . . . 1.6899999999999999 108.89 171.32 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -92.22 -145.71 16.65 Favored Glycine 0 C--N 1.311 -0.829 0 C-N-CA 120.65 -0.786 . . . . 0.45000000000000001 111.905 -178.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -84.37 140.02 31.86 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.915 -0.402 . . . . 4.7400000000000002 109.915 177.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -152.98 155.6 37.26 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.836 -0.62 . . . . 1.6499999999999999 110.028 -178.241 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 50.5 m -79.74 139.58 37.25 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.463 -0.335 . . . . 1.6899999999999999 110.695 -178.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 33.6 m -61.13 112.87 2.28 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.263 0.554 . . . . 1.55 110.317 179.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 113.82 -11.36 22.99 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.901 -0.666 . . . . 0.79000000000000004 112.023 -177.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -84.93 41.2 0.85 Allowed 'General case' 0 C--O 1.233 0.23 0 CA-C-O 121.657 0.741 . . . . 1.5800000000000001 110.475 -177.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.459 ' HE2' HD22 ' A' ' 77' ' ' LEU . 24.3 mmt -136.82 -127.41 0.14 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.797 -0.638 . . . . 1.1299999999999999 109.342 177.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 63.6 mtt -119.16 153.62 34.59 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 108.133 -1.062 . . . . 1.8899999999999999 108.133 175.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.412 ' HB3' ' HD3' ' A' ' 88' ' ' PRO . 88.4 tttt -52.29 -55.13 34.42 Favored Pre-proline 0 CA--C 1.539 0.526 0 N-CA-C 112.38 0.511 . . . . 2.7400000000000002 112.38 -175.445 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.412 ' HD3' ' HB3' ' A' ' 87' ' ' LYS . 73.4 Cg_endo -74.59 -26.76 11.48 Favored 'Trans proline' 0 C--N 1.357 0.982 0 C-N-CA 121.656 1.57 . . . . 0.29999999999999999 111.976 -176.543 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.606 ' O ' HG21 ' A' ' 93' ' ' VAL . 32.1 t80 -68.31 -56.16 9.57 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.496 -0.774 . . . . 0.28000000000000003 109.416 179.298 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -65.38 -35.17 80.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.72 -0.673 . . . . 2.1200000000000001 109.721 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.582 ' HA ' ' NE ' ' A' ' 94' ' ' ARG . 23.0 t70 -53.79 -33.55 56.31 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.432 -0.804 . . . . 0.60999999999999999 110.978 175.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.551 ' O ' ' HG ' ' A' ' 96' ' ' LEU . . . -84.2 -37.74 21.46 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.408 -0.36 . . . . 1.1000000000000001 111.132 178.571 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.606 HG21 ' O ' ' A' ' 89' ' ' PHE . 15.2 t -61.96 -44.17 98.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-O 121.447 0.641 . . . . 1.1200000000000001 110.723 -177.189 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.582 ' NE ' ' HA ' ' A' ' 91' ' ' ASP . 26.4 ptt180 -74.14 -16.66 60.99 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.606 -0.725 . . . . 3.1800000000000002 110.607 178.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -93.68 12.96 23.67 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.982 -0.554 . . . . 1.0800000000000001 111.51 -174.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.551 ' HG ' ' O ' ' A' ' 92' ' ' ALA . 0.7 OUTLIER -142.14 150.75 41.52 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.152 -0.476 . . . . 1.1200000000000001 110.432 175.396 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.567 ' HA ' ' NH2' ' A' ' 116' ' ' ARG . 23.1 tptm -91.87 164.74 13.56 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.285 -0.635 . . . . 2.1299999999999999 109.285 177.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.44 ' N ' ' HG3' ' A' ' 97' ' ' LYS . 75.7 mt -41.83 115.94 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 123.458 0.474 . . . . 1.6200000000000001 111.38 172.138 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 101.99 -8.07 55.51 Favored Glycine 0 N--CA 1.45 -0.427 0 CA-C-N 115.701 -0.681 . . . . 0.46000000000000002 113.421 177.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.509 ' HB2' ' HB2' ' A' ' 96' ' ' LEU . 40.7 m-20 -99.06 141.22 32.09 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 117.16 0.48 . . . . 0.46000000000000002 110.979 -179.428 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 8.3 mt -106.73 148.67 10.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.016 -0.538 . . . . 1.0800000000000001 110.218 179.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 89.1 p -89.79 150.93 44.88 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 116.245 -0.434 . . . . 1.45 110.671 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -69.88 164.61 34.01 Favored 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 122.379 2.053 . . . . 0.40999999999999998 111.041 171.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.449 HG23 HD21 ' A' ' 44' ' ' LEU . 24.9 mm -40.7 110.94 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 O-C-N 123.75 0.656 . . . . 1.04 112.506 179.577 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.1 p -119.07 123.51 71.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.183 -0.462 . . . . 1.6599999999999999 110.085 175.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -85.73 149.32 25.37 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.098 0.475 . . . . 0.55000000000000004 109.938 177.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 4.4 p -126.56 -172.03 2.54 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.768 -0.651 . . . . 1.05 110.936 -176.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -52.2 -44.36 64.68 Favored 'General case' 0 C--N 1.331 -0.238 0 O-C-N 123.508 0.505 . . . . 2.1600000000000001 110.993 177.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.491 ' O ' ' HB2' ' A' ' 20' ' ' SER . 4.4 m -92.35 -61.14 1.67 Allowed 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 120.05 -0.66 . . . . 1.0900000000000001 112.084 178.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -149.07 -128.35 1.68 Allowed Glycine 0 N--CA 1.438 -1.231 0 C-N-CA 118.749 -1.691 . . . . 0.39000000000000001 113.413 -170.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.476 ' HB3' ' CD2' ' A' ' 44' ' ' LEU . 8.9 mp -116.08 148.88 39.79 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.604 -0.298 . . . . 1.0600000000000001 111.53 -170.572 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . 0.582 ' HA ' ' O ' ' A' ' 13' ' ' LEU . 69.3 m-70 -145.51 150.92 37.32 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.215 0.531 . . . . 0.25 112.023 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.467 HG12 HD11 ' A' ' 44' ' ' LEU . 5.2 pt -130.17 133.87 63.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 107.669 -1.234 . . . . 1.03 107.669 159.659 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 2.8 mp -124.72 144.66 33.9 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 N-CA-C 110.07 -0.345 . . . . 1.0600000000000001 110.07 -176.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.412 ' HA ' ' O ' ' A' ' 100' ' ' ASP . 46.0 pttt -130.42 138.12 50.17 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.932 -0.766 . . . . 1.29 108.932 174.261 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . 0.567 ' NH2' ' HA ' ' A' ' 97' ' ' LYS . 3.6 ttp180 -82.62 135.47 35.05 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.474 -0.49 . . . . 2.6800000000000002 111.236 -177.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.419 HD21 ' HB3' ' A' ' 11' ' ' ALA . 0.3 OUTLIER -102.28 -30.65 10.96 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.69 -0.687 . . . . 1.54 110.974 177.714 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.453 ' O ' ' HD2' ' A' ' 116' ' ' ARG . . . . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.649 -0.691 . . . . 1.1499999999999999 110.689 -178.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 24.3 ptp . . . . . 0 N--CA 1.483 1.189 0 CA-C-O 121.039 0.447 . . . . 7.54 110.893 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 39.8 t -131.86 121.63 24.38 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.788 0.327 . . . . 3.0899999999999999 110.172 -178.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -89.61 106.94 18.79 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.178 -0.464 . . . . 2.7999999999999998 110.324 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 69.3 mmtt -137.74 149.0 46.09 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.527 0.68 . . . . 1.6899999999999999 111.487 -178.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.622 ' O ' ' HA ' ' A' ' 79' ' ' PHE . 3.2 tt -154.61 151.45 28.83 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.01 -1.107 . . . . 1.79 108.01 -176.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.563 ' N ' HD22 ' A' ' 8' ' ' LEU . 65.1 ttt180 -135.05 131.64 37.27 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 108.722 -0.844 . . . . 1.3700000000000001 108.722 173.476 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -148.99 150.9 33.63 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 120.066 -0.653 . . . . 1.0700000000000001 112.337 -175.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -104.42 133.39 49.38 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.318 -0.855 . . . . 1.04 109.057 178.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 26.0 p-80 -135.88 154.66 51.08 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.105 0.479 . . . . 0.34000000000000002 111.714 -172.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.544 HD23 ' N ' ' A' ' 14' ' ' LEU . 5.8 tt -123.93 148.98 46.44 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.538 -0.912 . . . . 1.0600000000000001 108.538 177.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.551 ' HA ' ' O ' ' A' ' 111' ' ' LEU . 24.5 tp -131.21 135.75 47.67 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 110.346 -0.242 . . . . 1.0800000000000001 110.346 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.408 HG21 HD11 ' A' ' 44' ' ' LEU . 57.4 t -121.17 128.98 76.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 N-CA-C 109.619 -0.511 . . . . 1.01 109.619 172.566 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.48 ' HE3' HD21 ' A' ' 14' ' ' LEU . 12.6 mmtp -103.57 148.48 25.94 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.996 -0.547 . . . . 1.22 109.777 178.115 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.471 ' HB3' ' HB1' ' A' ' 40' ' ' ALA . 53.6 p90 -143.75 162.62 35.54 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.144 -0.48 . . . . 0.29999999999999999 110.685 -178.442 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.42 ' HB3' ' HA ' ' A' ' 33' ' ' ALA . 19.7 p -49.46 112.25 0.61 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.144 -0.48 . . . . 1.6000000000000001 111.509 178.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 95.89 8.6 57.97 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.681 -0.771 . . . . 0.53000000000000003 113.56 178.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.45 ' C ' ' H ' ' A' ' 22' ' ' ASN . 77.3 p -91.11 43.3 1.14 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 117.59 0.695 . . . . 1.28 111.002 -177.672 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 74.5 ttt180 73.45 -32.79 0.25 Allowed 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.4 0.68 . . . . 4.1600000000000001 111.418 177.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.45 ' H ' ' C ' ' A' ' 20' ' ' SER . 43.7 m-80 -135.55 100.74 11.16 Favored Pre-proline 0 C--N 1.324 -0.527 0 N-CA-C 109.209 -0.663 . . . . 1.77 109.209 175.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.587 ' C ' HG21 ' A' ' 32' ' ' THR . 92.7 Cg_endo -82.69 41.35 1.1 Allowed 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.372 2.048 . . . . 1.71 112.756 -175.636 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.408 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 89.5 t -141.54 116.88 5.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 108.626 -0.879 . . . . 1.1599999999999999 108.626 177.529 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.545 ' HB2' ' OD1' ' A' ' 67' ' ' ASP . 19.7 p -103.57 154.85 19.04 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 110.286 -0.265 . . . . 1.4299999999999999 110.286 -177.487 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.432 ' CG ' ' HA ' ' A' ' 67' ' ' ASP . 35.2 mmt180 -69.03 -22.97 64.02 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 108.661 -0.866 . . . . 3.1200000000000001 108.661 173.352 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.421 ' HG3' ' HD2' ' A' ' 65' ' ' ARG . 5.3 tmm_? -70.74 -32.85 70.17 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 114.351 -1.295 . . . . 2.25 110.421 -179.209 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 75.4 p -100.04 -35.3 9.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.426 0.632 . . . . 1.1299999999999999 110.795 178.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 65.65 18.26 65.74 Favored Glycine 0 N--CA 1.453 -0.201 0 CA-C-N 114.877 -1.056 . . . . 0.81999999999999995 112.304 -178.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -141.95 -72.0 0.33 Allowed 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.769 -0.456 . . . . 2.1000000000000001 109.769 -179.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.408 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 6.2 p -155.2 148.74 25.2 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.885 -0.598 . . . . 1.3300000000000001 110.115 173.265 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.587 HG21 ' C ' ' A' ' 23' ' ' PRO . 14.5 t -113.42 22.69 13.94 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.939 0.876 . . . . 1.02 109.217 178.01 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.42 ' HA ' ' HB3' ' A' ' 18' ' ' SER . . . -72.58 -6.49 44.44 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.904 -1.044 . . . . 1.1299999999999999 111.719 -177.538 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -96.22 -24.0 16.45 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.108 0.48 . . . . 2.21 111.118 -178.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.453 HG21 ' HB2' ' A' ' 39' ' ' ASP . 0.2 OUTLIER -96.77 135.1 32.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.279 -0.419 . . . . 1.1100000000000001 109.972 179.531 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 59.6 p -96.31 -179.34 4.61 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.348 -0.387 . . . . 1.2 109.957 -175.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.412 ' O ' HG13 ' A' ' 41' ' ' ILE . 4.3 p90 -64.62 -27.22 68.79 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.967 -0.753 . . . . 2.21 108.967 175.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -74.13 -43.31 57.97 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 116.004 -0.544 . . . . 0.95999999999999996 110.412 178.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.453 ' HB2' HG21 ' A' ' 35' ' ' VAL . 19.4 m-20 -65.36 -33.63 76.41 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.523 0.677 . . . . 0.91000000000000003 109.934 175.602 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.471 ' HB1' ' HB3' ' A' ' 17' ' ' PHE . . . -70.79 -46.53 62.69 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.789 -1.096 . . . . 1.03 110.707 -179.631 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.412 HG13 ' O ' ' A' ' 37' ' ' TYR . 68.7 mt -63.18 -36.43 75.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 110.09 -0.337 . . . . 1.0800000000000001 110.09 176.471 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -64.3 -25.18 67.93 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.29 0.567 . . . . 2.8399999999999999 110.021 178.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.459 ' HG3' ' CD1' ' A' ' 47' ' ' TRP . 5.8 tp10 -84.87 -52.32 6.1 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.433 -0.803 . . . . 1.02 109.024 -178.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.485 HD13 HG12 ' A' ' 113' ' ' ILE . 30.9 tp -62.72 -37.57 87.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.045 -0.98 . . . . 1.02 110.535 -175.008 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.452 HE21 ' HA ' ' A' ' 45' ' ' GLN . 0.0 OUTLIER -67.18 -28.93 68.5 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 112.304 0.483 . . . . 0.87 112.304 -177.882 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -78.35 -43.39 27.81 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.636 -0.426 . . . . 1.98 110.131 178.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.459 ' CD1' ' HG3' ' A' ' 43' ' ' GLU . 49.3 m95 -64.48 -47.14 80.09 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 111.974 0.361 . . . . 0.60999999999999999 111.974 176.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.442 ' HB3' HG22 ' A' ' 113' ' ' ILE . 88.7 p -63.99 -25.58 68.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.987 0.422 . . . . 0.88 110.15 177.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.442 ' HB2' ' O ' ' A' ' 45' ' ' GLN . 14.2 tt0 -71.97 -56.13 6.22 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.994 -0.548 . . . . 0.55000000000000004 110.071 175.09 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.508 ' HB3' HG23 ' A' ' 56' ' ' VAL . 97.2 mtt180 -61.12 -41.93 97.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.935 -0.575 . . . . 0.47999999999999998 111.646 -176.443 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.468 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 93.9 mt -60.66 -36.82 73.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 120.976 0.417 . . . . 1.04 110.458 177.224 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -77.99 -37.37 47.39 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.01 -0.541 . . . . 1.0600000000000001 111.426 -179.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 55.4 p -78.69 -29.19 45.39 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.843 0.354 . . . . 0.34999999999999998 111.488 -177.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 106.28 9.56 31.37 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.764 -0.732 . . . . 0.33000000000000002 112.318 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.448 ' HB2' ' HB3' ' A' ' 50' ' ' ARG . 45.4 mt-10 -67.47 -45.11 76.87 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.895 0.379 . . . . 0.65000000000000002 110.348 178.473 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.508 HG23 ' HB3' ' A' ' 50' ' ' ARG . 11.5 m -135.95 154.78 34.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 109.088 -0.708 . . . . 1.05 109.088 171.493 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.5 m -85.65 159.0 19.94 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.191 -0.67 . . . . 1.3100000000000001 109.191 177.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -53.94 -46.97 71.72 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.938 0.399 . . . . 0.25 109.972 -177.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.546 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 48.8 mt-10 -61.58 -26.44 67.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.533 -0.758 . . . . 1.72 112.46 -179.061 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 53.8 mm-40 -72.92 -50.91 20.78 Favored 'General case' 0 CA--C 1.519 -0.223 0 C-N-CA 120.516 -0.473 . . . . 2.0899999999999999 110.358 178.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -67.95 -47.34 68.92 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.185 -0.461 . . . . 1.0700000000000001 111.127 -177.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -57.39 -53.62 56.04 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.217 0.451 . . . . 1.0600000000000001 112.217 -174.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.532 ' HA ' ' O ' ' A' ' 71' ' ' TYR . 23.5 m -52.3 -18.15 1.45 Allowed 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 113.614 0.968 . . . . 1.52 113.614 -178.227 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -110.41 -43.89 3.81 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-O 121.577 0.703 . . . . 0.60999999999999999 110.309 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.428 ' HG3' ' CE2' ' A' ' 47' ' ' TRP . 15.5 mmt180 -96.34 -36.86 10.72 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 114.212 1.19 . . . . 0.95999999999999996 114.212 -170.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.443 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 52.6 p -63.37 116.0 5.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.263 0.554 . . . . 1.0600000000000001 110.362 -176.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.545 ' OD1' ' HB2' ' A' ' 25' ' ' SER . 57.3 m-20 -84.71 9.68 13.3 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.536 -0.756 . . . . 2.2799999999999998 111.123 -177.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 1.1 m -80.95 -177.33 6.36 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.666 -0.697 . . . . 2.0499999999999998 110.294 170.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -76.09 -21.0 76.92 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.358 -0.925 . . . . 0.29999999999999999 111.699 175.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 71.2 p -65.84 0.46 1.77 Allowed 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 113.227 0.825 . . . . 0.46999999999999997 113.227 -178.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.532 ' O ' ' HA ' ' A' ' 63' ' ' SER . 27.7 p90 -62.94 -22.6 66.9 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 118.361 0.528 . . . . 0.94999999999999996 109.928 176.384 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -94.24 -2.94 51.58 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.382 0.61 . . . . 1.1100000000000001 110.087 177.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.6 m -115.49 1.01 13.54 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.296 -0.865 . . . . 0.70999999999999996 110.596 -175.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.546 ' O ' ' HA ' ' A' ' 59' ' ' GLU . . . 72.9 21.84 79.52 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.935 -0.65 . . . . 0.67000000000000004 111.998 -176.434 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 86.28 -20.58 21.04 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 121.026 -0.606 . . . . 0.42999999999999999 112.099 -177.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -69.93 132.04 45.34 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-N 115.553 -0.323 . . . . 1.6499999999999999 110.984 -176.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.489 ' O ' ' HG3' ' A' ' 9' ' ' ARG . 2.9 mp -118.17 161.82 19.24 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.248 0.547 . . . . 1.6899999999999999 110.283 174.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -85.71 -165.46 40.6 Favored Glycine 0 C--N 1.31 -0.913 0 CA-C-N 114.899 -1.046 . . . . 0.45000000000000001 112.834 -178.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.622 ' HA ' ' O ' ' A' ' 8' ' ' LEU . 85.0 m-85 -73.91 142.97 45.94 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.271 0.558 . . . . 4.7400000000000002 112.221 -176.301 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.528 ' CE1' ' HB3' ' A' ' 8' ' ' LEU . 2.3 p90 -149.69 167.93 25.03 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.964 -1.016 . . . . 1.6499999999999999 108.787 176.336 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 37.3 m -96.63 122.46 39.57 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 108.478 -0.934 . . . . 1.6899999999999999 108.478 170.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 4.6 p -47.14 123.05 4.97 Favored 'General case' 0 C--N 1.329 -0.306 0 O-C-N 123.662 0.602 . . . . 1.55 111.409 -179.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 114.49 17.78 6.91 Favored Glycine 0 N--CA 1.445 -0.766 0 N-CA-C 110.911 -0.875 . . . . 0.79000000000000004 110.911 -174.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -115.09 -17.02 11.54 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 120.587 0.232 . . . . 1.5800000000000001 111.173 -178.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 26.4 mmt -86.22 -92.37 0.09 Allowed 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.315 -0.554 . . . . 1.1299999999999999 110.895 -173.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' MET . . . . . 0.491 ' HB2' ' CB ' ' A' ' 89' ' ' PHE . 45.6 mtt -144.22 155.34 43.84 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 107.228 -1.397 . . . . 1.8899999999999999 107.228 177.06 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp -57.95 -53.54 64.72 Favored Pre-proline 0 C--N 1.317 -0.847 0 C-N-CA 120.274 -0.57 . . . . 2.7400000000000002 112.059 -176.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.457 ' HG2' HG22 ' A' ' 107' ' ' THR . 73.4 Cg_endo -74.81 -30.12 7.85 Favored 'Trans proline' 0 C--N 1.356 0.962 0 C-N-CA 121.736 1.624 . . . . 0.29999999999999999 111.855 -179.315 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.612 ' O ' HG22 ' A' ' 93' ' ' VAL . 11.2 t80 -61.97 -56.14 22.19 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.561 -0.745 . . . . 0.28000000000000003 109.181 176.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.15 -33.32 74.28 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.284 -0.871 . . . . 2.1200000000000001 110.5 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -60.55 -32.58 71.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.676 -0.693 . . . . 0.60999999999999999 110.581 178.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.427 ' O ' ' HG ' ' A' ' 96' ' ' LEU . . . -83.86 -31.18 25.9 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.0 -0.545 . . . . 1.1000000000000001 111.055 178.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.612 HG22 ' O ' ' A' ' 89' ' ' PHE . 20.2 t -68.8 -38.48 78.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.404 0.621 . . . . 1.1200000000000001 109.781 -176.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.45 ' C ' ' HD2' ' A' ' 94' ' ' ARG . 2.8 ppt_? -79.44 -1.31 36.75 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.522 -0.763 . . . . 3.1800000000000002 110.61 178.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -103.6 9.94 37.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 1.0800000000000001 111.285 -177.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.521 ' HB2' ' HB2' ' A' ' 100' ' ' ASP . 1.0 OUTLIER -145.96 146.26 30.96 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.354 -0.385 . . . . 1.1200000000000001 110.965 179.51 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.413 ' HG3' ' N ' ' A' ' 98' ' ' ILE . 56.6 tptt -91.01 168.98 11.26 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.773 -0.825 . . . . 2.1299999999999999 108.773 177.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.431 ' HA ' ' HG2' ' A' ' 116' ' ' ARG . 72.0 mt -45.43 116.94 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.111 0.481 . . . . 1.6200000000000001 111.234 173.593 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 103.47 -11.8 54.3 Favored Glycine 0 N--CA 1.449 -0.438 0 CA-C-N 115.54 -0.755 . . . . 0.46000000000000002 113.115 178.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.521 ' HB2' ' HB2' ' A' ' 96' ' ' LEU . 14.6 m-20 -93.96 144.28 25.6 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 117.191 0.496 . . . . 0.46000000000000002 110.716 -179.594 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 10.0 mt -112.62 147.93 16.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.756 -0.656 . . . . 1.0800000000000001 109.67 -179.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 91.4 p -89.89 157.41 46.11 Favored Pre-proline 0 C--N 1.319 -0.733 0 CA-C-N 116.356 -0.384 . . . . 1.45 110.365 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -74.23 173.82 13.53 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 122.267 1.978 . . . . 0.40999999999999998 111.132 171.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.44 HG23 HD23 ' A' ' 44' ' ' LEU . 21.9 mm -46.51 113.4 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-O 121.133 0.492 . . . . 1.04 112.019 176.266 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 93.4 t -111.72 117.77 55.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.91 -0.586 . . . . 1.6599999999999999 109.831 174.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -86.04 137.97 32.3 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.107 0.48 . . . . 0.55000000000000004 110.278 177.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.457 HG22 ' HG2' ' A' ' 88' ' ' PRO . 20.1 p -123.77 -172.23 2.49 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.664 -0.698 . . . . 1.05 110.21 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -66.67 -44.24 82.38 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.664 0.269 . . . . 2.1600000000000001 110.996 178.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 5.3 t -95.63 -1.41 50.3 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.302 0.482 . . . . 1.0900000000000001 112.302 -173.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 157.67 -124.68 1.44 Allowed Glycine 0 N--CA 1.437 -1.277 0 C-N-CA 119.775 -1.202 . . . . 0.39000000000000001 112.995 170.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.551 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 6.6 mp -127.9 145.66 50.88 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.112 -0.544 . . . . 1.0600000000000001 110.807 -170.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . 0.54 ' NE2' HD11 ' A' ' 14' ' ' LEU . 80.8 m-70 -143.95 143.06 31.07 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.486 0.551 . . . . 0.25 112.486 -178.276 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.485 HG12 HD13 ' A' ' 44' ' ' LEU . 3.9 pt -127.07 141.55 45.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 107.884 -1.154 . . . . 1.03 107.884 161.113 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 2.8 mp -132.35 148.47 31.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 C-N-CA 120.976 -0.29 . . . . 1.0600000000000001 110.396 -175.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 44.9 pttt -131.62 139.32 49.11 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.016 -0.735 . . . . 1.29 109.016 172.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . 0.431 ' HG2' ' HA ' ' A' ' 98' ' ' ILE . 5.9 ttp180 -84.1 136.48 33.99 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.104 0.478 . . . . 2.6800000000000002 111.494 -178.507 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -107.09 -27.96 10.28 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.295 -0.866 . . . . 1.54 110.743 177.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.868 0 CA-C-O 118.291 -0.862 . . . . 1.1499999999999999 110.452 179.691 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.8 mpt? . . . . . 0 N--CA 1.48 1.026 0 CA-C-O 120.915 0.388 . . . . 7.54 110.242 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 57.0 p -97.78 161.57 13.69 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.192 -0.458 . . . . 3.0899999999999999 110.657 -177.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -119.34 -6.75 10.31 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.018 -0.537 . . . . 2.7999999999999998 110.517 -177.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -79.06 127.34 31.87 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 121.859 0.838 . . . . 1.6899999999999999 111.532 -175.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.521 HD22 ' H ' ' A' ' 9' ' ' ARG . 2.4 tt -119.53 159.92 23.4 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 114.242 -1.345 . . . . 1.79 107.883 179.805 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.521 ' H ' HD22 ' A' ' 8' ' ' LEU . 63.2 ttt180 -140.46 127.07 20.26 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 108.869 -0.789 . . . . 1.3700000000000001 108.869 175.759 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.426 ' N ' ' HZ ' ' A' ' 80' ' ' PHE . . . -141.09 154.1 45.76 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 120.31 -0.556 . . . . 1.0700000000000001 112.231 -179.453 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.465 ' HA ' ' HA ' ' A' ' 76' ' ' ASP . . . -104.46 134.81 47.04 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.334 -0.848 . . . . 1.04 108.922 174.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 16.7 p-80 -141.59 138.51 32.67 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.969 0.414 . . . . 0.34000000000000002 111.125 -171.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.555 ' O ' ' HA ' ' A' ' 112' ' ' HIS . 6.0 tt -109.43 137.31 47.48 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.326 -0.99 . . . . 1.0600000000000001 108.326 177.378 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.587 HD12 ' NE2' ' A' ' 112' ' ' HIS . 17.4 tp -120.23 135.03 55.12 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.615 -0.266 . . . . 1.0800000000000001 110.837 -176.515 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.423 HG23 HD12 ' A' ' 44' ' ' LEU . 83.4 t -121.89 133.62 67.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 109.854 -0.424 . . . . 1.01 109.854 174.293 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.518 ' HE3' HD22 ' A' ' 14' ' ' LEU . 32.7 mmtp -104.76 149.75 25.35 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.917 -0.583 . . . . 1.22 110.495 177.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.525 ' HB3' ' HB3' ' A' ' 40' ' ' ALA . 49.9 p90 -145.4 163.04 35.85 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.702 -0.681 . . . . 0.29999999999999999 109.674 179.456 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.446 ' HB3' ' HA ' ' A' ' 33' ' ' ALA . 29.9 p -51.67 109.35 0.35 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.923 0.392 . . . . 1.6000000000000001 110.425 176.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 109.93 9.28 24.7 Favored Glycine 0 CA--C 1.523 0.585 0 C-N-CA 120.625 -0.798 . . . . 0.53000000000000003 112.795 -176.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.516 ' C ' ' H ' ' A' ' 22' ' ' ASN . 75.4 m -90.2 34.24 0.87 Allowed 'General case' 0 C--O 1.235 0.3 0 N-CA-C 112.359 0.503 . . . . 1.28 112.359 -177.599 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.451 ' HB3' ' O ' ' A' ' 20' ' ' SER . 20.8 ttt85 72.94 -30.33 0.21 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 122.925 0.49 . . . . 4.1600000000000001 110.917 -179.686 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.516 ' H ' ' C ' ' A' ' 20' ' ' SER . 6.1 p30 -146.96 114.54 4.29 Favored Pre-proline 0 C--N 1.322 -0.618 0 N-CA-C 108.843 -0.799 . . . . 1.77 108.843 172.34 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.448 ' C ' HG21 ' A' ' 32' ' ' THR . 93.6 Cg_endo -86.21 52.5 2.91 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 122.573 2.182 . . . . 1.71 113.403 -173.009 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 61.0 t -142.53 119.78 6.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 109.342 -0.614 . . . . 1.1599999999999999 109.342 177.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.447 ' HB3' ' HB2' ' A' ' 16' ' ' LYS . 13.5 p -103.83 156.08 18.11 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 121.211 -0.196 . . . . 1.4299999999999999 110.886 -179.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.63 ' HB2' ' HA ' ' A' ' 67' ' ' ASP . 1.7 mpt_? -69.82 -16.99 63.37 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 109.155 -0.683 . . . . 3.1200000000000001 109.155 173.443 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.463 ' HG2' ' HA ' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -82.42 -25.5 33.62 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.896 -1.047 . . . . 2.25 111.008 -178.629 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 73.3 p -105.33 -36.05 7.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.244 0.545 . . . . 1.1299999999999999 110.934 178.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 76.27 -21.63 2.24 Favored Glycine 0 CA--C 1.52 0.395 0 CA-C-N 115.308 -0.86 . . . . 0.81999999999999995 112.983 -179.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -101.76 -76.15 0.58 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.119 0.485 . . . . 2.1000000000000001 110.043 -179.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 21.4 m -154.75 151.47 28.73 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.804 -0.635 . . . . 1.3300000000000001 109.885 175.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.448 HG21 ' C ' ' A' ' 23' ' ' PRO . 12.4 t -113.8 23.0 13.46 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 122.181 0.991 . . . . 1.02 109.145 177.478 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.446 ' HA ' ' HB3' ' A' ' 18' ' ' SER . . . -71.71 -5.6 35.07 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.715 -1.129 . . . . 1.1299999999999999 111.401 -178.555 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -99.09 -15.24 19.07 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.602 -0.726 . . . . 2.21 110.688 -175.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -105.57 138.44 30.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.93 -0.577 . . . . 1.1100000000000001 109.704 179.772 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 62.4 p -94.77 -179.48 4.87 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.395 -0.366 . . . . 1.2 110.014 -175.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.519 ' O ' HG13 ' A' ' 41' ' ' ILE . 15.4 p90 -63.65 -28.35 69.85 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 119.986 -0.686 . . . . 2.21 109.223 176.302 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -75.11 -44.66 45.92 Favored 'General case' 0 CA--C 1.522 -0.132 0 CA-C-N 116.182 -0.463 . . . . 0.95999999999999996 110.682 178.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -62.87 -33.29 74.98 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.479 0.656 . . . . 0.91000000000000003 109.639 176.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.525 ' HB3' ' HB3' ' A' ' 17' ' ' PHE . . . -68.6 -44.64 73.91 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.944 -1.026 . . . . 1.03 110.671 178.269 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.519 HG13 ' O ' ' A' ' 37' ' ' TYR . 90.2 mt -63.28 -35.04 70.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 109.612 -0.514 . . . . 1.0800000000000001 109.612 175.023 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.421 ' HA ' ' HD2' ' A' ' 42' ' ' LYS . 23.5 mmmt -64.67 -21.29 66.7 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.072 -0.513 . . . . 2.8399999999999999 111.06 176.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.402 ' HG3' ' CD1' ' A' ' 47' ' ' TRP . 2.0 tp10 -88.57 -57.46 2.91 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.881 -0.6 . . . . 1.02 109.561 178.04 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.493 HD11 HG12 ' A' ' 113' ' ' ILE . 27.7 tp -58.8 -36.78 75.02 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.404 -0.816 . . . . 1.02 111.469 -175.302 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.524 ' O ' ' HB2' ' A' ' 49' ' ' GLN . 4.8 mm-40 -66.45 -26.5 67.24 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 112.23 0.456 . . . . 0.87 112.23 -177.397 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.404 ' HE3' ' O ' ' A' ' 42' ' ' LYS . 96.7 mttt -78.88 -45.52 20.46 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.101 0.476 . . . . 1.98 109.832 178.08 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.402 ' CD1' ' HG3' ' A' ' 43' ' ' GLU . 24.3 m95 -67.21 -43.52 81.85 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.799 -0.637 . . . . 0.60999999999999999 111.554 -178.095 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.474 ' HB3' HG22 ' A' ' 113' ' ' ILE . 97.2 p -67.18 -27.75 67.53 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 120.935 0.397 . . . . 0.88 109.969 177.211 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.524 ' HB2' ' O ' ' A' ' 45' ' ' GLN . 8.9 tt0 -67.58 -52.94 32.61 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 115.933 -0.576 . . . . 0.55000000000000004 109.638 175.611 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.479 ' HB3' HG21 ' A' ' 56' ' ' VAL . 91.6 mtt180 -60.97 -42.35 98.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.705 -0.68 . . . . 0.47999999999999998 111.556 -178.51 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.432 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 78.4 mt -60.29 -40.74 84.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.94 0.4 . . . . 1.04 110.744 177.354 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.4 -39.0 65.42 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.941 -0.572 . . . . 1.0600000000000001 111.979 179.035 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 74.7 p -79.75 -29.37 40.48 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 111.809 0.3 . . . . 0.34999999999999998 111.809 -175.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 109.11 4.27 31.18 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.599 -0.81 . . . . 0.33000000000000002 112.898 179.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.436 ' HB2' ' HB3' ' A' ' 50' ' ' ARG . 46.7 mt-10 -62.05 -47.01 86.59 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.089 0.471 . . . . 0.65000000000000002 110.084 177.443 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.479 HG21 ' HB3' ' A' ' 50' ' ' ARG . 10.2 m -134.9 159.0 41.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.821 -0.627 . . . . 1.05 109.378 171.743 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 19.7 m -92.98 161.96 14.25 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 109.562 -0.533 . . . . 1.3100000000000001 109.562 177.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -54.19 -48.19 71.26 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.728 0.299 . . . . 0.25 110.452 -175.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.451 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 43.6 mt-10 -56.4 -40.36 74.51 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.739 -0.664 . . . . 1.72 111.948 179.469 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -63.82 -50.25 69.67 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.0 0.429 . . . . 2.0899999999999999 110.738 -178.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -68.91 -46.5 68.14 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.877 -0.602 . . . . 1.0700000000000001 111.132 -177.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.405 ' O ' ' HB3' ' A' ' 66' ' ' SER . . . -60.12 -46.28 90.15 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.648 0.61 . . . . 1.0600000000000001 112.648 -173.304 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.483 ' HA ' ' HA ' ' A' ' 71' ' ' TYR . 20.4 m -57.75 -20.36 34.39 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.781 0.66 . . . . 1.52 112.781 -178.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -110.72 -46.58 3.35 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.521 0.677 . . . . 0.60999999999999999 110.726 -178.331 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.463 ' HA ' ' HG2' ' A' ' 27' ' ' ARG . 18.8 mmt180 -90.17 -37.65 14.03 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.963 -1.017 . . . . 0.95999999999999996 113.174 -170.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.447 ' O ' ' HB3' ' A' ' 71' ' ' TYR . 42.7 t -64.36 115.71 5.36 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.243 0.544 . . . . 1.0600000000000001 110.953 -177.57 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.63 ' HA ' ' HB2' ' A' ' 26' ' ' ARG . 44.5 m-20 -82.28 10.16 7.49 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.416 -0.811 . . . . 2.2799999999999998 111.024 179.589 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.479 ' O ' ' HD1' ' A' ' 71' ' ' TYR . 49.6 t -93.34 166.34 12.34 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.07 -0.513 . . . . 2.0499999999999998 109.728 172.458 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -56.19 -26.83 50.94 Favored Glycine 0 CA--C 1.519 0.293 0 O-C-N 123.41 0.444 . . . . 0.29999999999999999 113.315 -177.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.521 ' HB2' ' CA ' ' A' ' 75' ' ' GLY . 2.6 p -61.83 -8.26 4.68 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 112.849 0.685 . . . . 0.46999999999999997 112.849 -179.565 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.483 ' HA ' ' HA ' ' A' ' 63' ' ' SER . 15.5 p90 -59.46 -29.73 68.01 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 108.979 -0.749 . . . . 0.94999999999999996 108.979 174.112 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -95.33 8.59 42.69 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.741 -0.663 . . . . 1.1100000000000001 111.045 179.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 5.0 m -125.29 -20.87 4.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.626 -0.261 . . . . 0.70999999999999996 111.435 -177.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.451 ' O ' ' HA ' ' A' ' 59' ' ' GLU . . . 109.42 15.95 11.74 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.624 -0.798 . . . . 0.67000000000000004 112.343 -177.602 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.521 ' CA ' ' HB2' ' A' ' 70' ' ' SER . . . 89.63 -12.99 65.33 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.75 -0.738 . . . . 0.42999999999999999 113.04 177.701 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.465 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 10.6 p-10 -106.35 144.56 32.86 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.507 0.67 . . . . 1.6499999999999999 111.372 -171.266 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -105.74 174.48 5.86 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.756 -1.111 . . . . 1.6899999999999999 109.725 176.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -90.63 -143.75 11.34 Favored Glycine 0 C--N 1.315 -0.614 0 C-N-CA 121.019 -0.61 . . . . 0.45000000000000001 112.232 -179.15 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -88.31 123.77 33.23 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.018 0.437 . . . . 4.7400000000000002 110.621 178.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.426 ' HZ ' ' N ' ' A' ' 10' ' ' ALA . 2.3 p90 -137.82 146.45 43.51 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.887 -0.597 . . . . 1.6499999999999999 110.351 -179.515 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 36.6 m -76.19 137.88 40.31 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 120.829 0.347 . . . . 1.6899999999999999 110.096 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 16.7 m -63.92 118.99 9.2 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.984 -0.553 . . . . 1.55 111.332 -175.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 114.49 -5.34 23.06 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.986 -0.626 . . . . 0.79000000000000004 112.387 -178.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -104.24 59.96 0.72 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.255 0.55 . . . . 1.5800000000000001 110.682 -179.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 23.0 mmt -144.03 -97.46 0.11 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.031 0.443 . . . . 1.1299999999999999 110.453 177.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 63.6 mtt -146.32 151.04 36.88 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.015 -1.106 . . . . 1.8899999999999999 108.015 173.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.405 ' HB3' ' HD3' ' A' ' 88' ' ' PRO . 23.1 tptm -52.98 -53.16 58.31 Favored Pre-proline 0 C--N 1.319 -0.738 0 N-CA-C 112.445 0.535 . . . . 2.7400000000000002 112.445 -176.231 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.405 ' HD3' ' HB3' ' A' ' 87' ' ' LYS . 75.6 Cg_endo -77.77 -26.04 7.23 Favored 'Trans proline' 0 C--N 1.356 0.938 0 C-N-CA 121.734 1.623 . . . . 0.29999999999999999 112.587 -176.501 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.542 ' O ' HG21 ' A' ' 93' ' ' VAL . 43.6 t80 -73.26 -55.24 6.7 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.805 -0.634 . . . . 0.28000000000000003 109.824 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -64.27 -35.12 79.81 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.241 -0.891 . . . . 2.1200000000000001 110.022 -178.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.561 ' HA ' ' CZ ' ' A' ' 94' ' ' ARG . 15.6 t70 -50.16 -40.85 47.92 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.735 -0.666 . . . . 0.60999999999999999 110.795 175.107 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.586 ' O ' ' HG ' ' A' ' 96' ' ' LEU . . . -78.24 -30.74 48.84 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.098 -0.501 . . . . 1.1000000000000001 111.184 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.542 HG21 ' O ' ' A' ' 89' ' ' PHE . 26.3 t -63.39 -47.74 90.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.676 -0.238 . . . . 1.1200000000000001 111.244 -174.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.561 ' CZ ' ' HA ' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -83.75 -4.92 59.02 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.247 -0.581 . . . . 3.1800000000000002 110.582 -179.476 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.27 -20.68 40.4 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.057 0.456 . . . . 1.0800000000000001 110.906 -179.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.586 ' HG ' ' O ' ' A' ' 92' ' ' ALA . 0.7 OUTLIER -121.02 147.37 45.59 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.969 -0.559 . . . . 1.1200000000000001 110.441 -179.909 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.412 ' HG3' ' N ' ' A' ' 98' ' ' ILE . 51.3 tptt -90.19 172.67 8.63 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.438 -0.578 . . . . 2.1299999999999999 109.438 -179.519 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.415 ' HA ' ' HG2' ' A' ' 116' ' ' ARG . 71.4 mt -48.26 113.67 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.934 0.397 . . . . 1.6200000000000001 111.377 176.233 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 101.78 -3.69 52.94 Favored Glycine 0 CA--C 1.522 0.481 0 C-N-CA 120.939 -0.648 . . . . 0.46000000000000002 113.913 178.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.552 ' HB2' ' HB2' ' A' ' 96' ' ' LEU . 26.1 m-20 -99.15 142.47 30.6 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 117.599 0.7 . . . . 0.46000000000000002 110.353 178.565 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 8.9 mt -109.69 152.32 11.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.428 -0.351 . . . . 1.0800000000000001 110.307 -178.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 4.7 p -101.35 148.34 35.04 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-O 121.007 0.432 . . . . 1.45 111.555 -178.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -68.94 159.85 52.23 Favored 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.697 2.265 . . . . 0.40999999999999998 111.145 171.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.452 HG21 HD21 ' A' ' 44' ' ' LEU . 22.1 mm -39.26 112.19 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 O-C-N 123.823 0.702 . . . . 1.04 112.557 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 1.9 p -116.37 128.1 73.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.813 -0.63 . . . . 1.6599999999999999 110.128 175.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -90.53 138.37 31.61 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 121.247 0.546 . . . . 0.55000000000000004 110.15 178.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.403 HG22 ' HG2' ' A' ' 88' ' ' PRO . 11.5 p -116.35 -175.91 2.85 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.577 -0.738 . . . . 1.05 110.68 -177.316 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -57.99 -42.21 84.66 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 123.287 0.367 . . . . 2.1600000000000001 111.009 179.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.437 ' OG ' ' HE2' ' A' ' 16' ' ' LYS . 24.5 t -85.16 -61.38 1.78 Allowed 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 116.493 -0.321 . . . . 1.0900000000000001 110.56 179.394 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -154.39 -128.68 1.22 Allowed Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 119.399 -1.381 . . . . 0.39000000000000001 113.39 -174.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.407 ' HB3' HD22 ' A' ' 44' ' ' LEU . 5.8 mp -112.35 145.43 40.08 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 122.379 0.272 . . . . 1.0600000000000001 111.676 -171.795 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . 0.587 ' NE2' HD12 ' A' ' 14' ' ' LEU . 76.5 m-70 -142.2 153.36 43.95 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 112.947 0.721 . . . . 0.25 112.947 178.001 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.493 HG12 HD11 ' A' ' 44' ' ' LEU . 4.3 pt -131.38 134.74 60.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 114.347 -1.297 . . . . 1.03 107.684 159.67 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.4 HD11 ' HB2' ' A' ' 92' ' ' ALA . 1.5 mp -128.14 146.22 34.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 C-N-CA 120.734 -0.386 . . . . 1.0600000000000001 110.905 -176.126 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 37.2 pttt -129.5 141.06 51.08 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.346 -0.983 . . . . 1.29 108.346 170.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . 0.483 ' HD3' HD21 ' A' ' 8' ' ' LEU . 4.7 ttp180 -82.22 134.9 35.32 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.255 -0.578 . . . . 2.6800000000000002 110.857 -179.189 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -103.07 -35.1 8.64 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.191 -0.913 . . . . 1.54 110.286 -179.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.937 0 CA-C-O 118.555 -0.736 . . . . 1.1499999999999999 110.485 -179.607 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 22.8 ptp . . . . . 0 N--CA 1.48 1.037 0 N-CA-C 111.581 0.215 . . . . 7.54 111.581 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 20.6 p -76.79 -84.4 0.06 Allowed 'General case' 0 C--O 1.233 0.201 0 N-CA-C 110.184 -0.302 . . . . 3.0899999999999999 110.184 178.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.532 ' O ' ' HA ' ' A' ' 81' ' ' SER . 6.4 pt-20 -93.03 -31.34 14.9 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.243 -1.021 . . . . 2.7999999999999998 108.243 170.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.475 ' HA ' ' O ' ' A' ' 80' ' ' PHE . 73.2 mmtt -85.63 105.33 16.12 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.401 -0.818 . . . . 1.6899999999999999 110.415 -177.813 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.647 ' HB3' ' CE1' ' A' ' 80' ' ' PHE . 2.8 tt -100.62 155.5 17.84 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 113.878 -1.51 . . . . 1.79 108.489 -178.044 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.54 ' N ' HD23 ' A' ' 8' ' ' LEU . 71.8 ttt180 -132.65 127.97 36.03 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 108.674 -0.861 . . . . 1.3700000000000001 108.674 170.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -146.4 153.8 40.89 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.258 -0.577 . . . . 1.0700000000000001 112.095 -175.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -106.16 136.66 45.47 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.382 -0.826 . . . . 1.04 109.417 178.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 35.7 p-80 -137.15 149.48 47.32 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.917 0.389 . . . . 0.34000000000000002 111.321 -173.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.677 ' O ' ' HA ' ' A' ' 112' ' ' HIS . 5.2 tt -123.09 131.75 53.82 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.818 -0.808 . . . . 1.0600000000000001 108.818 179.293 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.596 HD11 ' NE2' ' A' ' 112' ' ' HIS . 25.6 tp -116.57 123.51 47.53 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.493 -0.321 . . . . 1.0800000000000001 110.767 -177.531 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.455 HG21 HD12 ' A' ' 44' ' ' LEU . 63.3 t -110.84 134.04 54.42 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 N-CA-C 109.349 -0.611 . . . . 1.01 109.349 173.522 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.493 ' HE2' ' OG ' ' A' ' 109' ' ' SER . 30.4 mmtp -105.91 154.3 20.76 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.492 -0.558 . . . . 1.22 109.492 178.703 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.435 ' HB3' ' HB3' ' A' ' 40' ' ' ALA . 48.9 p90 -146.53 160.57 41.96 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.801 0.334 . . . . 0.29999999999999999 110.954 -177.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.3 t -52.56 112.21 0.78 Allowed 'General case' 0 N--CA 1.435 -1.193 0 CA-C-N 115.997 -0.547 . . . . 1.6000000000000001 111.323 178.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 100.46 2.86 55.52 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.605 -0.807 . . . . 0.53000000000000003 113.205 177.033 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.448 ' C ' ' H ' ' A' ' 22' ' ' ASN . 91.3 p -90.19 40.15 1.0 Allowed 'General case' 0 C--O 1.234 0.277 0 CA-C-N 117.62 0.71 . . . . 1.28 111.086 -176.109 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.407 ' CZ ' ' HB2' ' A' ' 108' ' ' ASP . 96.3 mtt180 72.2 -32.85 0.25 Allowed 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.36 0.664 . . . . 4.1600000000000001 111.771 178.291 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.448 ' H ' ' C ' ' A' ' 20' ' ' SER . 52.5 m-80 -136.99 93.11 13.64 Favored Pre-proline 0 C--N 1.326 -0.453 0 N-CA-C 109.308 -0.627 . . . . 1.77 109.308 175.802 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.579 ' C ' HG23 ' A' ' 32' ' ' THR . 95.5 Cg_endo -83.69 51.72 3.57 Favored 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 122.546 2.164 . . . . 1.71 113.233 -174.51 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.471 ' N ' HG23 ' A' ' 32' ' ' THR . 61.2 t -144.89 118.56 2.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 109.323 -0.621 . . . . 1.1599999999999999 109.323 177.133 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 23.5 p -105.18 153.07 22.05 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 110.503 -0.184 . . . . 1.4299999999999999 110.503 178.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.574 ' HB2' ' HA ' ' A' ' 67' ' ' ASP . 7.4 mpt_? -66.2 -10.22 39.55 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.007 0.432 . . . . 3.1200000000000001 110.565 173.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.57 ' HG3' ' CD ' ' A' ' 65' ' ' ARG . 17.6 ttp180 -75.59 -41.12 55.37 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.812 -0.631 . . . . 2.25 109.506 176.288 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.407 ' C ' ' H ' ' A' ' 30' ' ' ASP . 40.0 p -95.79 -35.41 11.53 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.234 -0.894 . . . . 1.1299999999999999 111.231 -175.122 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 78.03 -35.07 1.69 Allowed Glycine 0 CA--C 1.518 0.244 0 CA-C-N 115.341 -0.845 . . . . 0.81999999999999995 112.637 178.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.407 ' H ' ' C ' ' A' ' 28' ' ' THR . 17.2 t70 -94.88 -69.39 0.75 Allowed 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 110.177 -0.305 . . . . 2.1000000000000001 110.177 -179.71 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 10.1 p -154.83 150.46 27.52 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.094 0.474 . . . . 1.3300000000000001 111.043 176.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.579 HG23 ' C ' ' A' ' 23' ' ' PRO . 13.8 t -113.44 30.26 7.36 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 122.349 1.071 . . . . 1.02 108.891 177.5 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.24 -3.47 49.32 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.475 -1.239 . . . . 1.1299999999999999 112.031 -175.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -92.87 -24.61 18.41 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.482 0.658 . . . . 2.21 109.979 177.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -98.02 135.93 30.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.284 -0.871 . . . . 1.1100000000000001 110.281 -179.458 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 34.0 p -96.19 -179.53 4.7 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.094 -0.503 . . . . 1.2 109.769 -176.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.545 ' O ' HG13 ' A' ' 41' ' ' ILE . 0.1 OUTLIER -64.87 -23.63 67.29 Favored 'General case' 0 C--O 1.222 -0.348 0 C-N-CA 119.04 -1.064 . . . . 2.21 110.026 173.505 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.454 ' N ' ' HD1' ' A' ' 37' ' ' TYR . 34.4 mt-10 -70.89 -46.93 61.71 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.649 -0.5 . . . . 0.95999999999999996 109.649 176.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -70.76 -28.88 65.01 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.066 0.46 . . . . 0.91000000000000003 110.404 176.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.435 ' HB3' ' HB3' ' A' ' 17' ' ' PHE . . . -66.32 -45.65 79.56 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.728 -0.669 . . . . 1.03 109.825 175.157 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.545 HG13 ' O ' ' A' ' 37' ' ' TYR . 72.9 mt -64.98 -38.41 82.72 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.382 0 CA-C-N 116.064 -0.517 . . . . 1.0800000000000001 109.7 174.101 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.423 ' O ' ' HG3' ' A' ' 46' ' ' LYS . 3.6 ttpm? -64.78 -20.94 66.64 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.863 -0.608 . . . . 2.8399999999999999 110.233 179.652 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.408 ' HG3' ' CD1' ' A' ' 47' ' ' TRP . 1.7 tp10 -88.29 -56.85 3.15 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.305 -0.628 . . . . 1.02 109.305 176.569 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.539 HD22 ' HB3' ' A' ' 111' ' ' LEU . 19.5 tp -58.92 -35.9 73.83 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.03 -0.986 . . . . 1.02 110.895 -174.479 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.445 ' HG2' HG13 ' A' ' 104' ' ' ILE . 4.6 mm-40 -64.42 -39.57 94.09 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-N 116.391 -0.368 . . . . 0.87 111.962 -178.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.458 ' O ' ' HG3' ' A' ' 50' ' ' ARG . 60.7 mttm -70.09 -43.77 70.43 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 110.122 -0.325 . . . . 1.98 110.122 -178.576 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.44 ' NE1' ' HG3' ' A' ' 65' ' ' ARG . 64.6 m95 -65.79 -46.38 78.93 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.479 -0.328 . . . . 0.60999999999999999 111.454 175.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 36.5 t -57.96 -34.0 69.45 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.755 -0.461 . . . . 0.88 109.755 176.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 -66.75 -56.84 8.71 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 115.907 -0.588 . . . . 0.55000000000000004 110.555 175.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.529 ' HB3' HG22 ' A' ' 56' ' ' VAL . 93.6 mtt180 -61.21 -42.12 98.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.676 -0.693 . . . . 0.47999999999999998 111.368 -175.634 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.43 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 98.2 mt -60.71 -39.43 81.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 120.96 0.409 . . . . 1.04 110.506 176.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.26 -39.92 65.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.979 -0.555 . . . . 1.0600000000000001 111.663 -179.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 55.8 p -78.61 -30.5 46.56 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.931 0.396 . . . . 0.34999999999999998 111.547 -177.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 107.61 9.25 29.2 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.727 -0.749 . . . . 0.33000000000000002 112.057 -178.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.496 ' HB2' ' HB3' ' A' ' 50' ' ' ARG . 43.1 mt-10 -64.9 -44.26 90.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.115 0.483 . . . . 0.65000000000000002 110.102 177.683 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.529 HG22 ' HB3' ' A' ' 50' ' ' ARG . 22.3 m -138.16 153.69 27.2 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.451 0 CA-C-N 115.791 -0.64 . . . . 1.05 109.456 173.767 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.6 m -77.39 157.89 30.36 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 109.327 -0.62 . . . . 1.3100000000000001 109.327 175.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -54.76 -41.28 70.28 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.171 -0.678 . . . . 0.25 109.171 177.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.479 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 41.0 mt-10 -56.0 -46.6 78.7 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.785 -1.098 . . . . 1.72 112.197 178.775 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -60.91 -44.73 96.77 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 120.936 0.398 . . . . 2.0899999999999999 111.019 -176.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -71.72 -43.72 65.4 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.346 -0.388 . . . . 1.0700000000000001 111.001 -178.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.68 -53.05 60.38 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.185 0.439 . . . . 1.0600000000000001 112.185 -175.005 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.495 ' HA ' ' O ' ' A' ' 71' ' ' TYR . 71.9 m -51.76 -27.8 13.24 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 113.121 0.785 . . . . 1.52 113.121 -177.61 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -100.03 -44.67 5.93 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.603 0.716 . . . . 0.60999999999999999 110.616 -177.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.57 ' CD ' ' HG3' ' A' ' 27' ' ' ARG . 17.4 mmt180 -94.41 -43.48 8.35 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.873 -1.058 . . . . 0.95999999999999996 113.576 -170.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.542 ' HB2' ' SG ' ' A' ' 68' ' ' CYS . 19.3 p -62.73 127.65 32.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.145 0.497 . . . . 1.0600000000000001 111.557 -173.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.574 ' HA ' ' HB2' ' A' ' 26' ' ' ARG . 27.0 t70 -81.68 -11.08 59.21 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.421 -0.809 . . . . 2.2799999999999998 110.616 176.694 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.542 ' SG ' ' HB2' ' A' ' 66' ' ' SER . 5.1 p -75.77 150.19 37.82 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.017 -0.538 . . . . 2.0499999999999998 110.12 179.657 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -54.88 -21.66 24.16 Favored Glycine 0 N--CA 1.452 -0.247 0 CA-C-N 114.665 -1.152 . . . . 0.29999999999999999 113.757 -172.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.449 ' HB2' ' CA ' ' A' ' 75' ' ' GLY . 1.5 p -67.99 -2.44 7.63 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 112.635 0.606 . . . . 0.46999999999999997 112.635 177.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.495 ' O ' ' HA ' ' A' ' 63' ' ' SER . 33.1 p90 -55.13 -24.27 25.24 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 118.038 0.381 . . . . 0.94999999999999996 110.421 174.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -87.65 -8.94 55.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.857 0.36 . . . . 1.1100000000000001 111.115 -178.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 16.0 m -126.18 14.95 7.84 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.367 -0.379 . . . . 0.70999999999999996 111.28 -177.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.479 ' O ' ' HA ' ' A' ' 59' ' ' GLU . . . 74.86 33.48 55.21 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.745 -0.74 . . . . 0.67000000000000004 113.133 178.445 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.449 ' CA ' ' HB2' ' A' ' 70' ' ' SER . . . 77.88 5.07 86.46 Favored Glycine 0 C--O 1.228 -0.236 0 C-N-CA 120.811 -0.709 . . . . 0.42999999999999999 112.867 176.385 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -92.21 141.17 28.86 Favored 'General case' 0 C--N 1.322 -0.629 0 O-C-N 122.844 -0.209 . . . . 1.6499999999999999 110.448 -172.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -120.38 169.87 9.89 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.322 0.582 . . . . 1.6899999999999999 110.582 176.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -89.04 -158.8 34.62 Favored Glycine 0 C--N 1.314 -0.691 0 CA-C-N 115.025 -0.989 . . . . 0.45000000000000001 112.078 177.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.592 ' HA ' ' O ' ' A' ' 8' ' ' LEU . 96.7 m-85 -84.57 151.7 24.36 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.083 0.468 . . . . 4.7400000000000002 111.677 -178.495 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.647 ' CE1' ' HB3' ' A' ' 8' ' ' LEU . 2.5 p90 -157.87 160.36 37.59 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.492 -0.929 . . . . 1.6499999999999999 108.492 178.683 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.532 ' HA ' ' O ' ' A' ' 6' ' ' GLU . 23.6 m -85.44 138.78 32.02 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 109.162 -0.681 . . . . 1.6899999999999999 109.162 177.067 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 14.7 m -59.71 112.24 1.74 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.159 0.504 . . . . 1.55 110.811 -174.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 114.53 12.91 10.07 Favored Glycine 0 N--CA 1.446 -0.647 0 CA-C-N 115.47 -0.786 . . . . 0.79000000000000004 112.184 -174.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -117.02 57.8 0.78 Allowed 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 121.069 0.462 . . . . 1.5800000000000001 110.377 177.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 22.5 mmt -146.42 -100.16 0.09 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.084 -0.507 . . . . 1.1299999999999999 110.512 178.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' MET . . . . . 0.422 ' HB2' ' HB3' ' A' ' 89' ' ' PHE . 61.4 mtt -142.99 155.77 44.73 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 108.17 -1.048 . . . . 1.8899999999999999 108.17 175.228 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.408 ' HB3' ' HD3' ' A' ' 88' ' ' PRO . 63.9 tttp -55.06 -57.75 18.16 Favored Pre-proline 0 C--N 1.321 -0.653 0 N-CA-C 112.448 0.536 . . . . 2.7400000000000002 112.448 -177.082 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.408 ' HD3' ' HB3' ' A' ' 87' ' ' LYS . 76.6 Cg_endo -75.35 -29.08 8.06 Favored 'Trans proline' 0 C--N 1.355 0.88 0 C-N-CA 121.643 1.562 . . . . 0.29999999999999999 111.908 -175.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.628 ' O ' HG21 ' A' ' 93' ' ' VAL . 38.5 t80 -68.12 -56.55 8.42 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.111 -0.949 . . . . 0.28000000000000003 109.942 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -65.24 -34.51 78.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.661 -0.7 . . . . 2.1200000000000001 109.855 -178.067 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -55.33 -34.67 64.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.636 -0.711 . . . . 0.60999999999999999 110.755 175.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.425 ' O ' ' HG ' ' A' ' 96' ' ' LEU . . . -83.74 -26.65 29.54 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.136 -0.484 . . . . 1.1000000000000001 110.951 179.05 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.628 HG21 ' O ' ' A' ' 89' ' ' PHE . 18.4 t -74.03 -38.17 48.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.157 0.503 . . . . 1.1200000000000001 110.186 -178.14 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.504 ' C ' ' HD2' ' A' ' 94' ' ' ARG . 6.5 ppt_? -76.32 -12.0 60.0 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.085 -0.507 . . . . 3.1800000000000002 110.261 178.055 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.07 -4.5 59.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.846 -0.615 . . . . 1.0800000000000001 111.254 -176.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.594 ' HB2' ' HB2' ' A' ' 100' ' ' ASP . 1.2 pp -132.79 151.91 51.9 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.173 0.511 . . . . 1.1200000000000001 111.167 179.192 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.563 ' HG3' ' H ' ' A' ' 98' ' ' ILE . 19.4 tptm -102.62 -178.48 3.69 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.688 -0.856 . . . . 2.1299999999999999 108.688 176.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.563 ' H ' ' HG3' ' A' ' 97' ' ' LYS . 65.9 mt -54.3 118.36 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 120.853 0.359 . . . . 1.6200000000000001 111.025 179.28 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 95.61 10.23 56.91 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.728 -0.749 . . . . 0.46000000000000002 113.14 178.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.594 ' HB2' ' HB2' ' A' ' 96' ' ' LEU . 27.0 m-20 -111.41 146.81 36.51 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 117.441 0.621 . . . . 0.46000000000000002 110.271 177.285 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 15.8 mt -120.17 148.89 23.01 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-N 116.455 -0.339 . . . . 1.0800000000000001 110.432 -178.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.442 ' HG ' ' CD2' ' A' ' 96' ' ' LEU . 38.3 m -96.78 151.08 37.63 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 116.234 -0.439 . . . . 1.45 111.206 179.026 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -74.17 176.94 8.9 Favored 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 122.583 2.189 . . . . 0.40999999999999998 111.432 172.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.445 HG13 ' HG2' ' A' ' 45' ' ' GLN . 22.5 mm -49.24 110.72 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 N-CA-C 112.775 0.657 . . . . 1.04 112.775 -178.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 55.0 t -109.75 115.71 50.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.886 -0.597 . . . . 1.6599999999999999 109.901 173.178 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 12.9 mt-30 -84.93 141.72 30.17 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.842 -0.429 . . . . 0.55000000000000004 109.842 177.396 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 16.6 p -123.55 -172.47 2.53 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.784 -0.644 . . . . 1.05 110.491 -179.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.407 ' HB2' ' CZ ' ' A' ' 21' ' ' ARG . 6.9 p-10 -66.57 -35.53 80.44 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.617 0.246 . . . . 2.1600000000000001 111.253 -178.11 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.493 ' OG ' ' HE2' ' A' ' 16' ' ' LYS . 4.6 t -106.24 -9.73 16.73 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 120.287 -0.565 . . . . 1.0900000000000001 112.291 -174.359 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 172.18 -126.2 1.25 Allowed Glycine 0 N--CA 1.438 -1.177 0 C-N-CA 119.216 -1.469 . . . . 0.39000000000000001 112.967 173.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.539 ' HB3' HD22 ' A' ' 44' ' ' LEU . 6.0 mp -130.78 149.42 52.43 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 115.045 -0.578 . . . . 1.0600000000000001 110.906 -171.488 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . 0.677 ' HA ' ' O ' ' A' ' 13' ' ' LEU . 82.0 m-70 -146.97 136.04 22.45 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.098 0.407 . . . . 0.25 112.098 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.464 HG12 HD11 ' A' ' 44' ' ' LEU . 2.1 pt -119.13 140.03 44.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 107.972 -1.121 . . . . 1.03 107.972 160.362 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 2.5 mp -130.93 148.12 33.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 C-N-CA 120.923 -0.311 . . . . 1.0600000000000001 110.532 -175.141 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 54.3 pttt -134.61 144.25 47.79 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.113 -0.699 . . . . 1.29 109.113 174.209 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . 0.517 ' HB2' ' CD1' ' A' ' 96' ' ' LEU . 67.4 ttt180 -91.0 132.57 35.91 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.196 0.522 . . . . 2.6800000000000002 111.583 -177.391 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -101.96 -35.53 8.94 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.116 -0.947 . . . . 1.54 110.781 179.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.945 -0.55 . . . . 1.1499999999999999 109.841 179.191 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 62.2 mtt . . . . . 0 N--CA 1.48 1.031 0 CA-C-O 120.749 0.309 . . . . 7.54 110.409 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 40.0 t -94.92 130.79 41.41 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.111 -0.495 . . . . 3.0899999999999999 110.371 177.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -112.64 -4.86 14.03 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.512 -0.551 . . . . 2.7999999999999998 109.512 175.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 13.6 tptt -72.7 128.17 34.75 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.709 0.766 . . . . 1.6899999999999999 110.871 -178.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.553 HD22 ' N ' ' A' ' 9' ' ' ARG . 2.4 tt -136.55 157.02 47.76 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 114.522 -1.217 . . . . 1.79 108.176 -178.052 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.553 ' N ' HD22 ' A' ' 8' ' ' LEU . 77.2 ttt180 -140.82 127.72 20.55 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 107.907 -1.146 . . . . 1.3700000000000001 107.907 173.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -140.95 157.88 44.73 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 120.037 -0.665 . . . . 1.0700000000000001 112.496 -176.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.542 ' HA ' ' HA ' ' A' ' 76' ' ' ASP . . . -109.81 136.46 49.09 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.195 -0.912 . . . . 1.04 109.599 177.094 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 11.2 p-80 -136.77 139.65 41.98 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.79 -0.364 . . . . 0.34000000000000002 110.949 -172.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.618 ' O ' ' HA ' ' A' ' 112' ' ' HIS . 6.6 tt -111.42 142.37 43.77 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.161 -1.052 . . . . 1.0600000000000001 108.161 176.002 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.531 HD12 ' NE2' ' A' ' 112' ' ' HIS . 22.1 tp -128.95 133.54 47.86 Favored 'General case' 0 C--N 1.323 -0.575 0 O-C-N 123.043 0.214 . . . . 1.0800000000000001 110.441 -176.336 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.423 HG23 HD12 ' A' ' 44' ' ' LEU . 53.5 t -119.07 133.53 65.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 O-C-N 123.589 0.556 . . . . 1.01 109.978 175.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.421 ' HE3' HD21 ' A' ' 14' ' ' LEU . 34.2 mmtp -103.65 158.31 16.46 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.802 -0.635 . . . . 1.22 109.727 176.349 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.448 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 42.1 p90 -158.51 161.27 37.35 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.118 -0.492 . . . . 0.29999999999999999 109.693 -177.049 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.1 t -50.84 108.69 0.25 Allowed 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 110.005 -0.369 . . . . 1.6000000000000001 110.005 173.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 109.68 9.85 24.17 Favored Glycine 0 N--CA 1.446 -0.7 0 C-N-CA 120.323 -0.942 . . . . 0.53000000000000003 112.975 -177.18 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.456 ' C ' ' H ' ' A' ' 22' ' ' ASN . 50.6 p -85.32 21.82 1.64 Allowed 'General case' 0 C--O 1.236 0.352 0 CA-C-N 117.938 0.869 . . . . 1.28 111.726 -176.732 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.45 ' NH1' ' HB3' ' A' ' 108' ' ' ASP . 97.3 mtt180 72.6 -34.98 0.31 Allowed 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.786 0.835 . . . . 4.1600000000000001 110.833 -178.832 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.456 ' H ' ' C ' ' A' ' 20' ' ' SER . 7.0 p30 -146.66 104.71 3.96 Favored Pre-proline 0 C--N 1.32 -0.686 0 N-CA-C 108.578 -0.897 . . . . 1.77 108.578 168.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -66.03 -156.7 0.03 OUTLIER 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 123.674 2.916 . . . . 1.71 113.2 -178.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.535 ' N ' HG23 ' A' ' 32' ' ' THR . 47.6 t 64.99 112.97 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-N 115.494 -0.775 . . . . 1.1599999999999999 111.165 -175.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 19.1 p -103.36 152.18 21.87 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.352 -0.385 . . . . 1.4299999999999999 110.015 178.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.533 ' CG ' ' HA ' ' A' ' 67' ' ' ASP . 38.5 mmt180 -67.58 -20.38 65.37 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 108.727 -0.842 . . . . 3.1200000000000001 108.727 173.193 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.448 ' HG2' ' HD3' ' A' ' 65' ' ' ARG . 4.8 tmm_? -71.73 -36.22 70.41 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 114.621 -1.172 . . . . 2.25 110.791 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 69.3 p -97.67 -35.76 10.47 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.522 0.677 . . . . 1.1299999999999999 110.421 178.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 73.35 -6.7 14.4 Favored Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 114.718 -1.128 . . . . 0.81999999999999995 112.655 -178.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -121.68 -72.29 0.69 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.757 0.313 . . . . 2.1000000000000001 110.357 -178.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.6 m -147.8 146.26 29.08 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-O 121.0 0.429 . . . . 1.3300000000000001 111.21 -178.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.535 HG23 ' N ' ' A' ' 24' ' ' VAL . 14.6 t -125.48 11.82 8.03 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.8 0.81 . . . . 1.02 109.49 174.58 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -68.94 -4.34 16.25 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.241 -0.89 . . . . 1.1299999999999999 112.289 179.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -96.55 -23.86 16.33 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.037 0.446 . . . . 2.21 110.694 177.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.463 HG22 ' HB2' ' A' ' 39' ' ' ASP . 0.4 OUTLIER -93.85 136.34 25.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 109.389 -0.597 . . . . 1.1100000000000001 109.389 177.505 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 75.0 p -95.0 179.99 5.03 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.359 -0.382 . . . . 1.2 110.081 -174.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.501 ' O ' HG13 ' A' ' 41' ' ' ILE . 11.3 p90 -63.42 -28.13 69.77 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.262 -0.644 . . . . 2.21 109.262 175.372 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -73.74 -44.77 55.34 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.905 -0.589 . . . . 0.95999999999999996 110.362 178.186 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.463 ' HB2' HG22 ' A' ' 35' ' ' VAL . 43.9 m-20 -65.81 -32.42 73.94 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.484 0.659 . . . . 0.91000000000000003 109.693 176.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.448 ' HB2' ' HB3' ' A' ' 17' ' ' PHE . . . -68.4 -43.88 76.27 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.976 -1.011 . . . . 1.03 110.416 178.254 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.501 HG13 ' O ' ' A' ' 37' ' ' TYR . 95.1 mt -62.6 -37.82 79.93 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.409 0 N-CA-C 109.667 -0.494 . . . . 1.0800000000000001 109.667 174.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 55.9 tttp -65.94 -23.11 66.54 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 121.381 0.61 . . . . 2.8399999999999999 109.997 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -87.84 -50.27 6.56 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.33 -0.85 . . . . 1.02 109.549 -179.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.48 HD11 HG12 ' A' ' 113' ' ' ILE . 35.4 tp -62.61 -38.08 88.78 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.588 -0.733 . . . . 1.02 110.41 -178.05 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.479 ' HG2' HG13 ' A' ' 104' ' ' ILE . 5.0 mm-40 -61.09 -31.35 71.03 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 115.957 -0.565 . . . . 0.87 112.399 -179.595 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -80.24 -40.85 26.22 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.631 -0.428 . . . . 1.98 110.606 -179.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.425 ' O ' HG13 ' A' ' 51' ' ' ILE . 57.5 m95 -66.66 -45.32 79.31 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.139 0.422 . . . . 0.60999999999999999 112.139 177.036 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.481 ' HB3' HG23 ' A' ' 113' ' ' ILE . 93.4 p -63.99 -30.5 71.57 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.758 -0.46 . . . . 0.88 109.758 176.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.476 ' HB2' ' O ' ' A' ' 45' ' ' GLN . 15.1 tt0 -65.16 -53.34 46.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.503 -0.772 . . . . 0.55000000000000004 110.381 175.402 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.523 ' HB3' HG22 ' A' ' 56' ' ' VAL . 97.1 mtt180 -65.39 -41.48 93.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.996 -0.547 . . . . 0.47999999999999998 111.657 -177.07 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.474 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 84.6 mt -61.25 -33.93 58.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.09 0.471 . . . . 1.04 110.691 176.629 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -77.81 -41.91 35.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 1.0600000000000001 111.205 179.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 52.9 p -76.13 -29.81 57.96 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.252 -0.431 . . . . 0.34999999999999998 111.569 -176.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 103.21 9.99 37.64 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.78 -0.724 . . . . 0.33000000000000002 112.234 -179.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.406 ' HB2' ' HB3' ' A' ' 50' ' ' ARG . 39.2 mt-10 -64.51 -43.58 93.64 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.583 -0.525 . . . . 0.65000000000000002 109.583 176.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.523 HG22 ' HB3' ' A' ' 50' ' ' ARG . 11.7 m -138.49 149.79 24.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 108.968 -0.753 . . . . 1.05 108.968 170.12 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 12.0 m -81.69 162.08 23.14 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 109.468 -0.567 . . . . 1.3100000000000001 109.468 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -55.01 -43.44 73.63 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.843 -0.429 . . . . 0.25 109.843 -178.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -58.04 -46.32 85.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.537 -0.756 . . . . 1.72 111.443 179.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 41.4 mm-40 -59.4 -48.36 81.94 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-O 121.119 0.485 . . . . 2.0899999999999999 110.822 -178.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -68.78 -49.96 54.27 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.924 -0.58 . . . . 1.0700000000000001 110.866 -179.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.403 ' HA ' ' HB3' ' A' ' 66' ' ' SER . . . -58.45 -55.37 35.97 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.629 0.603 . . . . 1.0600000000000001 112.629 -173.229 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.475 ' HA ' ' HA ' ' A' ' 71' ' ' TYR . 28.4 t -52.27 -28.01 17.21 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.684 0.624 . . . . 1.52 112.684 -175.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -100.01 -46.74 5.24 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.528 0.68 . . . . 0.60999999999999999 110.426 -179.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.448 ' HD3' ' HG2' ' A' ' 27' ' ' ARG . 31.3 mmt180 -94.21 -36.91 11.81 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.758 -1.11 . . . . 0.95999999999999996 113.944 -168.603 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.533 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 24.7 p -67.89 123.72 21.37 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.642 -0.423 . . . . 1.0600000000000001 110.651 -178.065 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.533 ' HA ' ' CG ' ' A' ' 26' ' ' ARG . 25.1 m-20 -83.77 -5.93 59.31 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.826 -0.625 . . . . 2.2799999999999998 110.676 179.5 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.511 ' SG ' ' HB2' ' A' ' 66' ' ' SER . 6.4 p -78.86 156.73 28.54 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.494 -0.776 . . . . 2.0499999999999998 110.215 175.413 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -54.83 -20.33 18.45 Favored Glycine 0 C--N 1.331 0.284 0 CA-C-N 114.959 -1.018 . . . . 0.29999999999999999 114.501 -171.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.52 ' HB2' ' CA ' ' A' ' 75' ' ' GLY . 1.3 p -70.08 -1.49 10.08 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.675 0.62 . . . . 0.46999999999999997 112.675 179.422 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.475 ' HA ' ' HA ' ' A' ' 63' ' ' SER . 41.6 p90 -56.55 -33.6 66.27 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 109.54 -0.541 . . . . 0.94999999999999996 109.54 173.671 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -95.29 8.32 43.48 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.021 -0.536 . . . . 1.1100000000000001 111.158 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 11.0 m -122.59 -20.16 6.08 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.698 0.285 . . . . 0.70999999999999996 111.605 -176.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 107.57 14.85 16.75 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.74 -0.743 . . . . 0.67000000000000004 112.226 -178.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.52 ' CA ' ' HB2' ' A' ' 70' ' ' SER . . . 92.99 -19.73 50.25 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.69 -0.767 . . . . 0.42999999999999999 112.904 178.449 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.542 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 7.6 p-10 -98.36 144.71 27.46 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.584 0.706 . . . . 1.6499999999999999 111.492 -171.758 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -100.35 175.72 5.61 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.504 -1.225 . . . . 1.6899999999999999 109.341 174.65 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -85.43 -148.0 10.13 Favored Glycine 0 C--N 1.315 -0.634 0 C-N-CA 120.709 -0.758 . . . . 0.45000000000000001 111.981 -179.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -91.85 139.44 30.66 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.931 0.396 . . . . 4.7400000000000002 110.16 178.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -152.14 174.03 14.22 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.992 -0.549 . . . . 1.6499999999999999 109.746 -177.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 13.9 p -95.57 135.4 37.28 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.333 0.587 . . . . 1.6899999999999999 110.942 179.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 13.2 m -63.83 128.11 34.35 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.483 -0.78 . . . . 1.55 110.585 -178.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 103.25 0.82 47.64 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.659 -0.782 . . . . 0.79000000000000004 112.395 -179.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -117.76 62.84 0.75 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.222 0.534 . . . . 1.5800000000000001 111.152 -179.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 21.0 mmt -139.49 -123.9 0.12 Allowed 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.066 -0.716 . . . . 1.1299999999999999 109.066 173.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' MET . . . . . 0.405 ' HB2' ' CB ' ' A' ' 89' ' ' PHE . 19.9 mmt -110.68 151.54 27.59 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.263 -1.014 . . . . 1.8899999999999999 108.263 173.191 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 24.5 ttmm -55.55 -51.72 77.8 Favored Pre-proline 0 C--N 1.319 -0.754 0 N-CA-C 112.379 0.511 . . . . 2.7400000000000002 112.379 -174.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -78.3 -22.9 9.27 Favored 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 121.474 1.449 . . . . 0.29999999999999999 111.72 -178.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.571 ' O ' HG22 ' A' ' 93' ' ' VAL . 33.1 t80 -70.89 -55.75 7.77 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.157 -0.929 . . . . 0.28000000000000003 109.718 179.682 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -65.81 -34.83 79.08 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.606 -0.725 . . . . 2.1200000000000001 109.99 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.506 ' HA ' ' NE ' ' A' ' 94' ' ' ARG . 15.6 t70 -51.25 -35.83 39.06 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.492 -0.776 . . . . 0.60999999999999999 110.7 173.68 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.565 ' O ' ' HG ' ' A' ' 96' ' ' LEU . . . -82.44 -37.15 25.85 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.072 -0.513 . . . . 1.1000000000000001 111.032 179.111 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.571 HG22 ' O ' ' A' ' 89' ' ' PHE . 15.2 t -62.75 -40.97 90.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-O 121.229 0.538 . . . . 1.1200000000000001 110.597 -177.168 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.506 ' NE ' ' HA ' ' A' ' 91' ' ' ASP . 37.7 ptt180 -74.8 -15.41 60.75 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.822 -0.626 . . . . 3.1800000000000002 110.566 178.26 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -95.64 14.42 23.06 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.026 -0.533 . . . . 1.0800000000000001 111.169 -174.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.583 ' HB2' ' HB2' ' A' ' 100' ' ' ASP . 1.4 pp -149.74 152.71 35.71 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.83 -0.623 . . . . 1.1200000000000001 110.307 177.005 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.434 ' HG3' ' H ' ' A' ' 98' ' ' ILE . 21.7 tptm -102.22 175.63 5.46 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.132 -0.692 . . . . 2.1299999999999999 109.132 179.536 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.436 ' HA ' ' HG2' ' A' ' 116' ' ' ARG . 70.7 mt -46.24 114.56 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.196 0.522 . . . . 1.6200000000000001 111.579 176.049 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 102.1 -15.96 56.06 Favored Glycine 0 CA--C 1.522 0.48 0 CA-C-N 115.649 -0.705 . . . . 0.46000000000000002 113.562 178.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.583 ' HB2' ' HB2' ' A' ' 96' ' ' LEU . 53.9 m-20 -89.08 141.19 28.71 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 117.346 0.573 . . . . 0.46000000000000002 110.348 -177.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 8.9 mt -112.68 147.99 16.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.18 -0.464 . . . . 1.0800000000000001 110.462 -176.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 99.3 p -89.65 160.1 42.26 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 116.256 -0.429 . . . . 1.45 110.643 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -74.23 176.36 9.7 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.324 2.016 . . . . 0.40999999999999998 111.196 171.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.479 HG13 ' HG2' ' A' ' 45' ' ' GLN . 23.9 mm -50.47 106.38 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 O-C-N 123.217 0.323 . . . . 1.04 111.541 174.78 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.4 p -112.92 123.02 68.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 109.794 -0.447 . . . . 1.6599999999999999 109.794 175.084 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -86.19 151.38 23.69 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.14 0.495 . . . . 0.55000000000000004 110.563 -179.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 6.8 p -126.78 -172.72 2.7 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.51 -0.768 . . . . 1.05 109.984 178.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.45 ' HB3' ' NH1' ' A' ' 21' ' ' ARG . 36.3 m-20 -62.36 -46.73 87.35 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.746 0.307 . . . . 2.1600000000000001 110.501 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 22.5 t -80.07 -59.43 2.72 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.836 -0.346 . . . . 1.0900000000000001 110.796 -178.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -152.05 -130.4 1.6 Allowed Glycine 0 N--CA 1.443 -0.884 0 C-N-CA 119.075 -1.536 . . . . 0.39000000000000001 113.649 -175.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.515 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 6.1 mp -116.56 147.79 41.49 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.283 -0.459 . . . . 1.0600000000000001 111.372 -170.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . 0.618 ' HA ' ' O ' ' A' ' 13' ' ' LEU . 82.0 m-70 -143.48 152.96 42.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.419 0.628 . . . . 0.25 112.484 179.454 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.481 HG23 ' HB3' ' A' ' 48' ' ' SER . 3.6 pt -133.42 138.17 51.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 107.604 -1.258 . . . . 1.03 107.604 159.579 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 2.8 mp -128.42 147.52 32.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 C-N-CA 120.768 -0.373 . . . . 1.0600000000000001 110.386 -175.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.417 ' HG2' ' HB3' ' A' ' 11' ' ' ALA . 33.4 pttt -132.11 144.63 50.85 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.664 -0.865 . . . . 1.29 108.664 172.437 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . 0.438 ' HD3' HD21 ' A' ' 8' ' ' LEU . 5.5 ttp180 -82.79 135.03 35.09 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.302 0.572 . . . . 2.6800000000000002 110.902 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -101.83 -38.33 7.89 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.996 -1.002 . . . . 1.54 109.768 -179.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.036 0 CA-C-N 115.544 -0.753 . . . . 1.1499999999999999 109.735 179.862 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 79.1 mmm . . . . . 0 N--CA 1.482 1.157 0 N-CA-C 111.528 0.196 . . . . 7.54 111.528 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.3 m -78.81 -35.35 44.34 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.388 0.613 . . . . 3.0899999999999999 109.59 177.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.572 ' O ' ' HA ' ' A' ' 81' ' ' SER . 0.0 OUTLIER -93.98 -42.18 9.18 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.125 -0.943 . . . . 2.7999999999999998 109.899 178.989 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -73.0 103.59 3.83 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 121.47 0.653 . . . . 1.6899999999999999 110.657 177.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.408 ' HG ' ' H ' ' A' ' 9' ' ' ARG . 11.4 tp -103.73 175.34 5.51 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 114.665 -1.152 . . . . 1.79 109.953 -174.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.442 ' HG2' ' HB2' ' A' ' 117' ' ' LEU . 53.8 ttt180 -146.08 132.49 19.65 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.567 -0.531 . . . . 1.3700000000000001 109.567 177.323 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.539 ' N ' ' HZ ' ' A' ' 80' ' ' PHE . . . -149.3 154.43 39.0 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.054 0.454 . . . . 1.0700000000000001 111.69 -179.149 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.406 ' HB1' ' HG2' ' A' ' 115' ' ' LYS . . . -101.83 131.85 47.93 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.517 -0.765 . . . . 1.04 108.95 175.413 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 29.6 p-80 -133.01 146.69 51.99 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.029 0.443 . . . . 0.34000000000000002 111.719 -172.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.55 HD21 ' N ' ' A' ' 14' ' ' LEU . 5.7 tt -117.46 144.65 44.81 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.478 -0.934 . . . . 1.0600000000000001 108.478 177.407 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.596 HD12 ' NE2' ' A' ' 112' ' ' HIS . 26.0 tp -131.03 119.91 22.69 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.64 0.257 . . . . 1.0800000000000001 110.675 -177.391 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.416 ' CG2' HD12 ' A' ' 44' ' ' LEU . 61.2 t -108.12 129.37 62.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 109.776 -0.453 . . . . 1.01 109.776 176.771 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.458 ' HE3' HD22 ' A' ' 14' ' ' LEU . 31.5 mmtp -105.87 149.99 26.04 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.089 -0.505 . . . . 1.22 110.022 178.68 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.479 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 43.1 p90 -145.88 162.54 37.5 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.331 -0.395 . . . . 0.29999999999999999 110.863 -176.451 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.46 ' HB3' ' C ' ' A' ' 33' ' ' ALA . 34.9 p -51.87 113.18 0.93 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.037 -0.529 . . . . 1.6000000000000001 111.129 177.272 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 95.5 8.58 58.41 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.587 -0.816 . . . . 0.53000000000000003 113.536 178.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.605 ' HB2' ' O ' ' A' ' 109' ' ' SER . 80.4 p -86.7 33.5 0.65 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 117.264 0.532 . . . . 1.28 110.921 -177.557 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.422 ' HB3' ' O ' ' A' ' 20' ' ' SER . 66.8 ttt180 71.25 -34.82 0.31 Allowed 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.245 0.618 . . . . 4.1600000000000001 111.122 -176.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.497 ' H ' ' C ' ' A' ' 20' ' ' SER . 33.2 m-80 -133.63 91.77 25.04 Favored Pre-proline 0 C--N 1.327 -0.398 0 N-CA-C 109.245 -0.65 . . . . 1.77 109.245 176.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.511 ' C ' HG22 ' A' ' 32' ' ' THR . 72.7 Cg_endo -80.47 57.72 6.65 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 122.258 1.972 . . . . 1.71 112.774 -176.308 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.515 ' N ' HG22 ' A' ' 32' ' ' THR . 48.5 t -143.7 118.67 4.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 109.418 -0.586 . . . . 1.1599999999999999 109.418 178.074 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 40.2 t -104.85 150.34 24.92 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 110.037 -0.357 . . . . 1.4299999999999999 110.037 178.095 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.534 ' HG2' ' HA ' ' A' ' 67' ' ' ASP . 5.2 mmp_? -66.07 -8.35 22.9 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.727 0.299 . . . . 3.1200000000000001 110.823 173.176 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.442 ' HD2' ' HD2' ' A' ' 65' ' ' ARG . 50.5 mtp180 -69.26 -50.68 44.77 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 121.555 0.693 . . . . 2.25 110.018 172.38 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.416 ' C ' ' H ' ' A' ' 30' ' ' ASP . 39.8 p -94.66 -33.62 12.9 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 115.154 -0.93 . . . . 1.1299999999999999 110.837 -172.73 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 80.31 -32.56 2.3 Favored Glycine 0 N--CA 1.451 -0.308 0 CA-C-N 115.813 -0.63 . . . . 0.81999999999999995 112.042 -178.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.416 ' H ' ' C ' ' A' ' 28' ' ' THR . 19.1 t70 -92.56 -69.85 0.72 Allowed 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 122.576 0.35 . . . . 2.1000000000000001 110.717 -177.663 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.5 p -154.79 155.56 34.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.602 -0.272 . . . . 1.3300000000000001 110.922 177.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.515 HG22 ' N ' ' A' ' 24' ' ' VAL . 8.9 t -118.82 34.87 5.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 122.309 1.052 . . . . 1.02 109.388 177.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.46 ' C ' ' HB3' ' A' ' 18' ' ' SER . . . -76.58 -5.25 46.93 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.695 -1.139 . . . . 1.1299999999999999 112.901 -173.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -94.8 -24.75 16.93 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.032 0.444 . . . . 2.21 110.848 -179.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.477 HG13 ' OG1' ' A' ' 32' ' ' THR . 0.2 OUTLIER -95.72 135.89 28.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.941 -0.572 . . . . 1.1100000000000001 109.816 179.87 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 67.0 p -96.34 178.42 5.37 Favored 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 109.952 -0.388 . . . . 1.2 109.952 -175.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.456 ' O ' HG13 ' A' ' 41' ' ' ILE . 13.3 p90 -63.99 -27.89 69.44 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.224 -0.658 . . . . 2.21 109.224 176.467 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -70.73 -47.17 61.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.779 -0.646 . . . . 0.95999999999999996 110.204 177.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.446 ' HB2' HG21 ' A' ' 35' ' ' VAL . 47.1 m-20 -67.87 -29.59 68.75 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.401 0.62 . . . . 0.91000000000000003 109.752 178.233 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.479 ' HB2' ' HB3' ' A' ' 17' ' ' PHE . . . -70.35 -43.96 69.11 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.007 -0.997 . . . . 1.03 110.583 177.499 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.456 HG13 ' O ' ' A' ' 37' ' ' TYR . 80.0 mt -62.24 -37.35 78.34 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 N-CA-C 109.549 -0.537 . . . . 1.0800000000000001 109.549 173.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -62.19 -25.46 67.79 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.784 -0.644 . . . . 2.8399999999999999 110.174 177.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -84.82 -53.41 5.35 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.477 -0.783 . . . . 1.02 109.405 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.486 HD11 HG12 ' A' ' 113' ' ' ILE . 23.9 tp -62.01 -36.27 81.02 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.145 -0.934 . . . . 1.02 110.587 -175.031 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.527 ' O ' ' HB2' ' A' ' 49' ' ' GLN . 0.0 OUTLIER -68.53 -24.71 64.67 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 112.348 0.499 . . . . 0.87 112.348 -177.909 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -80.43 -45.69 17.19 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.95 -0.389 . . . . 1.98 109.95 178.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.426 ' NE1' ' HG3' ' A' ' 65' ' ' ARG . 52.9 m95 -65.69 -46.55 78.62 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.138 -0.483 . . . . 0.60999999999999999 111.207 177.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.451 ' HB3' HG23 ' A' ' 113' ' ' ILE . 92.2 p -64.01 -24.26 67.65 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.807 0.337 . . . . 0.88 110.166 178.469 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.527 ' HB2' ' O ' ' A' ' 45' ' ' GLN . 10.9 tt0 -73.28 -56.67 4.76 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-N 116.11 -0.496 . . . . 0.55000000000000004 110.034 175.284 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.531 ' HB3' HG21 ' A' ' 56' ' ' VAL . 97.0 mtt180 -60.79 -42.4 97.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.473 -0.785 . . . . 0.47999999999999998 111.401 -177.041 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.42 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 98.0 mt -62.07 -40.17 86.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 120.823 0.344 . . . . 1.04 110.613 177.648 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.39 -44.65 74.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.234 -0.439 . . . . 1.0600000000000001 111.373 -178.395 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 32.3 p -77.39 -31.02 53.95 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.842 0.354 . . . . 0.34999999999999998 111.38 -177.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 109.19 10.23 24.41 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.658 -0.782 . . . . 0.33000000000000002 112.548 179.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.46 ' HB2' ' HB3' ' A' ' 50' ' ' ARG . 45.5 mt-10 -60.17 -46.93 88.02 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.211 0.529 . . . . 0.65000000000000002 109.867 175.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.531 HG21 ' HB3' ' A' ' 50' ' ' ARG . 11.1 m -133.24 158.83 43.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.714 -0.676 . . . . 1.05 109.315 172.096 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 17.8 m -85.95 155.22 20.99 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 109.247 -0.649 . . . . 1.3100000000000001 109.247 178.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -52.39 -42.63 64.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.301 0.572 . . . . 0.25 109.783 -177.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.516 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 39.2 mt-10 -55.08 -41.73 71.9 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.811 -1.086 . . . . 1.72 112.044 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -65.94 -47.2 75.47 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-O 120.712 0.291 . . . . 2.0899999999999999 111.112 -174.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -69.48 -43.31 73.45 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.343 -0.39 . . . . 1.0700000000000001 110.784 -178.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.66 -51.3 69.97 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.105 -0.498 . . . . 1.0600000000000001 111.813 -176.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.568 ' HA ' ' O ' ' A' ' 71' ' ' TYR . 40.4 m -51.26 -27.44 9.21 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.939 0.718 . . . . 1.52 112.939 -177.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -98.55 -46.7 5.64 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.893 0.854 . . . . 0.60999999999999999 110.936 -179.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.442 ' HD2' ' HD2' ' A' ' 27' ' ' ARG . 37.4 mmt180 -94.97 -37.26 11.23 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 114.398 -1.274 . . . . 0.95999999999999996 113.713 -166.133 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.433 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 60.0 p -65.64 117.5 8.18 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.305 -0.558 . . . . 1.0600000000000001 110.065 -178.35 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.534 ' HA ' ' HG2' ' A' ' 26' ' ' ARG . 24.0 t70 -73.84 -15.82 61.15 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.345 0.593 . . . . 2.2799999999999998 111.089 179.33 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 46.2 t -77.37 160.84 28.49 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.307 0.575 . . . . 2.0499999999999998 109.939 179.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -57.1 -18.0 25.55 Favored Glycine 0 C--N 1.328 0.134 0 CA-C-N 114.691 -1.14 . . . . 0.29999999999999999 114.425 -170.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.499 ' HB2' ' CA ' ' A' ' 75' ' ' GLY . 3.0 p -70.28 -0.11 7.42 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.861 0.689 . . . . 0.46999999999999997 112.861 179.198 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.568 ' O ' ' HA ' ' A' ' 63' ' ' SER . 39.2 p90 -60.29 -27.57 67.4 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 118.395 0.543 . . . . 0.94999999999999996 109.973 175.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -94.43 5.37 52.01 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.246 0.545 . . . . 1.1100000000000001 110.223 178.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.5 m -124.67 0.63 8.15 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.666 -0.697 . . . . 0.70999999999999996 111.005 -176.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.516 ' O ' ' HA ' ' A' ' 59' ' ' GLU . . . 75.2 29.62 60.1 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.724 -0.75 . . . . 0.67000000000000004 112.316 -177.388 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.499 ' CA ' ' HB2' ' A' ' 70' ' ' SER . . . 84.4 -3.59 85.98 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 121.01 -0.614 . . . . 0.42999999999999999 112.317 179.622 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -84.57 140.8 31.15 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.667 0.27 . . . . 1.6499999999999999 111.56 -169.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -120.94 163.17 18.65 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.775 -0.648 . . . . 1.6899999999999999 110.493 172.118 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -79.01 -117.05 0.23 Allowed Glycine 0 C--N 1.31 -0.891 0 CA-C-N 114.964 -1.016 . . . . 0.45000000000000001 113.44 -177.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 37.0 p90 -116.15 141.06 48.63 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.864 0.364 . . . . 4.7400000000000002 110.95 -176.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.539 ' HZ ' ' N ' ' A' ' 10' ' ' ALA . 3.5 p90 -158.23 129.56 6.56 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.084 -0.507 . . . . 1.6499999999999999 111.014 -178.482 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.572 ' HA ' ' O ' ' A' ' 6' ' ' GLU . 82.2 p -74.31 155.33 38.32 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.308 -0.627 . . . . 1.6899999999999999 109.308 178.185 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 9.3 m -59.77 114.38 2.74 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.144 -0.48 . . . . 1.55 110.346 -178.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 114.05 1.49 23.81 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.685 -0.769 . . . . 0.79000000000000004 112.509 -176.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -90.84 15.22 11.69 Favored 'General case' 0 C--N 1.33 -0.281 0 O-C-N 122.593 -0.357 . . . . 1.5800000000000001 111.5 178.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 26.2 mmt -126.84 -126.99 0.23 Allowed 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 121.116 0.484 . . . . 1.1299999999999999 111.147 -176.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 54.7 mtt -123.19 149.26 44.87 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.09 -1.078 . . . . 1.8899999999999999 108.09 179.005 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 64.6 tttp -49.82 -54.98 26.61 Favored Pre-proline 0 CA--C 1.541 0.618 0 N-CA-C 112.52 0.563 . . . . 2.7400000000000002 112.52 -175.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -76.02 -22.47 13.06 Favored 'Trans proline' 0 C--N 1.356 0.965 0 C-N-CA 121.798 1.665 . . . . 0.29999999999999999 112.321 -176.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.618 ' O ' HG23 ' A' ' 93' ' ' VAL . 38.7 t80 -73.3 -56.22 5.37 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.402 -0.817 . . . . 0.28000000000000003 109.504 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -63.87 -33.55 75.94 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.595 -0.729 . . . . 2.1200000000000001 109.77 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.581 ' HA ' ' NE ' ' A' ' 94' ' ' ARG . 18.7 t70 -52.47 -37.74 57.78 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.237 -0.892 . . . . 0.60999999999999999 111.104 175.093 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.574 ' O ' ' HG ' ' A' ' 96' ' ' LEU . . . -81.76 -36.55 28.4 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.428 -0.351 . . . . 1.1000000000000001 110.895 178.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.618 HG23 ' O ' ' A' ' 89' ' ' PHE . 11.5 t -63.6 -41.25 91.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.267 0.556 . . . . 1.1200000000000001 110.699 -177.207 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.581 ' NE ' ' HA ' ' A' ' 91' ' ' ASP . 30.7 ptt180 -76.57 -18.55 58.6 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.776 -0.647 . . . . 3.1800000000000002 110.52 178.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -82.95 -5.91 59.25 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.923 -0.58 . . . . 1.0800000000000001 111.441 -172.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.574 ' HG ' ' O ' ' A' ' 92' ' ' ALA . 0.5 OUTLIER -133.45 160.51 37.19 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.18 0.514 . . . . 1.1200000000000001 111.244 -179.591 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.637 ' HG2' ' H ' ' A' ' 98' ' ' ILE . 33.6 tttp -102.33 178.42 4.6 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 115.656 -0.702 . . . . 2.1299999999999999 109.461 178.099 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.637 ' H ' ' HG2' ' A' ' 97' ' ' LYS . 8.2 mt -53.36 119.34 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.265 -0.425 . . . . 1.6200000000000001 111.138 178.346 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 102.1 -10.04 56.67 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.821 -0.704 . . . . 0.46000000000000002 113.057 178.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.559 ' HB2' ' HB2' ' A' ' 96' ' ' LEU . 61.5 m-20 -97.82 139.92 32.96 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 117.1 0.45 . . . . 0.46000000000000002 110.407 -177.774 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.434 HG12 ' HB3' ' A' ' 115' ' ' LYS . 9.5 mt -111.2 151.69 13.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.082 -0.508 . . . . 1.0800000000000001 110.499 -177.282 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.448 ' HG ' HD23 ' A' ' 96' ' ' LEU . 10.8 m -86.37 156.74 56.63 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 115.965 -0.561 . . . . 1.45 110.887 -178.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -75.99 176.49 9.96 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 122.477 2.118 . . . . 0.40999999999999998 110.183 166.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.405 HG13 ' HG2' ' A' ' 45' ' ' GLN . 22.8 mm -52.05 108.45 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 CA-C-O 121.052 0.454 . . . . 1.04 111.732 177.628 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 76.2 t -108.33 115.64 49.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.049 -0.523 . . . . 1.6599999999999999 110.004 175.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -85.9 140.77 30.09 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 121.195 0.521 . . . . 0.55000000000000004 110.235 177.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 8.4 p -118.37 -172.2 2.22 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.488 -0.778 . . . . 1.05 110.817 -177.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -63.41 -37.58 87.84 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.545 0.212 . . . . 2.1600000000000001 111.027 179.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.605 ' O ' ' HB2' ' A' ' 20' ' ' SER . 8.4 t -92.9 -61.37 1.6 Allowed 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.786 -0.366 . . . . 1.0900000000000001 110.478 179.241 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -145.63 -130.68 2.22 Favored Glycine 0 N--CA 1.443 -0.892 0 C-N-CA 119.026 -1.559 . . . . 0.39000000000000001 113.795 -173.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.44 HD23 ' CG1' ' A' ' 41' ' ' ILE . 6.7 mp -118.54 146.35 44.63 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.289 -0.455 . . . . 1.0600000000000001 111.139 -171.786 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . 0.596 ' NE2' HD12 ' A' ' 14' ' ' LEU . 80.6 m-70 -144.35 142.5 30.42 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.066 0.46 . . . . 0.25 112.061 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.486 HG12 HD11 ' A' ' 44' ' ' LEU . 3.4 pt -125.77 136.22 61.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 107.771 -1.196 . . . . 1.03 107.771 159.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 3.1 mp -128.58 141.23 47.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 C-N-CA 120.891 -0.324 . . . . 1.0600000000000001 110.372 -176.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.434 ' HB3' HG12 ' A' ' 101' ' ' ILE . 38.8 pttt -124.69 139.05 54.21 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.927 -0.768 . . . . 1.29 108.927 172.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 52.6 ttt180 -80.45 129.18 34.35 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.956 0.408 . . . . 2.6800000000000002 111.153 -176.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.442 ' HB2' ' HG2' ' A' ' 9' ' ' ARG . 3.5 mm? -100.99 -30.67 11.5 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.608 -0.724 . . . . 1.54 110.575 -177.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.992 0 CA-C-O 118.467 -0.777 . . . . 1.1499999999999999 110.012 178.612 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 N--CA 1.479 1.006 0 CA-C-O 120.77 0.319 . . . . 7.54 110.231 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 6.3 m -92.22 -65.4 1.01 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.3 -0.409 . . . . 3.0899999999999999 110.703 -178.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.417 ' O ' ' HA ' ' A' ' 81' ' ' SER . 14.7 pt-20 -80.05 -10.7 59.79 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.221 -0.445 . . . . 2.7999999999999998 111.031 -176.62 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 40.6 mmtm -78.93 114.88 18.24 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.342 0.591 . . . . 1.6899999999999999 110.693 176.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 10.5 tp -120.21 172.61 7.66 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.182 -0.917 . . . . 1.79 109.133 -179.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.409 ' HG2' ' HB2' ' A' ' 117' ' ' LEU . 69.0 ttt180 -147.63 127.38 13.43 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.385 -0.598 . . . . 1.3700000000000001 109.385 177.793 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.556 ' O ' ' HB2' ' A' ' 77' ' ' LEU . . . -146.76 150.15 34.77 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.265 -0.574 . . . . 1.0700000000000001 112.181 -177.484 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.425 ' N ' HD22 ' A' ' 117' ' ' LEU . . . -103.01 134.41 46.5 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.065 -0.717 . . . . 1.04 109.065 176.052 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.416 ' CE1' HD13 ' A' ' 77' ' ' LEU . 37.2 p-80 -136.18 151.32 49.61 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.098 0.475 . . . . 0.34000000000000002 112.05 -172.058 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.561 ' O ' ' HA ' ' A' ' 112' ' ' HIS . 4.7 tt -119.34 144.5 46.82 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.49 -0.929 . . . . 1.0600000000000001 108.49 175.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.585 HD12 ' NE2' ' A' ' 112' ' ' HIS . 28.9 tp -131.65 123.91 28.81 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.531 0.205 . . . . 1.0800000000000001 111.033 -176.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.403 HG23 HD12 ' A' ' 44' ' ' LEU . 71.1 t -113.82 138.03 44.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 109.87 -0.419 . . . . 1.01 109.87 176.052 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.475 ' HE3' HD23 ' A' ' 14' ' ' LEU . 34.0 mmtp -111.29 158.8 18.59 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.876 -0.416 . . . . 1.22 109.876 177.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.426 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 38.4 p90 -149.03 162.58 39.64 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.427 -0.351 . . . . 0.29999999999999999 110.306 -175.542 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.468 ' HB3' ' C ' ' A' ' 33' ' ' ALA . 35.5 p -52.18 109.61 0.4 Allowed 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 120.929 0.395 . . . . 1.6000000000000001 110.55 176.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 101.93 9.08 43.69 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.484 -0.865 . . . . 0.53000000000000003 112.947 -179.085 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.512 ' C ' ' H ' ' A' ' 22' ' ' ASN . 80.9 p -84.08 34.26 0.5 Allowed 'General case' 0 C--O 1.232 0.18 0 CA-C-N 117.29 0.545 . . . . 1.28 111.223 -178.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.439 ' HB2' ' O ' ' A' ' 20' ' ' SER . 89.9 mtt180 73.03 -28.61 0.19 Allowed 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.521 0.728 . . . . 4.1600000000000001 110.895 -177.17 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.512 ' H ' ' C ' ' A' ' 20' ' ' SER . 3.0 p30 -150.07 104.39 3.17 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 115.919 -0.582 . . . . 1.77 110.175 172.425 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.428 ' C ' HG23 ' A' ' 32' ' ' THR . 6.8 Cg_exo -75.3 57.95 4.92 Favored 'Trans proline' 0 CA--C 1.532 0.403 0 C-N-CA 123.448 2.766 . . . . 1.71 113.368 -178.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.418 ' N ' HG23 ' A' ' 32' ' ' THR . 40.3 t -148.48 110.81 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 109.867 -0.42 . . . . 1.1599999999999999 109.867 176.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.463 ' HB3' ' HB2' ' A' ' 16' ' ' LYS . 17.1 p -104.41 154.57 19.69 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.831 -0.168 . . . . 1.4299999999999999 110.689 177.094 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.64 ' HB2' ' HA ' ' A' ' 67' ' ' ASP . 1.2 mpt_? -62.2 -13.6 29.32 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.031 0.443 . . . . 3.1200000000000001 110.503 171.764 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.475 ' HG2' ' HA ' ' A' ' 65' ' ' ARG . 0.4 OUTLIER -80.59 -21.67 41.39 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.81 -0.632 . . . . 2.25 110.346 -179.689 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.419 ' C ' ' H ' ' A' ' 30' ' ' ASP . 36.3 p -115.35 -34.89 4.8 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.999 -0.546 . . . . 1.1299999999999999 110.79 -177.622 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 76.53 -33.11 1.38 Allowed Glycine 0 CA--C 1.517 0.207 0 CA-C-N 115.252 -0.886 . . . . 0.81999999999999995 113.065 176.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.419 ' H ' ' C ' ' A' ' 28' ' ' THR . 16.0 t70 -99.59 -69.13 0.78 Allowed 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 110.124 -0.324 . . . . 2.1000000000000001 110.124 -178.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 42.9 m -154.57 152.76 30.42 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.095 -0.502 . . . . 1.3300000000000001 110.495 175.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.428 HG23 ' C ' ' A' ' 23' ' ' PRO . 10.5 t -119.4 30.88 6.87 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 122.17 0.986 . . . . 1.02 108.903 175.743 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.468 ' C ' ' HB3' ' A' ' 18' ' ' SER . . . -79.96 -5.39 55.57 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 114.898 -1.046 . . . . 1.1299999999999999 111.364 -177.516 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -88.46 -25.68 22.49 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.413 0.625 . . . . 2.21 110.244 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -100.14 137.48 27.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.442 -0.799 . . . . 1.1100000000000001 109.895 -178.434 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 59.6 p -94.88 178.35 5.6 Favored 'General case' 0 CA--C 1.512 -0.487 0 N-CA-C 109.708 -0.478 . . . . 1.2 109.708 -176.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.47 ' O ' HG13 ' A' ' 41' ' ' ILE . 10.1 p90 -63.11 -29.23 70.63 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.009 -0.676 . . . . 2.21 109.561 177.436 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -72.96 -44.13 61.48 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.058 -0.519 . . . . 0.95999999999999996 110.539 178.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 39.7 m-20 -69.72 -27.12 64.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.299 0.571 . . . . 0.91000000000000003 109.89 177.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.426 ' HB2' ' HB3' ' A' ' 17' ' ' PHE . . . -73.37 -45.75 53.08 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.303 -0.862 . . . . 1.03 110.683 176.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.478 ' CG1' HD22 ' A' ' 111' ' ' LEU . 80.5 mt -61.81 -36.39 73.43 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.369 0 N-CA-C 109.619 -0.512 . . . . 1.0800000000000001 109.619 175.246 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -57.78 -32.05 67.15 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 115.561 -0.745 . . . . 2.8399999999999999 110.468 176.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -87.37 -46.18 9.88 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.605 -0.725 . . . . 1.02 109.904 -175.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.461 HD11 HG12 ' A' ' 113' ' ' ILE . 34.6 tp -62.16 -37.41 85.11 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.019 -0.537 . . . . 1.02 110.123 -178.551 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.51 ' O ' ' HB2' ' A' ' 49' ' ' GLN . 0.0 OUTLIER -64.72 -30.93 71.95 Favored 'General case' 0 C--O 1.225 -0.211 0 CA-C-N 116.271 -0.422 . . . . 0.87 111.779 179.581 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 59.4 mttm -72.08 -44.3 63.49 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.119 0.485 . . . . 1.98 110.503 179.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 25.5 m95 -71.54 -43.34 66.59 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.088 -0.506 . . . . 0.60999999999999999 111.414 -179.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.422 ' HB3' HG21 ' A' ' 113' ' ' ILE . 93.6 p -65.04 -22.95 67.06 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.903 -0.406 . . . . 0.88 109.903 175.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.51 ' HB2' ' O ' ' A' ' 45' ' ' GLN . 14.7 tt0 -71.55 -54.31 10.91 Favored 'General case' 0 C--O 1.224 -0.252 0 CA-C-N 116.047 -0.524 . . . . 0.55000000000000004 109.764 174.574 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.513 ' HB3' HG21 ' A' ' 56' ' ' VAL . 89.1 mtt180 -62.37 -41.69 98.83 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.903 -0.589 . . . . 0.47999999999999998 111.788 -177.59 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.43 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 82.1 mt -59.92 -40.01 81.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 120.998 0.427 . . . . 1.04 110.425 176.49 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.9 -41.26 64.79 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.012 -0.54 . . . . 1.0600000000000001 111.523 179.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 66.5 p -76.13 -29.43 57.81 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.829 0.347 . . . . 0.34999999999999998 111.505 -176.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 107.06 4.49 35.76 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.615 -0.802 . . . . 0.33000000000000002 112.271 178.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.469 ' OE1' ' HG2' ' A' ' 50' ' ' ARG . 46.3 mt-10 -61.05 -49.69 76.36 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.134 0.492 . . . . 0.65000000000000002 110.176 178.221 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.513 HG21 ' HB3' ' A' ' 50' ' ' ARG . 15.8 m -131.49 154.62 40.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.695 -0.684 . . . . 1.05 109.268 173.193 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 22.8 p -85.41 165.76 16.94 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 109.554 -0.536 . . . . 1.3100000000000001 109.554 177.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -57.38 -41.9 81.11 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.978 -0.378 . . . . 0.25 109.978 -177.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.577 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 42.0 mt-10 -59.23 -46.56 88.15 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.76 -0.654 . . . . 1.72 111.623 -179.179 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -60.53 -44.61 95.87 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-O 120.92 0.391 . . . . 2.0899999999999999 111.0 -178.018 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -70.76 -49.57 45.29 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.246 -0.434 . . . . 1.0700000000000001 111.084 -178.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.41 -51.86 68.08 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.332 0.493 . . . . 1.0600000000000001 112.332 -174.424 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.508 ' HA ' ' O ' ' A' ' 71' ' ' TYR . 52.8 m -51.12 -24.09 3.75 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 113.041 0.756 . . . . 1.52 113.041 -178.083 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -104.18 -44.94 4.85 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.493 0.663 . . . . 0.60999999999999999 110.494 -179.018 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.475 ' HA ' ' HG2' ' A' ' 27' ' ' ARG . 16.3 mmt180 -90.81 -42.73 10.49 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 113.848 1.055 . . . . 0.95999999999999996 113.848 -170.353 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.409 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 72.7 p -64.3 124.89 22.9 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.044 0.449 . . . . 1.0600000000000001 111.28 -175.305 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.64 ' HA ' ' HB2' ' A' ' 26' ' ' ARG . 25.7 t70 -76.6 -16.05 59.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.543 -0.753 . . . . 2.2799999999999998 111.475 178.204 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 52.6 t -78.05 155.79 30.44 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.201 0.524 . . . . 2.0499999999999998 110.15 -179.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -57.12 -18.1 26.1 Favored Glycine 0 N--CA 1.454 -0.138 0 CA-C-N 114.631 -1.168 . . . . 0.29999999999999999 113.638 -173.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 63.0 p -64.77 -7.7 12.04 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 112.035 0.383 . . . . 0.46999999999999997 112.035 176.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.508 ' O ' ' HA ' ' A' ' 63' ' ' SER . 25.2 p90 -57.88 -22.92 50.69 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.868 0.366 . . . . 0.94999999999999996 110.297 175.724 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -90.77 -0.23 57.64 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.06 0.457 . . . . 1.1100000000000001 110.674 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 16.3 m -126.34 14.38 7.72 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.888 -0.596 . . . . 0.70999999999999996 110.577 178.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.577 ' O ' ' HA ' ' A' ' 59' ' ' GLU . . . 70.75 27.33 72.56 Favored Glycine 0 CA--C 1.519 0.325 0 C-N-CA 120.839 -0.696 . . . . 0.67000000000000004 112.718 -178.708 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 82.3 -17.85 16.69 Favored Glycine 0 N--CA 1.454 -0.167 0 C-N-CA 121.034 -0.603 . . . . 0.42999999999999999 112.473 179.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -70.96 135.16 47.73 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-O 120.883 0.373 . . . . 1.6499999999999999 110.594 -176.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.556 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 19.2 mt -111.36 158.43 19.07 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.933 -0.576 . . . . 1.6899999999999999 110.291 176.408 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -81.84 -137.37 2.4 Favored Glycine 0 C--N 1.317 -0.507 0 CA-C-N 115.673 -0.694 . . . . 0.45000000000000001 112.625 179.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 38.1 p90 -98.43 135.57 39.82 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.189 0.519 . . . . 4.7400000000000002 110.626 -177.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.435 ' HZ ' ' N ' ' A' ' 10' ' ' ALA . 2.0 p90 -151.5 164.6 36.44 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.921 -0.581 . . . . 1.6499999999999999 110.21 -178.572 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.417 ' HA ' ' O ' ' A' ' 6' ' ' GLU . 13.2 m -89.54 120.42 30.83 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 109.788 -0.449 . . . . 1.6899999999999999 109.788 178.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.5 p -55.36 118.85 4.79 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.932 -0.576 . . . . 1.55 110.909 178.468 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 114.43 5.92 20.47 Favored Glycine 0 N--CA 1.447 -0.572 0 N-CA-C 111.538 -0.625 . . . . 0.79000000000000004 111.538 -176.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -105.04 -6.19 20.22 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.83 0.347 . . . . 1.5800000000000001 110.803 -177.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 26.0 mmt -86.14 -97.48 0.07 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.252 0.549 . . . . 1.1299999999999999 110.873 -175.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 55.9 mtt -145.16 150.96 37.68 Favored 'General case' 0 CA--C 1.507 -0.694 0 N-CA-C 107.187 -1.412 . . . . 1.8899999999999999 107.187 176.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -55.85 -52.63 70.76 Favored Pre-proline 0 C--N 1.318 -0.797 0 CA-C-N 118.188 0.449 . . . . 2.7400000000000002 112.115 -174.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -74.03 -31.34 8.04 Favored 'Trans proline' 0 C--N 1.358 1.033 0 C-N-CA 121.466 1.444 . . . . 0.29999999999999999 111.891 -177.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.618 ' O ' HG21 ' A' ' 93' ' ' VAL . 29.7 t80 -65.74 -55.73 15.78 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.62 -0.718 . . . . 0.28000000000000003 109.481 177.018 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -64.52 -34.6 78.6 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.338 -0.846 . . . . 2.1200000000000001 110.461 -177.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -56.99 -36.54 70.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.824 -0.625 . . . . 0.60999999999999999 110.516 175.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.44 ' O ' ' HG ' ' A' ' 96' ' ' LEU . . . -78.97 -28.26 43.54 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.192 -0.458 . . . . 1.1000000000000001 110.981 178.356 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.618 HG21 ' O ' ' A' ' 89' ' ' PHE . 17.2 t -71.42 -36.48 61.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 121.267 0.556 . . . . 1.1200000000000001 110.14 -177.55 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.509 ' C ' ' HD2' ' A' ' 94' ' ' ARG . 6.1 ppt_? -82.66 -9.23 59.47 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.918 -0.583 . . . . 3.1800000000000002 110.446 179.008 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.35 -2.66 58.78 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.989 -0.551 . . . . 1.0800000000000001 110.955 -177.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.523 ' HB2' ' HB2' ' A' ' 100' ' ' ASP . 0.7 OUTLIER -135.87 152.9 51.5 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.896 -0.593 . . . . 1.1200000000000001 110.442 178.906 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.613 ' HG2' ' H ' ' A' ' 98' ' ' ILE . 47.0 tttt -102.88 -174.13 2.48 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.634 -0.506 . . . . 2.1299999999999999 109.634 176.64 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.613 ' H ' ' HG2' ' A' ' 97' ' ' LYS . 10.4 mt -57.54 116.08 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 121.061 0.458 . . . . 1.6200000000000001 111.692 -176.387 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 98.23 3.83 57.62 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.813 -0.708 . . . . 0.46000000000000002 113.239 179.326 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.523 ' HB2' ' HB2' ' A' ' 96' ' ' LEU . 7.7 m-20 -104.67 141.76 35.87 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 117.196 0.498 . . . . 0.46000000000000002 110.811 178.719 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 8.3 mt -111.84 146.58 16.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.774 -0.648 . . . . 1.0800000000000001 109.737 -178.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 88.1 p -93.35 155.46 40.9 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 116.374 -0.376 . . . . 1.45 110.292 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -74.23 175.54 10.81 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 122.125 1.883 . . . . 0.40999999999999998 111.131 171.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.43 HG13 ' HG2' ' A' ' 45' ' ' GLN . 20.3 mm -48.99 108.48 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 O-C-N 123.459 0.474 . . . . 1.04 112.144 177.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.4 p -115.84 120.08 63.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 120.91 0.386 . . . . 1.6599999999999999 110.125 175.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -85.42 152.45 23.21 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.141 0.496 . . . . 0.55000000000000004 110.964 -179.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 4.3 p -126.27 -172.51 2.64 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.434 -0.803 . . . . 1.05 110.237 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -60.78 -38.46 85.4 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.83 0.348 . . . . 2.1600000000000001 110.642 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.455 ' O ' ' HB2' ' A' ' 20' ' ' SER . 16.2 t -90.95 -60.63 1.86 Allowed 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 120.867 -0.333 . . . . 1.0900000000000001 110.694 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -150.55 -130.85 1.79 Allowed Glycine 0 N--CA 1.441 -1.019 0 C-N-CA 119.057 -1.544 . . . . 0.39000000000000001 114.084 -173.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.513 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 6.7 mp -116.07 146.2 42.39 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.184 -0.508 . . . . 1.0600000000000001 111.844 -168.012 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . 0.585 ' NE2' HD12 ' A' ' 14' ' ' LEU . 85.0 m-70 -141.99 150.0 40.78 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.578 0.584 . . . . 0.25 112.578 178.422 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.461 HG12 HD11 ' A' ' 44' ' ' LEU . 3.3 pt -132.42 138.21 52.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 107.446 -1.316 . . . . 1.03 107.446 159.379 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 2.2 mp -129.69 145.74 35.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 C-N-CA 120.755 -0.378 . . . . 1.0600000000000001 110.641 -175.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.426 ' HA ' ' O ' ' A' ' 100' ' ' ASP . 42.0 pttt -126.64 139.01 53.49 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.796 -0.816 . . . . 1.29 108.796 171.365 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . 0.451 ' HD3' ' HA ' ' A' ' 97' ' ' LYS . 60.7 ttt180 -83.63 125.12 31.5 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.174 0.512 . . . . 2.6800000000000002 110.86 -178.087 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.425 HD22 ' N ' ' A' ' 11' ' ' ALA . 4.2 mm? -93.06 -31.96 14.65 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.487 -0.779 . . . . 1.54 110.247 -179.114 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.865 0 CA-C-N 115.54 -0.755 . . . . 1.1499999999999999 109.962 179.747 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 27.9 ttt . . . . . 0 N--CA 1.48 1.064 0 CA-C-O 120.643 0.258 . . . . 7.54 110.315 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 38.3 t -65.18 139.04 58.62 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.15 -0.477 . . . . 3.0899999999999999 110.212 179.108 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.406 ' H ' ' CD ' ' A' ' 6' ' ' GLU . 0.1 OUTLIER -95.87 -8.25 34.59 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.993 -0.549 . . . . 2.7999999999999998 109.942 179.455 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.42 ' HG3' ' HB2' ' A' ' 79' ' ' PHE . 10.8 mptt -81.63 115.96 21.15 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.838 0.827 . . . . 1.6899999999999999 110.82 -179.089 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.57 HD22 ' H ' ' A' ' 9' ' ' ARG . 1.8 tt -116.01 159.53 21.51 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 114.2 -1.364 . . . . 1.79 108.001 -178.512 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.57 ' H ' HD22 ' A' ' 8' ' ' LEU . 79.0 ttt180 -136.28 127.85 28.75 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.431 -0.581 . . . . 1.3700000000000001 109.431 174.274 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.484 ' N ' ' HZ ' ' A' ' 80' ' ' PHE . . . -150.05 152.17 34.41 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.093 0.473 . . . . 1.0700000000000001 111.714 -179.244 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -101.87 136.78 41.12 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.458 -0.792 . . . . 1.04 109.527 177.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 37.4 p-80 -136.45 149.1 48.07 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.964 0.412 . . . . 0.34000000000000002 111.286 -173.327 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.555 ' O ' ' HA ' ' A' ' 112' ' ' HIS . 6.2 tt -118.37 149.46 41.16 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.836 -0.802 . . . . 1.0600000000000001 108.836 177.275 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.563 ' O ' ' HA ' ' A' ' 66' ' ' SER . 29.6 tp -130.84 124.61 31.65 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.611 0.243 . . . . 1.0800000000000001 111.052 -179.228 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.415 HG21 HD13 ' A' ' 44' ' ' LEU . 85.1 t -111.34 138.03 41.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 109.405 -0.591 . . . . 1.01 109.405 173.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.471 ' HB2' ' HB2' ' A' ' 25' ' ' SER . 24.9 mmtp -105.72 162.07 13.85 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.157 -0.474 . . . . 1.22 110.491 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.44 ' HB3' ' HB3' ' A' ' 40' ' ' ALA . 51.5 p90 -158.86 161.6 36.87 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.053 -0.521 . . . . 0.29999999999999999 109.92 179.48 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.486 ' HB3' ' C ' ' A' ' 33' ' ' ALA . 21.5 p -53.35 109.97 0.5 Allowed 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.347 -0.388 . . . . 1.6000000000000001 111.026 178.576 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 104.46 10.36 33.71 Favored Glycine 0 N--CA 1.443 -0.86 0 C-N-CA 120.229 -0.986 . . . . 0.53000000000000003 113.371 178.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.658 ' HB2' ' O ' ' A' ' 109' ' ' SER . 39.8 p -81.49 46.24 0.94 Allowed 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 117.855 0.828 . . . . 1.28 111.577 -174.065 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 56.2 ttt180 68.95 -37.01 0.35 Allowed 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.905 0.882 . . . . 4.1600000000000001 111.355 -177.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.515 ' H ' ' C ' ' A' ' 20' ' ' SER . 8.1 p30 -155.01 126.48 3.67 Favored Pre-proline 0 C--N 1.316 -0.866 0 N-CA-C 107.67 -1.233 . . . . 1.77 107.67 175.565 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -82.39 -156.11 0.07 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 122.302 2.001 . . . . 1.71 111.784 -175.106 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.591 ' N ' HG22 ' A' ' 32' ' ' THR . 57.5 t 60.07 114.12 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 123.423 0.689 . . . . 1.1599999999999999 111.692 -173.738 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.471 ' HB2' ' HB2' ' A' ' 16' ' ' LYS . 29.8 t -103.4 159.82 15.24 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.815 -0.63 . . . . 1.4299999999999999 109.722 177.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.586 ' HB2' ' HA ' ' A' ' 67' ' ' ASP . 5.5 mpt_? -75.33 -12.73 60.33 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 109.018 -0.734 . . . . 3.1200000000000001 109.018 169.498 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.425 ' HG2' ' HD3' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -72.52 -49.75 30.67 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.249 -0.887 . . . . 2.25 109.195 174.066 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.412 ' C ' ' H ' ' A' ' 30' ' ' ASP . 55.6 p -85.39 -34.05 21.84 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.468 -0.787 . . . . 1.1299999999999999 111.249 -177.511 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 80.7 -34.73 2.29 Favored Glycine 0 C--N 1.322 -0.216 0 CA-C-N 115.314 -0.857 . . . . 0.81999999999999995 111.395 -176.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.561 ' O ' ' HA ' ' A' ' 24' ' ' VAL . 4.4 m-20 -114.56 -135.27 0.35 Allowed 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 108.349 -0.982 . . . . 2.1000000000000001 108.349 173.025 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -70.82 142.03 51.3 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 112.703 0.631 . . . . 1.3300000000000001 112.703 -171.261 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.591 HG22 ' N ' ' A' ' 24' ' ' VAL . 8.9 t -124.25 14.51 9.01 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.337 -0.847 . . . . 1.02 109.461 175.219 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.486 ' C ' ' HB3' ' A' ' 18' ' ' SER . . . -68.75 -4.35 15.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.302 -0.863 . . . . 1.1299999999999999 111.565 177.587 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -88.73 -24.95 22.55 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.99 -0.55 . . . . 2.21 110.802 -178.053 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.557 HG22 ' HB3' ' A' ' 39' ' ' ASP . 0.1 OUTLIER -100.58 141.55 17.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.088 -0.505 . . . . 1.1100000000000001 110.211 -179.126 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 40.7 p -98.1 174.75 6.38 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 110.212 -0.292 . . . . 1.2 110.212 -176.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.519 ' O ' HG13 ' A' ' 41' ' ' ILE . 11.5 p90 -63.94 -26.85 68.77 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.101 -0.64 . . . . 2.21 109.507 177.713 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -71.04 -46.14 62.57 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.06 -0.518 . . . . 0.95999999999999996 110.526 178.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.557 ' HB3' HG22 ' A' ' 35' ' ' VAL . 2.7 t70 -70.0 -31.22 68.79 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.473 0.654 . . . . 0.91000000000000003 109.695 178.15 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.44 ' HB3' ' HB3' ' A' ' 17' ' ' PHE . . . -66.64 -41.97 87.43 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.232 -0.895 . . . . 1.03 110.347 175.658 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.519 HG13 ' O ' ' A' ' 37' ' ' TYR . 78.1 mt -64.63 -33.13 61.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 109.516 -0.549 . . . . 1.0800000000000001 109.516 173.517 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.513 ' HB3' ' O ' ' A' ' 39' ' ' ASP . 3.9 ttpm? -60.75 -28.32 68.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.298 0.571 . . . . 2.8399999999999999 109.993 176.212 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.437 ' HG3' ' CD1' ' A' ' 47' ' ' TRP . 6.2 tp10 -84.92 -52.88 5.69 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.403 -0.817 . . . . 1.02 109.487 -178.635 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.486 HD12 HG12 ' A' ' 113' ' ' ILE . 22.8 tp -64.61 -34.15 77.61 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.329 -0.851 . . . . 1.02 110.762 -174.267 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.503 ' O ' ' HB2' ' A' ' 49' ' ' GLN . 4.7 mm-40 -70.41 -19.63 62.98 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.353 -0.385 . . . . 0.87 111.892 -178.481 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.43 ' HG3' ' O ' ' A' ' 42' ' ' LYS . 67.9 mttm -84.25 -46.95 11.29 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.741 -0.466 . . . . 1.98 109.741 175.489 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.452 ' NE1' ' HG3' ' A' ' 65' ' ' ARG . 44.0 m95 -63.61 -48.05 78.9 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.144 -0.48 . . . . 0.60999999999999999 111.821 179.782 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.446 ' HB3' HG21 ' A' ' 113' ' ' ILE . 98.5 p -64.81 -20.53 66.44 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.507 -0.477 . . . . 0.88 110.023 177.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.503 ' HB2' ' O ' ' A' ' 45' ' ' GLN . 11.8 tt0 -77.52 -54.72 6.08 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.183 -0.462 . . . . 0.55000000000000004 110.014 175.771 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.497 ' HB3' HG21 ' A' ' 56' ' ' VAL . 97.9 mtt180 -63.21 -41.5 99.15 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.637 -0.711 . . . . 0.47999999999999998 111.435 -176.627 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.474 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 98.3 mt -61.12 -33.59 56.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.159 0.504 . . . . 1.04 110.48 176.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -79.75 -35.55 38.57 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.907 -0.588 . . . . 1.0600000000000001 111.444 -179.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 31.1 p -82.35 -28.98 31.23 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.811 0.338 . . . . 0.34999999999999998 111.602 -176.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 107.98 3.77 33.9 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.762 -0.732 . . . . 0.33000000000000002 112.375 179.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.441 ' HB2' ' HB3' ' A' ' 50' ' ' ARG . 36.8 mt-10 -61.79 -48.16 81.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.075 0.464 . . . . 0.65000000000000002 110.258 178.435 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.497 HG21 ' HB3' ' A' ' 50' ' ' ARG . 15.6 m -135.32 156.22 38.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 109.31 -0.626 . . . . 1.05 109.31 172.242 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.574 ' OG ' ' HG3' ' A' ' 60' ' ' GLU . 77.7 p -83.79 165.49 18.79 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.795 -0.446 . . . . 1.3100000000000001 109.795 178.035 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -57.7 -41.01 80.83 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.516 -0.55 . . . . 0.25 109.516 179.172 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.485 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 43.8 mt-10 -62.24 -41.35 98.34 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.062 -0.972 . . . . 1.72 111.962 -178.122 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.574 ' HG3' ' OG ' ' A' ' 57' ' ' SER . 41.2 mt-10 -60.76 -49.24 78.28 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.021 0.439 . . . . 2.0899999999999999 110.859 -179.659 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.14 -50.61 63.38 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.926 -0.579 . . . . 1.0700000000000001 111.073 -178.257 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -58.86 -52.1 67.19 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.351 0.5 . . . . 1.0600000000000001 112.351 -174.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.546 ' HA ' ' O ' ' A' ' 71' ' ' TYR . 20.2 m -51.5 -24.23 4.92 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 113.122 0.786 . . . . 1.52 113.122 -176.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -105.49 -44.12 4.78 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.583 0.706 . . . . 0.60999999999999999 110.615 -179.15 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.452 ' HG3' ' NE1' ' A' ' 47' ' ' TRP . 38.7 mmt-85 -90.92 -41.88 10.9 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 113.882 1.067 . . . . 0.95999999999999996 113.882 -170.131 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.563 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 75.9 p -64.17 122.7 17.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.055 0.455 . . . . 1.0600000000000001 111.615 -174.314 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.586 ' HA ' ' HB2' ' A' ' 26' ' ' ARG . 28.6 t70 -76.55 -9.33 58.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.618 -0.719 . . . . 2.2799999999999998 110.827 175.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.428 ' SG ' HD22 ' A' ' 14' ' ' LEU . 4.1 m -77.13 163.43 26.6 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.897 -0.592 . . . . 2.0499999999999998 110.267 175.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -65.9 -16.28 63.71 Favored Glycine 0 CA--C 1.512 -0.142 0 CA-C-N 114.912 -1.04 . . . . 0.29999999999999999 113.203 -173.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.51 ' HB2' ' CA ' ' A' ' 75' ' ' GLY . 3.6 p -68.96 0.56 4.34 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 112.426 0.528 . . . . 0.46999999999999997 112.426 177.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.546 ' O ' ' HA ' ' A' ' 63' ' ' SER . 34.5 p90 -58.33 -26.47 63.14 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.137 0.494 . . . . 0.94999999999999996 110.154 175.515 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -95.29 -6.99 40.07 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.162 0.505 . . . . 1.1100000000000001 110.585 178.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.8 m -110.67 -0.02 17.31 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.835 -0.62 . . . . 0.70999999999999996 111.066 -175.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.485 ' O ' ' HA ' ' A' ' 59' ' ' GLU . . . 77.79 27.64 58.37 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.852 -0.689 . . . . 0.67000000000000004 112.218 -177.086 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.51 ' CA ' ' HB2' ' A' ' 70' ' ' SER . . . 81.94 -1.2 87.24 Favored Glycine 0 C--O 1.226 -0.373 0 C-N-CA 120.873 -0.679 . . . . 0.42999999999999999 111.85 -178.264 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -92.15 136.07 33.48 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 120.962 0.41 . . . . 1.6499999999999999 111.436 -169.215 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.6 mp -115.75 158.08 23.38 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.709 -0.678 . . . . 1.6899999999999999 109.548 172.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -85.35 -127.2 1.77 Allowed Glycine 0 C--N 1.308 -1.001 0 CA-C-N 114.944 -1.025 . . . . 0.45000000000000001 112.255 -179.118 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.42 ' HB2' ' HG3' ' A' ' 7' ' ' LYS . 46.4 p90 -92.67 147.31 22.98 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.83 0.348 . . . . 4.7400000000000002 110.734 -177.694 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.484 ' HZ ' ' N ' ' A' ' 10' ' ' ALA . 2.3 p90 -163.59 147.25 10.32 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.098 -0.501 . . . . 1.6499999999999999 110.499 179.056 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 17.5 m -76.08 135.03 39.89 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.13 -0.486 . . . . 1.6899999999999999 110.577 179.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 16.0 m -61.03 114.64 3.21 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.939 -0.573 . . . . 1.55 110.024 177.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 112.58 -8.08 26.18 Favored Glycine 0 N--CA 1.447 -0.606 0 CA-C-N 115.79 -0.641 . . . . 0.79000000000000004 111.895 -177.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -101.14 47.01 0.92 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.655 0.741 . . . . 1.5800000000000001 110.371 -177.296 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 21.6 mmt -135.82 -127.21 0.15 Allowed 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.87 -0.789 . . . . 1.1299999999999999 108.87 176.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 59.9 mtt -113.45 149.85 33.65 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.438 -0.949 . . . . 1.8899999999999999 108.438 174.028 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -53.3 -54.37 45.85 Favored Pre-proline 0 C--N 1.321 -0.646 0 N-CA-C 112.647 0.61 . . . . 2.7400000000000002 112.647 -174.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -74.61 -31.22 7.1 Favored 'Trans proline' 0 C--N 1.355 0.89 0 C-N-CA 121.387 1.391 . . . . 0.29999999999999999 111.667 -176.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.598 ' O ' HG21 ' A' ' 93' ' ' VAL . 42.9 t80 -66.03 -56.06 13.47 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.113 -0.949 . . . . 0.28000000000000003 110.099 179.309 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -64.61 -37.96 89.37 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.598 -0.728 . . . . 2.1200000000000001 110.218 -177.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.409 ' HA ' ' HD2' ' A' ' 94' ' ' ARG . 35.2 t70 -59.46 -26.93 65.64 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.874 -0.603 . . . . 0.60999999999999999 110.7 177.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -85.59 -21.39 28.52 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.495 -0.32 . . . . 1.1000000000000001 111.408 176.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.598 HG21 ' O ' ' A' ' 89' ' ' PHE . 44.8 t -74.83 -47.9 35.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 121.253 0.549 . . . . 1.1200000000000001 110.567 -173.737 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.409 ' HD2' ' HA ' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -78.49 1.79 21.18 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.195 -0.457 . . . . 3.1800000000000002 111.028 176.888 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -92.68 0.44 57.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.973 0.416 . . . . 1.0800000000000001 110.758 -179.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.538 ' HB2' ' HB2' ' A' ' 100' ' ' ASP . 0.4 OUTLIER -137.28 160.37 39.22 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.968 -0.56 . . . . 1.1200000000000001 110.627 177.876 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.498 ' HG3' ' H ' ' A' ' 98' ' ' ILE . 50.8 tptt -102.21 175.83 5.39 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.246 -0.65 . . . . 2.1299999999999999 109.246 179.433 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.498 ' H ' ' HG3' ' A' ' 97' ' ' LYS . 63.0 mt -57.71 114.66 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 120.97 0.414 . . . . 1.6200000000000001 110.725 177.797 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 104.76 -0.49 42.14 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.802 -0.714 . . . . 0.46000000000000002 112.528 -179.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.538 ' HB2' ' HB2' ' A' ' 96' ' ' LEU . 24.6 m-20 -105.17 137.45 42.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.797 0.298 . . . . 0.46000000000000002 110.522 179.732 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 12.7 mt -108.94 148.77 12.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.986 -0.552 . . . . 1.0800000000000001 109.902 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 95.7 p -91.28 156.05 43.95 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-N 116.469 -0.332 . . . . 1.45 110.539 -179.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -69.69 174.08 9.97 Favored 'Trans proline' 0 C--O 1.233 0.271 0 C-N-CA 122.478 2.118 . . . . 0.40999999999999998 111.245 171.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.434 HG22 HD22 ' A' ' 44' ' ' LEU . 26.1 mm -51.67 100.78 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 O-C-N 123.314 0.383 . . . . 1.04 111.447 176.025 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.5 p -104.76 118.34 51.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.2 0.524 . . . . 1.6599999999999999 109.868 175.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -85.23 146.96 26.82 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.214 0.531 . . . . 0.55000000000000004 110.674 -179.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 18.5 p -124.49 -172.38 2.55 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.395 -0.82 . . . . 1.05 109.76 179.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -73.46 -29.43 62.53 Favored 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 120.967 -0.293 . . . . 2.1600000000000001 110.81 178.085 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.658 ' O ' ' HB2' ' A' ' 20' ' ' SER . 8.4 t -101.3 -9.31 21.33 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.1 0.407 . . . . 1.0900000000000001 112.1 -175.377 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 160.66 -127.47 1.78 Allowed Glycine 0 N--CA 1.437 -1.293 0 C-N-CA 119.871 -1.157 . . . . 0.39000000000000001 112.638 170.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.51 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 6.1 mp -120.9 144.11 48.6 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 114.981 -0.61 . . . . 1.0600000000000001 110.846 -172.36 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . 0.555 ' HA ' ' O ' ' A' ' 13' ' ' LEU . 72.9 m-70 -143.06 151.72 41.09 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.262 0.553 . . . . 0.25 112.044 -179.773 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.486 HG12 HD12 ' A' ' 44' ' ' LEU . 2.8 pt -134.64 141.36 43.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 107.658 -1.238 . . . . 1.03 107.658 161.126 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 1.8 mp -129.98 143.31 41.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 C-N-CA 120.773 -0.371 . . . . 1.0600000000000001 110.62 -176.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.402 ' HA ' ' O ' ' A' ' 100' ' ' ASP . 43.8 pttt -125.14 138.17 54.16 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.63 -0.878 . . . . 1.29 108.63 172.136 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . 0.417 ' HB2' ' CD1' ' A' ' 96' ' ' LEU . 61.3 ttt180 -85.64 136.39 33.39 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.079 0.466 . . . . 2.6800000000000002 111.268 -177.079 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 6.6 mp -115.25 -24.29 8.54 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.62 -0.718 . . . . 1.54 111.508 -178.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.774 0 CA-C-O 118.22 -0.895 . . . . 1.1499999999999999 109.882 175.718 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 98.2 mmm . . . . . 0 N--CA 1.479 1.009 0 N-CA-C 110.194 -0.299 . . . . 7.54 110.194 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 57.4 m -139.87 169.84 16.98 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.169 -0.469 . . . . 3.0899999999999999 110.616 178.174 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -130.07 104.44 7.34 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.792 -0.64 . . . . 2.7999999999999998 109.865 176.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 24.3 tptt -149.76 134.07 17.33 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.281 0.563 . . . . 1.6899999999999999 110.004 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.659 HD23 ' N ' ' A' ' 9' ' ' ARG . 2.9 tt -139.29 155.92 47.4 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 115.065 -0.97 . . . . 1.79 108.467 -177.449 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.659 ' N ' HD23 ' A' ' 8' ' ' LEU . 44.3 ttt180 -139.56 128.48 23.52 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 108.199 -1.038 . . . . 1.3700000000000001 108.199 173.422 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.418 ' O ' ' HB2' ' A' ' 77' ' ' LEU . . . -146.04 148.71 32.98 Favored 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 120.402 -0.519 . . . . 1.0700000000000001 111.983 -177.106 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -102.44 137.15 41.07 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.428 -0.806 . . . . 1.04 109.264 176.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 23.1 p-80 -137.37 152.68 49.95 Favored 'General case' 0 C--N 1.323 -0.587 0 C-N-CA 120.418 -0.513 . . . . 0.34000000000000002 111.872 -172.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.573 HD23 ' N ' ' A' ' 14' ' ' LEU . 5.4 tt -121.1 148.3 44.37 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.467 -0.938 . . . . 1.0600000000000001 108.467 177.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.573 ' N ' HD23 ' A' ' 13' ' ' LEU . 27.4 tp -131.23 130.96 43.58 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 110.378 -0.23 . . . . 1.0800000000000001 110.378 -179.355 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.41 ' CG2' HD12 ' A' ' 44' ' ' LEU . 63.6 t -120.83 129.22 75.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 109.518 -0.549 . . . . 1.01 109.518 173.241 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.6 ' HE2' ' OG ' ' A' ' 109' ' ' SER . 32.1 mmtp -104.58 158.33 16.57 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.214 -0.448 . . . . 1.22 110.504 178.336 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -150.68 162.13 41.28 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.954 -0.566 . . . . 0.29999999999999999 110.125 -175.07 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.448 ' HB3' ' C ' ' A' ' 33' ' ' ALA . 45.8 p -55.0 111.42 0.83 Allowed 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 110.117 -0.327 . . . . 1.6000000000000001 110.117 175.209 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 104.24 9.84 35.47 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.074 -1.06 . . . . 0.53000000000000003 112.394 -177.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.493 ' C ' ' H ' ' A' ' 22' ' ' ASN . 79.5 p -92.98 24.21 3.82 Favored 'General case' 0 N--CA 1.453 -0.308 0 O-C-N 122.376 -0.485 . . . . 1.28 110.791 -177.541 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 60.3 mtt180 71.79 -33.39 0.27 Allowed 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 123.225 0.61 . . . . 4.1600000000000001 111.406 -178.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.493 ' H ' ' C ' ' A' ' 20' ' ' SER . 38.5 m-80 -127.8 89.05 51.77 Favored Pre-proline 0 C--N 1.324 -0.541 0 N-CA-C 109.109 -0.7 . . . . 1.77 109.109 176.336 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.533 ' C ' HG22 ' A' ' 32' ' ' THR . 90.5 Cg_endo -79.84 45.46 1.96 Allowed 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 122.678 2.252 . . . . 1.71 112.82 -173.522 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 60.7 t -141.53 115.14 4.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 108.68 -0.859 . . . . 1.1599999999999999 108.68 178.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.459 ' HB2' ' OD1' ' A' ' 67' ' ' ASP . 15.9 p -100.84 158.35 16.04 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 110.173 -0.306 . . . . 1.4299999999999999 110.173 -178.04 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.448 ' HG2' ' HA ' ' A' ' 67' ' ' ASP . 18.3 mmm180 -72.97 -17.24 61.49 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 108.362 -0.977 . . . . 3.1200000000000001 108.362 172.122 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 13.2 ttp180 -65.83 -48.64 70.97 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 114.463 -1.244 . . . . 2.25 110.054 177.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 33.3 p -96.35 -34.49 11.55 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.153 0.501 . . . . 1.1299999999999999 110.765 -178.078 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 85.91 -31.37 4.01 Favored Glycine 0 N--CA 1.45 -0.381 0 CA-C-N 115.752 -0.658 . . . . 0.81999999999999995 113.148 -179.375 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -101.24 -61.23 1.4 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.973 0.386 . . . . 2.1000000000000001 111.424 -178.128 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 10.3 p -154.77 149.62 26.68 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.986 0.422 . . . . 1.3300000000000001 111.674 178.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.533 HG22 ' C ' ' A' ' 23' ' ' PRO . 12.6 t -116.86 27.31 9.23 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 122.305 1.05 . . . . 1.02 108.733 173.2 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.448 ' C ' ' HB3' ' A' ' 18' ' ' SER . . . -75.83 -4.43 40.68 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.598 -1.183 . . . . 1.1299999999999999 112.162 -175.213 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -97.94 -19.8 17.84 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.943 0.401 . . . . 2.21 110.632 -178.263 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.459 HG23 ' HB2' ' A' ' 39' ' ' ASP . 0.2 OUTLIER -101.85 137.85 28.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 116.062 -0.517 . . . . 1.1100000000000001 110.36 -178.667 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 61.8 p -96.91 177.9 5.47 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 109.531 -0.544 . . . . 1.2 109.531 -178.257 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.415 ' O ' HG13 ' A' ' 41' ' ' ILE . 0.1 OUTLIER -68.39 -21.26 64.7 Favored 'General case' 0 C--O 1.217 -0.616 0 C-N-CA 118.72 -1.192 . . . . 2.21 110.288 174.26 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -72.41 -41.98 65.63 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.931 -0.396 . . . . 0.95999999999999996 109.931 175.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.459 ' HB2' HG23 ' A' ' 35' ' ' VAL . 23.9 m-20 -71.04 -35.17 71.88 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.404 0.621 . . . . 0.91000000000000003 109.853 175.035 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.99 -48.25 66.29 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.098 -0.955 . . . . 1.03 110.613 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.437 ' CG1' HD21 ' A' ' 111' ' ' LEU . 69.8 mt -62.15 -36.83 76.44 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.462 0 N-CA-C 109.833 -0.432 . . . . 1.0800000000000001 109.833 175.661 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 59.6 tttp -59.86 -29.09 68.07 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.832 -0.622 . . . . 2.8399999999999999 109.891 178.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -88.91 -49.54 6.73 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.461 -0.791 . . . . 1.02 110.473 -178.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.453 HD11 HG12 ' A' ' 113' ' ' ILE . 33.9 tp -58.73 -36.42 74.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.969 -0.56 . . . . 1.02 110.039 -177.503 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.444 ' HG2' HG13 ' A' ' 104' ' ' ILE . 0.0 OUTLIER -66.92 -23.56 65.99 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-N 115.954 -0.566 . . . . 0.87 112.078 -179.692 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -85.01 -40.29 17.05 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 110.196 -0.298 . . . . 1.98 110.196 179.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.421 ' O ' HG13 ' A' ' 51' ' ' ILE . 36.8 m95 -66.46 -47.87 71.73 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.96 -0.296 . . . . 0.60999999999999999 111.293 174.829 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 88.6 p -62.75 -28.24 69.83 Favored 'General case' 0 C--N 1.333 -0.128 0 C-N-CA 120.719 -0.392 . . . . 0.88 110.062 177.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.443 ' HB2' ' O ' ' A' ' 45' ' ' GLN . 11.4 tt0 -66.74 -57.17 7.64 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.925 -0.58 . . . . 0.55000000000000004 110.323 173.774 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.508 ' HB3' HG23 ' A' ' 56' ' ' VAL . 86.2 mtt180 -61.14 -42.14 98.01 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.943 -0.571 . . . . 0.47999999999999998 111.58 -176.437 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.48 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 92.4 mt -61.51 -36.63 74.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 120.929 0.395 . . . . 1.04 110.43 177.479 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -77.46 -35.45 53.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.068 -0.515 . . . . 1.0600000000000001 111.684 -179.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 51.1 p -80.49 -30.34 37.33 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.893 0.377 . . . . 0.34999999999999998 111.481 -177.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 108.55 4.43 32.37 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.76 -0.733 . . . . 0.33000000000000002 112.218 -179.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.416 ' HB2' ' HB3' ' A' ' 50' ' ' ARG . 40.0 mt-10 -61.49 -48.7 79.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.007 0.432 . . . . 0.65000000000000002 110.104 178.039 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.508 HG23 ' HB3' ' A' ' 50' ' ' ARG . 13.6 m -133.77 157.45 42.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 109.354 -0.61 . . . . 1.05 109.354 171.824 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 49.6 m -85.93 160.02 19.5 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 109.471 -0.566 . . . . 1.3100000000000001 109.471 177.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -53.66 -43.92 69.2 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.272 0.558 . . . . 0.25 109.948 -177.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.581 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 2.8 mp0 -56.96 -39.13 74.01 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.845 -1.071 . . . . 1.72 111.916 -178.307 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 31.5 mm-40 -65.39 -48.94 71.14 Favored 'General case' 0 CA--C 1.521 -0.16 0 CA-C-O 120.836 0.35 . . . . 2.0899999999999999 111.118 -177.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -68.94 -42.72 76.33 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.386 -0.37 . . . . 1.0700000000000001 111.108 -177.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.11 -53.82 52.22 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.331 -0.395 . . . . 1.0600000000000001 112.051 -175.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.53 ' HA ' ' O ' ' A' ' 71' ' ' TYR . 16.0 m -51.56 -21.8 2.79 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 113.149 0.796 . . . . 1.52 113.149 -177.342 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -104.99 -46.71 4.2 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.519 0.676 . . . . 0.60999999999999999 110.473 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 21.2 mmt180 -94.8 -36.11 11.81 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.745 -1.116 . . . . 0.95999999999999996 113.99 -168.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.462 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 54.4 p -63.23 116.81 5.79 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.031 0.443 . . . . 1.0600000000000001 110.479 -177.684 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.459 ' OD1' ' HB2' ' A' ' 25' ' ' SER . 48.5 m-20 -82.15 0.72 39.6 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.772 -0.649 . . . . 2.2799999999999998 111.251 -178.657 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.443 ' O ' ' HD1' ' A' ' 71' ' ' TYR . 1.7 m -78.42 173.67 12.1 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.869 -0.605 . . . . 2.0499999999999998 109.978 172.159 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -69.28 -16.54 71.32 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.706 -0.759 . . . . 0.29999999999999999 112.026 179.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 67.2 p -65.98 -5.51 9.74 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 112.576 0.584 . . . . 0.46999999999999997 112.576 -179.046 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.53 ' O ' ' HA ' ' A' ' 63' ' ' SER . 30.4 p90 -60.36 -25.76 66.1 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.005 0.431 . . . . 0.94999999999999996 110.33 177.78 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -94.36 -2.58 51.85 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.239 0.542 . . . . 1.1100000000000001 110.448 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 7.0 m -116.84 9.36 13.85 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.832 -0.622 . . . . 0.70999999999999996 110.748 -178.1 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.581 ' O ' ' HA ' ' A' ' 59' ' ' GLU . . . 68.27 28.51 73.27 Favored Glycine 0 C--O 1.227 -0.288 0 C-N-CA 120.915 -0.66 . . . . 0.67000000000000004 112.039 -177.435 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 83.29 -21.2 8.78 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 121.145 -0.55 . . . . 0.42999999999999999 112.282 -178.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -72.68 136.81 45.7 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.787 0.327 . . . . 1.6499999999999999 111.192 -173.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.418 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 2.6 mp -116.17 166.79 11.62 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.955 -0.566 . . . . 1.6899999999999999 110.027 174.665 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -81.24 -148.52 6.16 Favored Glycine 0 C--N 1.314 -0.669 0 CA-C-N 115.393 -0.821 . . . . 0.45000000000000001 113.138 -177.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -99.33 143.92 29.03 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.993 0.425 . . . . 4.7400000000000002 110.864 -179.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -157.31 175.23 14.29 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.856 -0.611 . . . . 1.6499999999999999 109.815 -174.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 16.2 m -104.17 139.52 39.11 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.876 -0.787 . . . . 1.6899999999999999 108.876 175.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 48.0 m -61.96 126.96 29.18 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.076 0.465 . . . . 1.55 110.812 -179.375 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 114.74 -4.25 22.87 Favored Glycine 0 N--CA 1.443 -0.898 0 CA-C-N 115.392 -0.822 . . . . 0.79000000000000004 111.276 -176.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -95.85 6.99 47.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.699 0.285 . . . . 1.5800000000000001 111.363 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 25.0 mmt -104.16 -122.6 0.21 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.047 0.451 . . . . 1.1299999999999999 110.572 179.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 54.8 mtt -123.69 152.15 42.36 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 107.919 -1.141 . . . . 1.8899999999999999 107.919 175.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm -53.17 -53.99 49.64 Favored Pre-proline 0 C--N 1.319 -0.721 0 N-CA-C 112.249 0.463 . . . . 2.7400000000000002 112.249 -175.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.05 -30.68 10.54 Favored 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 121.457 1.438 . . . . 0.29999999999999999 111.836 -177.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.625 ' O ' HG22 ' A' ' 93' ' ' VAL . 26.3 t80 -67.36 -56.48 9.53 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.247 -0.888 . . . . 0.28000000000000003 109.885 179.742 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -62.19 -35.32 78.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.535 -0.757 . . . . 2.1200000000000001 110.449 -178.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -61.12 -30.47 70.39 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.362 -0.836 . . . . 0.60999999999999999 110.905 178.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.47 ' O ' ' HG ' ' A' ' 96' ' ' LEU . . . -83.35 -26.84 30.16 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.851 0.357 . . . . 1.1000000000000001 110.659 178.001 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.625 HG22 ' O ' ' A' ' 89' ' ' PHE . 27.4 t -70.43 -37.62 71.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.255 0.55 . . . . 1.1200000000000001 110.165 -176.633 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.478 ' C ' ' HD2' ' A' ' 94' ' ' ARG . 6.2 ppt_? -78.92 -13.68 59.66 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.882 -0.599 . . . . 3.1800000000000002 110.735 178.657 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -84.23 -11.04 57.15 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.185 0.517 . . . . 1.0800000000000001 110.963 -175.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.53 ' HB2' ' HB2' ' A' ' 100' ' ' ASP . 0.9 OUTLIER -127.64 145.18 50.97 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.828 -0.624 . . . . 1.1200000000000001 110.761 179.713 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.431 ' HG3' ' H ' ' A' ' 98' ' ' ILE . 20.7 tptm -92.95 173.12 7.91 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 109.021 -0.733 . . . . 2.1299999999999999 109.021 178.754 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.434 ' HA ' ' HG2' ' A' ' 116' ' ' ARG . 72.1 mt -45.76 115.96 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.913 0.387 . . . . 1.6200000000000001 111.649 176.393 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 106.16 -12.27 44.47 Favored Glycine 0 CA--C 1.521 0.45 0 C-N-CA 120.946 -0.645 . . . . 0.46000000000000002 113.736 177.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.53 ' HB2' ' HB2' ' A' ' 96' ' ' LEU . 15.7 m-20 -97.95 148.98 22.91 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 117.566 0.683 . . . . 0.46000000000000002 111.144 -178.005 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 13.0 mt -115.83 149.08 18.15 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-N 115.951 -0.568 . . . . 1.0800000000000001 110.872 -174.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.474 ' HG ' HD22 ' A' ' 96' ' ' LEU . 5.9 m -81.72 151.18 67.59 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 115.953 -0.567 . . . . 1.45 110.806 -178.333 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -73.75 165.22 32.8 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 122.2 1.934 . . . . 0.40999999999999998 109.989 166.221 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.444 HG13 ' HG2' ' A' ' 45' ' ' GLN . 20.1 mm -46.47 108.54 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 O-C-N 123.32 0.387 . . . . 1.04 111.956 178.292 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.3 p -115.32 117.59 56.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.193 -0.458 . . . . 1.6599999999999999 110.157 176.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 16.8 mt-30 -85.25 147.24 26.67 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.055 0.455 . . . . 0.55000000000000004 110.07 178.105 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 8.8 p -121.38 -172.46 2.42 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.421 -0.808 . . . . 1.05 110.389 -177.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -59.86 -35.27 74.44 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.589 0.233 . . . . 2.1600000000000001 110.78 178.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.6 ' OG ' ' HE2' ' A' ' 16' ' ' LYS . 6.4 t -96.78 -60.93 1.49 Allowed 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.69 -0.404 . . . . 1.0900000000000001 110.884 -179.713 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -147.72 -135.02 2.57 Favored Glycine 0 N--CA 1.443 -0.884 0 C-N-CA 118.9 -1.619 . . . . 0.39000000000000001 113.733 -173.321 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.535 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 7.7 mp -113.83 146.34 40.11 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 114.962 -0.619 . . . . 1.0600000000000001 111.232 -170.643 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . 0.55 ' HA ' ' O ' ' A' ' 13' ' ' LEU . 77.0 m-70 -144.16 150.14 37.58 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.144 0.497 . . . . 0.25 111.902 179.659 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.453 HG12 HD11 ' A' ' 44' ' ' LEU . 2.1 pt -134.57 137.58 51.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 107.715 -1.217 . . . . 1.03 107.715 160.651 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.406 ' H ' ' HB2' ' A' ' 102' ' ' SER . 2.1 mp -128.1 145.96 34.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 C-N-CA 121.035 -0.266 . . . . 1.0600000000000001 110.735 -174.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 47.4 pttt -127.84 139.86 52.38 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.733 -0.84 . . . . 1.29 108.733 172.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . 0.466 ' HD3' HD22 ' A' ' 8' ' ' LEU . 4.7 ttp180 -83.11 133.92 35.03 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.12 -0.632 . . . . 2.6800000000000002 110.868 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -103.04 -36.0 8.33 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.87 -1.059 . . . . 1.54 109.729 -178.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.855 0 CA-C-O 117.992 -1.004 . . . . 1.1499999999999999 109.569 178.848 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 22.3 ptt? . . . . . 0 N--CA 1.481 1.088 0 N-CA-C 111.523 0.194 . . . . 7.54 111.523 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 17.5 p -80.05 -16.22 55.52 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 112.111 0.411 . . . . 3.0899999999999999 112.111 -174.013 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.503 ' O ' ' HA ' ' A' ' 81' ' ' SER . 0.4 OUTLIER -88.54 1.05 55.64 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.876 -0.329 . . . . 2.7999999999999998 110.688 -178.513 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -71.81 114.78 10.26 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.281 0.562 . . . . 1.6899999999999999 109.95 176.425 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.555 HD22 ' H ' ' A' ' 9' ' ' ARG . 0.4 OUTLIER -124.04 164.37 19.52 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.046 -0.979 . . . . 1.79 109.529 -174.63 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.555 ' H ' HD22 ' A' ' 8' ' ' LEU . 58.4 ttt180 -145.35 128.85 17.0 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.395 -0.594 . . . . 1.3700000000000001 109.395 175.539 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.473 ' N ' ' HZ ' ' A' ' 80' ' ' PHE . . . -146.35 153.74 40.86 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.12 0.486 . . . . 1.0700000000000001 112.036 -179.456 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -106.81 133.03 52.1 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.457 -0.792 . . . . 1.04 109.089 176.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 38.0 p-80 -137.06 155.65 49.39 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.366 0.506 . . . . 0.34000000000000002 112.366 -170.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.57 HD21 ' N ' ' A' ' 14' ' ' LEU . 5.3 tt -123.13 147.25 46.99 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.694 -0.854 . . . . 1.0600000000000001 108.694 176.377 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.57 ' N ' HD21 ' A' ' 13' ' ' LEU . 23.6 tp -131.64 124.4 29.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.486 0.184 . . . . 1.0800000000000001 111.126 -178.677 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.41 HG21 HD11 ' A' ' 44' ' ' LEU . 58.9 t -112.85 142.03 26.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 109.787 -0.449 . . . . 1.01 109.787 175.577 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.406 ' HE3' HD22 ' A' ' 14' ' ' LEU . 31.2 mmtp -114.39 156.36 24.62 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.789 -0.448 . . . . 1.22 109.789 178.306 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -149.96 162.74 39.77 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.513 -0.312 . . . . 0.29999999999999999 110.26 -176.087 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.466 ' HB3' ' C ' ' A' ' 33' ' ' ALA . 54.0 p -52.06 112.88 0.86 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.786 0.327 . . . . 1.6000000000000001 111.111 179.046 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.402 ' C ' ' H ' ' A' ' 21' ' ' ARG . . . 99.63 10.37 47.34 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.327 -0.939 . . . . 0.53000000000000003 113.007 179.547 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.559 ' C ' ' H ' ' A' ' 22' ' ' ASN . 33.0 p -76.29 23.07 0.15 Allowed 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 117.459 0.63 . . . . 1.28 112.462 -174.438 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.402 ' H ' ' C ' ' A' ' 19' ' ' GLY . 86.1 mtt180 69.55 -35.28 0.31 Allowed 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.708 0.803 . . . . 4.1600000000000001 110.355 -175.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.559 ' H ' ' C ' ' A' ' 20' ' ' SER . 13.2 m-80 -140.13 102.25 6.85 Favored Pre-proline 0 N--CA 1.445 -0.717 0 N-CA-C 108.08 -1.082 . . . . 1.77 108.08 174.046 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -68.31 -159.27 0.05 OUTLIER 'Trans proline' 0 CA--C 1.531 0.371 0 C-N-CA 122.894 2.396 . . . . 1.71 111.821 179.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.506 ' N ' HG23 ' A' ' 32' ' ' THR . 16.5 t 62.25 107.16 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-N 115.487 -0.779 . . . . 1.1599999999999999 111.976 178.202 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.401 ' HB3' ' HB2' ' A' ' 16' ' ' LYS . 59.3 p -103.72 155.88 18.24 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.644 -0.502 . . . . 1.4299999999999999 109.644 175.425 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.52 ' HB2' ' HA ' ' A' ' 67' ' ' ASP . 4.7 mpt_? -66.33 -7.85 21.54 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.123 0.487 . . . . 3.1200000000000001 110.486 174.509 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.431 ' HG2' ' HD3' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -85.54 -27.23 25.71 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.421 -0.808 . . . . 2.25 110.237 178.887 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 26.8 p -108.31 -35.53 6.5 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.873 -0.603 . . . . 1.1299999999999999 111.193 -176.005 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 80.41 -33.98 2.26 Favored Glycine 0 CA--C 1.519 0.304 0 CA-C-N 115.443 -0.799 . . . . 0.81999999999999995 113.483 175.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.433 ' O ' HG22 ' A' ' 24' ' ' VAL . 15.0 t70 -105.13 -66.19 0.99 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.911 0.355 . . . . 2.1000000000000001 110.635 179.44 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 19.2 m -152.3 150.89 30.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.111 0.481 . . . . 1.3300000000000001 111.155 -179.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.506 HG23 ' N ' ' A' ' 24' ' ' VAL . 8.9 t -123.62 19.03 9.56 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 122.005 0.907 . . . . 1.02 109.347 178.012 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.466 ' C ' ' HB3' ' A' ' 18' ' ' SER . . . -67.35 -5.26 13.61 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.066 -0.97 . . . . 1.1299999999999999 112.364 177.449 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -92.39 -24.34 18.91 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.889 0.376 . . . . 2.21 111.111 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.449 HG12 ' OG1' ' A' ' 32' ' ' THR . 0.2 OUTLIER -101.78 137.15 30.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 116.138 -0.483 . . . . 1.1100000000000001 109.965 -179.573 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 77.1 p -94.04 177.48 5.96 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 116.289 -0.414 . . . . 1.2 110.054 -173.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.535 ' O ' HG13 ' A' ' 41' ' ' ILE . 15.4 p90 -63.37 -30.53 71.65 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 119.917 -0.713 . . . . 2.21 109.435 176.408 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -69.46 -47.78 62.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.081 -0.509 . . . . 0.95999999999999996 110.595 178.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 39.5 m-20 -70.38 -27.84 64.63 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.98 -0.555 . . . . 0.91000000000000003 110.26 179.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -74.31 -39.06 63.12 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.495 -0.775 . . . . 1.03 110.329 177.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.535 HG13 ' O ' ' A' ' 37' ' ' TYR . 80.6 mt -64.46 -36.71 78.05 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 109.524 -0.547 . . . . 1.0800000000000001 109.524 174.133 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.457 ' O ' ' HG3' ' A' ' 46' ' ' LYS . 26.3 mtpp -64.12 -25.0 67.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.942 0.401 . . . . 2.8399999999999999 110.485 175.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.433 ' HG3' ' NE1' ' A' ' 47' ' ' TRP . 6.9 tt0 -83.88 -51.76 6.92 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.892 -0.595 . . . . 1.02 109.823 -179.188 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.483 HD13 HG12 ' A' ' 113' ' ' ILE . 34.0 tp -60.69 -38.76 86.07 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.786 -0.643 . . . . 1.02 110.479 -179.744 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.476 ' O ' ' HB2' ' A' ' 49' ' ' GLN . 5.0 mm-40 -61.51 -38.28 86.8 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.189 -0.459 . . . . 0.87 112.146 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.457 ' HG3' ' O ' ' A' ' 42' ' ' LYS . 68.3 mttm -72.78 -38.68 67.19 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.672 0.273 . . . . 1.98 111.083 -177.723 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.449 ' O ' HG13 ' A' ' 51' ' ' ILE . 9.8 m95 -70.83 -45.85 63.81 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.885 -0.326 . . . . 0.60999999999999999 110.863 178.06 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.417 ' HB3' HG23 ' A' ' 113' ' ' ILE . 89.1 p -64.36 -28.3 69.61 Favored 'General case' 0 CA--C 1.528 0.122 0 N-CA-C 110.073 -0.343 . . . . 0.88 110.073 177.356 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.476 ' HB2' ' O ' ' A' ' 45' ' ' GLN . 12.5 tt0 -64.68 -52.05 59.3 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 116.018 -0.537 . . . . 0.55000000000000004 109.952 175.368 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.576 ' HB3' HG23 ' A' ' 56' ' ' VAL . 84.4 mtt180 -61.05 -46.73 89.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.548 -0.751 . . . . 0.47999999999999998 111.205 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.453 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 85.3 mt -56.69 -43.67 79.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.291 -0.413 . . . . 1.04 110.872 177.185 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.68 -42.62 81.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.117 -0.492 . . . . 1.0600000000000001 111.927 -179.339 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 51.3 p -77.7 -30.39 51.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.934 0.397 . . . . 0.34999999999999998 111.367 -177.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 108.68 8.96 27.6 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.564 -0.827 . . . . 0.33000000000000002 112.242 179.006 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.492 ' OE1' ' HG2' ' A' ' 50' ' ' ARG . 48.6 mt-10 -60.84 -49.37 77.77 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.096 0.475 . . . . 0.65000000000000002 109.913 176.657 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.576 HG23 ' HB3' ' A' ' 50' ' ' ARG . 31.4 m -134.44 154.68 37.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.719 -0.673 . . . . 1.05 109.41 173.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.416 ' OG ' ' HG2' ' A' ' 60' ' ' GLU . 19.8 p -79.44 161.83 25.86 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 110.042 -0.355 . . . . 1.3100000000000001 110.042 176.569 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -55.04 -38.4 67.92 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.377 0.608 . . . . 0.25 109.548 178.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -59.2 -43.45 92.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.885 -1.052 . . . . 1.72 111.828 -179.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.416 ' HG2' ' OG ' ' A' ' 57' ' ' SER . 12.1 mm-40 -64.48 -42.09 96.1 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-O 121.016 0.436 . . . . 2.0899999999999999 110.85 -178.589 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.427 ' O ' ' HG2' ' A' ' 65' ' ' ARG . . . -70.01 -55.85 8.51 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.896 -0.593 . . . . 1.0700000000000001 110.455 179.611 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -54.63 -52.96 60.61 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.513 0.56 . . . . 1.0600000000000001 112.513 -174.041 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.492 ' HA ' ' O ' ' A' ' 71' ' ' TYR . 20.8 t -52.0 -27.95 15.26 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.695 0.628 . . . . 1.52 112.695 -175.633 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -105.28 -44.19 4.81 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.492 0.663 . . . . 0.60999999999999999 110.894 -177.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.431 ' HD3' ' HG2' ' A' ' 27' ' ' ARG . 16.6 mmt180 -83.59 -44.4 14.64 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.944 -1.026 . . . . 0.95999999999999996 113.114 -171.852 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.411 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 77.6 p -65.21 120.04 11.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.128 0.49 . . . . 1.0600000000000001 111.429 -173.753 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.52 ' HA ' ' HB2' ' A' ' 26' ' ' ARG . 19.6 t70 -70.81 -16.9 62.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.48 -0.782 . . . . 2.2799999999999998 110.885 177.132 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.476 ' O ' ' HD2' ' A' ' 71' ' ' TYR . 53.7 t -77.99 154.96 31.05 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.259 0.552 . . . . 2.0499999999999998 109.931 178.815 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -58.94 -12.37 14.83 Favored Glycine 0 C--O 1.234 0.148 0 CA-C-N 114.66 -1.155 . . . . 0.29999999999999999 113.714 -173.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 52.3 p -64.72 -8.07 13.29 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 111.771 0.285 . . . . 0.46999999999999997 111.771 176.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.492 ' O ' ' HA ' ' A' ' 63' ' ' SER . 51.1 p90 -57.59 -25.38 59.95 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.932 0.396 . . . . 0.94999999999999996 110.596 176.631 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -93.98 3.35 55.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.058 0.456 . . . . 1.1100000000000001 111.035 -179.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 9.0 m -126.78 14.42 7.47 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.099 -0.5 . . . . 0.70999999999999996 110.772 179.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 67.97 24.7 74.44 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 121.063 -0.589 . . . . 0.67000000000000004 112.54 -178.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 86.91 -17.2 42.57 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 121.16 -0.543 . . . . 0.42999999999999999 112.219 -179.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -74.55 136.79 42.12 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.733 0.302 . . . . 1.6499999999999999 110.682 -176.01 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.4 ' O ' ' HG3' ' A' ' 9' ' ' ARG . 2.4 mp -113.46 157.88 21.39 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 116.248 -0.433 . . . . 1.6899999999999999 110.055 173.218 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -76.19 -107.03 0.13 Allowed Glycine 0 C--N 1.309 -0.953 0 CA-C-N 115.226 -0.897 . . . . 0.45000000000000001 113.504 -175.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 9.1 p90 -120.87 149.0 43.28 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.716 0.293 . . . . 4.7400000000000002 110.796 -178.12 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.473 ' HZ ' ' N ' ' A' ' 10' ' ' ALA . 3.8 p90 -166.27 161.32 16.66 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.547 -0.538 . . . . 1.6499999999999999 109.547 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.503 ' HA ' ' O ' ' A' ' 6' ' ' GLU . 73.0 p -105.11 125.45 50.99 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 109.292 -0.632 . . . . 1.6899999999999999 109.292 176.337 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 11.0 p -44.69 122.09 3.0 Favored 'General case' 0 C--O 1.234 0.288 0 O-C-N 123.79 0.681 . . . . 1.55 111.618 -178.048 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 114.42 10.46 13.22 Favored Glycine 0 N--CA 1.446 -0.655 0 CA-C-N 115.824 -0.626 . . . . 0.79000000000000004 111.662 -177.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -109.23 -5.48 15.9 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 111.481 0.178 . . . . 1.5800000000000001 111.481 179.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 26.2 mmt -95.15 -105.05 0.15 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.285 0.564 . . . . 1.1299999999999999 111.085 -175.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' MET . . . . . 0.434 ' HB2' ' HB3' ' A' ' 89' ' ' PHE . 44.1 mtt -138.12 148.81 45.33 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 107.381 -1.34 . . . . 1.8899999999999999 107.381 177.789 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 64.6 tttp -51.16 -54.55 36.75 Favored Pre-proline 0 C--N 1.32 -0.685 0 N-CA-C 112.472 0.545 . . . . 2.7400000000000002 112.472 -175.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.456 ' HG2' HG23 ' A' ' 107' ' ' THR . 86.5 Cg_endo -75.67 -29.7 6.96 Favored 'Trans proline' 0 C--N 1.356 0.965 0 C-N-CA 121.664 1.576 . . . . 0.29999999999999999 111.997 -177.557 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.58 ' O ' HG21 ' A' ' 93' ' ' VAL . 12.4 t80 -66.32 -56.42 11.23 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.722 -0.672 . . . . 0.28000000000000003 109.428 178.466 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.532 ' O ' ' HD3' ' A' ' 94' ' ' ARG . 4.2 tp10 -61.4 -36.14 79.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.16 -0.927 . . . . 2.1200000000000001 109.812 -179.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.756 ' HA ' ' NE ' ' A' ' 94' ' ' ARG . 27.2 t70 -54.44 -43.73 71.85 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 115.155 -0.929 . . . . 0.60999999999999999 110.77 177.529 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.667 ' O ' ' HG ' ' A' ' 96' ' ' LEU . . . -71.5 -34.4 70.09 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.022 -0.536 . . . . 1.1000000000000001 110.765 179.617 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.58 HG21 ' O ' ' A' ' 89' ' ' PHE . 28.4 t -60.86 -49.53 84.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.406 -0.361 . . . . 1.1200000000000001 111.219 -176.06 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.756 ' NE ' ' HA ' ' A' ' 91' ' ' ASP . 0.1 OUTLIER -75.91 -16.66 59.99 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.516 -0.474 . . . . 3.1800000000000002 110.479 179.463 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -78.34 -13.51 59.82 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.065 -0.516 . . . . 1.0800000000000001 111.439 -176.032 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.667 ' HG ' ' O ' ' A' ' 92' ' ' ALA . 0.4 OUTLIER -123.21 159.6 28.34 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.174 0.511 . . . . 1.1200000000000001 111.137 178.052 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.498 ' HE3' HD12 ' A' ' 98' ' ' ILE . 54.5 tptt -102.27 176.78 5.07 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.321 -0.854 . . . . 2.1299999999999999 109.321 178.769 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.498 HD12 ' HE3' ' A' ' 97' ' ' LYS . 1.1 mp -47.43 119.97 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 C-N-CA 123.423 0.689 . . . . 1.6200000000000001 111.298 178.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 92.92 -10.53 73.75 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 121.002 -0.618 . . . . 0.46000000000000002 113.071 176.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.541 ' HB2' ' HB2' ' A' ' 96' ' ' LEU . 23.1 m-20 -85.64 131.68 34.3 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 117.115 0.457 . . . . 0.46000000000000002 110.301 -178.418 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 8.7 mt -104.52 143.64 15.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.073 -0.512 . . . . 1.0800000000000001 109.779 179.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 89.2 p -88.22 148.49 42.86 Favored Pre-proline 0 C--N 1.318 -0.799 0 CA-C-N 116.341 -0.39 . . . . 1.45 110.402 -178.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -70.1 163.73 37.47 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 122.032 1.821 . . . . 0.40999999999999998 110.615 170.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.461 HG13 ' HG2' ' A' ' 45' ' ' GLN . 21.5 mm -39.64 100.33 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 N-CA-C 112.959 0.726 . . . . 1.04 112.959 179.318 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 1.8 p -104.69 118.13 51.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.979 -0.555 . . . . 1.6599999999999999 109.798 175.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -85.8 145.52 27.18 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.266 0.555 . . . . 0.55000000000000004 110.801 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.456 HG23 ' HG2' ' A' ' 88' ' ' PRO . 6.1 p -117.28 -172.82 2.29 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.309 -0.86 . . . . 1.05 110.161 179.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -65.63 -35.39 80.67 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 121.011 -0.275 . . . . 2.1600000000000001 110.363 177.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.405 ' O ' ' HB2' ' A' ' 20' ' ' SER . 4.8 t -92.33 -60.96 1.71 Allowed 'General case' 0 N--CA 1.443 -0.778 0 C-N-CA 120.254 -0.578 . . . . 1.0900000000000001 110.606 -179.125 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -145.03 -131.98 2.44 Favored Glycine 0 N--CA 1.44 -1.077 0 C-N-CA 119.015 -1.564 . . . . 0.39000000000000001 113.793 -174.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.481 HD23 ' CG1' ' A' ' 41' ' ' ILE . 6.0 mp -121.53 147.99 45.08 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 114.917 -0.641 . . . . 1.0600000000000001 111.08 -170.57 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . 0.515 ' HA ' ' O ' ' A' ' 13' ' ' LEU . 85.4 m-70 -143.25 148.97 37.25 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.313 0.577 . . . . 0.25 112.254 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.483 HG12 HD13 ' A' ' 44' ' ' LEU . 2.5 pt -131.05 135.04 60.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 107.491 -1.3 . . . . 1.03 107.491 160.055 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 3.0 mp -130.2 142.79 42.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 C-N-CA 120.866 -0.334 . . . . 1.0600000000000001 110.439 -175.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.457 ' HA ' ' O ' ' A' ' 100' ' ' ASP . 40.9 pttt -123.21 139.18 54.32 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.622 -0.881 . . . . 1.29 108.622 172.359 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . 0.499 ' HB2' ' CD1' ' A' ' 96' ' ' LEU . 57.1 ttt180 -83.74 131.74 34.9 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.155 0.502 . . . . 2.6800000000000002 111.052 -177.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.437 ' HB2' ' HG2' ' A' ' 9' ' ' ARG . 4.3 mm? -98.9 -41.11 7.75 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.259 -0.882 . . . . 1.54 109.832 179.004 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.899 0 CA-C-O 118.622 -0.704 . . . . 1.1499999999999999 110.409 179.341 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 N--CA 1.479 0.998 0 N-CA-C 110.323 -0.251 . . . . 7.54 110.323 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 25.1 t 61.96 82.91 0.16 Allowed 'General case' 0 C--O 1.233 0.214 0 O-C-N 123.638 0.586 . . . . 3.0899999999999999 110.689 -178.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.607 ' O ' ' HA ' ' A' ' 81' ' ' SER . 12.3 pt-20 -103.88 -25.75 12.94 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.41 -0.589 . . . . 2.7999999999999998 109.41 177.29 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.507 ' HA ' ' O ' ' A' ' 80' ' ' PHE . 73.1 mmtt -75.06 134.46 41.36 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 115.81 -0.632 . . . . 1.6899999999999999 111.034 -177.567 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.598 ' HB3' ' CE1' ' A' ' 80' ' ' PHE . 3.2 tt -140.58 154.19 46.39 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 114.921 -1.036 . . . . 1.79 108.284 -177.256 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.537 ' N ' HD21 ' A' ' 8' ' ' LEU . 26.5 ttt180 -133.64 132.93 41.34 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.348 -0.982 . . . . 1.3700000000000001 108.348 172.494 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -147.06 150.44 35.07 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.459 -0.496 . . . . 1.0700000000000001 111.975 -174.094 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.588 ' HA ' ' HA ' ' A' ' 76' ' ' ASP . . . -108.45 133.74 52.2 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-N 115.698 -0.683 . . . . 1.04 109.8 177.544 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 45.8 p-80 -138.73 145.09 39.84 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 120.93 0.395 . . . . 0.34000000000000002 111.108 -172.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.568 ' O ' ' HA ' ' A' ' 112' ' ' HIS . 6.6 tt -112.82 142.92 44.91 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.251 -1.018 . . . . 1.0600000000000001 108.251 176.339 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.613 HD13 ' NE2' ' A' ' 112' ' ' HIS . 29.3 tp -128.97 118.41 22.56 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.739 0.304 . . . . 1.0800000000000001 111.021 -175.763 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.402 HG23 HD12 ' A' ' 44' ' ' LEU . 46.3 t -107.88 134.19 50.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 109.501 -0.555 . . . . 1.01 109.501 176.348 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.473 ' HZ2' ' HB2' ' A' ' 22' ' ' ASN . 32.7 mmtp -109.45 152.41 25.43 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.754 -0.462 . . . . 1.22 109.754 178.309 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.438 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 47.0 p90 -143.37 162.51 35.55 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.515 -0.311 . . . . 0.29999999999999999 110.533 -176.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 19.9 p -52.08 113.44 1.02 Allowed 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.276 -0.42 . . . . 1.6000000000000001 111.14 177.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 95.29 10.04 57.45 Favored Glycine 0 C--N 1.334 0.429 0 C-N-CA 120.761 -0.733 . . . . 0.53000000000000003 113.318 179.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.65 ' HB2' ' O ' ' A' ' 109' ' ' SER . 85.6 p -90.0 35.05 0.84 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 117.368 0.584 . . . . 1.28 111.523 -175.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.456 ' HB3' ' O ' ' A' ' 20' ' ' SER . 73.7 ttt180 71.82 -34.26 0.29 Allowed 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 120.995 0.426 . . . . 4.1600000000000001 111.16 -179.092 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.493 ' H ' ' C ' ' A' ' 20' ' ' SER . 45.7 m-80 -132.81 93.59 23.4 Favored Pre-proline 0 C--N 1.327 -0.385 0 N-CA-C 109.409 -0.589 . . . . 1.77 109.409 176.069 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.579 ' C ' HG23 ' A' ' 32' ' ' THR . 95.4 Cg_endo -80.83 49.16 3.14 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 122.507 2.138 . . . . 1.71 112.959 -176.326 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.424 ' N ' HG23 ' A' ' 32' ' ' THR . 47.3 t -147.26 117.0 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 N-CA-C 108.759 -0.83 . . . . 1.1599999999999999 108.759 178.052 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 41.2 t -105.89 154.23 20.85 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 110.203 -0.295 . . . . 1.4299999999999999 110.203 177.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.594 ' HB2' ' HA ' ' A' ' 67' ' ' ASP . 6.6 mpt_? -69.01 -5.27 20.7 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.087 0.47 . . . . 3.1200000000000001 110.422 171.363 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.582 ' HG3' ' CD ' ' A' ' 65' ' ' ARG . 18.3 ttp180 -78.21 -29.58 48.41 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.654 -0.703 . . . . 2.25 109.623 175.822 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 71.6 p -115.28 -33.78 5.2 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.753 -0.658 . . . . 1.1299999999999999 111.454 -174.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 81.55 -36.39 2.44 Favored Glycine 0 CA--C 1.52 0.371 0 CA-C-N 115.977 -0.556 . . . . 0.81999999999999995 112.905 178.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -95.03 -65.99 0.94 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.801 0.334 . . . . 2.1000000000000001 110.625 -178.059 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 13.7 p -153.94 156.26 37.16 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.949 0.404 . . . . 1.3300000000000001 110.932 178.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.579 HG23 ' C ' ' A' ' 23' ' ' PRO . 14.8 t -120.07 28.63 7.96 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 122.076 0.941 . . . . 1.02 109.146 174.054 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -75.78 -5.7 47.09 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.92 -1.036 . . . . 1.1299999999999999 111.422 -178.085 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -93.82 -25.72 17.24 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.902 -0.59 . . . . 2.21 111.095 -179.042 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.463 HG12 ' OG1' ' A' ' 32' ' ' THR . 0.2 OUTLIER -98.61 138.77 22.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 116.135 -0.484 . . . . 1.1100000000000001 109.76 -178.663 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 72.8 p -94.76 176.77 6.14 Favored 'General case' 0 CA--C 1.513 -0.474 0 N-CA-C 109.84 -0.43 . . . . 1.2 109.84 -174.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.461 ' O ' HG13 ' A' ' 41' ' ' ILE . 4.1 p90 -63.88 -27.17 68.97 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 119.897 -0.721 . . . . 2.21 109.099 175.534 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -72.75 -46.78 51.66 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.956 -0.565 . . . . 0.95999999999999996 110.301 178.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.438 ' HB2' HG21 ' A' ' 35' ' ' VAL . 42.1 m-20 -64.68 -33.52 76.14 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 121.375 0.607 . . . . 0.91000000000000003 109.633 177.108 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.438 ' HB2' ' HB3' ' A' ' 17' ' ' PHE . . . -68.8 -45.73 70.52 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.985 -1.007 . . . . 1.03 110.64 179.311 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.465 ' CG1' HD23 ' A' ' 111' ' ' LEU . 70.1 mt -62.55 -37.68 79.51 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.345 0 N-CA-C 109.704 -0.48 . . . . 1.0800000000000001 109.704 174.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.445 ' O ' ' HG3' ' A' ' 46' ' ' LYS . 27.8 ttpt -63.73 -22.88 67.13 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.902 -0.59 . . . . 2.8399999999999999 110.126 179.343 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.42 ' HG3' ' CD1' ' A' ' 47' ' ' TRP . 8.7 tp10 -85.45 -54.52 4.52 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.662 -0.699 . . . . 1.02 109.309 179.506 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.465 HD11 HG12 ' A' ' 113' ' ' ILE . 29.6 tp -59.81 -36.25 76.38 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.859 -1.064 . . . . 1.02 110.55 -174.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.426 ' HA ' HD11 ' A' ' 104' ' ' ILE . 3.9 mm-40 -64.2 -35.82 82.04 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.811 -0.632 . . . . 0.87 112.265 -179.353 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.445 ' HG3' ' O ' ' A' ' 42' ' ' LYS . 95.0 mttt -70.62 -47.42 60.16 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.153 0.501 . . . . 1.98 109.801 178.582 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.486 ' NE1' ' HG3' ' A' ' 65' ' ' ARG . 51.3 m95 -61.9 -47.59 84.27 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.8 -0.636 . . . . 0.60999999999999999 111.687 179.199 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.492 ' HB3' HG23 ' A' ' 113' ' ' ILE . 97.5 p -64.32 -22.71 67.04 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.954 0.407 . . . . 0.88 110.15 178.251 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -74.17 -57.37 4.0 Favored 'General case' 0 C--O 1.224 -0.261 0 CA-C-N 116.1 -0.5 . . . . 0.55000000000000004 110.063 174.083 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.535 ' HB3' HG21 ' A' ' 56' ' ' VAL . 96.9 mtt180 -61.6 -42.58 99.08 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.624 -0.716 . . . . 0.47999999999999998 111.46 -174.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 98.3 mt -60.39 -35.59 63.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.003 -0.544 . . . . 1.04 110.739 177.123 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -79.73 -41.32 26.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.086 -0.506 . . . . 1.0600000000000001 111.32 -179.002 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 58.3 p -74.6 -29.96 61.51 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.21 -0.45 . . . . 0.34999999999999998 111.641 -176.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 107.73 4.87 34.1 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.749 -0.738 . . . . 0.33000000000000002 112.14 -178.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.414 ' HB2' ' HB3' ' A' ' 50' ' ' ARG . 38.3 mt-10 -61.92 -47.23 85.85 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.847 0.356 . . . . 0.65000000000000002 110.049 178.443 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.535 HG21 ' HB3' ' A' ' 50' ' ' ARG . 14.3 m -136.57 165.26 29.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.963 -0.562 . . . . 1.05 109.652 172.212 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 54.5 p -86.15 165.7 16.36 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.945 -0.391 . . . . 1.3100000000000001 109.945 176.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -58.89 -39.4 81.35 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.248 -0.649 . . . . 0.25 109.248 176.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -54.35 -54.88 34.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.633 -1.167 . . . . 1.72 111.959 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -56.59 -44.29 80.91 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.09 -0.505 . . . . 2.0899999999999999 111.621 -176.009 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -68.83 -45.9 69.95 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.798 0.332 . . . . 1.0700000000000001 110.816 -179.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.44 -53.52 55.41 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.119 -0.491 . . . . 1.0600000000000001 111.957 -175.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.409 ' HA ' ' O ' ' A' ' 71' ' ' TYR . 50.0 m -53.33 -21.33 5.5 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 113.293 0.849 . . . . 1.52 113.293 -176.42 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -105.22 -46.1 4.32 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.439 0.637 . . . . 0.60999999999999999 110.718 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.582 ' CD ' ' HG3' ' A' ' 27' ' ' ARG . 24.7 mmt180 -93.97 -42.92 8.79 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 114.855 -1.066 . . . . 0.95999999999999996 113.65 -168.806 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.476 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 80.2 p -64.33 121.77 15.1 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.994 0.426 . . . . 1.0600000000000001 111.437 -174.38 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.594 ' HA ' ' HB2' ' A' ' 26' ' ' ARG . 25.0 t70 -73.63 -17.24 61.19 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.66 -0.7 . . . . 2.2799999999999998 111.568 178.624 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.418 ' O ' ' HD1' ' A' ' 71' ' ' TYR . 52.2 t -76.91 155.87 32.49 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.178 0.513 . . . . 2.0499999999999998 109.926 -179.145 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -58.82 -12.44 14.6 Favored Glycine 0 N--CA 1.454 -0.112 0 CA-C-N 114.81 -1.087 . . . . 0.29999999999999999 113.621 -173.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.414 ' HB3' ' CD1' ' A' ' 77' ' ' LEU . 52.7 p -70.14 -7.82 44.72 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 116.579 0.19 . . . . 0.46999999999999997 111.207 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.418 ' HD1' ' O ' ' A' ' 68' ' ' CYS . 35.0 p90 -56.08 -29.62 60.81 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.861 0.362 . . . . 0.94999999999999996 110.21 175.723 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -90.45 2.85 55.27 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.372 -0.377 . . . . 1.1100000000000001 111.673 -174.063 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 30.0 m -125.39 -15.16 6.25 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.762 0.315 . . . . 0.70999999999999996 111.447 -179.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 107.22 24.14 6.66 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.524 -0.846 . . . . 0.67000000000000004 112.507 -179.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 91.34 -27.57 9.27 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.796 -0.716 . . . . 0.42999999999999999 113.063 176.124 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.588 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 7.5 p-10 -79.89 141.56 36.01 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-O 121.561 0.696 . . . . 1.6499999999999999 111.204 -176.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.414 ' CD1' ' HB3' ' A' ' 70' ' ' SER . 0.6 OUTLIER -106.13 176.0 5.31 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 114.755 -1.111 . . . . 1.6899999999999999 109.604 177.187 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -83.88 -150.28 10.51 Favored Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 120.871 -0.68 . . . . 0.45000000000000001 111.856 178.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.433 ' HA ' ' O ' ' A' ' 8' ' ' LEU . 21.3 p90 -94.15 145.91 24.36 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.101 0.477 . . . . 4.7400000000000002 111.214 -178.481 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.598 ' CE1' ' HB3' ' A' ' 8' ' ' LEU . 2.6 p90 -152.16 172.18 16.77 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.315 -0.995 . . . . 1.6499999999999999 108.315 179.031 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.607 ' HA ' ' O ' ' A' ' 6' ' ' GLU . 89.0 p -103.71 142.27 34.63 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 109.139 -0.689 . . . . 1.6899999999999999 109.139 174.382 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 10.1 m -52.38 122.76 9.37 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.704 -0.68 . . . . 1.55 111.615 -173.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 114.69 -12.7 20.64 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.892 -0.67 . . . . 0.79000000000000004 112.998 179.371 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -90.59 45.19 1.24 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 117.013 0.406 . . . . 1.5800000000000001 111.665 -177.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.403 ' HE3' HD21 ' A' ' 77' ' ' LEU . 26.2 mmt -137.66 -108.28 0.19 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.043 0.449 . . . . 1.1299999999999999 110.297 178.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 59.5 mtt -140.26 150.68 44.38 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.278 -1.008 . . . . 1.8899999999999999 108.278 176.034 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -50.38 -54.27 36.44 Favored Pre-proline 0 C--N 1.322 -0.589 0 N-CA-C 112.682 0.623 . . . . 2.7400000000000002 112.682 -175.478 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -76.23 -27.45 8.09 Favored 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 121.63 1.553 . . . . 0.29999999999999999 112.036 -176.402 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.618 ' O ' HG21 ' A' ' 93' ' ' VAL . 24.2 t80 -70.06 -55.86 8.42 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.214 -0.903 . . . . 0.28000000000000003 109.719 -179.422 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -66.24 -34.78 78.78 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.392 -0.822 . . . . 2.1200000000000001 110.246 -177.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.482 ' HA ' ' NE ' ' A' ' 94' ' ' ARG . 19.6 t70 -54.64 -36.24 64.32 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.63 -0.713 . . . . 0.60999999999999999 110.86 175.021 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.565 ' O ' ' HG ' ' A' ' 96' ' ' LEU . . . -80.79 -35.47 33.07 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.213 -0.448 . . . . 1.1000000000000001 110.958 179.172 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.618 HG21 ' O ' ' A' ' 89' ' ' PHE . 21.0 t -62.12 -44.55 99.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.303 0.573 . . . . 1.1200000000000001 110.625 -178.178 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.482 ' NE ' ' HA ' ' A' ' 91' ' ' ASP . 38.1 ptt180 -73.87 -12.73 60.76 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.714 -0.676 . . . . 3.1800000000000002 110.564 179.279 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -95.11 6.16 49.83 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.067 -0.515 . . . . 1.0800000000000001 111.689 -173.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.565 ' HG ' ' O ' ' A' ' 92' ' ' ALA . 0.7 OUTLIER -141.26 146.87 37.36 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.425 -0.352 . . . . 1.1200000000000001 110.719 177.226 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.431 ' HG3' ' N ' ' A' ' 98' ' ' ILE . 55.2 tptt -88.89 168.95 12.0 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.372 -0.603 . . . . 2.1299999999999999 109.372 178.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.431 ' N ' ' HG3' ' A' ' 97' ' ' LYS . 70.7 mt -45.54 115.96 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 121.137 0.494 . . . . 1.6200000000000001 111.649 175.737 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 99.63 -4.62 58.1 Favored Glycine 0 N--CA 1.45 -0.416 0 CA-C-N 115.779 -0.646 . . . . 0.46000000000000002 113.324 177.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.493 ' HB2' ' HB2' ' A' ' 96' ' ' LEU . 66.4 m-20 -100.22 144.57 29.09 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 117.099 0.449 . . . . 0.46000000000000002 110.331 179.511 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 8.8 mt -116.03 147.95 19.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.19 -0.459 . . . . 1.0800000000000001 110.562 -174.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 92.5 p -92.5 155.54 42.13 Favored Pre-proline 0 C--N 1.322 -0.588 0 CA-C-N 116.041 -0.527 . . . . 1.45 110.612 -179.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -71.64 171.63 15.98 Favored 'Trans proline' 0 C--O 1.235 0.345 0 C-N-CA 122.323 2.016 . . . . 0.40999999999999998 111.393 171.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.426 HD11 ' HA ' ' A' ' 45' ' ' GLN . 22.7 mm -47.62 112.68 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 O-C-N 123.381 0.426 . . . . 1.04 111.986 178.514 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.1 p -117.59 118.67 59.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.004 0.431 . . . . 1.6599999999999999 110.258 176.257 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -85.44 141.65 29.8 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.2 0.524 . . . . 0.55000000000000004 110.373 178.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 7.5 p -115.94 -172.52 2.18 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.461 -0.791 . . . . 1.05 110.637 -178.263 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -58.21 -42.64 86.64 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.903 0.383 . . . . 2.1600000000000001 110.374 178.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.65 ' O ' ' HB2' ' A' ' 20' ' ' SER . 7.8 t -90.68 -61.62 1.63 Allowed 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 116.112 -0.494 . . . . 1.0900000000000001 110.652 -178.476 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -146.62 -133.14 2.42 Favored Glycine 0 N--CA 1.442 -0.941 0 C-N-CA 118.946 -1.597 . . . . 0.39000000000000001 113.499 -172.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.465 HD23 ' CG1' ' A' ' 41' ' ' ILE . 7.6 mp -115.58 145.92 42.23 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.199 -0.501 . . . . 1.0600000000000001 111.408 -170.625 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . 0.613 ' NE2' HD13 ' A' ' 14' ' ' LEU . 75.4 m-70 -142.06 152.2 43.1 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.392 0.615 . . . . 0.25 112.374 178.611 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.492 HG23 ' HB3' ' A' ' 48' ' ' SER . 2.8 pt -134.01 140.73 45.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 107.317 -1.364 . . . . 1.03 107.317 158.388 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 2.2 mp -130.76 148.33 33.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 C-N-CA 120.656 -0.418 . . . . 1.0600000000000001 110.657 -175.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.409 ' HG2' ' HB3' ' A' ' 11' ' ' ALA . 35.6 pttt -132.41 141.3 48.8 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.451 -0.944 . . . . 1.29 108.451 171.459 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . 0.429 ' HD3' HD23 ' A' ' 8' ' ' LEU . 5.6 ttp180 -81.47 135.72 35.63 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.198 0.523 . . . . 2.6800000000000002 110.768 -178.77 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -104.75 -31.87 9.13 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.258 -0.883 . . . . 1.54 110.561 -178.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.915 0 CA-C-O 118.445 -0.788 . . . . 1.1499999999999999 110.579 179.88 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 70.5 mtm . . . . . 0 N--CA 1.48 1.037 0 CA-C-O 120.841 0.353 . . . . 7.54 110.446 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 28.4 p -90.11 -53.94 4.25 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.358 -0.383 . . . . 3.0899999999999999 110.884 -179.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.426 ' HG3' ' HD3' ' A' ' 7' ' ' LYS . 13.1 pt-20 -83.91 -21.67 31.81 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.175 -0.466 . . . . 2.7999999999999998 110.527 -178.054 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.617 ' HA ' ' O ' ' A' ' 80' ' ' PHE . 5.9 mptt -73.82 115.65 13.5 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.566 0.698 . . . . 1.6899999999999999 111.707 -176.734 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.617 ' O ' ' HA ' ' A' ' 79' ' ' PHE . 1.5 tt -117.59 160.75 20.75 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 114.494 -1.23 . . . . 1.79 107.886 178.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.565 ' H ' HD22 ' A' ' 8' ' ' LEU . 70.4 ttt180 -131.24 132.17 44.43 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 109.42 -0.585 . . . . 1.3700000000000001 109.42 172.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -150.45 150.27 31.11 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.933 0.397 . . . . 1.0700000000000001 111.824 -175.404 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -108.54 136.04 48.8 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.732 -0.667 . . . . 1.04 109.51 177.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 35.9 p-80 -138.83 157.24 46.42 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.088 0.471 . . . . 0.34000000000000002 111.852 -171.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.57 ' O ' ' HA ' ' A' ' 112' ' ' HIS . 4.8 tt -124.34 146.92 48.54 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.584 -0.895 . . . . 1.0600000000000001 108.584 176.786 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.556 ' N ' HD22 ' A' ' 13' ' ' LEU . 28.7 tp -131.51 120.66 23.26 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.512 0.196 . . . . 1.0800000000000001 111.028 -178.217 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.435 HG23 HD13 ' A' ' 44' ' ' LEU . 65.2 t -109.32 138.91 34.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 109.874 -0.417 . . . . 1.01 109.874 176.417 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.49 ' HE2' ' OG ' ' A' ' 109' ' ' SER . 33.8 mmtp -112.04 154.4 25.42 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.731 -0.47 . . . . 1.22 109.731 176.804 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.473 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 41.4 p90 -144.26 162.53 36.15 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.267 -0.424 . . . . 0.29999999999999999 110.351 -176.054 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.462 ' HB3' ' HA ' ' A' ' 33' ' ' ALA . 29.0 p -53.44 108.12 0.31 Allowed 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.046 0.45 . . . . 1.6000000000000001 110.699 179.144 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 101.32 7.95 48.05 Favored Glycine 0 CA--C 1.522 0.502 0 C-N-CA 120.823 -0.704 . . . . 0.53000000000000003 113.208 -179.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.628 ' HB2' ' O ' ' A' ' 109' ' ' SER . 89.5 p -85.03 49.44 1.74 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 117.33 0.565 . . . . 1.28 111.156 -177.862 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 71.66 -32.99 0.26 Allowed 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.631 0.772 . . . . 4.1600000000000001 110.954 -177.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.512 ' H ' ' C ' ' A' ' 20' ' ' SER . 4.8 p30 -151.97 118.04 3.12 Favored Pre-proline 0 C--N 1.321 -0.673 0 N-CA-C 109.095 -0.706 . . . . 1.77 109.095 174.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.512 ' C ' HG21 ' A' ' 32' ' ' THR . 95.0 Cg_endo -85.39 55.8 4.12 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.52 2.147 . . . . 1.71 113.135 -175.735 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.443 ' N ' HG21 ' A' ' 32' ' ' THR . 25.5 t -146.21 116.4 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 109.577 -0.527 . . . . 1.1599999999999999 109.577 176.197 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.429 ' HB3' ' HB2' ' A' ' 16' ' ' LYS . 66.3 p -104.1 159.24 15.84 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.926 -0.398 . . . . 1.4299999999999999 109.926 175.679 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.486 ' HG2' ' HA ' ' A' ' 67' ' ' ASP . 6.3 mmp_? -71.48 -7.17 45.74 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.397 0.618 . . . . 3.1200000000000001 109.691 172.066 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.477 ' CG ' ' HD2' ' A' ' 65' ' ' ARG . 3.7 tmm_? -81.06 -36.18 30.81 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.279 -0.873 . . . . 2.25 110.054 178.779 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.446 ' HG1' ' C ' ' A' ' 31' ' ' SER . 61.8 p -101.71 -34.81 9.32 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.296 0.57 . . . . 1.1299999999999999 110.789 179.805 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 85.67 -43.85 3.29 Favored Glycine 0 N--CA 1.45 -0.383 0 CA-C-N 115.738 -0.665 . . . . 0.81999999999999995 112.986 177.241 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -93.0 -63.77 1.18 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.764 0.316 . . . . 2.1000000000000001 110.248 -177.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.446 ' C ' ' HG1' ' A' ' 28' ' ' THR . 19.8 m -153.12 151.67 30.42 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.365 -0.38 . . . . 1.3300000000000001 110.652 176.216 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.512 HG21 ' C ' ' A' ' 23' ' ' PRO . 12.1 t -115.09 34.36 4.9 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 122.19 0.995 . . . . 1.02 108.915 176.234 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.462 ' HA ' ' HB3' ' A' ' 18' ' ' SER . . . -80.49 -6.09 57.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 114.946 -1.025 . . . . 1.1299999999999999 112.102 -172.563 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -94.13 -23.83 17.79 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.38 0.609 . . . . 2.21 110.528 -178.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.423 HG13 ' OG1' ' A' ' 32' ' ' THR . 0.2 OUTLIER -98.19 135.78 31.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.702 -0.681 . . . . 1.1100000000000001 110.103 -179.135 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 71.0 p -95.83 179.46 5.1 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.024 -0.535 . . . . 1.2 109.95 -175.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.514 ' O ' HG13 ' A' ' 41' ' ' ILE . 13.6 p90 -62.92 -31.11 72.12 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.006 -0.678 . . . . 2.21 109.468 176.335 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -71.89 -46.34 58.09 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-N 116.044 -0.525 . . . . 0.95999999999999996 110.596 178.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -67.25 -27.78 67.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.245 0.545 . . . . 0.91000000000000003 109.87 177.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.473 ' HB2' ' HB3' ' A' ' 17' ' ' PHE . . . -71.07 -43.05 68.57 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.513 -0.767 . . . . 1.03 110.366 176.48 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.514 HG13 ' O ' ' A' ' 37' ' ' TYR . 86.5 mt -64.78 -37.08 79.24 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.414 0 N-CA-C 109.494 -0.558 . . . . 1.0800000000000001 109.494 174.358 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.404 ' O ' ' HG3' ' A' ' 46' ' ' LYS . 62.2 tttp -61.49 -28.25 69.17 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.599 -0.728 . . . . 2.8399999999999999 110.209 177.522 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 58.8 tt0 -88.08 -48.23 7.9 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.663 -0.699 . . . . 1.02 110.082 -178.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.485 HD12 HG12 ' A' ' 113' ' ' ILE . 32.2 tp -61.15 -36.58 80.17 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.871 -0.604 . . . . 1.02 110.021 -179.256 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.438 ' O ' ' HB2' ' A' ' 49' ' ' GLN . 4.4 mm-40 -64.08 -36.21 83.26 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-N 115.96 -0.564 . . . . 0.87 111.97 178.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.404 ' HG3' ' O ' ' A' ' 42' ' ' LYS . 98.1 mttt -69.23 -46.3 67.71 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.843 -0.343 . . . . 1.98 110.461 179.653 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.408 ' O ' HG13 ' A' ' 51' ' ' ILE . 54.0 m95 -66.0 -46.14 79.06 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.475 -0.33 . . . . 0.60999999999999999 111.188 177.55 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 44.7 t -57.77 -35.27 70.53 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.881 -0.414 . . . . 0.88 109.881 175.006 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.438 ' HB2' ' O ' ' A' ' 45' ' ' GLN . 13.0 tt0 -65.6 -55.98 14.69 Favored 'General case' 0 C--O 1.225 -0.233 0 CA-C-N 115.915 -0.584 . . . . 0.55000000000000004 110.488 176.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.509 ' HB3' HG22 ' A' ' 56' ' ' VAL . 93.5 mtt180 -62.15 -42.31 99.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.097 -0.501 . . . . 0.47999999999999998 111.609 -176.235 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.418 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 98.3 mt -60.24 -35.21 60.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.012 0.434 . . . . 1.04 110.657 176.474 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -79.99 -38.89 31.22 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.943 -0.571 . . . . 1.0600000000000001 111.542 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 65.2 p -76.68 -29.99 56.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.72 0.295 . . . . 0.34999999999999998 111.456 -176.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 106.38 10.31 29.67 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.539 -0.839 . . . . 0.33000000000000002 112.141 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.415 ' HB2' ' HB3' ' A' ' 50' ' ' ARG . 41.4 mt-10 -67.1 -52.16 45.36 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.047 0.451 . . . . 0.65000000000000002 110.011 176.696 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.509 HG22 ' HB3' ' A' ' 50' ' ' ARG . 15.8 m -132.04 156.06 42.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.925 -0.58 . . . . 1.05 109.748 175.145 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 50.5 m -86.27 159.34 19.47 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.575 -0.528 . . . . 1.3100000000000001 109.575 178.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -52.41 -43.44 64.81 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.027 0.442 . . . . 0.25 110.249 -176.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.584 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 39.9 mt-10 -56.82 -43.49 81.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.236 -0.893 . . . . 1.72 112.105 -179.013 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -60.86 -46.34 90.95 Favored 'General case' 0 CA--C 1.521 -0.141 0 CA-C-O 120.958 0.408 . . . . 2.0899999999999999 110.587 -177.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -69.15 -51.1 41.64 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.048 -0.523 . . . . 1.0700000000000001 110.921 -179.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.78 -52.11 66.86 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.741 0.645 . . . . 1.0600000000000001 112.741 -173.231 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.519 ' HA ' ' O ' ' A' ' 71' ' ' TYR . 20.4 m -51.5 -25.47 6.64 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 112.859 0.688 . . . . 1.52 112.859 -176.726 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -105.36 -46.25 4.26 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.63 0.728 . . . . 0.60999999999999999 110.673 -177.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.477 ' HD2' ' CG ' ' A' ' 27' ' ' ARG . 27.8 mmt180 -88.26 -41.03 13.19 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.872 -1.058 . . . . 0.95999999999999996 113.54 -169.813 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.474 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 59.6 p -64.79 127.2 30.58 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.68 -0.408 . . . . 1.0600000000000001 111.14 -176.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.486 ' HA ' ' HG2' ' A' ' 26' ' ' ARG . 33.6 t70 -80.15 -10.84 59.78 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.424 0.631 . . . . 2.2799999999999998 111.157 179.091 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 44.8 t -77.56 163.04 26.64 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.94 -0.573 . . . . 2.0499999999999998 109.688 179.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -61.26 -16.45 49.09 Favored Glycine 0 N--CA 1.454 -0.146 0 CA-C-N 115.642 -0.708 . . . . 0.29999999999999999 112.598 -176.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 61.8 p -65.51 -7.63 15.41 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 112.021 0.378 . . . . 0.46999999999999997 112.021 177.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.519 ' O ' ' HA ' ' A' ' 63' ' ' SER . 14.1 p90 -60.96 -23.64 65.48 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 109.479 -0.563 . . . . 0.94999999999999996 109.479 175.466 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -95.09 5.97 50.37 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.084 0.469 . . . . 1.1100000000000001 110.613 178.003 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 6.2 m -126.02 3.24 7.26 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.097 -0.501 . . . . 0.70999999999999996 110.823 -179.084 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.584 ' O ' ' HA ' ' A' ' 59' ' ' GLU . . . 73.16 25.43 73.34 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.812 -0.708 . . . . 0.67000000000000004 112.047 -175.731 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 83.66 -20.31 12.22 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 121.202 -0.523 . . . . 0.42999999999999999 111.809 -177.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -73.36 133.13 43.72 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.294 -0.453 . . . . 1.6499999999999999 110.672 -175.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.441 HD22 ' HE2' ' A' ' 85' ' ' MET . 2.5 mp -115.78 164.1 14.87 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-O 121.307 0.575 . . . . 1.6899999999999999 110.009 175.05 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -82.5 -154.95 15.97 Favored Glycine 0 C--N 1.305 -1.169 0 CA-C-N 114.964 -1.016 . . . . 0.45000000000000001 111.808 176.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.617 ' HA ' ' O ' ' A' ' 8' ' ' LEU . 93.3 m-85 -84.17 147.77 27.12 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.037 0.446 . . . . 4.7400000000000002 110.933 -179.478 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.617 ' O ' ' HA ' ' A' ' 7' ' ' LYS . 14.9 p90 -147.8 165.63 29.99 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.647 -0.871 . . . . 1.6499999999999999 108.647 -177.237 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -90.5 149.98 21.97 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 109.645 -0.502 . . . . 1.6899999999999999 109.645 -178.498 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.6 p -58.77 111.7 1.37 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.838 0.351 . . . . 1.55 110.629 177.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 99.64 18.11 24.14 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.672 -0.775 . . . . 0.79000000000000004 112.514 -177.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -101.08 18.07 20.74 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.061 0.458 . . . . 1.5800000000000001 110.98 -178.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.441 ' HE2' HD22 ' A' ' 77' ' ' LEU . 26.3 mmt -124.51 -105.31 0.35 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.885 0.374 . . . . 1.1299999999999999 111.057 -177.045 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 82.7 mmm -141.26 152.6 44.66 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.133 -1.062 . . . . 1.8899999999999999 108.133 175.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.409 ' HB3' ' HD3' ' A' ' 88' ' ' PRO . 23.8 ttmm -50.77 -56.39 19.63 Favored Pre-proline 0 C--N 1.321 -0.642 0 N-CA-C 112.701 0.63 . . . . 2.7400000000000002 112.701 -175.707 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.409 ' HD3' ' HB3' ' A' ' 87' ' ' LYS . 85.1 Cg_endo -77.44 -27.85 6.05 Favored 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 121.48 1.453 . . . . 0.29999999999999999 111.928 -176.163 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.671 ' O ' HG21 ' A' ' 93' ' ' VAL . 14.5 t80 -67.98 -56.81 7.6 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.187 -0.915 . . . . 0.28000000000000003 109.854 -179.325 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -65.25 -38.21 89.62 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.502 -0.772 . . . . 2.1200000000000001 110.143 -178.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -57.03 -34.28 68.05 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.475 -0.784 . . . . 0.60999999999999999 110.617 177.17 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -78.91 -26.84 43.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 1.1000000000000001 110.707 177.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.671 HG21 ' O ' ' A' ' 89' ' ' PHE . 35.5 t -72.28 -36.94 57.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.332 0.587 . . . . 1.1200000000000001 109.977 -178.577 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.437 ' C ' ' HD2' ' A' ' 94' ' ' ARG . 2.0 ppt_? -83.08 -2.74 56.17 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.844 -0.617 . . . . 3.1800000000000002 110.246 179.237 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -97.43 9.69 41.7 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.093 -0.503 . . . . 1.0800000000000001 111.339 -177.386 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.487 ' HB2' ' HB2' ' A' ' 100' ' ' ASP . 0.4 OUTLIER -144.24 151.11 38.99 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.31 0.576 . . . . 1.1200000000000001 111.461 178.684 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.496 ' HG3' ' N ' ' A' ' 98' ' ' ILE . 22.5 tptm -91.34 172.25 8.66 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.253 -0.885 . . . . 2.1299999999999999 109.402 177.011 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.496 ' N ' ' HG3' ' A' ' 97' ' ' LYS . 1.3 mp -46.73 120.59 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 C-N-CA 123.344 0.658 . . . . 1.6200000000000001 110.85 176.689 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 97.72 -9.37 64.16 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.761 -0.733 . . . . 0.46000000000000002 113.28 176.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.487 ' HB2' ' HB2' ' A' ' 96' ' ' LEU . 12.1 m-20 -93.11 141.84 27.96 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 117.133 0.466 . . . . 0.46000000000000002 111.055 -177.802 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 9.4 mt -111.4 146.15 16.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.707 -0.679 . . . . 1.0800000000000001 109.668 -179.141 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 97.8 p -89.42 152.45 47.5 Favored Pre-proline 0 C--N 1.319 -0.755 0 CA-C-N 116.361 -0.382 . . . . 1.45 110.422 -179.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -69.18 166.79 25.68 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 122.35 2.033 . . . . 0.40999999999999998 111.111 171.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.438 HG13 ' HG2' ' A' ' 45' ' ' GLN . 29.0 mm -46.07 105.09 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 O-C-N 123.562 0.539 . . . . 1.04 112.05 178.693 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.0 p -111.52 121.18 63.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.253 -0.43 . . . . 1.6599999999999999 110.196 177.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -85.57 156.47 20.72 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.228 0.537 . . . . 0.55000000000000004 110.92 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 2.8 p -130.09 -173.17 2.97 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.383 -0.826 . . . . 1.05 110.019 177.357 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -56.51 -49.1 75.73 Favored 'General case' 0 C--N 1.328 -0.341 0 O-C-N 123.213 0.32 . . . . 2.1600000000000001 110.887 177.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.628 ' O ' ' HB2' ' A' ' 20' ' ' SER . 8.3 t -84.14 -60.69 2.02 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 116.212 -0.449 . . . . 1.0900000000000001 110.638 -177.139 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -146.76 -132.71 2.36 Favored Glycine 0 N--CA 1.441 -1.004 0 C-N-CA 118.921 -1.609 . . . . 0.39000000000000001 113.982 -173.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.507 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 6.8 mp -118.77 150.41 39.85 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.964 -0.618 . . . . 1.0600000000000001 111.377 -169.543 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . 0.57 ' HA ' ' O ' ' A' ' 13' ' ' LEU . 85.3 m-70 -144.58 150.15 36.99 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.205 0.526 . . . . 0.25 111.995 179.625 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.485 HG12 HD12 ' A' ' 44' ' ' LEU . 1.4 pt -134.25 137.02 52.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 107.514 -1.291 . . . . 1.03 107.514 160.27 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 2.8 mp -130.53 144.77 36.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 C-N-CA 120.87 -0.332 . . . . 1.0600000000000001 110.826 -175.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.447 ' HA ' ' O ' ' A' ' 100' ' ' ASP . 43.2 pttt -126.18 142.53 51.49 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.116 -0.698 . . . . 1.29 109.116 173.229 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . 0.442 ' HB2' ' CD1' ' A' ' 96' ' ' LEU . 68.4 ttt180 -84.8 129.03 34.88 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.282 0.563 . . . . 2.6800000000000002 111.338 -178.309 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -97.34 -39.53 9.17 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.187 -0.915 . . . . 1.54 110.4 -179.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.243 0.712 0 CA-C-O 118.374 -0.822 . . . . 1.1499999999999999 110.305 -179.332 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.592 ' HA ' ' O ' ' A' ' 80' ' ' PHE . 69.0 mmtt . . . . . 0 N--CA 1.453 -0.284 0 CA-C-O 121.434 0.635 . . . . 1.19 111.365 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.631 ' HB3' ' CE1' ' A' ' 80' ' ' PHE . 2.3 tt -137.02 158.31 44.74 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 114.748 -1.115 . . . . 1.18 108.032 -176.661 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.63 ' H ' HD23 ' A' ' 8' ' ' LEU . 72.2 ttt180 -132.18 130.93 41.71 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 108.928 -0.767 . . . . 1.06 108.928 172.42 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -145.96 154.83 42.34 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.394 -0.523 . . . . 0.22 111.886 -175.172 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.519 ' HA ' ' HA ' ' A' ' 76' ' ' ASP . . . -114.86 137.04 52.43 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.901 -0.591 . . . . 0.2 109.823 177.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 32.4 p-80 -139.69 151.42 45.89 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.06 0.457 . . . . 0.23 111.538 -172.014 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.603 ' O ' ' HA ' ' A' ' 112' ' ' HIS . 5.5 tt -119.08 144.51 46.55 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 108.336 -0.986 . . . . 0.24 108.336 177.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.781 HD13 ' CE1' ' A' ' 112' ' ' HIS . 27.0 tp -130.4 120.97 25.07 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.724 0.297 . . . . 0.27 111.061 -177.805 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.535 HG23 HD13 ' A' ' 44' ' ' LEU . 57.3 t -109.04 133.9 52.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 116.108 -0.496 . . . . 0.15 109.693 176.119 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.484 ' HE3' HD21 ' A' ' 14' ' ' LEU . 32.7 mmtp -106.03 151.22 24.93 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.274 -0.639 . . . . 0.62 109.274 176.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.422 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 46.6 p90 -142.61 162.23 36.02 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.707 0.289 . . . . 0.25 110.859 -178.736 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.465 ' HB3' ' HA ' ' A' ' 33' ' ' ALA . 28.7 p -50.59 110.78 0.45 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.93 -0.577 . . . . 1.04 111.194 179.297 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 94.75 8.33 59.47 Favored Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.458 -0.877 . . . . 0.53 113.36 177.186 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.446 ' C ' ' H ' ' A' ' 22' ' ' ASN . 88.5 p -90.83 46.84 1.36 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 117.841 0.82 . . . . 0.7 110.51 -178.791 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 70.8 ttt180 70.87 -35.55 0.33 Allowed 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 123.53 0.732 . . . . 3.49 111.511 -178.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.446 ' H ' ' C ' ' A' ' 20' ' ' SER . 49.4 m-80 -140.52 96.86 7.6 Favored Pre-proline 0 C--N 1.326 -0.434 0 N-CA-C 109.623 -0.51 . . . . 1.77 109.623 179.526 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.51 ' C ' HG22 ' A' ' 32' ' ' THR . 87.4 Cg_endo -83.35 51.67 3.66 Favored 'Trans proline' 0 CA--C 1.536 0.618 0 C-N-CA 122.585 2.19 . . . . 1.71 113.133 -176.141 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.472 ' N ' HG22 ' A' ' 32' ' ' THR . 42.7 t -147.6 113.11 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 123.265 0.626 . . . . 0.48 109.332 177.136 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.441 ' HB3' ' HB2' ' A' ' 16' ' ' LYS . 21.5 p -104.36 158.07 16.71 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.946 -0.115 . . . . 1.12 110.728 178.405 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.542 ' HB2' ' HA ' ' A' ' 67' ' ' ASP . 0.0 OUTLIER -63.37 -13.78 43.1 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-O 121.551 0.691 . . . . 2.54 110.033 172.313 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.519 ' HG3' ' HD2' ' A' ' 65' ' ' ARG . 0.1 OUTLIER -87.87 -13.81 41.04 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.92 -1.036 . . . . 1.77 110.827 -177.432 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 20.7 p -118.84 -35.22 3.73 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.326 0.584 . . . . 0.67 110.511 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 79.4 -42.67 2.42 Favored Glycine 0 N--CA 1.452 -0.262 0 CA-C-N 115.083 -0.962 . . . . 0.82 112.852 176.604 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -94.27 -67.98 0.83 Allowed 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 110.118 -0.327 . . . . 2.1 110.118 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.2 m -153.63 146.59 24.48 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.075 -0.512 . . . . 1.08 110.304 178.533 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.51 HG22 ' C ' ' A' ' 23' ' ' PRO . 9.9 t -112.8 33.79 4.79 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 122.545 1.164 . . . . 0.34 108.589 175.264 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.465 ' HA ' ' HB3' ' A' ' 18' ' ' SER . . . -80.67 -4.55 54.7 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 114.165 -1.38 . . . . 0.37 111.712 -175.074 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -95.26 -21.42 18.45 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.97 0.415 . . . . 2.21 111.007 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.446 HG23 ' HB2' ' A' ' 39' ' ' ASP . 0.2 OUTLIER -99.18 136.54 29.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.052 -0.522 . . . . 0.31 110.052 179.822 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 56.1 p -95.48 -178.4 4.41 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.329 -0.396 . . . . 0.39 110.325 -174.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.423 ' O ' HG13 ' A' ' 41' ' ' ILE . 6.6 p90 -65.17 -27.98 69.08 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.102 -0.703 . . . . 1.53 109.102 176.041 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -72.1 -49.2 38.13 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 115.89 -0.596 . . . . 0.96 110.064 177.699 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.446 ' HB2' HG23 ' A' ' 35' ' ' VAL . 49.1 m-20 -65.12 -30.55 71.49 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-O 121.339 0.59 . . . . 0.91 110.041 179.422 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.422 ' HB2' ' HB3' ' A' ' 17' ' ' PHE . . . -70.4 -46.47 63.91 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.184 -0.916 . . . . 0.19 110.427 177.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.497 ' CG1' HD21 ' A' ' 111' ' ' LEU . 70.4 mt -63.33 -36.83 77.67 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.383 0 N-CA-C 109.726 -0.472 . . . . 0.3 109.726 175.537 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.445 ' O ' ' HG3' ' A' ' 46' ' ' LYS . 79.5 tttt -59.16 -31.8 69.31 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.66 -0.7 . . . . 2.32 110.169 177.65 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 53.1 tt0 -88.12 -46.84 8.96 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.635 -0.711 . . . . 1.02 110.149 -176.385 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.948 HD23 HG23 ' A' ' 104' ' ' ILE . 33.5 tp -60.19 -37.52 80.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.12 -0.491 . . . . 0.17 109.854 -179.302 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.5 ' HG2' HG13 ' A' ' 104' ' ' ILE . 1.2 mm100 -68.06 -21.35 65.0 Favored 'General case' 0 C--O 1.226 -0.175 0 CA-C-N 115.936 -0.575 . . . . 0.87 112.123 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.445 ' HG3' ' O ' ' A' ' 42' ' ' LYS . 68.4 mttm -82.43 -44.87 15.53 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.853 -0.339 . . . . 1.31 110.262 178.335 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 43.9 m95 -67.8 -44.44 77.32 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.999 -0.28 . . . . 0.52 110.618 177.097 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 32.4 t -61.15 -26.94 68.04 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.883 -0.414 . . . . 0.82 109.883 175.146 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.459 ' HB2' ' O ' ' A' ' 45' ' ' GLN . 3.9 tt0 -73.0 -56.62 4.87 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 116.152 -0.476 . . . . 0.53 109.844 175.319 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.574 ' HB3' HG22 ' A' ' 56' ' ' VAL . 87.0 mtt180 -59.86 -41.97 92.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.84 -0.618 . . . . 0.42 111.882 -176.179 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.482 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 98.0 mt -59.23 -34.76 54.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.101 0.476 . . . . 0.2 110.157 176.746 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -82.22 -37.91 25.31 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.559 -0.746 . . . . 0.27 111.87 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.475 ' OG ' ' HA ' ' A' ' 50' ' ' ARG . 46.3 p -78.92 -29.55 44.26 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 111.99 0.367 . . . . 0.35 111.99 -176.008 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 107.38 13.1 21.8 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.541 -0.838 . . . . 0.3 112.667 179.719 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.454 ' HB2' ' HB3' ' A' ' 50' ' ' ARG . 33.5 mt-10 -73.99 -44.85 53.24 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.858 0.361 . . . . 0.65 110.239 177.518 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.574 HG22 ' HB3' ' A' ' 50' ' ' ARG . 14.2 m -138.86 158.34 29.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 109.355 -0.609 . . . . 0.19 109.355 172.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 55.1 p -84.53 164.91 18.47 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.68 -0.489 . . . . 0.97 109.68 176.059 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.409 ' HA ' ' CD1' ' A' ' 51' ' ' ILE . 2.2 t80 -57.95 -41.04 81.99 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.224 -0.658 . . . . 0.22 109.224 178.074 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.459 ' CD ' ' H ' ' A' ' 59' ' ' GLU . 1.4 mp0 -56.56 -53.28 59.41 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.898 -1.046 . . . . 1.72 111.381 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 30.6 mm-40 -56.54 -45.48 81.15 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 120.965 0.412 . . . . 2.09 111.161 -178.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -68.1 -49.83 58.71 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.192 -0.458 . . . . 0.26 111.121 -179.334 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.33 -53.74 54.74 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.236 0.458 . . . . 0.24 112.236 -174.479 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.557 ' HA ' ' O ' ' A' ' 71' ' ' TYR . 74.7 m -51.63 -24.53 5.63 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 113.35 0.87 . . . . 1.0 113.35 -176.532 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -104.59 -48.1 3.89 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.564 0.697 . . . . 0.61 110.457 -179.475 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.519 ' HD2' ' HG3' ' A' ' 27' ' ' ARG . 18.5 mmt180 -87.41 -41.37 13.62 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.993 -1.003 . . . . 0.86 113.443 -168.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.535 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 58.5 p -64.77 125.43 24.76 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.049 0.452 . . . . 0.82 111.301 -175.568 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.542 ' HA ' ' HB2' ' A' ' 26' ' ' ARG . 24.8 t70 -75.96 -17.76 59.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.69 -0.686 . . . . 2.28 111.342 177.68 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 0.43 ' O ' ' HD1' ' A' ' 71' ' ' TYR . 41.2 t -77.48 157.43 30.45 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.317 0.579 . . . . 1.52 110.21 -178.536 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -57.11 -17.79 24.77 Favored Glycine 0 C--N 1.329 0.181 0 CA-C-N 114.482 -1.235 . . . . 0.26 114.269 -170.551 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 51.1 p -69.38 -5.61 24.63 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 111.891 0.33 . . . . 0.32 111.891 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.557 ' O ' ' HA ' ' A' ' 63' ' ' SER . 34.6 p90 -56.02 -33.58 65.03 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.014 0.435 . . . . 0.54 109.988 175.033 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -94.45 4.82 53.37 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.119 0.485 . . . . 0.49 110.911 -177.16 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.0 m -114.44 -15.99 12.0 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.002 -0.545 . . . . 0.71 110.905 -177.446 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 101.7 19.57 15.23 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.861 -0.685 . . . . 0.54 111.641 -176.717 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 85.8 -27.87 5.2 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 121.193 -0.527 . . . . 0.35 112.656 178.741 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.519 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 7.6 p-10 -86.41 140.86 29.6 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-O 121.776 0.798 . . . . 1.65 111.333 -175.275 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.3 mp -102.09 175.57 5.49 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 114.422 -1.263 . . . . 0.94 109.84 177.123 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -86.49 -156.53 28.64 Favored Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 120.842 -0.694 . . . . 0.44 111.413 177.788 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.558 ' HA ' ' O ' ' A' ' 8' ' ' LEU . 99.3 m-85 -85.29 136.96 33.27 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.022 0.439 . . . . 3.87 110.52 179.337 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.631 ' CE1' ' HB3' ' A' ' 8' ' ' LEU . 13.8 p90 -137.96 166.34 24.3 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.655 -0.702 . . . . 1.31 109.21 -179.604 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.521 ' O ' ' HB2' ' A' ' 84' ' ' GLU . 15.5 m -90.02 133.12 35.01 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 108.931 -0.766 . . . . 1.17 108.931 176.75 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 20.0 m -53.02 121.42 7.36 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.828 0.347 . . . . 1.19 110.834 -178.304 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 104.86 1.09 42.4 Favored Glycine 0 CA--C 1.519 0.324 0 C-N-CA 120.964 -0.636 . . . . 0.79 112.237 -176.61 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.521 ' HB2' ' O ' ' A' ' 81' ' ' SER . 28.5 tt0 -82.78 -3.79 57.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.777 0.322 . . . . 1.55 111.609 -175.519 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 26.5 mmt -107.94 -144.97 0.39 Allowed 'General case' 0 N--CA 1.438 -1.035 0 N-CA-C 109.451 -0.574 . . . . 0.73 109.451 -175.096 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -93.54 154.52 17.83 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 115.369 -0.832 . . . . 1.39 109.089 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.402 ' HB3' ' HD3' ' A' ' 88' ' ' PRO . 22.3 tptm -53.94 -57.1 19.31 Favored Pre-proline 0 C--N 1.321 -0.671 0 N-CA-C 112.07 0.396 . . . . 2.37 112.07 -178.127 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.402 ' HD3' ' HB3' ' A' ' 87' ' ' LYS . 68.0 Cg_endo -74.0 -22.1 17.56 Favored 'Trans proline' 0 C--N 1.356 0.962 0 C-N-CA 121.506 1.47 . . . . 0.27 111.661 -176.724 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.615 ' O ' HG23 ' A' ' 93' ' ' VAL . 23.8 t80 -72.8 -56.45 5.22 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.293 -0.867 . . . . 0.22 109.608 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -64.48 -34.83 79.12 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.812 -0.631 . . . . 2.12 109.654 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.457 ' HA ' ' NE ' ' A' ' 94' ' ' ARG . 9.9 t70 -52.35 -36.69 54.17 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.74 -0.664 . . . . 0.61 111.091 175.029 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.541 ' O ' ' HG ' ' A' ' 96' ' ' LEU . . . -81.98 -35.34 29.06 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.937 -0.574 . . . . 0.22 110.883 179.424 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.615 HG23 ' O ' ' A' ' 89' ' ' PHE . 14.7 t -64.17 -42.76 96.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.201 0.524 . . . . 0.25 110.585 -177.674 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.457 ' NE ' ' HA ' ' A' ' 91' ' ' ASP . 39.4 ptt180 -70.86 -18.41 62.7 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.022 -0.535 . . . . 2.59 110.583 177.415 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -88.66 2.6 52.94 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.921 -0.581 . . . . 0.47 111.415 -174.162 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.632 ' HB2' ' HB2' ' A' ' 100' ' ' ASP . 0.8 OUTLIER -137.98 153.53 49.42 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.132 -0.485 . . . . 0.28 110.64 177.621 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.683 ' HG2' ' H ' ' A' ' 98' ' ' ILE . 39.8 tttp -102.7 -179.18 3.89 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 109.18 -0.674 . . . . 1.61 109.18 176.413 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.683 ' H ' ' HG2' ' A' ' 97' ' ' LYS . 9.2 mt -51.49 122.4 2.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 120.891 0.377 . . . . 0.9 111.309 178.828 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 93.12 -2.12 71.23 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.9 -0.667 . . . . 0.46 113.271 178.834 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.632 ' HB2' ' HB2' ' A' ' 96' ' ' LEU . 45.7 m-20 -100.19 141.98 32.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 117.423 0.611 . . . . 0.46 110.657 -179.474 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 11.8 mt -111.55 147.02 15.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.954 -0.566 . . . . 0.23 110.0 -179.408 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 91.3 p -92.19 152.45 42.58 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 116.419 -0.355 . . . . 0.92 110.953 -177.731 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -68.25 160.15 50.17 Favored 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 122.335 2.023 . . . . 0.34 111.095 172.443 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.948 HG23 HD23 ' A' ' 44' ' ' LEU . 25.6 mm -43.1 107.95 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 O-C-N 123.889 0.743 . . . . 0.2 112.115 178.585 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 1.8 p -113.31 121.78 66.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.991 -0.549 . . . . 1.04 109.983 177.665 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -85.41 155.44 21.28 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.97 0.414 . . . . 0.55 110.4 179.467 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 4.4 p -135.85 -171.17 2.79 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.695 -0.684 . . . . 0.37 110.929 -178.306 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -56.37 -42.69 78.28 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.122 -0.49 . . . . 2.16 111.672 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.44 ' O ' ' HD3' ' A' ' 16' ' ' LYS . 5.4 t -113.58 -0.38 14.38 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 112.593 0.59 . . . . 1.09 112.593 -170.146 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 166.25 -126.86 1.52 Allowed Glycine 0 N--CA 1.436 -1.31 0 C-N-CA 119.198 -1.477 . . . . 0.24 113.31 171.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.902 ' HB3' HD22 ' A' ' 44' ' ' LEU . 7.4 mp -125.79 149.08 48.88 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 114.767 -0.717 . . . . 0.19 111.135 -168.725 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' HIS . . . . . 0.781 ' CE1' HD13 ' A' ' 14' ' ' LEU . 74.9 m80 -144.05 150.08 37.64 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.21 0.529 . . . . 0.22 111.854 178.8 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.628 HG12 HD11 ' A' ' 44' ' ' LEU . 2.5 pt -132.7 140.7 46.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 107.577 -1.268 . . . . 0.17 107.577 159.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 2.7 mp -130.43 145.17 35.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 C-N-CA 120.813 -0.355 . . . . 0.18 110.643 -176.218 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.456 ' HG2' ' HB3' ' A' ' 11' ' ' ALA . 43.3 pttt -127.74 141.5 51.57 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.725 -0.842 . . . . 0.61 108.725 173.047 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ARG . . . . . 0.56 ' HB2' ' CD1' ' A' ' 96' ' ' LEU . 55.1 ttt180 -83.72 129.06 34.95 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.212 0.53 . . . . 1.87 111.097 -178.033 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -97.02 -34.51 11.15 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.137 -0.938 . . . . 0.89 110.105 -179.561 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.404 ' HB3' ' HB3' ' A' ' 9' ' ' ARG . . . . . . . . 0 C--O 1.246 0.882 0 CA-C-O 118.647 -0.692 . . . . 1.1 109.958 178.562 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.417 ' HG3' ' HB3' ' A' ' 79' ' ' PHE . 10.3 tptt . . . . . 0 N--CA 1.45 -0.441 0 CA-C-O 121.703 0.763 . . . . 1.19 111.419 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.587 HD23 ' N ' ' A' ' 9' ' ' ARG . 2.1 tt -113.93 157.6 22.2 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 114.25 -1.341 . . . . 1.18 107.898 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.587 ' N ' HD23 ' A' ' 8' ' ' LEU . 63.2 ttt180 -141.0 130.32 23.66 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 109.164 -0.68 . . . . 1.06 109.164 173.336 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -147.19 152.5 38.5 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 120.251 -0.58 . . . . 0.22 112.15 -178.245 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -103.97 134.08 47.86 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.311 -0.858 . . . . 0.2 109.019 176.125 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 29.1 p-80 -135.13 148.05 49.66 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.101 0.477 . . . . 0.23 111.851 -172.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.556 HD23 ' N ' ' A' ' 14' ' ' LEU . 5.2 tt -115.0 147.97 39.41 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.518 -0.919 . . . . 0.24 108.518 177.457 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.702 HD13 ' CE1' ' A' ' 112' ' ' HIS . 18.1 tp -131.65 130.24 41.83 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 110.35 -0.241 . . . . 0.27 110.35 -177.777 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.529 HG23 HD13 ' A' ' 44' ' ' LEU . 56.5 t -119.7 133.63 65.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 109.827 -0.435 . . . . 0.15 109.827 174.785 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.53 ' HE3' HD21 ' A' ' 14' ' ' LEU . 33.4 mmtp -104.96 154.91 19.47 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.066 -0.516 . . . . 0.62 110.503 178.145 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.412 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 50.4 p90 -149.64 161.62 41.83 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.633 -0.712 . . . . 0.25 109.523 -178.057 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.473 ' HB3' ' C ' ' A' ' 33' ' ' ALA . 38.1 p -54.59 110.16 0.6 Allowed 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.147 0.499 . . . . 1.04 110.5 177.797 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 108.84 9.47 26.4 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.918 -0.658 . . . . 0.53 112.356 -176.227 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.456 ' C ' ' H ' ' A' ' 22' ' ' ASN . 42.5 p -88.06 26.69 1.32 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 117.095 0.448 . . . . 0.7 111.81 -175.537 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.417 ' HB2' ' O ' ' A' ' 20' ' ' SER . 83.2 mtt180 72.5 -20.04 0.28 Allowed 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.173 0.589 . . . . 3.49 111.459 -178.767 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.456 ' H ' ' C ' ' A' ' 20' ' ' SER . 7.4 p30 -155.08 107.31 2.28 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-O 121.47 0.653 . . . . 1.77 109.345 171.182 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.41 ' C ' HG22 ' A' ' 32' ' ' THR . 87.5 Cg_endo -81.77 58.81 6.92 Favored 'Trans proline' 0 CA--C 1.534 0.49 0 C-N-CA 122.824 2.35 . . . . 1.71 113.47 -171.289 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.438 ' N ' HG22 ' A' ' 32' ' ' THR . 63.9 t -140.22 121.91 15.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 122.6 0.36 . . . . 0.48 110.138 178.77 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 28.3 t -103.06 149.55 24.47 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 109.235 -0.654 . . . . 1.12 109.235 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.57 ' HB2' ' HA ' ' A' ' 67' ' ' ASP . 2.1 mpt_? -77.38 -14.55 59.69 Favored 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 108.443 -0.947 . . . . 2.54 108.443 173.089 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.488 ' HG2' ' HD3' ' A' ' 65' ' ' ARG . 1.9 tmm_? -76.41 -35.51 58.54 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 114.575 -1.193 . . . . 1.77 109.558 175.784 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 44.2 p -97.62 -34.19 11.04 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 121.273 0.558 . . . . 0.67 110.595 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 75.37 -10.41 11.43 Favored Glycine 0 N--CA 1.452 -0.269 0 CA-C-N 115.492 -0.776 . . . . 0.82 113.032 178.363 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -115.93 -71.36 0.74 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.886 0.374 . . . . 2.1 109.995 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.2 p -152.51 154.83 36.26 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.031 -0.531 . . . . 1.08 110.679 179.039 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.447 HG21 ' CB ' ' A' ' 16' ' ' LYS . 8.8 t -123.01 34.9 5.01 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 122.147 0.975 . . . . 0.34 109.712 175.332 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.473 ' C ' ' HB3' ' A' ' 18' ' ' SER . . . -79.6 -5.57 55.29 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.181 -0.918 . . . . 0.37 112.309 -174.392 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -97.68 -25.27 15.16 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.083 0.468 . . . . 2.21 111.159 -179.485 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.502 HG23 ' HB2' ' A' ' 39' ' ' ASP . 0.3 OUTLIER -93.5 137.68 22.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 116.128 -0.487 . . . . 0.31 110.174 -177.074 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 56.8 p -98.17 -178.29 4.0 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.442 -0.577 . . . . 0.39 109.442 -178.516 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.517 ' O ' HG13 ' A' ' 41' ' ' ILE . 0.2 OUTLIER -66.18 -24.27 66.61 Favored 'General case' 0 C--O 1.219 -0.518 0 C-N-CA 119.291 -0.963 . . . . 1.53 110.013 173.522 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -70.01 -45.7 66.67 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.887 -0.412 . . . . 0.96 109.887 175.339 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.502 ' HB2' HG23 ' A' ' 35' ' ' VAL . 26.3 m-20 -69.01 -30.96 69.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.503 0.668 . . . . 0.91 109.758 177.334 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.412 ' HB2' ' HB3' ' A' ' 17' ' ' PHE . . . -73.3 -42.26 62.59 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.139 -0.937 . . . . 0.19 110.863 179.15 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.517 HG13 ' O ' ' A' ' 37' ' ' TYR . 69.4 mt -63.54 -35.89 74.29 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.299 0 N-CA-C 109.494 -0.558 . . . . 0.3 109.494 174.663 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 20.3 ttpt -62.96 -23.62 67.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.363 0.601 . . . . 2.32 109.896 178.312 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.509 ' HG3' ' CD1' ' A' ' 47' ' ' TRP . 2.2 tp10 -87.67 -56.95 3.13 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.09 -0.959 . . . . 1.02 109.378 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.884 HD23 HG23 ' A' ' 104' ' ' ILE . 31.9 tp -59.24 -36.8 76.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.088 -0.96 . . . . 0.17 110.82 -174.213 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.589 ' O ' ' HB2' ' A' ' 49' ' ' GLN . 7.2 mm-40 -67.07 -29.76 69.63 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 116.159 -0.473 . . . . 0.87 112.25 -177.407 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 44.5 mttp -78.29 -42.76 29.91 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.814 0.34 . . . . 1.31 110.316 178.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.509 ' CD1' ' HG3' ' A' ' 43' ' ' GLU . 49.4 m95 -66.81 -44.45 81.15 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.384 -0.371 . . . . 0.52 111.364 178.226 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.508 ' HB3' HG21 ' A' ' 113' ' ' ILE . 88.9 p -64.7 -32.17 73.72 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 110.017 -0.364 . . . . 0.82 110.017 176.245 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.589 ' HB2' ' O ' ' A' ' 45' ' ' GLN . 11.0 tt0 -66.13 -49.81 66.16 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.1 -0.5 . . . . 0.53 110.274 177.615 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.602 ' HB3' HG22 ' A' ' 56' ' ' VAL . 87.9 mtt180 -64.14 -44.49 91.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.755 -0.657 . . . . 0.42 111.272 -179.0 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.412 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 88.3 mt -59.84 -39.35 79.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.362 -0.381 . . . . 0.2 110.654 177.085 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.27 -36.21 68.94 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.232 -0.44 . . . . 0.27 111.863 -179.145 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 24.6 p -85.19 -30.32 24.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.896 0.379 . . . . 0.35 111.474 -177.658 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 108.91 11.34 22.86 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.62 -0.8 . . . . 0.3 112.742 178.678 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.47 ' OE1' ' HG2' ' A' ' 50' ' ' ARG . 46.9 mt-10 -62.56 -49.51 74.99 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.612 -0.514 . . . . 0.65 109.612 175.319 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.602 HG22 ' HB3' ' A' ' 50' ' ' ARG . 14.6 m -132.16 155.28 41.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.591 -0.731 . . . . 0.19 109.359 173.586 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.1 m -83.29 160.43 21.71 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 109.236 -0.653 . . . . 0.97 109.236 178.206 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -54.93 -44.11 73.96 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.619 -0.512 . . . . 0.22 109.619 -179.097 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.552 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 39.9 mt-10 -59.15 -43.41 92.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.12 -0.945 . . . . 1.72 111.8 -179.178 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 -61.62 -49.05 78.14 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 120.964 0.411 . . . . 2.09 110.519 -177.512 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -67.53 -50.16 59.97 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.926 -0.579 . . . . 0.26 110.902 -178.559 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -58.6 -51.97 67.67 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.573 0.583 . . . . 0.24 112.573 -174.21 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.571 ' HA ' ' O ' ' A' ' 71' ' ' TYR . 23.9 m -51.32 -27.26 9.13 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.736 0.643 . . . . 1.0 112.736 -177.559 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -102.68 -44.67 5.24 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.533 0.683 . . . . 0.61 110.654 -178.157 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.488 ' HD3' ' HG2' ' A' ' 27' ' ' ARG . 25.3 mmt180 -94.6 -35.91 12.02 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 114.2 1.185 . . . . 0.86 114.2 -169.615 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.544 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 33.7 p -66.7 128.13 35.07 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.9 0.381 . . . . 0.82 110.797 -177.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.57 ' HA ' ' HB2' ' A' ' 26' ' ' ARG . 40.0 m-20 -90.92 5.54 48.22 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.701 -0.681 . . . . 2.28 111.644 -177.707 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 0.472 ' O ' ' HD1' ' A' ' 71' ' ' TYR . 36.1 t -88.22 170.0 11.39 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.67 -0.493 . . . . 1.52 109.67 174.671 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -63.56 -19.02 62.06 Favored Glycine 0 N--CA 1.454 -0.142 0 C-N-CA 121.08 -0.581 . . . . 0.26 111.962 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 55.3 p -65.93 -6.92 13.94 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 112.532 0.567 . . . . 0.32 112.532 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.571 ' O ' ' HA ' ' A' ' 63' ' ' SER . 20.0 p90 -60.68 -23.16 64.62 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.216 0.532 . . . . 0.54 109.747 176.171 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -89.28 -1.48 58.08 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.188 -0.46 . . . . 0.49 111.055 179.668 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.5 m -126.17 6.94 7.15 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.91 0.386 . . . . 0.71 110.998 -179.409 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.552 ' O ' ' HA ' ' A' ' 59' ' ' GLU . . . 73.37 30.39 62.59 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.634 -0.793 . . . . 0.54 112.195 -177.701 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 85.45 -22.21 11.3 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 121.12 -0.562 . . . . 0.35 111.801 -179.096 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -64.32 134.67 55.13 Favored 'General case' 0 CA--C 1.508 -0.663 0 CA-C-N 115.203 -0.498 . . . . 1.65 111.49 -176.664 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.431 ' HB3' ' HE2' ' A' ' 80' ' ' PHE . 2.6 mp -117.52 158.18 25.0 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 115.685 -0.689 . . . . 0.94 109.334 169.719 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -78.63 -150.05 4.83 Favored Glycine 0 C--N 1.308 -0.977 0 CA-C-N 115.023 -0.989 . . . . 0.44 112.72 -179.243 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.417 ' HB3' ' HG3' ' A' ' 7' ' ' LYS . 97.7 m-85 -88.52 144.82 26.1 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.203 0.525 . . . . 3.87 111.697 -178.525 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.431 ' HE2' ' HB3' ' A' ' 77' ' ' LEU . 1.6 p90 -158.3 153.63 25.82 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.123 -0.944 . . . . 1.31 108.803 -177.677 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 29.3 m -82.39 133.64 35.22 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.115 -0.698 . . . . 1.17 109.115 178.666 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 4.5 p -49.98 121.14 5.02 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.997 -0.547 . . . . 1.19 111.514 -178.091 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 114.49 -17.18 18.86 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.847 -0.692 . . . . 0.79 112.938 -178.582 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 65.6 mt-10 -83.55 46.71 1.18 Allowed 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 117.092 0.446 . . . . 1.55 111.486 -176.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 25.7 mmt -137.68 -122.59 0.14 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.053 0.454 . . . . 0.73 110.482 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 54.9 mtt -125.34 149.59 47.97 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.163 -1.051 . . . . 1.39 108.163 176.81 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 16.3 tppt? -54.12 -52.76 65.71 Favored Pre-proline 0 C--N 1.32 -0.715 0 N-CA-C 112.423 0.527 . . . . 2.37 112.423 -174.112 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.49 ' HG2' HG22 ' A' ' 107' ' ' THR . 74.0 Cg_endo -75.42 -23.62 12.95 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 121.336 1.357 . . . . 0.27 112.136 -176.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.596 ' O ' HG23 ' A' ' 93' ' ' VAL . 45.3 t80 -74.34 -55.39 6.06 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.396 -0.82 . . . . 0.22 109.868 179.354 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -64.75 -34.33 78.07 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.614 -0.721 . . . . 2.12 110.087 -178.756 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.498 ' HA ' ' NE ' ' A' ' 94' ' ' ARG . 19.2 t70 -53.44 -35.94 61.03 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.929 -0.578 . . . . 0.61 110.753 175.13 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.478 ' O ' ' HG ' ' A' ' 96' ' ' LEU . . . -80.4 -36.19 34.15 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.341 -0.391 . . . . 0.22 110.957 178.511 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.596 HG23 ' O ' ' A' ' 89' ' ' PHE . 15.4 t -64.27 -41.67 93.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.275 0.559 . . . . 0.25 110.693 -177.917 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.498 ' NE ' ' HA ' ' A' ' 91' ' ' ASP . 36.4 ptt180 -76.1 -12.21 60.07 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.833 -0.621 . . . . 2.59 110.449 178.194 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -97.32 21.16 10.42 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.085 -0.507 . . . . 0.47 111.314 -174.826 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.543 ' HB2' ' HB2' ' A' ' 100' ' ' ASP . 0.4 OUTLIER -152.32 156.35 39.44 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.86 -0.609 . . . . 0.28 110.604 175.074 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.468 ' HG3' ' H ' ' A' ' 98' ' ' ILE . 50.8 tptt -99.01 175.92 5.75 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.502 -0.772 . . . . 1.61 108.96 179.603 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.468 ' H ' ' HG3' ' A' ' 97' ' ' LYS . 67.3 mt -57.19 117.66 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 120.887 0.375 . . . . 0.9 110.752 178.184 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 96.37 9.09 57.1 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.821 -0.704 . . . . 0.46 112.748 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.543 ' HB2' ' HB2' ' A' ' 96' ' ' LEU . 21.7 m-20 -110.83 141.62 43.95 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 110.001 -0.37 . . . . 0.46 110.001 176.833 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 12.3 mt -111.8 149.94 14.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.212 -0.449 . . . . 0.23 110.002 -177.666 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 99.6 p -95.04 143.36 25.97 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 116.619 -0.264 . . . . 0.92 110.525 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -66.65 164.79 27.7 Favored 'Trans proline' 0 N--CA 1.461 -0.41 0 C-N-CA 122.319 2.013 . . . . 0.34 110.93 171.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.884 HG23 HD23 ' A' ' 44' ' ' LEU . 20.2 mm -39.48 113.34 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 O-C-N 123.817 0.698 . . . . 0.2 112.571 -179.08 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 1.8 p -121.37 121.62 65.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.949 -0.568 . . . . 1.04 110.121 175.53 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLN . . . . . 0.437 ' HG2' ' CD1' ' A' ' 111' ' ' LEU . 49.2 mt-30 -85.09 156.58 21.01 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.059 0.457 . . . . 0.55 110.394 178.428 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.49 HG22 ' HG2' ' A' ' 88' ' ' PRO . 3.0 p -130.24 -172.49 2.8 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.684 -0.689 . . . . 0.37 110.212 179.042 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -60.96 -36.36 79.18 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.574 0.226 . . . . 2.16 110.693 177.517 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.434 ' OG ' ' HE2' ' A' ' 16' ' ' LYS . 23.3 t -91.51 -61.37 1.66 Allowed 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 120.89 -0.324 . . . . 1.09 110.657 -178.554 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -150.67 -130.93 1.78 Allowed Glycine 0 N--CA 1.442 -0.901 0 C-N-CA 119.287 -1.435 . . . . 0.24 113.635 -174.752 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.882 ' HB3' HD22 ' A' ' 44' ' ' LEU . 7.4 mp -116.48 148.7 40.52 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.332 -0.434 . . . . 0.19 111.392 -171.511 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' HIS . . . . . 0.702 ' CE1' HD13 ' A' ' 14' ' ' LEU . 73.9 m80 -144.09 151.88 40.2 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.267 0.556 . . . . 0.22 112.398 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.621 HG12 HD11 ' A' ' 44' ' ' LEU . 3.4 pt -133.21 136.26 55.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 107.484 -1.302 . . . . 0.17 107.484 159.273 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 2.8 mp -127.48 144.3 37.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 C-N-CA 120.753 -0.379 . . . . 0.18 110.478 -176.694 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 41.3 pttt -125.76 140.81 52.37 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.773 -0.825 . . . . 0.61 108.773 172.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ARG . . . . . 0.493 ' HB2' ' CD1' ' A' ' 96' ' ' LEU . 59.2 ttt180 -87.36 134.47 33.57 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.072 0.463 . . . . 1.87 111.384 -177.736 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 6.7 mp -112.1 -24.06 10.1 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.568 -0.742 . . . . 0.89 111.187 -178.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.53 ' HB3' ' HB3' ' A' ' 9' ' ' ARG . . . . . . . . 0 C--O 1.243 0.744 0 CA-C-O 118.019 -0.991 . . . . 1.1 109.697 176.62 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 10.9 tptt . . . . . 0 N--CA 1.452 -0.346 0 CA-C-O 121.297 0.57 . . . . 1.19 109.91 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.682 HD23 ' H ' ' A' ' 9' ' ' ARG . 0.3 OUTLIER -128.21 168.51 15.34 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 114.962 -1.017 . . . . 1.18 109.808 -171.807 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.682 ' H ' HD23 ' A' ' 8' ' ' LEU . 70.1 ttt180 -145.64 125.03 13.07 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.064 -0.717 . . . . 1.06 109.064 174.701 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.497 ' N ' ' HZ ' ' A' ' 80' ' ' PHE . . . -145.93 160.57 41.64 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.353 -0.539 . . . . 0.22 112.003 -177.726 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.582 ' HA ' ' HA ' ' A' ' 76' ' ' ASP . . . -106.65 131.66 53.53 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.282 -0.872 . . . . 0.2 109.573 178.701 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 22.5 p-80 -133.54 140.1 46.99 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.995 0.426 . . . . 0.23 111.115 -173.041 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.674 ' O ' ' HA ' ' A' ' 112' ' ' HIS . 5.9 tt -113.24 137.54 51.32 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.852 -0.796 . . . . 0.24 108.852 179.195 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.673 HD13 ' CE1' ' A' ' 112' ' ' HIS . 23.2 tp -120.8 122.43 40.3 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.892 0.377 . . . . 0.27 111.364 -178.764 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.625 HG23 HD13 ' A' ' 44' ' ' LEU . 57.7 t -108.04 137.69 38.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 109.059 -0.719 . . . . 0.15 109.059 171.828 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.607 ' HE2' ' OG ' ' A' ' 109' ' ' SER . 28.6 mmtp -105.22 164.33 11.91 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.806 -0.442 . . . . 0.62 109.806 178.616 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 42.9 p90 -155.55 160.57 40.62 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.418 -0.586 . . . . 0.25 109.418 -177.515 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.436 ' HB3' ' C ' ' A' ' 33' ' ' ALA . 54.2 p -58.09 110.3 0.91 Allowed 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.483 -0.326 . . . . 1.04 110.557 178.659 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 105.51 10.16 31.8 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.475 -0.869 . . . . 0.53 113.15 -178.449 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.487 ' C ' ' H ' ' A' ' 22' ' ' ASN . 49.8 p -77.44 37.21 0.21 Allowed 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 117.639 0.719 . . . . 0.7 112.11 -174.833 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 60.6 ttt180 68.31 -36.17 0.31 Allowed 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.621 0.769 . . . . 3.49 111.065 -176.396 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.487 ' H ' ' C ' ' A' ' 20' ' ' SER . 8.6 p30 -154.68 119.01 2.58 Favored Pre-proline 0 C--N 1.319 -0.731 0 N-CA-C 107.757 -1.201 . . . . 1.77 107.757 171.877 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.401 ' HB2' ' H ' ' A' ' 24' ' ' VAL . 68.9 Cg_endo -81.99 -151.72 0.04 OUTLIER 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 122.528 2.152 . . . . 1.71 111.885 -174.474 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.597 ' N ' HG22 ' A' ' 32' ' ' THR . 48.0 t 64.06 111.17 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 123.329 0.652 . . . . 0.48 111.588 -175.764 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.488 ' HB3' ' HB2' ' A' ' 16' ' ' LYS . 35.7 p -103.93 152.92 21.4 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.377 -0.374 . . . . 1.12 110.115 177.796 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.582 ' HG2' ' HA ' ' A' ' 67' ' ' ASP . 3.8 mmp_? -65.34 -12.01 47.68 Favored 'General case' 0 N--CA 1.462 0.159 0 N-CA-C 109.522 -0.547 . . . . 2.54 109.522 172.256 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.555 ' HG3' ' CD ' ' A' ' 65' ' ' ARG . 31.5 ttp180 -67.79 -55.82 11.57 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.377 -0.828 . . . . 1.77 110.01 177.115 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 31.8 p -87.83 -34.11 18.35 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 121.446 0.641 . . . . 0.67 110.63 -176.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 70.12 16.89 73.37 Favored Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 115.292 -0.867 . . . . 0.82 111.962 -179.335 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -144.79 -68.41 0.31 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.582 0.229 . . . . 2.1 110.548 -178.833 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.8 p -150.14 147.19 27.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.967 0.413 . . . . 1.08 111.61 179.338 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.597 HG22 ' N ' ' A' ' 24' ' ' VAL . 9.6 t -127.51 16.16 7.06 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.67 0.748 . . . . 0.34 109.943 174.813 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.436 ' C ' ' HB3' ' A' ' 18' ' ' SER . . . -67.77 -4.34 12.16 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.126 -0.943 . . . . 0.37 112.973 -178.851 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -95.07 -25.5 16.43 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.091 0.472 . . . . 2.21 110.968 -179.461 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.514 HG23 ' HB2' ' A' ' 39' ' ' ASP . 0.2 OUTLIER -95.6 135.06 30.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.097 -0.501 . . . . 0.31 110.277 -178.364 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 63.4 p -93.36 178.22 5.79 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 109.548 -0.538 . . . . 0.39 109.548 -176.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.489 ' O ' HG13 ' A' ' 41' ' ' ILE . 0.1 OUTLIER -67.05 -22.25 65.87 Favored 'General case' 0 C--O 1.22 -0.463 0 C-N-CA 118.809 -1.156 . . . . 1.53 110.12 174.045 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -71.86 -46.97 56.1 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.975 -0.38 . . . . 0.96 109.975 175.033 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.514 ' HB2' HG23 ' A' ' 35' ' ' VAL . 24.9 m-20 -64.19 -35.72 81.71 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.612 0.72 . . . . 0.91 109.636 175.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.83 -47.4 66.12 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.888 -1.051 . . . . 0.19 110.788 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.489 HG13 ' O ' ' A' ' 37' ' ' TYR . 60.9 mt -63.02 -35.47 71.75 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.388 0 N-CA-C 110.001 -0.37 . . . . 0.3 110.001 176.682 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.471 ' O ' ' HG3' ' A' ' 46' ' ' LYS . 27.8 ttpt -61.63 -28.69 69.55 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 121.3 0.572 . . . . 2.32 109.695 179.424 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -88.6 -48.48 7.53 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.392 -0.822 . . . . 1.02 110.352 -177.752 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.93 HD23 HG23 ' A' ' 104' ' ' ILE . 29.3 tp -59.57 -36.99 77.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.002 -0.545 . . . . 0.17 110.366 -178.529 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.41 ' O ' ' HB2' ' A' ' 49' ' ' GLN . 11.6 mm-40 -67.97 -21.48 65.07 Favored 'General case' 0 N--CA 1.462 0.134 0 N-CA-C 112.114 0.413 . . . . 0.87 112.114 -179.042 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.471 ' HG3' ' O ' ' A' ' 42' ' ' LYS . 67.8 mttm -82.97 -44.62 15.08 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.929 -0.397 . . . . 1.31 109.929 177.556 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 43.2 m95 -65.63 -45.38 83.25 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.299 -0.409 . . . . 0.52 111.181 177.069 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.512 ' HB3' HG21 ' A' ' 113' ' ' ILE . 97.1 p -65.24 -20.4 66.41 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.885 -0.413 . . . . 0.82 109.885 178.191 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.41 ' HB2' ' O ' ' A' ' 45' ' ' GLN . 14.2 tt0 -76.34 -56.6 4.49 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 109.541 -0.54 . . . . 0.53 109.541 173.693 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.589 ' HB3' HG22 ' A' ' 56' ' ' VAL . 92.5 mtt180 -59.88 -43.09 94.93 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.724 -0.671 . . . . 0.42 111.808 -176.443 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.469 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 95.3 mt -60.46 -33.64 55.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 120.985 0.421 . . . . 0.2 110.57 177.279 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -81.42 -38.75 25.99 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.102 -0.499 . . . . 0.27 111.317 -179.544 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 26.7 p -75.99 -29.56 58.25 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.002 0.429 . . . . 0.35 111.135 -178.793 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 106.33 6.54 36.09 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.869 -0.682 . . . . 0.3 111.962 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.459 ' HB2' ' HB3' ' A' ' 50' ' ' ARG . 43.2 mt-10 -63.44 -45.65 89.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.809 0.338 . . . . 0.65 110.376 178.772 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.589 HG22 ' HB3' ' A' ' 50' ' ' ARG . 12.7 m -136.73 155.9 34.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 109.562 -0.533 . . . . 0.19 109.562 172.548 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 13.0 m -83.28 159.61 21.88 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.431 -0.581 . . . . 0.97 109.431 178.202 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -56.23 -40.68 74.47 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.544 -0.539 . . . . 0.22 109.544 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -52.12 -50.15 62.25 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.342 -0.844 . . . . 1.72 111.493 178.553 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -62.18 -46.76 87.52 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.852 -0.613 . . . . 2.09 111.392 -173.513 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -71.1 -40.86 71.26 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.79 0.329 . . . . 0.26 111.066 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -64.64 -45.92 84.75 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.445 -0.343 . . . . 0.24 111.777 -176.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.47 ' HA ' ' O ' ' A' ' 71' ' ' TYR . 41.9 t -56.63 -27.43 58.35 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 112.658 0.614 . . . . 1.0 112.658 -177.788 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.483 ' O ' ' HA ' ' A' ' 27' ' ' ARG . 36.4 mt-30 -104.92 -48.58 3.71 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.378 0.609 . . . . 0.61 110.632 -176.824 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.555 ' CD ' ' HG3' ' A' ' 27' ' ' ARG . 21.5 mmt180 -88.66 -41.75 12.43 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.134 -0.939 . . . . 0.86 113.174 -169.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.509 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 22.8 t -60.62 122.25 14.23 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.701 0.286 . . . . 0.82 111.189 -177.561 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.582 ' HA ' ' HG2' ' A' ' 26' ' ' ARG . 31.6 t70 -80.18 -7.61 59.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.382 0.61 . . . . 2.28 110.639 176.587 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 0.485 ' SG ' HD22 ' A' ' 14' ' ' LEU . 1.5 m -76.83 160.71 29.03 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.293 0.568 . . . . 1.52 110.082 177.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -67.77 -11.53 60.53 Favored Glycine 0 N--CA 1.45 -0.423 0 CA-C-N 114.785 -1.098 . . . . 0.26 112.554 -172.141 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 76.5 p -75.01 -5.69 45.38 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 111.518 0.192 . . . . 0.32 111.518 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.47 ' O ' ' HA ' ' A' ' 63' ' ' SER . 16.8 p90 -54.91 -37.86 66.9 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.156 0.503 . . . . 0.54 110.027 175.143 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -95.37 7.54 45.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.146 -0.479 . . . . 0.49 110.591 -178.301 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.9 m -113.54 -14.82 12.64 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.959 -0.564 . . . . 0.71 110.998 -177.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 103.5 14.39 25.78 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.775 -0.726 . . . . 0.54 112.235 -177.756 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 88.49 -31.18 4.96 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.995 -0.621 . . . . 0.35 112.428 179.438 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.582 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 8.5 p-10 -85.06 144.61 28.14 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-O 121.579 0.704 . . . . 1.65 111.099 -176.217 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.538 ' O ' ' HG3' ' A' ' 9' ' ' ARG . 0.7 OUTLIER -106.4 176.98 4.99 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 114.631 -1.168 . . . . 0.94 109.979 177.54 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -90.42 -125.4 3.02 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.928 -0.653 . . . . 0.44 113.006 -176.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 34.3 p90 -98.3 136.32 38.64 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.128 0.489 . . . . 3.87 110.96 -177.472 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.497 ' HZ ' ' N ' ' A' ' 10' ' ' ALA . 5.9 p90 -159.44 144.83 15.8 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.053 -0.721 . . . . 1.31 109.053 179.09 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.0 p -94.02 154.51 17.61 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 120.994 0.426 . . . . 1.17 110.497 -177.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 15.2 m -64.85 111.43 2.81 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.951 -0.568 . . . . 1.19 110.117 179.615 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.63 ' H ' ' HG3' ' A' ' 90' ' ' GLU . . . 113.46 5.18 22.96 Favored Glycine 0 N--CA 1.447 -0.578 0 CA-C-N 115.601 -0.727 . . . . 0.79 111.454 -174.83 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -111.77 32.84 5.15 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 121.493 0.664 . . . . 1.55 110.366 -177.684 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 22.1 mmt -137.41 -122.02 0.14 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.068 -0.515 . . . . 0.73 110.277 179.017 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 63.8 mtt -121.1 155.1 35.18 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.293 -1.002 . . . . 1.39 108.293 174.409 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.452 ' HB2' ' HD3' ' A' ' 88' ' ' PRO . 29.9 mmmt -53.15 -58.11 13.77 Favored Pre-proline 0 C--N 1.322 -0.598 0 N-CA-C 112.393 0.516 . . . . 2.37 112.393 -177.396 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.452 ' HD3' ' HB2' ' A' ' 87' ' ' LYS . 77.1 Cg_endo -75.61 -23.7 12.58 Favored 'Trans proline' 0 C--N 1.354 0.838 0 C-N-CA 121.516 1.477 . . . . 0.27 111.931 -175.47 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.616 ' O ' HG23 ' A' ' 93' ' ' VAL . 52.7 t80 -71.64 -56.15 6.38 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.472 -0.786 . . . . 0.22 109.762 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.63 ' HG3' ' H ' ' A' ' 83' ' ' GLY . 4.6 tm-20 -67.08 -37.19 83.55 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.647 -0.706 . . . . 2.12 110.192 -179.026 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -51.98 -36.01 48.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.687 -0.688 . . . . 0.61 110.491 174.283 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.51 ' O ' ' HG ' ' A' ' 96' ' ' LEU . . . -79.63 -32.95 41.78 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.998 -0.546 . . . . 0.22 111.419 178.609 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.616 HG23 ' O ' ' A' ' 89' ' ' PHE . 25.9 t -67.4 -39.74 83.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.564 0.697 . . . . 0.25 110.121 -176.247 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.456 ' C ' ' HD2' ' A' ' 94' ' ' ARG . 0.2 OUTLIER -84.04 -8.0 59.24 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.421 -0.809 . . . . 2.59 110.841 179.644 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -88.35 0.77 55.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.296 -0.411 . . . . 0.47 111.067 -177.392 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.598 ' HB2' ' HB2' ' A' ' 100' ' ' ASP . 0.6 OUTLIER -139.36 157.29 46.13 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.1 -0.5 . . . . 0.28 110.625 179.446 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.553 ' HG2' ' H ' ' A' ' 98' ' ' ILE . 10.7 tttt -102.53 -175.0 2.7 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.161 -0.681 . . . . 1.61 109.161 176.53 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.553 ' H ' ' HG2' ' A' ' 97' ' ' LYS . 1.3 mp -54.67 120.34 2.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 C-N-CA 123.087 0.555 . . . . 0.9 110.584 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 93.18 1.21 67.13 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.812 -0.709 . . . . 0.46 113.078 176.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.598 ' HB2' ' HB2' ' A' ' 96' ' ' LEU . 33.4 m-20 -102.17 139.63 37.53 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 117.006 0.403 . . . . 0.46 110.411 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 11.9 mt -111.3 148.92 14.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.01 -0.541 . . . . 0.23 110.239 -178.323 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 97.7 p -93.3 158.67 36.71 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 116.404 -0.362 . . . . 0.92 110.725 -178.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -71.42 170.0 19.49 Favored 'Trans proline' 0 C--O 1.234 0.285 0 C-N-CA 122.475 2.117 . . . . 0.34 111.518 172.015 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.93 HG23 HD23 ' A' ' 44' ' ' LEU . 19.5 mm -47.33 112.12 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 O-C-N 123.399 0.437 . . . . 0.2 111.911 175.08 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 58.9 t -116.75 122.65 70.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.155 -0.475 . . . . 1.04 110.201 176.546 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -85.78 149.35 25.33 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.032 0.444 . . . . 0.55 110.102 176.25 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 8.1 p -127.77 -172.24 2.63 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.797 -0.638 . . . . 0.37 111.018 -177.743 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -52.26 -40.75 62.13 Favored 'General case' 0 CA--C 1.518 -0.277 0 O-C-N 123.418 0.449 . . . . 2.16 111.276 176.829 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.607 ' OG ' ' HE2' ' A' ' 16' ' ' LYS . 8.8 t -100.3 -60.53 1.51 Allowed 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 120.196 -0.601 . . . . 1.09 111.323 -178.324 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -146.03 -137.13 3.02 Favored Glycine 0 N--CA 1.44 -1.034 0 C-N-CA 118.673 -1.727 . . . . 0.24 113.733 -172.534 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.879 ' HB3' HD22 ' A' ' 44' ' ' LEU . 6.9 mp -109.65 143.16 39.79 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 114.87 -0.665 . . . . 0.19 111.164 -170.6 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' HIS . . . . . 0.674 ' HA ' ' O ' ' A' ' 13' ' ' LEU . 72.2 m80 -143.21 138.49 29.72 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.6 0.593 . . . . 0.22 112.6 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.567 HG12 HD11 ' A' ' 44' ' ' LEU . 3.9 pt -120.96 138.86 50.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 107.753 -1.203 . . . . 0.17 107.753 161.068 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 2.9 mp -129.43 143.09 42.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 C-N-CA 120.807 -0.357 . . . . 0.18 110.48 -175.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.515 ' HG2' ' HB3' ' A' ' 11' ' ' ALA . 48.8 pttt -127.51 138.57 52.96 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.187 -0.671 . . . . 0.61 109.187 173.817 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ARG . . . . . 0.507 ' HB2' ' CD1' ' A' ' 96' ' ' LEU . 70.4 ttt180 -84.22 128.38 34.53 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.051 0.453 . . . . 1.87 111.545 -175.906 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.439 HD21 ' HB2' ' A' ' 11' ' ' ALA . 1.2 mm? -95.12 -45.46 7.2 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.613 -0.721 . . . . 0.89 109.999 176.57 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.892 0 CA-C-O 118.58 -0.724 . . . . 1.1 110.379 -179.97 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 43.2 mmtm . . . . . 0 N--CA 1.453 -0.292 0 CA-C-O 121.343 0.592 . . . . 1.19 111.305 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.79 HD23 ' H ' ' A' ' 9' ' ' ARG . 1.3 tt -124.8 165.82 17.32 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 107.413 -1.329 . . . . 1.18 107.413 178.84 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.79 ' H ' HD23 ' A' ' 8' ' ' LEU . 65.9 ttt180 -143.78 127.68 17.35 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 118.11 0.414 . . . . 1.06 110.097 177.21 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -150.11 151.5 33.26 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.03 0.443 . . . . 0.22 111.772 -179.551 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -102.0 138.04 39.49 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.64 -0.709 . . . . 0.2 109.114 176.754 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 33.5 p-80 -138.08 153.34 49.31 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 120.564 -0.454 . . . . 0.23 111.842 -171.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.563 HD23 ' N ' ' A' ' 14' ' ' LEU . 5.2 tt -120.69 145.44 47.46 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.508 -0.923 . . . . 0.24 108.508 176.116 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.777 HD13 ' CE1' ' A' ' 112' ' ' HIS . 31.2 tp -131.0 118.2 20.27 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.59 0.233 . . . . 0.27 110.962 -177.92 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.615 HG23 HD13 ' A' ' 44' ' ' LEU . 58.5 t -104.72 133.17 49.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 N-CA-C 109.607 -0.516 . . . . 0.15 109.607 176.182 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.542 ' HE3' HD21 ' A' ' 14' ' ' LEU . 32.2 mmtp -105.53 138.26 42.01 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.998 -0.547 . . . . 0.62 109.881 177.496 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.539 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 40.0 p90 -131.1 163.28 28.0 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.845 -0.616 . . . . 0.25 109.344 178.46 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 43.8 p -53.16 109.5 0.43 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.109 0.481 . . . . 1.04 110.269 176.481 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 108.07 7.94 30.23 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.637 -0.792 . . . . 0.53 113.132 -177.637 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.757 ' HB3' ' O ' ' A' ' 109' ' ' SER . 74.5 m -84.46 38.76 0.7 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 117.042 0.421 . . . . 0.7 111.749 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 32.3 ttt85 72.86 -34.0 0.28 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.306 0.643 . . . . 3.49 110.944 179.431 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.447 ' H ' ' C ' ' A' ' 20' ' ' SER . 6.3 p30 -145.08 111.51 4.75 Favored Pre-proline 0 C--N 1.325 -0.482 0 N-CA-C 109.175 -0.676 . . . . 1.77 109.175 171.849 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.446 ' C ' HG22 ' A' ' 32' ' ' THR . 91.8 Cg_endo -82.62 59.8 7.0 Favored 'Trans proline' 0 CA--C 1.533 0.467 0 C-N-CA 122.92 2.413 . . . . 1.71 113.889 -173.19 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.447 ' N ' HG22 ' A' ' 32' ' ' THR . 43.9 t -145.99 120.81 2.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 109.385 -0.598 . . . . 0.48 109.385 175.525 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 37.7 t -104.73 152.19 22.83 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 110.299 -0.26 . . . . 1.12 110.299 178.407 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.608 ' HG2' ' HA ' ' A' ' 67' ' ' ASP . 5.5 mmp_? -67.72 -9.81 47.04 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.275 0.559 . . . . 2.54 109.764 171.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.57 ' HG3' ' CD ' ' A' ' 65' ' ' ARG . 13.8 ttp180 -76.36 -35.86 58.49 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.369 -0.832 . . . . 1.77 109.78 177.618 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 64.1 p -105.07 -35.44 7.63 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.896 -0.593 . . . . 0.67 111.048 -175.773 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 84.75 -39.49 2.95 Favored Glycine 0 N--CA 1.451 -0.343 0 CA-C-N 115.683 -0.69 . . . . 0.82 112.817 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.419 ' CG ' ' H ' ' A' ' 31' ' ' SER . 8.7 p-10 -91.72 -65.59 1.0 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.747 0.273 . . . . 2.1 110.874 -178.032 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.419 ' H ' ' CG ' ' A' ' 30' ' ' ASP . 11.6 p -155.53 157.79 37.43 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.618 0.247 . . . . 1.08 110.465 178.702 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.447 HG22 ' N ' ' A' ' 24' ' ' VAL . 13.4 t -121.76 34.44 5.18 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 122.308 1.051 . . . . 0.34 109.148 173.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -79.31 -5.99 55.71 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.853 -1.067 . . . . 0.37 112.146 -173.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -98.1 -24.92 15.11 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.887 0.375 . . . . 2.21 111.156 -178.484 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.494 HG23 ' HB2' ' A' ' 39' ' ' ASP . 0.3 OUTLIER -91.43 135.73 26.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 120.975 0.417 . . . . 0.31 109.916 -178.795 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 65.7 p -94.5 179.03 5.41 Favored 'General case' 0 CA--C 1.513 -0.476 0 N-CA-C 109.583 -0.525 . . . . 0.39 109.583 -175.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.553 ' O ' HG13 ' A' ' 41' ' ' ILE . 8.1 p90 -64.82 -26.26 68.26 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 119.803 -0.759 . . . . 1.53 109.31 176.621 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -74.83 -44.35 49.73 Favored 'General case' 0 C--N 1.334 -0.087 0 CA-C-N 116.205 -0.452 . . . . 0.96 110.629 177.745 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.494 ' HB2' HG23 ' A' ' 35' ' ' VAL . 45.7 m-20 -64.68 -32.64 74.4 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.642 0.734 . . . . 0.91 109.435 177.001 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.539 ' HB2' ' HB3' ' A' ' 17' ' ' PHE . . . -71.07 -38.6 72.45 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.77 -1.104 . . . . 0.19 110.645 178.362 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.553 HG13 ' O ' ' A' ' 37' ' ' TYR . 77.2 mt -65.09 -36.83 78.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.486 -0.561 . . . . 0.3 109.486 173.213 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 9.2 mtpm? -65.53 -17.78 64.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.249 0.547 . . . . 2.32 110.774 176.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.536 ' HG3' ' CD1' ' A' ' 47' ' ' TRP . 3.8 tp10 -87.69 -61.22 1.77 Allowed 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.978 -0.749 . . . . 1.02 108.978 175.704 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.894 HD22 ' HB3' ' A' ' 111' ' ' LEU . 20.9 tp -58.95 -38.12 78.3 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 114.84 -1.073 . . . . 0.17 111.572 -173.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.531 ' HB2' ' O ' ' A' ' 41' ' ' ILE . 3.6 mm100 -68.8 -29.7 68.12 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 112.276 0.473 . . . . 0.87 112.276 -177.048 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 64.4 mttm -81.58 -38.44 26.1 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 120.501 -0.48 . . . . 1.31 110.223 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.536 ' CD1' ' HG3' ' A' ' 43' ' ' GLU . 35.4 m95 -67.48 -46.54 72.68 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.198 -0.455 . . . . 0.52 111.536 175.462 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.54 ' HB3' HG21 ' A' ' 113' ' ' ILE . 94.3 p -63.77 -30.06 71.2 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.848 -0.427 . . . . 0.82 109.848 177.503 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.442 ' HB2' ' O ' ' A' ' 45' ' ' GLN . 11.9 tt0 -65.29 -53.55 42.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.907 -0.588 . . . . 0.53 110.529 174.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.575 ' HB3' HG22 ' A' ' 56' ' ' VAL . 99.4 mtt180 -66.04 -39.49 90.2 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.04 -0.527 . . . . 0.42 111.769 -176.835 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.468 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 99.3 mt -62.45 -34.31 63.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.207 0.527 . . . . 0.2 110.236 176.001 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -77.65 -34.98 52.95 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.891 -0.595 . . . . 0.27 111.55 179.322 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.424 ' OG ' ' HA ' ' A' ' 50' ' ' ARG . 33.1 p -82.04 -29.28 32.01 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.963 0.411 . . . . 0.35 111.067 -179.053 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 103.65 9.28 38.33 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 121.027 -0.606 . . . . 0.3 112.112 179.071 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -65.13 -45.14 86.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.158 0.504 . . . . 0.65 110.019 177.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.575 HG22 ' HB3' ' A' ' 50' ' ' ARG . 11.3 m -135.02 154.78 36.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 109.141 -0.689 . . . . 0.19 109.141 171.115 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 26.1 m -88.2 160.95 17.5 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.676 -0.491 . . . . 0.97 109.676 179.524 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -53.18 -44.69 68.09 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.125 0.488 . . . . 0.22 110.12 -178.176 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.649 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 44.1 mt-10 -59.32 -32.45 70.08 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.286 -0.87 . . . . 1.72 112.328 -178.293 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -72.95 -51.74 17.26 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.822 0.344 . . . . 2.09 110.921 -177.296 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -65.76 -42.69 90.58 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.216 -0.447 . . . . 0.26 111.029 -178.497 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.8 -53.38 58.65 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.182 -0.463 . . . . 0.24 112.079 -175.811 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.435 ' HA ' ' O ' ' A' ' 71' ' ' TYR . 23.8 t -53.47 -25.49 16.5 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.665 0.617 . . . . 1.0 112.665 -175.65 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -102.9 -43.01 5.65 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.406 0.622 . . . . 0.61 110.567 -176.115 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.57 ' CD ' ' HG3' ' A' ' 27' ' ' ARG . 17.3 mmt180 -93.72 -42.36 9.19 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 113.858 1.058 . . . . 0.86 113.858 -171.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.583 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 54.6 p -65.92 129.84 41.18 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.625 -0.43 . . . . 0.82 110.884 -176.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.608 ' HA ' ' HG2' ' A' ' 26' ' ' ARG . 30.1 t70 -85.18 -12.08 53.52 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.294 0.568 . . . . 2.28 111.453 179.59 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 0.456 ' O ' ' HD1' ' A' ' 71' ' ' TYR . 51.2 t -76.18 157.86 32.27 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.459 -0.571 . . . . 1.52 109.459 179.413 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -56.89 -17.02 20.33 Favored Glycine 0 C--N 1.33 0.228 0 CA-C-N 115.189 -0.914 . . . . 0.26 113.09 -174.552 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 57.3 p -63.21 -12.88 31.64 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 111.885 0.328 . . . . 0.32 111.885 176.693 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.456 ' HD1' ' O ' ' A' ' 68' ' ' CYS . 27.3 p90 -57.84 -28.77 64.4 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.996 0.427 . . . . 0.54 110.198 176.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -88.84 -1.75 58.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.307 0.575 . . . . 0.49 110.365 -178.378 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 5.3 m -125.38 8.17 7.78 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.554 -0.748 . . . . 0.71 110.562 -177.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.649 ' O ' ' HA ' ' A' ' 59' ' ' GLU . . . 73.05 29.72 64.3 Favored Glycine 0 CA--C 1.52 0.371 0 CA-C-N 116.041 -0.527 . . . . 0.54 113.118 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.22 -21.16 6.16 Favored Glycine 0 C--O 1.233 0.088 0 C-N-CA 120.94 -0.648 . . . . 0.35 112.236 178.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -71.01 132.15 44.72 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 122.853 0.461 . . . . 1.65 110.772 -175.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.5 mp -116.02 158.98 22.29 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 121.26 0.552 . . . . 0.94 109.885 173.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -86.1 -148.36 11.54 Favored Glycine 0 C--N 1.308 -0.99 0 CA-C-N 114.623 -1.171 . . . . 0.44 112.347 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -80.26 135.46 36.25 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.314 0.578 . . . . 3.87 111.462 -179.44 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -148.02 141.3 25.16 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.249 -0.887 . . . . 1.31 109.898 177.528 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 48.2 m -66.7 129.44 39.87 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 120.813 0.34 . . . . 1.17 110.201 177.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.4 p -52.25 116.21 2.11 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.779 -0.646 . . . . 1.19 111.216 178.362 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 114.31 -5.89 23.24 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.967 -0.635 . . . . 0.79 112.12 -177.418 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -91.21 34.27 0.94 Allowed 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 121.158 0.504 . . . . 1.55 110.885 -179.058 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 25.3 mmt -131.05 -123.16 0.21 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.908 0.385 . . . . 0.73 110.411 179.307 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 65.0 mtt -122.92 157.79 31.82 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.665 -0.865 . . . . 1.39 108.665 174.787 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.506 ' HB3' ' HD3' ' A' ' 88' ' ' PRO . 45.1 tttm -54.39 -55.6 35.58 Favored Pre-proline 0 C--N 1.321 -0.633 0 N-CA-C 112.223 0.453 . . . . 2.37 112.223 -174.75 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.506 ' HD3' ' HB3' ' A' ' 87' ' ' LYS . 91.8 Cg_endo -77.51 -24.06 9.36 Favored 'Trans proline' 0 C--N 1.357 0.986 0 C-N-CA 121.655 1.57 . . . . 0.27 111.97 -176.314 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.583 ' O ' HG23 ' A' ' 93' ' ' VAL . 14.7 t80 -67.94 -55.52 12.45 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.672 -0.695 . . . . 0.22 109.162 177.888 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.422 ' OE2' ' HD2' ' A' ' 94' ' ' ARG . 1.2 tm-20 -63.05 -34.99 78.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.282 -0.872 . . . . 2.12 109.859 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.639 ' HA ' ' CZ ' ' A' ' 94' ' ' ARG . 14.7 t70 -51.34 -41.66 60.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.312 -0.858 . . . . 0.61 111.365 175.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.618 ' O ' ' HG ' ' A' ' 96' ' ' LEU . . . -77.84 -29.72 50.65 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.274 -0.421 . . . . 0.22 111.318 -179.213 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.583 HG23 ' O ' ' A' ' 89' ' ' PHE . 41.1 t -63.1 -49.36 83.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.281 -0.418 . . . . 0.25 111.661 -173.497 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.639 ' CZ ' ' HA ' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -83.47 -2.81 56.77 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.17 -0.612 . . . . 2.59 110.551 -179.233 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -86.2 -16.86 36.44 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.299 -0.41 . . . . 0.47 111.219 -178.577 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.618 ' HG ' ' O ' ' A' ' 92' ' ' ALA . 0.6 OUTLIER -119.21 147.04 44.68 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.243 -0.435 . . . . 0.28 110.829 -179.519 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.519 ' HA ' ' NH2' ' A' ' 116' ' ' ARG . 22.5 tptm -82.34 163.13 21.95 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.495 -0.558 . . . . 1.61 109.495 177.182 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.517 ' H ' ' CD1' ' A' ' 98' ' ' ILE . 1.3 mp -38.05 118.09 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 O-C-N 123.369 0.418 . . . . 0.9 110.644 169.276 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 94.71 -6.36 70.31 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.823 -0.703 . . . . 0.46 113.699 176.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.586 ' HB2' ' HB2' ' A' ' 96' ' ' LEU . 44.8 m-20 -94.59 141.89 28.07 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 117.453 0.627 . . . . 0.46 110.419 178.882 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 9.9 mt -110.26 148.76 13.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.095 -0.502 . . . . 0.23 110.212 -178.482 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 88.5 p -93.85 146.46 31.75 Favored Pre-proline 0 C--N 1.319 -0.718 0 CA-C-N 116.315 -0.402 . . . . 0.92 110.615 -179.412 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -68.8 163.27 37.93 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 122.213 1.942 . . . . 0.34 110.821 171.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.834 HG23 HD23 ' A' ' 44' ' ' LEU . 22.6 mm -39.86 109.86 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 O-C-N 123.774 0.672 . . . . 0.2 112.639 -178.831 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.0 p -115.35 120.5 64.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.991 -0.55 . . . . 1.04 109.774 175.715 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -85.56 152.09 23.42 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.267 0.556 . . . . 0.55 110.934 -179.074 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.469 HG22 ' HG2' ' A' ' 88' ' ' PRO . 14.6 p -131.74 -173.61 3.18 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.293 -0.867 . . . . 0.37 110.076 178.047 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -72.3 -22.24 61.22 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.534 0.207 . . . . 2.16 111.457 178.711 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.757 ' O ' ' HB3' ' A' ' 20' ' ' SER . 7.8 t -110.23 -6.35 15.07 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.348 -0.541 . . . . 1.09 112.021 -176.336 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 157.14 -131.91 3.07 Favored Glycine 0 N--CA 1.436 -1.327 0 C-N-CA 119.902 -1.142 . . . . 0.24 112.545 169.791 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.894 ' HB3' HD22 ' A' ' 44' ' ' LEU . 5.0 mp -118.17 143.17 46.72 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 114.925 -0.637 . . . . 0.19 111.192 -171.494 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' HIS . . . . . 0.777 ' CE1' HD13 ' A' ' 14' ' ' LEU . 70.3 m80 -139.28 150.04 44.98 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.695 0.628 . . . . 0.22 112.695 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.69 HG12 HD11 ' A' ' 44' ' ' LEU . 2.6 pt -132.31 140.17 48.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 107.615 -1.254 . . . . 0.17 107.615 159.0 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 2.7 mp -131.9 147.58 32.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 C-N-CA 120.948 -0.301 . . . . 0.18 110.327 -176.233 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.424 ' HA ' ' O ' ' A' ' 100' ' ' ASP . 35.9 pttt -130.08 139.13 50.99 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.557 -0.905 . . . . 0.61 108.557 172.099 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ARG . . . . . 0.724 ' HD3' HD21 ' A' ' 8' ' ' LEU . 5.9 ttp180 -80.85 132.34 35.46 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.241 -0.584 . . . . 1.87 110.967 -179.136 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -96.18 -40.52 9.15 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.197 -0.911 . . . . 0.89 109.716 177.867 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.4 ' HB3' ' HB3' ' A' ' 9' ' ' ARG . . . . . . . . 0 C--O 1.244 0.79 0 CA-C-O 118.347 -0.835 . . . . 1.1 110.015 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 66.9 mmtt . . . . . 0 C--O 1.232 0.162 0 CA-C-O 121.365 0.602 . . . . 1.19 110.731 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.475 HD11 ' CD ' ' A' ' 116' ' ' ARG . 15.6 tp -116.7 173.4 6.65 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.007 -0.997 . . . . 1.18 109.385 -178.319 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.453 ' H ' ' HG ' ' A' ' 8' ' ' LEU . 65.3 ttt180 -146.26 126.56 13.94 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.802 -0.444 . . . . 1.06 109.802 178.37 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.429 ' N ' ' HZ ' ' A' ' 80' ' ' PHE . . . -146.56 155.02 42.18 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.085 0.469 . . . . 0.22 111.638 -179.477 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.4 ' N ' HD23 ' A' ' 117' ' ' LEU . . . -106.05 140.7 38.64 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.519 -0.764 . . . . 0.2 109.401 177.052 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 50.6 p-80 -139.29 150.45 45.44 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.003 0.43 . . . . 0.23 111.341 -173.549 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.567 ' O ' ' HA ' ' A' ' 112' ' ' HIS . 5.2 tt -118.28 142.75 47.18 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.233 -1.025 . . . . 0.24 108.233 176.595 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.59 HD13 ' NE2' ' A' ' 112' ' ' HIS . 26.6 tp -127.82 121.82 31.09 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.597 0.236 . . . . 0.27 110.715 -176.413 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.563 HG23 HD13 ' A' ' 44' ' ' LEU . 97.4 t -112.01 136.61 47.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 116.133 -0.485 . . . . 0.15 109.727 176.032 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.543 ' HE2' ' OG ' ' A' ' 109' ' ' SER . 32.5 mmtp -108.82 164.79 12.07 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.104 -0.498 . . . . 0.62 109.976 177.636 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.5 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 49.8 p90 -158.65 163.14 37.17 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.992 -0.549 . . . . 0.25 110.141 -176.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.496 ' HB3' ' C ' ' A' ' 33' ' ' ALA . 35.8 p -54.13 109.51 0.49 Allowed 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 120.983 0.42 . . . . 1.04 110.715 177.717 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 103.27 9.82 37.95 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.463 -0.875 . . . . 0.53 112.841 -178.229 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.415 ' C ' ' H ' ' A' ' 22' ' ' ASN . 73.5 p -90.12 40.17 0.99 Allowed 'General case' 0 C--O 1.234 0.264 0 CA-C-N 117.338 0.569 . . . . 0.7 111.296 -175.675 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 50.1 ttt180 75.38 -34.2 0.25 Allowed 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 123.534 0.733 . . . . 3.49 110.662 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.415 ' H ' ' C ' ' A' ' 20' ' ' SER . 5.7 p30 -149.6 118.55 3.81 Favored Pre-proline 0 C--N 1.323 -0.55 0 N-CA-C 109.321 -0.622 . . . . 1.77 109.321 173.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.557 ' O ' ' HA ' ' A' ' 31' ' ' SER . 66.2 Cg_endo -86.29 53.33 3.06 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 122.792 2.328 . . . . 1.71 113.353 -172.434 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.484 HG13 ' O ' ' A' ' 30' ' ' ASP . 81.7 t -143.32 121.12 6.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 109.242 -0.651 . . . . 0.48 109.242 178.155 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 44.5 t -103.88 152.34 22.06 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.739 -0.467 . . . . 1.12 109.739 177.289 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.641 ' CB ' ' HA ' ' A' ' 67' ' ' ASP . 9.2 tpt180 -73.72 -9.89 59.12 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.241 -0.651 . . . . 2.54 109.241 174.038 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.619 ' HG3' ' HD3' ' A' ' 65' ' ' ARG . 13.9 ttp180 -79.94 -38.27 32.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.306 -0.861 . . . . 1.77 109.737 174.057 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 69.9 p -93.74 -34.14 13.34 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.661 -0.699 . . . . 0.67 111.09 -175.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 81.83 -39.24 2.55 Favored Glycine 0 N--CA 1.451 -0.361 0 CA-C-N 115.238 -0.892 . . . . 0.82 111.428 -177.409 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.484 ' O ' HG13 ' A' ' 24' ' ' VAL . 31.2 m-20 -107.45 -139.18 0.37 Allowed 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 108.408 -0.96 . . . . 2.1 108.408 175.211 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.557 ' HA ' ' O ' ' A' ' 23' ' ' PRO . 2.7 p -75.27 135.11 40.96 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-O 121.27 0.557 . . . . 1.08 111.763 -172.438 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.507 HG22 ' C ' ' A' ' 23' ' ' PRO . 12.3 t -106.79 31.26 5.42 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 107.689 -1.226 . . . . 0.34 107.689 168.353 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.496 ' C ' ' HB3' ' A' ' 18' ' ' SER . . . -82.32 -5.14 58.38 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 114.085 -1.416 . . . . 0.37 112.178 -172.738 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -97.22 -22.77 16.51 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 120.938 0.399 . . . . 2.21 110.906 178.779 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.491 HG23 ' HB2' ' A' ' 39' ' ' ASP . 0.2 OUTLIER -90.4 136.3 24.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 109.574 -0.528 . . . . 0.31 109.574 179.148 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 71.6 p -94.31 178.42 5.63 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.954 -0.388 . . . . 0.39 109.954 -176.064 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.447 ' O ' HG13 ' A' ' 41' ' ' ILE . 7.8 p90 -64.83 -26.24 68.25 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.003 -0.74 . . . . 1.53 109.003 174.643 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -71.04 -50.97 28.21 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 115.892 -0.594 . . . . 0.96 109.896 176.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.491 ' HB2' HG23 ' A' ' 35' ' ' VAL . 11.6 m-20 -59.04 -37.99 78.29 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-O 121.439 0.638 . . . . 0.91 109.711 177.199 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.5 ' HB2' ' HB3' ' A' ' 17' ' ' PHE . . . -67.26 -45.68 75.94 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.821 -1.081 . . . . 0.19 110.7 -178.724 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.488 ' CG1' HD21 ' A' ' 111' ' ' LEU . 68.8 mt -63.05 -36.83 77.5 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 CA-C-N 116.261 -0.427 . . . . 0.3 109.986 176.051 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.418 ' HA ' ' HD2' ' A' ' 42' ' ' LYS . 11.1 mmmm -68.55 -17.83 64.23 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 116.107 -0.497 . . . . 2.32 110.982 179.567 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.452 ' HG3' ' CD1' ' A' ' 47' ' ' TRP . 1.6 tt0 -88.56 -54.67 4.06 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.8 -0.636 . . . . 1.02 109.666 175.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.924 HD22 ' HB3' ' A' ' 111' ' ' LEU . 32.4 tp -58.69 -37.19 75.52 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.629 -0.714 . . . . 0.17 110.888 -176.751 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.457 ' HA ' HD11 ' A' ' 104' ' ' ILE . 3.1 mm100 -63.77 -40.39 96.57 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.969 0.359 . . . . 0.87 111.969 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -70.5 -41.62 72.42 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 120.919 -0.313 . . . . 1.31 110.969 -177.457 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.452 ' CD1' ' HG3' ' A' ' 43' ' ' GLU . 39.3 m95 -66.76 -46.1 76.41 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.915 -0.314 . . . . 0.52 110.621 176.472 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 33.0 t -57.91 -38.96 76.81 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.676 -0.49 . . . . 0.82 109.676 175.634 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -61.06 -52.04 66.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.683 -0.69 . . . . 0.53 110.888 176.86 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.586 ' HB3' HG22 ' A' ' 56' ' ' VAL . 87.0 mtt180 -65.75 -41.18 92.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.812 -0.631 . . . . 0.42 111.547 -176.937 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.432 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 96.7 mt -60.49 -38.24 77.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.146 0.498 . . . . 0.2 110.249 175.775 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.32 -35.24 71.17 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.837 -0.62 . . . . 0.27 111.708 178.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 28.2 p -83.97 -31.15 25.7 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.827 0.346 . . . . 0.35 111.594 -177.187 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 107.1 5.25 35.28 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.717 -0.754 . . . . 0.3 111.819 -178.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.44 ' HB2' ' HB3' ' A' ' 50' ' ' ARG . 38.8 mt-10 -60.01 -53.18 60.9 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.829 -0.434 . . . . 0.65 109.829 176.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.586 HG22 ' HB3' ' A' ' 50' ' ' ARG . 15.8 m -129.81 150.84 35.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 109.292 -0.633 . . . . 0.19 109.292 173.095 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.5 m -80.79 158.39 25.46 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.451 -0.574 . . . . 0.97 109.451 179.565 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.44 ' CD2' ' HD3' ' A' ' 115' ' ' LYS . 2.2 t80 -52.75 -44.15 66.27 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.587 -0.523 . . . . 0.22 109.587 179.494 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.468 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 48.1 mt-10 -56.06 -45.22 79.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.135 -0.939 . . . . 1.72 112.002 179.468 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 34.2 mm-40 -63.85 -47.59 80.13 Favored 'General case' 0 CA--C 1.522 -0.132 0 CA-C-O 120.983 0.42 . . . . 2.09 110.808 -175.756 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -67.76 -46.22 72.68 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.203 -0.453 . . . . 0.26 110.767 -179.374 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.12 -52.63 64.52 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.344 -0.389 . . . . 0.24 112.002 -176.528 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.442 ' HA ' ' O ' ' A' ' 71' ' ' TYR . 33.0 t -51.9 -25.49 8.15 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.856 0.687 . . . . 1.0 112.856 -177.131 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -102.18 -44.63 5.38 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.535 0.683 . . . . 0.61 110.456 -179.083 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.619 ' HD3' ' HG3' ' A' ' 27' ' ' ARG . 21.5 mmt180 -93.64 -39.53 10.76 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 114.334 1.235 . . . . 0.86 114.334 -169.598 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.452 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 59.7 p -63.23 123.75 19.44 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.118 0.485 . . . . 0.82 111.059 -176.604 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.641 ' HA ' ' CB ' ' A' ' 26' ' ' ARG . 17.2 t70 -71.82 -18.8 62.06 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.441 -0.799 . . . . 2.28 111.268 177.649 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 46.6 t -77.1 157.36 31.08 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.54 0.686 . . . . 1.52 110.808 -178.649 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -58.63 -16.47 30.09 Favored Glycine 0 N--CA 1.453 -0.181 0 CA-C-N 114.388 -1.278 . . . . 0.26 113.922 -174.516 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.449 ' HB2' ' CA ' ' A' ' 75' ' ' GLY . 2.6 p -66.17 -4.1 6.94 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 112.287 0.477 . . . . 0.32 112.287 176.558 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.442 ' O ' ' HA ' ' A' ' 63' ' ' SER . 33.0 p90 -56.68 -27.99 59.9 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.112 0.482 . . . . 0.54 110.069 175.541 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -92.12 -0.25 57.45 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.387 0.613 . . . . 0.49 110.389 -179.068 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.2 m -124.72 9.32 8.27 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.647 -0.706 . . . . 0.71 110.796 -175.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.468 ' O ' ' HA ' ' A' ' 59' ' ' GLU . . . 73.42 31.0 61.56 Favored Glycine 0 CA--C 1.519 0.335 0 C-N-CA 120.884 -0.674 . . . . 0.54 112.738 -178.831 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.449 ' CA ' ' HB2' ' A' ' 70' ' ' SER . . . 76.78 3.09 78.95 Favored Glycine 0 C--O 1.227 -0.325 0 C-N-CA 121.081 -0.58 . . . . 0.35 112.217 179.612 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -97.92 144.35 27.56 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 110.283 -0.266 . . . . 1.65 110.283 -168.266 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.7 mp -120.39 171.45 8.52 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.129 -0.487 . . . . 0.94 110.276 178.672 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -91.03 -148.6 21.78 Favored Glycine 0 C--N 1.317 -0.514 0 CA-C-N 115.783 -0.644 . . . . 0.44 112.22 -178.012 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 99.8 m-85 -88.13 123.22 32.58 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.222 0.534 . . . . 3.87 110.556 178.361 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.429 ' HZ ' ' N ' ' A' ' 10' ' ' ALA . 1.6 p90 -134.61 147.13 50.14 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.567 -0.742 . . . . 1.31 110.085 -178.696 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 21.8 m -80.87 124.08 28.81 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 109.926 -0.398 . . . . 1.17 109.926 179.162 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 24.6 m -54.25 119.1 4.69 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.99 -0.55 . . . . 1.19 110.925 -179.296 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 114.71 13.03 9.78 Favored Glycine 0 N--CA 1.443 -0.883 0 CA-C-N 115.627 -0.715 . . . . 0.79 111.794 -178.267 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -116.56 7.45 13.67 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 111.521 0.193 . . . . 1.55 111.521 179.041 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 24.9 mmt -99.06 -105.44 0.21 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.157 0.503 . . . . 0.73 110.807 -179.34 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 68.9 mtm -142.18 147.38 36.5 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 107.904 -1.147 . . . . 1.39 107.904 176.37 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -48.45 -54.81 22.84 Favored Pre-proline 0 CA--C 1.539 0.552 0 N-CA-C 113.0 0.741 . . . . 2.37 113.0 -173.761 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.501 ' HG2' HG22 ' A' ' 107' ' ' THR . 71.8 Cg_endo -75.43 -27.49 9.29 Favored 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 121.401 1.4 . . . . 0.27 111.739 -175.533 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.644 ' O ' HG23 ' A' ' 93' ' ' VAL . 42.4 t80 -72.35 -56.26 5.77 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.23 -0.896 . . . . 0.22 109.984 -179.258 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -61.8 -38.28 87.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.462 -0.79 . . . . 2.12 110.441 -177.469 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -60.65 -31.59 70.8 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.454 -0.794 . . . . 0.61 110.502 178.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.489 ' O ' ' HG ' ' A' ' 96' ' ' LEU . . . -81.06 -25.98 36.67 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.037 -0.529 . . . . 0.22 110.72 178.275 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.644 HG23 ' O ' ' A' ' 89' ' ' PHE . 25.7 t -70.95 -36.05 62.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.421 0.629 . . . . 0.25 110.124 -178.465 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.509 ' C ' ' HD2' ' A' ' 94' ' ' ARG . 5.5 ppt_? -85.74 -16.47 38.84 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.679 -0.691 . . . . 2.59 110.622 179.653 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -76.09 -17.07 59.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.012 -0.54 . . . . 0.47 111.187 -176.106 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.609 ' HB2' ' HB2' ' A' ' 100' ' ' ASP . 0.9 OUTLIER -119.61 151.92 37.89 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.143 -0.481 . . . . 0.28 110.736 179.443 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.436 ' HA ' ' NH2' ' A' ' 116' ' ' ARG . 23.5 tptm -92.57 167.46 11.91 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.053 -0.721 . . . . 1.61 109.053 178.325 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.459 ' HA ' ' HG2' ' A' ' 116' ' ' ARG . 58.8 mt -46.25 115.97 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.851 0.358 . . . . 0.9 111.301 173.507 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 100.46 -2.06 56.02 Favored Glycine 0 CA--C 1.521 0.428 0 C-N-CA 120.715 -0.755 . . . . 0.46 113.528 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.609 ' HB2' ' HB2' ' A' ' 96' ' ' LEU . 68.1 m-20 -104.53 152.43 22.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 117.412 0.606 . . . . 0.46 110.692 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 9.5 mt -121.8 149.11 25.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-O 120.988 0.423 . . . . 0.23 110.873 -177.087 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 70.4 m -96.48 150.41 37.03 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 115.896 -0.593 . . . . 0.92 110.491 177.176 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.428 ' O ' HG23 ' A' ' 105' ' ' VAL . 73.5 Cg_endo -74.71 177.91 7.85 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.558 2.172 . . . . 0.34 111.188 173.373 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.768 HG23 HD23 ' A' ' 44' ' ' LEU . 22.8 mm -44.62 108.28 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 O-C-N 123.501 0.501 . . . . 0.2 112.169 178.732 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 103' ' ' PRO . 69.6 t -110.98 115.19 49.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.919 -0.582 . . . . 1.04 109.59 174.429 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -84.68 147.78 26.75 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.287 0.565 . . . . 0.55 110.285 178.531 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.501 HG22 ' HG2' ' A' ' 88' ' ' PRO . 10.0 p -123.31 -172.81 2.59 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.445 -0.798 . . . . 0.37 110.297 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -64.82 -37.8 88.82 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.63 0.252 . . . . 2.16 110.472 178.839 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.543 ' OG ' ' HE2' ' A' ' 16' ' ' LYS . 9.2 t -86.48 -61.61 1.7 Allowed 'General case' 0 C--O 1.222 -0.391 0 C-N-CA 120.918 -0.313 . . . . 1.09 110.419 179.264 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -152.81 -131.04 1.6 Allowed Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 119.163 -1.494 . . . . 0.24 113.605 -174.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.924 ' HB3' HD22 ' A' ' 44' ' ' LEU . 6.6 mp -116.03 145.96 42.55 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.425 -0.388 . . . . 0.19 111.71 -169.486 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' HIS . . . . . 0.59 ' NE2' HD13 ' A' ' 14' ' ' LEU . 84.5 m-70 -144.87 142.04 29.59 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.101 0.477 . . . . 0.22 112.274 179.51 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.656 HG12 HD11 ' A' ' 44' ' ' LEU . 2.8 pt -123.47 140.55 46.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 107.707 -1.22 . . . . 0.17 107.707 159.815 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.418 HG21 HG22 ' A' ' 93' ' ' VAL . 2.6 mp -132.57 150.32 33.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 C-N-CA 120.731 -0.387 . . . . 0.18 110.485 -175.134 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.513 ' HE3' HD21 ' A' ' 117' ' ' LEU . 7.1 pttp -136.24 141.95 43.99 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.494 -0.928 . . . . 0.61 108.494 173.53 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ARG . . . . . 0.475 ' CD ' HD11 ' A' ' 8' ' ' LEU . 5.5 ttp180 -84.36 132.26 34.62 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.477 -0.489 . . . . 1.87 110.826 179.374 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.513 HD21 ' HE3' ' A' ' 115' ' ' LYS . 4.1 mm? -99.76 -35.4 9.81 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.21 -0.905 . . . . 0.89 110.281 -178.372 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.893 0 CA-C-O 118.411 -0.804 . . . . 1.1 110.165 179.97 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.518 ' HA ' ' O ' ' A' ' 80' ' ' PHE . 42.4 mmtm . . . . . 0 N--CA 1.453 -0.315 0 CA-C-O 121.241 0.544 . . . . 1.19 111.258 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.599 ' O ' ' HA ' ' A' ' 79' ' ' PHE . 12.0 tp -118.65 169.8 9.5 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.349 -0.982 . . . . 1.18 108.349 176.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.418 ' HG3' ' O ' ' A' ' 77' ' ' LEU . 56.2 ttt180 -142.79 134.32 26.44 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 117.799 0.272 . . . . 1.06 110.301 177.05 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.638 ' O ' ' HB2' ' A' ' 77' ' ' LEU . . . -155.69 154.24 31.23 Favored 'General case' 0 C--O 1.222 -0.364 0 C-N-CA 120.086 -0.646 . . . . 0.22 112.063 -177.813 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.492 ' HB3' ' HG2' ' A' ' 115' ' ' LYS . . . -102.16 132.23 48.19 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.216 -0.661 . . . . 0.2 109.216 178.243 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 12.4 p-80 -133.19 148.77 52.06 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.178 0.513 . . . . 0.23 111.768 -172.381 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.566 HD23 ' N ' ' A' ' 14' ' ' LEU . 5.2 tt -121.4 146.91 46.4 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.41 -0.959 . . . . 0.24 108.41 177.587 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.757 HD13 ' CE1' ' A' ' 112' ' ' HIS . 23.4 tp -131.34 132.86 44.78 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 110.091 -0.337 . . . . 0.27 110.091 -178.337 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.529 HG23 HD13 ' A' ' 44' ' ' LEU . 58.4 t -123.2 130.67 74.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 O-C-N 123.353 0.408 . . . . 0.15 109.942 175.575 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.502 ' HE3' HD21 ' A' ' 14' ' ' LEU . 33.6 mmtp -104.44 152.44 22.33 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.903 -0.59 . . . . 0.62 110.025 177.073 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.511 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 42.7 p90 -143.23 162.94 34.3 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.006 -0.543 . . . . 0.25 110.477 -177.794 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.46 ' HB3' ' HA ' ' A' ' 33' ' ' ALA . 32.6 p -51.84 112.84 0.84 Allowed 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.103 0.478 . . . . 1.04 110.892 178.419 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 97.79 8.51 55.65 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.582 -0.818 . . . . 0.53 113.141 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.614 ' HB2' ' O ' ' A' ' 109' ' ' SER . 80.3 p -88.68 45.59 1.3 Allowed 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 117.366 0.583 . . . . 0.7 110.893 -175.881 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.487 ' HB3' ' O ' ' A' ' 20' ' ' SER . 76.8 ttt180 75.8 -32.5 0.21 Allowed 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 123.175 0.59 . . . . 3.49 110.93 -179.021 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.413 ' H ' ' C ' ' A' ' 20' ' ' SER . 3.5 p30 -153.31 109.0 2.61 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-O 121.09 0.471 . . . . 1.77 110.291 174.729 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.408 ' C ' HG22 ' A' ' 32' ' ' THR . 11.3 Cg_exo -73.69 52.86 2.6 Favored 'Trans proline' 0 CA--C 1.534 0.481 0 C-N-CA 123.236 2.624 . . . . 1.71 113.401 -179.338 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.461 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 83.9 t -141.84 116.88 5.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 109.722 -0.473 . . . . 0.48 109.722 176.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.522 ' HB2' ' OD1' ' A' ' 67' ' ' ASP . 6.4 p -103.85 151.52 23.0 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 116.535 -0.302 . . . . 1.12 110.308 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.69 ' CB ' ' HA ' ' A' ' 67' ' ' ASP . 3.3 tpp180 -69.33 -20.65 63.87 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 108.028 -1.101 . . . . 2.54 108.028 173.041 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.441 ' CG ' ' HA ' ' A' ' 65' ' ' ARG . 2.7 tmm_? -69.43 -37.41 77.39 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 114.27 -1.332 . . . . 1.77 110.472 179.002 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 81.1 p -99.29 -36.37 9.65 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.498 0.666 . . . . 0.67 110.803 179.321 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 72.57 -3.84 23.65 Favored Glycine 0 N--CA 1.451 -0.33 0 CA-C-N 115.203 -0.908 . . . . 0.82 112.338 -176.622 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -113.78 -79.22 0.58 Allowed 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.605 -0.517 . . . . 2.1 109.605 179.255 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.461 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 20.2 m -153.77 153.26 31.86 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.73 -0.668 . . . . 1.08 109.82 176.296 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.411 ' OG1' HG13 ' A' ' 35' ' ' VAL . 10.2 t -117.52 30.66 7.16 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 122.286 1.041 . . . . 0.34 109.307 177.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.46 ' HA ' ' HB3' ' A' ' 18' ' ' SER . . . -77.03 -5.94 50.72 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.711 -1.131 . . . . 0.37 112.514 -176.495 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -95.74 -25.37 16.11 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.183 0.516 . . . . 2.21 110.651 -179.232 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.411 HG13 ' OG1' ' A' ' 32' ' ' THR . 0.2 OUTLIER -95.78 134.68 32.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.943 -0.571 . . . . 0.31 110.293 -178.886 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 64.7 p -93.0 179.93 5.29 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.181 -0.463 . . . . 0.39 109.873 -175.767 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.464 ' O ' HG13 ' A' ' 41' ' ' ILE . 9.3 p90 -64.36 -28.47 69.72 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 119.934 -0.707 . . . . 1.53 109.142 175.877 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -72.13 -48.98 39.69 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 115.968 -0.56 . . . . 0.96 110.345 177.765 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.409 ' HB2' HG23 ' A' ' 35' ' ' VAL . 43.4 m-20 -64.91 -28.78 69.77 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.189 0.518 . . . . 0.91 110.161 178.743 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.511 ' HB2' ' HB3' ' A' ' 17' ' ' PHE . . . -71.36 -43.01 67.74 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.483 -0.78 . . . . 0.19 110.513 176.593 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.464 HG13 ' O ' ' A' ' 37' ' ' TYR . 87.1 mt -62.8 -35.95 73.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.477 -0.564 . . . . 0.3 109.477 174.044 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 35.2 tttm -62.44 -24.52 67.47 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.402 -0.817 . . . . 2.32 110.857 176.703 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.431 ' HG3' ' CD1' ' A' ' 47' ' ' TRP . 0.7 OUTLIER -87.28 -52.47 5.38 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.115 -0.698 . . . . 1.02 109.115 178.845 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.894 HD23 HG23 ' A' ' 104' ' ' ILE . 32.3 tp -63.46 -37.7 88.28 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.202 -0.908 . . . . 0.17 110.695 -173.465 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.43 ' HA ' HD11 ' A' ' 104' ' ' ILE . 11.1 mm-40 -65.93 -30.7 71.33 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-N 116.152 -0.477 . . . . 0.87 112.133 -176.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -74.73 -44.18 51.22 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.941 0.4 . . . . 1.31 110.104 179.004 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.431 ' CD1' ' HG3' ' A' ' 43' ' ' GLU . 49.2 m95 -67.22 -44.51 79.33 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.205 -0.452 . . . . 0.52 111.115 178.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.555 ' HB3' HG21 ' A' ' 113' ' ' ILE . 97.8 p -66.43 -22.29 66.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.83 0.348 . . . . 0.82 110.203 177.147 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.42 ' HB2' ' O ' ' A' ' 45' ' ' GLN . 10.0 tt0 -73.97 -56.95 4.33 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 116.013 -0.54 . . . . 0.53 109.986 173.662 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.616 ' HB3' HG22 ' A' ' 56' ' ' VAL . 96.6 mtt180 -61.85 -41.37 97.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.556 -0.747 . . . . 0.42 111.499 -175.102 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.43 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 97.5 mt -60.59 -36.31 69.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.006 0.431 . . . . 0.2 110.434 176.309 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -76.76 -42.7 39.98 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.078 -0.51 . . . . 0.27 111.441 179.552 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 35.3 p -74.4 -29.63 61.6 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.916 0.389 . . . . 0.35 111.294 -176.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 107.86 1.44 34.25 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.824 -0.703 . . . . 0.3 112.366 -179.433 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.453 ' HB2' ' HB3' ' A' ' 50' ' ' ARG . 39.0 mt-10 -59.5 -44.41 93.12 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 121.047 0.451 . . . . 0.65 110.513 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.616 HG22 ' HB3' ' A' ' 50' ' ' ARG . 13.0 m -137.8 157.55 33.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 109.401 -0.592 . . . . 0.19 109.401 172.16 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 14.5 m -86.43 160.26 19.09 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.348 -0.612 . . . . 0.97 109.348 178.204 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -55.23 -44.25 75.28 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.024 0.44 . . . . 0.22 109.976 -177.697 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.603 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 50.8 mt-10 -60.54 -35.19 75.42 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.372 -0.831 . . . . 1.72 111.893 -178.718 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -62.39 -52.9 61.74 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-O 121.055 0.455 . . . . 2.09 110.378 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -69.81 -46.32 65.94 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.605 -0.725 . . . . 0.26 111.399 -175.766 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.92 -52.32 65.91 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.439 0.533 . . . . 0.24 112.439 -173.298 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.46 ' HA ' ' O ' ' A' ' 71' ' ' TYR . 67.0 m -51.18 -21.97 2.32 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.993 0.738 . . . . 1.0 112.993 -179.606 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -103.75 -46.53 4.49 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.584 0.707 . . . . 0.61 110.148 179.162 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.441 ' HA ' ' CG ' ' A' ' 27' ' ' ARG . 36.7 mmt-85 -95.63 -36.3 11.28 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 114.271 1.212 . . . . 0.86 114.271 -169.097 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.488 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 54.3 p -63.87 114.84 4.32 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.274 0.559 . . . . 0.82 110.279 -177.596 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.69 ' HA ' ' CB ' ' A' ' 26' ' ' ARG . 74.6 m-20 -75.57 -9.51 58.64 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.484 -0.78 . . . . 2.28 111.632 -177.393 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 36.0 t -85.56 160.74 19.57 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.755 -0.657 . . . . 1.52 110.163 178.333 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -56.28 -18.88 22.76 Favored Glycine 0 CA--C 1.518 0.237 0 CA-C-N 114.465 -1.243 . . . . 0.26 114.378 -173.5 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.413 ' HB3' HD21 ' A' ' 77' ' ' LEU . 60.5 p -65.19 -7.23 11.79 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 112.502 0.556 . . . . 0.32 112.502 177.546 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.46 ' O ' ' HA ' ' A' ' 63' ' ' SER . 32.0 p90 -52.5 -36.56 55.5 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 120.994 0.426 . . . . 0.54 110.325 176.713 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -81.06 -1.25 43.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.002 0.429 . . . . 0.49 111.039 -177.845 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 7.7 m -125.01 8.12 8.02 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.103 -0.499 . . . . 0.71 110.501 -178.847 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.603 ' O ' ' HA ' ' A' ' 59' ' ' GLU . . . 75.14 26.24 66.86 Favored Glycine 0 C--O 1.226 -0.35 0 C-N-CA 121.014 -0.612 . . . . 0.54 112.622 -179.508 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.49 -20.37 6.18 Favored Glycine 0 N--CA 1.454 -0.149 0 C-N-CA 121.012 -0.613 . . . . 0.35 111.937 -179.208 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -68.43 128.6 37.18 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.179 -0.511 . . . . 1.65 110.537 -177.359 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.638 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 19.4 mt -108.24 157.53 18.26 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 116.076 -0.511 . . . . 0.94 110.065 176.562 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -87.82 -165.31 41.16 Favored Glycine 0 N--CA 1.443 -0.847 0 CA-C-N 115.478 -0.783 . . . . 0.44 111.232 174.339 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.599 ' HA ' ' O ' ' A' ' 8' ' ' LEU . 75.4 m-85 -71.67 133.05 45.4 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.287 0.565 . . . . 3.87 111.609 -178.046 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.518 ' O ' ' HA ' ' A' ' 7' ' ' LYS . 21.0 p90 -133.96 160.3 38.12 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.366 -0.834 . . . . 1.31 109.399 178.628 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 12.1 m -79.75 123.57 27.81 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 109.032 -0.729 . . . . 1.17 109.032 175.5 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 33.1 m -52.73 117.43 2.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.14 -0.482 . . . . 1.19 110.675 -178.105 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 113.97 -6.18 23.78 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.734 -0.746 . . . . 0.79 112.425 -177.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -97.99 48.18 1.01 Allowed 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.453 0.644 . . . . 1.55 110.435 179.452 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 25.3 mmt -135.58 -101.22 0.22 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.101 -0.5 . . . . 0.73 110.502 177.546 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' MET . . . . . 0.508 ' HB2' ' HB3' ' A' ' 89' ' ' PHE . 48.4 mtt -145.8 149.71 34.85 Favored 'General case' 0 CA--C 1.513 -0.464 0 N-CA-C 107.79 -1.189 . . . . 1.39 107.79 177.256 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.448 ' HB3' ' HD3' ' A' ' 88' ' ' PRO . 27.2 ttpp -53.38 -54.79 41.39 Favored Pre-proline 0 C--N 1.322 -0.605 0 N-CA-C 112.134 0.42 . . . . 2.37 112.134 -174.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.448 ' HD3' ' HB3' ' A' ' 87' ' ' LYS . 83.4 Cg_endo -76.45 -27.82 7.43 Favored 'Trans proline' 0 C--N 1.356 0.97 0 C-N-CA 121.6 1.533 . . . . 0.27 112.061 -176.916 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.644 ' O ' HG23 ' A' ' 93' ' ' VAL . 34.3 t80 -68.55 -56.59 7.78 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.248 -0.887 . . . . 0.22 109.999 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -65.08 -37.08 86.38 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.398 -0.819 . . . . 2.12 109.661 -177.524 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -52.75 -36.02 57.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.173 -0.921 . . . . 0.61 110.995 174.819 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -83.77 -27.32 28.96 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.112 -0.494 . . . . 0.22 111.207 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.644 HG23 ' O ' ' A' ' 89' ' ' PHE . 21.8 t -69.92 -48.17 65.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.243 0.544 . . . . 0.25 109.947 -177.187 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -73.2 -6.81 48.31 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.446 -0.797 . . . . 2.59 110.784 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -82.94 -20.51 35.14 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.865 -0.607 . . . . 0.47 110.222 177.744 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.671 ' HB3' ' HB2' ' A' ' 100' ' ' ASP . 0.8 OUTLIER -89.22 146.33 24.83 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-N 116.198 -0.456 . . . . 0.28 109.912 -179.895 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 55.2 tptt -86.49 166.08 15.76 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 106.684 -1.599 . . . . 1.61 106.684 163.546 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 51.8 mt -55.24 115.32 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 120.77 0.319 . . . . 0.9 110.368 179.58 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 102.64 10.94 36.7 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.51 -0.852 . . . . 0.46 113.559 -178.342 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.671 ' HB2' ' HB3' ' A' ' 96' ' ' LEU . 8.9 m-20 -108.08 149.1 28.88 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 117.896 0.848 . . . . 0.46 110.462 -179.434 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 16.2 mt -116.14 144.84 22.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 121.066 0.46 . . . . 0.23 110.671 -178.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.65 ' OG ' HD21 ' A' ' 96' ' ' LEU . 19.7 m -90.86 148.91 39.3 Favored Pre-proline 0 C--N 1.321 -0.657 0 CA-C-N 115.801 -0.636 . . . . 0.92 110.534 -179.459 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.69 176.2 10.3 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 122.642 2.228 . . . . 0.34 111.195 172.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.894 HG23 HD23 ' A' ' 44' ' ' LEU . 19.6 mm -50.11 100.2 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 O-C-N 123.475 0.484 . . . . 0.2 112.133 178.74 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.6 p -107.75 119.59 57.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.101 0.477 . . . . 1.04 110.21 176.511 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -85.99 149.86 24.89 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.935 0.398 . . . . 0.55 110.73 -179.085 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.435 HG22 ' HG2' ' A' ' 88' ' ' PRO . 3.9 p -126.26 -172.33 2.6 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.601 -0.727 . . . . 0.37 111.122 -178.451 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -61.03 -34.84 75.47 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.556 0.217 . . . . 2.16 111.527 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.614 ' O ' ' HB2' ' A' ' 20' ' ' SER . 6.8 t -97.5 -60.76 1.51 Allowed 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.55 -0.46 . . . . 1.09 110.544 179.458 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -146.59 -133.42 2.46 Favored Glycine 0 N--CA 1.441 -0.986 0 C-N-CA 119.015 -1.564 . . . . 0.24 113.877 -173.846 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.894 ' HB3' HD22 ' A' ' 44' ' ' LEU . 5.9 mp -114.58 148.08 38.55 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.06 -0.57 . . . . 0.19 111.407 -169.845 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' HIS . . . . . 0.757 ' CE1' HD13 ' A' ' 14' ' ' LEU . 70.0 m80 -144.2 151.82 40.01 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.316 0.579 . . . . 0.22 112.268 179.073 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.606 HG12 HD11 ' A' ' 44' ' ' LEU . 3.9 pt -134.35 143.91 36.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 107.774 -1.195 . . . . 0.17 107.774 159.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.444 ' H ' ' HB2' ' A' ' 102' ' ' SER . 1.0 OUTLIER -133.22 138.19 51.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 C-N-CA 120.829 -0.348 . . . . 0.18 110.665 -176.963 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.492 ' HG2' ' HB3' ' A' ' 11' ' ' ALA . 50.4 pttt -121.83 135.08 54.9 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.416 -0.587 . . . . 0.61 109.416 172.111 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ARG . . . . . 0.419 ' HB2' HD12 ' A' ' 96' ' ' LEU . 68.5 ttt180 -84.78 123.0 29.92 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.837 0.351 . . . . 1.87 111.064 -175.185 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.411 HD21 ' HB2' ' A' ' 11' ' ' ALA . 2.2 mm? -93.15 -32.59 14.36 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.025 -0.534 . . . . 0.89 110.843 179.459 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.955 0 CA-C-O 118.569 -0.729 . . . . 1.1 110.156 179.514 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 40.1 mmtm . . . . . 0 N--CA 1.454 -0.247 0 CA-C-O 121.546 0.688 . . . . 1.19 111.039 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.642 HD23 ' H ' ' A' ' 9' ' ' ARG . 2.1 tt -115.19 158.71 21.88 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 114.651 -1.158 . . . . 1.18 108.178 179.282 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.642 ' H ' HD23 ' A' ' 8' ' ' LEU . 48.8 ttt180 -137.53 130.8 30.83 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 108.61 -0.885 . . . . 1.06 108.61 175.153 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.442 ' N ' ' HZ ' ' A' ' 80' ' ' PHE . . . -144.78 155.47 43.54 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.244 -0.583 . . . . 0.22 112.419 -178.361 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.608 ' HA ' ' HA ' ' A' ' 76' ' ' ASP . . . -109.67 133.6 52.94 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-N 115.421 -0.808 . . . . 0.2 109.538 176.225 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 37.9 p-80 -139.52 143.51 37.46 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.97 0.414 . . . . 0.23 111.365 -172.146 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.641 ' O ' ' HA ' ' A' ' 112' ' ' HIS . 6.1 tt -111.82 134.84 53.13 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.536 -0.913 . . . . 0.24 108.536 177.159 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.732 HD13 ' CE1' ' A' ' 112' ' ' HIS . 24.4 tp -117.36 122.34 43.6 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.811 0.339 . . . . 0.27 111.224 -178.187 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.569 HG23 HD13 ' A' ' 44' ' ' LEU . 70.5 t -108.57 134.05 51.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 109.786 -0.45 . . . . 0.15 109.786 174.242 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.471 ' HE3' HD21 ' A' ' 14' ' ' LEU . 31.3 mmtp -106.43 149.54 26.94 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.431 -0.581 . . . . 0.62 109.431 176.744 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.448 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 49.6 p90 -138.68 161.32 37.46 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.721 0.296 . . . . 0.25 110.749 -179.027 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.568 ' HB3' ' HA ' ' A' ' 33' ' ' ALA . 59.8 p -52.62 109.8 0.44 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.849 -0.614 . . . . 1.04 111.094 -179.173 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 97.8 9.46 54.4 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.63 -0.795 . . . . 0.53 113.769 177.647 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.441 ' C ' ' H ' ' A' ' 22' ' ' ASN . 88.9 p -91.6 48.67 1.49 Allowed 'General case' 0 C--O 1.235 0.321 0 CA-C-N 118.293 1.047 . . . . 0.7 110.903 -177.911 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 71.27 -34.46 0.3 Allowed 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.531 0.732 . . . . 3.49 111.537 -178.376 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.441 ' H ' ' C ' ' A' ' 20' ' ' SER . 41.5 m-80 -142.99 91.1 7.25 Favored Pre-proline 0 C--N 1.328 -0.367 0 N-CA-C 110.387 -0.227 . . . . 1.77 110.387 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.412 ' C ' HG22 ' A' ' 32' ' ' THR . 16.7 Cg_exo -73.99 54.81 3.24 Favored 'Trans proline' 0 CA--C 1.534 0.523 0 C-N-CA 123.408 2.739 . . . . 1.71 113.07 179.435 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.462 ' N ' HG22 ' A' ' 32' ' ' THR . 64.4 t -146.83 117.67 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 109.302 -0.629 . . . . 0.48 109.302 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 42.1 t -106.45 151.74 24.55 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 110.344 -0.243 . . . . 1.12 110.344 178.797 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.588 ' HB2' ' HA ' ' A' ' 67' ' ' ASP . 7.5 mpt_? -65.61 -14.71 61.71 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.994 0.426 . . . . 2.54 109.894 170.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.52 ' HG3' ' HD3' ' A' ' 65' ' ' ARG . 23.9 ttp180 -66.86 -38.94 87.29 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.404 -0.817 . . . . 1.77 109.471 177.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 33.2 p -105.42 -35.14 7.6 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-O 121.433 0.635 . . . . 0.67 110.979 -176.718 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 72.92 8.15 72.48 Favored Glycine 0 N--CA 1.451 -0.325 0 CA-C-N 115.419 -0.81 . . . . 0.82 112.054 -178.156 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -131.03 -70.07 0.61 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.964 0.412 . . . . 2.1 110.312 -178.45 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.404 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 11.0 p -154.54 157.65 38.63 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.16 -0.473 . . . . 1.08 110.584 177.565 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.462 HG22 ' N ' ' A' ' 24' ' ' VAL . 10.1 t -125.11 28.0 6.51 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 122.082 0.944 . . . . 0.34 109.66 172.815 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.568 ' HA ' ' HB3' ' A' ' 18' ' ' SER . . . -69.27 -5.53 23.6 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 114.979 -1.009 . . . . 0.37 111.893 178.636 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -85.57 -25.18 26.88 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.833 -0.621 . . . . 2.21 110.754 -178.193 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.456 HG13 ' OG1' ' A' ' 32' ' ' THR . 0.2 OUTLIER -109.75 135.16 49.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.647 -0.706 . . . . 0.31 110.47 -175.547 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 41.7 p -92.19 178.73 5.77 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 109.743 -0.466 . . . . 0.39 109.743 -178.039 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.511 ' O ' HG13 ' A' ' 41' ' ' ILE . 18.6 p90 -62.16 -29.63 70.48 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 119.885 -0.726 . . . . 1.53 109.57 177.336 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -72.39 -48.36 42.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.12 -0.491 . . . . 0.96 110.446 177.392 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -64.22 -29.04 70.16 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.317 0.579 . . . . 0.91 109.705 178.51 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.448 ' HB2' ' HB3' ' A' ' 17' ' ' PHE . . . -72.62 -46.34 54.59 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.09 -0.959 . . . . 0.19 110.696 177.838 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.511 HG13 ' O ' ' A' ' 37' ' ' TYR . 97.0 mt -62.41 -38.13 80.51 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 N-CA-C 109.635 -0.506 . . . . 0.3 109.635 175.483 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.455 ' O ' ' HG3' ' A' ' 46' ' ' LYS . 82.6 tttt -60.87 -29.68 69.69 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.455 -0.793 . . . . 2.32 110.162 178.216 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -87.62 -47.53 8.62 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.687 -0.688 . . . . 1.02 110.091 -177.116 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.94 HD23 HG23 ' A' ' 104' ' ' ILE . 35.5 tp -58.67 -38.57 78.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.896 -0.593 . . . . 0.17 109.743 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.451 ' HG2' HG13 ' A' ' 104' ' ' ILE . 2.2 mm100 -62.63 -35.96 81.26 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.94 -0.573 . . . . 0.87 112.165 178.602 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.455 ' HG3' ' O ' ' A' ' 42' ' ' LYS . 68.8 mttm -70.78 -45.81 64.04 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.741 0.305 . . . . 1.31 110.77 -178.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 51.0 m95 -67.9 -44.34 77.2 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.98 -0.288 . . . . 0.52 110.468 177.231 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 40.9 t -57.03 -33.5 67.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.024 0.44 . . . . 0.82 110.219 174.68 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.415 ' HB2' ' O ' ' A' ' 45' ' ' GLN . 12.1 tt0 -68.03 -54.38 18.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 0.53 110.294 177.578 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.614 ' HB3' HG22 ' A' ' 56' ' ' VAL . 87.6 mtt180 -60.23 -45.24 93.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.96 -0.564 . . . . 0.42 111.594 -178.897 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.41 HG21 ' CD2' ' A' ' 58' ' ' PHE . 97.2 mt -59.42 -40.69 82.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 120.997 0.427 . . . . 0.2 110.727 177.14 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.49 -38.42 71.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.152 -0.476 . . . . 0.27 111.615 -179.273 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 58.1 p -78.22 -30.78 48.98 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.055 0.455 . . . . 0.35 110.947 -179.174 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 106.68 3.0 37.32 Favored Glycine 0 N--CA 1.445 -0.725 0 N-CA-C 111.574 -0.61 . . . . 0.3 111.574 -179.075 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.408 ' HB3' ' HB3' ' A' ' 50' ' ' ARG . 5.6 tt0 -55.57 -46.68 77.18 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 122.803 0.441 . . . . 0.65 110.784 177.875 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.614 HG22 ' HB3' ' A' ' 50' ' ' ARG . 11.9 m -134.78 155.33 38.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 109.472 -0.566 . . . . 0.19 109.472 170.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.5 m -77.8 155.8 30.88 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.266 -0.642 . . . . 0.97 109.266 178.455 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.41 ' CD2' HG21 ' A' ' 51' ' ' ILE . 2.2 t80 -54.3 -40.01 67.52 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.184 -0.673 . . . . 0.22 109.184 177.643 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -57.94 -44.8 87.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.892 -1.049 . . . . 1.72 111.671 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -64.11 -45.68 87.52 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.863 0.363 . . . . 2.09 111.11 -175.27 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -70.56 -43.66 69.02 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.42 -0.354 . . . . 0.26 110.896 -179.199 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.84 -46.02 89.85 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.248 0.462 . . . . 0.24 112.248 -175.733 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.496 ' HA ' ' O ' ' A' ' 71' ' ' TYR . 21.7 m -59.2 -19.73 47.93 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 112.907 0.706 . . . . 1.0 112.907 -177.138 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.412 ' O ' ' HA ' ' A' ' 27' ' ' ARG . 35.7 mt-30 -110.69 -45.65 3.47 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.48 0.657 . . . . 0.61 110.988 -178.182 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.52 ' HD3' ' HG3' ' A' ' 27' ' ' ARG . 25.6 mmt180 -92.35 -38.43 12.04 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 114.929 -1.032 . . . . 0.86 113.278 -170.772 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.456 ' HB2' ' HG ' ' A' ' 13' ' ' LEU . 21.6 t -63.31 124.62 21.7 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.028 0.442 . . . . 0.82 110.889 -178.624 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.588 ' HA ' ' HB2' ' A' ' 26' ' ' ARG . 22.8 t70 -80.99 -10.49 59.7 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.741 -0.663 . . . . 2.28 111.11 177.644 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 48.3 t -80.24 158.59 26.16 Favored 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 120.132 -0.627 . . . . 1.52 109.608 179.051 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -60.3 -12.06 23.0 Favored Glycine 0 N--CA 1.454 -0.108 0 CA-C-N 115.014 -0.994 . . . . 0.26 113.122 -174.884 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 70.5 p -69.6 -10.15 57.01 Favored 'General case' 0 N--CA 1.448 -0.565 0 O-C-N 123.052 -0.087 . . . . 0.32 110.984 176.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.496 ' O ' ' HA ' ' A' ' 63' ' ' SER . 12.8 p90 -57.42 -31.01 65.43 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 109.617 -0.512 . . . . 0.54 109.617 174.013 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -95.35 2.63 54.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.141 0.496 . . . . 0.49 110.626 179.619 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 5.0 m -116.37 -2.03 12.17 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.913 -0.585 . . . . 0.71 111.284 -175.603 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 86.11 20.01 56.16 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.722 -0.751 . . . . 0.54 112.233 -177.375 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 86.34 -29.34 4.84 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 121.092 -0.575 . . . . 0.35 112.639 178.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.608 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 8.1 p-10 -89.41 144.93 25.68 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-O 121.573 0.702 . . . . 1.65 111.397 -175.538 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.438 ' O ' ' HG3' ' A' ' 9' ' ' ARG . 1.7 mp -106.34 175.74 5.4 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 114.635 -1.166 . . . . 0.94 110.131 178.612 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -82.76 -147.18 6.67 Favored Glycine 0 C--N 1.317 -0.509 0 C-N-CA 121.033 -0.604 . . . . 0.44 112.497 179.313 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -99.16 124.19 44.01 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.109 0.48 . . . . 3.87 110.807 -178.56 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.442 ' HZ ' ' N ' ' A' ' 10' ' ' ALA . 1.1 p90 -134.36 138.5 44.94 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.46 -0.791 . . . . 1.31 110.425 -177.009 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 18.6 m -68.06 129.67 40.62 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.703 -0.481 . . . . 1.17 109.703 177.585 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 17.8 m -49.47 121.47 5.11 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.8 -0.636 . . . . 1.19 111.832 -174.345 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 111.09 3.21 28.02 Favored Glycine 0 N--CA 1.452 -0.289 0 CA-C-N 115.847 -0.615 . . . . 0.79 112.148 -177.77 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -91.7 26.31 2.4 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.945 0.402 . . . . 1.55 111.304 -175.304 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 26.5 mmt -122.13 -131.78 0.28 Allowed 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 109.687 -0.486 . . . . 0.73 109.687 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 5.1 mpp? -91.97 -93.3 0.14 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.939 0.4 . . . . 1.39 109.931 177.521 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.499 ' H ' ' HD2' ' A' ' 88' ' ' PRO . 27.8 ttpp -163.58 -56.43 0.01 OUTLIER Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 115.852 -0.613 . . . . 2.37 110.026 175.262 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.499 ' HD2' ' H ' ' A' ' 87' ' ' LYS . 60.5 Cg_endo -70.14 -30.0 21.16 Favored 'Trans proline' 0 C--N 1.359 1.097 0 C-N-CA 121.923 1.749 . . . . 0.27 111.096 178.373 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.644 ' O ' HG23 ' A' ' 93' ' ' VAL . 20.1 t80 -61.66 -56.44 19.76 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.631 -1.168 . . . . 0.22 109.762 176.468 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.8 tm-20 -64.36 -36.85 85.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.493 -0.776 . . . . 2.12 110.165 -179.38 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -53.54 -33.52 54.89 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.354 -0.839 . . . . 0.61 110.964 175.802 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.435 ' O ' ' HG ' ' A' ' 96' ' ' LEU . . . -84.35 -34.36 23.67 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.359 -0.382 . . . . 0.22 111.298 177.789 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.644 HG23 ' O ' ' A' ' 89' ' ' PHE . 35.7 t -62.72 -44.52 99.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-O 121.417 0.627 . . . . 0.25 110.596 -177.678 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 38.3 ptt180 -73.47 -11.29 60.41 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.612 -0.722 . . . . 2.59 110.748 178.594 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -96.86 14.64 24.61 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.328 -0.396 . . . . 0.47 111.815 -173.13 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.539 ' HB2' ' HB2' ' A' ' 100' ' ' ASP . 0.5 OUTLIER -148.17 155.75 41.77 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.022 0.439 . . . . 0.28 110.857 177.395 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.58 ' HA ' ' NH2' ' A' ' 116' ' ' ARG . 23.8 tptm -92.25 162.73 14.18 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.789 -0.641 . . . . 1.61 109.517 179.294 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.517 ' HA ' ' HG2' ' A' ' 116' ' ' ARG . 66.2 mt -42.63 114.33 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.974 0.416 . . . . 0.9 111.241 171.52 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 103.3 -8.87 53.31 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.804 -0.712 . . . . 0.46 113.449 178.283 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.539 ' HB2' ' HB2' ' A' ' 96' ' ' LEU . 18.4 m-20 -97.24 135.82 38.62 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 117.23 0.515 . . . . 0.46 110.383 179.121 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.483 HG12 ' HB3' ' A' ' 115' ' ' LYS . 8.3 mt -103.98 149.72 7.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.946 -0.57 . . . . 0.23 109.902 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 93.4 p -91.46 159.62 38.57 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 116.095 -0.502 . . . . 0.92 110.914 -177.124 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -71.22 166.55 28.88 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 122.383 2.055 . . . . 0.34 111.342 170.381 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.94 HG23 HD23 ' A' ' 44' ' ' LEU . 25.7 mm -47.57 112.7 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 O-C-N 123.547 0.53 . . . . 0.2 111.793 176.629 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 1.9 p -118.47 124.8 73.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.154 -0.475 . . . . 1.04 109.961 175.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -85.51 151.32 24.04 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.0 0.429 . . . . 0.55 110.285 178.539 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 10.9 p -131.3 -172.21 2.79 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.942 -0.572 . . . . 0.37 110.855 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -55.5 -48.16 75.06 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.893 -0.594 . . . . 2.16 111.928 -179.601 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.462 ' OG ' ' HE2' ' A' ' 16' ' ' LYS . 4.8 t -106.98 -3.93 19.58 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.791 0.663 . . . . 1.09 112.791 -172.306 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 172.68 -128.59 1.56 Allowed Glycine 0 N--CA 1.439 -1.15 0 C-N-CA 118.984 -1.579 . . . . 0.24 113.615 173.782 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.879 ' HB3' HD22 ' A' ' 44' ' ' LEU . 7.4 mp -126.4 151.0 48.26 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 114.976 -0.612 . . . . 0.19 110.961 -170.2 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' HIS . . . . . 0.732 ' CE1' HD13 ' A' ' 14' ' ' LEU . 74.9 m80 -146.48 149.99 34.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.378 0.608 . . . . 0.22 112.53 178.309 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.632 HG12 HD11 ' A' ' 44' ' ' LEU . 2.9 pt -128.07 137.43 57.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 107.351 -1.351 . . . . 0.17 107.351 158.39 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 2.6 mp -130.57 144.02 39.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 C-N-CA 120.736 -0.386 . . . . 0.18 110.85 -175.213 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.483 ' HB3' HG12 ' A' ' 101' ' ' ILE . 39.2 pttt -127.2 142.19 51.55 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.655 -0.868 . . . . 0.61 108.655 172.428 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ARG . . . . . 0.58 ' NH2' ' HA ' ' A' ' 97' ' ' LYS . 3.1 ttp180 -79.81 134.77 36.36 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.295 0.569 . . . . 1.87 111.095 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -102.66 -32.42 9.88 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.144 -0.935 . . . . 0.89 109.922 178.215 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.576 ' OXT' ' HD2' ' A' ' 116' ' ' ARG . . . . . . . . 0 C--O 1.246 0.888 0 CA-C-O 118.368 -0.825 . . . . 1.1 110.401 178.434 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.48 ' HD2' ' HB3' ' A' ' 79' ' ' PHE . 60.1 mmtt . . . . . 0 N--CA 1.454 -0.241 0 CA-C-O 121.359 0.6 . . . . 1.19 110.798 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.684 HD23 ' H ' ' A' ' 9' ' ' ARG . 1.3 tt -114.9 161.23 18.54 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 108.162 -1.051 . . . . 1.18 108.162 178.139 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.684 ' H ' HD23 ' A' ' 8' ' ' LEU . 48.2 ttt180 -141.45 128.61 20.91 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.082 -0.71 . . . . 1.06 109.082 175.704 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.441 ' O ' ' HB2' ' A' ' 77' ' ' LEU . . . -146.97 158.74 44.01 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 119.97 -0.692 . . . . 0.22 112.143 -178.459 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.495 ' HB3' ' HG2' ' A' ' 115' ' ' LYS . . . -106.73 135.75 47.73 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.641 -0.708 . . . . 0.2 109.177 177.521 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 2.0 p80 -138.71 140.12 38.64 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 120.37 -0.532 . . . . 0.23 111.463 -171.478 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.546 ' HG ' ' HB3' ' A' ' 66' ' ' SER . 7.0 tt -111.71 143.28 42.88 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.493 -0.929 . . . . 0.24 108.493 175.557 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.786 HD13 ' CE1' ' A' ' 112' ' ' HIS . 23.9 tp -129.61 120.4 25.19 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.768 0.318 . . . . 0.27 111.097 -177.028 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.51 HG23 HD13 ' A' ' 44' ' ' LEU . 37.5 t -106.98 132.39 54.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 109.379 -0.6 . . . . 0.15 109.379 175.456 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.649 ' HE2' ' OG ' ' A' ' 109' ' ' SER . 31.7 mmtp -106.21 154.37 20.81 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.837 -0.431 . . . . 0.62 109.837 177.61 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -149.19 160.95 42.92 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.056 -0.52 . . . . 0.25 110.353 -176.122 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 5.6 t -54.27 109.49 0.49 Allowed 'General case' 0 N--CA 1.432 -1.327 0 CA-C-N 116.392 -0.367 . . . . 1.04 110.071 174.754 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 105.74 9.61 32.45 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.502 -0.856 . . . . 0.53 112.759 -178.235 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.49 ' HB2' ' O ' ' A' ' 109' ' ' SER . 78.3 p -95.03 39.44 1.11 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 117.258 0.529 . . . . 0.7 111.202 -176.71 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.424 ' HB3' ' O ' ' A' ' 20' ' ' SER . 54.8 ttt180 74.77 -34.29 0.26 Allowed 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.286 0.634 . . . . 3.49 111.045 179.399 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -151.06 114.07 3.12 Favored Pre-proline 0 C--N 1.324 -0.521 0 N-CA-C 109.265 -0.643 . . . . 1.77 109.265 172.296 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.43 ' C ' HG22 ' A' ' 32' ' ' THR . 89.9 Cg_endo -83.61 64.12 7.42 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 122.594 2.196 . . . . 1.71 112.88 -172.747 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.482 ' N ' HG22 ' A' ' 32' ' ' THR . 47.0 t -147.9 116.17 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 C-N-CA 122.855 0.462 . . . . 0.48 109.851 179.406 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.435 ' HB3' ' HB2' ' A' ' 16' ' ' LYS . 28.7 p -105.63 158.47 16.68 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 110.585 -0.154 . . . . 1.12 110.585 175.924 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.585 ' HB2' ' HA ' ' A' ' 67' ' ' ASP . 5.6 mpt_? -71.05 -4.0 22.68 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.111 0.481 . . . . 2.54 110.216 171.525 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.574 ' HG3' ' CD ' ' A' ' 65' ' ' ARG . 22.0 ttp180 -76.26 -40.1 52.73 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.706 -0.679 . . . . 1.77 109.362 175.86 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 59.8 p -103.19 -35.8 8.34 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.707 -0.679 . . . . 0.67 111.035 -176.581 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 80.95 -28.31 2.89 Favored Glycine 0 CA--C 1.52 0.365 0 CA-C-N 115.963 -0.562 . . . . 0.82 112.21 -179.173 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -98.48 -71.21 0.7 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.839 0.352 . . . . 2.1 110.64 -178.618 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 44.7 m -154.11 156.7 37.74 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.109 -0.496 . . . . 1.08 110.212 177.016 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.482 HG22 ' N ' ' A' ' 24' ' ' VAL . 8.9 t -123.22 35.5 4.85 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 122.29 1.043 . . . . 0.34 109.695 178.285 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -77.67 -4.58 46.83 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.833 -1.076 . . . . 0.37 111.528 -176.435 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -96.76 1.21 50.58 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.798 -0.637 . . . . 2.21 110.747 -178.082 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.46 HG23 ' HB2' ' A' ' 39' ' ' ASP . 0.2 OUTLIER -129.46 134.75 63.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.685 -0.689 . . . . 0.31 109.787 -179.955 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 41.2 p -96.49 -176.19 3.55 Favored 'General case' 0 CA--C 1.513 -0.468 0 N-CA-C 109.487 -0.56 . . . . 0.39 109.487 -178.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.543 ' O ' HG13 ' A' ' 41' ' ' ILE . 0.2 OUTLIER -67.93 -22.8 65.04 Favored 'General case' 0 C--O 1.219 -0.532 0 C-N-CA 118.883 -1.127 . . . . 1.53 110.036 173.583 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -68.82 -49.3 59.6 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.761 -0.459 . . . . 0.96 109.761 174.021 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.46 ' HB2' HG23 ' A' ' 35' ' ' VAL . 8.4 m-20 -66.54 -32.44 73.79 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.368 0.604 . . . . 0.91 109.967 177.703 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.428 ' HB3' ' HA ' ' A' ' 37' ' ' TYR . . . -71.85 -40.91 68.7 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.272 -0.876 . . . . 0.19 110.832 179.383 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.543 HG13 ' O ' ' A' ' 37' ' ' TYR . 61.8 mt -62.3 -34.67 65.35 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.312 0 N-CA-C 109.316 -0.624 . . . . 0.3 109.316 173.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.421 ' O ' ' HG3' ' A' ' 46' ' ' LYS . 19.7 mtpt -65.34 -21.28 66.68 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 116.336 -0.393 . . . . 2.32 111.085 176.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.447 ' HG3' ' CD1' ' A' ' 47' ' ' TRP . 1.6 tp10 -87.85 -57.61 2.87 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.34 -0.615 . . . . 1.02 109.34 178.187 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.934 HD23 HG23 ' A' ' 104' ' ' ILE . 23.8 tp -57.93 -38.89 76.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 114.965 -1.016 . . . . 0.17 111.101 -175.722 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.516 ' HB2' ' O ' ' A' ' 41' ' ' ILE . 3.6 mm-40 -66.22 -28.66 68.91 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 112.047 0.388 . . . . 0.87 112.047 -178.425 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.421 ' HG3' ' O ' ' A' ' 42' ' ' LYS . 66.4 mttm -77.56 -45.02 26.6 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.986 -0.376 . . . . 1.31 109.986 178.858 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.447 ' CD1' ' HG3' ' A' ' 43' ' ' GLU . 58.2 m95 -66.11 -45.5 80.94 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.249 -0.432 . . . . 0.52 111.695 177.706 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.567 ' HB3' HG21 ' A' ' 113' ' ' ILE . 96.0 p -65.22 -23.82 67.18 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.957 0.408 . . . . 0.82 109.989 177.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.473 ' HB2' ' O ' ' A' ' 45' ' ' GLN . 10.1 tt0 -73.3 -56.68 4.75 Favored 'General case' 0 C--O 1.223 -0.337 0 CA-C-N 116.094 -0.503 . . . . 0.53 109.776 173.691 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.618 ' HB3' HG22 ' A' ' 56' ' ' VAL . 92.4 mtt180 -61.1 -41.7 97.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.77 -0.65 . . . . 0.42 111.81 -176.136 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.495 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 98.2 mt -60.7 -36.42 70.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.367 -0.378 . . . . 0.2 110.496 176.437 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -77.64 -36.95 51.0 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.243 -0.435 . . . . 0.27 111.692 178.04 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.473 ' OG ' ' HA ' ' A' ' 50' ' ' ARG . 67.9 p -79.09 -29.8 43.5 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 111.76 0.282 . . . . 0.35 111.76 -175.347 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 109.15 1.37 31.54 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.671 -0.776 . . . . 0.3 112.318 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.439 ' HB2' ' HB3' ' A' ' 50' ' ' ARG . 43.5 mt-10 -61.97 -50.97 69.97 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.882 0.372 . . . . 0.65 110.509 178.721 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.618 HG22 ' HB3' ' A' ' 50' ' ' ARG . 16.2 m -134.8 152.4 32.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 109.564 -0.532 . . . . 0.19 109.564 174.285 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 19.5 m -82.39 160.15 22.85 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.542 -0.54 . . . . 0.97 109.542 178.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.427 ' HA ' ' CD1' ' A' ' 51' ' ' ILE . 2.6 t80 -54.95 -39.8 69.3 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.412 0.625 . . . . 0.22 109.74 -178.632 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -55.79 -45.56 78.17 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.541 -1.209 . . . . 1.72 111.351 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.455 ' O ' ' HG3' ' A' ' 64' ' ' GLN . 3.9 mm-40 -65.64 -47.83 74.24 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.964 -0.562 . . . . 2.09 111.177 -173.154 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -67.25 -38.44 85.15 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.369 -0.378 . . . . 0.26 110.845 -179.151 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.37 -53.18 58.73 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.131 -0.486 . . . . 0.24 111.331 -178.648 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.553 ' HA ' ' O ' ' A' ' 71' ' ' TYR . 47.6 m -51.58 -29.56 17.68 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.892 0.701 . . . . 1.0 112.892 -177.337 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.455 ' HG3' ' O ' ' A' ' 60' ' ' GLU . 19.1 mt-30 -97.33 -50.48 4.53 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.738 0.78 . . . . 0.61 110.708 -177.536 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.574 ' CD ' ' HG3' ' A' ' 27' ' ' ARG . 19.1 mmt180 -93.57 -40.26 10.39 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 114.55 -1.205 . . . . 0.86 113.386 -166.18 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.546 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 38.7 p -63.84 121.52 14.23 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.106 0.479 . . . . 0.82 111.177 -174.029 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.585 ' HA ' ' HB2' ' A' ' 26' ' ' ARG . 31.5 t70 -74.66 -15.08 60.82 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.571 -0.741 . . . . 2.28 110.813 177.13 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 0.505 ' SG ' ' HB2' ' A' ' 66' ' ' SER . 5.2 p -77.57 150.34 34.74 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.94 -0.573 . . . . 1.52 110.556 -179.505 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -53.82 -18.04 7.83 Favored Glycine 0 C--N 1.329 0.176 0 CA-C-N 114.823 -1.08 . . . . 0.26 114.742 -171.675 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 77.9 p -73.06 0.32 11.78 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 117.293 0.546 . . . . 0.32 111.907 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.553 ' O ' ' HA ' ' A' ' 63' ' ' SER . 54.8 p90 -52.97 -41.27 64.41 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.767 0.318 . . . . 0.54 110.295 174.045 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -95.14 2.68 55.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.045 0.45 . . . . 0.49 110.983 -179.06 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 5.3 m -103.37 -6.78 21.59 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.076 -0.511 . . . . 0.71 110.735 -178.274 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 90.61 19.85 42.95 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.891 -0.671 . . . . 0.54 112.181 -177.299 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 84.7 -31.83 3.53 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 121.044 -0.598 . . . . 0.35 112.697 179.104 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.466 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 6.9 p-10 -83.04 145.2 29.43 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-O 121.672 0.749 . . . . 1.65 111.224 -176.031 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.441 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 16.6 mt -105.43 175.74 5.4 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 114.399 -1.273 . . . . 0.94 110.388 179.745 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -87.43 -152.38 22.95 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 121.234 -0.508 . . . . 0.44 112.014 177.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.48 ' HB3' ' HD2' ' A' ' 7' ' ' LYS . 91.6 m-85 -96.16 124.11 40.04 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.27 0.557 . . . . 3.87 110.988 179.498 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.42 ' HZ ' ' N ' ' A' ' 10' ' ' ALA . 1.0 OUTLIER -134.44 160.2 38.72 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.491 -0.777 . . . . 1.31 110.45 -176.214 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 40.8 p -89.22 126.59 35.55 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 109.598 -0.519 . . . . 1.17 109.598 178.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 17.2 m -56.57 122.67 12.55 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.305 -0.407 . . . . 1.19 111.093 -178.373 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 113.23 6.85 21.81 Favored Glycine 0 N--CA 1.445 -0.708 0 N-CA-C 111.533 -0.627 . . . . 0.79 111.533 -179.005 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -112.82 10.55 19.15 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.135 0.493 . . . . 1.55 110.446 -178.811 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 23.6 mmt -99.17 -108.8 0.19 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.027 0.441 . . . . 0.73 110.642 178.47 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 56.7 mtt -134.69 150.5 50.63 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 107.88 -1.155 . . . . 1.39 107.88 175.398 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.403 ' HB2' ' HD3' ' A' ' 88' ' ' PRO . 14.4 mmmm -54.05 -53.19 61.27 Favored Pre-proline 0 C--N 1.32 -0.697 0 N-CA-C 112.518 0.562 . . . . 2.37 112.518 -175.142 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.442 ' HG2' HG22 ' A' ' 107' ' ' THR . 64.2 Cg_endo -75.16 -25.18 11.87 Favored 'Trans proline' 0 C--N 1.355 0.902 0 C-N-CA 121.561 1.507 . . . . 0.27 112.152 -177.866 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.514 ' O ' HG23 ' A' ' 93' ' ' VAL . 27.0 t80 -72.88 -55.78 6.14 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.475 -0.784 . . . . 0.22 109.723 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -60.41 -36.19 77.56 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.263 -0.88 . . . . 2.12 110.214 -179.39 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.566 ' HA ' ' CZ ' ' A' ' 94' ' ' ARG . 26.6 t70 -56.38 -32.97 65.28 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.613 -0.721 . . . . 0.61 111.117 177.69 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.475 ' O ' ' HG ' ' A' ' 96' ' ' LEU . . . -82.79 -26.98 31.28 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.381 -0.372 . . . . 0.22 111.037 179.114 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.514 HG23 ' O ' ' A' ' 89' ' ' PHE . 28.0 t -67.36 -45.38 85.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.47 -0.332 . . . . 0.25 111.666 -174.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.566 ' CZ ' ' HA ' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -83.32 -2.49 55.83 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.239 -0.584 . . . . 2.59 110.408 178.262 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -86.5 -2.77 58.75 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.18 0.514 . . . . 0.47 110.339 179.335 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.642 ' HB2' ' HB2' ' A' ' 100' ' ' ASP . 0.7 OUTLIER -136.26 153.61 51.14 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.614 -0.721 . . . . 0.28 110.128 176.785 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.546 ' HG3' ' H ' ' A' ' 98' ' ' ILE . 20.2 tptm -102.42 179.17 4.38 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.128 -0.693 . . . . 1.61 109.128 179.197 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.546 ' H ' ' HG3' ' A' ' 97' ' ' LYS . 65.3 mt -54.81 116.05 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.011 0.434 . . . . 0.9 111.197 179.588 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 104.45 -6.18 45.31 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 121.016 -0.612 . . . . 0.46 112.975 179.494 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.642 ' HB2' ' HB2' ' A' ' 96' ' ' LEU . 31.0 m-20 -98.14 138.86 34.81 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.906 0.353 . . . . 0.46 110.886 -178.253 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 11.2 mt -108.56 147.62 13.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 109.385 -0.598 . . . . 0.23 109.385 178.005 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 88.3 p -91.4 158.11 41.35 Favored Pre-proline 0 C--N 1.321 -0.658 0 CA-C-O 120.667 0.27 . . . . 0.92 110.571 -179.53 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -74.99 175.87 10.66 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.272 1.982 . . . . 0.34 110.94 170.164 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.934 HG23 HD23 ' A' ' 44' ' ' LEU . 21.1 mm -49.0 112.8 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.898 0.38 . . . . 0.2 111.58 176.23 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.4 p -119.24 120.82 64.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.093 0.473 . . . . 1.04 110.078 174.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -85.14 145.25 27.71 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 121.269 0.556 . . . . 0.55 109.995 177.839 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.442 HG22 ' HG2' ' A' ' 88' ' ' PRO . 8.2 p -120.6 -171.93 2.27 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.349 -0.841 . . . . 0.37 110.886 -176.708 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -54.69 -45.4 73.97 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.811 -0.631 . . . . 2.16 110.723 176.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.649 ' OG ' ' HE2' ' A' ' 16' ' ' LYS . 15.0 t -93.59 -60.81 1.68 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.921 -0.581 . . . . 1.09 111.078 -177.21 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -144.95 -134.85 2.8 Favored Glycine 0 N--CA 1.442 -0.929 0 C-N-CA 118.865 -1.636 . . . . 0.24 113.448 -172.885 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.903 ' HB3' HD22 ' A' ' 44' ' ' LEU . 6.8 mp -113.19 146.33 39.47 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.204 -0.498 . . . . 0.19 111.116 -172.499 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' HIS . . . . . 0.786 ' CE1' HD13 ' A' ' 14' ' ' LEU . 68.7 m80 -143.23 152.67 41.99 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.459 0.647 . . . . 0.22 112.484 179.35 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.686 HG12 HD11 ' A' ' 44' ' ' LEU . 3.6 pt -131.55 137.42 55.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 107.372 -1.344 . . . . 0.17 107.372 157.907 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 2.4 mp -127.57 144.17 38.32 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 C-N-CA 120.781 -0.368 . . . . 0.18 110.247 -176.764 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.495 ' HG2' ' HB3' ' A' ' 11' ' ' ALA . 52.0 pttt -127.94 137.25 52.2 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.041 -0.726 . . . . 0.61 109.041 173.866 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ARG . . . . . 0.538 ' HB2' ' CD1' ' A' ' 96' ' ' LEU . 65.2 ttt180 -85.49 126.61 33.97 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 120.989 0.424 . . . . 1.87 111.358 -175.62 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.49 HD21 ' HB2' ' A' ' 11' ' ' ALA . 0.7 OUTLIER -97.26 -33.56 11.42 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.594 -0.73 . . . . 0.89 110.625 178.268 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.587 ' HB3' ' HB3' ' A' ' 9' ' ' ARG . . . . . . . . 0 C--O 1.247 0.936 0 CA-C-O 118.736 -0.65 . . . . 1.1 110.662 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt . . . . . 0 N--CA 1.454 -0.247 0 CA-C-O 121.162 0.506 . . . . 1.19 111.315 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.497 HD11 ' CD ' ' A' ' 116' ' ' ARG . 15.3 tp -132.18 171.97 12.99 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.022 -0.99 . . . . 1.18 108.779 -179.673 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 68.2 ttt180 -145.26 132.15 20.17 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 110.178 -0.304 . . . . 1.06 110.178 175.779 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -148.51 160.31 43.2 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.329 0.585 . . . . 0.22 112.421 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.527 ' HB2' HD21 ' A' ' 117' ' ' LEU . . . -107.47 138.96 42.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.239 -0.892 . . . . 0.2 109.129 176.489 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 20.0 p-80 -139.5 141.68 37.32 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.016 0.436 . . . . 0.23 111.341 -172.476 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.572 ' O ' ' HA ' ' A' ' 112' ' ' HIS . 7.1 tt -113.47 138.39 50.18 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.549 -0.908 . . . . 0.24 108.549 177.226 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.744 HD13 ' CE1' ' A' ' 112' ' ' HIS . 16.6 tp -121.2 137.5 54.65 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.697 0.284 . . . . 0.27 111.501 -179.046 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.434 HG23 HD13 ' A' ' 44' ' ' LEU . 43.8 t -119.66 126.47 75.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.854 -0.612 . . . . 0.15 109.721 172.699 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.609 ' HE3' HD21 ' A' ' 14' ' ' LEU . 28.5 mmtp -103.31 154.82 18.97 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.982 -0.554 . . . . 0.62 109.821 177.171 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -151.67 162.32 41.19 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.133 -0.485 . . . . 0.25 110.127 -176.448 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.455 ' CB ' ' HA ' ' A' ' 33' ' ' ALA . 4.1 t -47.25 110.01 0.26 Allowed 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 122.949 0.499 . . . . 1.04 111.484 177.302 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 93.74 10.47 58.92 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.323 -0.941 . . . . 0.53 113.588 177.531 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.506 ' HB2' ' O ' ' A' ' 109' ' ' SER . 83.4 p -81.84 46.98 1.04 Allowed 'General case' 0 C--O 1.234 0.252 0 CA-C-N 117.684 0.742 . . . . 0.7 111.326 -175.058 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 27.1 ttt180 69.32 -36.29 0.33 Allowed 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.805 0.842 . . . . 3.49 111.115 -179.602 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.475 ' H ' ' C ' ' A' ' 20' ' ' SER . 28.2 m120 -150.92 104.86 3.01 Favored Pre-proline 0 C--N 1.323 -0.576 0 N-CA-C 108.711 -0.848 . . . . 1.77 108.711 174.703 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_exo -64.04 -163.05 0.05 OUTLIER 'Trans proline' 0 CA--C 1.536 0.597 0 C-N-CA 123.172 2.581 . . . . 1.71 112.879 177.312 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.579 ' N ' HG22 ' A' ' 32' ' ' THR . 40.0 t 66.74 119.84 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-O 121.651 0.739 . . . . 0.48 111.596 -175.636 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.7 t -102.0 152.3 21.11 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 115.357 -0.838 . . . . 1.12 109.319 -179.278 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.682 ' CB ' ' HA ' ' A' ' 67' ' ' ASP . 8.6 tpp180 -79.91 -11.41 59.81 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.263 -1.014 . . . . 2.54 108.263 175.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.592 ' HG3' ' HD3' ' A' ' 65' ' ' ARG . 17.2 ttp180 -80.68 -43.65 20.02 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 114.75 -1.113 . . . . 1.77 109.285 173.729 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 32.3 p -91.05 -33.77 15.37 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 116.038 -0.528 . . . . 0.67 111.058 -175.41 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 81.78 -35.39 2.5 Favored Glycine 0 N--CA 1.452 -0.244 0 CA-C-N 116.089 -0.505 . . . . 0.82 113.154 176.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 -99.52 -64.19 1.06 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.757 0.313 . . . . 2.1 110.615 -175.806 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.1 p -154.08 150.49 28.26 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.308 -0.405 . . . . 1.08 111.608 -178.549 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.579 HG22 ' N ' ' A' ' 24' ' ' VAL . 8.9 t -124.73 14.92 8.7 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.905 0.859 . . . . 0.34 110.095 176.681 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.455 ' HA ' ' CB ' ' A' ' 18' ' ' SER . . . -63.67 -4.42 3.0 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.447 -0.797 . . . . 0.37 113.019 177.033 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 52.3 m-20 -89.88 -25.09 21.17 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.873 0.368 . . . . 2.21 110.538 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.435 HG13 ' OG1' ' A' ' 32' ' ' THR . 0.2 OUTLIER -102.29 139.22 23.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.989 -0.55 . . . . 0.31 110.081 -178.568 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.413 ' H ' ' HB2' ' A' ' 39' ' ' ASP . 25.3 p -100.02 -178.62 3.9 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 116.107 -0.497 . . . . 0.39 110.395 -175.904 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.494 ' O ' HG13 ' A' ' 41' ' ' ILE . 11.6 p90 -62.95 -30.78 71.83 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.517 -0.473 . . . . 1.53 109.872 177.223 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -72.66 -45.32 59.53 Favored 'General case' 0 CA--C 1.52 -0.173 0 CA-C-N 116.418 -0.355 . . . . 0.96 110.545 179.005 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.413 ' HB2' ' H ' ' A' ' 36' ' ' THR . 0.7 OUTLIER -67.35 -28.17 67.74 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-O 121.167 0.508 . . . . 0.91 110.345 176.389 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -69.34 -43.93 72.66 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.376 -0.829 . . . . 0.19 110.337 175.563 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.507 HG12 HD21 ' A' ' 111' ' ' LEU . 97.9 mt -62.65 -38.39 81.45 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.412 0 N-CA-C 109.529 -0.545 . . . . 0.3 109.529 173.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 3.5 ttpm? -61.16 -25.99 67.39 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.342 -0.844 . . . . 2.32 109.919 179.041 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.492 ' HG3' ' CD1' ' A' ' 47' ' ' TRP . 3.1 tp10 -87.99 -51.68 5.68 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.605 -0.725 . . . . 1.02 109.927 -178.444 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.967 HD22 ' HB3' ' A' ' 111' ' ' LEU . 33.0 tp -61.26 -37.85 84.6 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.421 -0.808 . . . . 0.17 110.573 -175.836 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.54 ' O ' ' HB2' ' A' ' 49' ' ' GLN . 3.5 mm100 -65.27 -26.57 68.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.19 -0.459 . . . . 0.87 112.077 -178.86 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.41 ' O ' ' HB3' ' A' ' 49' ' ' GLN . 68.5 mttm -81.29 -45.24 16.51 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.911 0.386 . . . . 1.31 110.41 178.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.492 ' CD1' ' HG3' ' A' ' 43' ' ' GLU . 42.9 m95 -65.36 -46.35 80.52 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.474 -0.33 . . . . 0.52 111.556 177.617 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.57 ' HB3' HG21 ' A' ' 113' ' ' ILE . 83.8 p -65.27 -22.49 66.86 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.11 0.481 . . . . 0.82 110.16 177.393 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.54 ' HB2' ' O ' ' A' ' 45' ' ' GLN . 11.2 tt0 -72.09 -56.9 4.81 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 115.762 -0.654 . . . . 0.53 109.753 174.886 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.633 ' HB3' HG22 ' A' ' 56' ' ' VAL . 97.0 mtt180 -61.42 -41.82 97.77 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.574 -0.739 . . . . 0.42 111.611 -176.462 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.518 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 92.3 mt -62.05 -35.17 67.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.212 -0.449 . . . . 0.2 110.738 177.368 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -79.59 -36.83 37.52 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.098 -0.501 . . . . 0.27 111.615 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 47.8 p -79.39 -29.78 42.2 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.794 0.33 . . . . 0.35 111.591 -175.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 108.63 5.89 31.27 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.6 -0.81 . . . . 0.3 112.142 -179.347 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.423 ' HB2' ' HB3' ' A' ' 50' ' ' ARG . 37.1 mt-10 -65.3 -47.89 75.02 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.931 0.396 . . . . 0.65 110.117 178.557 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.633 HG22 ' HB3' ' A' ' 50' ' ' ARG . 14.5 m -136.53 156.44 35.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 109.679 -0.489 . . . . 0.19 109.679 172.241 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.7 m -81.01 161.54 24.2 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.696 -0.483 . . . . 0.97 109.696 177.318 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -57.66 -42.53 83.69 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.025 -0.731 . . . . 0.22 109.025 177.003 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.46 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 38.6 mt-10 -57.47 -41.16 80.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.891 -1.05 . . . . 1.72 111.649 179.604 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -66.51 -45.72 78.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.128 0.49 . . . . 2.09 110.637 -178.13 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -71.09 -46.06 62.52 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.077 -0.511 . . . . 0.26 111.267 -179.034 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.69 -50.48 73.7 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.58 0.585 . . . . 0.24 112.58 -174.108 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.57 ' HA ' ' O ' ' A' ' 71' ' ' TYR . 67.5 m -55.83 -25.0 39.76 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 113.132 0.79 . . . . 1.0 113.132 -177.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -105.85 -44.57 4.6 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.275 0.56 . . . . 0.61 111.152 -177.247 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.592 ' HD3' ' HG3' ' A' ' 27' ' ' ARG . 22.6 mmt180 -96.69 -36.59 10.63 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 114.015 1.117 . . . . 0.86 114.015 -169.144 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.514 ' HB2' ' HG ' ' A' ' 13' ' ' LEU . 31.7 t -62.48 119.54 9.34 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.977 0.418 . . . . 0.82 110.623 -178.605 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.682 ' HA ' ' CB ' ' A' ' 26' ' ' ARG . 68.6 m-20 -79.05 -4.9 52.47 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.729 -0.669 . . . . 2.28 110.749 179.149 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 0.53 ' SG ' HD22 ' A' ' 14' ' ' LEU . 1.4 m -81.04 161.27 24.27 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.503 0.668 . . . . 1.52 110.888 173.091 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -63.2 -17.64 59.47 Favored Glycine 0 CA--C 1.516 0.149 0 CA-C-N 114.328 -1.306 . . . . 0.26 114.119 -173.387 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.503 ' HB2' ' CA ' ' A' ' 75' ' ' GLY . 2.3 p -67.01 -6.69 18.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 117.207 0.503 . . . . 0.32 112.283 177.787 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.57 ' O ' ' HA ' ' A' ' 63' ' ' SER . 35.2 p90 -52.03 -33.51 38.92 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.136 0.494 . . . . 0.54 110.396 174.901 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -92.36 1.57 57.15 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.058 0.456 . . . . 0.49 110.991 -176.574 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.6 m -115.58 -21.9 9.5 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.147 0.499 . . . . 0.71 110.709 -178.331 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.46 ' O ' ' HA ' ' A' ' 59' ' ' GLU . . . 108.04 15.7 14.0 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.906 -0.664 . . . . 0.54 112.02 -175.792 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.503 ' CA ' ' HB2' ' A' ' 70' ' ' SER . . . 96.65 -9.2 66.43 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.803 -0.713 . . . . 0.35 112.885 178.195 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -95.54 145.32 25.3 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.633 0.73 . . . . 1.65 111.559 -169.701 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -111.96 172.51 6.86 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 114.54 -1.209 . . . . 0.94 108.89 171.32 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -92.22 -145.71 16.65 Favored Glycine 0 C--N 1.311 -0.829 0 C-N-CA 120.65 -0.786 . . . . 0.44 111.905 -178.782 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -84.37 140.02 31.86 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.915 -0.402 . . . . 3.87 109.915 177.226 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -152.98 155.6 37.26 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.836 -0.62 . . . . 1.31 110.028 -178.241 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 50.5 m -79.74 139.58 37.25 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.463 -0.335 . . . . 1.17 110.695 -178.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 33.6 m -61.13 112.87 2.28 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.263 0.554 . . . . 1.19 110.317 179.26 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.467 ' H ' ' HG3' ' A' ' 90' ' ' GLU . . . 113.82 -11.36 22.99 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.901 -0.666 . . . . 0.79 112.023 -177.578 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -84.93 41.2 0.85 Allowed 'General case' 0 C--O 1.233 0.23 0 CA-C-O 121.657 0.741 . . . . 1.55 110.475 -177.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 24.3 mmt -136.82 -127.41 0.14 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.797 -0.638 . . . . 0.73 109.342 177.601 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 63.6 mtt -119.16 153.62 34.59 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 108.133 -1.062 . . . . 1.39 108.133 175.076 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.44 ' HB3' ' HD3' ' A' ' 88' ' ' PRO . 88.4 tttt -52.29 -55.13 34.42 Favored Pre-proline 0 CA--C 1.539 0.526 0 N-CA-C 112.38 0.511 . . . . 2.37 112.38 -175.445 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.44 ' HD3' ' HB3' ' A' ' 87' ' ' LYS . 73.4 Cg_endo -74.59 -26.76 11.48 Favored 'Trans proline' 0 C--N 1.357 0.982 0 C-N-CA 121.656 1.57 . . . . 0.27 111.976 -176.543 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.649 ' O ' HG23 ' A' ' 93' ' ' VAL . 32.1 t80 -68.31 -56.16 9.57 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.496 -0.774 . . . . 0.22 109.416 179.298 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.467 ' HG3' ' H ' ' A' ' 83' ' ' GLY . 4.2 tm-20 -65.38 -35.17 80.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.72 -0.673 . . . . 2.12 109.721 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.59 ' HA ' ' NE ' ' A' ' 94' ' ' ARG . 23.0 t70 -53.79 -33.55 56.31 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.432 -0.804 . . . . 0.61 110.978 175.601 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.551 ' O ' ' HG ' ' A' ' 96' ' ' LEU . . . -84.2 -37.74 21.46 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.408 -0.36 . . . . 0.22 111.132 178.571 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.649 HG23 ' O ' ' A' ' 89' ' ' PHE . 15.2 t -61.96 -44.17 98.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-O 121.447 0.641 . . . . 0.25 110.723 -177.189 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.59 ' NE ' ' HA ' ' A' ' 91' ' ' ASP . 26.4 ptt180 -74.14 -16.66 60.99 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.606 -0.725 . . . . 2.59 110.607 178.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -93.68 12.96 23.67 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.982 -0.554 . . . . 0.47 111.51 -174.069 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.556 ' HB2' ' HB2' ' A' ' 100' ' ' ASP . 0.7 OUTLIER -142.14 150.75 41.52 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.152 -0.476 . . . . 0.28 110.432 175.396 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.571 ' HA ' ' NH2' ' A' ' 116' ' ' ARG . 23.1 tptm -91.87 164.74 13.56 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.285 -0.635 . . . . 1.61 109.285 177.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.449 ' HA ' ' HG2' ' A' ' 116' ' ' ARG . 75.7 mt -41.83 115.94 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 123.458 0.474 . . . . 0.9 111.38 172.138 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 101.99 -8.07 55.51 Favored Glycine 0 N--CA 1.45 -0.427 0 CA-C-N 115.701 -0.681 . . . . 0.46 113.421 177.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.556 ' HB2' ' HB2' ' A' ' 96' ' ' LEU . 40.7 m-20 -99.06 141.22 32.09 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 117.16 0.48 . . . . 0.46 110.979 -179.428 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 8.3 mt -106.73 148.67 10.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.016 -0.538 . . . . 0.23 110.218 179.121 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 89.1 p -89.79 150.93 44.88 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 116.245 -0.434 . . . . 0.92 110.671 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -69.88 164.61 34.01 Favored 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 122.379 2.053 . . . . 0.34 111.041 171.708 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.872 HG23 HD23 ' A' ' 44' ' ' LEU . 24.9 mm -40.7 110.94 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 O-C-N 123.75 0.656 . . . . 0.2 112.506 179.577 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.1 p -119.07 123.51 71.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.183 -0.462 . . . . 1.04 110.085 175.715 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -85.73 149.32 25.37 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.098 0.475 . . . . 0.55 109.938 177.635 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 4.4 p -126.56 -172.03 2.54 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.768 -0.651 . . . . 0.37 110.936 -176.644 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -52.2 -44.36 64.68 Favored 'General case' 0 C--N 1.331 -0.238 0 O-C-N 123.508 0.505 . . . . 2.16 110.993 177.454 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.506 ' O ' ' HB2' ' A' ' 20' ' ' SER . 4.4 m -92.35 -61.14 1.67 Allowed 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 120.05 -0.66 . . . . 1.09 112.084 178.672 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -149.07 -128.35 1.68 Allowed Glycine 0 N--CA 1.438 -1.231 0 C-N-CA 118.749 -1.691 . . . . 0.24 113.413 -170.507 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.967 ' HB3' HD22 ' A' ' 44' ' ' LEU . 8.9 mp -116.08 148.88 39.79 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.604 -0.298 . . . . 0.19 111.53 -170.572 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' HIS . . . . . 0.744 ' CE1' HD13 ' A' ' 14' ' ' LEU . 69.1 m80 -145.51 150.92 37.32 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.215 0.531 . . . . 0.22 112.023 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.617 HG12 HD11 ' A' ' 44' ' ' LEU . 5.2 pt -130.17 133.87 63.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 107.669 -1.234 . . . . 0.17 107.669 159.659 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.442 HG21 HG22 ' A' ' 93' ' ' VAL . 2.8 mp -124.72 144.66 33.9 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 N-CA-C 110.07 -0.345 . . . . 0.18 110.07 -176.197 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.447 ' HG2' ' HB3' ' A' ' 11' ' ' ALA . 46.0 pttt -130.42 138.12 50.17 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.932 -0.766 . . . . 0.61 108.932 174.261 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ARG . . . . . 0.571 ' NH2' ' HA ' ' A' ' 97' ' ' LYS . 3.6 ttp180 -82.62 135.47 35.05 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.474 -0.49 . . . . 1.87 111.236 -177.792 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.527 HD21 ' HB2' ' A' ' 11' ' ' ALA . 0.3 OUTLIER -102.28 -30.65 10.96 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.69 -0.687 . . . . 0.89 110.974 177.714 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.466 ' O ' ' HD2' ' A' ' 116' ' ' ARG . . . . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.649 -0.691 . . . . 1.1 110.689 -178.682 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 69.3 mmtt . . . . . 0 CA--C 1.518 -0.271 0 CA-C-O 121.527 0.68 . . . . 1.19 111.487 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.628 HD23 ' N ' ' A' ' 9' ' ' ARG . 3.2 tt -154.61 151.45 28.83 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.01 -1.107 . . . . 1.18 108.01 -176.862 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.628 ' N ' HD23 ' A' ' 8' ' ' LEU . 65.1 ttt180 -135.05 131.64 37.27 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 108.722 -0.844 . . . . 1.06 108.722 173.476 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -148.99 150.9 33.63 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 120.066 -0.653 . . . . 0.22 112.337 -175.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.406 ' HB3' ' HG2' ' A' ' 115' ' ' LYS . . . -104.42 133.39 49.38 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.318 -0.855 . . . . 0.2 109.057 178.116 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 26.0 p-80 -135.88 154.66 51.08 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.105 0.479 . . . . 0.23 111.714 -172.667 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.552 HD23 ' N ' ' A' ' 14' ' ' LEU . 5.8 tt -123.93 148.98 46.44 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.538 -0.912 . . . . 0.24 108.538 177.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.747 HD13 ' CE1' ' A' ' 112' ' ' HIS . 24.5 tp -131.21 135.75 47.67 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 110.346 -0.242 . . . . 0.27 110.346 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.508 HG23 HD13 ' A' ' 44' ' ' LEU . 57.4 t -121.17 128.98 76.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 N-CA-C 109.619 -0.511 . . . . 0.15 109.619 172.566 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.49 ' HE3' HD21 ' A' ' 14' ' ' LEU . 12.6 mmtp -103.57 148.48 25.94 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.996 -0.547 . . . . 0.62 109.777 178.115 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.49 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 53.6 p90 -143.75 162.62 35.54 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.144 -0.48 . . . . 0.25 110.685 -178.442 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.477 ' HB3' ' HA ' ' A' ' 33' ' ' ALA . 19.7 p -49.46 112.25 0.61 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.144 -0.48 . . . . 1.04 111.509 178.679 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 95.89 8.6 57.97 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.681 -0.771 . . . . 0.53 113.56 178.646 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.407 ' C ' ' H ' ' A' ' 22' ' ' ASN . 77.3 p -91.11 43.3 1.14 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 117.59 0.695 . . . . 0.7 111.002 -177.672 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 74.5 ttt180 73.45 -32.79 0.25 Allowed 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.4 0.68 . . . . 3.49 111.418 177.806 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.407 ' H ' ' C ' ' A' ' 20' ' ' SER . 43.7 m-80 -135.55 100.74 11.16 Favored Pre-proline 0 C--N 1.324 -0.527 0 N-CA-C 109.209 -0.663 . . . . 1.77 109.209 175.663 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.546 ' C ' HG22 ' A' ' 32' ' ' THR . 92.7 Cg_endo -82.69 41.35 1.1 Allowed 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.372 2.048 . . . . 1.71 112.756 -175.636 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.443 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 89.5 t -141.54 116.88 5.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 108.626 -0.879 . . . . 0.48 108.626 177.529 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.559 ' HB2' ' OD1' ' A' ' 67' ' ' ASP . 19.7 p -103.57 154.85 19.04 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 110.286 -0.265 . . . . 1.12 110.286 -177.487 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.452 ' CG ' ' HA ' ' A' ' 67' ' ' ASP . 35.2 mmt180 -69.03 -22.97 64.02 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 108.661 -0.866 . . . . 2.54 108.661 173.352 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.465 ' HG3' ' HD2' ' A' ' 65' ' ' ARG . 5.3 tmm_? -70.74 -32.85 70.17 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 114.351 -1.295 . . . . 1.77 110.421 -179.209 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 75.4 p -100.04 -35.3 9.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.426 0.632 . . . . 0.67 110.795 178.33 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 65.65 18.26 65.74 Favored Glycine 0 N--CA 1.453 -0.201 0 CA-C-N 114.877 -1.056 . . . . 0.82 112.304 -178.782 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -141.95 -72.0 0.33 Allowed 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.769 -0.456 . . . . 2.1 109.769 -179.457 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.443 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 6.2 p -155.2 148.74 25.2 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.885 -0.598 . . . . 1.08 110.115 173.265 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.546 HG22 ' C ' ' A' ' 23' ' ' PRO . 14.5 t -113.42 22.69 13.94 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.939 0.876 . . . . 0.34 109.217 178.01 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.477 ' HA ' ' HB3' ' A' ' 18' ' ' SER . . . -72.58 -6.49 44.44 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.904 -1.044 . . . . 0.37 111.719 -177.538 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -96.22 -24.0 16.45 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.108 0.48 . . . . 2.21 111.118 -178.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.489 HG23 ' HB2' ' A' ' 39' ' ' ASP . 0.2 OUTLIER -96.77 135.1 32.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.279 -0.419 . . . . 0.31 109.972 179.531 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 59.6 p -96.31 -179.34 4.61 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.348 -0.387 . . . . 0.39 109.957 -175.351 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.41 ' O ' HG13 ' A' ' 41' ' ' ILE . 4.3 p90 -64.62 -27.22 68.79 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.967 -0.753 . . . . 1.53 108.967 175.651 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -74.13 -43.31 57.97 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 116.004 -0.544 . . . . 0.96 110.412 178.278 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.489 ' HB2' HG23 ' A' ' 35' ' ' VAL . 19.4 m-20 -65.36 -33.63 76.41 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.523 0.677 . . . . 0.91 109.934 175.602 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.49 ' HB2' ' HB3' ' A' ' 17' ' ' PHE . . . -70.79 -46.53 62.69 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.789 -1.096 . . . . 0.19 110.707 -179.631 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.41 HG13 ' O ' ' A' ' 37' ' ' TYR . 68.7 mt -63.18 -36.43 75.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 110.09 -0.337 . . . . 0.3 110.09 176.471 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -64.3 -25.18 67.93 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.29 0.567 . . . . 2.32 110.021 178.702 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.477 ' HG3' ' CD1' ' A' ' 47' ' ' TRP . 5.8 tp10 -84.87 -52.32 6.1 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.433 -0.803 . . . . 1.02 109.024 -178.894 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.909 HD22 ' HB3' ' A' ' 111' ' ' LEU . 30.9 tp -62.72 -37.57 87.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.045 -0.98 . . . . 0.17 110.535 -175.008 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.45 ' O ' ' HB2' ' A' ' 49' ' ' GLN . 11.3 mm-40 -67.18 -28.93 68.5 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 112.304 0.483 . . . . 0.87 112.304 -177.882 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -78.35 -43.39 27.81 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.636 -0.426 . . . . 1.31 110.131 178.219 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.477 ' CD1' ' HG3' ' A' ' 43' ' ' GLU . 49.3 m95 -64.48 -47.14 80.09 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 111.974 0.361 . . . . 0.52 111.974 176.794 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.507 ' HB3' HG21 ' A' ' 113' ' ' ILE . 88.7 p -63.99 -25.58 68.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.987 0.422 . . . . 0.82 110.15 177.867 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.45 ' HB2' ' O ' ' A' ' 45' ' ' GLN . 14.2 tt0 -71.97 -56.13 6.22 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.994 -0.548 . . . . 0.53 110.071 175.09 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.566 ' HB3' HG22 ' A' ' 56' ' ' VAL . 97.2 mtt180 -61.12 -41.93 97.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.935 -0.575 . . . . 0.42 111.646 -176.443 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.478 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 93.9 mt -60.66 -36.82 73.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 120.976 0.417 . . . . 0.2 110.458 177.224 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -77.99 -37.37 47.39 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.01 -0.541 . . . . 0.27 111.426 -179.059 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 55.4 p -78.69 -29.19 45.39 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.843 0.354 . . . . 0.35 111.488 -177.529 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 106.28 9.56 31.37 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.764 -0.732 . . . . 0.3 112.318 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.453 ' HB2' ' HB3' ' A' ' 50' ' ' ARG . 45.4 mt-10 -67.47 -45.11 76.87 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.895 0.379 . . . . 0.65 110.348 178.473 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.566 HG22 ' HB3' ' A' ' 50' ' ' ARG . 11.5 m -135.95 154.78 34.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 109.088 -0.708 . . . . 0.19 109.088 171.493 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.5 m -85.65 159.0 19.94 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.191 -0.67 . . . . 0.97 109.191 177.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -53.94 -46.97 71.72 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.938 0.399 . . . . 0.22 109.972 -177.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.543 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 48.8 mt-10 -61.58 -26.44 67.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.533 -0.758 . . . . 1.72 112.46 -179.061 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 53.8 mm-40 -72.92 -50.91 20.78 Favored 'General case' 0 CA--C 1.519 -0.223 0 C-N-CA 120.516 -0.473 . . . . 2.09 110.358 178.54 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -67.95 -47.34 68.92 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.185 -0.461 . . . . 0.26 111.127 -177.742 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -57.39 -53.62 56.04 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.217 0.451 . . . . 0.24 112.217 -174.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.52 ' HA ' ' O ' ' A' ' 71' ' ' TYR . 23.5 m -52.3 -18.15 1.45 Allowed 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 113.614 0.968 . . . . 1.0 113.614 -178.227 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -110.41 -43.89 3.81 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-O 121.577 0.703 . . . . 0.61 110.309 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.465 ' HD2' ' HG3' ' A' ' 27' ' ' ARG . 15.5 mmt180 -96.34 -36.86 10.72 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 114.212 1.19 . . . . 0.86 114.212 -170.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.476 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 52.6 p -63.37 116.0 5.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.263 0.554 . . . . 0.82 110.362 -176.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.559 ' OD1' ' HB2' ' A' ' 25' ' ' SER . 57.3 m-20 -84.71 9.68 13.3 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.536 -0.756 . . . . 2.28 111.123 -177.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 0.48 ' SG ' HD22 ' A' ' 14' ' ' LEU . 1.1 m -80.95 -177.33 6.36 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.666 -0.697 . . . . 1.52 110.294 170.361 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -76.09 -21.0 76.92 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.358 -0.925 . . . . 0.26 111.699 175.858 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 71.2 p -65.84 0.46 1.77 Allowed 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 113.227 0.825 . . . . 0.32 113.227 -178.725 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.52 ' O ' ' HA ' ' A' ' 63' ' ' SER . 27.7 p90 -62.94 -22.6 66.9 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 118.361 0.528 . . . . 0.54 109.928 176.384 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -94.24 -2.94 51.58 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.382 0.61 . . . . 0.49 110.087 177.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.6 m -115.49 1.01 13.54 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.296 -0.865 . . . . 0.71 110.596 -175.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.543 ' O ' ' HA ' ' A' ' 59' ' ' GLU . . . 72.9 21.84 79.52 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.935 -0.65 . . . . 0.54 111.998 -176.434 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 86.28 -20.58 21.04 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 121.026 -0.606 . . . . 0.35 112.099 -177.672 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -69.93 132.04 45.34 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-N 115.553 -0.323 . . . . 1.65 110.984 -176.027 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.511 ' O ' ' HG3' ' A' ' 9' ' ' ARG . 2.9 mp -118.17 161.82 19.24 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.248 0.547 . . . . 0.94 110.283 174.741 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -85.71 -165.46 40.6 Favored Glycine 0 C--N 1.31 -0.913 0 CA-C-N 114.899 -1.046 . . . . 0.44 112.834 -178.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.627 ' HA ' ' O ' ' A' ' 8' ' ' LEU . 85.0 m-85 -73.91 142.97 45.94 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.271 0.558 . . . . 3.87 112.221 -176.301 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.535 ' CE1' ' HB3' ' A' ' 8' ' ' LEU . 2.3 p90 -149.69 167.93 25.03 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.964 -1.016 . . . . 1.31 108.787 176.336 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 37.3 m -96.63 122.46 39.57 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 108.478 -0.934 . . . . 1.17 108.478 170.721 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 4.6 p -47.14 123.05 4.97 Favored 'General case' 0 C--N 1.329 -0.306 0 O-C-N 123.662 0.602 . . . . 1.19 111.409 -179.148 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 114.49 17.78 6.91 Favored Glycine 0 N--CA 1.445 -0.766 0 N-CA-C 110.911 -0.875 . . . . 0.79 110.911 -174.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -115.09 -17.02 11.54 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 120.587 0.232 . . . . 1.55 111.173 -178.464 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 26.4 mmt -86.22 -92.37 0.09 Allowed 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.315 -0.554 . . . . 0.73 110.895 -173.163 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' MET . . . . . 0.495 ' HB2' ' CB ' ' A' ' 89' ' ' PHE . 45.6 mtt -144.22 155.34 43.84 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 107.228 -1.397 . . . . 1.39 107.228 177.06 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp -57.95 -53.54 64.72 Favored Pre-proline 0 C--N 1.317 -0.847 0 C-N-CA 120.274 -0.57 . . . . 2.37 112.059 -176.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.509 ' HG2' HG22 ' A' ' 107' ' ' THR . 73.4 Cg_endo -74.81 -30.12 7.85 Favored 'Trans proline' 0 C--N 1.356 0.962 0 C-N-CA 121.736 1.624 . . . . 0.27 111.855 -179.315 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.634 ' O ' HG23 ' A' ' 93' ' ' VAL . 11.2 t80 -61.97 -56.14 22.19 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.561 -0.745 . . . . 0.22 109.181 176.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.407 ' HB2' ' O ' ' A' ' 86' ' ' MET . 0.7 OUTLIER -62.15 -33.32 74.28 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.284 -0.871 . . . . 2.12 110.5 -179.891 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -60.55 -32.58 71.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.676 -0.693 . . . . 0.61 110.581 178.631 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.426 ' O ' ' HG ' ' A' ' 96' ' ' LEU . . . -83.86 -31.18 25.9 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.0 -0.545 . . . . 0.22 111.055 178.821 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.634 HG23 ' O ' ' A' ' 89' ' ' PHE . 20.2 t -68.8 -38.48 78.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.404 0.621 . . . . 0.25 109.781 -176.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.456 ' C ' ' HD2' ' A' ' 94' ' ' ARG . 2.8 ppt_? -79.44 -1.31 36.75 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.522 -0.763 . . . . 2.59 110.61 178.591 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -103.6 9.94 37.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 0.47 111.285 -177.365 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.567 ' HB2' ' HB2' ' A' ' 100' ' ' ASP . 1.0 OUTLIER -145.96 146.26 30.96 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.354 -0.385 . . . . 0.28 110.965 179.51 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.401 ' HG3' ' N ' ' A' ' 98' ' ' ILE . 56.6 tptt -91.01 168.98 11.26 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.773 -0.825 . . . . 1.61 108.773 177.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.453 ' HA ' ' HG2' ' A' ' 116' ' ' ARG . 72.0 mt -45.43 116.94 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.111 0.481 . . . . 0.9 111.234 173.593 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 103.47 -11.8 54.3 Favored Glycine 0 N--CA 1.449 -0.438 0 CA-C-N 115.54 -0.755 . . . . 0.46 113.115 178.341 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.567 ' HB2' ' HB2' ' A' ' 96' ' ' LEU . 14.6 m-20 -93.96 144.28 25.6 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 117.191 0.496 . . . . 0.46 110.716 -179.594 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 10.0 mt -112.62 147.93 16.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.756 -0.656 . . . . 0.23 109.67 -179.45 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 91.4 p -89.89 157.41 46.11 Favored Pre-proline 0 C--N 1.319 -0.733 0 CA-C-N 116.356 -0.384 . . . . 0.92 110.365 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -74.23 173.82 13.53 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 122.267 1.978 . . . . 0.34 111.132 171.206 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.893 HG23 HD23 ' A' ' 44' ' ' LEU . 21.9 mm -46.51 113.4 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-O 121.133 0.492 . . . . 0.2 112.019 176.266 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 93.4 t -111.72 117.77 55.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.91 -0.586 . . . . 1.04 109.831 174.456 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -86.04 137.97 32.3 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.107 0.48 . . . . 0.55 110.278 177.479 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.509 HG22 ' HG2' ' A' ' 88' ' ' PRO . 20.1 p -123.77 -172.23 2.49 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.664 -0.698 . . . . 0.37 110.21 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -66.67 -44.24 82.38 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.664 0.269 . . . . 2.16 110.996 178.362 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 5.3 t -95.63 -1.41 50.3 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.302 0.482 . . . . 1.09 112.302 -173.781 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 157.67 -124.68 1.44 Allowed Glycine 0 N--CA 1.437 -1.277 0 C-N-CA 119.775 -1.202 . . . . 0.24 112.995 170.399 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.909 ' HB3' HD22 ' A' ' 44' ' ' LEU . 6.6 mp -127.9 145.66 50.88 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.112 -0.544 . . . . 0.19 110.807 -170.77 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' HIS . . . . . 0.747 ' CE1' HD13 ' A' ' 14' ' ' LEU . 72.7 m80 -143.95 143.06 31.07 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.486 0.551 . . . . 0.22 112.486 -178.276 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.619 HG12 HD11 ' A' ' 44' ' ' LEU . 3.9 pt -127.07 141.55 45.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 107.884 -1.154 . . . . 0.17 107.884 161.113 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 2.8 mp -132.35 148.47 31.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 C-N-CA 120.976 -0.29 . . . . 0.18 110.396 -175.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.452 ' HE3' HD11 ' A' ' 117' ' ' LEU . 44.9 pttt -131.62 139.32 49.11 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.016 -0.735 . . . . 0.61 109.016 172.719 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ARG . . . . . 0.484 ' HD3' HD21 ' A' ' 8' ' ' LEU . 5.9 ttp180 -84.1 136.48 33.99 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.104 0.478 . . . . 1.87 111.494 -178.507 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.452 HD11 ' HE3' ' A' ' 115' ' ' LYS . 1.4 mm? -107.09 -27.96 10.28 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.295 -0.866 . . . . 0.89 110.743 177.216 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.505 ' HB3' ' HB3' ' A' ' 9' ' ' ARG . . . . . . . . 0 C--O 1.245 0.868 0 CA-C-O 118.291 -0.862 . . . . 1.1 110.452 179.691 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt . . . . . 0 N--CA 1.45 -0.442 0 CA-C-O 121.859 0.838 . . . . 1.19 111.532 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.816 HD21 ' HD3' ' A' ' 116' ' ' ARG . 2.4 tt -119.53 159.92 23.4 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 114.242 -1.345 . . . . 1.18 107.883 179.805 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.694 ' H ' HD23 ' A' ' 8' ' ' LEU . 63.2 ttt180 -140.46 127.07 20.26 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 108.869 -0.789 . . . . 1.06 108.869 175.759 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -141.09 154.1 45.76 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 120.31 -0.556 . . . . 0.22 112.231 -179.453 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.498 ' HA ' ' HA ' ' A' ' 76' ' ' ASP . . . -104.46 134.81 47.04 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.334 -0.848 . . . . 0.2 108.922 174.859 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.515 ' HE1' HD13 ' A' ' 77' ' ' LEU . 16.7 p-80 -141.59 138.51 32.67 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.969 0.414 . . . . 0.23 111.125 -171.031 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.532 ' O ' ' HA ' ' A' ' 112' ' ' HIS . 6.0 tt -109.43 137.31 47.48 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.326 -0.99 . . . . 0.24 108.326 177.378 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.792 HD13 ' CE1' ' A' ' 112' ' ' HIS . 17.4 tp -120.23 135.03 55.12 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.615 -0.266 . . . . 0.27 110.837 -176.515 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.549 HG23 HD13 ' A' ' 44' ' ' LEU . 83.4 t -121.89 133.62 67.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 109.854 -0.424 . . . . 0.15 109.854 174.293 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.693 ' HE3' HD21 ' A' ' 14' ' ' LEU . 32.7 mmtp -104.76 149.75 25.35 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.917 -0.583 . . . . 0.62 110.495 177.752 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.561 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 49.9 p90 -145.4 163.04 35.85 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.702 -0.681 . . . . 0.25 109.674 179.456 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.489 ' HB3' ' HA ' ' A' ' 33' ' ' ALA . 29.9 p -51.67 109.35 0.35 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.923 0.392 . . . . 1.04 110.425 176.962 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 109.93 9.28 24.7 Favored Glycine 0 CA--C 1.523 0.585 0 C-N-CA 120.625 -0.798 . . . . 0.53 112.795 -176.585 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.487 ' C ' ' H ' ' A' ' 22' ' ' ASN . 75.4 m -90.2 34.24 0.87 Allowed 'General case' 0 C--O 1.235 0.3 0 N-CA-C 112.359 0.503 . . . . 0.7 112.359 -177.599 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.457 ' HB3' ' O ' ' A' ' 20' ' ' SER . 20.8 ttt85 72.94 -30.33 0.21 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 122.925 0.49 . . . . 3.49 110.917 -179.686 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.487 ' H ' ' C ' ' A' ' 20' ' ' SER . 6.1 p30 -146.96 114.54 4.29 Favored Pre-proline 0 C--N 1.322 -0.618 0 N-CA-C 108.843 -0.799 . . . . 1.77 108.843 172.34 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.429 ' C ' HG22 ' A' ' 32' ' ' THR . 93.6 Cg_endo -86.21 52.5 2.91 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 122.573 2.182 . . . . 1.71 113.403 -173.009 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.415 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 61.0 t -142.53 119.78 6.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 109.342 -0.614 . . . . 0.48 109.342 177.324 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.46 ' HB3' ' HB2' ' A' ' 16' ' ' LYS . 13.5 p -103.83 156.08 18.11 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 121.211 -0.196 . . . . 1.12 110.886 -179.61 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.66 ' HB2' ' HA ' ' A' ' 67' ' ' ASP . 1.7 mpt_? -69.82 -16.99 63.37 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 109.155 -0.683 . . . . 2.54 109.155 173.443 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.515 ' HG2' ' HA ' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -82.42 -25.5 33.62 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.896 -1.047 . . . . 1.77 111.008 -178.629 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 73.3 p -105.33 -36.05 7.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.244 0.545 . . . . 0.67 110.934 178.324 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 76.27 -21.63 2.24 Favored Glycine 0 CA--C 1.52 0.395 0 CA-C-N 115.308 -0.86 . . . . 0.82 112.983 -179.354 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -101.76 -76.15 0.58 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.119 0.485 . . . . 2.1 110.043 -179.723 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.415 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 21.4 m -154.75 151.47 28.73 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.804 -0.635 . . . . 1.08 109.885 175.927 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.429 HG22 ' C ' ' A' ' 23' ' ' PRO . 12.4 t -113.8 23.0 13.46 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 122.181 0.991 . . . . 0.34 109.145 177.478 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.489 ' HA ' ' HB3' ' A' ' 18' ' ' SER . . . -71.71 -5.6 35.07 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.715 -1.129 . . . . 0.37 111.401 -178.555 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -99.09 -15.24 19.07 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.602 -0.726 . . . . 2.21 110.688 -175.51 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -105.57 138.44 30.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.93 -0.577 . . . . 0.31 109.704 179.772 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 62.4 p -94.77 -179.48 4.87 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.395 -0.366 . . . . 0.39 110.014 -175.882 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.519 ' O ' HG13 ' A' ' 41' ' ' ILE . 15.4 p90 -63.65 -28.35 69.85 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 119.986 -0.686 . . . . 1.53 109.223 176.302 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -75.11 -44.66 45.92 Favored 'General case' 0 CA--C 1.522 -0.132 0 CA-C-N 116.182 -0.463 . . . . 0.96 110.682 178.288 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -62.87 -33.29 74.98 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.479 0.656 . . . . 0.91 109.639 176.905 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.561 ' HB2' ' HB3' ' A' ' 17' ' ' PHE . . . -68.6 -44.64 73.91 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.944 -1.026 . . . . 0.19 110.671 178.269 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.519 HG13 ' O ' ' A' ' 37' ' ' TYR . 90.2 mt -63.28 -35.04 70.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 109.612 -0.514 . . . . 0.3 109.612 175.023 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.42 ' HD2' ' HA ' ' A' ' 42' ' ' LYS . 23.5 mmmt -64.67 -21.29 66.7 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.072 -0.513 . . . . 2.32 111.06 176.869 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.422 ' HG3' ' CD1' ' A' ' 47' ' ' TRP . 2.0 tp10 -88.57 -57.46 2.91 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.881 -0.6 . . . . 1.02 109.561 178.04 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.887 HD23 HG23 ' A' ' 104' ' ' ILE . 27.7 tp -58.8 -36.78 75.02 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.404 -0.816 . . . . 0.17 111.469 -175.302 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.535 ' O ' ' HB2' ' A' ' 49' ' ' GLN . 3.8 mm100 -66.45 -26.5 67.24 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 112.23 0.456 . . . . 0.87 112.23 -177.397 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.402 ' HE3' ' O ' ' A' ' 42' ' ' LYS . 96.7 mttt -78.88 -45.52 20.46 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.101 0.476 . . . . 1.31 109.832 178.08 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.422 ' CD1' ' HG3' ' A' ' 43' ' ' GLU . 24.3 m95 -67.21 -43.52 81.85 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.799 -0.637 . . . . 0.52 111.554 -178.095 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.553 ' HB3' HG21 ' A' ' 113' ' ' ILE . 97.2 p -67.18 -27.75 67.53 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 120.935 0.397 . . . . 0.82 109.969 177.211 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.535 ' HB2' ' O ' ' A' ' 45' ' ' GLN . 8.9 tt0 -67.58 -52.94 32.61 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 115.933 -0.576 . . . . 0.53 109.638 175.611 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.604 ' HB3' HG22 ' A' ' 56' ' ' VAL . 91.6 mtt180 -60.97 -42.35 98.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.705 -0.68 . . . . 0.42 111.556 -178.51 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.441 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 78.4 mt -60.29 -40.74 84.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.94 0.4 . . . . 0.2 110.744 177.354 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.4 -39.0 65.42 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.941 -0.572 . . . . 0.27 111.979 179.035 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 74.7 p -79.75 -29.37 40.48 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 111.809 0.3 . . . . 0.35 111.809 -175.473 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 109.11 4.27 31.18 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.599 -0.81 . . . . 0.3 112.898 179.367 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.437 ' HB2' ' HB3' ' A' ' 50' ' ' ARG . 46.7 mt-10 -62.05 -47.01 86.59 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.089 0.471 . . . . 0.65 110.084 177.443 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.604 HG22 ' HB3' ' A' ' 50' ' ' ARG . 10.2 m -134.9 159.0 41.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.821 -0.627 . . . . 0.19 109.378 171.743 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 19.7 m -92.98 161.96 14.25 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 109.562 -0.533 . . . . 0.97 109.562 177.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -54.19 -48.19 71.26 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.728 0.299 . . . . 0.22 110.452 -175.557 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.452 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 43.6 mt-10 -56.4 -40.36 74.51 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.739 -0.664 . . . . 1.72 111.948 179.469 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -63.82 -50.25 69.67 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.0 0.429 . . . . 2.09 110.738 -178.327 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -68.91 -46.5 68.14 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.877 -0.602 . . . . 0.26 111.132 -177.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.427 ' O ' ' HB3' ' A' ' 66' ' ' SER . . . -60.12 -46.28 90.15 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.648 0.61 . . . . 0.24 112.648 -173.304 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.492 ' HA ' ' HA ' ' A' ' 71' ' ' TYR . 20.4 m -57.75 -20.36 34.39 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.781 0.66 . . . . 1.0 112.781 -178.87 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -110.72 -46.58 3.35 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.521 0.677 . . . . 0.61 110.726 -178.331 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.515 ' HA ' ' HG2' ' A' ' 27' ' ' ARG . 18.8 mmt180 -90.17 -37.65 14.03 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.963 -1.017 . . . . 0.86 113.174 -170.961 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.448 ' O ' ' HB3' ' A' ' 71' ' ' TYR . 42.7 t -64.36 115.71 5.36 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.243 0.544 . . . . 0.82 110.953 -177.57 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.66 ' HA ' ' HB2' ' A' ' 26' ' ' ARG . 44.5 m-20 -82.28 10.16 7.49 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.416 -0.811 . . . . 2.28 111.024 179.589 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 0.477 ' O ' ' HD1' ' A' ' 71' ' ' TYR . 49.6 t -93.34 166.34 12.34 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.07 -0.513 . . . . 1.52 109.728 172.458 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -56.19 -26.83 50.94 Favored Glycine 0 CA--C 1.519 0.293 0 O-C-N 123.41 0.444 . . . . 0.26 113.315 -177.88 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.529 ' HB2' ' CA ' ' A' ' 75' ' ' GLY . 2.6 p -61.83 -8.26 4.68 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 112.849 0.685 . . . . 0.32 112.849 -179.565 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.492 ' HA ' ' HA ' ' A' ' 63' ' ' SER . 15.5 p90 -59.46 -29.73 68.01 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 108.979 -0.749 . . . . 0.54 108.979 174.112 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -95.33 8.59 42.69 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.741 -0.663 . . . . 0.49 111.045 179.361 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 5.0 m -125.29 -20.87 4.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.626 -0.261 . . . . 0.71 111.435 -177.798 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.452 ' O ' ' HA ' ' A' ' 59' ' ' GLU . . . 109.42 15.95 11.74 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.624 -0.798 . . . . 0.54 112.343 -177.602 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.529 ' CA ' ' HB2' ' A' ' 70' ' ' SER . . . 89.63 -12.99 65.33 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.75 -0.738 . . . . 0.35 113.04 177.701 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.498 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 10.6 p-10 -106.35 144.56 32.86 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.507 0.67 . . . . 1.65 111.372 -171.266 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.515 HD13 ' HE1' ' A' ' 12' ' ' HIS . 0.3 OUTLIER -105.74 174.48 5.86 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.756 -1.111 . . . . 0.94 109.725 176.931 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -90.63 -143.75 11.34 Favored Glycine 0 C--N 1.315 -0.614 0 C-N-CA 121.019 -0.61 . . . . 0.44 112.232 -179.15 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -88.31 123.77 33.23 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.018 0.437 . . . . 3.87 110.621 178.819 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.406 ' CE1' ' HB3' ' A' ' 8' ' ' LEU . 2.3 p90 -137.82 146.45 43.51 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.887 -0.597 . . . . 1.31 110.351 -179.515 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 36.6 m -76.19 137.88 40.31 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 120.829 0.347 . . . . 1.17 110.096 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 16.7 m -63.92 118.99 9.2 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.984 -0.553 . . . . 1.19 111.332 -175.792 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 114.49 -5.34 23.06 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.986 -0.626 . . . . 0.79 112.387 -178.706 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -104.24 59.96 0.72 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.255 0.55 . . . . 1.55 110.682 -179.41 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 23.0 mmt -144.03 -97.46 0.11 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.031 0.443 . . . . 0.73 110.453 177.451 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 63.6 mtt -146.32 151.04 36.88 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.015 -1.106 . . . . 1.39 108.015 173.87 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.428 ' HB3' ' HD3' ' A' ' 88' ' ' PRO . 23.1 tptm -52.98 -53.16 58.31 Favored Pre-proline 0 C--N 1.319 -0.738 0 N-CA-C 112.445 0.535 . . . . 2.37 112.445 -176.231 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.46 ' HG2' HG22 ' A' ' 107' ' ' THR . 75.6 Cg_endo -77.77 -26.04 7.23 Favored 'Trans proline' 0 C--N 1.356 0.938 0 C-N-CA 121.734 1.623 . . . . 0.27 112.587 -176.501 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.546 ' O ' HG23 ' A' ' 93' ' ' VAL . 43.6 t80 -73.26 -55.24 6.7 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.805 -0.634 . . . . 0.22 109.824 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.409 ' O ' ' HD3' ' A' ' 94' ' ' ARG . 4.8 tm-20 -64.27 -35.12 79.81 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.241 -0.891 . . . . 2.12 110.022 -178.638 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.571 ' HA ' ' CZ ' ' A' ' 94' ' ' ARG . 15.6 t70 -50.16 -40.85 47.92 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.735 -0.666 . . . . 0.61 110.795 175.107 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.587 ' O ' ' HG ' ' A' ' 96' ' ' LEU . . . -78.24 -30.74 48.84 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.098 -0.501 . . . . 0.22 111.184 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.546 HG23 ' O ' ' A' ' 89' ' ' PHE . 26.3 t -63.39 -47.74 90.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.676 -0.238 . . . . 0.25 111.244 -174.841 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.571 ' CZ ' ' HA ' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -83.75 -4.92 59.02 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.247 -0.581 . . . . 2.59 110.582 -179.476 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.27 -20.68 40.4 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.057 0.456 . . . . 0.47 110.906 -179.453 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.603 ' HB2' ' HB2' ' A' ' 100' ' ' ASP . 0.7 OUTLIER -121.02 147.37 45.59 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.969 -0.559 . . . . 0.28 110.441 -179.909 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.401 ' HG3' ' N ' ' A' ' 98' ' ' ILE . 51.3 tptt -90.19 172.67 8.63 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.438 -0.578 . . . . 1.61 109.438 -179.519 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.441 ' HA ' ' HG2' ' A' ' 116' ' ' ARG . 71.4 mt -48.26 113.67 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.934 0.397 . . . . 0.9 111.377 176.233 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 101.78 -3.69 52.94 Favored Glycine 0 CA--C 1.522 0.481 0 C-N-CA 120.939 -0.648 . . . . 0.46 113.913 178.225 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.603 ' HB2' ' HB2' ' A' ' 96' ' ' LEU . 26.1 m-20 -99.15 142.47 30.6 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 117.599 0.7 . . . . 0.46 110.353 178.565 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 8.9 mt -109.69 152.32 11.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.428 -0.351 . . . . 0.23 110.307 -178.38 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 4.7 p -101.35 148.34 35.04 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-O 121.007 0.432 . . . . 0.92 111.555 -178.478 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -68.94 159.85 52.23 Favored 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.697 2.265 . . . . 0.34 111.145 171.855 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.887 HG23 HD23 ' A' ' 44' ' ' LEU . 22.1 mm -39.26 112.19 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 O-C-N 123.823 0.702 . . . . 0.2 112.557 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 1.9 p -116.37 128.1 73.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.813 -0.63 . . . . 1.04 110.128 175.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -90.53 138.37 31.61 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 121.247 0.546 . . . . 0.55 110.15 178.471 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.46 HG22 ' HG2' ' A' ' 88' ' ' PRO . 11.5 p -116.35 -175.91 2.85 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.577 -0.738 . . . . 0.37 110.68 -177.316 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -57.99 -42.21 84.66 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 123.287 0.367 . . . . 2.16 111.009 179.353 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.44 ' OG ' ' HE2' ' A' ' 16' ' ' LYS . 24.5 t -85.16 -61.38 1.78 Allowed 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 116.493 -0.321 . . . . 1.09 110.56 179.394 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -154.39 -128.68 1.22 Allowed Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 119.399 -1.381 . . . . 0.24 113.39 -174.551 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.856 ' HB3' HD22 ' A' ' 44' ' ' LEU . 5.8 mp -112.35 145.43 40.08 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 122.379 0.272 . . . . 0.19 111.676 -171.795 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' HIS . . . . . 0.792 ' CE1' HD13 ' A' ' 14' ' ' LEU . 61.0 m80 -142.2 153.36 43.95 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 112.947 0.721 . . . . 0.22 112.947 178.001 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.574 HG12 HD11 ' A' ' 44' ' ' LEU . 4.3 pt -131.38 134.74 60.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 114.347 -1.297 . . . . 0.17 107.684 159.67 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.413 HD13 ' HB3' ' A' ' 92' ' ' ALA . 1.5 mp -128.14 146.22 34.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 C-N-CA 120.734 -0.386 . . . . 0.18 110.905 -176.126 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 37.2 pttt -129.5 141.06 51.08 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.346 -0.983 . . . . 0.61 108.346 170.884 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ARG . . . . . 0.816 ' HD3' HD21 ' A' ' 8' ' ' LEU . 4.7 ttp180 -82.22 134.9 35.32 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.255 -0.578 . . . . 1.87 110.857 -179.189 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -103.07 -35.1 8.64 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.191 -0.913 . . . . 0.89 110.286 -179.104 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.937 0 CA-C-O 118.555 -0.736 . . . . 1.1 110.485 -179.607 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.486 ' HA ' ' O ' ' A' ' 80' ' ' PHE . 73.2 mmtt . . . . . 0 N--CA 1.449 -0.477 0 CA-C-O 121.748 0.785 . . . . 1.19 110.415 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.657 ' HB3' ' CE1' ' A' ' 80' ' ' PHE . 2.8 tt -100.62 155.5 17.84 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 113.878 -1.51 . . . . 1.18 108.489 -178.044 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.593 ' N ' HD23 ' A' ' 8' ' ' LEU . 71.8 ttt180 -132.65 127.97 36.03 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 108.674 -0.861 . . . . 1.06 108.674 170.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -146.4 153.8 40.89 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.258 -0.577 . . . . 0.22 112.095 -175.131 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.417 ' HB3' ' HG2' ' A' ' 115' ' ' LYS . . . -106.16 136.66 45.47 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.382 -0.826 . . . . 0.2 109.417 178.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 35.7 p-80 -137.15 149.48 47.32 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.917 0.389 . . . . 0.23 111.321 -173.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.676 ' O ' ' HA ' ' A' ' 112' ' ' HIS . 5.2 tt -123.09 131.75 53.82 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.818 -0.808 . . . . 0.24 108.818 179.293 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.796 HD13 ' CE1' ' A' ' 112' ' ' HIS . 25.6 tp -116.57 123.51 47.53 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.493 -0.321 . . . . 0.27 110.767 -177.531 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.623 HG23 HD13 ' A' ' 44' ' ' LEU . 63.3 t -110.84 134.04 54.42 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 N-CA-C 109.349 -0.611 . . . . 0.15 109.349 173.522 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.495 ' HE2' ' OG ' ' A' ' 109' ' ' SER . 30.4 mmtp -105.91 154.3 20.76 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.492 -0.558 . . . . 0.62 109.492 178.703 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.46 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 48.9 p90 -146.53 160.57 41.96 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.801 0.334 . . . . 0.25 110.954 -177.858 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.3 t -52.56 112.21 0.78 Allowed 'General case' 0 N--CA 1.435 -1.193 0 CA-C-N 115.997 -0.547 . . . . 1.04 111.323 178.634 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 100.46 2.86 55.52 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.605 -0.807 . . . . 0.53 113.205 177.033 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.41 ' C ' ' H ' ' A' ' 22' ' ' ASN . 91.3 p -90.19 40.15 1.0 Allowed 'General case' 0 C--O 1.234 0.277 0 CA-C-N 117.62 0.71 . . . . 0.7 111.086 -176.109 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.416 ' CZ ' ' HB2' ' A' ' 108' ' ' ASP . 96.3 mtt180 72.2 -32.85 0.25 Allowed 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.36 0.664 . . . . 3.49 111.771 178.291 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.41 ' H ' ' C ' ' A' ' 20' ' ' SER . 52.5 m-80 -136.99 93.11 13.64 Favored Pre-proline 0 C--N 1.326 -0.453 0 N-CA-C 109.308 -0.627 . . . . 1.77 109.308 175.802 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.56 ' C ' HG22 ' A' ' 32' ' ' THR . 95.5 Cg_endo -83.69 51.72 3.57 Favored 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 122.546 2.164 . . . . 1.71 113.233 -174.51 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.498 ' N ' HG22 ' A' ' 32' ' ' THR . 61.2 t -144.89 118.56 2.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 109.323 -0.621 . . . . 0.48 109.323 177.133 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 23.5 p -105.18 153.07 22.05 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 110.503 -0.184 . . . . 1.12 110.503 178.399 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.585 ' HB2' ' HA ' ' A' ' 67' ' ' ASP . 7.4 mpt_? -66.2 -10.22 39.55 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.007 0.432 . . . . 2.54 110.565 173.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.586 ' HG3' ' CD ' ' A' ' 65' ' ' ARG . 17.6 ttp180 -75.59 -41.12 55.37 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.812 -0.631 . . . . 1.77 109.506 176.288 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 40.0 p -95.79 -35.41 11.53 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.234 -0.894 . . . . 0.67 111.231 -175.122 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 78.03 -35.07 1.69 Allowed Glycine 0 CA--C 1.518 0.244 0 CA-C-N 115.341 -0.845 . . . . 0.82 112.637 178.91 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -94.88 -69.39 0.75 Allowed 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 110.177 -0.305 . . . . 2.1 110.177 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 10.1 p -154.83 150.46 27.52 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.094 0.474 . . . . 1.08 111.043 176.527 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.56 HG22 ' C ' ' A' ' 23' ' ' PRO . 13.8 t -113.44 30.26 7.36 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 122.349 1.071 . . . . 0.34 108.891 177.5 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.24 -3.47 49.32 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.475 -1.239 . . . . 0.37 112.031 -175.511 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -92.87 -24.61 18.41 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.482 0.658 . . . . 2.21 109.979 177.589 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -98.02 135.93 30.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.284 -0.871 . . . . 0.31 110.281 -179.458 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 34.0 p -96.19 -179.53 4.7 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.094 -0.503 . . . . 0.39 109.769 -176.703 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.544 ' O ' HG13 ' A' ' 41' ' ' ILE . 0.1 OUTLIER -64.87 -23.63 67.29 Favored 'General case' 0 C--O 1.222 -0.348 0 C-N-CA 119.04 -1.064 . . . . 1.53 110.026 173.505 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.451 ' N ' ' HD1' ' A' ' 37' ' ' TYR . 34.4 mt-10 -70.89 -46.93 61.71 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.649 -0.5 . . . . 0.96 109.649 176.899 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -70.76 -28.88 65.01 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.066 0.46 . . . . 0.91 110.404 176.923 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.46 ' HB2' ' HB3' ' A' ' 17' ' ' PHE . . . -66.32 -45.65 79.56 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.728 -0.669 . . . . 0.19 109.825 175.157 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.544 HG13 ' O ' ' A' ' 37' ' ' TYR . 72.9 mt -64.98 -38.41 82.72 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.382 0 CA-C-N 116.064 -0.517 . . . . 0.3 109.7 174.101 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.419 ' O ' ' HG3' ' A' ' 46' ' ' LYS . 3.6 ttpm? -64.78 -20.94 66.64 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.863 -0.608 . . . . 2.32 110.233 179.652 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.427 ' HG3' ' CD1' ' A' ' 47' ' ' TRP . 1.7 tp10 -88.29 -56.85 3.15 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.305 -0.628 . . . . 1.02 109.305 176.569 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.733 HD22 ' HB3' ' A' ' 111' ' ' LEU . 19.5 tp -58.92 -35.9 73.83 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.03 -0.986 . . . . 0.17 110.895 -174.479 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.461 ' HG2' HG13 ' A' ' 104' ' ' ILE . 4.3 mm100 -64.42 -39.57 94.09 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-N 116.391 -0.368 . . . . 0.87 111.962 -178.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.448 ' O ' ' HG3' ' A' ' 50' ' ' ARG . 60.7 mttm -70.09 -43.77 70.43 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 110.122 -0.325 . . . . 1.31 110.122 -178.576 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.443 ' NE1' ' HG3' ' A' ' 65' ' ' ARG . 64.6 m95 -65.79 -46.38 78.93 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.479 -0.328 . . . . 0.52 111.454 175.94 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 36.5 t -57.96 -34.0 69.45 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.755 -0.461 . . . . 0.82 109.755 176.355 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 -66.75 -56.84 8.71 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 115.907 -0.588 . . . . 0.53 110.555 175.181 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.627 ' HB3' HG22 ' A' ' 56' ' ' VAL . 93.6 mtt180 -61.21 -42.12 98.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.676 -0.693 . . . . 0.42 111.368 -175.634 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.44 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 98.2 mt -60.71 -39.43 81.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 120.96 0.409 . . . . 0.2 110.506 176.876 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.26 -39.92 65.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.979 -0.555 . . . . 0.27 111.663 -179.292 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 55.8 p -78.61 -30.5 46.56 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.931 0.396 . . . . 0.35 111.547 -177.354 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 107.61 9.25 29.2 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.727 -0.749 . . . . 0.3 112.057 -178.831 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.498 ' HB2' ' HB3' ' A' ' 50' ' ' ARG . 43.1 mt-10 -64.9 -44.26 90.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.115 0.483 . . . . 0.65 110.102 177.683 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.627 HG22 ' HB3' ' A' ' 50' ' ' ARG . 22.3 m -138.16 153.69 27.2 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.451 0 CA-C-N 115.791 -0.64 . . . . 0.19 109.456 173.767 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.6 m -77.39 157.89 30.36 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 109.327 -0.62 . . . . 0.97 109.327 175.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -54.76 -41.28 70.28 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.171 -0.678 . . . . 0.22 109.171 177.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.476 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 41.0 mt-10 -56.0 -46.6 78.7 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.785 -1.098 . . . . 1.72 112.197 178.775 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -60.91 -44.73 96.77 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 120.936 0.398 . . . . 2.09 111.019 -176.236 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -71.72 -43.72 65.4 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.346 -0.388 . . . . 0.26 111.001 -178.806 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.68 -53.05 60.38 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.185 0.439 . . . . 0.24 112.185 -175.005 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.474 ' HA ' ' O ' ' A' ' 71' ' ' TYR . 71.9 m -51.76 -27.8 13.24 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 113.121 0.785 . . . . 1.0 113.121 -177.61 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -100.03 -44.67 5.93 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.603 0.716 . . . . 0.61 110.616 -177.285 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.586 ' CD ' ' HG3' ' A' ' 27' ' ' ARG . 17.4 mmt180 -94.41 -43.48 8.35 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.873 -1.058 . . . . 0.86 113.576 -170.815 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.573 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 19.3 p -62.73 127.65 32.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.145 0.497 . . . . 0.82 111.557 -173.937 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.585 ' HA ' ' HB2' ' A' ' 26' ' ' ARG . 27.0 t70 -81.68 -11.08 59.21 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.421 -0.809 . . . . 2.28 110.616 176.694 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 0.541 ' SG ' ' HB2' ' A' ' 66' ' ' SER . 5.1 p -75.77 150.19 37.82 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.017 -0.538 . . . . 1.52 110.12 179.657 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -54.88 -21.66 24.16 Favored Glycine 0 N--CA 1.452 -0.247 0 CA-C-N 114.665 -1.152 . . . . 0.26 113.757 -172.381 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.449 ' HB2' ' CA ' ' A' ' 75' ' ' GLY . 1.5 p -67.99 -2.44 7.63 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 112.635 0.606 . . . . 0.32 112.635 177.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.474 ' O ' ' HA ' ' A' ' 63' ' ' SER . 33.1 p90 -55.13 -24.27 25.24 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 118.038 0.381 . . . . 0.54 110.421 174.872 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -87.65 -8.94 55.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.857 0.36 . . . . 0.49 111.115 -178.873 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 16.0 m -126.18 14.95 7.84 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.367 -0.379 . . . . 0.71 111.28 -177.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.476 ' O ' ' HA ' ' A' ' 59' ' ' GLU . . . 74.86 33.48 55.21 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.745 -0.74 . . . . 0.54 113.133 178.445 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.449 ' CA ' ' HB2' ' A' ' 70' ' ' SER . . . 77.88 5.07 86.46 Favored Glycine 0 C--O 1.228 -0.236 0 C-N-CA 120.811 -0.709 . . . . 0.35 112.867 176.385 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -92.21 141.17 28.86 Favored 'General case' 0 C--N 1.322 -0.629 0 O-C-N 122.844 -0.209 . . . . 1.65 110.448 -172.212 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -120.38 169.87 9.89 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.322 0.582 . . . . 0.94 110.582 176.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -89.04 -158.8 34.62 Favored Glycine 0 C--N 1.314 -0.691 0 CA-C-N 115.025 -0.989 . . . . 0.44 112.078 177.872 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.6 ' HA ' ' O ' ' A' ' 8' ' ' LEU . 96.7 m-85 -84.57 151.7 24.36 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.083 0.468 . . . . 3.87 111.677 -178.495 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.657 ' CE1' ' HB3' ' A' ' 8' ' ' LEU . 2.5 p90 -157.87 160.36 37.59 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.492 -0.929 . . . . 1.31 108.492 178.683 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 23.6 m -85.44 138.78 32.02 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 109.162 -0.681 . . . . 1.17 109.162 177.067 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 14.7 m -59.71 112.24 1.74 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.159 0.504 . . . . 1.19 110.811 -174.53 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 114.53 12.91 10.07 Favored Glycine 0 N--CA 1.446 -0.647 0 CA-C-N 115.47 -0.786 . . . . 0.79 112.184 -174.709 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -117.02 57.8 0.78 Allowed 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 121.069 0.462 . . . . 1.55 110.377 177.914 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 22.5 mmt -146.42 -100.16 0.09 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.084 -0.507 . . . . 0.73 110.512 178.048 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' MET . . . . . 0.452 ' HB2' ' HB3' ' A' ' 89' ' ' PHE . 61.4 mtt -142.99 155.77 44.73 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 108.17 -1.048 . . . . 1.39 108.17 175.228 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.431 ' HB3' ' HD3' ' A' ' 88' ' ' PRO . 63.9 tttp -55.06 -57.75 18.16 Favored Pre-proline 0 C--N 1.321 -0.653 0 N-CA-C 112.448 0.536 . . . . 2.37 112.448 -177.082 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.435 ' HG2' HG22 ' A' ' 107' ' ' THR . 76.6 Cg_endo -75.35 -29.08 8.06 Favored 'Trans proline' 0 C--N 1.355 0.88 0 C-N-CA 121.643 1.562 . . . . 0.27 111.908 -175.89 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.651 ' O ' HG23 ' A' ' 93' ' ' VAL . 38.5 t80 -68.12 -56.55 8.42 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.111 -0.949 . . . . 0.22 109.942 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -65.24 -34.51 78.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.661 -0.7 . . . . 2.12 109.855 -178.067 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -55.33 -34.67 64.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.636 -0.711 . . . . 0.61 110.755 175.289 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.42 ' O ' ' HG ' ' A' ' 96' ' ' LEU . . . -83.74 -26.65 29.54 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.136 -0.484 . . . . 0.22 110.951 179.05 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.651 HG23 ' O ' ' A' ' 89' ' ' PHE . 18.4 t -74.03 -38.17 48.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.157 0.503 . . . . 0.25 110.186 -178.14 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.503 ' C ' ' HD2' ' A' ' 94' ' ' ARG . 6.5 ppt_? -76.32 -12.0 60.0 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.085 -0.507 . . . . 2.59 110.261 178.055 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.07 -4.5 59.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.846 -0.615 . . . . 0.47 111.254 -176.696 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.655 ' HB2' ' HB2' ' A' ' 100' ' ' ASP . 1.2 pp -132.79 151.91 51.9 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.173 0.511 . . . . 0.28 111.167 179.192 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.563 ' HG3' ' H ' ' A' ' 98' ' ' ILE . 19.4 tptm -102.62 -178.48 3.69 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.688 -0.856 . . . . 1.61 108.688 176.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.563 ' H ' ' HG3' ' A' ' 97' ' ' LYS . 65.9 mt -54.3 118.36 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 120.853 0.359 . . . . 0.9 111.025 179.28 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 95.61 10.23 56.91 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.728 -0.749 . . . . 0.46 113.14 178.412 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.655 ' HB2' ' HB2' ' A' ' 96' ' ' LEU . 27.0 m-20 -111.41 146.81 36.51 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 117.441 0.621 . . . . 0.46 110.271 177.285 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 15.8 mt -120.17 148.89 23.01 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-N 116.455 -0.339 . . . . 0.23 110.432 -178.44 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 38.3 m -96.78 151.08 37.63 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 116.234 -0.439 . . . . 0.92 111.206 179.026 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -74.17 176.94 8.9 Favored 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 122.583 2.189 . . . . 0.34 111.432 172.421 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.669 HG23 HD23 ' A' ' 44' ' ' LEU . 22.5 mm -49.24 110.72 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 N-CA-C 112.775 0.657 . . . . 0.2 112.775 -178.77 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 55.0 t -109.75 115.71 50.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.886 -0.597 . . . . 1.04 109.901 173.178 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 12.9 mt-30 -84.93 141.72 30.17 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.842 -0.429 . . . . 0.55 109.842 177.396 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.435 HG22 ' HG2' ' A' ' 88' ' ' PRO . 16.6 p -123.55 -172.47 2.53 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.784 -0.644 . . . . 0.37 110.491 -179.684 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ASP . . . . . 0.416 ' HB2' ' CZ ' ' A' ' 21' ' ' ARG . 6.9 p-10 -66.57 -35.53 80.44 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.617 0.246 . . . . 2.16 111.253 -178.11 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.495 ' OG ' ' HE2' ' A' ' 16' ' ' LYS . 4.6 t -106.24 -9.73 16.73 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 120.287 -0.565 . . . . 1.09 112.291 -174.359 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 172.18 -126.2 1.25 Allowed Glycine 0 N--CA 1.438 -1.177 0 C-N-CA 119.216 -1.469 . . . . 0.24 112.967 173.871 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.733 ' HB3' HD22 ' A' ' 44' ' ' LEU . 6.0 mp -130.78 149.42 52.43 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 115.045 -0.578 . . . . 0.19 110.906 -171.488 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' HIS . . . . . 0.796 ' CE1' HD13 ' A' ' 14' ' ' LEU . 75.8 m80 -146.97 136.04 22.45 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.098 0.407 . . . . 0.22 112.098 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.619 HG12 HD11 ' A' ' 44' ' ' LEU . 2.1 pt -119.13 140.03 44.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 107.972 -1.121 . . . . 0.17 107.972 160.362 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.435 HG21 HG22 ' A' ' 93' ' ' VAL . 2.5 mp -130.93 148.12 33.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 C-N-CA 120.923 -0.311 . . . . 0.18 110.532 -175.141 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.417 ' HG2' ' HB3' ' A' ' 11' ' ' ALA . 54.3 pttt -134.61 144.25 47.79 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.113 -0.699 . . . . 0.61 109.113 174.209 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ARG . . . . . 0.541 ' HB2' ' CD1' ' A' ' 96' ' ' LEU . 67.4 ttt180 -91.0 132.57 35.91 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.196 0.522 . . . . 1.87 111.583 -177.391 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.401 HD21 ' HB2' ' A' ' 11' ' ' ALA . 2.1 mm? -101.96 -35.53 8.94 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.116 -0.947 . . . . 0.89 110.781 179.398 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.428 ' HB3' ' HB3' ' A' ' 9' ' ' ARG . . . . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.945 -0.55 . . . . 1.1 109.841 179.191 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.402 ' HA ' ' O ' ' A' ' 80' ' ' PHE . 13.6 tptt . . . . . 0 N--CA 1.453 -0.316 0 CA-C-O 121.709 0.766 . . . . 1.19 110.871 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.62 HD23 ' N ' ' A' ' 9' ' ' ARG . 2.4 tt -136.55 157.02 47.76 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 114.522 -1.217 . . . . 1.18 108.176 -178.052 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.62 ' N ' HD23 ' A' ' 8' ' ' LEU . 77.2 ttt180 -140.82 127.72 20.55 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 107.907 -1.146 . . . . 1.06 107.907 173.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -140.95 157.88 44.73 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 120.037 -0.665 . . . . 0.22 112.496 -176.778 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.58 ' HA ' ' HA ' ' A' ' 76' ' ' ASP . . . -109.81 136.46 49.09 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.195 -0.912 . . . . 0.2 109.599 177.094 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 2.2 p80 -136.77 139.65 41.98 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.79 -0.364 . . . . 0.23 110.949 -172.898 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.608 ' O ' ' HA ' ' A' ' 112' ' ' HIS . 6.6 tt -111.42 142.37 43.77 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.161 -1.052 . . . . 0.24 108.161 176.002 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.738 HD13 ' CE1' ' A' ' 112' ' ' HIS . 22.1 tp -128.95 133.54 47.86 Favored 'General case' 0 C--N 1.323 -0.575 0 O-C-N 123.043 0.214 . . . . 0.27 110.441 -176.336 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.504 HG23 HD13 ' A' ' 44' ' ' LEU . 53.5 t -119.07 133.53 65.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 O-C-N 123.589 0.556 . . . . 0.15 109.978 175.796 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.523 ' HE3' HD21 ' A' ' 14' ' ' LEU . 34.2 mmtp -103.65 158.31 16.46 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.802 -0.635 . . . . 0.62 109.727 176.349 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.487 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 42.1 p90 -158.51 161.27 37.35 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.118 -0.492 . . . . 0.25 109.693 -177.049 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.1 t -50.84 108.69 0.25 Allowed 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 110.005 -0.369 . . . . 1.04 110.005 173.074 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 109.68 9.85 24.17 Favored Glycine 0 N--CA 1.446 -0.7 0 C-N-CA 120.323 -0.942 . . . . 0.53 112.975 -177.18 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.421 ' C ' ' H ' ' A' ' 22' ' ' ASN . 50.6 p -85.32 21.82 1.64 Allowed 'General case' 0 C--O 1.236 0.352 0 CA-C-N 117.938 0.869 . . . . 0.7 111.726 -176.732 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.457 ' NH1' ' HB3' ' A' ' 108' ' ' ASP . 97.3 mtt180 72.6 -34.98 0.31 Allowed 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.786 0.835 . . . . 3.49 110.833 -178.832 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.421 ' H ' ' C ' ' A' ' 20' ' ' SER . 7.0 p30 -146.66 104.71 3.96 Favored Pre-proline 0 C--N 1.32 -0.686 0 N-CA-C 108.578 -0.897 . . . . 1.77 108.578 168.866 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -66.03 -156.7 0.03 OUTLIER 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 123.674 2.916 . . . . 1.71 113.2 -178.46 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.546 ' N ' HG22 ' A' ' 32' ' ' THR . 47.6 t 64.99 112.97 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-N 115.494 -0.775 . . . . 0.48 111.165 -175.883 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.406 ' HB2' ' OD1' ' A' ' 67' ' ' ASP . 19.1 p -103.36 152.18 21.87 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.352 -0.385 . . . . 1.12 110.015 178.293 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.55 ' CG ' ' HA ' ' A' ' 67' ' ' ASP . 38.5 mmt180 -67.58 -20.38 65.37 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 108.727 -0.842 . . . . 2.54 108.727 173.193 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.496 ' HG2' ' HD3' ' A' ' 65' ' ' ARG . 4.8 tmm_? -71.73 -36.22 70.41 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 114.621 -1.172 . . . . 1.77 110.791 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 69.3 p -97.67 -35.76 10.47 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.522 0.677 . . . . 0.67 110.421 178.716 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 73.35 -6.7 14.4 Favored Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 114.718 -1.128 . . . . 0.82 112.655 -178.907 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -121.68 -72.29 0.69 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.757 0.313 . . . . 2.1 110.357 -178.898 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.6 m -147.8 146.26 29.08 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-O 121.0 0.429 . . . . 1.08 111.21 -178.733 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.546 HG22 ' N ' ' A' ' 24' ' ' VAL . 14.6 t -125.48 11.82 8.03 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.8 0.81 . . . . 0.34 109.49 174.58 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -68.94 -4.34 16.25 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.241 -0.89 . . . . 0.37 112.289 179.349 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -96.55 -23.86 16.33 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.037 0.446 . . . . 2.21 110.694 177.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.509 HG23 ' HB2' ' A' ' 39' ' ' ASP . 0.4 OUTLIER -93.85 136.34 25.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 109.389 -0.597 . . . . 0.31 109.389 177.505 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 75.0 p -95.0 179.99 5.03 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.359 -0.382 . . . . 0.39 110.081 -174.692 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.498 ' O ' HG13 ' A' ' 41' ' ' ILE . 11.3 p90 -63.42 -28.13 69.77 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.262 -0.644 . . . . 1.53 109.262 175.372 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -73.74 -44.77 55.34 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.905 -0.589 . . . . 0.96 110.362 178.186 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.509 ' HB2' HG23 ' A' ' 35' ' ' VAL . 43.9 m-20 -65.81 -32.42 73.94 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.484 0.659 . . . . 0.91 109.693 176.705 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.487 ' HB2' ' HB3' ' A' ' 17' ' ' PHE . . . -68.4 -43.88 76.27 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.976 -1.011 . . . . 0.19 110.416 178.254 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.498 HG13 ' O ' ' A' ' 37' ' ' TYR . 95.1 mt -62.6 -37.82 79.93 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.409 0 N-CA-C 109.667 -0.494 . . . . 0.3 109.667 174.925 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 55.9 tttp -65.94 -23.11 66.54 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 121.381 0.61 . . . . 2.32 109.997 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -87.84 -50.27 6.56 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.33 -0.85 . . . . 1.02 109.549 -179.082 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.903 HD22 ' HB3' ' A' ' 111' ' ' LEU . 35.4 tp -62.61 -38.08 88.78 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.588 -0.733 . . . . 0.17 110.41 -178.05 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.494 ' HG2' HG13 ' A' ' 104' ' ' ILE . 3.8 mm100 -61.09 -31.35 71.03 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 115.957 -0.565 . . . . 0.87 112.399 -179.595 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -80.24 -40.85 26.22 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.631 -0.428 . . . . 1.31 110.606 -179.708 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.422 ' O ' HG13 ' A' ' 51' ' ' ILE . 57.5 m95 -66.66 -45.32 79.31 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.139 0.422 . . . . 0.52 112.139 177.036 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.571 ' HB3' HG21 ' A' ' 113' ' ' ILE . 93.4 p -63.99 -30.5 71.57 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.758 -0.46 . . . . 0.82 109.758 176.728 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.491 ' HB2' ' O ' ' A' ' 45' ' ' GLN . 15.1 tt0 -65.16 -53.34 46.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.503 -0.772 . . . . 0.53 110.381 175.402 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.618 ' HB3' HG22 ' A' ' 56' ' ' VAL . 97.1 mtt180 -65.39 -41.48 93.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.996 -0.547 . . . . 0.42 111.657 -177.07 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.484 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 84.6 mt -61.25 -33.93 58.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.09 0.471 . . . . 0.2 110.691 176.629 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -77.81 -41.91 35.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 0.27 111.205 179.612 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 52.9 p -76.13 -29.81 57.96 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.252 -0.431 . . . . 0.35 111.569 -176.916 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 103.21 9.99 37.64 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.78 -0.724 . . . . 0.3 112.234 -179.008 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.403 ' HB2' ' HB3' ' A' ' 50' ' ' ARG . 39.2 mt-10 -64.51 -43.58 93.64 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.583 -0.525 . . . . 0.65 109.583 176.772 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.618 HG22 ' HB3' ' A' ' 50' ' ' ARG . 11.7 m -138.49 149.79 24.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 108.968 -0.753 . . . . 0.19 108.968 170.12 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 12.0 m -81.69 162.08 23.14 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 109.468 -0.567 . . . . 0.97 109.468 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -55.01 -43.44 73.63 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.843 -0.429 . . . . 0.22 109.843 -178.212 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -58.04 -46.32 85.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.537 -0.756 . . . . 1.72 111.443 179.008 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 41.4 mm-40 -59.4 -48.36 81.94 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-O 121.119 0.485 . . . . 2.09 110.822 -178.647 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -68.78 -49.96 54.27 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.924 -0.58 . . . . 0.26 110.866 -179.052 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -58.45 -55.37 35.97 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.629 0.603 . . . . 0.24 112.629 -173.229 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.482 ' HA ' ' HA ' ' A' ' 71' ' ' TYR . 28.4 t -52.27 -28.01 17.21 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.684 0.624 . . . . 1.0 112.684 -175.884 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -100.01 -46.74 5.24 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.528 0.68 . . . . 0.61 110.426 -179.155 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.496 ' HD3' ' HG2' ' A' ' 27' ' ' ARG . 31.3 mmt180 -94.21 -36.91 11.81 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.758 -1.11 . . . . 0.86 113.944 -168.603 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.577 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 24.7 p -67.89 123.72 21.37 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.642 -0.423 . . . . 0.82 110.651 -178.065 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.55 ' HA ' ' CG ' ' A' ' 26' ' ' ARG . 25.1 m-20 -83.77 -5.93 59.31 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.826 -0.625 . . . . 2.28 110.676 179.5 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 0.51 ' SG ' ' HB2' ' A' ' 66' ' ' SER . 6.4 p -78.86 156.73 28.54 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.494 -0.776 . . . . 1.52 110.215 175.413 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -54.83 -20.33 18.45 Favored Glycine 0 C--N 1.331 0.284 0 CA-C-N 114.959 -1.018 . . . . 0.26 114.501 -171.342 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.528 ' HB2' ' CA ' ' A' ' 75' ' ' GLY . 1.3 p -70.08 -1.49 10.08 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.675 0.62 . . . . 0.32 112.675 179.422 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.482 ' HA ' ' HA ' ' A' ' 63' ' ' SER . 41.6 p90 -56.55 -33.6 66.27 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 109.54 -0.541 . . . . 0.54 109.54 173.671 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -95.29 8.32 43.48 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.021 -0.536 . . . . 0.49 111.158 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 11.0 m -122.59 -20.16 6.08 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.698 0.285 . . . . 0.71 111.605 -176.216 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 107.57 14.85 16.75 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.74 -0.743 . . . . 0.54 112.226 -178.073 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.528 ' CA ' ' HB2' ' A' ' 70' ' ' SER . . . 92.99 -19.73 50.25 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.69 -0.767 . . . . 0.35 112.904 178.449 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.58 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 7.6 p-10 -98.36 144.71 27.46 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.584 0.706 . . . . 1.65 111.492 -171.758 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.412 ' HB3' ' HE2' ' A' ' 80' ' ' PHE . 0.9 OUTLIER -100.35 175.72 5.61 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.504 -1.225 . . . . 0.94 109.341 174.65 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -85.43 -148.0 10.13 Favored Glycine 0 C--N 1.315 -0.634 0 C-N-CA 120.709 -0.758 . . . . 0.44 111.981 -179.041 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -91.85 139.44 30.66 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.931 0.396 . . . . 3.87 110.16 178.36 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.412 ' HE2' ' HB3' ' A' ' 77' ' ' LEU . 1.5 p90 -152.14 174.03 14.22 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.992 -0.549 . . . . 1.31 109.746 -177.606 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 13.9 p -95.57 135.4 37.28 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.333 0.587 . . . . 1.17 110.942 179.802 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 13.2 m -63.83 128.11 34.35 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.483 -0.78 . . . . 1.19 110.585 -178.904 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 103.25 0.82 47.64 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.659 -0.782 . . . . 0.79 112.395 -179.399 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -117.76 62.84 0.75 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.222 0.534 . . . . 1.55 111.152 -179.055 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 21.0 mmt -139.49 -123.9 0.12 Allowed 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.066 -0.716 . . . . 0.73 109.066 173.556 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' MET . . . . . 0.414 ' HB2' ' CB ' ' A' ' 89' ' ' PHE . 19.9 mmt -110.68 151.54 27.59 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.263 -1.014 . . . . 1.39 108.263 173.191 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.403 ' HB3' ' HD3' ' A' ' 88' ' ' PRO . 24.5 ttmm -55.55 -51.72 77.8 Favored Pre-proline 0 C--N 1.319 -0.754 0 N-CA-C 112.379 0.511 . . . . 2.37 112.379 -174.108 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.403 ' HD3' ' HB3' ' A' ' 87' ' ' LYS . 86.2 Cg_endo -78.3 -22.9 9.27 Favored 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 121.474 1.449 . . . . 0.27 111.72 -178.44 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.581 ' O ' HG23 ' A' ' 93' ' ' VAL . 33.1 t80 -70.89 -55.75 7.77 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.157 -0.929 . . . . 0.22 109.718 179.682 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -65.81 -34.83 79.08 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.606 -0.725 . . . . 2.12 109.99 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.515 ' HA ' ' NE ' ' A' ' 94' ' ' ARG . 15.6 t70 -51.25 -35.83 39.06 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.492 -0.776 . . . . 0.61 110.7 173.68 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.567 ' O ' ' HG ' ' A' ' 96' ' ' LEU . . . -82.44 -37.15 25.85 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.072 -0.513 . . . . 0.22 111.032 179.111 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.581 HG23 ' O ' ' A' ' 89' ' ' PHE . 15.2 t -62.75 -40.97 90.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-O 121.229 0.538 . . . . 0.25 110.597 -177.168 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.515 ' NE ' ' HA ' ' A' ' 91' ' ' ASP . 37.7 ptt180 -74.8 -15.41 60.75 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.822 -0.626 . . . . 2.59 110.566 178.26 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -95.64 14.42 23.06 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.026 -0.533 . . . . 0.47 111.169 -174.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.634 ' HB2' ' HB2' ' A' ' 100' ' ' ASP . 1.4 pp -149.74 152.71 35.71 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.83 -0.623 . . . . 0.28 110.307 177.005 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.438 ' HG3' ' H ' ' A' ' 98' ' ' ILE . 21.7 tptm -102.22 175.63 5.46 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.132 -0.692 . . . . 1.61 109.132 179.536 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.459 ' HA ' ' HG2' ' A' ' 116' ' ' ARG . 70.7 mt -46.24 114.56 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.196 0.522 . . . . 0.9 111.579 176.049 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 102.1 -15.96 56.06 Favored Glycine 0 CA--C 1.522 0.48 0 CA-C-N 115.649 -0.705 . . . . 0.46 113.562 178.496 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.634 ' HB2' ' HB2' ' A' ' 96' ' ' LEU . 53.9 m-20 -89.08 141.19 28.71 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 117.346 0.573 . . . . 0.46 110.348 -177.797 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 8.9 mt -112.68 147.99 16.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.18 -0.464 . . . . 0.23 110.462 -176.816 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 99.3 p -89.65 160.1 42.26 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 116.256 -0.429 . . . . 0.92 110.643 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -74.23 176.36 9.7 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.324 2.016 . . . . 0.34 111.196 171.405 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.882 HG23 HD23 ' A' ' 44' ' ' LEU . 23.9 mm -50.47 106.38 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 O-C-N 123.217 0.323 . . . . 0.2 111.541 174.78 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.4 p -112.92 123.02 68.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 109.794 -0.447 . . . . 1.04 109.794 175.084 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -86.19 151.38 23.69 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.14 0.495 . . . . 0.55 110.563 -179.558 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 6.8 p -126.78 -172.72 2.7 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.51 -0.768 . . . . 0.37 109.984 178.827 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ASP . . . . . 0.457 ' HB3' ' NH1' ' A' ' 21' ' ' ARG . 36.3 m-20 -62.36 -46.73 87.35 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.746 0.307 . . . . 2.16 110.501 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 22.5 t -80.07 -59.43 2.72 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.836 -0.346 . . . . 1.09 110.796 -178.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -152.05 -130.4 1.6 Allowed Glycine 0 N--CA 1.443 -0.884 0 C-N-CA 119.075 -1.536 . . . . 0.24 113.649 -175.569 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.903 ' HB3' HD22 ' A' ' 44' ' ' LEU . 6.1 mp -116.56 147.79 41.49 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.283 -0.459 . . . . 0.19 111.372 -170.851 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' HIS . . . . . 0.738 ' CE1' HD13 ' A' ' 14' ' ' LEU . 71.0 m80 -143.48 152.96 42.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.419 0.628 . . . . 0.22 112.484 179.454 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.59 HG12 HD11 ' A' ' 44' ' ' LEU . 3.6 pt -133.42 138.17 51.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 107.604 -1.258 . . . . 0.17 107.604 159.579 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 2.8 mp -128.42 147.52 32.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 C-N-CA 120.768 -0.373 . . . . 0.18 110.386 -175.684 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.448 ' HG2' ' HB3' ' A' ' 11' ' ' ALA . 33.4 pttt -132.11 144.63 50.85 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.664 -0.865 . . . . 0.61 108.664 172.437 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ARG . . . . . 0.537 ' HD3' HD21 ' A' ' 8' ' ' LEU . 5.5 ttp180 -82.79 135.03 35.09 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.302 0.572 . . . . 1.87 110.902 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -101.83 -38.33 7.89 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.996 -1.002 . . . . 0.89 109.768 -179.514 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.456 ' HB3' ' HB3' ' A' ' 9' ' ' ARG . . . . . . . . 0 C--O 1.249 1.036 0 CA-C-N 115.544 -0.753 . . . . 1.1 109.735 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt . . . . . 0 N--CA 1.454 -0.248 0 CA-C-O 121.47 0.653 . . . . 1.19 110.657 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.505 HD23 HG12 ' A' ' 93' ' ' VAL . 11.4 tp -103.73 175.34 5.51 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 114.665 -1.152 . . . . 1.18 109.953 -174.872 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.494 ' HB3' ' HB3' ' A' ' 118' ' ' ALA . 53.8 ttt180 -146.08 132.49 19.65 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.567 -0.531 . . . . 1.06 109.567 177.323 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.532 ' N ' ' HZ ' ' A' ' 80' ' ' PHE . . . -149.3 154.43 39.0 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.054 0.454 . . . . 0.22 111.69 -179.149 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.432 ' HB3' ' HG2' ' A' ' 115' ' ' LYS . . . -101.83 131.85 47.93 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.517 -0.765 . . . . 0.2 108.95 175.413 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 29.6 p-80 -133.01 146.69 51.99 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.029 0.443 . . . . 0.23 111.719 -172.011 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.555 HD23 ' N ' ' A' ' 14' ' ' LEU . 5.7 tt -117.46 144.65 44.81 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.478 -0.934 . . . . 0.24 108.478 177.407 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.8 HD13 ' CE1' ' A' ' 112' ' ' HIS . 26.0 tp -131.03 119.91 22.69 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.64 0.257 . . . . 0.27 110.675 -177.391 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.528 HG23 HD13 ' A' ' 44' ' ' LEU . 61.2 t -108.12 129.37 62.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 109.776 -0.453 . . . . 0.15 109.776 176.771 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.477 ' HE3' HD21 ' A' ' 14' ' ' LEU . 31.5 mmtp -105.87 149.99 26.04 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.089 -0.505 . . . . 0.62 110.022 178.68 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.5 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 43.1 p90 -145.88 162.54 37.5 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.331 -0.395 . . . . 0.25 110.863 -176.451 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.481 ' HB3' ' HA ' ' A' ' 33' ' ' ALA . 34.9 p -51.87 113.18 0.93 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.037 -0.529 . . . . 1.04 111.129 177.272 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 95.5 8.58 58.41 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.587 -0.816 . . . . 0.53 113.536 178.528 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.615 ' HB2' ' O ' ' A' ' 109' ' ' SER . 80.4 p -86.7 33.5 0.65 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 117.264 0.532 . . . . 0.7 110.921 -177.557 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.432 ' HB3' ' O ' ' A' ' 20' ' ' SER . 66.8 ttt180 71.25 -34.82 0.31 Allowed 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.245 0.618 . . . . 3.49 111.122 -176.684 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.459 ' H ' ' C ' ' A' ' 20' ' ' SER . 33.2 m-80 -133.63 91.77 25.04 Favored Pre-proline 0 C--N 1.327 -0.398 0 N-CA-C 109.245 -0.65 . . . . 1.77 109.245 176.838 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.509 ' C ' HG22 ' A' ' 32' ' ' THR . 72.7 Cg_endo -80.47 57.72 6.65 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 122.258 1.972 . . . . 1.71 112.774 -176.308 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.53 ' N ' HG22 ' A' ' 32' ' ' THR . 48.5 t -143.7 118.67 4.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 109.418 -0.586 . . . . 0.48 109.418 178.074 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 40.2 t -104.85 150.34 24.92 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 110.037 -0.357 . . . . 1.12 110.037 178.095 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.571 ' HG2' ' HA ' ' A' ' 67' ' ' ASP . 5.2 mmp_? -66.07 -8.35 22.9 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.727 0.299 . . . . 2.54 110.823 173.176 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.473 ' HD2' ' HD2' ' A' ' 65' ' ' ARG . 50.5 mtp180 -69.26 -50.68 44.77 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 121.555 0.693 . . . . 1.77 110.018 172.38 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 39.8 p -94.66 -33.62 12.9 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 115.154 -0.93 . . . . 0.67 110.837 -172.73 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 80.31 -32.56 2.3 Favored Glycine 0 N--CA 1.451 -0.308 0 CA-C-N 115.813 -0.63 . . . . 0.82 112.042 -178.89 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -92.56 -69.85 0.72 Allowed 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 122.576 0.35 . . . . 2.1 110.717 -177.663 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.434 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 5.5 p -154.79 155.56 34.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.602 -0.272 . . . . 1.08 110.922 177.207 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.53 HG22 ' N ' ' A' ' 24' ' ' VAL . 8.9 t -118.82 34.87 5.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 122.309 1.052 . . . . 0.34 109.388 177.806 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.481 ' HA ' ' HB3' ' A' ' 18' ' ' SER . . . -76.58 -5.25 46.93 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.695 -1.139 . . . . 0.37 112.901 -173.962 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -94.8 -24.75 16.93 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.032 0.444 . . . . 2.21 110.848 -179.076 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.487 HG23 ' HB2' ' A' ' 39' ' ' ASP . 0.2 OUTLIER -95.72 135.89 28.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.941 -0.572 . . . . 0.31 109.816 179.87 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 67.0 p -96.34 178.42 5.37 Favored 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 109.952 -0.388 . . . . 0.39 109.952 -175.133 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.454 ' O ' HG13 ' A' ' 41' ' ' ILE . 13.3 p90 -63.99 -27.89 69.44 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.224 -0.658 . . . . 1.53 109.224 176.467 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -70.73 -47.17 61.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.779 -0.646 . . . . 0.96 110.204 177.367 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.487 ' HB2' HG23 ' A' ' 35' ' ' VAL . 47.1 m-20 -67.87 -29.59 68.75 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.401 0.62 . . . . 0.91 109.752 178.233 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.5 ' HB2' ' HB3' ' A' ' 17' ' ' PHE . . . -70.35 -43.96 69.11 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.007 -0.997 . . . . 0.19 110.583 177.499 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.454 HG13 ' O ' ' A' ' 37' ' ' TYR . 80.0 mt -62.24 -37.35 78.34 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 N-CA-C 109.549 -0.537 . . . . 0.3 109.549 173.788 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -62.19 -25.46 67.79 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.784 -0.644 . . . . 2.32 110.174 177.73 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -84.82 -53.41 5.35 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.477 -0.783 . . . . 1.02 109.405 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.92 HD22 ' HB3' ' A' ' 111' ' ' LEU . 23.9 tp -62.01 -36.27 81.02 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.145 -0.934 . . . . 0.17 110.587 -175.031 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.537 ' O ' ' HB2' ' A' ' 49' ' ' GLN . 11.1 mm-40 -68.53 -24.71 64.67 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 112.348 0.499 . . . . 0.87 112.348 -177.909 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -80.43 -45.69 17.19 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.95 -0.389 . . . . 1.31 109.95 178.497 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.436 ' NE1' ' HG3' ' A' ' 65' ' ' ARG . 52.9 m95 -65.69 -46.55 78.62 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.138 -0.483 . . . . 0.52 111.207 177.705 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.522 ' HB3' HG21 ' A' ' 113' ' ' ILE . 92.2 p -64.01 -24.26 67.65 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.807 0.337 . . . . 0.82 110.166 178.469 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.537 ' HB2' ' O ' ' A' ' 45' ' ' GLN . 10.9 tt0 -73.28 -56.67 4.76 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-N 116.11 -0.496 . . . . 0.53 110.034 175.284 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.607 ' HB3' HG22 ' A' ' 56' ' ' VAL . 97.0 mtt180 -60.79 -42.4 97.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.473 -0.785 . . . . 0.42 111.401 -177.041 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.448 HG22 HD13 ' A' ' 101' ' ' ILE . 98.0 mt -62.07 -40.17 86.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 120.823 0.344 . . . . 0.2 110.613 177.648 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.39 -44.65 74.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.234 -0.439 . . . . 0.27 111.373 -178.395 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 32.3 p -77.39 -31.02 53.95 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.842 0.354 . . . . 0.35 111.38 -177.721 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 109.19 10.23 24.41 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.658 -0.782 . . . . 0.3 112.548 179.353 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.463 ' HB2' ' HB3' ' A' ' 50' ' ' ARG . 45.5 mt-10 -60.17 -46.93 88.02 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.211 0.529 . . . . 0.65 109.867 175.822 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.607 HG22 ' HB3' ' A' ' 50' ' ' ARG . 11.1 m -133.24 158.83 43.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.714 -0.676 . . . . 0.19 109.315 172.096 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 17.8 m -85.95 155.22 20.99 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 109.247 -0.649 . . . . 0.97 109.247 178.31 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -52.39 -42.63 64.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.301 0.572 . . . . 0.22 109.783 -177.62 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.517 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 39.2 mt-10 -55.08 -41.73 71.9 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.811 -1.086 . . . . 1.72 112.044 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -65.94 -47.2 75.47 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-O 120.712 0.291 . . . . 2.09 111.112 -174.644 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -69.48 -43.31 73.45 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.343 -0.39 . . . . 0.26 110.784 -178.786 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.66 -51.3 69.97 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.105 -0.498 . . . . 0.24 111.813 -176.541 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.561 ' HA ' ' O ' ' A' ' 71' ' ' TYR . 40.4 m -51.26 -27.44 9.21 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.939 0.718 . . . . 1.0 112.939 -177.805 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -98.55 -46.7 5.64 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.893 0.854 . . . . 0.61 110.936 -179.559 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.473 ' HD2' ' HD2' ' A' ' 27' ' ' ARG . 37.4 mmt180 -94.97 -37.26 11.23 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 114.398 -1.274 . . . . 0.86 113.713 -166.133 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.47 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 60.0 p -65.64 117.5 8.18 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.305 -0.558 . . . . 0.82 110.065 -178.35 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.571 ' HA ' ' HG2' ' A' ' 26' ' ' ARG . 24.0 t70 -73.84 -15.82 61.15 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.345 0.593 . . . . 2.28 111.089 179.33 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 46.2 t -77.37 160.84 28.49 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.307 0.575 . . . . 1.52 109.939 179.515 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -57.1 -18.0 25.55 Favored Glycine 0 C--N 1.328 0.134 0 CA-C-N 114.691 -1.14 . . . . 0.26 114.425 -170.06 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.502 ' HB2' ' CA ' ' A' ' 75' ' ' GLY . 3.0 p -70.28 -0.11 7.42 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.861 0.689 . . . . 0.32 112.861 179.198 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.561 ' O ' ' HA ' ' A' ' 63' ' ' SER . 39.2 p90 -60.29 -27.57 67.4 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 118.395 0.543 . . . . 0.54 109.973 175.917 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -94.43 5.37 52.01 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.246 0.545 . . . . 0.49 110.223 178.059 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.5 m -124.67 0.63 8.15 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.666 -0.697 . . . . 0.71 111.005 -176.528 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.517 ' O ' ' HA ' ' A' ' 59' ' ' GLU . . . 75.2 29.62 60.1 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.724 -0.75 . . . . 0.54 112.316 -177.388 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.502 ' CA ' ' HB2' ' A' ' 70' ' ' SER . . . 84.4 -3.59 85.98 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 121.01 -0.614 . . . . 0.35 112.317 179.622 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -84.57 140.8 31.15 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.667 0.27 . . . . 1.65 111.56 -169.557 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.449 HD12 ' HA ' ' A' ' 77' ' ' LEU . 0.5 OUTLIER -120.94 163.17 18.65 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.775 -0.648 . . . . 0.94 110.493 172.118 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -79.01 -117.05 0.23 Allowed Glycine 0 C--N 1.31 -0.891 0 CA-C-N 114.964 -1.016 . . . . 0.44 113.44 -177.515 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 37.0 p90 -116.15 141.06 48.63 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.864 0.364 . . . . 3.87 110.95 -176.649 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.532 ' HZ ' ' N ' ' A' ' 10' ' ' ALA . 3.5 p90 -158.23 129.56 6.56 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.084 -0.507 . . . . 1.31 111.014 -178.482 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 82.2 p -74.31 155.33 38.32 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.308 -0.627 . . . . 1.17 109.308 178.185 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 9.3 m -59.77 114.38 2.74 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.144 -0.48 . . . . 1.19 110.346 -178.799 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 114.05 1.49 23.81 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.685 -0.769 . . . . 0.79 112.509 -176.891 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -90.84 15.22 11.69 Favored 'General case' 0 C--N 1.33 -0.281 0 O-C-N 122.593 -0.357 . . . . 1.55 111.5 178.667 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 26.2 mmt -126.84 -126.99 0.23 Allowed 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 121.116 0.484 . . . . 0.73 111.147 -176.842 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 54.7 mtt -123.19 149.26 44.87 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.09 -1.078 . . . . 1.39 108.09 179.005 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 64.6 tttp -49.82 -54.98 26.61 Favored Pre-proline 0 CA--C 1.541 0.618 0 N-CA-C 112.52 0.563 . . . . 2.37 112.52 -175.804 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.433 ' HG2' HG22 ' A' ' 107' ' ' THR . 82.8 Cg_endo -76.02 -22.47 13.06 Favored 'Trans proline' 0 C--N 1.356 0.965 0 C-N-CA 121.798 1.665 . . . . 0.27 112.321 -176.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.644 ' O ' HG23 ' A' ' 93' ' ' VAL . 38.7 t80 -73.3 -56.22 5.37 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.402 -0.817 . . . . 0.22 109.504 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.407 ' OE2' ' HD3' ' A' ' 94' ' ' ARG . 1.5 tm-20 -63.87 -33.55 75.94 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.595 -0.729 . . . . 2.12 109.77 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.592 ' HA ' ' NE ' ' A' ' 94' ' ' ARG . 18.7 t70 -52.47 -37.74 57.78 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.237 -0.892 . . . . 0.61 111.104 175.093 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.576 ' O ' ' HG ' ' A' ' 96' ' ' LEU . . . -81.76 -36.55 28.4 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.428 -0.351 . . . . 0.22 110.895 178.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.644 HG23 ' O ' ' A' ' 89' ' ' PHE . 11.5 t -63.6 -41.25 91.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.267 0.556 . . . . 0.25 110.699 -177.207 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.592 ' NE ' ' HA ' ' A' ' 91' ' ' ASP . 30.7 ptt180 -76.57 -18.55 58.6 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.776 -0.647 . . . . 2.59 110.52 178.86 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -82.95 -5.91 59.25 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.923 -0.58 . . . . 0.47 111.441 -172.666 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.617 ' HB2' ' HB2' ' A' ' 100' ' ' ASP . 0.5 OUTLIER -133.45 160.51 37.19 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.18 0.514 . . . . 0.28 111.244 -179.591 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.648 ' HG2' ' H ' ' A' ' 98' ' ' ILE . 33.6 tttp -102.33 178.42 4.6 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 115.656 -0.702 . . . . 1.61 109.461 178.099 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.648 ' H ' ' HG2' ' A' ' 97' ' ' LYS . 8.2 mt -53.36 119.34 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.265 -0.425 . . . . 0.9 111.138 178.346 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 102.1 -10.04 56.67 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.821 -0.704 . . . . 0.46 113.057 178.065 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.617 ' HB2' ' HB2' ' A' ' 96' ' ' LEU . 61.5 m-20 -97.82 139.92 32.96 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 117.1 0.45 . . . . 0.46 110.407 -177.774 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.478 HG12 ' HB3' ' A' ' 115' ' ' LYS . 9.5 mt -111.2 151.69 13.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.082 -0.508 . . . . 0.23 110.499 -177.282 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.413 ' OG ' HD21 ' A' ' 96' ' ' LEU . 10.8 m -86.37 156.74 56.63 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 115.965 -0.561 . . . . 0.92 110.887 -178.772 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -75.99 176.49 9.96 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 122.477 2.118 . . . . 0.34 110.183 166.675 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.88 HG23 HD23 ' A' ' 44' ' ' LEU . 22.8 mm -52.05 108.45 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 CA-C-O 121.052 0.454 . . . . 0.2 111.732 177.628 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 76.2 t -108.33 115.64 49.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.049 -0.523 . . . . 1.04 110.004 175.777 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -85.9 140.77 30.09 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 121.195 0.521 . . . . 0.55 110.235 177.475 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.433 HG22 ' HG2' ' A' ' 88' ' ' PRO . 8.4 p -118.37 -172.2 2.22 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.488 -0.778 . . . . 0.37 110.817 -177.692 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -63.41 -37.58 87.84 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.545 0.212 . . . . 2.16 111.027 179.367 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.615 ' O ' ' HB2' ' A' ' 20' ' ' SER . 8.4 t -92.9 -61.37 1.6 Allowed 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.786 -0.366 . . . . 1.09 110.478 179.241 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -145.63 -130.68 2.22 Favored Glycine 0 N--CA 1.443 -0.892 0 C-N-CA 119.026 -1.559 . . . . 0.24 113.795 -173.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.92 ' HB3' HD22 ' A' ' 44' ' ' LEU . 6.7 mp -118.54 146.35 44.63 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.289 -0.455 . . . . 0.19 111.139 -171.786 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' HIS . . . . . 0.8 ' CE1' HD13 ' A' ' 14' ' ' LEU . 71.9 m80 -144.35 142.5 30.42 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.066 0.46 . . . . 0.22 112.061 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.715 HG12 HD11 ' A' ' 44' ' ' LEU . 3.4 pt -125.77 136.22 61.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 107.771 -1.196 . . . . 0.17 107.771 159.897 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.427 HG21 HG22 ' A' ' 93' ' ' VAL . 3.1 mp -128.58 141.23 47.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 C-N-CA 120.891 -0.324 . . . . 0.18 110.372 -176.317 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.478 ' HB3' HG12 ' A' ' 101' ' ' ILE . 38.8 pttt -124.69 139.05 54.21 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.927 -0.768 . . . . 0.61 108.927 172.89 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 52.6 ttt180 -80.45 129.18 34.35 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.956 0.408 . . . . 1.87 111.153 -176.785 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.46 ' HB2' ' HG2' ' A' ' 9' ' ' ARG . 3.5 mm? -100.99 -30.67 11.5 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.608 -0.724 . . . . 0.89 110.575 -177.865 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.494 ' HB3' ' HB3' ' A' ' 9' ' ' ARG . . . . . . . . 0 C--O 1.248 0.992 0 CA-C-O 118.467 -0.777 . . . . 1.1 110.012 178.612 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 40.6 mmtm . . . . . 0 N--CA 1.454 -0.272 0 CA-C-O 121.342 0.591 . . . . 1.19 110.693 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 10.5 tp -120.21 172.61 7.66 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.182 -0.917 . . . . 1.18 109.133 -179.516 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.424 ' HG2' ' HB2' ' A' ' 117' ' ' LEU . 69.0 ttt180 -147.63 127.38 13.43 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.385 -0.598 . . . . 1.06 109.385 177.793 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.546 ' O ' ' HB2' ' A' ' 77' ' ' LEU . . . -146.76 150.15 34.77 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.265 -0.574 . . . . 0.22 112.181 -177.484 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.421 ' HB3' ' HG2' ' A' ' 115' ' ' LYS . . . -103.01 134.41 46.5 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.065 -0.717 . . . . 0.2 109.065 176.052 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.456 ' CE1' HD11 ' A' ' 77' ' ' LEU . 37.2 p-80 -136.18 151.32 49.61 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.098 0.475 . . . . 0.23 112.05 -172.058 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.551 HD23 ' N ' ' A' ' 14' ' ' LEU . 4.7 tt -119.34 144.5 46.82 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.49 -0.929 . . . . 0.24 108.49 175.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.796 HD13 ' CE1' ' A' ' 112' ' ' HIS . 28.9 tp -131.65 123.91 28.81 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.531 0.205 . . . . 0.27 111.033 -176.754 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.552 HG23 HD13 ' A' ' 44' ' ' LEU . 71.1 t -113.82 138.03 44.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 109.87 -0.419 . . . . 0.15 109.87 176.052 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.529 ' HE3' HD21 ' A' ' 14' ' ' LEU . 34.0 mmtp -111.29 158.8 18.59 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.876 -0.416 . . . . 0.62 109.876 177.755 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.457 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 38.4 p90 -149.03 162.58 39.64 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.427 -0.351 . . . . 0.25 110.306 -175.542 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.487 ' HB3' ' HA ' ' A' ' 33' ' ' ALA . 35.5 p -52.18 109.61 0.4 Allowed 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 120.929 0.395 . . . . 1.04 110.55 176.842 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 101.93 9.08 43.69 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.484 -0.865 . . . . 0.53 112.947 -179.085 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.482 ' C ' ' H ' ' A' ' 22' ' ' ASN . 80.9 p -84.08 34.26 0.5 Allowed 'General case' 0 C--O 1.232 0.18 0 CA-C-N 117.29 0.545 . . . . 0.7 111.223 -178.855 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.43 ' HB2' ' O ' ' A' ' 20' ' ' SER . 89.9 mtt180 73.03 -28.61 0.19 Allowed 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.521 0.728 . . . . 3.49 110.895 -177.17 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.482 ' H ' ' C ' ' A' ' 20' ' ' SER . 3.0 p30 -150.07 104.39 3.17 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 115.919 -0.582 . . . . 1.77 110.175 172.425 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.427 ' C ' HG22 ' A' ' 32' ' ' THR . 6.8 Cg_exo -75.3 57.95 4.92 Favored 'Trans proline' 0 CA--C 1.532 0.403 0 C-N-CA 123.448 2.766 . . . . 1.71 113.368 -178.851 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.428 ' N ' HG22 ' A' ' 32' ' ' THR . 40.3 t -148.48 110.81 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 109.867 -0.42 . . . . 0.48 109.867 176.881 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.471 ' HB3' ' HB2' ' A' ' 16' ' ' LYS . 17.1 p -104.41 154.57 19.69 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.831 -0.168 . . . . 1.12 110.689 177.094 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.684 ' HB2' ' HA ' ' A' ' 67' ' ' ASP . 1.2 mpt_? -62.2 -13.6 29.32 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.031 0.443 . . . . 2.54 110.503 171.764 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.516 ' HG2' ' HA ' ' A' ' 65' ' ' ARG . 0.4 OUTLIER -80.59 -21.67 41.39 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.81 -0.632 . . . . 1.77 110.346 -179.689 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 36.3 p -115.35 -34.89 4.8 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.999 -0.546 . . . . 0.67 110.79 -177.622 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 76.53 -33.11 1.38 Allowed Glycine 0 CA--C 1.517 0.207 0 CA-C-N 115.252 -0.886 . . . . 0.82 113.065 176.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -99.59 -69.13 0.78 Allowed 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 110.124 -0.324 . . . . 2.1 110.124 -178.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 42.9 m -154.57 152.76 30.42 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.095 -0.502 . . . . 1.08 110.495 175.25 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.428 HG22 ' N ' ' A' ' 24' ' ' VAL . 10.5 t -119.4 30.88 6.87 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 122.17 0.986 . . . . 0.34 108.903 175.743 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.487 ' HA ' ' HB3' ' A' ' 18' ' ' SER . . . -79.96 -5.39 55.57 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 114.898 -1.046 . . . . 0.37 111.364 -177.516 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -88.46 -25.68 22.49 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.413 0.625 . . . . 2.21 110.244 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.428 HG23 ' HB2' ' A' ' 39' ' ' ASP . 0.2 OUTLIER -100.14 137.48 27.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.442 -0.799 . . . . 0.31 109.895 -178.434 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 59.6 p -94.88 178.35 5.6 Favored 'General case' 0 CA--C 1.512 -0.487 0 N-CA-C 109.708 -0.478 . . . . 0.39 109.708 -176.657 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.464 ' O ' HG13 ' A' ' 41' ' ' ILE . 10.1 p90 -63.11 -29.23 70.63 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.009 -0.676 . . . . 1.53 109.561 177.436 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -72.96 -44.13 61.48 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.058 -0.519 . . . . 0.96 110.539 178.121 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.428 ' HB2' HG23 ' A' ' 35' ' ' VAL . 39.7 m-20 -69.72 -27.12 64.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.299 0.571 . . . . 0.91 109.89 177.907 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.457 ' HB2' ' HB3' ' A' ' 17' ' ' PHE . . . -73.37 -45.75 53.08 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.303 -0.862 . . . . 0.19 110.683 176.874 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.493 ' CG1' HD21 ' A' ' 111' ' ' LEU . 80.5 mt -61.81 -36.39 73.43 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.369 0 N-CA-C 109.619 -0.512 . . . . 0.3 109.619 175.246 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -57.78 -32.05 67.15 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 115.561 -0.745 . . . . 2.32 110.468 176.623 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -87.37 -46.18 9.88 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.605 -0.725 . . . . 1.02 109.904 -175.219 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.895 HD22 ' HB3' ' A' ' 111' ' ' LEU . 34.6 tp -62.16 -37.41 85.11 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.019 -0.537 . . . . 0.17 110.123 -178.551 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.519 ' O ' ' HB2' ' A' ' 49' ' ' GLN . 13.7 mm-40 -64.72 -30.93 71.95 Favored 'General case' 0 C--O 1.225 -0.211 0 CA-C-N 116.271 -0.422 . . . . 0.87 111.779 179.581 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 59.4 mttm -72.08 -44.3 63.49 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.119 0.485 . . . . 1.31 110.503 179.127 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 25.5 m95 -71.54 -43.34 66.59 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.088 -0.506 . . . . 0.52 111.414 -179.474 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.474 ' HB3' HG21 ' A' ' 113' ' ' ILE . 93.6 p -65.04 -22.95 67.06 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.903 -0.406 . . . . 0.82 109.903 175.843 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.519 ' HB2' ' O ' ' A' ' 45' ' ' GLN . 14.7 tt0 -71.55 -54.31 10.91 Favored 'General case' 0 C--O 1.224 -0.252 0 CA-C-N 116.047 -0.524 . . . . 0.53 109.764 174.574 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.639 ' HB3' HG22 ' A' ' 56' ' ' VAL . 89.1 mtt180 -62.37 -41.69 98.83 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.903 -0.589 . . . . 0.42 111.788 -177.59 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.44 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 82.1 mt -59.92 -40.01 81.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 120.998 0.427 . . . . 0.2 110.425 176.49 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.9 -41.26 64.79 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.012 -0.54 . . . . 0.27 111.523 179.418 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 66.5 p -76.13 -29.43 57.81 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.829 0.347 . . . . 0.35 111.505 -176.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 107.06 4.49 35.76 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.615 -0.802 . . . . 0.3 112.271 178.349 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.488 ' OE1' ' HG2' ' A' ' 50' ' ' ARG . 46.3 mt-10 -61.05 -49.69 76.36 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.134 0.492 . . . . 0.65 110.176 178.221 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.639 HG22 ' HB3' ' A' ' 50' ' ' ARG . 15.8 m -131.49 154.62 40.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.695 -0.684 . . . . 0.19 109.268 173.193 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 22.8 p -85.41 165.76 16.94 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 109.554 -0.536 . . . . 0.97 109.554 177.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -57.38 -41.9 81.11 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.978 -0.378 . . . . 0.22 109.978 -177.73 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.584 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 42.0 mt-10 -59.23 -46.56 88.15 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.76 -0.654 . . . . 1.72 111.623 -179.179 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -60.53 -44.61 95.87 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-O 120.92 0.391 . . . . 2.09 111.0 -178.018 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -70.76 -49.57 45.29 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.246 -0.434 . . . . 0.26 111.084 -178.671 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.41 -51.86 68.08 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.332 0.493 . . . . 0.24 112.332 -174.424 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.491 ' HA ' ' O ' ' A' ' 71' ' ' TYR . 52.8 m -51.12 -24.09 3.75 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 113.041 0.756 . . . . 1.0 113.041 -178.083 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -104.18 -44.94 4.85 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.493 0.663 . . . . 0.61 110.494 -179.018 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.516 ' HA ' ' HG2' ' A' ' 27' ' ' ARG . 16.3 mmt180 -90.81 -42.73 10.49 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 113.848 1.055 . . . . 0.86 113.848 -170.353 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.444 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 72.7 p -64.3 124.89 22.9 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.044 0.449 . . . . 0.82 111.28 -175.305 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.684 ' HA ' ' HB2' ' A' ' 26' ' ' ARG . 25.7 t70 -76.6 -16.05 59.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.543 -0.753 . . . . 2.28 111.475 178.204 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 52.6 t -78.05 155.79 30.44 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.201 0.524 . . . . 1.52 110.15 -179.581 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -57.12 -18.1 26.1 Favored Glycine 0 N--CA 1.454 -0.138 0 CA-C-N 114.631 -1.168 . . . . 0.26 113.638 -173.805 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 63.0 p -64.77 -7.7 12.04 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 112.035 0.383 . . . . 0.32 112.035 176.857 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.491 ' O ' ' HA ' ' A' ' 63' ' ' SER . 25.2 p90 -57.88 -22.92 50.69 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.868 0.366 . . . . 0.54 110.297 175.724 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -90.77 -0.23 57.64 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.06 0.457 . . . . 0.49 110.674 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 16.3 m -126.34 14.38 7.72 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.888 -0.596 . . . . 0.71 110.577 178.942 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.584 ' O ' ' HA ' ' A' ' 59' ' ' GLU . . . 70.75 27.33 72.56 Favored Glycine 0 CA--C 1.519 0.325 0 C-N-CA 120.839 -0.696 . . . . 0.54 112.718 -178.708 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 82.3 -17.85 16.69 Favored Glycine 0 N--CA 1.454 -0.167 0 C-N-CA 121.034 -0.603 . . . . 0.35 112.473 179.161 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -70.96 135.16 47.73 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-O 120.883 0.373 . . . . 1.65 110.594 -176.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.546 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 19.2 mt -111.36 158.43 19.07 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.933 -0.576 . . . . 0.94 110.291 176.408 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -81.84 -137.37 2.4 Favored Glycine 0 C--N 1.317 -0.507 0 CA-C-N 115.673 -0.694 . . . . 0.44 112.625 179.238 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 38.1 p90 -98.43 135.57 39.82 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.189 0.519 . . . . 3.87 110.626 -177.595 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.43 ' HZ ' ' N ' ' A' ' 10' ' ' ALA . 2.0 p90 -151.5 164.6 36.44 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.921 -0.581 . . . . 1.31 110.21 -178.572 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 13.2 m -89.54 120.42 30.83 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 109.788 -0.449 . . . . 1.17 109.788 178.754 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.5 p -55.36 118.85 4.79 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.932 -0.576 . . . . 1.19 110.909 178.468 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 114.43 5.92 20.47 Favored Glycine 0 N--CA 1.447 -0.572 0 N-CA-C 111.538 -0.625 . . . . 0.79 111.538 -176.642 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -105.04 -6.19 20.22 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.83 0.347 . . . . 1.55 110.803 -177.906 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 26.0 mmt -86.14 -97.48 0.07 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.252 0.549 . . . . 0.73 110.873 -175.453 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 55.9 mtt -145.16 150.96 37.68 Favored 'General case' 0 CA--C 1.507 -0.694 0 N-CA-C 107.187 -1.412 . . . . 1.39 107.187 176.048 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -55.85 -52.63 70.76 Favored Pre-proline 0 C--N 1.318 -0.797 0 CA-C-N 118.188 0.449 . . . . 2.37 112.115 -174.521 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -74.03 -31.34 8.04 Favored 'Trans proline' 0 C--N 1.358 1.033 0 C-N-CA 121.466 1.444 . . . . 0.27 111.891 -177.214 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.626 ' O ' HG23 ' A' ' 93' ' ' VAL . 29.7 t80 -65.74 -55.73 15.78 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.62 -0.718 . . . . 0.22 109.481 177.018 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -64.52 -34.6 78.6 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.338 -0.846 . . . . 2.12 110.461 -177.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -56.99 -36.54 70.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.824 -0.625 . . . . 0.61 110.516 175.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.436 ' O ' ' HG ' ' A' ' 96' ' ' LEU . . . -78.97 -28.26 43.54 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.192 -0.458 . . . . 0.22 110.981 178.356 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.626 HG23 ' O ' ' A' ' 89' ' ' PHE . 17.2 t -71.42 -36.48 61.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 121.267 0.556 . . . . 0.25 110.14 -177.55 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.511 ' C ' ' HD2' ' A' ' 94' ' ' ARG . 6.1 ppt_? -82.66 -9.23 59.47 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.918 -0.583 . . . . 2.59 110.446 179.008 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.35 -2.66 58.78 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.989 -0.551 . . . . 0.47 110.955 -177.386 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.567 ' HB2' ' HB2' ' A' ' 100' ' ' ASP . 0.7 OUTLIER -135.87 152.9 51.5 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.896 -0.593 . . . . 0.28 110.442 178.906 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.607 ' HG2' ' H ' ' A' ' 98' ' ' ILE . 47.0 tttt -102.88 -174.13 2.48 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.634 -0.506 . . . . 1.61 109.634 176.64 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.607 ' H ' ' HG2' ' A' ' 97' ' ' LYS . 10.4 mt -57.54 116.08 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 121.061 0.458 . . . . 0.9 111.692 -176.387 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 98.23 3.83 57.62 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.813 -0.708 . . . . 0.46 113.239 179.326 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.567 ' HB2' ' HB2' ' A' ' 96' ' ' LEU . 7.7 m-20 -104.67 141.76 35.87 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 117.196 0.498 . . . . 0.46 110.811 178.719 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 8.3 mt -111.84 146.58 16.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.774 -0.648 . . . . 0.23 109.737 -178.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 88.1 p -93.35 155.46 40.9 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 116.374 -0.376 . . . . 0.92 110.292 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -74.23 175.54 10.81 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 122.125 1.883 . . . . 0.34 111.131 171.461 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.851 HG23 HD23 ' A' ' 44' ' ' LEU . 20.3 mm -48.99 108.48 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 O-C-N 123.459 0.474 . . . . 0.2 112.144 177.896 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.4 p -115.84 120.08 63.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 120.91 0.386 . . . . 1.04 110.125 175.558 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -85.42 152.45 23.21 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.141 0.496 . . . . 0.55 110.964 -179.16 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 4.3 p -126.27 -172.51 2.64 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.434 -0.803 . . . . 0.37 110.237 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -60.78 -38.46 85.4 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.83 0.348 . . . . 2.16 110.642 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.47 ' O ' ' HB2' ' A' ' 20' ' ' SER . 16.2 t -90.95 -60.63 1.86 Allowed 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 120.867 -0.333 . . . . 1.09 110.694 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -150.55 -130.85 1.79 Allowed Glycine 0 N--CA 1.441 -1.019 0 C-N-CA 119.057 -1.544 . . . . 0.24 114.084 -173.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.895 ' HB3' HD22 ' A' ' 44' ' ' LEU . 6.7 mp -116.07 146.2 42.39 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.184 -0.508 . . . . 0.19 111.844 -168.012 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' HIS . . . . . 0.796 ' CE1' HD13 ' A' ' 14' ' ' LEU . 70.1 m80 -141.99 150.0 40.78 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.578 0.584 . . . . 0.22 112.578 178.422 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.571 HG12 HD11 ' A' ' 44' ' ' LEU . 3.3 pt -132.42 138.21 52.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 107.446 -1.316 . . . . 0.17 107.446 159.379 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 2.2 mp -129.69 145.74 35.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 C-N-CA 120.755 -0.378 . . . . 0.18 110.641 -175.948 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.449 ' HA ' ' O ' ' A' ' 100' ' ' ASP . 42.0 pttt -126.64 139.01 53.49 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.796 -0.816 . . . . 0.61 108.796 171.365 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ARG . . . . . 0.45 ' HB2' ' CD1' ' A' ' 96' ' ' LEU . 60.7 ttt180 -83.63 125.12 31.5 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.174 0.512 . . . . 1.87 110.86 -178.087 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.424 ' HB2' ' HG2' ' A' ' 9' ' ' ARG . 4.2 mm? -93.06 -31.96 14.65 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.487 -0.779 . . . . 0.89 110.247 -179.114 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.865 0 CA-C-N 115.54 -0.755 . . . . 1.1 109.962 179.747 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.456 ' HG3' ' HB2' ' A' ' 79' ' ' PHE . 10.8 mptt . . . . . 0 N--CA 1.45 -0.459 0 CA-C-O 121.838 0.827 . . . . 1.19 110.82 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.58 HD23 ' H ' ' A' ' 9' ' ' ARG . 1.8 tt -116.01 159.53 21.51 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 114.2 -1.364 . . . . 1.18 108.001 -178.512 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.59 ' HB3' ' HB3' ' A' ' 118' ' ' ALA . 79.0 ttt180 -136.28 127.85 28.75 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.431 -0.581 . . . . 1.06 109.431 174.274 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.425 ' N ' ' HZ ' ' A' ' 80' ' ' PHE . . . -150.05 152.17 34.41 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.093 0.473 . . . . 0.22 111.714 -179.244 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.417 ' HB3' ' HG2' ' A' ' 115' ' ' LYS . . . -101.87 136.78 41.12 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.458 -0.792 . . . . 0.2 109.527 177.39 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 37.4 p-80 -136.45 149.1 48.07 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.964 0.412 . . . . 0.23 111.286 -173.327 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.56 HD23 ' N ' ' A' ' 14' ' ' LEU . 6.2 tt -118.37 149.46 41.16 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.836 -0.802 . . . . 0.24 108.836 177.275 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.736 HD13 ' CE1' ' A' ' 112' ' ' HIS . 29.6 tp -130.84 124.61 31.65 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.611 0.243 . . . . 0.27 111.052 -179.228 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.546 HG23 HD13 ' A' ' 44' ' ' LEU . 85.1 t -111.34 138.03 41.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 109.405 -0.591 . . . . 0.15 109.405 173.884 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.485 ' HB2' ' HB2' ' A' ' 25' ' ' SER . 24.9 mmtp -105.72 162.07 13.85 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.157 -0.474 . . . . 0.62 110.491 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.462 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 51.5 p90 -158.86 161.6 36.87 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.053 -0.521 . . . . 0.25 109.92 179.48 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.522 ' HB3' ' HA ' ' A' ' 33' ' ' ALA . 21.5 p -53.35 109.97 0.5 Allowed 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.347 -0.388 . . . . 1.04 111.026 178.576 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 104.46 10.36 33.71 Favored Glycine 0 N--CA 1.443 -0.86 0 C-N-CA 120.229 -0.986 . . . . 0.53 113.371 178.87 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.661 ' HB2' ' O ' ' A' ' 109' ' ' SER . 39.8 p -81.49 46.24 0.94 Allowed 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 117.855 0.828 . . . . 0.7 111.577 -174.065 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.402 ' HB3' ' O ' ' A' ' 20' ' ' SER . 56.2 ttt180 68.95 -37.01 0.35 Allowed 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.905 0.882 . . . . 3.49 111.355 -177.213 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.488 ' H ' ' C ' ' A' ' 20' ' ' SER . 8.1 p30 -155.01 126.48 3.67 Favored Pre-proline 0 C--N 1.316 -0.866 0 N-CA-C 107.67 -1.233 . . . . 1.77 107.67 175.565 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -82.39 -156.11 0.07 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 122.302 2.001 . . . . 1.71 111.784 -175.106 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.615 ' N ' HG22 ' A' ' 32' ' ' THR . 57.5 t 60.07 114.12 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 123.423 0.689 . . . . 0.48 111.692 -173.738 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.485 ' HB2' ' HB2' ' A' ' 16' ' ' LYS . 29.8 t -103.4 159.82 15.24 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.815 -0.63 . . . . 1.12 109.722 177.886 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.589 ' HB2' ' HA ' ' A' ' 67' ' ' ASP . 5.5 mpt_? -75.33 -12.73 60.33 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 109.018 -0.734 . . . . 2.54 109.018 169.498 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.474 ' HG2' ' HD3' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -72.52 -49.75 30.67 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.249 -0.887 . . . . 1.77 109.195 174.066 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 55.6 p -85.39 -34.05 21.84 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.468 -0.787 . . . . 0.67 111.249 -177.511 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 80.7 -34.73 2.29 Favored Glycine 0 C--N 1.322 -0.216 0 CA-C-N 115.314 -0.857 . . . . 0.82 111.395 -176.81 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.556 ' O ' ' HA ' ' A' ' 24' ' ' VAL . 4.4 m-20 -114.56 -135.27 0.35 Allowed 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 108.349 -0.982 . . . . 2.1 108.349 173.025 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -70.82 142.03 51.3 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 112.703 0.631 . . . . 1.08 112.703 -171.261 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.615 HG22 ' N ' ' A' ' 24' ' ' VAL . 8.9 t -124.25 14.51 9.01 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.337 -0.847 . . . . 0.34 109.461 175.219 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.522 ' HA ' ' HB3' ' A' ' 18' ' ' SER . . . -68.75 -4.35 15.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.302 -0.863 . . . . 0.37 111.565 177.587 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -88.73 -24.95 22.55 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.99 -0.55 . . . . 2.21 110.802 -178.053 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.77 HG23 ' HB3' ' A' ' 39' ' ' ASP . 0.1 OUTLIER -100.58 141.55 17.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.088 -0.505 . . . . 0.31 110.211 -179.126 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 40.7 p -98.1 174.75 6.38 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 110.212 -0.292 . . . . 0.39 110.212 -176.448 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.516 ' O ' HG13 ' A' ' 41' ' ' ILE . 11.5 p90 -63.94 -26.85 68.77 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.101 -0.64 . . . . 1.53 109.507 177.713 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -71.04 -46.14 62.57 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.06 -0.518 . . . . 0.96 110.526 178.668 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.77 ' HB3' HG23 ' A' ' 35' ' ' VAL . 2.7 t70 -70.0 -31.22 68.79 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.473 0.654 . . . . 0.91 109.695 178.15 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.462 ' HB2' ' HB3' ' A' ' 17' ' ' PHE . . . -66.64 -41.97 87.43 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.232 -0.895 . . . . 0.19 110.347 175.658 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.516 HG13 ' O ' ' A' ' 37' ' ' TYR . 78.1 mt -64.63 -33.13 61.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 109.516 -0.549 . . . . 0.3 109.516 173.517 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.521 ' HB3' ' O ' ' A' ' 39' ' ' ASP . 3.9 ttpm? -60.75 -28.32 68.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.298 0.571 . . . . 2.32 109.993 176.212 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.457 ' HG3' ' CD1' ' A' ' 47' ' ' TRP . 6.2 tp10 -84.92 -52.88 5.69 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.403 -0.817 . . . . 1.02 109.487 -178.635 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.916 HD23 HG23 ' A' ' 104' ' ' ILE . 22.8 tp -64.61 -34.15 77.61 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.329 -0.851 . . . . 0.17 110.762 -174.267 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.51 ' O ' ' HB2' ' A' ' 49' ' ' GLN . 4.7 mm-40 -70.41 -19.63 62.98 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.353 -0.385 . . . . 0.87 111.892 -178.481 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.425 ' HG3' ' O ' ' A' ' 42' ' ' LYS . 67.9 mttm -84.25 -46.95 11.29 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.741 -0.466 . . . . 1.31 109.741 175.489 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.458 ' NE1' ' HG3' ' A' ' 65' ' ' ARG . 44.0 m95 -63.61 -48.05 78.9 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.144 -0.48 . . . . 0.52 111.821 179.782 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.508 ' HB3' HG21 ' A' ' 113' ' ' ILE . 98.5 p -64.81 -20.53 66.44 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.507 -0.477 . . . . 0.82 110.023 177.876 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.51 ' HB2' ' O ' ' A' ' 45' ' ' GLN . 11.8 tt0 -77.52 -54.72 6.08 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.183 -0.462 . . . . 0.53 110.014 175.771 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.598 ' HB3' HG22 ' A' ' 56' ' ' VAL . 97.9 mtt180 -63.21 -41.5 99.15 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.637 -0.711 . . . . 0.42 111.435 -176.627 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.483 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 98.3 mt -61.12 -33.59 56.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.159 0.504 . . . . 0.2 110.48 176.8 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -79.75 -35.55 38.57 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.907 -0.588 . . . . 0.27 111.444 -179.711 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 31.1 p -82.35 -28.98 31.23 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.811 0.338 . . . . 0.35 111.602 -176.874 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 107.98 3.77 33.9 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.762 -0.732 . . . . 0.3 112.375 179.748 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.448 ' HB2' ' HB3' ' A' ' 50' ' ' ARG . 36.8 mt-10 -61.79 -48.16 81.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.075 0.464 . . . . 0.65 110.258 178.435 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.598 HG22 ' HB3' ' A' ' 50' ' ' ARG . 15.6 m -135.32 156.22 38.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 109.31 -0.626 . . . . 0.19 109.31 172.242 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.582 ' OG ' ' HG3' ' A' ' 60' ' ' GLU . 77.7 p -83.79 165.49 18.79 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.795 -0.446 . . . . 0.97 109.795 178.035 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -57.7 -41.01 80.83 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.516 -0.55 . . . . 0.22 109.516 179.172 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.479 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 43.8 mt-10 -62.24 -41.35 98.34 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.062 -0.972 . . . . 1.72 111.962 -178.122 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.582 ' HG3' ' OG ' ' A' ' 57' ' ' SER . 41.2 mt-10 -60.76 -49.24 78.28 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.021 0.439 . . . . 2.09 110.859 -179.659 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.14 -50.61 63.38 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.926 -0.579 . . . . 0.26 111.073 -178.257 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -58.86 -52.1 67.19 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.351 0.5 . . . . 0.24 112.351 -174.622 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.534 ' HA ' ' O ' ' A' ' 71' ' ' TYR . 20.2 m -51.5 -24.23 4.92 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 113.122 0.786 . . . . 1.0 113.122 -176.979 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -105.49 -44.12 4.78 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.583 0.706 . . . . 0.61 110.615 -179.15 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.474 ' HD3' ' HG2' ' A' ' 27' ' ' ARG . 38.7 mmt-85 -90.92 -41.88 10.9 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 113.882 1.067 . . . . 0.86 113.882 -170.131 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.569 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 75.9 p -64.17 122.7 17.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.055 0.455 . . . . 0.82 111.615 -174.314 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.589 ' HA ' ' HB2' ' A' ' 26' ' ' ARG . 28.6 t70 -76.55 -9.33 58.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.618 -0.719 . . . . 2.28 110.827 175.891 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 0.543 ' SG ' HD22 ' A' ' 14' ' ' LEU . 4.1 m -77.13 163.43 26.6 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.897 -0.592 . . . . 1.52 110.267 175.901 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -65.9 -16.28 63.71 Favored Glycine 0 CA--C 1.512 -0.142 0 CA-C-N 114.912 -1.04 . . . . 0.26 113.203 -173.316 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.512 ' HB2' ' CA ' ' A' ' 75' ' ' GLY . 3.6 p -68.96 0.56 4.34 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 112.426 0.528 . . . . 0.32 112.426 177.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.534 ' O ' ' HA ' ' A' ' 63' ' ' SER . 34.5 p90 -58.33 -26.47 63.14 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.137 0.494 . . . . 0.54 110.154 175.515 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -95.29 -6.99 40.07 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.162 0.505 . . . . 0.49 110.585 178.181 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.8 m -110.67 -0.02 17.31 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.835 -0.62 . . . . 0.71 111.066 -175.354 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.479 ' O ' ' HA ' ' A' ' 59' ' ' GLU . . . 77.79 27.64 58.37 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.852 -0.689 . . . . 0.54 112.218 -177.086 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.512 ' CA ' ' HB2' ' A' ' 70' ' ' SER . . . 81.94 -1.2 87.24 Favored Glycine 0 C--O 1.226 -0.373 0 C-N-CA 120.873 -0.679 . . . . 0.35 111.85 -178.264 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -92.15 136.07 33.48 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 120.962 0.41 . . . . 1.65 111.436 -169.215 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.6 mp -115.75 158.08 23.38 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.709 -0.678 . . . . 0.94 109.548 172.882 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -85.35 -127.2 1.77 Allowed Glycine 0 C--N 1.308 -1.001 0 CA-C-N 114.944 -1.025 . . . . 0.44 112.255 -179.118 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.456 ' HB2' ' HG3' ' A' ' 7' ' ' LYS . 46.4 p90 -92.67 147.31 22.98 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.83 0.348 . . . . 3.87 110.734 -177.694 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.446 ' CE1' ' HB3' ' A' ' 8' ' ' LEU . 2.3 p90 -163.59 147.25 10.32 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.098 -0.501 . . . . 1.31 110.499 179.056 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 17.5 m -76.08 135.03 39.89 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.13 -0.486 . . . . 1.17 110.577 179.651 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 16.0 m -61.03 114.64 3.21 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.939 -0.573 . . . . 1.19 110.024 177.552 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.436 ' H ' ' HG3' ' A' ' 90' ' ' GLU . . . 112.58 -8.08 26.18 Favored Glycine 0 N--CA 1.447 -0.606 0 CA-C-N 115.79 -0.641 . . . . 0.79 111.895 -177.522 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -101.14 47.01 0.92 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.655 0.741 . . . . 1.55 110.371 -177.296 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 21.6 mmt -135.82 -127.21 0.15 Allowed 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.87 -0.789 . . . . 0.73 108.87 176.265 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 59.9 mtt -113.45 149.85 33.65 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.438 -0.949 . . . . 1.39 108.438 174.028 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -53.3 -54.37 45.85 Favored Pre-proline 0 C--N 1.321 -0.646 0 N-CA-C 112.647 0.61 . . . . 2.37 112.647 -174.57 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -74.61 -31.22 7.1 Favored 'Trans proline' 0 C--N 1.355 0.89 0 C-N-CA 121.387 1.391 . . . . 0.27 111.667 -176.315 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.589 ' O ' HG23 ' A' ' 93' ' ' VAL . 42.9 t80 -66.03 -56.06 13.47 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.113 -0.949 . . . . 0.22 110.099 179.309 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.436 ' HG3' ' H ' ' A' ' 83' ' ' GLY . 5.6 tm-20 -64.61 -37.96 89.37 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.598 -0.728 . . . . 2.12 110.218 -177.841 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.443 ' HA ' ' HD2' ' A' ' 94' ' ' ARG . 35.2 t70 -59.46 -26.93 65.64 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.874 -0.603 . . . . 0.61 110.7 177.879 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -85.59 -21.39 28.52 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.495 -0.32 . . . . 0.22 111.408 176.452 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.589 HG23 ' O ' ' A' ' 89' ' ' PHE . 44.8 t -74.83 -47.9 35.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 121.253 0.549 . . . . 0.25 110.567 -173.737 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.443 ' HD2' ' HA ' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -78.49 1.79 21.18 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.195 -0.457 . . . . 2.59 111.028 176.888 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -92.68 0.44 57.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.973 0.416 . . . . 0.47 110.758 -179.485 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.589 ' HB2' ' HB2' ' A' ' 100' ' ' ASP . 0.4 OUTLIER -137.28 160.37 39.22 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.968 -0.56 . . . . 0.28 110.627 177.876 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.482 ' HG3' ' H ' ' A' ' 98' ' ' ILE . 50.8 tptt -102.21 175.83 5.39 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.246 -0.65 . . . . 1.61 109.246 179.433 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.482 ' H ' ' HG3' ' A' ' 97' ' ' LYS . 63.0 mt -57.71 114.66 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 120.97 0.414 . . . . 0.9 110.725 177.797 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 104.76 -0.49 42.14 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.802 -0.714 . . . . 0.46 112.528 -179.499 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.589 ' HB2' ' HB2' ' A' ' 96' ' ' LEU . 24.6 m-20 -105.17 137.45 42.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.797 0.298 . . . . 0.46 110.522 179.732 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 12.7 mt -108.94 148.77 12.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.986 -0.552 . . . . 0.23 109.902 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 95.7 p -91.28 156.05 43.95 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-N 116.469 -0.332 . . . . 0.92 110.539 -179.625 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -69.69 174.08 9.97 Favored 'Trans proline' 0 C--O 1.233 0.271 0 C-N-CA 122.478 2.118 . . . . 0.34 111.245 171.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.916 HG23 HD23 ' A' ' 44' ' ' LEU . 26.1 mm -51.67 100.78 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 O-C-N 123.314 0.383 . . . . 0.2 111.447 176.025 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.5 p -104.76 118.34 51.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.2 0.524 . . . . 1.04 109.868 175.765 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -85.23 146.96 26.82 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.214 0.531 . . . . 0.55 110.674 -179.427 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 18.5 p -124.49 -172.38 2.55 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.395 -0.82 . . . . 0.37 109.76 179.553 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -73.46 -29.43 62.53 Favored 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 120.967 -0.293 . . . . 2.16 110.81 178.085 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.661 ' O ' ' HB2' ' A' ' 20' ' ' SER . 8.4 t -101.3 -9.31 21.33 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.1 0.407 . . . . 1.09 112.1 -175.377 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 160.66 -127.47 1.78 Allowed Glycine 0 N--CA 1.437 -1.293 0 C-N-CA 119.871 -1.157 . . . . 0.24 112.638 170.416 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.888 ' HB3' HD22 ' A' ' 44' ' ' LEU . 6.1 mp -120.9 144.11 48.6 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 114.981 -0.61 . . . . 0.19 110.846 -172.36 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' HIS . . . . . 0.736 ' CE1' HD13 ' A' ' 14' ' ' LEU . 70.8 m80 -143.06 151.72 41.09 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.262 0.553 . . . . 0.22 112.044 -179.773 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.633 HG12 HD11 ' A' ' 44' ' ' LEU . 2.8 pt -134.64 141.36 43.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 107.658 -1.238 . . . . 0.17 107.658 161.126 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 1.8 mp -129.98 143.31 41.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 C-N-CA 120.773 -0.371 . . . . 0.18 110.62 -176.761 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.425 ' HA ' ' O ' ' A' ' 100' ' ' ASP . 43.8 pttt -125.14 138.17 54.16 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.63 -0.878 . . . . 0.61 108.63 172.136 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' ARG . . . . . 0.441 ' HB2' ' CD1' ' A' ' 96' ' ' LEU . 61.3 ttt180 -85.64 136.39 33.39 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.079 0.466 . . . . 1.87 111.268 -177.079 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 6.6 mp -115.25 -24.29 8.54 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.62 -0.718 . . . . 0.89 111.508 -178.627 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.59 ' HB3' ' HB3' ' A' ' 9' ' ' ARG . . . . . . . . 0 C--O 1.244 0.774 0 CA-C-O 118.22 -0.895 . . . . 1.1 109.882 175.718 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 24.3 tptt . . . . . 0 N--CA 1.451 -0.421 0 CA-C-O 121.281 0.563 . . . . 1.19 110.004 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.667 HD23 ' N ' ' A' ' 9' ' ' ARG . 2.9 tt -139.29 155.92 47.4 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 115.065 -0.97 . . . . 1.18 108.467 -177.449 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.667 ' N ' HD23 ' A' ' 8' ' ' LEU . 44.3 ttt180 -139.56 128.48 23.52 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 108.199 -1.038 . . . . 1.06 108.199 173.422 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.43 ' O ' ' HB2' ' A' ' 77' ' ' LEU . . . -146.04 148.71 32.98 Favored 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 120.402 -0.519 . . . . 0.22 111.983 -177.106 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.42 ' HB3' ' HG2' ' A' ' 115' ' ' LYS . . . -102.44 137.15 41.07 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.428 -0.806 . . . . 0.2 109.264 176.592 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 23.1 p-80 -137.37 152.68 49.95 Favored 'General case' 0 C--N 1.323 -0.587 0 C-N-CA 120.418 -0.513 . . . . 0.23 111.872 -172.569 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.579 HD23 ' N ' ' A' ' 14' ' ' LEU . 5.4 tt -121.1 148.3 44.37 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.467 -0.938 . . . . 0.24 108.467 177.841 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.612 HD21 ' HE3' ' A' ' 16' ' ' LYS . 27.4 tp -131.23 130.96 43.58 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 110.378 -0.23 . . . . 0.27 110.378 -179.355 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.544 HG23 HD13 ' A' ' 44' ' ' LEU . 63.6 t -120.83 129.22 75.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 109.518 -0.549 . . . . 0.15 109.518 173.241 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.612 ' HE3' HD21 ' A' ' 14' ' ' LEU . 32.1 mmtp -104.58 158.33 16.57 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.214 -0.448 . . . . 0.62 110.504 178.336 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -150.68 162.13 41.28 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.954 -0.566 . . . . 0.25 110.125 -175.07 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.463 ' HB3' ' C ' ' A' ' 33' ' ' ALA . 45.8 p -55.0 111.42 0.83 Allowed 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 110.117 -0.327 . . . . 1.04 110.117 175.209 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 104.24 9.84 35.47 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.074 -1.06 . . . . 0.53 112.394 -177.113 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.475 ' HB2' ' O ' ' A' ' 109' ' ' SER . 79.5 p -92.98 24.21 3.82 Favored 'General case' 0 N--CA 1.453 -0.308 0 O-C-N 122.376 -0.485 . . . . 0.7 110.791 -177.541 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 60.3 mtt180 71.79 -33.39 0.27 Allowed 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 123.225 0.61 . . . . 3.49 111.406 -178.193 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.455 ' H ' ' C ' ' A' ' 20' ' ' SER . 38.5 m-80 -127.8 89.05 51.77 Favored Pre-proline 0 C--N 1.324 -0.541 0 N-CA-C 109.109 -0.7 . . . . 1.77 109.109 176.336 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.498 ' C ' HG22 ' A' ' 32' ' ' THR . 90.5 Cg_endo -79.84 45.46 1.96 Allowed 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 122.678 2.252 . . . . 1.71 112.82 -173.522 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.41 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 60.7 t -141.53 115.14 4.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 108.68 -0.859 . . . . 0.48 108.68 178.796 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.473 ' HB2' ' OD1' ' A' ' 67' ' ' ASP . 15.9 p -100.84 158.35 16.04 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 110.173 -0.306 . . . . 1.12 110.173 -178.04 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.485 ' HG2' ' HA ' ' A' ' 67' ' ' ASP . 18.3 mmm180 -72.97 -17.24 61.49 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 108.362 -0.977 . . . . 2.54 108.362 172.122 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 13.2 ttp180 -65.83 -48.64 70.97 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 114.463 -1.244 . . . . 1.77 110.054 177.821 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 33.3 p -96.35 -34.49 11.55 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.153 0.501 . . . . 0.67 110.765 -178.078 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 85.91 -31.37 4.01 Favored Glycine 0 N--CA 1.45 -0.381 0 CA-C-N 115.752 -0.658 . . . . 0.82 113.148 -179.375 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -101.24 -61.23 1.4 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.973 0.386 . . . . 2.1 111.424 -178.128 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.41 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 10.3 p -154.77 149.62 26.68 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.986 0.422 . . . . 1.08 111.674 178.798 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.498 HG22 ' C ' ' A' ' 23' ' ' PRO . 12.6 t -116.86 27.31 9.23 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 122.305 1.05 . . . . 0.34 108.733 173.2 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.463 ' C ' ' HB3' ' A' ' 18' ' ' SER . . . -75.83 -4.43 40.68 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.598 -1.183 . . . . 0.37 112.162 -175.213 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -97.94 -19.8 17.84 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.943 0.401 . . . . 2.21 110.632 -178.263 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.505 HG23 ' HB2' ' A' ' 39' ' ' ASP . 0.2 OUTLIER -101.85 137.85 28.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 116.062 -0.517 . . . . 0.31 110.36 -178.667 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 61.8 p -96.91 177.9 5.47 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 109.531 -0.544 . . . . 0.39 109.531 -178.257 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.472 ' HA ' ' HB3' ' A' ' 40' ' ' ALA . 0.1 OUTLIER -68.39 -21.26 64.7 Favored 'General case' 0 C--O 1.217 -0.616 0 C-N-CA 118.72 -1.192 . . . . 1.53 110.288 174.26 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -72.41 -41.98 65.63 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.931 -0.396 . . . . 0.96 109.931 175.821 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.505 ' HB2' HG23 ' A' ' 35' ' ' VAL . 23.9 m-20 -71.04 -35.17 71.88 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.404 0.621 . . . . 0.91 109.853 175.035 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.472 ' HB3' ' HA ' ' A' ' 37' ' ' TYR . . . -67.99 -48.25 66.29 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.098 -0.955 . . . . 0.19 110.613 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.437 ' CG1' HD21 ' A' ' 111' ' ' LEU . 69.8 mt -62.15 -36.83 76.44 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.462 0 N-CA-C 109.833 -0.432 . . . . 0.3 109.833 175.661 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 59.6 tttp -59.86 -29.09 68.07 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.832 -0.622 . . . . 2.32 109.891 178.818 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -88.91 -49.54 6.73 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.461 -0.791 . . . . 1.02 110.473 -178.502 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.928 HD23 HG23 ' A' ' 104' ' ' ILE . 33.9 tp -58.73 -36.42 74.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.969 -0.56 . . . . 0.17 110.039 -177.503 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.456 ' O ' ' HB2' ' A' ' 49' ' ' GLN . 11.8 mm-40 -66.92 -23.56 65.99 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-N 115.954 -0.566 . . . . 0.87 112.078 -179.692 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -85.01 -40.29 17.05 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 110.196 -0.298 . . . . 1.31 110.196 179.672 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.413 ' O ' HG13 ' A' ' 51' ' ' ILE . 36.8 m95 -66.46 -47.87 71.73 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.96 -0.296 . . . . 0.52 111.293 174.829 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.44 ' HB3' HG21 ' A' ' 113' ' ' ILE . 88.6 p -62.75 -28.24 69.83 Favored 'General case' 0 C--N 1.333 -0.128 0 C-N-CA 120.719 -0.392 . . . . 0.82 110.062 177.449 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.456 ' HB2' ' O ' ' A' ' 45' ' ' GLN . 11.4 tt0 -66.74 -57.17 7.64 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.925 -0.58 . . . . 0.53 110.323 173.774 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.622 ' HB3' HG22 ' A' ' 56' ' ' VAL . 86.2 mtt180 -61.14 -42.14 98.01 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.943 -0.571 . . . . 0.42 111.58 -176.437 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.489 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 92.4 mt -61.51 -36.63 74.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 120.929 0.395 . . . . 0.2 110.43 177.479 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -77.46 -35.45 53.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.068 -0.515 . . . . 0.27 111.684 -179.476 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 51.1 p -80.49 -30.34 37.33 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.893 0.377 . . . . 0.35 111.481 -177.702 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 108.55 4.43 32.37 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.76 -0.733 . . . . 0.3 112.218 -179.73 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.42 ' HB2' ' HB3' ' A' ' 50' ' ' ARG . 40.0 mt-10 -61.49 -48.7 79.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.007 0.432 . . . . 0.65 110.104 178.039 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.622 HG22 ' HB3' ' A' ' 50' ' ' ARG . 13.6 m -133.77 157.45 42.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 109.354 -0.61 . . . . 0.19 109.354 171.824 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 49.6 m -85.93 160.02 19.5 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 109.471 -0.566 . . . . 0.97 109.471 177.211 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.424 ' HA ' HD13 ' A' ' 51' ' ' ILE . 2.7 t80 -53.66 -43.92 69.2 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.272 0.558 . . . . 0.22 109.948 -177.662 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.583 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 2.8 mp0 -56.96 -39.13 74.01 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.845 -1.071 . . . . 1.72 111.916 -178.307 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 31.5 mm-40 -65.39 -48.94 71.14 Favored 'General case' 0 CA--C 1.521 -0.16 0 CA-C-O 120.836 0.35 . . . . 2.09 111.118 -177.739 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -68.94 -42.72 76.33 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.386 -0.37 . . . . 0.26 111.108 -177.814 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.11 -53.82 52.22 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.331 -0.395 . . . . 0.24 112.051 -175.657 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.519 ' HA ' ' O ' ' A' ' 71' ' ' TYR . 16.0 m -51.56 -21.8 2.79 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 113.149 0.796 . . . . 1.0 113.149 -177.342 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -104.99 -46.71 4.2 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.519 0.676 . . . . 0.61 110.473 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' A' ' 65' ' ' ARG . 21.2 mmt180 -94.8 -36.11 11.81 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.745 -1.116 . . . . 0.86 113.99 -168.784 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.499 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 54.4 p -63.23 116.81 5.79 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.031 0.443 . . . . 0.82 110.479 -177.684 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.485 ' HA ' ' HG2' ' A' ' 26' ' ' ARG . 48.5 m-20 -82.15 0.72 39.6 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.772 -0.649 . . . . 2.28 111.251 -178.657 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 0.565 ' SG ' HD22 ' A' ' 14' ' ' LEU . 1.7 m -78.42 173.67 12.1 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.869 -0.605 . . . . 1.52 109.978 172.159 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -69.28 -16.54 71.32 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.706 -0.759 . . . . 0.26 112.026 179.533 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 67.2 p -65.98 -5.51 9.74 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 112.576 0.584 . . . . 0.32 112.576 -179.046 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.519 ' O ' ' HA ' ' A' ' 63' ' ' SER . 30.4 p90 -60.36 -25.76 66.1 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.005 0.431 . . . . 0.54 110.33 177.78 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -94.36 -2.58 51.85 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.239 0.542 . . . . 0.49 110.448 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 7.0 m -116.84 9.36 13.85 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.832 -0.622 . . . . 0.71 110.748 -178.1 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.583 ' O ' ' HA ' ' A' ' 59' ' ' GLU . . . 68.27 28.51 73.27 Favored Glycine 0 C--O 1.227 -0.288 0 C-N-CA 120.915 -0.66 . . . . 0.54 112.039 -177.435 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 83.29 -21.2 8.78 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 121.145 -0.55 . . . . 0.35 112.282 -178.881 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -72.68 136.81 45.7 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.787 0.327 . . . . 1.65 111.192 -173.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.43 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 2.6 mp -116.17 166.79 11.62 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.955 -0.566 . . . . 0.94 110.027 174.665 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -81.24 -148.52 6.16 Favored Glycine 0 C--N 1.314 -0.669 0 CA-C-N 115.393 -0.821 . . . . 0.44 113.138 -177.246 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -99.33 143.92 29.03 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.993 0.425 . . . . 3.87 110.864 -179.293 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.411 ' HE2' ' HB3' ' A' ' 77' ' ' LEU . 0.9 OUTLIER -157.31 175.23 14.29 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.856 -0.611 . . . . 1.31 109.815 -174.925 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 16.2 m -104.17 139.52 39.11 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.876 -0.787 . . . . 1.17 108.876 175.802 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 48.0 m -61.96 126.96 29.18 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.076 0.465 . . . . 1.19 110.812 -179.375 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 114.74 -4.25 22.87 Favored Glycine 0 N--CA 1.443 -0.898 0 CA-C-N 115.392 -0.822 . . . . 0.79 111.276 -176.883 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -95.85 6.99 47.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.699 0.285 . . . . 1.55 111.363 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 25.0 mmt -104.16 -122.6 0.21 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.047 0.451 . . . . 0.73 110.572 179.36 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 54.8 mtt -123.69 152.15 42.36 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 107.919 -1.141 . . . . 1.39 107.919 175.795 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm -53.17 -53.99 49.64 Favored Pre-proline 0 C--N 1.319 -0.721 0 N-CA-C 112.249 0.463 . . . . 2.37 112.249 -175.219 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.05 -30.68 10.54 Favored 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 121.457 1.438 . . . . 0.27 111.836 -177.551 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.646 ' O ' HG23 ' A' ' 93' ' ' VAL . 26.3 t80 -67.36 -56.48 9.53 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.247 -0.888 . . . . 0.22 109.885 179.742 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -62.19 -35.32 78.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.535 -0.757 . . . . 2.12 110.449 -178.728 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -61.12 -30.47 70.39 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.362 -0.836 . . . . 0.61 110.905 178.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.465 ' O ' ' HG ' ' A' ' 96' ' ' LEU . . . -83.35 -26.84 30.16 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.851 0.357 . . . . 0.22 110.659 178.001 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.646 HG23 ' O ' ' A' ' 89' ' ' PHE . 27.4 t -70.43 -37.62 71.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.255 0.55 . . . . 0.25 110.165 -176.633 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.479 ' C ' ' HD2' ' A' ' 94' ' ' ARG . 6.2 ppt_? -78.92 -13.68 59.66 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.882 -0.599 . . . . 2.59 110.735 178.657 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -84.23 -11.04 57.15 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.185 0.517 . . . . 0.47 110.963 -175.694 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.583 ' HB2' ' HB2' ' A' ' 100' ' ' ASP . 0.9 OUTLIER -127.64 145.18 50.97 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.828 -0.624 . . . . 0.28 110.761 179.713 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.424 ' HG3' ' H ' ' A' ' 98' ' ' ILE . 20.7 tptm -92.95 173.12 7.91 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 109.021 -0.733 . . . . 1.61 109.021 178.754 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.463 ' HA ' ' HG2' ' A' ' 116' ' ' ARG . 72.1 mt -45.76 115.96 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.913 0.387 . . . . 0.9 111.649 176.393 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 106.16 -12.27 44.47 Favored Glycine 0 CA--C 1.521 0.45 0 C-N-CA 120.946 -0.645 . . . . 0.46 113.736 177.78 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.583 ' HB2' ' HB2' ' A' ' 96' ' ' LEU . 15.7 m-20 -97.95 148.98 22.91 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 117.566 0.683 . . . . 0.46 111.144 -178.005 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 13.0 mt -115.83 149.08 18.15 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-N 115.951 -0.568 . . . . 0.23 110.872 -174.869 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.411 ' HB2' ' H ' ' A' ' 114' ' ' ILE . 5.9 m -81.72 151.18 67.59 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 115.953 -0.567 . . . . 0.92 110.806 -178.333 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -73.75 165.22 32.8 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 122.2 1.934 . . . . 0.34 109.989 166.221 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.928 HG23 HD23 ' A' ' 44' ' ' LEU . 20.1 mm -46.47 108.54 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 O-C-N 123.32 0.387 . . . . 0.2 111.956 178.292 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.3 p -115.32 117.59 56.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.193 -0.458 . . . . 1.04 110.157 176.812 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 16.8 mt-30 -85.25 147.24 26.67 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.055 0.455 . . . . 0.55 110.07 178.105 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 8.8 p -121.38 -172.46 2.42 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.421 -0.808 . . . . 0.37 110.389 -177.474 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -59.86 -35.27 74.44 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.589 0.233 . . . . 2.16 110.78 178.649 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.603 ' OG ' ' HE2' ' A' ' 16' ' ' LYS . 6.4 t -96.78 -60.93 1.49 Allowed 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.69 -0.404 . . . . 1.09 110.884 -179.713 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -147.72 -135.02 2.57 Favored Glycine 0 N--CA 1.443 -0.884 0 C-N-CA 118.9 -1.619 . . . . 0.24 113.733 -173.321 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.896 ' HB3' HD22 ' A' ' 44' ' ' LEU . 7.7 mp -113.83 146.34 40.11 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 114.962 -0.619 . . . . 0.19 111.232 -170.643 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' HIS . . . . . 0.538 ' HA ' ' O ' ' A' ' 13' ' ' LEU . 77.0 m-70 -144.16 150.14 37.58 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.144 0.497 . . . . 0.22 111.902 179.659 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.557 HG12 HD11 ' A' ' 44' ' ' LEU . 2.1 pt -134.57 137.58 51.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 107.715 -1.217 . . . . 0.17 107.715 160.651 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.411 ' H ' ' HB2' ' A' ' 102' ' ' SER . 2.1 mp -128.1 145.96 34.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 C-N-CA 121.035 -0.266 . . . . 0.18 110.735 -174.758 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.42 ' HG2' ' HB3' ' A' ' 11' ' ' ALA . 47.4 pttt -127.84 139.86 52.38 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.733 -0.84 . . . . 0.61 108.733 172.887 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' ARG . . . . . 0.483 ' HD3' HD21 ' A' ' 8' ' ' LEU . 4.7 ttp180 -83.11 133.92 35.03 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.12 -0.632 . . . . 1.87 110.868 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -103.04 -36.0 8.33 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.87 -1.059 . . . . 0.89 109.729 -178.839 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.475 ' HB3' ' HB3' ' A' ' 9' ' ' ARG . . . . . . . . 0 C--O 1.245 0.855 0 CA-C-O 117.992 -1.004 . . . . 1.1 109.569 178.848 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt . . . . . 0 N--CA 1.453 -0.289 0 CA-C-O 121.281 0.562 . . . . 1.19 109.95 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.655 HD23 ' H ' ' A' ' 9' ' ' ARG . 0.4 OUTLIER -124.04 164.37 19.52 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.046 -0.979 . . . . 1.18 109.529 -174.63 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.655 ' H ' HD23 ' A' ' 8' ' ' LEU . 58.4 ttt180 -145.35 128.85 17.0 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.395 -0.594 . . . . 1.06 109.395 175.539 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.432 ' N ' ' HZ ' ' A' ' 80' ' ' PHE . . . -146.35 153.74 40.86 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.12 0.486 . . . . 0.22 112.036 -179.456 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.41 ' HB3' ' HG2' ' A' ' 115' ' ' LYS . . . -106.81 133.03 52.1 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.457 -0.792 . . . . 0.2 109.089 176.573 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 38.0 p-80 -137.06 155.65 49.39 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.366 0.506 . . . . 0.23 112.366 -170.628 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.577 HD23 ' N ' ' A' ' 14' ' ' LEU . 5.3 tt -123.13 147.25 46.99 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.694 -0.854 . . . . 0.24 108.694 176.377 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.577 ' N ' HD23 ' A' ' 13' ' ' LEU . 23.6 tp -131.64 124.4 29.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.486 0.184 . . . . 0.27 111.126 -178.677 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.527 HG23 HD13 ' A' ' 44' ' ' LEU . 58.9 t -112.85 142.03 26.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 109.787 -0.449 . . . . 0.15 109.787 175.577 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.429 ' HE3' HD21 ' A' ' 14' ' ' LEU . 31.2 mmtp -114.39 156.36 24.62 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.789 -0.448 . . . . 0.62 109.789 178.306 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.409 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 41.7 p90 -149.96 162.74 39.77 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.513 -0.312 . . . . 0.25 110.26 -176.087 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.474 ' HB3' ' C ' ' A' ' 33' ' ' ALA . 54.0 p -52.06 112.88 0.86 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.786 0.327 . . . . 1.04 111.111 179.046 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 99.63 10.37 47.34 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.327 -0.939 . . . . 0.53 113.007 179.547 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.521 ' C ' ' H ' ' A' ' 22' ' ' ASN . 33.0 p -76.29 23.07 0.15 Allowed 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 117.459 0.63 . . . . 0.7 112.462 -174.438 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 86.1 mtt180 69.55 -35.28 0.31 Allowed 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.708 0.803 . . . . 3.49 110.355 -175.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.521 ' H ' ' C ' ' A' ' 20' ' ' SER . 13.2 m-80 -140.13 102.25 6.85 Favored Pre-proline 0 N--CA 1.445 -0.717 0 N-CA-C 108.08 -1.082 . . . . 1.77 108.08 174.046 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -68.31 -159.27 0.05 OUTLIER 'Trans proline' 0 CA--C 1.531 0.371 0 C-N-CA 122.894 2.396 . . . . 1.71 111.821 179.453 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.523 ' N ' HG22 ' A' ' 32' ' ' THR . 16.5 t 62.25 107.16 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-N 115.487 -0.779 . . . . 0.48 111.976 178.202 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.417 ' HB3' ' HB2' ' A' ' 16' ' ' LYS . 59.3 p -103.72 155.88 18.24 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.644 -0.502 . . . . 1.12 109.644 175.425 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.516 ' HB2' ' HA ' ' A' ' 67' ' ' ASP . 4.7 mpt_? -66.33 -7.85 21.54 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.123 0.487 . . . . 2.54 110.486 174.509 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.484 ' HG2' ' HD3' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -85.54 -27.23 25.71 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.421 -0.808 . . . . 1.77 110.237 178.887 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 26.8 p -108.31 -35.53 6.5 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.873 -0.603 . . . . 0.67 111.193 -176.005 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 80.41 -33.98 2.26 Favored Glycine 0 CA--C 1.519 0.304 0 CA-C-N 115.443 -0.799 . . . . 0.82 113.483 175.567 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.439 ' O ' HG22 ' A' ' 24' ' ' VAL . 15.0 t70 -105.13 -66.19 0.99 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.911 0.355 . . . . 2.1 110.635 179.44 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 19.2 m -152.3 150.89 30.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.111 0.481 . . . . 1.08 111.155 -179.223 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.523 HG22 ' N ' ' A' ' 24' ' ' VAL . 8.9 t -123.62 19.03 9.56 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 122.005 0.907 . . . . 0.34 109.347 178.012 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.474 ' C ' ' HB3' ' A' ' 18' ' ' SER . . . -67.35 -5.26 13.61 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.066 -0.97 . . . . 0.37 112.364 177.449 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -92.39 -24.34 18.91 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.889 0.376 . . . . 2.21 111.111 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.444 HG13 ' OG1' ' A' ' 32' ' ' THR . 0.2 OUTLIER -101.78 137.15 30.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 116.138 -0.483 . . . . 0.31 109.965 -179.573 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 77.1 p -94.04 177.48 5.96 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 116.289 -0.414 . . . . 0.39 110.054 -173.783 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.53 ' O ' HG13 ' A' ' 41' ' ' ILE . 15.4 p90 -63.37 -30.53 71.65 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 119.917 -0.713 . . . . 1.53 109.435 176.408 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -69.46 -47.78 62.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.081 -0.509 . . . . 0.96 110.595 178.369 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 39.5 m-20 -70.38 -27.84 64.63 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.98 -0.555 . . . . 0.91 110.26 179.465 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.409 ' HB2' ' HB3' ' A' ' 17' ' ' PHE . . . -74.31 -39.06 63.12 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.495 -0.775 . . . . 0.19 110.329 177.73 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.53 HG13 ' O ' ' A' ' 37' ' ' TYR . 80.6 mt -64.46 -36.71 78.05 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 109.524 -0.547 . . . . 0.3 109.524 174.133 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.45 ' O ' ' HG3' ' A' ' 46' ' ' LYS . 26.3 mtpp -64.12 -25.0 67.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.942 0.401 . . . . 2.32 110.485 175.931 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.45 ' HG3' ' NE1' ' A' ' 47' ' ' TRP . 6.9 tt0 -83.88 -51.76 6.92 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.892 -0.595 . . . . 1.02 109.823 -179.188 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.912 HD22 ' HB3' ' A' ' 111' ' ' LEU . 34.0 tp -60.69 -38.76 86.07 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.786 -0.643 . . . . 0.17 110.479 -179.744 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.491 ' O ' ' HB2' ' A' ' 49' ' ' GLN . 4.1 mm100 -61.51 -38.28 86.8 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.189 -0.459 . . . . 0.87 112.146 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.45 ' HG3' ' O ' ' A' ' 42' ' ' LYS . 68.3 mttm -72.78 -38.68 67.19 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.672 0.273 . . . . 1.31 111.083 -177.723 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.45 ' NE1' ' HG3' ' A' ' 43' ' ' GLU . 9.8 m95 -70.83 -45.85 63.81 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.885 -0.326 . . . . 0.52 110.863 178.06 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.463 ' HB3' HG21 ' A' ' 113' ' ' ILE . 89.1 p -64.36 -28.3 69.61 Favored 'General case' 0 CA--C 1.528 0.122 0 N-CA-C 110.073 -0.343 . . . . 0.82 110.073 177.356 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.491 ' HB2' ' O ' ' A' ' 45' ' ' GLN . 12.5 tt0 -64.68 -52.05 59.3 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 116.018 -0.537 . . . . 0.53 109.952 175.368 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.639 ' HB3' HG22 ' A' ' 56' ' ' VAL . 84.4 mtt180 -61.05 -46.73 89.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.548 -0.751 . . . . 0.42 111.205 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.465 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 85.3 mt -56.69 -43.67 79.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.291 -0.413 . . . . 0.2 110.872 177.185 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.68 -42.62 81.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.117 -0.492 . . . . 0.27 111.927 -179.339 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 51.3 p -77.7 -30.39 51.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.934 0.397 . . . . 0.35 111.367 -177.187 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 108.68 8.96 27.6 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.564 -0.827 . . . . 0.3 112.242 179.006 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.504 ' OE1' ' HG2' ' A' ' 50' ' ' ARG . 48.6 mt-10 -60.84 -49.37 77.77 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.096 0.475 . . . . 0.65 109.913 176.657 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.639 HG22 ' HB3' ' A' ' 50' ' ' ARG . 31.4 m -134.44 154.68 37.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.719 -0.673 . . . . 0.19 109.41 173.991 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.435 ' OG ' ' HG2' ' A' ' 60' ' ' GLU . 19.8 p -79.44 161.83 25.86 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 110.042 -0.355 . . . . 0.97 110.042 176.569 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -55.04 -38.4 67.92 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.377 0.608 . . . . 0.22 109.548 178.24 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -59.2 -43.45 92.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.885 -1.052 . . . . 1.72 111.828 -179.223 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.435 ' HG2' ' OG ' ' A' ' 57' ' ' SER . 12.1 mm-40 -64.48 -42.09 96.1 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-O 121.016 0.436 . . . . 2.09 110.85 -178.589 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.429 ' O ' ' HG2' ' A' ' 65' ' ' ARG . . . -70.01 -55.85 8.51 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.896 -0.593 . . . . 0.26 110.455 179.611 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -54.63 -52.96 60.61 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.513 0.56 . . . . 0.24 112.513 -174.041 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.483 ' HA ' ' O ' ' A' ' 71' ' ' TYR . 20.8 t -52.0 -27.95 15.26 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.695 0.628 . . . . 1.0 112.695 -175.633 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -105.28 -44.19 4.81 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.492 0.663 . . . . 0.61 110.894 -177.886 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.484 ' HD3' ' HG2' ' A' ' 27' ' ' ARG . 16.6 mmt180 -83.59 -44.4 14.64 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.944 -1.026 . . . . 0.86 113.114 -171.852 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.449 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 77.6 p -65.21 120.04 11.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.128 0.49 . . . . 0.82 111.429 -173.753 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.516 ' HA ' ' HB2' ' A' ' 26' ' ' ARG . 19.6 t70 -70.81 -16.9 62.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.48 -0.782 . . . . 2.28 110.885 177.132 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 0.473 ' O ' ' HD2' ' A' ' 71' ' ' TYR . 53.7 t -77.99 154.96 31.05 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.259 0.552 . . . . 1.52 109.931 178.815 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -58.94 -12.37 14.83 Favored Glycine 0 C--O 1.234 0.148 0 CA-C-N 114.66 -1.155 . . . . 0.26 113.714 -173.909 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 52.3 p -64.72 -8.07 13.29 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 111.771 0.285 . . . . 0.32 111.771 176.92 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.483 ' O ' ' HA ' ' A' ' 63' ' ' SER . 51.1 p90 -57.59 -25.38 59.95 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.932 0.396 . . . . 0.54 110.596 176.631 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -93.98 3.35 55.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.058 0.456 . . . . 0.49 111.035 -179.382 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 9.0 m -126.78 14.42 7.47 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.099 -0.5 . . . . 0.71 110.772 179.356 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 67.97 24.7 74.44 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 121.063 -0.589 . . . . 0.54 112.54 -178.104 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 86.91 -17.2 42.57 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 121.16 -0.543 . . . . 0.35 112.219 -179.612 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -74.55 136.79 42.12 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.733 0.302 . . . . 1.65 110.682 -176.01 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.419 ' O ' ' HG3' ' A' ' 9' ' ' ARG . 2.4 mp -113.46 157.88 21.39 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 116.248 -0.433 . . . . 0.94 110.055 173.218 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -76.19 -107.03 0.13 Allowed Glycine 0 C--N 1.309 -0.953 0 CA-C-N 115.226 -0.897 . . . . 0.44 113.504 -175.497 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 9.1 p90 -120.87 149.0 43.28 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.716 0.293 . . . . 3.87 110.796 -178.12 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.432 ' HZ ' ' N ' ' A' ' 10' ' ' ALA . 3.8 p90 -166.27 161.32 16.66 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.547 -0.538 . . . . 1.31 109.547 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 73.0 p -105.11 125.45 50.99 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 109.292 -0.632 . . . . 1.17 109.292 176.337 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 11.0 p -44.69 122.09 3.0 Favored 'General case' 0 C--O 1.234 0.288 0 O-C-N 123.79 0.681 . . . . 1.19 111.618 -178.048 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 114.42 10.46 13.22 Favored Glycine 0 N--CA 1.446 -0.655 0 CA-C-N 115.824 -0.626 . . . . 0.79 111.662 -177.76 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -109.23 -5.48 15.9 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 111.481 0.178 . . . . 1.55 111.481 179.64 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 26.2 mmt -95.15 -105.05 0.15 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.285 0.564 . . . . 0.73 111.085 -175.854 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' MET . . . . . 0.458 ' HB2' ' HB3' ' A' ' 89' ' ' PHE . 44.1 mtt -138.12 148.81 45.33 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 107.381 -1.34 . . . . 1.39 107.381 177.789 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.418 ' HB3' ' HD3' ' A' ' 88' ' ' PRO . 64.6 tttp -51.16 -54.55 36.75 Favored Pre-proline 0 C--N 1.32 -0.685 0 N-CA-C 112.472 0.545 . . . . 2.37 112.472 -175.496 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.552 ' HG2' HG22 ' A' ' 107' ' ' THR . 86.5 Cg_endo -75.67 -29.7 6.96 Favored 'Trans proline' 0 C--N 1.356 0.965 0 C-N-CA 121.664 1.576 . . . . 0.27 111.997 -177.557 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.595 ' O ' HG23 ' A' ' 93' ' ' VAL . 12.4 t80 -66.32 -56.42 11.23 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.722 -0.672 . . . . 0.22 109.428 178.466 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.534 ' O ' ' HD3' ' A' ' 94' ' ' ARG . 4.2 tp10 -61.4 -36.14 79.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.16 -0.927 . . . . 2.12 109.812 -179.773 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.765 ' HA ' ' NE ' ' A' ' 94' ' ' ARG . 27.2 t70 -54.44 -43.73 71.85 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 115.155 -0.929 . . . . 0.61 110.77 177.529 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.67 ' O ' ' HG ' ' A' ' 96' ' ' LEU . . . -71.5 -34.4 70.09 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.022 -0.536 . . . . 0.22 110.765 179.617 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.595 HG23 ' O ' ' A' ' 89' ' ' PHE . 28.4 t -60.86 -49.53 84.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.406 -0.361 . . . . 0.25 111.219 -176.06 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.765 ' NE ' ' HA ' ' A' ' 91' ' ' ASP . 0.1 OUTLIER -75.91 -16.66 59.99 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.516 -0.474 . . . . 2.59 110.479 179.463 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -78.34 -13.51 59.82 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.065 -0.516 . . . . 0.47 111.439 -176.032 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.67 ' HG ' ' O ' ' A' ' 92' ' ' ALA . 0.4 OUTLIER -123.21 159.6 28.34 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.174 0.511 . . . . 0.28 111.137 178.052 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.487 ' HE3' HD13 ' A' ' 98' ' ' ILE . 54.5 tptt -102.27 176.78 5.07 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.321 -0.854 . . . . 1.61 109.321 178.769 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.487 HD13 ' HE3' ' A' ' 97' ' ' LYS . 1.1 mp -47.43 119.97 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 C-N-CA 123.423 0.689 . . . . 0.9 111.298 178.8 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 92.92 -10.53 73.75 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 121.002 -0.618 . . . . 0.46 113.071 176.863 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.59 ' HB2' ' HB2' ' A' ' 96' ' ' LEU . 23.1 m-20 -85.64 131.68 34.3 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 117.115 0.457 . . . . 0.46 110.301 -178.418 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 8.7 mt -104.52 143.64 15.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.073 -0.512 . . . . 0.23 109.779 179.706 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 89.2 p -88.22 148.49 42.86 Favored Pre-proline 0 C--N 1.318 -0.799 0 CA-C-N 116.341 -0.39 . . . . 0.92 110.402 -178.884 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -70.1 163.73 37.47 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 122.032 1.821 . . . . 0.34 110.615 170.723 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.862 HG23 HD23 ' A' ' 44' ' ' LEU . 21.5 mm -39.64 100.33 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 N-CA-C 112.959 0.726 . . . . 0.2 112.959 179.318 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 1.8 p -104.69 118.13 51.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.979 -0.555 . . . . 1.04 109.798 175.782 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -85.8 145.52 27.18 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.266 0.555 . . . . 0.55 110.801 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.552 HG22 ' HG2' ' A' ' 88' ' ' PRO . 6.1 p -117.28 -172.82 2.29 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.309 -0.86 . . . . 0.37 110.161 179.694 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -65.63 -35.39 80.67 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 121.011 -0.275 . . . . 2.16 110.363 177.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.423 ' O ' ' HB2' ' A' ' 20' ' ' SER . 4.8 t -92.33 -60.96 1.71 Allowed 'General case' 0 N--CA 1.443 -0.778 0 C-N-CA 120.254 -0.578 . . . . 1.09 110.606 -179.125 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -145.03 -131.98 2.44 Favored Glycine 0 N--CA 1.44 -1.077 0 C-N-CA 119.015 -1.564 . . . . 0.24 113.793 -174.433 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.912 ' HB3' HD22 ' A' ' 44' ' ' LEU . 6.0 mp -121.53 147.99 45.08 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 114.917 -0.641 . . . . 0.19 111.08 -170.57 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' HIS . . . . . 0.5 ' HA ' ' O ' ' A' ' 13' ' ' LEU . 85.4 m-70 -143.25 148.97 37.25 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.313 0.577 . . . . 0.22 112.254 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.659 HG12 HD11 ' A' ' 44' ' ' LEU . 2.5 pt -131.05 135.04 60.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 107.491 -1.3 . . . . 0.17 107.491 160.055 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 3.0 mp -130.2 142.79 42.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 C-N-CA 120.866 -0.334 . . . . 0.18 110.439 -175.921 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.483 ' HA ' ' O ' ' A' ' 100' ' ' ASP . 40.9 pttt -123.21 139.18 54.32 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.622 -0.881 . . . . 0.61 108.622 172.359 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' ARG . . . . . 0.521 ' HB2' ' CD1' ' A' ' 96' ' ' LEU . 57.1 ttt180 -83.74 131.74 34.9 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.155 0.502 . . . . 1.87 111.052 -177.855 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.459 ' HB2' ' HG2' ' A' ' 9' ' ' ARG . 4.3 mm? -98.9 -41.11 7.75 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.259 -0.882 . . . . 0.89 109.832 179.004 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.4 ' HB3' ' HB3' ' A' ' 9' ' ' ARG . . . . . . . . 0 C--O 1.246 0.899 0 CA-C-O 118.622 -0.704 . . . . 1.1 110.409 179.341 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.52 ' HA ' ' O ' ' A' ' 80' ' ' PHE . 73.1 mmtt . . . . . 0 N--CA 1.452 -0.346 0 CA-C-O 121.304 0.573 . . . . 1.19 111.034 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.643 HD23 ' N ' ' A' ' 9' ' ' ARG . 3.2 tt -140.58 154.19 46.39 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 114.921 -1.036 . . . . 1.18 108.284 -177.256 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.643 ' N ' HD23 ' A' ' 8' ' ' LEU . 26.5 ttt180 -133.64 132.93 41.34 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.348 -0.982 . . . . 1.06 108.348 172.494 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -147.06 150.44 35.07 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.459 -0.496 . . . . 0.22 111.975 -174.094 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.623 ' HA ' ' HA ' ' A' ' 76' ' ' ASP . . . -108.45 133.74 52.2 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-N 115.698 -0.683 . . . . 0.2 109.8 177.544 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 45.8 p-80 -138.73 145.09 39.84 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 120.93 0.395 . . . . 0.23 111.108 -172.797 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.562 ' O ' ' HA ' ' A' ' 112' ' ' HIS . 6.6 tt -112.82 142.92 44.91 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.251 -1.018 . . . . 0.24 108.251 176.339 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.823 HD13 ' CE1' ' A' ' 112' ' ' HIS . 29.3 tp -128.97 118.41 22.56 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.739 0.304 . . . . 0.27 111.021 -175.763 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.519 HG23 HD13 ' A' ' 44' ' ' LEU . 46.3 t -107.88 134.19 50.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 109.501 -0.555 . . . . 0.15 109.501 176.348 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.475 ' HE3' HD21 ' A' ' 14' ' ' LEU . 32.7 mmtp -109.45 152.41 25.43 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.754 -0.462 . . . . 0.62 109.754 178.309 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.451 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 47.0 p90 -143.37 162.51 35.55 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.515 -0.311 . . . . 0.25 110.533 -176.95 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.414 ' HB3' ' HA ' ' A' ' 33' ' ' ALA . 19.9 p -52.08 113.44 1.02 Allowed 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.276 -0.42 . . . . 1.04 111.14 177.926 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 95.29 10.04 57.45 Favored Glycine 0 C--N 1.334 0.429 0 C-N-CA 120.761 -0.733 . . . . 0.53 113.318 179.497 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.664 ' HB2' ' O ' ' A' ' 109' ' ' SER . 85.6 p -90.0 35.05 0.84 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 117.368 0.584 . . . . 0.7 111.523 -175.804 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.464 ' HB3' ' O ' ' A' ' 20' ' ' SER . 73.7 ttt180 71.82 -34.26 0.29 Allowed 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 120.995 0.426 . . . . 3.49 111.16 -179.092 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.451 ' H ' ' C ' ' A' ' 20' ' ' SER . 45.7 m-80 -132.81 93.59 23.4 Favored Pre-proline 0 C--N 1.327 -0.385 0 N-CA-C 109.409 -0.589 . . . . 1.77 109.409 176.069 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.555 ' C ' HG22 ' A' ' 32' ' ' THR . 95.4 Cg_endo -80.83 49.16 3.14 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 122.507 2.138 . . . . 1.71 112.959 -176.326 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.482 ' N ' HG22 ' A' ' 32' ' ' THR . 47.3 t -147.26 117.0 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 N-CA-C 108.759 -0.83 . . . . 0.48 108.759 178.052 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 41.2 t -105.89 154.23 20.85 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 110.203 -0.295 . . . . 1.12 110.203 177.88 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.623 ' HB2' ' HA ' ' A' ' 67' ' ' ASP . 6.6 mpt_? -69.01 -5.27 20.7 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.087 0.47 . . . . 2.54 110.422 171.363 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.605 ' HG3' ' CD ' ' A' ' 65' ' ' ARG . 18.3 ttp180 -78.21 -29.58 48.41 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.654 -0.703 . . . . 1.77 109.623 175.822 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 71.6 p -115.28 -33.78 5.2 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.753 -0.658 . . . . 0.67 111.454 -174.434 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 81.55 -36.39 2.44 Favored Glycine 0 CA--C 1.52 0.371 0 CA-C-N 115.977 -0.556 . . . . 0.82 112.905 178.445 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -95.03 -65.99 0.94 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.801 0.334 . . . . 2.1 110.625 -178.059 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 13.7 p -153.94 156.26 37.16 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.949 0.404 . . . . 1.08 110.932 178.66 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.555 HG22 ' C ' ' A' ' 23' ' ' PRO . 14.8 t -120.07 28.63 7.96 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 122.076 0.941 . . . . 0.34 109.146 174.054 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.414 ' HA ' ' HB3' ' A' ' 18' ' ' SER . . . -75.78 -5.7 47.09 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.92 -1.036 . . . . 0.37 111.422 -178.085 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -93.82 -25.72 17.24 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.902 -0.59 . . . . 2.21 111.095 -179.042 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.523 HG23 ' HB2' ' A' ' 39' ' ' ASP . 0.2 OUTLIER -98.61 138.77 22.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 116.135 -0.484 . . . . 0.31 109.76 -178.663 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 72.8 p -94.76 176.77 6.14 Favored 'General case' 0 CA--C 1.513 -0.474 0 N-CA-C 109.84 -0.43 . . . . 0.39 109.84 -174.801 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.46 ' O ' HG13 ' A' ' 41' ' ' ILE . 4.1 p90 -63.88 -27.17 68.97 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 119.897 -0.721 . . . . 1.53 109.099 175.534 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -72.75 -46.78 51.66 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.956 -0.565 . . . . 0.96 110.301 178.589 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.523 ' HB2' HG23 ' A' ' 35' ' ' VAL . 42.1 m-20 -64.68 -33.52 76.14 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 121.375 0.607 . . . . 0.91 109.633 177.108 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.451 ' HB2' ' HB3' ' A' ' 17' ' ' PHE . . . -68.8 -45.73 70.52 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.985 -1.007 . . . . 0.19 110.64 179.311 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.487 ' CG1' HD21 ' A' ' 111' ' ' LEU . 70.1 mt -62.55 -37.68 79.51 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.345 0 N-CA-C 109.704 -0.48 . . . . 0.3 109.704 174.909 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.446 ' O ' ' HG3' ' A' ' 46' ' ' LYS . 27.8 ttpt -63.73 -22.88 67.13 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.902 -0.59 . . . . 2.32 110.126 179.343 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.44 ' HG3' ' CD1' ' A' ' 47' ' ' TRP . 8.7 tp10 -85.45 -54.52 4.52 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.662 -0.699 . . . . 1.02 109.309 179.506 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.947 HD22 ' HB3' ' A' ' 111' ' ' LEU . 29.6 tp -59.81 -36.25 76.38 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.859 -1.064 . . . . 0.17 110.55 -174.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.441 ' HA ' HD11 ' A' ' 104' ' ' ILE . 3.9 mm-40 -64.2 -35.82 82.04 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.811 -0.632 . . . . 0.87 112.265 -179.353 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.446 ' HG3' ' O ' ' A' ' 42' ' ' LYS . 95.0 mttt -70.62 -47.42 60.16 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.153 0.501 . . . . 1.31 109.801 178.582 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.492 ' NE1' ' HG3' ' A' ' 65' ' ' ARG . 51.3 m95 -61.9 -47.59 84.27 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.8 -0.636 . . . . 0.52 111.687 179.199 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.564 ' HB3' HG21 ' A' ' 113' ' ' ILE . 97.5 p -64.32 -22.71 67.04 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.954 0.407 . . . . 0.82 110.15 178.251 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -74.17 -57.37 4.0 Favored 'General case' 0 C--O 1.224 -0.261 0 CA-C-N 116.1 -0.5 . . . . 0.53 110.063 174.083 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.658 ' HB3' HG22 ' A' ' 56' ' ' VAL . 96.9 mtt180 -61.6 -42.58 99.08 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.624 -0.716 . . . . 0.42 111.46 -174.939 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 98.3 mt -60.39 -35.59 63.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.003 -0.544 . . . . 0.2 110.739 177.123 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -79.73 -41.32 26.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.086 -0.506 . . . . 0.27 111.32 -179.002 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 58.3 p -74.6 -29.96 61.51 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.21 -0.45 . . . . 0.35 111.641 -176.844 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 107.73 4.87 34.1 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.749 -0.738 . . . . 0.3 112.14 -178.908 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.417 ' HB2' ' HB3' ' A' ' 50' ' ' ARG . 38.3 mt-10 -61.92 -47.23 85.85 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.847 0.356 . . . . 0.65 110.049 178.443 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.658 HG22 ' HB3' ' A' ' 50' ' ' ARG . 14.3 m -136.57 165.26 29.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.963 -0.562 . . . . 0.19 109.652 172.212 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 54.5 p -86.15 165.7 16.36 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.945 -0.391 . . . . 0.97 109.945 176.444 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -58.89 -39.4 81.35 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.248 -0.649 . . . . 0.22 109.248 176.366 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -54.35 -54.88 34.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.633 -1.167 . . . . 1.72 111.959 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -56.59 -44.29 80.91 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.09 -0.505 . . . . 2.09 111.621 -176.009 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -68.83 -45.9 69.95 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.798 0.332 . . . . 0.26 110.816 -179.651 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.44 -53.52 55.41 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.119 -0.491 . . . . 0.24 111.957 -175.767 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 50.0 m -53.33 -21.33 5.5 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 113.293 0.849 . . . . 1.0 113.293 -176.42 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -105.22 -46.1 4.32 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.439 0.637 . . . . 0.61 110.718 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.605 ' CD ' ' HG3' ' A' ' 27' ' ' ARG . 24.7 mmt180 -93.97 -42.92 8.79 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 114.855 -1.066 . . . . 0.86 113.65 -168.806 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.51 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 80.2 p -64.33 121.77 15.1 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.994 0.426 . . . . 0.82 111.437 -174.38 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.623 ' HA ' ' HB2' ' A' ' 26' ' ' ARG . 25.0 t70 -73.63 -17.24 61.19 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.66 -0.7 . . . . 2.28 111.568 178.624 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 0.416 ' O ' ' HD1' ' A' ' 71' ' ' TYR . 52.2 t -76.91 155.87 32.49 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.178 0.513 . . . . 1.52 109.926 -179.145 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -58.82 -12.44 14.6 Favored Glycine 0 N--CA 1.454 -0.112 0 CA-C-N 114.81 -1.087 . . . . 0.26 113.621 -173.391 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.437 ' HB3' ' CD1' ' A' ' 77' ' ' LEU . 52.7 p -70.14 -7.82 44.72 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 116.579 0.19 . . . . 0.32 111.207 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.416 ' HD1' ' O ' ' A' ' 68' ' ' CYS . 35.0 p90 -56.08 -29.62 60.81 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.861 0.362 . . . . 0.54 110.21 175.723 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -90.45 2.85 55.27 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.372 -0.377 . . . . 0.49 111.673 -174.063 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 30.0 m -125.39 -15.16 6.25 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.762 0.315 . . . . 0.71 111.447 -179.803 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 107.22 24.14 6.66 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.524 -0.846 . . . . 0.54 112.507 -179.577 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 91.34 -27.57 9.27 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.796 -0.716 . . . . 0.35 113.063 176.124 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.623 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 7.5 p-10 -79.89 141.56 36.01 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-O 121.561 0.696 . . . . 1.65 111.204 -176.876 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.472 HD12 ' HA ' ' A' ' 77' ' ' LEU . 0.6 OUTLIER -106.13 176.0 5.31 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 114.755 -1.111 . . . . 0.94 109.604 177.187 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -83.88 -150.28 10.51 Favored Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 120.871 -0.68 . . . . 0.44 111.856 178.369 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.447 ' HA ' ' O ' ' A' ' 8' ' ' LEU . 21.3 p90 -94.15 145.91 24.36 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.101 0.477 . . . . 3.87 111.214 -178.481 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.61 ' CE1' ' HB3' ' A' ' 8' ' ' LEU . 2.6 p90 -152.16 172.18 16.77 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.315 -0.995 . . . . 1.31 108.315 179.031 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 89.0 p -103.71 142.27 34.63 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 109.139 -0.689 . . . . 1.17 109.139 174.382 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 10.1 m -52.38 122.76 9.37 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.704 -0.68 . . . . 1.19 111.615 -173.936 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.456 ' H ' ' HG3' ' A' ' 90' ' ' GLU . . . 114.69 -12.7 20.64 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.892 -0.67 . . . . 0.79 112.998 179.371 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -90.59 45.19 1.24 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 117.013 0.406 . . . . 1.55 111.665 -177.411 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 26.2 mmt -137.66 -108.28 0.19 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.043 0.449 . . . . 0.73 110.297 178.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 59.5 mtt -140.26 150.68 44.38 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.278 -1.008 . . . . 1.39 108.278 176.034 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -50.38 -54.27 36.44 Favored Pre-proline 0 C--N 1.322 -0.589 0 N-CA-C 112.682 0.623 . . . . 2.37 112.682 -175.478 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.472 ' HG2' HG22 ' A' ' 107' ' ' THR . 84.5 Cg_endo -76.23 -27.45 8.09 Favored 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 121.63 1.553 . . . . 0.27 112.036 -176.402 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.635 ' O ' HG23 ' A' ' 93' ' ' VAL . 24.2 t80 -70.06 -55.86 8.42 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.214 -0.903 . . . . 0.22 109.719 -179.422 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.456 ' HG3' ' H ' ' A' ' 83' ' ' GLY . 3.5 tm-20 -66.24 -34.78 78.78 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.392 -0.822 . . . . 2.12 110.246 -177.802 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.49 ' HA ' ' NE ' ' A' ' 94' ' ' ARG . 19.6 t70 -54.64 -36.24 64.32 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.63 -0.713 . . . . 0.61 110.86 175.021 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.561 ' O ' ' HG ' ' A' ' 96' ' ' LEU . . . -80.79 -35.47 33.07 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.213 -0.448 . . . . 0.22 110.958 179.172 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.635 HG23 ' O ' ' A' ' 89' ' ' PHE . 21.0 t -62.12 -44.55 99.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.303 0.573 . . . . 0.25 110.625 -178.178 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.49 ' NE ' ' HA ' ' A' ' 91' ' ' ASP . 38.1 ptt180 -73.87 -12.73 60.76 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.714 -0.676 . . . . 2.59 110.564 179.279 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -95.11 6.16 49.83 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.067 -0.515 . . . . 0.47 111.689 -173.794 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.561 ' HG ' ' O ' ' A' ' 92' ' ' ALA . 0.7 OUTLIER -141.26 146.87 37.36 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.425 -0.352 . . . . 0.28 110.719 177.226 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.419 ' HG3' ' N ' ' A' ' 98' ' ' ILE . 55.2 tptt -88.89 168.95 12.0 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.372 -0.603 . . . . 1.61 109.372 178.966 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.441 ' HA ' ' HG2' ' A' ' 116' ' ' ARG . 70.7 mt -45.54 115.96 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 121.137 0.494 . . . . 0.9 111.649 175.737 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 99.63 -4.62 58.1 Favored Glycine 0 N--CA 1.45 -0.416 0 CA-C-N 115.779 -0.646 . . . . 0.46 113.324 177.713 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.533 ' HB2' ' HB2' ' A' ' 96' ' ' LEU . 66.4 m-20 -100.22 144.57 29.09 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 117.099 0.449 . . . . 0.46 110.331 179.511 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 8.8 mt -116.03 147.95 19.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.19 -0.459 . . . . 0.23 110.562 -174.493 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 92.5 p -92.5 155.54 42.13 Favored Pre-proline 0 C--N 1.322 -0.588 0 CA-C-N 116.041 -0.527 . . . . 0.92 110.612 -179.324 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -71.64 171.63 15.98 Favored 'Trans proline' 0 C--O 1.235 0.345 0 C-N-CA 122.323 2.016 . . . . 0.34 111.393 171.837 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.931 HG23 HD23 ' A' ' 44' ' ' LEU . 22.7 mm -47.62 112.68 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 O-C-N 123.381 0.426 . . . . 0.2 111.986 178.514 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.1 p -117.59 118.67 59.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.004 0.431 . . . . 1.04 110.258 176.257 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 -85.44 141.65 29.8 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.2 0.524 . . . . 0.55 110.373 178.631 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.472 HG22 ' HG2' ' A' ' 88' ' ' PRO . 7.5 p -115.94 -172.52 2.18 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.461 -0.791 . . . . 0.37 110.637 -178.263 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -58.21 -42.64 86.64 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.903 0.383 . . . . 2.16 110.374 178.454 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.664 ' O ' ' HB2' ' A' ' 20' ' ' SER . 7.8 t -90.68 -61.62 1.63 Allowed 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 116.112 -0.494 . . . . 1.09 110.652 -178.476 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -146.62 -133.14 2.42 Favored Glycine 0 N--CA 1.442 -0.941 0 C-N-CA 118.946 -1.597 . . . . 0.24 113.499 -172.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.947 ' HB3' HD22 ' A' ' 44' ' ' LEU . 7.6 mp -115.58 145.92 42.23 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.199 -0.501 . . . . 0.19 111.408 -170.625 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' HIS . . . . . 0.823 ' CE1' HD13 ' A' ' 14' ' ' LEU . 64.3 m80 -142.06 152.2 43.1 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.392 0.615 . . . . 0.22 112.374 178.611 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.66 HG12 HD11 ' A' ' 44' ' ' LEU . 2.8 pt -134.01 140.73 45.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 107.317 -1.364 . . . . 0.17 107.317 158.388 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.409 HG21 HG22 ' A' ' 93' ' ' VAL . 2.2 mp -130.76 148.33 33.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 C-N-CA 120.656 -0.418 . . . . 0.18 110.657 -175.887 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.443 ' HG2' ' HB3' ' A' ' 11' ' ' ALA . 35.6 pttt -132.41 141.3 48.8 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.451 -0.944 . . . . 0.61 108.451 171.459 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' ARG . . . . . 0.546 ' HD3' HD21 ' A' ' 8' ' ' LEU . 5.6 ttp180 -81.47 135.72 35.63 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.198 0.523 . . . . 1.87 110.768 -178.77 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -104.75 -31.87 9.13 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.258 -0.883 . . . . 0.89 110.561 -178.694 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.496 ' HB3' ' HB3' ' A' ' 9' ' ' ARG . . . . . . . . 0 C--O 1.246 0.915 0 CA-C-O 118.445 -0.788 . . . . 1.1 110.579 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.629 ' HA ' ' O ' ' A' ' 80' ' ' PHE . 5.9 mptt . . . . . 0 C--O 1.232 0.166 0 CA-C-O 121.566 0.698 . . . . 1.19 111.707 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.693 HD23 ' H ' ' A' ' 9' ' ' ARG . 1.5 tt -117.59 160.75 20.75 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 114.494 -1.23 . . . . 1.18 107.886 178.899 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.693 ' H ' HD23 ' A' ' 8' ' ' LEU . 70.4 ttt180 -131.24 132.17 44.43 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 109.42 -0.585 . . . . 1.06 109.42 172.974 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -150.45 150.27 31.11 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.933 0.397 . . . . 0.22 111.824 -175.404 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.407 ' HB3' ' HG2' ' A' ' 115' ' ' LYS . . . -108.54 136.04 48.8 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.732 -0.667 . . . . 0.2 109.51 177.481 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 35.9 p-80 -138.83 157.24 46.42 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.088 0.471 . . . . 0.23 111.852 -171.865 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.561 HD23 ' N ' ' A' ' 14' ' ' LEU . 4.8 tt -124.34 146.92 48.54 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.584 -0.895 . . . . 0.24 108.584 176.786 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.738 HD13 ' CE1' ' A' ' 112' ' ' HIS . 28.7 tp -131.51 120.66 23.26 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.512 0.196 . . . . 0.27 111.028 -178.217 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.581 HG23 HD13 ' A' ' 44' ' ' LEU . 65.2 t -109.32 138.91 34.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 109.874 -0.417 . . . . 0.15 109.874 176.417 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.485 ' HE2' ' OG ' ' A' ' 109' ' ' SER . 33.8 mmtp -112.04 154.4 25.42 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.731 -0.47 . . . . 0.62 109.731 176.804 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.497 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 41.4 p90 -144.26 162.53 36.15 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.267 -0.424 . . . . 0.25 110.351 -176.054 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.517 ' HB3' ' HA ' ' A' ' 33' ' ' ALA . 29.0 p -53.44 108.12 0.31 Allowed 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.046 0.45 . . . . 1.04 110.699 179.144 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 101.32 7.95 48.05 Favored Glycine 0 CA--C 1.522 0.502 0 C-N-CA 120.823 -0.704 . . . . 0.53 113.208 -179.45 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.643 ' HB2' ' O ' ' A' ' 109' ' ' SER . 89.5 p -85.03 49.44 1.74 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 117.33 0.565 . . . . 0.7 111.156 -177.862 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 71.66 -32.99 0.26 Allowed 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.631 0.772 . . . . 3.49 110.954 -177.731 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.487 ' H ' ' C ' ' A' ' 20' ' ' SER . 4.8 p30 -151.97 118.04 3.12 Favored Pre-proline 0 C--N 1.321 -0.673 0 N-CA-C 109.095 -0.706 . . . . 1.77 109.095 174.895 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.495 ' C ' HG22 ' A' ' 32' ' ' THR . 95.0 Cg_endo -85.39 55.8 4.12 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.52 2.147 . . . . 1.71 113.135 -175.735 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.46 ' N ' HG22 ' A' ' 32' ' ' THR . 25.5 t -146.21 116.4 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 109.577 -0.527 . . . . 0.48 109.577 176.197 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.45 ' HB3' ' HB2' ' A' ' 16' ' ' LYS . 66.3 p -104.1 159.24 15.84 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.926 -0.398 . . . . 1.12 109.926 175.679 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.52 ' HG2' ' HA ' ' A' ' 67' ' ' ASP . 6.3 mmp_? -71.48 -7.17 45.74 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.397 0.618 . . . . 2.54 109.691 172.066 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.506 ' CG ' ' HD2' ' A' ' 65' ' ' ARG . 3.7 tmm_? -81.06 -36.18 30.81 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.279 -0.873 . . . . 1.77 110.054 178.779 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 61.8 p -101.71 -34.81 9.32 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.296 0.57 . . . . 0.67 110.789 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 85.67 -43.85 3.29 Favored Glycine 0 N--CA 1.45 -0.383 0 CA-C-N 115.738 -0.665 . . . . 0.82 112.986 177.241 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -93.0 -63.77 1.18 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.764 0.316 . . . . 2.1 110.248 -177.578 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 19.8 m -153.12 151.67 30.42 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.365 -0.38 . . . . 1.08 110.652 176.216 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.495 HG22 ' C ' ' A' ' 23' ' ' PRO . 12.1 t -115.09 34.36 4.9 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 122.19 0.995 . . . . 0.34 108.915 176.234 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.517 ' HA ' ' HB3' ' A' ' 18' ' ' SER . . . -80.49 -6.09 57.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 114.946 -1.025 . . . . 0.37 112.102 -172.563 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -94.13 -23.83 17.79 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.38 0.609 . . . . 2.21 110.528 -178.95 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.4 HG23 ' HB2' ' A' ' 39' ' ' ASP . 0.2 OUTLIER -98.19 135.78 31.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.702 -0.681 . . . . 0.31 110.103 -179.135 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 71.0 p -95.83 179.46 5.1 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.024 -0.535 . . . . 0.39 109.95 -175.754 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.51 ' O ' HG13 ' A' ' 41' ' ' ILE . 13.6 p90 -62.92 -31.11 72.12 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.006 -0.678 . . . . 1.53 109.468 176.335 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -71.89 -46.34 58.09 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-N 116.044 -0.525 . . . . 0.96 110.596 178.535 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.4 ' HB2' HG23 ' A' ' 35' ' ' VAL . 28.8 m-20 -67.25 -27.78 67.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.245 0.545 . . . . 0.91 109.87 177.997 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.497 ' HB2' ' HB3' ' A' ' 17' ' ' PHE . . . -71.07 -43.05 68.57 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.513 -0.767 . . . . 0.19 110.366 176.48 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.51 HG13 ' O ' ' A' ' 37' ' ' TYR . 86.5 mt -64.78 -37.08 79.24 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.414 0 N-CA-C 109.494 -0.558 . . . . 0.3 109.494 174.358 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.404 ' O ' ' HG3' ' A' ' 46' ' ' LYS . 62.2 tttp -61.49 -28.25 69.17 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.599 -0.728 . . . . 2.32 110.209 177.522 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 58.8 tt0 -88.08 -48.23 7.9 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.663 -0.699 . . . . 1.02 110.082 -178.388 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.885 HD23 HG23 ' A' ' 104' ' ' ILE . 32.2 tp -61.15 -36.58 80.17 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.871 -0.604 . . . . 0.17 110.021 -179.256 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.46 ' HG2' HG13 ' A' ' 104' ' ' ILE . 3.6 mm100 -64.08 -36.21 83.26 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-N 115.96 -0.564 . . . . 0.87 111.97 178.787 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.404 ' HG3' ' O ' ' A' ' 42' ' ' LYS . 98.1 mttt -69.23 -46.3 67.71 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.843 -0.343 . . . . 1.31 110.461 179.653 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.4 ' O ' HG13 ' A' ' 51' ' ' ILE . 54.0 m95 -66.0 -46.14 79.06 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.475 -0.33 . . . . 0.52 111.188 177.55 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 44.7 t -57.77 -35.27 70.53 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.881 -0.414 . . . . 0.82 109.881 175.006 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.449 ' HB2' ' O ' ' A' ' 45' ' ' GLN . 13.0 tt0 -65.6 -55.98 14.69 Favored 'General case' 0 C--O 1.225 -0.233 0 CA-C-N 115.915 -0.584 . . . . 0.53 110.488 176.94 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.634 ' HB3' HG22 ' A' ' 56' ' ' VAL . 93.5 mtt180 -62.15 -42.31 99.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.097 -0.501 . . . . 0.42 111.609 -176.235 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.428 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 98.3 mt -60.24 -35.21 60.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.012 0.434 . . . . 0.2 110.657 176.474 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -79.99 -38.89 31.22 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.943 -0.571 . . . . 0.27 111.542 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 65.2 p -76.68 -29.99 56.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.72 0.295 . . . . 0.35 111.456 -176.526 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 106.38 10.31 29.67 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.539 -0.839 . . . . 0.3 112.141 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.424 ' HB2' ' HB3' ' A' ' 50' ' ' ARG . 41.4 mt-10 -67.1 -52.16 45.36 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.047 0.451 . . . . 0.65 110.011 176.696 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.634 HG22 ' HB3' ' A' ' 50' ' ' ARG . 15.8 m -132.04 156.06 42.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.925 -0.58 . . . . 0.19 109.748 175.145 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 50.5 m -86.27 159.34 19.47 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.575 -0.528 . . . . 0.97 109.575 178.78 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -52.41 -43.44 64.81 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.027 0.442 . . . . 0.22 110.249 -176.617 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.591 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 39.9 mt-10 -56.82 -43.49 81.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.236 -0.893 . . . . 1.72 112.105 -179.013 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -60.86 -46.34 90.95 Favored 'General case' 0 CA--C 1.521 -0.141 0 CA-C-O 120.958 0.408 . . . . 2.09 110.587 -177.22 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -69.15 -51.1 41.64 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.048 -0.523 . . . . 0.26 110.921 -179.476 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.78 -52.11 66.86 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.741 0.645 . . . . 0.24 112.741 -173.231 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.507 ' HA ' ' O ' ' A' ' 71' ' ' TYR . 20.4 m -51.5 -25.47 6.64 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 112.859 0.688 . . . . 1.0 112.859 -176.726 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -105.36 -46.25 4.26 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.63 0.728 . . . . 0.61 110.673 -177.821 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.506 ' HD2' ' CG ' ' A' ' 27' ' ' ARG . 27.8 mmt180 -88.26 -41.03 13.19 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.872 -1.058 . . . . 0.86 113.54 -169.813 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.513 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 59.6 p -64.79 127.2 30.58 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.68 -0.408 . . . . 0.82 111.14 -176.847 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.52 ' HA ' ' HG2' ' A' ' 26' ' ' ARG . 33.6 t70 -80.15 -10.84 59.78 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.424 0.631 . . . . 2.28 111.157 179.091 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 44.8 t -77.56 163.04 26.64 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.94 -0.573 . . . . 1.52 109.688 179.521 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -61.26 -16.45 49.09 Favored Glycine 0 N--CA 1.454 -0.146 0 CA-C-N 115.642 -0.708 . . . . 0.26 112.598 -176.722 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 61.8 p -65.51 -7.63 15.41 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 112.021 0.378 . . . . 0.32 112.021 177.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.507 ' O ' ' HA ' ' A' ' 63' ' ' SER . 14.1 p90 -60.96 -23.64 65.48 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 109.479 -0.563 . . . . 0.54 109.479 175.466 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -95.09 5.97 50.37 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.084 0.469 . . . . 0.49 110.613 178.003 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 6.2 m -126.02 3.24 7.26 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.097 -0.501 . . . . 0.71 110.823 -179.084 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.591 ' O ' ' HA ' ' A' ' 59' ' ' GLU . . . 73.16 25.43 73.34 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.812 -0.708 . . . . 0.54 112.047 -175.731 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 83.66 -20.31 12.22 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 121.202 -0.523 . . . . 0.35 111.809 -177.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -73.36 133.13 43.72 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.294 -0.453 . . . . 1.65 110.672 -175.614 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.5 mp -115.78 164.1 14.87 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-O 121.307 0.575 . . . . 0.94 110.009 175.05 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -82.5 -154.95 15.97 Favored Glycine 0 C--N 1.305 -1.169 0 CA-C-N 114.964 -1.016 . . . . 0.44 111.808 176.943 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.631 ' HA ' ' O ' ' A' ' 8' ' ' LEU . 93.3 m-85 -84.17 147.77 27.12 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.037 0.446 . . . . 3.87 110.933 -179.478 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.629 ' O ' ' HA ' ' A' ' 7' ' ' LYS . 14.9 p90 -147.8 165.63 29.99 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.647 -0.871 . . . . 1.31 108.647 -177.237 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -90.5 149.98 21.97 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 109.645 -0.502 . . . . 1.17 109.645 -178.498 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.6 p -58.77 111.7 1.37 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.838 0.351 . . . . 1.19 110.629 177.72 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 99.64 18.11 24.14 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.672 -0.775 . . . . 0.79 112.514 -177.467 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -101.08 18.07 20.74 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.061 0.458 . . . . 1.55 110.98 -178.162 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 26.3 mmt -124.51 -105.31 0.35 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.885 0.374 . . . . 0.73 111.057 -177.045 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 82.7 mmm -141.26 152.6 44.66 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.133 -1.062 . . . . 1.39 108.133 175.896 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.431 ' HB3' ' HD3' ' A' ' 88' ' ' PRO . 23.8 ttmm -50.77 -56.39 19.63 Favored Pre-proline 0 C--N 1.321 -0.642 0 N-CA-C 112.701 0.63 . . . . 2.37 112.701 -175.707 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.431 ' HD3' ' HB3' ' A' ' 87' ' ' LYS . 85.1 Cg_endo -77.44 -27.85 6.05 Favored 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 121.48 1.453 . . . . 0.27 111.928 -176.163 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.683 ' O ' HG23 ' A' ' 93' ' ' VAL . 14.5 t80 -67.98 -56.81 7.6 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.187 -0.915 . . . . 0.22 109.854 -179.325 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -65.25 -38.21 89.62 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.502 -0.772 . . . . 2.12 110.143 -178.132 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -57.03 -34.28 68.05 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.475 -0.784 . . . . 0.61 110.617 177.17 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -78.91 -26.84 43.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 0.22 110.707 177.748 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.683 HG23 ' O ' ' A' ' 89' ' ' PHE . 35.5 t -72.28 -36.94 57.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.332 0.587 . . . . 0.25 109.977 -178.577 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.438 ' C ' ' HD2' ' A' ' 94' ' ' ARG . 2.0 ppt_? -83.08 -2.74 56.17 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.844 -0.617 . . . . 2.59 110.246 179.237 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -97.43 9.69 41.7 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.093 -0.503 . . . . 0.47 111.339 -177.386 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.531 ' HB2' ' HB2' ' A' ' 100' ' ' ASP . 0.4 OUTLIER -144.24 151.11 38.99 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.31 0.576 . . . . 0.28 111.461 178.684 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.526 ' HE2' HD13 ' A' ' 98' ' ' ILE . 22.5 tptm -91.34 172.25 8.66 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.253 -0.885 . . . . 1.61 109.402 177.011 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.526 HD13 ' HE2' ' A' ' 97' ' ' LYS . 1.3 mp -46.73 120.59 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 C-N-CA 123.344 0.658 . . . . 0.9 110.85 176.689 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 97.72 -9.37 64.16 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.761 -0.733 . . . . 0.46 113.28 176.764 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.531 ' HB2' ' HB2' ' A' ' 96' ' ' LEU . 12.1 m-20 -93.11 141.84 27.96 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 117.133 0.466 . . . . 0.46 111.055 -177.802 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 9.4 mt -111.4 146.15 16.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.707 -0.679 . . . . 0.23 109.668 -179.141 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 97.8 p -89.42 152.45 47.5 Favored Pre-proline 0 C--N 1.319 -0.755 0 CA-C-N 116.361 -0.382 . . . . 0.92 110.422 -179.449 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -69.18 166.79 25.68 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 122.35 2.033 . . . . 0.34 111.111 171.88 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.885 HG23 HD23 ' A' ' 44' ' ' LEU . 29.0 mm -46.07 105.09 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 O-C-N 123.562 0.539 . . . . 0.2 112.05 178.693 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.0 p -111.52 121.18 63.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.253 -0.43 . . . . 1.04 110.196 177.445 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -85.57 156.47 20.72 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.228 0.537 . . . . 0.55 110.92 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 2.8 p -130.09 -173.17 2.97 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.383 -0.826 . . . . 0.37 110.019 177.357 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -56.51 -49.1 75.73 Favored 'General case' 0 C--N 1.328 -0.341 0 O-C-N 123.213 0.32 . . . . 2.16 110.887 177.424 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.643 ' O ' ' HB2' ' A' ' 20' ' ' SER . 8.3 t -84.14 -60.69 2.02 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 116.212 -0.449 . . . . 1.09 110.638 -177.139 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -146.76 -132.71 2.36 Favored Glycine 0 N--CA 1.441 -1.004 0 C-N-CA 118.921 -1.609 . . . . 0.24 113.982 -173.919 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.883 ' HB3' HD22 ' A' ' 44' ' ' LEU . 6.8 mp -118.77 150.41 39.85 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.964 -0.618 . . . . 0.19 111.377 -169.543 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' HIS . . . . . 0.738 ' CE1' HD13 ' A' ' 14' ' ' LEU . 75.7 m80 -144.58 150.15 36.99 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.205 0.526 . . . . 0.22 111.995 179.625 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.632 HG12 HD11 ' A' ' 44' ' ' LEU . 1.4 pt -134.25 137.02 52.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 107.514 -1.291 . . . . 0.17 107.514 160.27 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.468 HG21 HG22 ' A' ' 93' ' ' VAL . 2.8 mp -130.53 144.77 36.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 C-N-CA 120.87 -0.332 . . . . 0.18 110.826 -175.021 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.472 ' HA ' ' O ' ' A' ' 100' ' ' ASP . 43.2 pttt -126.18 142.53 51.49 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.116 -0.698 . . . . 0.61 109.116 173.229 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' ARG . . . . . 0.462 ' HB2' ' CD1' ' A' ' 96' ' ' LEU . 68.4 ttt180 -84.8 129.03 34.88 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.282 0.563 . . . . 1.87 111.338 -178.309 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.407 ' HB2' ' HG2' ' A' ' 9' ' ' ARG . 4.2 mm? -97.34 -39.53 9.17 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.187 -0.915 . . . . 0.89 110.4 -179.568 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.243 0.712 0 CA-C-O 118.374 -0.822 . . . . 1.1 110.305 -179.332 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 94.8 mmm . . . . . 0 N--CA 1.481 1.117 0 N-CA-C 110.216 -0.29 . . . . 7.23 110.216 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 32.0 t 63.86 89.25 0.09 Allowed 'General case' 0 C--N 1.331 -0.2 0 O-C-N 123.634 0.583 . . . . 2.88 110.849 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -85.94 -21.08 28.1 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.047 -0.524 . . . . 2.8 109.958 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.592 ' HA ' ' O ' ' A' ' 80' ' ' PHE . 69.0 mmtt -77.48 134.6 38.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.434 0.635 . . . . 1.19 111.365 -177.485 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.631 ' HB3' ' CE1' ' A' ' 80' ' ' PHE . 2.3 tt -137.02 158.31 44.74 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 114.748 -1.115 . . . . 1.18 108.032 -176.661 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.63 ' H ' HD23 ' A' ' 8' ' ' LEU . 72.2 ttt180 -132.18 130.93 41.71 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 108.928 -0.767 . . . . 1.06 108.928 172.42 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -145.96 154.83 42.34 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.394 -0.523 . . . . 0.22 111.886 -175.172 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.519 ' HA ' ' HA ' ' A' ' 76' ' ' ASP . . . -114.86 137.04 52.43 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.901 -0.591 . . . . 0.2 109.823 177.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 32.4 p-80 -139.69 151.42 45.89 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.06 0.457 . . . . 0.23 111.538 -172.014 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.603 ' O ' ' HA ' ' A' ' 112' ' ' HIS . 5.5 tt -119.08 144.51 46.55 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 108.336 -0.986 . . . . 0.24 108.336 177.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.781 HD13 ' CE1' ' A' ' 112' ' ' HIS . 27.0 tp -130.4 120.97 25.07 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.724 0.297 . . . . 0.27 111.061 -177.805 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.535 HG23 HD13 ' A' ' 44' ' ' LEU . 57.3 t -109.04 133.9 52.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 116.108 -0.496 . . . . 0.15 109.693 176.119 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.484 ' HE3' HD21 ' A' ' 14' ' ' LEU . 32.7 mmtp -106.03 151.22 24.93 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.274 -0.639 . . . . 0.62 109.274 176.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.422 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 46.6 p90 -142.61 162.23 36.02 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.707 0.289 . . . . 0.25 110.859 -178.736 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.465 ' HB3' ' HA ' ' A' ' 33' ' ' ALA . 28.7 p -50.59 110.78 0.45 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.93 -0.577 . . . . 1.04 111.194 179.297 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 94.75 8.33 59.47 Favored Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.458 -0.877 . . . . 0.53 113.36 177.186 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.446 ' C ' ' H ' ' A' ' 22' ' ' ASN . 88.5 p -90.83 46.84 1.36 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 117.841 0.82 . . . . 0.7 110.51 -178.791 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 70.8 ttt180 70.87 -35.55 0.33 Allowed 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 123.53 0.732 . . . . 3.49 111.511 -178.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.446 ' H ' ' C ' ' A' ' 20' ' ' SER . 49.4 m-80 -140.52 96.86 7.6 Favored Pre-proline 0 C--N 1.326 -0.434 0 N-CA-C 109.623 -0.51 . . . . 1.77 109.623 179.526 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.51 ' C ' HG22 ' A' ' 32' ' ' THR . 87.4 Cg_endo -83.35 51.67 3.66 Favored 'Trans proline' 0 CA--C 1.536 0.618 0 C-N-CA 122.585 2.19 . . . . 1.71 113.133 -176.141 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.472 ' N ' HG22 ' A' ' 32' ' ' THR . 42.7 t -147.6 113.11 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 123.265 0.626 . . . . 0.48 109.332 177.136 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.441 ' HB3' ' HB2' ' A' ' 16' ' ' LYS . 21.5 p -104.36 158.07 16.71 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.946 -0.115 . . . . 1.12 110.728 178.405 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.542 ' HB2' ' HA ' ' A' ' 67' ' ' ASP . 0.0 OUTLIER -63.37 -13.78 43.1 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-O 121.551 0.691 . . . . 2.54 110.033 172.313 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.519 ' HG3' ' HD2' ' A' ' 65' ' ' ARG . 0.1 OUTLIER -87.87 -13.81 41.04 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.92 -1.036 . . . . 1.77 110.827 -177.432 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 20.7 p -118.84 -35.22 3.73 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.326 0.584 . . . . 0.67 110.511 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 79.4 -42.67 2.42 Favored Glycine 0 N--CA 1.452 -0.262 0 CA-C-N 115.083 -0.962 . . . . 0.82 112.852 176.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -94.27 -67.98 0.83 Allowed 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 110.118 -0.327 . . . . 2.1 110.118 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.2 m -153.63 146.59 24.48 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.075 -0.512 . . . . 1.08 110.304 178.533 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.51 HG22 ' C ' ' A' ' 23' ' ' PRO . 9.9 t -112.8 33.79 4.79 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 122.545 1.164 . . . . 0.34 108.589 175.264 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.465 ' HA ' ' HB3' ' A' ' 18' ' ' SER . . . -80.67 -4.55 54.7 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 114.165 -1.38 . . . . 0.37 111.712 -175.074 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -95.26 -21.42 18.45 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.97 0.415 . . . . 2.21 111.007 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.446 HG23 ' HB2' ' A' ' 39' ' ' ASP . 0.2 OUTLIER -99.18 136.54 29.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.052 -0.522 . . . . 0.31 110.052 179.822 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 56.1 p -95.48 -178.4 4.41 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.329 -0.396 . . . . 0.39 110.325 -174.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.423 ' O ' HG13 ' A' ' 41' ' ' ILE . 6.6 p90 -65.17 -27.98 69.08 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.102 -0.703 . . . . 1.53 109.102 176.041 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -72.1 -49.2 38.13 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 115.89 -0.596 . . . . 0.96 110.064 177.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.446 ' HB2' HG23 ' A' ' 35' ' ' VAL . 49.1 m-20 -65.12 -30.55 71.49 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-O 121.339 0.59 . . . . 0.91 110.041 179.422 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.422 ' HB2' ' HB3' ' A' ' 17' ' ' PHE . . . -70.4 -46.47 63.91 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.184 -0.916 . . . . 0.19 110.427 177.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.497 ' CG1' HD21 ' A' ' 111' ' ' LEU . 70.4 mt -63.33 -36.83 77.67 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.383 0 N-CA-C 109.726 -0.472 . . . . 0.3 109.726 175.537 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.445 ' O ' ' HG3' ' A' ' 46' ' ' LYS . 79.5 tttt -59.16 -31.8 69.31 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.66 -0.7 . . . . 2.32 110.169 177.65 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 53.1 tt0 -88.12 -46.84 8.96 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.635 -0.711 . . . . 1.02 110.149 -176.385 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.948 HD23 HG23 ' A' ' 104' ' ' ILE . 33.5 tp -60.19 -37.52 80.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.12 -0.491 . . . . 0.17 109.854 -179.302 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.5 ' HG2' HG13 ' A' ' 104' ' ' ILE . 1.2 mm100 -68.06 -21.35 65.0 Favored 'General case' 0 C--O 1.226 -0.175 0 CA-C-N 115.936 -0.575 . . . . 0.87 112.123 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.445 ' HG3' ' O ' ' A' ' 42' ' ' LYS . 68.4 mttm -82.43 -44.87 15.53 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.853 -0.339 . . . . 1.31 110.262 178.335 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 43.9 m95 -67.8 -44.44 77.32 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.999 -0.28 . . . . 0.52 110.618 177.097 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 32.4 t -61.15 -26.94 68.04 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.883 -0.414 . . . . 0.82 109.883 175.146 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.459 ' HB2' ' O ' ' A' ' 45' ' ' GLN . 3.9 tt0 -73.0 -56.62 4.87 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 116.152 -0.476 . . . . 0.53 109.844 175.319 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.574 ' HB3' HG22 ' A' ' 56' ' ' VAL . 87.0 mtt180 -59.86 -41.97 92.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.84 -0.618 . . . . 0.42 111.882 -176.179 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.482 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 98.0 mt -59.23 -34.76 54.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.101 0.476 . . . . 0.2 110.157 176.746 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -82.22 -37.91 25.31 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.559 -0.746 . . . . 0.27 111.87 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.475 ' OG ' ' HA ' ' A' ' 50' ' ' ARG . 46.3 p -78.92 -29.55 44.26 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 111.99 0.367 . . . . 0.35 111.99 -176.008 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 107.38 13.1 21.8 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.541 -0.838 . . . . 0.3 112.667 179.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.454 ' HB2' ' HB3' ' A' ' 50' ' ' ARG . 33.5 mt-10 -73.99 -44.85 53.24 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.858 0.361 . . . . 0.65 110.239 177.518 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.574 HG22 ' HB3' ' A' ' 50' ' ' ARG . 14.2 m -138.86 158.34 29.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 109.355 -0.609 . . . . 0.19 109.355 172.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 55.1 p -84.53 164.91 18.47 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.68 -0.489 . . . . 0.97 109.68 176.059 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.409 ' HA ' ' CD1' ' A' ' 51' ' ' ILE . 2.2 t80 -57.95 -41.04 81.99 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.224 -0.658 . . . . 0.22 109.224 178.074 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.459 ' CD ' ' H ' ' A' ' 59' ' ' GLU . 1.4 mp0 -56.56 -53.28 59.41 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.898 -1.046 . . . . 1.72 111.381 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 30.6 mm-40 -56.54 -45.48 81.15 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 120.965 0.412 . . . . 2.09 111.161 -178.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -68.1 -49.83 58.71 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.192 -0.458 . . . . 0.26 111.121 -179.334 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.33 -53.74 54.74 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.236 0.458 . . . . 0.24 112.236 -174.479 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.557 ' HA ' ' O ' ' A' ' 71' ' ' TYR . 74.7 m -51.63 -24.53 5.63 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 113.35 0.87 . . . . 1.0 113.35 -176.532 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -104.59 -48.1 3.89 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.564 0.697 . . . . 0.61 110.457 -179.475 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.519 ' HD2' ' HG3' ' A' ' 27' ' ' ARG . 18.5 mmt180 -87.41 -41.37 13.62 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.993 -1.003 . . . . 0.86 113.443 -168.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.535 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 58.5 p -64.77 125.43 24.76 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.049 0.452 . . . . 0.82 111.301 -175.568 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.542 ' HA ' ' HB2' ' A' ' 26' ' ' ARG . 24.8 t70 -75.96 -17.76 59.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.69 -0.686 . . . . 2.28 111.342 177.68 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.43 ' O ' ' HD1' ' A' ' 71' ' ' TYR . 41.2 t -77.48 157.43 30.45 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.317 0.579 . . . . 1.52 110.21 -178.536 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -57.11 -17.79 24.77 Favored Glycine 0 C--N 1.329 0.181 0 CA-C-N 114.482 -1.235 . . . . 0.26 114.269 -170.551 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 51.1 p -69.38 -5.61 24.63 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 111.891 0.33 . . . . 0.32 111.891 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.557 ' O ' ' HA ' ' A' ' 63' ' ' SER . 34.6 p90 -56.02 -33.58 65.03 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.014 0.435 . . . . 0.54 109.988 175.033 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -94.45 4.82 53.37 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.119 0.485 . . . . 0.49 110.911 -177.16 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.0 m -114.44 -15.99 12.0 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.002 -0.545 . . . . 0.71 110.905 -177.446 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 101.7 19.57 15.23 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.861 -0.685 . . . . 0.54 111.641 -176.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 85.8 -27.87 5.2 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 121.193 -0.527 . . . . 0.35 112.656 178.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.519 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 7.6 p-10 -86.41 140.86 29.6 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-O 121.776 0.798 . . . . 1.65 111.333 -175.275 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.3 mp -102.09 175.57 5.49 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 114.422 -1.263 . . . . 0.94 109.84 177.123 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -86.49 -156.53 28.64 Favored Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 120.842 -0.694 . . . . 0.44 111.413 177.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.558 ' HA ' ' O ' ' A' ' 8' ' ' LEU . 99.3 m-85 -85.29 136.96 33.27 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.022 0.439 . . . . 3.87 110.52 179.337 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.631 ' CE1' ' HB3' ' A' ' 8' ' ' LEU . 13.8 p90 -137.96 166.34 24.3 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.655 -0.702 . . . . 1.31 109.21 -179.604 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.521 ' O ' ' HB2' ' A' ' 84' ' ' GLU . 15.5 m -90.02 133.12 35.01 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 108.931 -0.766 . . . . 1.17 108.931 176.75 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 20.0 m -53.02 121.42 7.36 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.828 0.347 . . . . 1.19 110.834 -178.304 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 104.86 1.09 42.4 Favored Glycine 0 CA--C 1.519 0.324 0 C-N-CA 120.964 -0.636 . . . . 0.79 112.237 -176.61 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.521 ' HB2' ' O ' ' A' ' 81' ' ' SER . 28.5 tt0 -82.78 -3.79 57.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.777 0.322 . . . . 1.55 111.609 -175.519 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 26.5 mmt -107.94 -144.97 0.39 Allowed 'General case' 0 N--CA 1.438 -1.035 0 N-CA-C 109.451 -0.574 . . . . 0.73 109.451 -175.096 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -93.54 154.52 17.83 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 115.369 -0.832 . . . . 1.39 109.089 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.402 ' HB3' ' HD3' ' A' ' 88' ' ' PRO . 22.3 tptm -53.94 -57.1 19.31 Favored Pre-proline 0 C--N 1.321 -0.671 0 N-CA-C 112.07 0.396 . . . . 2.37 112.07 -178.127 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.402 ' HD3' ' HB3' ' A' ' 87' ' ' LYS . 68.0 Cg_endo -74.0 -22.1 17.56 Favored 'Trans proline' 0 C--N 1.356 0.962 0 C-N-CA 121.506 1.47 . . . . 0.27 111.661 -176.724 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.615 ' O ' HG23 ' A' ' 93' ' ' VAL . 23.8 t80 -72.8 -56.45 5.22 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.293 -0.867 . . . . 0.22 109.608 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -64.48 -34.83 79.12 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.812 -0.631 . . . . 2.12 109.654 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.457 ' HA ' ' NE ' ' A' ' 94' ' ' ARG . 9.9 t70 -52.35 -36.69 54.17 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.74 -0.664 . . . . 0.61 111.091 175.029 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.541 ' O ' ' HG ' ' A' ' 96' ' ' LEU . . . -81.98 -35.34 29.06 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.937 -0.574 . . . . 0.22 110.883 179.424 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.615 HG23 ' O ' ' A' ' 89' ' ' PHE . 14.7 t -64.17 -42.76 96.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.201 0.524 . . . . 0.25 110.585 -177.674 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.457 ' NE ' ' HA ' ' A' ' 91' ' ' ASP . 39.4 ptt180 -70.86 -18.41 62.7 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.022 -0.535 . . . . 2.59 110.583 177.415 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -88.66 2.6 52.94 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.921 -0.581 . . . . 0.47 111.415 -174.162 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.632 ' HB2' ' HB2' ' A' ' 100' ' ' ASP . 0.8 OUTLIER -137.98 153.53 49.42 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.132 -0.485 . . . . 0.28 110.64 177.621 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.683 ' HG2' ' H ' ' A' ' 98' ' ' ILE . 39.8 tttp -102.7 -179.18 3.89 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 109.18 -0.674 . . . . 1.61 109.18 176.413 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.683 ' H ' ' HG2' ' A' ' 97' ' ' LYS . 9.2 mt -51.49 122.4 2.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 120.891 0.377 . . . . 0.9 111.309 178.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 93.12 -2.12 71.23 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.9 -0.667 . . . . 0.46 113.271 178.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.632 ' HB2' ' HB2' ' A' ' 96' ' ' LEU . 45.7 m-20 -100.19 141.98 32.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 117.423 0.611 . . . . 0.46 110.657 -179.474 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 11.8 mt -111.55 147.02 15.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.954 -0.566 . . . . 0.23 110.0 -179.408 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 91.3 p -92.19 152.45 42.58 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 116.419 -0.355 . . . . 0.92 110.953 -177.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -68.25 160.15 50.17 Favored 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 122.335 2.023 . . . . 0.34 111.095 172.443 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.948 HG23 HD23 ' A' ' 44' ' ' LEU . 25.6 mm -43.1 107.95 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 O-C-N 123.889 0.743 . . . . 0.2 112.115 178.585 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 1.8 p -113.31 121.78 66.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.991 -0.549 . . . . 1.04 109.983 177.665 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -85.41 155.44 21.28 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.97 0.414 . . . . 0.55 110.4 179.467 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 4.4 p -135.85 -171.17 2.79 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.695 -0.684 . . . . 0.37 110.929 -178.306 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -56.37 -42.69 78.28 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.122 -0.49 . . . . 2.16 111.672 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.44 ' O ' ' HD3' ' A' ' 16' ' ' LYS . 5.4 t -113.58 -0.38 14.38 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 112.593 0.59 . . . . 1.09 112.593 -170.146 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 166.25 -126.86 1.52 Allowed Glycine 0 N--CA 1.436 -1.31 0 C-N-CA 119.198 -1.477 . . . . 0.24 113.31 171.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.902 ' HB3' HD22 ' A' ' 44' ' ' LEU . 7.4 mp -125.79 149.08 48.88 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 114.767 -0.717 . . . . 0.19 111.135 -168.725 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' HIS . . . . . 0.781 ' CE1' HD13 ' A' ' 14' ' ' LEU . 74.9 m80 -144.05 150.08 37.64 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.21 0.529 . . . . 0.22 111.854 178.8 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.628 HG12 HD11 ' A' ' 44' ' ' LEU . 2.5 pt -132.7 140.7 46.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 107.577 -1.268 . . . . 0.17 107.577 159.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 2.7 mp -130.43 145.17 35.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 C-N-CA 120.813 -0.355 . . . . 0.18 110.643 -176.218 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.456 ' HG2' ' HB3' ' A' ' 11' ' ' ALA . 43.3 pttt -127.74 141.5 51.57 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.725 -0.842 . . . . 0.61 108.725 173.047 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.56 ' HB2' ' CD1' ' A' ' 96' ' ' LEU . 55.1 ttt180 -83.72 129.06 34.95 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.212 0.53 . . . . 1.87 111.097 -178.033 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -97.02 -34.51 11.15 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.137 -0.938 . . . . 0.89 110.105 -179.561 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.404 ' HB3' ' HB3' ' A' ' 9' ' ' ARG . . . . . . . . 0 C--O 1.246 0.882 0 CA-C-O 118.647 -0.692 . . . . 1.1 109.958 178.562 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 92.9 mtp . . . . . 0 N--CA 1.483 1.183 0 CA-C-O 120.661 0.267 . . . . 7.23 110.793 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 35.9 t -153.38 131.73 12.04 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.778 0.323 . . . . 2.88 110.479 -178.469 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -101.31 -9.0 21.59 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.142 0.496 . . . . 2.8 110.028 178.118 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.417 ' HG3' ' HB3' ' A' ' 79' ' ' PHE . 10.3 tptt -83.74 122.05 28.13 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 121.703 0.763 . . . . 1.19 111.419 -175.378 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.587 HD23 ' N ' ' A' ' 9' ' ' ARG . 2.1 tt -113.93 157.6 22.2 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 114.25 -1.341 . . . . 1.18 107.898 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.587 ' N ' HD23 ' A' ' 8' ' ' LEU . 63.2 ttt180 -141.0 130.32 23.66 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 109.164 -0.68 . . . . 1.06 109.164 173.336 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -147.19 152.5 38.5 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 120.251 -0.58 . . . . 0.22 112.15 -178.245 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -103.97 134.08 47.86 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.311 -0.858 . . . . 0.2 109.019 176.125 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 29.1 p-80 -135.13 148.05 49.66 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.101 0.477 . . . . 0.23 111.851 -172.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.556 HD23 ' N ' ' A' ' 14' ' ' LEU . 5.2 tt -115.0 147.97 39.41 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.518 -0.919 . . . . 0.24 108.518 177.457 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.702 HD13 ' CE1' ' A' ' 112' ' ' HIS . 18.1 tp -131.65 130.24 41.83 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 110.35 -0.241 . . . . 0.27 110.35 -177.777 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.529 HG23 HD13 ' A' ' 44' ' ' LEU . 56.5 t -119.7 133.63 65.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 109.827 -0.435 . . . . 0.15 109.827 174.785 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.53 ' HE3' HD21 ' A' ' 14' ' ' LEU . 33.4 mmtp -104.96 154.91 19.47 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.066 -0.516 . . . . 0.62 110.503 178.145 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.412 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 50.4 p90 -149.64 161.62 41.83 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.633 -0.712 . . . . 0.25 109.523 -178.057 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.473 ' HB3' ' C ' ' A' ' 33' ' ' ALA . 38.1 p -54.59 110.16 0.6 Allowed 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.147 0.499 . . . . 1.04 110.5 177.797 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 108.84 9.47 26.4 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.918 -0.658 . . . . 0.53 112.356 -176.227 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.456 ' C ' ' H ' ' A' ' 22' ' ' ASN . 42.5 p -88.06 26.69 1.32 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 117.095 0.448 . . . . 0.7 111.81 -175.537 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.417 ' HB2' ' O ' ' A' ' 20' ' ' SER . 83.2 mtt180 72.5 -20.04 0.28 Allowed 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.173 0.589 . . . . 3.49 111.459 -178.767 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.456 ' H ' ' C ' ' A' ' 20' ' ' SER . 7.4 p30 -155.08 107.31 2.28 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-O 121.47 0.653 . . . . 1.77 109.345 171.182 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.41 ' C ' HG22 ' A' ' 32' ' ' THR . 87.5 Cg_endo -81.77 58.81 6.92 Favored 'Trans proline' 0 CA--C 1.534 0.49 0 C-N-CA 122.824 2.35 . . . . 1.71 113.47 -171.289 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.438 ' N ' HG22 ' A' ' 32' ' ' THR . 63.9 t -140.22 121.91 15.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 122.6 0.36 . . . . 0.48 110.138 178.77 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 28.3 t -103.06 149.55 24.47 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 109.235 -0.654 . . . . 1.12 109.235 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.57 ' HB2' ' HA ' ' A' ' 67' ' ' ASP . 2.1 mpt_? -77.38 -14.55 59.69 Favored 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 108.443 -0.947 . . . . 2.54 108.443 173.089 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.488 ' HG2' ' HD3' ' A' ' 65' ' ' ARG . 1.9 tmm_? -76.41 -35.51 58.54 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 114.575 -1.193 . . . . 1.77 109.558 175.784 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 44.2 p -97.62 -34.19 11.04 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 121.273 0.558 . . . . 0.67 110.595 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 75.37 -10.41 11.43 Favored Glycine 0 N--CA 1.452 -0.269 0 CA-C-N 115.492 -0.776 . . . . 0.82 113.032 178.363 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -115.93 -71.36 0.74 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.886 0.374 . . . . 2.1 109.995 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.2 p -152.51 154.83 36.26 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.031 -0.531 . . . . 1.08 110.679 179.039 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.447 HG21 ' CB ' ' A' ' 16' ' ' LYS . 8.8 t -123.01 34.9 5.01 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 122.147 0.975 . . . . 0.34 109.712 175.332 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.473 ' C ' ' HB3' ' A' ' 18' ' ' SER . . . -79.6 -5.57 55.29 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.181 -0.918 . . . . 0.37 112.309 -174.392 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -97.68 -25.27 15.16 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.083 0.468 . . . . 2.21 111.159 -179.485 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.502 HG23 ' HB2' ' A' ' 39' ' ' ASP . 0.3 OUTLIER -93.5 137.68 22.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 116.128 -0.487 . . . . 0.31 110.174 -177.074 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 56.8 p -98.17 -178.29 4.0 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.442 -0.577 . . . . 0.39 109.442 -178.516 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.517 ' O ' HG13 ' A' ' 41' ' ' ILE . 0.2 OUTLIER -66.18 -24.27 66.61 Favored 'General case' 0 C--O 1.219 -0.518 0 C-N-CA 119.291 -0.963 . . . . 1.53 110.013 173.522 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -70.01 -45.7 66.67 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.887 -0.412 . . . . 0.96 109.887 175.339 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.502 ' HB2' HG23 ' A' ' 35' ' ' VAL . 26.3 m-20 -69.01 -30.96 69.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.503 0.668 . . . . 0.91 109.758 177.334 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.412 ' HB2' ' HB3' ' A' ' 17' ' ' PHE . . . -73.3 -42.26 62.59 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.139 -0.937 . . . . 0.19 110.863 179.15 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.517 HG13 ' O ' ' A' ' 37' ' ' TYR . 69.4 mt -63.54 -35.89 74.29 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.299 0 N-CA-C 109.494 -0.558 . . . . 0.3 109.494 174.663 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 20.3 ttpt -62.96 -23.62 67.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.363 0.601 . . . . 2.32 109.896 178.312 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.509 ' HG3' ' CD1' ' A' ' 47' ' ' TRP . 2.2 tp10 -87.67 -56.95 3.13 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.09 -0.959 . . . . 1.02 109.378 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.884 HD23 HG23 ' A' ' 104' ' ' ILE . 31.9 tp -59.24 -36.8 76.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.088 -0.96 . . . . 0.17 110.82 -174.213 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.589 ' O ' ' HB2' ' A' ' 49' ' ' GLN . 7.2 mm-40 -67.07 -29.76 69.63 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 116.159 -0.473 . . . . 0.87 112.25 -177.407 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 44.5 mttp -78.29 -42.76 29.91 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.814 0.34 . . . . 1.31 110.316 178.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.509 ' CD1' ' HG3' ' A' ' 43' ' ' GLU . 49.4 m95 -66.81 -44.45 81.15 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.384 -0.371 . . . . 0.52 111.364 178.226 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.508 ' HB3' HG21 ' A' ' 113' ' ' ILE . 88.9 p -64.7 -32.17 73.72 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 110.017 -0.364 . . . . 0.82 110.017 176.245 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.589 ' HB2' ' O ' ' A' ' 45' ' ' GLN . 11.0 tt0 -66.13 -49.81 66.16 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.1 -0.5 . . . . 0.53 110.274 177.615 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.602 ' HB3' HG22 ' A' ' 56' ' ' VAL . 87.9 mtt180 -64.14 -44.49 91.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.755 -0.657 . . . . 0.42 111.272 -179.0 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.412 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 88.3 mt -59.84 -39.35 79.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.362 -0.381 . . . . 0.2 110.654 177.085 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.27 -36.21 68.94 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.232 -0.44 . . . . 0.27 111.863 -179.145 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 24.6 p -85.19 -30.32 24.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.896 0.379 . . . . 0.35 111.474 -177.658 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 108.91 11.34 22.86 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.62 -0.8 . . . . 0.3 112.742 178.678 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.47 ' OE1' ' HG2' ' A' ' 50' ' ' ARG . 46.9 mt-10 -62.56 -49.51 74.99 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.612 -0.514 . . . . 0.65 109.612 175.319 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.602 HG22 ' HB3' ' A' ' 50' ' ' ARG . 14.6 m -132.16 155.28 41.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.591 -0.731 . . . . 0.19 109.359 173.586 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.1 m -83.29 160.43 21.71 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 109.236 -0.653 . . . . 0.97 109.236 178.206 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -54.93 -44.11 73.96 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.619 -0.512 . . . . 0.22 109.619 -179.097 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.552 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 39.9 mt-10 -59.15 -43.41 92.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.12 -0.945 . . . . 1.72 111.8 -179.178 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 -61.62 -49.05 78.14 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 120.964 0.411 . . . . 2.09 110.519 -177.512 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -67.53 -50.16 59.97 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.926 -0.579 . . . . 0.26 110.902 -178.559 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -58.6 -51.97 67.67 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.573 0.583 . . . . 0.24 112.573 -174.21 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.571 ' HA ' ' O ' ' A' ' 71' ' ' TYR . 23.9 m -51.32 -27.26 9.13 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.736 0.643 . . . . 1.0 112.736 -177.559 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -102.68 -44.67 5.24 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.533 0.683 . . . . 0.61 110.654 -178.157 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.488 ' HD3' ' HG2' ' A' ' 27' ' ' ARG . 25.3 mmt180 -94.6 -35.91 12.02 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 114.2 1.185 . . . . 0.86 114.2 -169.615 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.544 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 33.7 p -66.7 128.13 35.07 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.9 0.381 . . . . 0.82 110.797 -177.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.57 ' HA ' ' HB2' ' A' ' 26' ' ' ARG . 40.0 m-20 -90.92 5.54 48.22 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.701 -0.681 . . . . 2.28 111.644 -177.707 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.472 ' O ' ' HD1' ' A' ' 71' ' ' TYR . 36.1 t -88.22 170.0 11.39 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.67 -0.493 . . . . 1.52 109.67 174.671 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -63.56 -19.02 62.06 Favored Glycine 0 N--CA 1.454 -0.142 0 C-N-CA 121.08 -0.581 . . . . 0.26 111.962 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 55.3 p -65.93 -6.92 13.94 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 112.532 0.567 . . . . 0.32 112.532 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.571 ' O ' ' HA ' ' A' ' 63' ' ' SER . 20.0 p90 -60.68 -23.16 64.62 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.216 0.532 . . . . 0.54 109.747 176.171 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -89.28 -1.48 58.08 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.188 -0.46 . . . . 0.49 111.055 179.668 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.5 m -126.17 6.94 7.15 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.91 0.386 . . . . 0.71 110.998 -179.409 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.552 ' O ' ' HA ' ' A' ' 59' ' ' GLU . . . 73.37 30.39 62.59 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.634 -0.793 . . . . 0.54 112.195 -177.701 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 85.45 -22.21 11.3 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 121.12 -0.562 . . . . 0.35 111.801 -179.096 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -64.32 134.67 55.13 Favored 'General case' 0 CA--C 1.508 -0.663 0 CA-C-N 115.203 -0.498 . . . . 1.65 111.49 -176.664 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.431 ' HB3' ' HE2' ' A' ' 80' ' ' PHE . 2.6 mp -117.52 158.18 25.0 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 115.685 -0.689 . . . . 0.94 109.334 169.719 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -78.63 -150.05 4.83 Favored Glycine 0 C--N 1.308 -0.977 0 CA-C-N 115.023 -0.989 . . . . 0.44 112.72 -179.243 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.417 ' HB3' ' HG3' ' A' ' 7' ' ' LYS . 97.7 m-85 -88.52 144.82 26.1 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.203 0.525 . . . . 3.87 111.697 -178.525 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.431 ' HE2' ' HB3' ' A' ' 77' ' ' LEU . 1.6 p90 -158.3 153.63 25.82 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.123 -0.944 . . . . 1.31 108.803 -177.677 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 29.3 m -82.39 133.64 35.22 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.115 -0.698 . . . . 1.17 109.115 178.666 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 4.5 p -49.98 121.14 5.02 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.997 -0.547 . . . . 1.19 111.514 -178.091 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 114.49 -17.18 18.86 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.847 -0.692 . . . . 0.79 112.938 -178.582 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 65.6 mt-10 -83.55 46.71 1.18 Allowed 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 117.092 0.446 . . . . 1.55 111.486 -176.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 25.7 mmt -137.68 -122.59 0.14 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.053 0.454 . . . . 0.73 110.482 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 54.9 mtt -125.34 149.59 47.97 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.163 -1.051 . . . . 1.39 108.163 176.81 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 16.3 tppt? -54.12 -52.76 65.71 Favored Pre-proline 0 C--N 1.32 -0.715 0 N-CA-C 112.423 0.527 . . . . 2.37 112.423 -174.112 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.49 ' HG2' HG22 ' A' ' 107' ' ' THR . 74.0 Cg_endo -75.42 -23.62 12.95 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 121.336 1.357 . . . . 0.27 112.136 -176.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.596 ' O ' HG23 ' A' ' 93' ' ' VAL . 45.3 t80 -74.34 -55.39 6.06 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.396 -0.82 . . . . 0.22 109.868 179.354 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -64.75 -34.33 78.07 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.614 -0.721 . . . . 2.12 110.087 -178.756 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.498 ' HA ' ' NE ' ' A' ' 94' ' ' ARG . 19.2 t70 -53.44 -35.94 61.03 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.929 -0.578 . . . . 0.61 110.753 175.13 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.478 ' O ' ' HG ' ' A' ' 96' ' ' LEU . . . -80.4 -36.19 34.15 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.341 -0.391 . . . . 0.22 110.957 178.511 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.596 HG23 ' O ' ' A' ' 89' ' ' PHE . 15.4 t -64.27 -41.67 93.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.275 0.559 . . . . 0.25 110.693 -177.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.498 ' NE ' ' HA ' ' A' ' 91' ' ' ASP . 36.4 ptt180 -76.1 -12.21 60.07 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.833 -0.621 . . . . 2.59 110.449 178.194 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -97.32 21.16 10.42 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.085 -0.507 . . . . 0.47 111.314 -174.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.543 ' HB2' ' HB2' ' A' ' 100' ' ' ASP . 0.4 OUTLIER -152.32 156.35 39.44 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.86 -0.609 . . . . 0.28 110.604 175.074 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.468 ' HG3' ' H ' ' A' ' 98' ' ' ILE . 50.8 tptt -99.01 175.92 5.75 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.502 -0.772 . . . . 1.61 108.96 179.603 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.468 ' H ' ' HG3' ' A' ' 97' ' ' LYS . 67.3 mt -57.19 117.66 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 120.887 0.375 . . . . 0.9 110.752 178.184 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 96.37 9.09 57.1 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.821 -0.704 . . . . 0.46 112.748 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.543 ' HB2' ' HB2' ' A' ' 96' ' ' LEU . 21.7 m-20 -110.83 141.62 43.95 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 110.001 -0.37 . . . . 0.46 110.001 176.833 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 12.3 mt -111.8 149.94 14.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.212 -0.449 . . . . 0.23 110.002 -177.666 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 99.6 p -95.04 143.36 25.97 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 116.619 -0.264 . . . . 0.92 110.525 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -66.65 164.79 27.7 Favored 'Trans proline' 0 N--CA 1.461 -0.41 0 C-N-CA 122.319 2.013 . . . . 0.34 110.93 171.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.884 HG23 HD23 ' A' ' 44' ' ' LEU . 20.2 mm -39.48 113.34 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 O-C-N 123.817 0.698 . . . . 0.2 112.571 -179.08 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 1.8 p -121.37 121.62 65.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.949 -0.568 . . . . 1.04 110.121 175.53 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLN . . . . . 0.437 ' HG2' ' CD1' ' A' ' 111' ' ' LEU . 49.2 mt-30 -85.09 156.58 21.01 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.059 0.457 . . . . 0.55 110.394 178.428 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.49 HG22 ' HG2' ' A' ' 88' ' ' PRO . 3.0 p -130.24 -172.49 2.8 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.684 -0.689 . . . . 0.37 110.212 179.042 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -60.96 -36.36 79.18 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.574 0.226 . . . . 2.16 110.693 177.517 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.434 ' OG ' ' HE2' ' A' ' 16' ' ' LYS . 23.3 t -91.51 -61.37 1.66 Allowed 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 120.89 -0.324 . . . . 1.09 110.657 -178.554 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -150.67 -130.93 1.78 Allowed Glycine 0 N--CA 1.442 -0.901 0 C-N-CA 119.287 -1.435 . . . . 0.24 113.635 -174.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.882 ' HB3' HD22 ' A' ' 44' ' ' LEU . 7.4 mp -116.48 148.7 40.52 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.332 -0.434 . . . . 0.19 111.392 -171.511 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' HIS . . . . . 0.702 ' CE1' HD13 ' A' ' 14' ' ' LEU . 73.9 m80 -144.09 151.88 40.2 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.267 0.556 . . . . 0.22 112.398 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.621 HG12 HD11 ' A' ' 44' ' ' LEU . 3.4 pt -133.21 136.26 55.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 107.484 -1.302 . . . . 0.17 107.484 159.273 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 2.8 mp -127.48 144.3 37.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 C-N-CA 120.753 -0.379 . . . . 0.18 110.478 -176.694 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 41.3 pttt -125.76 140.81 52.37 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.773 -0.825 . . . . 0.61 108.773 172.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.493 ' HB2' ' CD1' ' A' ' 96' ' ' LEU . 59.2 ttt180 -87.36 134.47 33.57 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.072 0.463 . . . . 1.87 111.384 -177.736 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 6.7 mp -112.1 -24.06 10.1 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.568 -0.742 . . . . 0.89 111.187 -178.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.53 ' HB3' ' HB3' ' A' ' 9' ' ' ARG . . . . . . . . 0 C--O 1.243 0.744 0 CA-C-O 118.019 -0.991 . . . . 1.1 109.697 176.62 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 26.7 ptt? . . . . . 0 N--CA 1.484 1.24 0 CA-C-O 120.527 0.203 . . . . 7.23 111.148 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 13.5 p -144.83 -80.37 0.17 Allowed 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 120.738 0.304 . . . . 2.88 110.664 178.666 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.52 ' O ' ' HA ' ' A' ' 81' ' ' SER . 12.2 pt-20 -149.22 5.43 0.64 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.136 -0.484 . . . . 2.8 111.018 177.507 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 10.9 tptt -84.61 131.62 34.59 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 121.297 0.57 . . . . 1.19 109.91 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.682 HD23 ' H ' ' A' ' 9' ' ' ARG . 0.3 OUTLIER -128.21 168.51 15.34 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 114.962 -1.017 . . . . 1.18 109.808 -171.807 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.682 ' H ' HD23 ' A' ' 8' ' ' LEU . 70.1 ttt180 -145.64 125.03 13.07 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.064 -0.717 . . . . 1.06 109.064 174.701 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.497 ' N ' ' HZ ' ' A' ' 80' ' ' PHE . . . -145.93 160.57 41.64 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.353 -0.539 . . . . 0.22 112.003 -177.726 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.582 ' HA ' ' HA ' ' A' ' 76' ' ' ASP . . . -106.65 131.66 53.53 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.282 -0.872 . . . . 0.2 109.573 178.701 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 22.5 p-80 -133.54 140.1 46.99 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.995 0.426 . . . . 0.23 111.115 -173.041 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.674 ' O ' ' HA ' ' A' ' 112' ' ' HIS . 5.9 tt -113.24 137.54 51.32 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.852 -0.796 . . . . 0.24 108.852 179.195 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.673 HD13 ' CE1' ' A' ' 112' ' ' HIS . 23.2 tp -120.8 122.43 40.3 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.892 0.377 . . . . 0.27 111.364 -178.764 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.625 HG23 HD13 ' A' ' 44' ' ' LEU . 57.7 t -108.04 137.69 38.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 109.059 -0.719 . . . . 0.15 109.059 171.828 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.607 ' HE2' ' OG ' ' A' ' 109' ' ' SER . 28.6 mmtp -105.22 164.33 11.91 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.806 -0.442 . . . . 0.62 109.806 178.616 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 42.9 p90 -155.55 160.57 40.62 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.418 -0.586 . . . . 0.25 109.418 -177.515 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.436 ' HB3' ' C ' ' A' ' 33' ' ' ALA . 54.2 p -58.09 110.3 0.91 Allowed 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.483 -0.326 . . . . 1.04 110.557 178.659 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 105.51 10.16 31.8 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.475 -0.869 . . . . 0.53 113.15 -178.449 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.487 ' C ' ' H ' ' A' ' 22' ' ' ASN . 49.8 p -77.44 37.21 0.21 Allowed 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 117.639 0.719 . . . . 0.7 112.11 -174.833 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 60.6 ttt180 68.31 -36.17 0.31 Allowed 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.621 0.769 . . . . 3.49 111.065 -176.396 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.487 ' H ' ' C ' ' A' ' 20' ' ' SER . 8.6 p30 -154.68 119.01 2.58 Favored Pre-proline 0 C--N 1.319 -0.731 0 N-CA-C 107.757 -1.201 . . . . 1.77 107.757 171.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.401 ' HB2' ' H ' ' A' ' 24' ' ' VAL . 68.9 Cg_endo -81.99 -151.72 0.04 OUTLIER 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 122.528 2.152 . . . . 1.71 111.885 -174.474 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.597 ' N ' HG22 ' A' ' 32' ' ' THR . 48.0 t 64.06 111.17 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 123.329 0.652 . . . . 0.48 111.588 -175.764 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.488 ' HB3' ' HB2' ' A' ' 16' ' ' LYS . 35.7 p -103.93 152.92 21.4 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.377 -0.374 . . . . 1.12 110.115 177.796 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.582 ' HG2' ' HA ' ' A' ' 67' ' ' ASP . 3.8 mmp_? -65.34 -12.01 47.68 Favored 'General case' 0 N--CA 1.462 0.159 0 N-CA-C 109.522 -0.547 . . . . 2.54 109.522 172.256 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.555 ' HG3' ' CD ' ' A' ' 65' ' ' ARG . 31.5 ttp180 -67.79 -55.82 11.57 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.377 -0.828 . . . . 1.77 110.01 177.115 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 31.8 p -87.83 -34.11 18.35 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 121.446 0.641 . . . . 0.67 110.63 -176.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 70.12 16.89 73.37 Favored Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 115.292 -0.867 . . . . 0.82 111.962 -179.335 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -144.79 -68.41 0.31 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.582 0.229 . . . . 2.1 110.548 -178.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.8 p -150.14 147.19 27.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.967 0.413 . . . . 1.08 111.61 179.338 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.597 HG22 ' N ' ' A' ' 24' ' ' VAL . 9.6 t -127.51 16.16 7.06 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.67 0.748 . . . . 0.34 109.943 174.813 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.436 ' C ' ' HB3' ' A' ' 18' ' ' SER . . . -67.77 -4.34 12.16 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.126 -0.943 . . . . 0.37 112.973 -178.851 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -95.07 -25.5 16.43 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.091 0.472 . . . . 2.21 110.968 -179.461 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.514 HG23 ' HB2' ' A' ' 39' ' ' ASP . 0.2 OUTLIER -95.6 135.06 30.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.097 -0.501 . . . . 0.31 110.277 -178.364 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 63.4 p -93.36 178.22 5.79 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 109.548 -0.538 . . . . 0.39 109.548 -176.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.489 ' O ' HG13 ' A' ' 41' ' ' ILE . 0.1 OUTLIER -67.05 -22.25 65.87 Favored 'General case' 0 C--O 1.22 -0.463 0 C-N-CA 118.809 -1.156 . . . . 1.53 110.12 174.045 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -71.86 -46.97 56.1 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.975 -0.38 . . . . 0.96 109.975 175.033 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.514 ' HB2' HG23 ' A' ' 35' ' ' VAL . 24.9 m-20 -64.19 -35.72 81.71 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.612 0.72 . . . . 0.91 109.636 175.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.83 -47.4 66.12 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.888 -1.051 . . . . 0.19 110.788 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.489 HG13 ' O ' ' A' ' 37' ' ' TYR . 60.9 mt -63.02 -35.47 71.75 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.388 0 N-CA-C 110.001 -0.37 . . . . 0.3 110.001 176.682 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.471 ' O ' ' HG3' ' A' ' 46' ' ' LYS . 27.8 ttpt -61.63 -28.69 69.55 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 121.3 0.572 . . . . 2.32 109.695 179.424 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -88.6 -48.48 7.53 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.392 -0.822 . . . . 1.02 110.352 -177.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.93 HD23 HG23 ' A' ' 104' ' ' ILE . 29.3 tp -59.57 -36.99 77.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.002 -0.545 . . . . 0.17 110.366 -178.529 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.41 ' O ' ' HB2' ' A' ' 49' ' ' GLN . 11.6 mm-40 -67.97 -21.48 65.07 Favored 'General case' 0 N--CA 1.462 0.134 0 N-CA-C 112.114 0.413 . . . . 0.87 112.114 -179.042 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.471 ' HG3' ' O ' ' A' ' 42' ' ' LYS . 67.8 mttm -82.97 -44.62 15.08 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.929 -0.397 . . . . 1.31 109.929 177.556 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 43.2 m95 -65.63 -45.38 83.25 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.299 -0.409 . . . . 0.52 111.181 177.069 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.512 ' HB3' HG21 ' A' ' 113' ' ' ILE . 97.1 p -65.24 -20.4 66.41 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.885 -0.413 . . . . 0.82 109.885 178.191 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.41 ' HB2' ' O ' ' A' ' 45' ' ' GLN . 14.2 tt0 -76.34 -56.6 4.49 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 109.541 -0.54 . . . . 0.53 109.541 173.693 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.589 ' HB3' HG22 ' A' ' 56' ' ' VAL . 92.5 mtt180 -59.88 -43.09 94.93 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.724 -0.671 . . . . 0.42 111.808 -176.443 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.469 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 95.3 mt -60.46 -33.64 55.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 120.985 0.421 . . . . 0.2 110.57 177.279 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -81.42 -38.75 25.99 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.102 -0.499 . . . . 0.27 111.317 -179.544 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 26.7 p -75.99 -29.56 58.25 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.002 0.429 . . . . 0.35 111.135 -178.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 106.33 6.54 36.09 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.869 -0.682 . . . . 0.3 111.962 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.459 ' HB2' ' HB3' ' A' ' 50' ' ' ARG . 43.2 mt-10 -63.44 -45.65 89.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.809 0.338 . . . . 0.65 110.376 178.772 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.589 HG22 ' HB3' ' A' ' 50' ' ' ARG . 12.7 m -136.73 155.9 34.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 109.562 -0.533 . . . . 0.19 109.562 172.548 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 13.0 m -83.28 159.61 21.88 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.431 -0.581 . . . . 0.97 109.431 178.202 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -56.23 -40.68 74.47 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.544 -0.539 . . . . 0.22 109.544 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -52.12 -50.15 62.25 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.342 -0.844 . . . . 1.72 111.493 178.553 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -62.18 -46.76 87.52 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.852 -0.613 . . . . 2.09 111.392 -173.513 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -71.1 -40.86 71.26 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.79 0.329 . . . . 0.26 111.066 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -64.64 -45.92 84.75 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.445 -0.343 . . . . 0.24 111.777 -176.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.47 ' HA ' ' O ' ' A' ' 71' ' ' TYR . 41.9 t -56.63 -27.43 58.35 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 112.658 0.614 . . . . 1.0 112.658 -177.788 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.483 ' O ' ' HA ' ' A' ' 27' ' ' ARG . 36.4 mt-30 -104.92 -48.58 3.71 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.378 0.609 . . . . 0.61 110.632 -176.824 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.555 ' CD ' ' HG3' ' A' ' 27' ' ' ARG . 21.5 mmt180 -88.66 -41.75 12.43 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.134 -0.939 . . . . 0.86 113.174 -169.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.509 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 22.8 t -60.62 122.25 14.23 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.701 0.286 . . . . 0.82 111.189 -177.561 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.582 ' HA ' ' HG2' ' A' ' 26' ' ' ARG . 31.6 t70 -80.18 -7.61 59.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.382 0.61 . . . . 2.28 110.639 176.587 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.485 ' SG ' HD22 ' A' ' 14' ' ' LEU . 1.5 m -76.83 160.71 29.03 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.293 0.568 . . . . 1.52 110.082 177.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -67.77 -11.53 60.53 Favored Glycine 0 N--CA 1.45 -0.423 0 CA-C-N 114.785 -1.098 . . . . 0.26 112.554 -172.141 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 76.5 p -75.01 -5.69 45.38 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 111.518 0.192 . . . . 0.32 111.518 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.47 ' O ' ' HA ' ' A' ' 63' ' ' SER . 16.8 p90 -54.91 -37.86 66.9 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.156 0.503 . . . . 0.54 110.027 175.143 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -95.37 7.54 45.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.146 -0.479 . . . . 0.49 110.591 -178.301 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.9 m -113.54 -14.82 12.64 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.959 -0.564 . . . . 0.71 110.998 -177.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 103.5 14.39 25.78 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.775 -0.726 . . . . 0.54 112.235 -177.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 88.49 -31.18 4.96 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.995 -0.621 . . . . 0.35 112.428 179.438 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.582 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 8.5 p-10 -85.06 144.61 28.14 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-O 121.579 0.704 . . . . 1.65 111.099 -176.217 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.538 ' O ' ' HG3' ' A' ' 9' ' ' ARG . 0.7 OUTLIER -106.4 176.98 4.99 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 114.631 -1.168 . . . . 0.94 109.979 177.54 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -90.42 -125.4 3.02 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.928 -0.653 . . . . 0.44 113.006 -176.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 34.3 p90 -98.3 136.32 38.64 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.128 0.489 . . . . 3.87 110.96 -177.472 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.497 ' HZ ' ' N ' ' A' ' 10' ' ' ALA . 5.9 p90 -159.44 144.83 15.8 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.053 -0.721 . . . . 1.31 109.053 179.09 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.52 ' HA ' ' O ' ' A' ' 6' ' ' GLU . 4.0 p -94.02 154.51 17.61 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 120.994 0.426 . . . . 1.17 110.497 -177.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 15.2 m -64.85 111.43 2.81 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.951 -0.568 . . . . 1.19 110.117 179.615 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.63 ' H ' ' HG3' ' A' ' 90' ' ' GLU . . . 113.46 5.18 22.96 Favored Glycine 0 N--CA 1.447 -0.578 0 CA-C-N 115.601 -0.727 . . . . 0.79 111.454 -174.83 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -111.77 32.84 5.15 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 121.493 0.664 . . . . 1.55 110.366 -177.684 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 22.1 mmt -137.41 -122.02 0.14 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.068 -0.515 . . . . 0.73 110.277 179.017 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 63.8 mtt -121.1 155.1 35.18 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.293 -1.002 . . . . 1.39 108.293 174.409 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.452 ' HB2' ' HD3' ' A' ' 88' ' ' PRO . 29.9 mmmt -53.15 -58.11 13.77 Favored Pre-proline 0 C--N 1.322 -0.598 0 N-CA-C 112.393 0.516 . . . . 2.37 112.393 -177.396 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.452 ' HD3' ' HB2' ' A' ' 87' ' ' LYS . 77.1 Cg_endo -75.61 -23.7 12.58 Favored 'Trans proline' 0 C--N 1.354 0.838 0 C-N-CA 121.516 1.477 . . . . 0.27 111.931 -175.47 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.616 ' O ' HG23 ' A' ' 93' ' ' VAL . 52.7 t80 -71.64 -56.15 6.38 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.472 -0.786 . . . . 0.22 109.762 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.63 ' HG3' ' H ' ' A' ' 83' ' ' GLY . 4.6 tm-20 -67.08 -37.19 83.55 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.647 -0.706 . . . . 2.12 110.192 -179.026 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -51.98 -36.01 48.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.687 -0.688 . . . . 0.61 110.491 174.283 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.51 ' O ' ' HG ' ' A' ' 96' ' ' LEU . . . -79.63 -32.95 41.78 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.998 -0.546 . . . . 0.22 111.419 178.609 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.616 HG23 ' O ' ' A' ' 89' ' ' PHE . 25.9 t -67.4 -39.74 83.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.564 0.697 . . . . 0.25 110.121 -176.247 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.456 ' C ' ' HD2' ' A' ' 94' ' ' ARG . 0.2 OUTLIER -84.04 -8.0 59.24 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.421 -0.809 . . . . 2.59 110.841 179.644 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -88.35 0.77 55.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.296 -0.411 . . . . 0.47 111.067 -177.392 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.598 ' HB2' ' HB2' ' A' ' 100' ' ' ASP . 0.6 OUTLIER -139.36 157.29 46.13 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.1 -0.5 . . . . 0.28 110.625 179.446 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.553 ' HG2' ' H ' ' A' ' 98' ' ' ILE . 10.7 tttt -102.53 -175.0 2.7 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.161 -0.681 . . . . 1.61 109.161 176.53 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.553 ' H ' ' HG2' ' A' ' 97' ' ' LYS . 1.3 mp -54.67 120.34 2.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 C-N-CA 123.087 0.555 . . . . 0.9 110.584 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 93.18 1.21 67.13 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.812 -0.709 . . . . 0.46 113.078 176.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.598 ' HB2' ' HB2' ' A' ' 96' ' ' LEU . 33.4 m-20 -102.17 139.63 37.53 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 117.006 0.403 . . . . 0.46 110.411 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 11.9 mt -111.3 148.92 14.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.01 -0.541 . . . . 0.23 110.239 -178.323 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 97.7 p -93.3 158.67 36.71 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 116.404 -0.362 . . . . 0.92 110.725 -178.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -71.42 170.0 19.49 Favored 'Trans proline' 0 C--O 1.234 0.285 0 C-N-CA 122.475 2.117 . . . . 0.34 111.518 172.015 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.93 HG23 HD23 ' A' ' 44' ' ' LEU . 19.5 mm -47.33 112.12 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 O-C-N 123.399 0.437 . . . . 0.2 111.911 175.08 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 58.9 t -116.75 122.65 70.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.155 -0.475 . . . . 1.04 110.201 176.546 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -85.78 149.35 25.33 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.032 0.444 . . . . 0.55 110.102 176.25 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 8.1 p -127.77 -172.24 2.63 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.797 -0.638 . . . . 0.37 111.018 -177.743 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -52.26 -40.75 62.13 Favored 'General case' 0 CA--C 1.518 -0.277 0 O-C-N 123.418 0.449 . . . . 2.16 111.276 176.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.607 ' OG ' ' HE2' ' A' ' 16' ' ' LYS . 8.8 t -100.3 -60.53 1.51 Allowed 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 120.196 -0.601 . . . . 1.09 111.323 -178.324 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -146.03 -137.13 3.02 Favored Glycine 0 N--CA 1.44 -1.034 0 C-N-CA 118.673 -1.727 . . . . 0.24 113.733 -172.534 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.879 ' HB3' HD22 ' A' ' 44' ' ' LEU . 6.9 mp -109.65 143.16 39.79 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 114.87 -0.665 . . . . 0.19 111.164 -170.6 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' HIS . . . . . 0.674 ' HA ' ' O ' ' A' ' 13' ' ' LEU . 72.2 m80 -143.21 138.49 29.72 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.6 0.593 . . . . 0.22 112.6 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.567 HG12 HD11 ' A' ' 44' ' ' LEU . 3.9 pt -120.96 138.86 50.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 107.753 -1.203 . . . . 0.17 107.753 161.068 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 2.9 mp -129.43 143.09 42.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 C-N-CA 120.807 -0.357 . . . . 0.18 110.48 -175.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.515 ' HG2' ' HB3' ' A' ' 11' ' ' ALA . 48.8 pttt -127.51 138.57 52.96 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.187 -0.671 . . . . 0.61 109.187 173.817 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.507 ' HB2' ' CD1' ' A' ' 96' ' ' LEU . 70.4 ttt180 -84.22 128.38 34.53 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.051 0.453 . . . . 1.87 111.545 -175.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.439 HD21 ' HB2' ' A' ' 11' ' ' ALA . 1.2 mm? -95.12 -45.46 7.2 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.613 -0.721 . . . . 0.89 109.999 176.57 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.892 0 CA-C-O 118.58 -0.724 . . . . 1.1 110.379 -179.97 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 22.7 ptm . . . . . 0 N--CA 1.482 1.17 0 CA-C-O 121.471 0.653 . . . . 7.23 110.839 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 12.2 p -78.53 -53.51 7.14 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.087 -0.506 . . . . 2.88 110.383 179.183 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -98.29 -18.84 18.15 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.079 -0.51 . . . . 2.8 110.038 177.782 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 43.2 mmtm -76.21 131.28 39.22 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.789 -0.641 . . . . 1.19 111.305 -177.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.79 HD23 ' H ' ' A' ' 9' ' ' ARG . 1.3 tt -124.8 165.82 17.32 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 107.413 -1.329 . . . . 1.18 107.413 178.84 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.79 ' H ' HD23 ' A' ' 8' ' ' LEU . 65.9 ttt180 -143.78 127.68 17.35 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 118.11 0.414 . . . . 1.06 110.097 177.21 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -150.11 151.5 33.26 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.03 0.443 . . . . 0.22 111.772 -179.551 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -102.0 138.04 39.49 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.64 -0.709 . . . . 0.2 109.114 176.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 33.5 p-80 -138.08 153.34 49.31 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 120.564 -0.454 . . . . 0.23 111.842 -171.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.563 HD23 ' N ' ' A' ' 14' ' ' LEU . 5.2 tt -120.69 145.44 47.46 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.508 -0.923 . . . . 0.24 108.508 176.116 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.777 HD13 ' CE1' ' A' ' 112' ' ' HIS . 31.2 tp -131.0 118.2 20.27 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.59 0.233 . . . . 0.27 110.962 -177.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.615 HG23 HD13 ' A' ' 44' ' ' LEU . 58.5 t -104.72 133.17 49.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 N-CA-C 109.607 -0.516 . . . . 0.15 109.607 176.182 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.542 ' HE3' HD21 ' A' ' 14' ' ' LEU . 32.2 mmtp -105.53 138.26 42.01 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.998 -0.547 . . . . 0.62 109.881 177.496 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.539 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 40.0 p90 -131.1 163.28 28.0 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.845 -0.616 . . . . 0.25 109.344 178.46 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 43.8 p -53.16 109.5 0.43 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.109 0.481 . . . . 1.04 110.269 176.481 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 108.07 7.94 30.23 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.637 -0.792 . . . . 0.53 113.132 -177.637 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.757 ' HB3' ' O ' ' A' ' 109' ' ' SER . 74.5 m -84.46 38.76 0.7 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 117.042 0.421 . . . . 0.7 111.749 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 32.3 ttt85 72.86 -34.0 0.28 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.306 0.643 . . . . 3.49 110.944 179.431 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.447 ' H ' ' C ' ' A' ' 20' ' ' SER . 6.3 p30 -145.08 111.51 4.75 Favored Pre-proline 0 C--N 1.325 -0.482 0 N-CA-C 109.175 -0.676 . . . . 1.77 109.175 171.849 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.446 ' C ' HG22 ' A' ' 32' ' ' THR . 91.8 Cg_endo -82.62 59.8 7.0 Favored 'Trans proline' 0 CA--C 1.533 0.467 0 C-N-CA 122.92 2.413 . . . . 1.71 113.889 -173.19 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.447 ' N ' HG22 ' A' ' 32' ' ' THR . 43.9 t -145.99 120.81 2.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 109.385 -0.598 . . . . 0.48 109.385 175.525 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 37.7 t -104.73 152.19 22.83 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 110.299 -0.26 . . . . 1.12 110.299 178.407 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.608 ' HG2' ' HA ' ' A' ' 67' ' ' ASP . 5.5 mmp_? -67.72 -9.81 47.04 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.275 0.559 . . . . 2.54 109.764 171.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.57 ' HG3' ' CD ' ' A' ' 65' ' ' ARG . 13.8 ttp180 -76.36 -35.86 58.49 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.369 -0.832 . . . . 1.77 109.78 177.618 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 64.1 p -105.07 -35.44 7.63 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.896 -0.593 . . . . 0.67 111.048 -175.773 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 84.75 -39.49 2.95 Favored Glycine 0 N--CA 1.451 -0.343 0 CA-C-N 115.683 -0.69 . . . . 0.82 112.817 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.419 ' CG ' ' H ' ' A' ' 31' ' ' SER . 8.7 p-10 -91.72 -65.59 1.0 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.747 0.273 . . . . 2.1 110.874 -178.032 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.419 ' H ' ' CG ' ' A' ' 30' ' ' ASP . 11.6 p -155.53 157.79 37.43 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.618 0.247 . . . . 1.08 110.465 178.702 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.447 HG22 ' N ' ' A' ' 24' ' ' VAL . 13.4 t -121.76 34.44 5.18 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 122.308 1.051 . . . . 0.34 109.148 173.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -79.31 -5.99 55.71 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.853 -1.067 . . . . 0.37 112.146 -173.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -98.1 -24.92 15.11 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.887 0.375 . . . . 2.21 111.156 -178.484 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.494 HG23 ' HB2' ' A' ' 39' ' ' ASP . 0.3 OUTLIER -91.43 135.73 26.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 120.975 0.417 . . . . 0.31 109.916 -178.795 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 65.7 p -94.5 179.03 5.41 Favored 'General case' 0 CA--C 1.513 -0.476 0 N-CA-C 109.583 -0.525 . . . . 0.39 109.583 -175.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.553 ' O ' HG13 ' A' ' 41' ' ' ILE . 8.1 p90 -64.82 -26.26 68.26 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 119.803 -0.759 . . . . 1.53 109.31 176.621 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -74.83 -44.35 49.73 Favored 'General case' 0 C--N 1.334 -0.087 0 CA-C-N 116.205 -0.452 . . . . 0.96 110.629 177.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.494 ' HB2' HG23 ' A' ' 35' ' ' VAL . 45.7 m-20 -64.68 -32.64 74.4 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.642 0.734 . . . . 0.91 109.435 177.001 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.539 ' HB2' ' HB3' ' A' ' 17' ' ' PHE . . . -71.07 -38.6 72.45 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.77 -1.104 . . . . 0.19 110.645 178.362 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.553 HG13 ' O ' ' A' ' 37' ' ' TYR . 77.2 mt -65.09 -36.83 78.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.486 -0.561 . . . . 0.3 109.486 173.213 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 9.2 mtpm? -65.53 -17.78 64.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.249 0.547 . . . . 2.32 110.774 176.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.536 ' HG3' ' CD1' ' A' ' 47' ' ' TRP . 3.8 tp10 -87.69 -61.22 1.77 Allowed 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.978 -0.749 . . . . 1.02 108.978 175.704 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.894 HD22 ' HB3' ' A' ' 111' ' ' LEU . 20.9 tp -58.95 -38.12 78.3 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 114.84 -1.073 . . . . 0.17 111.572 -173.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.531 ' HB2' ' O ' ' A' ' 41' ' ' ILE . 3.6 mm100 -68.8 -29.7 68.12 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 112.276 0.473 . . . . 0.87 112.276 -177.048 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 64.4 mttm -81.58 -38.44 26.1 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 120.501 -0.48 . . . . 1.31 110.223 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.536 ' CD1' ' HG3' ' A' ' 43' ' ' GLU . 35.4 m95 -67.48 -46.54 72.68 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.198 -0.455 . . . . 0.52 111.536 175.462 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.54 ' HB3' HG21 ' A' ' 113' ' ' ILE . 94.3 p -63.77 -30.06 71.2 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.848 -0.427 . . . . 0.82 109.848 177.503 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.442 ' HB2' ' O ' ' A' ' 45' ' ' GLN . 11.9 tt0 -65.29 -53.55 42.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.907 -0.588 . . . . 0.53 110.529 174.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.575 ' HB3' HG22 ' A' ' 56' ' ' VAL . 99.4 mtt180 -66.04 -39.49 90.2 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.04 -0.527 . . . . 0.42 111.769 -176.835 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.468 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 99.3 mt -62.45 -34.31 63.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.207 0.527 . . . . 0.2 110.236 176.001 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -77.65 -34.98 52.95 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.891 -0.595 . . . . 0.27 111.55 179.322 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.424 ' OG ' ' HA ' ' A' ' 50' ' ' ARG . 33.1 p -82.04 -29.28 32.01 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.963 0.411 . . . . 0.35 111.067 -179.053 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 103.65 9.28 38.33 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 121.027 -0.606 . . . . 0.3 112.112 179.071 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -65.13 -45.14 86.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.158 0.504 . . . . 0.65 110.019 177.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.575 HG22 ' HB3' ' A' ' 50' ' ' ARG . 11.3 m -135.02 154.78 36.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 109.141 -0.689 . . . . 0.19 109.141 171.115 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 26.1 m -88.2 160.95 17.5 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.676 -0.491 . . . . 0.97 109.676 179.524 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -53.18 -44.69 68.09 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.125 0.488 . . . . 0.22 110.12 -178.176 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.649 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 44.1 mt-10 -59.32 -32.45 70.08 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.286 -0.87 . . . . 1.72 112.328 -178.293 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -72.95 -51.74 17.26 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.822 0.344 . . . . 2.09 110.921 -177.296 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -65.76 -42.69 90.58 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.216 -0.447 . . . . 0.26 111.029 -178.497 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.8 -53.38 58.65 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.182 -0.463 . . . . 0.24 112.079 -175.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.435 ' HA ' ' O ' ' A' ' 71' ' ' TYR . 23.8 t -53.47 -25.49 16.5 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.665 0.617 . . . . 1.0 112.665 -175.65 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -102.9 -43.01 5.65 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.406 0.622 . . . . 0.61 110.567 -176.115 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.57 ' CD ' ' HG3' ' A' ' 27' ' ' ARG . 17.3 mmt180 -93.72 -42.36 9.19 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 113.858 1.058 . . . . 0.86 113.858 -171.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.583 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 54.6 p -65.92 129.84 41.18 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.625 -0.43 . . . . 0.82 110.884 -176.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.608 ' HA ' ' HG2' ' A' ' 26' ' ' ARG . 30.1 t70 -85.18 -12.08 53.52 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.294 0.568 . . . . 2.28 111.453 179.59 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.456 ' O ' ' HD1' ' A' ' 71' ' ' TYR . 51.2 t -76.18 157.86 32.27 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.459 -0.571 . . . . 1.52 109.459 179.413 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -56.89 -17.02 20.33 Favored Glycine 0 C--N 1.33 0.228 0 CA-C-N 115.189 -0.914 . . . . 0.26 113.09 -174.552 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 57.3 p -63.21 -12.88 31.64 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 111.885 0.328 . . . . 0.32 111.885 176.693 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.456 ' HD1' ' O ' ' A' ' 68' ' ' CYS . 27.3 p90 -57.84 -28.77 64.4 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.996 0.427 . . . . 0.54 110.198 176.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -88.84 -1.75 58.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.307 0.575 . . . . 0.49 110.365 -178.378 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 5.3 m -125.38 8.17 7.78 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.554 -0.748 . . . . 0.71 110.562 -177.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.649 ' O ' ' HA ' ' A' ' 59' ' ' GLU . . . 73.05 29.72 64.3 Favored Glycine 0 CA--C 1.52 0.371 0 CA-C-N 116.041 -0.527 . . . . 0.54 113.118 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.22 -21.16 6.16 Favored Glycine 0 C--O 1.233 0.088 0 C-N-CA 120.94 -0.648 . . . . 0.35 112.236 178.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -71.01 132.15 44.72 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 122.853 0.461 . . . . 1.65 110.772 -175.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.5 mp -116.02 158.98 22.29 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 121.26 0.552 . . . . 0.94 109.885 173.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -86.1 -148.36 11.54 Favored Glycine 0 C--N 1.308 -0.99 0 CA-C-N 114.623 -1.171 . . . . 0.44 112.347 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -80.26 135.46 36.25 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.314 0.578 . . . . 3.87 111.462 -179.44 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -148.02 141.3 25.16 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.249 -0.887 . . . . 1.31 109.898 177.528 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 48.2 m -66.7 129.44 39.87 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 120.813 0.34 . . . . 1.17 110.201 177.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.4 p -52.25 116.21 2.11 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.779 -0.646 . . . . 1.19 111.216 178.362 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 114.31 -5.89 23.24 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.967 -0.635 . . . . 0.79 112.12 -177.418 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -91.21 34.27 0.94 Allowed 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 121.158 0.504 . . . . 1.55 110.885 -179.058 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 25.3 mmt -131.05 -123.16 0.21 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.908 0.385 . . . . 0.73 110.411 179.307 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 65.0 mtt -122.92 157.79 31.82 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.665 -0.865 . . . . 1.39 108.665 174.787 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.506 ' HB3' ' HD3' ' A' ' 88' ' ' PRO . 45.1 tttm -54.39 -55.6 35.58 Favored Pre-proline 0 C--N 1.321 -0.633 0 N-CA-C 112.223 0.453 . . . . 2.37 112.223 -174.75 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.506 ' HD3' ' HB3' ' A' ' 87' ' ' LYS . 91.8 Cg_endo -77.51 -24.06 9.36 Favored 'Trans proline' 0 C--N 1.357 0.986 0 C-N-CA 121.655 1.57 . . . . 0.27 111.97 -176.314 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.583 ' O ' HG23 ' A' ' 93' ' ' VAL . 14.7 t80 -67.94 -55.52 12.45 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.672 -0.695 . . . . 0.22 109.162 177.888 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.422 ' OE2' ' HD2' ' A' ' 94' ' ' ARG . 1.2 tm-20 -63.05 -34.99 78.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.282 -0.872 . . . . 2.12 109.859 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.639 ' HA ' ' CZ ' ' A' ' 94' ' ' ARG . 14.7 t70 -51.34 -41.66 60.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.312 -0.858 . . . . 0.61 111.365 175.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.618 ' O ' ' HG ' ' A' ' 96' ' ' LEU . . . -77.84 -29.72 50.65 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.274 -0.421 . . . . 0.22 111.318 -179.213 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.583 HG23 ' O ' ' A' ' 89' ' ' PHE . 41.1 t -63.1 -49.36 83.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.281 -0.418 . . . . 0.25 111.661 -173.497 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.639 ' CZ ' ' HA ' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -83.47 -2.81 56.77 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.17 -0.612 . . . . 2.59 110.551 -179.233 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -86.2 -16.86 36.44 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.299 -0.41 . . . . 0.47 111.219 -178.577 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.618 ' HG ' ' O ' ' A' ' 92' ' ' ALA . 0.6 OUTLIER -119.21 147.04 44.68 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.243 -0.435 . . . . 0.28 110.829 -179.519 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.519 ' HA ' ' NH2' ' A' ' 116' ' ' ARG . 22.5 tptm -82.34 163.13 21.95 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.495 -0.558 . . . . 1.61 109.495 177.182 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.517 ' H ' ' CD1' ' A' ' 98' ' ' ILE . 1.3 mp -38.05 118.09 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 O-C-N 123.369 0.418 . . . . 0.9 110.644 169.276 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 94.71 -6.36 70.31 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.823 -0.703 . . . . 0.46 113.699 176.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.586 ' HB2' ' HB2' ' A' ' 96' ' ' LEU . 44.8 m-20 -94.59 141.89 28.07 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 117.453 0.627 . . . . 0.46 110.419 178.882 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 9.9 mt -110.26 148.76 13.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.095 -0.502 . . . . 0.23 110.212 -178.482 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 88.5 p -93.85 146.46 31.75 Favored Pre-proline 0 C--N 1.319 -0.718 0 CA-C-N 116.315 -0.402 . . . . 0.92 110.615 -179.412 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -68.8 163.27 37.93 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 122.213 1.942 . . . . 0.34 110.821 171.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.834 HG23 HD23 ' A' ' 44' ' ' LEU . 22.6 mm -39.86 109.86 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 O-C-N 123.774 0.672 . . . . 0.2 112.639 -178.831 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.0 p -115.35 120.5 64.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.991 -0.55 . . . . 1.04 109.774 175.715 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -85.56 152.09 23.42 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.267 0.556 . . . . 0.55 110.934 -179.074 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.469 HG22 ' HG2' ' A' ' 88' ' ' PRO . 14.6 p -131.74 -173.61 3.18 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.293 -0.867 . . . . 0.37 110.076 178.047 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -72.3 -22.24 61.22 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.534 0.207 . . . . 2.16 111.457 178.711 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.757 ' O ' ' HB3' ' A' ' 20' ' ' SER . 7.8 t -110.23 -6.35 15.07 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.348 -0.541 . . . . 1.09 112.021 -176.336 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 157.14 -131.91 3.07 Favored Glycine 0 N--CA 1.436 -1.327 0 C-N-CA 119.902 -1.142 . . . . 0.24 112.545 169.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.894 ' HB3' HD22 ' A' ' 44' ' ' LEU . 5.0 mp -118.17 143.17 46.72 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 114.925 -0.637 . . . . 0.19 111.192 -171.494 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' HIS . . . . . 0.777 ' CE1' HD13 ' A' ' 14' ' ' LEU . 70.3 m80 -139.28 150.04 44.98 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.695 0.628 . . . . 0.22 112.695 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.69 HG12 HD11 ' A' ' 44' ' ' LEU . 2.6 pt -132.31 140.17 48.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 107.615 -1.254 . . . . 0.17 107.615 159.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 2.7 mp -131.9 147.58 32.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 C-N-CA 120.948 -0.301 . . . . 0.18 110.327 -176.233 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.424 ' HA ' ' O ' ' A' ' 100' ' ' ASP . 35.9 pttt -130.08 139.13 50.99 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.557 -0.905 . . . . 0.61 108.557 172.099 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.724 ' HD3' HD21 ' A' ' 8' ' ' LEU . 5.9 ttp180 -80.85 132.34 35.46 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.241 -0.584 . . . . 1.87 110.967 -179.136 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -96.18 -40.52 9.15 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.197 -0.911 . . . . 0.89 109.716 177.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.4 ' HB3' ' HB3' ' A' ' 9' ' ' ARG . . . . . . . . 0 C--O 1.244 0.79 0 CA-C-O 118.347 -0.835 . . . . 1.1 110.015 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 12.0 tpt . . . . . 0 N--CA 1.48 1.061 0 N-CA-C 109.712 -0.477 . . . . 7.23 109.712 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 9.3 p -55.04 -75.96 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 112.249 0.463 . . . . 2.88 112.249 -175.052 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.462 ' O ' ' HA ' ' A' ' 81' ' ' SER . 12.8 pt-20 -94.77 -25.12 16.8 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.992 -0.283 . . . . 2.8 110.66 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 66.9 mmtt -74.28 108.76 7.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.365 0.602 . . . . 1.19 110.731 177.202 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.475 HD11 ' CD ' ' A' ' 116' ' ' ARG . 15.6 tp -116.7 173.4 6.65 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.007 -0.997 . . . . 1.18 109.385 -178.319 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.453 ' H ' ' HG ' ' A' ' 8' ' ' LEU . 65.3 ttt180 -146.26 126.56 13.94 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.802 -0.444 . . . . 1.06 109.802 178.37 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.429 ' N ' ' HZ ' ' A' ' 80' ' ' PHE . . . -146.56 155.02 42.18 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.085 0.469 . . . . 0.22 111.638 -179.477 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.4 ' N ' HD23 ' A' ' 117' ' ' LEU . . . -106.05 140.7 38.64 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.519 -0.764 . . . . 0.2 109.401 177.052 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 50.6 p-80 -139.29 150.45 45.44 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.003 0.43 . . . . 0.23 111.341 -173.549 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.567 ' O ' ' HA ' ' A' ' 112' ' ' HIS . 5.2 tt -118.28 142.75 47.18 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.233 -1.025 . . . . 0.24 108.233 176.595 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.59 HD13 ' NE2' ' A' ' 112' ' ' HIS . 26.6 tp -127.82 121.82 31.09 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.597 0.236 . . . . 0.27 110.715 -176.413 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.563 HG23 HD13 ' A' ' 44' ' ' LEU . 97.4 t -112.01 136.61 47.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 116.133 -0.485 . . . . 0.15 109.727 176.032 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.543 ' HE2' ' OG ' ' A' ' 109' ' ' SER . 32.5 mmtp -108.82 164.79 12.07 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.104 -0.498 . . . . 0.62 109.976 177.636 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.5 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 49.8 p90 -158.65 163.14 37.17 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.992 -0.549 . . . . 0.25 110.141 -176.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.496 ' HB3' ' C ' ' A' ' 33' ' ' ALA . 35.8 p -54.13 109.51 0.49 Allowed 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 120.983 0.42 . . . . 1.04 110.715 177.717 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 103.27 9.82 37.95 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.463 -0.875 . . . . 0.53 112.841 -178.229 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.415 ' C ' ' H ' ' A' ' 22' ' ' ASN . 73.5 p -90.12 40.17 0.99 Allowed 'General case' 0 C--O 1.234 0.264 0 CA-C-N 117.338 0.569 . . . . 0.7 111.296 -175.675 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 50.1 ttt180 75.38 -34.2 0.25 Allowed 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 123.534 0.733 . . . . 3.49 110.662 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.415 ' H ' ' C ' ' A' ' 20' ' ' SER . 5.7 p30 -149.6 118.55 3.81 Favored Pre-proline 0 C--N 1.323 -0.55 0 N-CA-C 109.321 -0.622 . . . . 1.77 109.321 173.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.557 ' O ' ' HA ' ' A' ' 31' ' ' SER . 66.2 Cg_endo -86.29 53.33 3.06 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 122.792 2.328 . . . . 1.71 113.353 -172.434 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.484 HG13 ' O ' ' A' ' 30' ' ' ASP . 81.7 t -143.32 121.12 6.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 109.242 -0.651 . . . . 0.48 109.242 178.155 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 44.5 t -103.88 152.34 22.06 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.739 -0.467 . . . . 1.12 109.739 177.289 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.641 ' CB ' ' HA ' ' A' ' 67' ' ' ASP . 9.2 tpt180 -73.72 -9.89 59.12 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.241 -0.651 . . . . 2.54 109.241 174.038 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.619 ' HG3' ' HD3' ' A' ' 65' ' ' ARG . 13.9 ttp180 -79.94 -38.27 32.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.306 -0.861 . . . . 1.77 109.737 174.057 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 69.9 p -93.74 -34.14 13.34 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.661 -0.699 . . . . 0.67 111.09 -175.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 81.83 -39.24 2.55 Favored Glycine 0 N--CA 1.451 -0.361 0 CA-C-N 115.238 -0.892 . . . . 0.82 111.428 -177.409 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.484 ' O ' HG13 ' A' ' 24' ' ' VAL . 31.2 m-20 -107.45 -139.18 0.37 Allowed 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 108.408 -0.96 . . . . 2.1 108.408 175.211 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.557 ' HA ' ' O ' ' A' ' 23' ' ' PRO . 2.7 p -75.27 135.11 40.96 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-O 121.27 0.557 . . . . 1.08 111.763 -172.438 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.507 HG22 ' C ' ' A' ' 23' ' ' PRO . 12.3 t -106.79 31.26 5.42 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 107.689 -1.226 . . . . 0.34 107.689 168.353 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.496 ' C ' ' HB3' ' A' ' 18' ' ' SER . . . -82.32 -5.14 58.38 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 114.085 -1.416 . . . . 0.37 112.178 -172.738 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -97.22 -22.77 16.51 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 120.938 0.399 . . . . 2.21 110.906 178.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.491 HG23 ' HB2' ' A' ' 39' ' ' ASP . 0.2 OUTLIER -90.4 136.3 24.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 109.574 -0.528 . . . . 0.31 109.574 179.148 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 71.6 p -94.31 178.42 5.63 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.954 -0.388 . . . . 0.39 109.954 -176.064 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.447 ' O ' HG13 ' A' ' 41' ' ' ILE . 7.8 p90 -64.83 -26.24 68.25 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.003 -0.74 . . . . 1.53 109.003 174.643 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -71.04 -50.97 28.21 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 115.892 -0.594 . . . . 0.96 109.896 176.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.491 ' HB2' HG23 ' A' ' 35' ' ' VAL . 11.6 m-20 -59.04 -37.99 78.29 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-O 121.439 0.638 . . . . 0.91 109.711 177.199 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.5 ' HB2' ' HB3' ' A' ' 17' ' ' PHE . . . -67.26 -45.68 75.94 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.821 -1.081 . . . . 0.19 110.7 -178.724 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.488 ' CG1' HD21 ' A' ' 111' ' ' LEU . 68.8 mt -63.05 -36.83 77.5 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 CA-C-N 116.261 -0.427 . . . . 0.3 109.986 176.051 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.418 ' HA ' ' HD2' ' A' ' 42' ' ' LYS . 11.1 mmmm -68.55 -17.83 64.23 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 116.107 -0.497 . . . . 2.32 110.982 179.567 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.452 ' HG3' ' CD1' ' A' ' 47' ' ' TRP . 1.6 tt0 -88.56 -54.67 4.06 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.8 -0.636 . . . . 1.02 109.666 175.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.924 HD22 ' HB3' ' A' ' 111' ' ' LEU . 32.4 tp -58.69 -37.19 75.52 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.629 -0.714 . . . . 0.17 110.888 -176.751 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.457 ' HA ' HD11 ' A' ' 104' ' ' ILE . 3.1 mm100 -63.77 -40.39 96.57 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.969 0.359 . . . . 0.87 111.969 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -70.5 -41.62 72.42 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 120.919 -0.313 . . . . 1.31 110.969 -177.457 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.452 ' CD1' ' HG3' ' A' ' 43' ' ' GLU . 39.3 m95 -66.76 -46.1 76.41 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.915 -0.314 . . . . 0.52 110.621 176.472 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 33.0 t -57.91 -38.96 76.81 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.676 -0.49 . . . . 0.82 109.676 175.634 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -61.06 -52.04 66.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.683 -0.69 . . . . 0.53 110.888 176.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.586 ' HB3' HG22 ' A' ' 56' ' ' VAL . 87.0 mtt180 -65.75 -41.18 92.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.812 -0.631 . . . . 0.42 111.547 -176.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.432 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 96.7 mt -60.49 -38.24 77.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.146 0.498 . . . . 0.2 110.249 175.775 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.32 -35.24 71.17 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.837 -0.62 . . . . 0.27 111.708 178.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 28.2 p -83.97 -31.15 25.7 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.827 0.346 . . . . 0.35 111.594 -177.187 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 107.1 5.25 35.28 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.717 -0.754 . . . . 0.3 111.819 -178.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.44 ' HB2' ' HB3' ' A' ' 50' ' ' ARG . 38.8 mt-10 -60.01 -53.18 60.9 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.829 -0.434 . . . . 0.65 109.829 176.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.586 HG22 ' HB3' ' A' ' 50' ' ' ARG . 15.8 m -129.81 150.84 35.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 109.292 -0.633 . . . . 0.19 109.292 173.095 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.5 m -80.79 158.39 25.46 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.451 -0.574 . . . . 0.97 109.451 179.565 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.44 ' CD2' ' HD3' ' A' ' 115' ' ' LYS . 2.2 t80 -52.75 -44.15 66.27 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.587 -0.523 . . . . 0.22 109.587 179.494 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.468 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 48.1 mt-10 -56.06 -45.22 79.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.135 -0.939 . . . . 1.72 112.002 179.468 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 34.2 mm-40 -63.85 -47.59 80.13 Favored 'General case' 0 CA--C 1.522 -0.132 0 CA-C-O 120.983 0.42 . . . . 2.09 110.808 -175.756 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -67.76 -46.22 72.68 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.203 -0.453 . . . . 0.26 110.767 -179.374 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.12 -52.63 64.52 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.344 -0.389 . . . . 0.24 112.002 -176.528 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.442 ' HA ' ' O ' ' A' ' 71' ' ' TYR . 33.0 t -51.9 -25.49 8.15 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.856 0.687 . . . . 1.0 112.856 -177.131 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -102.18 -44.63 5.38 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.535 0.683 . . . . 0.61 110.456 -179.083 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.619 ' HD3' ' HG3' ' A' ' 27' ' ' ARG . 21.5 mmt180 -93.64 -39.53 10.76 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 114.334 1.235 . . . . 0.86 114.334 -169.598 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.452 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 59.7 p -63.23 123.75 19.44 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.118 0.485 . . . . 0.82 111.059 -176.604 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.641 ' HA ' ' CB ' ' A' ' 26' ' ' ARG . 17.2 t70 -71.82 -18.8 62.06 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.441 -0.799 . . . . 2.28 111.268 177.649 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 46.6 t -77.1 157.36 31.08 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.54 0.686 . . . . 1.52 110.808 -178.649 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -58.63 -16.47 30.09 Favored Glycine 0 N--CA 1.453 -0.181 0 CA-C-N 114.388 -1.278 . . . . 0.26 113.922 -174.516 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.449 ' HB2' ' CA ' ' A' ' 75' ' ' GLY . 2.6 p -66.17 -4.1 6.94 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 112.287 0.477 . . . . 0.32 112.287 176.558 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.442 ' O ' ' HA ' ' A' ' 63' ' ' SER . 33.0 p90 -56.68 -27.99 59.9 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.112 0.482 . . . . 0.54 110.069 175.541 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -92.12 -0.25 57.45 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.387 0.613 . . . . 0.49 110.389 -179.068 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.2 m -124.72 9.32 8.27 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.647 -0.706 . . . . 0.71 110.796 -175.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.468 ' O ' ' HA ' ' A' ' 59' ' ' GLU . . . 73.42 31.0 61.56 Favored Glycine 0 CA--C 1.519 0.335 0 C-N-CA 120.884 -0.674 . . . . 0.54 112.738 -178.831 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.449 ' CA ' ' HB2' ' A' ' 70' ' ' SER . . . 76.78 3.09 78.95 Favored Glycine 0 C--O 1.227 -0.325 0 C-N-CA 121.081 -0.58 . . . . 0.35 112.217 179.612 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -97.92 144.35 27.56 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 110.283 -0.266 . . . . 1.65 110.283 -168.266 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.7 mp -120.39 171.45 8.52 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.129 -0.487 . . . . 0.94 110.276 178.672 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -91.03 -148.6 21.78 Favored Glycine 0 C--N 1.317 -0.514 0 CA-C-N 115.783 -0.644 . . . . 0.44 112.22 -178.012 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 99.8 m-85 -88.13 123.22 32.58 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.222 0.534 . . . . 3.87 110.556 178.361 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.429 ' HZ ' ' N ' ' A' ' 10' ' ' ALA . 1.6 p90 -134.61 147.13 50.14 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.567 -0.742 . . . . 1.31 110.085 -178.696 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.462 ' HA ' ' O ' ' A' ' 6' ' ' GLU . 21.8 m -80.87 124.08 28.81 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 109.926 -0.398 . . . . 1.17 109.926 179.162 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 24.6 m -54.25 119.1 4.69 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.99 -0.55 . . . . 1.19 110.925 -179.296 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 114.71 13.03 9.78 Favored Glycine 0 N--CA 1.443 -0.883 0 CA-C-N 115.627 -0.715 . . . . 0.79 111.794 -178.267 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -116.56 7.45 13.67 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 111.521 0.193 . . . . 1.55 111.521 179.041 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 24.9 mmt -99.06 -105.44 0.21 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.157 0.503 . . . . 0.73 110.807 -179.34 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 68.9 mtm -142.18 147.38 36.5 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 107.904 -1.147 . . . . 1.39 107.904 176.37 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -48.45 -54.81 22.84 Favored Pre-proline 0 CA--C 1.539 0.552 0 N-CA-C 113.0 0.741 . . . . 2.37 113.0 -173.761 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.501 ' HG2' HG22 ' A' ' 107' ' ' THR . 71.8 Cg_endo -75.43 -27.49 9.29 Favored 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 121.401 1.4 . . . . 0.27 111.739 -175.533 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.644 ' O ' HG23 ' A' ' 93' ' ' VAL . 42.4 t80 -72.35 -56.26 5.77 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.23 -0.896 . . . . 0.22 109.984 -179.258 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -61.8 -38.28 87.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.462 -0.79 . . . . 2.12 110.441 -177.469 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -60.65 -31.59 70.8 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.454 -0.794 . . . . 0.61 110.502 178.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.489 ' O ' ' HG ' ' A' ' 96' ' ' LEU . . . -81.06 -25.98 36.67 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.037 -0.529 . . . . 0.22 110.72 178.275 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.644 HG23 ' O ' ' A' ' 89' ' ' PHE . 25.7 t -70.95 -36.05 62.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.421 0.629 . . . . 0.25 110.124 -178.465 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.509 ' C ' ' HD2' ' A' ' 94' ' ' ARG . 5.5 ppt_? -85.74 -16.47 38.84 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.679 -0.691 . . . . 2.59 110.622 179.653 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -76.09 -17.07 59.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.012 -0.54 . . . . 0.47 111.187 -176.106 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.609 ' HB2' ' HB2' ' A' ' 100' ' ' ASP . 0.9 OUTLIER -119.61 151.92 37.89 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.143 -0.481 . . . . 0.28 110.736 179.443 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.436 ' HA ' ' NH2' ' A' ' 116' ' ' ARG . 23.5 tptm -92.57 167.46 11.91 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.053 -0.721 . . . . 1.61 109.053 178.325 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.459 ' HA ' ' HG2' ' A' ' 116' ' ' ARG . 58.8 mt -46.25 115.97 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.851 0.358 . . . . 0.9 111.301 173.507 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 100.46 -2.06 56.02 Favored Glycine 0 CA--C 1.521 0.428 0 C-N-CA 120.715 -0.755 . . . . 0.46 113.528 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.609 ' HB2' ' HB2' ' A' ' 96' ' ' LEU . 68.1 m-20 -104.53 152.43 22.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 117.412 0.606 . . . . 0.46 110.692 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 9.5 mt -121.8 149.11 25.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-O 120.988 0.423 . . . . 0.23 110.873 -177.087 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 70.4 m -96.48 150.41 37.03 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 115.896 -0.593 . . . . 0.92 110.491 177.176 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.428 ' O ' HG23 ' A' ' 105' ' ' VAL . 73.5 Cg_endo -74.71 177.91 7.85 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.558 2.172 . . . . 0.34 111.188 173.373 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.768 HG23 HD23 ' A' ' 44' ' ' LEU . 22.8 mm -44.62 108.28 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 O-C-N 123.501 0.501 . . . . 0.2 112.169 178.732 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 103' ' ' PRO . 69.6 t -110.98 115.19 49.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.919 -0.582 . . . . 1.04 109.59 174.429 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -84.68 147.78 26.75 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.287 0.565 . . . . 0.55 110.285 178.531 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.501 HG22 ' HG2' ' A' ' 88' ' ' PRO . 10.0 p -123.31 -172.81 2.59 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.445 -0.798 . . . . 0.37 110.297 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -64.82 -37.8 88.82 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.63 0.252 . . . . 2.16 110.472 178.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.543 ' OG ' ' HE2' ' A' ' 16' ' ' LYS . 9.2 t -86.48 -61.61 1.7 Allowed 'General case' 0 C--O 1.222 -0.391 0 C-N-CA 120.918 -0.313 . . . . 1.09 110.419 179.264 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -152.81 -131.04 1.6 Allowed Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 119.163 -1.494 . . . . 0.24 113.605 -174.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.924 ' HB3' HD22 ' A' ' 44' ' ' LEU . 6.6 mp -116.03 145.96 42.55 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.425 -0.388 . . . . 0.19 111.71 -169.486 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' HIS . . . . . 0.59 ' NE2' HD13 ' A' ' 14' ' ' LEU . 84.5 m-70 -144.87 142.04 29.59 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.101 0.477 . . . . 0.22 112.274 179.51 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.656 HG12 HD11 ' A' ' 44' ' ' LEU . 2.8 pt -123.47 140.55 46.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 107.707 -1.22 . . . . 0.17 107.707 159.815 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.418 HG21 HG22 ' A' ' 93' ' ' VAL . 2.6 mp -132.57 150.32 33.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 C-N-CA 120.731 -0.387 . . . . 0.18 110.485 -175.134 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.513 ' HE3' HD21 ' A' ' 117' ' ' LEU . 7.1 pttp -136.24 141.95 43.99 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.494 -0.928 . . . . 0.61 108.494 173.53 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.475 ' CD ' HD11 ' A' ' 8' ' ' LEU . 5.5 ttp180 -84.36 132.26 34.62 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.477 -0.489 . . . . 1.87 110.826 179.374 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.513 HD21 ' HE3' ' A' ' 115' ' ' LYS . 4.1 mm? -99.76 -35.4 9.81 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.21 -0.905 . . . . 0.89 110.281 -178.372 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.893 0 CA-C-O 118.411 -0.804 . . . . 1.1 110.165 179.97 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 61.9 mtt . . . . . 0 N--CA 1.483 1.219 0 CA-C-O 121.07 0.462 . . . . 7.23 110.838 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 16.0 p -158.51 172.32 18.53 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.963 -0.562 . . . . 2.88 109.821 178.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -147.46 -17.59 0.38 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.502 -0.317 . . . . 2.8 110.652 178.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.518 ' HA ' ' O ' ' A' ' 80' ' ' PHE . 42.4 mmtm -76.41 115.54 16.25 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.241 0.544 . . . . 1.19 111.258 -178.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.599 ' O ' ' HA ' ' A' ' 79' ' ' PHE . 12.0 tp -118.65 169.8 9.5 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.349 -0.982 . . . . 1.18 108.349 176.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.418 ' HG3' ' O ' ' A' ' 77' ' ' LEU . 56.2 ttt180 -142.79 134.32 26.44 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 117.799 0.272 . . . . 1.06 110.301 177.05 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.638 ' O ' ' HB2' ' A' ' 77' ' ' LEU . . . -155.69 154.24 31.23 Favored 'General case' 0 C--O 1.222 -0.364 0 C-N-CA 120.086 -0.646 . . . . 0.22 112.063 -177.813 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.492 ' HB3' ' HG2' ' A' ' 115' ' ' LYS . . . -102.16 132.23 48.19 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.216 -0.661 . . . . 0.2 109.216 178.243 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 12.4 p-80 -133.19 148.77 52.06 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.178 0.513 . . . . 0.23 111.768 -172.381 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.566 HD23 ' N ' ' A' ' 14' ' ' LEU . 5.2 tt -121.4 146.91 46.4 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.41 -0.959 . . . . 0.24 108.41 177.587 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.757 HD13 ' CE1' ' A' ' 112' ' ' HIS . 23.4 tp -131.34 132.86 44.78 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 110.091 -0.337 . . . . 0.27 110.091 -178.337 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.529 HG23 HD13 ' A' ' 44' ' ' LEU . 58.4 t -123.2 130.67 74.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 O-C-N 123.353 0.408 . . . . 0.15 109.942 175.575 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.502 ' HE3' HD21 ' A' ' 14' ' ' LEU . 33.6 mmtp -104.44 152.44 22.33 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.903 -0.59 . . . . 0.62 110.025 177.073 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.511 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 42.7 p90 -143.23 162.94 34.3 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.006 -0.543 . . . . 0.25 110.477 -177.794 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.46 ' HB3' ' HA ' ' A' ' 33' ' ' ALA . 32.6 p -51.84 112.84 0.84 Allowed 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.103 0.478 . . . . 1.04 110.892 178.419 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 97.79 8.51 55.65 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.582 -0.818 . . . . 0.53 113.141 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.614 ' HB2' ' O ' ' A' ' 109' ' ' SER . 80.3 p -88.68 45.59 1.3 Allowed 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 117.366 0.583 . . . . 0.7 110.893 -175.881 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.487 ' HB3' ' O ' ' A' ' 20' ' ' SER . 76.8 ttt180 75.8 -32.5 0.21 Allowed 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 123.175 0.59 . . . . 3.49 110.93 -179.021 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.413 ' H ' ' C ' ' A' ' 20' ' ' SER . 3.5 p30 -153.31 109.0 2.61 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-O 121.09 0.471 . . . . 1.77 110.291 174.729 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.408 ' C ' HG22 ' A' ' 32' ' ' THR . 11.3 Cg_exo -73.69 52.86 2.6 Favored 'Trans proline' 0 CA--C 1.534 0.481 0 C-N-CA 123.236 2.624 . . . . 1.71 113.401 -179.338 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.461 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 83.9 t -141.84 116.88 5.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 109.722 -0.473 . . . . 0.48 109.722 176.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.522 ' HB2' ' OD1' ' A' ' 67' ' ' ASP . 6.4 p -103.85 151.52 23.0 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 116.535 -0.302 . . . . 1.12 110.308 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.69 ' CB ' ' HA ' ' A' ' 67' ' ' ASP . 3.3 tpp180 -69.33 -20.65 63.87 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 108.028 -1.101 . . . . 2.54 108.028 173.041 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.441 ' CG ' ' HA ' ' A' ' 65' ' ' ARG . 2.7 tmm_? -69.43 -37.41 77.39 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 114.27 -1.332 . . . . 1.77 110.472 179.002 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 81.1 p -99.29 -36.37 9.65 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.498 0.666 . . . . 0.67 110.803 179.321 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 72.57 -3.84 23.65 Favored Glycine 0 N--CA 1.451 -0.33 0 CA-C-N 115.203 -0.908 . . . . 0.82 112.338 -176.622 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -113.78 -79.22 0.58 Allowed 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.605 -0.517 . . . . 2.1 109.605 179.255 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.461 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 20.2 m -153.77 153.26 31.86 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.73 -0.668 . . . . 1.08 109.82 176.296 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.411 ' OG1' HG13 ' A' ' 35' ' ' VAL . 10.2 t -117.52 30.66 7.16 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 122.286 1.041 . . . . 0.34 109.307 177.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.46 ' HA ' ' HB3' ' A' ' 18' ' ' SER . . . -77.03 -5.94 50.72 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.711 -1.131 . . . . 0.37 112.514 -176.495 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -95.74 -25.37 16.11 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.183 0.516 . . . . 2.21 110.651 -179.232 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.411 HG13 ' OG1' ' A' ' 32' ' ' THR . 0.2 OUTLIER -95.78 134.68 32.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.943 -0.571 . . . . 0.31 110.293 -178.886 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 64.7 p -93.0 179.93 5.29 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.181 -0.463 . . . . 0.39 109.873 -175.767 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.464 ' O ' HG13 ' A' ' 41' ' ' ILE . 9.3 p90 -64.36 -28.47 69.72 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 119.934 -0.707 . . . . 1.53 109.142 175.877 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -72.13 -48.98 39.69 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 115.968 -0.56 . . . . 0.96 110.345 177.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.409 ' HB2' HG23 ' A' ' 35' ' ' VAL . 43.4 m-20 -64.91 -28.78 69.77 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.189 0.518 . . . . 0.91 110.161 178.743 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.511 ' HB2' ' HB3' ' A' ' 17' ' ' PHE . . . -71.36 -43.01 67.74 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.483 -0.78 . . . . 0.19 110.513 176.593 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.464 HG13 ' O ' ' A' ' 37' ' ' TYR . 87.1 mt -62.8 -35.95 73.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.477 -0.564 . . . . 0.3 109.477 174.044 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 35.2 tttm -62.44 -24.52 67.47 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.402 -0.817 . . . . 2.32 110.857 176.703 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.431 ' HG3' ' CD1' ' A' ' 47' ' ' TRP . 0.7 OUTLIER -87.28 -52.47 5.38 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.115 -0.698 . . . . 1.02 109.115 178.845 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.894 HD23 HG23 ' A' ' 104' ' ' ILE . 32.3 tp -63.46 -37.7 88.28 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.202 -0.908 . . . . 0.17 110.695 -173.465 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.43 ' HA ' HD11 ' A' ' 104' ' ' ILE . 11.1 mm-40 -65.93 -30.7 71.33 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-N 116.152 -0.477 . . . . 0.87 112.133 -176.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -74.73 -44.18 51.22 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.941 0.4 . . . . 1.31 110.104 179.004 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.431 ' CD1' ' HG3' ' A' ' 43' ' ' GLU . 49.2 m95 -67.22 -44.51 79.33 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.205 -0.452 . . . . 0.52 111.115 178.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.555 ' HB3' HG21 ' A' ' 113' ' ' ILE . 97.8 p -66.43 -22.29 66.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.83 0.348 . . . . 0.82 110.203 177.147 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.42 ' HB2' ' O ' ' A' ' 45' ' ' GLN . 10.0 tt0 -73.97 -56.95 4.33 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 116.013 -0.54 . . . . 0.53 109.986 173.662 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.616 ' HB3' HG22 ' A' ' 56' ' ' VAL . 96.6 mtt180 -61.85 -41.37 97.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.556 -0.747 . . . . 0.42 111.499 -175.102 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.43 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 97.5 mt -60.59 -36.31 69.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.006 0.431 . . . . 0.2 110.434 176.309 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -76.76 -42.7 39.98 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.078 -0.51 . . . . 0.27 111.441 179.552 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 35.3 p -74.4 -29.63 61.6 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.916 0.389 . . . . 0.35 111.294 -176.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 107.86 1.44 34.25 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.824 -0.703 . . . . 0.3 112.366 -179.433 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.453 ' HB2' ' HB3' ' A' ' 50' ' ' ARG . 39.0 mt-10 -59.5 -44.41 93.12 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 121.047 0.451 . . . . 0.65 110.513 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.616 HG22 ' HB3' ' A' ' 50' ' ' ARG . 13.0 m -137.8 157.55 33.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 109.401 -0.592 . . . . 0.19 109.401 172.16 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 14.5 m -86.43 160.26 19.09 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.348 -0.612 . . . . 0.97 109.348 178.204 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -55.23 -44.25 75.28 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.024 0.44 . . . . 0.22 109.976 -177.697 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.603 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 50.8 mt-10 -60.54 -35.19 75.42 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.372 -0.831 . . . . 1.72 111.893 -178.718 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -62.39 -52.9 61.74 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-O 121.055 0.455 . . . . 2.09 110.378 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -69.81 -46.32 65.94 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.605 -0.725 . . . . 0.26 111.399 -175.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.92 -52.32 65.91 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.439 0.533 . . . . 0.24 112.439 -173.298 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.46 ' HA ' ' O ' ' A' ' 71' ' ' TYR . 67.0 m -51.18 -21.97 2.32 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.993 0.738 . . . . 1.0 112.993 -179.606 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -103.75 -46.53 4.49 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.584 0.707 . . . . 0.61 110.148 179.162 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.441 ' HA ' ' CG ' ' A' ' 27' ' ' ARG . 36.7 mmt-85 -95.63 -36.3 11.28 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 114.271 1.212 . . . . 0.86 114.271 -169.097 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.488 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 54.3 p -63.87 114.84 4.32 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.274 0.559 . . . . 0.82 110.279 -177.596 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.69 ' HA ' ' CB ' ' A' ' 26' ' ' ARG . 74.6 m-20 -75.57 -9.51 58.64 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.484 -0.78 . . . . 2.28 111.632 -177.393 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 36.0 t -85.56 160.74 19.57 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.755 -0.657 . . . . 1.52 110.163 178.333 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -56.28 -18.88 22.76 Favored Glycine 0 CA--C 1.518 0.237 0 CA-C-N 114.465 -1.243 . . . . 0.26 114.378 -173.5 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.413 ' HB3' HD21 ' A' ' 77' ' ' LEU . 60.5 p -65.19 -7.23 11.79 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 112.502 0.556 . . . . 0.32 112.502 177.546 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.46 ' O ' ' HA ' ' A' ' 63' ' ' SER . 32.0 p90 -52.5 -36.56 55.5 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 120.994 0.426 . . . . 0.54 110.325 176.713 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -81.06 -1.25 43.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.002 0.429 . . . . 0.49 111.039 -177.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 7.7 m -125.01 8.12 8.02 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.103 -0.499 . . . . 0.71 110.501 -178.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.603 ' O ' ' HA ' ' A' ' 59' ' ' GLU . . . 75.14 26.24 66.86 Favored Glycine 0 C--O 1.226 -0.35 0 C-N-CA 121.014 -0.612 . . . . 0.54 112.622 -179.508 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.49 -20.37 6.18 Favored Glycine 0 N--CA 1.454 -0.149 0 C-N-CA 121.012 -0.613 . . . . 0.35 111.937 -179.208 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -68.43 128.6 37.18 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.179 -0.511 . . . . 1.65 110.537 -177.359 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.638 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 19.4 mt -108.24 157.53 18.26 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 116.076 -0.511 . . . . 0.94 110.065 176.562 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -87.82 -165.31 41.16 Favored Glycine 0 N--CA 1.443 -0.847 0 CA-C-N 115.478 -0.783 . . . . 0.44 111.232 174.339 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.599 ' HA ' ' O ' ' A' ' 8' ' ' LEU . 75.4 m-85 -71.67 133.05 45.4 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.287 0.565 . . . . 3.87 111.609 -178.046 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.518 ' O ' ' HA ' ' A' ' 7' ' ' LYS . 21.0 p90 -133.96 160.3 38.12 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.366 -0.834 . . . . 1.31 109.399 178.628 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 12.1 m -79.75 123.57 27.81 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 109.032 -0.729 . . . . 1.17 109.032 175.5 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 33.1 m -52.73 117.43 2.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.14 -0.482 . . . . 1.19 110.675 -178.105 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 113.97 -6.18 23.78 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.734 -0.746 . . . . 0.79 112.425 -177.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -97.99 48.18 1.01 Allowed 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.453 0.644 . . . . 1.55 110.435 179.452 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 25.3 mmt -135.58 -101.22 0.22 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.101 -0.5 . . . . 0.73 110.502 177.546 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.508 ' HB2' ' HB3' ' A' ' 89' ' ' PHE . 48.4 mtt -145.8 149.71 34.85 Favored 'General case' 0 CA--C 1.513 -0.464 0 N-CA-C 107.79 -1.189 . . . . 1.39 107.79 177.256 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.448 ' HB3' ' HD3' ' A' ' 88' ' ' PRO . 27.2 ttpp -53.38 -54.79 41.39 Favored Pre-proline 0 C--N 1.322 -0.605 0 N-CA-C 112.134 0.42 . . . . 2.37 112.134 -174.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.448 ' HD3' ' HB3' ' A' ' 87' ' ' LYS . 83.4 Cg_endo -76.45 -27.82 7.43 Favored 'Trans proline' 0 C--N 1.356 0.97 0 C-N-CA 121.6 1.533 . . . . 0.27 112.061 -176.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.644 ' O ' HG23 ' A' ' 93' ' ' VAL . 34.3 t80 -68.55 -56.59 7.78 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.248 -0.887 . . . . 0.22 109.999 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -65.08 -37.08 86.38 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.398 -0.819 . . . . 2.12 109.661 -177.524 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -52.75 -36.02 57.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.173 -0.921 . . . . 0.61 110.995 174.819 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -83.77 -27.32 28.96 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.112 -0.494 . . . . 0.22 111.207 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.644 HG23 ' O ' ' A' ' 89' ' ' PHE . 21.8 t -69.92 -48.17 65.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.243 0.544 . . . . 0.25 109.947 -177.187 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -73.2 -6.81 48.31 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.446 -0.797 . . . . 2.59 110.784 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -82.94 -20.51 35.14 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.865 -0.607 . . . . 0.47 110.222 177.744 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.671 ' HB3' ' HB2' ' A' ' 100' ' ' ASP . 0.8 OUTLIER -89.22 146.33 24.83 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-N 116.198 -0.456 . . . . 0.28 109.912 -179.895 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 55.2 tptt -86.49 166.08 15.76 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 106.684 -1.599 . . . . 1.61 106.684 163.546 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 51.8 mt -55.24 115.32 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 120.77 0.319 . . . . 0.9 110.368 179.58 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 102.64 10.94 36.7 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.51 -0.852 . . . . 0.46 113.559 -178.342 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.671 ' HB2' ' HB3' ' A' ' 96' ' ' LEU . 8.9 m-20 -108.08 149.1 28.88 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 117.896 0.848 . . . . 0.46 110.462 -179.434 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 16.2 mt -116.14 144.84 22.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 121.066 0.46 . . . . 0.23 110.671 -178.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.65 ' OG ' HD21 ' A' ' 96' ' ' LEU . 19.7 m -90.86 148.91 39.3 Favored Pre-proline 0 C--N 1.321 -0.657 0 CA-C-N 115.801 -0.636 . . . . 0.92 110.534 -179.459 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.69 176.2 10.3 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 122.642 2.228 . . . . 0.34 111.195 172.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.894 HG23 HD23 ' A' ' 44' ' ' LEU . 19.6 mm -50.11 100.2 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 O-C-N 123.475 0.484 . . . . 0.2 112.133 178.74 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.6 p -107.75 119.59 57.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.101 0.477 . . . . 1.04 110.21 176.511 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -85.99 149.86 24.89 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.935 0.398 . . . . 0.55 110.73 -179.085 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.435 HG22 ' HG2' ' A' ' 88' ' ' PRO . 3.9 p -126.26 -172.33 2.6 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.601 -0.727 . . . . 0.37 111.122 -178.451 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -61.03 -34.84 75.47 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.556 0.217 . . . . 2.16 111.527 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.614 ' O ' ' HB2' ' A' ' 20' ' ' SER . 6.8 t -97.5 -60.76 1.51 Allowed 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.55 -0.46 . . . . 1.09 110.544 179.458 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -146.59 -133.42 2.46 Favored Glycine 0 N--CA 1.441 -0.986 0 C-N-CA 119.015 -1.564 . . . . 0.24 113.877 -173.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.894 ' HB3' HD22 ' A' ' 44' ' ' LEU . 5.9 mp -114.58 148.08 38.55 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.06 -0.57 . . . . 0.19 111.407 -169.845 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' HIS . . . . . 0.757 ' CE1' HD13 ' A' ' 14' ' ' LEU . 70.0 m80 -144.2 151.82 40.01 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.316 0.579 . . . . 0.22 112.268 179.073 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.606 HG12 HD11 ' A' ' 44' ' ' LEU . 3.9 pt -134.35 143.91 36.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 107.774 -1.195 . . . . 0.17 107.774 159.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.444 ' H ' ' HB2' ' A' ' 102' ' ' SER . 1.0 OUTLIER -133.22 138.19 51.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 C-N-CA 120.829 -0.348 . . . . 0.18 110.665 -176.963 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.492 ' HG2' ' HB3' ' A' ' 11' ' ' ALA . 50.4 pttt -121.83 135.08 54.9 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.416 -0.587 . . . . 0.61 109.416 172.111 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.419 ' HB2' HD12 ' A' ' 96' ' ' LEU . 68.5 ttt180 -84.78 123.0 29.92 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.837 0.351 . . . . 1.87 111.064 -175.185 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.411 HD21 ' HB2' ' A' ' 11' ' ' ALA . 2.2 mm? -93.15 -32.59 14.36 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.025 -0.534 . . . . 0.89 110.843 179.459 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.955 0 CA-C-O 118.569 -0.729 . . . . 1.1 110.156 179.514 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.9 mpt? . . . . . 0 N--CA 1.48 1.061 0 CA-C-O 121.013 0.435 . . . . 7.23 110.193 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 35.9 m -151.36 153.18 34.25 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.872 -0.604 . . . . 2.88 110.486 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.567 ' O ' ' HA ' ' A' ' 81' ' ' SER . 12.9 pt-20 -101.77 -26.87 13.32 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.68 -0.691 . . . . 2.8 109.778 177.603 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 40.1 mmtm -75.19 115.74 15.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.546 0.688 . . . . 1.19 111.039 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.642 HD23 ' H ' ' A' ' 9' ' ' ARG . 2.1 tt -115.19 158.71 21.88 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 114.651 -1.158 . . . . 1.18 108.178 179.282 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.642 ' H ' HD23 ' A' ' 8' ' ' LEU . 48.8 ttt180 -137.53 130.8 30.83 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 108.61 -0.885 . . . . 1.06 108.61 175.153 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.442 ' N ' ' HZ ' ' A' ' 80' ' ' PHE . . . -144.78 155.47 43.54 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.244 -0.583 . . . . 0.22 112.419 -178.361 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.608 ' HA ' ' HA ' ' A' ' 76' ' ' ASP . . . -109.67 133.6 52.94 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-N 115.421 -0.808 . . . . 0.2 109.538 176.225 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 37.9 p-80 -139.52 143.51 37.46 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.97 0.414 . . . . 0.23 111.365 -172.146 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.641 ' O ' ' HA ' ' A' ' 112' ' ' HIS . 6.1 tt -111.82 134.84 53.13 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.536 -0.913 . . . . 0.24 108.536 177.159 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.732 HD13 ' CE1' ' A' ' 112' ' ' HIS . 24.4 tp -117.36 122.34 43.6 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.811 0.339 . . . . 0.27 111.224 -178.187 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.569 HG23 HD13 ' A' ' 44' ' ' LEU . 70.5 t -108.57 134.05 51.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 109.786 -0.45 . . . . 0.15 109.786 174.242 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.471 ' HE3' HD21 ' A' ' 14' ' ' LEU . 31.3 mmtp -106.43 149.54 26.94 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.431 -0.581 . . . . 0.62 109.431 176.744 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.448 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 49.6 p90 -138.68 161.32 37.46 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.721 0.296 . . . . 0.25 110.749 -179.027 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.568 ' HB3' ' HA ' ' A' ' 33' ' ' ALA . 59.8 p -52.62 109.8 0.44 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.849 -0.614 . . . . 1.04 111.094 -179.173 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 97.8 9.46 54.4 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.63 -0.795 . . . . 0.53 113.769 177.647 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.441 ' C ' ' H ' ' A' ' 22' ' ' ASN . 88.9 p -91.6 48.67 1.49 Allowed 'General case' 0 C--O 1.235 0.321 0 CA-C-N 118.293 1.047 . . . . 0.7 110.903 -177.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 71.27 -34.46 0.3 Allowed 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.531 0.732 . . . . 3.49 111.537 -178.376 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.441 ' H ' ' C ' ' A' ' 20' ' ' SER . 41.5 m-80 -142.99 91.1 7.25 Favored Pre-proline 0 C--N 1.328 -0.367 0 N-CA-C 110.387 -0.227 . . . . 1.77 110.387 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.412 ' C ' HG22 ' A' ' 32' ' ' THR . 16.7 Cg_exo -73.99 54.81 3.24 Favored 'Trans proline' 0 CA--C 1.534 0.523 0 C-N-CA 123.408 2.739 . . . . 1.71 113.07 179.435 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.462 ' N ' HG22 ' A' ' 32' ' ' THR . 64.4 t -146.83 117.67 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 109.302 -0.629 . . . . 0.48 109.302 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 42.1 t -106.45 151.74 24.55 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 110.344 -0.243 . . . . 1.12 110.344 178.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.588 ' HB2' ' HA ' ' A' ' 67' ' ' ASP . 7.5 mpt_? -65.61 -14.71 61.71 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.994 0.426 . . . . 2.54 109.894 170.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.52 ' HG3' ' HD3' ' A' ' 65' ' ' ARG . 23.9 ttp180 -66.86 -38.94 87.29 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.404 -0.817 . . . . 1.77 109.471 177.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 33.2 p -105.42 -35.14 7.6 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-O 121.433 0.635 . . . . 0.67 110.979 -176.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 72.92 8.15 72.48 Favored Glycine 0 N--CA 1.451 -0.325 0 CA-C-N 115.419 -0.81 . . . . 0.82 112.054 -178.156 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -131.03 -70.07 0.61 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.964 0.412 . . . . 2.1 110.312 -178.45 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.404 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 11.0 p -154.54 157.65 38.63 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.16 -0.473 . . . . 1.08 110.584 177.565 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.462 HG22 ' N ' ' A' ' 24' ' ' VAL . 10.1 t -125.11 28.0 6.51 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 122.082 0.944 . . . . 0.34 109.66 172.815 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.568 ' HA ' ' HB3' ' A' ' 18' ' ' SER . . . -69.27 -5.53 23.6 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 114.979 -1.009 . . . . 0.37 111.893 178.636 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -85.57 -25.18 26.88 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.833 -0.621 . . . . 2.21 110.754 -178.193 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.456 HG13 ' OG1' ' A' ' 32' ' ' THR . 0.2 OUTLIER -109.75 135.16 49.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.647 -0.706 . . . . 0.31 110.47 -175.547 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 41.7 p -92.19 178.73 5.77 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 109.743 -0.466 . . . . 0.39 109.743 -178.039 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.511 ' O ' HG13 ' A' ' 41' ' ' ILE . 18.6 p90 -62.16 -29.63 70.48 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 119.885 -0.726 . . . . 1.53 109.57 177.336 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -72.39 -48.36 42.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.12 -0.491 . . . . 0.96 110.446 177.392 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -64.22 -29.04 70.16 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.317 0.579 . . . . 0.91 109.705 178.51 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.448 ' HB2' ' HB3' ' A' ' 17' ' ' PHE . . . -72.62 -46.34 54.59 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.09 -0.959 . . . . 0.19 110.696 177.838 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.511 HG13 ' O ' ' A' ' 37' ' ' TYR . 97.0 mt -62.41 -38.13 80.51 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 N-CA-C 109.635 -0.506 . . . . 0.3 109.635 175.483 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.455 ' O ' ' HG3' ' A' ' 46' ' ' LYS . 82.6 tttt -60.87 -29.68 69.69 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.455 -0.793 . . . . 2.32 110.162 178.216 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -87.62 -47.53 8.62 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.687 -0.688 . . . . 1.02 110.091 -177.116 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.94 HD23 HG23 ' A' ' 104' ' ' ILE . 35.5 tp -58.67 -38.57 78.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.896 -0.593 . . . . 0.17 109.743 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.451 ' HG2' HG13 ' A' ' 104' ' ' ILE . 2.2 mm100 -62.63 -35.96 81.26 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.94 -0.573 . . . . 0.87 112.165 178.602 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.455 ' HG3' ' O ' ' A' ' 42' ' ' LYS . 68.8 mttm -70.78 -45.81 64.04 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.741 0.305 . . . . 1.31 110.77 -178.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 51.0 m95 -67.9 -44.34 77.2 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.98 -0.288 . . . . 0.52 110.468 177.231 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 40.9 t -57.03 -33.5 67.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.024 0.44 . . . . 0.82 110.219 174.68 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.415 ' HB2' ' O ' ' A' ' 45' ' ' GLN . 12.1 tt0 -68.03 -54.38 18.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 0.53 110.294 177.578 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.614 ' HB3' HG22 ' A' ' 56' ' ' VAL . 87.6 mtt180 -60.23 -45.24 93.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.96 -0.564 . . . . 0.42 111.594 -178.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.41 HG21 ' CD2' ' A' ' 58' ' ' PHE . 97.2 mt -59.42 -40.69 82.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 120.997 0.427 . . . . 0.2 110.727 177.14 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.49 -38.42 71.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.152 -0.476 . . . . 0.27 111.615 -179.273 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 58.1 p -78.22 -30.78 48.98 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.055 0.455 . . . . 0.35 110.947 -179.174 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 106.68 3.0 37.32 Favored Glycine 0 N--CA 1.445 -0.725 0 N-CA-C 111.574 -0.61 . . . . 0.3 111.574 -179.075 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.408 ' HB3' ' HB3' ' A' ' 50' ' ' ARG . 5.6 tt0 -55.57 -46.68 77.18 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 122.803 0.441 . . . . 0.65 110.784 177.875 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.614 HG22 ' HB3' ' A' ' 50' ' ' ARG . 11.9 m -134.78 155.33 38.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 109.472 -0.566 . . . . 0.19 109.472 170.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.5 m -77.8 155.8 30.88 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.266 -0.642 . . . . 0.97 109.266 178.455 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.41 ' CD2' HG21 ' A' ' 51' ' ' ILE . 2.2 t80 -54.3 -40.01 67.52 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.184 -0.673 . . . . 0.22 109.184 177.643 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -57.94 -44.8 87.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.892 -1.049 . . . . 1.72 111.671 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -64.11 -45.68 87.52 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.863 0.363 . . . . 2.09 111.11 -175.27 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -70.56 -43.66 69.02 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.42 -0.354 . . . . 0.26 110.896 -179.199 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.84 -46.02 89.85 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.248 0.462 . . . . 0.24 112.248 -175.733 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.496 ' HA ' ' O ' ' A' ' 71' ' ' TYR . 21.7 m -59.2 -19.73 47.93 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 112.907 0.706 . . . . 1.0 112.907 -177.138 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.412 ' O ' ' HA ' ' A' ' 27' ' ' ARG . 35.7 mt-30 -110.69 -45.65 3.47 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.48 0.657 . . . . 0.61 110.988 -178.182 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.52 ' HD3' ' HG3' ' A' ' 27' ' ' ARG . 25.6 mmt180 -92.35 -38.43 12.04 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 114.929 -1.032 . . . . 0.86 113.278 -170.772 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.456 ' HB2' ' HG ' ' A' ' 13' ' ' LEU . 21.6 t -63.31 124.62 21.7 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.028 0.442 . . . . 0.82 110.889 -178.624 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.588 ' HA ' ' HB2' ' A' ' 26' ' ' ARG . 22.8 t70 -80.99 -10.49 59.7 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.741 -0.663 . . . . 2.28 111.11 177.644 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 48.3 t -80.24 158.59 26.16 Favored 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 120.132 -0.627 . . . . 1.52 109.608 179.051 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -60.3 -12.06 23.0 Favored Glycine 0 N--CA 1.454 -0.108 0 CA-C-N 115.014 -0.994 . . . . 0.26 113.122 -174.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 70.5 p -69.6 -10.15 57.01 Favored 'General case' 0 N--CA 1.448 -0.565 0 O-C-N 123.052 -0.087 . . . . 0.32 110.984 176.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.496 ' O ' ' HA ' ' A' ' 63' ' ' SER . 12.8 p90 -57.42 -31.01 65.43 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 109.617 -0.512 . . . . 0.54 109.617 174.013 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -95.35 2.63 54.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.141 0.496 . . . . 0.49 110.626 179.619 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 5.0 m -116.37 -2.03 12.17 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.913 -0.585 . . . . 0.71 111.284 -175.603 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 86.11 20.01 56.16 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.722 -0.751 . . . . 0.54 112.233 -177.375 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 86.34 -29.34 4.84 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 121.092 -0.575 . . . . 0.35 112.639 178.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.608 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 8.1 p-10 -89.41 144.93 25.68 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-O 121.573 0.702 . . . . 1.65 111.397 -175.538 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.438 ' O ' ' HG3' ' A' ' 9' ' ' ARG . 1.7 mp -106.34 175.74 5.4 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 114.635 -1.166 . . . . 0.94 110.131 178.612 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -82.76 -147.18 6.67 Favored Glycine 0 C--N 1.317 -0.509 0 C-N-CA 121.033 -0.604 . . . . 0.44 112.497 179.313 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -99.16 124.19 44.01 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.109 0.48 . . . . 3.87 110.807 -178.56 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.442 ' HZ ' ' N ' ' A' ' 10' ' ' ALA . 1.1 p90 -134.36 138.5 44.94 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.46 -0.791 . . . . 1.31 110.425 -177.009 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.567 ' HA ' ' O ' ' A' ' 6' ' ' GLU . 18.6 m -68.06 129.67 40.62 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.703 -0.481 . . . . 1.17 109.703 177.585 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 17.8 m -49.47 121.47 5.11 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.8 -0.636 . . . . 1.19 111.832 -174.345 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 111.09 3.21 28.02 Favored Glycine 0 N--CA 1.452 -0.289 0 CA-C-N 115.847 -0.615 . . . . 0.79 112.148 -177.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -91.7 26.31 2.4 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.945 0.402 . . . . 1.55 111.304 -175.304 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 26.5 mmt -122.13 -131.78 0.28 Allowed 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 109.687 -0.486 . . . . 0.73 109.687 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 5.1 mpp? -91.97 -93.3 0.14 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.939 0.4 . . . . 1.39 109.931 177.521 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.499 ' H ' ' HD2' ' A' ' 88' ' ' PRO . 27.8 ttpp -163.58 -56.43 0.01 OUTLIER Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 115.852 -0.613 . . . . 2.37 110.026 175.262 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.499 ' HD2' ' H ' ' A' ' 87' ' ' LYS . 60.5 Cg_endo -70.14 -30.0 21.16 Favored 'Trans proline' 0 C--N 1.359 1.097 0 C-N-CA 121.923 1.749 . . . . 0.27 111.096 178.373 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.644 ' O ' HG23 ' A' ' 93' ' ' VAL . 20.1 t80 -61.66 -56.44 19.76 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.631 -1.168 . . . . 0.22 109.762 176.468 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.8 tm-20 -64.36 -36.85 85.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.493 -0.776 . . . . 2.12 110.165 -179.38 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -53.54 -33.52 54.89 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.354 -0.839 . . . . 0.61 110.964 175.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.435 ' O ' ' HG ' ' A' ' 96' ' ' LEU . . . -84.35 -34.36 23.67 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.359 -0.382 . . . . 0.22 111.298 177.789 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.644 HG23 ' O ' ' A' ' 89' ' ' PHE . 35.7 t -62.72 -44.52 99.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-O 121.417 0.627 . . . . 0.25 110.596 -177.678 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 38.3 ptt180 -73.47 -11.29 60.41 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.612 -0.722 . . . . 2.59 110.748 178.594 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -96.86 14.64 24.61 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.328 -0.396 . . . . 0.47 111.815 -173.13 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.539 ' HB2' ' HB2' ' A' ' 100' ' ' ASP . 0.5 OUTLIER -148.17 155.75 41.77 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.022 0.439 . . . . 0.28 110.857 177.395 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.58 ' HA ' ' NH2' ' A' ' 116' ' ' ARG . 23.8 tptm -92.25 162.73 14.18 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.789 -0.641 . . . . 1.61 109.517 179.294 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.517 ' HA ' ' HG2' ' A' ' 116' ' ' ARG . 66.2 mt -42.63 114.33 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.974 0.416 . . . . 0.9 111.241 171.52 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 103.3 -8.87 53.31 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.804 -0.712 . . . . 0.46 113.449 178.283 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.539 ' HB2' ' HB2' ' A' ' 96' ' ' LEU . 18.4 m-20 -97.24 135.82 38.62 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 117.23 0.515 . . . . 0.46 110.383 179.121 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.483 HG12 ' HB3' ' A' ' 115' ' ' LYS . 8.3 mt -103.98 149.72 7.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.946 -0.57 . . . . 0.23 109.902 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 93.4 p -91.46 159.62 38.57 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 116.095 -0.502 . . . . 0.92 110.914 -177.124 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -71.22 166.55 28.88 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 122.383 2.055 . . . . 0.34 111.342 170.381 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.94 HG23 HD23 ' A' ' 44' ' ' LEU . 25.7 mm -47.57 112.7 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 O-C-N 123.547 0.53 . . . . 0.2 111.793 176.629 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 1.9 p -118.47 124.8 73.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.154 -0.475 . . . . 1.04 109.961 175.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -85.51 151.32 24.04 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.0 0.429 . . . . 0.55 110.285 178.539 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 10.9 p -131.3 -172.21 2.79 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.942 -0.572 . . . . 0.37 110.855 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -55.5 -48.16 75.06 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.893 -0.594 . . . . 2.16 111.928 -179.601 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.462 ' OG ' ' HE2' ' A' ' 16' ' ' LYS . 4.8 t -106.98 -3.93 19.58 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.791 0.663 . . . . 1.09 112.791 -172.306 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 172.68 -128.59 1.56 Allowed Glycine 0 N--CA 1.439 -1.15 0 C-N-CA 118.984 -1.579 . . . . 0.24 113.615 173.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.879 ' HB3' HD22 ' A' ' 44' ' ' LEU . 7.4 mp -126.4 151.0 48.26 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 114.976 -0.612 . . . . 0.19 110.961 -170.2 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' HIS . . . . . 0.732 ' CE1' HD13 ' A' ' 14' ' ' LEU . 74.9 m80 -146.48 149.99 34.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.378 0.608 . . . . 0.22 112.53 178.309 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.632 HG12 HD11 ' A' ' 44' ' ' LEU . 2.9 pt -128.07 137.43 57.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 107.351 -1.351 . . . . 0.17 107.351 158.39 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 2.6 mp -130.57 144.02 39.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 C-N-CA 120.736 -0.386 . . . . 0.18 110.85 -175.213 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.483 ' HB3' HG12 ' A' ' 101' ' ' ILE . 39.2 pttt -127.2 142.19 51.55 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.655 -0.868 . . . . 0.61 108.655 172.428 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.58 ' NH2' ' HA ' ' A' ' 97' ' ' LYS . 3.1 ttp180 -79.81 134.77 36.36 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.295 0.569 . . . . 1.87 111.095 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -102.66 -32.42 9.88 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.144 -0.935 . . . . 0.89 109.922 178.215 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.576 ' OXT' ' HD2' ' A' ' 116' ' ' ARG . . . . . . . . 0 C--O 1.246 0.888 0 CA-C-O 118.368 -0.825 . . . . 1.1 110.401 178.434 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 24.0 ttt . . . . . 0 N--CA 1.48 1.064 0 CA-C-O 120.901 0.382 . . . . 7.23 110.906 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 2.5 p -75.21 -33.3 61.38 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.151 -0.477 . . . . 2.88 112.079 -174.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -86.26 98.13 10.78 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.834 0.349 . . . . 2.8 110.594 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.48 ' HD2' ' HB3' ' A' ' 79' ' ' PHE . 60.1 mmtt -142.12 113.78 7.89 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.359 0.6 . . . . 1.19 110.798 178.774 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.684 HD23 ' H ' ' A' ' 9' ' ' ARG . 1.3 tt -114.9 161.23 18.54 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 108.162 -1.051 . . . . 1.18 108.162 178.139 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.684 ' H ' HD23 ' A' ' 8' ' ' LEU . 48.2 ttt180 -141.45 128.61 20.91 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.082 -0.71 . . . . 1.06 109.082 175.704 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.441 ' O ' ' HB2' ' A' ' 77' ' ' LEU . . . -146.97 158.74 44.01 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 119.97 -0.692 . . . . 0.22 112.143 -178.459 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.495 ' HB3' ' HG2' ' A' ' 115' ' ' LYS . . . -106.73 135.75 47.73 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.641 -0.708 . . . . 0.2 109.177 177.521 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 2.0 p80 -138.71 140.12 38.64 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 120.37 -0.532 . . . . 0.23 111.463 -171.478 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.546 ' HG ' ' HB3' ' A' ' 66' ' ' SER . 7.0 tt -111.71 143.28 42.88 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.493 -0.929 . . . . 0.24 108.493 175.557 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.786 HD13 ' CE1' ' A' ' 112' ' ' HIS . 23.9 tp -129.61 120.4 25.19 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.768 0.318 . . . . 0.27 111.097 -177.028 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.51 HG23 HD13 ' A' ' 44' ' ' LEU . 37.5 t -106.98 132.39 54.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 109.379 -0.6 . . . . 0.15 109.379 175.456 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.649 ' HE2' ' OG ' ' A' ' 109' ' ' SER . 31.7 mmtp -106.21 154.37 20.81 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.837 -0.431 . . . . 0.62 109.837 177.61 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -149.19 160.95 42.92 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.056 -0.52 . . . . 0.25 110.353 -176.122 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 5.6 t -54.27 109.49 0.49 Allowed 'General case' 0 N--CA 1.432 -1.327 0 CA-C-N 116.392 -0.367 . . . . 1.04 110.071 174.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 105.74 9.61 32.45 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.502 -0.856 . . . . 0.53 112.759 -178.235 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.49 ' HB2' ' O ' ' A' ' 109' ' ' SER . 78.3 p -95.03 39.44 1.11 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 117.258 0.529 . . . . 0.7 111.202 -176.71 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.424 ' HB3' ' O ' ' A' ' 20' ' ' SER . 54.8 ttt180 74.77 -34.29 0.26 Allowed 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.286 0.634 . . . . 3.49 111.045 179.399 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -151.06 114.07 3.12 Favored Pre-proline 0 C--N 1.324 -0.521 0 N-CA-C 109.265 -0.643 . . . . 1.77 109.265 172.296 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.43 ' C ' HG22 ' A' ' 32' ' ' THR . 89.9 Cg_endo -83.61 64.12 7.42 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 122.594 2.196 . . . . 1.71 112.88 -172.747 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.482 ' N ' HG22 ' A' ' 32' ' ' THR . 47.0 t -147.9 116.17 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 C-N-CA 122.855 0.462 . . . . 0.48 109.851 179.406 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.435 ' HB3' ' HB2' ' A' ' 16' ' ' LYS . 28.7 p -105.63 158.47 16.68 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 110.585 -0.154 . . . . 1.12 110.585 175.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.585 ' HB2' ' HA ' ' A' ' 67' ' ' ASP . 5.6 mpt_? -71.05 -4.0 22.68 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.111 0.481 . . . . 2.54 110.216 171.525 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.574 ' HG3' ' CD ' ' A' ' 65' ' ' ARG . 22.0 ttp180 -76.26 -40.1 52.73 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.706 -0.679 . . . . 1.77 109.362 175.86 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 59.8 p -103.19 -35.8 8.34 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.707 -0.679 . . . . 0.67 111.035 -176.581 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 80.95 -28.31 2.89 Favored Glycine 0 CA--C 1.52 0.365 0 CA-C-N 115.963 -0.562 . . . . 0.82 112.21 -179.173 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -98.48 -71.21 0.7 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.839 0.352 . . . . 2.1 110.64 -178.618 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 44.7 m -154.11 156.7 37.74 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.109 -0.496 . . . . 1.08 110.212 177.016 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.482 HG22 ' N ' ' A' ' 24' ' ' VAL . 8.9 t -123.22 35.5 4.85 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 122.29 1.043 . . . . 0.34 109.695 178.285 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -77.67 -4.58 46.83 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.833 -1.076 . . . . 0.37 111.528 -176.435 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -96.76 1.21 50.58 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.798 -0.637 . . . . 2.21 110.747 -178.082 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.46 HG23 ' HB2' ' A' ' 39' ' ' ASP . 0.2 OUTLIER -129.46 134.75 63.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.685 -0.689 . . . . 0.31 109.787 -179.955 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 41.2 p -96.49 -176.19 3.55 Favored 'General case' 0 CA--C 1.513 -0.468 0 N-CA-C 109.487 -0.56 . . . . 0.39 109.487 -178.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.543 ' O ' HG13 ' A' ' 41' ' ' ILE . 0.2 OUTLIER -67.93 -22.8 65.04 Favored 'General case' 0 C--O 1.219 -0.532 0 C-N-CA 118.883 -1.127 . . . . 1.53 110.036 173.583 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -68.82 -49.3 59.6 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.761 -0.459 . . . . 0.96 109.761 174.021 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.46 ' HB2' HG23 ' A' ' 35' ' ' VAL . 8.4 m-20 -66.54 -32.44 73.79 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.368 0.604 . . . . 0.91 109.967 177.703 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.428 ' HB3' ' HA ' ' A' ' 37' ' ' TYR . . . -71.85 -40.91 68.7 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.272 -0.876 . . . . 0.19 110.832 179.383 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.543 HG13 ' O ' ' A' ' 37' ' ' TYR . 61.8 mt -62.3 -34.67 65.35 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.312 0 N-CA-C 109.316 -0.624 . . . . 0.3 109.316 173.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.421 ' O ' ' HG3' ' A' ' 46' ' ' LYS . 19.7 mtpt -65.34 -21.28 66.68 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 116.336 -0.393 . . . . 2.32 111.085 176.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.447 ' HG3' ' CD1' ' A' ' 47' ' ' TRP . 1.6 tp10 -87.85 -57.61 2.87 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.34 -0.615 . . . . 1.02 109.34 178.187 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.934 HD23 HG23 ' A' ' 104' ' ' ILE . 23.8 tp -57.93 -38.89 76.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 114.965 -1.016 . . . . 0.17 111.101 -175.722 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.516 ' HB2' ' O ' ' A' ' 41' ' ' ILE . 3.6 mm-40 -66.22 -28.66 68.91 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 112.047 0.388 . . . . 0.87 112.047 -178.425 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.421 ' HG3' ' O ' ' A' ' 42' ' ' LYS . 66.4 mttm -77.56 -45.02 26.6 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.986 -0.376 . . . . 1.31 109.986 178.858 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.447 ' CD1' ' HG3' ' A' ' 43' ' ' GLU . 58.2 m95 -66.11 -45.5 80.94 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.249 -0.432 . . . . 0.52 111.695 177.706 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.567 ' HB3' HG21 ' A' ' 113' ' ' ILE . 96.0 p -65.22 -23.82 67.18 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.957 0.408 . . . . 0.82 109.989 177.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.473 ' HB2' ' O ' ' A' ' 45' ' ' GLN . 10.1 tt0 -73.3 -56.68 4.75 Favored 'General case' 0 C--O 1.223 -0.337 0 CA-C-N 116.094 -0.503 . . . . 0.53 109.776 173.691 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.618 ' HB3' HG22 ' A' ' 56' ' ' VAL . 92.4 mtt180 -61.1 -41.7 97.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.77 -0.65 . . . . 0.42 111.81 -176.136 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.495 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 98.2 mt -60.7 -36.42 70.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.367 -0.378 . . . . 0.2 110.496 176.437 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -77.64 -36.95 51.0 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.243 -0.435 . . . . 0.27 111.692 178.04 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.473 ' OG ' ' HA ' ' A' ' 50' ' ' ARG . 67.9 p -79.09 -29.8 43.5 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 111.76 0.282 . . . . 0.35 111.76 -175.347 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 109.15 1.37 31.54 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.671 -0.776 . . . . 0.3 112.318 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.439 ' HB2' ' HB3' ' A' ' 50' ' ' ARG . 43.5 mt-10 -61.97 -50.97 69.97 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.882 0.372 . . . . 0.65 110.509 178.721 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.618 HG22 ' HB3' ' A' ' 50' ' ' ARG . 16.2 m -134.8 152.4 32.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 109.564 -0.532 . . . . 0.19 109.564 174.285 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 19.5 m -82.39 160.15 22.85 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.542 -0.54 . . . . 0.97 109.542 178.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.427 ' HA ' ' CD1' ' A' ' 51' ' ' ILE . 2.6 t80 -54.95 -39.8 69.3 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.412 0.625 . . . . 0.22 109.74 -178.632 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -55.79 -45.56 78.17 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.541 -1.209 . . . . 1.72 111.351 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.455 ' O ' ' HG3' ' A' ' 64' ' ' GLN . 3.9 mm-40 -65.64 -47.83 74.24 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.964 -0.562 . . . . 2.09 111.177 -173.154 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -67.25 -38.44 85.15 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.369 -0.378 . . . . 0.26 110.845 -179.151 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.37 -53.18 58.73 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.131 -0.486 . . . . 0.24 111.331 -178.648 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.553 ' HA ' ' O ' ' A' ' 71' ' ' TYR . 47.6 m -51.58 -29.56 17.68 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.892 0.701 . . . . 1.0 112.892 -177.337 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.455 ' HG3' ' O ' ' A' ' 60' ' ' GLU . 19.1 mt-30 -97.33 -50.48 4.53 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.738 0.78 . . . . 0.61 110.708 -177.536 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.574 ' CD ' ' HG3' ' A' ' 27' ' ' ARG . 19.1 mmt180 -93.57 -40.26 10.39 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 114.55 -1.205 . . . . 0.86 113.386 -166.18 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.546 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 38.7 p -63.84 121.52 14.23 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.106 0.479 . . . . 0.82 111.177 -174.029 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.585 ' HA ' ' HB2' ' A' ' 26' ' ' ARG . 31.5 t70 -74.66 -15.08 60.82 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.571 -0.741 . . . . 2.28 110.813 177.13 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.505 ' SG ' ' HB2' ' A' ' 66' ' ' SER . 5.2 p -77.57 150.34 34.74 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.94 -0.573 . . . . 1.52 110.556 -179.505 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -53.82 -18.04 7.83 Favored Glycine 0 C--N 1.329 0.176 0 CA-C-N 114.823 -1.08 . . . . 0.26 114.742 -171.675 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 77.9 p -73.06 0.32 11.78 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 117.293 0.546 . . . . 0.32 111.907 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.553 ' O ' ' HA ' ' A' ' 63' ' ' SER . 54.8 p90 -52.97 -41.27 64.41 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.767 0.318 . . . . 0.54 110.295 174.045 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -95.14 2.68 55.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.045 0.45 . . . . 0.49 110.983 -179.06 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 5.3 m -103.37 -6.78 21.59 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.076 -0.511 . . . . 0.71 110.735 -178.274 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 90.61 19.85 42.95 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.891 -0.671 . . . . 0.54 112.181 -177.299 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 84.7 -31.83 3.53 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 121.044 -0.598 . . . . 0.35 112.697 179.104 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.466 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 6.9 p-10 -83.04 145.2 29.43 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-O 121.672 0.749 . . . . 1.65 111.224 -176.031 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.441 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 16.6 mt -105.43 175.74 5.4 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 114.399 -1.273 . . . . 0.94 110.388 179.745 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -87.43 -152.38 22.95 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 121.234 -0.508 . . . . 0.44 112.014 177.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.48 ' HB3' ' HD2' ' A' ' 7' ' ' LYS . 91.6 m-85 -96.16 124.11 40.04 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.27 0.557 . . . . 3.87 110.988 179.498 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.42 ' HZ ' ' N ' ' A' ' 10' ' ' ALA . 1.0 OUTLIER -134.44 160.2 38.72 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.491 -0.777 . . . . 1.31 110.45 -176.214 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 40.8 p -89.22 126.59 35.55 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 109.598 -0.519 . . . . 1.17 109.598 178.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 17.2 m -56.57 122.67 12.55 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.305 -0.407 . . . . 1.19 111.093 -178.373 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 113.23 6.85 21.81 Favored Glycine 0 N--CA 1.445 -0.708 0 N-CA-C 111.533 -0.627 . . . . 0.79 111.533 -179.005 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -112.82 10.55 19.15 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.135 0.493 . . . . 1.55 110.446 -178.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 23.6 mmt -99.17 -108.8 0.19 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.027 0.441 . . . . 0.73 110.642 178.47 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 56.7 mtt -134.69 150.5 50.63 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 107.88 -1.155 . . . . 1.39 107.88 175.398 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.403 ' HB2' ' HD3' ' A' ' 88' ' ' PRO . 14.4 mmmm -54.05 -53.19 61.27 Favored Pre-proline 0 C--N 1.32 -0.697 0 N-CA-C 112.518 0.562 . . . . 2.37 112.518 -175.142 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.442 ' HG2' HG22 ' A' ' 107' ' ' THR . 64.2 Cg_endo -75.16 -25.18 11.87 Favored 'Trans proline' 0 C--N 1.355 0.902 0 C-N-CA 121.561 1.507 . . . . 0.27 112.152 -177.866 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.514 ' O ' HG23 ' A' ' 93' ' ' VAL . 27.0 t80 -72.88 -55.78 6.14 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.475 -0.784 . . . . 0.22 109.723 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -60.41 -36.19 77.56 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.263 -0.88 . . . . 2.12 110.214 -179.39 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.566 ' HA ' ' CZ ' ' A' ' 94' ' ' ARG . 26.6 t70 -56.38 -32.97 65.28 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.613 -0.721 . . . . 0.61 111.117 177.69 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.475 ' O ' ' HG ' ' A' ' 96' ' ' LEU . . . -82.79 -26.98 31.28 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.381 -0.372 . . . . 0.22 111.037 179.114 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.514 HG23 ' O ' ' A' ' 89' ' ' PHE . 28.0 t -67.36 -45.38 85.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.47 -0.332 . . . . 0.25 111.666 -174.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.566 ' CZ ' ' HA ' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -83.32 -2.49 55.83 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.239 -0.584 . . . . 2.59 110.408 178.262 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -86.5 -2.77 58.75 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.18 0.514 . . . . 0.47 110.339 179.335 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.642 ' HB2' ' HB2' ' A' ' 100' ' ' ASP . 0.7 OUTLIER -136.26 153.61 51.14 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.614 -0.721 . . . . 0.28 110.128 176.785 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.546 ' HG3' ' H ' ' A' ' 98' ' ' ILE . 20.2 tptm -102.42 179.17 4.38 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.128 -0.693 . . . . 1.61 109.128 179.197 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.546 ' H ' ' HG3' ' A' ' 97' ' ' LYS . 65.3 mt -54.81 116.05 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.011 0.434 . . . . 0.9 111.197 179.588 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 104.45 -6.18 45.31 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 121.016 -0.612 . . . . 0.46 112.975 179.494 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.642 ' HB2' ' HB2' ' A' ' 96' ' ' LEU . 31.0 m-20 -98.14 138.86 34.81 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.906 0.353 . . . . 0.46 110.886 -178.253 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 11.2 mt -108.56 147.62 13.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 109.385 -0.598 . . . . 0.23 109.385 178.005 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 88.3 p -91.4 158.11 41.35 Favored Pre-proline 0 C--N 1.321 -0.658 0 CA-C-O 120.667 0.27 . . . . 0.92 110.571 -179.53 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -74.99 175.87 10.66 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.272 1.982 . . . . 0.34 110.94 170.164 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.934 HG23 HD23 ' A' ' 44' ' ' LEU . 21.1 mm -49.0 112.8 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.898 0.38 . . . . 0.2 111.58 176.23 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.4 p -119.24 120.82 64.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.093 0.473 . . . . 1.04 110.078 174.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -85.14 145.25 27.71 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 121.269 0.556 . . . . 0.55 109.995 177.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.442 HG22 ' HG2' ' A' ' 88' ' ' PRO . 8.2 p -120.6 -171.93 2.27 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.349 -0.841 . . . . 0.37 110.886 -176.708 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -54.69 -45.4 73.97 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.811 -0.631 . . . . 2.16 110.723 176.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.649 ' OG ' ' HE2' ' A' ' 16' ' ' LYS . 15.0 t -93.59 -60.81 1.68 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.921 -0.581 . . . . 1.09 111.078 -177.21 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -144.95 -134.85 2.8 Favored Glycine 0 N--CA 1.442 -0.929 0 C-N-CA 118.865 -1.636 . . . . 0.24 113.448 -172.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.903 ' HB3' HD22 ' A' ' 44' ' ' LEU . 6.8 mp -113.19 146.33 39.47 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.204 -0.498 . . . . 0.19 111.116 -172.499 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' HIS . . . . . 0.786 ' CE1' HD13 ' A' ' 14' ' ' LEU . 68.7 m80 -143.23 152.67 41.99 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.459 0.647 . . . . 0.22 112.484 179.35 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.686 HG12 HD11 ' A' ' 44' ' ' LEU . 3.6 pt -131.55 137.42 55.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 107.372 -1.344 . . . . 0.17 107.372 157.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 2.4 mp -127.57 144.17 38.32 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 C-N-CA 120.781 -0.368 . . . . 0.18 110.247 -176.764 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.495 ' HG2' ' HB3' ' A' ' 11' ' ' ALA . 52.0 pttt -127.94 137.25 52.2 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.041 -0.726 . . . . 0.61 109.041 173.866 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.538 ' HB2' ' CD1' ' A' ' 96' ' ' LEU . 65.2 ttt180 -85.49 126.61 33.97 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 120.989 0.424 . . . . 1.87 111.358 -175.62 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.49 HD21 ' HB2' ' A' ' 11' ' ' ALA . 0.7 OUTLIER -97.26 -33.56 11.42 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.594 -0.73 . . . . 0.89 110.625 178.268 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.587 ' HB3' ' HB3' ' A' ' 9' ' ' ARG . . . . . . . . 0 C--O 1.247 0.936 0 CA-C-O 118.736 -0.65 . . . . 1.1 110.662 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 25.4 ptt? . . . . . 0 N--CA 1.478 0.938 0 CA-C-O 120.975 0.417 . . . . 7.23 110.355 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 39.8 t -111.89 -44.42 3.46 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.212 -0.449 . . . . 2.88 111.078 -178.261 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -77.07 -11.77 59.85 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.457 -0.338 . . . . 2.8 110.872 -177.437 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -82.44 130.52 35.12 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.162 0.506 . . . . 1.19 111.315 -175.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.497 HD11 ' CD ' ' A' ' 116' ' ' ARG . 15.3 tp -132.18 171.97 12.99 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.022 -0.99 . . . . 1.18 108.779 -179.673 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 68.2 ttt180 -145.26 132.15 20.17 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 110.178 -0.304 . . . . 1.06 110.178 175.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -148.51 160.31 43.2 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.329 0.585 . . . . 0.22 112.421 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.527 ' HB2' HD21 ' A' ' 117' ' ' LEU . . . -107.47 138.96 42.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.239 -0.892 . . . . 0.2 109.129 176.489 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 20.0 p-80 -139.5 141.68 37.32 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.016 0.436 . . . . 0.23 111.341 -172.476 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.572 ' O ' ' HA ' ' A' ' 112' ' ' HIS . 7.1 tt -113.47 138.39 50.18 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.549 -0.908 . . . . 0.24 108.549 177.226 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.744 HD13 ' CE1' ' A' ' 112' ' ' HIS . 16.6 tp -121.2 137.5 54.65 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.697 0.284 . . . . 0.27 111.501 -179.046 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.434 HG23 HD13 ' A' ' 44' ' ' LEU . 43.8 t -119.66 126.47 75.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.854 -0.612 . . . . 0.15 109.721 172.699 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.609 ' HE3' HD21 ' A' ' 14' ' ' LEU . 28.5 mmtp -103.31 154.82 18.97 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.982 -0.554 . . . . 0.62 109.821 177.171 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -151.67 162.32 41.19 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.133 -0.485 . . . . 0.25 110.127 -176.448 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.455 ' CB ' ' HA ' ' A' ' 33' ' ' ALA . 4.1 t -47.25 110.01 0.26 Allowed 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 122.949 0.499 . . . . 1.04 111.484 177.302 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 93.74 10.47 58.92 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.323 -0.941 . . . . 0.53 113.588 177.531 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.506 ' HB2' ' O ' ' A' ' 109' ' ' SER . 83.4 p -81.84 46.98 1.04 Allowed 'General case' 0 C--O 1.234 0.252 0 CA-C-N 117.684 0.742 . . . . 0.7 111.326 -175.058 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 27.1 ttt180 69.32 -36.29 0.33 Allowed 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.805 0.842 . . . . 3.49 111.115 -179.602 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.475 ' H ' ' C ' ' A' ' 20' ' ' SER . 28.2 m120 -150.92 104.86 3.01 Favored Pre-proline 0 C--N 1.323 -0.576 0 N-CA-C 108.711 -0.848 . . . . 1.77 108.711 174.703 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_exo -64.04 -163.05 0.05 OUTLIER 'Trans proline' 0 CA--C 1.536 0.597 0 C-N-CA 123.172 2.581 . . . . 1.71 112.879 177.312 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.579 ' N ' HG22 ' A' ' 32' ' ' THR . 40.0 t 66.74 119.84 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-O 121.651 0.739 . . . . 0.48 111.596 -175.636 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.7 t -102.0 152.3 21.11 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 115.357 -0.838 . . . . 1.12 109.319 -179.278 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.682 ' CB ' ' HA ' ' A' ' 67' ' ' ASP . 8.6 tpp180 -79.91 -11.41 59.81 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.263 -1.014 . . . . 2.54 108.263 175.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.592 ' HG3' ' HD3' ' A' ' 65' ' ' ARG . 17.2 ttp180 -80.68 -43.65 20.02 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 114.75 -1.113 . . . . 1.77 109.285 173.729 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 32.3 p -91.05 -33.77 15.37 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 116.038 -0.528 . . . . 0.67 111.058 -175.41 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 81.78 -35.39 2.5 Favored Glycine 0 N--CA 1.452 -0.244 0 CA-C-N 116.089 -0.505 . . . . 0.82 113.154 176.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 -99.52 -64.19 1.06 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.757 0.313 . . . . 2.1 110.615 -175.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.1 p -154.08 150.49 28.26 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.308 -0.405 . . . . 1.08 111.608 -178.549 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.579 HG22 ' N ' ' A' ' 24' ' ' VAL . 8.9 t -124.73 14.92 8.7 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.905 0.859 . . . . 0.34 110.095 176.681 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.455 ' HA ' ' CB ' ' A' ' 18' ' ' SER . . . -63.67 -4.42 3.0 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.447 -0.797 . . . . 0.37 113.019 177.033 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 52.3 m-20 -89.88 -25.09 21.17 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.873 0.368 . . . . 2.21 110.538 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.435 HG13 ' OG1' ' A' ' 32' ' ' THR . 0.2 OUTLIER -102.29 139.22 23.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.989 -0.55 . . . . 0.31 110.081 -178.568 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.413 ' H ' ' HB2' ' A' ' 39' ' ' ASP . 25.3 p -100.02 -178.62 3.9 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 116.107 -0.497 . . . . 0.39 110.395 -175.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.494 ' O ' HG13 ' A' ' 41' ' ' ILE . 11.6 p90 -62.95 -30.78 71.83 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.517 -0.473 . . . . 1.53 109.872 177.223 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -72.66 -45.32 59.53 Favored 'General case' 0 CA--C 1.52 -0.173 0 CA-C-N 116.418 -0.355 . . . . 0.96 110.545 179.005 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.413 ' HB2' ' H ' ' A' ' 36' ' ' THR . 0.7 OUTLIER -67.35 -28.17 67.74 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-O 121.167 0.508 . . . . 0.91 110.345 176.389 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -69.34 -43.93 72.66 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.376 -0.829 . . . . 0.19 110.337 175.563 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.507 HG12 HD21 ' A' ' 111' ' ' LEU . 97.9 mt -62.65 -38.39 81.45 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.412 0 N-CA-C 109.529 -0.545 . . . . 0.3 109.529 173.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 3.5 ttpm? -61.16 -25.99 67.39 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.342 -0.844 . . . . 2.32 109.919 179.041 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.492 ' HG3' ' CD1' ' A' ' 47' ' ' TRP . 3.1 tp10 -87.99 -51.68 5.68 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.605 -0.725 . . . . 1.02 109.927 -178.444 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.967 HD22 ' HB3' ' A' ' 111' ' ' LEU . 33.0 tp -61.26 -37.85 84.6 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.421 -0.808 . . . . 0.17 110.573 -175.836 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.54 ' O ' ' HB2' ' A' ' 49' ' ' GLN . 3.5 mm100 -65.27 -26.57 68.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.19 -0.459 . . . . 0.87 112.077 -178.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.41 ' O ' ' HB3' ' A' ' 49' ' ' GLN . 68.5 mttm -81.29 -45.24 16.51 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.911 0.386 . . . . 1.31 110.41 178.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.492 ' CD1' ' HG3' ' A' ' 43' ' ' GLU . 42.9 m95 -65.36 -46.35 80.52 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.474 -0.33 . . . . 0.52 111.556 177.617 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.57 ' HB3' HG21 ' A' ' 113' ' ' ILE . 83.8 p -65.27 -22.49 66.86 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.11 0.481 . . . . 0.82 110.16 177.393 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.54 ' HB2' ' O ' ' A' ' 45' ' ' GLN . 11.2 tt0 -72.09 -56.9 4.81 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 115.762 -0.654 . . . . 0.53 109.753 174.886 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.633 ' HB3' HG22 ' A' ' 56' ' ' VAL . 97.0 mtt180 -61.42 -41.82 97.77 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.574 -0.739 . . . . 0.42 111.611 -176.462 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.518 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 92.3 mt -62.05 -35.17 67.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.212 -0.449 . . . . 0.2 110.738 177.368 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -79.59 -36.83 37.52 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.098 -0.501 . . . . 0.27 111.615 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 47.8 p -79.39 -29.78 42.2 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.794 0.33 . . . . 0.35 111.591 -175.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 108.63 5.89 31.27 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.6 -0.81 . . . . 0.3 112.142 -179.347 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.423 ' HB2' ' HB3' ' A' ' 50' ' ' ARG . 37.1 mt-10 -65.3 -47.89 75.02 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.931 0.396 . . . . 0.65 110.117 178.557 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.633 HG22 ' HB3' ' A' ' 50' ' ' ARG . 14.5 m -136.53 156.44 35.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 109.679 -0.489 . . . . 0.19 109.679 172.241 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.7 m -81.01 161.54 24.2 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.696 -0.483 . . . . 0.97 109.696 177.318 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -57.66 -42.53 83.69 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.025 -0.731 . . . . 0.22 109.025 177.003 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.46 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 38.6 mt-10 -57.47 -41.16 80.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.891 -1.05 . . . . 1.72 111.649 179.604 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -66.51 -45.72 78.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.128 0.49 . . . . 2.09 110.637 -178.13 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -71.09 -46.06 62.52 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.077 -0.511 . . . . 0.26 111.267 -179.034 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.69 -50.48 73.7 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.58 0.585 . . . . 0.24 112.58 -174.108 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.57 ' HA ' ' O ' ' A' ' 71' ' ' TYR . 67.5 m -55.83 -25.0 39.76 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 113.132 0.79 . . . . 1.0 113.132 -177.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -105.85 -44.57 4.6 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.275 0.56 . . . . 0.61 111.152 -177.247 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.592 ' HD3' ' HG3' ' A' ' 27' ' ' ARG . 22.6 mmt180 -96.69 -36.59 10.63 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 114.015 1.117 . . . . 0.86 114.015 -169.144 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.514 ' HB2' ' HG ' ' A' ' 13' ' ' LEU . 31.7 t -62.48 119.54 9.34 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.977 0.418 . . . . 0.82 110.623 -178.605 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.682 ' HA ' ' CB ' ' A' ' 26' ' ' ARG . 68.6 m-20 -79.05 -4.9 52.47 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.729 -0.669 . . . . 2.28 110.749 179.149 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.53 ' SG ' HD22 ' A' ' 14' ' ' LEU . 1.4 m -81.04 161.27 24.27 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.503 0.668 . . . . 1.52 110.888 173.091 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -63.2 -17.64 59.47 Favored Glycine 0 CA--C 1.516 0.149 0 CA-C-N 114.328 -1.306 . . . . 0.26 114.119 -173.387 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.503 ' HB2' ' CA ' ' A' ' 75' ' ' GLY . 2.3 p -67.01 -6.69 18.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 117.207 0.503 . . . . 0.32 112.283 177.787 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.57 ' O ' ' HA ' ' A' ' 63' ' ' SER . 35.2 p90 -52.03 -33.51 38.92 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.136 0.494 . . . . 0.54 110.396 174.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -92.36 1.57 57.15 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.058 0.456 . . . . 0.49 110.991 -176.574 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.6 m -115.58 -21.9 9.5 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.147 0.499 . . . . 0.71 110.709 -178.331 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.46 ' O ' ' HA ' ' A' ' 59' ' ' GLU . . . 108.04 15.7 14.0 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.906 -0.664 . . . . 0.54 112.02 -175.792 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.503 ' CA ' ' HB2' ' A' ' 70' ' ' SER . . . 96.65 -9.2 66.43 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.803 -0.713 . . . . 0.35 112.885 178.195 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -95.54 145.32 25.3 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.633 0.73 . . . . 1.65 111.559 -169.701 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -111.96 172.51 6.86 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 114.54 -1.209 . . . . 0.94 108.89 171.32 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -92.22 -145.71 16.65 Favored Glycine 0 C--N 1.311 -0.829 0 C-N-CA 120.65 -0.786 . . . . 0.44 111.905 -178.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -84.37 140.02 31.86 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.915 -0.402 . . . . 3.87 109.915 177.226 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -152.98 155.6 37.26 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.836 -0.62 . . . . 1.31 110.028 -178.241 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 50.5 m -79.74 139.58 37.25 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.463 -0.335 . . . . 1.17 110.695 -178.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 33.6 m -61.13 112.87 2.28 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.263 0.554 . . . . 1.19 110.317 179.26 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.467 ' H ' ' HG3' ' A' ' 90' ' ' GLU . . . 113.82 -11.36 22.99 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.901 -0.666 . . . . 0.79 112.023 -177.578 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -84.93 41.2 0.85 Allowed 'General case' 0 C--O 1.233 0.23 0 CA-C-O 121.657 0.741 . . . . 1.55 110.475 -177.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 24.3 mmt -136.82 -127.41 0.14 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.797 -0.638 . . . . 0.73 109.342 177.601 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 63.6 mtt -119.16 153.62 34.59 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 108.133 -1.062 . . . . 1.39 108.133 175.076 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.44 ' HB3' ' HD3' ' A' ' 88' ' ' PRO . 88.4 tttt -52.29 -55.13 34.42 Favored Pre-proline 0 CA--C 1.539 0.526 0 N-CA-C 112.38 0.511 . . . . 2.37 112.38 -175.445 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.44 ' HD3' ' HB3' ' A' ' 87' ' ' LYS . 73.4 Cg_endo -74.59 -26.76 11.48 Favored 'Trans proline' 0 C--N 1.357 0.982 0 C-N-CA 121.656 1.57 . . . . 0.27 111.976 -176.543 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.649 ' O ' HG23 ' A' ' 93' ' ' VAL . 32.1 t80 -68.31 -56.16 9.57 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.496 -0.774 . . . . 0.22 109.416 179.298 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.467 ' HG3' ' H ' ' A' ' 83' ' ' GLY . 4.2 tm-20 -65.38 -35.17 80.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.72 -0.673 . . . . 2.12 109.721 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.59 ' HA ' ' NE ' ' A' ' 94' ' ' ARG . 23.0 t70 -53.79 -33.55 56.31 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.432 -0.804 . . . . 0.61 110.978 175.601 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.551 ' O ' ' HG ' ' A' ' 96' ' ' LEU . . . -84.2 -37.74 21.46 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.408 -0.36 . . . . 0.22 111.132 178.571 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.649 HG23 ' O ' ' A' ' 89' ' ' PHE . 15.2 t -61.96 -44.17 98.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-O 121.447 0.641 . . . . 0.25 110.723 -177.189 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.59 ' NE ' ' HA ' ' A' ' 91' ' ' ASP . 26.4 ptt180 -74.14 -16.66 60.99 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.606 -0.725 . . . . 2.59 110.607 178.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -93.68 12.96 23.67 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.982 -0.554 . . . . 0.47 111.51 -174.069 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.556 ' HB2' ' HB2' ' A' ' 100' ' ' ASP . 0.7 OUTLIER -142.14 150.75 41.52 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.152 -0.476 . . . . 0.28 110.432 175.396 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.571 ' HA ' ' NH2' ' A' ' 116' ' ' ARG . 23.1 tptm -91.87 164.74 13.56 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.285 -0.635 . . . . 1.61 109.285 177.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.449 ' HA ' ' HG2' ' A' ' 116' ' ' ARG . 75.7 mt -41.83 115.94 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 123.458 0.474 . . . . 0.9 111.38 172.138 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 101.99 -8.07 55.51 Favored Glycine 0 N--CA 1.45 -0.427 0 CA-C-N 115.701 -0.681 . . . . 0.46 113.421 177.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.556 ' HB2' ' HB2' ' A' ' 96' ' ' LEU . 40.7 m-20 -99.06 141.22 32.09 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 117.16 0.48 . . . . 0.46 110.979 -179.428 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 8.3 mt -106.73 148.67 10.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.016 -0.538 . . . . 0.23 110.218 179.121 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 89.1 p -89.79 150.93 44.88 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 116.245 -0.434 . . . . 0.92 110.671 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -69.88 164.61 34.01 Favored 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 122.379 2.053 . . . . 0.34 111.041 171.708 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.872 HG23 HD23 ' A' ' 44' ' ' LEU . 24.9 mm -40.7 110.94 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 O-C-N 123.75 0.656 . . . . 0.2 112.506 179.577 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.1 p -119.07 123.51 71.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.183 -0.462 . . . . 1.04 110.085 175.715 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -85.73 149.32 25.37 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.098 0.475 . . . . 0.55 109.938 177.635 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 4.4 p -126.56 -172.03 2.54 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.768 -0.651 . . . . 0.37 110.936 -176.644 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -52.2 -44.36 64.68 Favored 'General case' 0 C--N 1.331 -0.238 0 O-C-N 123.508 0.505 . . . . 2.16 110.993 177.454 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.506 ' O ' ' HB2' ' A' ' 20' ' ' SER . 4.4 m -92.35 -61.14 1.67 Allowed 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 120.05 -0.66 . . . . 1.09 112.084 178.672 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -149.07 -128.35 1.68 Allowed Glycine 0 N--CA 1.438 -1.231 0 C-N-CA 118.749 -1.691 . . . . 0.24 113.413 -170.507 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.967 ' HB3' HD22 ' A' ' 44' ' ' LEU . 8.9 mp -116.08 148.88 39.79 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.604 -0.298 . . . . 0.19 111.53 -170.572 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' HIS . . . . . 0.744 ' CE1' HD13 ' A' ' 14' ' ' LEU . 69.1 m80 -145.51 150.92 37.32 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.215 0.531 . . . . 0.22 112.023 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.617 HG12 HD11 ' A' ' 44' ' ' LEU . 5.2 pt -130.17 133.87 63.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 107.669 -1.234 . . . . 0.17 107.669 159.659 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.442 HG21 HG22 ' A' ' 93' ' ' VAL . 2.8 mp -124.72 144.66 33.9 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 N-CA-C 110.07 -0.345 . . . . 0.18 110.07 -176.197 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.447 ' HG2' ' HB3' ' A' ' 11' ' ' ALA . 46.0 pttt -130.42 138.12 50.17 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.932 -0.766 . . . . 0.61 108.932 174.261 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.571 ' NH2' ' HA ' ' A' ' 97' ' ' LYS . 3.6 ttp180 -82.62 135.47 35.05 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.474 -0.49 . . . . 1.87 111.236 -177.792 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.527 HD21 ' HB2' ' A' ' 11' ' ' ALA . 0.3 OUTLIER -102.28 -30.65 10.96 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.69 -0.687 . . . . 0.89 110.974 177.714 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.466 ' O ' ' HD2' ' A' ' 116' ' ' ARG . . . . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.649 -0.691 . . . . 1.1 110.689 -178.682 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 24.3 ptp . . . . . 0 N--CA 1.483 1.189 0 CA-C-O 121.039 0.447 . . . . 7.23 110.893 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 39.8 t -131.86 121.63 24.38 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.788 0.327 . . . . 2.88 110.172 -178.702 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -89.61 106.94 18.79 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.178 -0.464 . . . . 2.8 110.324 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 69.3 mmtt -137.74 149.0 46.09 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.527 0.68 . . . . 1.19 111.487 -178.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.628 HD23 ' N ' ' A' ' 9' ' ' ARG . 3.2 tt -154.61 151.45 28.83 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.01 -1.107 . . . . 1.18 108.01 -176.862 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.628 ' N ' HD23 ' A' ' 8' ' ' LEU . 65.1 ttt180 -135.05 131.64 37.27 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 108.722 -0.844 . . . . 1.06 108.722 173.476 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -148.99 150.9 33.63 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 120.066 -0.653 . . . . 0.22 112.337 -175.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.406 ' HB3' ' HG2' ' A' ' 115' ' ' LYS . . . -104.42 133.39 49.38 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.318 -0.855 . . . . 0.2 109.057 178.116 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 26.0 p-80 -135.88 154.66 51.08 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.105 0.479 . . . . 0.23 111.714 -172.667 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.552 HD23 ' N ' ' A' ' 14' ' ' LEU . 5.8 tt -123.93 148.98 46.44 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.538 -0.912 . . . . 0.24 108.538 177.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.747 HD13 ' CE1' ' A' ' 112' ' ' HIS . 24.5 tp -131.21 135.75 47.67 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 110.346 -0.242 . . . . 0.27 110.346 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.508 HG23 HD13 ' A' ' 44' ' ' LEU . 57.4 t -121.17 128.98 76.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 N-CA-C 109.619 -0.511 . . . . 0.15 109.619 172.566 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.49 ' HE3' HD21 ' A' ' 14' ' ' LEU . 12.6 mmtp -103.57 148.48 25.94 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.996 -0.547 . . . . 0.62 109.777 178.115 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.49 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 53.6 p90 -143.75 162.62 35.54 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.144 -0.48 . . . . 0.25 110.685 -178.442 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.477 ' HB3' ' HA ' ' A' ' 33' ' ' ALA . 19.7 p -49.46 112.25 0.61 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.144 -0.48 . . . . 1.04 111.509 178.679 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 95.89 8.6 57.97 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.681 -0.771 . . . . 0.53 113.56 178.646 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.407 ' C ' ' H ' ' A' ' 22' ' ' ASN . 77.3 p -91.11 43.3 1.14 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 117.59 0.695 . . . . 0.7 111.002 -177.672 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 74.5 ttt180 73.45 -32.79 0.25 Allowed 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.4 0.68 . . . . 3.49 111.418 177.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.407 ' H ' ' C ' ' A' ' 20' ' ' SER . 43.7 m-80 -135.55 100.74 11.16 Favored Pre-proline 0 C--N 1.324 -0.527 0 N-CA-C 109.209 -0.663 . . . . 1.77 109.209 175.663 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.546 ' C ' HG22 ' A' ' 32' ' ' THR . 92.7 Cg_endo -82.69 41.35 1.1 Allowed 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.372 2.048 . . . . 1.71 112.756 -175.636 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.443 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 89.5 t -141.54 116.88 5.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 108.626 -0.879 . . . . 0.48 108.626 177.529 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.559 ' HB2' ' OD1' ' A' ' 67' ' ' ASP . 19.7 p -103.57 154.85 19.04 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 110.286 -0.265 . . . . 1.12 110.286 -177.487 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.452 ' CG ' ' HA ' ' A' ' 67' ' ' ASP . 35.2 mmt180 -69.03 -22.97 64.02 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 108.661 -0.866 . . . . 2.54 108.661 173.352 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.465 ' HG3' ' HD2' ' A' ' 65' ' ' ARG . 5.3 tmm_? -70.74 -32.85 70.17 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 114.351 -1.295 . . . . 1.77 110.421 -179.209 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 75.4 p -100.04 -35.3 9.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.426 0.632 . . . . 0.67 110.795 178.33 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 65.65 18.26 65.74 Favored Glycine 0 N--CA 1.453 -0.201 0 CA-C-N 114.877 -1.056 . . . . 0.82 112.304 -178.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -141.95 -72.0 0.33 Allowed 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.769 -0.456 . . . . 2.1 109.769 -179.457 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.443 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 6.2 p -155.2 148.74 25.2 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.885 -0.598 . . . . 1.08 110.115 173.265 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.546 HG22 ' C ' ' A' ' 23' ' ' PRO . 14.5 t -113.42 22.69 13.94 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.939 0.876 . . . . 0.34 109.217 178.01 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.477 ' HA ' ' HB3' ' A' ' 18' ' ' SER . . . -72.58 -6.49 44.44 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.904 -1.044 . . . . 0.37 111.719 -177.538 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -96.22 -24.0 16.45 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.108 0.48 . . . . 2.21 111.118 -178.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.489 HG23 ' HB2' ' A' ' 39' ' ' ASP . 0.2 OUTLIER -96.77 135.1 32.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.279 -0.419 . . . . 0.31 109.972 179.531 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 59.6 p -96.31 -179.34 4.61 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.348 -0.387 . . . . 0.39 109.957 -175.351 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.41 ' O ' HG13 ' A' ' 41' ' ' ILE . 4.3 p90 -64.62 -27.22 68.79 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.967 -0.753 . . . . 1.53 108.967 175.651 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -74.13 -43.31 57.97 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 116.004 -0.544 . . . . 0.96 110.412 178.278 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.489 ' HB2' HG23 ' A' ' 35' ' ' VAL . 19.4 m-20 -65.36 -33.63 76.41 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.523 0.677 . . . . 0.91 109.934 175.602 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.49 ' HB2' ' HB3' ' A' ' 17' ' ' PHE . . . -70.79 -46.53 62.69 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.789 -1.096 . . . . 0.19 110.707 -179.631 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.41 HG13 ' O ' ' A' ' 37' ' ' TYR . 68.7 mt -63.18 -36.43 75.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 110.09 -0.337 . . . . 0.3 110.09 176.471 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -64.3 -25.18 67.93 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.29 0.567 . . . . 2.32 110.021 178.702 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.477 ' HG3' ' CD1' ' A' ' 47' ' ' TRP . 5.8 tp10 -84.87 -52.32 6.1 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.433 -0.803 . . . . 1.02 109.024 -178.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.909 HD22 ' HB3' ' A' ' 111' ' ' LEU . 30.9 tp -62.72 -37.57 87.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.045 -0.98 . . . . 0.17 110.535 -175.008 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.45 ' O ' ' HB2' ' A' ' 49' ' ' GLN . 11.3 mm-40 -67.18 -28.93 68.5 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 112.304 0.483 . . . . 0.87 112.304 -177.882 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -78.35 -43.39 27.81 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.636 -0.426 . . . . 1.31 110.131 178.219 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.477 ' CD1' ' HG3' ' A' ' 43' ' ' GLU . 49.3 m95 -64.48 -47.14 80.09 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 111.974 0.361 . . . . 0.52 111.974 176.794 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.507 ' HB3' HG21 ' A' ' 113' ' ' ILE . 88.7 p -63.99 -25.58 68.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.987 0.422 . . . . 0.82 110.15 177.867 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.45 ' HB2' ' O ' ' A' ' 45' ' ' GLN . 14.2 tt0 -71.97 -56.13 6.22 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.994 -0.548 . . . . 0.53 110.071 175.09 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.566 ' HB3' HG22 ' A' ' 56' ' ' VAL . 97.2 mtt180 -61.12 -41.93 97.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.935 -0.575 . . . . 0.42 111.646 -176.443 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.478 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 93.9 mt -60.66 -36.82 73.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 120.976 0.417 . . . . 0.2 110.458 177.224 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -77.99 -37.37 47.39 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.01 -0.541 . . . . 0.27 111.426 -179.059 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 55.4 p -78.69 -29.19 45.39 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.843 0.354 . . . . 0.35 111.488 -177.529 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 106.28 9.56 31.37 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.764 -0.732 . . . . 0.3 112.318 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.453 ' HB2' ' HB3' ' A' ' 50' ' ' ARG . 45.4 mt-10 -67.47 -45.11 76.87 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.895 0.379 . . . . 0.65 110.348 178.473 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.566 HG22 ' HB3' ' A' ' 50' ' ' ARG . 11.5 m -135.95 154.78 34.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 109.088 -0.708 . . . . 0.19 109.088 171.493 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.5 m -85.65 159.0 19.94 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.191 -0.67 . . . . 0.97 109.191 177.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -53.94 -46.97 71.72 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.938 0.399 . . . . 0.22 109.972 -177.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.543 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 48.8 mt-10 -61.58 -26.44 67.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.533 -0.758 . . . . 1.72 112.46 -179.061 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 53.8 mm-40 -72.92 -50.91 20.78 Favored 'General case' 0 CA--C 1.519 -0.223 0 C-N-CA 120.516 -0.473 . . . . 2.09 110.358 178.54 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -67.95 -47.34 68.92 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.185 -0.461 . . . . 0.26 111.127 -177.742 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -57.39 -53.62 56.04 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.217 0.451 . . . . 0.24 112.217 -174.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.52 ' HA ' ' O ' ' A' ' 71' ' ' TYR . 23.5 m -52.3 -18.15 1.45 Allowed 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 113.614 0.968 . . . . 1.0 113.614 -178.227 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -110.41 -43.89 3.81 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-O 121.577 0.703 . . . . 0.61 110.309 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.465 ' HD2' ' HG3' ' A' ' 27' ' ' ARG . 15.5 mmt180 -96.34 -36.86 10.72 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 114.212 1.19 . . . . 0.86 114.212 -170.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.476 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 52.6 p -63.37 116.0 5.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.263 0.554 . . . . 0.82 110.362 -176.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.559 ' OD1' ' HB2' ' A' ' 25' ' ' SER . 57.3 m-20 -84.71 9.68 13.3 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.536 -0.756 . . . . 2.28 111.123 -177.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.48 ' SG ' HD22 ' A' ' 14' ' ' LEU . 1.1 m -80.95 -177.33 6.36 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.666 -0.697 . . . . 1.52 110.294 170.361 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -76.09 -21.0 76.92 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.358 -0.925 . . . . 0.26 111.699 175.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 71.2 p -65.84 0.46 1.77 Allowed 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 113.227 0.825 . . . . 0.32 113.227 -178.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.52 ' O ' ' HA ' ' A' ' 63' ' ' SER . 27.7 p90 -62.94 -22.6 66.9 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 118.361 0.528 . . . . 0.54 109.928 176.384 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -94.24 -2.94 51.58 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.382 0.61 . . . . 0.49 110.087 177.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.6 m -115.49 1.01 13.54 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.296 -0.865 . . . . 0.71 110.596 -175.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.543 ' O ' ' HA ' ' A' ' 59' ' ' GLU . . . 72.9 21.84 79.52 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.935 -0.65 . . . . 0.54 111.998 -176.434 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 86.28 -20.58 21.04 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 121.026 -0.606 . . . . 0.35 112.099 -177.672 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -69.93 132.04 45.34 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-N 115.553 -0.323 . . . . 1.65 110.984 -176.027 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.511 ' O ' ' HG3' ' A' ' 9' ' ' ARG . 2.9 mp -118.17 161.82 19.24 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.248 0.547 . . . . 0.94 110.283 174.741 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -85.71 -165.46 40.6 Favored Glycine 0 C--N 1.31 -0.913 0 CA-C-N 114.899 -1.046 . . . . 0.44 112.834 -178.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.627 ' HA ' ' O ' ' A' ' 8' ' ' LEU . 85.0 m-85 -73.91 142.97 45.94 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.271 0.558 . . . . 3.87 112.221 -176.301 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.535 ' CE1' ' HB3' ' A' ' 8' ' ' LEU . 2.3 p90 -149.69 167.93 25.03 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.964 -1.016 . . . . 1.31 108.787 176.336 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 37.3 m -96.63 122.46 39.57 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 108.478 -0.934 . . . . 1.17 108.478 170.721 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 4.6 p -47.14 123.05 4.97 Favored 'General case' 0 C--N 1.329 -0.306 0 O-C-N 123.662 0.602 . . . . 1.19 111.409 -179.148 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 114.49 17.78 6.91 Favored Glycine 0 N--CA 1.445 -0.766 0 N-CA-C 110.911 -0.875 . . . . 0.79 110.911 -174.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -115.09 -17.02 11.54 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 120.587 0.232 . . . . 1.55 111.173 -178.464 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 26.4 mmt -86.22 -92.37 0.09 Allowed 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.315 -0.554 . . . . 0.73 110.895 -173.163 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.495 ' HB2' ' CB ' ' A' ' 89' ' ' PHE . 45.6 mtt -144.22 155.34 43.84 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 107.228 -1.397 . . . . 1.39 107.228 177.06 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp -57.95 -53.54 64.72 Favored Pre-proline 0 C--N 1.317 -0.847 0 C-N-CA 120.274 -0.57 . . . . 2.37 112.059 -176.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.509 ' HG2' HG22 ' A' ' 107' ' ' THR . 73.4 Cg_endo -74.81 -30.12 7.85 Favored 'Trans proline' 0 C--N 1.356 0.962 0 C-N-CA 121.736 1.624 . . . . 0.27 111.855 -179.315 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.634 ' O ' HG23 ' A' ' 93' ' ' VAL . 11.2 t80 -61.97 -56.14 22.19 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.561 -0.745 . . . . 0.22 109.181 176.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.407 ' HB2' ' O ' ' A' ' 86' ' ' MET . 0.7 OUTLIER -62.15 -33.32 74.28 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.284 -0.871 . . . . 2.12 110.5 -179.891 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -60.55 -32.58 71.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.676 -0.693 . . . . 0.61 110.581 178.631 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.426 ' O ' ' HG ' ' A' ' 96' ' ' LEU . . . -83.86 -31.18 25.9 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.0 -0.545 . . . . 0.22 111.055 178.821 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.634 HG23 ' O ' ' A' ' 89' ' ' PHE . 20.2 t -68.8 -38.48 78.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.404 0.621 . . . . 0.25 109.781 -176.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.456 ' C ' ' HD2' ' A' ' 94' ' ' ARG . 2.8 ppt_? -79.44 -1.31 36.75 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.522 -0.763 . . . . 2.59 110.61 178.591 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -103.6 9.94 37.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 0.47 111.285 -177.365 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.567 ' HB2' ' HB2' ' A' ' 100' ' ' ASP . 1.0 OUTLIER -145.96 146.26 30.96 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.354 -0.385 . . . . 0.28 110.965 179.51 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.401 ' HG3' ' N ' ' A' ' 98' ' ' ILE . 56.6 tptt -91.01 168.98 11.26 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.773 -0.825 . . . . 1.61 108.773 177.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.453 ' HA ' ' HG2' ' A' ' 116' ' ' ARG . 72.0 mt -45.43 116.94 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.111 0.481 . . . . 0.9 111.234 173.593 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 103.47 -11.8 54.3 Favored Glycine 0 N--CA 1.449 -0.438 0 CA-C-N 115.54 -0.755 . . . . 0.46 113.115 178.341 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.567 ' HB2' ' HB2' ' A' ' 96' ' ' LEU . 14.6 m-20 -93.96 144.28 25.6 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 117.191 0.496 . . . . 0.46 110.716 -179.594 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 10.0 mt -112.62 147.93 16.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.756 -0.656 . . . . 0.23 109.67 -179.45 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 91.4 p -89.89 157.41 46.11 Favored Pre-proline 0 C--N 1.319 -0.733 0 CA-C-N 116.356 -0.384 . . . . 0.92 110.365 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -74.23 173.82 13.53 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 122.267 1.978 . . . . 0.34 111.132 171.206 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.893 HG23 HD23 ' A' ' 44' ' ' LEU . 21.9 mm -46.51 113.4 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-O 121.133 0.492 . . . . 0.2 112.019 176.266 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 93.4 t -111.72 117.77 55.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.91 -0.586 . . . . 1.04 109.831 174.456 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -86.04 137.97 32.3 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.107 0.48 . . . . 0.55 110.278 177.479 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.509 HG22 ' HG2' ' A' ' 88' ' ' PRO . 20.1 p -123.77 -172.23 2.49 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.664 -0.698 . . . . 0.37 110.21 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -66.67 -44.24 82.38 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.664 0.269 . . . . 2.16 110.996 178.362 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 5.3 t -95.63 -1.41 50.3 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.302 0.482 . . . . 1.09 112.302 -173.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 157.67 -124.68 1.44 Allowed Glycine 0 N--CA 1.437 -1.277 0 C-N-CA 119.775 -1.202 . . . . 0.24 112.995 170.399 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.909 ' HB3' HD22 ' A' ' 44' ' ' LEU . 6.6 mp -127.9 145.66 50.88 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.112 -0.544 . . . . 0.19 110.807 -170.77 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' HIS . . . . . 0.747 ' CE1' HD13 ' A' ' 14' ' ' LEU . 72.7 m80 -143.95 143.06 31.07 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.486 0.551 . . . . 0.22 112.486 -178.276 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.619 HG12 HD11 ' A' ' 44' ' ' LEU . 3.9 pt -127.07 141.55 45.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 107.884 -1.154 . . . . 0.17 107.884 161.113 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 2.8 mp -132.35 148.47 31.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 C-N-CA 120.976 -0.29 . . . . 0.18 110.396 -175.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.452 ' HE3' HD11 ' A' ' 117' ' ' LEU . 44.9 pttt -131.62 139.32 49.11 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.016 -0.735 . . . . 0.61 109.016 172.719 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.484 ' HD3' HD21 ' A' ' 8' ' ' LEU . 5.9 ttp180 -84.1 136.48 33.99 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.104 0.478 . . . . 1.87 111.494 -178.507 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.452 HD11 ' HE3' ' A' ' 115' ' ' LYS . 1.4 mm? -107.09 -27.96 10.28 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.295 -0.866 . . . . 0.89 110.743 177.216 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.505 ' HB3' ' HB3' ' A' ' 9' ' ' ARG . . . . . . . . 0 C--O 1.245 0.868 0 CA-C-O 118.291 -0.862 . . . . 1.1 110.452 179.691 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.8 mpt? . . . . . 0 N--CA 1.48 1.026 0 CA-C-O 120.915 0.388 . . . . 7.23 110.242 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 57.0 p -97.78 161.57 13.69 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.192 -0.458 . . . . 2.88 110.657 -177.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -119.34 -6.75 10.31 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.018 -0.537 . . . . 2.8 110.517 -177.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -79.06 127.34 31.87 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 121.859 0.838 . . . . 1.19 111.532 -175.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.816 HD21 ' HD3' ' A' ' 116' ' ' ARG . 2.4 tt -119.53 159.92 23.4 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 114.242 -1.345 . . . . 1.18 107.883 179.805 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.694 ' H ' HD23 ' A' ' 8' ' ' LEU . 63.2 ttt180 -140.46 127.07 20.26 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 108.869 -0.789 . . . . 1.06 108.869 175.759 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -141.09 154.1 45.76 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 120.31 -0.556 . . . . 0.22 112.231 -179.453 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.498 ' HA ' ' HA ' ' A' ' 76' ' ' ASP . . . -104.46 134.81 47.04 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.334 -0.848 . . . . 0.2 108.922 174.859 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.515 ' HE1' HD13 ' A' ' 77' ' ' LEU . 16.7 p-80 -141.59 138.51 32.67 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.969 0.414 . . . . 0.23 111.125 -171.031 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.532 ' O ' ' HA ' ' A' ' 112' ' ' HIS . 6.0 tt -109.43 137.31 47.48 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.326 -0.99 . . . . 0.24 108.326 177.378 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.792 HD13 ' CE1' ' A' ' 112' ' ' HIS . 17.4 tp -120.23 135.03 55.12 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.615 -0.266 . . . . 0.27 110.837 -176.515 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.549 HG23 HD13 ' A' ' 44' ' ' LEU . 83.4 t -121.89 133.62 67.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 109.854 -0.424 . . . . 0.15 109.854 174.293 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.693 ' HE3' HD21 ' A' ' 14' ' ' LEU . 32.7 mmtp -104.76 149.75 25.35 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.917 -0.583 . . . . 0.62 110.495 177.752 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.561 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 49.9 p90 -145.4 163.04 35.85 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.702 -0.681 . . . . 0.25 109.674 179.456 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.489 ' HB3' ' HA ' ' A' ' 33' ' ' ALA . 29.9 p -51.67 109.35 0.35 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.923 0.392 . . . . 1.04 110.425 176.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 109.93 9.28 24.7 Favored Glycine 0 CA--C 1.523 0.585 0 C-N-CA 120.625 -0.798 . . . . 0.53 112.795 -176.585 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.487 ' C ' ' H ' ' A' ' 22' ' ' ASN . 75.4 m -90.2 34.24 0.87 Allowed 'General case' 0 C--O 1.235 0.3 0 N-CA-C 112.359 0.503 . . . . 0.7 112.359 -177.599 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.457 ' HB3' ' O ' ' A' ' 20' ' ' SER . 20.8 ttt85 72.94 -30.33 0.21 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 122.925 0.49 . . . . 3.49 110.917 -179.686 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.487 ' H ' ' C ' ' A' ' 20' ' ' SER . 6.1 p30 -146.96 114.54 4.29 Favored Pre-proline 0 C--N 1.322 -0.618 0 N-CA-C 108.843 -0.799 . . . . 1.77 108.843 172.34 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.429 ' C ' HG22 ' A' ' 32' ' ' THR . 93.6 Cg_endo -86.21 52.5 2.91 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 122.573 2.182 . . . . 1.71 113.403 -173.009 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.415 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 61.0 t -142.53 119.78 6.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 109.342 -0.614 . . . . 0.48 109.342 177.324 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.46 ' HB3' ' HB2' ' A' ' 16' ' ' LYS . 13.5 p -103.83 156.08 18.11 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 121.211 -0.196 . . . . 1.12 110.886 -179.61 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.66 ' HB2' ' HA ' ' A' ' 67' ' ' ASP . 1.7 mpt_? -69.82 -16.99 63.37 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 109.155 -0.683 . . . . 2.54 109.155 173.443 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.515 ' HG2' ' HA ' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -82.42 -25.5 33.62 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.896 -1.047 . . . . 1.77 111.008 -178.629 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 73.3 p -105.33 -36.05 7.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.244 0.545 . . . . 0.67 110.934 178.324 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 76.27 -21.63 2.24 Favored Glycine 0 CA--C 1.52 0.395 0 CA-C-N 115.308 -0.86 . . . . 0.82 112.983 -179.354 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -101.76 -76.15 0.58 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.119 0.485 . . . . 2.1 110.043 -179.723 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.415 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 21.4 m -154.75 151.47 28.73 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.804 -0.635 . . . . 1.08 109.885 175.927 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.429 HG22 ' C ' ' A' ' 23' ' ' PRO . 12.4 t -113.8 23.0 13.46 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 122.181 0.991 . . . . 0.34 109.145 177.478 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.489 ' HA ' ' HB3' ' A' ' 18' ' ' SER . . . -71.71 -5.6 35.07 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.715 -1.129 . . . . 0.37 111.401 -178.555 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -99.09 -15.24 19.07 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.602 -0.726 . . . . 2.21 110.688 -175.51 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -105.57 138.44 30.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.93 -0.577 . . . . 0.31 109.704 179.772 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 62.4 p -94.77 -179.48 4.87 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.395 -0.366 . . . . 0.39 110.014 -175.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.519 ' O ' HG13 ' A' ' 41' ' ' ILE . 15.4 p90 -63.65 -28.35 69.85 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 119.986 -0.686 . . . . 1.53 109.223 176.302 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -75.11 -44.66 45.92 Favored 'General case' 0 CA--C 1.522 -0.132 0 CA-C-N 116.182 -0.463 . . . . 0.96 110.682 178.288 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -62.87 -33.29 74.98 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.479 0.656 . . . . 0.91 109.639 176.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.561 ' HB2' ' HB3' ' A' ' 17' ' ' PHE . . . -68.6 -44.64 73.91 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.944 -1.026 . . . . 0.19 110.671 178.269 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.519 HG13 ' O ' ' A' ' 37' ' ' TYR . 90.2 mt -63.28 -35.04 70.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 109.612 -0.514 . . . . 0.3 109.612 175.023 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.42 ' HD2' ' HA ' ' A' ' 42' ' ' LYS . 23.5 mmmt -64.67 -21.29 66.7 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.072 -0.513 . . . . 2.32 111.06 176.869 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.422 ' HG3' ' CD1' ' A' ' 47' ' ' TRP . 2.0 tp10 -88.57 -57.46 2.91 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.881 -0.6 . . . . 1.02 109.561 178.04 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.887 HD23 HG23 ' A' ' 104' ' ' ILE . 27.7 tp -58.8 -36.78 75.02 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.404 -0.816 . . . . 0.17 111.469 -175.302 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.535 ' O ' ' HB2' ' A' ' 49' ' ' GLN . 3.8 mm100 -66.45 -26.5 67.24 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 112.23 0.456 . . . . 0.87 112.23 -177.397 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.402 ' HE3' ' O ' ' A' ' 42' ' ' LYS . 96.7 mttt -78.88 -45.52 20.46 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.101 0.476 . . . . 1.31 109.832 178.08 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.422 ' CD1' ' HG3' ' A' ' 43' ' ' GLU . 24.3 m95 -67.21 -43.52 81.85 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.799 -0.637 . . . . 0.52 111.554 -178.095 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.553 ' HB3' HG21 ' A' ' 113' ' ' ILE . 97.2 p -67.18 -27.75 67.53 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 120.935 0.397 . . . . 0.82 109.969 177.211 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.535 ' HB2' ' O ' ' A' ' 45' ' ' GLN . 8.9 tt0 -67.58 -52.94 32.61 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 115.933 -0.576 . . . . 0.53 109.638 175.611 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.604 ' HB3' HG22 ' A' ' 56' ' ' VAL . 91.6 mtt180 -60.97 -42.35 98.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.705 -0.68 . . . . 0.42 111.556 -178.51 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.441 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 78.4 mt -60.29 -40.74 84.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.94 0.4 . . . . 0.2 110.744 177.354 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.4 -39.0 65.42 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.941 -0.572 . . . . 0.27 111.979 179.035 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 74.7 p -79.75 -29.37 40.48 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 111.809 0.3 . . . . 0.35 111.809 -175.473 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 109.11 4.27 31.18 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.599 -0.81 . . . . 0.3 112.898 179.367 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.437 ' HB2' ' HB3' ' A' ' 50' ' ' ARG . 46.7 mt-10 -62.05 -47.01 86.59 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.089 0.471 . . . . 0.65 110.084 177.443 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.604 HG22 ' HB3' ' A' ' 50' ' ' ARG . 10.2 m -134.9 159.0 41.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.821 -0.627 . . . . 0.19 109.378 171.743 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 19.7 m -92.98 161.96 14.25 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 109.562 -0.533 . . . . 0.97 109.562 177.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -54.19 -48.19 71.26 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.728 0.299 . . . . 0.22 110.452 -175.557 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.452 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 43.6 mt-10 -56.4 -40.36 74.51 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.739 -0.664 . . . . 1.72 111.948 179.469 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -63.82 -50.25 69.67 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.0 0.429 . . . . 2.09 110.738 -178.327 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -68.91 -46.5 68.14 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.877 -0.602 . . . . 0.26 111.132 -177.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.427 ' O ' ' HB3' ' A' ' 66' ' ' SER . . . -60.12 -46.28 90.15 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.648 0.61 . . . . 0.24 112.648 -173.304 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.492 ' HA ' ' HA ' ' A' ' 71' ' ' TYR . 20.4 m -57.75 -20.36 34.39 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.781 0.66 . . . . 1.0 112.781 -178.87 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -110.72 -46.58 3.35 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.521 0.677 . . . . 0.61 110.726 -178.331 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.515 ' HA ' ' HG2' ' A' ' 27' ' ' ARG . 18.8 mmt180 -90.17 -37.65 14.03 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.963 -1.017 . . . . 0.86 113.174 -170.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.448 ' O ' ' HB3' ' A' ' 71' ' ' TYR . 42.7 t -64.36 115.71 5.36 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.243 0.544 . . . . 0.82 110.953 -177.57 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.66 ' HA ' ' HB2' ' A' ' 26' ' ' ARG . 44.5 m-20 -82.28 10.16 7.49 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.416 -0.811 . . . . 2.28 111.024 179.589 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.477 ' O ' ' HD1' ' A' ' 71' ' ' TYR . 49.6 t -93.34 166.34 12.34 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.07 -0.513 . . . . 1.52 109.728 172.458 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -56.19 -26.83 50.94 Favored Glycine 0 CA--C 1.519 0.293 0 O-C-N 123.41 0.444 . . . . 0.26 113.315 -177.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.529 ' HB2' ' CA ' ' A' ' 75' ' ' GLY . 2.6 p -61.83 -8.26 4.68 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 112.849 0.685 . . . . 0.32 112.849 -179.565 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.492 ' HA ' ' HA ' ' A' ' 63' ' ' SER . 15.5 p90 -59.46 -29.73 68.01 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 108.979 -0.749 . . . . 0.54 108.979 174.112 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -95.33 8.59 42.69 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.741 -0.663 . . . . 0.49 111.045 179.361 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 5.0 m -125.29 -20.87 4.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.626 -0.261 . . . . 0.71 111.435 -177.798 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.452 ' O ' ' HA ' ' A' ' 59' ' ' GLU . . . 109.42 15.95 11.74 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.624 -0.798 . . . . 0.54 112.343 -177.602 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.529 ' CA ' ' HB2' ' A' ' 70' ' ' SER . . . 89.63 -12.99 65.33 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.75 -0.738 . . . . 0.35 113.04 177.701 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.498 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 10.6 p-10 -106.35 144.56 32.86 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.507 0.67 . . . . 1.65 111.372 -171.266 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.515 HD13 ' HE1' ' A' ' 12' ' ' HIS . 0.3 OUTLIER -105.74 174.48 5.86 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.756 -1.111 . . . . 0.94 109.725 176.931 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -90.63 -143.75 11.34 Favored Glycine 0 C--N 1.315 -0.614 0 C-N-CA 121.019 -0.61 . . . . 0.44 112.232 -179.15 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -88.31 123.77 33.23 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.018 0.437 . . . . 3.87 110.621 178.819 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.406 ' CE1' ' HB3' ' A' ' 8' ' ' LEU . 2.3 p90 -137.82 146.45 43.51 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.887 -0.597 . . . . 1.31 110.351 -179.515 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 36.6 m -76.19 137.88 40.31 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 120.829 0.347 . . . . 1.17 110.096 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 16.7 m -63.92 118.99 9.2 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.984 -0.553 . . . . 1.19 111.332 -175.792 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 114.49 -5.34 23.06 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.986 -0.626 . . . . 0.79 112.387 -178.706 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -104.24 59.96 0.72 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.255 0.55 . . . . 1.55 110.682 -179.41 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 23.0 mmt -144.03 -97.46 0.11 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.031 0.443 . . . . 0.73 110.453 177.451 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 63.6 mtt -146.32 151.04 36.88 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.015 -1.106 . . . . 1.39 108.015 173.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.428 ' HB3' ' HD3' ' A' ' 88' ' ' PRO . 23.1 tptm -52.98 -53.16 58.31 Favored Pre-proline 0 C--N 1.319 -0.738 0 N-CA-C 112.445 0.535 . . . . 2.37 112.445 -176.231 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.46 ' HG2' HG22 ' A' ' 107' ' ' THR . 75.6 Cg_endo -77.77 -26.04 7.23 Favored 'Trans proline' 0 C--N 1.356 0.938 0 C-N-CA 121.734 1.623 . . . . 0.27 112.587 -176.501 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.546 ' O ' HG23 ' A' ' 93' ' ' VAL . 43.6 t80 -73.26 -55.24 6.7 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.805 -0.634 . . . . 0.22 109.824 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.409 ' O ' ' HD3' ' A' ' 94' ' ' ARG . 4.8 tm-20 -64.27 -35.12 79.81 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.241 -0.891 . . . . 2.12 110.022 -178.638 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.571 ' HA ' ' CZ ' ' A' ' 94' ' ' ARG . 15.6 t70 -50.16 -40.85 47.92 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.735 -0.666 . . . . 0.61 110.795 175.107 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.587 ' O ' ' HG ' ' A' ' 96' ' ' LEU . . . -78.24 -30.74 48.84 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.098 -0.501 . . . . 0.22 111.184 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.546 HG23 ' O ' ' A' ' 89' ' ' PHE . 26.3 t -63.39 -47.74 90.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.676 -0.238 . . . . 0.25 111.244 -174.841 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.571 ' CZ ' ' HA ' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -83.75 -4.92 59.02 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.247 -0.581 . . . . 2.59 110.582 -179.476 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.27 -20.68 40.4 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.057 0.456 . . . . 0.47 110.906 -179.453 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.603 ' HB2' ' HB2' ' A' ' 100' ' ' ASP . 0.7 OUTLIER -121.02 147.37 45.59 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.969 -0.559 . . . . 0.28 110.441 -179.909 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.401 ' HG3' ' N ' ' A' ' 98' ' ' ILE . 51.3 tptt -90.19 172.67 8.63 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.438 -0.578 . . . . 1.61 109.438 -179.519 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.441 ' HA ' ' HG2' ' A' ' 116' ' ' ARG . 71.4 mt -48.26 113.67 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.934 0.397 . . . . 0.9 111.377 176.233 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 101.78 -3.69 52.94 Favored Glycine 0 CA--C 1.522 0.481 0 C-N-CA 120.939 -0.648 . . . . 0.46 113.913 178.225 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.603 ' HB2' ' HB2' ' A' ' 96' ' ' LEU . 26.1 m-20 -99.15 142.47 30.6 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 117.599 0.7 . . . . 0.46 110.353 178.565 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 8.9 mt -109.69 152.32 11.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.428 -0.351 . . . . 0.23 110.307 -178.38 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 4.7 p -101.35 148.34 35.04 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-O 121.007 0.432 . . . . 0.92 111.555 -178.478 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -68.94 159.85 52.23 Favored 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.697 2.265 . . . . 0.34 111.145 171.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.887 HG23 HD23 ' A' ' 44' ' ' LEU . 22.1 mm -39.26 112.19 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 O-C-N 123.823 0.702 . . . . 0.2 112.557 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 1.9 p -116.37 128.1 73.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.813 -0.63 . . . . 1.04 110.128 175.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -90.53 138.37 31.61 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 121.247 0.546 . . . . 0.55 110.15 178.471 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.46 HG22 ' HG2' ' A' ' 88' ' ' PRO . 11.5 p -116.35 -175.91 2.85 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.577 -0.738 . . . . 0.37 110.68 -177.316 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -57.99 -42.21 84.66 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 123.287 0.367 . . . . 2.16 111.009 179.353 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.44 ' OG ' ' HE2' ' A' ' 16' ' ' LYS . 24.5 t -85.16 -61.38 1.78 Allowed 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 116.493 -0.321 . . . . 1.09 110.56 179.394 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -154.39 -128.68 1.22 Allowed Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 119.399 -1.381 . . . . 0.24 113.39 -174.551 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.856 ' HB3' HD22 ' A' ' 44' ' ' LEU . 5.8 mp -112.35 145.43 40.08 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 122.379 0.272 . . . . 0.19 111.676 -171.795 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' HIS . . . . . 0.792 ' CE1' HD13 ' A' ' 14' ' ' LEU . 61.0 m80 -142.2 153.36 43.95 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 112.947 0.721 . . . . 0.22 112.947 178.001 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.574 HG12 HD11 ' A' ' 44' ' ' LEU . 4.3 pt -131.38 134.74 60.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 114.347 -1.297 . . . . 0.17 107.684 159.67 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.413 HD13 ' HB3' ' A' ' 92' ' ' ALA . 1.5 mp -128.14 146.22 34.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 C-N-CA 120.734 -0.386 . . . . 0.18 110.905 -176.126 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 37.2 pttt -129.5 141.06 51.08 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.346 -0.983 . . . . 0.61 108.346 170.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.816 ' HD3' HD21 ' A' ' 8' ' ' LEU . 4.7 ttp180 -82.22 134.9 35.32 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.255 -0.578 . . . . 1.87 110.857 -179.189 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -103.07 -35.1 8.64 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.191 -0.913 . . . . 0.89 110.286 -179.104 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.937 0 CA-C-O 118.555 -0.736 . . . . 1.1 110.485 -179.607 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 22.8 ptp . . . . . 0 N--CA 1.48 1.037 0 N-CA-C 111.581 0.215 . . . . 7.23 111.581 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 20.6 p -76.79 -84.4 0.06 Allowed 'General case' 0 C--O 1.233 0.201 0 N-CA-C 110.184 -0.302 . . . . 2.88 110.184 178.686 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.537 ' O ' ' HA ' ' A' ' 81' ' ' SER . 6.4 pt-20 -93.03 -31.34 14.9 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.243 -1.021 . . . . 2.8 108.243 170.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.486 ' HA ' ' O ' ' A' ' 80' ' ' PHE . 73.2 mmtt -85.63 105.33 16.12 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.401 -0.818 . . . . 1.19 110.415 -177.813 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.657 ' HB3' ' CE1' ' A' ' 80' ' ' PHE . 2.8 tt -100.62 155.5 17.84 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 113.878 -1.51 . . . . 1.18 108.489 -178.044 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.593 ' N ' HD23 ' A' ' 8' ' ' LEU . 71.8 ttt180 -132.65 127.97 36.03 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 108.674 -0.861 . . . . 1.06 108.674 170.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -146.4 153.8 40.89 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.258 -0.577 . . . . 0.22 112.095 -175.131 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.417 ' HB3' ' HG2' ' A' ' 115' ' ' LYS . . . -106.16 136.66 45.47 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.382 -0.826 . . . . 0.2 109.417 178.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 35.7 p-80 -137.15 149.48 47.32 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.917 0.389 . . . . 0.23 111.321 -173.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.676 ' O ' ' HA ' ' A' ' 112' ' ' HIS . 5.2 tt -123.09 131.75 53.82 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.818 -0.808 . . . . 0.24 108.818 179.293 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.796 HD13 ' CE1' ' A' ' 112' ' ' HIS . 25.6 tp -116.57 123.51 47.53 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.493 -0.321 . . . . 0.27 110.767 -177.531 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.623 HG23 HD13 ' A' ' 44' ' ' LEU . 63.3 t -110.84 134.04 54.42 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 N-CA-C 109.349 -0.611 . . . . 0.15 109.349 173.522 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.495 ' HE2' ' OG ' ' A' ' 109' ' ' SER . 30.4 mmtp -105.91 154.3 20.76 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.492 -0.558 . . . . 0.62 109.492 178.703 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.46 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 48.9 p90 -146.53 160.57 41.96 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.801 0.334 . . . . 0.25 110.954 -177.858 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.3 t -52.56 112.21 0.78 Allowed 'General case' 0 N--CA 1.435 -1.193 0 CA-C-N 115.997 -0.547 . . . . 1.04 111.323 178.634 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 100.46 2.86 55.52 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.605 -0.807 . . . . 0.53 113.205 177.033 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.41 ' C ' ' H ' ' A' ' 22' ' ' ASN . 91.3 p -90.19 40.15 1.0 Allowed 'General case' 0 C--O 1.234 0.277 0 CA-C-N 117.62 0.71 . . . . 0.7 111.086 -176.109 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.416 ' CZ ' ' HB2' ' A' ' 108' ' ' ASP . 96.3 mtt180 72.2 -32.85 0.25 Allowed 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.36 0.664 . . . . 3.49 111.771 178.291 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.41 ' H ' ' C ' ' A' ' 20' ' ' SER . 52.5 m-80 -136.99 93.11 13.64 Favored Pre-proline 0 C--N 1.326 -0.453 0 N-CA-C 109.308 -0.627 . . . . 1.77 109.308 175.802 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.56 ' C ' HG22 ' A' ' 32' ' ' THR . 95.5 Cg_endo -83.69 51.72 3.57 Favored 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 122.546 2.164 . . . . 1.71 113.233 -174.51 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.498 ' N ' HG22 ' A' ' 32' ' ' THR . 61.2 t -144.89 118.56 2.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 109.323 -0.621 . . . . 0.48 109.323 177.133 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 23.5 p -105.18 153.07 22.05 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 110.503 -0.184 . . . . 1.12 110.503 178.399 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.585 ' HB2' ' HA ' ' A' ' 67' ' ' ASP . 7.4 mpt_? -66.2 -10.22 39.55 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.007 0.432 . . . . 2.54 110.565 173.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.586 ' HG3' ' CD ' ' A' ' 65' ' ' ARG . 17.6 ttp180 -75.59 -41.12 55.37 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.812 -0.631 . . . . 1.77 109.506 176.288 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 40.0 p -95.79 -35.41 11.53 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.234 -0.894 . . . . 0.67 111.231 -175.122 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 78.03 -35.07 1.69 Allowed Glycine 0 CA--C 1.518 0.244 0 CA-C-N 115.341 -0.845 . . . . 0.82 112.637 178.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -94.88 -69.39 0.75 Allowed 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 110.177 -0.305 . . . . 2.1 110.177 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 10.1 p -154.83 150.46 27.52 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.094 0.474 . . . . 1.08 111.043 176.527 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.56 HG22 ' C ' ' A' ' 23' ' ' PRO . 13.8 t -113.44 30.26 7.36 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 122.349 1.071 . . . . 0.34 108.891 177.5 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.24 -3.47 49.32 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.475 -1.239 . . . . 0.37 112.031 -175.511 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -92.87 -24.61 18.41 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.482 0.658 . . . . 2.21 109.979 177.589 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -98.02 135.93 30.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.284 -0.871 . . . . 0.31 110.281 -179.458 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 34.0 p -96.19 -179.53 4.7 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.094 -0.503 . . . . 0.39 109.769 -176.703 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.544 ' O ' HG13 ' A' ' 41' ' ' ILE . 0.1 OUTLIER -64.87 -23.63 67.29 Favored 'General case' 0 C--O 1.222 -0.348 0 C-N-CA 119.04 -1.064 . . . . 1.53 110.026 173.505 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.451 ' N ' ' HD1' ' A' ' 37' ' ' TYR . 34.4 mt-10 -70.89 -46.93 61.71 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.649 -0.5 . . . . 0.96 109.649 176.899 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -70.76 -28.88 65.01 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.066 0.46 . . . . 0.91 110.404 176.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.46 ' HB2' ' HB3' ' A' ' 17' ' ' PHE . . . -66.32 -45.65 79.56 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.728 -0.669 . . . . 0.19 109.825 175.157 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.544 HG13 ' O ' ' A' ' 37' ' ' TYR . 72.9 mt -64.98 -38.41 82.72 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.382 0 CA-C-N 116.064 -0.517 . . . . 0.3 109.7 174.101 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.419 ' O ' ' HG3' ' A' ' 46' ' ' LYS . 3.6 ttpm? -64.78 -20.94 66.64 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.863 -0.608 . . . . 2.32 110.233 179.652 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.427 ' HG3' ' CD1' ' A' ' 47' ' ' TRP . 1.7 tp10 -88.29 -56.85 3.15 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.305 -0.628 . . . . 1.02 109.305 176.569 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.733 HD22 ' HB3' ' A' ' 111' ' ' LEU . 19.5 tp -58.92 -35.9 73.83 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.03 -0.986 . . . . 0.17 110.895 -174.479 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.461 ' HG2' HG13 ' A' ' 104' ' ' ILE . 4.3 mm100 -64.42 -39.57 94.09 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-N 116.391 -0.368 . . . . 0.87 111.962 -178.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.448 ' O ' ' HG3' ' A' ' 50' ' ' ARG . 60.7 mttm -70.09 -43.77 70.43 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 110.122 -0.325 . . . . 1.31 110.122 -178.576 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.443 ' NE1' ' HG3' ' A' ' 65' ' ' ARG . 64.6 m95 -65.79 -46.38 78.93 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.479 -0.328 . . . . 0.52 111.454 175.94 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 36.5 t -57.96 -34.0 69.45 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.755 -0.461 . . . . 0.82 109.755 176.355 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 -66.75 -56.84 8.71 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 115.907 -0.588 . . . . 0.53 110.555 175.181 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.627 ' HB3' HG22 ' A' ' 56' ' ' VAL . 93.6 mtt180 -61.21 -42.12 98.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.676 -0.693 . . . . 0.42 111.368 -175.634 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.44 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 98.2 mt -60.71 -39.43 81.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 120.96 0.409 . . . . 0.2 110.506 176.876 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.26 -39.92 65.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.979 -0.555 . . . . 0.27 111.663 -179.292 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 55.8 p -78.61 -30.5 46.56 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.931 0.396 . . . . 0.35 111.547 -177.354 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 107.61 9.25 29.2 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.727 -0.749 . . . . 0.3 112.057 -178.831 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.498 ' HB2' ' HB3' ' A' ' 50' ' ' ARG . 43.1 mt-10 -64.9 -44.26 90.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.115 0.483 . . . . 0.65 110.102 177.683 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.627 HG22 ' HB3' ' A' ' 50' ' ' ARG . 22.3 m -138.16 153.69 27.2 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.451 0 CA-C-N 115.791 -0.64 . . . . 0.19 109.456 173.767 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.6 m -77.39 157.89 30.36 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 109.327 -0.62 . . . . 0.97 109.327 175.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -54.76 -41.28 70.28 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.171 -0.678 . . . . 0.22 109.171 177.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.476 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 41.0 mt-10 -56.0 -46.6 78.7 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.785 -1.098 . . . . 1.72 112.197 178.775 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -60.91 -44.73 96.77 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 120.936 0.398 . . . . 2.09 111.019 -176.236 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -71.72 -43.72 65.4 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.346 -0.388 . . . . 0.26 111.001 -178.806 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.68 -53.05 60.38 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.185 0.439 . . . . 0.24 112.185 -175.005 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.474 ' HA ' ' O ' ' A' ' 71' ' ' TYR . 71.9 m -51.76 -27.8 13.24 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 113.121 0.785 . . . . 1.0 113.121 -177.61 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -100.03 -44.67 5.93 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.603 0.716 . . . . 0.61 110.616 -177.285 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.586 ' CD ' ' HG3' ' A' ' 27' ' ' ARG . 17.4 mmt180 -94.41 -43.48 8.35 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.873 -1.058 . . . . 0.86 113.576 -170.815 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.573 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 19.3 p -62.73 127.65 32.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.145 0.497 . . . . 0.82 111.557 -173.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.585 ' HA ' ' HB2' ' A' ' 26' ' ' ARG . 27.0 t70 -81.68 -11.08 59.21 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.421 -0.809 . . . . 2.28 110.616 176.694 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.541 ' SG ' ' HB2' ' A' ' 66' ' ' SER . 5.1 p -75.77 150.19 37.82 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.017 -0.538 . . . . 1.52 110.12 179.657 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -54.88 -21.66 24.16 Favored Glycine 0 N--CA 1.452 -0.247 0 CA-C-N 114.665 -1.152 . . . . 0.26 113.757 -172.381 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.449 ' HB2' ' CA ' ' A' ' 75' ' ' GLY . 1.5 p -67.99 -2.44 7.63 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 112.635 0.606 . . . . 0.32 112.635 177.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.474 ' O ' ' HA ' ' A' ' 63' ' ' SER . 33.1 p90 -55.13 -24.27 25.24 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 118.038 0.381 . . . . 0.54 110.421 174.872 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -87.65 -8.94 55.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.857 0.36 . . . . 0.49 111.115 -178.873 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 16.0 m -126.18 14.95 7.84 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.367 -0.379 . . . . 0.71 111.28 -177.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.476 ' O ' ' HA ' ' A' ' 59' ' ' GLU . . . 74.86 33.48 55.21 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.745 -0.74 . . . . 0.54 113.133 178.445 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.449 ' CA ' ' HB2' ' A' ' 70' ' ' SER . . . 77.88 5.07 86.46 Favored Glycine 0 C--O 1.228 -0.236 0 C-N-CA 120.811 -0.709 . . . . 0.35 112.867 176.385 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -92.21 141.17 28.86 Favored 'General case' 0 C--N 1.322 -0.629 0 O-C-N 122.844 -0.209 . . . . 1.65 110.448 -172.212 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -120.38 169.87 9.89 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.322 0.582 . . . . 0.94 110.582 176.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -89.04 -158.8 34.62 Favored Glycine 0 C--N 1.314 -0.691 0 CA-C-N 115.025 -0.989 . . . . 0.44 112.078 177.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.6 ' HA ' ' O ' ' A' ' 8' ' ' LEU . 96.7 m-85 -84.57 151.7 24.36 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.083 0.468 . . . . 3.87 111.677 -178.495 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.657 ' CE1' ' HB3' ' A' ' 8' ' ' LEU . 2.5 p90 -157.87 160.36 37.59 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.492 -0.929 . . . . 1.31 108.492 178.683 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.537 ' HA ' ' O ' ' A' ' 6' ' ' GLU . 23.6 m -85.44 138.78 32.02 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 109.162 -0.681 . . . . 1.17 109.162 177.067 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 14.7 m -59.71 112.24 1.74 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.159 0.504 . . . . 1.19 110.811 -174.53 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 114.53 12.91 10.07 Favored Glycine 0 N--CA 1.446 -0.647 0 CA-C-N 115.47 -0.786 . . . . 0.79 112.184 -174.709 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -117.02 57.8 0.78 Allowed 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 121.069 0.462 . . . . 1.55 110.377 177.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 22.5 mmt -146.42 -100.16 0.09 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.084 -0.507 . . . . 0.73 110.512 178.048 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.452 ' HB2' ' HB3' ' A' ' 89' ' ' PHE . 61.4 mtt -142.99 155.77 44.73 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 108.17 -1.048 . . . . 1.39 108.17 175.228 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.431 ' HB3' ' HD3' ' A' ' 88' ' ' PRO . 63.9 tttp -55.06 -57.75 18.16 Favored Pre-proline 0 C--N 1.321 -0.653 0 N-CA-C 112.448 0.536 . . . . 2.37 112.448 -177.082 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.435 ' HG2' HG22 ' A' ' 107' ' ' THR . 76.6 Cg_endo -75.35 -29.08 8.06 Favored 'Trans proline' 0 C--N 1.355 0.88 0 C-N-CA 121.643 1.562 . . . . 0.27 111.908 -175.89 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.651 ' O ' HG23 ' A' ' 93' ' ' VAL . 38.5 t80 -68.12 -56.55 8.42 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.111 -0.949 . . . . 0.22 109.942 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -65.24 -34.51 78.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.661 -0.7 . . . . 2.12 109.855 -178.067 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -55.33 -34.67 64.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.636 -0.711 . . . . 0.61 110.755 175.289 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.42 ' O ' ' HG ' ' A' ' 96' ' ' LEU . . . -83.74 -26.65 29.54 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.136 -0.484 . . . . 0.22 110.951 179.05 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.651 HG23 ' O ' ' A' ' 89' ' ' PHE . 18.4 t -74.03 -38.17 48.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.157 0.503 . . . . 0.25 110.186 -178.14 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.503 ' C ' ' HD2' ' A' ' 94' ' ' ARG . 6.5 ppt_? -76.32 -12.0 60.0 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.085 -0.507 . . . . 2.59 110.261 178.055 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.07 -4.5 59.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.846 -0.615 . . . . 0.47 111.254 -176.696 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.655 ' HB2' ' HB2' ' A' ' 100' ' ' ASP . 1.2 pp -132.79 151.91 51.9 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.173 0.511 . . . . 0.28 111.167 179.192 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.563 ' HG3' ' H ' ' A' ' 98' ' ' ILE . 19.4 tptm -102.62 -178.48 3.69 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.688 -0.856 . . . . 1.61 108.688 176.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.563 ' H ' ' HG3' ' A' ' 97' ' ' LYS . 65.9 mt -54.3 118.36 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 120.853 0.359 . . . . 0.9 111.025 179.28 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 95.61 10.23 56.91 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.728 -0.749 . . . . 0.46 113.14 178.412 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.655 ' HB2' ' HB2' ' A' ' 96' ' ' LEU . 27.0 m-20 -111.41 146.81 36.51 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 117.441 0.621 . . . . 0.46 110.271 177.285 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 15.8 mt -120.17 148.89 23.01 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-N 116.455 -0.339 . . . . 0.23 110.432 -178.44 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 38.3 m -96.78 151.08 37.63 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 116.234 -0.439 . . . . 0.92 111.206 179.026 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -74.17 176.94 8.9 Favored 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 122.583 2.189 . . . . 0.34 111.432 172.421 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.669 HG23 HD23 ' A' ' 44' ' ' LEU . 22.5 mm -49.24 110.72 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 N-CA-C 112.775 0.657 . . . . 0.2 112.775 -178.77 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 55.0 t -109.75 115.71 50.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.886 -0.597 . . . . 1.04 109.901 173.178 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 12.9 mt-30 -84.93 141.72 30.17 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.842 -0.429 . . . . 0.55 109.842 177.396 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.435 HG22 ' HG2' ' A' ' 88' ' ' PRO . 16.6 p -123.55 -172.47 2.53 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.784 -0.644 . . . . 0.37 110.491 -179.684 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.416 ' HB2' ' CZ ' ' A' ' 21' ' ' ARG . 6.9 p-10 -66.57 -35.53 80.44 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.617 0.246 . . . . 2.16 111.253 -178.11 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.495 ' OG ' ' HE2' ' A' ' 16' ' ' LYS . 4.6 t -106.24 -9.73 16.73 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 120.287 -0.565 . . . . 1.09 112.291 -174.359 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 172.18 -126.2 1.25 Allowed Glycine 0 N--CA 1.438 -1.177 0 C-N-CA 119.216 -1.469 . . . . 0.24 112.967 173.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.733 ' HB3' HD22 ' A' ' 44' ' ' LEU . 6.0 mp -130.78 149.42 52.43 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 115.045 -0.578 . . . . 0.19 110.906 -171.488 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' HIS . . . . . 0.796 ' CE1' HD13 ' A' ' 14' ' ' LEU . 75.8 m80 -146.97 136.04 22.45 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.098 0.407 . . . . 0.22 112.098 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.619 HG12 HD11 ' A' ' 44' ' ' LEU . 2.1 pt -119.13 140.03 44.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 107.972 -1.121 . . . . 0.17 107.972 160.362 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.435 HG21 HG22 ' A' ' 93' ' ' VAL . 2.5 mp -130.93 148.12 33.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 C-N-CA 120.923 -0.311 . . . . 0.18 110.532 -175.141 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.417 ' HG2' ' HB3' ' A' ' 11' ' ' ALA . 54.3 pttt -134.61 144.25 47.79 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.113 -0.699 . . . . 0.61 109.113 174.209 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.541 ' HB2' ' CD1' ' A' ' 96' ' ' LEU . 67.4 ttt180 -91.0 132.57 35.91 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.196 0.522 . . . . 1.87 111.583 -177.391 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.401 HD21 ' HB2' ' A' ' 11' ' ' ALA . 2.1 mm? -101.96 -35.53 8.94 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.116 -0.947 . . . . 0.89 110.781 179.398 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.428 ' HB3' ' HB3' ' A' ' 9' ' ' ARG . . . . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.945 -0.55 . . . . 1.1 109.841 179.191 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 62.2 mtt . . . . . 0 N--CA 1.48 1.031 0 CA-C-O 120.749 0.309 . . . . 7.23 110.409 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 40.0 t -94.92 130.79 41.41 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.111 -0.495 . . . . 2.88 110.371 177.452 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -112.64 -4.86 14.03 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.512 -0.551 . . . . 2.8 109.512 175.172 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.402 ' HA ' ' O ' ' A' ' 80' ' ' PHE . 13.6 tptt -72.7 128.17 34.75 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.709 0.766 . . . . 1.19 110.871 -178.283 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.62 HD23 ' N ' ' A' ' 9' ' ' ARG . 2.4 tt -136.55 157.02 47.76 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 114.522 -1.217 . . . . 1.18 108.176 -178.052 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.62 ' N ' HD23 ' A' ' 8' ' ' LEU . 77.2 ttt180 -140.82 127.72 20.55 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 107.907 -1.146 . . . . 1.06 107.907 173.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -140.95 157.88 44.73 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 120.037 -0.665 . . . . 0.22 112.496 -176.778 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.58 ' HA ' ' HA ' ' A' ' 76' ' ' ASP . . . -109.81 136.46 49.09 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.195 -0.912 . . . . 0.2 109.599 177.094 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 2.2 p80 -136.77 139.65 41.98 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.79 -0.364 . . . . 0.23 110.949 -172.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.608 ' O ' ' HA ' ' A' ' 112' ' ' HIS . 6.6 tt -111.42 142.37 43.77 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.161 -1.052 . . . . 0.24 108.161 176.002 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.738 HD13 ' CE1' ' A' ' 112' ' ' HIS . 22.1 tp -128.95 133.54 47.86 Favored 'General case' 0 C--N 1.323 -0.575 0 O-C-N 123.043 0.214 . . . . 0.27 110.441 -176.336 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.504 HG23 HD13 ' A' ' 44' ' ' LEU . 53.5 t -119.07 133.53 65.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 O-C-N 123.589 0.556 . . . . 0.15 109.978 175.796 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.523 ' HE3' HD21 ' A' ' 14' ' ' LEU . 34.2 mmtp -103.65 158.31 16.46 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.802 -0.635 . . . . 0.62 109.727 176.349 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.487 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 42.1 p90 -158.51 161.27 37.35 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.118 -0.492 . . . . 0.25 109.693 -177.049 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.1 t -50.84 108.69 0.25 Allowed 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 110.005 -0.369 . . . . 1.04 110.005 173.074 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 109.68 9.85 24.17 Favored Glycine 0 N--CA 1.446 -0.7 0 C-N-CA 120.323 -0.942 . . . . 0.53 112.975 -177.18 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.421 ' C ' ' H ' ' A' ' 22' ' ' ASN . 50.6 p -85.32 21.82 1.64 Allowed 'General case' 0 C--O 1.236 0.352 0 CA-C-N 117.938 0.869 . . . . 0.7 111.726 -176.732 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.457 ' NH1' ' HB3' ' A' ' 108' ' ' ASP . 97.3 mtt180 72.6 -34.98 0.31 Allowed 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.786 0.835 . . . . 3.49 110.833 -178.832 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.421 ' H ' ' C ' ' A' ' 20' ' ' SER . 7.0 p30 -146.66 104.71 3.96 Favored Pre-proline 0 C--N 1.32 -0.686 0 N-CA-C 108.578 -0.897 . . . . 1.77 108.578 168.866 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -66.03 -156.7 0.03 OUTLIER 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 123.674 2.916 . . . . 1.71 113.2 -178.46 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.546 ' N ' HG22 ' A' ' 32' ' ' THR . 47.6 t 64.99 112.97 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-N 115.494 -0.775 . . . . 0.48 111.165 -175.883 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.406 ' HB2' ' OD1' ' A' ' 67' ' ' ASP . 19.1 p -103.36 152.18 21.87 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.352 -0.385 . . . . 1.12 110.015 178.293 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.55 ' CG ' ' HA ' ' A' ' 67' ' ' ASP . 38.5 mmt180 -67.58 -20.38 65.37 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 108.727 -0.842 . . . . 2.54 108.727 173.193 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.496 ' HG2' ' HD3' ' A' ' 65' ' ' ARG . 4.8 tmm_? -71.73 -36.22 70.41 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 114.621 -1.172 . . . . 1.77 110.791 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 69.3 p -97.67 -35.76 10.47 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.522 0.677 . . . . 0.67 110.421 178.716 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 73.35 -6.7 14.4 Favored Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 114.718 -1.128 . . . . 0.82 112.655 -178.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -121.68 -72.29 0.69 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.757 0.313 . . . . 2.1 110.357 -178.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.6 m -147.8 146.26 29.08 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-O 121.0 0.429 . . . . 1.08 111.21 -178.733 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.546 HG22 ' N ' ' A' ' 24' ' ' VAL . 14.6 t -125.48 11.82 8.03 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.8 0.81 . . . . 0.34 109.49 174.58 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -68.94 -4.34 16.25 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.241 -0.89 . . . . 0.37 112.289 179.349 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -96.55 -23.86 16.33 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.037 0.446 . . . . 2.21 110.694 177.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.509 HG23 ' HB2' ' A' ' 39' ' ' ASP . 0.4 OUTLIER -93.85 136.34 25.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 109.389 -0.597 . . . . 0.31 109.389 177.505 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 75.0 p -95.0 179.99 5.03 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.359 -0.382 . . . . 0.39 110.081 -174.692 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.498 ' O ' HG13 ' A' ' 41' ' ' ILE . 11.3 p90 -63.42 -28.13 69.77 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.262 -0.644 . . . . 1.53 109.262 175.372 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -73.74 -44.77 55.34 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.905 -0.589 . . . . 0.96 110.362 178.186 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.509 ' HB2' HG23 ' A' ' 35' ' ' VAL . 43.9 m-20 -65.81 -32.42 73.94 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.484 0.659 . . . . 0.91 109.693 176.705 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.487 ' HB2' ' HB3' ' A' ' 17' ' ' PHE . . . -68.4 -43.88 76.27 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.976 -1.011 . . . . 0.19 110.416 178.254 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.498 HG13 ' O ' ' A' ' 37' ' ' TYR . 95.1 mt -62.6 -37.82 79.93 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.409 0 N-CA-C 109.667 -0.494 . . . . 0.3 109.667 174.925 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 55.9 tttp -65.94 -23.11 66.54 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 121.381 0.61 . . . . 2.32 109.997 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -87.84 -50.27 6.56 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.33 -0.85 . . . . 1.02 109.549 -179.082 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.903 HD22 ' HB3' ' A' ' 111' ' ' LEU . 35.4 tp -62.61 -38.08 88.78 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.588 -0.733 . . . . 0.17 110.41 -178.05 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.494 ' HG2' HG13 ' A' ' 104' ' ' ILE . 3.8 mm100 -61.09 -31.35 71.03 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 115.957 -0.565 . . . . 0.87 112.399 -179.595 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -80.24 -40.85 26.22 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.631 -0.428 . . . . 1.31 110.606 -179.708 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.422 ' O ' HG13 ' A' ' 51' ' ' ILE . 57.5 m95 -66.66 -45.32 79.31 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.139 0.422 . . . . 0.52 112.139 177.036 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.571 ' HB3' HG21 ' A' ' 113' ' ' ILE . 93.4 p -63.99 -30.5 71.57 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.758 -0.46 . . . . 0.82 109.758 176.728 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.491 ' HB2' ' O ' ' A' ' 45' ' ' GLN . 15.1 tt0 -65.16 -53.34 46.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.503 -0.772 . . . . 0.53 110.381 175.402 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.618 ' HB3' HG22 ' A' ' 56' ' ' VAL . 97.1 mtt180 -65.39 -41.48 93.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.996 -0.547 . . . . 0.42 111.657 -177.07 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.484 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 84.6 mt -61.25 -33.93 58.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.09 0.471 . . . . 0.2 110.691 176.629 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -77.81 -41.91 35.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 0.27 111.205 179.612 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 52.9 p -76.13 -29.81 57.96 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.252 -0.431 . . . . 0.35 111.569 -176.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 103.21 9.99 37.64 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.78 -0.724 . . . . 0.3 112.234 -179.008 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.403 ' HB2' ' HB3' ' A' ' 50' ' ' ARG . 39.2 mt-10 -64.51 -43.58 93.64 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.583 -0.525 . . . . 0.65 109.583 176.772 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.618 HG22 ' HB3' ' A' ' 50' ' ' ARG . 11.7 m -138.49 149.79 24.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 108.968 -0.753 . . . . 0.19 108.968 170.12 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 12.0 m -81.69 162.08 23.14 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 109.468 -0.567 . . . . 0.97 109.468 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -55.01 -43.44 73.63 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.843 -0.429 . . . . 0.22 109.843 -178.212 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -58.04 -46.32 85.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.537 -0.756 . . . . 1.72 111.443 179.008 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 41.4 mm-40 -59.4 -48.36 81.94 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-O 121.119 0.485 . . . . 2.09 110.822 -178.647 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -68.78 -49.96 54.27 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.924 -0.58 . . . . 0.26 110.866 -179.052 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -58.45 -55.37 35.97 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.629 0.603 . . . . 0.24 112.629 -173.229 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.482 ' HA ' ' HA ' ' A' ' 71' ' ' TYR . 28.4 t -52.27 -28.01 17.21 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.684 0.624 . . . . 1.0 112.684 -175.884 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -100.01 -46.74 5.24 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.528 0.68 . . . . 0.61 110.426 -179.155 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.496 ' HD3' ' HG2' ' A' ' 27' ' ' ARG . 31.3 mmt180 -94.21 -36.91 11.81 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.758 -1.11 . . . . 0.86 113.944 -168.603 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.577 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 24.7 p -67.89 123.72 21.37 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.642 -0.423 . . . . 0.82 110.651 -178.065 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.55 ' HA ' ' CG ' ' A' ' 26' ' ' ARG . 25.1 m-20 -83.77 -5.93 59.31 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.826 -0.625 . . . . 2.28 110.676 179.5 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.51 ' SG ' ' HB2' ' A' ' 66' ' ' SER . 6.4 p -78.86 156.73 28.54 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.494 -0.776 . . . . 1.52 110.215 175.413 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -54.83 -20.33 18.45 Favored Glycine 0 C--N 1.331 0.284 0 CA-C-N 114.959 -1.018 . . . . 0.26 114.501 -171.342 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.528 ' HB2' ' CA ' ' A' ' 75' ' ' GLY . 1.3 p -70.08 -1.49 10.08 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.675 0.62 . . . . 0.32 112.675 179.422 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.482 ' HA ' ' HA ' ' A' ' 63' ' ' SER . 41.6 p90 -56.55 -33.6 66.27 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 109.54 -0.541 . . . . 0.54 109.54 173.671 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -95.29 8.32 43.48 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.021 -0.536 . . . . 0.49 111.158 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 11.0 m -122.59 -20.16 6.08 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.698 0.285 . . . . 0.71 111.605 -176.216 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 107.57 14.85 16.75 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.74 -0.743 . . . . 0.54 112.226 -178.073 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.528 ' CA ' ' HB2' ' A' ' 70' ' ' SER . . . 92.99 -19.73 50.25 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.69 -0.767 . . . . 0.35 112.904 178.449 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.58 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 7.6 p-10 -98.36 144.71 27.46 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.584 0.706 . . . . 1.65 111.492 -171.758 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.412 ' HB3' ' HE2' ' A' ' 80' ' ' PHE . 0.9 OUTLIER -100.35 175.72 5.61 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.504 -1.225 . . . . 0.94 109.341 174.65 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -85.43 -148.0 10.13 Favored Glycine 0 C--N 1.315 -0.634 0 C-N-CA 120.709 -0.758 . . . . 0.44 111.981 -179.041 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -91.85 139.44 30.66 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.931 0.396 . . . . 3.87 110.16 178.36 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.412 ' HE2' ' HB3' ' A' ' 77' ' ' LEU . 1.5 p90 -152.14 174.03 14.22 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.992 -0.549 . . . . 1.31 109.746 -177.606 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 13.9 p -95.57 135.4 37.28 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.333 0.587 . . . . 1.17 110.942 179.802 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 13.2 m -63.83 128.11 34.35 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.483 -0.78 . . . . 1.19 110.585 -178.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 103.25 0.82 47.64 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.659 -0.782 . . . . 0.79 112.395 -179.399 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -117.76 62.84 0.75 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.222 0.534 . . . . 1.55 111.152 -179.055 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 21.0 mmt -139.49 -123.9 0.12 Allowed 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.066 -0.716 . . . . 0.73 109.066 173.556 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.414 ' HB2' ' CB ' ' A' ' 89' ' ' PHE . 19.9 mmt -110.68 151.54 27.59 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.263 -1.014 . . . . 1.39 108.263 173.191 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.403 ' HB3' ' HD3' ' A' ' 88' ' ' PRO . 24.5 ttmm -55.55 -51.72 77.8 Favored Pre-proline 0 C--N 1.319 -0.754 0 N-CA-C 112.379 0.511 . . . . 2.37 112.379 -174.108 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.403 ' HD3' ' HB3' ' A' ' 87' ' ' LYS . 86.2 Cg_endo -78.3 -22.9 9.27 Favored 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 121.474 1.449 . . . . 0.27 111.72 -178.44 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.581 ' O ' HG23 ' A' ' 93' ' ' VAL . 33.1 t80 -70.89 -55.75 7.77 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.157 -0.929 . . . . 0.22 109.718 179.682 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -65.81 -34.83 79.08 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.606 -0.725 . . . . 2.12 109.99 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.515 ' HA ' ' NE ' ' A' ' 94' ' ' ARG . 15.6 t70 -51.25 -35.83 39.06 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.492 -0.776 . . . . 0.61 110.7 173.68 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.567 ' O ' ' HG ' ' A' ' 96' ' ' LEU . . . -82.44 -37.15 25.85 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.072 -0.513 . . . . 0.22 111.032 179.111 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.581 HG23 ' O ' ' A' ' 89' ' ' PHE . 15.2 t -62.75 -40.97 90.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-O 121.229 0.538 . . . . 0.25 110.597 -177.168 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.515 ' NE ' ' HA ' ' A' ' 91' ' ' ASP . 37.7 ptt180 -74.8 -15.41 60.75 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.822 -0.626 . . . . 2.59 110.566 178.26 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -95.64 14.42 23.06 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.026 -0.533 . . . . 0.47 111.169 -174.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.634 ' HB2' ' HB2' ' A' ' 100' ' ' ASP . 1.4 pp -149.74 152.71 35.71 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.83 -0.623 . . . . 0.28 110.307 177.005 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.438 ' HG3' ' H ' ' A' ' 98' ' ' ILE . 21.7 tptm -102.22 175.63 5.46 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.132 -0.692 . . . . 1.61 109.132 179.536 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.459 ' HA ' ' HG2' ' A' ' 116' ' ' ARG . 70.7 mt -46.24 114.56 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.196 0.522 . . . . 0.9 111.579 176.049 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 102.1 -15.96 56.06 Favored Glycine 0 CA--C 1.522 0.48 0 CA-C-N 115.649 -0.705 . . . . 0.46 113.562 178.496 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.634 ' HB2' ' HB2' ' A' ' 96' ' ' LEU . 53.9 m-20 -89.08 141.19 28.71 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 117.346 0.573 . . . . 0.46 110.348 -177.797 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 8.9 mt -112.68 147.99 16.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.18 -0.464 . . . . 0.23 110.462 -176.816 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 99.3 p -89.65 160.1 42.26 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 116.256 -0.429 . . . . 0.92 110.643 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -74.23 176.36 9.7 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.324 2.016 . . . . 0.34 111.196 171.405 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.882 HG23 HD23 ' A' ' 44' ' ' LEU . 23.9 mm -50.47 106.38 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 O-C-N 123.217 0.323 . . . . 0.2 111.541 174.78 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.4 p -112.92 123.02 68.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 109.794 -0.447 . . . . 1.04 109.794 175.084 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -86.19 151.38 23.69 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.14 0.495 . . . . 0.55 110.563 -179.558 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 6.8 p -126.78 -172.72 2.7 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.51 -0.768 . . . . 0.37 109.984 178.827 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.457 ' HB3' ' NH1' ' A' ' 21' ' ' ARG . 36.3 m-20 -62.36 -46.73 87.35 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.746 0.307 . . . . 2.16 110.501 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 22.5 t -80.07 -59.43 2.72 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.836 -0.346 . . . . 1.09 110.796 -178.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -152.05 -130.4 1.6 Allowed Glycine 0 N--CA 1.443 -0.884 0 C-N-CA 119.075 -1.536 . . . . 0.24 113.649 -175.569 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.903 ' HB3' HD22 ' A' ' 44' ' ' LEU . 6.1 mp -116.56 147.79 41.49 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.283 -0.459 . . . . 0.19 111.372 -170.851 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' HIS . . . . . 0.738 ' CE1' HD13 ' A' ' 14' ' ' LEU . 71.0 m80 -143.48 152.96 42.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.419 0.628 . . . . 0.22 112.484 179.454 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.59 HG12 HD11 ' A' ' 44' ' ' LEU . 3.6 pt -133.42 138.17 51.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 107.604 -1.258 . . . . 0.17 107.604 159.579 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 2.8 mp -128.42 147.52 32.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 C-N-CA 120.768 -0.373 . . . . 0.18 110.386 -175.684 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.448 ' HG2' ' HB3' ' A' ' 11' ' ' ALA . 33.4 pttt -132.11 144.63 50.85 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.664 -0.865 . . . . 0.61 108.664 172.437 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.537 ' HD3' HD21 ' A' ' 8' ' ' LEU . 5.5 ttp180 -82.79 135.03 35.09 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.302 0.572 . . . . 1.87 110.902 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -101.83 -38.33 7.89 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.996 -1.002 . . . . 0.89 109.768 -179.514 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.456 ' HB3' ' HB3' ' A' ' 9' ' ' ARG . . . . . . . . 0 C--O 1.249 1.036 0 CA-C-N 115.544 -0.753 . . . . 1.1 109.735 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 79.1 mmm . . . . . 0 N--CA 1.482 1.157 0 N-CA-C 111.528 0.196 . . . . 7.23 111.528 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.3 m -78.81 -35.35 44.34 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.388 0.613 . . . . 2.88 109.59 177.595 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.582 ' O ' ' HA ' ' A' ' 81' ' ' SER . 0.0 OUTLIER -93.98 -42.18 9.18 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.125 -0.943 . . . . 2.8 109.899 178.989 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -73.0 103.59 3.83 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 121.47 0.653 . . . . 1.19 110.657 177.719 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.505 HD23 HG12 ' A' ' 93' ' ' VAL . 11.4 tp -103.73 175.34 5.51 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 114.665 -1.152 . . . . 1.18 109.953 -174.872 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.494 ' HB3' ' HB3' ' A' ' 118' ' ' ALA . 53.8 ttt180 -146.08 132.49 19.65 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.567 -0.531 . . . . 1.06 109.567 177.323 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.532 ' N ' ' HZ ' ' A' ' 80' ' ' PHE . . . -149.3 154.43 39.0 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.054 0.454 . . . . 0.22 111.69 -179.149 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.432 ' HB3' ' HG2' ' A' ' 115' ' ' LYS . . . -101.83 131.85 47.93 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.517 -0.765 . . . . 0.2 108.95 175.413 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 29.6 p-80 -133.01 146.69 51.99 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.029 0.443 . . . . 0.23 111.719 -172.011 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.555 HD23 ' N ' ' A' ' 14' ' ' LEU . 5.7 tt -117.46 144.65 44.81 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.478 -0.934 . . . . 0.24 108.478 177.407 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.8 HD13 ' CE1' ' A' ' 112' ' ' HIS . 26.0 tp -131.03 119.91 22.69 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.64 0.257 . . . . 0.27 110.675 -177.391 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.528 HG23 HD13 ' A' ' 44' ' ' LEU . 61.2 t -108.12 129.37 62.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 109.776 -0.453 . . . . 0.15 109.776 176.771 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.477 ' HE3' HD21 ' A' ' 14' ' ' LEU . 31.5 mmtp -105.87 149.99 26.04 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.089 -0.505 . . . . 0.62 110.022 178.68 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.5 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 43.1 p90 -145.88 162.54 37.5 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.331 -0.395 . . . . 0.25 110.863 -176.451 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.481 ' HB3' ' HA ' ' A' ' 33' ' ' ALA . 34.9 p -51.87 113.18 0.93 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.037 -0.529 . . . . 1.04 111.129 177.272 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 95.5 8.58 58.41 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.587 -0.816 . . . . 0.53 113.536 178.528 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.615 ' HB2' ' O ' ' A' ' 109' ' ' SER . 80.4 p -86.7 33.5 0.65 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 117.264 0.532 . . . . 0.7 110.921 -177.557 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.432 ' HB3' ' O ' ' A' ' 20' ' ' SER . 66.8 ttt180 71.25 -34.82 0.31 Allowed 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.245 0.618 . . . . 3.49 111.122 -176.684 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.459 ' H ' ' C ' ' A' ' 20' ' ' SER . 33.2 m-80 -133.63 91.77 25.04 Favored Pre-proline 0 C--N 1.327 -0.398 0 N-CA-C 109.245 -0.65 . . . . 1.77 109.245 176.838 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.509 ' C ' HG22 ' A' ' 32' ' ' THR . 72.7 Cg_endo -80.47 57.72 6.65 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 122.258 1.972 . . . . 1.71 112.774 -176.308 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.53 ' N ' HG22 ' A' ' 32' ' ' THR . 48.5 t -143.7 118.67 4.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 109.418 -0.586 . . . . 0.48 109.418 178.074 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 40.2 t -104.85 150.34 24.92 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 110.037 -0.357 . . . . 1.12 110.037 178.095 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.571 ' HG2' ' HA ' ' A' ' 67' ' ' ASP . 5.2 mmp_? -66.07 -8.35 22.9 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.727 0.299 . . . . 2.54 110.823 173.176 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.473 ' HD2' ' HD2' ' A' ' 65' ' ' ARG . 50.5 mtp180 -69.26 -50.68 44.77 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 121.555 0.693 . . . . 1.77 110.018 172.38 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 39.8 p -94.66 -33.62 12.9 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 115.154 -0.93 . . . . 0.67 110.837 -172.73 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 80.31 -32.56 2.3 Favored Glycine 0 N--CA 1.451 -0.308 0 CA-C-N 115.813 -0.63 . . . . 0.82 112.042 -178.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -92.56 -69.85 0.72 Allowed 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 122.576 0.35 . . . . 2.1 110.717 -177.663 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.434 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 5.5 p -154.79 155.56 34.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.602 -0.272 . . . . 1.08 110.922 177.207 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.53 HG22 ' N ' ' A' ' 24' ' ' VAL . 8.9 t -118.82 34.87 5.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 122.309 1.052 . . . . 0.34 109.388 177.806 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.481 ' HA ' ' HB3' ' A' ' 18' ' ' SER . . . -76.58 -5.25 46.93 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.695 -1.139 . . . . 0.37 112.901 -173.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -94.8 -24.75 16.93 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.032 0.444 . . . . 2.21 110.848 -179.076 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.487 HG23 ' HB2' ' A' ' 39' ' ' ASP . 0.2 OUTLIER -95.72 135.89 28.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.941 -0.572 . . . . 0.31 109.816 179.87 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 67.0 p -96.34 178.42 5.37 Favored 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 109.952 -0.388 . . . . 0.39 109.952 -175.133 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.454 ' O ' HG13 ' A' ' 41' ' ' ILE . 13.3 p90 -63.99 -27.89 69.44 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.224 -0.658 . . . . 1.53 109.224 176.467 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -70.73 -47.17 61.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.779 -0.646 . . . . 0.96 110.204 177.367 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.487 ' HB2' HG23 ' A' ' 35' ' ' VAL . 47.1 m-20 -67.87 -29.59 68.75 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.401 0.62 . . . . 0.91 109.752 178.233 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.5 ' HB2' ' HB3' ' A' ' 17' ' ' PHE . . . -70.35 -43.96 69.11 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.007 -0.997 . . . . 0.19 110.583 177.499 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.454 HG13 ' O ' ' A' ' 37' ' ' TYR . 80.0 mt -62.24 -37.35 78.34 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 N-CA-C 109.549 -0.537 . . . . 0.3 109.549 173.788 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -62.19 -25.46 67.79 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.784 -0.644 . . . . 2.32 110.174 177.73 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -84.82 -53.41 5.35 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.477 -0.783 . . . . 1.02 109.405 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.92 HD22 ' HB3' ' A' ' 111' ' ' LEU . 23.9 tp -62.01 -36.27 81.02 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.145 -0.934 . . . . 0.17 110.587 -175.031 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.537 ' O ' ' HB2' ' A' ' 49' ' ' GLN . 11.1 mm-40 -68.53 -24.71 64.67 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 112.348 0.499 . . . . 0.87 112.348 -177.909 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -80.43 -45.69 17.19 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.95 -0.389 . . . . 1.31 109.95 178.497 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.436 ' NE1' ' HG3' ' A' ' 65' ' ' ARG . 52.9 m95 -65.69 -46.55 78.62 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.138 -0.483 . . . . 0.52 111.207 177.705 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.522 ' HB3' HG21 ' A' ' 113' ' ' ILE . 92.2 p -64.01 -24.26 67.65 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.807 0.337 . . . . 0.82 110.166 178.469 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.537 ' HB2' ' O ' ' A' ' 45' ' ' GLN . 10.9 tt0 -73.28 -56.67 4.76 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-N 116.11 -0.496 . . . . 0.53 110.034 175.284 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.607 ' HB3' HG22 ' A' ' 56' ' ' VAL . 97.0 mtt180 -60.79 -42.4 97.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.473 -0.785 . . . . 0.42 111.401 -177.041 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.448 HG22 HD13 ' A' ' 101' ' ' ILE . 98.0 mt -62.07 -40.17 86.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 120.823 0.344 . . . . 0.2 110.613 177.648 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.39 -44.65 74.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.234 -0.439 . . . . 0.27 111.373 -178.395 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 32.3 p -77.39 -31.02 53.95 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.842 0.354 . . . . 0.35 111.38 -177.721 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 109.19 10.23 24.41 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.658 -0.782 . . . . 0.3 112.548 179.353 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.463 ' HB2' ' HB3' ' A' ' 50' ' ' ARG . 45.5 mt-10 -60.17 -46.93 88.02 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.211 0.529 . . . . 0.65 109.867 175.822 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.607 HG22 ' HB3' ' A' ' 50' ' ' ARG . 11.1 m -133.24 158.83 43.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.714 -0.676 . . . . 0.19 109.315 172.096 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 17.8 m -85.95 155.22 20.99 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 109.247 -0.649 . . . . 0.97 109.247 178.31 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -52.39 -42.63 64.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.301 0.572 . . . . 0.22 109.783 -177.62 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.517 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 39.2 mt-10 -55.08 -41.73 71.9 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.811 -1.086 . . . . 1.72 112.044 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -65.94 -47.2 75.47 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-O 120.712 0.291 . . . . 2.09 111.112 -174.644 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -69.48 -43.31 73.45 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.343 -0.39 . . . . 0.26 110.784 -178.786 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.66 -51.3 69.97 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.105 -0.498 . . . . 0.24 111.813 -176.541 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.561 ' HA ' ' O ' ' A' ' 71' ' ' TYR . 40.4 m -51.26 -27.44 9.21 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.939 0.718 . . . . 1.0 112.939 -177.805 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -98.55 -46.7 5.64 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.893 0.854 . . . . 0.61 110.936 -179.559 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.473 ' HD2' ' HD2' ' A' ' 27' ' ' ARG . 37.4 mmt180 -94.97 -37.26 11.23 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 114.398 -1.274 . . . . 0.86 113.713 -166.133 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.47 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 60.0 p -65.64 117.5 8.18 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.305 -0.558 . . . . 0.82 110.065 -178.35 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.571 ' HA ' ' HG2' ' A' ' 26' ' ' ARG . 24.0 t70 -73.84 -15.82 61.15 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.345 0.593 . . . . 2.28 111.089 179.33 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 46.2 t -77.37 160.84 28.49 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.307 0.575 . . . . 1.52 109.939 179.515 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -57.1 -18.0 25.55 Favored Glycine 0 C--N 1.328 0.134 0 CA-C-N 114.691 -1.14 . . . . 0.26 114.425 -170.06 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.502 ' HB2' ' CA ' ' A' ' 75' ' ' GLY . 3.0 p -70.28 -0.11 7.42 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.861 0.689 . . . . 0.32 112.861 179.198 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.561 ' O ' ' HA ' ' A' ' 63' ' ' SER . 39.2 p90 -60.29 -27.57 67.4 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 118.395 0.543 . . . . 0.54 109.973 175.917 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -94.43 5.37 52.01 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.246 0.545 . . . . 0.49 110.223 178.059 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.5 m -124.67 0.63 8.15 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.666 -0.697 . . . . 0.71 111.005 -176.528 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.517 ' O ' ' HA ' ' A' ' 59' ' ' GLU . . . 75.2 29.62 60.1 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.724 -0.75 . . . . 0.54 112.316 -177.388 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.502 ' CA ' ' HB2' ' A' ' 70' ' ' SER . . . 84.4 -3.59 85.98 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 121.01 -0.614 . . . . 0.35 112.317 179.622 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -84.57 140.8 31.15 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.667 0.27 . . . . 1.65 111.56 -169.557 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.449 HD12 ' HA ' ' A' ' 77' ' ' LEU . 0.5 OUTLIER -120.94 163.17 18.65 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.775 -0.648 . . . . 0.94 110.493 172.118 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -79.01 -117.05 0.23 Allowed Glycine 0 C--N 1.31 -0.891 0 CA-C-N 114.964 -1.016 . . . . 0.44 113.44 -177.515 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 37.0 p90 -116.15 141.06 48.63 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.864 0.364 . . . . 3.87 110.95 -176.649 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.532 ' HZ ' ' N ' ' A' ' 10' ' ' ALA . 3.5 p90 -158.23 129.56 6.56 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.084 -0.507 . . . . 1.31 111.014 -178.482 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.582 ' HA ' ' O ' ' A' ' 6' ' ' GLU . 82.2 p -74.31 155.33 38.32 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.308 -0.627 . . . . 1.17 109.308 178.185 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 9.3 m -59.77 114.38 2.74 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.144 -0.48 . . . . 1.19 110.346 -178.799 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 114.05 1.49 23.81 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.685 -0.769 . . . . 0.79 112.509 -176.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -90.84 15.22 11.69 Favored 'General case' 0 C--N 1.33 -0.281 0 O-C-N 122.593 -0.357 . . . . 1.55 111.5 178.667 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 26.2 mmt -126.84 -126.99 0.23 Allowed 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 121.116 0.484 . . . . 0.73 111.147 -176.842 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 54.7 mtt -123.19 149.26 44.87 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.09 -1.078 . . . . 1.39 108.09 179.005 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 64.6 tttp -49.82 -54.98 26.61 Favored Pre-proline 0 CA--C 1.541 0.618 0 N-CA-C 112.52 0.563 . . . . 2.37 112.52 -175.804 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.433 ' HG2' HG22 ' A' ' 107' ' ' THR . 82.8 Cg_endo -76.02 -22.47 13.06 Favored 'Trans proline' 0 C--N 1.356 0.965 0 C-N-CA 121.798 1.665 . . . . 0.27 112.321 -176.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.644 ' O ' HG23 ' A' ' 93' ' ' VAL . 38.7 t80 -73.3 -56.22 5.37 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.402 -0.817 . . . . 0.22 109.504 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.407 ' OE2' ' HD3' ' A' ' 94' ' ' ARG . 1.5 tm-20 -63.87 -33.55 75.94 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.595 -0.729 . . . . 2.12 109.77 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.592 ' HA ' ' NE ' ' A' ' 94' ' ' ARG . 18.7 t70 -52.47 -37.74 57.78 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.237 -0.892 . . . . 0.61 111.104 175.093 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.576 ' O ' ' HG ' ' A' ' 96' ' ' LEU . . . -81.76 -36.55 28.4 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.428 -0.351 . . . . 0.22 110.895 178.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.644 HG23 ' O ' ' A' ' 89' ' ' PHE . 11.5 t -63.6 -41.25 91.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.267 0.556 . . . . 0.25 110.699 -177.207 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.592 ' NE ' ' HA ' ' A' ' 91' ' ' ASP . 30.7 ptt180 -76.57 -18.55 58.6 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.776 -0.647 . . . . 2.59 110.52 178.86 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -82.95 -5.91 59.25 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.923 -0.58 . . . . 0.47 111.441 -172.666 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.617 ' HB2' ' HB2' ' A' ' 100' ' ' ASP . 0.5 OUTLIER -133.45 160.51 37.19 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.18 0.514 . . . . 0.28 111.244 -179.591 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.648 ' HG2' ' H ' ' A' ' 98' ' ' ILE . 33.6 tttp -102.33 178.42 4.6 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 115.656 -0.702 . . . . 1.61 109.461 178.099 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.648 ' H ' ' HG2' ' A' ' 97' ' ' LYS . 8.2 mt -53.36 119.34 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.265 -0.425 . . . . 0.9 111.138 178.346 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 102.1 -10.04 56.67 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.821 -0.704 . . . . 0.46 113.057 178.065 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.617 ' HB2' ' HB2' ' A' ' 96' ' ' LEU . 61.5 m-20 -97.82 139.92 32.96 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 117.1 0.45 . . . . 0.46 110.407 -177.774 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.478 HG12 ' HB3' ' A' ' 115' ' ' LYS . 9.5 mt -111.2 151.69 13.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.082 -0.508 . . . . 0.23 110.499 -177.282 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.413 ' OG ' HD21 ' A' ' 96' ' ' LEU . 10.8 m -86.37 156.74 56.63 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 115.965 -0.561 . . . . 0.92 110.887 -178.772 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -75.99 176.49 9.96 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 122.477 2.118 . . . . 0.34 110.183 166.675 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.88 HG23 HD23 ' A' ' 44' ' ' LEU . 22.8 mm -52.05 108.45 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 CA-C-O 121.052 0.454 . . . . 0.2 111.732 177.628 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 76.2 t -108.33 115.64 49.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.049 -0.523 . . . . 1.04 110.004 175.777 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -85.9 140.77 30.09 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 121.195 0.521 . . . . 0.55 110.235 177.475 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.433 HG22 ' HG2' ' A' ' 88' ' ' PRO . 8.4 p -118.37 -172.2 2.22 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.488 -0.778 . . . . 0.37 110.817 -177.692 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -63.41 -37.58 87.84 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.545 0.212 . . . . 2.16 111.027 179.367 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.615 ' O ' ' HB2' ' A' ' 20' ' ' SER . 8.4 t -92.9 -61.37 1.6 Allowed 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.786 -0.366 . . . . 1.09 110.478 179.241 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -145.63 -130.68 2.22 Favored Glycine 0 N--CA 1.443 -0.892 0 C-N-CA 119.026 -1.559 . . . . 0.24 113.795 -173.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.92 ' HB3' HD22 ' A' ' 44' ' ' LEU . 6.7 mp -118.54 146.35 44.63 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.289 -0.455 . . . . 0.19 111.139 -171.786 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' HIS . . . . . 0.8 ' CE1' HD13 ' A' ' 14' ' ' LEU . 71.9 m80 -144.35 142.5 30.42 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.066 0.46 . . . . 0.22 112.061 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.715 HG12 HD11 ' A' ' 44' ' ' LEU . 3.4 pt -125.77 136.22 61.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 107.771 -1.196 . . . . 0.17 107.771 159.897 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.427 HG21 HG22 ' A' ' 93' ' ' VAL . 3.1 mp -128.58 141.23 47.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 C-N-CA 120.891 -0.324 . . . . 0.18 110.372 -176.317 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.478 ' HB3' HG12 ' A' ' 101' ' ' ILE . 38.8 pttt -124.69 139.05 54.21 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.927 -0.768 . . . . 0.61 108.927 172.89 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 52.6 ttt180 -80.45 129.18 34.35 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.956 0.408 . . . . 1.87 111.153 -176.785 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.46 ' HB2' ' HG2' ' A' ' 9' ' ' ARG . 3.5 mm? -100.99 -30.67 11.5 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.608 -0.724 . . . . 0.89 110.575 -177.865 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.494 ' HB3' ' HB3' ' A' ' 9' ' ' ARG . . . . . . . . 0 C--O 1.248 0.992 0 CA-C-O 118.467 -0.777 . . . . 1.1 110.012 178.612 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.41 ' N ' ' SD ' ' A' ' 4' ' ' MET . 1.5 mpt? . . . . . 0 N--CA 1.479 1.006 0 CA-C-O 120.77 0.319 . . . . 7.23 110.231 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 6.3 m -92.22 -65.4 1.01 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.3 -0.409 . . . . 2.88 110.703 -178.277 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.434 ' O ' ' HA ' ' A' ' 81' ' ' SER . 14.7 pt-20 -80.05 -10.7 59.79 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.221 -0.445 . . . . 2.8 111.031 -176.62 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 40.6 mmtm -78.93 114.88 18.24 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.342 0.591 . . . . 1.19 110.693 176.584 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 10.5 tp -120.21 172.61 7.66 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.182 -0.917 . . . . 1.18 109.133 -179.516 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.424 ' HG2' ' HB2' ' A' ' 117' ' ' LEU . 69.0 ttt180 -147.63 127.38 13.43 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.385 -0.598 . . . . 1.06 109.385 177.793 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.546 ' O ' ' HB2' ' A' ' 77' ' ' LEU . . . -146.76 150.15 34.77 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.265 -0.574 . . . . 0.22 112.181 -177.484 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.421 ' HB3' ' HG2' ' A' ' 115' ' ' LYS . . . -103.01 134.41 46.5 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.065 -0.717 . . . . 0.2 109.065 176.052 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.456 ' CE1' HD11 ' A' ' 77' ' ' LEU . 37.2 p-80 -136.18 151.32 49.61 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.098 0.475 . . . . 0.23 112.05 -172.058 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.551 HD23 ' N ' ' A' ' 14' ' ' LEU . 4.7 tt -119.34 144.5 46.82 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.49 -0.929 . . . . 0.24 108.49 175.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.796 HD13 ' CE1' ' A' ' 112' ' ' HIS . 28.9 tp -131.65 123.91 28.81 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.531 0.205 . . . . 0.27 111.033 -176.754 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.552 HG23 HD13 ' A' ' 44' ' ' LEU . 71.1 t -113.82 138.03 44.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 109.87 -0.419 . . . . 0.15 109.87 176.052 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.529 ' HE3' HD21 ' A' ' 14' ' ' LEU . 34.0 mmtp -111.29 158.8 18.59 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.876 -0.416 . . . . 0.62 109.876 177.755 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.457 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 38.4 p90 -149.03 162.58 39.64 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.427 -0.351 . . . . 0.25 110.306 -175.542 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.487 ' HB3' ' HA ' ' A' ' 33' ' ' ALA . 35.5 p -52.18 109.61 0.4 Allowed 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 120.929 0.395 . . . . 1.04 110.55 176.842 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 101.93 9.08 43.69 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.484 -0.865 . . . . 0.53 112.947 -179.085 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.482 ' C ' ' H ' ' A' ' 22' ' ' ASN . 80.9 p -84.08 34.26 0.5 Allowed 'General case' 0 C--O 1.232 0.18 0 CA-C-N 117.29 0.545 . . . . 0.7 111.223 -178.855 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.43 ' HB2' ' O ' ' A' ' 20' ' ' SER . 89.9 mtt180 73.03 -28.61 0.19 Allowed 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.521 0.728 . . . . 3.49 110.895 -177.17 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.482 ' H ' ' C ' ' A' ' 20' ' ' SER . 3.0 p30 -150.07 104.39 3.17 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 115.919 -0.582 . . . . 1.77 110.175 172.425 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.427 ' C ' HG22 ' A' ' 32' ' ' THR . 6.8 Cg_exo -75.3 57.95 4.92 Favored 'Trans proline' 0 CA--C 1.532 0.403 0 C-N-CA 123.448 2.766 . . . . 1.71 113.368 -178.851 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.428 ' N ' HG22 ' A' ' 32' ' ' THR . 40.3 t -148.48 110.81 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 109.867 -0.42 . . . . 0.48 109.867 176.881 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.471 ' HB3' ' HB2' ' A' ' 16' ' ' LYS . 17.1 p -104.41 154.57 19.69 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.831 -0.168 . . . . 1.12 110.689 177.094 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.684 ' HB2' ' HA ' ' A' ' 67' ' ' ASP . 1.2 mpt_? -62.2 -13.6 29.32 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.031 0.443 . . . . 2.54 110.503 171.764 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.516 ' HG2' ' HA ' ' A' ' 65' ' ' ARG . 0.4 OUTLIER -80.59 -21.67 41.39 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.81 -0.632 . . . . 1.77 110.346 -179.689 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 36.3 p -115.35 -34.89 4.8 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.999 -0.546 . . . . 0.67 110.79 -177.622 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 76.53 -33.11 1.38 Allowed Glycine 0 CA--C 1.517 0.207 0 CA-C-N 115.252 -0.886 . . . . 0.82 113.065 176.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -99.59 -69.13 0.78 Allowed 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 110.124 -0.324 . . . . 2.1 110.124 -178.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 42.9 m -154.57 152.76 30.42 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.095 -0.502 . . . . 1.08 110.495 175.25 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.428 HG22 ' N ' ' A' ' 24' ' ' VAL . 10.5 t -119.4 30.88 6.87 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 122.17 0.986 . . . . 0.34 108.903 175.743 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.487 ' HA ' ' HB3' ' A' ' 18' ' ' SER . . . -79.96 -5.39 55.57 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 114.898 -1.046 . . . . 0.37 111.364 -177.516 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -88.46 -25.68 22.49 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.413 0.625 . . . . 2.21 110.244 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.428 HG23 ' HB2' ' A' ' 39' ' ' ASP . 0.2 OUTLIER -100.14 137.48 27.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.442 -0.799 . . . . 0.31 109.895 -178.434 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 59.6 p -94.88 178.35 5.6 Favored 'General case' 0 CA--C 1.512 -0.487 0 N-CA-C 109.708 -0.478 . . . . 0.39 109.708 -176.657 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.464 ' O ' HG13 ' A' ' 41' ' ' ILE . 10.1 p90 -63.11 -29.23 70.63 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.009 -0.676 . . . . 1.53 109.561 177.436 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -72.96 -44.13 61.48 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.058 -0.519 . . . . 0.96 110.539 178.121 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.428 ' HB2' HG23 ' A' ' 35' ' ' VAL . 39.7 m-20 -69.72 -27.12 64.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.299 0.571 . . . . 0.91 109.89 177.907 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.457 ' HB2' ' HB3' ' A' ' 17' ' ' PHE . . . -73.37 -45.75 53.08 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.303 -0.862 . . . . 0.19 110.683 176.874 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.493 ' CG1' HD21 ' A' ' 111' ' ' LEU . 80.5 mt -61.81 -36.39 73.43 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.369 0 N-CA-C 109.619 -0.512 . . . . 0.3 109.619 175.246 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -57.78 -32.05 67.15 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 115.561 -0.745 . . . . 2.32 110.468 176.623 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -87.37 -46.18 9.88 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.605 -0.725 . . . . 1.02 109.904 -175.219 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.895 HD22 ' HB3' ' A' ' 111' ' ' LEU . 34.6 tp -62.16 -37.41 85.11 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.019 -0.537 . . . . 0.17 110.123 -178.551 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.519 ' O ' ' HB2' ' A' ' 49' ' ' GLN . 13.7 mm-40 -64.72 -30.93 71.95 Favored 'General case' 0 C--O 1.225 -0.211 0 CA-C-N 116.271 -0.422 . . . . 0.87 111.779 179.581 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 59.4 mttm -72.08 -44.3 63.49 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.119 0.485 . . . . 1.31 110.503 179.127 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 25.5 m95 -71.54 -43.34 66.59 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.088 -0.506 . . . . 0.52 111.414 -179.474 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.474 ' HB3' HG21 ' A' ' 113' ' ' ILE . 93.6 p -65.04 -22.95 67.06 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.903 -0.406 . . . . 0.82 109.903 175.843 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.519 ' HB2' ' O ' ' A' ' 45' ' ' GLN . 14.7 tt0 -71.55 -54.31 10.91 Favored 'General case' 0 C--O 1.224 -0.252 0 CA-C-N 116.047 -0.524 . . . . 0.53 109.764 174.574 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.639 ' HB3' HG22 ' A' ' 56' ' ' VAL . 89.1 mtt180 -62.37 -41.69 98.83 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.903 -0.589 . . . . 0.42 111.788 -177.59 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.44 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 82.1 mt -59.92 -40.01 81.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 120.998 0.427 . . . . 0.2 110.425 176.49 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.9 -41.26 64.79 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.012 -0.54 . . . . 0.27 111.523 179.418 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 66.5 p -76.13 -29.43 57.81 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.829 0.347 . . . . 0.35 111.505 -176.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 107.06 4.49 35.76 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.615 -0.802 . . . . 0.3 112.271 178.349 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.488 ' OE1' ' HG2' ' A' ' 50' ' ' ARG . 46.3 mt-10 -61.05 -49.69 76.36 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.134 0.492 . . . . 0.65 110.176 178.221 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.639 HG22 ' HB3' ' A' ' 50' ' ' ARG . 15.8 m -131.49 154.62 40.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.695 -0.684 . . . . 0.19 109.268 173.193 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 22.8 p -85.41 165.76 16.94 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 109.554 -0.536 . . . . 0.97 109.554 177.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -57.38 -41.9 81.11 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.978 -0.378 . . . . 0.22 109.978 -177.73 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.584 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 42.0 mt-10 -59.23 -46.56 88.15 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.76 -0.654 . . . . 1.72 111.623 -179.179 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -60.53 -44.61 95.87 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-O 120.92 0.391 . . . . 2.09 111.0 -178.018 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -70.76 -49.57 45.29 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.246 -0.434 . . . . 0.26 111.084 -178.671 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.41 -51.86 68.08 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.332 0.493 . . . . 0.24 112.332 -174.424 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.491 ' HA ' ' O ' ' A' ' 71' ' ' TYR . 52.8 m -51.12 -24.09 3.75 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 113.041 0.756 . . . . 1.0 113.041 -178.083 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -104.18 -44.94 4.85 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.493 0.663 . . . . 0.61 110.494 -179.018 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.516 ' HA ' ' HG2' ' A' ' 27' ' ' ARG . 16.3 mmt180 -90.81 -42.73 10.49 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 113.848 1.055 . . . . 0.86 113.848 -170.353 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.444 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 72.7 p -64.3 124.89 22.9 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.044 0.449 . . . . 0.82 111.28 -175.305 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.684 ' HA ' ' HB2' ' A' ' 26' ' ' ARG . 25.7 t70 -76.6 -16.05 59.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.543 -0.753 . . . . 2.28 111.475 178.204 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 52.6 t -78.05 155.79 30.44 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.201 0.524 . . . . 1.52 110.15 -179.581 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -57.12 -18.1 26.1 Favored Glycine 0 N--CA 1.454 -0.138 0 CA-C-N 114.631 -1.168 . . . . 0.26 113.638 -173.805 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 63.0 p -64.77 -7.7 12.04 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 112.035 0.383 . . . . 0.32 112.035 176.857 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.491 ' O ' ' HA ' ' A' ' 63' ' ' SER . 25.2 p90 -57.88 -22.92 50.69 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.868 0.366 . . . . 0.54 110.297 175.724 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -90.77 -0.23 57.64 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.06 0.457 . . . . 0.49 110.674 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 16.3 m -126.34 14.38 7.72 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.888 -0.596 . . . . 0.71 110.577 178.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.584 ' O ' ' HA ' ' A' ' 59' ' ' GLU . . . 70.75 27.33 72.56 Favored Glycine 0 CA--C 1.519 0.325 0 C-N-CA 120.839 -0.696 . . . . 0.54 112.718 -178.708 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 82.3 -17.85 16.69 Favored Glycine 0 N--CA 1.454 -0.167 0 C-N-CA 121.034 -0.603 . . . . 0.35 112.473 179.161 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -70.96 135.16 47.73 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-O 120.883 0.373 . . . . 1.65 110.594 -176.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.546 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 19.2 mt -111.36 158.43 19.07 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.933 -0.576 . . . . 0.94 110.291 176.408 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -81.84 -137.37 2.4 Favored Glycine 0 C--N 1.317 -0.507 0 CA-C-N 115.673 -0.694 . . . . 0.44 112.625 179.238 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 38.1 p90 -98.43 135.57 39.82 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.189 0.519 . . . . 3.87 110.626 -177.595 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.43 ' HZ ' ' N ' ' A' ' 10' ' ' ALA . 2.0 p90 -151.5 164.6 36.44 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.921 -0.581 . . . . 1.31 110.21 -178.572 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.434 ' HA ' ' O ' ' A' ' 6' ' ' GLU . 13.2 m -89.54 120.42 30.83 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 109.788 -0.449 . . . . 1.17 109.788 178.754 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.5 p -55.36 118.85 4.79 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.932 -0.576 . . . . 1.19 110.909 178.468 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 114.43 5.92 20.47 Favored Glycine 0 N--CA 1.447 -0.572 0 N-CA-C 111.538 -0.625 . . . . 0.79 111.538 -176.642 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -105.04 -6.19 20.22 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.83 0.347 . . . . 1.55 110.803 -177.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 26.0 mmt -86.14 -97.48 0.07 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.252 0.549 . . . . 0.73 110.873 -175.453 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 55.9 mtt -145.16 150.96 37.68 Favored 'General case' 0 CA--C 1.507 -0.694 0 N-CA-C 107.187 -1.412 . . . . 1.39 107.187 176.048 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -55.85 -52.63 70.76 Favored Pre-proline 0 C--N 1.318 -0.797 0 CA-C-N 118.188 0.449 . . . . 2.37 112.115 -174.521 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -74.03 -31.34 8.04 Favored 'Trans proline' 0 C--N 1.358 1.033 0 C-N-CA 121.466 1.444 . . . . 0.27 111.891 -177.214 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.626 ' O ' HG23 ' A' ' 93' ' ' VAL . 29.7 t80 -65.74 -55.73 15.78 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.62 -0.718 . . . . 0.22 109.481 177.018 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -64.52 -34.6 78.6 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.338 -0.846 . . . . 2.12 110.461 -177.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -56.99 -36.54 70.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.824 -0.625 . . . . 0.61 110.516 175.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.436 ' O ' ' HG ' ' A' ' 96' ' ' LEU . . . -78.97 -28.26 43.54 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.192 -0.458 . . . . 0.22 110.981 178.356 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.626 HG23 ' O ' ' A' ' 89' ' ' PHE . 17.2 t -71.42 -36.48 61.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 121.267 0.556 . . . . 0.25 110.14 -177.55 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.511 ' C ' ' HD2' ' A' ' 94' ' ' ARG . 6.1 ppt_? -82.66 -9.23 59.47 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.918 -0.583 . . . . 2.59 110.446 179.008 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.35 -2.66 58.78 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.989 -0.551 . . . . 0.47 110.955 -177.386 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.567 ' HB2' ' HB2' ' A' ' 100' ' ' ASP . 0.7 OUTLIER -135.87 152.9 51.5 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.896 -0.593 . . . . 0.28 110.442 178.906 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.607 ' HG2' ' H ' ' A' ' 98' ' ' ILE . 47.0 tttt -102.88 -174.13 2.48 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.634 -0.506 . . . . 1.61 109.634 176.64 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.607 ' H ' ' HG2' ' A' ' 97' ' ' LYS . 10.4 mt -57.54 116.08 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 121.061 0.458 . . . . 0.9 111.692 -176.387 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 98.23 3.83 57.62 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.813 -0.708 . . . . 0.46 113.239 179.326 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.567 ' HB2' ' HB2' ' A' ' 96' ' ' LEU . 7.7 m-20 -104.67 141.76 35.87 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 117.196 0.498 . . . . 0.46 110.811 178.719 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 8.3 mt -111.84 146.58 16.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.774 -0.648 . . . . 0.23 109.737 -178.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 88.1 p -93.35 155.46 40.9 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 116.374 -0.376 . . . . 0.92 110.292 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -74.23 175.54 10.81 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 122.125 1.883 . . . . 0.34 111.131 171.461 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.851 HG23 HD23 ' A' ' 44' ' ' LEU . 20.3 mm -48.99 108.48 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 O-C-N 123.459 0.474 . . . . 0.2 112.144 177.896 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.4 p -115.84 120.08 63.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 120.91 0.386 . . . . 1.04 110.125 175.558 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -85.42 152.45 23.21 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.141 0.496 . . . . 0.55 110.964 -179.16 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 4.3 p -126.27 -172.51 2.64 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.434 -0.803 . . . . 0.37 110.237 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -60.78 -38.46 85.4 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.83 0.348 . . . . 2.16 110.642 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.47 ' O ' ' HB2' ' A' ' 20' ' ' SER . 16.2 t -90.95 -60.63 1.86 Allowed 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 120.867 -0.333 . . . . 1.09 110.694 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -150.55 -130.85 1.79 Allowed Glycine 0 N--CA 1.441 -1.019 0 C-N-CA 119.057 -1.544 . . . . 0.24 114.084 -173.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.895 ' HB3' HD22 ' A' ' 44' ' ' LEU . 6.7 mp -116.07 146.2 42.39 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.184 -0.508 . . . . 0.19 111.844 -168.012 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' HIS . . . . . 0.796 ' CE1' HD13 ' A' ' 14' ' ' LEU . 70.1 m80 -141.99 150.0 40.78 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.578 0.584 . . . . 0.22 112.578 178.422 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.571 HG12 HD11 ' A' ' 44' ' ' LEU . 3.3 pt -132.42 138.21 52.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 107.446 -1.316 . . . . 0.17 107.446 159.379 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 2.2 mp -129.69 145.74 35.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 C-N-CA 120.755 -0.378 . . . . 0.18 110.641 -175.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.449 ' HA ' ' O ' ' A' ' 100' ' ' ASP . 42.0 pttt -126.64 139.01 53.49 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.796 -0.816 . . . . 0.61 108.796 171.365 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.45 ' HB2' ' CD1' ' A' ' 96' ' ' LEU . 60.7 ttt180 -83.63 125.12 31.5 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.174 0.512 . . . . 1.87 110.86 -178.087 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.424 ' HB2' ' HG2' ' A' ' 9' ' ' ARG . 4.2 mm? -93.06 -31.96 14.65 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.487 -0.779 . . . . 0.89 110.247 -179.114 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.865 0 CA-C-N 115.54 -0.755 . . . . 1.1 109.962 179.747 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 27.9 ttt . . . . . 0 N--CA 1.48 1.064 0 CA-C-O 120.643 0.258 . . . . 7.23 110.315 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 38.3 t -65.18 139.04 58.62 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.15 -0.477 . . . . 2.88 110.212 179.108 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.494 ' CD ' ' H ' ' A' ' 6' ' ' GLU . 0.1 OUTLIER -95.87 -8.25 34.59 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.993 -0.549 . . . . 2.8 109.942 179.455 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.456 ' HG3' ' HB2' ' A' ' 79' ' ' PHE . 10.8 mptt -81.63 115.96 21.15 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.838 0.827 . . . . 1.19 110.82 -179.089 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.58 HD23 ' H ' ' A' ' 9' ' ' ARG . 1.8 tt -116.01 159.53 21.51 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 114.2 -1.364 . . . . 1.18 108.001 -178.512 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.59 ' HB3' ' HB3' ' A' ' 118' ' ' ALA . 79.0 ttt180 -136.28 127.85 28.75 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.431 -0.581 . . . . 1.06 109.431 174.274 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.425 ' N ' ' HZ ' ' A' ' 80' ' ' PHE . . . -150.05 152.17 34.41 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.093 0.473 . . . . 0.22 111.714 -179.244 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.417 ' HB3' ' HG2' ' A' ' 115' ' ' LYS . . . -101.87 136.78 41.12 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.458 -0.792 . . . . 0.2 109.527 177.39 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 37.4 p-80 -136.45 149.1 48.07 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.964 0.412 . . . . 0.23 111.286 -173.327 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.56 HD23 ' N ' ' A' ' 14' ' ' LEU . 6.2 tt -118.37 149.46 41.16 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.836 -0.802 . . . . 0.24 108.836 177.275 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.736 HD13 ' CE1' ' A' ' 112' ' ' HIS . 29.6 tp -130.84 124.61 31.65 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.611 0.243 . . . . 0.27 111.052 -179.228 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.546 HG23 HD13 ' A' ' 44' ' ' LEU . 85.1 t -111.34 138.03 41.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 109.405 -0.591 . . . . 0.15 109.405 173.884 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.485 ' HB2' ' HB2' ' A' ' 25' ' ' SER . 24.9 mmtp -105.72 162.07 13.85 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.157 -0.474 . . . . 0.62 110.491 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.462 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 51.5 p90 -158.86 161.6 36.87 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.053 -0.521 . . . . 0.25 109.92 179.48 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.522 ' HB3' ' HA ' ' A' ' 33' ' ' ALA . 21.5 p -53.35 109.97 0.5 Allowed 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.347 -0.388 . . . . 1.04 111.026 178.576 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 104.46 10.36 33.71 Favored Glycine 0 N--CA 1.443 -0.86 0 C-N-CA 120.229 -0.986 . . . . 0.53 113.371 178.87 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.661 ' HB2' ' O ' ' A' ' 109' ' ' SER . 39.8 p -81.49 46.24 0.94 Allowed 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 117.855 0.828 . . . . 0.7 111.577 -174.065 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.402 ' HB3' ' O ' ' A' ' 20' ' ' SER . 56.2 ttt180 68.95 -37.01 0.35 Allowed 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.905 0.882 . . . . 3.49 111.355 -177.213 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.488 ' H ' ' C ' ' A' ' 20' ' ' SER . 8.1 p30 -155.01 126.48 3.67 Favored Pre-proline 0 C--N 1.316 -0.866 0 N-CA-C 107.67 -1.233 . . . . 1.77 107.67 175.565 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -82.39 -156.11 0.07 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 122.302 2.001 . . . . 1.71 111.784 -175.106 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.615 ' N ' HG22 ' A' ' 32' ' ' THR . 57.5 t 60.07 114.12 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 123.423 0.689 . . . . 0.48 111.692 -173.738 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.485 ' HB2' ' HB2' ' A' ' 16' ' ' LYS . 29.8 t -103.4 159.82 15.24 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.815 -0.63 . . . . 1.12 109.722 177.886 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.589 ' HB2' ' HA ' ' A' ' 67' ' ' ASP . 5.5 mpt_? -75.33 -12.73 60.33 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 109.018 -0.734 . . . . 2.54 109.018 169.498 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.474 ' HG2' ' HD3' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -72.52 -49.75 30.67 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.249 -0.887 . . . . 1.77 109.195 174.066 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 55.6 p -85.39 -34.05 21.84 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.468 -0.787 . . . . 0.67 111.249 -177.511 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 80.7 -34.73 2.29 Favored Glycine 0 C--N 1.322 -0.216 0 CA-C-N 115.314 -0.857 . . . . 0.82 111.395 -176.81 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.556 ' O ' ' HA ' ' A' ' 24' ' ' VAL . 4.4 m-20 -114.56 -135.27 0.35 Allowed 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 108.349 -0.982 . . . . 2.1 108.349 173.025 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -70.82 142.03 51.3 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 112.703 0.631 . . . . 1.08 112.703 -171.261 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.615 HG22 ' N ' ' A' ' 24' ' ' VAL . 8.9 t -124.25 14.51 9.01 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.337 -0.847 . . . . 0.34 109.461 175.219 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.522 ' HA ' ' HB3' ' A' ' 18' ' ' SER . . . -68.75 -4.35 15.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.302 -0.863 . . . . 0.37 111.565 177.587 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -88.73 -24.95 22.55 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.99 -0.55 . . . . 2.21 110.802 -178.053 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.77 HG23 ' HB3' ' A' ' 39' ' ' ASP . 0.1 OUTLIER -100.58 141.55 17.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.088 -0.505 . . . . 0.31 110.211 -179.126 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 40.7 p -98.1 174.75 6.38 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 110.212 -0.292 . . . . 0.39 110.212 -176.448 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.516 ' O ' HG13 ' A' ' 41' ' ' ILE . 11.5 p90 -63.94 -26.85 68.77 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.101 -0.64 . . . . 1.53 109.507 177.713 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -71.04 -46.14 62.57 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.06 -0.518 . . . . 0.96 110.526 178.668 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.77 ' HB3' HG23 ' A' ' 35' ' ' VAL . 2.7 t70 -70.0 -31.22 68.79 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.473 0.654 . . . . 0.91 109.695 178.15 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.462 ' HB2' ' HB3' ' A' ' 17' ' ' PHE . . . -66.64 -41.97 87.43 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.232 -0.895 . . . . 0.19 110.347 175.658 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.516 HG13 ' O ' ' A' ' 37' ' ' TYR . 78.1 mt -64.63 -33.13 61.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 109.516 -0.549 . . . . 0.3 109.516 173.517 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.521 ' HB3' ' O ' ' A' ' 39' ' ' ASP . 3.9 ttpm? -60.75 -28.32 68.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.298 0.571 . . . . 2.32 109.993 176.212 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.457 ' HG3' ' CD1' ' A' ' 47' ' ' TRP . 6.2 tp10 -84.92 -52.88 5.69 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.403 -0.817 . . . . 1.02 109.487 -178.635 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.916 HD23 HG23 ' A' ' 104' ' ' ILE . 22.8 tp -64.61 -34.15 77.61 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.329 -0.851 . . . . 0.17 110.762 -174.267 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.51 ' O ' ' HB2' ' A' ' 49' ' ' GLN . 4.7 mm-40 -70.41 -19.63 62.98 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.353 -0.385 . . . . 0.87 111.892 -178.481 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.425 ' HG3' ' O ' ' A' ' 42' ' ' LYS . 67.9 mttm -84.25 -46.95 11.29 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.741 -0.466 . . . . 1.31 109.741 175.489 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.458 ' NE1' ' HG3' ' A' ' 65' ' ' ARG . 44.0 m95 -63.61 -48.05 78.9 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.144 -0.48 . . . . 0.52 111.821 179.782 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.508 ' HB3' HG21 ' A' ' 113' ' ' ILE . 98.5 p -64.81 -20.53 66.44 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.507 -0.477 . . . . 0.82 110.023 177.876 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.51 ' HB2' ' O ' ' A' ' 45' ' ' GLN . 11.8 tt0 -77.52 -54.72 6.08 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.183 -0.462 . . . . 0.53 110.014 175.771 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.598 ' HB3' HG22 ' A' ' 56' ' ' VAL . 97.9 mtt180 -63.21 -41.5 99.15 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.637 -0.711 . . . . 0.42 111.435 -176.627 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.483 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 98.3 mt -61.12 -33.59 56.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.159 0.504 . . . . 0.2 110.48 176.8 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -79.75 -35.55 38.57 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.907 -0.588 . . . . 0.27 111.444 -179.711 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 31.1 p -82.35 -28.98 31.23 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.811 0.338 . . . . 0.35 111.602 -176.874 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 107.98 3.77 33.9 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.762 -0.732 . . . . 0.3 112.375 179.748 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.448 ' HB2' ' HB3' ' A' ' 50' ' ' ARG . 36.8 mt-10 -61.79 -48.16 81.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.075 0.464 . . . . 0.65 110.258 178.435 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.598 HG22 ' HB3' ' A' ' 50' ' ' ARG . 15.6 m -135.32 156.22 38.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 109.31 -0.626 . . . . 0.19 109.31 172.242 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.582 ' OG ' ' HG3' ' A' ' 60' ' ' GLU . 77.7 p -83.79 165.49 18.79 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.795 -0.446 . . . . 0.97 109.795 178.035 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -57.7 -41.01 80.83 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.516 -0.55 . . . . 0.22 109.516 179.172 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.479 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 43.8 mt-10 -62.24 -41.35 98.34 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.062 -0.972 . . . . 1.72 111.962 -178.122 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.582 ' HG3' ' OG ' ' A' ' 57' ' ' SER . 41.2 mt-10 -60.76 -49.24 78.28 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.021 0.439 . . . . 2.09 110.859 -179.659 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.14 -50.61 63.38 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.926 -0.579 . . . . 0.26 111.073 -178.257 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -58.86 -52.1 67.19 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.351 0.5 . . . . 0.24 112.351 -174.622 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.534 ' HA ' ' O ' ' A' ' 71' ' ' TYR . 20.2 m -51.5 -24.23 4.92 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 113.122 0.786 . . . . 1.0 113.122 -176.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -105.49 -44.12 4.78 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.583 0.706 . . . . 0.61 110.615 -179.15 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.474 ' HD3' ' HG2' ' A' ' 27' ' ' ARG . 38.7 mmt-85 -90.92 -41.88 10.9 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 113.882 1.067 . . . . 0.86 113.882 -170.131 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.569 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 75.9 p -64.17 122.7 17.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.055 0.455 . . . . 0.82 111.615 -174.314 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.589 ' HA ' ' HB2' ' A' ' 26' ' ' ARG . 28.6 t70 -76.55 -9.33 58.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.618 -0.719 . . . . 2.28 110.827 175.891 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.543 ' SG ' HD22 ' A' ' 14' ' ' LEU . 4.1 m -77.13 163.43 26.6 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.897 -0.592 . . . . 1.52 110.267 175.901 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -65.9 -16.28 63.71 Favored Glycine 0 CA--C 1.512 -0.142 0 CA-C-N 114.912 -1.04 . . . . 0.26 113.203 -173.316 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.512 ' HB2' ' CA ' ' A' ' 75' ' ' GLY . 3.6 p -68.96 0.56 4.34 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 112.426 0.528 . . . . 0.32 112.426 177.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.534 ' O ' ' HA ' ' A' ' 63' ' ' SER . 34.5 p90 -58.33 -26.47 63.14 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.137 0.494 . . . . 0.54 110.154 175.515 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -95.29 -6.99 40.07 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.162 0.505 . . . . 0.49 110.585 178.181 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.8 m -110.67 -0.02 17.31 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.835 -0.62 . . . . 0.71 111.066 -175.354 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.479 ' O ' ' HA ' ' A' ' 59' ' ' GLU . . . 77.79 27.64 58.37 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.852 -0.689 . . . . 0.54 112.218 -177.086 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.512 ' CA ' ' HB2' ' A' ' 70' ' ' SER . . . 81.94 -1.2 87.24 Favored Glycine 0 C--O 1.226 -0.373 0 C-N-CA 120.873 -0.679 . . . . 0.35 111.85 -178.264 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -92.15 136.07 33.48 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 120.962 0.41 . . . . 1.65 111.436 -169.215 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.6 mp -115.75 158.08 23.38 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.709 -0.678 . . . . 0.94 109.548 172.882 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -85.35 -127.2 1.77 Allowed Glycine 0 C--N 1.308 -1.001 0 CA-C-N 114.944 -1.025 . . . . 0.44 112.255 -179.118 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.456 ' HB2' ' HG3' ' A' ' 7' ' ' LYS . 46.4 p90 -92.67 147.31 22.98 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.83 0.348 . . . . 3.87 110.734 -177.694 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.446 ' CE1' ' HB3' ' A' ' 8' ' ' LEU . 2.3 p90 -163.59 147.25 10.32 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.098 -0.501 . . . . 1.31 110.499 179.056 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 17.5 m -76.08 135.03 39.89 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.13 -0.486 . . . . 1.17 110.577 179.651 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 16.0 m -61.03 114.64 3.21 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.939 -0.573 . . . . 1.19 110.024 177.552 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.436 ' H ' ' HG3' ' A' ' 90' ' ' GLU . . . 112.58 -8.08 26.18 Favored Glycine 0 N--CA 1.447 -0.606 0 CA-C-N 115.79 -0.641 . . . . 0.79 111.895 -177.522 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -101.14 47.01 0.92 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.655 0.741 . . . . 1.55 110.371 -177.296 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 21.6 mmt -135.82 -127.21 0.15 Allowed 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.87 -0.789 . . . . 0.73 108.87 176.265 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 59.9 mtt -113.45 149.85 33.65 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.438 -0.949 . . . . 1.39 108.438 174.028 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -53.3 -54.37 45.85 Favored Pre-proline 0 C--N 1.321 -0.646 0 N-CA-C 112.647 0.61 . . . . 2.37 112.647 -174.57 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -74.61 -31.22 7.1 Favored 'Trans proline' 0 C--N 1.355 0.89 0 C-N-CA 121.387 1.391 . . . . 0.27 111.667 -176.315 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.589 ' O ' HG23 ' A' ' 93' ' ' VAL . 42.9 t80 -66.03 -56.06 13.47 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.113 -0.949 . . . . 0.22 110.099 179.309 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.436 ' HG3' ' H ' ' A' ' 83' ' ' GLY . 5.6 tm-20 -64.61 -37.96 89.37 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.598 -0.728 . . . . 2.12 110.218 -177.841 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.443 ' HA ' ' HD2' ' A' ' 94' ' ' ARG . 35.2 t70 -59.46 -26.93 65.64 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.874 -0.603 . . . . 0.61 110.7 177.879 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -85.59 -21.39 28.52 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.495 -0.32 . . . . 0.22 111.408 176.452 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.589 HG23 ' O ' ' A' ' 89' ' ' PHE . 44.8 t -74.83 -47.9 35.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 121.253 0.549 . . . . 0.25 110.567 -173.737 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.443 ' HD2' ' HA ' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -78.49 1.79 21.18 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.195 -0.457 . . . . 2.59 111.028 176.888 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -92.68 0.44 57.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.973 0.416 . . . . 0.47 110.758 -179.485 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.589 ' HB2' ' HB2' ' A' ' 100' ' ' ASP . 0.4 OUTLIER -137.28 160.37 39.22 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.968 -0.56 . . . . 0.28 110.627 177.876 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.482 ' HG3' ' H ' ' A' ' 98' ' ' ILE . 50.8 tptt -102.21 175.83 5.39 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.246 -0.65 . . . . 1.61 109.246 179.433 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.482 ' H ' ' HG3' ' A' ' 97' ' ' LYS . 63.0 mt -57.71 114.66 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 120.97 0.414 . . . . 0.9 110.725 177.797 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 104.76 -0.49 42.14 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.802 -0.714 . . . . 0.46 112.528 -179.499 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.589 ' HB2' ' HB2' ' A' ' 96' ' ' LEU . 24.6 m-20 -105.17 137.45 42.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.797 0.298 . . . . 0.46 110.522 179.732 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 12.7 mt -108.94 148.77 12.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.986 -0.552 . . . . 0.23 109.902 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 95.7 p -91.28 156.05 43.95 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-N 116.469 -0.332 . . . . 0.92 110.539 -179.625 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -69.69 174.08 9.97 Favored 'Trans proline' 0 C--O 1.233 0.271 0 C-N-CA 122.478 2.118 . . . . 0.34 111.245 171.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.916 HG23 HD23 ' A' ' 44' ' ' LEU . 26.1 mm -51.67 100.78 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 O-C-N 123.314 0.383 . . . . 0.2 111.447 176.025 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.5 p -104.76 118.34 51.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.2 0.524 . . . . 1.04 109.868 175.765 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -85.23 146.96 26.82 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.214 0.531 . . . . 0.55 110.674 -179.427 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 18.5 p -124.49 -172.38 2.55 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.395 -0.82 . . . . 0.37 109.76 179.553 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -73.46 -29.43 62.53 Favored 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 120.967 -0.293 . . . . 2.16 110.81 178.085 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.661 ' O ' ' HB2' ' A' ' 20' ' ' SER . 8.4 t -101.3 -9.31 21.33 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.1 0.407 . . . . 1.09 112.1 -175.377 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 160.66 -127.47 1.78 Allowed Glycine 0 N--CA 1.437 -1.293 0 C-N-CA 119.871 -1.157 . . . . 0.24 112.638 170.416 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.888 ' HB3' HD22 ' A' ' 44' ' ' LEU . 6.1 mp -120.9 144.11 48.6 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 114.981 -0.61 . . . . 0.19 110.846 -172.36 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' HIS . . . . . 0.736 ' CE1' HD13 ' A' ' 14' ' ' LEU . 70.8 m80 -143.06 151.72 41.09 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.262 0.553 . . . . 0.22 112.044 -179.773 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.633 HG12 HD11 ' A' ' 44' ' ' LEU . 2.8 pt -134.64 141.36 43.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 107.658 -1.238 . . . . 0.17 107.658 161.126 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 1.8 mp -129.98 143.31 41.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 C-N-CA 120.773 -0.371 . . . . 0.18 110.62 -176.761 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.425 ' HA ' ' O ' ' A' ' 100' ' ' ASP . 43.8 pttt -125.14 138.17 54.16 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.63 -0.878 . . . . 0.61 108.63 172.136 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.441 ' HB2' ' CD1' ' A' ' 96' ' ' LEU . 61.3 ttt180 -85.64 136.39 33.39 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.079 0.466 . . . . 1.87 111.268 -177.079 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 6.6 mp -115.25 -24.29 8.54 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.62 -0.718 . . . . 0.89 111.508 -178.627 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.59 ' HB3' ' HB3' ' A' ' 9' ' ' ARG . . . . . . . . 0 C--O 1.244 0.774 0 CA-C-O 118.22 -0.895 . . . . 1.1 109.882 175.718 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 98.2 mmm . . . . . 0 N--CA 1.479 1.009 0 N-CA-C 110.194 -0.299 . . . . 7.23 110.194 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 57.4 m -139.87 169.84 16.98 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.169 -0.469 . . . . 2.88 110.616 178.174 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -130.07 104.44 7.34 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.792 -0.64 . . . . 2.8 109.865 176.728 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 24.3 tptt -149.76 134.07 17.33 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.281 0.563 . . . . 1.19 110.004 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.667 HD23 ' N ' ' A' ' 9' ' ' ARG . 2.9 tt -139.29 155.92 47.4 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 115.065 -0.97 . . . . 1.18 108.467 -177.449 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.667 ' N ' HD23 ' A' ' 8' ' ' LEU . 44.3 ttt180 -139.56 128.48 23.52 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 108.199 -1.038 . . . . 1.06 108.199 173.422 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.43 ' O ' ' HB2' ' A' ' 77' ' ' LEU . . . -146.04 148.71 32.98 Favored 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 120.402 -0.519 . . . . 0.22 111.983 -177.106 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.42 ' HB3' ' HG2' ' A' ' 115' ' ' LYS . . . -102.44 137.15 41.07 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.428 -0.806 . . . . 0.2 109.264 176.592 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 23.1 p-80 -137.37 152.68 49.95 Favored 'General case' 0 C--N 1.323 -0.587 0 C-N-CA 120.418 -0.513 . . . . 0.23 111.872 -172.569 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.579 HD23 ' N ' ' A' ' 14' ' ' LEU . 5.4 tt -121.1 148.3 44.37 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.467 -0.938 . . . . 0.24 108.467 177.841 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.612 HD21 ' HE3' ' A' ' 16' ' ' LYS . 27.4 tp -131.23 130.96 43.58 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 110.378 -0.23 . . . . 0.27 110.378 -179.355 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.544 HG23 HD13 ' A' ' 44' ' ' LEU . 63.6 t -120.83 129.22 75.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 109.518 -0.549 . . . . 0.15 109.518 173.241 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.612 ' HE3' HD21 ' A' ' 14' ' ' LEU . 32.1 mmtp -104.58 158.33 16.57 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.214 -0.448 . . . . 0.62 110.504 178.336 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -150.68 162.13 41.28 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.954 -0.566 . . . . 0.25 110.125 -175.07 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.463 ' HB3' ' C ' ' A' ' 33' ' ' ALA . 45.8 p -55.0 111.42 0.83 Allowed 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 110.117 -0.327 . . . . 1.04 110.117 175.209 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 104.24 9.84 35.47 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.074 -1.06 . . . . 0.53 112.394 -177.113 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.475 ' HB2' ' O ' ' A' ' 109' ' ' SER . 79.5 p -92.98 24.21 3.82 Favored 'General case' 0 N--CA 1.453 -0.308 0 O-C-N 122.376 -0.485 . . . . 0.7 110.791 -177.541 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 60.3 mtt180 71.79 -33.39 0.27 Allowed 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 123.225 0.61 . . . . 3.49 111.406 -178.193 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.455 ' H ' ' C ' ' A' ' 20' ' ' SER . 38.5 m-80 -127.8 89.05 51.77 Favored Pre-proline 0 C--N 1.324 -0.541 0 N-CA-C 109.109 -0.7 . . . . 1.77 109.109 176.336 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.498 ' C ' HG22 ' A' ' 32' ' ' THR . 90.5 Cg_endo -79.84 45.46 1.96 Allowed 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 122.678 2.252 . . . . 1.71 112.82 -173.522 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.41 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 60.7 t -141.53 115.14 4.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 108.68 -0.859 . . . . 0.48 108.68 178.796 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.473 ' HB2' ' OD1' ' A' ' 67' ' ' ASP . 15.9 p -100.84 158.35 16.04 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 110.173 -0.306 . . . . 1.12 110.173 -178.04 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.485 ' HG2' ' HA ' ' A' ' 67' ' ' ASP . 18.3 mmm180 -72.97 -17.24 61.49 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 108.362 -0.977 . . . . 2.54 108.362 172.122 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 13.2 ttp180 -65.83 -48.64 70.97 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 114.463 -1.244 . . . . 1.77 110.054 177.821 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 33.3 p -96.35 -34.49 11.55 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.153 0.501 . . . . 0.67 110.765 -178.078 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 85.91 -31.37 4.01 Favored Glycine 0 N--CA 1.45 -0.381 0 CA-C-N 115.752 -0.658 . . . . 0.82 113.148 -179.375 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -101.24 -61.23 1.4 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.973 0.386 . . . . 2.1 111.424 -178.128 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.41 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 10.3 p -154.77 149.62 26.68 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.986 0.422 . . . . 1.08 111.674 178.798 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.498 HG22 ' C ' ' A' ' 23' ' ' PRO . 12.6 t -116.86 27.31 9.23 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 122.305 1.05 . . . . 0.34 108.733 173.2 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.463 ' C ' ' HB3' ' A' ' 18' ' ' SER . . . -75.83 -4.43 40.68 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.598 -1.183 . . . . 0.37 112.162 -175.213 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -97.94 -19.8 17.84 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.943 0.401 . . . . 2.21 110.632 -178.263 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.505 HG23 ' HB2' ' A' ' 39' ' ' ASP . 0.2 OUTLIER -101.85 137.85 28.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 116.062 -0.517 . . . . 0.31 110.36 -178.667 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 61.8 p -96.91 177.9 5.47 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 109.531 -0.544 . . . . 0.39 109.531 -178.257 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.472 ' HA ' ' HB3' ' A' ' 40' ' ' ALA . 0.1 OUTLIER -68.39 -21.26 64.7 Favored 'General case' 0 C--O 1.217 -0.616 0 C-N-CA 118.72 -1.192 . . . . 1.53 110.288 174.26 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -72.41 -41.98 65.63 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.931 -0.396 . . . . 0.96 109.931 175.821 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.505 ' HB2' HG23 ' A' ' 35' ' ' VAL . 23.9 m-20 -71.04 -35.17 71.88 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.404 0.621 . . . . 0.91 109.853 175.035 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.472 ' HB3' ' HA ' ' A' ' 37' ' ' TYR . . . -67.99 -48.25 66.29 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.098 -0.955 . . . . 0.19 110.613 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.437 ' CG1' HD21 ' A' ' 111' ' ' LEU . 69.8 mt -62.15 -36.83 76.44 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.462 0 N-CA-C 109.833 -0.432 . . . . 0.3 109.833 175.661 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 59.6 tttp -59.86 -29.09 68.07 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.832 -0.622 . . . . 2.32 109.891 178.818 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -88.91 -49.54 6.73 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.461 -0.791 . . . . 1.02 110.473 -178.502 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.928 HD23 HG23 ' A' ' 104' ' ' ILE . 33.9 tp -58.73 -36.42 74.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.969 -0.56 . . . . 0.17 110.039 -177.503 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.456 ' O ' ' HB2' ' A' ' 49' ' ' GLN . 11.8 mm-40 -66.92 -23.56 65.99 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-N 115.954 -0.566 . . . . 0.87 112.078 -179.692 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -85.01 -40.29 17.05 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 110.196 -0.298 . . . . 1.31 110.196 179.672 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.413 ' O ' HG13 ' A' ' 51' ' ' ILE . 36.8 m95 -66.46 -47.87 71.73 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.96 -0.296 . . . . 0.52 111.293 174.829 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.44 ' HB3' HG21 ' A' ' 113' ' ' ILE . 88.6 p -62.75 -28.24 69.83 Favored 'General case' 0 C--N 1.333 -0.128 0 C-N-CA 120.719 -0.392 . . . . 0.82 110.062 177.449 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.456 ' HB2' ' O ' ' A' ' 45' ' ' GLN . 11.4 tt0 -66.74 -57.17 7.64 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.925 -0.58 . . . . 0.53 110.323 173.774 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.622 ' HB3' HG22 ' A' ' 56' ' ' VAL . 86.2 mtt180 -61.14 -42.14 98.01 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.943 -0.571 . . . . 0.42 111.58 -176.437 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.489 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 92.4 mt -61.51 -36.63 74.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 120.929 0.395 . . . . 0.2 110.43 177.479 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -77.46 -35.45 53.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.068 -0.515 . . . . 0.27 111.684 -179.476 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 51.1 p -80.49 -30.34 37.33 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.893 0.377 . . . . 0.35 111.481 -177.702 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 108.55 4.43 32.37 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.76 -0.733 . . . . 0.3 112.218 -179.73 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.42 ' HB2' ' HB3' ' A' ' 50' ' ' ARG . 40.0 mt-10 -61.49 -48.7 79.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.007 0.432 . . . . 0.65 110.104 178.039 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.622 HG22 ' HB3' ' A' ' 50' ' ' ARG . 13.6 m -133.77 157.45 42.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 109.354 -0.61 . . . . 0.19 109.354 171.824 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 49.6 m -85.93 160.02 19.5 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 109.471 -0.566 . . . . 0.97 109.471 177.211 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.424 ' HA ' HD13 ' A' ' 51' ' ' ILE . 2.7 t80 -53.66 -43.92 69.2 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.272 0.558 . . . . 0.22 109.948 -177.662 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.583 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 2.8 mp0 -56.96 -39.13 74.01 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.845 -1.071 . . . . 1.72 111.916 -178.307 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 31.5 mm-40 -65.39 -48.94 71.14 Favored 'General case' 0 CA--C 1.521 -0.16 0 CA-C-O 120.836 0.35 . . . . 2.09 111.118 -177.739 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -68.94 -42.72 76.33 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.386 -0.37 . . . . 0.26 111.108 -177.814 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.11 -53.82 52.22 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.331 -0.395 . . . . 0.24 112.051 -175.657 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.519 ' HA ' ' O ' ' A' ' 71' ' ' TYR . 16.0 m -51.56 -21.8 2.79 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 113.149 0.796 . . . . 1.0 113.149 -177.342 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -104.99 -46.71 4.2 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.519 0.676 . . . . 0.61 110.473 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' A' ' 65' ' ' ARG . 21.2 mmt180 -94.8 -36.11 11.81 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.745 -1.116 . . . . 0.86 113.99 -168.784 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.499 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 54.4 p -63.23 116.81 5.79 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.031 0.443 . . . . 0.82 110.479 -177.684 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.485 ' HA ' ' HG2' ' A' ' 26' ' ' ARG . 48.5 m-20 -82.15 0.72 39.6 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.772 -0.649 . . . . 2.28 111.251 -178.657 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.565 ' SG ' HD22 ' A' ' 14' ' ' LEU . 1.7 m -78.42 173.67 12.1 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.869 -0.605 . . . . 1.52 109.978 172.159 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -69.28 -16.54 71.32 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.706 -0.759 . . . . 0.26 112.026 179.533 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 67.2 p -65.98 -5.51 9.74 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 112.576 0.584 . . . . 0.32 112.576 -179.046 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.519 ' O ' ' HA ' ' A' ' 63' ' ' SER . 30.4 p90 -60.36 -25.76 66.1 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.005 0.431 . . . . 0.54 110.33 177.78 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -94.36 -2.58 51.85 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.239 0.542 . . . . 0.49 110.448 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 7.0 m -116.84 9.36 13.85 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.832 -0.622 . . . . 0.71 110.748 -178.1 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.583 ' O ' ' HA ' ' A' ' 59' ' ' GLU . . . 68.27 28.51 73.27 Favored Glycine 0 C--O 1.227 -0.288 0 C-N-CA 120.915 -0.66 . . . . 0.54 112.039 -177.435 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 83.29 -21.2 8.78 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 121.145 -0.55 . . . . 0.35 112.282 -178.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -72.68 136.81 45.7 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.787 0.327 . . . . 1.65 111.192 -173.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.43 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 2.6 mp -116.17 166.79 11.62 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.955 -0.566 . . . . 0.94 110.027 174.665 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -81.24 -148.52 6.16 Favored Glycine 0 C--N 1.314 -0.669 0 CA-C-N 115.393 -0.821 . . . . 0.44 113.138 -177.246 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -99.33 143.92 29.03 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.993 0.425 . . . . 3.87 110.864 -179.293 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.411 ' HE2' ' HB3' ' A' ' 77' ' ' LEU . 0.9 OUTLIER -157.31 175.23 14.29 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.856 -0.611 . . . . 1.31 109.815 -174.925 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 16.2 m -104.17 139.52 39.11 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.876 -0.787 . . . . 1.17 108.876 175.802 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 48.0 m -61.96 126.96 29.18 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.076 0.465 . . . . 1.19 110.812 -179.375 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 114.74 -4.25 22.87 Favored Glycine 0 N--CA 1.443 -0.898 0 CA-C-N 115.392 -0.822 . . . . 0.79 111.276 -176.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -95.85 6.99 47.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.699 0.285 . . . . 1.55 111.363 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 25.0 mmt -104.16 -122.6 0.21 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.047 0.451 . . . . 0.73 110.572 179.36 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 54.8 mtt -123.69 152.15 42.36 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 107.919 -1.141 . . . . 1.39 107.919 175.795 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm -53.17 -53.99 49.64 Favored Pre-proline 0 C--N 1.319 -0.721 0 N-CA-C 112.249 0.463 . . . . 2.37 112.249 -175.219 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.05 -30.68 10.54 Favored 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 121.457 1.438 . . . . 0.27 111.836 -177.551 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.646 ' O ' HG23 ' A' ' 93' ' ' VAL . 26.3 t80 -67.36 -56.48 9.53 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.247 -0.888 . . . . 0.22 109.885 179.742 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -62.19 -35.32 78.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.535 -0.757 . . . . 2.12 110.449 -178.728 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -61.12 -30.47 70.39 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.362 -0.836 . . . . 0.61 110.905 178.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.465 ' O ' ' HG ' ' A' ' 96' ' ' LEU . . . -83.35 -26.84 30.16 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.851 0.357 . . . . 0.22 110.659 178.001 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.646 HG23 ' O ' ' A' ' 89' ' ' PHE . 27.4 t -70.43 -37.62 71.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.255 0.55 . . . . 0.25 110.165 -176.633 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.479 ' C ' ' HD2' ' A' ' 94' ' ' ARG . 6.2 ppt_? -78.92 -13.68 59.66 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.882 -0.599 . . . . 2.59 110.735 178.657 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -84.23 -11.04 57.15 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.185 0.517 . . . . 0.47 110.963 -175.694 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.583 ' HB2' ' HB2' ' A' ' 100' ' ' ASP . 0.9 OUTLIER -127.64 145.18 50.97 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.828 -0.624 . . . . 0.28 110.761 179.713 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.424 ' HG3' ' H ' ' A' ' 98' ' ' ILE . 20.7 tptm -92.95 173.12 7.91 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 109.021 -0.733 . . . . 1.61 109.021 178.754 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.463 ' HA ' ' HG2' ' A' ' 116' ' ' ARG . 72.1 mt -45.76 115.96 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.913 0.387 . . . . 0.9 111.649 176.393 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 106.16 -12.27 44.47 Favored Glycine 0 CA--C 1.521 0.45 0 C-N-CA 120.946 -0.645 . . . . 0.46 113.736 177.78 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.583 ' HB2' ' HB2' ' A' ' 96' ' ' LEU . 15.7 m-20 -97.95 148.98 22.91 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 117.566 0.683 . . . . 0.46 111.144 -178.005 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 13.0 mt -115.83 149.08 18.15 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-N 115.951 -0.568 . . . . 0.23 110.872 -174.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.411 ' HB2' ' H ' ' A' ' 114' ' ' ILE . 5.9 m -81.72 151.18 67.59 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 115.953 -0.567 . . . . 0.92 110.806 -178.333 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -73.75 165.22 32.8 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 122.2 1.934 . . . . 0.34 109.989 166.221 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.928 HG23 HD23 ' A' ' 44' ' ' LEU . 20.1 mm -46.47 108.54 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 O-C-N 123.32 0.387 . . . . 0.2 111.956 178.292 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.3 p -115.32 117.59 56.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.193 -0.458 . . . . 1.04 110.157 176.812 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 16.8 mt-30 -85.25 147.24 26.67 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.055 0.455 . . . . 0.55 110.07 178.105 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 8.8 p -121.38 -172.46 2.42 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.421 -0.808 . . . . 0.37 110.389 -177.474 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -59.86 -35.27 74.44 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.589 0.233 . . . . 2.16 110.78 178.649 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.603 ' OG ' ' HE2' ' A' ' 16' ' ' LYS . 6.4 t -96.78 -60.93 1.49 Allowed 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.69 -0.404 . . . . 1.09 110.884 -179.713 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -147.72 -135.02 2.57 Favored Glycine 0 N--CA 1.443 -0.884 0 C-N-CA 118.9 -1.619 . . . . 0.24 113.733 -173.321 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.896 ' HB3' HD22 ' A' ' 44' ' ' LEU . 7.7 mp -113.83 146.34 40.11 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 114.962 -0.619 . . . . 0.19 111.232 -170.643 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' HIS . . . . . 0.538 ' HA ' ' O ' ' A' ' 13' ' ' LEU . 77.0 m-70 -144.16 150.14 37.58 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.144 0.497 . . . . 0.22 111.902 179.659 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.557 HG12 HD11 ' A' ' 44' ' ' LEU . 2.1 pt -134.57 137.58 51.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 107.715 -1.217 . . . . 0.17 107.715 160.651 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.411 ' H ' ' HB2' ' A' ' 102' ' ' SER . 2.1 mp -128.1 145.96 34.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 C-N-CA 121.035 -0.266 . . . . 0.18 110.735 -174.758 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.42 ' HG2' ' HB3' ' A' ' 11' ' ' ALA . 47.4 pttt -127.84 139.86 52.38 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.733 -0.84 . . . . 0.61 108.733 172.887 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.483 ' HD3' HD21 ' A' ' 8' ' ' LEU . 4.7 ttp180 -83.11 133.92 35.03 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.12 -0.632 . . . . 1.87 110.868 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -103.04 -36.0 8.33 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.87 -1.059 . . . . 0.89 109.729 -178.839 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.475 ' HB3' ' HB3' ' A' ' 9' ' ' ARG . . . . . . . . 0 C--O 1.245 0.855 0 CA-C-O 117.992 -1.004 . . . . 1.1 109.569 178.848 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 22.3 ptt? . . . . . 0 N--CA 1.481 1.088 0 N-CA-C 111.523 0.194 . . . . 7.23 111.523 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 17.5 p -80.05 -16.22 55.52 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 112.111 0.411 . . . . 2.88 112.111 -174.013 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.523 ' O ' ' HA ' ' A' ' 81' ' ' SER . 0.4 OUTLIER -88.54 1.05 55.64 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.876 -0.329 . . . . 2.8 110.688 -178.513 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -71.81 114.78 10.26 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.281 0.562 . . . . 1.19 109.95 176.425 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.655 HD23 ' H ' ' A' ' 9' ' ' ARG . 0.4 OUTLIER -124.04 164.37 19.52 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.046 -0.979 . . . . 1.18 109.529 -174.63 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.655 ' H ' HD23 ' A' ' 8' ' ' LEU . 58.4 ttt180 -145.35 128.85 17.0 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.395 -0.594 . . . . 1.06 109.395 175.539 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.432 ' N ' ' HZ ' ' A' ' 80' ' ' PHE . . . -146.35 153.74 40.86 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.12 0.486 . . . . 0.22 112.036 -179.456 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.41 ' HB3' ' HG2' ' A' ' 115' ' ' LYS . . . -106.81 133.03 52.1 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.457 -0.792 . . . . 0.2 109.089 176.573 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 38.0 p-80 -137.06 155.65 49.39 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.366 0.506 . . . . 0.23 112.366 -170.628 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.577 HD23 ' N ' ' A' ' 14' ' ' LEU . 5.3 tt -123.13 147.25 46.99 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.694 -0.854 . . . . 0.24 108.694 176.377 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.577 ' N ' HD23 ' A' ' 13' ' ' LEU . 23.6 tp -131.64 124.4 29.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.486 0.184 . . . . 0.27 111.126 -178.677 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.527 HG23 HD13 ' A' ' 44' ' ' LEU . 58.9 t -112.85 142.03 26.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 109.787 -0.449 . . . . 0.15 109.787 175.577 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.429 ' HE3' HD21 ' A' ' 14' ' ' LEU . 31.2 mmtp -114.39 156.36 24.62 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.789 -0.448 . . . . 0.62 109.789 178.306 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.409 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 41.7 p90 -149.96 162.74 39.77 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.513 -0.312 . . . . 0.25 110.26 -176.087 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.474 ' HB3' ' C ' ' A' ' 33' ' ' ALA . 54.0 p -52.06 112.88 0.86 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.786 0.327 . . . . 1.04 111.111 179.046 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 99.63 10.37 47.34 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.327 -0.939 . . . . 0.53 113.007 179.547 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.521 ' C ' ' H ' ' A' ' 22' ' ' ASN . 33.0 p -76.29 23.07 0.15 Allowed 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 117.459 0.63 . . . . 0.7 112.462 -174.438 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 86.1 mtt180 69.55 -35.28 0.31 Allowed 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.708 0.803 . . . . 3.49 110.355 -175.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.521 ' H ' ' C ' ' A' ' 20' ' ' SER . 13.2 m-80 -140.13 102.25 6.85 Favored Pre-proline 0 N--CA 1.445 -0.717 0 N-CA-C 108.08 -1.082 . . . . 1.77 108.08 174.046 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -68.31 -159.27 0.05 OUTLIER 'Trans proline' 0 CA--C 1.531 0.371 0 C-N-CA 122.894 2.396 . . . . 1.71 111.821 179.453 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.523 ' N ' HG22 ' A' ' 32' ' ' THR . 16.5 t 62.25 107.16 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-N 115.487 -0.779 . . . . 0.48 111.976 178.202 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.417 ' HB3' ' HB2' ' A' ' 16' ' ' LYS . 59.3 p -103.72 155.88 18.24 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.644 -0.502 . . . . 1.12 109.644 175.425 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.516 ' HB2' ' HA ' ' A' ' 67' ' ' ASP . 4.7 mpt_? -66.33 -7.85 21.54 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.123 0.487 . . . . 2.54 110.486 174.509 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.484 ' HG2' ' HD3' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -85.54 -27.23 25.71 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.421 -0.808 . . . . 1.77 110.237 178.887 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 26.8 p -108.31 -35.53 6.5 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.873 -0.603 . . . . 0.67 111.193 -176.005 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 80.41 -33.98 2.26 Favored Glycine 0 CA--C 1.519 0.304 0 CA-C-N 115.443 -0.799 . . . . 0.82 113.483 175.567 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.439 ' O ' HG22 ' A' ' 24' ' ' VAL . 15.0 t70 -105.13 -66.19 0.99 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.911 0.355 . . . . 2.1 110.635 179.44 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 19.2 m -152.3 150.89 30.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.111 0.481 . . . . 1.08 111.155 -179.223 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.523 HG22 ' N ' ' A' ' 24' ' ' VAL . 8.9 t -123.62 19.03 9.56 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 122.005 0.907 . . . . 0.34 109.347 178.012 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.474 ' C ' ' HB3' ' A' ' 18' ' ' SER . . . -67.35 -5.26 13.61 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.066 -0.97 . . . . 0.37 112.364 177.449 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -92.39 -24.34 18.91 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.889 0.376 . . . . 2.21 111.111 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.444 HG13 ' OG1' ' A' ' 32' ' ' THR . 0.2 OUTLIER -101.78 137.15 30.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 116.138 -0.483 . . . . 0.31 109.965 -179.573 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 77.1 p -94.04 177.48 5.96 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 116.289 -0.414 . . . . 0.39 110.054 -173.783 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.53 ' O ' HG13 ' A' ' 41' ' ' ILE . 15.4 p90 -63.37 -30.53 71.65 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 119.917 -0.713 . . . . 1.53 109.435 176.408 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -69.46 -47.78 62.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.081 -0.509 . . . . 0.96 110.595 178.369 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 39.5 m-20 -70.38 -27.84 64.63 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.98 -0.555 . . . . 0.91 110.26 179.465 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.409 ' HB2' ' HB3' ' A' ' 17' ' ' PHE . . . -74.31 -39.06 63.12 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.495 -0.775 . . . . 0.19 110.329 177.73 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.53 HG13 ' O ' ' A' ' 37' ' ' TYR . 80.6 mt -64.46 -36.71 78.05 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 109.524 -0.547 . . . . 0.3 109.524 174.133 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.45 ' O ' ' HG3' ' A' ' 46' ' ' LYS . 26.3 mtpp -64.12 -25.0 67.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.942 0.401 . . . . 2.32 110.485 175.931 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.45 ' HG3' ' NE1' ' A' ' 47' ' ' TRP . 6.9 tt0 -83.88 -51.76 6.92 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.892 -0.595 . . . . 1.02 109.823 -179.188 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.912 HD22 ' HB3' ' A' ' 111' ' ' LEU . 34.0 tp -60.69 -38.76 86.07 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.786 -0.643 . . . . 0.17 110.479 -179.744 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.491 ' O ' ' HB2' ' A' ' 49' ' ' GLN . 4.1 mm100 -61.51 -38.28 86.8 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.189 -0.459 . . . . 0.87 112.146 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.45 ' HG3' ' O ' ' A' ' 42' ' ' LYS . 68.3 mttm -72.78 -38.68 67.19 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.672 0.273 . . . . 1.31 111.083 -177.723 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.45 ' NE1' ' HG3' ' A' ' 43' ' ' GLU . 9.8 m95 -70.83 -45.85 63.81 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.885 -0.326 . . . . 0.52 110.863 178.06 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.463 ' HB3' HG21 ' A' ' 113' ' ' ILE . 89.1 p -64.36 -28.3 69.61 Favored 'General case' 0 CA--C 1.528 0.122 0 N-CA-C 110.073 -0.343 . . . . 0.82 110.073 177.356 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.491 ' HB2' ' O ' ' A' ' 45' ' ' GLN . 12.5 tt0 -64.68 -52.05 59.3 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 116.018 -0.537 . . . . 0.53 109.952 175.368 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.639 ' HB3' HG22 ' A' ' 56' ' ' VAL . 84.4 mtt180 -61.05 -46.73 89.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.548 -0.751 . . . . 0.42 111.205 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.465 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 85.3 mt -56.69 -43.67 79.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.291 -0.413 . . . . 0.2 110.872 177.185 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.68 -42.62 81.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.117 -0.492 . . . . 0.27 111.927 -179.339 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 51.3 p -77.7 -30.39 51.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.934 0.397 . . . . 0.35 111.367 -177.187 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 108.68 8.96 27.6 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.564 -0.827 . . . . 0.3 112.242 179.006 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.504 ' OE1' ' HG2' ' A' ' 50' ' ' ARG . 48.6 mt-10 -60.84 -49.37 77.77 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.096 0.475 . . . . 0.65 109.913 176.657 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.639 HG22 ' HB3' ' A' ' 50' ' ' ARG . 31.4 m -134.44 154.68 37.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.719 -0.673 . . . . 0.19 109.41 173.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.435 ' OG ' ' HG2' ' A' ' 60' ' ' GLU . 19.8 p -79.44 161.83 25.86 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 110.042 -0.355 . . . . 0.97 110.042 176.569 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -55.04 -38.4 67.92 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.377 0.608 . . . . 0.22 109.548 178.24 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -59.2 -43.45 92.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.885 -1.052 . . . . 1.72 111.828 -179.223 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.435 ' HG2' ' OG ' ' A' ' 57' ' ' SER . 12.1 mm-40 -64.48 -42.09 96.1 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-O 121.016 0.436 . . . . 2.09 110.85 -178.589 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.429 ' O ' ' HG2' ' A' ' 65' ' ' ARG . . . -70.01 -55.85 8.51 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.896 -0.593 . . . . 0.26 110.455 179.611 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -54.63 -52.96 60.61 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.513 0.56 . . . . 0.24 112.513 -174.041 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.483 ' HA ' ' O ' ' A' ' 71' ' ' TYR . 20.8 t -52.0 -27.95 15.26 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.695 0.628 . . . . 1.0 112.695 -175.633 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -105.28 -44.19 4.81 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.492 0.663 . . . . 0.61 110.894 -177.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.484 ' HD3' ' HG2' ' A' ' 27' ' ' ARG . 16.6 mmt180 -83.59 -44.4 14.64 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.944 -1.026 . . . . 0.86 113.114 -171.852 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.449 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 77.6 p -65.21 120.04 11.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.128 0.49 . . . . 0.82 111.429 -173.753 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.516 ' HA ' ' HB2' ' A' ' 26' ' ' ARG . 19.6 t70 -70.81 -16.9 62.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.48 -0.782 . . . . 2.28 110.885 177.132 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.473 ' O ' ' HD2' ' A' ' 71' ' ' TYR . 53.7 t -77.99 154.96 31.05 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.259 0.552 . . . . 1.52 109.931 178.815 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -58.94 -12.37 14.83 Favored Glycine 0 C--O 1.234 0.148 0 CA-C-N 114.66 -1.155 . . . . 0.26 113.714 -173.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 52.3 p -64.72 -8.07 13.29 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 111.771 0.285 . . . . 0.32 111.771 176.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.483 ' O ' ' HA ' ' A' ' 63' ' ' SER . 51.1 p90 -57.59 -25.38 59.95 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.932 0.396 . . . . 0.54 110.596 176.631 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -93.98 3.35 55.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.058 0.456 . . . . 0.49 111.035 -179.382 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 9.0 m -126.78 14.42 7.47 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.099 -0.5 . . . . 0.71 110.772 179.356 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 67.97 24.7 74.44 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 121.063 -0.589 . . . . 0.54 112.54 -178.104 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 86.91 -17.2 42.57 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 121.16 -0.543 . . . . 0.35 112.219 -179.612 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -74.55 136.79 42.12 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.733 0.302 . . . . 1.65 110.682 -176.01 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.419 ' O ' ' HG3' ' A' ' 9' ' ' ARG . 2.4 mp -113.46 157.88 21.39 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 116.248 -0.433 . . . . 0.94 110.055 173.218 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -76.19 -107.03 0.13 Allowed Glycine 0 C--N 1.309 -0.953 0 CA-C-N 115.226 -0.897 . . . . 0.44 113.504 -175.497 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 9.1 p90 -120.87 149.0 43.28 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.716 0.293 . . . . 3.87 110.796 -178.12 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.432 ' HZ ' ' N ' ' A' ' 10' ' ' ALA . 3.8 p90 -166.27 161.32 16.66 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.547 -0.538 . . . . 1.31 109.547 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.523 ' HA ' ' O ' ' A' ' 6' ' ' GLU . 73.0 p -105.11 125.45 50.99 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 109.292 -0.632 . . . . 1.17 109.292 176.337 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 11.0 p -44.69 122.09 3.0 Favored 'General case' 0 C--O 1.234 0.288 0 O-C-N 123.79 0.681 . . . . 1.19 111.618 -178.048 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 114.42 10.46 13.22 Favored Glycine 0 N--CA 1.446 -0.655 0 CA-C-N 115.824 -0.626 . . . . 0.79 111.662 -177.76 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -109.23 -5.48 15.9 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 111.481 0.178 . . . . 1.55 111.481 179.64 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 26.2 mmt -95.15 -105.05 0.15 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.285 0.564 . . . . 0.73 111.085 -175.854 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.458 ' HB2' ' HB3' ' A' ' 89' ' ' PHE . 44.1 mtt -138.12 148.81 45.33 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 107.381 -1.34 . . . . 1.39 107.381 177.789 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.418 ' HB3' ' HD3' ' A' ' 88' ' ' PRO . 64.6 tttp -51.16 -54.55 36.75 Favored Pre-proline 0 C--N 1.32 -0.685 0 N-CA-C 112.472 0.545 . . . . 2.37 112.472 -175.496 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.552 ' HG2' HG22 ' A' ' 107' ' ' THR . 86.5 Cg_endo -75.67 -29.7 6.96 Favored 'Trans proline' 0 C--N 1.356 0.965 0 C-N-CA 121.664 1.576 . . . . 0.27 111.997 -177.557 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.595 ' O ' HG23 ' A' ' 93' ' ' VAL . 12.4 t80 -66.32 -56.42 11.23 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.722 -0.672 . . . . 0.22 109.428 178.466 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.534 ' O ' ' HD3' ' A' ' 94' ' ' ARG . 4.2 tp10 -61.4 -36.14 79.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.16 -0.927 . . . . 2.12 109.812 -179.773 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.765 ' HA ' ' NE ' ' A' ' 94' ' ' ARG . 27.2 t70 -54.44 -43.73 71.85 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 115.155 -0.929 . . . . 0.61 110.77 177.529 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.67 ' O ' ' HG ' ' A' ' 96' ' ' LEU . . . -71.5 -34.4 70.09 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.022 -0.536 . . . . 0.22 110.765 179.617 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.595 HG23 ' O ' ' A' ' 89' ' ' PHE . 28.4 t -60.86 -49.53 84.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.406 -0.361 . . . . 0.25 111.219 -176.06 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.765 ' NE ' ' HA ' ' A' ' 91' ' ' ASP . 0.1 OUTLIER -75.91 -16.66 59.99 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.516 -0.474 . . . . 2.59 110.479 179.463 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -78.34 -13.51 59.82 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.065 -0.516 . . . . 0.47 111.439 -176.032 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.67 ' HG ' ' O ' ' A' ' 92' ' ' ALA . 0.4 OUTLIER -123.21 159.6 28.34 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.174 0.511 . . . . 0.28 111.137 178.052 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.487 ' HE3' HD13 ' A' ' 98' ' ' ILE . 54.5 tptt -102.27 176.78 5.07 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.321 -0.854 . . . . 1.61 109.321 178.769 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.487 HD13 ' HE3' ' A' ' 97' ' ' LYS . 1.1 mp -47.43 119.97 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 C-N-CA 123.423 0.689 . . . . 0.9 111.298 178.8 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 92.92 -10.53 73.75 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 121.002 -0.618 . . . . 0.46 113.071 176.863 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.59 ' HB2' ' HB2' ' A' ' 96' ' ' LEU . 23.1 m-20 -85.64 131.68 34.3 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 117.115 0.457 . . . . 0.46 110.301 -178.418 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 8.7 mt -104.52 143.64 15.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.073 -0.512 . . . . 0.23 109.779 179.706 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 89.2 p -88.22 148.49 42.86 Favored Pre-proline 0 C--N 1.318 -0.799 0 CA-C-N 116.341 -0.39 . . . . 0.92 110.402 -178.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -70.1 163.73 37.47 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 122.032 1.821 . . . . 0.34 110.615 170.723 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.862 HG23 HD23 ' A' ' 44' ' ' LEU . 21.5 mm -39.64 100.33 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 N-CA-C 112.959 0.726 . . . . 0.2 112.959 179.318 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 1.8 p -104.69 118.13 51.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.979 -0.555 . . . . 1.04 109.798 175.782 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -85.8 145.52 27.18 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.266 0.555 . . . . 0.55 110.801 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.552 HG22 ' HG2' ' A' ' 88' ' ' PRO . 6.1 p -117.28 -172.82 2.29 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.309 -0.86 . . . . 0.37 110.161 179.694 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -65.63 -35.39 80.67 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 121.011 -0.275 . . . . 2.16 110.363 177.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.423 ' O ' ' HB2' ' A' ' 20' ' ' SER . 4.8 t -92.33 -60.96 1.71 Allowed 'General case' 0 N--CA 1.443 -0.778 0 C-N-CA 120.254 -0.578 . . . . 1.09 110.606 -179.125 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -145.03 -131.98 2.44 Favored Glycine 0 N--CA 1.44 -1.077 0 C-N-CA 119.015 -1.564 . . . . 0.24 113.793 -174.433 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.912 ' HB3' HD22 ' A' ' 44' ' ' LEU . 6.0 mp -121.53 147.99 45.08 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 114.917 -0.641 . . . . 0.19 111.08 -170.57 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' HIS . . . . . 0.5 ' HA ' ' O ' ' A' ' 13' ' ' LEU . 85.4 m-70 -143.25 148.97 37.25 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.313 0.577 . . . . 0.22 112.254 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.659 HG12 HD11 ' A' ' 44' ' ' LEU . 2.5 pt -131.05 135.04 60.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 107.491 -1.3 . . . . 0.17 107.491 160.055 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 3.0 mp -130.2 142.79 42.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 C-N-CA 120.866 -0.334 . . . . 0.18 110.439 -175.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.483 ' HA ' ' O ' ' A' ' 100' ' ' ASP . 40.9 pttt -123.21 139.18 54.32 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.622 -0.881 . . . . 0.61 108.622 172.359 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.521 ' HB2' ' CD1' ' A' ' 96' ' ' LEU . 57.1 ttt180 -83.74 131.74 34.9 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.155 0.502 . . . . 1.87 111.052 -177.855 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.459 ' HB2' ' HG2' ' A' ' 9' ' ' ARG . 4.3 mm? -98.9 -41.11 7.75 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.259 -0.882 . . . . 0.89 109.832 179.004 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.4 ' HB3' ' HB3' ' A' ' 9' ' ' ARG . . . . . . . . 0 C--O 1.246 0.899 0 CA-C-O 118.622 -0.704 . . . . 1.1 110.409 179.341 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 N--CA 1.479 0.998 0 N-CA-C 110.323 -0.251 . . . . 7.23 110.323 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 25.1 t 61.96 82.91 0.16 Allowed 'General case' 0 C--O 1.233 0.214 0 O-C-N 123.638 0.586 . . . . 2.88 110.689 -178.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.623 ' O ' ' HA ' ' A' ' 81' ' ' SER . 12.3 pt-20 -103.88 -25.75 12.94 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.41 -0.589 . . . . 2.8 109.41 177.29 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.52 ' HA ' ' O ' ' A' ' 80' ' ' PHE . 73.1 mmtt -75.06 134.46 41.36 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 115.81 -0.632 . . . . 1.19 111.034 -177.567 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.643 HD23 ' N ' ' A' ' 9' ' ' ARG . 3.2 tt -140.58 154.19 46.39 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 114.921 -1.036 . . . . 1.18 108.284 -177.256 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.643 ' N ' HD23 ' A' ' 8' ' ' LEU . 26.5 ttt180 -133.64 132.93 41.34 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.348 -0.982 . . . . 1.06 108.348 172.494 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -147.06 150.44 35.07 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.459 -0.496 . . . . 0.22 111.975 -174.094 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.623 ' HA ' ' HA ' ' A' ' 76' ' ' ASP . . . -108.45 133.74 52.2 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-N 115.698 -0.683 . . . . 0.2 109.8 177.544 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 45.8 p-80 -138.73 145.09 39.84 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 120.93 0.395 . . . . 0.23 111.108 -172.797 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.562 ' O ' ' HA ' ' A' ' 112' ' ' HIS . 6.6 tt -112.82 142.92 44.91 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.251 -1.018 . . . . 0.24 108.251 176.339 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.823 HD13 ' CE1' ' A' ' 112' ' ' HIS . 29.3 tp -128.97 118.41 22.56 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.739 0.304 . . . . 0.27 111.021 -175.763 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.519 HG23 HD13 ' A' ' 44' ' ' LEU . 46.3 t -107.88 134.19 50.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 109.501 -0.555 . . . . 0.15 109.501 176.348 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.475 ' HE3' HD21 ' A' ' 14' ' ' LEU . 32.7 mmtp -109.45 152.41 25.43 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.754 -0.462 . . . . 0.62 109.754 178.309 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.451 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 47.0 p90 -143.37 162.51 35.55 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.515 -0.311 . . . . 0.25 110.533 -176.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.414 ' HB3' ' HA ' ' A' ' 33' ' ' ALA . 19.9 p -52.08 113.44 1.02 Allowed 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.276 -0.42 . . . . 1.04 111.14 177.926 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 95.29 10.04 57.45 Favored Glycine 0 C--N 1.334 0.429 0 C-N-CA 120.761 -0.733 . . . . 0.53 113.318 179.497 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.664 ' HB2' ' O ' ' A' ' 109' ' ' SER . 85.6 p -90.0 35.05 0.84 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 117.368 0.584 . . . . 0.7 111.523 -175.804 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.464 ' HB3' ' O ' ' A' ' 20' ' ' SER . 73.7 ttt180 71.82 -34.26 0.29 Allowed 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 120.995 0.426 . . . . 3.49 111.16 -179.092 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.451 ' H ' ' C ' ' A' ' 20' ' ' SER . 45.7 m-80 -132.81 93.59 23.4 Favored Pre-proline 0 C--N 1.327 -0.385 0 N-CA-C 109.409 -0.589 . . . . 1.77 109.409 176.069 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.555 ' C ' HG22 ' A' ' 32' ' ' THR . 95.4 Cg_endo -80.83 49.16 3.14 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 122.507 2.138 . . . . 1.71 112.959 -176.326 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.482 ' N ' HG22 ' A' ' 32' ' ' THR . 47.3 t -147.26 117.0 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 N-CA-C 108.759 -0.83 . . . . 0.48 108.759 178.052 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 41.2 t -105.89 154.23 20.85 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 110.203 -0.295 . . . . 1.12 110.203 177.88 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.623 ' HB2' ' HA ' ' A' ' 67' ' ' ASP . 6.6 mpt_? -69.01 -5.27 20.7 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.087 0.47 . . . . 2.54 110.422 171.363 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.605 ' HG3' ' CD ' ' A' ' 65' ' ' ARG . 18.3 ttp180 -78.21 -29.58 48.41 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.654 -0.703 . . . . 1.77 109.623 175.822 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 71.6 p -115.28 -33.78 5.2 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.753 -0.658 . . . . 0.67 111.454 -174.434 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 81.55 -36.39 2.44 Favored Glycine 0 CA--C 1.52 0.371 0 CA-C-N 115.977 -0.556 . . . . 0.82 112.905 178.445 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -95.03 -65.99 0.94 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.801 0.334 . . . . 2.1 110.625 -178.059 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 13.7 p -153.94 156.26 37.16 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.949 0.404 . . . . 1.08 110.932 178.66 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.555 HG22 ' C ' ' A' ' 23' ' ' PRO . 14.8 t -120.07 28.63 7.96 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 122.076 0.941 . . . . 0.34 109.146 174.054 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.414 ' HA ' ' HB3' ' A' ' 18' ' ' SER . . . -75.78 -5.7 47.09 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.92 -1.036 . . . . 0.37 111.422 -178.085 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -93.82 -25.72 17.24 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.902 -0.59 . . . . 2.21 111.095 -179.042 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.523 HG23 ' HB2' ' A' ' 39' ' ' ASP . 0.2 OUTLIER -98.61 138.77 22.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 116.135 -0.484 . . . . 0.31 109.76 -178.663 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 72.8 p -94.76 176.77 6.14 Favored 'General case' 0 CA--C 1.513 -0.474 0 N-CA-C 109.84 -0.43 . . . . 0.39 109.84 -174.801 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.46 ' O ' HG13 ' A' ' 41' ' ' ILE . 4.1 p90 -63.88 -27.17 68.97 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 119.897 -0.721 . . . . 1.53 109.099 175.534 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -72.75 -46.78 51.66 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.956 -0.565 . . . . 0.96 110.301 178.589 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.523 ' HB2' HG23 ' A' ' 35' ' ' VAL . 42.1 m-20 -64.68 -33.52 76.14 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 121.375 0.607 . . . . 0.91 109.633 177.108 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.451 ' HB2' ' HB3' ' A' ' 17' ' ' PHE . . . -68.8 -45.73 70.52 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.985 -1.007 . . . . 0.19 110.64 179.311 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.487 ' CG1' HD21 ' A' ' 111' ' ' LEU . 70.1 mt -62.55 -37.68 79.51 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.345 0 N-CA-C 109.704 -0.48 . . . . 0.3 109.704 174.909 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.446 ' O ' ' HG3' ' A' ' 46' ' ' LYS . 27.8 ttpt -63.73 -22.88 67.13 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.902 -0.59 . . . . 2.32 110.126 179.343 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.44 ' HG3' ' CD1' ' A' ' 47' ' ' TRP . 8.7 tp10 -85.45 -54.52 4.52 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.662 -0.699 . . . . 1.02 109.309 179.506 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.947 HD22 ' HB3' ' A' ' 111' ' ' LEU . 29.6 tp -59.81 -36.25 76.38 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.859 -1.064 . . . . 0.17 110.55 -174.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.441 ' HA ' HD11 ' A' ' 104' ' ' ILE . 3.9 mm-40 -64.2 -35.82 82.04 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.811 -0.632 . . . . 0.87 112.265 -179.353 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.446 ' HG3' ' O ' ' A' ' 42' ' ' LYS . 95.0 mttt -70.62 -47.42 60.16 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.153 0.501 . . . . 1.31 109.801 178.582 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.492 ' NE1' ' HG3' ' A' ' 65' ' ' ARG . 51.3 m95 -61.9 -47.59 84.27 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.8 -0.636 . . . . 0.52 111.687 179.199 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.564 ' HB3' HG21 ' A' ' 113' ' ' ILE . 97.5 p -64.32 -22.71 67.04 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.954 0.407 . . . . 0.82 110.15 178.251 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -74.17 -57.37 4.0 Favored 'General case' 0 C--O 1.224 -0.261 0 CA-C-N 116.1 -0.5 . . . . 0.53 110.063 174.083 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.658 ' HB3' HG22 ' A' ' 56' ' ' VAL . 96.9 mtt180 -61.6 -42.58 99.08 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.624 -0.716 . . . . 0.42 111.46 -174.939 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 98.3 mt -60.39 -35.59 63.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.003 -0.544 . . . . 0.2 110.739 177.123 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -79.73 -41.32 26.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.086 -0.506 . . . . 0.27 111.32 -179.002 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 58.3 p -74.6 -29.96 61.51 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.21 -0.45 . . . . 0.35 111.641 -176.844 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 107.73 4.87 34.1 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.749 -0.738 . . . . 0.3 112.14 -178.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.417 ' HB2' ' HB3' ' A' ' 50' ' ' ARG . 38.3 mt-10 -61.92 -47.23 85.85 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.847 0.356 . . . . 0.65 110.049 178.443 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.658 HG22 ' HB3' ' A' ' 50' ' ' ARG . 14.3 m -136.57 165.26 29.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.963 -0.562 . . . . 0.19 109.652 172.212 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 54.5 p -86.15 165.7 16.36 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.945 -0.391 . . . . 0.97 109.945 176.444 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -58.89 -39.4 81.35 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.248 -0.649 . . . . 0.22 109.248 176.366 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -54.35 -54.88 34.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.633 -1.167 . . . . 1.72 111.959 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -56.59 -44.29 80.91 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.09 -0.505 . . . . 2.09 111.621 -176.009 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -68.83 -45.9 69.95 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.798 0.332 . . . . 0.26 110.816 -179.651 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.44 -53.52 55.41 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.119 -0.491 . . . . 0.24 111.957 -175.767 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 50.0 m -53.33 -21.33 5.5 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 113.293 0.849 . . . . 1.0 113.293 -176.42 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -105.22 -46.1 4.32 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.439 0.637 . . . . 0.61 110.718 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.605 ' CD ' ' HG3' ' A' ' 27' ' ' ARG . 24.7 mmt180 -93.97 -42.92 8.79 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 114.855 -1.066 . . . . 0.86 113.65 -168.806 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.51 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 80.2 p -64.33 121.77 15.1 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.994 0.426 . . . . 0.82 111.437 -174.38 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.623 ' HA ' ' HB2' ' A' ' 26' ' ' ARG . 25.0 t70 -73.63 -17.24 61.19 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.66 -0.7 . . . . 2.28 111.568 178.624 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.416 ' O ' ' HD1' ' A' ' 71' ' ' TYR . 52.2 t -76.91 155.87 32.49 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.178 0.513 . . . . 1.52 109.926 -179.145 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -58.82 -12.44 14.6 Favored Glycine 0 N--CA 1.454 -0.112 0 CA-C-N 114.81 -1.087 . . . . 0.26 113.621 -173.391 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.437 ' HB3' ' CD1' ' A' ' 77' ' ' LEU . 52.7 p -70.14 -7.82 44.72 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 116.579 0.19 . . . . 0.32 111.207 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.416 ' HD1' ' O ' ' A' ' 68' ' ' CYS . 35.0 p90 -56.08 -29.62 60.81 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.861 0.362 . . . . 0.54 110.21 175.723 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -90.45 2.85 55.27 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.372 -0.377 . . . . 0.49 111.673 -174.063 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 30.0 m -125.39 -15.16 6.25 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.762 0.315 . . . . 0.71 111.447 -179.803 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 107.22 24.14 6.66 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.524 -0.846 . . . . 0.54 112.507 -179.577 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 91.34 -27.57 9.27 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.796 -0.716 . . . . 0.35 113.063 176.124 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.623 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 7.5 p-10 -79.89 141.56 36.01 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-O 121.561 0.696 . . . . 1.65 111.204 -176.876 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.472 HD12 ' HA ' ' A' ' 77' ' ' LEU . 0.6 OUTLIER -106.13 176.0 5.31 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 114.755 -1.111 . . . . 0.94 109.604 177.187 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -83.88 -150.28 10.51 Favored Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 120.871 -0.68 . . . . 0.44 111.856 178.369 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.447 ' HA ' ' O ' ' A' ' 8' ' ' LEU . 21.3 p90 -94.15 145.91 24.36 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.101 0.477 . . . . 3.87 111.214 -178.481 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.61 ' CE1' ' HB3' ' A' ' 8' ' ' LEU . 2.6 p90 -152.16 172.18 16.77 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.315 -0.995 . . . . 1.31 108.315 179.031 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.623 ' HA ' ' O ' ' A' ' 6' ' ' GLU . 89.0 p -103.71 142.27 34.63 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 109.139 -0.689 . . . . 1.17 109.139 174.382 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 10.1 m -52.38 122.76 9.37 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.704 -0.68 . . . . 1.19 111.615 -173.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.456 ' H ' ' HG3' ' A' ' 90' ' ' GLU . . . 114.69 -12.7 20.64 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.892 -0.67 . . . . 0.79 112.998 179.371 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -90.59 45.19 1.24 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 117.013 0.406 . . . . 1.55 111.665 -177.411 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 26.2 mmt -137.66 -108.28 0.19 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.043 0.449 . . . . 0.73 110.297 178.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 59.5 mtt -140.26 150.68 44.38 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.278 -1.008 . . . . 1.39 108.278 176.034 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -50.38 -54.27 36.44 Favored Pre-proline 0 C--N 1.322 -0.589 0 N-CA-C 112.682 0.623 . . . . 2.37 112.682 -175.478 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.472 ' HG2' HG22 ' A' ' 107' ' ' THR . 84.5 Cg_endo -76.23 -27.45 8.09 Favored 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 121.63 1.553 . . . . 0.27 112.036 -176.402 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.635 ' O ' HG23 ' A' ' 93' ' ' VAL . 24.2 t80 -70.06 -55.86 8.42 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.214 -0.903 . . . . 0.22 109.719 -179.422 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.456 ' HG3' ' H ' ' A' ' 83' ' ' GLY . 3.5 tm-20 -66.24 -34.78 78.78 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.392 -0.822 . . . . 2.12 110.246 -177.802 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.49 ' HA ' ' NE ' ' A' ' 94' ' ' ARG . 19.6 t70 -54.64 -36.24 64.32 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.63 -0.713 . . . . 0.61 110.86 175.021 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.561 ' O ' ' HG ' ' A' ' 96' ' ' LEU . . . -80.79 -35.47 33.07 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.213 -0.448 . . . . 0.22 110.958 179.172 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.635 HG23 ' O ' ' A' ' 89' ' ' PHE . 21.0 t -62.12 -44.55 99.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.303 0.573 . . . . 0.25 110.625 -178.178 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.49 ' NE ' ' HA ' ' A' ' 91' ' ' ASP . 38.1 ptt180 -73.87 -12.73 60.76 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.714 -0.676 . . . . 2.59 110.564 179.279 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -95.11 6.16 49.83 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.067 -0.515 . . . . 0.47 111.689 -173.794 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.561 ' HG ' ' O ' ' A' ' 92' ' ' ALA . 0.7 OUTLIER -141.26 146.87 37.36 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.425 -0.352 . . . . 0.28 110.719 177.226 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.419 ' HG3' ' N ' ' A' ' 98' ' ' ILE . 55.2 tptt -88.89 168.95 12.0 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.372 -0.603 . . . . 1.61 109.372 178.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.441 ' HA ' ' HG2' ' A' ' 116' ' ' ARG . 70.7 mt -45.54 115.96 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 121.137 0.494 . . . . 0.9 111.649 175.737 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 99.63 -4.62 58.1 Favored Glycine 0 N--CA 1.45 -0.416 0 CA-C-N 115.779 -0.646 . . . . 0.46 113.324 177.713 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.533 ' HB2' ' HB2' ' A' ' 96' ' ' LEU . 66.4 m-20 -100.22 144.57 29.09 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 117.099 0.449 . . . . 0.46 110.331 179.511 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 8.8 mt -116.03 147.95 19.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.19 -0.459 . . . . 0.23 110.562 -174.493 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 92.5 p -92.5 155.54 42.13 Favored Pre-proline 0 C--N 1.322 -0.588 0 CA-C-N 116.041 -0.527 . . . . 0.92 110.612 -179.324 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -71.64 171.63 15.98 Favored 'Trans proline' 0 C--O 1.235 0.345 0 C-N-CA 122.323 2.016 . . . . 0.34 111.393 171.837 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.931 HG23 HD23 ' A' ' 44' ' ' LEU . 22.7 mm -47.62 112.68 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 O-C-N 123.381 0.426 . . . . 0.2 111.986 178.514 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.1 p -117.59 118.67 59.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.004 0.431 . . . . 1.04 110.258 176.257 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 -85.44 141.65 29.8 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.2 0.524 . . . . 0.55 110.373 178.631 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.472 HG22 ' HG2' ' A' ' 88' ' ' PRO . 7.5 p -115.94 -172.52 2.18 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.461 -0.791 . . . . 0.37 110.637 -178.263 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -58.21 -42.64 86.64 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.903 0.383 . . . . 2.16 110.374 178.454 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.664 ' O ' ' HB2' ' A' ' 20' ' ' SER . 7.8 t -90.68 -61.62 1.63 Allowed 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 116.112 -0.494 . . . . 1.09 110.652 -178.476 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -146.62 -133.14 2.42 Favored Glycine 0 N--CA 1.442 -0.941 0 C-N-CA 118.946 -1.597 . . . . 0.24 113.499 -172.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.947 ' HB3' HD22 ' A' ' 44' ' ' LEU . 7.6 mp -115.58 145.92 42.23 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.199 -0.501 . . . . 0.19 111.408 -170.625 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' HIS . . . . . 0.823 ' CE1' HD13 ' A' ' 14' ' ' LEU . 64.3 m80 -142.06 152.2 43.1 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.392 0.615 . . . . 0.22 112.374 178.611 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.66 HG12 HD11 ' A' ' 44' ' ' LEU . 2.8 pt -134.01 140.73 45.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 107.317 -1.364 . . . . 0.17 107.317 158.388 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.409 HG21 HG22 ' A' ' 93' ' ' VAL . 2.2 mp -130.76 148.33 33.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 C-N-CA 120.656 -0.418 . . . . 0.18 110.657 -175.887 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.443 ' HG2' ' HB3' ' A' ' 11' ' ' ALA . 35.6 pttt -132.41 141.3 48.8 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.451 -0.944 . . . . 0.61 108.451 171.459 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.546 ' HD3' HD21 ' A' ' 8' ' ' LEU . 5.6 ttp180 -81.47 135.72 35.63 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.198 0.523 . . . . 1.87 110.768 -178.77 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -104.75 -31.87 9.13 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.258 -0.883 . . . . 0.89 110.561 -178.694 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.496 ' HB3' ' HB3' ' A' ' 9' ' ' ARG . . . . . . . . 0 C--O 1.246 0.915 0 CA-C-O 118.445 -0.788 . . . . 1.1 110.579 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 70.5 mtm . . . . . 0 N--CA 1.48 1.037 0 CA-C-O 120.841 0.353 . . . . 7.23 110.446 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 28.4 p -90.11 -53.94 4.25 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.358 -0.383 . . . . 2.88 110.884 -179.603 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.471 ' HG3' ' HD3' ' A' ' 7' ' ' LYS . 13.1 pt-20 -83.91 -21.67 31.81 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.175 -0.466 . . . . 2.8 110.527 -178.054 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.629 ' HA ' ' O ' ' A' ' 80' ' ' PHE . 5.9 mptt -73.82 115.65 13.5 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.566 0.698 . . . . 1.19 111.707 -176.734 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.693 HD23 ' H ' ' A' ' 9' ' ' ARG . 1.5 tt -117.59 160.75 20.75 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 114.494 -1.23 . . . . 1.18 107.886 178.899 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.693 ' H ' HD23 ' A' ' 8' ' ' LEU . 70.4 ttt180 -131.24 132.17 44.43 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 109.42 -0.585 . . . . 1.06 109.42 172.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -150.45 150.27 31.11 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.933 0.397 . . . . 0.22 111.824 -175.404 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.407 ' HB3' ' HG2' ' A' ' 115' ' ' LYS . . . -108.54 136.04 48.8 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.732 -0.667 . . . . 0.2 109.51 177.481 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 35.9 p-80 -138.83 157.24 46.42 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.088 0.471 . . . . 0.23 111.852 -171.865 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.561 HD23 ' N ' ' A' ' 14' ' ' LEU . 4.8 tt -124.34 146.92 48.54 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.584 -0.895 . . . . 0.24 108.584 176.786 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.738 HD13 ' CE1' ' A' ' 112' ' ' HIS . 28.7 tp -131.51 120.66 23.26 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.512 0.196 . . . . 0.27 111.028 -178.217 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.581 HG23 HD13 ' A' ' 44' ' ' LEU . 65.2 t -109.32 138.91 34.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 109.874 -0.417 . . . . 0.15 109.874 176.417 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.485 ' HE2' ' OG ' ' A' ' 109' ' ' SER . 33.8 mmtp -112.04 154.4 25.42 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.731 -0.47 . . . . 0.62 109.731 176.804 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.497 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 41.4 p90 -144.26 162.53 36.15 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.267 -0.424 . . . . 0.25 110.351 -176.054 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.517 ' HB3' ' HA ' ' A' ' 33' ' ' ALA . 29.0 p -53.44 108.12 0.31 Allowed 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.046 0.45 . . . . 1.04 110.699 179.144 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 101.32 7.95 48.05 Favored Glycine 0 CA--C 1.522 0.502 0 C-N-CA 120.823 -0.704 . . . . 0.53 113.208 -179.45 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.643 ' HB2' ' O ' ' A' ' 109' ' ' SER . 89.5 p -85.03 49.44 1.74 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 117.33 0.565 . . . . 0.7 111.156 -177.862 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 71.66 -32.99 0.26 Allowed 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.631 0.772 . . . . 3.49 110.954 -177.731 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.487 ' H ' ' C ' ' A' ' 20' ' ' SER . 4.8 p30 -151.97 118.04 3.12 Favored Pre-proline 0 C--N 1.321 -0.673 0 N-CA-C 109.095 -0.706 . . . . 1.77 109.095 174.895 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.495 ' C ' HG22 ' A' ' 32' ' ' THR . 95.0 Cg_endo -85.39 55.8 4.12 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.52 2.147 . . . . 1.71 113.135 -175.735 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.46 ' N ' HG22 ' A' ' 32' ' ' THR . 25.5 t -146.21 116.4 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 109.577 -0.527 . . . . 0.48 109.577 176.197 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.45 ' HB3' ' HB2' ' A' ' 16' ' ' LYS . 66.3 p -104.1 159.24 15.84 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.926 -0.398 . . . . 1.12 109.926 175.679 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.52 ' HG2' ' HA ' ' A' ' 67' ' ' ASP . 6.3 mmp_? -71.48 -7.17 45.74 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.397 0.618 . . . . 2.54 109.691 172.066 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.506 ' CG ' ' HD2' ' A' ' 65' ' ' ARG . 3.7 tmm_? -81.06 -36.18 30.81 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.279 -0.873 . . . . 1.77 110.054 178.779 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 61.8 p -101.71 -34.81 9.32 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.296 0.57 . . . . 0.67 110.789 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 85.67 -43.85 3.29 Favored Glycine 0 N--CA 1.45 -0.383 0 CA-C-N 115.738 -0.665 . . . . 0.82 112.986 177.241 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -93.0 -63.77 1.18 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.764 0.316 . . . . 2.1 110.248 -177.578 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 19.8 m -153.12 151.67 30.42 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.365 -0.38 . . . . 1.08 110.652 176.216 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.495 HG22 ' C ' ' A' ' 23' ' ' PRO . 12.1 t -115.09 34.36 4.9 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 122.19 0.995 . . . . 0.34 108.915 176.234 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.517 ' HA ' ' HB3' ' A' ' 18' ' ' SER . . . -80.49 -6.09 57.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 114.946 -1.025 . . . . 0.37 112.102 -172.563 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -94.13 -23.83 17.79 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.38 0.609 . . . . 2.21 110.528 -178.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.4 HG23 ' HB2' ' A' ' 39' ' ' ASP . 0.2 OUTLIER -98.19 135.78 31.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.702 -0.681 . . . . 0.31 110.103 -179.135 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 71.0 p -95.83 179.46 5.1 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.024 -0.535 . . . . 0.39 109.95 -175.754 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.51 ' O ' HG13 ' A' ' 41' ' ' ILE . 13.6 p90 -62.92 -31.11 72.12 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.006 -0.678 . . . . 1.53 109.468 176.335 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -71.89 -46.34 58.09 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-N 116.044 -0.525 . . . . 0.96 110.596 178.535 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.4 ' HB2' HG23 ' A' ' 35' ' ' VAL . 28.8 m-20 -67.25 -27.78 67.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.245 0.545 . . . . 0.91 109.87 177.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.497 ' HB2' ' HB3' ' A' ' 17' ' ' PHE . . . -71.07 -43.05 68.57 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.513 -0.767 . . . . 0.19 110.366 176.48 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.51 HG13 ' O ' ' A' ' 37' ' ' TYR . 86.5 mt -64.78 -37.08 79.24 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.414 0 N-CA-C 109.494 -0.558 . . . . 0.3 109.494 174.358 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.404 ' O ' ' HG3' ' A' ' 46' ' ' LYS . 62.2 tttp -61.49 -28.25 69.17 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.599 -0.728 . . . . 2.32 110.209 177.522 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 58.8 tt0 -88.08 -48.23 7.9 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.663 -0.699 . . . . 1.02 110.082 -178.388 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.885 HD23 HG23 ' A' ' 104' ' ' ILE . 32.2 tp -61.15 -36.58 80.17 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.871 -0.604 . . . . 0.17 110.021 -179.256 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.46 ' HG2' HG13 ' A' ' 104' ' ' ILE . 3.6 mm100 -64.08 -36.21 83.26 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-N 115.96 -0.564 . . . . 0.87 111.97 178.787 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.404 ' HG3' ' O ' ' A' ' 42' ' ' LYS . 98.1 mttt -69.23 -46.3 67.71 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.843 -0.343 . . . . 1.31 110.461 179.653 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.4 ' O ' HG13 ' A' ' 51' ' ' ILE . 54.0 m95 -66.0 -46.14 79.06 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.475 -0.33 . . . . 0.52 111.188 177.55 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 44.7 t -57.77 -35.27 70.53 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.881 -0.414 . . . . 0.82 109.881 175.006 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.449 ' HB2' ' O ' ' A' ' 45' ' ' GLN . 13.0 tt0 -65.6 -55.98 14.69 Favored 'General case' 0 C--O 1.225 -0.233 0 CA-C-N 115.915 -0.584 . . . . 0.53 110.488 176.94 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.634 ' HB3' HG22 ' A' ' 56' ' ' VAL . 93.5 mtt180 -62.15 -42.31 99.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.097 -0.501 . . . . 0.42 111.609 -176.235 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.428 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 98.3 mt -60.24 -35.21 60.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.012 0.434 . . . . 0.2 110.657 176.474 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -79.99 -38.89 31.22 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.943 -0.571 . . . . 0.27 111.542 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 65.2 p -76.68 -29.99 56.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.72 0.295 . . . . 0.35 111.456 -176.526 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 106.38 10.31 29.67 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.539 -0.839 . . . . 0.3 112.141 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.424 ' HB2' ' HB3' ' A' ' 50' ' ' ARG . 41.4 mt-10 -67.1 -52.16 45.36 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.047 0.451 . . . . 0.65 110.011 176.696 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.634 HG22 ' HB3' ' A' ' 50' ' ' ARG . 15.8 m -132.04 156.06 42.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.925 -0.58 . . . . 0.19 109.748 175.145 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 50.5 m -86.27 159.34 19.47 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.575 -0.528 . . . . 0.97 109.575 178.78 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -52.41 -43.44 64.81 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.027 0.442 . . . . 0.22 110.249 -176.617 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.591 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 39.9 mt-10 -56.82 -43.49 81.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.236 -0.893 . . . . 1.72 112.105 -179.013 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -60.86 -46.34 90.95 Favored 'General case' 0 CA--C 1.521 -0.141 0 CA-C-O 120.958 0.408 . . . . 2.09 110.587 -177.22 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -69.15 -51.1 41.64 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.048 -0.523 . . . . 0.26 110.921 -179.476 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.78 -52.11 66.86 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.741 0.645 . . . . 0.24 112.741 -173.231 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.507 ' HA ' ' O ' ' A' ' 71' ' ' TYR . 20.4 m -51.5 -25.47 6.64 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 112.859 0.688 . . . . 1.0 112.859 -176.726 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -105.36 -46.25 4.26 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.63 0.728 . . . . 0.61 110.673 -177.821 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.506 ' HD2' ' CG ' ' A' ' 27' ' ' ARG . 27.8 mmt180 -88.26 -41.03 13.19 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.872 -1.058 . . . . 0.86 113.54 -169.813 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.513 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 59.6 p -64.79 127.2 30.58 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.68 -0.408 . . . . 0.82 111.14 -176.847 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.52 ' HA ' ' HG2' ' A' ' 26' ' ' ARG . 33.6 t70 -80.15 -10.84 59.78 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.424 0.631 . . . . 2.28 111.157 179.091 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 44.8 t -77.56 163.04 26.64 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.94 -0.573 . . . . 1.52 109.688 179.521 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -61.26 -16.45 49.09 Favored Glycine 0 N--CA 1.454 -0.146 0 CA-C-N 115.642 -0.708 . . . . 0.26 112.598 -176.722 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 61.8 p -65.51 -7.63 15.41 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 112.021 0.378 . . . . 0.32 112.021 177.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.507 ' O ' ' HA ' ' A' ' 63' ' ' SER . 14.1 p90 -60.96 -23.64 65.48 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 109.479 -0.563 . . . . 0.54 109.479 175.466 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -95.09 5.97 50.37 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.084 0.469 . . . . 0.49 110.613 178.003 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 6.2 m -126.02 3.24 7.26 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.097 -0.501 . . . . 0.71 110.823 -179.084 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.591 ' O ' ' HA ' ' A' ' 59' ' ' GLU . . . 73.16 25.43 73.34 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.812 -0.708 . . . . 0.54 112.047 -175.731 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 83.66 -20.31 12.22 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 121.202 -0.523 . . . . 0.35 111.809 -177.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -73.36 133.13 43.72 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.294 -0.453 . . . . 1.65 110.672 -175.614 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.5 mp -115.78 164.1 14.87 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-O 121.307 0.575 . . . . 0.94 110.009 175.05 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -82.5 -154.95 15.97 Favored Glycine 0 C--N 1.305 -1.169 0 CA-C-N 114.964 -1.016 . . . . 0.44 111.808 176.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.631 ' HA ' ' O ' ' A' ' 8' ' ' LEU . 93.3 m-85 -84.17 147.77 27.12 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.037 0.446 . . . . 3.87 110.933 -179.478 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.629 ' O ' ' HA ' ' A' ' 7' ' ' LYS . 14.9 p90 -147.8 165.63 29.99 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.647 -0.871 . . . . 1.31 108.647 -177.237 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -90.5 149.98 21.97 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 109.645 -0.502 . . . . 1.17 109.645 -178.498 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.6 p -58.77 111.7 1.37 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.838 0.351 . . . . 1.19 110.629 177.72 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 99.64 18.11 24.14 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.672 -0.775 . . . . 0.79 112.514 -177.467 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -101.08 18.07 20.74 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.061 0.458 . . . . 1.55 110.98 -178.162 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 26.3 mmt -124.51 -105.31 0.35 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.885 0.374 . . . . 0.73 111.057 -177.045 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 82.7 mmm -141.26 152.6 44.66 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.133 -1.062 . . . . 1.39 108.133 175.896 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.431 ' HB3' ' HD3' ' A' ' 88' ' ' PRO . 23.8 ttmm -50.77 -56.39 19.63 Favored Pre-proline 0 C--N 1.321 -0.642 0 N-CA-C 112.701 0.63 . . . . 2.37 112.701 -175.707 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.431 ' HD3' ' HB3' ' A' ' 87' ' ' LYS . 85.1 Cg_endo -77.44 -27.85 6.05 Favored 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 121.48 1.453 . . . . 0.27 111.928 -176.163 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.683 ' O ' HG23 ' A' ' 93' ' ' VAL . 14.5 t80 -67.98 -56.81 7.6 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.187 -0.915 . . . . 0.22 109.854 -179.325 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -65.25 -38.21 89.62 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.502 -0.772 . . . . 2.12 110.143 -178.132 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -57.03 -34.28 68.05 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.475 -0.784 . . . . 0.61 110.617 177.17 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -78.91 -26.84 43.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 0.22 110.707 177.748 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.683 HG23 ' O ' ' A' ' 89' ' ' PHE . 35.5 t -72.28 -36.94 57.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.332 0.587 . . . . 0.25 109.977 -178.577 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.438 ' C ' ' HD2' ' A' ' 94' ' ' ARG . 2.0 ppt_? -83.08 -2.74 56.17 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.844 -0.617 . . . . 2.59 110.246 179.237 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -97.43 9.69 41.7 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.093 -0.503 . . . . 0.47 111.339 -177.386 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.531 ' HB2' ' HB2' ' A' ' 100' ' ' ASP . 0.4 OUTLIER -144.24 151.11 38.99 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.31 0.576 . . . . 0.28 111.461 178.684 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.526 ' HE2' HD13 ' A' ' 98' ' ' ILE . 22.5 tptm -91.34 172.25 8.66 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.253 -0.885 . . . . 1.61 109.402 177.011 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.526 HD13 ' HE2' ' A' ' 97' ' ' LYS . 1.3 mp -46.73 120.59 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 C-N-CA 123.344 0.658 . . . . 0.9 110.85 176.689 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 97.72 -9.37 64.16 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.761 -0.733 . . . . 0.46 113.28 176.764 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.531 ' HB2' ' HB2' ' A' ' 96' ' ' LEU . 12.1 m-20 -93.11 141.84 27.96 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 117.133 0.466 . . . . 0.46 111.055 -177.802 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 9.4 mt -111.4 146.15 16.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.707 -0.679 . . . . 0.23 109.668 -179.141 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 97.8 p -89.42 152.45 47.5 Favored Pre-proline 0 C--N 1.319 -0.755 0 CA-C-N 116.361 -0.382 . . . . 0.92 110.422 -179.449 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -69.18 166.79 25.68 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 122.35 2.033 . . . . 0.34 111.111 171.88 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.885 HG23 HD23 ' A' ' 44' ' ' LEU . 29.0 mm -46.07 105.09 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 O-C-N 123.562 0.539 . . . . 0.2 112.05 178.693 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.0 p -111.52 121.18 63.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.253 -0.43 . . . . 1.04 110.196 177.445 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -85.57 156.47 20.72 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.228 0.537 . . . . 0.55 110.92 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 2.8 p -130.09 -173.17 2.97 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.383 -0.826 . . . . 0.37 110.019 177.357 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -56.51 -49.1 75.73 Favored 'General case' 0 C--N 1.328 -0.341 0 O-C-N 123.213 0.32 . . . . 2.16 110.887 177.424 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.643 ' O ' ' HB2' ' A' ' 20' ' ' SER . 8.3 t -84.14 -60.69 2.02 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 116.212 -0.449 . . . . 1.09 110.638 -177.139 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -146.76 -132.71 2.36 Favored Glycine 0 N--CA 1.441 -1.004 0 C-N-CA 118.921 -1.609 . . . . 0.24 113.982 -173.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.883 ' HB3' HD22 ' A' ' 44' ' ' LEU . 6.8 mp -118.77 150.41 39.85 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.964 -0.618 . . . . 0.19 111.377 -169.543 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' HIS . . . . . 0.738 ' CE1' HD13 ' A' ' 14' ' ' LEU . 75.7 m80 -144.58 150.15 36.99 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.205 0.526 . . . . 0.22 111.995 179.625 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.632 HG12 HD11 ' A' ' 44' ' ' LEU . 1.4 pt -134.25 137.02 52.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 107.514 -1.291 . . . . 0.17 107.514 160.27 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.468 HG21 HG22 ' A' ' 93' ' ' VAL . 2.8 mp -130.53 144.77 36.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 C-N-CA 120.87 -0.332 . . . . 0.18 110.826 -175.021 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.472 ' HA ' ' O ' ' A' ' 100' ' ' ASP . 43.2 pttt -126.18 142.53 51.49 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.116 -0.698 . . . . 0.61 109.116 173.229 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.462 ' HB2' ' CD1' ' A' ' 96' ' ' LEU . 68.4 ttt180 -84.8 129.03 34.88 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.282 0.563 . . . . 1.87 111.338 -178.309 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.407 ' HB2' ' HG2' ' A' ' 9' ' ' ARG . 4.2 mm? -97.34 -39.53 9.17 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.187 -0.915 . . . . 0.89 110.4 -179.568 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.243 0.712 0 CA-C-O 118.374 -0.822 . . . . 1.1 110.305 -179.332 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.592 ' HA ' ' O ' ' A' ' 80' ' ' PHE . 69.0 mmtt . . . . . 0 N--CA 1.453 -0.284 0 CA-C-O 121.434 0.635 . . . . 1.1899999999999999 111.365 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.631 ' HB3' ' CE1' ' A' ' 80' ' ' PHE . 2.3 tt -137.02 158.31 44.74 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 114.748 -1.115 . . . . 1.1799999999999999 108.032 -176.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.63 ' H ' HD23 ' A' ' 8' ' ' LEU . 72.2 ttt180 -132.18 130.93 41.71 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 108.928 -0.767 . . . . 1.0600000000000001 108.928 172.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -145.96 154.83 42.34 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.394 -0.523 . . . . 0.22 111.886 -175.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.519 ' HA ' ' HA ' ' A' ' 76' ' ' ASP . . . -114.86 137.04 52.43 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.901 -0.591 . . . . 0.20000000000000001 109.823 177.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 32.4 p-80 -139.69 151.42 45.89 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.06 0.457 . . . . 0.23000000000000001 111.538 -172.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.603 ' O ' ' HA ' ' A' ' 112' ' ' HIS . 5.5 tt -119.08 144.51 46.55 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 108.336 -0.986 . . . . 0.23999999999999999 108.336 177.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.582 HD13 ' NE2' ' A' ' 112' ' ' HIS . 27.0 tp -130.4 120.97 25.07 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.724 0.297 . . . . 0.27000000000000002 111.061 -177.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.535 HG23 HD13 ' A' ' 44' ' ' LEU . 57.3 t -109.04 133.9 52.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 116.108 -0.496 . . . . 0.14999999999999999 109.693 176.119 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.484 ' HE3' HD21 ' A' ' 14' ' ' LEU . 32.7 mmtp -106.03 151.22 24.93 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.274 -0.639 . . . . 0.62 109.274 176.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.422 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 46.6 p90 -142.61 162.23 36.02 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.707 0.289 . . . . 0.25 110.859 -178.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.465 ' HB3' ' HA ' ' A' ' 33' ' ' ALA . 28.7 p -50.59 110.78 0.45 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.93 -0.577 . . . . 1.04 111.194 179.297 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 94.75 8.33 59.47 Favored Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.458 -0.877 . . . . 0.53000000000000003 113.36 177.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.446 ' C ' ' H ' ' A' ' 22' ' ' ASN . 88.5 p -90.83 46.84 1.36 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 117.841 0.82 . . . . 0.69999999999999996 110.51 -178.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 70.8 ttt180 70.87 -35.55 0.33 Allowed 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 123.53 0.732 . . . . 3.4900000000000002 111.511 -178.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.446 ' H ' ' C ' ' A' ' 20' ' ' SER . 49.4 m-80 -140.52 96.86 7.6 Favored Pre-proline 0 C--N 1.326 -0.434 0 N-CA-C 109.623 -0.51 . . . . 1.77 109.623 179.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.51 ' C ' HG22 ' A' ' 32' ' ' THR . 87.4 Cg_endo -83.35 51.67 3.66 Favored 'Trans proline' 0 CA--C 1.536 0.618 0 C-N-CA 122.585 2.19 . . . . 1.71 113.133 -176.141 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.472 ' N ' HG22 ' A' ' 32' ' ' THR . 42.7 t -147.6 113.11 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 123.265 0.626 . . . . 0.47999999999999998 109.332 177.136 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.441 ' HB3' ' HB2' ' A' ' 16' ' ' LYS . 21.5 p -104.36 158.07 16.71 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.946 -0.115 . . . . 1.1200000000000001 110.728 178.405 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.542 ' HB2' ' HA ' ' A' ' 67' ' ' ASP . 0.0 OUTLIER -63.37 -13.78 43.1 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-O 121.551 0.691 . . . . 2.54 110.033 172.313 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.519 ' HG3' ' HD2' ' A' ' 65' ' ' ARG . 0.1 OUTLIER -87.87 -13.81 41.04 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.92 -1.036 . . . . 1.77 110.827 -177.432 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 20.7 p -118.84 -35.22 3.73 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.326 0.584 . . . . 0.67000000000000004 110.511 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 79.4 -42.67 2.42 Favored Glycine 0 N--CA 1.452 -0.262 0 CA-C-N 115.083 -0.962 . . . . 0.81999999999999995 112.852 176.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -94.27 -67.98 0.83 Allowed 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 110.118 -0.327 . . . . 2.1000000000000001 110.118 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.2 m -153.63 146.59 24.48 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.075 -0.512 . . . . 1.0800000000000001 110.304 178.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.51 HG22 ' C ' ' A' ' 23' ' ' PRO . 9.9 t -112.8 33.79 4.79 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 122.545 1.164 . . . . 0.34000000000000002 108.589 175.264 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.465 ' HA ' ' HB3' ' A' ' 18' ' ' SER . . . -80.67 -4.55 54.7 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 114.165 -1.38 . . . . 0.37 111.712 -175.074 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -95.26 -21.42 18.45 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.97 0.415 . . . . 2.21 111.007 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.446 HG23 ' HB2' ' A' ' 39' ' ' ASP . 0.2 OUTLIER -99.18 136.54 29.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.052 -0.522 . . . . 0.31 110.052 179.822 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 56.1 p -95.48 -178.4 4.41 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.329 -0.396 . . . . 0.39000000000000001 110.325 -174.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.423 ' O ' HG13 ' A' ' 41' ' ' ILE . 6.6 p90 -65.17 -27.98 69.08 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.102 -0.703 . . . . 1.53 109.102 176.041 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -72.1 -49.2 38.13 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 115.89 -0.596 . . . . 0.95999999999999996 110.064 177.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.446 ' HB2' HG23 ' A' ' 35' ' ' VAL . 49.1 m-20 -65.12 -30.55 71.49 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-O 121.339 0.59 . . . . 0.91000000000000003 110.041 179.422 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.422 ' HB2' ' HB3' ' A' ' 17' ' ' PHE . . . -70.4 -46.47 63.91 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.184 -0.916 . . . . 0.19 110.427 177.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.497 ' CG1' HD21 ' A' ' 111' ' ' LEU . 70.4 mt -63.33 -36.83 77.67 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.383 0 N-CA-C 109.726 -0.472 . . . . 0.29999999999999999 109.726 175.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.445 ' O ' ' HG3' ' A' ' 46' ' ' LYS . 79.5 tttt -59.16 -31.8 69.31 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.66 -0.7 . . . . 2.3199999999999998 110.169 177.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 53.1 tt0 -88.12 -46.84 8.96 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.635 -0.711 . . . . 1.02 110.149 -176.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.948 HD23 HG23 ' A' ' 104' ' ' ILE . 33.5 tp -60.19 -37.52 80.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.12 -0.491 . . . . 0.17000000000000001 109.854 -179.302 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.5 ' HG2' HG13 ' A' ' 104' ' ' ILE . 1.6 mm-40 -68.06 -21.35 65.0 Favored 'General case' 0 C--O 1.226 -0.175 0 CA-C-N 115.936 -0.575 . . . . 0.87 112.123 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.445 ' HG3' ' O ' ' A' ' 42' ' ' LYS . 68.4 mttm -82.43 -44.87 15.53 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.853 -0.339 . . . . 1.3100000000000001 110.262 178.335 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 43.9 m95 -67.8 -44.44 77.32 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.999 -0.28 . . . . 0.52000000000000002 110.618 177.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 32.4 t -61.15 -26.94 68.04 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.883 -0.414 . . . . 0.81999999999999995 109.883 175.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.459 ' HB2' ' O ' ' A' ' 45' ' ' GLN . 3.9 tt0 -73.0 -56.62 4.87 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 116.152 -0.476 . . . . 0.53000000000000003 109.844 175.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.574 ' HB3' HG22 ' A' ' 56' ' ' VAL . 87.0 mtt180 -59.86 -41.97 92.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.84 -0.618 . . . . 0.41999999999999998 111.882 -176.179 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.482 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 98.0 mt -59.23 -34.76 54.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.101 0.476 . . . . 0.20000000000000001 110.157 176.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -82.22 -37.91 25.31 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.559 -0.746 . . . . 0.27000000000000002 111.87 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.475 ' OG ' ' HA ' ' A' ' 50' ' ' ARG . 46.3 p -78.92 -29.55 44.26 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 111.99 0.367 . . . . 0.34999999999999998 111.99 -176.008 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 107.38 13.1 21.8 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.541 -0.838 . . . . 0.29999999999999999 112.667 179.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.454 ' HB2' ' HB3' ' A' ' 50' ' ' ARG . 33.5 mt-10 -73.99 -44.85 53.24 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.858 0.361 . . . . 0.65000000000000002 110.239 177.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.574 HG22 ' HB3' ' A' ' 50' ' ' ARG . 14.2 m -138.86 158.34 29.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 109.355 -0.609 . . . . 0.19 109.355 172.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 55.1 p -84.53 164.91 18.47 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.68 -0.489 . . . . 0.96999999999999997 109.68 176.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.409 ' HA ' ' CD1' ' A' ' 51' ' ' ILE . 2.2 t80 -57.95 -41.04 81.99 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.224 -0.658 . . . . 0.22 109.224 178.074 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.459 ' CD ' ' H ' ' A' ' 59' ' ' GLU . 1.4 mp0 -56.56 -53.28 59.41 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.898 -1.046 . . . . 1.72 111.381 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 30.6 mm-40 -56.54 -45.48 81.15 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 120.965 0.412 . . . . 2.0899999999999999 111.161 -178.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -68.1 -49.83 58.71 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.192 -0.458 . . . . 0.26000000000000001 111.121 -179.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.33 -53.74 54.74 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.236 0.458 . . . . 0.23999999999999999 112.236 -174.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.557 ' HA ' ' O ' ' A' ' 71' ' ' TYR . 74.7 m -51.63 -24.53 5.63 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 113.35 0.87 . . . . 1.0 113.35 -176.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -104.59 -48.1 3.89 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.564 0.697 . . . . 0.60999999999999999 110.457 -179.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.519 ' HD2' ' HG3' ' A' ' 27' ' ' ARG . 18.5 mmt180 -87.41 -41.37 13.62 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.993 -1.003 . . . . 0.85999999999999999 113.443 -168.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.535 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 58.5 p -64.77 125.43 24.76 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.049 0.452 . . . . 0.81999999999999995 111.301 -175.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.542 ' HA ' ' HB2' ' A' ' 26' ' ' ARG . 24.8 t70 -75.96 -17.76 59.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.69 -0.686 . . . . 2.2799999999999998 111.342 177.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 0.43 ' O ' ' HD1' ' A' ' 71' ' ' TYR . 41.2 t -77.48 157.43 30.45 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.317 0.579 . . . . 1.52 110.21 -178.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -57.11 -17.79 24.77 Favored Glycine 0 C--N 1.329 0.181 0 CA-C-N 114.482 -1.235 . . . . 0.26000000000000001 114.269 -170.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 51.1 p -69.38 -5.61 24.63 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 111.891 0.33 . . . . 0.32000000000000001 111.891 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.557 ' O ' ' HA ' ' A' ' 63' ' ' SER . 34.6 p90 -56.02 -33.58 65.03 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.014 0.435 . . . . 0.54000000000000004 109.988 175.033 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -94.45 4.82 53.37 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.119 0.485 . . . . 0.48999999999999999 110.911 -177.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.0 m -114.44 -15.99 12.0 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.002 -0.545 . . . . 0.70999999999999996 110.905 -177.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 101.7 19.57 15.23 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.861 -0.685 . . . . 0.54000000000000004 111.641 -176.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 85.8 -27.87 5.2 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 121.193 -0.527 . . . . 0.34999999999999998 112.656 178.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.519 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 7.6 p-10 -86.41 140.86 29.6 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-O 121.776 0.798 . . . . 1.6499999999999999 111.333 -175.275 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.3 mp -102.09 175.57 5.49 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 114.422 -1.263 . . . . 0.93999999999999995 109.84 177.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -86.49 -156.53 28.64 Favored Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 120.842 -0.694 . . . . 0.44 111.413 177.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.558 ' HA ' ' O ' ' A' ' 8' ' ' LEU . 99.3 m-85 -85.29 136.96 33.27 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.022 0.439 . . . . 3.8700000000000001 110.52 179.337 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.631 ' CE1' ' HB3' ' A' ' 8' ' ' LEU . 13.8 p90 -137.96 166.34 24.3 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.655 -0.702 . . . . 1.3100000000000001 109.21 -179.604 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.521 ' O ' ' HB2' ' A' ' 84' ' ' GLU . 15.5 m -90.02 133.12 35.01 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 108.931 -0.766 . . . . 1.1699999999999999 108.931 176.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 20.0 m -53.02 121.42 7.36 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.828 0.347 . . . . 1.1899999999999999 110.834 -178.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 104.86 1.09 42.4 Favored Glycine 0 CA--C 1.519 0.324 0 C-N-CA 120.964 -0.636 . . . . 0.79000000000000004 112.237 -176.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.521 ' HB2' ' O ' ' A' ' 81' ' ' SER . 28.5 tt0 -82.78 -3.79 57.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.777 0.322 . . . . 1.55 111.609 -175.519 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 26.5 mmt -107.94 -144.97 0.39 Allowed 'General case' 0 N--CA 1.438 -1.035 0 N-CA-C 109.451 -0.574 . . . . 0.72999999999999998 109.451 -175.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -93.54 154.52 17.83 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 115.369 -0.832 . . . . 1.3899999999999999 109.089 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.402 ' HB3' ' HD3' ' A' ' 88' ' ' PRO . 22.3 tptm -53.94 -57.1 19.31 Favored Pre-proline 0 C--N 1.321 -0.671 0 N-CA-C 112.07 0.396 . . . . 2.3700000000000001 112.07 -178.127 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.402 ' HD3' ' HB3' ' A' ' 87' ' ' LYS . 68.0 Cg_endo -74.0 -22.1 17.56 Favored 'Trans proline' 0 C--N 1.356 0.962 0 C-N-CA 121.506 1.47 . . . . 0.27000000000000002 111.661 -176.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.615 ' O ' HG23 ' A' ' 93' ' ' VAL . 23.8 t80 -72.8 -56.45 5.22 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.293 -0.867 . . . . 0.22 109.608 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -64.48 -34.83 79.12 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.812 -0.631 . . . . 2.1200000000000001 109.654 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.457 ' HA ' ' NE ' ' A' ' 94' ' ' ARG . 9.9 t70 -52.35 -36.69 54.17 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.74 -0.664 . . . . 0.60999999999999999 111.091 175.029 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.541 ' O ' ' HG ' ' A' ' 96' ' ' LEU . . . -81.98 -35.34 29.06 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.937 -0.574 . . . . 0.22 110.883 179.424 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.615 HG23 ' O ' ' A' ' 89' ' ' PHE . 14.7 t -64.17 -42.76 96.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.201 0.524 . . . . 0.25 110.585 -177.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.457 ' NE ' ' HA ' ' A' ' 91' ' ' ASP . 39.4 ptt180 -70.86 -18.41 62.7 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.022 -0.535 . . . . 2.5899999999999999 110.583 177.415 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -88.66 2.6 52.94 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.921 -0.581 . . . . 0.46999999999999997 111.415 -174.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.632 ' HB2' ' HB2' ' A' ' 100' ' ' ASP . 0.8 OUTLIER -137.98 153.53 49.42 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.132 -0.485 . . . . 0.28000000000000003 110.64 177.621 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.683 ' HG2' ' H ' ' A' ' 98' ' ' ILE . 39.8 tttp -102.7 -179.18 3.89 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 109.18 -0.674 . . . . 1.6100000000000001 109.18 176.413 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.683 ' H ' ' HG2' ' A' ' 97' ' ' LYS . 9.2 mt -51.49 122.4 2.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 120.891 0.377 . . . . 0.90000000000000002 111.309 178.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 93.12 -2.12 71.23 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.9 -0.667 . . . . 0.46000000000000002 113.271 178.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.632 ' HB2' ' HB2' ' A' ' 96' ' ' LEU . 45.7 m-20 -100.19 141.98 32.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 117.423 0.611 . . . . 0.46000000000000002 110.657 -179.474 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 11.8 mt -111.55 147.02 15.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.954 -0.566 . . . . 0.23000000000000001 110.0 -179.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 91.3 p -92.19 152.45 42.58 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 116.419 -0.355 . . . . 0.92000000000000004 110.953 -177.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -68.25 160.15 50.17 Favored 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 122.335 2.023 . . . . 0.34000000000000002 111.095 172.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.948 HG23 HD23 ' A' ' 44' ' ' LEU . 25.6 mm -43.1 107.95 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 O-C-N 123.889 0.743 . . . . 0.20000000000000001 112.115 178.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 1.8 p -113.31 121.78 66.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.991 -0.549 . . . . 1.04 109.983 177.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -85.41 155.44 21.28 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.97 0.414 . . . . 0.55000000000000004 110.4 179.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.403 ' OG1' ' HD2' ' A' ' 112' ' ' HIS . 4.4 p -135.85 -171.17 2.79 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.695 -0.684 . . . . 0.37 110.929 -178.306 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -56.37 -42.69 78.28 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.122 -0.49 . . . . 2.1600000000000001 111.672 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.44 ' O ' ' HD3' ' A' ' 16' ' ' LYS . 5.4 t -113.58 -0.38 14.38 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 112.593 0.59 . . . . 1.0900000000000001 112.593 -170.146 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 166.25 -126.86 1.52 Allowed Glycine 0 N--CA 1.436 -1.31 0 C-N-CA 119.198 -1.477 . . . . 0.23999999999999999 113.31 171.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.902 ' HB3' HD22 ' A' ' 44' ' ' LEU . 7.4 mp -125.79 149.08 48.88 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 114.767 -0.717 . . . . 0.19 111.135 -168.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . 0.603 ' HA ' ' O ' ' A' ' 13' ' ' LEU . 78.4 m-70 -144.05 150.08 37.64 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.21 0.529 . . . . 0.22 111.854 178.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.628 HG12 HD11 ' A' ' 44' ' ' LEU . 2.5 pt -132.7 140.7 46.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 107.577 -1.268 . . . . 0.17000000000000001 107.577 159.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 2.7 mp -130.43 145.17 35.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 C-N-CA 120.813 -0.355 . . . . 0.17999999999999999 110.643 -176.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.456 ' HG2' ' HB3' ' A' ' 11' ' ' ALA . 43.3 pttt -127.74 141.5 51.57 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.725 -0.842 . . . . 0.60999999999999999 108.725 173.047 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . 0.56 ' HB2' ' CD1' ' A' ' 96' ' ' LEU . 55.1 ttt180 -83.72 129.06 34.95 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.212 0.53 . . . . 1.8700000000000001 111.097 -178.033 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -97.02 -34.51 11.15 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.137 -0.938 . . . . 0.89000000000000001 110.105 -179.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.404 ' HB3' ' HB3' ' A' ' 9' ' ' ARG . . . . . . . . 0 C--O 1.246 0.882 0 CA-C-O 118.647 -0.692 . . . . 1.1000000000000001 109.958 178.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.417 ' HG3' ' HB3' ' A' ' 79' ' ' PHE . 10.3 tptt . . . . . 0 N--CA 1.45 -0.441 0 CA-C-O 121.703 0.763 . . . . 1.1899999999999999 111.419 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.587 HD23 ' N ' ' A' ' 9' ' ' ARG . 2.1 tt -113.93 157.6 22.2 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 114.25 -1.341 . . . . 1.1799999999999999 107.898 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.587 ' N ' HD23 ' A' ' 8' ' ' LEU . 63.2 ttt180 -141.0 130.32 23.66 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 109.164 -0.68 . . . . 1.0600000000000001 109.164 173.336 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -147.19 152.5 38.5 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 120.251 -0.58 . . . . 0.22 112.15 -178.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -103.97 134.08 47.86 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.311 -0.858 . . . . 0.20000000000000001 109.019 176.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 29.1 p-80 -135.13 148.05 49.66 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.101 0.477 . . . . 0.23000000000000001 111.851 -172.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.556 HD23 ' N ' ' A' ' 14' ' ' LEU . 5.2 tt -115.0 147.97 39.41 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.518 -0.919 . . . . 0.23999999999999999 108.518 177.457 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.556 ' N ' HD23 ' A' ' 13' ' ' LEU . 18.1 tp -131.65 130.24 41.83 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 110.35 -0.241 . . . . 0.27000000000000002 110.35 -177.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.529 HG23 HD13 ' A' ' 44' ' ' LEU . 56.5 t -119.7 133.63 65.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 109.827 -0.435 . . . . 0.14999999999999999 109.827 174.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.53 ' HE3' HD21 ' A' ' 14' ' ' LEU . 33.4 mmtp -104.96 154.91 19.47 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.066 -0.516 . . . . 0.62 110.503 178.145 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.412 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 50.4 p90 -149.64 161.62 41.83 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.633 -0.712 . . . . 0.25 109.523 -178.057 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.473 ' HB3' ' C ' ' A' ' 33' ' ' ALA . 38.1 p -54.59 110.16 0.6 Allowed 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.147 0.499 . . . . 1.04 110.5 177.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 108.84 9.47 26.4 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.918 -0.658 . . . . 0.53000000000000003 112.356 -176.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.456 ' C ' ' H ' ' A' ' 22' ' ' ASN . 42.5 p -88.06 26.69 1.32 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 117.095 0.448 . . . . 0.69999999999999996 111.81 -175.537 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.417 ' HB2' ' O ' ' A' ' 20' ' ' SER . 83.2 mtt180 72.5 -20.04 0.28 Allowed 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.173 0.589 . . . . 3.4900000000000002 111.459 -178.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.456 ' H ' ' C ' ' A' ' 20' ' ' SER . 7.4 p30 -155.08 107.31 2.28 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-O 121.47 0.653 . . . . 1.77 109.345 171.182 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.41 ' C ' HG22 ' A' ' 32' ' ' THR . 87.5 Cg_endo -81.77 58.81 6.92 Favored 'Trans proline' 0 CA--C 1.534 0.49 0 C-N-CA 122.824 2.35 . . . . 1.71 113.47 -171.289 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.438 ' N ' HG22 ' A' ' 32' ' ' THR . 63.9 t -140.22 121.91 15.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 122.6 0.36 . . . . 0.47999999999999998 110.138 178.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 28.3 t -103.06 149.55 24.47 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 109.235 -0.654 . . . . 1.1200000000000001 109.235 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.57 ' HB2' ' HA ' ' A' ' 67' ' ' ASP . 2.1 mpt_? -77.38 -14.55 59.69 Favored 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 108.443 -0.947 . . . . 2.54 108.443 173.089 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.488 ' HG2' ' HD3' ' A' ' 65' ' ' ARG . 1.9 tmm_? -76.41 -35.51 58.54 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 114.575 -1.193 . . . . 1.77 109.558 175.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 44.2 p -97.62 -34.19 11.04 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 121.273 0.558 . . . . 0.67000000000000004 110.595 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 75.37 -10.41 11.43 Favored Glycine 0 N--CA 1.452 -0.269 0 CA-C-N 115.492 -0.776 . . . . 0.81999999999999995 113.032 178.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -115.93 -71.36 0.74 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.886 0.374 . . . . 2.1000000000000001 109.995 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.2 p -152.51 154.83 36.26 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.031 -0.531 . . . . 1.0800000000000001 110.679 179.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.447 HG21 ' CB ' ' A' ' 16' ' ' LYS . 8.8 t -123.01 34.9 5.01 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 122.147 0.975 . . . . 0.34000000000000002 109.712 175.332 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.473 ' C ' ' HB3' ' A' ' 18' ' ' SER . . . -79.6 -5.57 55.29 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.181 -0.918 . . . . 0.37 112.309 -174.392 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -97.68 -25.27 15.16 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.083 0.468 . . . . 2.21 111.159 -179.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.502 HG23 ' HB2' ' A' ' 39' ' ' ASP . 0.3 OUTLIER -93.5 137.68 22.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 116.128 -0.487 . . . . 0.31 110.174 -177.074 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 56.8 p -98.17 -178.29 4.0 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.442 -0.577 . . . . 0.39000000000000001 109.442 -178.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.517 ' O ' HG13 ' A' ' 41' ' ' ILE . 0.2 OUTLIER -66.18 -24.27 66.61 Favored 'General case' 0 C--O 1.219 -0.518 0 C-N-CA 119.291 -0.963 . . . . 1.53 110.013 173.522 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -70.01 -45.7 66.67 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.887 -0.412 . . . . 0.95999999999999996 109.887 175.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.502 ' HB2' HG23 ' A' ' 35' ' ' VAL . 26.3 m-20 -69.01 -30.96 69.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.503 0.668 . . . . 0.91000000000000003 109.758 177.334 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.412 ' HB2' ' HB3' ' A' ' 17' ' ' PHE . . . -73.3 -42.26 62.59 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.139 -0.937 . . . . 0.19 110.863 179.15 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.517 HG13 ' O ' ' A' ' 37' ' ' TYR . 69.4 mt -63.54 -35.89 74.29 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.299 0 N-CA-C 109.494 -0.558 . . . . 0.29999999999999999 109.494 174.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 20.3 ttpt -62.96 -23.62 67.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.363 0.601 . . . . 2.3199999999999998 109.896 178.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.509 ' HG3' ' CD1' ' A' ' 47' ' ' TRP . 2.2 tp10 -87.67 -56.95 3.13 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.09 -0.959 . . . . 1.02 109.378 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.884 HD23 HG23 ' A' ' 104' ' ' ILE . 31.9 tp -59.24 -36.8 76.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.088 -0.96 . . . . 0.17000000000000001 110.82 -174.213 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.589 ' O ' ' HB2' ' A' ' 49' ' ' GLN . 0.0 OUTLIER -67.07 -29.76 69.63 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 116.159 -0.473 . . . . 0.87 112.25 -177.407 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 44.5 mttp -78.29 -42.76 29.91 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.814 0.34 . . . . 1.3100000000000001 110.316 178.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.509 ' CD1' ' HG3' ' A' ' 43' ' ' GLU . 49.4 m95 -66.81 -44.45 81.15 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.384 -0.371 . . . . 0.52000000000000002 111.364 178.226 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.508 ' HB3' HG21 ' A' ' 113' ' ' ILE . 88.9 p -64.7 -32.17 73.72 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 110.017 -0.364 . . . . 0.81999999999999995 110.017 176.245 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.589 ' HB2' ' O ' ' A' ' 45' ' ' GLN . 11.0 tt0 -66.13 -49.81 66.16 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.1 -0.5 . . . . 0.53000000000000003 110.274 177.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.602 ' HB3' HG22 ' A' ' 56' ' ' VAL . 87.9 mtt180 -64.14 -44.49 91.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.755 -0.657 . . . . 0.41999999999999998 111.272 -179.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.412 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 88.3 mt -59.84 -39.35 79.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.362 -0.381 . . . . 0.20000000000000001 110.654 177.085 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.27 -36.21 68.94 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.232 -0.44 . . . . 0.27000000000000002 111.863 -179.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 24.6 p -85.19 -30.32 24.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.896 0.379 . . . . 0.34999999999999998 111.474 -177.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 108.91 11.34 22.86 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.62 -0.8 . . . . 0.29999999999999999 112.742 178.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.47 ' OE1' ' HG2' ' A' ' 50' ' ' ARG . 46.9 mt-10 -62.56 -49.51 74.99 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.612 -0.514 . . . . 0.65000000000000002 109.612 175.319 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.602 HG22 ' HB3' ' A' ' 50' ' ' ARG . 14.6 m -132.16 155.28 41.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.591 -0.731 . . . . 0.19 109.359 173.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.1 m -83.29 160.43 21.71 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 109.236 -0.653 . . . . 0.96999999999999997 109.236 178.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -54.93 -44.11 73.96 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.619 -0.512 . . . . 0.22 109.619 -179.097 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.552 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 39.9 mt-10 -59.15 -43.41 92.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.12 -0.945 . . . . 1.72 111.8 -179.178 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 -61.62 -49.05 78.14 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 120.964 0.411 . . . . 2.0899999999999999 110.519 -177.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -67.53 -50.16 59.97 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.926 -0.579 . . . . 0.26000000000000001 110.902 -178.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -58.6 -51.97 67.67 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.573 0.583 . . . . 0.23999999999999999 112.573 -174.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.571 ' HA ' ' O ' ' A' ' 71' ' ' TYR . 23.9 m -51.32 -27.26 9.13 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.736 0.643 . . . . 1.0 112.736 -177.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -102.68 -44.67 5.24 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.533 0.683 . . . . 0.60999999999999999 110.654 -178.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.488 ' HD3' ' HG2' ' A' ' 27' ' ' ARG . 25.3 mmt180 -94.6 -35.91 12.02 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 114.2 1.185 . . . . 0.85999999999999999 114.2 -169.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.544 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 33.7 p -66.7 128.13 35.07 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.9 0.381 . . . . 0.81999999999999995 110.797 -177.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.57 ' HA ' ' HB2' ' A' ' 26' ' ' ARG . 40.0 m-20 -90.92 5.54 48.22 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.701 -0.681 . . . . 2.2799999999999998 111.644 -177.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 0.472 ' O ' ' HD1' ' A' ' 71' ' ' TYR . 36.1 t -88.22 170.0 11.39 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.67 -0.493 . . . . 1.52 109.67 174.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -63.56 -19.02 62.06 Favored Glycine 0 N--CA 1.454 -0.142 0 C-N-CA 121.08 -0.581 . . . . 0.26000000000000001 111.962 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 55.3 p -65.93 -6.92 13.94 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 112.532 0.567 . . . . 0.32000000000000001 112.532 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.571 ' O ' ' HA ' ' A' ' 63' ' ' SER . 20.0 p90 -60.68 -23.16 64.62 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.216 0.532 . . . . 0.54000000000000004 109.747 176.171 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -89.28 -1.48 58.08 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.188 -0.46 . . . . 0.48999999999999999 111.055 179.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.5 m -126.17 6.94 7.15 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.91 0.386 . . . . 0.70999999999999996 110.998 -179.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.552 ' O ' ' HA ' ' A' ' 59' ' ' GLU . . . 73.37 30.39 62.59 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.634 -0.793 . . . . 0.54000000000000004 112.195 -177.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 85.45 -22.21 11.3 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 121.12 -0.562 . . . . 0.34999999999999998 111.801 -179.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -64.32 134.67 55.13 Favored 'General case' 0 CA--C 1.508 -0.663 0 CA-C-N 115.203 -0.498 . . . . 1.6499999999999999 111.49 -176.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.431 ' HB3' ' HE2' ' A' ' 80' ' ' PHE . 2.6 mp -117.52 158.18 25.0 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 115.685 -0.689 . . . . 0.93999999999999995 109.334 169.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -78.63 -150.05 4.83 Favored Glycine 0 C--N 1.308 -0.977 0 CA-C-N 115.023 -0.989 . . . . 0.44 112.72 -179.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.417 ' HB3' ' HG3' ' A' ' 7' ' ' LYS . 97.7 m-85 -88.52 144.82 26.1 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.203 0.525 . . . . 3.8700000000000001 111.697 -178.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.431 ' HE2' ' HB3' ' A' ' 77' ' ' LEU . 1.6 p90 -158.3 153.63 25.82 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.123 -0.944 . . . . 1.3100000000000001 108.803 -177.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 29.3 m -82.39 133.64 35.22 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.115 -0.698 . . . . 1.1699999999999999 109.115 178.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 4.5 p -49.98 121.14 5.02 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.997 -0.547 . . . . 1.1899999999999999 111.514 -178.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 114.49 -17.18 18.86 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.847 -0.692 . . . . 0.79000000000000004 112.938 -178.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 65.6 mt-10 -83.55 46.71 1.18 Allowed 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 117.092 0.446 . . . . 1.55 111.486 -176.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 25.7 mmt -137.68 -122.59 0.14 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.053 0.454 . . . . 0.72999999999999998 110.482 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 54.9 mtt -125.34 149.59 47.97 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.163 -1.051 . . . . 1.3899999999999999 108.163 176.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 16.3 tppt? -54.12 -52.76 65.71 Favored Pre-proline 0 C--N 1.32 -0.715 0 N-CA-C 112.423 0.527 . . . . 2.3700000000000001 112.423 -174.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.49 ' HG2' HG22 ' A' ' 107' ' ' THR . 74.0 Cg_endo -75.42 -23.62 12.95 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 121.336 1.357 . . . . 0.27000000000000002 112.136 -176.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.596 ' O ' HG23 ' A' ' 93' ' ' VAL . 45.3 t80 -74.34 -55.39 6.06 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.396 -0.82 . . . . 0.22 109.868 179.354 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -64.75 -34.33 78.07 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.614 -0.721 . . . . 2.1200000000000001 110.087 -178.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.498 ' HA ' ' NE ' ' A' ' 94' ' ' ARG . 19.2 t70 -53.44 -35.94 61.03 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.929 -0.578 . . . . 0.60999999999999999 110.753 175.13 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.478 ' O ' ' HG ' ' A' ' 96' ' ' LEU . . . -80.4 -36.19 34.15 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.341 -0.391 . . . . 0.22 110.957 178.511 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.596 HG23 ' O ' ' A' ' 89' ' ' PHE . 15.4 t -64.27 -41.67 93.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.275 0.559 . . . . 0.25 110.693 -177.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.498 ' NE ' ' HA ' ' A' ' 91' ' ' ASP . 36.4 ptt180 -76.1 -12.21 60.07 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.833 -0.621 . . . . 2.5899999999999999 110.449 178.194 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -97.32 21.16 10.42 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.085 -0.507 . . . . 0.46999999999999997 111.314 -174.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.543 ' HB2' ' HB2' ' A' ' 100' ' ' ASP . 0.4 OUTLIER -152.32 156.35 39.44 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.86 -0.609 . . . . 0.28000000000000003 110.604 175.074 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.468 ' HG3' ' H ' ' A' ' 98' ' ' ILE . 50.8 tptt -99.01 175.92 5.75 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.502 -0.772 . . . . 1.6100000000000001 108.96 179.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.468 ' H ' ' HG3' ' A' ' 97' ' ' LYS . 67.3 mt -57.19 117.66 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 120.887 0.375 . . . . 0.90000000000000002 110.752 178.184 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 96.37 9.09 57.1 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.821 -0.704 . . . . 0.46000000000000002 112.748 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.543 ' HB2' ' HB2' ' A' ' 96' ' ' LEU . 21.7 m-20 -110.83 141.62 43.95 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 110.001 -0.37 . . . . 0.46000000000000002 110.001 176.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 12.3 mt -111.8 149.94 14.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.212 -0.449 . . . . 0.23000000000000001 110.002 -177.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 99.6 p -95.04 143.36 25.97 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 116.619 -0.264 . . . . 0.92000000000000004 110.525 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -66.65 164.79 27.7 Favored 'Trans proline' 0 N--CA 1.461 -0.41 0 C-N-CA 122.319 2.013 . . . . 0.34000000000000002 110.93 171.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.884 HG23 HD23 ' A' ' 44' ' ' LEU . 20.2 mm -39.48 113.34 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 O-C-N 123.817 0.698 . . . . 0.20000000000000001 112.571 -179.08 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 1.8 p -121.37 121.62 65.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.949 -0.568 . . . . 1.04 110.121 175.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . 0.437 ' HG2' ' CD1' ' A' ' 111' ' ' LEU . 49.2 mt-30 -85.09 156.58 21.01 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.059 0.457 . . . . 0.55000000000000004 110.394 178.428 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.49 HG22 ' HG2' ' A' ' 88' ' ' PRO . 3.0 p -130.24 -172.49 2.8 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.684 -0.689 . . . . 0.37 110.212 179.042 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -60.96 -36.36 79.18 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.574 0.226 . . . . 2.1600000000000001 110.693 177.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.434 ' OG ' ' HE2' ' A' ' 16' ' ' LYS . 23.3 t -91.51 -61.37 1.66 Allowed 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 120.89 -0.324 . . . . 1.0900000000000001 110.657 -178.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -150.67 -130.93 1.78 Allowed Glycine 0 N--CA 1.442 -0.901 0 C-N-CA 119.287 -1.435 . . . . 0.23999999999999999 113.635 -174.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.882 ' HB3' HD22 ' A' ' 44' ' ' LEU . 7.4 mp -116.48 148.7 40.52 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.332 -0.434 . . . . 0.19 111.392 -171.511 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . 0.502 ' NE2' HD13 ' A' ' 14' ' ' LEU . 86.4 m-70 -144.09 151.88 40.2 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.267 0.556 . . . . 0.22 112.398 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.621 HG12 HD11 ' A' ' 44' ' ' LEU . 3.4 pt -133.21 136.26 55.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 107.484 -1.302 . . . . 0.17000000000000001 107.484 159.273 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 2.8 mp -127.48 144.3 37.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 C-N-CA 120.753 -0.379 . . . . 0.17999999999999999 110.478 -176.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 41.3 pttt -125.76 140.81 52.37 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.773 -0.825 . . . . 0.60999999999999999 108.773 172.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . 0.493 ' HB2' ' CD1' ' A' ' 96' ' ' LEU . 59.2 ttt180 -87.36 134.47 33.57 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.072 0.463 . . . . 1.8700000000000001 111.384 -177.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 6.7 mp -112.1 -24.06 10.1 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.568 -0.742 . . . . 0.89000000000000001 111.187 -178.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.53 ' HB3' ' HB3' ' A' ' 9' ' ' ARG . . . . . . . . 0 C--O 1.243 0.744 0 CA-C-O 118.019 -0.991 . . . . 1.1000000000000001 109.697 176.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 10.9 tptt . . . . . 0 N--CA 1.452 -0.346 0 CA-C-O 121.297 0.57 . . . . 1.1899999999999999 109.91 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.682 HD23 ' H ' ' A' ' 9' ' ' ARG . 0.3 OUTLIER -128.21 168.51 15.34 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 114.962 -1.017 . . . . 1.1799999999999999 109.808 -171.807 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.682 ' H ' HD23 ' A' ' 8' ' ' LEU . 70.1 ttt180 -145.64 125.03 13.07 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.064 -0.717 . . . . 1.0600000000000001 109.064 174.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.497 ' N ' ' HZ ' ' A' ' 80' ' ' PHE . . . -145.93 160.57 41.64 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.353 -0.539 . . . . 0.22 112.003 -177.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.582 ' HA ' ' HA ' ' A' ' 76' ' ' ASP . . . -106.65 131.66 53.53 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.282 -0.872 . . . . 0.20000000000000001 109.573 178.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 22.5 p-80 -133.54 140.1 46.99 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.995 0.426 . . . . 0.23000000000000001 111.115 -173.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.674 ' O ' ' HA ' ' A' ' 112' ' ' HIS . 5.9 tt -113.24 137.54 51.32 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.852 -0.796 . . . . 0.23999999999999999 108.852 179.195 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.614 ' HA ' ' O ' ' A' ' 111' ' ' LEU . 23.2 tp -120.8 122.43 40.3 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.892 0.377 . . . . 0.27000000000000002 111.364 -178.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.625 HG23 HD13 ' A' ' 44' ' ' LEU . 57.7 t -108.04 137.69 38.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 109.059 -0.719 . . . . 0.14999999999999999 109.059 171.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.607 ' HE2' ' OG ' ' A' ' 109' ' ' SER . 28.6 mmtp -105.22 164.33 11.91 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.806 -0.442 . . . . 0.62 109.806 178.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 42.9 p90 -155.55 160.57 40.62 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.418 -0.586 . . . . 0.25 109.418 -177.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.436 ' HB3' ' C ' ' A' ' 33' ' ' ALA . 54.2 p -58.09 110.3 0.91 Allowed 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.483 -0.326 . . . . 1.04 110.557 178.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 105.51 10.16 31.8 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.475 -0.869 . . . . 0.53000000000000003 113.15 -178.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.487 ' C ' ' H ' ' A' ' 22' ' ' ASN . 49.8 p -77.44 37.21 0.21 Allowed 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 117.639 0.719 . . . . 0.69999999999999996 112.11 -174.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 60.6 ttt180 68.31 -36.17 0.31 Allowed 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.621 0.769 . . . . 3.4900000000000002 111.065 -176.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.487 ' H ' ' C ' ' A' ' 20' ' ' SER . 8.6 p30 -154.68 119.01 2.58 Favored Pre-proline 0 C--N 1.319 -0.731 0 N-CA-C 107.757 -1.201 . . . . 1.77 107.757 171.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.401 ' HB2' ' H ' ' A' ' 24' ' ' VAL . 68.9 Cg_endo -81.99 -151.72 0.04 OUTLIER 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 122.528 2.152 . . . . 1.71 111.885 -174.474 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.597 ' N ' HG22 ' A' ' 32' ' ' THR . 48.0 t 64.06 111.17 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 123.329 0.652 . . . . 0.47999999999999998 111.588 -175.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.488 ' HB3' ' HB2' ' A' ' 16' ' ' LYS . 35.7 p -103.93 152.92 21.4 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.377 -0.374 . . . . 1.1200000000000001 110.115 177.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.582 ' HG2' ' HA ' ' A' ' 67' ' ' ASP . 3.8 mmp_? -65.34 -12.01 47.68 Favored 'General case' 0 N--CA 1.462 0.159 0 N-CA-C 109.522 -0.547 . . . . 2.54 109.522 172.256 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.555 ' HG3' ' CD ' ' A' ' 65' ' ' ARG . 31.5 ttp180 -67.79 -55.82 11.57 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.377 -0.828 . . . . 1.77 110.01 177.115 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 31.8 p -87.83 -34.11 18.35 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 121.446 0.641 . . . . 0.67000000000000004 110.63 -176.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 70.12 16.89 73.37 Favored Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 115.292 -0.867 . . . . 0.81999999999999995 111.962 -179.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -144.79 -68.41 0.31 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.582 0.229 . . . . 2.1000000000000001 110.548 -178.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.8 p -150.14 147.19 27.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.967 0.413 . . . . 1.0800000000000001 111.61 179.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.597 HG22 ' N ' ' A' ' 24' ' ' VAL . 9.6 t -127.51 16.16 7.06 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.67 0.748 . . . . 0.34000000000000002 109.943 174.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.436 ' C ' ' HB3' ' A' ' 18' ' ' SER . . . -67.77 -4.34 12.16 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.126 -0.943 . . . . 0.37 112.973 -178.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -95.07 -25.5 16.43 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.091 0.472 . . . . 2.21 110.968 -179.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.514 HG23 ' HB2' ' A' ' 39' ' ' ASP . 0.2 OUTLIER -95.6 135.06 30.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.097 -0.501 . . . . 0.31 110.277 -178.364 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 63.4 p -93.36 178.22 5.79 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 109.548 -0.538 . . . . 0.39000000000000001 109.548 -176.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.489 ' O ' HG13 ' A' ' 41' ' ' ILE . 0.1 OUTLIER -67.05 -22.25 65.87 Favored 'General case' 0 C--O 1.22 -0.463 0 C-N-CA 118.809 -1.156 . . . . 1.53 110.12 174.045 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -71.86 -46.97 56.1 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.975 -0.38 . . . . 0.95999999999999996 109.975 175.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.514 ' HB2' HG23 ' A' ' 35' ' ' VAL . 24.9 m-20 -64.19 -35.72 81.71 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.612 0.72 . . . . 0.91000000000000003 109.636 175.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.83 -47.4 66.12 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.888 -1.051 . . . . 0.19 110.788 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.489 HG13 ' O ' ' A' ' 37' ' ' TYR . 60.9 mt -63.02 -35.47 71.75 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.388 0 N-CA-C 110.001 -0.37 . . . . 0.29999999999999999 110.001 176.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.471 ' O ' ' HG3' ' A' ' 46' ' ' LYS . 27.8 ttpt -61.63 -28.69 69.55 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 121.3 0.572 . . . . 2.3199999999999998 109.695 179.424 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -88.6 -48.48 7.53 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.392 -0.822 . . . . 1.02 110.352 -177.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.93 HD23 HG23 ' A' ' 104' ' ' ILE . 29.3 tp -59.57 -36.99 77.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.002 -0.545 . . . . 0.17000000000000001 110.366 -178.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.454 HE21 ' HA ' ' A' ' 45' ' ' GLN . 0.0 OUTLIER -67.97 -21.48 65.07 Favored 'General case' 0 N--CA 1.462 0.134 0 N-CA-C 112.114 0.413 . . . . 0.87 112.114 -179.042 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.471 ' HG3' ' O ' ' A' ' 42' ' ' LYS . 67.8 mttm -82.97 -44.62 15.08 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.929 -0.397 . . . . 1.3100000000000001 109.929 177.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 43.2 m95 -65.63 -45.38 83.25 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.299 -0.409 . . . . 0.52000000000000002 111.181 177.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.512 ' HB3' HG21 ' A' ' 113' ' ' ILE . 97.1 p -65.24 -20.4 66.41 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.885 -0.413 . . . . 0.81999999999999995 109.885 178.191 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.41 ' HB2' ' O ' ' A' ' 45' ' ' GLN . 0.9 OUTLIER -76.34 -56.6 4.49 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 109.541 -0.54 . . . . 0.53000000000000003 109.541 173.693 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.589 ' HB3' HG22 ' A' ' 56' ' ' VAL . 92.5 mtt180 -59.88 -43.09 94.93 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.724 -0.671 . . . . 0.41999999999999998 111.808 -176.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.469 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 95.3 mt -60.46 -33.64 55.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 120.985 0.421 . . . . 0.20000000000000001 110.57 177.279 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -81.42 -38.75 25.99 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.102 -0.499 . . . . 0.27000000000000002 111.317 -179.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 26.7 p -75.99 -29.56 58.25 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.002 0.429 . . . . 0.34999999999999998 111.135 -178.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 106.33 6.54 36.09 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.869 -0.682 . . . . 0.29999999999999999 111.962 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.459 ' HB2' ' HB3' ' A' ' 50' ' ' ARG . 43.2 mt-10 -63.44 -45.65 89.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.809 0.338 . . . . 0.65000000000000002 110.376 178.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.589 HG22 ' HB3' ' A' ' 50' ' ' ARG . 12.7 m -136.73 155.9 34.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 109.562 -0.533 . . . . 0.19 109.562 172.548 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 13.0 m -83.28 159.61 21.88 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.431 -0.581 . . . . 0.96999999999999997 109.431 178.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -56.23 -40.68 74.47 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.544 -0.539 . . . . 0.22 109.544 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -52.12 -50.15 62.25 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.342 -0.844 . . . . 1.72 111.493 178.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -62.18 -46.76 87.52 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.852 -0.613 . . . . 2.0899999999999999 111.392 -173.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -71.1 -40.86 71.26 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.79 0.329 . . . . 0.26000000000000001 111.066 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -64.64 -45.92 84.75 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.445 -0.343 . . . . 0.23999999999999999 111.777 -176.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.47 ' HA ' ' O ' ' A' ' 71' ' ' TYR . 41.9 t -56.63 -27.43 58.35 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 112.658 0.614 . . . . 1.0 112.658 -177.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.483 ' O ' ' HA ' ' A' ' 27' ' ' ARG . 36.4 mt-30 -104.92 -48.58 3.71 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.378 0.609 . . . . 0.60999999999999999 110.632 -176.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.555 ' CD ' ' HG3' ' A' ' 27' ' ' ARG . 21.5 mmt180 -88.66 -41.75 12.43 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.134 -0.939 . . . . 0.85999999999999999 113.174 -169.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.509 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 22.8 t -60.62 122.25 14.23 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.701 0.286 . . . . 0.81999999999999995 111.189 -177.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.582 ' HA ' ' HG2' ' A' ' 26' ' ' ARG . 31.6 t70 -80.18 -7.61 59.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.382 0.61 . . . . 2.2799999999999998 110.639 176.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 0.492 ' SG ' ' HE1' ' A' ' 112' ' ' HIS . 1.5 m -76.83 160.71 29.03 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.293 0.568 . . . . 1.52 110.082 177.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -67.77 -11.53 60.53 Favored Glycine 0 N--CA 1.45 -0.423 0 CA-C-N 114.785 -1.098 . . . . 0.26000000000000001 112.554 -172.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 76.5 p -75.01 -5.69 45.38 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 111.518 0.192 . . . . 0.32000000000000001 111.518 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.47 ' O ' ' HA ' ' A' ' 63' ' ' SER . 16.8 p90 -54.91 -37.86 66.9 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.156 0.503 . . . . 0.54000000000000004 110.027 175.143 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -95.37 7.54 45.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.146 -0.479 . . . . 0.48999999999999999 110.591 -178.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.9 m -113.54 -14.82 12.64 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.959 -0.564 . . . . 0.70999999999999996 110.998 -177.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 103.5 14.39 25.78 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.775 -0.726 . . . . 0.54000000000000004 112.235 -177.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 88.49 -31.18 4.96 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.995 -0.621 . . . . 0.34999999999999998 112.428 179.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.582 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 8.5 p-10 -85.06 144.61 28.14 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-O 121.579 0.704 . . . . 1.6499999999999999 111.099 -176.217 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.538 ' O ' ' HG3' ' A' ' 9' ' ' ARG . 0.7 OUTLIER -106.4 176.98 4.99 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 114.631 -1.168 . . . . 0.93999999999999995 109.979 177.54 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -90.42 -125.4 3.02 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.928 -0.653 . . . . 0.44 113.006 -176.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 34.3 p90 -98.3 136.32 38.64 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.128 0.489 . . . . 3.8700000000000001 110.96 -177.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.497 ' HZ ' ' N ' ' A' ' 10' ' ' ALA . 5.9 p90 -159.44 144.83 15.8 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.053 -0.721 . . . . 1.3100000000000001 109.053 179.09 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.0 p -94.02 154.51 17.61 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 120.994 0.426 . . . . 1.1699999999999999 110.497 -177.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 15.2 m -64.85 111.43 2.81 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.951 -0.568 . . . . 1.1899999999999999 110.117 179.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.63 ' H ' ' HG3' ' A' ' 90' ' ' GLU . . . 113.46 5.18 22.96 Favored Glycine 0 N--CA 1.447 -0.578 0 CA-C-N 115.601 -0.727 . . . . 0.79000000000000004 111.454 -174.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -111.77 32.84 5.15 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 121.493 0.664 . . . . 1.55 110.366 -177.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 22.1 mmt -137.41 -122.02 0.14 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.068 -0.515 . . . . 0.72999999999999998 110.277 179.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 63.8 mtt -121.1 155.1 35.18 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.293 -1.002 . . . . 1.3899999999999999 108.293 174.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.452 ' HB2' ' HD3' ' A' ' 88' ' ' PRO . 29.9 mmmt -53.15 -58.11 13.77 Favored Pre-proline 0 C--N 1.322 -0.598 0 N-CA-C 112.393 0.516 . . . . 2.3700000000000001 112.393 -177.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.452 ' HD3' ' HB2' ' A' ' 87' ' ' LYS . 77.1 Cg_endo -75.61 -23.7 12.58 Favored 'Trans proline' 0 C--N 1.354 0.838 0 C-N-CA 121.516 1.477 . . . . 0.27000000000000002 111.931 -175.47 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.616 ' O ' HG23 ' A' ' 93' ' ' VAL . 52.7 t80 -71.64 -56.15 6.38 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.472 -0.786 . . . . 0.22 109.762 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.63 ' HG3' ' H ' ' A' ' 83' ' ' GLY . 4.6 tm-20 -67.08 -37.19 83.55 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.647 -0.706 . . . . 2.1200000000000001 110.192 -179.026 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -51.98 -36.01 48.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.687 -0.688 . . . . 0.60999999999999999 110.491 174.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.51 ' O ' ' HG ' ' A' ' 96' ' ' LEU . . . -79.63 -32.95 41.78 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.998 -0.546 . . . . 0.22 111.419 178.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.616 HG23 ' O ' ' A' ' 89' ' ' PHE . 25.9 t -67.4 -39.74 83.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.564 0.697 . . . . 0.25 110.121 -176.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.456 ' C ' ' HD2' ' A' ' 94' ' ' ARG . 0.2 OUTLIER -84.04 -8.0 59.24 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.421 -0.809 . . . . 2.5899999999999999 110.841 179.644 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -88.35 0.77 55.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.296 -0.411 . . . . 0.46999999999999997 111.067 -177.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.598 ' HB2' ' HB2' ' A' ' 100' ' ' ASP . 0.6 OUTLIER -139.36 157.29 46.13 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.1 -0.5 . . . . 0.28000000000000003 110.625 179.446 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.553 ' HG2' ' H ' ' A' ' 98' ' ' ILE . 10.7 tttt -102.53 -175.0 2.7 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.161 -0.681 . . . . 1.6100000000000001 109.161 176.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.553 ' H ' ' HG2' ' A' ' 97' ' ' LYS . 1.3 mp -54.67 120.34 2.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 C-N-CA 123.087 0.555 . . . . 0.90000000000000002 110.584 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 93.18 1.21 67.13 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.812 -0.709 . . . . 0.46000000000000002 113.078 176.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.598 ' HB2' ' HB2' ' A' ' 96' ' ' LEU . 33.4 m-20 -102.17 139.63 37.53 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 117.006 0.403 . . . . 0.46000000000000002 110.411 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 11.9 mt -111.3 148.92 14.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.01 -0.541 . . . . 0.23000000000000001 110.239 -178.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 97.7 p -93.3 158.67 36.71 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 116.404 -0.362 . . . . 0.92000000000000004 110.725 -178.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -71.42 170.0 19.49 Favored 'Trans proline' 0 C--O 1.234 0.285 0 C-N-CA 122.475 2.117 . . . . 0.34000000000000002 111.518 172.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.93 HG23 HD23 ' A' ' 44' ' ' LEU . 19.5 mm -47.33 112.12 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 O-C-N 123.399 0.437 . . . . 0.20000000000000001 111.911 175.08 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 58.9 t -116.75 122.65 70.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.155 -0.475 . . . . 1.04 110.201 176.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -85.78 149.35 25.33 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.032 0.444 . . . . 0.55000000000000004 110.102 176.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 8.1 p -127.77 -172.24 2.63 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.797 -0.638 . . . . 0.37 111.018 -177.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -52.26 -40.75 62.13 Favored 'General case' 0 CA--C 1.518 -0.277 0 O-C-N 123.418 0.449 . . . . 2.1600000000000001 111.276 176.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.607 ' OG ' ' HE2' ' A' ' 16' ' ' LYS . 8.8 t -100.3 -60.53 1.51 Allowed 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 120.196 -0.601 . . . . 1.0900000000000001 111.323 -178.324 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -146.03 -137.13 3.02 Favored Glycine 0 N--CA 1.44 -1.034 0 C-N-CA 118.673 -1.727 . . . . 0.23999999999999999 113.733 -172.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.879 ' HB3' HD22 ' A' ' 44' ' ' LEU . 6.9 mp -109.65 143.16 39.79 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 114.87 -0.665 . . . . 0.19 111.164 -170.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . 0.674 ' HA ' ' O ' ' A' ' 13' ' ' LEU . 85.6 m-70 -143.21 138.49 29.72 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.6 0.593 . . . . 0.22 112.6 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.567 HG12 HD11 ' A' ' 44' ' ' LEU . 3.9 pt -120.96 138.86 50.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 107.753 -1.203 . . . . 0.17000000000000001 107.753 161.068 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 2.9 mp -129.43 143.09 42.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 C-N-CA 120.807 -0.357 . . . . 0.17999999999999999 110.48 -175.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.515 ' HG2' ' HB3' ' A' ' 11' ' ' ALA . 48.8 pttt -127.51 138.57 52.96 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.187 -0.671 . . . . 0.60999999999999999 109.187 173.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . 0.507 ' HB2' ' CD1' ' A' ' 96' ' ' LEU . 70.4 ttt180 -84.22 128.38 34.53 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.051 0.453 . . . . 1.8700000000000001 111.545 -175.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.439 HD21 ' HB2' ' A' ' 11' ' ' ALA . 1.2 mm? -95.12 -45.46 7.2 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.613 -0.721 . . . . 0.89000000000000001 109.999 176.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.892 0 CA-C-O 118.58 -0.724 . . . . 1.1000000000000001 110.379 -179.97 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 43.2 mmtm . . . . . 0 N--CA 1.453 -0.292 0 CA-C-O 121.343 0.592 . . . . 1.1899999999999999 111.305 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.79 HD23 ' H ' ' A' ' 9' ' ' ARG . 1.3 tt -124.8 165.82 17.32 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 107.413 -1.329 . . . . 1.1799999999999999 107.413 178.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.79 ' H ' HD23 ' A' ' 8' ' ' LEU . 65.9 ttt180 -143.78 127.68 17.35 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 118.11 0.414 . . . . 1.0600000000000001 110.097 177.21 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -150.11 151.5 33.26 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.03 0.443 . . . . 0.22 111.772 -179.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -102.0 138.04 39.49 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.64 -0.709 . . . . 0.20000000000000001 109.114 176.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 33.5 p-80 -138.08 153.34 49.31 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 120.564 -0.454 . . . . 0.23000000000000001 111.842 -171.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.563 HD23 ' N ' ' A' ' 14' ' ' LEU . 5.2 tt -120.69 145.44 47.46 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.508 -0.923 . . . . 0.23999999999999999 108.508 176.116 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.583 ' O ' ' HA ' ' A' ' 66' ' ' SER . 31.2 tp -131.0 118.2 20.27 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.59 0.233 . . . . 0.27000000000000002 110.962 -177.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.615 HG23 HD13 ' A' ' 44' ' ' LEU . 58.5 t -104.72 133.17 49.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 N-CA-C 109.607 -0.516 . . . . 0.14999999999999999 109.607 176.182 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.542 ' HE3' HD21 ' A' ' 14' ' ' LEU . 32.2 mmtp -105.53 138.26 42.01 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.998 -0.547 . . . . 0.62 109.881 177.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.539 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 40.0 p90 -131.1 163.28 28.0 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.845 -0.616 . . . . 0.25 109.344 178.46 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 43.8 p -53.16 109.5 0.43 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.109 0.481 . . . . 1.04 110.269 176.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 108.07 7.94 30.23 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.637 -0.792 . . . . 0.53000000000000003 113.132 -177.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.757 ' HB3' ' O ' ' A' ' 109' ' ' SER . 74.5 m -84.46 38.76 0.7 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 117.042 0.421 . . . . 0.69999999999999996 111.749 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 32.3 ttt85 72.86 -34.0 0.28 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.306 0.643 . . . . 3.4900000000000002 110.944 179.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.447 ' H ' ' C ' ' A' ' 20' ' ' SER . 6.3 p30 -145.08 111.51 4.75 Favored Pre-proline 0 C--N 1.325 -0.482 0 N-CA-C 109.175 -0.676 . . . . 1.77 109.175 171.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.446 ' C ' HG22 ' A' ' 32' ' ' THR . 91.8 Cg_endo -82.62 59.8 7.0 Favored 'Trans proline' 0 CA--C 1.533 0.467 0 C-N-CA 122.92 2.413 . . . . 1.71 113.889 -173.19 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.447 ' N ' HG22 ' A' ' 32' ' ' THR . 43.9 t -145.99 120.81 2.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 109.385 -0.598 . . . . 0.47999999999999998 109.385 175.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 37.7 t -104.73 152.19 22.83 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 110.299 -0.26 . . . . 1.1200000000000001 110.299 178.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.608 ' HG2' ' HA ' ' A' ' 67' ' ' ASP . 5.5 mmp_? -67.72 -9.81 47.04 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.275 0.559 . . . . 2.54 109.764 171.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.57 ' HG3' ' CD ' ' A' ' 65' ' ' ARG . 13.8 ttp180 -76.36 -35.86 58.49 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.369 -0.832 . . . . 1.77 109.78 177.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 64.1 p -105.07 -35.44 7.63 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.896 -0.593 . . . . 0.67000000000000004 111.048 -175.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 84.75 -39.49 2.95 Favored Glycine 0 N--CA 1.451 -0.343 0 CA-C-N 115.683 -0.69 . . . . 0.81999999999999995 112.817 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.419 ' CG ' ' H ' ' A' ' 31' ' ' SER . 8.7 p-10 -91.72 -65.59 1.0 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.747 0.273 . . . . 2.1000000000000001 110.874 -178.032 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.419 ' H ' ' CG ' ' A' ' 30' ' ' ASP . 11.6 p -155.53 157.79 37.43 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.618 0.247 . . . . 1.0800000000000001 110.465 178.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.447 HG22 ' N ' ' A' ' 24' ' ' VAL . 13.4 t -121.76 34.44 5.18 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 122.308 1.051 . . . . 0.34000000000000002 109.148 173.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -79.31 -5.99 55.71 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.853 -1.067 . . . . 0.37 112.146 -173.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -98.1 -24.92 15.11 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.887 0.375 . . . . 2.21 111.156 -178.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.494 HG23 ' HB2' ' A' ' 39' ' ' ASP . 0.3 OUTLIER -91.43 135.73 26.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 120.975 0.417 . . . . 0.31 109.916 -178.795 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 65.7 p -94.5 179.03 5.41 Favored 'General case' 0 CA--C 1.513 -0.476 0 N-CA-C 109.583 -0.525 . . . . 0.39000000000000001 109.583 -175.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.553 ' O ' HG13 ' A' ' 41' ' ' ILE . 8.1 p90 -64.82 -26.26 68.26 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 119.803 -0.759 . . . . 1.53 109.31 176.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -74.83 -44.35 49.73 Favored 'General case' 0 C--N 1.334 -0.087 0 CA-C-N 116.205 -0.452 . . . . 0.95999999999999996 110.629 177.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.494 ' HB2' HG23 ' A' ' 35' ' ' VAL . 45.7 m-20 -64.68 -32.64 74.4 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.642 0.734 . . . . 0.91000000000000003 109.435 177.001 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.539 ' HB2' ' HB3' ' A' ' 17' ' ' PHE . . . -71.07 -38.6 72.45 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.77 -1.104 . . . . 0.19 110.645 178.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.553 HG13 ' O ' ' A' ' 37' ' ' TYR . 77.2 mt -65.09 -36.83 78.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.486 -0.561 . . . . 0.29999999999999999 109.486 173.213 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 9.2 mtpm? -65.53 -17.78 64.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.249 0.547 . . . . 2.3199999999999998 110.774 176.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.536 ' HG3' ' CD1' ' A' ' 47' ' ' TRP . 3.8 tp10 -87.69 -61.22 1.77 Allowed 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.978 -0.749 . . . . 1.02 108.978 175.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.894 HD22 ' HB3' ' A' ' 111' ' ' LEU . 20.9 tp -58.95 -38.12 78.3 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 114.84 -1.073 . . . . 0.17000000000000001 111.572 -173.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.531 ' HB2' ' O ' ' A' ' 41' ' ' ILE . 3.8 mm-40 -68.8 -29.7 68.12 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 112.276 0.473 . . . . 0.87 112.276 -177.048 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 64.4 mttm -81.58 -38.44 26.1 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 120.501 -0.48 . . . . 1.3100000000000001 110.223 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.536 ' CD1' ' HG3' ' A' ' 43' ' ' GLU . 35.4 m95 -67.48 -46.54 72.68 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.198 -0.455 . . . . 0.52000000000000002 111.536 175.462 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.54 ' HB3' HG21 ' A' ' 113' ' ' ILE . 94.3 p -63.77 -30.06 71.2 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.848 -0.427 . . . . 0.81999999999999995 109.848 177.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.442 ' HB2' ' O ' ' A' ' 45' ' ' GLN . 11.9 tt0 -65.29 -53.55 42.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.907 -0.588 . . . . 0.53000000000000003 110.529 174.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.575 ' HB3' HG22 ' A' ' 56' ' ' VAL . 99.4 mtt180 -66.04 -39.49 90.2 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.04 -0.527 . . . . 0.41999999999999998 111.769 -176.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.468 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 99.3 mt -62.45 -34.31 63.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.207 0.527 . . . . 0.20000000000000001 110.236 176.001 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -77.65 -34.98 52.95 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.891 -0.595 . . . . 0.27000000000000002 111.55 179.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.424 ' OG ' ' HA ' ' A' ' 50' ' ' ARG . 33.1 p -82.04 -29.28 32.01 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.963 0.411 . . . . 0.34999999999999998 111.067 -179.053 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 103.65 9.28 38.33 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 121.027 -0.606 . . . . 0.29999999999999999 112.112 179.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -65.13 -45.14 86.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.158 0.504 . . . . 0.65000000000000002 110.019 177.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.575 HG22 ' HB3' ' A' ' 50' ' ' ARG . 11.3 m -135.02 154.78 36.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 109.141 -0.689 . . . . 0.19 109.141 171.115 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 26.1 m -88.2 160.95 17.5 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.676 -0.491 . . . . 0.96999999999999997 109.676 179.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -53.18 -44.69 68.09 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.125 0.488 . . . . 0.22 110.12 -178.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.649 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 44.1 mt-10 -59.32 -32.45 70.08 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.286 -0.87 . . . . 1.72 112.328 -178.293 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -72.95 -51.74 17.26 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.822 0.344 . . . . 2.0899999999999999 110.921 -177.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -65.76 -42.69 90.58 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.216 -0.447 . . . . 0.26000000000000001 111.029 -178.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.8 -53.38 58.65 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.182 -0.463 . . . . 0.23999999999999999 112.079 -175.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.435 ' HA ' ' O ' ' A' ' 71' ' ' TYR . 23.8 t -53.47 -25.49 16.5 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.665 0.617 . . . . 1.0 112.665 -175.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -102.9 -43.01 5.65 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.406 0.622 . . . . 0.60999999999999999 110.567 -176.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.57 ' CD ' ' HG3' ' A' ' 27' ' ' ARG . 17.3 mmt180 -93.72 -42.36 9.19 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 113.858 1.058 . . . . 0.85999999999999999 113.858 -171.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.583 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 54.6 p -65.92 129.84 41.18 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.625 -0.43 . . . . 0.81999999999999995 110.884 -176.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.608 ' HA ' ' HG2' ' A' ' 26' ' ' ARG . 30.1 t70 -85.18 -12.08 53.52 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.294 0.568 . . . . 2.2799999999999998 111.453 179.59 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 0.456 ' O ' ' HD1' ' A' ' 71' ' ' TYR . 51.2 t -76.18 157.86 32.27 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.459 -0.571 . . . . 1.52 109.459 179.413 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -56.89 -17.02 20.33 Favored Glycine 0 C--N 1.33 0.228 0 CA-C-N 115.189 -0.914 . . . . 0.26000000000000001 113.09 -174.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 57.3 p -63.21 -12.88 31.64 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 111.885 0.328 . . . . 0.32000000000000001 111.885 176.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.456 ' HD1' ' O ' ' A' ' 68' ' ' CYS . 27.3 p90 -57.84 -28.77 64.4 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.996 0.427 . . . . 0.54000000000000004 110.198 176.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -88.84 -1.75 58.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.307 0.575 . . . . 0.48999999999999999 110.365 -178.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 5.3 m -125.38 8.17 7.78 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.554 -0.748 . . . . 0.70999999999999996 110.562 -177.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.649 ' O ' ' HA ' ' A' ' 59' ' ' GLU . . . 73.05 29.72 64.3 Favored Glycine 0 CA--C 1.52 0.371 0 CA-C-N 116.041 -0.527 . . . . 0.54000000000000004 113.118 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.22 -21.16 6.16 Favored Glycine 0 C--O 1.233 0.088 0 C-N-CA 120.94 -0.648 . . . . 0.34999999999999998 112.236 178.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -71.01 132.15 44.72 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 122.853 0.461 . . . . 1.6499999999999999 110.772 -175.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.5 mp -116.02 158.98 22.29 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 121.26 0.552 . . . . 0.93999999999999995 109.885 173.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -86.1 -148.36 11.54 Favored Glycine 0 C--N 1.308 -0.99 0 CA-C-N 114.623 -1.171 . . . . 0.44 112.347 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -80.26 135.46 36.25 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.314 0.578 . . . . 3.8700000000000001 111.462 -179.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -148.02 141.3 25.16 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.249 -0.887 . . . . 1.3100000000000001 109.898 177.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 48.2 m -66.7 129.44 39.87 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 120.813 0.34 . . . . 1.1699999999999999 110.201 177.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.4 p -52.25 116.21 2.11 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.779 -0.646 . . . . 1.1899999999999999 111.216 178.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 114.31 -5.89 23.24 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.967 -0.635 . . . . 0.79000000000000004 112.12 -177.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -91.21 34.27 0.94 Allowed 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 121.158 0.504 . . . . 1.55 110.885 -179.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 25.3 mmt -131.05 -123.16 0.21 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.908 0.385 . . . . 0.72999999999999998 110.411 179.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 65.0 mtt -122.92 157.79 31.82 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.665 -0.865 . . . . 1.3899999999999999 108.665 174.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.506 ' HB3' ' HD3' ' A' ' 88' ' ' PRO . 45.1 tttm -54.39 -55.6 35.58 Favored Pre-proline 0 C--N 1.321 -0.633 0 N-CA-C 112.223 0.453 . . . . 2.3700000000000001 112.223 -174.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.506 ' HD3' ' HB3' ' A' ' 87' ' ' LYS . 91.8 Cg_endo -77.51 -24.06 9.36 Favored 'Trans proline' 0 C--N 1.357 0.986 0 C-N-CA 121.655 1.57 . . . . 0.27000000000000002 111.97 -176.314 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.583 ' O ' HG23 ' A' ' 93' ' ' VAL . 14.7 t80 -67.94 -55.52 12.45 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.672 -0.695 . . . . 0.22 109.162 177.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.422 ' OE2' ' HD2' ' A' ' 94' ' ' ARG . 1.2 tm-20 -63.05 -34.99 78.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.282 -0.872 . . . . 2.1200000000000001 109.859 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.639 ' HA ' ' CZ ' ' A' ' 94' ' ' ARG . 14.7 t70 -51.34 -41.66 60.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.312 -0.858 . . . . 0.60999999999999999 111.365 175.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.618 ' O ' ' HG ' ' A' ' 96' ' ' LEU . . . -77.84 -29.72 50.65 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.274 -0.421 . . . . 0.22 111.318 -179.213 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.583 HG23 ' O ' ' A' ' 89' ' ' PHE . 41.1 t -63.1 -49.36 83.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.281 -0.418 . . . . 0.25 111.661 -173.497 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.639 ' CZ ' ' HA ' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -83.47 -2.81 56.77 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.17 -0.612 . . . . 2.5899999999999999 110.551 -179.233 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -86.2 -16.86 36.44 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.299 -0.41 . . . . 0.46999999999999997 111.219 -178.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.618 ' HG ' ' O ' ' A' ' 92' ' ' ALA . 0.6 OUTLIER -119.21 147.04 44.68 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.243 -0.435 . . . . 0.28000000000000003 110.829 -179.519 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.519 ' HA ' ' NH2' ' A' ' 116' ' ' ARG . 22.5 tptm -82.34 163.13 21.95 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.495 -0.558 . . . . 1.6100000000000001 109.495 177.182 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.517 ' H ' ' CD1' ' A' ' 98' ' ' ILE . 1.3 mp -38.05 118.09 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 O-C-N 123.369 0.418 . . . . 0.90000000000000002 110.644 169.276 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 94.71 -6.36 70.31 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.823 -0.703 . . . . 0.46000000000000002 113.699 176.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.586 ' HB2' ' HB2' ' A' ' 96' ' ' LEU . 44.8 m-20 -94.59 141.89 28.07 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 117.453 0.627 . . . . 0.46000000000000002 110.419 178.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 9.9 mt -110.26 148.76 13.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.095 -0.502 . . . . 0.23000000000000001 110.212 -178.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 88.5 p -93.85 146.46 31.75 Favored Pre-proline 0 C--N 1.319 -0.718 0 CA-C-N 116.315 -0.402 . . . . 0.92000000000000004 110.615 -179.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -68.8 163.27 37.93 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 122.213 1.942 . . . . 0.34000000000000002 110.821 171.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.834 HG23 HD23 ' A' ' 44' ' ' LEU . 22.6 mm -39.86 109.86 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 O-C-N 123.774 0.672 . . . . 0.20000000000000001 112.639 -178.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.0 p -115.35 120.5 64.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.991 -0.55 . . . . 1.04 109.774 175.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -85.56 152.09 23.42 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.267 0.556 . . . . 0.55000000000000004 110.934 -179.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.469 HG22 ' HG2' ' A' ' 88' ' ' PRO . 14.6 p -131.74 -173.61 3.18 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.293 -0.867 . . . . 0.37 110.076 178.047 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -72.3 -22.24 61.22 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.534 0.207 . . . . 2.1600000000000001 111.457 178.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.757 ' O ' ' HB3' ' A' ' 20' ' ' SER . 7.8 t -110.23 -6.35 15.07 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.348 -0.541 . . . . 1.0900000000000001 112.021 -176.336 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 157.14 -131.91 3.07 Favored Glycine 0 N--CA 1.436 -1.327 0 C-N-CA 119.902 -1.142 . . . . 0.23999999999999999 112.545 169.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.894 ' HB3' HD22 ' A' ' 44' ' ' LEU . 5.0 mp -118.17 143.17 46.72 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 114.925 -0.637 . . . . 0.19 111.192 -171.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . 0.577 ' NE2' HD13 ' A' ' 14' ' ' LEU . 86.9 m-70 -139.28 150.04 44.98 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.695 0.628 . . . . 0.22 112.695 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.69 HG12 HD11 ' A' ' 44' ' ' LEU . 2.6 pt -132.31 140.17 48.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 107.615 -1.254 . . . . 0.17000000000000001 107.615 159.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 2.7 mp -131.9 147.58 32.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 C-N-CA 120.948 -0.301 . . . . 0.17999999999999999 110.327 -176.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.424 ' HA ' ' O ' ' A' ' 100' ' ' ASP . 35.9 pttt -130.08 139.13 50.99 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.557 -0.905 . . . . 0.60999999999999999 108.557 172.099 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . 0.724 ' HD3' HD21 ' A' ' 8' ' ' LEU . 5.9 ttp180 -80.85 132.34 35.46 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.241 -0.584 . . . . 1.8700000000000001 110.967 -179.136 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -96.18 -40.52 9.15 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.197 -0.911 . . . . 0.89000000000000001 109.716 177.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.4 ' HB3' ' HB3' ' A' ' 9' ' ' ARG . . . . . . . . 0 C--O 1.244 0.79 0 CA-C-O 118.347 -0.835 . . . . 1.1000000000000001 110.015 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 66.9 mmtt . . . . . 0 C--O 1.232 0.162 0 CA-C-O 121.365 0.602 . . . . 1.1899999999999999 110.731 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.475 HD11 ' CD ' ' A' ' 116' ' ' ARG . 15.6 tp -116.7 173.4 6.65 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.007 -0.997 . . . . 1.1799999999999999 109.385 -178.319 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.453 ' H ' ' HG ' ' A' ' 8' ' ' LEU . 65.3 ttt180 -146.26 126.56 13.94 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.802 -0.444 . . . . 1.0600000000000001 109.802 178.37 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.429 ' N ' ' HZ ' ' A' ' 80' ' ' PHE . . . -146.56 155.02 42.18 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.085 0.469 . . . . 0.22 111.638 -179.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.4 ' N ' HD23 ' A' ' 117' ' ' LEU . . . -106.05 140.7 38.64 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.519 -0.764 . . . . 0.20000000000000001 109.401 177.052 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 50.6 p-80 -139.29 150.45 45.44 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.003 0.43 . . . . 0.23000000000000001 111.341 -173.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.567 ' O ' ' HA ' ' A' ' 112' ' ' HIS . 5.2 tt -118.28 142.75 47.18 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.233 -1.025 . . . . 0.23999999999999999 108.233 176.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.59 HD13 ' NE2' ' A' ' 112' ' ' HIS . 26.6 tp -127.82 121.82 31.09 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.597 0.236 . . . . 0.27000000000000002 110.715 -176.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.563 HG23 HD13 ' A' ' 44' ' ' LEU . 97.4 t -112.01 136.61 47.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 116.133 -0.485 . . . . 0.14999999999999999 109.727 176.032 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.543 ' HE2' ' OG ' ' A' ' 109' ' ' SER . 32.5 mmtp -108.82 164.79 12.07 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.104 -0.498 . . . . 0.62 109.976 177.636 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.5 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 49.8 p90 -158.65 163.14 37.17 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.992 -0.549 . . . . 0.25 110.141 -176.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.496 ' HB3' ' C ' ' A' ' 33' ' ' ALA . 35.8 p -54.13 109.51 0.49 Allowed 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 120.983 0.42 . . . . 1.04 110.715 177.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 103.27 9.82 37.95 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.463 -0.875 . . . . 0.53000000000000003 112.841 -178.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.415 ' C ' ' H ' ' A' ' 22' ' ' ASN . 73.5 p -90.12 40.17 0.99 Allowed 'General case' 0 C--O 1.234 0.264 0 CA-C-N 117.338 0.569 . . . . 0.69999999999999996 111.296 -175.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 50.1 ttt180 75.38 -34.2 0.25 Allowed 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 123.534 0.733 . . . . 3.4900000000000002 110.662 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.415 ' H ' ' C ' ' A' ' 20' ' ' SER . 5.7 p30 -149.6 118.55 3.81 Favored Pre-proline 0 C--N 1.323 -0.55 0 N-CA-C 109.321 -0.622 . . . . 1.77 109.321 173.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.557 ' O ' ' HA ' ' A' ' 31' ' ' SER . 66.2 Cg_endo -86.29 53.33 3.06 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 122.792 2.328 . . . . 1.71 113.353 -172.434 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.484 HG13 ' O ' ' A' ' 30' ' ' ASP . 81.7 t -143.32 121.12 6.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 109.242 -0.651 . . . . 0.47999999999999998 109.242 178.155 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 44.5 t -103.88 152.34 22.06 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.739 -0.467 . . . . 1.1200000000000001 109.739 177.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.641 ' CB ' ' HA ' ' A' ' 67' ' ' ASP . 9.2 tpt180 -73.72 -9.89 59.12 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.241 -0.651 . . . . 2.54 109.241 174.038 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.619 ' HG3' ' HD3' ' A' ' 65' ' ' ARG . 13.9 ttp180 -79.94 -38.27 32.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.306 -0.861 . . . . 1.77 109.737 174.057 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 69.9 p -93.74 -34.14 13.34 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.661 -0.699 . . . . 0.67000000000000004 111.09 -175.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 81.83 -39.24 2.55 Favored Glycine 0 N--CA 1.451 -0.361 0 CA-C-N 115.238 -0.892 . . . . 0.81999999999999995 111.428 -177.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.484 ' O ' HG13 ' A' ' 24' ' ' VAL . 31.2 m-20 -107.45 -139.18 0.37 Allowed 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 108.408 -0.96 . . . . 2.1000000000000001 108.408 175.211 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.557 ' HA ' ' O ' ' A' ' 23' ' ' PRO . 2.7 p -75.27 135.11 40.96 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-O 121.27 0.557 . . . . 1.0800000000000001 111.763 -172.438 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.507 HG22 ' C ' ' A' ' 23' ' ' PRO . 12.3 t -106.79 31.26 5.42 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 107.689 -1.226 . . . . 0.34000000000000002 107.689 168.353 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.496 ' C ' ' HB3' ' A' ' 18' ' ' SER . . . -82.32 -5.14 58.38 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 114.085 -1.416 . . . . 0.37 112.178 -172.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -97.22 -22.77 16.51 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 120.938 0.399 . . . . 2.21 110.906 178.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.491 HG23 ' HB2' ' A' ' 39' ' ' ASP . 0.2 OUTLIER -90.4 136.3 24.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 109.574 -0.528 . . . . 0.31 109.574 179.148 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 71.6 p -94.31 178.42 5.63 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.954 -0.388 . . . . 0.39000000000000001 109.954 -176.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.447 ' O ' HG13 ' A' ' 41' ' ' ILE . 7.8 p90 -64.83 -26.24 68.25 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.003 -0.74 . . . . 1.53 109.003 174.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -71.04 -50.97 28.21 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 115.892 -0.594 . . . . 0.95999999999999996 109.896 176.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.491 ' HB2' HG23 ' A' ' 35' ' ' VAL . 11.6 m-20 -59.04 -37.99 78.29 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-O 121.439 0.638 . . . . 0.91000000000000003 109.711 177.199 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.5 ' HB2' ' HB3' ' A' ' 17' ' ' PHE . . . -67.26 -45.68 75.94 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.821 -1.081 . . . . 0.19 110.7 -178.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.488 ' CG1' HD21 ' A' ' 111' ' ' LEU . 68.8 mt -63.05 -36.83 77.5 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 CA-C-N 116.261 -0.427 . . . . 0.29999999999999999 109.986 176.051 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.418 ' HA ' ' HD2' ' A' ' 42' ' ' LYS . 11.1 mmmm -68.55 -17.83 64.23 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 116.107 -0.497 . . . . 2.3199999999999998 110.982 179.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.452 ' HG3' ' CD1' ' A' ' 47' ' ' TRP . 1.6 tt0 -88.56 -54.67 4.06 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.8 -0.636 . . . . 1.02 109.666 175.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.924 HD22 ' HB3' ' A' ' 111' ' ' LEU . 32.4 tp -58.69 -37.19 75.52 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.629 -0.714 . . . . 0.17000000000000001 110.888 -176.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.457 ' HA ' HD11 ' A' ' 104' ' ' ILE . 3.1 mm-40 -63.77 -40.39 96.57 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.969 0.359 . . . . 0.87 111.969 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -70.5 -41.62 72.42 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 120.919 -0.313 . . . . 1.3100000000000001 110.969 -177.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.452 ' CD1' ' HG3' ' A' ' 43' ' ' GLU . 39.3 m95 -66.76 -46.1 76.41 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.915 -0.314 . . . . 0.52000000000000002 110.621 176.472 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 33.0 t -57.91 -38.96 76.81 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.676 -0.49 . . . . 0.81999999999999995 109.676 175.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -61.06 -52.04 66.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.683 -0.69 . . . . 0.53000000000000003 110.888 176.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.586 ' HB3' HG22 ' A' ' 56' ' ' VAL . 87.0 mtt180 -65.75 -41.18 92.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.812 -0.631 . . . . 0.41999999999999998 111.547 -176.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.432 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 96.7 mt -60.49 -38.24 77.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.146 0.498 . . . . 0.20000000000000001 110.249 175.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.32 -35.24 71.17 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.837 -0.62 . . . . 0.27000000000000002 111.708 178.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 28.2 p -83.97 -31.15 25.7 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.827 0.346 . . . . 0.34999999999999998 111.594 -177.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 107.1 5.25 35.28 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.717 -0.754 . . . . 0.29999999999999999 111.819 -178.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.44 ' HB2' ' HB3' ' A' ' 50' ' ' ARG . 38.8 mt-10 -60.01 -53.18 60.9 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.829 -0.434 . . . . 0.65000000000000002 109.829 176.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.586 HG22 ' HB3' ' A' ' 50' ' ' ARG . 15.8 m -129.81 150.84 35.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 109.292 -0.633 . . . . 0.19 109.292 173.095 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.5 m -80.79 158.39 25.46 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.451 -0.574 . . . . 0.96999999999999997 109.451 179.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.44 ' CD2' ' HD3' ' A' ' 115' ' ' LYS . 2.2 t80 -52.75 -44.15 66.27 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.587 -0.523 . . . . 0.22 109.587 179.494 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.468 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 48.1 mt-10 -56.06 -45.22 79.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.135 -0.939 . . . . 1.72 112.002 179.468 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 34.2 mm-40 -63.85 -47.59 80.13 Favored 'General case' 0 CA--C 1.522 -0.132 0 CA-C-O 120.983 0.42 . . . . 2.0899999999999999 110.808 -175.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -67.76 -46.22 72.68 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.203 -0.453 . . . . 0.26000000000000001 110.767 -179.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.12 -52.63 64.52 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.344 -0.389 . . . . 0.23999999999999999 112.002 -176.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.442 ' HA ' ' O ' ' A' ' 71' ' ' TYR . 33.0 t -51.9 -25.49 8.15 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.856 0.687 . . . . 1.0 112.856 -177.131 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -102.18 -44.63 5.38 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.535 0.683 . . . . 0.60999999999999999 110.456 -179.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.619 ' HD3' ' HG3' ' A' ' 27' ' ' ARG . 21.5 mmt180 -93.64 -39.53 10.76 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 114.334 1.235 . . . . 0.85999999999999999 114.334 -169.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.452 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 59.7 p -63.23 123.75 19.44 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.118 0.485 . . . . 0.81999999999999995 111.059 -176.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.641 ' HA ' ' CB ' ' A' ' 26' ' ' ARG . 17.2 t70 -71.82 -18.8 62.06 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.441 -0.799 . . . . 2.2799999999999998 111.268 177.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 46.6 t -77.1 157.36 31.08 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.54 0.686 . . . . 1.52 110.808 -178.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -58.63 -16.47 30.09 Favored Glycine 0 N--CA 1.453 -0.181 0 CA-C-N 114.388 -1.278 . . . . 0.26000000000000001 113.922 -174.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.449 ' HB2' ' CA ' ' A' ' 75' ' ' GLY . 2.6 p -66.17 -4.1 6.94 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 112.287 0.477 . . . . 0.32000000000000001 112.287 176.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.442 ' O ' ' HA ' ' A' ' 63' ' ' SER . 33.0 p90 -56.68 -27.99 59.9 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.112 0.482 . . . . 0.54000000000000004 110.069 175.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -92.12 -0.25 57.45 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.387 0.613 . . . . 0.48999999999999999 110.389 -179.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.2 m -124.72 9.32 8.27 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.647 -0.706 . . . . 0.70999999999999996 110.796 -175.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.468 ' O ' ' HA ' ' A' ' 59' ' ' GLU . . . 73.42 31.0 61.56 Favored Glycine 0 CA--C 1.519 0.335 0 C-N-CA 120.884 -0.674 . . . . 0.54000000000000004 112.738 -178.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.449 ' CA ' ' HB2' ' A' ' 70' ' ' SER . . . 76.78 3.09 78.95 Favored Glycine 0 C--O 1.227 -0.325 0 C-N-CA 121.081 -0.58 . . . . 0.34999999999999998 112.217 179.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -97.92 144.35 27.56 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 110.283 -0.266 . . . . 1.6499999999999999 110.283 -168.266 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.7 mp -120.39 171.45 8.52 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.129 -0.487 . . . . 0.93999999999999995 110.276 178.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -91.03 -148.6 21.78 Favored Glycine 0 C--N 1.317 -0.514 0 CA-C-N 115.783 -0.644 . . . . 0.44 112.22 -178.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 99.8 m-85 -88.13 123.22 32.58 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.222 0.534 . . . . 3.8700000000000001 110.556 178.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.429 ' HZ ' ' N ' ' A' ' 10' ' ' ALA . 1.6 p90 -134.61 147.13 50.14 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.567 -0.742 . . . . 1.3100000000000001 110.085 -178.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 21.8 m -80.87 124.08 28.81 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 109.926 -0.398 . . . . 1.1699999999999999 109.926 179.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 24.6 m -54.25 119.1 4.69 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.99 -0.55 . . . . 1.1899999999999999 110.925 -179.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 114.71 13.03 9.78 Favored Glycine 0 N--CA 1.443 -0.883 0 CA-C-N 115.627 -0.715 . . . . 0.79000000000000004 111.794 -178.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -116.56 7.45 13.67 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 111.521 0.193 . . . . 1.55 111.521 179.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 24.9 mmt -99.06 -105.44 0.21 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.157 0.503 . . . . 0.72999999999999998 110.807 -179.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 68.9 mtm -142.18 147.38 36.5 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 107.904 -1.147 . . . . 1.3899999999999999 107.904 176.37 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -48.45 -54.81 22.84 Favored Pre-proline 0 CA--C 1.539 0.552 0 N-CA-C 113.0 0.741 . . . . 2.3700000000000001 113.0 -173.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.501 ' HG2' HG22 ' A' ' 107' ' ' THR . 71.8 Cg_endo -75.43 -27.49 9.29 Favored 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 121.401 1.4 . . . . 0.27000000000000002 111.739 -175.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.644 ' O ' HG23 ' A' ' 93' ' ' VAL . 42.4 t80 -72.35 -56.26 5.77 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.23 -0.896 . . . . 0.22 109.984 -179.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -61.8 -38.28 87.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.462 -0.79 . . . . 2.1200000000000001 110.441 -177.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -60.65 -31.59 70.8 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.454 -0.794 . . . . 0.60999999999999999 110.502 178.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.489 ' O ' ' HG ' ' A' ' 96' ' ' LEU . . . -81.06 -25.98 36.67 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.037 -0.529 . . . . 0.22 110.72 178.275 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.644 HG23 ' O ' ' A' ' 89' ' ' PHE . 25.7 t -70.95 -36.05 62.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.421 0.629 . . . . 0.25 110.124 -178.465 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.509 ' C ' ' HD2' ' A' ' 94' ' ' ARG . 5.5 ppt_? -85.74 -16.47 38.84 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.679 -0.691 . . . . 2.5899999999999999 110.622 179.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -76.09 -17.07 59.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.012 -0.54 . . . . 0.46999999999999997 111.187 -176.106 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.609 ' HB2' ' HB2' ' A' ' 100' ' ' ASP . 0.9 OUTLIER -119.61 151.92 37.89 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.143 -0.481 . . . . 0.28000000000000003 110.736 179.443 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.436 ' HA ' ' NH2' ' A' ' 116' ' ' ARG . 23.5 tptm -92.57 167.46 11.91 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.053 -0.721 . . . . 1.6100000000000001 109.053 178.325 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.459 ' HA ' ' HG2' ' A' ' 116' ' ' ARG . 58.8 mt -46.25 115.97 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.851 0.358 . . . . 0.90000000000000002 111.301 173.507 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 100.46 -2.06 56.02 Favored Glycine 0 CA--C 1.521 0.428 0 C-N-CA 120.715 -0.755 . . . . 0.46000000000000002 113.528 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.609 ' HB2' ' HB2' ' A' ' 96' ' ' LEU . 68.1 m-20 -104.53 152.43 22.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 117.412 0.606 . . . . 0.46000000000000002 110.692 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 9.5 mt -121.8 149.11 25.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-O 120.988 0.423 . . . . 0.23000000000000001 110.873 -177.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 70.4 m -96.48 150.41 37.03 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 115.896 -0.593 . . . . 0.92000000000000004 110.491 177.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.428 ' O ' HG23 ' A' ' 105' ' ' VAL . 73.5 Cg_endo -74.71 177.91 7.85 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.558 2.172 . . . . 0.34000000000000002 111.188 173.373 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.768 HG23 HD23 ' A' ' 44' ' ' LEU . 22.8 mm -44.62 108.28 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 O-C-N 123.501 0.501 . . . . 0.20000000000000001 112.169 178.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 103' ' ' PRO . 69.6 t -110.98 115.19 49.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.919 -0.582 . . . . 1.04 109.59 174.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -84.68 147.78 26.75 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.287 0.565 . . . . 0.55000000000000004 110.285 178.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.501 HG22 ' HG2' ' A' ' 88' ' ' PRO . 10.0 p -123.31 -172.81 2.59 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.445 -0.798 . . . . 0.37 110.297 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -64.82 -37.8 88.82 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.63 0.252 . . . . 2.1600000000000001 110.472 178.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.543 ' OG ' ' HE2' ' A' ' 16' ' ' LYS . 9.2 t -86.48 -61.61 1.7 Allowed 'General case' 0 C--O 1.222 -0.391 0 C-N-CA 120.918 -0.313 . . . . 1.0900000000000001 110.419 179.264 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -152.81 -131.04 1.6 Allowed Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 119.163 -1.494 . . . . 0.23999999999999999 113.605 -174.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.924 ' HB3' HD22 ' A' ' 44' ' ' LEU . 6.6 mp -116.03 145.96 42.55 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.425 -0.388 . . . . 0.19 111.71 -169.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . 0.59 ' NE2' HD13 ' A' ' 14' ' ' LEU . 84.5 m-70 -144.87 142.04 29.59 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.101 0.477 . . . . 0.22 112.274 179.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.656 HG12 HD11 ' A' ' 44' ' ' LEU . 2.8 pt -123.47 140.55 46.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 107.707 -1.22 . . . . 0.17000000000000001 107.707 159.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.418 HG21 HG22 ' A' ' 93' ' ' VAL . 2.6 mp -132.57 150.32 33.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 C-N-CA 120.731 -0.387 . . . . 0.17999999999999999 110.485 -175.134 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.513 ' HE3' HD21 ' A' ' 117' ' ' LEU . 7.1 pttp -136.24 141.95 43.99 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.494 -0.928 . . . . 0.60999999999999999 108.494 173.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . 0.475 ' CD ' HD11 ' A' ' 8' ' ' LEU . 5.5 ttp180 -84.36 132.26 34.62 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.477 -0.489 . . . . 1.8700000000000001 110.826 179.374 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.513 HD21 ' HE3' ' A' ' 115' ' ' LYS . 4.1 mm? -99.76 -35.4 9.81 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.21 -0.905 . . . . 0.89000000000000001 110.281 -178.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.893 0 CA-C-O 118.411 -0.804 . . . . 1.1000000000000001 110.165 179.97 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.518 ' HA ' ' O ' ' A' ' 80' ' ' PHE . 42.4 mmtm . . . . . 0 N--CA 1.453 -0.315 0 CA-C-O 121.241 0.544 . . . . 1.1899999999999999 111.258 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.599 ' O ' ' HA ' ' A' ' 79' ' ' PHE . 12.0 tp -118.65 169.8 9.5 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.349 -0.982 . . . . 1.1799999999999999 108.349 176.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.418 ' HG3' ' O ' ' A' ' 77' ' ' LEU . 56.2 ttt180 -142.79 134.32 26.44 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 117.799 0.272 . . . . 1.0600000000000001 110.301 177.05 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.638 ' O ' ' HB2' ' A' ' 77' ' ' LEU . . . -155.69 154.24 31.23 Favored 'General case' 0 C--O 1.222 -0.364 0 C-N-CA 120.086 -0.646 . . . . 0.22 112.063 -177.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.492 ' HB3' ' HG2' ' A' ' 115' ' ' LYS . . . -102.16 132.23 48.19 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.216 -0.661 . . . . 0.20000000000000001 109.216 178.243 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 12.4 p-80 -133.19 148.77 52.06 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.178 0.513 . . . . 0.23000000000000001 111.768 -172.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.566 HD23 ' N ' ' A' ' 14' ' ' LEU . 5.2 tt -121.4 146.91 46.4 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.41 -0.959 . . . . 0.23999999999999999 108.41 177.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.566 ' N ' HD23 ' A' ' 13' ' ' LEU . 23.4 tp -131.34 132.86 44.78 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 110.091 -0.337 . . . . 0.27000000000000002 110.091 -178.337 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.529 HG23 HD13 ' A' ' 44' ' ' LEU . 58.4 t -123.2 130.67 74.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 O-C-N 123.353 0.408 . . . . 0.14999999999999999 109.942 175.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.502 ' HE3' HD21 ' A' ' 14' ' ' LEU . 33.6 mmtp -104.44 152.44 22.33 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.903 -0.59 . . . . 0.62 110.025 177.073 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.511 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 42.7 p90 -143.23 162.94 34.3 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.006 -0.543 . . . . 0.25 110.477 -177.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.46 ' HB3' ' HA ' ' A' ' 33' ' ' ALA . 32.6 p -51.84 112.84 0.84 Allowed 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.103 0.478 . . . . 1.04 110.892 178.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 97.79 8.51 55.65 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.582 -0.818 . . . . 0.53000000000000003 113.141 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.614 ' HB2' ' O ' ' A' ' 109' ' ' SER . 80.3 p -88.68 45.59 1.3 Allowed 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 117.366 0.583 . . . . 0.69999999999999996 110.893 -175.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.487 ' HB3' ' O ' ' A' ' 20' ' ' SER . 76.8 ttt180 75.8 -32.5 0.21 Allowed 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 123.175 0.59 . . . . 3.4900000000000002 110.93 -179.021 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.413 ' H ' ' C ' ' A' ' 20' ' ' SER . 3.5 p30 -153.31 109.0 2.61 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-O 121.09 0.471 . . . . 1.77 110.291 174.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.408 ' C ' HG22 ' A' ' 32' ' ' THR . 11.3 Cg_exo -73.69 52.86 2.6 Favored 'Trans proline' 0 CA--C 1.534 0.481 0 C-N-CA 123.236 2.624 . . . . 1.71 113.401 -179.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.461 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 83.9 t -141.84 116.88 5.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 109.722 -0.473 . . . . 0.47999999999999998 109.722 176.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.522 ' HB2' ' OD1' ' A' ' 67' ' ' ASP . 6.4 p -103.85 151.52 23.0 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 116.535 -0.302 . . . . 1.1200000000000001 110.308 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.69 ' CB ' ' HA ' ' A' ' 67' ' ' ASP . 3.3 tpp180 -69.33 -20.65 63.87 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 108.028 -1.101 . . . . 2.54 108.028 173.041 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.441 ' CG ' ' HA ' ' A' ' 65' ' ' ARG . 2.7 tmm_? -69.43 -37.41 77.39 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 114.27 -1.332 . . . . 1.77 110.472 179.002 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 81.1 p -99.29 -36.37 9.65 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.498 0.666 . . . . 0.67000000000000004 110.803 179.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 72.57 -3.84 23.65 Favored Glycine 0 N--CA 1.451 -0.33 0 CA-C-N 115.203 -0.908 . . . . 0.81999999999999995 112.338 -176.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -113.78 -79.22 0.58 Allowed 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.605 -0.517 . . . . 2.1000000000000001 109.605 179.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.461 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 20.2 m -153.77 153.26 31.86 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.73 -0.668 . . . . 1.0800000000000001 109.82 176.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.411 ' OG1' HG13 ' A' ' 35' ' ' VAL . 10.2 t -117.52 30.66 7.16 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 122.286 1.041 . . . . 0.34000000000000002 109.307 177.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.46 ' HA ' ' HB3' ' A' ' 18' ' ' SER . . . -77.03 -5.94 50.72 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.711 -1.131 . . . . 0.37 112.514 -176.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -95.74 -25.37 16.11 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.183 0.516 . . . . 2.21 110.651 -179.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.411 HG13 ' OG1' ' A' ' 32' ' ' THR . 0.2 OUTLIER -95.78 134.68 32.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.943 -0.571 . . . . 0.31 110.293 -178.886 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 64.7 p -93.0 179.93 5.29 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.181 -0.463 . . . . 0.39000000000000001 109.873 -175.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.464 ' O ' HG13 ' A' ' 41' ' ' ILE . 9.3 p90 -64.36 -28.47 69.72 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 119.934 -0.707 . . . . 1.53 109.142 175.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -72.13 -48.98 39.69 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 115.968 -0.56 . . . . 0.95999999999999996 110.345 177.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.409 ' HB2' HG23 ' A' ' 35' ' ' VAL . 43.4 m-20 -64.91 -28.78 69.77 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.189 0.518 . . . . 0.91000000000000003 110.161 178.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.511 ' HB2' ' HB3' ' A' ' 17' ' ' PHE . . . -71.36 -43.01 67.74 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.483 -0.78 . . . . 0.19 110.513 176.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.464 HG13 ' O ' ' A' ' 37' ' ' TYR . 87.1 mt -62.8 -35.95 73.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.477 -0.564 . . . . 0.29999999999999999 109.477 174.044 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 35.2 tttm -62.44 -24.52 67.47 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.402 -0.817 . . . . 2.3199999999999998 110.857 176.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.431 ' HG3' ' CD1' ' A' ' 47' ' ' TRP . 0.7 OUTLIER -87.28 -52.47 5.38 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.115 -0.698 . . . . 1.02 109.115 178.845 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.894 HD23 HG23 ' A' ' 104' ' ' ILE . 32.3 tp -63.46 -37.7 88.28 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.202 -0.908 . . . . 0.17000000000000001 110.695 -173.465 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.457 HE21 ' HA ' ' A' ' 45' ' ' GLN . 0.0 OUTLIER -65.93 -30.7 71.33 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-N 116.152 -0.477 . . . . 0.87 112.133 -176.903 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -74.73 -44.18 51.22 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.941 0.4 . . . . 1.3100000000000001 110.104 179.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.431 ' CD1' ' HG3' ' A' ' 43' ' ' GLU . 49.2 m95 -67.22 -44.51 79.33 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.205 -0.452 . . . . 0.52000000000000002 111.115 178.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.555 ' HB3' HG21 ' A' ' 113' ' ' ILE . 97.8 p -66.43 -22.29 66.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.83 0.348 . . . . 0.81999999999999995 110.203 177.147 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.42 ' HB2' ' O ' ' A' ' 45' ' ' GLN . 10.0 tt0 -73.97 -56.95 4.33 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 116.013 -0.54 . . . . 0.53000000000000003 109.986 173.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.616 ' HB3' HG22 ' A' ' 56' ' ' VAL . 96.6 mtt180 -61.85 -41.37 97.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.556 -0.747 . . . . 0.41999999999999998 111.499 -175.102 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.43 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 97.5 mt -60.59 -36.31 69.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.006 0.431 . . . . 0.20000000000000001 110.434 176.309 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -76.76 -42.7 39.98 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.078 -0.51 . . . . 0.27000000000000002 111.441 179.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 35.3 p -74.4 -29.63 61.6 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.916 0.389 . . . . 0.34999999999999998 111.294 -176.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 107.86 1.44 34.25 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.824 -0.703 . . . . 0.29999999999999999 112.366 -179.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.453 ' HB2' ' HB3' ' A' ' 50' ' ' ARG . 39.0 mt-10 -59.5 -44.41 93.12 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 121.047 0.451 . . . . 0.65000000000000002 110.513 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.616 HG22 ' HB3' ' A' ' 50' ' ' ARG . 13.0 m -137.8 157.55 33.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 109.401 -0.592 . . . . 0.19 109.401 172.16 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 14.5 m -86.43 160.26 19.09 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.348 -0.612 . . . . 0.96999999999999997 109.348 178.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -55.23 -44.25 75.28 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.024 0.44 . . . . 0.22 109.976 -177.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.603 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 50.8 mt-10 -60.54 -35.19 75.42 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.372 -0.831 . . . . 1.72 111.893 -178.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -62.39 -52.9 61.74 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-O 121.055 0.455 . . . . 2.0899999999999999 110.378 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -69.81 -46.32 65.94 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.605 -0.725 . . . . 0.26000000000000001 111.399 -175.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.92 -52.32 65.91 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.439 0.533 . . . . 0.23999999999999999 112.439 -173.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.46 ' HA ' ' O ' ' A' ' 71' ' ' TYR . 67.0 m -51.18 -21.97 2.32 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.993 0.738 . . . . 1.0 112.993 -179.606 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -103.75 -46.53 4.49 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.584 0.707 . . . . 0.60999999999999999 110.148 179.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.441 ' HA ' ' CG ' ' A' ' 27' ' ' ARG . 36.7 mmt-85 -95.63 -36.3 11.28 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 114.271 1.212 . . . . 0.85999999999999999 114.271 -169.097 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.488 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 54.3 p -63.87 114.84 4.32 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.274 0.559 . . . . 0.81999999999999995 110.279 -177.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.69 ' HA ' ' CB ' ' A' ' 26' ' ' ARG . 74.6 m-20 -75.57 -9.51 58.64 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.484 -0.78 . . . . 2.2799999999999998 111.632 -177.393 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 36.0 t -85.56 160.74 19.57 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.755 -0.657 . . . . 1.52 110.163 178.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -56.28 -18.88 22.76 Favored Glycine 0 CA--C 1.518 0.237 0 CA-C-N 114.465 -1.243 . . . . 0.26000000000000001 114.378 -173.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.413 ' HB3' HD21 ' A' ' 77' ' ' LEU . 60.5 p -65.19 -7.23 11.79 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 112.502 0.556 . . . . 0.32000000000000001 112.502 177.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.46 ' O ' ' HA ' ' A' ' 63' ' ' SER . 32.0 p90 -52.5 -36.56 55.5 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 120.994 0.426 . . . . 0.54000000000000004 110.325 176.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -81.06 -1.25 43.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.002 0.429 . . . . 0.48999999999999999 111.039 -177.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 7.7 m -125.01 8.12 8.02 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.103 -0.499 . . . . 0.70999999999999996 110.501 -178.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.603 ' O ' ' HA ' ' A' ' 59' ' ' GLU . . . 75.14 26.24 66.86 Favored Glycine 0 C--O 1.226 -0.35 0 C-N-CA 121.014 -0.612 . . . . 0.54000000000000004 112.622 -179.508 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.49 -20.37 6.18 Favored Glycine 0 N--CA 1.454 -0.149 0 C-N-CA 121.012 -0.613 . . . . 0.34999999999999998 111.937 -179.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -68.43 128.6 37.18 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.179 -0.511 . . . . 1.6499999999999999 110.537 -177.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.638 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 19.4 mt -108.24 157.53 18.26 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 116.076 -0.511 . . . . 0.93999999999999995 110.065 176.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -87.82 -165.31 41.16 Favored Glycine 0 N--CA 1.443 -0.847 0 CA-C-N 115.478 -0.783 . . . . 0.44 111.232 174.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.599 ' HA ' ' O ' ' A' ' 8' ' ' LEU . 75.4 m-85 -71.67 133.05 45.4 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.287 0.565 . . . . 3.8700000000000001 111.609 -178.046 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.518 ' O ' ' HA ' ' A' ' 7' ' ' LYS . 21.0 p90 -133.96 160.3 38.12 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.366 -0.834 . . . . 1.3100000000000001 109.399 178.628 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 12.1 m -79.75 123.57 27.81 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 109.032 -0.729 . . . . 1.1699999999999999 109.032 175.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 33.1 m -52.73 117.43 2.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.14 -0.482 . . . . 1.1899999999999999 110.675 -178.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 113.97 -6.18 23.78 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.734 -0.746 . . . . 0.79000000000000004 112.425 -177.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -97.99 48.18 1.01 Allowed 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.453 0.644 . . . . 1.55 110.435 179.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 25.3 mmt -135.58 -101.22 0.22 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.101 -0.5 . . . . 0.72999999999999998 110.502 177.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . 0.508 ' HB2' ' HB3' ' A' ' 89' ' ' PHE . 48.4 mtt -145.8 149.71 34.85 Favored 'General case' 0 CA--C 1.513 -0.464 0 N-CA-C 107.79 -1.189 . . . . 1.3899999999999999 107.79 177.256 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.448 ' HB3' ' HD3' ' A' ' 88' ' ' PRO . 27.2 ttpp -53.38 -54.79 41.39 Favored Pre-proline 0 C--N 1.322 -0.605 0 N-CA-C 112.134 0.42 . . . . 2.3700000000000001 112.134 -174.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.448 ' HD3' ' HB3' ' A' ' 87' ' ' LYS . 83.4 Cg_endo -76.45 -27.82 7.43 Favored 'Trans proline' 0 C--N 1.356 0.97 0 C-N-CA 121.6 1.533 . . . . 0.27000000000000002 112.061 -176.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.644 ' O ' HG23 ' A' ' 93' ' ' VAL . 34.3 t80 -68.55 -56.59 7.78 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.248 -0.887 . . . . 0.22 109.999 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -65.08 -37.08 86.38 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.398 -0.819 . . . . 2.1200000000000001 109.661 -177.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -52.75 -36.02 57.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.173 -0.921 . . . . 0.60999999999999999 110.995 174.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -83.77 -27.32 28.96 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.112 -0.494 . . . . 0.22 111.207 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.644 HG23 ' O ' ' A' ' 89' ' ' PHE . 21.8 t -69.92 -48.17 65.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.243 0.544 . . . . 0.25 109.947 -177.187 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -73.2 -6.81 48.31 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.446 -0.797 . . . . 2.5899999999999999 110.784 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -82.94 -20.51 35.14 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.865 -0.607 . . . . 0.46999999999999997 110.222 177.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.671 ' HB3' ' HB2' ' A' ' 100' ' ' ASP . 0.8 OUTLIER -89.22 146.33 24.83 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-N 116.198 -0.456 . . . . 0.28000000000000003 109.912 -179.895 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 55.2 tptt -86.49 166.08 15.76 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 106.684 -1.599 . . . . 1.6100000000000001 106.684 163.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 51.8 mt -55.24 115.32 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 120.77 0.319 . . . . 0.90000000000000002 110.368 179.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 102.64 10.94 36.7 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.51 -0.852 . . . . 0.46000000000000002 113.559 -178.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.671 ' HB2' ' HB3' ' A' ' 96' ' ' LEU . 8.9 m-20 -108.08 149.1 28.88 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 117.896 0.848 . . . . 0.46000000000000002 110.462 -179.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 16.2 mt -116.14 144.84 22.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 121.066 0.46 . . . . 0.23000000000000001 110.671 -178.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.65 ' OG ' HD21 ' A' ' 96' ' ' LEU . 19.7 m -90.86 148.91 39.3 Favored Pre-proline 0 C--N 1.321 -0.657 0 CA-C-N 115.801 -0.636 . . . . 0.92000000000000004 110.534 -179.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.69 176.2 10.3 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 122.642 2.228 . . . . 0.34000000000000002 111.195 172.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.894 HG23 HD23 ' A' ' 44' ' ' LEU . 19.6 mm -50.11 100.2 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 O-C-N 123.475 0.484 . . . . 0.20000000000000001 112.133 178.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.6 p -107.75 119.59 57.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.101 0.477 . . . . 1.04 110.21 176.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -85.99 149.86 24.89 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.935 0.398 . . . . 0.55000000000000004 110.73 -179.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.435 HG22 ' HG2' ' A' ' 88' ' ' PRO . 3.9 p -126.26 -172.33 2.6 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.601 -0.727 . . . . 0.37 111.122 -178.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -61.03 -34.84 75.47 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.556 0.217 . . . . 2.1600000000000001 111.527 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.614 ' O ' ' HB2' ' A' ' 20' ' ' SER . 6.8 t -97.5 -60.76 1.51 Allowed 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.55 -0.46 . . . . 1.0900000000000001 110.544 179.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -146.59 -133.42 2.46 Favored Glycine 0 N--CA 1.441 -0.986 0 C-N-CA 119.015 -1.564 . . . . 0.23999999999999999 113.877 -173.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.894 ' HB3' HD22 ' A' ' 44' ' ' LEU . 5.9 mp -114.58 148.08 38.55 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.06 -0.57 . . . . 0.19 111.407 -169.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . 0.562 ' NE2' HD13 ' A' ' 14' ' ' LEU . 80.7 m-70 -144.2 151.82 40.01 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.316 0.579 . . . . 0.22 112.268 179.073 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.606 HG12 HD11 ' A' ' 44' ' ' LEU . 3.9 pt -134.35 143.91 36.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 107.774 -1.195 . . . . 0.17000000000000001 107.774 159.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.444 ' H ' ' HB2' ' A' ' 102' ' ' SER . 1.0 OUTLIER -133.22 138.19 51.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 C-N-CA 120.829 -0.348 . . . . 0.17999999999999999 110.665 -176.963 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.492 ' HG2' ' HB3' ' A' ' 11' ' ' ALA . 50.4 pttt -121.83 135.08 54.9 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.416 -0.587 . . . . 0.60999999999999999 109.416 172.111 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . 0.419 ' HB2' HD12 ' A' ' 96' ' ' LEU . 68.5 ttt180 -84.78 123.0 29.92 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.837 0.351 . . . . 1.8700000000000001 111.064 -175.185 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.411 HD21 ' HB2' ' A' ' 11' ' ' ALA . 2.2 mm? -93.15 -32.59 14.36 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.025 -0.534 . . . . 0.89000000000000001 110.843 179.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.955 0 CA-C-O 118.569 -0.729 . . . . 1.1000000000000001 110.156 179.514 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 40.1 mmtm . . . . . 0 N--CA 1.454 -0.247 0 CA-C-O 121.546 0.688 . . . . 1.1899999999999999 111.039 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.642 HD23 ' H ' ' A' ' 9' ' ' ARG . 2.1 tt -115.19 158.71 21.88 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 114.651 -1.158 . . . . 1.1799999999999999 108.178 179.282 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.642 ' H ' HD23 ' A' ' 8' ' ' LEU . 48.8 ttt180 -137.53 130.8 30.83 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 108.61 -0.885 . . . . 1.0600000000000001 108.61 175.153 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.442 ' N ' ' HZ ' ' A' ' 80' ' ' PHE . . . -144.78 155.47 43.54 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.244 -0.583 . . . . 0.22 112.419 -178.361 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.608 ' HA ' ' HA ' ' A' ' 76' ' ' ASP . . . -109.67 133.6 52.94 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-N 115.421 -0.808 . . . . 0.20000000000000001 109.538 176.225 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 37.9 p-80 -139.52 143.51 37.46 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.97 0.414 . . . . 0.23000000000000001 111.365 -172.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.641 ' O ' ' HA ' ' A' ' 112' ' ' HIS . 6.1 tt -111.82 134.84 53.13 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.536 -0.913 . . . . 0.23999999999999999 108.536 177.159 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.532 HD13 ' NE2' ' A' ' 112' ' ' HIS . 24.4 tp -117.36 122.34 43.6 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.811 0.339 . . . . 0.27000000000000002 111.224 -178.187 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.569 HG23 HD13 ' A' ' 44' ' ' LEU . 70.5 t -108.57 134.05 51.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 109.786 -0.45 . . . . 0.14999999999999999 109.786 174.242 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.471 ' HE3' HD21 ' A' ' 14' ' ' LEU . 31.3 mmtp -106.43 149.54 26.94 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.431 -0.581 . . . . 0.62 109.431 176.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.448 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 49.6 p90 -138.68 161.32 37.46 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.721 0.296 . . . . 0.25 110.749 -179.027 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.568 ' HB3' ' HA ' ' A' ' 33' ' ' ALA . 59.8 p -52.62 109.8 0.44 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.849 -0.614 . . . . 1.04 111.094 -179.173 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 97.8 9.46 54.4 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.63 -0.795 . . . . 0.53000000000000003 113.769 177.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.441 ' C ' ' H ' ' A' ' 22' ' ' ASN . 88.9 p -91.6 48.67 1.49 Allowed 'General case' 0 C--O 1.235 0.321 0 CA-C-N 118.293 1.047 . . . . 0.69999999999999996 110.903 -177.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 71.27 -34.46 0.3 Allowed 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.531 0.732 . . . . 3.4900000000000002 111.537 -178.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.441 ' H ' ' C ' ' A' ' 20' ' ' SER . 41.5 m-80 -142.99 91.1 7.25 Favored Pre-proline 0 C--N 1.328 -0.367 0 N-CA-C 110.387 -0.227 . . . . 1.77 110.387 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.412 ' C ' HG22 ' A' ' 32' ' ' THR . 16.7 Cg_exo -73.99 54.81 3.24 Favored 'Trans proline' 0 CA--C 1.534 0.523 0 C-N-CA 123.408 2.739 . . . . 1.71 113.07 179.435 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.462 ' N ' HG22 ' A' ' 32' ' ' THR . 64.4 t -146.83 117.67 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 109.302 -0.629 . . . . 0.47999999999999998 109.302 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 42.1 t -106.45 151.74 24.55 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 110.344 -0.243 . . . . 1.1200000000000001 110.344 178.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.588 ' HB2' ' HA ' ' A' ' 67' ' ' ASP . 7.5 mpt_? -65.61 -14.71 61.71 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.994 0.426 . . . . 2.54 109.894 170.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.52 ' HG3' ' HD3' ' A' ' 65' ' ' ARG . 23.9 ttp180 -66.86 -38.94 87.29 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.404 -0.817 . . . . 1.77 109.471 177.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 33.2 p -105.42 -35.14 7.6 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-O 121.433 0.635 . . . . 0.67000000000000004 110.979 -176.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 72.92 8.15 72.48 Favored Glycine 0 N--CA 1.451 -0.325 0 CA-C-N 115.419 -0.81 . . . . 0.81999999999999995 112.054 -178.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -131.03 -70.07 0.61 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.964 0.412 . . . . 2.1000000000000001 110.312 -178.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.404 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 11.0 p -154.54 157.65 38.63 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.16 -0.473 . . . . 1.0800000000000001 110.584 177.565 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.462 HG22 ' N ' ' A' ' 24' ' ' VAL . 10.1 t -125.11 28.0 6.51 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 122.082 0.944 . . . . 0.34000000000000002 109.66 172.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.568 ' HA ' ' HB3' ' A' ' 18' ' ' SER . . . -69.27 -5.53 23.6 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 114.979 -1.009 . . . . 0.37 111.893 178.636 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -85.57 -25.18 26.88 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.833 -0.621 . . . . 2.21 110.754 -178.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.456 HG13 ' OG1' ' A' ' 32' ' ' THR . 0.2 OUTLIER -109.75 135.16 49.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.647 -0.706 . . . . 0.31 110.47 -175.547 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 41.7 p -92.19 178.73 5.77 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 109.743 -0.466 . . . . 0.39000000000000001 109.743 -178.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.511 ' O ' HG13 ' A' ' 41' ' ' ILE . 18.6 p90 -62.16 -29.63 70.48 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 119.885 -0.726 . . . . 1.53 109.57 177.336 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -72.39 -48.36 42.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.12 -0.491 . . . . 0.95999999999999996 110.446 177.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -64.22 -29.04 70.16 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.317 0.579 . . . . 0.91000000000000003 109.705 178.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.448 ' HB2' ' HB3' ' A' ' 17' ' ' PHE . . . -72.62 -46.34 54.59 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.09 -0.959 . . . . 0.19 110.696 177.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.511 HG13 ' O ' ' A' ' 37' ' ' TYR . 97.0 mt -62.41 -38.13 80.51 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 N-CA-C 109.635 -0.506 . . . . 0.29999999999999999 109.635 175.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.455 ' O ' ' HG3' ' A' ' 46' ' ' LYS . 82.6 tttt -60.87 -29.68 69.69 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.455 -0.793 . . . . 2.3199999999999998 110.162 178.216 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -87.62 -47.53 8.62 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.687 -0.688 . . . . 1.02 110.091 -177.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.94 HD23 HG23 ' A' ' 104' ' ' ILE . 35.5 tp -58.67 -38.57 78.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.896 -0.593 . . . . 0.17000000000000001 109.743 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.451 ' HG2' HG13 ' A' ' 104' ' ' ILE . 2.5 mm-40 -62.63 -35.96 81.26 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.94 -0.573 . . . . 0.87 112.165 178.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.455 ' HG3' ' O ' ' A' ' 42' ' ' LYS . 68.8 mttm -70.78 -45.81 64.04 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.741 0.305 . . . . 1.3100000000000001 110.77 -178.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 51.0 m95 -67.9 -44.34 77.2 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.98 -0.288 . . . . 0.52000000000000002 110.468 177.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 40.9 t -57.03 -33.5 67.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.024 0.44 . . . . 0.81999999999999995 110.219 174.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.415 ' HB2' ' O ' ' A' ' 45' ' ' GLN . 12.1 tt0 -68.03 -54.38 18.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 0.53000000000000003 110.294 177.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.614 ' HB3' HG22 ' A' ' 56' ' ' VAL . 87.6 mtt180 -60.23 -45.24 93.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.96 -0.564 . . . . 0.41999999999999998 111.594 -178.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.41 HG21 ' CD2' ' A' ' 58' ' ' PHE . 97.2 mt -59.42 -40.69 82.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 120.997 0.427 . . . . 0.20000000000000001 110.727 177.14 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.49 -38.42 71.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.152 -0.476 . . . . 0.27000000000000002 111.615 -179.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 58.1 p -78.22 -30.78 48.98 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.055 0.455 . . . . 0.34999999999999998 110.947 -179.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 106.68 3.0 37.32 Favored Glycine 0 N--CA 1.445 -0.725 0 N-CA-C 111.574 -0.61 . . . . 0.29999999999999999 111.574 -179.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.408 ' HB3' ' HB3' ' A' ' 50' ' ' ARG . 5.6 tt0 -55.57 -46.68 77.18 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 122.803 0.441 . . . . 0.65000000000000002 110.784 177.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.614 HG22 ' HB3' ' A' ' 50' ' ' ARG . 11.9 m -134.78 155.33 38.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 109.472 -0.566 . . . . 0.19 109.472 170.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.5 m -77.8 155.8 30.88 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.266 -0.642 . . . . 0.96999999999999997 109.266 178.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.41 ' CD2' HG21 ' A' ' 51' ' ' ILE . 2.2 t80 -54.3 -40.01 67.52 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.184 -0.673 . . . . 0.22 109.184 177.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -57.94 -44.8 87.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.892 -1.049 . . . . 1.72 111.671 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -64.11 -45.68 87.52 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.863 0.363 . . . . 2.0899999999999999 111.11 -175.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -70.56 -43.66 69.02 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.42 -0.354 . . . . 0.26000000000000001 110.896 -179.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.84 -46.02 89.85 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.248 0.462 . . . . 0.23999999999999999 112.248 -175.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.496 ' HA ' ' O ' ' A' ' 71' ' ' TYR . 21.7 m -59.2 -19.73 47.93 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 112.907 0.706 . . . . 1.0 112.907 -177.138 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.412 ' O ' ' HA ' ' A' ' 27' ' ' ARG . 35.7 mt-30 -110.69 -45.65 3.47 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.48 0.657 . . . . 0.60999999999999999 110.988 -178.182 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.52 ' HD3' ' HG3' ' A' ' 27' ' ' ARG . 25.6 mmt180 -92.35 -38.43 12.04 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 114.929 -1.032 . . . . 0.85999999999999999 113.278 -170.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.456 ' HB2' ' HG ' ' A' ' 13' ' ' LEU . 21.6 t -63.31 124.62 21.7 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.028 0.442 . . . . 0.81999999999999995 110.889 -178.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.588 ' HA ' ' HB2' ' A' ' 26' ' ' ARG . 22.8 t70 -80.99 -10.49 59.7 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.741 -0.663 . . . . 2.2799999999999998 111.11 177.644 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 48.3 t -80.24 158.59 26.16 Favored 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 120.132 -0.627 . . . . 1.52 109.608 179.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -60.3 -12.06 23.0 Favored Glycine 0 N--CA 1.454 -0.108 0 CA-C-N 115.014 -0.994 . . . . 0.26000000000000001 113.122 -174.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 70.5 p -69.6 -10.15 57.01 Favored 'General case' 0 N--CA 1.448 -0.565 0 O-C-N 123.052 -0.087 . . . . 0.32000000000000001 110.984 176.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.496 ' O ' ' HA ' ' A' ' 63' ' ' SER . 12.8 p90 -57.42 -31.01 65.43 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 109.617 -0.512 . . . . 0.54000000000000004 109.617 174.013 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -95.35 2.63 54.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.141 0.496 . . . . 0.48999999999999999 110.626 179.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 5.0 m -116.37 -2.03 12.17 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.913 -0.585 . . . . 0.70999999999999996 111.284 -175.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 86.11 20.01 56.16 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.722 -0.751 . . . . 0.54000000000000004 112.233 -177.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 86.34 -29.34 4.84 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 121.092 -0.575 . . . . 0.34999999999999998 112.639 178.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.608 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 8.1 p-10 -89.41 144.93 25.68 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-O 121.573 0.702 . . . . 1.6499999999999999 111.397 -175.538 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.438 ' O ' ' HG3' ' A' ' 9' ' ' ARG . 1.7 mp -106.34 175.74 5.4 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 114.635 -1.166 . . . . 0.93999999999999995 110.131 178.612 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -82.76 -147.18 6.67 Favored Glycine 0 C--N 1.317 -0.509 0 C-N-CA 121.033 -0.604 . . . . 0.44 112.497 179.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -99.16 124.19 44.01 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.109 0.48 . . . . 3.8700000000000001 110.807 -178.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.442 ' HZ ' ' N ' ' A' ' 10' ' ' ALA . 1.1 p90 -134.36 138.5 44.94 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.46 -0.791 . . . . 1.3100000000000001 110.425 -177.009 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 18.6 m -68.06 129.67 40.62 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.703 -0.481 . . . . 1.1699999999999999 109.703 177.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 17.8 m -49.47 121.47 5.11 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.8 -0.636 . . . . 1.1899999999999999 111.832 -174.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 111.09 3.21 28.02 Favored Glycine 0 N--CA 1.452 -0.289 0 CA-C-N 115.847 -0.615 . . . . 0.79000000000000004 112.148 -177.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -91.7 26.31 2.4 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.945 0.402 . . . . 1.55 111.304 -175.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 26.5 mmt -122.13 -131.78 0.28 Allowed 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 109.687 -0.486 . . . . 0.72999999999999998 109.687 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 5.1 mpp? -91.97 -93.3 0.14 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.939 0.4 . . . . 1.3899999999999999 109.931 177.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.499 ' H ' ' HD2' ' A' ' 88' ' ' PRO . 27.8 ttpp -163.58 -56.43 0.01 OUTLIER Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 115.852 -0.613 . . . . 2.3700000000000001 110.026 175.262 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.499 ' HD2' ' H ' ' A' ' 87' ' ' LYS . 60.5 Cg_endo -70.14 -30.0 21.16 Favored 'Trans proline' 0 C--N 1.359 1.097 0 C-N-CA 121.923 1.749 . . . . 0.27000000000000002 111.096 178.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.644 ' O ' HG23 ' A' ' 93' ' ' VAL . 20.1 t80 -61.66 -56.44 19.76 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.631 -1.168 . . . . 0.22 109.762 176.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.8 tm-20 -64.36 -36.85 85.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.493 -0.776 . . . . 2.1200000000000001 110.165 -179.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -53.54 -33.52 54.89 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.354 -0.839 . . . . 0.60999999999999999 110.964 175.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.435 ' O ' ' HG ' ' A' ' 96' ' ' LEU . . . -84.35 -34.36 23.67 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.359 -0.382 . . . . 0.22 111.298 177.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.644 HG23 ' O ' ' A' ' 89' ' ' PHE . 35.7 t -62.72 -44.52 99.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-O 121.417 0.627 . . . . 0.25 110.596 -177.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 38.3 ptt180 -73.47 -11.29 60.41 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.612 -0.722 . . . . 2.5899999999999999 110.748 178.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -96.86 14.64 24.61 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.328 -0.396 . . . . 0.46999999999999997 111.815 -173.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.539 ' HB2' ' HB2' ' A' ' 100' ' ' ASP . 0.5 OUTLIER -148.17 155.75 41.77 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.022 0.439 . . . . 0.28000000000000003 110.857 177.395 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.58 ' HA ' ' NH2' ' A' ' 116' ' ' ARG . 23.8 tptm -92.25 162.73 14.18 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.789 -0.641 . . . . 1.6100000000000001 109.517 179.294 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.517 ' HA ' ' HG2' ' A' ' 116' ' ' ARG . 66.2 mt -42.63 114.33 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.974 0.416 . . . . 0.90000000000000002 111.241 171.52 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 103.3 -8.87 53.31 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.804 -0.712 . . . . 0.46000000000000002 113.449 178.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.539 ' HB2' ' HB2' ' A' ' 96' ' ' LEU . 18.4 m-20 -97.24 135.82 38.62 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 117.23 0.515 . . . . 0.46000000000000002 110.383 179.121 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.483 HG12 ' HB3' ' A' ' 115' ' ' LYS . 8.3 mt -103.98 149.72 7.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.946 -0.57 . . . . 0.23000000000000001 109.902 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 93.4 p -91.46 159.62 38.57 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 116.095 -0.502 . . . . 0.92000000000000004 110.914 -177.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -71.22 166.55 28.88 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 122.383 2.055 . . . . 0.34000000000000002 111.342 170.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.94 HG23 HD23 ' A' ' 44' ' ' LEU . 25.7 mm -47.57 112.7 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 O-C-N 123.547 0.53 . . . . 0.20000000000000001 111.793 176.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 1.9 p -118.47 124.8 73.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.154 -0.475 . . . . 1.04 109.961 175.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -85.51 151.32 24.04 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.0 0.429 . . . . 0.55000000000000004 110.285 178.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 10.9 p -131.3 -172.21 2.79 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.942 -0.572 . . . . 0.37 110.855 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -55.5 -48.16 75.06 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.893 -0.594 . . . . 2.1600000000000001 111.928 -179.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.462 ' OG ' ' HE2' ' A' ' 16' ' ' LYS . 4.8 t -106.98 -3.93 19.58 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.791 0.663 . . . . 1.0900000000000001 112.791 -172.306 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 172.68 -128.59 1.56 Allowed Glycine 0 N--CA 1.439 -1.15 0 C-N-CA 118.984 -1.579 . . . . 0.23999999999999999 113.615 173.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.879 ' HB3' HD22 ' A' ' 44' ' ' LEU . 7.4 mp -126.4 151.0 48.26 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 114.976 -0.612 . . . . 0.19 110.961 -170.2 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . 0.641 ' HA ' ' O ' ' A' ' 13' ' ' LEU . 84.7 m-70 -146.48 149.99 34.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.378 0.608 . . . . 0.22 112.53 178.309 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.632 HG12 HD11 ' A' ' 44' ' ' LEU . 2.9 pt -128.07 137.43 57.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 107.351 -1.351 . . . . 0.17000000000000001 107.351 158.39 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 2.6 mp -130.57 144.02 39.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 C-N-CA 120.736 -0.386 . . . . 0.17999999999999999 110.85 -175.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.483 ' HB3' HG12 ' A' ' 101' ' ' ILE . 39.2 pttt -127.2 142.19 51.55 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.655 -0.868 . . . . 0.60999999999999999 108.655 172.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . 0.58 ' NH2' ' HA ' ' A' ' 97' ' ' LYS . 3.1 ttp180 -79.81 134.77 36.36 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.295 0.569 . . . . 1.8700000000000001 111.095 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -102.66 -32.42 9.88 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.144 -0.935 . . . . 0.89000000000000001 109.922 178.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.576 ' OXT' ' HD2' ' A' ' 116' ' ' ARG . . . . . . . . 0 C--O 1.246 0.888 0 CA-C-O 118.368 -0.825 . . . . 1.1000000000000001 110.401 178.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.48 ' HD2' ' HB3' ' A' ' 79' ' ' PHE . 60.1 mmtt . . . . . 0 N--CA 1.454 -0.241 0 CA-C-O 121.359 0.6 . . . . 1.1899999999999999 110.798 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.684 HD23 ' H ' ' A' ' 9' ' ' ARG . 1.3 tt -114.9 161.23 18.54 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 108.162 -1.051 . . . . 1.1799999999999999 108.162 178.139 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.684 ' H ' HD23 ' A' ' 8' ' ' LEU . 48.2 ttt180 -141.45 128.61 20.91 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.082 -0.71 . . . . 1.0600000000000001 109.082 175.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.441 ' O ' ' HB2' ' A' ' 77' ' ' LEU . . . -146.97 158.74 44.01 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 119.97 -0.692 . . . . 0.22 112.143 -178.459 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.495 ' HB3' ' HG2' ' A' ' 115' ' ' LYS . . . -106.73 135.75 47.73 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.641 -0.708 . . . . 0.20000000000000001 109.177 177.521 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.45 ' HE1' HD21 ' A' ' 77' ' ' LEU . 10.1 p-80 -138.71 140.12 38.64 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 120.37 -0.532 . . . . 0.23000000000000001 111.463 -171.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.546 ' HG ' ' HB3' ' A' ' 66' ' ' SER . 7.0 tt -111.71 143.28 42.88 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.493 -0.929 . . . . 0.23999999999999999 108.493 175.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.584 HD13 ' NE2' ' A' ' 112' ' ' HIS . 23.9 tp -129.61 120.4 25.19 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.768 0.318 . . . . 0.27000000000000002 111.097 -177.028 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.51 HG23 HD13 ' A' ' 44' ' ' LEU . 37.5 t -106.98 132.39 54.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 109.379 -0.6 . . . . 0.14999999999999999 109.379 175.456 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.649 ' HE2' ' OG ' ' A' ' 109' ' ' SER . 31.7 mmtp -106.21 154.37 20.81 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.837 -0.431 . . . . 0.62 109.837 177.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -149.19 160.95 42.92 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.056 -0.52 . . . . 0.25 110.353 -176.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 5.6 t -54.27 109.49 0.49 Allowed 'General case' 0 N--CA 1.432 -1.327 0 CA-C-N 116.392 -0.367 . . . . 1.04 110.071 174.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 105.74 9.61 32.45 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.502 -0.856 . . . . 0.53000000000000003 112.759 -178.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.49 ' HB2' ' O ' ' A' ' 109' ' ' SER . 78.3 p -95.03 39.44 1.11 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 117.258 0.529 . . . . 0.69999999999999996 111.202 -176.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.424 ' HB3' ' O ' ' A' ' 20' ' ' SER . 54.8 ttt180 74.77 -34.29 0.26 Allowed 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.286 0.634 . . . . 3.4900000000000002 111.045 179.399 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -151.06 114.07 3.12 Favored Pre-proline 0 C--N 1.324 -0.521 0 N-CA-C 109.265 -0.643 . . . . 1.77 109.265 172.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.43 ' C ' HG22 ' A' ' 32' ' ' THR . 89.9 Cg_endo -83.61 64.12 7.42 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 122.594 2.196 . . . . 1.71 112.88 -172.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.482 ' N ' HG22 ' A' ' 32' ' ' THR . 47.0 t -147.9 116.17 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 C-N-CA 122.855 0.462 . . . . 0.47999999999999998 109.851 179.406 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.435 ' HB3' ' HB2' ' A' ' 16' ' ' LYS . 28.7 p -105.63 158.47 16.68 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 110.585 -0.154 . . . . 1.1200000000000001 110.585 175.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.585 ' HB2' ' HA ' ' A' ' 67' ' ' ASP . 5.6 mpt_? -71.05 -4.0 22.68 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.111 0.481 . . . . 2.54 110.216 171.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.574 ' HG3' ' CD ' ' A' ' 65' ' ' ARG . 22.0 ttp180 -76.26 -40.1 52.73 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.706 -0.679 . . . . 1.77 109.362 175.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 59.8 p -103.19 -35.8 8.34 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.707 -0.679 . . . . 0.67000000000000004 111.035 -176.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 80.95 -28.31 2.89 Favored Glycine 0 CA--C 1.52 0.365 0 CA-C-N 115.963 -0.562 . . . . 0.81999999999999995 112.21 -179.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -98.48 -71.21 0.7 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.839 0.352 . . . . 2.1000000000000001 110.64 -178.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 44.7 m -154.11 156.7 37.74 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.109 -0.496 . . . . 1.0800000000000001 110.212 177.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.482 HG22 ' N ' ' A' ' 24' ' ' VAL . 8.9 t -123.22 35.5 4.85 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 122.29 1.043 . . . . 0.34000000000000002 109.695 178.285 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -77.67 -4.58 46.83 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.833 -1.076 . . . . 0.37 111.528 -176.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -96.76 1.21 50.58 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.798 -0.637 . . . . 2.21 110.747 -178.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.46 HG23 ' HB2' ' A' ' 39' ' ' ASP . 0.2 OUTLIER -129.46 134.75 63.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.685 -0.689 . . . . 0.31 109.787 -179.955 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 41.2 p -96.49 -176.19 3.55 Favored 'General case' 0 CA--C 1.513 -0.468 0 N-CA-C 109.487 -0.56 . . . . 0.39000000000000001 109.487 -178.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.543 ' O ' HG13 ' A' ' 41' ' ' ILE . 0.2 OUTLIER -67.93 -22.8 65.04 Favored 'General case' 0 C--O 1.219 -0.532 0 C-N-CA 118.883 -1.127 . . . . 1.53 110.036 173.583 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -68.82 -49.3 59.6 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.761 -0.459 . . . . 0.95999999999999996 109.761 174.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.46 ' HB2' HG23 ' A' ' 35' ' ' VAL . 8.4 m-20 -66.54 -32.44 73.79 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.368 0.604 . . . . 0.91000000000000003 109.967 177.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.428 ' HB3' ' HA ' ' A' ' 37' ' ' TYR . . . -71.85 -40.91 68.7 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.272 -0.876 . . . . 0.19 110.832 179.383 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.543 HG13 ' O ' ' A' ' 37' ' ' TYR . 61.8 mt -62.3 -34.67 65.35 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.312 0 N-CA-C 109.316 -0.624 . . . . 0.29999999999999999 109.316 173.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.421 ' O ' ' HG3' ' A' ' 46' ' ' LYS . 19.7 mtpt -65.34 -21.28 66.68 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 116.336 -0.393 . . . . 2.3199999999999998 111.085 176.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.447 ' HG3' ' CD1' ' A' ' 47' ' ' TRP . 1.6 tp10 -87.85 -57.61 2.87 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.34 -0.615 . . . . 1.02 109.34 178.187 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.934 HD23 HG23 ' A' ' 104' ' ' ILE . 23.8 tp -57.93 -38.89 76.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 114.965 -1.016 . . . . 0.17000000000000001 111.101 -175.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.516 ' HB2' ' O ' ' A' ' 41' ' ' ILE . 3.6 mm-40 -66.22 -28.66 68.91 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 112.047 0.388 . . . . 0.87 112.047 -178.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.421 ' HG3' ' O ' ' A' ' 42' ' ' LYS . 66.4 mttm -77.56 -45.02 26.6 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.986 -0.376 . . . . 1.3100000000000001 109.986 178.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.447 ' CD1' ' HG3' ' A' ' 43' ' ' GLU . 58.2 m95 -66.11 -45.5 80.94 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.249 -0.432 . . . . 0.52000000000000002 111.695 177.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.567 ' HB3' HG21 ' A' ' 113' ' ' ILE . 96.0 p -65.22 -23.82 67.18 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.957 0.408 . . . . 0.81999999999999995 109.989 177.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.473 ' HB2' ' O ' ' A' ' 45' ' ' GLN . 10.1 tt0 -73.3 -56.68 4.75 Favored 'General case' 0 C--O 1.223 -0.337 0 CA-C-N 116.094 -0.503 . . . . 0.53000000000000003 109.776 173.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.618 ' HB3' HG22 ' A' ' 56' ' ' VAL . 92.4 mtt180 -61.1 -41.7 97.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.77 -0.65 . . . . 0.41999999999999998 111.81 -176.136 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.495 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 98.2 mt -60.7 -36.42 70.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.367 -0.378 . . . . 0.20000000000000001 110.496 176.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -77.64 -36.95 51.0 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.243 -0.435 . . . . 0.27000000000000002 111.692 178.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.473 ' OG ' ' HA ' ' A' ' 50' ' ' ARG . 67.9 p -79.09 -29.8 43.5 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 111.76 0.282 . . . . 0.34999999999999998 111.76 -175.347 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 109.15 1.37 31.54 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.671 -0.776 . . . . 0.29999999999999999 112.318 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.439 ' HB2' ' HB3' ' A' ' 50' ' ' ARG . 43.5 mt-10 -61.97 -50.97 69.97 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.882 0.372 . . . . 0.65000000000000002 110.509 178.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.618 HG22 ' HB3' ' A' ' 50' ' ' ARG . 16.2 m -134.8 152.4 32.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 109.564 -0.532 . . . . 0.19 109.564 174.285 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 19.5 m -82.39 160.15 22.85 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.542 -0.54 . . . . 0.96999999999999997 109.542 178.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.427 ' HA ' ' CD1' ' A' ' 51' ' ' ILE . 2.6 t80 -54.95 -39.8 69.3 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.412 0.625 . . . . 0.22 109.74 -178.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -55.79 -45.56 78.17 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.541 -1.209 . . . . 1.72 111.351 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.455 ' O ' ' HG3' ' A' ' 64' ' ' GLN . 3.9 mm-40 -65.64 -47.83 74.24 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.964 -0.562 . . . . 2.0899999999999999 111.177 -173.154 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -67.25 -38.44 85.15 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.369 -0.378 . . . . 0.26000000000000001 110.845 -179.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.37 -53.18 58.73 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.131 -0.486 . . . . 0.23999999999999999 111.331 -178.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.553 ' HA ' ' O ' ' A' ' 71' ' ' TYR . 47.6 m -51.58 -29.56 17.68 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.892 0.701 . . . . 1.0 112.892 -177.337 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.455 ' HG3' ' O ' ' A' ' 60' ' ' GLU . 19.1 mt-30 -97.33 -50.48 4.53 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.738 0.78 . . . . 0.60999999999999999 110.708 -177.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.574 ' CD ' ' HG3' ' A' ' 27' ' ' ARG . 19.1 mmt180 -93.57 -40.26 10.39 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 114.55 -1.205 . . . . 0.85999999999999999 113.386 -166.18 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.546 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 38.7 p -63.84 121.52 14.23 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.106 0.479 . . . . 0.81999999999999995 111.177 -174.029 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.585 ' HA ' ' HB2' ' A' ' 26' ' ' ARG . 31.5 t70 -74.66 -15.08 60.82 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.571 -0.741 . . . . 2.2799999999999998 110.813 177.13 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 0.505 ' SG ' ' HB2' ' A' ' 66' ' ' SER . 5.2 p -77.57 150.34 34.74 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.94 -0.573 . . . . 1.52 110.556 -179.505 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -53.82 -18.04 7.83 Favored Glycine 0 C--N 1.329 0.176 0 CA-C-N 114.823 -1.08 . . . . 0.26000000000000001 114.742 -171.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 77.9 p -73.06 0.32 11.78 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 117.293 0.546 . . . . 0.32000000000000001 111.907 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.553 ' O ' ' HA ' ' A' ' 63' ' ' SER . 54.8 p90 -52.97 -41.27 64.41 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.767 0.318 . . . . 0.54000000000000004 110.295 174.045 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -95.14 2.68 55.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.045 0.45 . . . . 0.48999999999999999 110.983 -179.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 5.3 m -103.37 -6.78 21.59 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.076 -0.511 . . . . 0.70999999999999996 110.735 -178.274 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 90.61 19.85 42.95 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.891 -0.671 . . . . 0.54000000000000004 112.181 -177.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 84.7 -31.83 3.53 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 121.044 -0.598 . . . . 0.34999999999999998 112.697 179.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.466 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 6.9 p-10 -83.04 145.2 29.43 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-O 121.672 0.749 . . . . 1.6499999999999999 111.224 -176.031 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.45 HD21 ' HE1' ' A' ' 12' ' ' HIS . 16.6 mt -105.43 175.74 5.4 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 114.399 -1.273 . . . . 0.93999999999999995 110.388 179.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -87.43 -152.38 22.95 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 121.234 -0.508 . . . . 0.44 112.014 177.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.48 ' HB3' ' HD2' ' A' ' 7' ' ' LYS . 91.6 m-85 -96.16 124.11 40.04 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.27 0.557 . . . . 3.8700000000000001 110.988 179.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.42 ' HZ ' ' N ' ' A' ' 10' ' ' ALA . 1.0 OUTLIER -134.44 160.2 38.72 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.491 -0.777 . . . . 1.3100000000000001 110.45 -176.214 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 40.8 p -89.22 126.59 35.55 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 109.598 -0.519 . . . . 1.1699999999999999 109.598 178.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 17.2 m -56.57 122.67 12.55 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.305 -0.407 . . . . 1.1899999999999999 111.093 -178.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 113.23 6.85 21.81 Favored Glycine 0 N--CA 1.445 -0.708 0 N-CA-C 111.533 -0.627 . . . . 0.79000000000000004 111.533 -179.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -112.82 10.55 19.15 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.135 0.493 . . . . 1.55 110.446 -178.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 23.6 mmt -99.17 -108.8 0.19 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.027 0.441 . . . . 0.72999999999999998 110.642 178.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 56.7 mtt -134.69 150.5 50.63 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 107.88 -1.155 . . . . 1.3899999999999999 107.88 175.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.403 ' HB2' ' HD3' ' A' ' 88' ' ' PRO . 14.4 mmmm -54.05 -53.19 61.27 Favored Pre-proline 0 C--N 1.32 -0.697 0 N-CA-C 112.518 0.562 . . . . 2.3700000000000001 112.518 -175.142 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.442 ' HG2' HG22 ' A' ' 107' ' ' THR . 64.2 Cg_endo -75.16 -25.18 11.87 Favored 'Trans proline' 0 C--N 1.355 0.902 0 C-N-CA 121.561 1.507 . . . . 0.27000000000000002 112.152 -177.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.514 ' O ' HG23 ' A' ' 93' ' ' VAL . 27.0 t80 -72.88 -55.78 6.14 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.475 -0.784 . . . . 0.22 109.723 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -60.41 -36.19 77.56 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.263 -0.88 . . . . 2.1200000000000001 110.214 -179.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.566 ' HA ' ' CZ ' ' A' ' 94' ' ' ARG . 26.6 t70 -56.38 -32.97 65.28 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.613 -0.721 . . . . 0.60999999999999999 111.117 177.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.475 ' O ' ' HG ' ' A' ' 96' ' ' LEU . . . -82.79 -26.98 31.28 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.381 -0.372 . . . . 0.22 111.037 179.114 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.514 HG23 ' O ' ' A' ' 89' ' ' PHE . 28.0 t -67.36 -45.38 85.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.47 -0.332 . . . . 0.25 111.666 -174.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.566 ' CZ ' ' HA ' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -83.32 -2.49 55.83 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.239 -0.584 . . . . 2.5899999999999999 110.408 178.262 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -86.5 -2.77 58.75 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.18 0.514 . . . . 0.46999999999999997 110.339 179.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.642 ' HB2' ' HB2' ' A' ' 100' ' ' ASP . 0.7 OUTLIER -136.26 153.61 51.14 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.614 -0.721 . . . . 0.28000000000000003 110.128 176.785 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.546 ' HG3' ' H ' ' A' ' 98' ' ' ILE . 20.2 tptm -102.42 179.17 4.38 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.128 -0.693 . . . . 1.6100000000000001 109.128 179.197 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.546 ' H ' ' HG3' ' A' ' 97' ' ' LYS . 65.3 mt -54.81 116.05 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.011 0.434 . . . . 0.90000000000000002 111.197 179.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 104.45 -6.18 45.31 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 121.016 -0.612 . . . . 0.46000000000000002 112.975 179.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.642 ' HB2' ' HB2' ' A' ' 96' ' ' LEU . 31.0 m-20 -98.14 138.86 34.81 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.906 0.353 . . . . 0.46000000000000002 110.886 -178.253 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 11.2 mt -108.56 147.62 13.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 109.385 -0.598 . . . . 0.23000000000000001 109.385 178.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 88.3 p -91.4 158.11 41.35 Favored Pre-proline 0 C--N 1.321 -0.658 0 CA-C-O 120.667 0.27 . . . . 0.92000000000000004 110.571 -179.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -74.99 175.87 10.66 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.272 1.982 . . . . 0.34000000000000002 110.94 170.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.934 HG23 HD23 ' A' ' 44' ' ' LEU . 21.1 mm -49.0 112.8 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.898 0.38 . . . . 0.20000000000000001 111.58 176.23 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.4 p -119.24 120.82 64.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.093 0.473 . . . . 1.04 110.078 174.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -85.14 145.25 27.71 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 121.269 0.556 . . . . 0.55000000000000004 109.995 177.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.442 HG22 ' HG2' ' A' ' 88' ' ' PRO . 8.2 p -120.6 -171.93 2.27 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.349 -0.841 . . . . 0.37 110.886 -176.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -54.69 -45.4 73.97 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.811 -0.631 . . . . 2.1600000000000001 110.723 176.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.649 ' OG ' ' HE2' ' A' ' 16' ' ' LYS . 15.0 t -93.59 -60.81 1.68 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.921 -0.581 . . . . 1.0900000000000001 111.078 -177.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -144.95 -134.85 2.8 Favored Glycine 0 N--CA 1.442 -0.929 0 C-N-CA 118.865 -1.636 . . . . 0.23999999999999999 113.448 -172.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.903 ' HB3' HD22 ' A' ' 44' ' ' LEU . 6.8 mp -113.19 146.33 39.47 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.204 -0.498 . . . . 0.19 111.116 -172.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . 0.584 ' NE2' HD13 ' A' ' 14' ' ' LEU . 77.9 m-70 -143.23 152.67 41.99 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.459 0.647 . . . . 0.22 112.484 179.35 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.686 HG12 HD11 ' A' ' 44' ' ' LEU . 3.6 pt -131.55 137.42 55.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 107.372 -1.344 . . . . 0.17000000000000001 107.372 157.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 2.4 mp -127.57 144.17 38.32 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 C-N-CA 120.781 -0.368 . . . . 0.17999999999999999 110.247 -176.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.495 ' HG2' ' HB3' ' A' ' 11' ' ' ALA . 52.0 pttt -127.94 137.25 52.2 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.041 -0.726 . . . . 0.60999999999999999 109.041 173.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . 0.538 ' HB2' ' CD1' ' A' ' 96' ' ' LEU . 65.2 ttt180 -85.49 126.61 33.97 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 120.989 0.424 . . . . 1.8700000000000001 111.358 -175.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.49 HD21 ' HB2' ' A' ' 11' ' ' ALA . 0.7 OUTLIER -97.26 -33.56 11.42 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.594 -0.73 . . . . 0.89000000000000001 110.625 178.268 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.587 ' HB3' ' HB3' ' A' ' 9' ' ' ARG . . . . . . . . 0 C--O 1.247 0.936 0 CA-C-O 118.736 -0.65 . . . . 1.1000000000000001 110.662 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt . . . . . 0 N--CA 1.454 -0.247 0 CA-C-O 121.162 0.506 . . . . 1.1899999999999999 111.315 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.497 HD11 ' CD ' ' A' ' 116' ' ' ARG . 15.3 tp -132.18 171.97 12.99 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.022 -0.99 . . . . 1.1799999999999999 108.779 -179.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 68.2 ttt180 -145.26 132.15 20.17 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 110.178 -0.304 . . . . 1.0600000000000001 110.178 175.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -148.51 160.31 43.2 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.329 0.585 . . . . 0.22 112.421 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.527 ' HB2' HD21 ' A' ' 117' ' ' LEU . . . -107.47 138.96 42.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.239 -0.892 . . . . 0.20000000000000001 109.129 176.489 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 20.0 p-80 -139.5 141.68 37.32 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.016 0.436 . . . . 0.23000000000000001 111.341 -172.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.572 ' O ' ' HA ' ' A' ' 112' ' ' HIS . 7.1 tt -113.47 138.39 50.18 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.549 -0.908 . . . . 0.23999999999999999 108.549 177.226 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.609 HD21 ' HE3' ' A' ' 16' ' ' LYS . 16.6 tp -121.2 137.5 54.65 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.697 0.284 . . . . 0.27000000000000002 111.501 -179.046 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.434 HG23 HD13 ' A' ' 44' ' ' LEU . 43.8 t -119.66 126.47 75.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.854 -0.612 . . . . 0.14999999999999999 109.721 172.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.609 ' HE3' HD21 ' A' ' 14' ' ' LEU . 28.5 mmtp -103.31 154.82 18.97 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.982 -0.554 . . . . 0.62 109.821 177.171 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -151.67 162.32 41.19 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.133 -0.485 . . . . 0.25 110.127 -176.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.455 ' CB ' ' HA ' ' A' ' 33' ' ' ALA . 4.1 t -47.25 110.01 0.26 Allowed 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 122.949 0.499 . . . . 1.04 111.484 177.302 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 93.74 10.47 58.92 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.323 -0.941 . . . . 0.53000000000000003 113.588 177.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.506 ' HB2' ' O ' ' A' ' 109' ' ' SER . 83.4 p -81.84 46.98 1.04 Allowed 'General case' 0 C--O 1.234 0.252 0 CA-C-N 117.684 0.742 . . . . 0.69999999999999996 111.326 -175.058 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 27.1 ttt180 69.32 -36.29 0.33 Allowed 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.805 0.842 . . . . 3.4900000000000002 111.115 -179.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.475 ' H ' ' C ' ' A' ' 20' ' ' SER . 57.5 m-80 -150.92 104.86 3.01 Favored Pre-proline 0 C--N 1.323 -0.576 0 N-CA-C 108.711 -0.848 . . . . 1.77 108.711 174.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_exo -64.04 -163.05 0.05 OUTLIER 'Trans proline' 0 CA--C 1.536 0.597 0 C-N-CA 123.172 2.581 . . . . 1.71 112.879 177.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.579 ' N ' HG22 ' A' ' 32' ' ' THR . 40.0 t 66.74 119.84 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-O 121.651 0.739 . . . . 0.47999999999999998 111.596 -175.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.7 t -102.0 152.3 21.11 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 115.357 -0.838 . . . . 1.1200000000000001 109.319 -179.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.682 ' CB ' ' HA ' ' A' ' 67' ' ' ASP . 8.6 tpp180 -79.91 -11.41 59.81 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.263 -1.014 . . . . 2.54 108.263 175.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.592 ' HG3' ' HD3' ' A' ' 65' ' ' ARG . 17.2 ttp180 -80.68 -43.65 20.02 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 114.75 -1.113 . . . . 1.77 109.285 173.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 32.3 p -91.05 -33.77 15.37 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 116.038 -0.528 . . . . 0.67000000000000004 111.058 -175.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 81.78 -35.39 2.5 Favored Glycine 0 N--CA 1.452 -0.244 0 CA-C-N 116.089 -0.505 . . . . 0.81999999999999995 113.154 176.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 -99.52 -64.19 1.06 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.757 0.313 . . . . 2.1000000000000001 110.615 -175.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.1 p -154.08 150.49 28.26 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.308 -0.405 . . . . 1.0800000000000001 111.608 -178.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.579 HG22 ' N ' ' A' ' 24' ' ' VAL . 8.9 t -124.73 14.92 8.7 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.905 0.859 . . . . 0.34000000000000002 110.095 176.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.455 ' HA ' ' CB ' ' A' ' 18' ' ' SER . . . -63.67 -4.42 3.0 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.447 -0.797 . . . . 0.37 113.019 177.033 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 52.3 m-20 -89.88 -25.09 21.17 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.873 0.368 . . . . 2.21 110.538 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.435 HG13 ' OG1' ' A' ' 32' ' ' THR . 0.2 OUTLIER -102.29 139.22 23.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.989 -0.55 . . . . 0.31 110.081 -178.568 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.413 ' H ' ' HB2' ' A' ' 39' ' ' ASP . 25.3 p -100.02 -178.62 3.9 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 116.107 -0.497 . . . . 0.39000000000000001 110.395 -175.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.494 ' O ' HG13 ' A' ' 41' ' ' ILE . 11.6 p90 -62.95 -30.78 71.83 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.517 -0.473 . . . . 1.53 109.872 177.223 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -72.66 -45.32 59.53 Favored 'General case' 0 CA--C 1.52 -0.173 0 CA-C-N 116.418 -0.355 . . . . 0.95999999999999996 110.545 179.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.413 ' HB2' ' H ' ' A' ' 36' ' ' THR . 0.7 OUTLIER -67.35 -28.17 67.74 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-O 121.167 0.508 . . . . 0.91000000000000003 110.345 176.389 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -69.34 -43.93 72.66 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.376 -0.829 . . . . 0.19 110.337 175.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.507 HG12 HD21 ' A' ' 111' ' ' LEU . 97.9 mt -62.65 -38.39 81.45 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.412 0 N-CA-C 109.529 -0.545 . . . . 0.29999999999999999 109.529 173.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 3.5 ttpm? -61.16 -25.99 67.39 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.342 -0.844 . . . . 2.3199999999999998 109.919 179.041 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.492 ' HG3' ' CD1' ' A' ' 47' ' ' TRP . 3.1 tp10 -87.99 -51.68 5.68 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.605 -0.725 . . . . 1.02 109.927 -178.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.967 HD22 ' HB3' ' A' ' 111' ' ' LEU . 33.0 tp -61.26 -37.85 84.6 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.421 -0.808 . . . . 0.17000000000000001 110.573 -175.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.54 ' O ' ' HB2' ' A' ' 49' ' ' GLN . 4.7 mm-40 -65.27 -26.57 68.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.19 -0.459 . . . . 0.87 112.077 -178.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.41 ' O ' ' HB3' ' A' ' 49' ' ' GLN . 68.5 mttm -81.29 -45.24 16.51 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.911 0.386 . . . . 1.3100000000000001 110.41 178.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.492 ' CD1' ' HG3' ' A' ' 43' ' ' GLU . 42.9 m95 -65.36 -46.35 80.52 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.474 -0.33 . . . . 0.52000000000000002 111.556 177.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.57 ' HB3' HG21 ' A' ' 113' ' ' ILE . 83.8 p -65.27 -22.49 66.86 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.11 0.481 . . . . 0.81999999999999995 110.16 177.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.54 ' HB2' ' O ' ' A' ' 45' ' ' GLN . 11.2 tt0 -72.09 -56.9 4.81 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 115.762 -0.654 . . . . 0.53000000000000003 109.753 174.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.633 ' HB3' HG22 ' A' ' 56' ' ' VAL . 97.0 mtt180 -61.42 -41.82 97.77 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.574 -0.739 . . . . 0.41999999999999998 111.611 -176.462 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.518 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 92.3 mt -62.05 -35.17 67.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.212 -0.449 . . . . 0.20000000000000001 110.738 177.368 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -79.59 -36.83 37.52 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.098 -0.501 . . . . 0.27000000000000002 111.615 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 47.8 p -79.39 -29.78 42.2 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.794 0.33 . . . . 0.34999999999999998 111.591 -175.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 108.63 5.89 31.27 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.6 -0.81 . . . . 0.29999999999999999 112.142 -179.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.423 ' HB2' ' HB3' ' A' ' 50' ' ' ARG . 37.1 mt-10 -65.3 -47.89 75.02 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.931 0.396 . . . . 0.65000000000000002 110.117 178.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.633 HG22 ' HB3' ' A' ' 50' ' ' ARG . 14.5 m -136.53 156.44 35.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 109.679 -0.489 . . . . 0.19 109.679 172.241 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.7 m -81.01 161.54 24.2 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.696 -0.483 . . . . 0.96999999999999997 109.696 177.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -57.66 -42.53 83.69 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.025 -0.731 . . . . 0.22 109.025 177.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.46 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 38.6 mt-10 -57.47 -41.16 80.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.891 -1.05 . . . . 1.72 111.649 179.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -66.51 -45.72 78.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.128 0.49 . . . . 2.0899999999999999 110.637 -178.13 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -71.09 -46.06 62.52 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.077 -0.511 . . . . 0.26000000000000001 111.267 -179.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.69 -50.48 73.7 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.58 0.585 . . . . 0.23999999999999999 112.58 -174.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.57 ' HA ' ' O ' ' A' ' 71' ' ' TYR . 67.5 m -55.83 -25.0 39.76 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 113.132 0.79 . . . . 1.0 113.132 -177.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -105.85 -44.57 4.6 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.275 0.56 . . . . 0.60999999999999999 111.152 -177.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.592 ' HD3' ' HG3' ' A' ' 27' ' ' ARG . 22.6 mmt180 -96.69 -36.59 10.63 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 114.015 1.117 . . . . 0.85999999999999999 114.015 -169.144 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.514 ' HB2' ' HG ' ' A' ' 13' ' ' LEU . 31.7 t -62.48 119.54 9.34 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.977 0.418 . . . . 0.81999999999999995 110.623 -178.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.682 ' HA ' ' CB ' ' A' ' 26' ' ' ARG . 68.6 m-20 -79.05 -4.9 52.47 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.729 -0.669 . . . . 2.2799999999999998 110.749 179.149 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 0.53 ' SG ' HD22 ' A' ' 14' ' ' LEU . 1.4 m -81.04 161.27 24.27 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.503 0.668 . . . . 1.52 110.888 173.091 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -63.2 -17.64 59.47 Favored Glycine 0 CA--C 1.516 0.149 0 CA-C-N 114.328 -1.306 . . . . 0.26000000000000001 114.119 -173.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.503 ' HB2' ' CA ' ' A' ' 75' ' ' GLY . 2.3 p -67.01 -6.69 18.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 117.207 0.503 . . . . 0.32000000000000001 112.283 177.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.57 ' O ' ' HA ' ' A' ' 63' ' ' SER . 35.2 p90 -52.03 -33.51 38.92 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.136 0.494 . . . . 0.54000000000000004 110.396 174.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -92.36 1.57 57.15 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.058 0.456 . . . . 0.48999999999999999 110.991 -176.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.6 m -115.58 -21.9 9.5 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.147 0.499 . . . . 0.70999999999999996 110.709 -178.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.46 ' O ' ' HA ' ' A' ' 59' ' ' GLU . . . 108.04 15.7 14.0 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.906 -0.664 . . . . 0.54000000000000004 112.02 -175.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.503 ' CA ' ' HB2' ' A' ' 70' ' ' SER . . . 96.65 -9.2 66.43 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.803 -0.713 . . . . 0.34999999999999998 112.885 178.195 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -95.54 145.32 25.3 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.633 0.73 . . . . 1.6499999999999999 111.559 -169.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -111.96 172.51 6.86 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 114.54 -1.209 . . . . 0.93999999999999995 108.89 171.32 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -92.22 -145.71 16.65 Favored Glycine 0 C--N 1.311 -0.829 0 C-N-CA 120.65 -0.786 . . . . 0.44 111.905 -178.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -84.37 140.02 31.86 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.915 -0.402 . . . . 3.8700000000000001 109.915 177.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -152.98 155.6 37.26 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.836 -0.62 . . . . 1.3100000000000001 110.028 -178.241 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 50.5 m -79.74 139.58 37.25 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.463 -0.335 . . . . 1.1699999999999999 110.695 -178.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 33.6 m -61.13 112.87 2.28 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.263 0.554 . . . . 1.1899999999999999 110.317 179.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.467 ' H ' ' HG3' ' A' ' 90' ' ' GLU . . . 113.82 -11.36 22.99 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.901 -0.666 . . . . 0.79000000000000004 112.023 -177.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -84.93 41.2 0.85 Allowed 'General case' 0 C--O 1.233 0.23 0 CA-C-O 121.657 0.741 . . . . 1.55 110.475 -177.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 24.3 mmt -136.82 -127.41 0.14 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.797 -0.638 . . . . 0.72999999999999998 109.342 177.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 63.6 mtt -119.16 153.62 34.59 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 108.133 -1.062 . . . . 1.3899999999999999 108.133 175.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.44 ' HB3' ' HD3' ' A' ' 88' ' ' PRO . 88.4 tttt -52.29 -55.13 34.42 Favored Pre-proline 0 CA--C 1.539 0.526 0 N-CA-C 112.38 0.511 . . . . 2.3700000000000001 112.38 -175.445 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.44 ' HD3' ' HB3' ' A' ' 87' ' ' LYS . 73.4 Cg_endo -74.59 -26.76 11.48 Favored 'Trans proline' 0 C--N 1.357 0.982 0 C-N-CA 121.656 1.57 . . . . 0.27000000000000002 111.976 -176.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.649 ' O ' HG23 ' A' ' 93' ' ' VAL . 32.1 t80 -68.31 -56.16 9.57 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.496 -0.774 . . . . 0.22 109.416 179.298 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.467 ' HG3' ' H ' ' A' ' 83' ' ' GLY . 4.2 tm-20 -65.38 -35.17 80.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.72 -0.673 . . . . 2.1200000000000001 109.721 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.59 ' HA ' ' NE ' ' A' ' 94' ' ' ARG . 23.0 t70 -53.79 -33.55 56.31 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.432 -0.804 . . . . 0.60999999999999999 110.978 175.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.551 ' O ' ' HG ' ' A' ' 96' ' ' LEU . . . -84.2 -37.74 21.46 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.408 -0.36 . . . . 0.22 111.132 178.571 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.649 HG23 ' O ' ' A' ' 89' ' ' PHE . 15.2 t -61.96 -44.17 98.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-O 121.447 0.641 . . . . 0.25 110.723 -177.189 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.59 ' NE ' ' HA ' ' A' ' 91' ' ' ASP . 26.4 ptt180 -74.14 -16.66 60.99 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.606 -0.725 . . . . 2.5899999999999999 110.607 178.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -93.68 12.96 23.67 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.982 -0.554 . . . . 0.46999999999999997 111.51 -174.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.556 ' HB2' ' HB2' ' A' ' 100' ' ' ASP . 0.7 OUTLIER -142.14 150.75 41.52 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.152 -0.476 . . . . 0.28000000000000003 110.432 175.396 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.571 ' HA ' ' NH2' ' A' ' 116' ' ' ARG . 23.1 tptm -91.87 164.74 13.56 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.285 -0.635 . . . . 1.6100000000000001 109.285 177.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.449 ' HA ' ' HG2' ' A' ' 116' ' ' ARG . 75.7 mt -41.83 115.94 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 123.458 0.474 . . . . 0.90000000000000002 111.38 172.138 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 101.99 -8.07 55.51 Favored Glycine 0 N--CA 1.45 -0.427 0 CA-C-N 115.701 -0.681 . . . . 0.46000000000000002 113.421 177.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.556 ' HB2' ' HB2' ' A' ' 96' ' ' LEU . 40.7 m-20 -99.06 141.22 32.09 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 117.16 0.48 . . . . 0.46000000000000002 110.979 -179.428 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 8.3 mt -106.73 148.67 10.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.016 -0.538 . . . . 0.23000000000000001 110.218 179.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 89.1 p -89.79 150.93 44.88 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 116.245 -0.434 . . . . 0.92000000000000004 110.671 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -69.88 164.61 34.01 Favored 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 122.379 2.053 . . . . 0.34000000000000002 111.041 171.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.872 HG23 HD23 ' A' ' 44' ' ' LEU . 24.9 mm -40.7 110.94 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 O-C-N 123.75 0.656 . . . . 0.20000000000000001 112.506 179.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.1 p -119.07 123.51 71.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.183 -0.462 . . . . 1.04 110.085 175.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -85.73 149.32 25.37 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.098 0.475 . . . . 0.55000000000000004 109.938 177.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 4.4 p -126.56 -172.03 2.54 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.768 -0.651 . . . . 0.37 110.936 -176.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -52.2 -44.36 64.68 Favored 'General case' 0 C--N 1.331 -0.238 0 O-C-N 123.508 0.505 . . . . 2.1600000000000001 110.993 177.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.506 ' O ' ' HB2' ' A' ' 20' ' ' SER . 4.4 m -92.35 -61.14 1.67 Allowed 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 120.05 -0.66 . . . . 1.0900000000000001 112.084 178.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -149.07 -128.35 1.68 Allowed Glycine 0 N--CA 1.438 -1.231 0 C-N-CA 118.749 -1.691 . . . . 0.23999999999999999 113.413 -170.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.967 ' HB3' HD22 ' A' ' 44' ' ' LEU . 8.9 mp -116.08 148.88 39.79 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.604 -0.298 . . . . 0.19 111.53 -170.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . 0.572 ' HA ' ' O ' ' A' ' 13' ' ' LEU . 69.3 m-70 -145.51 150.92 37.32 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.215 0.531 . . . . 0.22 112.023 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.617 HG12 HD11 ' A' ' 44' ' ' LEU . 5.2 pt -130.17 133.87 63.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 107.669 -1.234 . . . . 0.17000000000000001 107.669 159.659 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.442 HG21 HG22 ' A' ' 93' ' ' VAL . 2.8 mp -124.72 144.66 33.9 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 N-CA-C 110.07 -0.345 . . . . 0.17999999999999999 110.07 -176.197 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.447 ' HG2' ' HB3' ' A' ' 11' ' ' ALA . 46.0 pttt -130.42 138.12 50.17 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.932 -0.766 . . . . 0.60999999999999999 108.932 174.261 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . 0.571 ' NH2' ' HA ' ' A' ' 97' ' ' LYS . 3.6 ttp180 -82.62 135.47 35.05 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.474 -0.49 . . . . 1.8700000000000001 111.236 -177.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.527 HD21 ' HB2' ' A' ' 11' ' ' ALA . 0.3 OUTLIER -102.28 -30.65 10.96 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.69 -0.687 . . . . 0.89000000000000001 110.974 177.714 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.466 ' O ' ' HD2' ' A' ' 116' ' ' ARG . . . . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.649 -0.691 . . . . 1.1000000000000001 110.689 -178.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 69.3 mmtt . . . . . 0 CA--C 1.518 -0.271 0 CA-C-O 121.527 0.68 . . . . 1.1899999999999999 111.487 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.628 HD23 ' N ' ' A' ' 9' ' ' ARG . 3.2 tt -154.61 151.45 28.83 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.01 -1.107 . . . . 1.1799999999999999 108.01 -176.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.628 ' N ' HD23 ' A' ' 8' ' ' LEU . 65.1 ttt180 -135.05 131.64 37.27 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 108.722 -0.844 . . . . 1.0600000000000001 108.722 173.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -148.99 150.9 33.63 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 120.066 -0.653 . . . . 0.22 112.337 -175.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.406 ' HB3' ' HG2' ' A' ' 115' ' ' LYS . . . -104.42 133.39 49.38 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.318 -0.855 . . . . 0.20000000000000001 109.057 178.116 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 26.0 p-80 -135.88 154.66 51.08 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.105 0.479 . . . . 0.23000000000000001 111.714 -172.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.552 HD23 ' N ' ' A' ' 14' ' ' LEU . 5.8 tt -123.93 148.98 46.44 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.538 -0.912 . . . . 0.23999999999999999 108.538 177.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.562 ' HA ' ' O ' ' A' ' 111' ' ' LEU . 24.5 tp -131.21 135.75 47.67 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 110.346 -0.242 . . . . 0.27000000000000002 110.346 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.508 HG23 HD13 ' A' ' 44' ' ' LEU . 57.4 t -121.17 128.98 76.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 N-CA-C 109.619 -0.511 . . . . 0.14999999999999999 109.619 172.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.49 ' HE3' HD21 ' A' ' 14' ' ' LEU . 12.6 mmtp -103.57 148.48 25.94 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.996 -0.547 . . . . 0.62 109.777 178.115 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.49 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 53.6 p90 -143.75 162.62 35.54 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.144 -0.48 . . . . 0.25 110.685 -178.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.477 ' HB3' ' HA ' ' A' ' 33' ' ' ALA . 19.7 p -49.46 112.25 0.61 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.144 -0.48 . . . . 1.04 111.509 178.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 95.89 8.6 57.97 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.681 -0.771 . . . . 0.53000000000000003 113.56 178.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.407 ' C ' ' H ' ' A' ' 22' ' ' ASN . 77.3 p -91.11 43.3 1.14 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 117.59 0.695 . . . . 0.69999999999999996 111.002 -177.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 74.5 ttt180 73.45 -32.79 0.25 Allowed 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.4 0.68 . . . . 3.4900000000000002 111.418 177.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.407 ' H ' ' C ' ' A' ' 20' ' ' SER . 43.7 m-80 -135.55 100.74 11.16 Favored Pre-proline 0 C--N 1.324 -0.527 0 N-CA-C 109.209 -0.663 . . . . 1.77 109.209 175.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.546 ' C ' HG22 ' A' ' 32' ' ' THR . 92.7 Cg_endo -82.69 41.35 1.1 Allowed 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.372 2.048 . . . . 1.71 112.756 -175.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.443 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 89.5 t -141.54 116.88 5.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 108.626 -0.879 . . . . 0.47999999999999998 108.626 177.529 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.559 ' HB2' ' OD1' ' A' ' 67' ' ' ASP . 19.7 p -103.57 154.85 19.04 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 110.286 -0.265 . . . . 1.1200000000000001 110.286 -177.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.452 ' CG ' ' HA ' ' A' ' 67' ' ' ASP . 35.2 mmt180 -69.03 -22.97 64.02 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 108.661 -0.866 . . . . 2.54 108.661 173.352 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.465 ' HG3' ' HD2' ' A' ' 65' ' ' ARG . 5.3 tmm_? -70.74 -32.85 70.17 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 114.351 -1.295 . . . . 1.77 110.421 -179.209 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 75.4 p -100.04 -35.3 9.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.426 0.632 . . . . 0.67000000000000004 110.795 178.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 65.65 18.26 65.74 Favored Glycine 0 N--CA 1.453 -0.201 0 CA-C-N 114.877 -1.056 . . . . 0.81999999999999995 112.304 -178.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -141.95 -72.0 0.33 Allowed 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.769 -0.456 . . . . 2.1000000000000001 109.769 -179.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.443 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 6.2 p -155.2 148.74 25.2 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.885 -0.598 . . . . 1.0800000000000001 110.115 173.265 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.546 HG22 ' C ' ' A' ' 23' ' ' PRO . 14.5 t -113.42 22.69 13.94 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.939 0.876 . . . . 0.34000000000000002 109.217 178.01 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.477 ' HA ' ' HB3' ' A' ' 18' ' ' SER . . . -72.58 -6.49 44.44 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.904 -1.044 . . . . 0.37 111.719 -177.538 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -96.22 -24.0 16.45 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.108 0.48 . . . . 2.21 111.118 -178.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.489 HG23 ' HB2' ' A' ' 39' ' ' ASP . 0.2 OUTLIER -96.77 135.1 32.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.279 -0.419 . . . . 0.31 109.972 179.531 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 59.6 p -96.31 -179.34 4.61 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.348 -0.387 . . . . 0.39000000000000001 109.957 -175.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.41 ' O ' HG13 ' A' ' 41' ' ' ILE . 4.3 p90 -64.62 -27.22 68.79 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.967 -0.753 . . . . 1.53 108.967 175.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -74.13 -43.31 57.97 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 116.004 -0.544 . . . . 0.95999999999999996 110.412 178.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.489 ' HB2' HG23 ' A' ' 35' ' ' VAL . 19.4 m-20 -65.36 -33.63 76.41 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.523 0.677 . . . . 0.91000000000000003 109.934 175.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.49 ' HB2' ' HB3' ' A' ' 17' ' ' PHE . . . -70.79 -46.53 62.69 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.789 -1.096 . . . . 0.19 110.707 -179.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.41 HG13 ' O ' ' A' ' 37' ' ' TYR . 68.7 mt -63.18 -36.43 75.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 110.09 -0.337 . . . . 0.29999999999999999 110.09 176.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -64.3 -25.18 67.93 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.29 0.567 . . . . 2.3199999999999998 110.021 178.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.477 ' HG3' ' CD1' ' A' ' 47' ' ' TRP . 5.8 tp10 -84.87 -52.32 6.1 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.433 -0.803 . . . . 1.02 109.024 -178.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.909 HD22 ' HB3' ' A' ' 111' ' ' LEU . 30.9 tp -62.72 -37.57 87.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.045 -0.98 . . . . 0.17000000000000001 110.535 -175.008 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.45 ' O ' ' HB2' ' A' ' 49' ' ' GLN . 0.0 OUTLIER -67.18 -28.93 68.5 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 112.304 0.483 . . . . 0.87 112.304 -177.882 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -78.35 -43.39 27.81 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.636 -0.426 . . . . 1.3100000000000001 110.131 178.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.477 ' CD1' ' HG3' ' A' ' 43' ' ' GLU . 49.3 m95 -64.48 -47.14 80.09 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 111.974 0.361 . . . . 0.52000000000000002 111.974 176.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.507 ' HB3' HG21 ' A' ' 113' ' ' ILE . 88.7 p -63.99 -25.58 68.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.987 0.422 . . . . 0.81999999999999995 110.15 177.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.45 ' HB2' ' O ' ' A' ' 45' ' ' GLN . 14.2 tt0 -71.97 -56.13 6.22 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.994 -0.548 . . . . 0.53000000000000003 110.071 175.09 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.566 ' HB3' HG22 ' A' ' 56' ' ' VAL . 97.2 mtt180 -61.12 -41.93 97.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.935 -0.575 . . . . 0.41999999999999998 111.646 -176.443 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.478 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 93.9 mt -60.66 -36.82 73.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 120.976 0.417 . . . . 0.20000000000000001 110.458 177.224 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -77.99 -37.37 47.39 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.01 -0.541 . . . . 0.27000000000000002 111.426 -179.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 55.4 p -78.69 -29.19 45.39 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.843 0.354 . . . . 0.34999999999999998 111.488 -177.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 106.28 9.56 31.37 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.764 -0.732 . . . . 0.29999999999999999 112.318 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.453 ' HB2' ' HB3' ' A' ' 50' ' ' ARG . 45.4 mt-10 -67.47 -45.11 76.87 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.895 0.379 . . . . 0.65000000000000002 110.348 178.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.566 HG22 ' HB3' ' A' ' 50' ' ' ARG . 11.5 m -135.95 154.78 34.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 109.088 -0.708 . . . . 0.19 109.088 171.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.5 m -85.65 159.0 19.94 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.191 -0.67 . . . . 0.96999999999999997 109.191 177.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -53.94 -46.97 71.72 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.938 0.399 . . . . 0.22 109.972 -177.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.543 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 48.8 mt-10 -61.58 -26.44 67.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.533 -0.758 . . . . 1.72 112.46 -179.061 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 53.8 mm-40 -72.92 -50.91 20.78 Favored 'General case' 0 CA--C 1.519 -0.223 0 C-N-CA 120.516 -0.473 . . . . 2.0899999999999999 110.358 178.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -67.95 -47.34 68.92 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.185 -0.461 . . . . 0.26000000000000001 111.127 -177.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -57.39 -53.62 56.04 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.217 0.451 . . . . 0.23999999999999999 112.217 -174.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.52 ' HA ' ' O ' ' A' ' 71' ' ' TYR . 23.5 m -52.3 -18.15 1.45 Allowed 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 113.614 0.968 . . . . 1.0 113.614 -178.227 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -110.41 -43.89 3.81 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-O 121.577 0.703 . . . . 0.60999999999999999 110.309 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.465 ' HD2' ' HG3' ' A' ' 27' ' ' ARG . 15.5 mmt180 -96.34 -36.86 10.72 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 114.212 1.19 . . . . 0.85999999999999999 114.212 -170.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.476 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 52.6 p -63.37 116.0 5.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.263 0.554 . . . . 0.81999999999999995 110.362 -176.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.559 ' OD1' ' HB2' ' A' ' 25' ' ' SER . 57.3 m-20 -84.71 9.68 13.3 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.536 -0.756 . . . . 2.2799999999999998 111.123 -177.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 0.48 ' SG ' HD22 ' A' ' 14' ' ' LEU . 1.1 m -80.95 -177.33 6.36 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.666 -0.697 . . . . 1.52 110.294 170.361 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -76.09 -21.0 76.92 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.358 -0.925 . . . . 0.26000000000000001 111.699 175.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 71.2 p -65.84 0.46 1.77 Allowed 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 113.227 0.825 . . . . 0.32000000000000001 113.227 -178.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.52 ' O ' ' HA ' ' A' ' 63' ' ' SER . 27.7 p90 -62.94 -22.6 66.9 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 118.361 0.528 . . . . 0.54000000000000004 109.928 176.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -94.24 -2.94 51.58 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.382 0.61 . . . . 0.48999999999999999 110.087 177.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.6 m -115.49 1.01 13.54 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.296 -0.865 . . . . 0.70999999999999996 110.596 -175.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.543 ' O ' ' HA ' ' A' ' 59' ' ' GLU . . . 72.9 21.84 79.52 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.935 -0.65 . . . . 0.54000000000000004 111.998 -176.434 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 86.28 -20.58 21.04 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 121.026 -0.606 . . . . 0.34999999999999998 112.099 -177.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -69.93 132.04 45.34 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-N 115.553 -0.323 . . . . 1.6499999999999999 110.984 -176.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.511 ' O ' ' HG3' ' A' ' 9' ' ' ARG . 2.9 mp -118.17 161.82 19.24 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.248 0.547 . . . . 0.93999999999999995 110.283 174.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -85.71 -165.46 40.6 Favored Glycine 0 C--N 1.31 -0.913 0 CA-C-N 114.899 -1.046 . . . . 0.44 112.834 -178.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.627 ' HA ' ' O ' ' A' ' 8' ' ' LEU . 85.0 m-85 -73.91 142.97 45.94 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.271 0.558 . . . . 3.8700000000000001 112.221 -176.301 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.535 ' CE1' ' HB3' ' A' ' 8' ' ' LEU . 2.3 p90 -149.69 167.93 25.03 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.964 -1.016 . . . . 1.3100000000000001 108.787 176.336 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 37.3 m -96.63 122.46 39.57 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 108.478 -0.934 . . . . 1.1699999999999999 108.478 170.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 4.6 p -47.14 123.05 4.97 Favored 'General case' 0 C--N 1.329 -0.306 0 O-C-N 123.662 0.602 . . . . 1.1899999999999999 111.409 -179.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 114.49 17.78 6.91 Favored Glycine 0 N--CA 1.445 -0.766 0 N-CA-C 110.911 -0.875 . . . . 0.79000000000000004 110.911 -174.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -115.09 -17.02 11.54 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 120.587 0.232 . . . . 1.55 111.173 -178.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 26.4 mmt -86.22 -92.37 0.09 Allowed 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.315 -0.554 . . . . 0.72999999999999998 110.895 -173.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . 0.495 ' HB2' ' CB ' ' A' ' 89' ' ' PHE . 45.6 mtt -144.22 155.34 43.84 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 107.228 -1.397 . . . . 1.3899999999999999 107.228 177.06 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp -57.95 -53.54 64.72 Favored Pre-proline 0 C--N 1.317 -0.847 0 C-N-CA 120.274 -0.57 . . . . 2.3700000000000001 112.059 -176.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.509 ' HG2' HG22 ' A' ' 107' ' ' THR . 73.4 Cg_endo -74.81 -30.12 7.85 Favored 'Trans proline' 0 C--N 1.356 0.962 0 C-N-CA 121.736 1.624 . . . . 0.27000000000000002 111.855 -179.315 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.634 ' O ' HG23 ' A' ' 93' ' ' VAL . 11.2 t80 -61.97 -56.14 22.19 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.561 -0.745 . . . . 0.22 109.181 176.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.407 ' HB2' ' O ' ' A' ' 86' ' ' MET . 0.7 OUTLIER -62.15 -33.32 74.28 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.284 -0.871 . . . . 2.1200000000000001 110.5 -179.891 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -60.55 -32.58 71.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.676 -0.693 . . . . 0.60999999999999999 110.581 178.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.426 ' O ' ' HG ' ' A' ' 96' ' ' LEU . . . -83.86 -31.18 25.9 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.0 -0.545 . . . . 0.22 111.055 178.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.634 HG23 ' O ' ' A' ' 89' ' ' PHE . 20.2 t -68.8 -38.48 78.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.404 0.621 . . . . 0.25 109.781 -176.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.456 ' C ' ' HD2' ' A' ' 94' ' ' ARG . 2.8 ppt_? -79.44 -1.31 36.75 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.522 -0.763 . . . . 2.5899999999999999 110.61 178.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -103.6 9.94 37.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 0.46999999999999997 111.285 -177.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.567 ' HB2' ' HB2' ' A' ' 100' ' ' ASP . 1.0 OUTLIER -145.96 146.26 30.96 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.354 -0.385 . . . . 0.28000000000000003 110.965 179.51 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.401 ' HG3' ' N ' ' A' ' 98' ' ' ILE . 56.6 tptt -91.01 168.98 11.26 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.773 -0.825 . . . . 1.6100000000000001 108.773 177.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.453 ' HA ' ' HG2' ' A' ' 116' ' ' ARG . 72.0 mt -45.43 116.94 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.111 0.481 . . . . 0.90000000000000002 111.234 173.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 103.47 -11.8 54.3 Favored Glycine 0 N--CA 1.449 -0.438 0 CA-C-N 115.54 -0.755 . . . . 0.46000000000000002 113.115 178.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.567 ' HB2' ' HB2' ' A' ' 96' ' ' LEU . 14.6 m-20 -93.96 144.28 25.6 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 117.191 0.496 . . . . 0.46000000000000002 110.716 -179.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 10.0 mt -112.62 147.93 16.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.756 -0.656 . . . . 0.23000000000000001 109.67 -179.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 91.4 p -89.89 157.41 46.11 Favored Pre-proline 0 C--N 1.319 -0.733 0 CA-C-N 116.356 -0.384 . . . . 0.92000000000000004 110.365 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -74.23 173.82 13.53 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 122.267 1.978 . . . . 0.34000000000000002 111.132 171.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.893 HG23 HD23 ' A' ' 44' ' ' LEU . 21.9 mm -46.51 113.4 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-O 121.133 0.492 . . . . 0.20000000000000001 112.019 176.266 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 93.4 t -111.72 117.77 55.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.91 -0.586 . . . . 1.04 109.831 174.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -86.04 137.97 32.3 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.107 0.48 . . . . 0.55000000000000004 110.278 177.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.509 HG22 ' HG2' ' A' ' 88' ' ' PRO . 20.1 p -123.77 -172.23 2.49 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.664 -0.698 . . . . 0.37 110.21 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -66.67 -44.24 82.38 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.664 0.269 . . . . 2.1600000000000001 110.996 178.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 5.3 t -95.63 -1.41 50.3 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.302 0.482 . . . . 1.0900000000000001 112.302 -173.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 157.67 -124.68 1.44 Allowed Glycine 0 N--CA 1.437 -1.277 0 C-N-CA 119.775 -1.202 . . . . 0.23999999999999999 112.995 170.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.909 ' HB3' HD22 ' A' ' 44' ' ' LEU . 6.6 mp -127.9 145.66 50.88 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.112 -0.544 . . . . 0.19 110.807 -170.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . 0.547 ' NE2' HD13 ' A' ' 14' ' ' LEU . 80.8 m-70 -143.95 143.06 31.07 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.486 0.551 . . . . 0.22 112.486 -178.276 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.619 HG12 HD11 ' A' ' 44' ' ' LEU . 3.9 pt -127.07 141.55 45.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 107.884 -1.154 . . . . 0.17000000000000001 107.884 161.113 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 2.8 mp -132.35 148.47 31.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 C-N-CA 120.976 -0.29 . . . . 0.17999999999999999 110.396 -175.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.452 ' HE3' HD11 ' A' ' 117' ' ' LEU . 44.9 pttt -131.62 139.32 49.11 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.016 -0.735 . . . . 0.60999999999999999 109.016 172.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . 0.484 ' HD3' HD21 ' A' ' 8' ' ' LEU . 5.9 ttp180 -84.1 136.48 33.99 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.104 0.478 . . . . 1.8700000000000001 111.494 -178.507 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.452 HD11 ' HE3' ' A' ' 115' ' ' LYS . 1.4 mm? -107.09 -27.96 10.28 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.295 -0.866 . . . . 0.89000000000000001 110.743 177.216 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.505 ' HB3' ' HB3' ' A' ' 9' ' ' ARG . . . . . . . . 0 C--O 1.245 0.868 0 CA-C-O 118.291 -0.862 . . . . 1.1000000000000001 110.452 179.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt . . . . . 0 N--CA 1.45 -0.442 0 CA-C-O 121.859 0.838 . . . . 1.1899999999999999 111.532 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.816 HD21 ' HD3' ' A' ' 116' ' ' ARG . 2.4 tt -119.53 159.92 23.4 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 114.242 -1.345 . . . . 1.1799999999999999 107.883 179.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.694 ' H ' HD23 ' A' ' 8' ' ' LEU . 63.2 ttt180 -140.46 127.07 20.26 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 108.869 -0.789 . . . . 1.0600000000000001 108.869 175.759 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -141.09 154.1 45.76 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 120.31 -0.556 . . . . 0.22 112.231 -179.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.498 ' HA ' ' HA ' ' A' ' 76' ' ' ASP . . . -104.46 134.81 47.04 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.334 -0.848 . . . . 0.20000000000000001 108.922 174.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.515 ' HE1' HD13 ' A' ' 77' ' ' LEU . 16.7 p-80 -141.59 138.51 32.67 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.969 0.414 . . . . 0.23000000000000001 111.125 -171.031 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.532 ' O ' ' HA ' ' A' ' 112' ' ' HIS . 6.0 tt -109.43 137.31 47.48 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.326 -0.99 . . . . 0.23999999999999999 108.326 177.378 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.693 HD21 ' HE3' ' A' ' 16' ' ' LYS . 17.4 tp -120.23 135.03 55.12 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.615 -0.266 . . . . 0.27000000000000002 110.837 -176.515 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.549 HG23 HD13 ' A' ' 44' ' ' LEU . 83.4 t -121.89 133.62 67.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 109.854 -0.424 . . . . 0.14999999999999999 109.854 174.293 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.693 ' HE3' HD21 ' A' ' 14' ' ' LEU . 32.7 mmtp -104.76 149.75 25.35 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.917 -0.583 . . . . 0.62 110.495 177.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.561 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 49.9 p90 -145.4 163.04 35.85 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.702 -0.681 . . . . 0.25 109.674 179.456 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.489 ' HB3' ' HA ' ' A' ' 33' ' ' ALA . 29.9 p -51.67 109.35 0.35 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.923 0.392 . . . . 1.04 110.425 176.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 109.93 9.28 24.7 Favored Glycine 0 CA--C 1.523 0.585 0 C-N-CA 120.625 -0.798 . . . . 0.53000000000000003 112.795 -176.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.487 ' C ' ' H ' ' A' ' 22' ' ' ASN . 75.4 m -90.2 34.24 0.87 Allowed 'General case' 0 C--O 1.235 0.3 0 N-CA-C 112.359 0.503 . . . . 0.69999999999999996 112.359 -177.599 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.457 ' HB3' ' O ' ' A' ' 20' ' ' SER . 20.8 ttt85 72.94 -30.33 0.21 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 122.925 0.49 . . . . 3.4900000000000002 110.917 -179.686 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.487 ' H ' ' C ' ' A' ' 20' ' ' SER . 6.1 p30 -146.96 114.54 4.29 Favored Pre-proline 0 C--N 1.322 -0.618 0 N-CA-C 108.843 -0.799 . . . . 1.77 108.843 172.34 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.429 ' C ' HG22 ' A' ' 32' ' ' THR . 93.6 Cg_endo -86.21 52.5 2.91 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 122.573 2.182 . . . . 1.71 113.403 -173.009 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.415 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 61.0 t -142.53 119.78 6.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 109.342 -0.614 . . . . 0.47999999999999998 109.342 177.324 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.46 ' HB3' ' HB2' ' A' ' 16' ' ' LYS . 13.5 p -103.83 156.08 18.11 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 121.211 -0.196 . . . . 1.1200000000000001 110.886 -179.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.66 ' HB2' ' HA ' ' A' ' 67' ' ' ASP . 1.7 mpt_? -69.82 -16.99 63.37 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 109.155 -0.683 . . . . 2.54 109.155 173.443 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.515 ' HG2' ' HA ' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -82.42 -25.5 33.62 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.896 -1.047 . . . . 1.77 111.008 -178.629 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 73.3 p -105.33 -36.05 7.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.244 0.545 . . . . 0.67000000000000004 110.934 178.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 76.27 -21.63 2.24 Favored Glycine 0 CA--C 1.52 0.395 0 CA-C-N 115.308 -0.86 . . . . 0.81999999999999995 112.983 -179.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -101.76 -76.15 0.58 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.119 0.485 . . . . 2.1000000000000001 110.043 -179.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.415 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 21.4 m -154.75 151.47 28.73 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.804 -0.635 . . . . 1.0800000000000001 109.885 175.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.429 HG22 ' C ' ' A' ' 23' ' ' PRO . 12.4 t -113.8 23.0 13.46 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 122.181 0.991 . . . . 0.34000000000000002 109.145 177.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.489 ' HA ' ' HB3' ' A' ' 18' ' ' SER . . . -71.71 -5.6 35.07 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.715 -1.129 . . . . 0.37 111.401 -178.555 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -99.09 -15.24 19.07 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.602 -0.726 . . . . 2.21 110.688 -175.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -105.57 138.44 30.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.93 -0.577 . . . . 0.31 109.704 179.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 62.4 p -94.77 -179.48 4.87 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.395 -0.366 . . . . 0.39000000000000001 110.014 -175.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.519 ' O ' HG13 ' A' ' 41' ' ' ILE . 15.4 p90 -63.65 -28.35 69.85 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 119.986 -0.686 . . . . 1.53 109.223 176.302 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -75.11 -44.66 45.92 Favored 'General case' 0 CA--C 1.522 -0.132 0 CA-C-N 116.182 -0.463 . . . . 0.95999999999999996 110.682 178.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -62.87 -33.29 74.98 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.479 0.656 . . . . 0.91000000000000003 109.639 176.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.561 ' HB2' ' HB3' ' A' ' 17' ' ' PHE . . . -68.6 -44.64 73.91 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.944 -1.026 . . . . 0.19 110.671 178.269 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.519 HG13 ' O ' ' A' ' 37' ' ' TYR . 90.2 mt -63.28 -35.04 70.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 109.612 -0.514 . . . . 0.29999999999999999 109.612 175.023 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.42 ' HD2' ' HA ' ' A' ' 42' ' ' LYS . 23.5 mmmt -64.67 -21.29 66.7 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.072 -0.513 . . . . 2.3199999999999998 111.06 176.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.422 ' HG3' ' CD1' ' A' ' 47' ' ' TRP . 2.0 tp10 -88.57 -57.46 2.91 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.881 -0.6 . . . . 1.02 109.561 178.04 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.887 HD23 HG23 ' A' ' 104' ' ' ILE . 27.7 tp -58.8 -36.78 75.02 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.404 -0.816 . . . . 0.17000000000000001 111.469 -175.302 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.535 ' O ' ' HB2' ' A' ' 49' ' ' GLN . 4.8 mm-40 -66.45 -26.5 67.24 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 112.23 0.456 . . . . 0.87 112.23 -177.397 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.402 ' HE3' ' O ' ' A' ' 42' ' ' LYS . 96.7 mttt -78.88 -45.52 20.46 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.101 0.476 . . . . 1.3100000000000001 109.832 178.08 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.422 ' CD1' ' HG3' ' A' ' 43' ' ' GLU . 24.3 m95 -67.21 -43.52 81.85 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.799 -0.637 . . . . 0.52000000000000002 111.554 -178.095 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.553 ' HB3' HG21 ' A' ' 113' ' ' ILE . 97.2 p -67.18 -27.75 67.53 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 120.935 0.397 . . . . 0.81999999999999995 109.969 177.211 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.535 ' HB2' ' O ' ' A' ' 45' ' ' GLN . 8.9 tt0 -67.58 -52.94 32.61 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 115.933 -0.576 . . . . 0.53000000000000003 109.638 175.611 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.604 ' HB3' HG22 ' A' ' 56' ' ' VAL . 91.6 mtt180 -60.97 -42.35 98.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.705 -0.68 . . . . 0.41999999999999998 111.556 -178.51 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.441 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 78.4 mt -60.29 -40.74 84.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.94 0.4 . . . . 0.20000000000000001 110.744 177.354 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.4 -39.0 65.42 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.941 -0.572 . . . . 0.27000000000000002 111.979 179.035 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 74.7 p -79.75 -29.37 40.48 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 111.809 0.3 . . . . 0.34999999999999998 111.809 -175.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 109.11 4.27 31.18 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.599 -0.81 . . . . 0.29999999999999999 112.898 179.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.437 ' HB2' ' HB3' ' A' ' 50' ' ' ARG . 46.7 mt-10 -62.05 -47.01 86.59 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.089 0.471 . . . . 0.65000000000000002 110.084 177.443 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.604 HG22 ' HB3' ' A' ' 50' ' ' ARG . 10.2 m -134.9 159.0 41.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.821 -0.627 . . . . 0.19 109.378 171.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 19.7 m -92.98 161.96 14.25 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 109.562 -0.533 . . . . 0.96999999999999997 109.562 177.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -54.19 -48.19 71.26 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.728 0.299 . . . . 0.22 110.452 -175.557 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.452 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 43.6 mt-10 -56.4 -40.36 74.51 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.739 -0.664 . . . . 1.72 111.948 179.469 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -63.82 -50.25 69.67 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.0 0.429 . . . . 2.0899999999999999 110.738 -178.327 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -68.91 -46.5 68.14 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.877 -0.602 . . . . 0.26000000000000001 111.132 -177.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.427 ' O ' ' HB3' ' A' ' 66' ' ' SER . . . -60.12 -46.28 90.15 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.648 0.61 . . . . 0.23999999999999999 112.648 -173.304 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.492 ' HA ' ' HA ' ' A' ' 71' ' ' TYR . 20.4 m -57.75 -20.36 34.39 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.781 0.66 . . . . 1.0 112.781 -178.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -110.72 -46.58 3.35 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.521 0.677 . . . . 0.60999999999999999 110.726 -178.331 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.515 ' HA ' ' HG2' ' A' ' 27' ' ' ARG . 18.8 mmt180 -90.17 -37.65 14.03 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.963 -1.017 . . . . 0.85999999999999999 113.174 -170.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.448 ' O ' ' HB3' ' A' ' 71' ' ' TYR . 42.7 t -64.36 115.71 5.36 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.243 0.544 . . . . 0.81999999999999995 110.953 -177.57 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.66 ' HA ' ' HB2' ' A' ' 26' ' ' ARG . 44.5 m-20 -82.28 10.16 7.49 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.416 -0.811 . . . . 2.2799999999999998 111.024 179.589 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 0.477 ' O ' ' HD1' ' A' ' 71' ' ' TYR . 49.6 t -93.34 166.34 12.34 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.07 -0.513 . . . . 1.52 109.728 172.458 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -56.19 -26.83 50.94 Favored Glycine 0 CA--C 1.519 0.293 0 O-C-N 123.41 0.444 . . . . 0.26000000000000001 113.315 -177.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.529 ' HB2' ' CA ' ' A' ' 75' ' ' GLY . 2.6 p -61.83 -8.26 4.68 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 112.849 0.685 . . . . 0.32000000000000001 112.849 -179.565 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.492 ' HA ' ' HA ' ' A' ' 63' ' ' SER . 15.5 p90 -59.46 -29.73 68.01 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 108.979 -0.749 . . . . 0.54000000000000004 108.979 174.112 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -95.33 8.59 42.69 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.741 -0.663 . . . . 0.48999999999999999 111.045 179.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 5.0 m -125.29 -20.87 4.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.626 -0.261 . . . . 0.70999999999999996 111.435 -177.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.452 ' O ' ' HA ' ' A' ' 59' ' ' GLU . . . 109.42 15.95 11.74 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.624 -0.798 . . . . 0.54000000000000004 112.343 -177.602 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.529 ' CA ' ' HB2' ' A' ' 70' ' ' SER . . . 89.63 -12.99 65.33 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.75 -0.738 . . . . 0.34999999999999998 113.04 177.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.498 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 10.6 p-10 -106.35 144.56 32.86 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.507 0.67 . . . . 1.6499999999999999 111.372 -171.266 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.515 HD13 ' HE1' ' A' ' 12' ' ' HIS . 0.3 OUTLIER -105.74 174.48 5.86 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.756 -1.111 . . . . 0.93999999999999995 109.725 176.931 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -90.63 -143.75 11.34 Favored Glycine 0 C--N 1.315 -0.614 0 C-N-CA 121.019 -0.61 . . . . 0.44 112.232 -179.15 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -88.31 123.77 33.23 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.018 0.437 . . . . 3.8700000000000001 110.621 178.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.406 ' CE1' ' HB3' ' A' ' 8' ' ' LEU . 2.3 p90 -137.82 146.45 43.51 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.887 -0.597 . . . . 1.3100000000000001 110.351 -179.515 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 36.6 m -76.19 137.88 40.31 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 120.829 0.347 . . . . 1.1699999999999999 110.096 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 16.7 m -63.92 118.99 9.2 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.984 -0.553 . . . . 1.1899999999999999 111.332 -175.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 114.49 -5.34 23.06 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.986 -0.626 . . . . 0.79000000000000004 112.387 -178.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -104.24 59.96 0.72 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.255 0.55 . . . . 1.55 110.682 -179.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 23.0 mmt -144.03 -97.46 0.11 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.031 0.443 . . . . 0.72999999999999998 110.453 177.451 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 63.6 mtt -146.32 151.04 36.88 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.015 -1.106 . . . . 1.3899999999999999 108.015 173.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.428 ' HB3' ' HD3' ' A' ' 88' ' ' PRO . 23.1 tptm -52.98 -53.16 58.31 Favored Pre-proline 0 C--N 1.319 -0.738 0 N-CA-C 112.445 0.535 . . . . 2.3700000000000001 112.445 -176.231 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.46 ' HG2' HG22 ' A' ' 107' ' ' THR . 75.6 Cg_endo -77.77 -26.04 7.23 Favored 'Trans proline' 0 C--N 1.356 0.938 0 C-N-CA 121.734 1.623 . . . . 0.27000000000000002 112.587 -176.501 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.546 ' O ' HG23 ' A' ' 93' ' ' VAL . 43.6 t80 -73.26 -55.24 6.7 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.805 -0.634 . . . . 0.22 109.824 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.409 ' O ' ' HD3' ' A' ' 94' ' ' ARG . 4.8 tm-20 -64.27 -35.12 79.81 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.241 -0.891 . . . . 2.1200000000000001 110.022 -178.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.571 ' HA ' ' CZ ' ' A' ' 94' ' ' ARG . 15.6 t70 -50.16 -40.85 47.92 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.735 -0.666 . . . . 0.60999999999999999 110.795 175.107 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.587 ' O ' ' HG ' ' A' ' 96' ' ' LEU . . . -78.24 -30.74 48.84 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.098 -0.501 . . . . 0.22 111.184 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.546 HG23 ' O ' ' A' ' 89' ' ' PHE . 26.3 t -63.39 -47.74 90.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.676 -0.238 . . . . 0.25 111.244 -174.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.571 ' CZ ' ' HA ' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -83.75 -4.92 59.02 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.247 -0.581 . . . . 2.5899999999999999 110.582 -179.476 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.27 -20.68 40.4 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.057 0.456 . . . . 0.46999999999999997 110.906 -179.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.603 ' HB2' ' HB2' ' A' ' 100' ' ' ASP . 0.7 OUTLIER -121.02 147.37 45.59 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.969 -0.559 . . . . 0.28000000000000003 110.441 -179.909 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.401 ' HG3' ' N ' ' A' ' 98' ' ' ILE . 51.3 tptt -90.19 172.67 8.63 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.438 -0.578 . . . . 1.6100000000000001 109.438 -179.519 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.441 ' HA ' ' HG2' ' A' ' 116' ' ' ARG . 71.4 mt -48.26 113.67 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.934 0.397 . . . . 0.90000000000000002 111.377 176.233 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 101.78 -3.69 52.94 Favored Glycine 0 CA--C 1.522 0.481 0 C-N-CA 120.939 -0.648 . . . . 0.46000000000000002 113.913 178.225 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.603 ' HB2' ' HB2' ' A' ' 96' ' ' LEU . 26.1 m-20 -99.15 142.47 30.6 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 117.599 0.7 . . . . 0.46000000000000002 110.353 178.565 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 8.9 mt -109.69 152.32 11.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.428 -0.351 . . . . 0.23000000000000001 110.307 -178.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 4.7 p -101.35 148.34 35.04 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-O 121.007 0.432 . . . . 0.92000000000000004 111.555 -178.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -68.94 159.85 52.23 Favored 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.697 2.265 . . . . 0.34000000000000002 111.145 171.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.887 HG23 HD23 ' A' ' 44' ' ' LEU . 22.1 mm -39.26 112.19 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 O-C-N 123.823 0.702 . . . . 0.20000000000000001 112.557 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 1.9 p -116.37 128.1 73.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.813 -0.63 . . . . 1.04 110.128 175.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -90.53 138.37 31.61 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 121.247 0.546 . . . . 0.55000000000000004 110.15 178.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.46 HG22 ' HG2' ' A' ' 88' ' ' PRO . 11.5 p -116.35 -175.91 2.85 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.577 -0.738 . . . . 0.37 110.68 -177.316 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -57.99 -42.21 84.66 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 123.287 0.367 . . . . 2.1600000000000001 111.009 179.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.44 ' OG ' ' HE2' ' A' ' 16' ' ' LYS . 24.5 t -85.16 -61.38 1.78 Allowed 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 116.493 -0.321 . . . . 1.0900000000000001 110.56 179.394 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -154.39 -128.68 1.22 Allowed Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 119.399 -1.381 . . . . 0.23999999999999999 113.39 -174.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.856 ' HB3' HD22 ' A' ' 44' ' ' LEU . 5.8 mp -112.35 145.43 40.08 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 122.379 0.272 . . . . 0.19 111.676 -171.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . 0.596 ' NE2' HD13 ' A' ' 14' ' ' LEU . 76.5 m-70 -142.2 153.36 43.95 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 112.947 0.721 . . . . 0.22 112.947 178.001 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.574 HG12 HD11 ' A' ' 44' ' ' LEU . 4.3 pt -131.38 134.74 60.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 114.347 -1.297 . . . . 0.17000000000000001 107.684 159.67 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.413 HD13 ' HB3' ' A' ' 92' ' ' ALA . 1.5 mp -128.14 146.22 34.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 C-N-CA 120.734 -0.386 . . . . 0.17999999999999999 110.905 -176.126 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 37.2 pttt -129.5 141.06 51.08 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.346 -0.983 . . . . 0.60999999999999999 108.346 170.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . 0.816 ' HD3' HD21 ' A' ' 8' ' ' LEU . 4.7 ttp180 -82.22 134.9 35.32 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.255 -0.578 . . . . 1.8700000000000001 110.857 -179.189 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -103.07 -35.1 8.64 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.191 -0.913 . . . . 0.89000000000000001 110.286 -179.104 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.937 0 CA-C-O 118.555 -0.736 . . . . 1.1000000000000001 110.485 -179.607 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.486 ' HA ' ' O ' ' A' ' 80' ' ' PHE . 73.2 mmtt . . . . . 0 N--CA 1.449 -0.477 0 CA-C-O 121.748 0.785 . . . . 1.1899999999999999 110.415 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.657 ' HB3' ' CE1' ' A' ' 80' ' ' PHE . 2.8 tt -100.62 155.5 17.84 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 113.878 -1.51 . . . . 1.1799999999999999 108.489 -178.044 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.593 ' N ' HD23 ' A' ' 8' ' ' LEU . 71.8 ttt180 -132.65 127.97 36.03 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 108.674 -0.861 . . . . 1.0600000000000001 108.674 170.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -146.4 153.8 40.89 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.258 -0.577 . . . . 0.22 112.095 -175.131 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.417 ' HB3' ' HG2' ' A' ' 115' ' ' LYS . . . -106.16 136.66 45.47 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.382 -0.826 . . . . 0.20000000000000001 109.417 178.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 35.7 p-80 -137.15 149.48 47.32 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.917 0.389 . . . . 0.23000000000000001 111.321 -173.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.676 ' O ' ' HA ' ' A' ' 112' ' ' HIS . 5.2 tt -123.09 131.75 53.82 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.818 -0.808 . . . . 0.23999999999999999 108.818 179.293 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.6 HD13 ' NE2' ' A' ' 112' ' ' HIS . 25.6 tp -116.57 123.51 47.53 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.493 -0.321 . . . . 0.27000000000000002 110.767 -177.531 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.623 HG23 HD13 ' A' ' 44' ' ' LEU . 63.3 t -110.84 134.04 54.42 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 N-CA-C 109.349 -0.611 . . . . 0.14999999999999999 109.349 173.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.495 ' HE2' ' OG ' ' A' ' 109' ' ' SER . 30.4 mmtp -105.91 154.3 20.76 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.492 -0.558 . . . . 0.62 109.492 178.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.46 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 48.9 p90 -146.53 160.57 41.96 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.801 0.334 . . . . 0.25 110.954 -177.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.3 t -52.56 112.21 0.78 Allowed 'General case' 0 N--CA 1.435 -1.193 0 CA-C-N 115.997 -0.547 . . . . 1.04 111.323 178.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 100.46 2.86 55.52 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.605 -0.807 . . . . 0.53000000000000003 113.205 177.033 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.41 ' C ' ' H ' ' A' ' 22' ' ' ASN . 91.3 p -90.19 40.15 1.0 Allowed 'General case' 0 C--O 1.234 0.277 0 CA-C-N 117.62 0.71 . . . . 0.69999999999999996 111.086 -176.109 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.416 ' CZ ' ' HB2' ' A' ' 108' ' ' ASP . 96.3 mtt180 72.2 -32.85 0.25 Allowed 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.36 0.664 . . . . 3.4900000000000002 111.771 178.291 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.41 ' H ' ' C ' ' A' ' 20' ' ' SER . 52.5 m-80 -136.99 93.11 13.64 Favored Pre-proline 0 C--N 1.326 -0.453 0 N-CA-C 109.308 -0.627 . . . . 1.77 109.308 175.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.56 ' C ' HG22 ' A' ' 32' ' ' THR . 95.5 Cg_endo -83.69 51.72 3.57 Favored 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 122.546 2.164 . . . . 1.71 113.233 -174.51 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.498 ' N ' HG22 ' A' ' 32' ' ' THR . 61.2 t -144.89 118.56 2.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 109.323 -0.621 . . . . 0.47999999999999998 109.323 177.133 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 23.5 p -105.18 153.07 22.05 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 110.503 -0.184 . . . . 1.1200000000000001 110.503 178.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.585 ' HB2' ' HA ' ' A' ' 67' ' ' ASP . 7.4 mpt_? -66.2 -10.22 39.55 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.007 0.432 . . . . 2.54 110.565 173.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.586 ' HG3' ' CD ' ' A' ' 65' ' ' ARG . 17.6 ttp180 -75.59 -41.12 55.37 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.812 -0.631 . . . . 1.77 109.506 176.288 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 40.0 p -95.79 -35.41 11.53 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.234 -0.894 . . . . 0.67000000000000004 111.231 -175.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 78.03 -35.07 1.69 Allowed Glycine 0 CA--C 1.518 0.244 0 CA-C-N 115.341 -0.845 . . . . 0.81999999999999995 112.637 178.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -94.88 -69.39 0.75 Allowed 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 110.177 -0.305 . . . . 2.1000000000000001 110.177 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 10.1 p -154.83 150.46 27.52 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.094 0.474 . . . . 1.0800000000000001 111.043 176.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.56 HG22 ' C ' ' A' ' 23' ' ' PRO . 13.8 t -113.44 30.26 7.36 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 122.349 1.071 . . . . 0.34000000000000002 108.891 177.5 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.24 -3.47 49.32 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.475 -1.239 . . . . 0.37 112.031 -175.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -92.87 -24.61 18.41 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.482 0.658 . . . . 2.21 109.979 177.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -98.02 135.93 30.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.284 -0.871 . . . . 0.31 110.281 -179.458 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 34.0 p -96.19 -179.53 4.7 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.094 -0.503 . . . . 0.39000000000000001 109.769 -176.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.544 ' O ' HG13 ' A' ' 41' ' ' ILE . 0.1 OUTLIER -64.87 -23.63 67.29 Favored 'General case' 0 C--O 1.222 -0.348 0 C-N-CA 119.04 -1.064 . . . . 1.53 110.026 173.505 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.451 ' N ' ' HD1' ' A' ' 37' ' ' TYR . 34.4 mt-10 -70.89 -46.93 61.71 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.649 -0.5 . . . . 0.95999999999999996 109.649 176.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -70.76 -28.88 65.01 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.066 0.46 . . . . 0.91000000000000003 110.404 176.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.46 ' HB2' ' HB3' ' A' ' 17' ' ' PHE . . . -66.32 -45.65 79.56 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.728 -0.669 . . . . 0.19 109.825 175.157 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.544 HG13 ' O ' ' A' ' 37' ' ' TYR . 72.9 mt -64.98 -38.41 82.72 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.382 0 CA-C-N 116.064 -0.517 . . . . 0.29999999999999999 109.7 174.101 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.419 ' O ' ' HG3' ' A' ' 46' ' ' LYS . 3.6 ttpm? -64.78 -20.94 66.64 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.863 -0.608 . . . . 2.3199999999999998 110.233 179.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.427 ' HG3' ' CD1' ' A' ' 47' ' ' TRP . 1.7 tp10 -88.29 -56.85 3.15 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.305 -0.628 . . . . 1.02 109.305 176.569 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.733 HD22 ' HB3' ' A' ' 111' ' ' LEU . 19.5 tp -58.92 -35.9 73.83 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.03 -0.986 . . . . 0.17000000000000001 110.895 -174.479 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.461 ' HG2' HG13 ' A' ' 104' ' ' ILE . 4.6 mm-40 -64.42 -39.57 94.09 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-N 116.391 -0.368 . . . . 0.87 111.962 -178.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.448 ' O ' ' HG3' ' A' ' 50' ' ' ARG . 60.7 mttm -70.09 -43.77 70.43 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 110.122 -0.325 . . . . 1.3100000000000001 110.122 -178.576 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.443 ' NE1' ' HG3' ' A' ' 65' ' ' ARG . 64.6 m95 -65.79 -46.38 78.93 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.479 -0.328 . . . . 0.52000000000000002 111.454 175.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 36.5 t -57.96 -34.0 69.45 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.755 -0.461 . . . . 0.81999999999999995 109.755 176.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 -66.75 -56.84 8.71 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 115.907 -0.588 . . . . 0.53000000000000003 110.555 175.181 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.627 ' HB3' HG22 ' A' ' 56' ' ' VAL . 93.6 mtt180 -61.21 -42.12 98.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.676 -0.693 . . . . 0.41999999999999998 111.368 -175.634 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.44 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 98.2 mt -60.71 -39.43 81.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 120.96 0.409 . . . . 0.20000000000000001 110.506 176.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.26 -39.92 65.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.979 -0.555 . . . . 0.27000000000000002 111.663 -179.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 55.8 p -78.61 -30.5 46.56 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.931 0.396 . . . . 0.34999999999999998 111.547 -177.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 107.61 9.25 29.2 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.727 -0.749 . . . . 0.29999999999999999 112.057 -178.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.498 ' HB2' ' HB3' ' A' ' 50' ' ' ARG . 43.1 mt-10 -64.9 -44.26 90.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.115 0.483 . . . . 0.65000000000000002 110.102 177.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.627 HG22 ' HB3' ' A' ' 50' ' ' ARG . 22.3 m -138.16 153.69 27.2 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.451 0 CA-C-N 115.791 -0.64 . . . . 0.19 109.456 173.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.6 m -77.39 157.89 30.36 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 109.327 -0.62 . . . . 0.96999999999999997 109.327 175.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -54.76 -41.28 70.28 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.171 -0.678 . . . . 0.22 109.171 177.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.476 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 41.0 mt-10 -56.0 -46.6 78.7 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.785 -1.098 . . . . 1.72 112.197 178.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -60.91 -44.73 96.77 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 120.936 0.398 . . . . 2.0899999999999999 111.019 -176.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -71.72 -43.72 65.4 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.346 -0.388 . . . . 0.26000000000000001 111.001 -178.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.68 -53.05 60.38 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.185 0.439 . . . . 0.23999999999999999 112.185 -175.005 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.474 ' HA ' ' O ' ' A' ' 71' ' ' TYR . 71.9 m -51.76 -27.8 13.24 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 113.121 0.785 . . . . 1.0 113.121 -177.61 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -100.03 -44.67 5.93 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.603 0.716 . . . . 0.60999999999999999 110.616 -177.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.586 ' CD ' ' HG3' ' A' ' 27' ' ' ARG . 17.4 mmt180 -94.41 -43.48 8.35 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.873 -1.058 . . . . 0.85999999999999999 113.576 -170.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.573 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 19.3 p -62.73 127.65 32.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.145 0.497 . . . . 0.81999999999999995 111.557 -173.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.585 ' HA ' ' HB2' ' A' ' 26' ' ' ARG . 27.0 t70 -81.68 -11.08 59.21 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.421 -0.809 . . . . 2.2799999999999998 110.616 176.694 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 0.541 ' SG ' ' HB2' ' A' ' 66' ' ' SER . 5.1 p -75.77 150.19 37.82 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.017 -0.538 . . . . 1.52 110.12 179.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -54.88 -21.66 24.16 Favored Glycine 0 N--CA 1.452 -0.247 0 CA-C-N 114.665 -1.152 . . . . 0.26000000000000001 113.757 -172.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.449 ' HB2' ' CA ' ' A' ' 75' ' ' GLY . 1.5 p -67.99 -2.44 7.63 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 112.635 0.606 . . . . 0.32000000000000001 112.635 177.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.474 ' O ' ' HA ' ' A' ' 63' ' ' SER . 33.1 p90 -55.13 -24.27 25.24 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 118.038 0.381 . . . . 0.54000000000000004 110.421 174.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -87.65 -8.94 55.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.857 0.36 . . . . 0.48999999999999999 111.115 -178.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 16.0 m -126.18 14.95 7.84 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.367 -0.379 . . . . 0.70999999999999996 111.28 -177.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.476 ' O ' ' HA ' ' A' ' 59' ' ' GLU . . . 74.86 33.48 55.21 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.745 -0.74 . . . . 0.54000000000000004 113.133 178.445 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.449 ' CA ' ' HB2' ' A' ' 70' ' ' SER . . . 77.88 5.07 86.46 Favored Glycine 0 C--O 1.228 -0.236 0 C-N-CA 120.811 -0.709 . . . . 0.34999999999999998 112.867 176.385 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -92.21 141.17 28.86 Favored 'General case' 0 C--N 1.322 -0.629 0 O-C-N 122.844 -0.209 . . . . 1.6499999999999999 110.448 -172.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -120.38 169.87 9.89 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.322 0.582 . . . . 0.93999999999999995 110.582 176.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -89.04 -158.8 34.62 Favored Glycine 0 C--N 1.314 -0.691 0 CA-C-N 115.025 -0.989 . . . . 0.44 112.078 177.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.6 ' HA ' ' O ' ' A' ' 8' ' ' LEU . 96.7 m-85 -84.57 151.7 24.36 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.083 0.468 . . . . 3.8700000000000001 111.677 -178.495 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.657 ' CE1' ' HB3' ' A' ' 8' ' ' LEU . 2.5 p90 -157.87 160.36 37.59 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.492 -0.929 . . . . 1.3100000000000001 108.492 178.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 23.6 m -85.44 138.78 32.02 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 109.162 -0.681 . . . . 1.1699999999999999 109.162 177.067 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 14.7 m -59.71 112.24 1.74 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.159 0.504 . . . . 1.1899999999999999 110.811 -174.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 114.53 12.91 10.07 Favored Glycine 0 N--CA 1.446 -0.647 0 CA-C-N 115.47 -0.786 . . . . 0.79000000000000004 112.184 -174.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -117.02 57.8 0.78 Allowed 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 121.069 0.462 . . . . 1.55 110.377 177.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 22.5 mmt -146.42 -100.16 0.09 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.084 -0.507 . . . . 0.72999999999999998 110.512 178.048 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . 0.452 ' HB2' ' HB3' ' A' ' 89' ' ' PHE . 61.4 mtt -142.99 155.77 44.73 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 108.17 -1.048 . . . . 1.3899999999999999 108.17 175.228 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.431 ' HB3' ' HD3' ' A' ' 88' ' ' PRO . 63.9 tttp -55.06 -57.75 18.16 Favored Pre-proline 0 C--N 1.321 -0.653 0 N-CA-C 112.448 0.536 . . . . 2.3700000000000001 112.448 -177.082 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.435 ' HG2' HG22 ' A' ' 107' ' ' THR . 76.6 Cg_endo -75.35 -29.08 8.06 Favored 'Trans proline' 0 C--N 1.355 0.88 0 C-N-CA 121.643 1.562 . . . . 0.27000000000000002 111.908 -175.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.651 ' O ' HG23 ' A' ' 93' ' ' VAL . 38.5 t80 -68.12 -56.55 8.42 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.111 -0.949 . . . . 0.22 109.942 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -65.24 -34.51 78.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.661 -0.7 . . . . 2.1200000000000001 109.855 -178.067 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -55.33 -34.67 64.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.636 -0.711 . . . . 0.60999999999999999 110.755 175.289 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.42 ' O ' ' HG ' ' A' ' 96' ' ' LEU . . . -83.74 -26.65 29.54 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.136 -0.484 . . . . 0.22 110.951 179.05 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.651 HG23 ' O ' ' A' ' 89' ' ' PHE . 18.4 t -74.03 -38.17 48.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.157 0.503 . . . . 0.25 110.186 -178.14 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.503 ' C ' ' HD2' ' A' ' 94' ' ' ARG . 6.5 ppt_? -76.32 -12.0 60.0 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.085 -0.507 . . . . 2.5899999999999999 110.261 178.055 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.07 -4.5 59.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.846 -0.615 . . . . 0.46999999999999997 111.254 -176.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.655 ' HB2' ' HB2' ' A' ' 100' ' ' ASP . 1.2 pp -132.79 151.91 51.9 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.173 0.511 . . . . 0.28000000000000003 111.167 179.192 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.563 ' HG3' ' H ' ' A' ' 98' ' ' ILE . 19.4 tptm -102.62 -178.48 3.69 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.688 -0.856 . . . . 1.6100000000000001 108.688 176.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.563 ' H ' ' HG3' ' A' ' 97' ' ' LYS . 65.9 mt -54.3 118.36 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 120.853 0.359 . . . . 0.90000000000000002 111.025 179.28 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 95.61 10.23 56.91 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.728 -0.749 . . . . 0.46000000000000002 113.14 178.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.655 ' HB2' ' HB2' ' A' ' 96' ' ' LEU . 27.0 m-20 -111.41 146.81 36.51 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 117.441 0.621 . . . . 0.46000000000000002 110.271 177.285 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 15.8 mt -120.17 148.89 23.01 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-N 116.455 -0.339 . . . . 0.23000000000000001 110.432 -178.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 38.3 m -96.78 151.08 37.63 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 116.234 -0.439 . . . . 0.92000000000000004 111.206 179.026 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -74.17 176.94 8.9 Favored 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 122.583 2.189 . . . . 0.34000000000000002 111.432 172.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.669 HG23 HD23 ' A' ' 44' ' ' LEU . 22.5 mm -49.24 110.72 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 N-CA-C 112.775 0.657 . . . . 0.20000000000000001 112.775 -178.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 55.0 t -109.75 115.71 50.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.886 -0.597 . . . . 1.04 109.901 173.178 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 12.9 mt-30 -84.93 141.72 30.17 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.842 -0.429 . . . . 0.55000000000000004 109.842 177.396 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.435 HG22 ' HG2' ' A' ' 88' ' ' PRO . 16.6 p -123.55 -172.47 2.53 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.784 -0.644 . . . . 0.37 110.491 -179.684 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . 0.416 ' HB2' ' CZ ' ' A' ' 21' ' ' ARG . 6.9 p-10 -66.57 -35.53 80.44 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.617 0.246 . . . . 2.1600000000000001 111.253 -178.11 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.495 ' OG ' ' HE2' ' A' ' 16' ' ' LYS . 4.6 t -106.24 -9.73 16.73 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 120.287 -0.565 . . . . 1.0900000000000001 112.291 -174.359 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 172.18 -126.2 1.25 Allowed Glycine 0 N--CA 1.438 -1.177 0 C-N-CA 119.216 -1.469 . . . . 0.23999999999999999 112.967 173.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.733 ' HB3' HD22 ' A' ' 44' ' ' LEU . 6.0 mp -130.78 149.42 52.43 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 115.045 -0.578 . . . . 0.19 110.906 -171.488 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . 0.676 ' HA ' ' O ' ' A' ' 13' ' ' LEU . 82.0 m-70 -146.97 136.04 22.45 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.098 0.407 . . . . 0.22 112.098 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.619 HG12 HD11 ' A' ' 44' ' ' LEU . 2.1 pt -119.13 140.03 44.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 107.972 -1.121 . . . . 0.17000000000000001 107.972 160.362 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.435 HG21 HG22 ' A' ' 93' ' ' VAL . 2.5 mp -130.93 148.12 33.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 C-N-CA 120.923 -0.311 . . . . 0.17999999999999999 110.532 -175.141 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.417 ' HG2' ' HB3' ' A' ' 11' ' ' ALA . 54.3 pttt -134.61 144.25 47.79 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.113 -0.699 . . . . 0.60999999999999999 109.113 174.209 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . 0.541 ' HB2' ' CD1' ' A' ' 96' ' ' LEU . 67.4 ttt180 -91.0 132.57 35.91 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.196 0.522 . . . . 1.8700000000000001 111.583 -177.391 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.401 HD21 ' HB2' ' A' ' 11' ' ' ALA . 2.1 mm? -101.96 -35.53 8.94 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.116 -0.947 . . . . 0.89000000000000001 110.781 179.398 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.428 ' HB3' ' HB3' ' A' ' 9' ' ' ARG . . . . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.945 -0.55 . . . . 1.1000000000000001 109.841 179.191 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.402 ' HA ' ' O ' ' A' ' 80' ' ' PHE . 13.6 tptt . . . . . 0 N--CA 1.453 -0.316 0 CA-C-O 121.709 0.766 . . . . 1.1899999999999999 110.871 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.62 HD23 ' N ' ' A' ' 9' ' ' ARG . 2.4 tt -136.55 157.02 47.76 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 114.522 -1.217 . . . . 1.1799999999999999 108.176 -178.052 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.62 ' N ' HD23 ' A' ' 8' ' ' LEU . 77.2 ttt180 -140.82 127.72 20.55 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 107.907 -1.146 . . . . 1.0600000000000001 107.907 173.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -140.95 157.88 44.73 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 120.037 -0.665 . . . . 0.22 112.496 -176.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.58 ' HA ' ' HA ' ' A' ' 76' ' ' ASP . . . -109.81 136.46 49.09 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.195 -0.912 . . . . 0.20000000000000001 109.599 177.094 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 11.2 p-80 -136.77 139.65 41.98 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.79 -0.364 . . . . 0.23000000000000001 110.949 -172.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.608 ' O ' ' HA ' ' A' ' 112' ' ' HIS . 6.6 tt -111.42 142.37 43.77 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.161 -1.052 . . . . 0.23999999999999999 108.161 176.002 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.542 HD13 ' NE2' ' A' ' 112' ' ' HIS . 22.1 tp -128.95 133.54 47.86 Favored 'General case' 0 C--N 1.323 -0.575 0 O-C-N 123.043 0.214 . . . . 0.27000000000000002 110.441 -176.336 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.504 HG23 HD13 ' A' ' 44' ' ' LEU . 53.5 t -119.07 133.53 65.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 O-C-N 123.589 0.556 . . . . 0.14999999999999999 109.978 175.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.523 ' HE3' HD21 ' A' ' 14' ' ' LEU . 34.2 mmtp -103.65 158.31 16.46 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.802 -0.635 . . . . 0.62 109.727 176.349 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.487 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 42.1 p90 -158.51 161.27 37.35 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.118 -0.492 . . . . 0.25 109.693 -177.049 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.1 t -50.84 108.69 0.25 Allowed 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 110.005 -0.369 . . . . 1.04 110.005 173.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 109.68 9.85 24.17 Favored Glycine 0 N--CA 1.446 -0.7 0 C-N-CA 120.323 -0.942 . . . . 0.53000000000000003 112.975 -177.18 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.421 ' C ' ' H ' ' A' ' 22' ' ' ASN . 50.6 p -85.32 21.82 1.64 Allowed 'General case' 0 C--O 1.236 0.352 0 CA-C-N 117.938 0.869 . . . . 0.69999999999999996 111.726 -176.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.457 ' NH1' ' HB3' ' A' ' 108' ' ' ASP . 97.3 mtt180 72.6 -34.98 0.31 Allowed 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.786 0.835 . . . . 3.4900000000000002 110.833 -178.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.421 ' H ' ' C ' ' A' ' 20' ' ' SER . 7.0 p30 -146.66 104.71 3.96 Favored Pre-proline 0 C--N 1.32 -0.686 0 N-CA-C 108.578 -0.897 . . . . 1.77 108.578 168.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -66.03 -156.7 0.03 OUTLIER 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 123.674 2.916 . . . . 1.71 113.2 -178.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.546 ' N ' HG22 ' A' ' 32' ' ' THR . 47.6 t 64.99 112.97 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-N 115.494 -0.775 . . . . 0.47999999999999998 111.165 -175.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.406 ' HB2' ' OD1' ' A' ' 67' ' ' ASP . 19.1 p -103.36 152.18 21.87 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.352 -0.385 . . . . 1.1200000000000001 110.015 178.293 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.55 ' CG ' ' HA ' ' A' ' 67' ' ' ASP . 38.5 mmt180 -67.58 -20.38 65.37 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 108.727 -0.842 . . . . 2.54 108.727 173.193 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.496 ' HG2' ' HD3' ' A' ' 65' ' ' ARG . 4.8 tmm_? -71.73 -36.22 70.41 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 114.621 -1.172 . . . . 1.77 110.791 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 69.3 p -97.67 -35.76 10.47 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.522 0.677 . . . . 0.67000000000000004 110.421 178.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 73.35 -6.7 14.4 Favored Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 114.718 -1.128 . . . . 0.81999999999999995 112.655 -178.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -121.68 -72.29 0.69 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.757 0.313 . . . . 2.1000000000000001 110.357 -178.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.6 m -147.8 146.26 29.08 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-O 121.0 0.429 . . . . 1.0800000000000001 111.21 -178.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.546 HG22 ' N ' ' A' ' 24' ' ' VAL . 14.6 t -125.48 11.82 8.03 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.8 0.81 . . . . 0.34000000000000002 109.49 174.58 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -68.94 -4.34 16.25 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.241 -0.89 . . . . 0.37 112.289 179.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -96.55 -23.86 16.33 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.037 0.446 . . . . 2.21 110.694 177.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.509 HG23 ' HB2' ' A' ' 39' ' ' ASP . 0.4 OUTLIER -93.85 136.34 25.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 109.389 -0.597 . . . . 0.31 109.389 177.505 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 75.0 p -95.0 179.99 5.03 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.359 -0.382 . . . . 0.39000000000000001 110.081 -174.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.498 ' O ' HG13 ' A' ' 41' ' ' ILE . 11.3 p90 -63.42 -28.13 69.77 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.262 -0.644 . . . . 1.53 109.262 175.372 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -73.74 -44.77 55.34 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.905 -0.589 . . . . 0.95999999999999996 110.362 178.186 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.509 ' HB2' HG23 ' A' ' 35' ' ' VAL . 43.9 m-20 -65.81 -32.42 73.94 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.484 0.659 . . . . 0.91000000000000003 109.693 176.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.487 ' HB2' ' HB3' ' A' ' 17' ' ' PHE . . . -68.4 -43.88 76.27 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.976 -1.011 . . . . 0.19 110.416 178.254 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.498 HG13 ' O ' ' A' ' 37' ' ' TYR . 95.1 mt -62.6 -37.82 79.93 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.409 0 N-CA-C 109.667 -0.494 . . . . 0.29999999999999999 109.667 174.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 55.9 tttp -65.94 -23.11 66.54 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 121.381 0.61 . . . . 2.3199999999999998 109.997 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -87.84 -50.27 6.56 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.33 -0.85 . . . . 1.02 109.549 -179.082 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.903 HD22 ' HB3' ' A' ' 111' ' ' LEU . 35.4 tp -62.61 -38.08 88.78 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.588 -0.733 . . . . 0.17000000000000001 110.41 -178.05 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.494 ' HG2' HG13 ' A' ' 104' ' ' ILE . 5.0 mm-40 -61.09 -31.35 71.03 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 115.957 -0.565 . . . . 0.87 112.399 -179.595 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -80.24 -40.85 26.22 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.631 -0.428 . . . . 1.3100000000000001 110.606 -179.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.422 ' O ' HG13 ' A' ' 51' ' ' ILE . 57.5 m95 -66.66 -45.32 79.31 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.139 0.422 . . . . 0.52000000000000002 112.139 177.036 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.571 ' HB3' HG21 ' A' ' 113' ' ' ILE . 93.4 p -63.99 -30.5 71.57 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.758 -0.46 . . . . 0.81999999999999995 109.758 176.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.491 ' HB2' ' O ' ' A' ' 45' ' ' GLN . 15.1 tt0 -65.16 -53.34 46.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.503 -0.772 . . . . 0.53000000000000003 110.381 175.402 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.618 ' HB3' HG22 ' A' ' 56' ' ' VAL . 97.1 mtt180 -65.39 -41.48 93.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.996 -0.547 . . . . 0.41999999999999998 111.657 -177.07 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.484 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 84.6 mt -61.25 -33.93 58.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.09 0.471 . . . . 0.20000000000000001 110.691 176.629 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -77.81 -41.91 35.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 0.27000000000000002 111.205 179.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 52.9 p -76.13 -29.81 57.96 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.252 -0.431 . . . . 0.34999999999999998 111.569 -176.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 103.21 9.99 37.64 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.78 -0.724 . . . . 0.29999999999999999 112.234 -179.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.403 ' HB2' ' HB3' ' A' ' 50' ' ' ARG . 39.2 mt-10 -64.51 -43.58 93.64 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.583 -0.525 . . . . 0.65000000000000002 109.583 176.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.618 HG22 ' HB3' ' A' ' 50' ' ' ARG . 11.7 m -138.49 149.79 24.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 108.968 -0.753 . . . . 0.19 108.968 170.12 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 12.0 m -81.69 162.08 23.14 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 109.468 -0.567 . . . . 0.96999999999999997 109.468 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -55.01 -43.44 73.63 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.843 -0.429 . . . . 0.22 109.843 -178.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -58.04 -46.32 85.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.537 -0.756 . . . . 1.72 111.443 179.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 41.4 mm-40 -59.4 -48.36 81.94 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-O 121.119 0.485 . . . . 2.0899999999999999 110.822 -178.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -68.78 -49.96 54.27 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.924 -0.58 . . . . 0.26000000000000001 110.866 -179.052 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -58.45 -55.37 35.97 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.629 0.603 . . . . 0.23999999999999999 112.629 -173.229 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.482 ' HA ' ' HA ' ' A' ' 71' ' ' TYR . 28.4 t -52.27 -28.01 17.21 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.684 0.624 . . . . 1.0 112.684 -175.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -100.01 -46.74 5.24 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.528 0.68 . . . . 0.60999999999999999 110.426 -179.155 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.496 ' HD3' ' HG2' ' A' ' 27' ' ' ARG . 31.3 mmt180 -94.21 -36.91 11.81 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.758 -1.11 . . . . 0.85999999999999999 113.944 -168.603 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.577 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 24.7 p -67.89 123.72 21.37 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.642 -0.423 . . . . 0.81999999999999995 110.651 -178.065 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.55 ' HA ' ' CG ' ' A' ' 26' ' ' ARG . 25.1 m-20 -83.77 -5.93 59.31 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.826 -0.625 . . . . 2.2799999999999998 110.676 179.5 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 0.51 ' SG ' ' HB2' ' A' ' 66' ' ' SER . 6.4 p -78.86 156.73 28.54 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.494 -0.776 . . . . 1.52 110.215 175.413 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -54.83 -20.33 18.45 Favored Glycine 0 C--N 1.331 0.284 0 CA-C-N 114.959 -1.018 . . . . 0.26000000000000001 114.501 -171.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.528 ' HB2' ' CA ' ' A' ' 75' ' ' GLY . 1.3 p -70.08 -1.49 10.08 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.675 0.62 . . . . 0.32000000000000001 112.675 179.422 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.482 ' HA ' ' HA ' ' A' ' 63' ' ' SER . 41.6 p90 -56.55 -33.6 66.27 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 109.54 -0.541 . . . . 0.54000000000000004 109.54 173.671 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -95.29 8.32 43.48 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.021 -0.536 . . . . 0.48999999999999999 111.158 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 11.0 m -122.59 -20.16 6.08 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.698 0.285 . . . . 0.70999999999999996 111.605 -176.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 107.57 14.85 16.75 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.74 -0.743 . . . . 0.54000000000000004 112.226 -178.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.528 ' CA ' ' HB2' ' A' ' 70' ' ' SER . . . 92.99 -19.73 50.25 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.69 -0.767 . . . . 0.34999999999999998 112.904 178.449 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.58 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 7.6 p-10 -98.36 144.71 27.46 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.584 0.706 . . . . 1.6499999999999999 111.492 -171.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.412 ' HB3' ' HE2' ' A' ' 80' ' ' PHE . 0.9 OUTLIER -100.35 175.72 5.61 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.504 -1.225 . . . . 0.93999999999999995 109.341 174.65 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -85.43 -148.0 10.13 Favored Glycine 0 C--N 1.315 -0.634 0 C-N-CA 120.709 -0.758 . . . . 0.44 111.981 -179.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -91.85 139.44 30.66 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.931 0.396 . . . . 3.8700000000000001 110.16 178.36 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.412 ' HE2' ' HB3' ' A' ' 77' ' ' LEU . 1.5 p90 -152.14 174.03 14.22 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.992 -0.549 . . . . 1.3100000000000001 109.746 -177.606 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 13.9 p -95.57 135.4 37.28 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.333 0.587 . . . . 1.1699999999999999 110.942 179.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 13.2 m -63.83 128.11 34.35 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.483 -0.78 . . . . 1.1899999999999999 110.585 -178.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 103.25 0.82 47.64 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.659 -0.782 . . . . 0.79000000000000004 112.395 -179.399 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -117.76 62.84 0.75 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.222 0.534 . . . . 1.55 111.152 -179.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 21.0 mmt -139.49 -123.9 0.12 Allowed 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.066 -0.716 . . . . 0.72999999999999998 109.066 173.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . 0.414 ' HB2' ' CB ' ' A' ' 89' ' ' PHE . 19.9 mmt -110.68 151.54 27.59 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.263 -1.014 . . . . 1.3899999999999999 108.263 173.191 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.403 ' HB3' ' HD3' ' A' ' 88' ' ' PRO . 24.5 ttmm -55.55 -51.72 77.8 Favored Pre-proline 0 C--N 1.319 -0.754 0 N-CA-C 112.379 0.511 . . . . 2.3700000000000001 112.379 -174.108 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.403 ' HD3' ' HB3' ' A' ' 87' ' ' LYS . 86.2 Cg_endo -78.3 -22.9 9.27 Favored 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 121.474 1.449 . . . . 0.27000000000000002 111.72 -178.44 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.581 ' O ' HG23 ' A' ' 93' ' ' VAL . 33.1 t80 -70.89 -55.75 7.77 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.157 -0.929 . . . . 0.22 109.718 179.682 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -65.81 -34.83 79.08 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.606 -0.725 . . . . 2.1200000000000001 109.99 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.515 ' HA ' ' NE ' ' A' ' 94' ' ' ARG . 15.6 t70 -51.25 -35.83 39.06 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.492 -0.776 . . . . 0.60999999999999999 110.7 173.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.567 ' O ' ' HG ' ' A' ' 96' ' ' LEU . . . -82.44 -37.15 25.85 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.072 -0.513 . . . . 0.22 111.032 179.111 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.581 HG23 ' O ' ' A' ' 89' ' ' PHE . 15.2 t -62.75 -40.97 90.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-O 121.229 0.538 . . . . 0.25 110.597 -177.168 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.515 ' NE ' ' HA ' ' A' ' 91' ' ' ASP . 37.7 ptt180 -74.8 -15.41 60.75 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.822 -0.626 . . . . 2.5899999999999999 110.566 178.26 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -95.64 14.42 23.06 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.026 -0.533 . . . . 0.46999999999999997 111.169 -174.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.634 ' HB2' ' HB2' ' A' ' 100' ' ' ASP . 1.4 pp -149.74 152.71 35.71 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.83 -0.623 . . . . 0.28000000000000003 110.307 177.005 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.438 ' HG3' ' H ' ' A' ' 98' ' ' ILE . 21.7 tptm -102.22 175.63 5.46 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.132 -0.692 . . . . 1.6100000000000001 109.132 179.536 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.459 ' HA ' ' HG2' ' A' ' 116' ' ' ARG . 70.7 mt -46.24 114.56 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.196 0.522 . . . . 0.90000000000000002 111.579 176.049 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 102.1 -15.96 56.06 Favored Glycine 0 CA--C 1.522 0.48 0 CA-C-N 115.649 -0.705 . . . . 0.46000000000000002 113.562 178.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.634 ' HB2' ' HB2' ' A' ' 96' ' ' LEU . 53.9 m-20 -89.08 141.19 28.71 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 117.346 0.573 . . . . 0.46000000000000002 110.348 -177.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 8.9 mt -112.68 147.99 16.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.18 -0.464 . . . . 0.23000000000000001 110.462 -176.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 99.3 p -89.65 160.1 42.26 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 116.256 -0.429 . . . . 0.92000000000000004 110.643 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -74.23 176.36 9.7 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.324 2.016 . . . . 0.34000000000000002 111.196 171.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.882 HG23 HD23 ' A' ' 44' ' ' LEU . 23.9 mm -50.47 106.38 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 O-C-N 123.217 0.323 . . . . 0.20000000000000001 111.541 174.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.4 p -112.92 123.02 68.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 109.794 -0.447 . . . . 1.04 109.794 175.084 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -86.19 151.38 23.69 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.14 0.495 . . . . 0.55000000000000004 110.563 -179.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 6.8 p -126.78 -172.72 2.7 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.51 -0.768 . . . . 0.37 109.984 178.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . 0.457 ' HB3' ' NH1' ' A' ' 21' ' ' ARG . 36.3 m-20 -62.36 -46.73 87.35 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.746 0.307 . . . . 2.1600000000000001 110.501 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 22.5 t -80.07 -59.43 2.72 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.836 -0.346 . . . . 1.0900000000000001 110.796 -178.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -152.05 -130.4 1.6 Allowed Glycine 0 N--CA 1.443 -0.884 0 C-N-CA 119.075 -1.536 . . . . 0.23999999999999999 113.649 -175.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.903 ' HB3' HD22 ' A' ' 44' ' ' LEU . 6.1 mp -116.56 147.79 41.49 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.283 -0.459 . . . . 0.19 111.372 -170.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . 0.608 ' HA ' ' O ' ' A' ' 13' ' ' LEU . 82.0 m-70 -143.48 152.96 42.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.419 0.628 . . . . 0.22 112.484 179.454 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.59 HG12 HD11 ' A' ' 44' ' ' LEU . 3.6 pt -133.42 138.17 51.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 107.604 -1.258 . . . . 0.17000000000000001 107.604 159.579 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 2.8 mp -128.42 147.52 32.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 C-N-CA 120.768 -0.373 . . . . 0.17999999999999999 110.386 -175.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.448 ' HG2' ' HB3' ' A' ' 11' ' ' ALA . 33.4 pttt -132.11 144.63 50.85 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.664 -0.865 . . . . 0.60999999999999999 108.664 172.437 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . 0.537 ' HD3' HD21 ' A' ' 8' ' ' LEU . 5.5 ttp180 -82.79 135.03 35.09 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.302 0.572 . . . . 1.8700000000000001 110.902 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -101.83 -38.33 7.89 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.996 -1.002 . . . . 0.89000000000000001 109.768 -179.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.456 ' HB3' ' HB3' ' A' ' 9' ' ' ARG . . . . . . . . 0 C--O 1.249 1.036 0 CA-C-N 115.544 -0.753 . . . . 1.1000000000000001 109.735 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt . . . . . 0 N--CA 1.454 -0.248 0 CA-C-O 121.47 0.653 . . . . 1.1899999999999999 110.657 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.505 HD23 HG12 ' A' ' 93' ' ' VAL . 11.4 tp -103.73 175.34 5.51 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 114.665 -1.152 . . . . 1.1799999999999999 109.953 -174.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.494 ' HB3' ' HB3' ' A' ' 118' ' ' ALA . 53.8 ttt180 -146.08 132.49 19.65 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.567 -0.531 . . . . 1.0600000000000001 109.567 177.323 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.532 ' N ' ' HZ ' ' A' ' 80' ' ' PHE . . . -149.3 154.43 39.0 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.054 0.454 . . . . 0.22 111.69 -179.149 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.432 ' HB3' ' HG2' ' A' ' 115' ' ' LYS . . . -101.83 131.85 47.93 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.517 -0.765 . . . . 0.20000000000000001 108.95 175.413 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 29.6 p-80 -133.01 146.69 51.99 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.029 0.443 . . . . 0.23000000000000001 111.719 -172.011 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.555 HD23 ' N ' ' A' ' 14' ' ' LEU . 5.7 tt -117.46 144.65 44.81 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.478 -0.934 . . . . 0.23999999999999999 108.478 177.407 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.6 HD13 ' NE2' ' A' ' 112' ' ' HIS . 26.0 tp -131.03 119.91 22.69 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.64 0.257 . . . . 0.27000000000000002 110.675 -177.391 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.528 HG23 HD13 ' A' ' 44' ' ' LEU . 61.2 t -108.12 129.37 62.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 109.776 -0.453 . . . . 0.14999999999999999 109.776 176.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.477 ' HE3' HD21 ' A' ' 14' ' ' LEU . 31.5 mmtp -105.87 149.99 26.04 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.089 -0.505 . . . . 0.62 110.022 178.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.5 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 43.1 p90 -145.88 162.54 37.5 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.331 -0.395 . . . . 0.25 110.863 -176.451 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.481 ' HB3' ' HA ' ' A' ' 33' ' ' ALA . 34.9 p -51.87 113.18 0.93 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.037 -0.529 . . . . 1.04 111.129 177.272 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 95.5 8.58 58.41 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.587 -0.816 . . . . 0.53000000000000003 113.536 178.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.615 ' HB2' ' O ' ' A' ' 109' ' ' SER . 80.4 p -86.7 33.5 0.65 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 117.264 0.532 . . . . 0.69999999999999996 110.921 -177.557 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.432 ' HB3' ' O ' ' A' ' 20' ' ' SER . 66.8 ttt180 71.25 -34.82 0.31 Allowed 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.245 0.618 . . . . 3.4900000000000002 111.122 -176.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.459 ' H ' ' C ' ' A' ' 20' ' ' SER . 33.2 m-80 -133.63 91.77 25.04 Favored Pre-proline 0 C--N 1.327 -0.398 0 N-CA-C 109.245 -0.65 . . . . 1.77 109.245 176.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.509 ' C ' HG22 ' A' ' 32' ' ' THR . 72.7 Cg_endo -80.47 57.72 6.65 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 122.258 1.972 . . . . 1.71 112.774 -176.308 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.53 ' N ' HG22 ' A' ' 32' ' ' THR . 48.5 t -143.7 118.67 4.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 109.418 -0.586 . . . . 0.47999999999999998 109.418 178.074 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 40.2 t -104.85 150.34 24.92 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 110.037 -0.357 . . . . 1.1200000000000001 110.037 178.095 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.571 ' HG2' ' HA ' ' A' ' 67' ' ' ASP . 5.2 mmp_? -66.07 -8.35 22.9 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.727 0.299 . . . . 2.54 110.823 173.176 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.473 ' HD2' ' HD2' ' A' ' 65' ' ' ARG . 50.5 mtp180 -69.26 -50.68 44.77 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 121.555 0.693 . . . . 1.77 110.018 172.38 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 39.8 p -94.66 -33.62 12.9 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 115.154 -0.93 . . . . 0.67000000000000004 110.837 -172.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 80.31 -32.56 2.3 Favored Glycine 0 N--CA 1.451 -0.308 0 CA-C-N 115.813 -0.63 . . . . 0.81999999999999995 112.042 -178.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -92.56 -69.85 0.72 Allowed 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 122.576 0.35 . . . . 2.1000000000000001 110.717 -177.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.434 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 5.5 p -154.79 155.56 34.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.602 -0.272 . . . . 1.0800000000000001 110.922 177.207 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.53 HG22 ' N ' ' A' ' 24' ' ' VAL . 8.9 t -118.82 34.87 5.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 122.309 1.052 . . . . 0.34000000000000002 109.388 177.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.481 ' HA ' ' HB3' ' A' ' 18' ' ' SER . . . -76.58 -5.25 46.93 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.695 -1.139 . . . . 0.37 112.901 -173.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -94.8 -24.75 16.93 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.032 0.444 . . . . 2.21 110.848 -179.076 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.487 HG23 ' HB2' ' A' ' 39' ' ' ASP . 0.2 OUTLIER -95.72 135.89 28.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.941 -0.572 . . . . 0.31 109.816 179.87 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 67.0 p -96.34 178.42 5.37 Favored 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 109.952 -0.388 . . . . 0.39000000000000001 109.952 -175.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.454 ' O ' HG13 ' A' ' 41' ' ' ILE . 13.3 p90 -63.99 -27.89 69.44 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.224 -0.658 . . . . 1.53 109.224 176.467 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -70.73 -47.17 61.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.779 -0.646 . . . . 0.95999999999999996 110.204 177.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.487 ' HB2' HG23 ' A' ' 35' ' ' VAL . 47.1 m-20 -67.87 -29.59 68.75 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.401 0.62 . . . . 0.91000000000000003 109.752 178.233 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.5 ' HB2' ' HB3' ' A' ' 17' ' ' PHE . . . -70.35 -43.96 69.11 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.007 -0.997 . . . . 0.19 110.583 177.499 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.454 HG13 ' O ' ' A' ' 37' ' ' TYR . 80.0 mt -62.24 -37.35 78.34 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 N-CA-C 109.549 -0.537 . . . . 0.29999999999999999 109.549 173.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -62.19 -25.46 67.79 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.784 -0.644 . . . . 2.3199999999999998 110.174 177.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -84.82 -53.41 5.35 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.477 -0.783 . . . . 1.02 109.405 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.92 HD22 ' HB3' ' A' ' 111' ' ' LEU . 23.9 tp -62.01 -36.27 81.02 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.145 -0.934 . . . . 0.17000000000000001 110.587 -175.031 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.537 ' O ' ' HB2' ' A' ' 49' ' ' GLN . 0.0 OUTLIER -68.53 -24.71 64.67 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 112.348 0.499 . . . . 0.87 112.348 -177.909 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -80.43 -45.69 17.19 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.95 -0.389 . . . . 1.3100000000000001 109.95 178.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.436 ' NE1' ' HG3' ' A' ' 65' ' ' ARG . 52.9 m95 -65.69 -46.55 78.62 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.138 -0.483 . . . . 0.52000000000000002 111.207 177.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.522 ' HB3' HG21 ' A' ' 113' ' ' ILE . 92.2 p -64.01 -24.26 67.65 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.807 0.337 . . . . 0.81999999999999995 110.166 178.469 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.537 ' HB2' ' O ' ' A' ' 45' ' ' GLN . 10.9 tt0 -73.28 -56.67 4.76 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-N 116.11 -0.496 . . . . 0.53000000000000003 110.034 175.284 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.607 ' HB3' HG22 ' A' ' 56' ' ' VAL . 97.0 mtt180 -60.79 -42.4 97.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.473 -0.785 . . . . 0.41999999999999998 111.401 -177.041 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.448 HG22 HD13 ' A' ' 101' ' ' ILE . 98.0 mt -62.07 -40.17 86.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 120.823 0.344 . . . . 0.20000000000000001 110.613 177.648 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.39 -44.65 74.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.234 -0.439 . . . . 0.27000000000000002 111.373 -178.395 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 32.3 p -77.39 -31.02 53.95 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.842 0.354 . . . . 0.34999999999999998 111.38 -177.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 109.19 10.23 24.41 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.658 -0.782 . . . . 0.29999999999999999 112.548 179.353 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.463 ' HB2' ' HB3' ' A' ' 50' ' ' ARG . 45.5 mt-10 -60.17 -46.93 88.02 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.211 0.529 . . . . 0.65000000000000002 109.867 175.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.607 HG22 ' HB3' ' A' ' 50' ' ' ARG . 11.1 m -133.24 158.83 43.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.714 -0.676 . . . . 0.19 109.315 172.096 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 17.8 m -85.95 155.22 20.99 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 109.247 -0.649 . . . . 0.96999999999999997 109.247 178.31 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -52.39 -42.63 64.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.301 0.572 . . . . 0.22 109.783 -177.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.517 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 39.2 mt-10 -55.08 -41.73 71.9 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.811 -1.086 . . . . 1.72 112.044 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -65.94 -47.2 75.47 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-O 120.712 0.291 . . . . 2.0899999999999999 111.112 -174.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -69.48 -43.31 73.45 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.343 -0.39 . . . . 0.26000000000000001 110.784 -178.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.66 -51.3 69.97 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.105 -0.498 . . . . 0.23999999999999999 111.813 -176.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.561 ' HA ' ' O ' ' A' ' 71' ' ' TYR . 40.4 m -51.26 -27.44 9.21 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.939 0.718 . . . . 1.0 112.939 -177.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -98.55 -46.7 5.64 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.893 0.854 . . . . 0.60999999999999999 110.936 -179.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.473 ' HD2' ' HD2' ' A' ' 27' ' ' ARG . 37.4 mmt180 -94.97 -37.26 11.23 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 114.398 -1.274 . . . . 0.85999999999999999 113.713 -166.133 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.47 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 60.0 p -65.64 117.5 8.18 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.305 -0.558 . . . . 0.81999999999999995 110.065 -178.35 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.571 ' HA ' ' HG2' ' A' ' 26' ' ' ARG . 24.0 t70 -73.84 -15.82 61.15 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.345 0.593 . . . . 2.2799999999999998 111.089 179.33 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 46.2 t -77.37 160.84 28.49 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.307 0.575 . . . . 1.52 109.939 179.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -57.1 -18.0 25.55 Favored Glycine 0 C--N 1.328 0.134 0 CA-C-N 114.691 -1.14 . . . . 0.26000000000000001 114.425 -170.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.502 ' HB2' ' CA ' ' A' ' 75' ' ' GLY . 3.0 p -70.28 -0.11 7.42 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.861 0.689 . . . . 0.32000000000000001 112.861 179.198 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.561 ' O ' ' HA ' ' A' ' 63' ' ' SER . 39.2 p90 -60.29 -27.57 67.4 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 118.395 0.543 . . . . 0.54000000000000004 109.973 175.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -94.43 5.37 52.01 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.246 0.545 . . . . 0.48999999999999999 110.223 178.059 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.5 m -124.67 0.63 8.15 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.666 -0.697 . . . . 0.70999999999999996 111.005 -176.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.517 ' O ' ' HA ' ' A' ' 59' ' ' GLU . . . 75.2 29.62 60.1 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.724 -0.75 . . . . 0.54000000000000004 112.316 -177.388 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.502 ' CA ' ' HB2' ' A' ' 70' ' ' SER . . . 84.4 -3.59 85.98 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 121.01 -0.614 . . . . 0.34999999999999998 112.317 179.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -84.57 140.8 31.15 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.667 0.27 . . . . 1.6499999999999999 111.56 -169.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.449 HD12 ' HA ' ' A' ' 77' ' ' LEU . 0.5 OUTLIER -120.94 163.17 18.65 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.775 -0.648 . . . . 0.93999999999999995 110.493 172.118 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -79.01 -117.05 0.23 Allowed Glycine 0 C--N 1.31 -0.891 0 CA-C-N 114.964 -1.016 . . . . 0.44 113.44 -177.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 37.0 p90 -116.15 141.06 48.63 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.864 0.364 . . . . 3.8700000000000001 110.95 -176.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.532 ' HZ ' ' N ' ' A' ' 10' ' ' ALA . 3.5 p90 -158.23 129.56 6.56 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.084 -0.507 . . . . 1.3100000000000001 111.014 -178.482 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 82.2 p -74.31 155.33 38.32 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.308 -0.627 . . . . 1.1699999999999999 109.308 178.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 9.3 m -59.77 114.38 2.74 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.144 -0.48 . . . . 1.1899999999999999 110.346 -178.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 114.05 1.49 23.81 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.685 -0.769 . . . . 0.79000000000000004 112.509 -176.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -90.84 15.22 11.69 Favored 'General case' 0 C--N 1.33 -0.281 0 O-C-N 122.593 -0.357 . . . . 1.55 111.5 178.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 26.2 mmt -126.84 -126.99 0.23 Allowed 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 121.116 0.484 . . . . 0.72999999999999998 111.147 -176.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 54.7 mtt -123.19 149.26 44.87 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.09 -1.078 . . . . 1.3899999999999999 108.09 179.005 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 64.6 tttp -49.82 -54.98 26.61 Favored Pre-proline 0 CA--C 1.541 0.618 0 N-CA-C 112.52 0.563 . . . . 2.3700000000000001 112.52 -175.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.433 ' HG2' HG22 ' A' ' 107' ' ' THR . 82.8 Cg_endo -76.02 -22.47 13.06 Favored 'Trans proline' 0 C--N 1.356 0.965 0 C-N-CA 121.798 1.665 . . . . 0.27000000000000002 112.321 -176.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.644 ' O ' HG23 ' A' ' 93' ' ' VAL . 38.7 t80 -73.3 -56.22 5.37 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.402 -0.817 . . . . 0.22 109.504 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.407 ' OE2' ' HD3' ' A' ' 94' ' ' ARG . 1.5 tm-20 -63.87 -33.55 75.94 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.595 -0.729 . . . . 2.1200000000000001 109.77 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.592 ' HA ' ' NE ' ' A' ' 94' ' ' ARG . 18.7 t70 -52.47 -37.74 57.78 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.237 -0.892 . . . . 0.60999999999999999 111.104 175.093 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.576 ' O ' ' HG ' ' A' ' 96' ' ' LEU . . . -81.76 -36.55 28.4 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.428 -0.351 . . . . 0.22 110.895 178.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.644 HG23 ' O ' ' A' ' 89' ' ' PHE . 11.5 t -63.6 -41.25 91.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.267 0.556 . . . . 0.25 110.699 -177.207 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.592 ' NE ' ' HA ' ' A' ' 91' ' ' ASP . 30.7 ptt180 -76.57 -18.55 58.6 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.776 -0.647 . . . . 2.5899999999999999 110.52 178.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -82.95 -5.91 59.25 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.923 -0.58 . . . . 0.46999999999999997 111.441 -172.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.617 ' HB2' ' HB2' ' A' ' 100' ' ' ASP . 0.5 OUTLIER -133.45 160.51 37.19 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.18 0.514 . . . . 0.28000000000000003 111.244 -179.591 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.648 ' HG2' ' H ' ' A' ' 98' ' ' ILE . 33.6 tttp -102.33 178.42 4.6 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 115.656 -0.702 . . . . 1.6100000000000001 109.461 178.099 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.648 ' H ' ' HG2' ' A' ' 97' ' ' LYS . 8.2 mt -53.36 119.34 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.265 -0.425 . . . . 0.90000000000000002 111.138 178.346 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 102.1 -10.04 56.67 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.821 -0.704 . . . . 0.46000000000000002 113.057 178.065 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.617 ' HB2' ' HB2' ' A' ' 96' ' ' LEU . 61.5 m-20 -97.82 139.92 32.96 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 117.1 0.45 . . . . 0.46000000000000002 110.407 -177.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.478 HG12 ' HB3' ' A' ' 115' ' ' LYS . 9.5 mt -111.2 151.69 13.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.082 -0.508 . . . . 0.23000000000000001 110.499 -177.282 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.413 ' OG ' HD21 ' A' ' 96' ' ' LEU . 10.8 m -86.37 156.74 56.63 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 115.965 -0.561 . . . . 0.92000000000000004 110.887 -178.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -75.99 176.49 9.96 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 122.477 2.118 . . . . 0.34000000000000002 110.183 166.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.88 HG23 HD23 ' A' ' 44' ' ' LEU . 22.8 mm -52.05 108.45 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 CA-C-O 121.052 0.454 . . . . 0.20000000000000001 111.732 177.628 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 76.2 t -108.33 115.64 49.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.049 -0.523 . . . . 1.04 110.004 175.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -85.9 140.77 30.09 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 121.195 0.521 . . . . 0.55000000000000004 110.235 177.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.433 HG22 ' HG2' ' A' ' 88' ' ' PRO . 8.4 p -118.37 -172.2 2.22 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.488 -0.778 . . . . 0.37 110.817 -177.692 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -63.41 -37.58 87.84 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.545 0.212 . . . . 2.1600000000000001 111.027 179.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.615 ' O ' ' HB2' ' A' ' 20' ' ' SER . 8.4 t -92.9 -61.37 1.6 Allowed 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.786 -0.366 . . . . 1.0900000000000001 110.478 179.241 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -145.63 -130.68 2.22 Favored Glycine 0 N--CA 1.443 -0.892 0 C-N-CA 119.026 -1.559 . . . . 0.23999999999999999 113.795 -173.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.92 ' HB3' HD22 ' A' ' 44' ' ' LEU . 6.7 mp -118.54 146.35 44.63 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.289 -0.455 . . . . 0.19 111.139 -171.786 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . 0.6 ' NE2' HD13 ' A' ' 14' ' ' LEU . 80.6 m-70 -144.35 142.5 30.42 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.066 0.46 . . . . 0.22 112.061 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.715 HG12 HD11 ' A' ' 44' ' ' LEU . 3.4 pt -125.77 136.22 61.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 107.771 -1.196 . . . . 0.17000000000000001 107.771 159.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.427 HG21 HG22 ' A' ' 93' ' ' VAL . 3.1 mp -128.58 141.23 47.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 C-N-CA 120.891 -0.324 . . . . 0.17999999999999999 110.372 -176.317 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.478 ' HB3' HG12 ' A' ' 101' ' ' ILE . 38.8 pttt -124.69 139.05 54.21 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.927 -0.768 . . . . 0.60999999999999999 108.927 172.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 52.6 ttt180 -80.45 129.18 34.35 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.956 0.408 . . . . 1.8700000000000001 111.153 -176.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.46 ' HB2' ' HG2' ' A' ' 9' ' ' ARG . 3.5 mm? -100.99 -30.67 11.5 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.608 -0.724 . . . . 0.89000000000000001 110.575 -177.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.494 ' HB3' ' HB3' ' A' ' 9' ' ' ARG . . . . . . . . 0 C--O 1.248 0.992 0 CA-C-O 118.467 -0.777 . . . . 1.1000000000000001 110.012 178.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 40.6 mmtm . . . . . 0 N--CA 1.454 -0.272 0 CA-C-O 121.342 0.591 . . . . 1.1899999999999999 110.693 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 10.5 tp -120.21 172.61 7.66 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.182 -0.917 . . . . 1.1799999999999999 109.133 -179.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.424 ' HG2' ' HB2' ' A' ' 117' ' ' LEU . 69.0 ttt180 -147.63 127.38 13.43 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.385 -0.598 . . . . 1.0600000000000001 109.385 177.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.546 ' O ' ' HB2' ' A' ' 77' ' ' LEU . . . -146.76 150.15 34.77 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.265 -0.574 . . . . 0.22 112.181 -177.484 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.421 ' HB3' ' HG2' ' A' ' 115' ' ' LYS . . . -103.01 134.41 46.5 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.065 -0.717 . . . . 0.20000000000000001 109.065 176.052 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.456 ' CE1' HD11 ' A' ' 77' ' ' LEU . 37.2 p-80 -136.18 151.32 49.61 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.098 0.475 . . . . 0.23000000000000001 112.05 -172.058 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.551 HD23 ' N ' ' A' ' 14' ' ' LEU . 4.7 tt -119.34 144.5 46.82 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.49 -0.929 . . . . 0.23999999999999999 108.49 175.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.598 HD13 ' NE2' ' A' ' 112' ' ' HIS . 28.9 tp -131.65 123.91 28.81 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.531 0.205 . . . . 0.27000000000000002 111.033 -176.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.552 HG23 HD13 ' A' ' 44' ' ' LEU . 71.1 t -113.82 138.03 44.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 109.87 -0.419 . . . . 0.14999999999999999 109.87 176.052 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.529 ' HE3' HD21 ' A' ' 14' ' ' LEU . 34.0 mmtp -111.29 158.8 18.59 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.876 -0.416 . . . . 0.62 109.876 177.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.457 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 38.4 p90 -149.03 162.58 39.64 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.427 -0.351 . . . . 0.25 110.306 -175.542 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.487 ' HB3' ' HA ' ' A' ' 33' ' ' ALA . 35.5 p -52.18 109.61 0.4 Allowed 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 120.929 0.395 . . . . 1.04 110.55 176.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 101.93 9.08 43.69 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.484 -0.865 . . . . 0.53000000000000003 112.947 -179.085 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.482 ' C ' ' H ' ' A' ' 22' ' ' ASN . 80.9 p -84.08 34.26 0.5 Allowed 'General case' 0 C--O 1.232 0.18 0 CA-C-N 117.29 0.545 . . . . 0.69999999999999996 111.223 -178.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.43 ' HB2' ' O ' ' A' ' 20' ' ' SER . 89.9 mtt180 73.03 -28.61 0.19 Allowed 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.521 0.728 . . . . 3.4900000000000002 110.895 -177.17 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.482 ' H ' ' C ' ' A' ' 20' ' ' SER . 3.0 p30 -150.07 104.39 3.17 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 115.919 -0.582 . . . . 1.77 110.175 172.425 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.427 ' C ' HG22 ' A' ' 32' ' ' THR . 6.8 Cg_exo -75.3 57.95 4.92 Favored 'Trans proline' 0 CA--C 1.532 0.403 0 C-N-CA 123.448 2.766 . . . . 1.71 113.368 -178.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.428 ' N ' HG22 ' A' ' 32' ' ' THR . 40.3 t -148.48 110.81 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 109.867 -0.42 . . . . 0.47999999999999998 109.867 176.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.471 ' HB3' ' HB2' ' A' ' 16' ' ' LYS . 17.1 p -104.41 154.57 19.69 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.831 -0.168 . . . . 1.1200000000000001 110.689 177.094 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.684 ' HB2' ' HA ' ' A' ' 67' ' ' ASP . 1.2 mpt_? -62.2 -13.6 29.32 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.031 0.443 . . . . 2.54 110.503 171.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.516 ' HG2' ' HA ' ' A' ' 65' ' ' ARG . 0.4 OUTLIER -80.59 -21.67 41.39 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.81 -0.632 . . . . 1.77 110.346 -179.689 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 36.3 p -115.35 -34.89 4.8 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.999 -0.546 . . . . 0.67000000000000004 110.79 -177.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 76.53 -33.11 1.38 Allowed Glycine 0 CA--C 1.517 0.207 0 CA-C-N 115.252 -0.886 . . . . 0.81999999999999995 113.065 176.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -99.59 -69.13 0.78 Allowed 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 110.124 -0.324 . . . . 2.1000000000000001 110.124 -178.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 42.9 m -154.57 152.76 30.42 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.095 -0.502 . . . . 1.0800000000000001 110.495 175.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.428 HG22 ' N ' ' A' ' 24' ' ' VAL . 10.5 t -119.4 30.88 6.87 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 122.17 0.986 . . . . 0.34000000000000002 108.903 175.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.487 ' HA ' ' HB3' ' A' ' 18' ' ' SER . . . -79.96 -5.39 55.57 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 114.898 -1.046 . . . . 0.37 111.364 -177.516 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -88.46 -25.68 22.49 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.413 0.625 . . . . 2.21 110.244 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.428 HG23 ' HB2' ' A' ' 39' ' ' ASP . 0.2 OUTLIER -100.14 137.48 27.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.442 -0.799 . . . . 0.31 109.895 -178.434 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 59.6 p -94.88 178.35 5.6 Favored 'General case' 0 CA--C 1.512 -0.487 0 N-CA-C 109.708 -0.478 . . . . 0.39000000000000001 109.708 -176.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.464 ' O ' HG13 ' A' ' 41' ' ' ILE . 10.1 p90 -63.11 -29.23 70.63 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.009 -0.676 . . . . 1.53 109.561 177.436 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -72.96 -44.13 61.48 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.058 -0.519 . . . . 0.95999999999999996 110.539 178.121 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.428 ' HB2' HG23 ' A' ' 35' ' ' VAL . 39.7 m-20 -69.72 -27.12 64.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.299 0.571 . . . . 0.91000000000000003 109.89 177.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.457 ' HB2' ' HB3' ' A' ' 17' ' ' PHE . . . -73.37 -45.75 53.08 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.303 -0.862 . . . . 0.19 110.683 176.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.493 ' CG1' HD21 ' A' ' 111' ' ' LEU . 80.5 mt -61.81 -36.39 73.43 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.369 0 N-CA-C 109.619 -0.512 . . . . 0.29999999999999999 109.619 175.246 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -57.78 -32.05 67.15 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 115.561 -0.745 . . . . 2.3199999999999998 110.468 176.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -87.37 -46.18 9.88 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.605 -0.725 . . . . 1.02 109.904 -175.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.895 HD22 ' HB3' ' A' ' 111' ' ' LEU . 34.6 tp -62.16 -37.41 85.11 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.019 -0.537 . . . . 0.17000000000000001 110.123 -178.551 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.519 ' O ' ' HB2' ' A' ' 49' ' ' GLN . 0.0 OUTLIER -64.72 -30.93 71.95 Favored 'General case' 0 C--O 1.225 -0.211 0 CA-C-N 116.271 -0.422 . . . . 0.87 111.779 179.581 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 59.4 mttm -72.08 -44.3 63.49 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.119 0.485 . . . . 1.3100000000000001 110.503 179.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 25.5 m95 -71.54 -43.34 66.59 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.088 -0.506 . . . . 0.52000000000000002 111.414 -179.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.474 ' HB3' HG21 ' A' ' 113' ' ' ILE . 93.6 p -65.04 -22.95 67.06 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.903 -0.406 . . . . 0.81999999999999995 109.903 175.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.519 ' HB2' ' O ' ' A' ' 45' ' ' GLN . 14.7 tt0 -71.55 -54.31 10.91 Favored 'General case' 0 C--O 1.224 -0.252 0 CA-C-N 116.047 -0.524 . . . . 0.53000000000000003 109.764 174.574 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.639 ' HB3' HG22 ' A' ' 56' ' ' VAL . 89.1 mtt180 -62.37 -41.69 98.83 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.903 -0.589 . . . . 0.41999999999999998 111.788 -177.59 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.44 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 82.1 mt -59.92 -40.01 81.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 120.998 0.427 . . . . 0.20000000000000001 110.425 176.49 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.9 -41.26 64.79 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.012 -0.54 . . . . 0.27000000000000002 111.523 179.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 66.5 p -76.13 -29.43 57.81 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.829 0.347 . . . . 0.34999999999999998 111.505 -176.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 107.06 4.49 35.76 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.615 -0.802 . . . . 0.29999999999999999 112.271 178.349 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.488 ' OE1' ' HG2' ' A' ' 50' ' ' ARG . 46.3 mt-10 -61.05 -49.69 76.36 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.134 0.492 . . . . 0.65000000000000002 110.176 178.221 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.639 HG22 ' HB3' ' A' ' 50' ' ' ARG . 15.8 m -131.49 154.62 40.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.695 -0.684 . . . . 0.19 109.268 173.193 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 22.8 p -85.41 165.76 16.94 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 109.554 -0.536 . . . . 0.96999999999999997 109.554 177.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -57.38 -41.9 81.11 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.978 -0.378 . . . . 0.22 109.978 -177.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.584 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 42.0 mt-10 -59.23 -46.56 88.15 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.76 -0.654 . . . . 1.72 111.623 -179.179 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -60.53 -44.61 95.87 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-O 120.92 0.391 . . . . 2.0899999999999999 111.0 -178.018 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -70.76 -49.57 45.29 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.246 -0.434 . . . . 0.26000000000000001 111.084 -178.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.41 -51.86 68.08 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.332 0.493 . . . . 0.23999999999999999 112.332 -174.424 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.491 ' HA ' ' O ' ' A' ' 71' ' ' TYR . 52.8 m -51.12 -24.09 3.75 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 113.041 0.756 . . . . 1.0 113.041 -178.083 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -104.18 -44.94 4.85 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.493 0.663 . . . . 0.60999999999999999 110.494 -179.018 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.516 ' HA ' ' HG2' ' A' ' 27' ' ' ARG . 16.3 mmt180 -90.81 -42.73 10.49 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 113.848 1.055 . . . . 0.85999999999999999 113.848 -170.353 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.444 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 72.7 p -64.3 124.89 22.9 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.044 0.449 . . . . 0.81999999999999995 111.28 -175.305 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.684 ' HA ' ' HB2' ' A' ' 26' ' ' ARG . 25.7 t70 -76.6 -16.05 59.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.543 -0.753 . . . . 2.2799999999999998 111.475 178.204 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 52.6 t -78.05 155.79 30.44 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.201 0.524 . . . . 1.52 110.15 -179.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -57.12 -18.1 26.1 Favored Glycine 0 N--CA 1.454 -0.138 0 CA-C-N 114.631 -1.168 . . . . 0.26000000000000001 113.638 -173.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 63.0 p -64.77 -7.7 12.04 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 112.035 0.383 . . . . 0.32000000000000001 112.035 176.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.491 ' O ' ' HA ' ' A' ' 63' ' ' SER . 25.2 p90 -57.88 -22.92 50.69 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.868 0.366 . . . . 0.54000000000000004 110.297 175.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -90.77 -0.23 57.64 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.06 0.457 . . . . 0.48999999999999999 110.674 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 16.3 m -126.34 14.38 7.72 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.888 -0.596 . . . . 0.70999999999999996 110.577 178.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.584 ' O ' ' HA ' ' A' ' 59' ' ' GLU . . . 70.75 27.33 72.56 Favored Glycine 0 CA--C 1.519 0.325 0 C-N-CA 120.839 -0.696 . . . . 0.54000000000000004 112.718 -178.708 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 82.3 -17.85 16.69 Favored Glycine 0 N--CA 1.454 -0.167 0 C-N-CA 121.034 -0.603 . . . . 0.34999999999999998 112.473 179.161 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -70.96 135.16 47.73 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-O 120.883 0.373 . . . . 1.6499999999999999 110.594 -176.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.546 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 19.2 mt -111.36 158.43 19.07 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.933 -0.576 . . . . 0.93999999999999995 110.291 176.408 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -81.84 -137.37 2.4 Favored Glycine 0 C--N 1.317 -0.507 0 CA-C-N 115.673 -0.694 . . . . 0.44 112.625 179.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 38.1 p90 -98.43 135.57 39.82 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.189 0.519 . . . . 3.8700000000000001 110.626 -177.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.43 ' HZ ' ' N ' ' A' ' 10' ' ' ALA . 2.0 p90 -151.5 164.6 36.44 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.921 -0.581 . . . . 1.3100000000000001 110.21 -178.572 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 13.2 m -89.54 120.42 30.83 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 109.788 -0.449 . . . . 1.1699999999999999 109.788 178.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.5 p -55.36 118.85 4.79 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.932 -0.576 . . . . 1.1899999999999999 110.909 178.468 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 114.43 5.92 20.47 Favored Glycine 0 N--CA 1.447 -0.572 0 N-CA-C 111.538 -0.625 . . . . 0.79000000000000004 111.538 -176.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -105.04 -6.19 20.22 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.83 0.347 . . . . 1.55 110.803 -177.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 26.0 mmt -86.14 -97.48 0.07 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.252 0.549 . . . . 0.72999999999999998 110.873 -175.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 55.9 mtt -145.16 150.96 37.68 Favored 'General case' 0 CA--C 1.507 -0.694 0 N-CA-C 107.187 -1.412 . . . . 1.3899999999999999 107.187 176.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -55.85 -52.63 70.76 Favored Pre-proline 0 C--N 1.318 -0.797 0 CA-C-N 118.188 0.449 . . . . 2.3700000000000001 112.115 -174.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -74.03 -31.34 8.04 Favored 'Trans proline' 0 C--N 1.358 1.033 0 C-N-CA 121.466 1.444 . . . . 0.27000000000000002 111.891 -177.214 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.626 ' O ' HG23 ' A' ' 93' ' ' VAL . 29.7 t80 -65.74 -55.73 15.78 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.62 -0.718 . . . . 0.22 109.481 177.018 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -64.52 -34.6 78.6 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.338 -0.846 . . . . 2.1200000000000001 110.461 -177.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -56.99 -36.54 70.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.824 -0.625 . . . . 0.60999999999999999 110.516 175.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.436 ' O ' ' HG ' ' A' ' 96' ' ' LEU . . . -78.97 -28.26 43.54 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.192 -0.458 . . . . 0.22 110.981 178.356 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.626 HG23 ' O ' ' A' ' 89' ' ' PHE . 17.2 t -71.42 -36.48 61.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 121.267 0.556 . . . . 0.25 110.14 -177.55 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.511 ' C ' ' HD2' ' A' ' 94' ' ' ARG . 6.1 ppt_? -82.66 -9.23 59.47 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.918 -0.583 . . . . 2.5899999999999999 110.446 179.008 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.35 -2.66 58.78 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.989 -0.551 . . . . 0.46999999999999997 110.955 -177.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.567 ' HB2' ' HB2' ' A' ' 100' ' ' ASP . 0.7 OUTLIER -135.87 152.9 51.5 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.896 -0.593 . . . . 0.28000000000000003 110.442 178.906 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.607 ' HG2' ' H ' ' A' ' 98' ' ' ILE . 47.0 tttt -102.88 -174.13 2.48 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.634 -0.506 . . . . 1.6100000000000001 109.634 176.64 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.607 ' H ' ' HG2' ' A' ' 97' ' ' LYS . 10.4 mt -57.54 116.08 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 121.061 0.458 . . . . 0.90000000000000002 111.692 -176.387 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 98.23 3.83 57.62 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.813 -0.708 . . . . 0.46000000000000002 113.239 179.326 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.567 ' HB2' ' HB2' ' A' ' 96' ' ' LEU . 7.7 m-20 -104.67 141.76 35.87 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 117.196 0.498 . . . . 0.46000000000000002 110.811 178.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 8.3 mt -111.84 146.58 16.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.774 -0.648 . . . . 0.23000000000000001 109.737 -178.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 88.1 p -93.35 155.46 40.9 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 116.374 -0.376 . . . . 0.92000000000000004 110.292 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -74.23 175.54 10.81 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 122.125 1.883 . . . . 0.34000000000000002 111.131 171.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.851 HG23 HD23 ' A' ' 44' ' ' LEU . 20.3 mm -48.99 108.48 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 O-C-N 123.459 0.474 . . . . 0.20000000000000001 112.144 177.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.4 p -115.84 120.08 63.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 120.91 0.386 . . . . 1.04 110.125 175.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -85.42 152.45 23.21 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.141 0.496 . . . . 0.55000000000000004 110.964 -179.16 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 4.3 p -126.27 -172.51 2.64 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.434 -0.803 . . . . 0.37 110.237 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -60.78 -38.46 85.4 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.83 0.348 . . . . 2.1600000000000001 110.642 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.47 ' O ' ' HB2' ' A' ' 20' ' ' SER . 16.2 t -90.95 -60.63 1.86 Allowed 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 120.867 -0.333 . . . . 1.0900000000000001 110.694 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -150.55 -130.85 1.79 Allowed Glycine 0 N--CA 1.441 -1.019 0 C-N-CA 119.057 -1.544 . . . . 0.23999999999999999 114.084 -173.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.895 ' HB3' HD22 ' A' ' 44' ' ' LEU . 6.7 mp -116.07 146.2 42.39 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.184 -0.508 . . . . 0.19 111.844 -168.012 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . 0.598 ' NE2' HD13 ' A' ' 14' ' ' LEU . 85.0 m-70 -141.99 150.0 40.78 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.578 0.584 . . . . 0.22 112.578 178.422 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.571 HG12 HD11 ' A' ' 44' ' ' LEU . 3.3 pt -132.42 138.21 52.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 107.446 -1.316 . . . . 0.17000000000000001 107.446 159.379 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 2.2 mp -129.69 145.74 35.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 C-N-CA 120.755 -0.378 . . . . 0.17999999999999999 110.641 -175.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.449 ' HA ' ' O ' ' A' ' 100' ' ' ASP . 42.0 pttt -126.64 139.01 53.49 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.796 -0.816 . . . . 0.60999999999999999 108.796 171.365 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . 0.45 ' HB2' ' CD1' ' A' ' 96' ' ' LEU . 60.7 ttt180 -83.63 125.12 31.5 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.174 0.512 . . . . 1.8700000000000001 110.86 -178.087 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.424 ' HB2' ' HG2' ' A' ' 9' ' ' ARG . 4.2 mm? -93.06 -31.96 14.65 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.487 -0.779 . . . . 0.89000000000000001 110.247 -179.114 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.865 0 CA-C-N 115.54 -0.755 . . . . 1.1000000000000001 109.962 179.747 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.456 ' HG3' ' HB2' ' A' ' 79' ' ' PHE . 10.8 mptt . . . . . 0 N--CA 1.45 -0.459 0 CA-C-O 121.838 0.827 . . . . 1.1899999999999999 110.82 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.58 HD23 ' H ' ' A' ' 9' ' ' ARG . 1.8 tt -116.01 159.53 21.51 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 114.2 -1.364 . . . . 1.1799999999999999 108.001 -178.512 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.59 ' HB3' ' HB3' ' A' ' 118' ' ' ALA . 79.0 ttt180 -136.28 127.85 28.75 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.431 -0.581 . . . . 1.0600000000000001 109.431 174.274 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.425 ' N ' ' HZ ' ' A' ' 80' ' ' PHE . . . -150.05 152.17 34.41 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.093 0.473 . . . . 0.22 111.714 -179.244 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.417 ' HB3' ' HG2' ' A' ' 115' ' ' LYS . . . -101.87 136.78 41.12 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.458 -0.792 . . . . 0.20000000000000001 109.527 177.39 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 37.4 p-80 -136.45 149.1 48.07 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.964 0.412 . . . . 0.23000000000000001 111.286 -173.327 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.56 HD23 ' N ' ' A' ' 14' ' ' LEU . 6.2 tt -118.37 149.46 41.16 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.836 -0.802 . . . . 0.23999999999999999 108.836 177.275 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.569 ' O ' ' HA ' ' A' ' 66' ' ' SER . 29.6 tp -130.84 124.61 31.65 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.611 0.243 . . . . 0.27000000000000002 111.052 -179.228 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.546 HG23 HD13 ' A' ' 44' ' ' LEU . 85.1 t -111.34 138.03 41.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 109.405 -0.591 . . . . 0.14999999999999999 109.405 173.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.485 ' HB2' ' HB2' ' A' ' 25' ' ' SER . 24.9 mmtp -105.72 162.07 13.85 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.157 -0.474 . . . . 0.62 110.491 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.462 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 51.5 p90 -158.86 161.6 36.87 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.053 -0.521 . . . . 0.25 109.92 179.48 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.522 ' HB3' ' HA ' ' A' ' 33' ' ' ALA . 21.5 p -53.35 109.97 0.5 Allowed 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.347 -0.388 . . . . 1.04 111.026 178.576 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 104.46 10.36 33.71 Favored Glycine 0 N--CA 1.443 -0.86 0 C-N-CA 120.229 -0.986 . . . . 0.53000000000000003 113.371 178.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.661 ' HB2' ' O ' ' A' ' 109' ' ' SER . 39.8 p -81.49 46.24 0.94 Allowed 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 117.855 0.828 . . . . 0.69999999999999996 111.577 -174.065 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.402 ' HB3' ' O ' ' A' ' 20' ' ' SER . 56.2 ttt180 68.95 -37.01 0.35 Allowed 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.905 0.882 . . . . 3.4900000000000002 111.355 -177.213 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.488 ' H ' ' C ' ' A' ' 20' ' ' SER . 8.1 p30 -155.01 126.48 3.67 Favored Pre-proline 0 C--N 1.316 -0.866 0 N-CA-C 107.67 -1.233 . . . . 1.77 107.67 175.565 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -82.39 -156.11 0.07 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 122.302 2.001 . . . . 1.71 111.784 -175.106 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.615 ' N ' HG22 ' A' ' 32' ' ' THR . 57.5 t 60.07 114.12 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 123.423 0.689 . . . . 0.47999999999999998 111.692 -173.738 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.485 ' HB2' ' HB2' ' A' ' 16' ' ' LYS . 29.8 t -103.4 159.82 15.24 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.815 -0.63 . . . . 1.1200000000000001 109.722 177.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.589 ' HB2' ' HA ' ' A' ' 67' ' ' ASP . 5.5 mpt_? -75.33 -12.73 60.33 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 109.018 -0.734 . . . . 2.54 109.018 169.498 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.474 ' HG2' ' HD3' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -72.52 -49.75 30.67 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.249 -0.887 . . . . 1.77 109.195 174.066 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 55.6 p -85.39 -34.05 21.84 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.468 -0.787 . . . . 0.67000000000000004 111.249 -177.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 80.7 -34.73 2.29 Favored Glycine 0 C--N 1.322 -0.216 0 CA-C-N 115.314 -0.857 . . . . 0.81999999999999995 111.395 -176.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.556 ' O ' ' HA ' ' A' ' 24' ' ' VAL . 4.4 m-20 -114.56 -135.27 0.35 Allowed 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 108.349 -0.982 . . . . 2.1000000000000001 108.349 173.025 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -70.82 142.03 51.3 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 112.703 0.631 . . . . 1.0800000000000001 112.703 -171.261 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.615 HG22 ' N ' ' A' ' 24' ' ' VAL . 8.9 t -124.25 14.51 9.01 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.337 -0.847 . . . . 0.34000000000000002 109.461 175.219 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.522 ' HA ' ' HB3' ' A' ' 18' ' ' SER . . . -68.75 -4.35 15.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.302 -0.863 . . . . 0.37 111.565 177.587 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -88.73 -24.95 22.55 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.99 -0.55 . . . . 2.21 110.802 -178.053 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.77 HG23 ' HB3' ' A' ' 39' ' ' ASP . 0.1 OUTLIER -100.58 141.55 17.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.088 -0.505 . . . . 0.31 110.211 -179.126 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 40.7 p -98.1 174.75 6.38 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 110.212 -0.292 . . . . 0.39000000000000001 110.212 -176.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.516 ' O ' HG13 ' A' ' 41' ' ' ILE . 11.5 p90 -63.94 -26.85 68.77 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.101 -0.64 . . . . 1.53 109.507 177.713 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -71.04 -46.14 62.57 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.06 -0.518 . . . . 0.95999999999999996 110.526 178.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.77 ' HB3' HG23 ' A' ' 35' ' ' VAL . 2.7 t70 -70.0 -31.22 68.79 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.473 0.654 . . . . 0.91000000000000003 109.695 178.15 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.462 ' HB2' ' HB3' ' A' ' 17' ' ' PHE . . . -66.64 -41.97 87.43 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.232 -0.895 . . . . 0.19 110.347 175.658 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.516 HG13 ' O ' ' A' ' 37' ' ' TYR . 78.1 mt -64.63 -33.13 61.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 109.516 -0.549 . . . . 0.29999999999999999 109.516 173.517 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.521 ' HB3' ' O ' ' A' ' 39' ' ' ASP . 3.9 ttpm? -60.75 -28.32 68.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.298 0.571 . . . . 2.3199999999999998 109.993 176.212 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.457 ' HG3' ' CD1' ' A' ' 47' ' ' TRP . 6.2 tp10 -84.92 -52.88 5.69 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.403 -0.817 . . . . 1.02 109.487 -178.635 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.916 HD23 HG23 ' A' ' 104' ' ' ILE . 22.8 tp -64.61 -34.15 77.61 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.329 -0.851 . . . . 0.17000000000000001 110.762 -174.267 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.51 ' O ' ' HB2' ' A' ' 49' ' ' GLN . 4.7 mm-40 -70.41 -19.63 62.98 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.353 -0.385 . . . . 0.87 111.892 -178.481 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.425 ' HG3' ' O ' ' A' ' 42' ' ' LYS . 67.9 mttm -84.25 -46.95 11.29 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.741 -0.466 . . . . 1.3100000000000001 109.741 175.489 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.458 ' NE1' ' HG3' ' A' ' 65' ' ' ARG . 44.0 m95 -63.61 -48.05 78.9 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.144 -0.48 . . . . 0.52000000000000002 111.821 179.782 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.508 ' HB3' HG21 ' A' ' 113' ' ' ILE . 98.5 p -64.81 -20.53 66.44 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.507 -0.477 . . . . 0.81999999999999995 110.023 177.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.51 ' HB2' ' O ' ' A' ' 45' ' ' GLN . 11.8 tt0 -77.52 -54.72 6.08 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.183 -0.462 . . . . 0.53000000000000003 110.014 175.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.598 ' HB3' HG22 ' A' ' 56' ' ' VAL . 97.9 mtt180 -63.21 -41.5 99.15 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.637 -0.711 . . . . 0.41999999999999998 111.435 -176.627 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.483 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 98.3 mt -61.12 -33.59 56.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.159 0.504 . . . . 0.20000000000000001 110.48 176.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -79.75 -35.55 38.57 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.907 -0.588 . . . . 0.27000000000000002 111.444 -179.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 31.1 p -82.35 -28.98 31.23 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.811 0.338 . . . . 0.34999999999999998 111.602 -176.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 107.98 3.77 33.9 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.762 -0.732 . . . . 0.29999999999999999 112.375 179.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.448 ' HB2' ' HB3' ' A' ' 50' ' ' ARG . 36.8 mt-10 -61.79 -48.16 81.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.075 0.464 . . . . 0.65000000000000002 110.258 178.435 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.598 HG22 ' HB3' ' A' ' 50' ' ' ARG . 15.6 m -135.32 156.22 38.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 109.31 -0.626 . . . . 0.19 109.31 172.242 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.582 ' OG ' ' HG3' ' A' ' 60' ' ' GLU . 77.7 p -83.79 165.49 18.79 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.795 -0.446 . . . . 0.96999999999999997 109.795 178.035 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -57.7 -41.01 80.83 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.516 -0.55 . . . . 0.22 109.516 179.172 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.479 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 43.8 mt-10 -62.24 -41.35 98.34 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.062 -0.972 . . . . 1.72 111.962 -178.122 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.582 ' HG3' ' OG ' ' A' ' 57' ' ' SER . 41.2 mt-10 -60.76 -49.24 78.28 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.021 0.439 . . . . 2.0899999999999999 110.859 -179.659 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.14 -50.61 63.38 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.926 -0.579 . . . . 0.26000000000000001 111.073 -178.257 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -58.86 -52.1 67.19 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.351 0.5 . . . . 0.23999999999999999 112.351 -174.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.534 ' HA ' ' O ' ' A' ' 71' ' ' TYR . 20.2 m -51.5 -24.23 4.92 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 113.122 0.786 . . . . 1.0 113.122 -176.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -105.49 -44.12 4.78 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.583 0.706 . . . . 0.60999999999999999 110.615 -179.15 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.474 ' HD3' ' HG2' ' A' ' 27' ' ' ARG . 38.7 mmt-85 -90.92 -41.88 10.9 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 113.882 1.067 . . . . 0.85999999999999999 113.882 -170.131 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.569 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 75.9 p -64.17 122.7 17.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.055 0.455 . . . . 0.81999999999999995 111.615 -174.314 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.589 ' HA ' ' HB2' ' A' ' 26' ' ' ARG . 28.6 t70 -76.55 -9.33 58.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.618 -0.719 . . . . 2.2799999999999998 110.827 175.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 0.543 ' SG ' HD22 ' A' ' 14' ' ' LEU . 4.1 m -77.13 163.43 26.6 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.897 -0.592 . . . . 1.52 110.267 175.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -65.9 -16.28 63.71 Favored Glycine 0 CA--C 1.512 -0.142 0 CA-C-N 114.912 -1.04 . . . . 0.26000000000000001 113.203 -173.316 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.512 ' HB2' ' CA ' ' A' ' 75' ' ' GLY . 3.6 p -68.96 0.56 4.34 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 112.426 0.528 . . . . 0.32000000000000001 112.426 177.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.534 ' O ' ' HA ' ' A' ' 63' ' ' SER . 34.5 p90 -58.33 -26.47 63.14 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.137 0.494 . . . . 0.54000000000000004 110.154 175.515 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -95.29 -6.99 40.07 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.162 0.505 . . . . 0.48999999999999999 110.585 178.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.8 m -110.67 -0.02 17.31 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.835 -0.62 . . . . 0.70999999999999996 111.066 -175.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.479 ' O ' ' HA ' ' A' ' 59' ' ' GLU . . . 77.79 27.64 58.37 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.852 -0.689 . . . . 0.54000000000000004 112.218 -177.086 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.512 ' CA ' ' HB2' ' A' ' 70' ' ' SER . . . 81.94 -1.2 87.24 Favored Glycine 0 C--O 1.226 -0.373 0 C-N-CA 120.873 -0.679 . . . . 0.34999999999999998 111.85 -178.264 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -92.15 136.07 33.48 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 120.962 0.41 . . . . 1.6499999999999999 111.436 -169.215 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.6 mp -115.75 158.08 23.38 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.709 -0.678 . . . . 0.93999999999999995 109.548 172.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -85.35 -127.2 1.77 Allowed Glycine 0 C--N 1.308 -1.001 0 CA-C-N 114.944 -1.025 . . . . 0.44 112.255 -179.118 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.456 ' HB2' ' HG3' ' A' ' 7' ' ' LYS . 46.4 p90 -92.67 147.31 22.98 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.83 0.348 . . . . 3.8700000000000001 110.734 -177.694 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.446 ' CE1' ' HB3' ' A' ' 8' ' ' LEU . 2.3 p90 -163.59 147.25 10.32 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.098 -0.501 . . . . 1.3100000000000001 110.499 179.056 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 17.5 m -76.08 135.03 39.89 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.13 -0.486 . . . . 1.1699999999999999 110.577 179.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 16.0 m -61.03 114.64 3.21 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.939 -0.573 . . . . 1.1899999999999999 110.024 177.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.436 ' H ' ' HG3' ' A' ' 90' ' ' GLU . . . 112.58 -8.08 26.18 Favored Glycine 0 N--CA 1.447 -0.606 0 CA-C-N 115.79 -0.641 . . . . 0.79000000000000004 111.895 -177.522 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -101.14 47.01 0.92 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.655 0.741 . . . . 1.55 110.371 -177.296 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 21.6 mmt -135.82 -127.21 0.15 Allowed 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.87 -0.789 . . . . 0.72999999999999998 108.87 176.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 59.9 mtt -113.45 149.85 33.65 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.438 -0.949 . . . . 1.3899999999999999 108.438 174.028 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -53.3 -54.37 45.85 Favored Pre-proline 0 C--N 1.321 -0.646 0 N-CA-C 112.647 0.61 . . . . 2.3700000000000001 112.647 -174.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -74.61 -31.22 7.1 Favored 'Trans proline' 0 C--N 1.355 0.89 0 C-N-CA 121.387 1.391 . . . . 0.27000000000000002 111.667 -176.315 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.589 ' O ' HG23 ' A' ' 93' ' ' VAL . 42.9 t80 -66.03 -56.06 13.47 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.113 -0.949 . . . . 0.22 110.099 179.309 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.436 ' HG3' ' H ' ' A' ' 83' ' ' GLY . 5.6 tm-20 -64.61 -37.96 89.37 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.598 -0.728 . . . . 2.1200000000000001 110.218 -177.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.443 ' HA ' ' HD2' ' A' ' 94' ' ' ARG . 35.2 t70 -59.46 -26.93 65.64 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.874 -0.603 . . . . 0.60999999999999999 110.7 177.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -85.59 -21.39 28.52 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.495 -0.32 . . . . 0.22 111.408 176.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.589 HG23 ' O ' ' A' ' 89' ' ' PHE . 44.8 t -74.83 -47.9 35.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 121.253 0.549 . . . . 0.25 110.567 -173.737 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.443 ' HD2' ' HA ' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -78.49 1.79 21.18 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.195 -0.457 . . . . 2.5899999999999999 111.028 176.888 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -92.68 0.44 57.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.973 0.416 . . . . 0.46999999999999997 110.758 -179.485 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.589 ' HB2' ' HB2' ' A' ' 100' ' ' ASP . 0.4 OUTLIER -137.28 160.37 39.22 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.968 -0.56 . . . . 0.28000000000000003 110.627 177.876 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.482 ' HG3' ' H ' ' A' ' 98' ' ' ILE . 50.8 tptt -102.21 175.83 5.39 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.246 -0.65 . . . . 1.6100000000000001 109.246 179.433 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.482 ' H ' ' HG3' ' A' ' 97' ' ' LYS . 63.0 mt -57.71 114.66 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 120.97 0.414 . . . . 0.90000000000000002 110.725 177.797 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 104.76 -0.49 42.14 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.802 -0.714 . . . . 0.46000000000000002 112.528 -179.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.589 ' HB2' ' HB2' ' A' ' 96' ' ' LEU . 24.6 m-20 -105.17 137.45 42.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.797 0.298 . . . . 0.46000000000000002 110.522 179.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 12.7 mt -108.94 148.77 12.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.986 -0.552 . . . . 0.23000000000000001 109.902 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 95.7 p -91.28 156.05 43.95 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-N 116.469 -0.332 . . . . 0.92000000000000004 110.539 -179.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -69.69 174.08 9.97 Favored 'Trans proline' 0 C--O 1.233 0.271 0 C-N-CA 122.478 2.118 . . . . 0.34000000000000002 111.245 171.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.916 HG23 HD23 ' A' ' 44' ' ' LEU . 26.1 mm -51.67 100.78 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 O-C-N 123.314 0.383 . . . . 0.20000000000000001 111.447 176.025 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.5 p -104.76 118.34 51.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.2 0.524 . . . . 1.04 109.868 175.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -85.23 146.96 26.82 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.214 0.531 . . . . 0.55000000000000004 110.674 -179.427 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 18.5 p -124.49 -172.38 2.55 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.395 -0.82 . . . . 0.37 109.76 179.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -73.46 -29.43 62.53 Favored 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 120.967 -0.293 . . . . 2.1600000000000001 110.81 178.085 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.661 ' O ' ' HB2' ' A' ' 20' ' ' SER . 8.4 t -101.3 -9.31 21.33 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.1 0.407 . . . . 1.0900000000000001 112.1 -175.377 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 160.66 -127.47 1.78 Allowed Glycine 0 N--CA 1.437 -1.293 0 C-N-CA 119.871 -1.157 . . . . 0.23999999999999999 112.638 170.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.888 ' HB3' HD22 ' A' ' 44' ' ' LEU . 6.1 mp -120.9 144.11 48.6 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 114.981 -0.61 . . . . 0.19 110.846 -172.36 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . 0.543 ' HA ' ' O ' ' A' ' 13' ' ' LEU . 72.9 m-70 -143.06 151.72 41.09 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.262 0.553 . . . . 0.22 112.044 -179.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.633 HG12 HD11 ' A' ' 44' ' ' LEU . 2.8 pt -134.64 141.36 43.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 107.658 -1.238 . . . . 0.17000000000000001 107.658 161.126 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 1.8 mp -129.98 143.31 41.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 C-N-CA 120.773 -0.371 . . . . 0.17999999999999999 110.62 -176.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.425 ' HA ' ' O ' ' A' ' 100' ' ' ASP . 43.8 pttt -125.14 138.17 54.16 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.63 -0.878 . . . . 0.60999999999999999 108.63 172.136 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . 0.441 ' HB2' ' CD1' ' A' ' 96' ' ' LEU . 61.3 ttt180 -85.64 136.39 33.39 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.079 0.466 . . . . 1.8700000000000001 111.268 -177.079 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 6.6 mp -115.25 -24.29 8.54 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.62 -0.718 . . . . 0.89000000000000001 111.508 -178.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.59 ' HB3' ' HB3' ' A' ' 9' ' ' ARG . . . . . . . . 0 C--O 1.244 0.774 0 CA-C-O 118.22 -0.895 . . . . 1.1000000000000001 109.882 175.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 24.3 tptt . . . . . 0 N--CA 1.451 -0.421 0 CA-C-O 121.281 0.563 . . . . 1.1899999999999999 110.004 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.667 HD23 ' N ' ' A' ' 9' ' ' ARG . 2.9 tt -139.29 155.92 47.4 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 115.065 -0.97 . . . . 1.1799999999999999 108.467 -177.449 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.667 ' N ' HD23 ' A' ' 8' ' ' LEU . 44.3 ttt180 -139.56 128.48 23.52 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 108.199 -1.038 . . . . 1.0600000000000001 108.199 173.422 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.43 ' O ' ' HB2' ' A' ' 77' ' ' LEU . . . -146.04 148.71 32.98 Favored 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 120.402 -0.519 . . . . 0.22 111.983 -177.106 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.42 ' HB3' ' HG2' ' A' ' 115' ' ' LYS . . . -102.44 137.15 41.07 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.428 -0.806 . . . . 0.20000000000000001 109.264 176.592 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 23.1 p-80 -137.37 152.68 49.95 Favored 'General case' 0 C--N 1.323 -0.587 0 C-N-CA 120.418 -0.513 . . . . 0.23000000000000001 111.872 -172.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.579 HD23 ' N ' ' A' ' 14' ' ' LEU . 5.4 tt -121.1 148.3 44.37 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.467 -0.938 . . . . 0.23999999999999999 108.467 177.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.612 HD21 ' HE3' ' A' ' 16' ' ' LYS . 27.4 tp -131.23 130.96 43.58 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 110.378 -0.23 . . . . 0.27000000000000002 110.378 -179.355 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.544 HG23 HD13 ' A' ' 44' ' ' LEU . 63.6 t -120.83 129.22 75.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 109.518 -0.549 . . . . 0.14999999999999999 109.518 173.241 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.612 ' HE3' HD21 ' A' ' 14' ' ' LEU . 32.1 mmtp -104.58 158.33 16.57 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.214 -0.448 . . . . 0.62 110.504 178.336 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -150.68 162.13 41.28 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.954 -0.566 . . . . 0.25 110.125 -175.07 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.463 ' HB3' ' C ' ' A' ' 33' ' ' ALA . 45.8 p -55.0 111.42 0.83 Allowed 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 110.117 -0.327 . . . . 1.04 110.117 175.209 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 104.24 9.84 35.47 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.074 -1.06 . . . . 0.53000000000000003 112.394 -177.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.475 ' HB2' ' O ' ' A' ' 109' ' ' SER . 79.5 p -92.98 24.21 3.82 Favored 'General case' 0 N--CA 1.453 -0.308 0 O-C-N 122.376 -0.485 . . . . 0.69999999999999996 110.791 -177.541 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 60.3 mtt180 71.79 -33.39 0.27 Allowed 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 123.225 0.61 . . . . 3.4900000000000002 111.406 -178.193 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.455 ' H ' ' C ' ' A' ' 20' ' ' SER . 38.5 m-80 -127.8 89.05 51.77 Favored Pre-proline 0 C--N 1.324 -0.541 0 N-CA-C 109.109 -0.7 . . . . 1.77 109.109 176.336 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.498 ' C ' HG22 ' A' ' 32' ' ' THR . 90.5 Cg_endo -79.84 45.46 1.96 Allowed 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 122.678 2.252 . . . . 1.71 112.82 -173.522 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.41 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 60.7 t -141.53 115.14 4.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 108.68 -0.859 . . . . 0.47999999999999998 108.68 178.796 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.473 ' HB2' ' OD1' ' A' ' 67' ' ' ASP . 15.9 p -100.84 158.35 16.04 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 110.173 -0.306 . . . . 1.1200000000000001 110.173 -178.04 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.485 ' HG2' ' HA ' ' A' ' 67' ' ' ASP . 18.3 mmm180 -72.97 -17.24 61.49 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 108.362 -0.977 . . . . 2.54 108.362 172.122 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 13.2 ttp180 -65.83 -48.64 70.97 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 114.463 -1.244 . . . . 1.77 110.054 177.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 33.3 p -96.35 -34.49 11.55 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.153 0.501 . . . . 0.67000000000000004 110.765 -178.078 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 85.91 -31.37 4.01 Favored Glycine 0 N--CA 1.45 -0.381 0 CA-C-N 115.752 -0.658 . . . . 0.81999999999999995 113.148 -179.375 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -101.24 -61.23 1.4 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.973 0.386 . . . . 2.1000000000000001 111.424 -178.128 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.41 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 10.3 p -154.77 149.62 26.68 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.986 0.422 . . . . 1.0800000000000001 111.674 178.798 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.498 HG22 ' C ' ' A' ' 23' ' ' PRO . 12.6 t -116.86 27.31 9.23 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 122.305 1.05 . . . . 0.34000000000000002 108.733 173.2 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.463 ' C ' ' HB3' ' A' ' 18' ' ' SER . . . -75.83 -4.43 40.68 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.598 -1.183 . . . . 0.37 112.162 -175.213 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -97.94 -19.8 17.84 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.943 0.401 . . . . 2.21 110.632 -178.263 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.505 HG23 ' HB2' ' A' ' 39' ' ' ASP . 0.2 OUTLIER -101.85 137.85 28.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 116.062 -0.517 . . . . 0.31 110.36 -178.667 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 61.8 p -96.91 177.9 5.47 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 109.531 -0.544 . . . . 0.39000000000000001 109.531 -178.257 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.472 ' HA ' ' HB3' ' A' ' 40' ' ' ALA . 0.1 OUTLIER -68.39 -21.26 64.7 Favored 'General case' 0 C--O 1.217 -0.616 0 C-N-CA 118.72 -1.192 . . . . 1.53 110.288 174.26 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -72.41 -41.98 65.63 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.931 -0.396 . . . . 0.95999999999999996 109.931 175.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.505 ' HB2' HG23 ' A' ' 35' ' ' VAL . 23.9 m-20 -71.04 -35.17 71.88 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.404 0.621 . . . . 0.91000000000000003 109.853 175.035 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.472 ' HB3' ' HA ' ' A' ' 37' ' ' TYR . . . -67.99 -48.25 66.29 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.098 -0.955 . . . . 0.19 110.613 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.437 ' CG1' HD21 ' A' ' 111' ' ' LEU . 69.8 mt -62.15 -36.83 76.44 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.462 0 N-CA-C 109.833 -0.432 . . . . 0.29999999999999999 109.833 175.661 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 59.6 tttp -59.86 -29.09 68.07 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.832 -0.622 . . . . 2.3199999999999998 109.891 178.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -88.91 -49.54 6.73 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.461 -0.791 . . . . 1.02 110.473 -178.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.928 HD23 HG23 ' A' ' 104' ' ' ILE . 33.9 tp -58.73 -36.42 74.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.969 -0.56 . . . . 0.17000000000000001 110.039 -177.503 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.456 ' O ' ' HB2' ' A' ' 49' ' ' GLN . 0.0 OUTLIER -66.92 -23.56 65.99 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-N 115.954 -0.566 . . . . 0.87 112.078 -179.692 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -85.01 -40.29 17.05 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 110.196 -0.298 . . . . 1.3100000000000001 110.196 179.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.413 ' O ' HG13 ' A' ' 51' ' ' ILE . 36.8 m95 -66.46 -47.87 71.73 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.96 -0.296 . . . . 0.52000000000000002 111.293 174.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.44 ' HB3' HG21 ' A' ' 113' ' ' ILE . 88.6 p -62.75 -28.24 69.83 Favored 'General case' 0 C--N 1.333 -0.128 0 C-N-CA 120.719 -0.392 . . . . 0.81999999999999995 110.062 177.449 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.456 ' HB2' ' O ' ' A' ' 45' ' ' GLN . 11.4 tt0 -66.74 -57.17 7.64 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.925 -0.58 . . . . 0.53000000000000003 110.323 173.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.622 ' HB3' HG22 ' A' ' 56' ' ' VAL . 86.2 mtt180 -61.14 -42.14 98.01 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.943 -0.571 . . . . 0.41999999999999998 111.58 -176.437 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.489 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 92.4 mt -61.51 -36.63 74.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 120.929 0.395 . . . . 0.20000000000000001 110.43 177.479 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -77.46 -35.45 53.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.068 -0.515 . . . . 0.27000000000000002 111.684 -179.476 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 51.1 p -80.49 -30.34 37.33 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.893 0.377 . . . . 0.34999999999999998 111.481 -177.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 108.55 4.43 32.37 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.76 -0.733 . . . . 0.29999999999999999 112.218 -179.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.42 ' HB2' ' HB3' ' A' ' 50' ' ' ARG . 40.0 mt-10 -61.49 -48.7 79.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.007 0.432 . . . . 0.65000000000000002 110.104 178.039 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.622 HG22 ' HB3' ' A' ' 50' ' ' ARG . 13.6 m -133.77 157.45 42.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 109.354 -0.61 . . . . 0.19 109.354 171.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 49.6 m -85.93 160.02 19.5 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 109.471 -0.566 . . . . 0.96999999999999997 109.471 177.211 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.424 ' HA ' HD13 ' A' ' 51' ' ' ILE . 2.7 t80 -53.66 -43.92 69.2 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.272 0.558 . . . . 0.22 109.948 -177.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.583 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 2.8 mp0 -56.96 -39.13 74.01 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.845 -1.071 . . . . 1.72 111.916 -178.307 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 31.5 mm-40 -65.39 -48.94 71.14 Favored 'General case' 0 CA--C 1.521 -0.16 0 CA-C-O 120.836 0.35 . . . . 2.0899999999999999 111.118 -177.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -68.94 -42.72 76.33 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.386 -0.37 . . . . 0.26000000000000001 111.108 -177.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.11 -53.82 52.22 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.331 -0.395 . . . . 0.23999999999999999 112.051 -175.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.519 ' HA ' ' O ' ' A' ' 71' ' ' TYR . 16.0 m -51.56 -21.8 2.79 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 113.149 0.796 . . . . 1.0 113.149 -177.342 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -104.99 -46.71 4.2 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.519 0.676 . . . . 0.60999999999999999 110.473 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' A' ' 65' ' ' ARG . 21.2 mmt180 -94.8 -36.11 11.81 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.745 -1.116 . . . . 0.85999999999999999 113.99 -168.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.499 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 54.4 p -63.23 116.81 5.79 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.031 0.443 . . . . 0.81999999999999995 110.479 -177.684 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.485 ' HA ' ' HG2' ' A' ' 26' ' ' ARG . 48.5 m-20 -82.15 0.72 39.6 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.772 -0.649 . . . . 2.2799999999999998 111.251 -178.657 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 0.565 ' SG ' HD22 ' A' ' 14' ' ' LEU . 1.7 m -78.42 173.67 12.1 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.869 -0.605 . . . . 1.52 109.978 172.159 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -69.28 -16.54 71.32 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.706 -0.759 . . . . 0.26000000000000001 112.026 179.533 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 67.2 p -65.98 -5.51 9.74 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 112.576 0.584 . . . . 0.32000000000000001 112.576 -179.046 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.519 ' O ' ' HA ' ' A' ' 63' ' ' SER . 30.4 p90 -60.36 -25.76 66.1 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.005 0.431 . . . . 0.54000000000000004 110.33 177.78 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -94.36 -2.58 51.85 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.239 0.542 . . . . 0.48999999999999999 110.448 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 7.0 m -116.84 9.36 13.85 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.832 -0.622 . . . . 0.70999999999999996 110.748 -178.1 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.583 ' O ' ' HA ' ' A' ' 59' ' ' GLU . . . 68.27 28.51 73.27 Favored Glycine 0 C--O 1.227 -0.288 0 C-N-CA 120.915 -0.66 . . . . 0.54000000000000004 112.039 -177.435 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 83.29 -21.2 8.78 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 121.145 -0.55 . . . . 0.34999999999999998 112.282 -178.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -72.68 136.81 45.7 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.787 0.327 . . . . 1.6499999999999999 111.192 -173.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.43 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 2.6 mp -116.17 166.79 11.62 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.955 -0.566 . . . . 0.93999999999999995 110.027 174.665 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -81.24 -148.52 6.16 Favored Glycine 0 C--N 1.314 -0.669 0 CA-C-N 115.393 -0.821 . . . . 0.44 113.138 -177.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -99.33 143.92 29.03 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.993 0.425 . . . . 3.8700000000000001 110.864 -179.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.411 ' HE2' ' HB3' ' A' ' 77' ' ' LEU . 0.9 OUTLIER -157.31 175.23 14.29 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.856 -0.611 . . . . 1.3100000000000001 109.815 -174.925 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 16.2 m -104.17 139.52 39.11 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.876 -0.787 . . . . 1.1699999999999999 108.876 175.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 48.0 m -61.96 126.96 29.18 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.076 0.465 . . . . 1.1899999999999999 110.812 -179.375 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 114.74 -4.25 22.87 Favored Glycine 0 N--CA 1.443 -0.898 0 CA-C-N 115.392 -0.822 . . . . 0.79000000000000004 111.276 -176.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -95.85 6.99 47.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.699 0.285 . . . . 1.55 111.363 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 25.0 mmt -104.16 -122.6 0.21 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.047 0.451 . . . . 0.72999999999999998 110.572 179.36 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 54.8 mtt -123.69 152.15 42.36 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 107.919 -1.141 . . . . 1.3899999999999999 107.919 175.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm -53.17 -53.99 49.64 Favored Pre-proline 0 C--N 1.319 -0.721 0 N-CA-C 112.249 0.463 . . . . 2.3700000000000001 112.249 -175.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.05 -30.68 10.54 Favored 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 121.457 1.438 . . . . 0.27000000000000002 111.836 -177.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.646 ' O ' HG23 ' A' ' 93' ' ' VAL . 26.3 t80 -67.36 -56.48 9.53 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.247 -0.888 . . . . 0.22 109.885 179.742 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -62.19 -35.32 78.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.535 -0.757 . . . . 2.1200000000000001 110.449 -178.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -61.12 -30.47 70.39 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.362 -0.836 . . . . 0.60999999999999999 110.905 178.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.465 ' O ' ' HG ' ' A' ' 96' ' ' LEU . . . -83.35 -26.84 30.16 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.851 0.357 . . . . 0.22 110.659 178.001 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.646 HG23 ' O ' ' A' ' 89' ' ' PHE . 27.4 t -70.43 -37.62 71.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.255 0.55 . . . . 0.25 110.165 -176.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.479 ' C ' ' HD2' ' A' ' 94' ' ' ARG . 6.2 ppt_? -78.92 -13.68 59.66 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.882 -0.599 . . . . 2.5899999999999999 110.735 178.657 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -84.23 -11.04 57.15 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.185 0.517 . . . . 0.46999999999999997 110.963 -175.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.583 ' HB2' ' HB2' ' A' ' 100' ' ' ASP . 0.9 OUTLIER -127.64 145.18 50.97 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.828 -0.624 . . . . 0.28000000000000003 110.761 179.713 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.424 ' HG3' ' H ' ' A' ' 98' ' ' ILE . 20.7 tptm -92.95 173.12 7.91 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 109.021 -0.733 . . . . 1.6100000000000001 109.021 178.754 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.463 ' HA ' ' HG2' ' A' ' 116' ' ' ARG . 72.1 mt -45.76 115.96 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.913 0.387 . . . . 0.90000000000000002 111.649 176.393 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 106.16 -12.27 44.47 Favored Glycine 0 CA--C 1.521 0.45 0 C-N-CA 120.946 -0.645 . . . . 0.46000000000000002 113.736 177.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.583 ' HB2' ' HB2' ' A' ' 96' ' ' LEU . 15.7 m-20 -97.95 148.98 22.91 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 117.566 0.683 . . . . 0.46000000000000002 111.144 -178.005 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 13.0 mt -115.83 149.08 18.15 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-N 115.951 -0.568 . . . . 0.23000000000000001 110.872 -174.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.411 ' HB2' ' H ' ' A' ' 114' ' ' ILE . 5.9 m -81.72 151.18 67.59 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 115.953 -0.567 . . . . 0.92000000000000004 110.806 -178.333 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -73.75 165.22 32.8 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 122.2 1.934 . . . . 0.34000000000000002 109.989 166.221 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.928 HG23 HD23 ' A' ' 44' ' ' LEU . 20.1 mm -46.47 108.54 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 O-C-N 123.32 0.387 . . . . 0.20000000000000001 111.956 178.292 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.3 p -115.32 117.59 56.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.193 -0.458 . . . . 1.04 110.157 176.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 16.8 mt-30 -85.25 147.24 26.67 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.055 0.455 . . . . 0.55000000000000004 110.07 178.105 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 8.8 p -121.38 -172.46 2.42 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.421 -0.808 . . . . 0.37 110.389 -177.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -59.86 -35.27 74.44 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.589 0.233 . . . . 2.1600000000000001 110.78 178.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.603 ' OG ' ' HE2' ' A' ' 16' ' ' LYS . 6.4 t -96.78 -60.93 1.49 Allowed 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.69 -0.404 . . . . 1.0900000000000001 110.884 -179.713 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -147.72 -135.02 2.57 Favored Glycine 0 N--CA 1.443 -0.884 0 C-N-CA 118.9 -1.619 . . . . 0.23999999999999999 113.733 -173.321 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.896 ' HB3' HD22 ' A' ' 44' ' ' LEU . 7.7 mp -113.83 146.34 40.11 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 114.962 -0.619 . . . . 0.19 111.232 -170.643 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . 0.538 ' HA ' ' O ' ' A' ' 13' ' ' LEU . 77.0 m-70 -144.16 150.14 37.58 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.144 0.497 . . . . 0.22 111.902 179.659 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.557 HG12 HD11 ' A' ' 44' ' ' LEU . 2.1 pt -134.57 137.58 51.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 107.715 -1.217 . . . . 0.17000000000000001 107.715 160.651 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.411 ' H ' ' HB2' ' A' ' 102' ' ' SER . 2.1 mp -128.1 145.96 34.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 C-N-CA 121.035 -0.266 . . . . 0.17999999999999999 110.735 -174.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.42 ' HG2' ' HB3' ' A' ' 11' ' ' ALA . 47.4 pttt -127.84 139.86 52.38 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.733 -0.84 . . . . 0.60999999999999999 108.733 172.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . 0.483 ' HD3' HD21 ' A' ' 8' ' ' LEU . 4.7 ttp180 -83.11 133.92 35.03 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.12 -0.632 . . . . 1.8700000000000001 110.868 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -103.04 -36.0 8.33 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.87 -1.059 . . . . 0.89000000000000001 109.729 -178.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.475 ' HB3' ' HB3' ' A' ' 9' ' ' ARG . . . . . . . . 0 C--O 1.245 0.855 0 CA-C-O 117.992 -1.004 . . . . 1.1000000000000001 109.569 178.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt . . . . . 0 N--CA 1.453 -0.289 0 CA-C-O 121.281 0.562 . . . . 1.1899999999999999 109.95 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.655 HD23 ' H ' ' A' ' 9' ' ' ARG . 0.4 OUTLIER -124.04 164.37 19.52 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.046 -0.979 . . . . 1.1799999999999999 109.529 -174.63 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.655 ' H ' HD23 ' A' ' 8' ' ' LEU . 58.4 ttt180 -145.35 128.85 17.0 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.395 -0.594 . . . . 1.0600000000000001 109.395 175.539 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.432 ' N ' ' HZ ' ' A' ' 80' ' ' PHE . . . -146.35 153.74 40.86 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.12 0.486 . . . . 0.22 112.036 -179.456 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.41 ' HB3' ' HG2' ' A' ' 115' ' ' LYS . . . -106.81 133.03 52.1 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.457 -0.792 . . . . 0.20000000000000001 109.089 176.573 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 38.0 p-80 -137.06 155.65 49.39 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.366 0.506 . . . . 0.23000000000000001 112.366 -170.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.577 HD23 ' N ' ' A' ' 14' ' ' LEU . 5.3 tt -123.13 147.25 46.99 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.694 -0.854 . . . . 0.23999999999999999 108.694 176.377 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.577 ' N ' HD23 ' A' ' 13' ' ' LEU . 23.6 tp -131.64 124.4 29.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.486 0.184 . . . . 0.27000000000000002 111.126 -178.677 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.527 HG23 HD13 ' A' ' 44' ' ' LEU . 58.9 t -112.85 142.03 26.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 109.787 -0.449 . . . . 0.14999999999999999 109.787 175.577 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.429 ' HE3' HD21 ' A' ' 14' ' ' LEU . 31.2 mmtp -114.39 156.36 24.62 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.789 -0.448 . . . . 0.62 109.789 178.306 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.409 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 41.7 p90 -149.96 162.74 39.77 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.513 -0.312 . . . . 0.25 110.26 -176.087 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.474 ' HB3' ' C ' ' A' ' 33' ' ' ALA . 54.0 p -52.06 112.88 0.86 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.786 0.327 . . . . 1.04 111.111 179.046 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 99.63 10.37 47.34 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.327 -0.939 . . . . 0.53000000000000003 113.007 179.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.521 ' C ' ' H ' ' A' ' 22' ' ' ASN . 33.0 p -76.29 23.07 0.15 Allowed 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 117.459 0.63 . . . . 0.69999999999999996 112.462 -174.438 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 86.1 mtt180 69.55 -35.28 0.31 Allowed 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.708 0.803 . . . . 3.4900000000000002 110.355 -175.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.521 ' H ' ' C ' ' A' ' 20' ' ' SER . 13.2 m-80 -140.13 102.25 6.85 Favored Pre-proline 0 N--CA 1.445 -0.717 0 N-CA-C 108.08 -1.082 . . . . 1.77 108.08 174.046 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -68.31 -159.27 0.05 OUTLIER 'Trans proline' 0 CA--C 1.531 0.371 0 C-N-CA 122.894 2.396 . . . . 1.71 111.821 179.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.523 ' N ' HG22 ' A' ' 32' ' ' THR . 16.5 t 62.25 107.16 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-N 115.487 -0.779 . . . . 0.47999999999999998 111.976 178.202 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.417 ' HB3' ' HB2' ' A' ' 16' ' ' LYS . 59.3 p -103.72 155.88 18.24 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.644 -0.502 . . . . 1.1200000000000001 109.644 175.425 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.516 ' HB2' ' HA ' ' A' ' 67' ' ' ASP . 4.7 mpt_? -66.33 -7.85 21.54 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.123 0.487 . . . . 2.54 110.486 174.509 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.484 ' HG2' ' HD3' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -85.54 -27.23 25.71 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.421 -0.808 . . . . 1.77 110.237 178.887 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 26.8 p -108.31 -35.53 6.5 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.873 -0.603 . . . . 0.67000000000000004 111.193 -176.005 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 80.41 -33.98 2.26 Favored Glycine 0 CA--C 1.519 0.304 0 CA-C-N 115.443 -0.799 . . . . 0.81999999999999995 113.483 175.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.439 ' O ' HG22 ' A' ' 24' ' ' VAL . 15.0 t70 -105.13 -66.19 0.99 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.911 0.355 . . . . 2.1000000000000001 110.635 179.44 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 19.2 m -152.3 150.89 30.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.111 0.481 . . . . 1.0800000000000001 111.155 -179.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.523 HG22 ' N ' ' A' ' 24' ' ' VAL . 8.9 t -123.62 19.03 9.56 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 122.005 0.907 . . . . 0.34000000000000002 109.347 178.012 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.474 ' C ' ' HB3' ' A' ' 18' ' ' SER . . . -67.35 -5.26 13.61 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.066 -0.97 . . . . 0.37 112.364 177.449 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -92.39 -24.34 18.91 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.889 0.376 . . . . 2.21 111.111 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.444 HG13 ' OG1' ' A' ' 32' ' ' THR . 0.2 OUTLIER -101.78 137.15 30.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 116.138 -0.483 . . . . 0.31 109.965 -179.573 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 77.1 p -94.04 177.48 5.96 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 116.289 -0.414 . . . . 0.39000000000000001 110.054 -173.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.53 ' O ' HG13 ' A' ' 41' ' ' ILE . 15.4 p90 -63.37 -30.53 71.65 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 119.917 -0.713 . . . . 1.53 109.435 176.408 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -69.46 -47.78 62.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.081 -0.509 . . . . 0.95999999999999996 110.595 178.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 39.5 m-20 -70.38 -27.84 64.63 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.98 -0.555 . . . . 0.91000000000000003 110.26 179.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.409 ' HB2' ' HB3' ' A' ' 17' ' ' PHE . . . -74.31 -39.06 63.12 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.495 -0.775 . . . . 0.19 110.329 177.73 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.53 HG13 ' O ' ' A' ' 37' ' ' TYR . 80.6 mt -64.46 -36.71 78.05 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 109.524 -0.547 . . . . 0.29999999999999999 109.524 174.133 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.45 ' O ' ' HG3' ' A' ' 46' ' ' LYS . 26.3 mtpp -64.12 -25.0 67.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.942 0.401 . . . . 2.3199999999999998 110.485 175.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.45 ' HG3' ' NE1' ' A' ' 47' ' ' TRP . 6.9 tt0 -83.88 -51.76 6.92 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.892 -0.595 . . . . 1.02 109.823 -179.188 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.912 HD22 ' HB3' ' A' ' 111' ' ' LEU . 34.0 tp -60.69 -38.76 86.07 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.786 -0.643 . . . . 0.17000000000000001 110.479 -179.744 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.491 ' O ' ' HB2' ' A' ' 49' ' ' GLN . 5.0 mm-40 -61.51 -38.28 86.8 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.189 -0.459 . . . . 0.87 112.146 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.45 ' HG3' ' O ' ' A' ' 42' ' ' LYS . 68.3 mttm -72.78 -38.68 67.19 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.672 0.273 . . . . 1.3100000000000001 111.083 -177.723 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.45 ' NE1' ' HG3' ' A' ' 43' ' ' GLU . 9.8 m95 -70.83 -45.85 63.81 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.885 -0.326 . . . . 0.52000000000000002 110.863 178.06 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.463 ' HB3' HG21 ' A' ' 113' ' ' ILE . 89.1 p -64.36 -28.3 69.61 Favored 'General case' 0 CA--C 1.528 0.122 0 N-CA-C 110.073 -0.343 . . . . 0.81999999999999995 110.073 177.356 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.491 ' HB2' ' O ' ' A' ' 45' ' ' GLN . 12.5 tt0 -64.68 -52.05 59.3 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 116.018 -0.537 . . . . 0.53000000000000003 109.952 175.368 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.639 ' HB3' HG22 ' A' ' 56' ' ' VAL . 84.4 mtt180 -61.05 -46.73 89.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.548 -0.751 . . . . 0.41999999999999998 111.205 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.465 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 85.3 mt -56.69 -43.67 79.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.291 -0.413 . . . . 0.20000000000000001 110.872 177.185 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.68 -42.62 81.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.117 -0.492 . . . . 0.27000000000000002 111.927 -179.339 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 51.3 p -77.7 -30.39 51.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.934 0.397 . . . . 0.34999999999999998 111.367 -177.187 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 108.68 8.96 27.6 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.564 -0.827 . . . . 0.29999999999999999 112.242 179.006 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.504 ' OE1' ' HG2' ' A' ' 50' ' ' ARG . 48.6 mt-10 -60.84 -49.37 77.77 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.096 0.475 . . . . 0.65000000000000002 109.913 176.657 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.639 HG22 ' HB3' ' A' ' 50' ' ' ARG . 31.4 m -134.44 154.68 37.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.719 -0.673 . . . . 0.19 109.41 173.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.435 ' OG ' ' HG2' ' A' ' 60' ' ' GLU . 19.8 p -79.44 161.83 25.86 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 110.042 -0.355 . . . . 0.96999999999999997 110.042 176.569 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -55.04 -38.4 67.92 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.377 0.608 . . . . 0.22 109.548 178.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -59.2 -43.45 92.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.885 -1.052 . . . . 1.72 111.828 -179.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.435 ' HG2' ' OG ' ' A' ' 57' ' ' SER . 12.1 mm-40 -64.48 -42.09 96.1 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-O 121.016 0.436 . . . . 2.0899999999999999 110.85 -178.589 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.429 ' O ' ' HG2' ' A' ' 65' ' ' ARG . . . -70.01 -55.85 8.51 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.896 -0.593 . . . . 0.26000000000000001 110.455 179.611 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -54.63 -52.96 60.61 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.513 0.56 . . . . 0.23999999999999999 112.513 -174.041 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.483 ' HA ' ' O ' ' A' ' 71' ' ' TYR . 20.8 t -52.0 -27.95 15.26 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.695 0.628 . . . . 1.0 112.695 -175.633 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -105.28 -44.19 4.81 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.492 0.663 . . . . 0.60999999999999999 110.894 -177.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.484 ' HD3' ' HG2' ' A' ' 27' ' ' ARG . 16.6 mmt180 -83.59 -44.4 14.64 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.944 -1.026 . . . . 0.85999999999999999 113.114 -171.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.449 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 77.6 p -65.21 120.04 11.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.128 0.49 . . . . 0.81999999999999995 111.429 -173.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.516 ' HA ' ' HB2' ' A' ' 26' ' ' ARG . 19.6 t70 -70.81 -16.9 62.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.48 -0.782 . . . . 2.2799999999999998 110.885 177.132 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 0.473 ' O ' ' HD2' ' A' ' 71' ' ' TYR . 53.7 t -77.99 154.96 31.05 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.259 0.552 . . . . 1.52 109.931 178.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -58.94 -12.37 14.83 Favored Glycine 0 C--O 1.234 0.148 0 CA-C-N 114.66 -1.155 . . . . 0.26000000000000001 113.714 -173.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 52.3 p -64.72 -8.07 13.29 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 111.771 0.285 . . . . 0.32000000000000001 111.771 176.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.483 ' O ' ' HA ' ' A' ' 63' ' ' SER . 51.1 p90 -57.59 -25.38 59.95 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.932 0.396 . . . . 0.54000000000000004 110.596 176.631 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -93.98 3.35 55.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.058 0.456 . . . . 0.48999999999999999 111.035 -179.382 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 9.0 m -126.78 14.42 7.47 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.099 -0.5 . . . . 0.70999999999999996 110.772 179.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 67.97 24.7 74.44 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 121.063 -0.589 . . . . 0.54000000000000004 112.54 -178.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 86.91 -17.2 42.57 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 121.16 -0.543 . . . . 0.34999999999999998 112.219 -179.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -74.55 136.79 42.12 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.733 0.302 . . . . 1.6499999999999999 110.682 -176.01 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.419 ' O ' ' HG3' ' A' ' 9' ' ' ARG . 2.4 mp -113.46 157.88 21.39 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 116.248 -0.433 . . . . 0.93999999999999995 110.055 173.218 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -76.19 -107.03 0.13 Allowed Glycine 0 C--N 1.309 -0.953 0 CA-C-N 115.226 -0.897 . . . . 0.44 113.504 -175.497 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 9.1 p90 -120.87 149.0 43.28 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.716 0.293 . . . . 3.8700000000000001 110.796 -178.12 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.432 ' HZ ' ' N ' ' A' ' 10' ' ' ALA . 3.8 p90 -166.27 161.32 16.66 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.547 -0.538 . . . . 1.3100000000000001 109.547 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 73.0 p -105.11 125.45 50.99 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 109.292 -0.632 . . . . 1.1699999999999999 109.292 176.337 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 11.0 p -44.69 122.09 3.0 Favored 'General case' 0 C--O 1.234 0.288 0 O-C-N 123.79 0.681 . . . . 1.1899999999999999 111.618 -178.048 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 114.42 10.46 13.22 Favored Glycine 0 N--CA 1.446 -0.655 0 CA-C-N 115.824 -0.626 . . . . 0.79000000000000004 111.662 -177.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -109.23 -5.48 15.9 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 111.481 0.178 . . . . 1.55 111.481 179.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 26.2 mmt -95.15 -105.05 0.15 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.285 0.564 . . . . 0.72999999999999998 111.085 -175.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . 0.458 ' HB2' ' HB3' ' A' ' 89' ' ' PHE . 44.1 mtt -138.12 148.81 45.33 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 107.381 -1.34 . . . . 1.3899999999999999 107.381 177.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.418 ' HB3' ' HD3' ' A' ' 88' ' ' PRO . 64.6 tttp -51.16 -54.55 36.75 Favored Pre-proline 0 C--N 1.32 -0.685 0 N-CA-C 112.472 0.545 . . . . 2.3700000000000001 112.472 -175.496 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.552 ' HG2' HG22 ' A' ' 107' ' ' THR . 86.5 Cg_endo -75.67 -29.7 6.96 Favored 'Trans proline' 0 C--N 1.356 0.965 0 C-N-CA 121.664 1.576 . . . . 0.27000000000000002 111.997 -177.557 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.595 ' O ' HG23 ' A' ' 93' ' ' VAL . 12.4 t80 -66.32 -56.42 11.23 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.722 -0.672 . . . . 0.22 109.428 178.466 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.534 ' O ' ' HD3' ' A' ' 94' ' ' ARG . 4.2 tp10 -61.4 -36.14 79.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.16 -0.927 . . . . 2.1200000000000001 109.812 -179.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.765 ' HA ' ' NE ' ' A' ' 94' ' ' ARG . 27.2 t70 -54.44 -43.73 71.85 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 115.155 -0.929 . . . . 0.60999999999999999 110.77 177.529 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.67 ' O ' ' HG ' ' A' ' 96' ' ' LEU . . . -71.5 -34.4 70.09 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.022 -0.536 . . . . 0.22 110.765 179.617 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.595 HG23 ' O ' ' A' ' 89' ' ' PHE . 28.4 t -60.86 -49.53 84.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.406 -0.361 . . . . 0.25 111.219 -176.06 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.765 ' NE ' ' HA ' ' A' ' 91' ' ' ASP . 0.1 OUTLIER -75.91 -16.66 59.99 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.516 -0.474 . . . . 2.5899999999999999 110.479 179.463 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -78.34 -13.51 59.82 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.065 -0.516 . . . . 0.46999999999999997 111.439 -176.032 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.67 ' HG ' ' O ' ' A' ' 92' ' ' ALA . 0.4 OUTLIER -123.21 159.6 28.34 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.174 0.511 . . . . 0.28000000000000003 111.137 178.052 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.487 ' HE3' HD13 ' A' ' 98' ' ' ILE . 54.5 tptt -102.27 176.78 5.07 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.321 -0.854 . . . . 1.6100000000000001 109.321 178.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.487 HD13 ' HE3' ' A' ' 97' ' ' LYS . 1.1 mp -47.43 119.97 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 C-N-CA 123.423 0.689 . . . . 0.90000000000000002 111.298 178.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 92.92 -10.53 73.75 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 121.002 -0.618 . . . . 0.46000000000000002 113.071 176.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.59 ' HB2' ' HB2' ' A' ' 96' ' ' LEU . 23.1 m-20 -85.64 131.68 34.3 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 117.115 0.457 . . . . 0.46000000000000002 110.301 -178.418 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 8.7 mt -104.52 143.64 15.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.073 -0.512 . . . . 0.23000000000000001 109.779 179.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 89.2 p -88.22 148.49 42.86 Favored Pre-proline 0 C--N 1.318 -0.799 0 CA-C-N 116.341 -0.39 . . . . 0.92000000000000004 110.402 -178.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -70.1 163.73 37.47 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 122.032 1.821 . . . . 0.34000000000000002 110.615 170.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.862 HG23 HD23 ' A' ' 44' ' ' LEU . 21.5 mm -39.64 100.33 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 N-CA-C 112.959 0.726 . . . . 0.20000000000000001 112.959 179.318 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 1.8 p -104.69 118.13 51.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.979 -0.555 . . . . 1.04 109.798 175.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -85.8 145.52 27.18 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.266 0.555 . . . . 0.55000000000000004 110.801 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.552 HG22 ' HG2' ' A' ' 88' ' ' PRO . 6.1 p -117.28 -172.82 2.29 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.309 -0.86 . . . . 0.37 110.161 179.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -65.63 -35.39 80.67 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 121.011 -0.275 . . . . 2.1600000000000001 110.363 177.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.423 ' O ' ' HB2' ' A' ' 20' ' ' SER . 4.8 t -92.33 -60.96 1.71 Allowed 'General case' 0 N--CA 1.443 -0.778 0 C-N-CA 120.254 -0.578 . . . . 1.0900000000000001 110.606 -179.125 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -145.03 -131.98 2.44 Favored Glycine 0 N--CA 1.44 -1.077 0 C-N-CA 119.015 -1.564 . . . . 0.23999999999999999 113.793 -174.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.912 ' HB3' HD22 ' A' ' 44' ' ' LEU . 6.0 mp -121.53 147.99 45.08 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 114.917 -0.641 . . . . 0.19 111.08 -170.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . 0.5 ' HA ' ' O ' ' A' ' 13' ' ' LEU . 85.4 m-70 -143.25 148.97 37.25 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.313 0.577 . . . . 0.22 112.254 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.659 HG12 HD11 ' A' ' 44' ' ' LEU . 2.5 pt -131.05 135.04 60.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 107.491 -1.3 . . . . 0.17000000000000001 107.491 160.055 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 3.0 mp -130.2 142.79 42.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 C-N-CA 120.866 -0.334 . . . . 0.17999999999999999 110.439 -175.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.483 ' HA ' ' O ' ' A' ' 100' ' ' ASP . 40.9 pttt -123.21 139.18 54.32 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.622 -0.881 . . . . 0.60999999999999999 108.622 172.359 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . 0.521 ' HB2' ' CD1' ' A' ' 96' ' ' LEU . 57.1 ttt180 -83.74 131.74 34.9 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.155 0.502 . . . . 1.8700000000000001 111.052 -177.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.459 ' HB2' ' HG2' ' A' ' 9' ' ' ARG . 4.3 mm? -98.9 -41.11 7.75 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.259 -0.882 . . . . 0.89000000000000001 109.832 179.004 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.4 ' HB3' ' HB3' ' A' ' 9' ' ' ARG . . . . . . . . 0 C--O 1.246 0.899 0 CA-C-O 118.622 -0.704 . . . . 1.1000000000000001 110.409 179.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.52 ' HA ' ' O ' ' A' ' 80' ' ' PHE . 73.1 mmtt . . . . . 0 N--CA 1.452 -0.346 0 CA-C-O 121.304 0.573 . . . . 1.1899999999999999 111.034 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.643 HD23 ' N ' ' A' ' 9' ' ' ARG . 3.2 tt -140.58 154.19 46.39 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 114.921 -1.036 . . . . 1.1799999999999999 108.284 -177.256 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.643 ' N ' HD23 ' A' ' 8' ' ' LEU . 26.5 ttt180 -133.64 132.93 41.34 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.348 -0.982 . . . . 1.0600000000000001 108.348 172.494 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -147.06 150.44 35.07 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.459 -0.496 . . . . 0.22 111.975 -174.094 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.623 ' HA ' ' HA ' ' A' ' 76' ' ' ASP . . . -108.45 133.74 52.2 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-N 115.698 -0.683 . . . . 0.20000000000000001 109.8 177.544 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 45.8 p-80 -138.73 145.09 39.84 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 120.93 0.395 . . . . 0.23000000000000001 111.108 -172.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.562 ' O ' ' HA ' ' A' ' 112' ' ' HIS . 6.6 tt -112.82 142.92 44.91 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.251 -1.018 . . . . 0.23999999999999999 108.251 176.339 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.618 HD13 ' NE2' ' A' ' 112' ' ' HIS . 29.3 tp -128.97 118.41 22.56 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.739 0.304 . . . . 0.27000000000000002 111.021 -175.763 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.519 HG23 HD13 ' A' ' 44' ' ' LEU . 46.3 t -107.88 134.19 50.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 109.501 -0.555 . . . . 0.14999999999999999 109.501 176.348 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.475 ' HE3' HD21 ' A' ' 14' ' ' LEU . 32.7 mmtp -109.45 152.41 25.43 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.754 -0.462 . . . . 0.62 109.754 178.309 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.451 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 47.0 p90 -143.37 162.51 35.55 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.515 -0.311 . . . . 0.25 110.533 -176.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.414 ' HB3' ' HA ' ' A' ' 33' ' ' ALA . 19.9 p -52.08 113.44 1.02 Allowed 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.276 -0.42 . . . . 1.04 111.14 177.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 95.29 10.04 57.45 Favored Glycine 0 C--N 1.334 0.429 0 C-N-CA 120.761 -0.733 . . . . 0.53000000000000003 113.318 179.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.664 ' HB2' ' O ' ' A' ' 109' ' ' SER . 85.6 p -90.0 35.05 0.84 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 117.368 0.584 . . . . 0.69999999999999996 111.523 -175.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.464 ' HB3' ' O ' ' A' ' 20' ' ' SER . 73.7 ttt180 71.82 -34.26 0.29 Allowed 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 120.995 0.426 . . . . 3.4900000000000002 111.16 -179.092 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.451 ' H ' ' C ' ' A' ' 20' ' ' SER . 45.7 m-80 -132.81 93.59 23.4 Favored Pre-proline 0 C--N 1.327 -0.385 0 N-CA-C 109.409 -0.589 . . . . 1.77 109.409 176.069 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.555 ' C ' HG22 ' A' ' 32' ' ' THR . 95.4 Cg_endo -80.83 49.16 3.14 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 122.507 2.138 . . . . 1.71 112.959 -176.326 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.482 ' N ' HG22 ' A' ' 32' ' ' THR . 47.3 t -147.26 117.0 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 N-CA-C 108.759 -0.83 . . . . 0.47999999999999998 108.759 178.052 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 41.2 t -105.89 154.23 20.85 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 110.203 -0.295 . . . . 1.1200000000000001 110.203 177.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.623 ' HB2' ' HA ' ' A' ' 67' ' ' ASP . 6.6 mpt_? -69.01 -5.27 20.7 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.087 0.47 . . . . 2.54 110.422 171.363 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.605 ' HG3' ' CD ' ' A' ' 65' ' ' ARG . 18.3 ttp180 -78.21 -29.58 48.41 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.654 -0.703 . . . . 1.77 109.623 175.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 71.6 p -115.28 -33.78 5.2 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.753 -0.658 . . . . 0.67000000000000004 111.454 -174.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 81.55 -36.39 2.44 Favored Glycine 0 CA--C 1.52 0.371 0 CA-C-N 115.977 -0.556 . . . . 0.81999999999999995 112.905 178.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -95.03 -65.99 0.94 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.801 0.334 . . . . 2.1000000000000001 110.625 -178.059 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 13.7 p -153.94 156.26 37.16 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.949 0.404 . . . . 1.0800000000000001 110.932 178.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.555 HG22 ' C ' ' A' ' 23' ' ' PRO . 14.8 t -120.07 28.63 7.96 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 122.076 0.941 . . . . 0.34000000000000002 109.146 174.054 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.414 ' HA ' ' HB3' ' A' ' 18' ' ' SER . . . -75.78 -5.7 47.09 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.92 -1.036 . . . . 0.37 111.422 -178.085 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -93.82 -25.72 17.24 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.902 -0.59 . . . . 2.21 111.095 -179.042 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.523 HG23 ' HB2' ' A' ' 39' ' ' ASP . 0.2 OUTLIER -98.61 138.77 22.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 116.135 -0.484 . . . . 0.31 109.76 -178.663 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 72.8 p -94.76 176.77 6.14 Favored 'General case' 0 CA--C 1.513 -0.474 0 N-CA-C 109.84 -0.43 . . . . 0.39000000000000001 109.84 -174.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.46 ' O ' HG13 ' A' ' 41' ' ' ILE . 4.1 p90 -63.88 -27.17 68.97 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 119.897 -0.721 . . . . 1.53 109.099 175.534 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -72.75 -46.78 51.66 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.956 -0.565 . . . . 0.95999999999999996 110.301 178.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.523 ' HB2' HG23 ' A' ' 35' ' ' VAL . 42.1 m-20 -64.68 -33.52 76.14 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 121.375 0.607 . . . . 0.91000000000000003 109.633 177.108 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.451 ' HB2' ' HB3' ' A' ' 17' ' ' PHE . . . -68.8 -45.73 70.52 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.985 -1.007 . . . . 0.19 110.64 179.311 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.487 ' CG1' HD21 ' A' ' 111' ' ' LEU . 70.1 mt -62.55 -37.68 79.51 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.345 0 N-CA-C 109.704 -0.48 . . . . 0.29999999999999999 109.704 174.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.446 ' O ' ' HG3' ' A' ' 46' ' ' LYS . 27.8 ttpt -63.73 -22.88 67.13 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.902 -0.59 . . . . 2.3199999999999998 110.126 179.343 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.44 ' HG3' ' CD1' ' A' ' 47' ' ' TRP . 8.7 tp10 -85.45 -54.52 4.52 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.662 -0.699 . . . . 1.02 109.309 179.506 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.947 HD22 ' HB3' ' A' ' 111' ' ' LEU . 29.6 tp -59.81 -36.25 76.38 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.859 -1.064 . . . . 0.17000000000000001 110.55 -174.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.441 ' HA ' HD11 ' A' ' 104' ' ' ILE . 3.9 mm-40 -64.2 -35.82 82.04 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.811 -0.632 . . . . 0.87 112.265 -179.353 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.446 ' HG3' ' O ' ' A' ' 42' ' ' LYS . 95.0 mttt -70.62 -47.42 60.16 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.153 0.501 . . . . 1.3100000000000001 109.801 178.582 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.492 ' NE1' ' HG3' ' A' ' 65' ' ' ARG . 51.3 m95 -61.9 -47.59 84.27 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.8 -0.636 . . . . 0.52000000000000002 111.687 179.199 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.564 ' HB3' HG21 ' A' ' 113' ' ' ILE . 97.5 p -64.32 -22.71 67.04 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.954 0.407 . . . . 0.81999999999999995 110.15 178.251 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -74.17 -57.37 4.0 Favored 'General case' 0 C--O 1.224 -0.261 0 CA-C-N 116.1 -0.5 . . . . 0.53000000000000003 110.063 174.083 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.658 ' HB3' HG22 ' A' ' 56' ' ' VAL . 96.9 mtt180 -61.6 -42.58 99.08 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.624 -0.716 . . . . 0.41999999999999998 111.46 -174.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 98.3 mt -60.39 -35.59 63.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.003 -0.544 . . . . 0.20000000000000001 110.739 177.123 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -79.73 -41.32 26.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.086 -0.506 . . . . 0.27000000000000002 111.32 -179.002 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 58.3 p -74.6 -29.96 61.51 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.21 -0.45 . . . . 0.34999999999999998 111.641 -176.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 107.73 4.87 34.1 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.749 -0.738 . . . . 0.29999999999999999 112.14 -178.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.417 ' HB2' ' HB3' ' A' ' 50' ' ' ARG . 38.3 mt-10 -61.92 -47.23 85.85 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.847 0.356 . . . . 0.65000000000000002 110.049 178.443 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.658 HG22 ' HB3' ' A' ' 50' ' ' ARG . 14.3 m -136.57 165.26 29.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.963 -0.562 . . . . 0.19 109.652 172.212 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 54.5 p -86.15 165.7 16.36 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.945 -0.391 . . . . 0.96999999999999997 109.945 176.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -58.89 -39.4 81.35 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.248 -0.649 . . . . 0.22 109.248 176.366 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -54.35 -54.88 34.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.633 -1.167 . . . . 1.72 111.959 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -56.59 -44.29 80.91 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.09 -0.505 . . . . 2.0899999999999999 111.621 -176.009 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -68.83 -45.9 69.95 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.798 0.332 . . . . 0.26000000000000001 110.816 -179.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.44 -53.52 55.41 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.119 -0.491 . . . . 0.23999999999999999 111.957 -175.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 50.0 m -53.33 -21.33 5.5 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 113.293 0.849 . . . . 1.0 113.293 -176.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -105.22 -46.1 4.32 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.439 0.637 . . . . 0.60999999999999999 110.718 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.605 ' CD ' ' HG3' ' A' ' 27' ' ' ARG . 24.7 mmt180 -93.97 -42.92 8.79 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 114.855 -1.066 . . . . 0.85999999999999999 113.65 -168.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.51 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 80.2 p -64.33 121.77 15.1 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.994 0.426 . . . . 0.81999999999999995 111.437 -174.38 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.623 ' HA ' ' HB2' ' A' ' 26' ' ' ARG . 25.0 t70 -73.63 -17.24 61.19 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.66 -0.7 . . . . 2.2799999999999998 111.568 178.624 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 0.416 ' O ' ' HD1' ' A' ' 71' ' ' TYR . 52.2 t -76.91 155.87 32.49 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.178 0.513 . . . . 1.52 109.926 -179.145 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -58.82 -12.44 14.6 Favored Glycine 0 N--CA 1.454 -0.112 0 CA-C-N 114.81 -1.087 . . . . 0.26000000000000001 113.621 -173.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.437 ' HB3' ' CD1' ' A' ' 77' ' ' LEU . 52.7 p -70.14 -7.82 44.72 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 116.579 0.19 . . . . 0.32000000000000001 111.207 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.416 ' HD1' ' O ' ' A' ' 68' ' ' CYS . 35.0 p90 -56.08 -29.62 60.81 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.861 0.362 . . . . 0.54000000000000004 110.21 175.723 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -90.45 2.85 55.27 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.372 -0.377 . . . . 0.48999999999999999 111.673 -174.063 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 30.0 m -125.39 -15.16 6.25 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.762 0.315 . . . . 0.70999999999999996 111.447 -179.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 107.22 24.14 6.66 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.524 -0.846 . . . . 0.54000000000000004 112.507 -179.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 91.34 -27.57 9.27 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.796 -0.716 . . . . 0.34999999999999998 113.063 176.124 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.623 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 7.5 p-10 -79.89 141.56 36.01 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-O 121.561 0.696 . . . . 1.6499999999999999 111.204 -176.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.472 HD12 ' HA ' ' A' ' 77' ' ' LEU . 0.6 OUTLIER -106.13 176.0 5.31 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 114.755 -1.111 . . . . 0.93999999999999995 109.604 177.187 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -83.88 -150.28 10.51 Favored Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 120.871 -0.68 . . . . 0.44 111.856 178.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.447 ' HA ' ' O ' ' A' ' 8' ' ' LEU . 21.3 p90 -94.15 145.91 24.36 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.101 0.477 . . . . 3.8700000000000001 111.214 -178.481 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.61 ' CE1' ' HB3' ' A' ' 8' ' ' LEU . 2.6 p90 -152.16 172.18 16.77 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.315 -0.995 . . . . 1.3100000000000001 108.315 179.031 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 89.0 p -103.71 142.27 34.63 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 109.139 -0.689 . . . . 1.1699999999999999 109.139 174.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 10.1 m -52.38 122.76 9.37 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.704 -0.68 . . . . 1.1899999999999999 111.615 -173.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.456 ' H ' ' HG3' ' A' ' 90' ' ' GLU . . . 114.69 -12.7 20.64 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.892 -0.67 . . . . 0.79000000000000004 112.998 179.371 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -90.59 45.19 1.24 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 117.013 0.406 . . . . 1.55 111.665 -177.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 26.2 mmt -137.66 -108.28 0.19 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.043 0.449 . . . . 0.72999999999999998 110.297 178.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 59.5 mtt -140.26 150.68 44.38 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.278 -1.008 . . . . 1.3899999999999999 108.278 176.034 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -50.38 -54.27 36.44 Favored Pre-proline 0 C--N 1.322 -0.589 0 N-CA-C 112.682 0.623 . . . . 2.3700000000000001 112.682 -175.478 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.472 ' HG2' HG22 ' A' ' 107' ' ' THR . 84.5 Cg_endo -76.23 -27.45 8.09 Favored 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 121.63 1.553 . . . . 0.27000000000000002 112.036 -176.402 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.635 ' O ' HG23 ' A' ' 93' ' ' VAL . 24.2 t80 -70.06 -55.86 8.42 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.214 -0.903 . . . . 0.22 109.719 -179.422 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.456 ' HG3' ' H ' ' A' ' 83' ' ' GLY . 3.5 tm-20 -66.24 -34.78 78.78 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.392 -0.822 . . . . 2.1200000000000001 110.246 -177.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.49 ' HA ' ' NE ' ' A' ' 94' ' ' ARG . 19.6 t70 -54.64 -36.24 64.32 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.63 -0.713 . . . . 0.60999999999999999 110.86 175.021 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.561 ' O ' ' HG ' ' A' ' 96' ' ' LEU . . . -80.79 -35.47 33.07 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.213 -0.448 . . . . 0.22 110.958 179.172 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.635 HG23 ' O ' ' A' ' 89' ' ' PHE . 21.0 t -62.12 -44.55 99.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.303 0.573 . . . . 0.25 110.625 -178.178 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.49 ' NE ' ' HA ' ' A' ' 91' ' ' ASP . 38.1 ptt180 -73.87 -12.73 60.76 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.714 -0.676 . . . . 2.5899999999999999 110.564 179.279 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -95.11 6.16 49.83 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.067 -0.515 . . . . 0.46999999999999997 111.689 -173.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.561 ' HG ' ' O ' ' A' ' 92' ' ' ALA . 0.7 OUTLIER -141.26 146.87 37.36 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.425 -0.352 . . . . 0.28000000000000003 110.719 177.226 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.419 ' HG3' ' N ' ' A' ' 98' ' ' ILE . 55.2 tptt -88.89 168.95 12.0 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.372 -0.603 . . . . 1.6100000000000001 109.372 178.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.441 ' HA ' ' HG2' ' A' ' 116' ' ' ARG . 70.7 mt -45.54 115.96 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 121.137 0.494 . . . . 0.90000000000000002 111.649 175.737 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 99.63 -4.62 58.1 Favored Glycine 0 N--CA 1.45 -0.416 0 CA-C-N 115.779 -0.646 . . . . 0.46000000000000002 113.324 177.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.533 ' HB2' ' HB2' ' A' ' 96' ' ' LEU . 66.4 m-20 -100.22 144.57 29.09 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 117.099 0.449 . . . . 0.46000000000000002 110.331 179.511 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 8.8 mt -116.03 147.95 19.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.19 -0.459 . . . . 0.23000000000000001 110.562 -174.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 92.5 p -92.5 155.54 42.13 Favored Pre-proline 0 C--N 1.322 -0.588 0 CA-C-N 116.041 -0.527 . . . . 0.92000000000000004 110.612 -179.324 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -71.64 171.63 15.98 Favored 'Trans proline' 0 C--O 1.235 0.345 0 C-N-CA 122.323 2.016 . . . . 0.34000000000000002 111.393 171.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.931 HG23 HD23 ' A' ' 44' ' ' LEU . 22.7 mm -47.62 112.68 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 O-C-N 123.381 0.426 . . . . 0.20000000000000001 111.986 178.514 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.1 p -117.59 118.67 59.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.004 0.431 . . . . 1.04 110.258 176.257 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -85.44 141.65 29.8 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.2 0.524 . . . . 0.55000000000000004 110.373 178.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.472 HG22 ' HG2' ' A' ' 88' ' ' PRO . 7.5 p -115.94 -172.52 2.18 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.461 -0.791 . . . . 0.37 110.637 -178.263 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -58.21 -42.64 86.64 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.903 0.383 . . . . 2.1600000000000001 110.374 178.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.664 ' O ' ' HB2' ' A' ' 20' ' ' SER . 7.8 t -90.68 -61.62 1.63 Allowed 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 116.112 -0.494 . . . . 1.0900000000000001 110.652 -178.476 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -146.62 -133.14 2.42 Favored Glycine 0 N--CA 1.442 -0.941 0 C-N-CA 118.946 -1.597 . . . . 0.23999999999999999 113.499 -172.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.947 ' HB3' HD22 ' A' ' 44' ' ' LEU . 7.6 mp -115.58 145.92 42.23 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.199 -0.501 . . . . 0.19 111.408 -170.625 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . 0.618 ' NE2' HD13 ' A' ' 14' ' ' LEU . 75.4 m-70 -142.06 152.2 43.1 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.392 0.615 . . . . 0.22 112.374 178.611 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.66 HG12 HD11 ' A' ' 44' ' ' LEU . 2.8 pt -134.01 140.73 45.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 107.317 -1.364 . . . . 0.17000000000000001 107.317 158.388 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.409 HG21 HG22 ' A' ' 93' ' ' VAL . 2.2 mp -130.76 148.33 33.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 C-N-CA 120.656 -0.418 . . . . 0.17999999999999999 110.657 -175.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.443 ' HG2' ' HB3' ' A' ' 11' ' ' ALA . 35.6 pttt -132.41 141.3 48.8 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.451 -0.944 . . . . 0.60999999999999999 108.451 171.459 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . 0.546 ' HD3' HD21 ' A' ' 8' ' ' LEU . 5.6 ttp180 -81.47 135.72 35.63 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.198 0.523 . . . . 1.8700000000000001 110.768 -178.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -104.75 -31.87 9.13 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.258 -0.883 . . . . 0.89000000000000001 110.561 -178.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.496 ' HB3' ' HB3' ' A' ' 9' ' ' ARG . . . . . . . . 0 C--O 1.246 0.915 0 CA-C-O 118.445 -0.788 . . . . 1.1000000000000001 110.579 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.629 ' HA ' ' O ' ' A' ' 80' ' ' PHE . 5.9 mptt . . . . . 0 C--O 1.232 0.166 0 CA-C-O 121.566 0.698 . . . . 1.1899999999999999 111.707 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.693 HD23 ' H ' ' A' ' 9' ' ' ARG . 1.5 tt -117.59 160.75 20.75 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 114.494 -1.23 . . . . 1.1799999999999999 107.886 178.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.693 ' H ' HD23 ' A' ' 8' ' ' LEU . 70.4 ttt180 -131.24 132.17 44.43 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 109.42 -0.585 . . . . 1.0600000000000001 109.42 172.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -150.45 150.27 31.11 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.933 0.397 . . . . 0.22 111.824 -175.404 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.407 ' HB3' ' HG2' ' A' ' 115' ' ' LYS . . . -108.54 136.04 48.8 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.732 -0.667 . . . . 0.20000000000000001 109.51 177.481 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 35.9 p-80 -138.83 157.24 46.42 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.088 0.471 . . . . 0.23000000000000001 111.852 -171.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.561 HD23 ' N ' ' A' ' 14' ' ' LEU . 4.8 tt -124.34 146.92 48.54 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.584 -0.895 . . . . 0.23999999999999999 108.584 176.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.561 ' N ' HD23 ' A' ' 13' ' ' LEU . 28.7 tp -131.51 120.66 23.26 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.512 0.196 . . . . 0.27000000000000002 111.028 -178.217 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.581 HG23 HD13 ' A' ' 44' ' ' LEU . 65.2 t -109.32 138.91 34.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 109.874 -0.417 . . . . 0.14999999999999999 109.874 176.417 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.485 ' HE2' ' OG ' ' A' ' 109' ' ' SER . 33.8 mmtp -112.04 154.4 25.42 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.731 -0.47 . . . . 0.62 109.731 176.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.497 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 41.4 p90 -144.26 162.53 36.15 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.267 -0.424 . . . . 0.25 110.351 -176.054 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.517 ' HB3' ' HA ' ' A' ' 33' ' ' ALA . 29.0 p -53.44 108.12 0.31 Allowed 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.046 0.45 . . . . 1.04 110.699 179.144 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 101.32 7.95 48.05 Favored Glycine 0 CA--C 1.522 0.502 0 C-N-CA 120.823 -0.704 . . . . 0.53000000000000003 113.208 -179.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.643 ' HB2' ' O ' ' A' ' 109' ' ' SER . 89.5 p -85.03 49.44 1.74 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 117.33 0.565 . . . . 0.69999999999999996 111.156 -177.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 71.66 -32.99 0.26 Allowed 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.631 0.772 . . . . 3.4900000000000002 110.954 -177.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.487 ' H ' ' C ' ' A' ' 20' ' ' SER . 4.8 p30 -151.97 118.04 3.12 Favored Pre-proline 0 C--N 1.321 -0.673 0 N-CA-C 109.095 -0.706 . . . . 1.77 109.095 174.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.495 ' C ' HG22 ' A' ' 32' ' ' THR . 95.0 Cg_endo -85.39 55.8 4.12 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.52 2.147 . . . . 1.71 113.135 -175.735 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.46 ' N ' HG22 ' A' ' 32' ' ' THR . 25.5 t -146.21 116.4 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 109.577 -0.527 . . . . 0.47999999999999998 109.577 176.197 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.45 ' HB3' ' HB2' ' A' ' 16' ' ' LYS . 66.3 p -104.1 159.24 15.84 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.926 -0.398 . . . . 1.1200000000000001 109.926 175.679 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.52 ' HG2' ' HA ' ' A' ' 67' ' ' ASP . 6.3 mmp_? -71.48 -7.17 45.74 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.397 0.618 . . . . 2.54 109.691 172.066 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.506 ' CG ' ' HD2' ' A' ' 65' ' ' ARG . 3.7 tmm_? -81.06 -36.18 30.81 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.279 -0.873 . . . . 1.77 110.054 178.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 61.8 p -101.71 -34.81 9.32 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.296 0.57 . . . . 0.67000000000000004 110.789 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 85.67 -43.85 3.29 Favored Glycine 0 N--CA 1.45 -0.383 0 CA-C-N 115.738 -0.665 . . . . 0.81999999999999995 112.986 177.241 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -93.0 -63.77 1.18 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.764 0.316 . . . . 2.1000000000000001 110.248 -177.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 19.8 m -153.12 151.67 30.42 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.365 -0.38 . . . . 1.0800000000000001 110.652 176.216 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.495 HG22 ' C ' ' A' ' 23' ' ' PRO . 12.1 t -115.09 34.36 4.9 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 122.19 0.995 . . . . 0.34000000000000002 108.915 176.234 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.517 ' HA ' ' HB3' ' A' ' 18' ' ' SER . . . -80.49 -6.09 57.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 114.946 -1.025 . . . . 0.37 112.102 -172.563 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -94.13 -23.83 17.79 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.38 0.609 . . . . 2.21 110.528 -178.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.4 HG23 ' HB2' ' A' ' 39' ' ' ASP . 0.2 OUTLIER -98.19 135.78 31.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.702 -0.681 . . . . 0.31 110.103 -179.135 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 71.0 p -95.83 179.46 5.1 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.024 -0.535 . . . . 0.39000000000000001 109.95 -175.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.51 ' O ' HG13 ' A' ' 41' ' ' ILE . 13.6 p90 -62.92 -31.11 72.12 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.006 -0.678 . . . . 1.53 109.468 176.335 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -71.89 -46.34 58.09 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-N 116.044 -0.525 . . . . 0.95999999999999996 110.596 178.535 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.4 ' HB2' HG23 ' A' ' 35' ' ' VAL . 28.8 m-20 -67.25 -27.78 67.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.245 0.545 . . . . 0.91000000000000003 109.87 177.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.497 ' HB2' ' HB3' ' A' ' 17' ' ' PHE . . . -71.07 -43.05 68.57 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.513 -0.767 . . . . 0.19 110.366 176.48 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.51 HG13 ' O ' ' A' ' 37' ' ' TYR . 86.5 mt -64.78 -37.08 79.24 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.414 0 N-CA-C 109.494 -0.558 . . . . 0.29999999999999999 109.494 174.358 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.404 ' O ' ' HG3' ' A' ' 46' ' ' LYS . 62.2 tttp -61.49 -28.25 69.17 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.599 -0.728 . . . . 2.3199999999999998 110.209 177.522 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 58.8 tt0 -88.08 -48.23 7.9 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.663 -0.699 . . . . 1.02 110.082 -178.388 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.885 HD23 HG23 ' A' ' 104' ' ' ILE . 32.2 tp -61.15 -36.58 80.17 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.871 -0.604 . . . . 0.17000000000000001 110.021 -179.256 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.46 ' HG2' HG13 ' A' ' 104' ' ' ILE . 4.4 mm-40 -64.08 -36.21 83.26 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-N 115.96 -0.564 . . . . 0.87 111.97 178.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.404 ' HG3' ' O ' ' A' ' 42' ' ' LYS . 98.1 mttt -69.23 -46.3 67.71 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.843 -0.343 . . . . 1.3100000000000001 110.461 179.653 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.4 ' O ' HG13 ' A' ' 51' ' ' ILE . 54.0 m95 -66.0 -46.14 79.06 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.475 -0.33 . . . . 0.52000000000000002 111.188 177.55 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 44.7 t -57.77 -35.27 70.53 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.881 -0.414 . . . . 0.81999999999999995 109.881 175.006 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.449 ' HB2' ' O ' ' A' ' 45' ' ' GLN . 13.0 tt0 -65.6 -55.98 14.69 Favored 'General case' 0 C--O 1.225 -0.233 0 CA-C-N 115.915 -0.584 . . . . 0.53000000000000003 110.488 176.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.634 ' HB3' HG22 ' A' ' 56' ' ' VAL . 93.5 mtt180 -62.15 -42.31 99.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.097 -0.501 . . . . 0.41999999999999998 111.609 -176.235 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.428 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 98.3 mt -60.24 -35.21 60.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.012 0.434 . . . . 0.20000000000000001 110.657 176.474 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -79.99 -38.89 31.22 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.943 -0.571 . . . . 0.27000000000000002 111.542 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 65.2 p -76.68 -29.99 56.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.72 0.295 . . . . 0.34999999999999998 111.456 -176.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 106.38 10.31 29.67 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.539 -0.839 . . . . 0.29999999999999999 112.141 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.424 ' HB2' ' HB3' ' A' ' 50' ' ' ARG . 41.4 mt-10 -67.1 -52.16 45.36 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.047 0.451 . . . . 0.65000000000000002 110.011 176.696 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.634 HG22 ' HB3' ' A' ' 50' ' ' ARG . 15.8 m -132.04 156.06 42.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.925 -0.58 . . . . 0.19 109.748 175.145 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 50.5 m -86.27 159.34 19.47 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.575 -0.528 . . . . 0.96999999999999997 109.575 178.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -52.41 -43.44 64.81 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.027 0.442 . . . . 0.22 110.249 -176.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.591 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 39.9 mt-10 -56.82 -43.49 81.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.236 -0.893 . . . . 1.72 112.105 -179.013 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -60.86 -46.34 90.95 Favored 'General case' 0 CA--C 1.521 -0.141 0 CA-C-O 120.958 0.408 . . . . 2.0899999999999999 110.587 -177.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -69.15 -51.1 41.64 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.048 -0.523 . . . . 0.26000000000000001 110.921 -179.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.78 -52.11 66.86 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.741 0.645 . . . . 0.23999999999999999 112.741 -173.231 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.507 ' HA ' ' O ' ' A' ' 71' ' ' TYR . 20.4 m -51.5 -25.47 6.64 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 112.859 0.688 . . . . 1.0 112.859 -176.726 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -105.36 -46.25 4.26 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.63 0.728 . . . . 0.60999999999999999 110.673 -177.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.506 ' HD2' ' CG ' ' A' ' 27' ' ' ARG . 27.8 mmt180 -88.26 -41.03 13.19 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.872 -1.058 . . . . 0.85999999999999999 113.54 -169.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.513 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 59.6 p -64.79 127.2 30.58 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.68 -0.408 . . . . 0.81999999999999995 111.14 -176.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.52 ' HA ' ' HG2' ' A' ' 26' ' ' ARG . 33.6 t70 -80.15 -10.84 59.78 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.424 0.631 . . . . 2.2799999999999998 111.157 179.091 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 44.8 t -77.56 163.04 26.64 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.94 -0.573 . . . . 1.52 109.688 179.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -61.26 -16.45 49.09 Favored Glycine 0 N--CA 1.454 -0.146 0 CA-C-N 115.642 -0.708 . . . . 0.26000000000000001 112.598 -176.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 61.8 p -65.51 -7.63 15.41 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 112.021 0.378 . . . . 0.32000000000000001 112.021 177.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.507 ' O ' ' HA ' ' A' ' 63' ' ' SER . 14.1 p90 -60.96 -23.64 65.48 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 109.479 -0.563 . . . . 0.54000000000000004 109.479 175.466 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -95.09 5.97 50.37 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.084 0.469 . . . . 0.48999999999999999 110.613 178.003 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 6.2 m -126.02 3.24 7.26 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.097 -0.501 . . . . 0.70999999999999996 110.823 -179.084 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.591 ' O ' ' HA ' ' A' ' 59' ' ' GLU . . . 73.16 25.43 73.34 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.812 -0.708 . . . . 0.54000000000000004 112.047 -175.731 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 83.66 -20.31 12.22 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 121.202 -0.523 . . . . 0.34999999999999998 111.809 -177.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -73.36 133.13 43.72 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.294 -0.453 . . . . 1.6499999999999999 110.672 -175.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.5 mp -115.78 164.1 14.87 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-O 121.307 0.575 . . . . 0.93999999999999995 110.009 175.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -82.5 -154.95 15.97 Favored Glycine 0 C--N 1.305 -1.169 0 CA-C-N 114.964 -1.016 . . . . 0.44 111.808 176.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.631 ' HA ' ' O ' ' A' ' 8' ' ' LEU . 93.3 m-85 -84.17 147.77 27.12 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.037 0.446 . . . . 3.8700000000000001 110.933 -179.478 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.629 ' O ' ' HA ' ' A' ' 7' ' ' LYS . 14.9 p90 -147.8 165.63 29.99 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.647 -0.871 . . . . 1.3100000000000001 108.647 -177.237 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -90.5 149.98 21.97 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 109.645 -0.502 . . . . 1.1699999999999999 109.645 -178.498 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.6 p -58.77 111.7 1.37 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.838 0.351 . . . . 1.1899999999999999 110.629 177.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 99.64 18.11 24.14 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.672 -0.775 . . . . 0.79000000000000004 112.514 -177.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -101.08 18.07 20.74 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.061 0.458 . . . . 1.55 110.98 -178.162 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 26.3 mmt -124.51 -105.31 0.35 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.885 0.374 . . . . 0.72999999999999998 111.057 -177.045 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 82.7 mmm -141.26 152.6 44.66 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.133 -1.062 . . . . 1.3899999999999999 108.133 175.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.431 ' HB3' ' HD3' ' A' ' 88' ' ' PRO . 23.8 ttmm -50.77 -56.39 19.63 Favored Pre-proline 0 C--N 1.321 -0.642 0 N-CA-C 112.701 0.63 . . . . 2.3700000000000001 112.701 -175.707 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.431 ' HD3' ' HB3' ' A' ' 87' ' ' LYS . 85.1 Cg_endo -77.44 -27.85 6.05 Favored 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 121.48 1.453 . . . . 0.27000000000000002 111.928 -176.163 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.683 ' O ' HG23 ' A' ' 93' ' ' VAL . 14.5 t80 -67.98 -56.81 7.6 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.187 -0.915 . . . . 0.22 109.854 -179.325 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -65.25 -38.21 89.62 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.502 -0.772 . . . . 2.1200000000000001 110.143 -178.132 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -57.03 -34.28 68.05 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.475 -0.784 . . . . 0.60999999999999999 110.617 177.17 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -78.91 -26.84 43.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 0.22 110.707 177.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.683 HG23 ' O ' ' A' ' 89' ' ' PHE . 35.5 t -72.28 -36.94 57.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.332 0.587 . . . . 0.25 109.977 -178.577 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.438 ' C ' ' HD2' ' A' ' 94' ' ' ARG . 2.0 ppt_? -83.08 -2.74 56.17 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.844 -0.617 . . . . 2.5899999999999999 110.246 179.237 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -97.43 9.69 41.7 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.093 -0.503 . . . . 0.46999999999999997 111.339 -177.386 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.531 ' HB2' ' HB2' ' A' ' 100' ' ' ASP . 0.4 OUTLIER -144.24 151.11 38.99 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.31 0.576 . . . . 0.28000000000000003 111.461 178.684 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.526 ' HE2' HD13 ' A' ' 98' ' ' ILE . 22.5 tptm -91.34 172.25 8.66 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.253 -0.885 . . . . 1.6100000000000001 109.402 177.011 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.526 HD13 ' HE2' ' A' ' 97' ' ' LYS . 1.3 mp -46.73 120.59 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 C-N-CA 123.344 0.658 . . . . 0.90000000000000002 110.85 176.689 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 97.72 -9.37 64.16 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.761 -0.733 . . . . 0.46000000000000002 113.28 176.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.531 ' HB2' ' HB2' ' A' ' 96' ' ' LEU . 12.1 m-20 -93.11 141.84 27.96 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 117.133 0.466 . . . . 0.46000000000000002 111.055 -177.802 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 9.4 mt -111.4 146.15 16.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.707 -0.679 . . . . 0.23000000000000001 109.668 -179.141 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 97.8 p -89.42 152.45 47.5 Favored Pre-proline 0 C--N 1.319 -0.755 0 CA-C-N 116.361 -0.382 . . . . 0.92000000000000004 110.422 -179.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -69.18 166.79 25.68 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 122.35 2.033 . . . . 0.34000000000000002 111.111 171.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.885 HG23 HD23 ' A' ' 44' ' ' LEU . 29.0 mm -46.07 105.09 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 O-C-N 123.562 0.539 . . . . 0.20000000000000001 112.05 178.693 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.0 p -111.52 121.18 63.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.253 -0.43 . . . . 1.04 110.196 177.445 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -85.57 156.47 20.72 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.228 0.537 . . . . 0.55000000000000004 110.92 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 2.8 p -130.09 -173.17 2.97 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.383 -0.826 . . . . 0.37 110.019 177.357 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -56.51 -49.1 75.73 Favored 'General case' 0 C--N 1.328 -0.341 0 O-C-N 123.213 0.32 . . . . 2.1600000000000001 110.887 177.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.643 ' O ' ' HB2' ' A' ' 20' ' ' SER . 8.3 t -84.14 -60.69 2.02 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 116.212 -0.449 . . . . 1.0900000000000001 110.638 -177.139 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -146.76 -132.71 2.36 Favored Glycine 0 N--CA 1.441 -1.004 0 C-N-CA 118.921 -1.609 . . . . 0.23999999999999999 113.982 -173.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.883 ' HB3' HD22 ' A' ' 44' ' ' LEU . 6.8 mp -118.77 150.41 39.85 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.964 -0.618 . . . . 0.19 111.377 -169.543 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . 0.561 ' HA ' ' O ' ' A' ' 13' ' ' LEU . 85.3 m-70 -144.58 150.15 36.99 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.205 0.526 . . . . 0.22 111.995 179.625 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.632 HG12 HD11 ' A' ' 44' ' ' LEU . 1.4 pt -134.25 137.02 52.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 107.514 -1.291 . . . . 0.17000000000000001 107.514 160.27 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.468 HG21 HG22 ' A' ' 93' ' ' VAL . 2.8 mp -130.53 144.77 36.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 C-N-CA 120.87 -0.332 . . . . 0.17999999999999999 110.826 -175.021 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.472 ' HA ' ' O ' ' A' ' 100' ' ' ASP . 43.2 pttt -126.18 142.53 51.49 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.116 -0.698 . . . . 0.60999999999999999 109.116 173.229 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . 0.462 ' HB2' ' CD1' ' A' ' 96' ' ' LEU . 68.4 ttt180 -84.8 129.03 34.88 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.282 0.563 . . . . 1.8700000000000001 111.338 -178.309 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.407 ' HB2' ' HG2' ' A' ' 9' ' ' ARG . 4.2 mm? -97.34 -39.53 9.17 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.187 -0.915 . . . . 0.89000000000000001 110.4 -179.568 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.243 0.712 0 CA-C-O 118.374 -0.822 . . . . 1.1000000000000001 110.305 -179.332 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 94.8 mmm . . . . . 0 N--CA 1.481 1.117 0 N-CA-C 110.216 -0.29 . . . . 7.2300000000000004 110.216 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 32.0 t 63.86 89.25 0.09 Allowed 'General case' 0 C--N 1.331 -0.2 0 O-C-N 123.634 0.583 . . . . 2.8799999999999999 110.849 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -85.94 -21.08 28.1 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.047 -0.524 . . . . 2.7999999999999998 109.958 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.592 ' HA ' ' O ' ' A' ' 80' ' ' PHE . 69.0 mmtt -77.48 134.6 38.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.434 0.635 . . . . 1.1899999999999999 111.365 -177.485 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.631 ' HB3' ' CE1' ' A' ' 80' ' ' PHE . 2.3 tt -137.02 158.31 44.74 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 114.748 -1.115 . . . . 1.1799999999999999 108.032 -176.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.63 ' H ' HD23 ' A' ' 8' ' ' LEU . 72.2 ttt180 -132.18 130.93 41.71 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 108.928 -0.767 . . . . 1.0600000000000001 108.928 172.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -145.96 154.83 42.34 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.394 -0.523 . . . . 0.22 111.886 -175.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.519 ' HA ' ' HA ' ' A' ' 76' ' ' ASP . . . -114.86 137.04 52.43 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.901 -0.591 . . . . 0.20000000000000001 109.823 177.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 32.4 p-80 -139.69 151.42 45.89 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.06 0.457 . . . . 0.23000000000000001 111.538 -172.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.603 ' O ' ' HA ' ' A' ' 112' ' ' HIS . 5.5 tt -119.08 144.51 46.55 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 108.336 -0.986 . . . . 0.23999999999999999 108.336 177.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.582 HD13 ' NE2' ' A' ' 112' ' ' HIS . 27.0 tp -130.4 120.97 25.07 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.724 0.297 . . . . 0.27000000000000002 111.061 -177.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.535 HG23 HD13 ' A' ' 44' ' ' LEU . 57.3 t -109.04 133.9 52.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 116.108 -0.496 . . . . 0.14999999999999999 109.693 176.119 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.484 ' HE3' HD21 ' A' ' 14' ' ' LEU . 32.7 mmtp -106.03 151.22 24.93 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.274 -0.639 . . . . 0.62 109.274 176.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.422 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 46.6 p90 -142.61 162.23 36.02 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.707 0.289 . . . . 0.25 110.859 -178.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.465 ' HB3' ' HA ' ' A' ' 33' ' ' ALA . 28.7 p -50.59 110.78 0.45 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.93 -0.577 . . . . 1.04 111.194 179.297 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 94.75 8.33 59.47 Favored Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.458 -0.877 . . . . 0.53000000000000003 113.36 177.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.446 ' C ' ' H ' ' A' ' 22' ' ' ASN . 88.5 p -90.83 46.84 1.36 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 117.841 0.82 . . . . 0.69999999999999996 110.51 -178.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 70.8 ttt180 70.87 -35.55 0.33 Allowed 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 123.53 0.732 . . . . 3.4900000000000002 111.511 -178.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.446 ' H ' ' C ' ' A' ' 20' ' ' SER . 49.4 m-80 -140.52 96.86 7.6 Favored Pre-proline 0 C--N 1.326 -0.434 0 N-CA-C 109.623 -0.51 . . . . 1.77 109.623 179.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.51 ' C ' HG22 ' A' ' 32' ' ' THR . 87.4 Cg_endo -83.35 51.67 3.66 Favored 'Trans proline' 0 CA--C 1.536 0.618 0 C-N-CA 122.585 2.19 . . . . 1.71 113.133 -176.141 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.472 ' N ' HG22 ' A' ' 32' ' ' THR . 42.7 t -147.6 113.11 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 123.265 0.626 . . . . 0.47999999999999998 109.332 177.136 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.441 ' HB3' ' HB2' ' A' ' 16' ' ' LYS . 21.5 p -104.36 158.07 16.71 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.946 -0.115 . . . . 1.1200000000000001 110.728 178.405 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.542 ' HB2' ' HA ' ' A' ' 67' ' ' ASP . 0.0 OUTLIER -63.37 -13.78 43.1 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-O 121.551 0.691 . . . . 2.54 110.033 172.313 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.519 ' HG3' ' HD2' ' A' ' 65' ' ' ARG . 0.1 OUTLIER -87.87 -13.81 41.04 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.92 -1.036 . . . . 1.77 110.827 -177.432 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 20.7 p -118.84 -35.22 3.73 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.326 0.584 . . . . 0.67000000000000004 110.511 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 79.4 -42.67 2.42 Favored Glycine 0 N--CA 1.452 -0.262 0 CA-C-N 115.083 -0.962 . . . . 0.81999999999999995 112.852 176.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -94.27 -67.98 0.83 Allowed 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 110.118 -0.327 . . . . 2.1000000000000001 110.118 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.2 m -153.63 146.59 24.48 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.075 -0.512 . . . . 1.0800000000000001 110.304 178.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.51 HG22 ' C ' ' A' ' 23' ' ' PRO . 9.9 t -112.8 33.79 4.79 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 122.545 1.164 . . . . 0.34000000000000002 108.589 175.264 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.465 ' HA ' ' HB3' ' A' ' 18' ' ' SER . . . -80.67 -4.55 54.7 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 114.165 -1.38 . . . . 0.37 111.712 -175.074 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -95.26 -21.42 18.45 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.97 0.415 . . . . 2.21 111.007 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.446 HG23 ' HB2' ' A' ' 39' ' ' ASP . 0.2 OUTLIER -99.18 136.54 29.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.052 -0.522 . . . . 0.31 110.052 179.822 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 56.1 p -95.48 -178.4 4.41 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.329 -0.396 . . . . 0.39000000000000001 110.325 -174.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.423 ' O ' HG13 ' A' ' 41' ' ' ILE . 6.6 p90 -65.17 -27.98 69.08 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.102 -0.703 . . . . 1.53 109.102 176.041 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -72.1 -49.2 38.13 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 115.89 -0.596 . . . . 0.95999999999999996 110.064 177.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.446 ' HB2' HG23 ' A' ' 35' ' ' VAL . 49.1 m-20 -65.12 -30.55 71.49 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-O 121.339 0.59 . . . . 0.91000000000000003 110.041 179.422 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.422 ' HB2' ' HB3' ' A' ' 17' ' ' PHE . . . -70.4 -46.47 63.91 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.184 -0.916 . . . . 0.19 110.427 177.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.497 ' CG1' HD21 ' A' ' 111' ' ' LEU . 70.4 mt -63.33 -36.83 77.67 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.383 0 N-CA-C 109.726 -0.472 . . . . 0.29999999999999999 109.726 175.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.445 ' O ' ' HG3' ' A' ' 46' ' ' LYS . 79.5 tttt -59.16 -31.8 69.31 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.66 -0.7 . . . . 2.3199999999999998 110.169 177.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 53.1 tt0 -88.12 -46.84 8.96 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.635 -0.711 . . . . 1.02 110.149 -176.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.948 HD23 HG23 ' A' ' 104' ' ' ILE . 33.5 tp -60.19 -37.52 80.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.12 -0.491 . . . . 0.17000000000000001 109.854 -179.302 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.5 ' HG2' HG13 ' A' ' 104' ' ' ILE . 1.6 mm-40 -68.06 -21.35 65.0 Favored 'General case' 0 C--O 1.226 -0.175 0 CA-C-N 115.936 -0.575 . . . . 0.87 112.123 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.445 ' HG3' ' O ' ' A' ' 42' ' ' LYS . 68.4 mttm -82.43 -44.87 15.53 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.853 -0.339 . . . . 1.3100000000000001 110.262 178.335 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 43.9 m95 -67.8 -44.44 77.32 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.999 -0.28 . . . . 0.52000000000000002 110.618 177.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 32.4 t -61.15 -26.94 68.04 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.883 -0.414 . . . . 0.81999999999999995 109.883 175.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.459 ' HB2' ' O ' ' A' ' 45' ' ' GLN . 3.9 tt0 -73.0 -56.62 4.87 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 116.152 -0.476 . . . . 0.53000000000000003 109.844 175.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.574 ' HB3' HG22 ' A' ' 56' ' ' VAL . 87.0 mtt180 -59.86 -41.97 92.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.84 -0.618 . . . . 0.41999999999999998 111.882 -176.179 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.482 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 98.0 mt -59.23 -34.76 54.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.101 0.476 . . . . 0.20000000000000001 110.157 176.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -82.22 -37.91 25.31 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.559 -0.746 . . . . 0.27000000000000002 111.87 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.475 ' OG ' ' HA ' ' A' ' 50' ' ' ARG . 46.3 p -78.92 -29.55 44.26 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 111.99 0.367 . . . . 0.34999999999999998 111.99 -176.008 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 107.38 13.1 21.8 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.541 -0.838 . . . . 0.29999999999999999 112.667 179.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.454 ' HB2' ' HB3' ' A' ' 50' ' ' ARG . 33.5 mt-10 -73.99 -44.85 53.24 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.858 0.361 . . . . 0.65000000000000002 110.239 177.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.574 HG22 ' HB3' ' A' ' 50' ' ' ARG . 14.2 m -138.86 158.34 29.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 109.355 -0.609 . . . . 0.19 109.355 172.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 55.1 p -84.53 164.91 18.47 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.68 -0.489 . . . . 0.96999999999999997 109.68 176.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.409 ' HA ' ' CD1' ' A' ' 51' ' ' ILE . 2.2 t80 -57.95 -41.04 81.99 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.224 -0.658 . . . . 0.22 109.224 178.074 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.459 ' CD ' ' H ' ' A' ' 59' ' ' GLU . 1.4 mp0 -56.56 -53.28 59.41 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.898 -1.046 . . . . 1.72 111.381 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 30.6 mm-40 -56.54 -45.48 81.15 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 120.965 0.412 . . . . 2.0899999999999999 111.161 -178.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -68.1 -49.83 58.71 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.192 -0.458 . . . . 0.26000000000000001 111.121 -179.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.33 -53.74 54.74 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.236 0.458 . . . . 0.23999999999999999 112.236 -174.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.557 ' HA ' ' O ' ' A' ' 71' ' ' TYR . 74.7 m -51.63 -24.53 5.63 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 113.35 0.87 . . . . 1.0 113.35 -176.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -104.59 -48.1 3.89 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.564 0.697 . . . . 0.60999999999999999 110.457 -179.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.519 ' HD2' ' HG3' ' A' ' 27' ' ' ARG . 18.5 mmt180 -87.41 -41.37 13.62 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.993 -1.003 . . . . 0.85999999999999999 113.443 -168.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.535 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 58.5 p -64.77 125.43 24.76 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.049 0.452 . . . . 0.81999999999999995 111.301 -175.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.542 ' HA ' ' HB2' ' A' ' 26' ' ' ARG . 24.8 t70 -75.96 -17.76 59.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.69 -0.686 . . . . 2.2799999999999998 111.342 177.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.43 ' O ' ' HD1' ' A' ' 71' ' ' TYR . 41.2 t -77.48 157.43 30.45 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.317 0.579 . . . . 1.52 110.21 -178.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -57.11 -17.79 24.77 Favored Glycine 0 C--N 1.329 0.181 0 CA-C-N 114.482 -1.235 . . . . 0.26000000000000001 114.269 -170.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 51.1 p -69.38 -5.61 24.63 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 111.891 0.33 . . . . 0.32000000000000001 111.891 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.557 ' O ' ' HA ' ' A' ' 63' ' ' SER . 34.6 p90 -56.02 -33.58 65.03 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.014 0.435 . . . . 0.54000000000000004 109.988 175.033 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -94.45 4.82 53.37 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.119 0.485 . . . . 0.48999999999999999 110.911 -177.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.0 m -114.44 -15.99 12.0 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.002 -0.545 . . . . 0.70999999999999996 110.905 -177.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 101.7 19.57 15.23 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.861 -0.685 . . . . 0.54000000000000004 111.641 -176.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 85.8 -27.87 5.2 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 121.193 -0.527 . . . . 0.34999999999999998 112.656 178.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.519 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 7.6 p-10 -86.41 140.86 29.6 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-O 121.776 0.798 . . . . 1.6499999999999999 111.333 -175.275 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.3 mp -102.09 175.57 5.49 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 114.422 -1.263 . . . . 0.93999999999999995 109.84 177.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -86.49 -156.53 28.64 Favored Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 120.842 -0.694 . . . . 0.44 111.413 177.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.558 ' HA ' ' O ' ' A' ' 8' ' ' LEU . 99.3 m-85 -85.29 136.96 33.27 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.022 0.439 . . . . 3.8700000000000001 110.52 179.337 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.631 ' CE1' ' HB3' ' A' ' 8' ' ' LEU . 13.8 p90 -137.96 166.34 24.3 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.655 -0.702 . . . . 1.3100000000000001 109.21 -179.604 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.521 ' O ' ' HB2' ' A' ' 84' ' ' GLU . 15.5 m -90.02 133.12 35.01 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 108.931 -0.766 . . . . 1.1699999999999999 108.931 176.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 20.0 m -53.02 121.42 7.36 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.828 0.347 . . . . 1.1899999999999999 110.834 -178.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 104.86 1.09 42.4 Favored Glycine 0 CA--C 1.519 0.324 0 C-N-CA 120.964 -0.636 . . . . 0.79000000000000004 112.237 -176.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.521 ' HB2' ' O ' ' A' ' 81' ' ' SER . 28.5 tt0 -82.78 -3.79 57.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.777 0.322 . . . . 1.55 111.609 -175.519 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 26.5 mmt -107.94 -144.97 0.39 Allowed 'General case' 0 N--CA 1.438 -1.035 0 N-CA-C 109.451 -0.574 . . . . 0.72999999999999998 109.451 -175.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -93.54 154.52 17.83 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 115.369 -0.832 . . . . 1.3899999999999999 109.089 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.402 ' HB3' ' HD3' ' A' ' 88' ' ' PRO . 22.3 tptm -53.94 -57.1 19.31 Favored Pre-proline 0 C--N 1.321 -0.671 0 N-CA-C 112.07 0.396 . . . . 2.3700000000000001 112.07 -178.127 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.402 ' HD3' ' HB3' ' A' ' 87' ' ' LYS . 68.0 Cg_endo -74.0 -22.1 17.56 Favored 'Trans proline' 0 C--N 1.356 0.962 0 C-N-CA 121.506 1.47 . . . . 0.27000000000000002 111.661 -176.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.615 ' O ' HG23 ' A' ' 93' ' ' VAL . 23.8 t80 -72.8 -56.45 5.22 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.293 -0.867 . . . . 0.22 109.608 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -64.48 -34.83 79.12 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.812 -0.631 . . . . 2.1200000000000001 109.654 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.457 ' HA ' ' NE ' ' A' ' 94' ' ' ARG . 9.9 t70 -52.35 -36.69 54.17 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.74 -0.664 . . . . 0.60999999999999999 111.091 175.029 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.541 ' O ' ' HG ' ' A' ' 96' ' ' LEU . . . -81.98 -35.34 29.06 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.937 -0.574 . . . . 0.22 110.883 179.424 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.615 HG23 ' O ' ' A' ' 89' ' ' PHE . 14.7 t -64.17 -42.76 96.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.201 0.524 . . . . 0.25 110.585 -177.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.457 ' NE ' ' HA ' ' A' ' 91' ' ' ASP . 39.4 ptt180 -70.86 -18.41 62.7 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.022 -0.535 . . . . 2.5899999999999999 110.583 177.415 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -88.66 2.6 52.94 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.921 -0.581 . . . . 0.46999999999999997 111.415 -174.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.632 ' HB2' ' HB2' ' A' ' 100' ' ' ASP . 0.8 OUTLIER -137.98 153.53 49.42 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.132 -0.485 . . . . 0.28000000000000003 110.64 177.621 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.683 ' HG2' ' H ' ' A' ' 98' ' ' ILE . 39.8 tttp -102.7 -179.18 3.89 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 109.18 -0.674 . . . . 1.6100000000000001 109.18 176.413 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.683 ' H ' ' HG2' ' A' ' 97' ' ' LYS . 9.2 mt -51.49 122.4 2.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 120.891 0.377 . . . . 0.90000000000000002 111.309 178.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 93.12 -2.12 71.23 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.9 -0.667 . . . . 0.46000000000000002 113.271 178.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.632 ' HB2' ' HB2' ' A' ' 96' ' ' LEU . 45.7 m-20 -100.19 141.98 32.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 117.423 0.611 . . . . 0.46000000000000002 110.657 -179.474 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 11.8 mt -111.55 147.02 15.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.954 -0.566 . . . . 0.23000000000000001 110.0 -179.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 91.3 p -92.19 152.45 42.58 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 116.419 -0.355 . . . . 0.92000000000000004 110.953 -177.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -68.25 160.15 50.17 Favored 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 122.335 2.023 . . . . 0.34000000000000002 111.095 172.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.948 HG23 HD23 ' A' ' 44' ' ' LEU . 25.6 mm -43.1 107.95 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 O-C-N 123.889 0.743 . . . . 0.20000000000000001 112.115 178.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 1.8 p -113.31 121.78 66.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.991 -0.549 . . . . 1.04 109.983 177.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -85.41 155.44 21.28 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.97 0.414 . . . . 0.55000000000000004 110.4 179.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.403 ' OG1' ' HD2' ' A' ' 112' ' ' HIS . 4.4 p -135.85 -171.17 2.79 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.695 -0.684 . . . . 0.37 110.929 -178.306 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -56.37 -42.69 78.28 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.122 -0.49 . . . . 2.1600000000000001 111.672 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.44 ' O ' ' HD3' ' A' ' 16' ' ' LYS . 5.4 t -113.58 -0.38 14.38 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 112.593 0.59 . . . . 1.0900000000000001 112.593 -170.146 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 166.25 -126.86 1.52 Allowed Glycine 0 N--CA 1.436 -1.31 0 C-N-CA 119.198 -1.477 . . . . 0.23999999999999999 113.31 171.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.902 ' HB3' HD22 ' A' ' 44' ' ' LEU . 7.4 mp -125.79 149.08 48.88 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 114.767 -0.717 . . . . 0.19 111.135 -168.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . 0.603 ' HA ' ' O ' ' A' ' 13' ' ' LEU . 78.4 m-70 -144.05 150.08 37.64 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.21 0.529 . . . . 0.22 111.854 178.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.628 HG12 HD11 ' A' ' 44' ' ' LEU . 2.5 pt -132.7 140.7 46.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 107.577 -1.268 . . . . 0.17000000000000001 107.577 159.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 2.7 mp -130.43 145.17 35.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 C-N-CA 120.813 -0.355 . . . . 0.17999999999999999 110.643 -176.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.456 ' HG2' ' HB3' ' A' ' 11' ' ' ALA . 43.3 pttt -127.74 141.5 51.57 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.725 -0.842 . . . . 0.60999999999999999 108.725 173.047 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.56 ' HB2' ' CD1' ' A' ' 96' ' ' LEU . 55.1 ttt180 -83.72 129.06 34.95 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.212 0.53 . . . . 1.8700000000000001 111.097 -178.033 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -97.02 -34.51 11.15 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.137 -0.938 . . . . 0.89000000000000001 110.105 -179.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.404 ' HB3' ' HB3' ' A' ' 9' ' ' ARG . . . . . . . . 0 C--O 1.246 0.882 0 CA-C-O 118.647 -0.692 . . . . 1.1000000000000001 109.958 178.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 92.9 mtp . . . . . 0 N--CA 1.483 1.183 0 CA-C-O 120.661 0.267 . . . . 7.2300000000000004 110.793 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 35.9 t -153.38 131.73 12.04 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.778 0.323 . . . . 2.8799999999999999 110.479 -178.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -101.31 -9.0 21.59 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.142 0.496 . . . . 2.7999999999999998 110.028 178.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.417 ' HG3' ' HB3' ' A' ' 79' ' ' PHE . 10.3 tptt -83.74 122.05 28.13 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 121.703 0.763 . . . . 1.1899999999999999 111.419 -175.378 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.587 HD23 ' N ' ' A' ' 9' ' ' ARG . 2.1 tt -113.93 157.6 22.2 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 114.25 -1.341 . . . . 1.1799999999999999 107.898 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.587 ' N ' HD23 ' A' ' 8' ' ' LEU . 63.2 ttt180 -141.0 130.32 23.66 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 109.164 -0.68 . . . . 1.0600000000000001 109.164 173.336 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -147.19 152.5 38.5 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 120.251 -0.58 . . . . 0.22 112.15 -178.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -103.97 134.08 47.86 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.311 -0.858 . . . . 0.20000000000000001 109.019 176.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 29.1 p-80 -135.13 148.05 49.66 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.101 0.477 . . . . 0.23000000000000001 111.851 -172.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.556 HD23 ' N ' ' A' ' 14' ' ' LEU . 5.2 tt -115.0 147.97 39.41 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.518 -0.919 . . . . 0.23999999999999999 108.518 177.457 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.556 ' N ' HD23 ' A' ' 13' ' ' LEU . 18.1 tp -131.65 130.24 41.83 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 110.35 -0.241 . . . . 0.27000000000000002 110.35 -177.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.529 HG23 HD13 ' A' ' 44' ' ' LEU . 56.5 t -119.7 133.63 65.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 109.827 -0.435 . . . . 0.14999999999999999 109.827 174.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.53 ' HE3' HD21 ' A' ' 14' ' ' LEU . 33.4 mmtp -104.96 154.91 19.47 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.066 -0.516 . . . . 0.62 110.503 178.145 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.412 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 50.4 p90 -149.64 161.62 41.83 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.633 -0.712 . . . . 0.25 109.523 -178.057 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.473 ' HB3' ' C ' ' A' ' 33' ' ' ALA . 38.1 p -54.59 110.16 0.6 Allowed 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.147 0.499 . . . . 1.04 110.5 177.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 108.84 9.47 26.4 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.918 -0.658 . . . . 0.53000000000000003 112.356 -176.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.456 ' C ' ' H ' ' A' ' 22' ' ' ASN . 42.5 p -88.06 26.69 1.32 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 117.095 0.448 . . . . 0.69999999999999996 111.81 -175.537 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.417 ' HB2' ' O ' ' A' ' 20' ' ' SER . 83.2 mtt180 72.5 -20.04 0.28 Allowed 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.173 0.589 . . . . 3.4900000000000002 111.459 -178.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.456 ' H ' ' C ' ' A' ' 20' ' ' SER . 7.4 p30 -155.08 107.31 2.28 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-O 121.47 0.653 . . . . 1.77 109.345 171.182 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.41 ' C ' HG22 ' A' ' 32' ' ' THR . 87.5 Cg_endo -81.77 58.81 6.92 Favored 'Trans proline' 0 CA--C 1.534 0.49 0 C-N-CA 122.824 2.35 . . . . 1.71 113.47 -171.289 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.438 ' N ' HG22 ' A' ' 32' ' ' THR . 63.9 t -140.22 121.91 15.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 122.6 0.36 . . . . 0.47999999999999998 110.138 178.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 28.3 t -103.06 149.55 24.47 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 109.235 -0.654 . . . . 1.1200000000000001 109.235 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.57 ' HB2' ' HA ' ' A' ' 67' ' ' ASP . 2.1 mpt_? -77.38 -14.55 59.69 Favored 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 108.443 -0.947 . . . . 2.54 108.443 173.089 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.488 ' HG2' ' HD3' ' A' ' 65' ' ' ARG . 1.9 tmm_? -76.41 -35.51 58.54 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 114.575 -1.193 . . . . 1.77 109.558 175.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 44.2 p -97.62 -34.19 11.04 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 121.273 0.558 . . . . 0.67000000000000004 110.595 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 75.37 -10.41 11.43 Favored Glycine 0 N--CA 1.452 -0.269 0 CA-C-N 115.492 -0.776 . . . . 0.81999999999999995 113.032 178.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -115.93 -71.36 0.74 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.886 0.374 . . . . 2.1000000000000001 109.995 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.2 p -152.51 154.83 36.26 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.031 -0.531 . . . . 1.0800000000000001 110.679 179.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.447 HG21 ' CB ' ' A' ' 16' ' ' LYS . 8.8 t -123.01 34.9 5.01 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 122.147 0.975 . . . . 0.34000000000000002 109.712 175.332 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.473 ' C ' ' HB3' ' A' ' 18' ' ' SER . . . -79.6 -5.57 55.29 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.181 -0.918 . . . . 0.37 112.309 -174.392 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -97.68 -25.27 15.16 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.083 0.468 . . . . 2.21 111.159 -179.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.502 HG23 ' HB2' ' A' ' 39' ' ' ASP . 0.3 OUTLIER -93.5 137.68 22.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 116.128 -0.487 . . . . 0.31 110.174 -177.074 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 56.8 p -98.17 -178.29 4.0 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.442 -0.577 . . . . 0.39000000000000001 109.442 -178.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.517 ' O ' HG13 ' A' ' 41' ' ' ILE . 0.2 OUTLIER -66.18 -24.27 66.61 Favored 'General case' 0 C--O 1.219 -0.518 0 C-N-CA 119.291 -0.963 . . . . 1.53 110.013 173.522 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -70.01 -45.7 66.67 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.887 -0.412 . . . . 0.95999999999999996 109.887 175.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.502 ' HB2' HG23 ' A' ' 35' ' ' VAL . 26.3 m-20 -69.01 -30.96 69.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.503 0.668 . . . . 0.91000000000000003 109.758 177.334 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.412 ' HB2' ' HB3' ' A' ' 17' ' ' PHE . . . -73.3 -42.26 62.59 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.139 -0.937 . . . . 0.19 110.863 179.15 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.517 HG13 ' O ' ' A' ' 37' ' ' TYR . 69.4 mt -63.54 -35.89 74.29 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.299 0 N-CA-C 109.494 -0.558 . . . . 0.29999999999999999 109.494 174.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 20.3 ttpt -62.96 -23.62 67.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.363 0.601 . . . . 2.3199999999999998 109.896 178.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.509 ' HG3' ' CD1' ' A' ' 47' ' ' TRP . 2.2 tp10 -87.67 -56.95 3.13 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.09 -0.959 . . . . 1.02 109.378 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.884 HD23 HG23 ' A' ' 104' ' ' ILE . 31.9 tp -59.24 -36.8 76.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.088 -0.96 . . . . 0.17000000000000001 110.82 -174.213 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.589 ' O ' ' HB2' ' A' ' 49' ' ' GLN . 0.0 OUTLIER -67.07 -29.76 69.63 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 116.159 -0.473 . . . . 0.87 112.25 -177.407 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 44.5 mttp -78.29 -42.76 29.91 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.814 0.34 . . . . 1.3100000000000001 110.316 178.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.509 ' CD1' ' HG3' ' A' ' 43' ' ' GLU . 49.4 m95 -66.81 -44.45 81.15 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.384 -0.371 . . . . 0.52000000000000002 111.364 178.226 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.508 ' HB3' HG21 ' A' ' 113' ' ' ILE . 88.9 p -64.7 -32.17 73.72 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 110.017 -0.364 . . . . 0.81999999999999995 110.017 176.245 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.589 ' HB2' ' O ' ' A' ' 45' ' ' GLN . 11.0 tt0 -66.13 -49.81 66.16 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.1 -0.5 . . . . 0.53000000000000003 110.274 177.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.602 ' HB3' HG22 ' A' ' 56' ' ' VAL . 87.9 mtt180 -64.14 -44.49 91.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.755 -0.657 . . . . 0.41999999999999998 111.272 -179.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.412 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 88.3 mt -59.84 -39.35 79.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.362 -0.381 . . . . 0.20000000000000001 110.654 177.085 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.27 -36.21 68.94 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.232 -0.44 . . . . 0.27000000000000002 111.863 -179.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 24.6 p -85.19 -30.32 24.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.896 0.379 . . . . 0.34999999999999998 111.474 -177.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 108.91 11.34 22.86 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.62 -0.8 . . . . 0.29999999999999999 112.742 178.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.47 ' OE1' ' HG2' ' A' ' 50' ' ' ARG . 46.9 mt-10 -62.56 -49.51 74.99 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.612 -0.514 . . . . 0.65000000000000002 109.612 175.319 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.602 HG22 ' HB3' ' A' ' 50' ' ' ARG . 14.6 m -132.16 155.28 41.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.591 -0.731 . . . . 0.19 109.359 173.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.1 m -83.29 160.43 21.71 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 109.236 -0.653 . . . . 0.96999999999999997 109.236 178.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -54.93 -44.11 73.96 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.619 -0.512 . . . . 0.22 109.619 -179.097 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.552 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 39.9 mt-10 -59.15 -43.41 92.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.12 -0.945 . . . . 1.72 111.8 -179.178 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 -61.62 -49.05 78.14 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 120.964 0.411 . . . . 2.0899999999999999 110.519 -177.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -67.53 -50.16 59.97 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.926 -0.579 . . . . 0.26000000000000001 110.902 -178.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -58.6 -51.97 67.67 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.573 0.583 . . . . 0.23999999999999999 112.573 -174.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.571 ' HA ' ' O ' ' A' ' 71' ' ' TYR . 23.9 m -51.32 -27.26 9.13 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.736 0.643 . . . . 1.0 112.736 -177.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -102.68 -44.67 5.24 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.533 0.683 . . . . 0.60999999999999999 110.654 -178.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.488 ' HD3' ' HG2' ' A' ' 27' ' ' ARG . 25.3 mmt180 -94.6 -35.91 12.02 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 114.2 1.185 . . . . 0.85999999999999999 114.2 -169.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.544 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 33.7 p -66.7 128.13 35.07 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.9 0.381 . . . . 0.81999999999999995 110.797 -177.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.57 ' HA ' ' HB2' ' A' ' 26' ' ' ARG . 40.0 m-20 -90.92 5.54 48.22 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.701 -0.681 . . . . 2.2799999999999998 111.644 -177.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.472 ' O ' ' HD1' ' A' ' 71' ' ' TYR . 36.1 t -88.22 170.0 11.39 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.67 -0.493 . . . . 1.52 109.67 174.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -63.56 -19.02 62.06 Favored Glycine 0 N--CA 1.454 -0.142 0 C-N-CA 121.08 -0.581 . . . . 0.26000000000000001 111.962 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 55.3 p -65.93 -6.92 13.94 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 112.532 0.567 . . . . 0.32000000000000001 112.532 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.571 ' O ' ' HA ' ' A' ' 63' ' ' SER . 20.0 p90 -60.68 -23.16 64.62 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.216 0.532 . . . . 0.54000000000000004 109.747 176.171 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -89.28 -1.48 58.08 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.188 -0.46 . . . . 0.48999999999999999 111.055 179.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.5 m -126.17 6.94 7.15 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.91 0.386 . . . . 0.70999999999999996 110.998 -179.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.552 ' O ' ' HA ' ' A' ' 59' ' ' GLU . . . 73.37 30.39 62.59 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.634 -0.793 . . . . 0.54000000000000004 112.195 -177.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 85.45 -22.21 11.3 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 121.12 -0.562 . . . . 0.34999999999999998 111.801 -179.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -64.32 134.67 55.13 Favored 'General case' 0 CA--C 1.508 -0.663 0 CA-C-N 115.203 -0.498 . . . . 1.6499999999999999 111.49 -176.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.431 ' HB3' ' HE2' ' A' ' 80' ' ' PHE . 2.6 mp -117.52 158.18 25.0 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 115.685 -0.689 . . . . 0.93999999999999995 109.334 169.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -78.63 -150.05 4.83 Favored Glycine 0 C--N 1.308 -0.977 0 CA-C-N 115.023 -0.989 . . . . 0.44 112.72 -179.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.417 ' HB3' ' HG3' ' A' ' 7' ' ' LYS . 97.7 m-85 -88.52 144.82 26.1 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.203 0.525 . . . . 3.8700000000000001 111.697 -178.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.431 ' HE2' ' HB3' ' A' ' 77' ' ' LEU . 1.6 p90 -158.3 153.63 25.82 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.123 -0.944 . . . . 1.3100000000000001 108.803 -177.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 29.3 m -82.39 133.64 35.22 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.115 -0.698 . . . . 1.1699999999999999 109.115 178.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 4.5 p -49.98 121.14 5.02 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.997 -0.547 . . . . 1.1899999999999999 111.514 -178.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 114.49 -17.18 18.86 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.847 -0.692 . . . . 0.79000000000000004 112.938 -178.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 65.6 mt-10 -83.55 46.71 1.18 Allowed 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 117.092 0.446 . . . . 1.55 111.486 -176.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 25.7 mmt -137.68 -122.59 0.14 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.053 0.454 . . . . 0.72999999999999998 110.482 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 54.9 mtt -125.34 149.59 47.97 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.163 -1.051 . . . . 1.3899999999999999 108.163 176.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 16.3 tppt? -54.12 -52.76 65.71 Favored Pre-proline 0 C--N 1.32 -0.715 0 N-CA-C 112.423 0.527 . . . . 2.3700000000000001 112.423 -174.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.49 ' HG2' HG22 ' A' ' 107' ' ' THR . 74.0 Cg_endo -75.42 -23.62 12.95 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 121.336 1.357 . . . . 0.27000000000000002 112.136 -176.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.596 ' O ' HG23 ' A' ' 93' ' ' VAL . 45.3 t80 -74.34 -55.39 6.06 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.396 -0.82 . . . . 0.22 109.868 179.354 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -64.75 -34.33 78.07 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.614 -0.721 . . . . 2.1200000000000001 110.087 -178.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.498 ' HA ' ' NE ' ' A' ' 94' ' ' ARG . 19.2 t70 -53.44 -35.94 61.03 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.929 -0.578 . . . . 0.60999999999999999 110.753 175.13 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.478 ' O ' ' HG ' ' A' ' 96' ' ' LEU . . . -80.4 -36.19 34.15 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.341 -0.391 . . . . 0.22 110.957 178.511 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.596 HG23 ' O ' ' A' ' 89' ' ' PHE . 15.4 t -64.27 -41.67 93.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.275 0.559 . . . . 0.25 110.693 -177.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.498 ' NE ' ' HA ' ' A' ' 91' ' ' ASP . 36.4 ptt180 -76.1 -12.21 60.07 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.833 -0.621 . . . . 2.5899999999999999 110.449 178.194 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -97.32 21.16 10.42 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.085 -0.507 . . . . 0.46999999999999997 111.314 -174.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.543 ' HB2' ' HB2' ' A' ' 100' ' ' ASP . 0.4 OUTLIER -152.32 156.35 39.44 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.86 -0.609 . . . . 0.28000000000000003 110.604 175.074 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.468 ' HG3' ' H ' ' A' ' 98' ' ' ILE . 50.8 tptt -99.01 175.92 5.75 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.502 -0.772 . . . . 1.6100000000000001 108.96 179.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.468 ' H ' ' HG3' ' A' ' 97' ' ' LYS . 67.3 mt -57.19 117.66 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 120.887 0.375 . . . . 0.90000000000000002 110.752 178.184 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 96.37 9.09 57.1 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.821 -0.704 . . . . 0.46000000000000002 112.748 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.543 ' HB2' ' HB2' ' A' ' 96' ' ' LEU . 21.7 m-20 -110.83 141.62 43.95 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 110.001 -0.37 . . . . 0.46000000000000002 110.001 176.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 12.3 mt -111.8 149.94 14.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.212 -0.449 . . . . 0.23000000000000001 110.002 -177.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 99.6 p -95.04 143.36 25.97 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 116.619 -0.264 . . . . 0.92000000000000004 110.525 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -66.65 164.79 27.7 Favored 'Trans proline' 0 N--CA 1.461 -0.41 0 C-N-CA 122.319 2.013 . . . . 0.34000000000000002 110.93 171.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.884 HG23 HD23 ' A' ' 44' ' ' LEU . 20.2 mm -39.48 113.34 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 O-C-N 123.817 0.698 . . . . 0.20000000000000001 112.571 -179.08 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 1.8 p -121.37 121.62 65.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.949 -0.568 . . . . 1.04 110.121 175.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . 0.437 ' HG2' ' CD1' ' A' ' 111' ' ' LEU . 49.2 mt-30 -85.09 156.58 21.01 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.059 0.457 . . . . 0.55000000000000004 110.394 178.428 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.49 HG22 ' HG2' ' A' ' 88' ' ' PRO . 3.0 p -130.24 -172.49 2.8 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.684 -0.689 . . . . 0.37 110.212 179.042 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -60.96 -36.36 79.18 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.574 0.226 . . . . 2.1600000000000001 110.693 177.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.434 ' OG ' ' HE2' ' A' ' 16' ' ' LYS . 23.3 t -91.51 -61.37 1.66 Allowed 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 120.89 -0.324 . . . . 1.0900000000000001 110.657 -178.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -150.67 -130.93 1.78 Allowed Glycine 0 N--CA 1.442 -0.901 0 C-N-CA 119.287 -1.435 . . . . 0.23999999999999999 113.635 -174.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.882 ' HB3' HD22 ' A' ' 44' ' ' LEU . 7.4 mp -116.48 148.7 40.52 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.332 -0.434 . . . . 0.19 111.392 -171.511 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . 0.502 ' NE2' HD13 ' A' ' 14' ' ' LEU . 86.4 m-70 -144.09 151.88 40.2 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.267 0.556 . . . . 0.22 112.398 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.621 HG12 HD11 ' A' ' 44' ' ' LEU . 3.4 pt -133.21 136.26 55.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 107.484 -1.302 . . . . 0.17000000000000001 107.484 159.273 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 2.8 mp -127.48 144.3 37.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 C-N-CA 120.753 -0.379 . . . . 0.17999999999999999 110.478 -176.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 41.3 pttt -125.76 140.81 52.37 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.773 -0.825 . . . . 0.60999999999999999 108.773 172.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.493 ' HB2' ' CD1' ' A' ' 96' ' ' LEU . 59.2 ttt180 -87.36 134.47 33.57 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.072 0.463 . . . . 1.8700000000000001 111.384 -177.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 6.7 mp -112.1 -24.06 10.1 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.568 -0.742 . . . . 0.89000000000000001 111.187 -178.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.53 ' HB3' ' HB3' ' A' ' 9' ' ' ARG . . . . . . . . 0 C--O 1.243 0.744 0 CA-C-O 118.019 -0.991 . . . . 1.1000000000000001 109.697 176.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 26.7 ptt? . . . . . 0 N--CA 1.484 1.24 0 CA-C-O 120.527 0.203 . . . . 7.2300000000000004 111.148 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 13.5 p -144.83 -80.37 0.17 Allowed 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 120.738 0.304 . . . . 2.8799999999999999 110.664 178.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.52 ' O ' ' HA ' ' A' ' 81' ' ' SER . 12.2 pt-20 -149.22 5.43 0.64 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.136 -0.484 . . . . 2.7999999999999998 111.018 177.507 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 10.9 tptt -84.61 131.62 34.59 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 121.297 0.57 . . . . 1.1899999999999999 109.91 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.682 HD23 ' H ' ' A' ' 9' ' ' ARG . 0.3 OUTLIER -128.21 168.51 15.34 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 114.962 -1.017 . . . . 1.1799999999999999 109.808 -171.807 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.682 ' H ' HD23 ' A' ' 8' ' ' LEU . 70.1 ttt180 -145.64 125.03 13.07 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.064 -0.717 . . . . 1.0600000000000001 109.064 174.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.497 ' N ' ' HZ ' ' A' ' 80' ' ' PHE . . . -145.93 160.57 41.64 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.353 -0.539 . . . . 0.22 112.003 -177.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.582 ' HA ' ' HA ' ' A' ' 76' ' ' ASP . . . -106.65 131.66 53.53 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.282 -0.872 . . . . 0.20000000000000001 109.573 178.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 22.5 p-80 -133.54 140.1 46.99 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.995 0.426 . . . . 0.23000000000000001 111.115 -173.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.674 ' O ' ' HA ' ' A' ' 112' ' ' HIS . 5.9 tt -113.24 137.54 51.32 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.852 -0.796 . . . . 0.23999999999999999 108.852 179.195 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.614 ' HA ' ' O ' ' A' ' 111' ' ' LEU . 23.2 tp -120.8 122.43 40.3 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.892 0.377 . . . . 0.27000000000000002 111.364 -178.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.625 HG23 HD13 ' A' ' 44' ' ' LEU . 57.7 t -108.04 137.69 38.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 109.059 -0.719 . . . . 0.14999999999999999 109.059 171.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.607 ' HE2' ' OG ' ' A' ' 109' ' ' SER . 28.6 mmtp -105.22 164.33 11.91 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.806 -0.442 . . . . 0.62 109.806 178.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 42.9 p90 -155.55 160.57 40.62 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.418 -0.586 . . . . 0.25 109.418 -177.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.436 ' HB3' ' C ' ' A' ' 33' ' ' ALA . 54.2 p -58.09 110.3 0.91 Allowed 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.483 -0.326 . . . . 1.04 110.557 178.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 105.51 10.16 31.8 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.475 -0.869 . . . . 0.53000000000000003 113.15 -178.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.487 ' C ' ' H ' ' A' ' 22' ' ' ASN . 49.8 p -77.44 37.21 0.21 Allowed 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 117.639 0.719 . . . . 0.69999999999999996 112.11 -174.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 60.6 ttt180 68.31 -36.17 0.31 Allowed 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.621 0.769 . . . . 3.4900000000000002 111.065 -176.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.487 ' H ' ' C ' ' A' ' 20' ' ' SER . 8.6 p30 -154.68 119.01 2.58 Favored Pre-proline 0 C--N 1.319 -0.731 0 N-CA-C 107.757 -1.201 . . . . 1.77 107.757 171.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.401 ' HB2' ' H ' ' A' ' 24' ' ' VAL . 68.9 Cg_endo -81.99 -151.72 0.04 OUTLIER 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 122.528 2.152 . . . . 1.71 111.885 -174.474 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.597 ' N ' HG22 ' A' ' 32' ' ' THR . 48.0 t 64.06 111.17 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 123.329 0.652 . . . . 0.47999999999999998 111.588 -175.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.488 ' HB3' ' HB2' ' A' ' 16' ' ' LYS . 35.7 p -103.93 152.92 21.4 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.377 -0.374 . . . . 1.1200000000000001 110.115 177.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.582 ' HG2' ' HA ' ' A' ' 67' ' ' ASP . 3.8 mmp_? -65.34 -12.01 47.68 Favored 'General case' 0 N--CA 1.462 0.159 0 N-CA-C 109.522 -0.547 . . . . 2.54 109.522 172.256 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.555 ' HG3' ' CD ' ' A' ' 65' ' ' ARG . 31.5 ttp180 -67.79 -55.82 11.57 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.377 -0.828 . . . . 1.77 110.01 177.115 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 31.8 p -87.83 -34.11 18.35 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 121.446 0.641 . . . . 0.67000000000000004 110.63 -176.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 70.12 16.89 73.37 Favored Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 115.292 -0.867 . . . . 0.81999999999999995 111.962 -179.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -144.79 -68.41 0.31 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.582 0.229 . . . . 2.1000000000000001 110.548 -178.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.8 p -150.14 147.19 27.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.967 0.413 . . . . 1.0800000000000001 111.61 179.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.597 HG22 ' N ' ' A' ' 24' ' ' VAL . 9.6 t -127.51 16.16 7.06 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.67 0.748 . . . . 0.34000000000000002 109.943 174.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.436 ' C ' ' HB3' ' A' ' 18' ' ' SER . . . -67.77 -4.34 12.16 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.126 -0.943 . . . . 0.37 112.973 -178.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -95.07 -25.5 16.43 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.091 0.472 . . . . 2.21 110.968 -179.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.514 HG23 ' HB2' ' A' ' 39' ' ' ASP . 0.2 OUTLIER -95.6 135.06 30.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.097 -0.501 . . . . 0.31 110.277 -178.364 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 63.4 p -93.36 178.22 5.79 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 109.548 -0.538 . . . . 0.39000000000000001 109.548 -176.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.489 ' O ' HG13 ' A' ' 41' ' ' ILE . 0.1 OUTLIER -67.05 -22.25 65.87 Favored 'General case' 0 C--O 1.22 -0.463 0 C-N-CA 118.809 -1.156 . . . . 1.53 110.12 174.045 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -71.86 -46.97 56.1 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.975 -0.38 . . . . 0.95999999999999996 109.975 175.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.514 ' HB2' HG23 ' A' ' 35' ' ' VAL . 24.9 m-20 -64.19 -35.72 81.71 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.612 0.72 . . . . 0.91000000000000003 109.636 175.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.83 -47.4 66.12 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.888 -1.051 . . . . 0.19 110.788 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.489 HG13 ' O ' ' A' ' 37' ' ' TYR . 60.9 mt -63.02 -35.47 71.75 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.388 0 N-CA-C 110.001 -0.37 . . . . 0.29999999999999999 110.001 176.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.471 ' O ' ' HG3' ' A' ' 46' ' ' LYS . 27.8 ttpt -61.63 -28.69 69.55 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 121.3 0.572 . . . . 2.3199999999999998 109.695 179.424 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -88.6 -48.48 7.53 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.392 -0.822 . . . . 1.02 110.352 -177.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.93 HD23 HG23 ' A' ' 104' ' ' ILE . 29.3 tp -59.57 -36.99 77.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.002 -0.545 . . . . 0.17000000000000001 110.366 -178.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.454 HE21 ' HA ' ' A' ' 45' ' ' GLN . 0.0 OUTLIER -67.97 -21.48 65.07 Favored 'General case' 0 N--CA 1.462 0.134 0 N-CA-C 112.114 0.413 . . . . 0.87 112.114 -179.042 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.471 ' HG3' ' O ' ' A' ' 42' ' ' LYS . 67.8 mttm -82.97 -44.62 15.08 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.929 -0.397 . . . . 1.3100000000000001 109.929 177.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 43.2 m95 -65.63 -45.38 83.25 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.299 -0.409 . . . . 0.52000000000000002 111.181 177.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.512 ' HB3' HG21 ' A' ' 113' ' ' ILE . 97.1 p -65.24 -20.4 66.41 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.885 -0.413 . . . . 0.81999999999999995 109.885 178.191 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.41 ' HB2' ' O ' ' A' ' 45' ' ' GLN . 0.9 OUTLIER -76.34 -56.6 4.49 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 109.541 -0.54 . . . . 0.53000000000000003 109.541 173.693 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.589 ' HB3' HG22 ' A' ' 56' ' ' VAL . 92.5 mtt180 -59.88 -43.09 94.93 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.724 -0.671 . . . . 0.41999999999999998 111.808 -176.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.469 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 95.3 mt -60.46 -33.64 55.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 120.985 0.421 . . . . 0.20000000000000001 110.57 177.279 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -81.42 -38.75 25.99 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.102 -0.499 . . . . 0.27000000000000002 111.317 -179.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 26.7 p -75.99 -29.56 58.25 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.002 0.429 . . . . 0.34999999999999998 111.135 -178.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 106.33 6.54 36.09 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.869 -0.682 . . . . 0.29999999999999999 111.962 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.459 ' HB2' ' HB3' ' A' ' 50' ' ' ARG . 43.2 mt-10 -63.44 -45.65 89.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.809 0.338 . . . . 0.65000000000000002 110.376 178.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.589 HG22 ' HB3' ' A' ' 50' ' ' ARG . 12.7 m -136.73 155.9 34.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 109.562 -0.533 . . . . 0.19 109.562 172.548 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 13.0 m -83.28 159.61 21.88 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.431 -0.581 . . . . 0.96999999999999997 109.431 178.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -56.23 -40.68 74.47 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.544 -0.539 . . . . 0.22 109.544 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -52.12 -50.15 62.25 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.342 -0.844 . . . . 1.72 111.493 178.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -62.18 -46.76 87.52 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.852 -0.613 . . . . 2.0899999999999999 111.392 -173.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -71.1 -40.86 71.26 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.79 0.329 . . . . 0.26000000000000001 111.066 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -64.64 -45.92 84.75 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.445 -0.343 . . . . 0.23999999999999999 111.777 -176.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.47 ' HA ' ' O ' ' A' ' 71' ' ' TYR . 41.9 t -56.63 -27.43 58.35 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 112.658 0.614 . . . . 1.0 112.658 -177.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.483 ' O ' ' HA ' ' A' ' 27' ' ' ARG . 36.4 mt-30 -104.92 -48.58 3.71 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.378 0.609 . . . . 0.60999999999999999 110.632 -176.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.555 ' CD ' ' HG3' ' A' ' 27' ' ' ARG . 21.5 mmt180 -88.66 -41.75 12.43 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.134 -0.939 . . . . 0.85999999999999999 113.174 -169.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.509 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 22.8 t -60.62 122.25 14.23 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.701 0.286 . . . . 0.81999999999999995 111.189 -177.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.582 ' HA ' ' HG2' ' A' ' 26' ' ' ARG . 31.6 t70 -80.18 -7.61 59.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.382 0.61 . . . . 2.2799999999999998 110.639 176.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.492 ' SG ' ' HE1' ' A' ' 112' ' ' HIS . 1.5 m -76.83 160.71 29.03 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.293 0.568 . . . . 1.52 110.082 177.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -67.77 -11.53 60.53 Favored Glycine 0 N--CA 1.45 -0.423 0 CA-C-N 114.785 -1.098 . . . . 0.26000000000000001 112.554 -172.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 76.5 p -75.01 -5.69 45.38 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 111.518 0.192 . . . . 0.32000000000000001 111.518 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.47 ' O ' ' HA ' ' A' ' 63' ' ' SER . 16.8 p90 -54.91 -37.86 66.9 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.156 0.503 . . . . 0.54000000000000004 110.027 175.143 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -95.37 7.54 45.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.146 -0.479 . . . . 0.48999999999999999 110.591 -178.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.9 m -113.54 -14.82 12.64 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.959 -0.564 . . . . 0.70999999999999996 110.998 -177.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 103.5 14.39 25.78 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.775 -0.726 . . . . 0.54000000000000004 112.235 -177.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 88.49 -31.18 4.96 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.995 -0.621 . . . . 0.34999999999999998 112.428 179.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.582 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 8.5 p-10 -85.06 144.61 28.14 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-O 121.579 0.704 . . . . 1.6499999999999999 111.099 -176.217 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.538 ' O ' ' HG3' ' A' ' 9' ' ' ARG . 0.7 OUTLIER -106.4 176.98 4.99 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 114.631 -1.168 . . . . 0.93999999999999995 109.979 177.54 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -90.42 -125.4 3.02 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.928 -0.653 . . . . 0.44 113.006 -176.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 34.3 p90 -98.3 136.32 38.64 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.128 0.489 . . . . 3.8700000000000001 110.96 -177.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.497 ' HZ ' ' N ' ' A' ' 10' ' ' ALA . 5.9 p90 -159.44 144.83 15.8 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.053 -0.721 . . . . 1.3100000000000001 109.053 179.09 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.52 ' HA ' ' O ' ' A' ' 6' ' ' GLU . 4.0 p -94.02 154.51 17.61 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 120.994 0.426 . . . . 1.1699999999999999 110.497 -177.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 15.2 m -64.85 111.43 2.81 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.951 -0.568 . . . . 1.1899999999999999 110.117 179.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.63 ' H ' ' HG3' ' A' ' 90' ' ' GLU . . . 113.46 5.18 22.96 Favored Glycine 0 N--CA 1.447 -0.578 0 CA-C-N 115.601 -0.727 . . . . 0.79000000000000004 111.454 -174.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -111.77 32.84 5.15 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 121.493 0.664 . . . . 1.55 110.366 -177.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 22.1 mmt -137.41 -122.02 0.14 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.068 -0.515 . . . . 0.72999999999999998 110.277 179.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 63.8 mtt -121.1 155.1 35.18 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.293 -1.002 . . . . 1.3899999999999999 108.293 174.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.452 ' HB2' ' HD3' ' A' ' 88' ' ' PRO . 29.9 mmmt -53.15 -58.11 13.77 Favored Pre-proline 0 C--N 1.322 -0.598 0 N-CA-C 112.393 0.516 . . . . 2.3700000000000001 112.393 -177.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.452 ' HD3' ' HB2' ' A' ' 87' ' ' LYS . 77.1 Cg_endo -75.61 -23.7 12.58 Favored 'Trans proline' 0 C--N 1.354 0.838 0 C-N-CA 121.516 1.477 . . . . 0.27000000000000002 111.931 -175.47 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.616 ' O ' HG23 ' A' ' 93' ' ' VAL . 52.7 t80 -71.64 -56.15 6.38 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.472 -0.786 . . . . 0.22 109.762 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.63 ' HG3' ' H ' ' A' ' 83' ' ' GLY . 4.6 tm-20 -67.08 -37.19 83.55 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.647 -0.706 . . . . 2.1200000000000001 110.192 -179.026 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -51.98 -36.01 48.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.687 -0.688 . . . . 0.60999999999999999 110.491 174.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.51 ' O ' ' HG ' ' A' ' 96' ' ' LEU . . . -79.63 -32.95 41.78 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.998 -0.546 . . . . 0.22 111.419 178.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.616 HG23 ' O ' ' A' ' 89' ' ' PHE . 25.9 t -67.4 -39.74 83.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.564 0.697 . . . . 0.25 110.121 -176.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.456 ' C ' ' HD2' ' A' ' 94' ' ' ARG . 0.2 OUTLIER -84.04 -8.0 59.24 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.421 -0.809 . . . . 2.5899999999999999 110.841 179.644 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -88.35 0.77 55.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.296 -0.411 . . . . 0.46999999999999997 111.067 -177.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.598 ' HB2' ' HB2' ' A' ' 100' ' ' ASP . 0.6 OUTLIER -139.36 157.29 46.13 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.1 -0.5 . . . . 0.28000000000000003 110.625 179.446 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.553 ' HG2' ' H ' ' A' ' 98' ' ' ILE . 10.7 tttt -102.53 -175.0 2.7 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.161 -0.681 . . . . 1.6100000000000001 109.161 176.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.553 ' H ' ' HG2' ' A' ' 97' ' ' LYS . 1.3 mp -54.67 120.34 2.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 C-N-CA 123.087 0.555 . . . . 0.90000000000000002 110.584 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 93.18 1.21 67.13 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.812 -0.709 . . . . 0.46000000000000002 113.078 176.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.598 ' HB2' ' HB2' ' A' ' 96' ' ' LEU . 33.4 m-20 -102.17 139.63 37.53 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 117.006 0.403 . . . . 0.46000000000000002 110.411 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 11.9 mt -111.3 148.92 14.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.01 -0.541 . . . . 0.23000000000000001 110.239 -178.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 97.7 p -93.3 158.67 36.71 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 116.404 -0.362 . . . . 0.92000000000000004 110.725 -178.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -71.42 170.0 19.49 Favored 'Trans proline' 0 C--O 1.234 0.285 0 C-N-CA 122.475 2.117 . . . . 0.34000000000000002 111.518 172.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.93 HG23 HD23 ' A' ' 44' ' ' LEU . 19.5 mm -47.33 112.12 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 O-C-N 123.399 0.437 . . . . 0.20000000000000001 111.911 175.08 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 58.9 t -116.75 122.65 70.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.155 -0.475 . . . . 1.04 110.201 176.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -85.78 149.35 25.33 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.032 0.444 . . . . 0.55000000000000004 110.102 176.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 8.1 p -127.77 -172.24 2.63 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.797 -0.638 . . . . 0.37 111.018 -177.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -52.26 -40.75 62.13 Favored 'General case' 0 CA--C 1.518 -0.277 0 O-C-N 123.418 0.449 . . . . 2.1600000000000001 111.276 176.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.607 ' OG ' ' HE2' ' A' ' 16' ' ' LYS . 8.8 t -100.3 -60.53 1.51 Allowed 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 120.196 -0.601 . . . . 1.0900000000000001 111.323 -178.324 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -146.03 -137.13 3.02 Favored Glycine 0 N--CA 1.44 -1.034 0 C-N-CA 118.673 -1.727 . . . . 0.23999999999999999 113.733 -172.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.879 ' HB3' HD22 ' A' ' 44' ' ' LEU . 6.9 mp -109.65 143.16 39.79 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 114.87 -0.665 . . . . 0.19 111.164 -170.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . 0.674 ' HA ' ' O ' ' A' ' 13' ' ' LEU . 85.6 m-70 -143.21 138.49 29.72 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.6 0.593 . . . . 0.22 112.6 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.567 HG12 HD11 ' A' ' 44' ' ' LEU . 3.9 pt -120.96 138.86 50.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 107.753 -1.203 . . . . 0.17000000000000001 107.753 161.068 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 2.9 mp -129.43 143.09 42.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 C-N-CA 120.807 -0.357 . . . . 0.17999999999999999 110.48 -175.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.515 ' HG2' ' HB3' ' A' ' 11' ' ' ALA . 48.8 pttt -127.51 138.57 52.96 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.187 -0.671 . . . . 0.60999999999999999 109.187 173.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.507 ' HB2' ' CD1' ' A' ' 96' ' ' LEU . 70.4 ttt180 -84.22 128.38 34.53 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.051 0.453 . . . . 1.8700000000000001 111.545 -175.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.439 HD21 ' HB2' ' A' ' 11' ' ' ALA . 1.2 mm? -95.12 -45.46 7.2 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.613 -0.721 . . . . 0.89000000000000001 109.999 176.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.892 0 CA-C-O 118.58 -0.724 . . . . 1.1000000000000001 110.379 -179.97 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 22.7 ptm . . . . . 0 N--CA 1.482 1.17 0 CA-C-O 121.471 0.653 . . . . 7.2300000000000004 110.839 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 12.2 p -78.53 -53.51 7.14 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.087 -0.506 . . . . 2.8799999999999999 110.383 179.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -98.29 -18.84 18.15 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.079 -0.51 . . . . 2.7999999999999998 110.038 177.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 43.2 mmtm -76.21 131.28 39.22 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.789 -0.641 . . . . 1.1899999999999999 111.305 -177.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.79 HD23 ' H ' ' A' ' 9' ' ' ARG . 1.3 tt -124.8 165.82 17.32 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 107.413 -1.329 . . . . 1.1799999999999999 107.413 178.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.79 ' H ' HD23 ' A' ' 8' ' ' LEU . 65.9 ttt180 -143.78 127.68 17.35 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 118.11 0.414 . . . . 1.0600000000000001 110.097 177.21 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -150.11 151.5 33.26 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.03 0.443 . . . . 0.22 111.772 -179.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -102.0 138.04 39.49 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.64 -0.709 . . . . 0.20000000000000001 109.114 176.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 33.5 p-80 -138.08 153.34 49.31 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 120.564 -0.454 . . . . 0.23000000000000001 111.842 -171.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.563 HD23 ' N ' ' A' ' 14' ' ' LEU . 5.2 tt -120.69 145.44 47.46 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.508 -0.923 . . . . 0.23999999999999999 108.508 176.116 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.583 ' O ' ' HA ' ' A' ' 66' ' ' SER . 31.2 tp -131.0 118.2 20.27 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.59 0.233 . . . . 0.27000000000000002 110.962 -177.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.615 HG23 HD13 ' A' ' 44' ' ' LEU . 58.5 t -104.72 133.17 49.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 N-CA-C 109.607 -0.516 . . . . 0.14999999999999999 109.607 176.182 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.542 ' HE3' HD21 ' A' ' 14' ' ' LEU . 32.2 mmtp -105.53 138.26 42.01 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.998 -0.547 . . . . 0.62 109.881 177.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.539 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 40.0 p90 -131.1 163.28 28.0 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.845 -0.616 . . . . 0.25 109.344 178.46 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 43.8 p -53.16 109.5 0.43 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.109 0.481 . . . . 1.04 110.269 176.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 108.07 7.94 30.23 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.637 -0.792 . . . . 0.53000000000000003 113.132 -177.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.757 ' HB3' ' O ' ' A' ' 109' ' ' SER . 74.5 m -84.46 38.76 0.7 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 117.042 0.421 . . . . 0.69999999999999996 111.749 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 32.3 ttt85 72.86 -34.0 0.28 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.306 0.643 . . . . 3.4900000000000002 110.944 179.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.447 ' H ' ' C ' ' A' ' 20' ' ' SER . 6.3 p30 -145.08 111.51 4.75 Favored Pre-proline 0 C--N 1.325 -0.482 0 N-CA-C 109.175 -0.676 . . . . 1.77 109.175 171.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.446 ' C ' HG22 ' A' ' 32' ' ' THR . 91.8 Cg_endo -82.62 59.8 7.0 Favored 'Trans proline' 0 CA--C 1.533 0.467 0 C-N-CA 122.92 2.413 . . . . 1.71 113.889 -173.19 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.447 ' N ' HG22 ' A' ' 32' ' ' THR . 43.9 t -145.99 120.81 2.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 109.385 -0.598 . . . . 0.47999999999999998 109.385 175.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 37.7 t -104.73 152.19 22.83 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 110.299 -0.26 . . . . 1.1200000000000001 110.299 178.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.608 ' HG2' ' HA ' ' A' ' 67' ' ' ASP . 5.5 mmp_? -67.72 -9.81 47.04 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.275 0.559 . . . . 2.54 109.764 171.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.57 ' HG3' ' CD ' ' A' ' 65' ' ' ARG . 13.8 ttp180 -76.36 -35.86 58.49 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.369 -0.832 . . . . 1.77 109.78 177.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 64.1 p -105.07 -35.44 7.63 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.896 -0.593 . . . . 0.67000000000000004 111.048 -175.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 84.75 -39.49 2.95 Favored Glycine 0 N--CA 1.451 -0.343 0 CA-C-N 115.683 -0.69 . . . . 0.81999999999999995 112.817 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.419 ' CG ' ' H ' ' A' ' 31' ' ' SER . 8.7 p-10 -91.72 -65.59 1.0 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.747 0.273 . . . . 2.1000000000000001 110.874 -178.032 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.419 ' H ' ' CG ' ' A' ' 30' ' ' ASP . 11.6 p -155.53 157.79 37.43 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.618 0.247 . . . . 1.0800000000000001 110.465 178.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.447 HG22 ' N ' ' A' ' 24' ' ' VAL . 13.4 t -121.76 34.44 5.18 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 122.308 1.051 . . . . 0.34000000000000002 109.148 173.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -79.31 -5.99 55.71 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.853 -1.067 . . . . 0.37 112.146 -173.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -98.1 -24.92 15.11 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.887 0.375 . . . . 2.21 111.156 -178.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.494 HG23 ' HB2' ' A' ' 39' ' ' ASP . 0.3 OUTLIER -91.43 135.73 26.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 120.975 0.417 . . . . 0.31 109.916 -178.795 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 65.7 p -94.5 179.03 5.41 Favored 'General case' 0 CA--C 1.513 -0.476 0 N-CA-C 109.583 -0.525 . . . . 0.39000000000000001 109.583 -175.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.553 ' O ' HG13 ' A' ' 41' ' ' ILE . 8.1 p90 -64.82 -26.26 68.26 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 119.803 -0.759 . . . . 1.53 109.31 176.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -74.83 -44.35 49.73 Favored 'General case' 0 C--N 1.334 -0.087 0 CA-C-N 116.205 -0.452 . . . . 0.95999999999999996 110.629 177.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.494 ' HB2' HG23 ' A' ' 35' ' ' VAL . 45.7 m-20 -64.68 -32.64 74.4 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.642 0.734 . . . . 0.91000000000000003 109.435 177.001 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.539 ' HB2' ' HB3' ' A' ' 17' ' ' PHE . . . -71.07 -38.6 72.45 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.77 -1.104 . . . . 0.19 110.645 178.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.553 HG13 ' O ' ' A' ' 37' ' ' TYR . 77.2 mt -65.09 -36.83 78.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.486 -0.561 . . . . 0.29999999999999999 109.486 173.213 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 9.2 mtpm? -65.53 -17.78 64.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.249 0.547 . . . . 2.3199999999999998 110.774 176.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.536 ' HG3' ' CD1' ' A' ' 47' ' ' TRP . 3.8 tp10 -87.69 -61.22 1.77 Allowed 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.978 -0.749 . . . . 1.02 108.978 175.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.894 HD22 ' HB3' ' A' ' 111' ' ' LEU . 20.9 tp -58.95 -38.12 78.3 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 114.84 -1.073 . . . . 0.17000000000000001 111.572 -173.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.531 ' HB2' ' O ' ' A' ' 41' ' ' ILE . 3.8 mm-40 -68.8 -29.7 68.12 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 112.276 0.473 . . . . 0.87 112.276 -177.048 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 64.4 mttm -81.58 -38.44 26.1 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 120.501 -0.48 . . . . 1.3100000000000001 110.223 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.536 ' CD1' ' HG3' ' A' ' 43' ' ' GLU . 35.4 m95 -67.48 -46.54 72.68 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.198 -0.455 . . . . 0.52000000000000002 111.536 175.462 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.54 ' HB3' HG21 ' A' ' 113' ' ' ILE . 94.3 p -63.77 -30.06 71.2 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.848 -0.427 . . . . 0.81999999999999995 109.848 177.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.442 ' HB2' ' O ' ' A' ' 45' ' ' GLN . 11.9 tt0 -65.29 -53.55 42.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.907 -0.588 . . . . 0.53000000000000003 110.529 174.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.575 ' HB3' HG22 ' A' ' 56' ' ' VAL . 99.4 mtt180 -66.04 -39.49 90.2 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.04 -0.527 . . . . 0.41999999999999998 111.769 -176.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.468 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 99.3 mt -62.45 -34.31 63.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.207 0.527 . . . . 0.20000000000000001 110.236 176.001 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -77.65 -34.98 52.95 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.891 -0.595 . . . . 0.27000000000000002 111.55 179.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.424 ' OG ' ' HA ' ' A' ' 50' ' ' ARG . 33.1 p -82.04 -29.28 32.01 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.963 0.411 . . . . 0.34999999999999998 111.067 -179.053 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 103.65 9.28 38.33 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 121.027 -0.606 . . . . 0.29999999999999999 112.112 179.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -65.13 -45.14 86.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.158 0.504 . . . . 0.65000000000000002 110.019 177.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.575 HG22 ' HB3' ' A' ' 50' ' ' ARG . 11.3 m -135.02 154.78 36.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 109.141 -0.689 . . . . 0.19 109.141 171.115 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 26.1 m -88.2 160.95 17.5 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.676 -0.491 . . . . 0.96999999999999997 109.676 179.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -53.18 -44.69 68.09 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.125 0.488 . . . . 0.22 110.12 -178.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.649 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 44.1 mt-10 -59.32 -32.45 70.08 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.286 -0.87 . . . . 1.72 112.328 -178.293 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -72.95 -51.74 17.26 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.822 0.344 . . . . 2.0899999999999999 110.921 -177.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -65.76 -42.69 90.58 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.216 -0.447 . . . . 0.26000000000000001 111.029 -178.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.8 -53.38 58.65 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.182 -0.463 . . . . 0.23999999999999999 112.079 -175.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.435 ' HA ' ' O ' ' A' ' 71' ' ' TYR . 23.8 t -53.47 -25.49 16.5 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.665 0.617 . . . . 1.0 112.665 -175.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -102.9 -43.01 5.65 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.406 0.622 . . . . 0.60999999999999999 110.567 -176.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.57 ' CD ' ' HG3' ' A' ' 27' ' ' ARG . 17.3 mmt180 -93.72 -42.36 9.19 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 113.858 1.058 . . . . 0.85999999999999999 113.858 -171.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.583 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 54.6 p -65.92 129.84 41.18 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.625 -0.43 . . . . 0.81999999999999995 110.884 -176.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.608 ' HA ' ' HG2' ' A' ' 26' ' ' ARG . 30.1 t70 -85.18 -12.08 53.52 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.294 0.568 . . . . 2.2799999999999998 111.453 179.59 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.456 ' O ' ' HD1' ' A' ' 71' ' ' TYR . 51.2 t -76.18 157.86 32.27 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.459 -0.571 . . . . 1.52 109.459 179.413 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -56.89 -17.02 20.33 Favored Glycine 0 C--N 1.33 0.228 0 CA-C-N 115.189 -0.914 . . . . 0.26000000000000001 113.09 -174.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 57.3 p -63.21 -12.88 31.64 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 111.885 0.328 . . . . 0.32000000000000001 111.885 176.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.456 ' HD1' ' O ' ' A' ' 68' ' ' CYS . 27.3 p90 -57.84 -28.77 64.4 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.996 0.427 . . . . 0.54000000000000004 110.198 176.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -88.84 -1.75 58.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.307 0.575 . . . . 0.48999999999999999 110.365 -178.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 5.3 m -125.38 8.17 7.78 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.554 -0.748 . . . . 0.70999999999999996 110.562 -177.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.649 ' O ' ' HA ' ' A' ' 59' ' ' GLU . . . 73.05 29.72 64.3 Favored Glycine 0 CA--C 1.52 0.371 0 CA-C-N 116.041 -0.527 . . . . 0.54000000000000004 113.118 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.22 -21.16 6.16 Favored Glycine 0 C--O 1.233 0.088 0 C-N-CA 120.94 -0.648 . . . . 0.34999999999999998 112.236 178.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -71.01 132.15 44.72 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 122.853 0.461 . . . . 1.6499999999999999 110.772 -175.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.5 mp -116.02 158.98 22.29 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 121.26 0.552 . . . . 0.93999999999999995 109.885 173.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -86.1 -148.36 11.54 Favored Glycine 0 C--N 1.308 -0.99 0 CA-C-N 114.623 -1.171 . . . . 0.44 112.347 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -80.26 135.46 36.25 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.314 0.578 . . . . 3.8700000000000001 111.462 -179.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -148.02 141.3 25.16 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.249 -0.887 . . . . 1.3100000000000001 109.898 177.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 48.2 m -66.7 129.44 39.87 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 120.813 0.34 . . . . 1.1699999999999999 110.201 177.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.4 p -52.25 116.21 2.11 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.779 -0.646 . . . . 1.1899999999999999 111.216 178.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 114.31 -5.89 23.24 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.967 -0.635 . . . . 0.79000000000000004 112.12 -177.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -91.21 34.27 0.94 Allowed 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 121.158 0.504 . . . . 1.55 110.885 -179.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 25.3 mmt -131.05 -123.16 0.21 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.908 0.385 . . . . 0.72999999999999998 110.411 179.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 65.0 mtt -122.92 157.79 31.82 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.665 -0.865 . . . . 1.3899999999999999 108.665 174.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.506 ' HB3' ' HD3' ' A' ' 88' ' ' PRO . 45.1 tttm -54.39 -55.6 35.58 Favored Pre-proline 0 C--N 1.321 -0.633 0 N-CA-C 112.223 0.453 . . . . 2.3700000000000001 112.223 -174.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.506 ' HD3' ' HB3' ' A' ' 87' ' ' LYS . 91.8 Cg_endo -77.51 -24.06 9.36 Favored 'Trans proline' 0 C--N 1.357 0.986 0 C-N-CA 121.655 1.57 . . . . 0.27000000000000002 111.97 -176.314 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.583 ' O ' HG23 ' A' ' 93' ' ' VAL . 14.7 t80 -67.94 -55.52 12.45 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.672 -0.695 . . . . 0.22 109.162 177.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.422 ' OE2' ' HD2' ' A' ' 94' ' ' ARG . 1.2 tm-20 -63.05 -34.99 78.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.282 -0.872 . . . . 2.1200000000000001 109.859 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.639 ' HA ' ' CZ ' ' A' ' 94' ' ' ARG . 14.7 t70 -51.34 -41.66 60.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.312 -0.858 . . . . 0.60999999999999999 111.365 175.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.618 ' O ' ' HG ' ' A' ' 96' ' ' LEU . . . -77.84 -29.72 50.65 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.274 -0.421 . . . . 0.22 111.318 -179.213 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.583 HG23 ' O ' ' A' ' 89' ' ' PHE . 41.1 t -63.1 -49.36 83.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.281 -0.418 . . . . 0.25 111.661 -173.497 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.639 ' CZ ' ' HA ' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -83.47 -2.81 56.77 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.17 -0.612 . . . . 2.5899999999999999 110.551 -179.233 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -86.2 -16.86 36.44 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.299 -0.41 . . . . 0.46999999999999997 111.219 -178.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.618 ' HG ' ' O ' ' A' ' 92' ' ' ALA . 0.6 OUTLIER -119.21 147.04 44.68 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.243 -0.435 . . . . 0.28000000000000003 110.829 -179.519 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.519 ' HA ' ' NH2' ' A' ' 116' ' ' ARG . 22.5 tptm -82.34 163.13 21.95 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.495 -0.558 . . . . 1.6100000000000001 109.495 177.182 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.517 ' H ' ' CD1' ' A' ' 98' ' ' ILE . 1.3 mp -38.05 118.09 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 O-C-N 123.369 0.418 . . . . 0.90000000000000002 110.644 169.276 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 94.71 -6.36 70.31 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.823 -0.703 . . . . 0.46000000000000002 113.699 176.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.586 ' HB2' ' HB2' ' A' ' 96' ' ' LEU . 44.8 m-20 -94.59 141.89 28.07 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 117.453 0.627 . . . . 0.46000000000000002 110.419 178.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 9.9 mt -110.26 148.76 13.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.095 -0.502 . . . . 0.23000000000000001 110.212 -178.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 88.5 p -93.85 146.46 31.75 Favored Pre-proline 0 C--N 1.319 -0.718 0 CA-C-N 116.315 -0.402 . . . . 0.92000000000000004 110.615 -179.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -68.8 163.27 37.93 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 122.213 1.942 . . . . 0.34000000000000002 110.821 171.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.834 HG23 HD23 ' A' ' 44' ' ' LEU . 22.6 mm -39.86 109.86 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 O-C-N 123.774 0.672 . . . . 0.20000000000000001 112.639 -178.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.0 p -115.35 120.5 64.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.991 -0.55 . . . . 1.04 109.774 175.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -85.56 152.09 23.42 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.267 0.556 . . . . 0.55000000000000004 110.934 -179.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.469 HG22 ' HG2' ' A' ' 88' ' ' PRO . 14.6 p -131.74 -173.61 3.18 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.293 -0.867 . . . . 0.37 110.076 178.047 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -72.3 -22.24 61.22 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.534 0.207 . . . . 2.1600000000000001 111.457 178.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.757 ' O ' ' HB3' ' A' ' 20' ' ' SER . 7.8 t -110.23 -6.35 15.07 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.348 -0.541 . . . . 1.0900000000000001 112.021 -176.336 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 157.14 -131.91 3.07 Favored Glycine 0 N--CA 1.436 -1.327 0 C-N-CA 119.902 -1.142 . . . . 0.23999999999999999 112.545 169.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.894 ' HB3' HD22 ' A' ' 44' ' ' LEU . 5.0 mp -118.17 143.17 46.72 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 114.925 -0.637 . . . . 0.19 111.192 -171.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . 0.577 ' NE2' HD13 ' A' ' 14' ' ' LEU . 86.9 m-70 -139.28 150.04 44.98 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.695 0.628 . . . . 0.22 112.695 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.69 HG12 HD11 ' A' ' 44' ' ' LEU . 2.6 pt -132.31 140.17 48.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 107.615 -1.254 . . . . 0.17000000000000001 107.615 159.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 2.7 mp -131.9 147.58 32.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 C-N-CA 120.948 -0.301 . . . . 0.17999999999999999 110.327 -176.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.424 ' HA ' ' O ' ' A' ' 100' ' ' ASP . 35.9 pttt -130.08 139.13 50.99 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.557 -0.905 . . . . 0.60999999999999999 108.557 172.099 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.724 ' HD3' HD21 ' A' ' 8' ' ' LEU . 5.9 ttp180 -80.85 132.34 35.46 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.241 -0.584 . . . . 1.8700000000000001 110.967 -179.136 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -96.18 -40.52 9.15 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.197 -0.911 . . . . 0.89000000000000001 109.716 177.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.4 ' HB3' ' HB3' ' A' ' 9' ' ' ARG . . . . . . . . 0 C--O 1.244 0.79 0 CA-C-O 118.347 -0.835 . . . . 1.1000000000000001 110.015 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 12.0 tpt . . . . . 0 N--CA 1.48 1.061 0 N-CA-C 109.712 -0.477 . . . . 7.2300000000000004 109.712 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 9.3 p -55.04 -75.96 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 112.249 0.463 . . . . 2.8799999999999999 112.249 -175.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.462 ' O ' ' HA ' ' A' ' 81' ' ' SER . 12.8 pt-20 -94.77 -25.12 16.8 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.992 -0.283 . . . . 2.7999999999999998 110.66 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 66.9 mmtt -74.28 108.76 7.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.365 0.602 . . . . 1.1899999999999999 110.731 177.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.475 HD11 ' CD ' ' A' ' 116' ' ' ARG . 15.6 tp -116.7 173.4 6.65 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.007 -0.997 . . . . 1.1799999999999999 109.385 -178.319 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.453 ' H ' ' HG ' ' A' ' 8' ' ' LEU . 65.3 ttt180 -146.26 126.56 13.94 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.802 -0.444 . . . . 1.0600000000000001 109.802 178.37 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.429 ' N ' ' HZ ' ' A' ' 80' ' ' PHE . . . -146.56 155.02 42.18 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.085 0.469 . . . . 0.22 111.638 -179.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.4 ' N ' HD23 ' A' ' 117' ' ' LEU . . . -106.05 140.7 38.64 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.519 -0.764 . . . . 0.20000000000000001 109.401 177.052 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 50.6 p-80 -139.29 150.45 45.44 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.003 0.43 . . . . 0.23000000000000001 111.341 -173.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.567 ' O ' ' HA ' ' A' ' 112' ' ' HIS . 5.2 tt -118.28 142.75 47.18 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.233 -1.025 . . . . 0.23999999999999999 108.233 176.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.59 HD13 ' NE2' ' A' ' 112' ' ' HIS . 26.6 tp -127.82 121.82 31.09 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.597 0.236 . . . . 0.27000000000000002 110.715 -176.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.563 HG23 HD13 ' A' ' 44' ' ' LEU . 97.4 t -112.01 136.61 47.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 116.133 -0.485 . . . . 0.14999999999999999 109.727 176.032 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.543 ' HE2' ' OG ' ' A' ' 109' ' ' SER . 32.5 mmtp -108.82 164.79 12.07 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.104 -0.498 . . . . 0.62 109.976 177.636 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.5 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 49.8 p90 -158.65 163.14 37.17 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.992 -0.549 . . . . 0.25 110.141 -176.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.496 ' HB3' ' C ' ' A' ' 33' ' ' ALA . 35.8 p -54.13 109.51 0.49 Allowed 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 120.983 0.42 . . . . 1.04 110.715 177.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 103.27 9.82 37.95 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.463 -0.875 . . . . 0.53000000000000003 112.841 -178.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.415 ' C ' ' H ' ' A' ' 22' ' ' ASN . 73.5 p -90.12 40.17 0.99 Allowed 'General case' 0 C--O 1.234 0.264 0 CA-C-N 117.338 0.569 . . . . 0.69999999999999996 111.296 -175.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 50.1 ttt180 75.38 -34.2 0.25 Allowed 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 123.534 0.733 . . . . 3.4900000000000002 110.662 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.415 ' H ' ' C ' ' A' ' 20' ' ' SER . 5.7 p30 -149.6 118.55 3.81 Favored Pre-proline 0 C--N 1.323 -0.55 0 N-CA-C 109.321 -0.622 . . . . 1.77 109.321 173.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.557 ' O ' ' HA ' ' A' ' 31' ' ' SER . 66.2 Cg_endo -86.29 53.33 3.06 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 122.792 2.328 . . . . 1.71 113.353 -172.434 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.484 HG13 ' O ' ' A' ' 30' ' ' ASP . 81.7 t -143.32 121.12 6.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 109.242 -0.651 . . . . 0.47999999999999998 109.242 178.155 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 44.5 t -103.88 152.34 22.06 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.739 -0.467 . . . . 1.1200000000000001 109.739 177.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.641 ' CB ' ' HA ' ' A' ' 67' ' ' ASP . 9.2 tpt180 -73.72 -9.89 59.12 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.241 -0.651 . . . . 2.54 109.241 174.038 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.619 ' HG3' ' HD3' ' A' ' 65' ' ' ARG . 13.9 ttp180 -79.94 -38.27 32.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.306 -0.861 . . . . 1.77 109.737 174.057 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 69.9 p -93.74 -34.14 13.34 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.661 -0.699 . . . . 0.67000000000000004 111.09 -175.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 81.83 -39.24 2.55 Favored Glycine 0 N--CA 1.451 -0.361 0 CA-C-N 115.238 -0.892 . . . . 0.81999999999999995 111.428 -177.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.484 ' O ' HG13 ' A' ' 24' ' ' VAL . 31.2 m-20 -107.45 -139.18 0.37 Allowed 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 108.408 -0.96 . . . . 2.1000000000000001 108.408 175.211 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.557 ' HA ' ' O ' ' A' ' 23' ' ' PRO . 2.7 p -75.27 135.11 40.96 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-O 121.27 0.557 . . . . 1.0800000000000001 111.763 -172.438 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.507 HG22 ' C ' ' A' ' 23' ' ' PRO . 12.3 t -106.79 31.26 5.42 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 107.689 -1.226 . . . . 0.34000000000000002 107.689 168.353 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.496 ' C ' ' HB3' ' A' ' 18' ' ' SER . . . -82.32 -5.14 58.38 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 114.085 -1.416 . . . . 0.37 112.178 -172.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -97.22 -22.77 16.51 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 120.938 0.399 . . . . 2.21 110.906 178.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.491 HG23 ' HB2' ' A' ' 39' ' ' ASP . 0.2 OUTLIER -90.4 136.3 24.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 109.574 -0.528 . . . . 0.31 109.574 179.148 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 71.6 p -94.31 178.42 5.63 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.954 -0.388 . . . . 0.39000000000000001 109.954 -176.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.447 ' O ' HG13 ' A' ' 41' ' ' ILE . 7.8 p90 -64.83 -26.24 68.25 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.003 -0.74 . . . . 1.53 109.003 174.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -71.04 -50.97 28.21 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 115.892 -0.594 . . . . 0.95999999999999996 109.896 176.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.491 ' HB2' HG23 ' A' ' 35' ' ' VAL . 11.6 m-20 -59.04 -37.99 78.29 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-O 121.439 0.638 . . . . 0.91000000000000003 109.711 177.199 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.5 ' HB2' ' HB3' ' A' ' 17' ' ' PHE . . . -67.26 -45.68 75.94 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.821 -1.081 . . . . 0.19 110.7 -178.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.488 ' CG1' HD21 ' A' ' 111' ' ' LEU . 68.8 mt -63.05 -36.83 77.5 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 CA-C-N 116.261 -0.427 . . . . 0.29999999999999999 109.986 176.051 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.418 ' HA ' ' HD2' ' A' ' 42' ' ' LYS . 11.1 mmmm -68.55 -17.83 64.23 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 116.107 -0.497 . . . . 2.3199999999999998 110.982 179.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.452 ' HG3' ' CD1' ' A' ' 47' ' ' TRP . 1.6 tt0 -88.56 -54.67 4.06 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.8 -0.636 . . . . 1.02 109.666 175.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.924 HD22 ' HB3' ' A' ' 111' ' ' LEU . 32.4 tp -58.69 -37.19 75.52 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.629 -0.714 . . . . 0.17000000000000001 110.888 -176.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.457 ' HA ' HD11 ' A' ' 104' ' ' ILE . 3.1 mm-40 -63.77 -40.39 96.57 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.969 0.359 . . . . 0.87 111.969 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -70.5 -41.62 72.42 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 120.919 -0.313 . . . . 1.3100000000000001 110.969 -177.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.452 ' CD1' ' HG3' ' A' ' 43' ' ' GLU . 39.3 m95 -66.76 -46.1 76.41 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.915 -0.314 . . . . 0.52000000000000002 110.621 176.472 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 33.0 t -57.91 -38.96 76.81 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.676 -0.49 . . . . 0.81999999999999995 109.676 175.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -61.06 -52.04 66.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.683 -0.69 . . . . 0.53000000000000003 110.888 176.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.586 ' HB3' HG22 ' A' ' 56' ' ' VAL . 87.0 mtt180 -65.75 -41.18 92.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.812 -0.631 . . . . 0.41999999999999998 111.547 -176.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.432 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 96.7 mt -60.49 -38.24 77.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.146 0.498 . . . . 0.20000000000000001 110.249 175.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.32 -35.24 71.17 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.837 -0.62 . . . . 0.27000000000000002 111.708 178.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 28.2 p -83.97 -31.15 25.7 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.827 0.346 . . . . 0.34999999999999998 111.594 -177.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 107.1 5.25 35.28 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.717 -0.754 . . . . 0.29999999999999999 111.819 -178.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.44 ' HB2' ' HB3' ' A' ' 50' ' ' ARG . 38.8 mt-10 -60.01 -53.18 60.9 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.829 -0.434 . . . . 0.65000000000000002 109.829 176.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.586 HG22 ' HB3' ' A' ' 50' ' ' ARG . 15.8 m -129.81 150.84 35.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 109.292 -0.633 . . . . 0.19 109.292 173.095 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.5 m -80.79 158.39 25.46 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.451 -0.574 . . . . 0.96999999999999997 109.451 179.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.44 ' CD2' ' HD3' ' A' ' 115' ' ' LYS . 2.2 t80 -52.75 -44.15 66.27 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.587 -0.523 . . . . 0.22 109.587 179.494 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.468 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 48.1 mt-10 -56.06 -45.22 79.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.135 -0.939 . . . . 1.72 112.002 179.468 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 34.2 mm-40 -63.85 -47.59 80.13 Favored 'General case' 0 CA--C 1.522 -0.132 0 CA-C-O 120.983 0.42 . . . . 2.0899999999999999 110.808 -175.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -67.76 -46.22 72.68 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.203 -0.453 . . . . 0.26000000000000001 110.767 -179.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.12 -52.63 64.52 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.344 -0.389 . . . . 0.23999999999999999 112.002 -176.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.442 ' HA ' ' O ' ' A' ' 71' ' ' TYR . 33.0 t -51.9 -25.49 8.15 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.856 0.687 . . . . 1.0 112.856 -177.131 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -102.18 -44.63 5.38 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.535 0.683 . . . . 0.60999999999999999 110.456 -179.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.619 ' HD3' ' HG3' ' A' ' 27' ' ' ARG . 21.5 mmt180 -93.64 -39.53 10.76 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 114.334 1.235 . . . . 0.85999999999999999 114.334 -169.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.452 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 59.7 p -63.23 123.75 19.44 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.118 0.485 . . . . 0.81999999999999995 111.059 -176.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.641 ' HA ' ' CB ' ' A' ' 26' ' ' ARG . 17.2 t70 -71.82 -18.8 62.06 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.441 -0.799 . . . . 2.2799999999999998 111.268 177.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 46.6 t -77.1 157.36 31.08 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.54 0.686 . . . . 1.52 110.808 -178.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -58.63 -16.47 30.09 Favored Glycine 0 N--CA 1.453 -0.181 0 CA-C-N 114.388 -1.278 . . . . 0.26000000000000001 113.922 -174.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.449 ' HB2' ' CA ' ' A' ' 75' ' ' GLY . 2.6 p -66.17 -4.1 6.94 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 112.287 0.477 . . . . 0.32000000000000001 112.287 176.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.442 ' O ' ' HA ' ' A' ' 63' ' ' SER . 33.0 p90 -56.68 -27.99 59.9 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.112 0.482 . . . . 0.54000000000000004 110.069 175.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -92.12 -0.25 57.45 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.387 0.613 . . . . 0.48999999999999999 110.389 -179.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.2 m -124.72 9.32 8.27 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.647 -0.706 . . . . 0.70999999999999996 110.796 -175.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.468 ' O ' ' HA ' ' A' ' 59' ' ' GLU . . . 73.42 31.0 61.56 Favored Glycine 0 CA--C 1.519 0.335 0 C-N-CA 120.884 -0.674 . . . . 0.54000000000000004 112.738 -178.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.449 ' CA ' ' HB2' ' A' ' 70' ' ' SER . . . 76.78 3.09 78.95 Favored Glycine 0 C--O 1.227 -0.325 0 C-N-CA 121.081 -0.58 . . . . 0.34999999999999998 112.217 179.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -97.92 144.35 27.56 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 110.283 -0.266 . . . . 1.6499999999999999 110.283 -168.266 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.7 mp -120.39 171.45 8.52 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.129 -0.487 . . . . 0.93999999999999995 110.276 178.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -91.03 -148.6 21.78 Favored Glycine 0 C--N 1.317 -0.514 0 CA-C-N 115.783 -0.644 . . . . 0.44 112.22 -178.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 99.8 m-85 -88.13 123.22 32.58 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.222 0.534 . . . . 3.8700000000000001 110.556 178.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.429 ' HZ ' ' N ' ' A' ' 10' ' ' ALA . 1.6 p90 -134.61 147.13 50.14 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.567 -0.742 . . . . 1.3100000000000001 110.085 -178.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.462 ' HA ' ' O ' ' A' ' 6' ' ' GLU . 21.8 m -80.87 124.08 28.81 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 109.926 -0.398 . . . . 1.1699999999999999 109.926 179.162 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 24.6 m -54.25 119.1 4.69 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.99 -0.55 . . . . 1.1899999999999999 110.925 -179.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 114.71 13.03 9.78 Favored Glycine 0 N--CA 1.443 -0.883 0 CA-C-N 115.627 -0.715 . . . . 0.79000000000000004 111.794 -178.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -116.56 7.45 13.67 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 111.521 0.193 . . . . 1.55 111.521 179.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 24.9 mmt -99.06 -105.44 0.21 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.157 0.503 . . . . 0.72999999999999998 110.807 -179.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 68.9 mtm -142.18 147.38 36.5 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 107.904 -1.147 . . . . 1.3899999999999999 107.904 176.37 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -48.45 -54.81 22.84 Favored Pre-proline 0 CA--C 1.539 0.552 0 N-CA-C 113.0 0.741 . . . . 2.3700000000000001 113.0 -173.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.501 ' HG2' HG22 ' A' ' 107' ' ' THR . 71.8 Cg_endo -75.43 -27.49 9.29 Favored 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 121.401 1.4 . . . . 0.27000000000000002 111.739 -175.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.644 ' O ' HG23 ' A' ' 93' ' ' VAL . 42.4 t80 -72.35 -56.26 5.77 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.23 -0.896 . . . . 0.22 109.984 -179.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -61.8 -38.28 87.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.462 -0.79 . . . . 2.1200000000000001 110.441 -177.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -60.65 -31.59 70.8 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.454 -0.794 . . . . 0.60999999999999999 110.502 178.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.489 ' O ' ' HG ' ' A' ' 96' ' ' LEU . . . -81.06 -25.98 36.67 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.037 -0.529 . . . . 0.22 110.72 178.275 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.644 HG23 ' O ' ' A' ' 89' ' ' PHE . 25.7 t -70.95 -36.05 62.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.421 0.629 . . . . 0.25 110.124 -178.465 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.509 ' C ' ' HD2' ' A' ' 94' ' ' ARG . 5.5 ppt_? -85.74 -16.47 38.84 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.679 -0.691 . . . . 2.5899999999999999 110.622 179.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -76.09 -17.07 59.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.012 -0.54 . . . . 0.46999999999999997 111.187 -176.106 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.609 ' HB2' ' HB2' ' A' ' 100' ' ' ASP . 0.9 OUTLIER -119.61 151.92 37.89 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.143 -0.481 . . . . 0.28000000000000003 110.736 179.443 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.436 ' HA ' ' NH2' ' A' ' 116' ' ' ARG . 23.5 tptm -92.57 167.46 11.91 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.053 -0.721 . . . . 1.6100000000000001 109.053 178.325 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.459 ' HA ' ' HG2' ' A' ' 116' ' ' ARG . 58.8 mt -46.25 115.97 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.851 0.358 . . . . 0.90000000000000002 111.301 173.507 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 100.46 -2.06 56.02 Favored Glycine 0 CA--C 1.521 0.428 0 C-N-CA 120.715 -0.755 . . . . 0.46000000000000002 113.528 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.609 ' HB2' ' HB2' ' A' ' 96' ' ' LEU . 68.1 m-20 -104.53 152.43 22.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 117.412 0.606 . . . . 0.46000000000000002 110.692 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 9.5 mt -121.8 149.11 25.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-O 120.988 0.423 . . . . 0.23000000000000001 110.873 -177.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 70.4 m -96.48 150.41 37.03 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 115.896 -0.593 . . . . 0.92000000000000004 110.491 177.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.428 ' O ' HG23 ' A' ' 105' ' ' VAL . 73.5 Cg_endo -74.71 177.91 7.85 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.558 2.172 . . . . 0.34000000000000002 111.188 173.373 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.768 HG23 HD23 ' A' ' 44' ' ' LEU . 22.8 mm -44.62 108.28 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 O-C-N 123.501 0.501 . . . . 0.20000000000000001 112.169 178.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 103' ' ' PRO . 69.6 t -110.98 115.19 49.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.919 -0.582 . . . . 1.04 109.59 174.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -84.68 147.78 26.75 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.287 0.565 . . . . 0.55000000000000004 110.285 178.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.501 HG22 ' HG2' ' A' ' 88' ' ' PRO . 10.0 p -123.31 -172.81 2.59 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.445 -0.798 . . . . 0.37 110.297 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -64.82 -37.8 88.82 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.63 0.252 . . . . 2.1600000000000001 110.472 178.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.543 ' OG ' ' HE2' ' A' ' 16' ' ' LYS . 9.2 t -86.48 -61.61 1.7 Allowed 'General case' 0 C--O 1.222 -0.391 0 C-N-CA 120.918 -0.313 . . . . 1.0900000000000001 110.419 179.264 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -152.81 -131.04 1.6 Allowed Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 119.163 -1.494 . . . . 0.23999999999999999 113.605 -174.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.924 ' HB3' HD22 ' A' ' 44' ' ' LEU . 6.6 mp -116.03 145.96 42.55 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.425 -0.388 . . . . 0.19 111.71 -169.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . 0.59 ' NE2' HD13 ' A' ' 14' ' ' LEU . 84.5 m-70 -144.87 142.04 29.59 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.101 0.477 . . . . 0.22 112.274 179.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.656 HG12 HD11 ' A' ' 44' ' ' LEU . 2.8 pt -123.47 140.55 46.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 107.707 -1.22 . . . . 0.17000000000000001 107.707 159.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.418 HG21 HG22 ' A' ' 93' ' ' VAL . 2.6 mp -132.57 150.32 33.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 C-N-CA 120.731 -0.387 . . . . 0.17999999999999999 110.485 -175.134 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.513 ' HE3' HD21 ' A' ' 117' ' ' LEU . 7.1 pttp -136.24 141.95 43.99 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.494 -0.928 . . . . 0.60999999999999999 108.494 173.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.475 ' CD ' HD11 ' A' ' 8' ' ' LEU . 5.5 ttp180 -84.36 132.26 34.62 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.477 -0.489 . . . . 1.8700000000000001 110.826 179.374 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.513 HD21 ' HE3' ' A' ' 115' ' ' LYS . 4.1 mm? -99.76 -35.4 9.81 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.21 -0.905 . . . . 0.89000000000000001 110.281 -178.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.893 0 CA-C-O 118.411 -0.804 . . . . 1.1000000000000001 110.165 179.97 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 61.9 mtt . . . . . 0 N--CA 1.483 1.219 0 CA-C-O 121.07 0.462 . . . . 7.2300000000000004 110.838 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 16.0 p -158.51 172.32 18.53 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.963 -0.562 . . . . 2.8799999999999999 109.821 178.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -147.46 -17.59 0.38 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.502 -0.317 . . . . 2.7999999999999998 110.652 178.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.518 ' HA ' ' O ' ' A' ' 80' ' ' PHE . 42.4 mmtm -76.41 115.54 16.25 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.241 0.544 . . . . 1.1899999999999999 111.258 -178.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.599 ' O ' ' HA ' ' A' ' 79' ' ' PHE . 12.0 tp -118.65 169.8 9.5 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.349 -0.982 . . . . 1.1799999999999999 108.349 176.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.418 ' HG3' ' O ' ' A' ' 77' ' ' LEU . 56.2 ttt180 -142.79 134.32 26.44 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 117.799 0.272 . . . . 1.0600000000000001 110.301 177.05 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.638 ' O ' ' HB2' ' A' ' 77' ' ' LEU . . . -155.69 154.24 31.23 Favored 'General case' 0 C--O 1.222 -0.364 0 C-N-CA 120.086 -0.646 . . . . 0.22 112.063 -177.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.492 ' HB3' ' HG2' ' A' ' 115' ' ' LYS . . . -102.16 132.23 48.19 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.216 -0.661 . . . . 0.20000000000000001 109.216 178.243 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 12.4 p-80 -133.19 148.77 52.06 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.178 0.513 . . . . 0.23000000000000001 111.768 -172.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.566 HD23 ' N ' ' A' ' 14' ' ' LEU . 5.2 tt -121.4 146.91 46.4 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.41 -0.959 . . . . 0.23999999999999999 108.41 177.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.566 ' N ' HD23 ' A' ' 13' ' ' LEU . 23.4 tp -131.34 132.86 44.78 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 110.091 -0.337 . . . . 0.27000000000000002 110.091 -178.337 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.529 HG23 HD13 ' A' ' 44' ' ' LEU . 58.4 t -123.2 130.67 74.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 O-C-N 123.353 0.408 . . . . 0.14999999999999999 109.942 175.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.502 ' HE3' HD21 ' A' ' 14' ' ' LEU . 33.6 mmtp -104.44 152.44 22.33 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.903 -0.59 . . . . 0.62 110.025 177.073 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.511 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 42.7 p90 -143.23 162.94 34.3 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.006 -0.543 . . . . 0.25 110.477 -177.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.46 ' HB3' ' HA ' ' A' ' 33' ' ' ALA . 32.6 p -51.84 112.84 0.84 Allowed 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.103 0.478 . . . . 1.04 110.892 178.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 97.79 8.51 55.65 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.582 -0.818 . . . . 0.53000000000000003 113.141 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.614 ' HB2' ' O ' ' A' ' 109' ' ' SER . 80.3 p -88.68 45.59 1.3 Allowed 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 117.366 0.583 . . . . 0.69999999999999996 110.893 -175.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.487 ' HB3' ' O ' ' A' ' 20' ' ' SER . 76.8 ttt180 75.8 -32.5 0.21 Allowed 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 123.175 0.59 . . . . 3.4900000000000002 110.93 -179.021 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.413 ' H ' ' C ' ' A' ' 20' ' ' SER . 3.5 p30 -153.31 109.0 2.61 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-O 121.09 0.471 . . . . 1.77 110.291 174.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.408 ' C ' HG22 ' A' ' 32' ' ' THR . 11.3 Cg_exo -73.69 52.86 2.6 Favored 'Trans proline' 0 CA--C 1.534 0.481 0 C-N-CA 123.236 2.624 . . . . 1.71 113.401 -179.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.461 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 83.9 t -141.84 116.88 5.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 109.722 -0.473 . . . . 0.47999999999999998 109.722 176.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.522 ' HB2' ' OD1' ' A' ' 67' ' ' ASP . 6.4 p -103.85 151.52 23.0 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 116.535 -0.302 . . . . 1.1200000000000001 110.308 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.69 ' CB ' ' HA ' ' A' ' 67' ' ' ASP . 3.3 tpp180 -69.33 -20.65 63.87 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 108.028 -1.101 . . . . 2.54 108.028 173.041 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.441 ' CG ' ' HA ' ' A' ' 65' ' ' ARG . 2.7 tmm_? -69.43 -37.41 77.39 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 114.27 -1.332 . . . . 1.77 110.472 179.002 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 81.1 p -99.29 -36.37 9.65 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.498 0.666 . . . . 0.67000000000000004 110.803 179.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 72.57 -3.84 23.65 Favored Glycine 0 N--CA 1.451 -0.33 0 CA-C-N 115.203 -0.908 . . . . 0.81999999999999995 112.338 -176.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -113.78 -79.22 0.58 Allowed 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.605 -0.517 . . . . 2.1000000000000001 109.605 179.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.461 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 20.2 m -153.77 153.26 31.86 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.73 -0.668 . . . . 1.0800000000000001 109.82 176.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.411 ' OG1' HG13 ' A' ' 35' ' ' VAL . 10.2 t -117.52 30.66 7.16 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 122.286 1.041 . . . . 0.34000000000000002 109.307 177.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.46 ' HA ' ' HB3' ' A' ' 18' ' ' SER . . . -77.03 -5.94 50.72 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.711 -1.131 . . . . 0.37 112.514 -176.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -95.74 -25.37 16.11 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.183 0.516 . . . . 2.21 110.651 -179.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.411 HG13 ' OG1' ' A' ' 32' ' ' THR . 0.2 OUTLIER -95.78 134.68 32.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.943 -0.571 . . . . 0.31 110.293 -178.886 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 64.7 p -93.0 179.93 5.29 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.181 -0.463 . . . . 0.39000000000000001 109.873 -175.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.464 ' O ' HG13 ' A' ' 41' ' ' ILE . 9.3 p90 -64.36 -28.47 69.72 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 119.934 -0.707 . . . . 1.53 109.142 175.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -72.13 -48.98 39.69 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 115.968 -0.56 . . . . 0.95999999999999996 110.345 177.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.409 ' HB2' HG23 ' A' ' 35' ' ' VAL . 43.4 m-20 -64.91 -28.78 69.77 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.189 0.518 . . . . 0.91000000000000003 110.161 178.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.511 ' HB2' ' HB3' ' A' ' 17' ' ' PHE . . . -71.36 -43.01 67.74 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.483 -0.78 . . . . 0.19 110.513 176.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.464 HG13 ' O ' ' A' ' 37' ' ' TYR . 87.1 mt -62.8 -35.95 73.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.477 -0.564 . . . . 0.29999999999999999 109.477 174.044 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 35.2 tttm -62.44 -24.52 67.47 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.402 -0.817 . . . . 2.3199999999999998 110.857 176.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.431 ' HG3' ' CD1' ' A' ' 47' ' ' TRP . 0.7 OUTLIER -87.28 -52.47 5.38 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.115 -0.698 . . . . 1.02 109.115 178.845 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.894 HD23 HG23 ' A' ' 104' ' ' ILE . 32.3 tp -63.46 -37.7 88.28 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.202 -0.908 . . . . 0.17000000000000001 110.695 -173.465 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.457 HE21 ' HA ' ' A' ' 45' ' ' GLN . 0.0 OUTLIER -65.93 -30.7 71.33 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-N 116.152 -0.477 . . . . 0.87 112.133 -176.903 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -74.73 -44.18 51.22 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.941 0.4 . . . . 1.3100000000000001 110.104 179.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.431 ' CD1' ' HG3' ' A' ' 43' ' ' GLU . 49.2 m95 -67.22 -44.51 79.33 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.205 -0.452 . . . . 0.52000000000000002 111.115 178.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.555 ' HB3' HG21 ' A' ' 113' ' ' ILE . 97.8 p -66.43 -22.29 66.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.83 0.348 . . . . 0.81999999999999995 110.203 177.147 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.42 ' HB2' ' O ' ' A' ' 45' ' ' GLN . 10.0 tt0 -73.97 -56.95 4.33 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 116.013 -0.54 . . . . 0.53000000000000003 109.986 173.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.616 ' HB3' HG22 ' A' ' 56' ' ' VAL . 96.6 mtt180 -61.85 -41.37 97.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.556 -0.747 . . . . 0.41999999999999998 111.499 -175.102 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.43 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 97.5 mt -60.59 -36.31 69.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.006 0.431 . . . . 0.20000000000000001 110.434 176.309 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -76.76 -42.7 39.98 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.078 -0.51 . . . . 0.27000000000000002 111.441 179.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 35.3 p -74.4 -29.63 61.6 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.916 0.389 . . . . 0.34999999999999998 111.294 -176.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 107.86 1.44 34.25 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.824 -0.703 . . . . 0.29999999999999999 112.366 -179.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.453 ' HB2' ' HB3' ' A' ' 50' ' ' ARG . 39.0 mt-10 -59.5 -44.41 93.12 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 121.047 0.451 . . . . 0.65000000000000002 110.513 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.616 HG22 ' HB3' ' A' ' 50' ' ' ARG . 13.0 m -137.8 157.55 33.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 109.401 -0.592 . . . . 0.19 109.401 172.16 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 14.5 m -86.43 160.26 19.09 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.348 -0.612 . . . . 0.96999999999999997 109.348 178.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -55.23 -44.25 75.28 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.024 0.44 . . . . 0.22 109.976 -177.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.603 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 50.8 mt-10 -60.54 -35.19 75.42 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.372 -0.831 . . . . 1.72 111.893 -178.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -62.39 -52.9 61.74 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-O 121.055 0.455 . . . . 2.0899999999999999 110.378 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -69.81 -46.32 65.94 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.605 -0.725 . . . . 0.26000000000000001 111.399 -175.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.92 -52.32 65.91 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.439 0.533 . . . . 0.23999999999999999 112.439 -173.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.46 ' HA ' ' O ' ' A' ' 71' ' ' TYR . 67.0 m -51.18 -21.97 2.32 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.993 0.738 . . . . 1.0 112.993 -179.606 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -103.75 -46.53 4.49 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.584 0.707 . . . . 0.60999999999999999 110.148 179.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.441 ' HA ' ' CG ' ' A' ' 27' ' ' ARG . 36.7 mmt-85 -95.63 -36.3 11.28 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 114.271 1.212 . . . . 0.85999999999999999 114.271 -169.097 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.488 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 54.3 p -63.87 114.84 4.32 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.274 0.559 . . . . 0.81999999999999995 110.279 -177.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.69 ' HA ' ' CB ' ' A' ' 26' ' ' ARG . 74.6 m-20 -75.57 -9.51 58.64 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.484 -0.78 . . . . 2.2799999999999998 111.632 -177.393 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 36.0 t -85.56 160.74 19.57 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.755 -0.657 . . . . 1.52 110.163 178.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -56.28 -18.88 22.76 Favored Glycine 0 CA--C 1.518 0.237 0 CA-C-N 114.465 -1.243 . . . . 0.26000000000000001 114.378 -173.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.413 ' HB3' HD21 ' A' ' 77' ' ' LEU . 60.5 p -65.19 -7.23 11.79 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 112.502 0.556 . . . . 0.32000000000000001 112.502 177.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.46 ' O ' ' HA ' ' A' ' 63' ' ' SER . 32.0 p90 -52.5 -36.56 55.5 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 120.994 0.426 . . . . 0.54000000000000004 110.325 176.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -81.06 -1.25 43.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.002 0.429 . . . . 0.48999999999999999 111.039 -177.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 7.7 m -125.01 8.12 8.02 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.103 -0.499 . . . . 0.70999999999999996 110.501 -178.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.603 ' O ' ' HA ' ' A' ' 59' ' ' GLU . . . 75.14 26.24 66.86 Favored Glycine 0 C--O 1.226 -0.35 0 C-N-CA 121.014 -0.612 . . . . 0.54000000000000004 112.622 -179.508 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.49 -20.37 6.18 Favored Glycine 0 N--CA 1.454 -0.149 0 C-N-CA 121.012 -0.613 . . . . 0.34999999999999998 111.937 -179.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -68.43 128.6 37.18 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.179 -0.511 . . . . 1.6499999999999999 110.537 -177.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.638 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 19.4 mt -108.24 157.53 18.26 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 116.076 -0.511 . . . . 0.93999999999999995 110.065 176.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -87.82 -165.31 41.16 Favored Glycine 0 N--CA 1.443 -0.847 0 CA-C-N 115.478 -0.783 . . . . 0.44 111.232 174.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.599 ' HA ' ' O ' ' A' ' 8' ' ' LEU . 75.4 m-85 -71.67 133.05 45.4 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.287 0.565 . . . . 3.8700000000000001 111.609 -178.046 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.518 ' O ' ' HA ' ' A' ' 7' ' ' LYS . 21.0 p90 -133.96 160.3 38.12 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.366 -0.834 . . . . 1.3100000000000001 109.399 178.628 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 12.1 m -79.75 123.57 27.81 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 109.032 -0.729 . . . . 1.1699999999999999 109.032 175.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 33.1 m -52.73 117.43 2.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.14 -0.482 . . . . 1.1899999999999999 110.675 -178.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 113.97 -6.18 23.78 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.734 -0.746 . . . . 0.79000000000000004 112.425 -177.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -97.99 48.18 1.01 Allowed 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.453 0.644 . . . . 1.55 110.435 179.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 25.3 mmt -135.58 -101.22 0.22 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.101 -0.5 . . . . 0.72999999999999998 110.502 177.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.508 ' HB2' ' HB3' ' A' ' 89' ' ' PHE . 48.4 mtt -145.8 149.71 34.85 Favored 'General case' 0 CA--C 1.513 -0.464 0 N-CA-C 107.79 -1.189 . . . . 1.3899999999999999 107.79 177.256 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.448 ' HB3' ' HD3' ' A' ' 88' ' ' PRO . 27.2 ttpp -53.38 -54.79 41.39 Favored Pre-proline 0 C--N 1.322 -0.605 0 N-CA-C 112.134 0.42 . . . . 2.3700000000000001 112.134 -174.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.448 ' HD3' ' HB3' ' A' ' 87' ' ' LYS . 83.4 Cg_endo -76.45 -27.82 7.43 Favored 'Trans proline' 0 C--N 1.356 0.97 0 C-N-CA 121.6 1.533 . . . . 0.27000000000000002 112.061 -176.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.644 ' O ' HG23 ' A' ' 93' ' ' VAL . 34.3 t80 -68.55 -56.59 7.78 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.248 -0.887 . . . . 0.22 109.999 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -65.08 -37.08 86.38 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.398 -0.819 . . . . 2.1200000000000001 109.661 -177.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -52.75 -36.02 57.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.173 -0.921 . . . . 0.60999999999999999 110.995 174.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -83.77 -27.32 28.96 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.112 -0.494 . . . . 0.22 111.207 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.644 HG23 ' O ' ' A' ' 89' ' ' PHE . 21.8 t -69.92 -48.17 65.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.243 0.544 . . . . 0.25 109.947 -177.187 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -73.2 -6.81 48.31 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.446 -0.797 . . . . 2.5899999999999999 110.784 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -82.94 -20.51 35.14 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.865 -0.607 . . . . 0.46999999999999997 110.222 177.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.671 ' HB3' ' HB2' ' A' ' 100' ' ' ASP . 0.8 OUTLIER -89.22 146.33 24.83 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-N 116.198 -0.456 . . . . 0.28000000000000003 109.912 -179.895 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 55.2 tptt -86.49 166.08 15.76 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 106.684 -1.599 . . . . 1.6100000000000001 106.684 163.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 51.8 mt -55.24 115.32 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 120.77 0.319 . . . . 0.90000000000000002 110.368 179.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 102.64 10.94 36.7 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.51 -0.852 . . . . 0.46000000000000002 113.559 -178.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.671 ' HB2' ' HB3' ' A' ' 96' ' ' LEU . 8.9 m-20 -108.08 149.1 28.88 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 117.896 0.848 . . . . 0.46000000000000002 110.462 -179.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 16.2 mt -116.14 144.84 22.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 121.066 0.46 . . . . 0.23000000000000001 110.671 -178.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.65 ' OG ' HD21 ' A' ' 96' ' ' LEU . 19.7 m -90.86 148.91 39.3 Favored Pre-proline 0 C--N 1.321 -0.657 0 CA-C-N 115.801 -0.636 . . . . 0.92000000000000004 110.534 -179.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.69 176.2 10.3 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 122.642 2.228 . . . . 0.34000000000000002 111.195 172.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.894 HG23 HD23 ' A' ' 44' ' ' LEU . 19.6 mm -50.11 100.2 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 O-C-N 123.475 0.484 . . . . 0.20000000000000001 112.133 178.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.6 p -107.75 119.59 57.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.101 0.477 . . . . 1.04 110.21 176.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -85.99 149.86 24.89 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.935 0.398 . . . . 0.55000000000000004 110.73 -179.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.435 HG22 ' HG2' ' A' ' 88' ' ' PRO . 3.9 p -126.26 -172.33 2.6 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.601 -0.727 . . . . 0.37 111.122 -178.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -61.03 -34.84 75.47 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.556 0.217 . . . . 2.1600000000000001 111.527 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.614 ' O ' ' HB2' ' A' ' 20' ' ' SER . 6.8 t -97.5 -60.76 1.51 Allowed 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.55 -0.46 . . . . 1.0900000000000001 110.544 179.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -146.59 -133.42 2.46 Favored Glycine 0 N--CA 1.441 -0.986 0 C-N-CA 119.015 -1.564 . . . . 0.23999999999999999 113.877 -173.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.894 ' HB3' HD22 ' A' ' 44' ' ' LEU . 5.9 mp -114.58 148.08 38.55 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.06 -0.57 . . . . 0.19 111.407 -169.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . 0.562 ' NE2' HD13 ' A' ' 14' ' ' LEU . 80.7 m-70 -144.2 151.82 40.01 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.316 0.579 . . . . 0.22 112.268 179.073 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.606 HG12 HD11 ' A' ' 44' ' ' LEU . 3.9 pt -134.35 143.91 36.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 107.774 -1.195 . . . . 0.17000000000000001 107.774 159.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.444 ' H ' ' HB2' ' A' ' 102' ' ' SER . 1.0 OUTLIER -133.22 138.19 51.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 C-N-CA 120.829 -0.348 . . . . 0.17999999999999999 110.665 -176.963 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.492 ' HG2' ' HB3' ' A' ' 11' ' ' ALA . 50.4 pttt -121.83 135.08 54.9 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.416 -0.587 . . . . 0.60999999999999999 109.416 172.111 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.419 ' HB2' HD12 ' A' ' 96' ' ' LEU . 68.5 ttt180 -84.78 123.0 29.92 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.837 0.351 . . . . 1.8700000000000001 111.064 -175.185 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.411 HD21 ' HB2' ' A' ' 11' ' ' ALA . 2.2 mm? -93.15 -32.59 14.36 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.025 -0.534 . . . . 0.89000000000000001 110.843 179.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.955 0 CA-C-O 118.569 -0.729 . . . . 1.1000000000000001 110.156 179.514 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.9 mpt? . . . . . 0 N--CA 1.48 1.061 0 CA-C-O 121.013 0.435 . . . . 7.2300000000000004 110.193 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 35.9 m -151.36 153.18 34.25 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.872 -0.604 . . . . 2.8799999999999999 110.486 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.567 ' O ' ' HA ' ' A' ' 81' ' ' SER . 12.9 pt-20 -101.77 -26.87 13.32 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.68 -0.691 . . . . 2.7999999999999998 109.778 177.603 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 40.1 mmtm -75.19 115.74 15.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.546 0.688 . . . . 1.1899999999999999 111.039 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.642 HD23 ' H ' ' A' ' 9' ' ' ARG . 2.1 tt -115.19 158.71 21.88 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 114.651 -1.158 . . . . 1.1799999999999999 108.178 179.282 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.642 ' H ' HD23 ' A' ' 8' ' ' LEU . 48.8 ttt180 -137.53 130.8 30.83 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 108.61 -0.885 . . . . 1.0600000000000001 108.61 175.153 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.442 ' N ' ' HZ ' ' A' ' 80' ' ' PHE . . . -144.78 155.47 43.54 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.244 -0.583 . . . . 0.22 112.419 -178.361 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.608 ' HA ' ' HA ' ' A' ' 76' ' ' ASP . . . -109.67 133.6 52.94 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-N 115.421 -0.808 . . . . 0.20000000000000001 109.538 176.225 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 37.9 p-80 -139.52 143.51 37.46 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.97 0.414 . . . . 0.23000000000000001 111.365 -172.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.641 ' O ' ' HA ' ' A' ' 112' ' ' HIS . 6.1 tt -111.82 134.84 53.13 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.536 -0.913 . . . . 0.23999999999999999 108.536 177.159 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.532 HD13 ' NE2' ' A' ' 112' ' ' HIS . 24.4 tp -117.36 122.34 43.6 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.811 0.339 . . . . 0.27000000000000002 111.224 -178.187 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.569 HG23 HD13 ' A' ' 44' ' ' LEU . 70.5 t -108.57 134.05 51.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 109.786 -0.45 . . . . 0.14999999999999999 109.786 174.242 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.471 ' HE3' HD21 ' A' ' 14' ' ' LEU . 31.3 mmtp -106.43 149.54 26.94 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.431 -0.581 . . . . 0.62 109.431 176.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.448 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 49.6 p90 -138.68 161.32 37.46 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.721 0.296 . . . . 0.25 110.749 -179.027 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.568 ' HB3' ' HA ' ' A' ' 33' ' ' ALA . 59.8 p -52.62 109.8 0.44 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.849 -0.614 . . . . 1.04 111.094 -179.173 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 97.8 9.46 54.4 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.63 -0.795 . . . . 0.53000000000000003 113.769 177.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.441 ' C ' ' H ' ' A' ' 22' ' ' ASN . 88.9 p -91.6 48.67 1.49 Allowed 'General case' 0 C--O 1.235 0.321 0 CA-C-N 118.293 1.047 . . . . 0.69999999999999996 110.903 -177.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 71.27 -34.46 0.3 Allowed 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.531 0.732 . . . . 3.4900000000000002 111.537 -178.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.441 ' H ' ' C ' ' A' ' 20' ' ' SER . 41.5 m-80 -142.99 91.1 7.25 Favored Pre-proline 0 C--N 1.328 -0.367 0 N-CA-C 110.387 -0.227 . . . . 1.77 110.387 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.412 ' C ' HG22 ' A' ' 32' ' ' THR . 16.7 Cg_exo -73.99 54.81 3.24 Favored 'Trans proline' 0 CA--C 1.534 0.523 0 C-N-CA 123.408 2.739 . . . . 1.71 113.07 179.435 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.462 ' N ' HG22 ' A' ' 32' ' ' THR . 64.4 t -146.83 117.67 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 109.302 -0.629 . . . . 0.47999999999999998 109.302 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 42.1 t -106.45 151.74 24.55 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 110.344 -0.243 . . . . 1.1200000000000001 110.344 178.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.588 ' HB2' ' HA ' ' A' ' 67' ' ' ASP . 7.5 mpt_? -65.61 -14.71 61.71 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.994 0.426 . . . . 2.54 109.894 170.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.52 ' HG3' ' HD3' ' A' ' 65' ' ' ARG . 23.9 ttp180 -66.86 -38.94 87.29 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.404 -0.817 . . . . 1.77 109.471 177.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 33.2 p -105.42 -35.14 7.6 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-O 121.433 0.635 . . . . 0.67000000000000004 110.979 -176.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 72.92 8.15 72.48 Favored Glycine 0 N--CA 1.451 -0.325 0 CA-C-N 115.419 -0.81 . . . . 0.81999999999999995 112.054 -178.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -131.03 -70.07 0.61 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.964 0.412 . . . . 2.1000000000000001 110.312 -178.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.404 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 11.0 p -154.54 157.65 38.63 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.16 -0.473 . . . . 1.0800000000000001 110.584 177.565 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.462 HG22 ' N ' ' A' ' 24' ' ' VAL . 10.1 t -125.11 28.0 6.51 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 122.082 0.944 . . . . 0.34000000000000002 109.66 172.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.568 ' HA ' ' HB3' ' A' ' 18' ' ' SER . . . -69.27 -5.53 23.6 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 114.979 -1.009 . . . . 0.37 111.893 178.636 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -85.57 -25.18 26.88 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.833 -0.621 . . . . 2.21 110.754 -178.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.456 HG13 ' OG1' ' A' ' 32' ' ' THR . 0.2 OUTLIER -109.75 135.16 49.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.647 -0.706 . . . . 0.31 110.47 -175.547 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 41.7 p -92.19 178.73 5.77 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 109.743 -0.466 . . . . 0.39000000000000001 109.743 -178.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.511 ' O ' HG13 ' A' ' 41' ' ' ILE . 18.6 p90 -62.16 -29.63 70.48 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 119.885 -0.726 . . . . 1.53 109.57 177.336 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -72.39 -48.36 42.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.12 -0.491 . . . . 0.95999999999999996 110.446 177.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -64.22 -29.04 70.16 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.317 0.579 . . . . 0.91000000000000003 109.705 178.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.448 ' HB2' ' HB3' ' A' ' 17' ' ' PHE . . . -72.62 -46.34 54.59 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.09 -0.959 . . . . 0.19 110.696 177.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.511 HG13 ' O ' ' A' ' 37' ' ' TYR . 97.0 mt -62.41 -38.13 80.51 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 N-CA-C 109.635 -0.506 . . . . 0.29999999999999999 109.635 175.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.455 ' O ' ' HG3' ' A' ' 46' ' ' LYS . 82.6 tttt -60.87 -29.68 69.69 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.455 -0.793 . . . . 2.3199999999999998 110.162 178.216 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -87.62 -47.53 8.62 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.687 -0.688 . . . . 1.02 110.091 -177.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.94 HD23 HG23 ' A' ' 104' ' ' ILE . 35.5 tp -58.67 -38.57 78.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.896 -0.593 . . . . 0.17000000000000001 109.743 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.451 ' HG2' HG13 ' A' ' 104' ' ' ILE . 2.5 mm-40 -62.63 -35.96 81.26 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.94 -0.573 . . . . 0.87 112.165 178.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.455 ' HG3' ' O ' ' A' ' 42' ' ' LYS . 68.8 mttm -70.78 -45.81 64.04 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.741 0.305 . . . . 1.3100000000000001 110.77 -178.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 51.0 m95 -67.9 -44.34 77.2 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.98 -0.288 . . . . 0.52000000000000002 110.468 177.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 40.9 t -57.03 -33.5 67.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.024 0.44 . . . . 0.81999999999999995 110.219 174.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.415 ' HB2' ' O ' ' A' ' 45' ' ' GLN . 12.1 tt0 -68.03 -54.38 18.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 0.53000000000000003 110.294 177.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.614 ' HB3' HG22 ' A' ' 56' ' ' VAL . 87.6 mtt180 -60.23 -45.24 93.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.96 -0.564 . . . . 0.41999999999999998 111.594 -178.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.41 HG21 ' CD2' ' A' ' 58' ' ' PHE . 97.2 mt -59.42 -40.69 82.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 120.997 0.427 . . . . 0.20000000000000001 110.727 177.14 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.49 -38.42 71.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.152 -0.476 . . . . 0.27000000000000002 111.615 -179.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 58.1 p -78.22 -30.78 48.98 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.055 0.455 . . . . 0.34999999999999998 110.947 -179.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 106.68 3.0 37.32 Favored Glycine 0 N--CA 1.445 -0.725 0 N-CA-C 111.574 -0.61 . . . . 0.29999999999999999 111.574 -179.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.408 ' HB3' ' HB3' ' A' ' 50' ' ' ARG . 5.6 tt0 -55.57 -46.68 77.18 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 122.803 0.441 . . . . 0.65000000000000002 110.784 177.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.614 HG22 ' HB3' ' A' ' 50' ' ' ARG . 11.9 m -134.78 155.33 38.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 109.472 -0.566 . . . . 0.19 109.472 170.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.5 m -77.8 155.8 30.88 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.266 -0.642 . . . . 0.96999999999999997 109.266 178.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.41 ' CD2' HG21 ' A' ' 51' ' ' ILE . 2.2 t80 -54.3 -40.01 67.52 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.184 -0.673 . . . . 0.22 109.184 177.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -57.94 -44.8 87.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.892 -1.049 . . . . 1.72 111.671 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -64.11 -45.68 87.52 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.863 0.363 . . . . 2.0899999999999999 111.11 -175.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -70.56 -43.66 69.02 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.42 -0.354 . . . . 0.26000000000000001 110.896 -179.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.84 -46.02 89.85 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.248 0.462 . . . . 0.23999999999999999 112.248 -175.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.496 ' HA ' ' O ' ' A' ' 71' ' ' TYR . 21.7 m -59.2 -19.73 47.93 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 112.907 0.706 . . . . 1.0 112.907 -177.138 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.412 ' O ' ' HA ' ' A' ' 27' ' ' ARG . 35.7 mt-30 -110.69 -45.65 3.47 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.48 0.657 . . . . 0.60999999999999999 110.988 -178.182 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.52 ' HD3' ' HG3' ' A' ' 27' ' ' ARG . 25.6 mmt180 -92.35 -38.43 12.04 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 114.929 -1.032 . . . . 0.85999999999999999 113.278 -170.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.456 ' HB2' ' HG ' ' A' ' 13' ' ' LEU . 21.6 t -63.31 124.62 21.7 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.028 0.442 . . . . 0.81999999999999995 110.889 -178.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.588 ' HA ' ' HB2' ' A' ' 26' ' ' ARG . 22.8 t70 -80.99 -10.49 59.7 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.741 -0.663 . . . . 2.2799999999999998 111.11 177.644 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 48.3 t -80.24 158.59 26.16 Favored 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 120.132 -0.627 . . . . 1.52 109.608 179.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -60.3 -12.06 23.0 Favored Glycine 0 N--CA 1.454 -0.108 0 CA-C-N 115.014 -0.994 . . . . 0.26000000000000001 113.122 -174.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 70.5 p -69.6 -10.15 57.01 Favored 'General case' 0 N--CA 1.448 -0.565 0 O-C-N 123.052 -0.087 . . . . 0.32000000000000001 110.984 176.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.496 ' O ' ' HA ' ' A' ' 63' ' ' SER . 12.8 p90 -57.42 -31.01 65.43 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 109.617 -0.512 . . . . 0.54000000000000004 109.617 174.013 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -95.35 2.63 54.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.141 0.496 . . . . 0.48999999999999999 110.626 179.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 5.0 m -116.37 -2.03 12.17 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.913 -0.585 . . . . 0.70999999999999996 111.284 -175.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 86.11 20.01 56.16 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.722 -0.751 . . . . 0.54000000000000004 112.233 -177.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 86.34 -29.34 4.84 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 121.092 -0.575 . . . . 0.34999999999999998 112.639 178.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.608 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 8.1 p-10 -89.41 144.93 25.68 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-O 121.573 0.702 . . . . 1.6499999999999999 111.397 -175.538 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.438 ' O ' ' HG3' ' A' ' 9' ' ' ARG . 1.7 mp -106.34 175.74 5.4 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 114.635 -1.166 . . . . 0.93999999999999995 110.131 178.612 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -82.76 -147.18 6.67 Favored Glycine 0 C--N 1.317 -0.509 0 C-N-CA 121.033 -0.604 . . . . 0.44 112.497 179.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -99.16 124.19 44.01 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.109 0.48 . . . . 3.8700000000000001 110.807 -178.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.442 ' HZ ' ' N ' ' A' ' 10' ' ' ALA . 1.1 p90 -134.36 138.5 44.94 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.46 -0.791 . . . . 1.3100000000000001 110.425 -177.009 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.567 ' HA ' ' O ' ' A' ' 6' ' ' GLU . 18.6 m -68.06 129.67 40.62 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.703 -0.481 . . . . 1.1699999999999999 109.703 177.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 17.8 m -49.47 121.47 5.11 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.8 -0.636 . . . . 1.1899999999999999 111.832 -174.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 111.09 3.21 28.02 Favored Glycine 0 N--CA 1.452 -0.289 0 CA-C-N 115.847 -0.615 . . . . 0.79000000000000004 112.148 -177.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -91.7 26.31 2.4 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.945 0.402 . . . . 1.55 111.304 -175.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 26.5 mmt -122.13 -131.78 0.28 Allowed 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 109.687 -0.486 . . . . 0.72999999999999998 109.687 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 5.1 mpp? -91.97 -93.3 0.14 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.939 0.4 . . . . 1.3899999999999999 109.931 177.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.499 ' H ' ' HD2' ' A' ' 88' ' ' PRO . 27.8 ttpp -163.58 -56.43 0.01 OUTLIER Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 115.852 -0.613 . . . . 2.3700000000000001 110.026 175.262 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.499 ' HD2' ' H ' ' A' ' 87' ' ' LYS . 60.5 Cg_endo -70.14 -30.0 21.16 Favored 'Trans proline' 0 C--N 1.359 1.097 0 C-N-CA 121.923 1.749 . . . . 0.27000000000000002 111.096 178.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.644 ' O ' HG23 ' A' ' 93' ' ' VAL . 20.1 t80 -61.66 -56.44 19.76 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.631 -1.168 . . . . 0.22 109.762 176.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.8 tm-20 -64.36 -36.85 85.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.493 -0.776 . . . . 2.1200000000000001 110.165 -179.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -53.54 -33.52 54.89 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.354 -0.839 . . . . 0.60999999999999999 110.964 175.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.435 ' O ' ' HG ' ' A' ' 96' ' ' LEU . . . -84.35 -34.36 23.67 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.359 -0.382 . . . . 0.22 111.298 177.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.644 HG23 ' O ' ' A' ' 89' ' ' PHE . 35.7 t -62.72 -44.52 99.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-O 121.417 0.627 . . . . 0.25 110.596 -177.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 38.3 ptt180 -73.47 -11.29 60.41 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.612 -0.722 . . . . 2.5899999999999999 110.748 178.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -96.86 14.64 24.61 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.328 -0.396 . . . . 0.46999999999999997 111.815 -173.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.539 ' HB2' ' HB2' ' A' ' 100' ' ' ASP . 0.5 OUTLIER -148.17 155.75 41.77 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.022 0.439 . . . . 0.28000000000000003 110.857 177.395 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.58 ' HA ' ' NH2' ' A' ' 116' ' ' ARG . 23.8 tptm -92.25 162.73 14.18 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.789 -0.641 . . . . 1.6100000000000001 109.517 179.294 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.517 ' HA ' ' HG2' ' A' ' 116' ' ' ARG . 66.2 mt -42.63 114.33 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.974 0.416 . . . . 0.90000000000000002 111.241 171.52 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 103.3 -8.87 53.31 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.804 -0.712 . . . . 0.46000000000000002 113.449 178.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.539 ' HB2' ' HB2' ' A' ' 96' ' ' LEU . 18.4 m-20 -97.24 135.82 38.62 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 117.23 0.515 . . . . 0.46000000000000002 110.383 179.121 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.483 HG12 ' HB3' ' A' ' 115' ' ' LYS . 8.3 mt -103.98 149.72 7.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.946 -0.57 . . . . 0.23000000000000001 109.902 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 93.4 p -91.46 159.62 38.57 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 116.095 -0.502 . . . . 0.92000000000000004 110.914 -177.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -71.22 166.55 28.88 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 122.383 2.055 . . . . 0.34000000000000002 111.342 170.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.94 HG23 HD23 ' A' ' 44' ' ' LEU . 25.7 mm -47.57 112.7 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 O-C-N 123.547 0.53 . . . . 0.20000000000000001 111.793 176.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 1.9 p -118.47 124.8 73.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.154 -0.475 . . . . 1.04 109.961 175.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -85.51 151.32 24.04 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.0 0.429 . . . . 0.55000000000000004 110.285 178.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 10.9 p -131.3 -172.21 2.79 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.942 -0.572 . . . . 0.37 110.855 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -55.5 -48.16 75.06 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.893 -0.594 . . . . 2.1600000000000001 111.928 -179.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.462 ' OG ' ' HE2' ' A' ' 16' ' ' LYS . 4.8 t -106.98 -3.93 19.58 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.791 0.663 . . . . 1.0900000000000001 112.791 -172.306 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 172.68 -128.59 1.56 Allowed Glycine 0 N--CA 1.439 -1.15 0 C-N-CA 118.984 -1.579 . . . . 0.23999999999999999 113.615 173.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.879 ' HB3' HD22 ' A' ' 44' ' ' LEU . 7.4 mp -126.4 151.0 48.26 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 114.976 -0.612 . . . . 0.19 110.961 -170.2 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . 0.641 ' HA ' ' O ' ' A' ' 13' ' ' LEU . 84.7 m-70 -146.48 149.99 34.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.378 0.608 . . . . 0.22 112.53 178.309 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.632 HG12 HD11 ' A' ' 44' ' ' LEU . 2.9 pt -128.07 137.43 57.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 107.351 -1.351 . . . . 0.17000000000000001 107.351 158.39 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 2.6 mp -130.57 144.02 39.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 C-N-CA 120.736 -0.386 . . . . 0.17999999999999999 110.85 -175.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.483 ' HB3' HG12 ' A' ' 101' ' ' ILE . 39.2 pttt -127.2 142.19 51.55 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.655 -0.868 . . . . 0.60999999999999999 108.655 172.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.58 ' NH2' ' HA ' ' A' ' 97' ' ' LYS . 3.1 ttp180 -79.81 134.77 36.36 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.295 0.569 . . . . 1.8700000000000001 111.095 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -102.66 -32.42 9.88 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.144 -0.935 . . . . 0.89000000000000001 109.922 178.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.576 ' OXT' ' HD2' ' A' ' 116' ' ' ARG . . . . . . . . 0 C--O 1.246 0.888 0 CA-C-O 118.368 -0.825 . . . . 1.1000000000000001 110.401 178.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 24.0 ttt . . . . . 0 N--CA 1.48 1.064 0 CA-C-O 120.901 0.382 . . . . 7.2300000000000004 110.906 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 2.5 p -75.21 -33.3 61.38 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.151 -0.477 . . . . 2.8799999999999999 112.079 -174.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -86.26 98.13 10.78 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.834 0.349 . . . . 2.7999999999999998 110.594 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.48 ' HD2' ' HB3' ' A' ' 79' ' ' PHE . 60.1 mmtt -142.12 113.78 7.89 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.359 0.6 . . . . 1.1899999999999999 110.798 178.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.684 HD23 ' H ' ' A' ' 9' ' ' ARG . 1.3 tt -114.9 161.23 18.54 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 108.162 -1.051 . . . . 1.1799999999999999 108.162 178.139 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.684 ' H ' HD23 ' A' ' 8' ' ' LEU . 48.2 ttt180 -141.45 128.61 20.91 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.082 -0.71 . . . . 1.0600000000000001 109.082 175.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.441 ' O ' ' HB2' ' A' ' 77' ' ' LEU . . . -146.97 158.74 44.01 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 119.97 -0.692 . . . . 0.22 112.143 -178.459 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.495 ' HB3' ' HG2' ' A' ' 115' ' ' LYS . . . -106.73 135.75 47.73 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.641 -0.708 . . . . 0.20000000000000001 109.177 177.521 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.45 ' HE1' HD21 ' A' ' 77' ' ' LEU . 10.1 p-80 -138.71 140.12 38.64 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 120.37 -0.532 . . . . 0.23000000000000001 111.463 -171.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.546 ' HG ' ' HB3' ' A' ' 66' ' ' SER . 7.0 tt -111.71 143.28 42.88 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.493 -0.929 . . . . 0.23999999999999999 108.493 175.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.584 HD13 ' NE2' ' A' ' 112' ' ' HIS . 23.9 tp -129.61 120.4 25.19 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.768 0.318 . . . . 0.27000000000000002 111.097 -177.028 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.51 HG23 HD13 ' A' ' 44' ' ' LEU . 37.5 t -106.98 132.39 54.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 109.379 -0.6 . . . . 0.14999999999999999 109.379 175.456 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.649 ' HE2' ' OG ' ' A' ' 109' ' ' SER . 31.7 mmtp -106.21 154.37 20.81 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.837 -0.431 . . . . 0.62 109.837 177.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -149.19 160.95 42.92 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.056 -0.52 . . . . 0.25 110.353 -176.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 5.6 t -54.27 109.49 0.49 Allowed 'General case' 0 N--CA 1.432 -1.327 0 CA-C-N 116.392 -0.367 . . . . 1.04 110.071 174.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 105.74 9.61 32.45 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.502 -0.856 . . . . 0.53000000000000003 112.759 -178.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.49 ' HB2' ' O ' ' A' ' 109' ' ' SER . 78.3 p -95.03 39.44 1.11 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 117.258 0.529 . . . . 0.69999999999999996 111.202 -176.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.424 ' HB3' ' O ' ' A' ' 20' ' ' SER . 54.8 ttt180 74.77 -34.29 0.26 Allowed 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.286 0.634 . . . . 3.4900000000000002 111.045 179.399 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -151.06 114.07 3.12 Favored Pre-proline 0 C--N 1.324 -0.521 0 N-CA-C 109.265 -0.643 . . . . 1.77 109.265 172.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.43 ' C ' HG22 ' A' ' 32' ' ' THR . 89.9 Cg_endo -83.61 64.12 7.42 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 122.594 2.196 . . . . 1.71 112.88 -172.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.482 ' N ' HG22 ' A' ' 32' ' ' THR . 47.0 t -147.9 116.17 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 C-N-CA 122.855 0.462 . . . . 0.47999999999999998 109.851 179.406 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.435 ' HB3' ' HB2' ' A' ' 16' ' ' LYS . 28.7 p -105.63 158.47 16.68 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 110.585 -0.154 . . . . 1.1200000000000001 110.585 175.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.585 ' HB2' ' HA ' ' A' ' 67' ' ' ASP . 5.6 mpt_? -71.05 -4.0 22.68 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.111 0.481 . . . . 2.54 110.216 171.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.574 ' HG3' ' CD ' ' A' ' 65' ' ' ARG . 22.0 ttp180 -76.26 -40.1 52.73 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.706 -0.679 . . . . 1.77 109.362 175.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 59.8 p -103.19 -35.8 8.34 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.707 -0.679 . . . . 0.67000000000000004 111.035 -176.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 80.95 -28.31 2.89 Favored Glycine 0 CA--C 1.52 0.365 0 CA-C-N 115.963 -0.562 . . . . 0.81999999999999995 112.21 -179.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -98.48 -71.21 0.7 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.839 0.352 . . . . 2.1000000000000001 110.64 -178.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 44.7 m -154.11 156.7 37.74 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.109 -0.496 . . . . 1.0800000000000001 110.212 177.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.482 HG22 ' N ' ' A' ' 24' ' ' VAL . 8.9 t -123.22 35.5 4.85 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 122.29 1.043 . . . . 0.34000000000000002 109.695 178.285 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -77.67 -4.58 46.83 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.833 -1.076 . . . . 0.37 111.528 -176.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -96.76 1.21 50.58 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.798 -0.637 . . . . 2.21 110.747 -178.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.46 HG23 ' HB2' ' A' ' 39' ' ' ASP . 0.2 OUTLIER -129.46 134.75 63.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.685 -0.689 . . . . 0.31 109.787 -179.955 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 41.2 p -96.49 -176.19 3.55 Favored 'General case' 0 CA--C 1.513 -0.468 0 N-CA-C 109.487 -0.56 . . . . 0.39000000000000001 109.487 -178.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.543 ' O ' HG13 ' A' ' 41' ' ' ILE . 0.2 OUTLIER -67.93 -22.8 65.04 Favored 'General case' 0 C--O 1.219 -0.532 0 C-N-CA 118.883 -1.127 . . . . 1.53 110.036 173.583 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -68.82 -49.3 59.6 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.761 -0.459 . . . . 0.95999999999999996 109.761 174.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.46 ' HB2' HG23 ' A' ' 35' ' ' VAL . 8.4 m-20 -66.54 -32.44 73.79 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.368 0.604 . . . . 0.91000000000000003 109.967 177.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.428 ' HB3' ' HA ' ' A' ' 37' ' ' TYR . . . -71.85 -40.91 68.7 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.272 -0.876 . . . . 0.19 110.832 179.383 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.543 HG13 ' O ' ' A' ' 37' ' ' TYR . 61.8 mt -62.3 -34.67 65.35 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.312 0 N-CA-C 109.316 -0.624 . . . . 0.29999999999999999 109.316 173.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.421 ' O ' ' HG3' ' A' ' 46' ' ' LYS . 19.7 mtpt -65.34 -21.28 66.68 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 116.336 -0.393 . . . . 2.3199999999999998 111.085 176.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.447 ' HG3' ' CD1' ' A' ' 47' ' ' TRP . 1.6 tp10 -87.85 -57.61 2.87 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.34 -0.615 . . . . 1.02 109.34 178.187 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.934 HD23 HG23 ' A' ' 104' ' ' ILE . 23.8 tp -57.93 -38.89 76.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 114.965 -1.016 . . . . 0.17000000000000001 111.101 -175.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.516 ' HB2' ' O ' ' A' ' 41' ' ' ILE . 3.6 mm-40 -66.22 -28.66 68.91 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 112.047 0.388 . . . . 0.87 112.047 -178.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.421 ' HG3' ' O ' ' A' ' 42' ' ' LYS . 66.4 mttm -77.56 -45.02 26.6 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.986 -0.376 . . . . 1.3100000000000001 109.986 178.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.447 ' CD1' ' HG3' ' A' ' 43' ' ' GLU . 58.2 m95 -66.11 -45.5 80.94 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.249 -0.432 . . . . 0.52000000000000002 111.695 177.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.567 ' HB3' HG21 ' A' ' 113' ' ' ILE . 96.0 p -65.22 -23.82 67.18 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.957 0.408 . . . . 0.81999999999999995 109.989 177.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.473 ' HB2' ' O ' ' A' ' 45' ' ' GLN . 10.1 tt0 -73.3 -56.68 4.75 Favored 'General case' 0 C--O 1.223 -0.337 0 CA-C-N 116.094 -0.503 . . . . 0.53000000000000003 109.776 173.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.618 ' HB3' HG22 ' A' ' 56' ' ' VAL . 92.4 mtt180 -61.1 -41.7 97.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.77 -0.65 . . . . 0.41999999999999998 111.81 -176.136 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.495 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 98.2 mt -60.7 -36.42 70.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.367 -0.378 . . . . 0.20000000000000001 110.496 176.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -77.64 -36.95 51.0 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.243 -0.435 . . . . 0.27000000000000002 111.692 178.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.473 ' OG ' ' HA ' ' A' ' 50' ' ' ARG . 67.9 p -79.09 -29.8 43.5 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 111.76 0.282 . . . . 0.34999999999999998 111.76 -175.347 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 109.15 1.37 31.54 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.671 -0.776 . . . . 0.29999999999999999 112.318 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.439 ' HB2' ' HB3' ' A' ' 50' ' ' ARG . 43.5 mt-10 -61.97 -50.97 69.97 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.882 0.372 . . . . 0.65000000000000002 110.509 178.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.618 HG22 ' HB3' ' A' ' 50' ' ' ARG . 16.2 m -134.8 152.4 32.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 109.564 -0.532 . . . . 0.19 109.564 174.285 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 19.5 m -82.39 160.15 22.85 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.542 -0.54 . . . . 0.96999999999999997 109.542 178.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.427 ' HA ' ' CD1' ' A' ' 51' ' ' ILE . 2.6 t80 -54.95 -39.8 69.3 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.412 0.625 . . . . 0.22 109.74 -178.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -55.79 -45.56 78.17 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.541 -1.209 . . . . 1.72 111.351 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.455 ' O ' ' HG3' ' A' ' 64' ' ' GLN . 3.9 mm-40 -65.64 -47.83 74.24 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.964 -0.562 . . . . 2.0899999999999999 111.177 -173.154 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -67.25 -38.44 85.15 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.369 -0.378 . . . . 0.26000000000000001 110.845 -179.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.37 -53.18 58.73 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.131 -0.486 . . . . 0.23999999999999999 111.331 -178.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.553 ' HA ' ' O ' ' A' ' 71' ' ' TYR . 47.6 m -51.58 -29.56 17.68 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.892 0.701 . . . . 1.0 112.892 -177.337 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.455 ' HG3' ' O ' ' A' ' 60' ' ' GLU . 19.1 mt-30 -97.33 -50.48 4.53 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.738 0.78 . . . . 0.60999999999999999 110.708 -177.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.574 ' CD ' ' HG3' ' A' ' 27' ' ' ARG . 19.1 mmt180 -93.57 -40.26 10.39 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 114.55 -1.205 . . . . 0.85999999999999999 113.386 -166.18 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.546 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 38.7 p -63.84 121.52 14.23 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.106 0.479 . . . . 0.81999999999999995 111.177 -174.029 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.585 ' HA ' ' HB2' ' A' ' 26' ' ' ARG . 31.5 t70 -74.66 -15.08 60.82 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.571 -0.741 . . . . 2.2799999999999998 110.813 177.13 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.505 ' SG ' ' HB2' ' A' ' 66' ' ' SER . 5.2 p -77.57 150.34 34.74 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.94 -0.573 . . . . 1.52 110.556 -179.505 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -53.82 -18.04 7.83 Favored Glycine 0 C--N 1.329 0.176 0 CA-C-N 114.823 -1.08 . . . . 0.26000000000000001 114.742 -171.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 77.9 p -73.06 0.32 11.78 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 117.293 0.546 . . . . 0.32000000000000001 111.907 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.553 ' O ' ' HA ' ' A' ' 63' ' ' SER . 54.8 p90 -52.97 -41.27 64.41 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.767 0.318 . . . . 0.54000000000000004 110.295 174.045 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -95.14 2.68 55.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.045 0.45 . . . . 0.48999999999999999 110.983 -179.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 5.3 m -103.37 -6.78 21.59 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.076 -0.511 . . . . 0.70999999999999996 110.735 -178.274 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 90.61 19.85 42.95 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.891 -0.671 . . . . 0.54000000000000004 112.181 -177.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 84.7 -31.83 3.53 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 121.044 -0.598 . . . . 0.34999999999999998 112.697 179.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.466 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 6.9 p-10 -83.04 145.2 29.43 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-O 121.672 0.749 . . . . 1.6499999999999999 111.224 -176.031 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.45 HD21 ' HE1' ' A' ' 12' ' ' HIS . 16.6 mt -105.43 175.74 5.4 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 114.399 -1.273 . . . . 0.93999999999999995 110.388 179.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -87.43 -152.38 22.95 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 121.234 -0.508 . . . . 0.44 112.014 177.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.48 ' HB3' ' HD2' ' A' ' 7' ' ' LYS . 91.6 m-85 -96.16 124.11 40.04 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.27 0.557 . . . . 3.8700000000000001 110.988 179.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.42 ' HZ ' ' N ' ' A' ' 10' ' ' ALA . 1.0 OUTLIER -134.44 160.2 38.72 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.491 -0.777 . . . . 1.3100000000000001 110.45 -176.214 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 40.8 p -89.22 126.59 35.55 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 109.598 -0.519 . . . . 1.1699999999999999 109.598 178.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 17.2 m -56.57 122.67 12.55 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.305 -0.407 . . . . 1.1899999999999999 111.093 -178.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 113.23 6.85 21.81 Favored Glycine 0 N--CA 1.445 -0.708 0 N-CA-C 111.533 -0.627 . . . . 0.79000000000000004 111.533 -179.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -112.82 10.55 19.15 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.135 0.493 . . . . 1.55 110.446 -178.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 23.6 mmt -99.17 -108.8 0.19 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.027 0.441 . . . . 0.72999999999999998 110.642 178.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 56.7 mtt -134.69 150.5 50.63 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 107.88 -1.155 . . . . 1.3899999999999999 107.88 175.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.403 ' HB2' ' HD3' ' A' ' 88' ' ' PRO . 14.4 mmmm -54.05 -53.19 61.27 Favored Pre-proline 0 C--N 1.32 -0.697 0 N-CA-C 112.518 0.562 . . . . 2.3700000000000001 112.518 -175.142 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.442 ' HG2' HG22 ' A' ' 107' ' ' THR . 64.2 Cg_endo -75.16 -25.18 11.87 Favored 'Trans proline' 0 C--N 1.355 0.902 0 C-N-CA 121.561 1.507 . . . . 0.27000000000000002 112.152 -177.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.514 ' O ' HG23 ' A' ' 93' ' ' VAL . 27.0 t80 -72.88 -55.78 6.14 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.475 -0.784 . . . . 0.22 109.723 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -60.41 -36.19 77.56 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.263 -0.88 . . . . 2.1200000000000001 110.214 -179.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.566 ' HA ' ' CZ ' ' A' ' 94' ' ' ARG . 26.6 t70 -56.38 -32.97 65.28 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.613 -0.721 . . . . 0.60999999999999999 111.117 177.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.475 ' O ' ' HG ' ' A' ' 96' ' ' LEU . . . -82.79 -26.98 31.28 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.381 -0.372 . . . . 0.22 111.037 179.114 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.514 HG23 ' O ' ' A' ' 89' ' ' PHE . 28.0 t -67.36 -45.38 85.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.47 -0.332 . . . . 0.25 111.666 -174.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.566 ' CZ ' ' HA ' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -83.32 -2.49 55.83 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.239 -0.584 . . . . 2.5899999999999999 110.408 178.262 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -86.5 -2.77 58.75 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.18 0.514 . . . . 0.46999999999999997 110.339 179.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.642 ' HB2' ' HB2' ' A' ' 100' ' ' ASP . 0.7 OUTLIER -136.26 153.61 51.14 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.614 -0.721 . . . . 0.28000000000000003 110.128 176.785 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.546 ' HG3' ' H ' ' A' ' 98' ' ' ILE . 20.2 tptm -102.42 179.17 4.38 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.128 -0.693 . . . . 1.6100000000000001 109.128 179.197 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.546 ' H ' ' HG3' ' A' ' 97' ' ' LYS . 65.3 mt -54.81 116.05 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.011 0.434 . . . . 0.90000000000000002 111.197 179.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 104.45 -6.18 45.31 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 121.016 -0.612 . . . . 0.46000000000000002 112.975 179.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.642 ' HB2' ' HB2' ' A' ' 96' ' ' LEU . 31.0 m-20 -98.14 138.86 34.81 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.906 0.353 . . . . 0.46000000000000002 110.886 -178.253 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 11.2 mt -108.56 147.62 13.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 109.385 -0.598 . . . . 0.23000000000000001 109.385 178.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 88.3 p -91.4 158.11 41.35 Favored Pre-proline 0 C--N 1.321 -0.658 0 CA-C-O 120.667 0.27 . . . . 0.92000000000000004 110.571 -179.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -74.99 175.87 10.66 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.272 1.982 . . . . 0.34000000000000002 110.94 170.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.934 HG23 HD23 ' A' ' 44' ' ' LEU . 21.1 mm -49.0 112.8 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.898 0.38 . . . . 0.20000000000000001 111.58 176.23 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.4 p -119.24 120.82 64.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.093 0.473 . . . . 1.04 110.078 174.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -85.14 145.25 27.71 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 121.269 0.556 . . . . 0.55000000000000004 109.995 177.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.442 HG22 ' HG2' ' A' ' 88' ' ' PRO . 8.2 p -120.6 -171.93 2.27 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.349 -0.841 . . . . 0.37 110.886 -176.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -54.69 -45.4 73.97 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.811 -0.631 . . . . 2.1600000000000001 110.723 176.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.649 ' OG ' ' HE2' ' A' ' 16' ' ' LYS . 15.0 t -93.59 -60.81 1.68 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.921 -0.581 . . . . 1.0900000000000001 111.078 -177.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -144.95 -134.85 2.8 Favored Glycine 0 N--CA 1.442 -0.929 0 C-N-CA 118.865 -1.636 . . . . 0.23999999999999999 113.448 -172.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.903 ' HB3' HD22 ' A' ' 44' ' ' LEU . 6.8 mp -113.19 146.33 39.47 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.204 -0.498 . . . . 0.19 111.116 -172.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . 0.584 ' NE2' HD13 ' A' ' 14' ' ' LEU . 77.9 m-70 -143.23 152.67 41.99 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.459 0.647 . . . . 0.22 112.484 179.35 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.686 HG12 HD11 ' A' ' 44' ' ' LEU . 3.6 pt -131.55 137.42 55.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 107.372 -1.344 . . . . 0.17000000000000001 107.372 157.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 2.4 mp -127.57 144.17 38.32 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 C-N-CA 120.781 -0.368 . . . . 0.17999999999999999 110.247 -176.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.495 ' HG2' ' HB3' ' A' ' 11' ' ' ALA . 52.0 pttt -127.94 137.25 52.2 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.041 -0.726 . . . . 0.60999999999999999 109.041 173.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.538 ' HB2' ' CD1' ' A' ' 96' ' ' LEU . 65.2 ttt180 -85.49 126.61 33.97 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 120.989 0.424 . . . . 1.8700000000000001 111.358 -175.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.49 HD21 ' HB2' ' A' ' 11' ' ' ALA . 0.7 OUTLIER -97.26 -33.56 11.42 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.594 -0.73 . . . . 0.89000000000000001 110.625 178.268 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.587 ' HB3' ' HB3' ' A' ' 9' ' ' ARG . . . . . . . . 0 C--O 1.247 0.936 0 CA-C-O 118.736 -0.65 . . . . 1.1000000000000001 110.662 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 25.4 ptt? . . . . . 0 N--CA 1.478 0.938 0 CA-C-O 120.975 0.417 . . . . 7.2300000000000004 110.355 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 39.8 t -111.89 -44.42 3.46 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.212 -0.449 . . . . 2.8799999999999999 111.078 -178.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -77.07 -11.77 59.85 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.457 -0.338 . . . . 2.7999999999999998 110.872 -177.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -82.44 130.52 35.12 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.162 0.506 . . . . 1.1899999999999999 111.315 -175.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.497 HD11 ' CD ' ' A' ' 116' ' ' ARG . 15.3 tp -132.18 171.97 12.99 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.022 -0.99 . . . . 1.1799999999999999 108.779 -179.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 68.2 ttt180 -145.26 132.15 20.17 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 110.178 -0.304 . . . . 1.0600000000000001 110.178 175.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -148.51 160.31 43.2 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.329 0.585 . . . . 0.22 112.421 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.527 ' HB2' HD21 ' A' ' 117' ' ' LEU . . . -107.47 138.96 42.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.239 -0.892 . . . . 0.20000000000000001 109.129 176.489 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 20.0 p-80 -139.5 141.68 37.32 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.016 0.436 . . . . 0.23000000000000001 111.341 -172.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.572 ' O ' ' HA ' ' A' ' 112' ' ' HIS . 7.1 tt -113.47 138.39 50.18 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.549 -0.908 . . . . 0.23999999999999999 108.549 177.226 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.609 HD21 ' HE3' ' A' ' 16' ' ' LYS . 16.6 tp -121.2 137.5 54.65 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.697 0.284 . . . . 0.27000000000000002 111.501 -179.046 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.434 HG23 HD13 ' A' ' 44' ' ' LEU . 43.8 t -119.66 126.47 75.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.854 -0.612 . . . . 0.14999999999999999 109.721 172.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.609 ' HE3' HD21 ' A' ' 14' ' ' LEU . 28.5 mmtp -103.31 154.82 18.97 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.982 -0.554 . . . . 0.62 109.821 177.171 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -151.67 162.32 41.19 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.133 -0.485 . . . . 0.25 110.127 -176.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.455 ' CB ' ' HA ' ' A' ' 33' ' ' ALA . 4.1 t -47.25 110.01 0.26 Allowed 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 122.949 0.499 . . . . 1.04 111.484 177.302 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 93.74 10.47 58.92 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.323 -0.941 . . . . 0.53000000000000003 113.588 177.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.506 ' HB2' ' O ' ' A' ' 109' ' ' SER . 83.4 p -81.84 46.98 1.04 Allowed 'General case' 0 C--O 1.234 0.252 0 CA-C-N 117.684 0.742 . . . . 0.69999999999999996 111.326 -175.058 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 27.1 ttt180 69.32 -36.29 0.33 Allowed 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.805 0.842 . . . . 3.4900000000000002 111.115 -179.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.475 ' H ' ' C ' ' A' ' 20' ' ' SER . 57.5 m-80 -150.92 104.86 3.01 Favored Pre-proline 0 C--N 1.323 -0.576 0 N-CA-C 108.711 -0.848 . . . . 1.77 108.711 174.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_exo -64.04 -163.05 0.05 OUTLIER 'Trans proline' 0 CA--C 1.536 0.597 0 C-N-CA 123.172 2.581 . . . . 1.71 112.879 177.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.579 ' N ' HG22 ' A' ' 32' ' ' THR . 40.0 t 66.74 119.84 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-O 121.651 0.739 . . . . 0.47999999999999998 111.596 -175.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.7 t -102.0 152.3 21.11 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 115.357 -0.838 . . . . 1.1200000000000001 109.319 -179.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.682 ' CB ' ' HA ' ' A' ' 67' ' ' ASP . 8.6 tpp180 -79.91 -11.41 59.81 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.263 -1.014 . . . . 2.54 108.263 175.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.592 ' HG3' ' HD3' ' A' ' 65' ' ' ARG . 17.2 ttp180 -80.68 -43.65 20.02 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 114.75 -1.113 . . . . 1.77 109.285 173.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 32.3 p -91.05 -33.77 15.37 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 116.038 -0.528 . . . . 0.67000000000000004 111.058 -175.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 81.78 -35.39 2.5 Favored Glycine 0 N--CA 1.452 -0.244 0 CA-C-N 116.089 -0.505 . . . . 0.81999999999999995 113.154 176.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 -99.52 -64.19 1.06 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.757 0.313 . . . . 2.1000000000000001 110.615 -175.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.1 p -154.08 150.49 28.26 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.308 -0.405 . . . . 1.0800000000000001 111.608 -178.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.579 HG22 ' N ' ' A' ' 24' ' ' VAL . 8.9 t -124.73 14.92 8.7 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.905 0.859 . . . . 0.34000000000000002 110.095 176.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.455 ' HA ' ' CB ' ' A' ' 18' ' ' SER . . . -63.67 -4.42 3.0 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.447 -0.797 . . . . 0.37 113.019 177.033 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 52.3 m-20 -89.88 -25.09 21.17 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.873 0.368 . . . . 2.21 110.538 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.435 HG13 ' OG1' ' A' ' 32' ' ' THR . 0.2 OUTLIER -102.29 139.22 23.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.989 -0.55 . . . . 0.31 110.081 -178.568 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.413 ' H ' ' HB2' ' A' ' 39' ' ' ASP . 25.3 p -100.02 -178.62 3.9 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 116.107 -0.497 . . . . 0.39000000000000001 110.395 -175.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.494 ' O ' HG13 ' A' ' 41' ' ' ILE . 11.6 p90 -62.95 -30.78 71.83 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.517 -0.473 . . . . 1.53 109.872 177.223 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -72.66 -45.32 59.53 Favored 'General case' 0 CA--C 1.52 -0.173 0 CA-C-N 116.418 -0.355 . . . . 0.95999999999999996 110.545 179.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.413 ' HB2' ' H ' ' A' ' 36' ' ' THR . 0.7 OUTLIER -67.35 -28.17 67.74 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-O 121.167 0.508 . . . . 0.91000000000000003 110.345 176.389 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -69.34 -43.93 72.66 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.376 -0.829 . . . . 0.19 110.337 175.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.507 HG12 HD21 ' A' ' 111' ' ' LEU . 97.9 mt -62.65 -38.39 81.45 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.412 0 N-CA-C 109.529 -0.545 . . . . 0.29999999999999999 109.529 173.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 3.5 ttpm? -61.16 -25.99 67.39 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.342 -0.844 . . . . 2.3199999999999998 109.919 179.041 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.492 ' HG3' ' CD1' ' A' ' 47' ' ' TRP . 3.1 tp10 -87.99 -51.68 5.68 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.605 -0.725 . . . . 1.02 109.927 -178.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.967 HD22 ' HB3' ' A' ' 111' ' ' LEU . 33.0 tp -61.26 -37.85 84.6 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.421 -0.808 . . . . 0.17000000000000001 110.573 -175.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.54 ' O ' ' HB2' ' A' ' 49' ' ' GLN . 4.7 mm-40 -65.27 -26.57 68.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.19 -0.459 . . . . 0.87 112.077 -178.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.41 ' O ' ' HB3' ' A' ' 49' ' ' GLN . 68.5 mttm -81.29 -45.24 16.51 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.911 0.386 . . . . 1.3100000000000001 110.41 178.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.492 ' CD1' ' HG3' ' A' ' 43' ' ' GLU . 42.9 m95 -65.36 -46.35 80.52 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.474 -0.33 . . . . 0.52000000000000002 111.556 177.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.57 ' HB3' HG21 ' A' ' 113' ' ' ILE . 83.8 p -65.27 -22.49 66.86 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.11 0.481 . . . . 0.81999999999999995 110.16 177.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.54 ' HB2' ' O ' ' A' ' 45' ' ' GLN . 11.2 tt0 -72.09 -56.9 4.81 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 115.762 -0.654 . . . . 0.53000000000000003 109.753 174.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.633 ' HB3' HG22 ' A' ' 56' ' ' VAL . 97.0 mtt180 -61.42 -41.82 97.77 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.574 -0.739 . . . . 0.41999999999999998 111.611 -176.462 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.518 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 92.3 mt -62.05 -35.17 67.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.212 -0.449 . . . . 0.20000000000000001 110.738 177.368 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -79.59 -36.83 37.52 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.098 -0.501 . . . . 0.27000000000000002 111.615 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 47.8 p -79.39 -29.78 42.2 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.794 0.33 . . . . 0.34999999999999998 111.591 -175.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 108.63 5.89 31.27 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.6 -0.81 . . . . 0.29999999999999999 112.142 -179.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.423 ' HB2' ' HB3' ' A' ' 50' ' ' ARG . 37.1 mt-10 -65.3 -47.89 75.02 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.931 0.396 . . . . 0.65000000000000002 110.117 178.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.633 HG22 ' HB3' ' A' ' 50' ' ' ARG . 14.5 m -136.53 156.44 35.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 109.679 -0.489 . . . . 0.19 109.679 172.241 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.7 m -81.01 161.54 24.2 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.696 -0.483 . . . . 0.96999999999999997 109.696 177.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -57.66 -42.53 83.69 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.025 -0.731 . . . . 0.22 109.025 177.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.46 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 38.6 mt-10 -57.47 -41.16 80.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.891 -1.05 . . . . 1.72 111.649 179.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -66.51 -45.72 78.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.128 0.49 . . . . 2.0899999999999999 110.637 -178.13 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -71.09 -46.06 62.52 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.077 -0.511 . . . . 0.26000000000000001 111.267 -179.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.69 -50.48 73.7 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.58 0.585 . . . . 0.23999999999999999 112.58 -174.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.57 ' HA ' ' O ' ' A' ' 71' ' ' TYR . 67.5 m -55.83 -25.0 39.76 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 113.132 0.79 . . . . 1.0 113.132 -177.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -105.85 -44.57 4.6 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.275 0.56 . . . . 0.60999999999999999 111.152 -177.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.592 ' HD3' ' HG3' ' A' ' 27' ' ' ARG . 22.6 mmt180 -96.69 -36.59 10.63 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 114.015 1.117 . . . . 0.85999999999999999 114.015 -169.144 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.514 ' HB2' ' HG ' ' A' ' 13' ' ' LEU . 31.7 t -62.48 119.54 9.34 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.977 0.418 . . . . 0.81999999999999995 110.623 -178.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.682 ' HA ' ' CB ' ' A' ' 26' ' ' ARG . 68.6 m-20 -79.05 -4.9 52.47 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.729 -0.669 . . . . 2.2799999999999998 110.749 179.149 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.53 ' SG ' HD22 ' A' ' 14' ' ' LEU . 1.4 m -81.04 161.27 24.27 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.503 0.668 . . . . 1.52 110.888 173.091 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -63.2 -17.64 59.47 Favored Glycine 0 CA--C 1.516 0.149 0 CA-C-N 114.328 -1.306 . . . . 0.26000000000000001 114.119 -173.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.503 ' HB2' ' CA ' ' A' ' 75' ' ' GLY . 2.3 p -67.01 -6.69 18.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 117.207 0.503 . . . . 0.32000000000000001 112.283 177.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.57 ' O ' ' HA ' ' A' ' 63' ' ' SER . 35.2 p90 -52.03 -33.51 38.92 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.136 0.494 . . . . 0.54000000000000004 110.396 174.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -92.36 1.57 57.15 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.058 0.456 . . . . 0.48999999999999999 110.991 -176.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.6 m -115.58 -21.9 9.5 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.147 0.499 . . . . 0.70999999999999996 110.709 -178.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.46 ' O ' ' HA ' ' A' ' 59' ' ' GLU . . . 108.04 15.7 14.0 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.906 -0.664 . . . . 0.54000000000000004 112.02 -175.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.503 ' CA ' ' HB2' ' A' ' 70' ' ' SER . . . 96.65 -9.2 66.43 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.803 -0.713 . . . . 0.34999999999999998 112.885 178.195 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -95.54 145.32 25.3 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.633 0.73 . . . . 1.6499999999999999 111.559 -169.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -111.96 172.51 6.86 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 114.54 -1.209 . . . . 0.93999999999999995 108.89 171.32 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -92.22 -145.71 16.65 Favored Glycine 0 C--N 1.311 -0.829 0 C-N-CA 120.65 -0.786 . . . . 0.44 111.905 -178.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -84.37 140.02 31.86 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.915 -0.402 . . . . 3.8700000000000001 109.915 177.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -152.98 155.6 37.26 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.836 -0.62 . . . . 1.3100000000000001 110.028 -178.241 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 50.5 m -79.74 139.58 37.25 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.463 -0.335 . . . . 1.1699999999999999 110.695 -178.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 33.6 m -61.13 112.87 2.28 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.263 0.554 . . . . 1.1899999999999999 110.317 179.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.467 ' H ' ' HG3' ' A' ' 90' ' ' GLU . . . 113.82 -11.36 22.99 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.901 -0.666 . . . . 0.79000000000000004 112.023 -177.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -84.93 41.2 0.85 Allowed 'General case' 0 C--O 1.233 0.23 0 CA-C-O 121.657 0.741 . . . . 1.55 110.475 -177.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 24.3 mmt -136.82 -127.41 0.14 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.797 -0.638 . . . . 0.72999999999999998 109.342 177.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 63.6 mtt -119.16 153.62 34.59 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 108.133 -1.062 . . . . 1.3899999999999999 108.133 175.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.44 ' HB3' ' HD3' ' A' ' 88' ' ' PRO . 88.4 tttt -52.29 -55.13 34.42 Favored Pre-proline 0 CA--C 1.539 0.526 0 N-CA-C 112.38 0.511 . . . . 2.3700000000000001 112.38 -175.445 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.44 ' HD3' ' HB3' ' A' ' 87' ' ' LYS . 73.4 Cg_endo -74.59 -26.76 11.48 Favored 'Trans proline' 0 C--N 1.357 0.982 0 C-N-CA 121.656 1.57 . . . . 0.27000000000000002 111.976 -176.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.649 ' O ' HG23 ' A' ' 93' ' ' VAL . 32.1 t80 -68.31 -56.16 9.57 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.496 -0.774 . . . . 0.22 109.416 179.298 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.467 ' HG3' ' H ' ' A' ' 83' ' ' GLY . 4.2 tm-20 -65.38 -35.17 80.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.72 -0.673 . . . . 2.1200000000000001 109.721 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.59 ' HA ' ' NE ' ' A' ' 94' ' ' ARG . 23.0 t70 -53.79 -33.55 56.31 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.432 -0.804 . . . . 0.60999999999999999 110.978 175.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.551 ' O ' ' HG ' ' A' ' 96' ' ' LEU . . . -84.2 -37.74 21.46 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.408 -0.36 . . . . 0.22 111.132 178.571 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.649 HG23 ' O ' ' A' ' 89' ' ' PHE . 15.2 t -61.96 -44.17 98.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-O 121.447 0.641 . . . . 0.25 110.723 -177.189 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.59 ' NE ' ' HA ' ' A' ' 91' ' ' ASP . 26.4 ptt180 -74.14 -16.66 60.99 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.606 -0.725 . . . . 2.5899999999999999 110.607 178.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -93.68 12.96 23.67 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.982 -0.554 . . . . 0.46999999999999997 111.51 -174.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.556 ' HB2' ' HB2' ' A' ' 100' ' ' ASP . 0.7 OUTLIER -142.14 150.75 41.52 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.152 -0.476 . . . . 0.28000000000000003 110.432 175.396 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.571 ' HA ' ' NH2' ' A' ' 116' ' ' ARG . 23.1 tptm -91.87 164.74 13.56 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.285 -0.635 . . . . 1.6100000000000001 109.285 177.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.449 ' HA ' ' HG2' ' A' ' 116' ' ' ARG . 75.7 mt -41.83 115.94 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 123.458 0.474 . . . . 0.90000000000000002 111.38 172.138 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 101.99 -8.07 55.51 Favored Glycine 0 N--CA 1.45 -0.427 0 CA-C-N 115.701 -0.681 . . . . 0.46000000000000002 113.421 177.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.556 ' HB2' ' HB2' ' A' ' 96' ' ' LEU . 40.7 m-20 -99.06 141.22 32.09 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 117.16 0.48 . . . . 0.46000000000000002 110.979 -179.428 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 8.3 mt -106.73 148.67 10.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.016 -0.538 . . . . 0.23000000000000001 110.218 179.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 89.1 p -89.79 150.93 44.88 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 116.245 -0.434 . . . . 0.92000000000000004 110.671 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -69.88 164.61 34.01 Favored 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 122.379 2.053 . . . . 0.34000000000000002 111.041 171.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.872 HG23 HD23 ' A' ' 44' ' ' LEU . 24.9 mm -40.7 110.94 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 O-C-N 123.75 0.656 . . . . 0.20000000000000001 112.506 179.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.1 p -119.07 123.51 71.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.183 -0.462 . . . . 1.04 110.085 175.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -85.73 149.32 25.37 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.098 0.475 . . . . 0.55000000000000004 109.938 177.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 4.4 p -126.56 -172.03 2.54 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.768 -0.651 . . . . 0.37 110.936 -176.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -52.2 -44.36 64.68 Favored 'General case' 0 C--N 1.331 -0.238 0 O-C-N 123.508 0.505 . . . . 2.1600000000000001 110.993 177.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.506 ' O ' ' HB2' ' A' ' 20' ' ' SER . 4.4 m -92.35 -61.14 1.67 Allowed 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 120.05 -0.66 . . . . 1.0900000000000001 112.084 178.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -149.07 -128.35 1.68 Allowed Glycine 0 N--CA 1.438 -1.231 0 C-N-CA 118.749 -1.691 . . . . 0.23999999999999999 113.413 -170.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.967 ' HB3' HD22 ' A' ' 44' ' ' LEU . 8.9 mp -116.08 148.88 39.79 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.604 -0.298 . . . . 0.19 111.53 -170.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . 0.572 ' HA ' ' O ' ' A' ' 13' ' ' LEU . 69.3 m-70 -145.51 150.92 37.32 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.215 0.531 . . . . 0.22 112.023 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.617 HG12 HD11 ' A' ' 44' ' ' LEU . 5.2 pt -130.17 133.87 63.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 107.669 -1.234 . . . . 0.17000000000000001 107.669 159.659 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.442 HG21 HG22 ' A' ' 93' ' ' VAL . 2.8 mp -124.72 144.66 33.9 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 N-CA-C 110.07 -0.345 . . . . 0.17999999999999999 110.07 -176.197 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.447 ' HG2' ' HB3' ' A' ' 11' ' ' ALA . 46.0 pttt -130.42 138.12 50.17 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.932 -0.766 . . . . 0.60999999999999999 108.932 174.261 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.571 ' NH2' ' HA ' ' A' ' 97' ' ' LYS . 3.6 ttp180 -82.62 135.47 35.05 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.474 -0.49 . . . . 1.8700000000000001 111.236 -177.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.527 HD21 ' HB2' ' A' ' 11' ' ' ALA . 0.3 OUTLIER -102.28 -30.65 10.96 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.69 -0.687 . . . . 0.89000000000000001 110.974 177.714 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.466 ' O ' ' HD2' ' A' ' 116' ' ' ARG . . . . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.649 -0.691 . . . . 1.1000000000000001 110.689 -178.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 24.3 ptp . . . . . 0 N--CA 1.483 1.189 0 CA-C-O 121.039 0.447 . . . . 7.2300000000000004 110.893 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 39.8 t -131.86 121.63 24.38 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.788 0.327 . . . . 2.8799999999999999 110.172 -178.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -89.61 106.94 18.79 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.178 -0.464 . . . . 2.7999999999999998 110.324 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 69.3 mmtt -137.74 149.0 46.09 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.527 0.68 . . . . 1.1899999999999999 111.487 -178.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.628 HD23 ' N ' ' A' ' 9' ' ' ARG . 3.2 tt -154.61 151.45 28.83 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.01 -1.107 . . . . 1.1799999999999999 108.01 -176.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.628 ' N ' HD23 ' A' ' 8' ' ' LEU . 65.1 ttt180 -135.05 131.64 37.27 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 108.722 -0.844 . . . . 1.0600000000000001 108.722 173.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -148.99 150.9 33.63 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 120.066 -0.653 . . . . 0.22 112.337 -175.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.406 ' HB3' ' HG2' ' A' ' 115' ' ' LYS . . . -104.42 133.39 49.38 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.318 -0.855 . . . . 0.20000000000000001 109.057 178.116 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 26.0 p-80 -135.88 154.66 51.08 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.105 0.479 . . . . 0.23000000000000001 111.714 -172.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.552 HD23 ' N ' ' A' ' 14' ' ' LEU . 5.8 tt -123.93 148.98 46.44 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.538 -0.912 . . . . 0.23999999999999999 108.538 177.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.562 ' HA ' ' O ' ' A' ' 111' ' ' LEU . 24.5 tp -131.21 135.75 47.67 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 110.346 -0.242 . . . . 0.27000000000000002 110.346 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.508 HG23 HD13 ' A' ' 44' ' ' LEU . 57.4 t -121.17 128.98 76.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 N-CA-C 109.619 -0.511 . . . . 0.14999999999999999 109.619 172.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.49 ' HE3' HD21 ' A' ' 14' ' ' LEU . 12.6 mmtp -103.57 148.48 25.94 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.996 -0.547 . . . . 0.62 109.777 178.115 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.49 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 53.6 p90 -143.75 162.62 35.54 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.144 -0.48 . . . . 0.25 110.685 -178.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.477 ' HB3' ' HA ' ' A' ' 33' ' ' ALA . 19.7 p -49.46 112.25 0.61 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.144 -0.48 . . . . 1.04 111.509 178.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 95.89 8.6 57.97 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.681 -0.771 . . . . 0.53000000000000003 113.56 178.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.407 ' C ' ' H ' ' A' ' 22' ' ' ASN . 77.3 p -91.11 43.3 1.14 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 117.59 0.695 . . . . 0.69999999999999996 111.002 -177.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 74.5 ttt180 73.45 -32.79 0.25 Allowed 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.4 0.68 . . . . 3.4900000000000002 111.418 177.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.407 ' H ' ' C ' ' A' ' 20' ' ' SER . 43.7 m-80 -135.55 100.74 11.16 Favored Pre-proline 0 C--N 1.324 -0.527 0 N-CA-C 109.209 -0.663 . . . . 1.77 109.209 175.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.546 ' C ' HG22 ' A' ' 32' ' ' THR . 92.7 Cg_endo -82.69 41.35 1.1 Allowed 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.372 2.048 . . . . 1.71 112.756 -175.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.443 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 89.5 t -141.54 116.88 5.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 108.626 -0.879 . . . . 0.47999999999999998 108.626 177.529 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.559 ' HB2' ' OD1' ' A' ' 67' ' ' ASP . 19.7 p -103.57 154.85 19.04 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 110.286 -0.265 . . . . 1.1200000000000001 110.286 -177.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.452 ' CG ' ' HA ' ' A' ' 67' ' ' ASP . 35.2 mmt180 -69.03 -22.97 64.02 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 108.661 -0.866 . . . . 2.54 108.661 173.352 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.465 ' HG3' ' HD2' ' A' ' 65' ' ' ARG . 5.3 tmm_? -70.74 -32.85 70.17 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 114.351 -1.295 . . . . 1.77 110.421 -179.209 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 75.4 p -100.04 -35.3 9.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.426 0.632 . . . . 0.67000000000000004 110.795 178.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 65.65 18.26 65.74 Favored Glycine 0 N--CA 1.453 -0.201 0 CA-C-N 114.877 -1.056 . . . . 0.81999999999999995 112.304 -178.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -141.95 -72.0 0.33 Allowed 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.769 -0.456 . . . . 2.1000000000000001 109.769 -179.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.443 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 6.2 p -155.2 148.74 25.2 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.885 -0.598 . . . . 1.0800000000000001 110.115 173.265 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.546 HG22 ' C ' ' A' ' 23' ' ' PRO . 14.5 t -113.42 22.69 13.94 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.939 0.876 . . . . 0.34000000000000002 109.217 178.01 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.477 ' HA ' ' HB3' ' A' ' 18' ' ' SER . . . -72.58 -6.49 44.44 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.904 -1.044 . . . . 0.37 111.719 -177.538 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -96.22 -24.0 16.45 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.108 0.48 . . . . 2.21 111.118 -178.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.489 HG23 ' HB2' ' A' ' 39' ' ' ASP . 0.2 OUTLIER -96.77 135.1 32.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.279 -0.419 . . . . 0.31 109.972 179.531 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 59.6 p -96.31 -179.34 4.61 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.348 -0.387 . . . . 0.39000000000000001 109.957 -175.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.41 ' O ' HG13 ' A' ' 41' ' ' ILE . 4.3 p90 -64.62 -27.22 68.79 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.967 -0.753 . . . . 1.53 108.967 175.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -74.13 -43.31 57.97 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 116.004 -0.544 . . . . 0.95999999999999996 110.412 178.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.489 ' HB2' HG23 ' A' ' 35' ' ' VAL . 19.4 m-20 -65.36 -33.63 76.41 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.523 0.677 . . . . 0.91000000000000003 109.934 175.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.49 ' HB2' ' HB3' ' A' ' 17' ' ' PHE . . . -70.79 -46.53 62.69 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.789 -1.096 . . . . 0.19 110.707 -179.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.41 HG13 ' O ' ' A' ' 37' ' ' TYR . 68.7 mt -63.18 -36.43 75.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 110.09 -0.337 . . . . 0.29999999999999999 110.09 176.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -64.3 -25.18 67.93 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.29 0.567 . . . . 2.3199999999999998 110.021 178.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.477 ' HG3' ' CD1' ' A' ' 47' ' ' TRP . 5.8 tp10 -84.87 -52.32 6.1 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.433 -0.803 . . . . 1.02 109.024 -178.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.909 HD22 ' HB3' ' A' ' 111' ' ' LEU . 30.9 tp -62.72 -37.57 87.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.045 -0.98 . . . . 0.17000000000000001 110.535 -175.008 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.45 ' O ' ' HB2' ' A' ' 49' ' ' GLN . 0.0 OUTLIER -67.18 -28.93 68.5 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 112.304 0.483 . . . . 0.87 112.304 -177.882 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -78.35 -43.39 27.81 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.636 -0.426 . . . . 1.3100000000000001 110.131 178.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.477 ' CD1' ' HG3' ' A' ' 43' ' ' GLU . 49.3 m95 -64.48 -47.14 80.09 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 111.974 0.361 . . . . 0.52000000000000002 111.974 176.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.507 ' HB3' HG21 ' A' ' 113' ' ' ILE . 88.7 p -63.99 -25.58 68.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.987 0.422 . . . . 0.81999999999999995 110.15 177.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.45 ' HB2' ' O ' ' A' ' 45' ' ' GLN . 14.2 tt0 -71.97 -56.13 6.22 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.994 -0.548 . . . . 0.53000000000000003 110.071 175.09 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.566 ' HB3' HG22 ' A' ' 56' ' ' VAL . 97.2 mtt180 -61.12 -41.93 97.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.935 -0.575 . . . . 0.41999999999999998 111.646 -176.443 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.478 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 93.9 mt -60.66 -36.82 73.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 120.976 0.417 . . . . 0.20000000000000001 110.458 177.224 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -77.99 -37.37 47.39 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.01 -0.541 . . . . 0.27000000000000002 111.426 -179.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 55.4 p -78.69 -29.19 45.39 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.843 0.354 . . . . 0.34999999999999998 111.488 -177.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 106.28 9.56 31.37 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.764 -0.732 . . . . 0.29999999999999999 112.318 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.453 ' HB2' ' HB3' ' A' ' 50' ' ' ARG . 45.4 mt-10 -67.47 -45.11 76.87 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.895 0.379 . . . . 0.65000000000000002 110.348 178.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.566 HG22 ' HB3' ' A' ' 50' ' ' ARG . 11.5 m -135.95 154.78 34.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 109.088 -0.708 . . . . 0.19 109.088 171.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.5 m -85.65 159.0 19.94 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.191 -0.67 . . . . 0.96999999999999997 109.191 177.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -53.94 -46.97 71.72 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.938 0.399 . . . . 0.22 109.972 -177.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.543 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 48.8 mt-10 -61.58 -26.44 67.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.533 -0.758 . . . . 1.72 112.46 -179.061 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 53.8 mm-40 -72.92 -50.91 20.78 Favored 'General case' 0 CA--C 1.519 -0.223 0 C-N-CA 120.516 -0.473 . . . . 2.0899999999999999 110.358 178.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -67.95 -47.34 68.92 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.185 -0.461 . . . . 0.26000000000000001 111.127 -177.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -57.39 -53.62 56.04 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.217 0.451 . . . . 0.23999999999999999 112.217 -174.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.52 ' HA ' ' O ' ' A' ' 71' ' ' TYR . 23.5 m -52.3 -18.15 1.45 Allowed 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 113.614 0.968 . . . . 1.0 113.614 -178.227 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -110.41 -43.89 3.81 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-O 121.577 0.703 . . . . 0.60999999999999999 110.309 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.465 ' HD2' ' HG3' ' A' ' 27' ' ' ARG . 15.5 mmt180 -96.34 -36.86 10.72 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 114.212 1.19 . . . . 0.85999999999999999 114.212 -170.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.476 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 52.6 p -63.37 116.0 5.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.263 0.554 . . . . 0.81999999999999995 110.362 -176.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.559 ' OD1' ' HB2' ' A' ' 25' ' ' SER . 57.3 m-20 -84.71 9.68 13.3 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.536 -0.756 . . . . 2.2799999999999998 111.123 -177.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.48 ' SG ' HD22 ' A' ' 14' ' ' LEU . 1.1 m -80.95 -177.33 6.36 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.666 -0.697 . . . . 1.52 110.294 170.361 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -76.09 -21.0 76.92 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.358 -0.925 . . . . 0.26000000000000001 111.699 175.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 71.2 p -65.84 0.46 1.77 Allowed 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 113.227 0.825 . . . . 0.32000000000000001 113.227 -178.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.52 ' O ' ' HA ' ' A' ' 63' ' ' SER . 27.7 p90 -62.94 -22.6 66.9 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 118.361 0.528 . . . . 0.54000000000000004 109.928 176.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -94.24 -2.94 51.58 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.382 0.61 . . . . 0.48999999999999999 110.087 177.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.6 m -115.49 1.01 13.54 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.296 -0.865 . . . . 0.70999999999999996 110.596 -175.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.543 ' O ' ' HA ' ' A' ' 59' ' ' GLU . . . 72.9 21.84 79.52 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.935 -0.65 . . . . 0.54000000000000004 111.998 -176.434 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 86.28 -20.58 21.04 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 121.026 -0.606 . . . . 0.34999999999999998 112.099 -177.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -69.93 132.04 45.34 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-N 115.553 -0.323 . . . . 1.6499999999999999 110.984 -176.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.511 ' O ' ' HG3' ' A' ' 9' ' ' ARG . 2.9 mp -118.17 161.82 19.24 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.248 0.547 . . . . 0.93999999999999995 110.283 174.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -85.71 -165.46 40.6 Favored Glycine 0 C--N 1.31 -0.913 0 CA-C-N 114.899 -1.046 . . . . 0.44 112.834 -178.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.627 ' HA ' ' O ' ' A' ' 8' ' ' LEU . 85.0 m-85 -73.91 142.97 45.94 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.271 0.558 . . . . 3.8700000000000001 112.221 -176.301 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.535 ' CE1' ' HB3' ' A' ' 8' ' ' LEU . 2.3 p90 -149.69 167.93 25.03 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.964 -1.016 . . . . 1.3100000000000001 108.787 176.336 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 37.3 m -96.63 122.46 39.57 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 108.478 -0.934 . . . . 1.1699999999999999 108.478 170.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 4.6 p -47.14 123.05 4.97 Favored 'General case' 0 C--N 1.329 -0.306 0 O-C-N 123.662 0.602 . . . . 1.1899999999999999 111.409 -179.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 114.49 17.78 6.91 Favored Glycine 0 N--CA 1.445 -0.766 0 N-CA-C 110.911 -0.875 . . . . 0.79000000000000004 110.911 -174.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -115.09 -17.02 11.54 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 120.587 0.232 . . . . 1.55 111.173 -178.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 26.4 mmt -86.22 -92.37 0.09 Allowed 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.315 -0.554 . . . . 0.72999999999999998 110.895 -173.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.495 ' HB2' ' CB ' ' A' ' 89' ' ' PHE . 45.6 mtt -144.22 155.34 43.84 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 107.228 -1.397 . . . . 1.3899999999999999 107.228 177.06 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp -57.95 -53.54 64.72 Favored Pre-proline 0 C--N 1.317 -0.847 0 C-N-CA 120.274 -0.57 . . . . 2.3700000000000001 112.059 -176.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.509 ' HG2' HG22 ' A' ' 107' ' ' THR . 73.4 Cg_endo -74.81 -30.12 7.85 Favored 'Trans proline' 0 C--N 1.356 0.962 0 C-N-CA 121.736 1.624 . . . . 0.27000000000000002 111.855 -179.315 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.634 ' O ' HG23 ' A' ' 93' ' ' VAL . 11.2 t80 -61.97 -56.14 22.19 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.561 -0.745 . . . . 0.22 109.181 176.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.407 ' HB2' ' O ' ' A' ' 86' ' ' MET . 0.7 OUTLIER -62.15 -33.32 74.28 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.284 -0.871 . . . . 2.1200000000000001 110.5 -179.891 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -60.55 -32.58 71.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.676 -0.693 . . . . 0.60999999999999999 110.581 178.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.426 ' O ' ' HG ' ' A' ' 96' ' ' LEU . . . -83.86 -31.18 25.9 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.0 -0.545 . . . . 0.22 111.055 178.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.634 HG23 ' O ' ' A' ' 89' ' ' PHE . 20.2 t -68.8 -38.48 78.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.404 0.621 . . . . 0.25 109.781 -176.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.456 ' C ' ' HD2' ' A' ' 94' ' ' ARG . 2.8 ppt_? -79.44 -1.31 36.75 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.522 -0.763 . . . . 2.5899999999999999 110.61 178.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -103.6 9.94 37.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 0.46999999999999997 111.285 -177.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.567 ' HB2' ' HB2' ' A' ' 100' ' ' ASP . 1.0 OUTLIER -145.96 146.26 30.96 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.354 -0.385 . . . . 0.28000000000000003 110.965 179.51 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.401 ' HG3' ' N ' ' A' ' 98' ' ' ILE . 56.6 tptt -91.01 168.98 11.26 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.773 -0.825 . . . . 1.6100000000000001 108.773 177.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.453 ' HA ' ' HG2' ' A' ' 116' ' ' ARG . 72.0 mt -45.43 116.94 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.111 0.481 . . . . 0.90000000000000002 111.234 173.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 103.47 -11.8 54.3 Favored Glycine 0 N--CA 1.449 -0.438 0 CA-C-N 115.54 -0.755 . . . . 0.46000000000000002 113.115 178.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.567 ' HB2' ' HB2' ' A' ' 96' ' ' LEU . 14.6 m-20 -93.96 144.28 25.6 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 117.191 0.496 . . . . 0.46000000000000002 110.716 -179.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 10.0 mt -112.62 147.93 16.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.756 -0.656 . . . . 0.23000000000000001 109.67 -179.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 91.4 p -89.89 157.41 46.11 Favored Pre-proline 0 C--N 1.319 -0.733 0 CA-C-N 116.356 -0.384 . . . . 0.92000000000000004 110.365 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -74.23 173.82 13.53 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 122.267 1.978 . . . . 0.34000000000000002 111.132 171.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.893 HG23 HD23 ' A' ' 44' ' ' LEU . 21.9 mm -46.51 113.4 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-O 121.133 0.492 . . . . 0.20000000000000001 112.019 176.266 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 93.4 t -111.72 117.77 55.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.91 -0.586 . . . . 1.04 109.831 174.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -86.04 137.97 32.3 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.107 0.48 . . . . 0.55000000000000004 110.278 177.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.509 HG22 ' HG2' ' A' ' 88' ' ' PRO . 20.1 p -123.77 -172.23 2.49 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.664 -0.698 . . . . 0.37 110.21 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -66.67 -44.24 82.38 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.664 0.269 . . . . 2.1600000000000001 110.996 178.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 5.3 t -95.63 -1.41 50.3 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.302 0.482 . . . . 1.0900000000000001 112.302 -173.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 157.67 -124.68 1.44 Allowed Glycine 0 N--CA 1.437 -1.277 0 C-N-CA 119.775 -1.202 . . . . 0.23999999999999999 112.995 170.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.909 ' HB3' HD22 ' A' ' 44' ' ' LEU . 6.6 mp -127.9 145.66 50.88 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.112 -0.544 . . . . 0.19 110.807 -170.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . 0.547 ' NE2' HD13 ' A' ' 14' ' ' LEU . 80.8 m-70 -143.95 143.06 31.07 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.486 0.551 . . . . 0.22 112.486 -178.276 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.619 HG12 HD11 ' A' ' 44' ' ' LEU . 3.9 pt -127.07 141.55 45.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 107.884 -1.154 . . . . 0.17000000000000001 107.884 161.113 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 2.8 mp -132.35 148.47 31.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 C-N-CA 120.976 -0.29 . . . . 0.17999999999999999 110.396 -175.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.452 ' HE3' HD11 ' A' ' 117' ' ' LEU . 44.9 pttt -131.62 139.32 49.11 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.016 -0.735 . . . . 0.60999999999999999 109.016 172.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.484 ' HD3' HD21 ' A' ' 8' ' ' LEU . 5.9 ttp180 -84.1 136.48 33.99 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.104 0.478 . . . . 1.8700000000000001 111.494 -178.507 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.452 HD11 ' HE3' ' A' ' 115' ' ' LYS . 1.4 mm? -107.09 -27.96 10.28 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.295 -0.866 . . . . 0.89000000000000001 110.743 177.216 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.505 ' HB3' ' HB3' ' A' ' 9' ' ' ARG . . . . . . . . 0 C--O 1.245 0.868 0 CA-C-O 118.291 -0.862 . . . . 1.1000000000000001 110.452 179.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.8 mpt? . . . . . 0 N--CA 1.48 1.026 0 CA-C-O 120.915 0.388 . . . . 7.2300000000000004 110.242 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 57.0 p -97.78 161.57 13.69 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.192 -0.458 . . . . 2.8799999999999999 110.657 -177.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -119.34 -6.75 10.31 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.018 -0.537 . . . . 2.7999999999999998 110.517 -177.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -79.06 127.34 31.87 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 121.859 0.838 . . . . 1.1899999999999999 111.532 -175.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.816 HD21 ' HD3' ' A' ' 116' ' ' ARG . 2.4 tt -119.53 159.92 23.4 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 114.242 -1.345 . . . . 1.1799999999999999 107.883 179.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.694 ' H ' HD23 ' A' ' 8' ' ' LEU . 63.2 ttt180 -140.46 127.07 20.26 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 108.869 -0.789 . . . . 1.0600000000000001 108.869 175.759 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -141.09 154.1 45.76 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 120.31 -0.556 . . . . 0.22 112.231 -179.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.498 ' HA ' ' HA ' ' A' ' 76' ' ' ASP . . . -104.46 134.81 47.04 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.334 -0.848 . . . . 0.20000000000000001 108.922 174.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.515 ' HE1' HD13 ' A' ' 77' ' ' LEU . 16.7 p-80 -141.59 138.51 32.67 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.969 0.414 . . . . 0.23000000000000001 111.125 -171.031 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.532 ' O ' ' HA ' ' A' ' 112' ' ' HIS . 6.0 tt -109.43 137.31 47.48 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.326 -0.99 . . . . 0.23999999999999999 108.326 177.378 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.693 HD21 ' HE3' ' A' ' 16' ' ' LYS . 17.4 tp -120.23 135.03 55.12 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.615 -0.266 . . . . 0.27000000000000002 110.837 -176.515 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.549 HG23 HD13 ' A' ' 44' ' ' LEU . 83.4 t -121.89 133.62 67.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 109.854 -0.424 . . . . 0.14999999999999999 109.854 174.293 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.693 ' HE3' HD21 ' A' ' 14' ' ' LEU . 32.7 mmtp -104.76 149.75 25.35 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.917 -0.583 . . . . 0.62 110.495 177.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.561 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 49.9 p90 -145.4 163.04 35.85 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.702 -0.681 . . . . 0.25 109.674 179.456 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.489 ' HB3' ' HA ' ' A' ' 33' ' ' ALA . 29.9 p -51.67 109.35 0.35 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.923 0.392 . . . . 1.04 110.425 176.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 109.93 9.28 24.7 Favored Glycine 0 CA--C 1.523 0.585 0 C-N-CA 120.625 -0.798 . . . . 0.53000000000000003 112.795 -176.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.487 ' C ' ' H ' ' A' ' 22' ' ' ASN . 75.4 m -90.2 34.24 0.87 Allowed 'General case' 0 C--O 1.235 0.3 0 N-CA-C 112.359 0.503 . . . . 0.69999999999999996 112.359 -177.599 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.457 ' HB3' ' O ' ' A' ' 20' ' ' SER . 20.8 ttt85 72.94 -30.33 0.21 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 122.925 0.49 . . . . 3.4900000000000002 110.917 -179.686 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.487 ' H ' ' C ' ' A' ' 20' ' ' SER . 6.1 p30 -146.96 114.54 4.29 Favored Pre-proline 0 C--N 1.322 -0.618 0 N-CA-C 108.843 -0.799 . . . . 1.77 108.843 172.34 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.429 ' C ' HG22 ' A' ' 32' ' ' THR . 93.6 Cg_endo -86.21 52.5 2.91 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 122.573 2.182 . . . . 1.71 113.403 -173.009 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.415 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 61.0 t -142.53 119.78 6.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 109.342 -0.614 . . . . 0.47999999999999998 109.342 177.324 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.46 ' HB3' ' HB2' ' A' ' 16' ' ' LYS . 13.5 p -103.83 156.08 18.11 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 121.211 -0.196 . . . . 1.1200000000000001 110.886 -179.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.66 ' HB2' ' HA ' ' A' ' 67' ' ' ASP . 1.7 mpt_? -69.82 -16.99 63.37 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 109.155 -0.683 . . . . 2.54 109.155 173.443 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.515 ' HG2' ' HA ' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -82.42 -25.5 33.62 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.896 -1.047 . . . . 1.77 111.008 -178.629 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 73.3 p -105.33 -36.05 7.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.244 0.545 . . . . 0.67000000000000004 110.934 178.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 76.27 -21.63 2.24 Favored Glycine 0 CA--C 1.52 0.395 0 CA-C-N 115.308 -0.86 . . . . 0.81999999999999995 112.983 -179.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -101.76 -76.15 0.58 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.119 0.485 . . . . 2.1000000000000001 110.043 -179.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.415 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 21.4 m -154.75 151.47 28.73 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.804 -0.635 . . . . 1.0800000000000001 109.885 175.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.429 HG22 ' C ' ' A' ' 23' ' ' PRO . 12.4 t -113.8 23.0 13.46 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 122.181 0.991 . . . . 0.34000000000000002 109.145 177.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.489 ' HA ' ' HB3' ' A' ' 18' ' ' SER . . . -71.71 -5.6 35.07 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.715 -1.129 . . . . 0.37 111.401 -178.555 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -99.09 -15.24 19.07 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.602 -0.726 . . . . 2.21 110.688 -175.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -105.57 138.44 30.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.93 -0.577 . . . . 0.31 109.704 179.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 62.4 p -94.77 -179.48 4.87 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.395 -0.366 . . . . 0.39000000000000001 110.014 -175.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.519 ' O ' HG13 ' A' ' 41' ' ' ILE . 15.4 p90 -63.65 -28.35 69.85 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 119.986 -0.686 . . . . 1.53 109.223 176.302 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -75.11 -44.66 45.92 Favored 'General case' 0 CA--C 1.522 -0.132 0 CA-C-N 116.182 -0.463 . . . . 0.95999999999999996 110.682 178.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -62.87 -33.29 74.98 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.479 0.656 . . . . 0.91000000000000003 109.639 176.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.561 ' HB2' ' HB3' ' A' ' 17' ' ' PHE . . . -68.6 -44.64 73.91 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.944 -1.026 . . . . 0.19 110.671 178.269 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.519 HG13 ' O ' ' A' ' 37' ' ' TYR . 90.2 mt -63.28 -35.04 70.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 109.612 -0.514 . . . . 0.29999999999999999 109.612 175.023 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.42 ' HD2' ' HA ' ' A' ' 42' ' ' LYS . 23.5 mmmt -64.67 -21.29 66.7 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.072 -0.513 . . . . 2.3199999999999998 111.06 176.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.422 ' HG3' ' CD1' ' A' ' 47' ' ' TRP . 2.0 tp10 -88.57 -57.46 2.91 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.881 -0.6 . . . . 1.02 109.561 178.04 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.887 HD23 HG23 ' A' ' 104' ' ' ILE . 27.7 tp -58.8 -36.78 75.02 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.404 -0.816 . . . . 0.17000000000000001 111.469 -175.302 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.535 ' O ' ' HB2' ' A' ' 49' ' ' GLN . 4.8 mm-40 -66.45 -26.5 67.24 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 112.23 0.456 . . . . 0.87 112.23 -177.397 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.402 ' HE3' ' O ' ' A' ' 42' ' ' LYS . 96.7 mttt -78.88 -45.52 20.46 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.101 0.476 . . . . 1.3100000000000001 109.832 178.08 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.422 ' CD1' ' HG3' ' A' ' 43' ' ' GLU . 24.3 m95 -67.21 -43.52 81.85 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.799 -0.637 . . . . 0.52000000000000002 111.554 -178.095 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.553 ' HB3' HG21 ' A' ' 113' ' ' ILE . 97.2 p -67.18 -27.75 67.53 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 120.935 0.397 . . . . 0.81999999999999995 109.969 177.211 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.535 ' HB2' ' O ' ' A' ' 45' ' ' GLN . 8.9 tt0 -67.58 -52.94 32.61 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 115.933 -0.576 . . . . 0.53000000000000003 109.638 175.611 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.604 ' HB3' HG22 ' A' ' 56' ' ' VAL . 91.6 mtt180 -60.97 -42.35 98.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.705 -0.68 . . . . 0.41999999999999998 111.556 -178.51 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.441 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 78.4 mt -60.29 -40.74 84.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.94 0.4 . . . . 0.20000000000000001 110.744 177.354 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.4 -39.0 65.42 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.941 -0.572 . . . . 0.27000000000000002 111.979 179.035 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 74.7 p -79.75 -29.37 40.48 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 111.809 0.3 . . . . 0.34999999999999998 111.809 -175.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 109.11 4.27 31.18 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.599 -0.81 . . . . 0.29999999999999999 112.898 179.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.437 ' HB2' ' HB3' ' A' ' 50' ' ' ARG . 46.7 mt-10 -62.05 -47.01 86.59 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.089 0.471 . . . . 0.65000000000000002 110.084 177.443 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.604 HG22 ' HB3' ' A' ' 50' ' ' ARG . 10.2 m -134.9 159.0 41.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.821 -0.627 . . . . 0.19 109.378 171.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 19.7 m -92.98 161.96 14.25 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 109.562 -0.533 . . . . 0.96999999999999997 109.562 177.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -54.19 -48.19 71.26 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.728 0.299 . . . . 0.22 110.452 -175.557 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.452 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 43.6 mt-10 -56.4 -40.36 74.51 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.739 -0.664 . . . . 1.72 111.948 179.469 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -63.82 -50.25 69.67 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.0 0.429 . . . . 2.0899999999999999 110.738 -178.327 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -68.91 -46.5 68.14 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.877 -0.602 . . . . 0.26000000000000001 111.132 -177.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.427 ' O ' ' HB3' ' A' ' 66' ' ' SER . . . -60.12 -46.28 90.15 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.648 0.61 . . . . 0.23999999999999999 112.648 -173.304 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.492 ' HA ' ' HA ' ' A' ' 71' ' ' TYR . 20.4 m -57.75 -20.36 34.39 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.781 0.66 . . . . 1.0 112.781 -178.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -110.72 -46.58 3.35 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.521 0.677 . . . . 0.60999999999999999 110.726 -178.331 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.515 ' HA ' ' HG2' ' A' ' 27' ' ' ARG . 18.8 mmt180 -90.17 -37.65 14.03 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.963 -1.017 . . . . 0.85999999999999999 113.174 -170.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.448 ' O ' ' HB3' ' A' ' 71' ' ' TYR . 42.7 t -64.36 115.71 5.36 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.243 0.544 . . . . 0.81999999999999995 110.953 -177.57 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.66 ' HA ' ' HB2' ' A' ' 26' ' ' ARG . 44.5 m-20 -82.28 10.16 7.49 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.416 -0.811 . . . . 2.2799999999999998 111.024 179.589 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.477 ' O ' ' HD1' ' A' ' 71' ' ' TYR . 49.6 t -93.34 166.34 12.34 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.07 -0.513 . . . . 1.52 109.728 172.458 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -56.19 -26.83 50.94 Favored Glycine 0 CA--C 1.519 0.293 0 O-C-N 123.41 0.444 . . . . 0.26000000000000001 113.315 -177.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.529 ' HB2' ' CA ' ' A' ' 75' ' ' GLY . 2.6 p -61.83 -8.26 4.68 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 112.849 0.685 . . . . 0.32000000000000001 112.849 -179.565 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.492 ' HA ' ' HA ' ' A' ' 63' ' ' SER . 15.5 p90 -59.46 -29.73 68.01 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 108.979 -0.749 . . . . 0.54000000000000004 108.979 174.112 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -95.33 8.59 42.69 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.741 -0.663 . . . . 0.48999999999999999 111.045 179.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 5.0 m -125.29 -20.87 4.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.626 -0.261 . . . . 0.70999999999999996 111.435 -177.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.452 ' O ' ' HA ' ' A' ' 59' ' ' GLU . . . 109.42 15.95 11.74 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.624 -0.798 . . . . 0.54000000000000004 112.343 -177.602 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.529 ' CA ' ' HB2' ' A' ' 70' ' ' SER . . . 89.63 -12.99 65.33 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.75 -0.738 . . . . 0.34999999999999998 113.04 177.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.498 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 10.6 p-10 -106.35 144.56 32.86 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.507 0.67 . . . . 1.6499999999999999 111.372 -171.266 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.515 HD13 ' HE1' ' A' ' 12' ' ' HIS . 0.3 OUTLIER -105.74 174.48 5.86 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.756 -1.111 . . . . 0.93999999999999995 109.725 176.931 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -90.63 -143.75 11.34 Favored Glycine 0 C--N 1.315 -0.614 0 C-N-CA 121.019 -0.61 . . . . 0.44 112.232 -179.15 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -88.31 123.77 33.23 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.018 0.437 . . . . 3.8700000000000001 110.621 178.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.406 ' CE1' ' HB3' ' A' ' 8' ' ' LEU . 2.3 p90 -137.82 146.45 43.51 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.887 -0.597 . . . . 1.3100000000000001 110.351 -179.515 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 36.6 m -76.19 137.88 40.31 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 120.829 0.347 . . . . 1.1699999999999999 110.096 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 16.7 m -63.92 118.99 9.2 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.984 -0.553 . . . . 1.1899999999999999 111.332 -175.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 114.49 -5.34 23.06 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.986 -0.626 . . . . 0.79000000000000004 112.387 -178.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -104.24 59.96 0.72 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.255 0.55 . . . . 1.55 110.682 -179.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 23.0 mmt -144.03 -97.46 0.11 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.031 0.443 . . . . 0.72999999999999998 110.453 177.451 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 63.6 mtt -146.32 151.04 36.88 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.015 -1.106 . . . . 1.3899999999999999 108.015 173.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.428 ' HB3' ' HD3' ' A' ' 88' ' ' PRO . 23.1 tptm -52.98 -53.16 58.31 Favored Pre-proline 0 C--N 1.319 -0.738 0 N-CA-C 112.445 0.535 . . . . 2.3700000000000001 112.445 -176.231 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.46 ' HG2' HG22 ' A' ' 107' ' ' THR . 75.6 Cg_endo -77.77 -26.04 7.23 Favored 'Trans proline' 0 C--N 1.356 0.938 0 C-N-CA 121.734 1.623 . . . . 0.27000000000000002 112.587 -176.501 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.546 ' O ' HG23 ' A' ' 93' ' ' VAL . 43.6 t80 -73.26 -55.24 6.7 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.805 -0.634 . . . . 0.22 109.824 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.409 ' O ' ' HD3' ' A' ' 94' ' ' ARG . 4.8 tm-20 -64.27 -35.12 79.81 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.241 -0.891 . . . . 2.1200000000000001 110.022 -178.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.571 ' HA ' ' CZ ' ' A' ' 94' ' ' ARG . 15.6 t70 -50.16 -40.85 47.92 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.735 -0.666 . . . . 0.60999999999999999 110.795 175.107 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.587 ' O ' ' HG ' ' A' ' 96' ' ' LEU . . . -78.24 -30.74 48.84 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.098 -0.501 . . . . 0.22 111.184 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.546 HG23 ' O ' ' A' ' 89' ' ' PHE . 26.3 t -63.39 -47.74 90.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.676 -0.238 . . . . 0.25 111.244 -174.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.571 ' CZ ' ' HA ' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -83.75 -4.92 59.02 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.247 -0.581 . . . . 2.5899999999999999 110.582 -179.476 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.27 -20.68 40.4 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.057 0.456 . . . . 0.46999999999999997 110.906 -179.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.603 ' HB2' ' HB2' ' A' ' 100' ' ' ASP . 0.7 OUTLIER -121.02 147.37 45.59 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.969 -0.559 . . . . 0.28000000000000003 110.441 -179.909 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.401 ' HG3' ' N ' ' A' ' 98' ' ' ILE . 51.3 tptt -90.19 172.67 8.63 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.438 -0.578 . . . . 1.6100000000000001 109.438 -179.519 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.441 ' HA ' ' HG2' ' A' ' 116' ' ' ARG . 71.4 mt -48.26 113.67 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.934 0.397 . . . . 0.90000000000000002 111.377 176.233 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 101.78 -3.69 52.94 Favored Glycine 0 CA--C 1.522 0.481 0 C-N-CA 120.939 -0.648 . . . . 0.46000000000000002 113.913 178.225 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.603 ' HB2' ' HB2' ' A' ' 96' ' ' LEU . 26.1 m-20 -99.15 142.47 30.6 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 117.599 0.7 . . . . 0.46000000000000002 110.353 178.565 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 8.9 mt -109.69 152.32 11.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.428 -0.351 . . . . 0.23000000000000001 110.307 -178.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 4.7 p -101.35 148.34 35.04 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-O 121.007 0.432 . . . . 0.92000000000000004 111.555 -178.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -68.94 159.85 52.23 Favored 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.697 2.265 . . . . 0.34000000000000002 111.145 171.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.887 HG23 HD23 ' A' ' 44' ' ' LEU . 22.1 mm -39.26 112.19 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 O-C-N 123.823 0.702 . . . . 0.20000000000000001 112.557 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 1.9 p -116.37 128.1 73.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.813 -0.63 . . . . 1.04 110.128 175.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -90.53 138.37 31.61 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 121.247 0.546 . . . . 0.55000000000000004 110.15 178.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.46 HG22 ' HG2' ' A' ' 88' ' ' PRO . 11.5 p -116.35 -175.91 2.85 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.577 -0.738 . . . . 0.37 110.68 -177.316 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -57.99 -42.21 84.66 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 123.287 0.367 . . . . 2.1600000000000001 111.009 179.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.44 ' OG ' ' HE2' ' A' ' 16' ' ' LYS . 24.5 t -85.16 -61.38 1.78 Allowed 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 116.493 -0.321 . . . . 1.0900000000000001 110.56 179.394 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -154.39 -128.68 1.22 Allowed Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 119.399 -1.381 . . . . 0.23999999999999999 113.39 -174.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.856 ' HB3' HD22 ' A' ' 44' ' ' LEU . 5.8 mp -112.35 145.43 40.08 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 122.379 0.272 . . . . 0.19 111.676 -171.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . 0.596 ' NE2' HD13 ' A' ' 14' ' ' LEU . 76.5 m-70 -142.2 153.36 43.95 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 112.947 0.721 . . . . 0.22 112.947 178.001 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.574 HG12 HD11 ' A' ' 44' ' ' LEU . 4.3 pt -131.38 134.74 60.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 114.347 -1.297 . . . . 0.17000000000000001 107.684 159.67 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.413 HD13 ' HB3' ' A' ' 92' ' ' ALA . 1.5 mp -128.14 146.22 34.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 C-N-CA 120.734 -0.386 . . . . 0.17999999999999999 110.905 -176.126 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 37.2 pttt -129.5 141.06 51.08 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.346 -0.983 . . . . 0.60999999999999999 108.346 170.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.816 ' HD3' HD21 ' A' ' 8' ' ' LEU . 4.7 ttp180 -82.22 134.9 35.32 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.255 -0.578 . . . . 1.8700000000000001 110.857 -179.189 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -103.07 -35.1 8.64 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.191 -0.913 . . . . 0.89000000000000001 110.286 -179.104 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.937 0 CA-C-O 118.555 -0.736 . . . . 1.1000000000000001 110.485 -179.607 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 22.8 ptp . . . . . 0 N--CA 1.48 1.037 0 N-CA-C 111.581 0.215 . . . . 7.2300000000000004 111.581 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 20.6 p -76.79 -84.4 0.06 Allowed 'General case' 0 C--O 1.233 0.201 0 N-CA-C 110.184 -0.302 . . . . 2.8799999999999999 110.184 178.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.537 ' O ' ' HA ' ' A' ' 81' ' ' SER . 6.4 pt-20 -93.03 -31.34 14.9 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.243 -1.021 . . . . 2.7999999999999998 108.243 170.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.486 ' HA ' ' O ' ' A' ' 80' ' ' PHE . 73.2 mmtt -85.63 105.33 16.12 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.401 -0.818 . . . . 1.1899999999999999 110.415 -177.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.657 ' HB3' ' CE1' ' A' ' 80' ' ' PHE . 2.8 tt -100.62 155.5 17.84 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 113.878 -1.51 . . . . 1.1799999999999999 108.489 -178.044 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.593 ' N ' HD23 ' A' ' 8' ' ' LEU . 71.8 ttt180 -132.65 127.97 36.03 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 108.674 -0.861 . . . . 1.0600000000000001 108.674 170.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -146.4 153.8 40.89 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.258 -0.577 . . . . 0.22 112.095 -175.131 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.417 ' HB3' ' HG2' ' A' ' 115' ' ' LYS . . . -106.16 136.66 45.47 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.382 -0.826 . . . . 0.20000000000000001 109.417 178.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 35.7 p-80 -137.15 149.48 47.32 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.917 0.389 . . . . 0.23000000000000001 111.321 -173.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.676 ' O ' ' HA ' ' A' ' 112' ' ' HIS . 5.2 tt -123.09 131.75 53.82 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.818 -0.808 . . . . 0.23999999999999999 108.818 179.293 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.6 HD13 ' NE2' ' A' ' 112' ' ' HIS . 25.6 tp -116.57 123.51 47.53 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.493 -0.321 . . . . 0.27000000000000002 110.767 -177.531 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.623 HG23 HD13 ' A' ' 44' ' ' LEU . 63.3 t -110.84 134.04 54.42 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 N-CA-C 109.349 -0.611 . . . . 0.14999999999999999 109.349 173.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.495 ' HE2' ' OG ' ' A' ' 109' ' ' SER . 30.4 mmtp -105.91 154.3 20.76 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.492 -0.558 . . . . 0.62 109.492 178.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.46 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 48.9 p90 -146.53 160.57 41.96 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.801 0.334 . . . . 0.25 110.954 -177.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.3 t -52.56 112.21 0.78 Allowed 'General case' 0 N--CA 1.435 -1.193 0 CA-C-N 115.997 -0.547 . . . . 1.04 111.323 178.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 100.46 2.86 55.52 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.605 -0.807 . . . . 0.53000000000000003 113.205 177.033 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.41 ' C ' ' H ' ' A' ' 22' ' ' ASN . 91.3 p -90.19 40.15 1.0 Allowed 'General case' 0 C--O 1.234 0.277 0 CA-C-N 117.62 0.71 . . . . 0.69999999999999996 111.086 -176.109 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.416 ' CZ ' ' HB2' ' A' ' 108' ' ' ASP . 96.3 mtt180 72.2 -32.85 0.25 Allowed 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.36 0.664 . . . . 3.4900000000000002 111.771 178.291 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.41 ' H ' ' C ' ' A' ' 20' ' ' SER . 52.5 m-80 -136.99 93.11 13.64 Favored Pre-proline 0 C--N 1.326 -0.453 0 N-CA-C 109.308 -0.627 . . . . 1.77 109.308 175.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.56 ' C ' HG22 ' A' ' 32' ' ' THR . 95.5 Cg_endo -83.69 51.72 3.57 Favored 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 122.546 2.164 . . . . 1.71 113.233 -174.51 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.498 ' N ' HG22 ' A' ' 32' ' ' THR . 61.2 t -144.89 118.56 2.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 109.323 -0.621 . . . . 0.47999999999999998 109.323 177.133 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 23.5 p -105.18 153.07 22.05 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 110.503 -0.184 . . . . 1.1200000000000001 110.503 178.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.585 ' HB2' ' HA ' ' A' ' 67' ' ' ASP . 7.4 mpt_? -66.2 -10.22 39.55 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.007 0.432 . . . . 2.54 110.565 173.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.586 ' HG3' ' CD ' ' A' ' 65' ' ' ARG . 17.6 ttp180 -75.59 -41.12 55.37 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.812 -0.631 . . . . 1.77 109.506 176.288 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 40.0 p -95.79 -35.41 11.53 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.234 -0.894 . . . . 0.67000000000000004 111.231 -175.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 78.03 -35.07 1.69 Allowed Glycine 0 CA--C 1.518 0.244 0 CA-C-N 115.341 -0.845 . . . . 0.81999999999999995 112.637 178.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -94.88 -69.39 0.75 Allowed 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 110.177 -0.305 . . . . 2.1000000000000001 110.177 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 10.1 p -154.83 150.46 27.52 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.094 0.474 . . . . 1.0800000000000001 111.043 176.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.56 HG22 ' C ' ' A' ' 23' ' ' PRO . 13.8 t -113.44 30.26 7.36 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 122.349 1.071 . . . . 0.34000000000000002 108.891 177.5 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.24 -3.47 49.32 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.475 -1.239 . . . . 0.37 112.031 -175.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -92.87 -24.61 18.41 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.482 0.658 . . . . 2.21 109.979 177.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -98.02 135.93 30.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.284 -0.871 . . . . 0.31 110.281 -179.458 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 34.0 p -96.19 -179.53 4.7 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.094 -0.503 . . . . 0.39000000000000001 109.769 -176.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.544 ' O ' HG13 ' A' ' 41' ' ' ILE . 0.1 OUTLIER -64.87 -23.63 67.29 Favored 'General case' 0 C--O 1.222 -0.348 0 C-N-CA 119.04 -1.064 . . . . 1.53 110.026 173.505 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.451 ' N ' ' HD1' ' A' ' 37' ' ' TYR . 34.4 mt-10 -70.89 -46.93 61.71 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.649 -0.5 . . . . 0.95999999999999996 109.649 176.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -70.76 -28.88 65.01 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.066 0.46 . . . . 0.91000000000000003 110.404 176.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.46 ' HB2' ' HB3' ' A' ' 17' ' ' PHE . . . -66.32 -45.65 79.56 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.728 -0.669 . . . . 0.19 109.825 175.157 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.544 HG13 ' O ' ' A' ' 37' ' ' TYR . 72.9 mt -64.98 -38.41 82.72 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.382 0 CA-C-N 116.064 -0.517 . . . . 0.29999999999999999 109.7 174.101 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.419 ' O ' ' HG3' ' A' ' 46' ' ' LYS . 3.6 ttpm? -64.78 -20.94 66.64 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.863 -0.608 . . . . 2.3199999999999998 110.233 179.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.427 ' HG3' ' CD1' ' A' ' 47' ' ' TRP . 1.7 tp10 -88.29 -56.85 3.15 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.305 -0.628 . . . . 1.02 109.305 176.569 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.733 HD22 ' HB3' ' A' ' 111' ' ' LEU . 19.5 tp -58.92 -35.9 73.83 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.03 -0.986 . . . . 0.17000000000000001 110.895 -174.479 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.461 ' HG2' HG13 ' A' ' 104' ' ' ILE . 4.6 mm-40 -64.42 -39.57 94.09 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-N 116.391 -0.368 . . . . 0.87 111.962 -178.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.448 ' O ' ' HG3' ' A' ' 50' ' ' ARG . 60.7 mttm -70.09 -43.77 70.43 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 110.122 -0.325 . . . . 1.3100000000000001 110.122 -178.576 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.443 ' NE1' ' HG3' ' A' ' 65' ' ' ARG . 64.6 m95 -65.79 -46.38 78.93 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.479 -0.328 . . . . 0.52000000000000002 111.454 175.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 36.5 t -57.96 -34.0 69.45 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.755 -0.461 . . . . 0.81999999999999995 109.755 176.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 -66.75 -56.84 8.71 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 115.907 -0.588 . . . . 0.53000000000000003 110.555 175.181 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.627 ' HB3' HG22 ' A' ' 56' ' ' VAL . 93.6 mtt180 -61.21 -42.12 98.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.676 -0.693 . . . . 0.41999999999999998 111.368 -175.634 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.44 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 98.2 mt -60.71 -39.43 81.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 120.96 0.409 . . . . 0.20000000000000001 110.506 176.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.26 -39.92 65.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.979 -0.555 . . . . 0.27000000000000002 111.663 -179.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 55.8 p -78.61 -30.5 46.56 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.931 0.396 . . . . 0.34999999999999998 111.547 -177.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 107.61 9.25 29.2 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.727 -0.749 . . . . 0.29999999999999999 112.057 -178.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.498 ' HB2' ' HB3' ' A' ' 50' ' ' ARG . 43.1 mt-10 -64.9 -44.26 90.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.115 0.483 . . . . 0.65000000000000002 110.102 177.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.627 HG22 ' HB3' ' A' ' 50' ' ' ARG . 22.3 m -138.16 153.69 27.2 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.451 0 CA-C-N 115.791 -0.64 . . . . 0.19 109.456 173.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.6 m -77.39 157.89 30.36 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 109.327 -0.62 . . . . 0.96999999999999997 109.327 175.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -54.76 -41.28 70.28 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.171 -0.678 . . . . 0.22 109.171 177.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.476 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 41.0 mt-10 -56.0 -46.6 78.7 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.785 -1.098 . . . . 1.72 112.197 178.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -60.91 -44.73 96.77 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 120.936 0.398 . . . . 2.0899999999999999 111.019 -176.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -71.72 -43.72 65.4 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.346 -0.388 . . . . 0.26000000000000001 111.001 -178.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.68 -53.05 60.38 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.185 0.439 . . . . 0.23999999999999999 112.185 -175.005 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.474 ' HA ' ' O ' ' A' ' 71' ' ' TYR . 71.9 m -51.76 -27.8 13.24 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 113.121 0.785 . . . . 1.0 113.121 -177.61 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -100.03 -44.67 5.93 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.603 0.716 . . . . 0.60999999999999999 110.616 -177.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.586 ' CD ' ' HG3' ' A' ' 27' ' ' ARG . 17.4 mmt180 -94.41 -43.48 8.35 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.873 -1.058 . . . . 0.85999999999999999 113.576 -170.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.573 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 19.3 p -62.73 127.65 32.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.145 0.497 . . . . 0.81999999999999995 111.557 -173.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.585 ' HA ' ' HB2' ' A' ' 26' ' ' ARG . 27.0 t70 -81.68 -11.08 59.21 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.421 -0.809 . . . . 2.2799999999999998 110.616 176.694 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.541 ' SG ' ' HB2' ' A' ' 66' ' ' SER . 5.1 p -75.77 150.19 37.82 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.017 -0.538 . . . . 1.52 110.12 179.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -54.88 -21.66 24.16 Favored Glycine 0 N--CA 1.452 -0.247 0 CA-C-N 114.665 -1.152 . . . . 0.26000000000000001 113.757 -172.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.449 ' HB2' ' CA ' ' A' ' 75' ' ' GLY . 1.5 p -67.99 -2.44 7.63 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 112.635 0.606 . . . . 0.32000000000000001 112.635 177.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.474 ' O ' ' HA ' ' A' ' 63' ' ' SER . 33.1 p90 -55.13 -24.27 25.24 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 118.038 0.381 . . . . 0.54000000000000004 110.421 174.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -87.65 -8.94 55.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.857 0.36 . . . . 0.48999999999999999 111.115 -178.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 16.0 m -126.18 14.95 7.84 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.367 -0.379 . . . . 0.70999999999999996 111.28 -177.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.476 ' O ' ' HA ' ' A' ' 59' ' ' GLU . . . 74.86 33.48 55.21 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.745 -0.74 . . . . 0.54000000000000004 113.133 178.445 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.449 ' CA ' ' HB2' ' A' ' 70' ' ' SER . . . 77.88 5.07 86.46 Favored Glycine 0 C--O 1.228 -0.236 0 C-N-CA 120.811 -0.709 . . . . 0.34999999999999998 112.867 176.385 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -92.21 141.17 28.86 Favored 'General case' 0 C--N 1.322 -0.629 0 O-C-N 122.844 -0.209 . . . . 1.6499999999999999 110.448 -172.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -120.38 169.87 9.89 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.322 0.582 . . . . 0.93999999999999995 110.582 176.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -89.04 -158.8 34.62 Favored Glycine 0 C--N 1.314 -0.691 0 CA-C-N 115.025 -0.989 . . . . 0.44 112.078 177.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.6 ' HA ' ' O ' ' A' ' 8' ' ' LEU . 96.7 m-85 -84.57 151.7 24.36 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.083 0.468 . . . . 3.8700000000000001 111.677 -178.495 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.657 ' CE1' ' HB3' ' A' ' 8' ' ' LEU . 2.5 p90 -157.87 160.36 37.59 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.492 -0.929 . . . . 1.3100000000000001 108.492 178.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.537 ' HA ' ' O ' ' A' ' 6' ' ' GLU . 23.6 m -85.44 138.78 32.02 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 109.162 -0.681 . . . . 1.1699999999999999 109.162 177.067 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 14.7 m -59.71 112.24 1.74 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.159 0.504 . . . . 1.1899999999999999 110.811 -174.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 114.53 12.91 10.07 Favored Glycine 0 N--CA 1.446 -0.647 0 CA-C-N 115.47 -0.786 . . . . 0.79000000000000004 112.184 -174.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -117.02 57.8 0.78 Allowed 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 121.069 0.462 . . . . 1.55 110.377 177.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 22.5 mmt -146.42 -100.16 0.09 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.084 -0.507 . . . . 0.72999999999999998 110.512 178.048 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.452 ' HB2' ' HB3' ' A' ' 89' ' ' PHE . 61.4 mtt -142.99 155.77 44.73 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 108.17 -1.048 . . . . 1.3899999999999999 108.17 175.228 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.431 ' HB3' ' HD3' ' A' ' 88' ' ' PRO . 63.9 tttp -55.06 -57.75 18.16 Favored Pre-proline 0 C--N 1.321 -0.653 0 N-CA-C 112.448 0.536 . . . . 2.3700000000000001 112.448 -177.082 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.435 ' HG2' HG22 ' A' ' 107' ' ' THR . 76.6 Cg_endo -75.35 -29.08 8.06 Favored 'Trans proline' 0 C--N 1.355 0.88 0 C-N-CA 121.643 1.562 . . . . 0.27000000000000002 111.908 -175.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.651 ' O ' HG23 ' A' ' 93' ' ' VAL . 38.5 t80 -68.12 -56.55 8.42 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.111 -0.949 . . . . 0.22 109.942 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -65.24 -34.51 78.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.661 -0.7 . . . . 2.1200000000000001 109.855 -178.067 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -55.33 -34.67 64.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.636 -0.711 . . . . 0.60999999999999999 110.755 175.289 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.42 ' O ' ' HG ' ' A' ' 96' ' ' LEU . . . -83.74 -26.65 29.54 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.136 -0.484 . . . . 0.22 110.951 179.05 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.651 HG23 ' O ' ' A' ' 89' ' ' PHE . 18.4 t -74.03 -38.17 48.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.157 0.503 . . . . 0.25 110.186 -178.14 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.503 ' C ' ' HD2' ' A' ' 94' ' ' ARG . 6.5 ppt_? -76.32 -12.0 60.0 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.085 -0.507 . . . . 2.5899999999999999 110.261 178.055 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.07 -4.5 59.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.846 -0.615 . . . . 0.46999999999999997 111.254 -176.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.655 ' HB2' ' HB2' ' A' ' 100' ' ' ASP . 1.2 pp -132.79 151.91 51.9 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.173 0.511 . . . . 0.28000000000000003 111.167 179.192 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.563 ' HG3' ' H ' ' A' ' 98' ' ' ILE . 19.4 tptm -102.62 -178.48 3.69 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.688 -0.856 . . . . 1.6100000000000001 108.688 176.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.563 ' H ' ' HG3' ' A' ' 97' ' ' LYS . 65.9 mt -54.3 118.36 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 120.853 0.359 . . . . 0.90000000000000002 111.025 179.28 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 95.61 10.23 56.91 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.728 -0.749 . . . . 0.46000000000000002 113.14 178.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.655 ' HB2' ' HB2' ' A' ' 96' ' ' LEU . 27.0 m-20 -111.41 146.81 36.51 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 117.441 0.621 . . . . 0.46000000000000002 110.271 177.285 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 15.8 mt -120.17 148.89 23.01 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-N 116.455 -0.339 . . . . 0.23000000000000001 110.432 -178.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 38.3 m -96.78 151.08 37.63 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 116.234 -0.439 . . . . 0.92000000000000004 111.206 179.026 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -74.17 176.94 8.9 Favored 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 122.583 2.189 . . . . 0.34000000000000002 111.432 172.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.669 HG23 HD23 ' A' ' 44' ' ' LEU . 22.5 mm -49.24 110.72 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 N-CA-C 112.775 0.657 . . . . 0.20000000000000001 112.775 -178.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 55.0 t -109.75 115.71 50.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.886 -0.597 . . . . 1.04 109.901 173.178 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 12.9 mt-30 -84.93 141.72 30.17 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.842 -0.429 . . . . 0.55000000000000004 109.842 177.396 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.435 HG22 ' HG2' ' A' ' 88' ' ' PRO . 16.6 p -123.55 -172.47 2.53 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.784 -0.644 . . . . 0.37 110.491 -179.684 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.416 ' HB2' ' CZ ' ' A' ' 21' ' ' ARG . 6.9 p-10 -66.57 -35.53 80.44 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.617 0.246 . . . . 2.1600000000000001 111.253 -178.11 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.495 ' OG ' ' HE2' ' A' ' 16' ' ' LYS . 4.6 t -106.24 -9.73 16.73 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 120.287 -0.565 . . . . 1.0900000000000001 112.291 -174.359 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 172.18 -126.2 1.25 Allowed Glycine 0 N--CA 1.438 -1.177 0 C-N-CA 119.216 -1.469 . . . . 0.23999999999999999 112.967 173.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.733 ' HB3' HD22 ' A' ' 44' ' ' LEU . 6.0 mp -130.78 149.42 52.43 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 115.045 -0.578 . . . . 0.19 110.906 -171.488 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . 0.676 ' HA ' ' O ' ' A' ' 13' ' ' LEU . 82.0 m-70 -146.97 136.04 22.45 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.098 0.407 . . . . 0.22 112.098 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.619 HG12 HD11 ' A' ' 44' ' ' LEU . 2.1 pt -119.13 140.03 44.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 107.972 -1.121 . . . . 0.17000000000000001 107.972 160.362 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.435 HG21 HG22 ' A' ' 93' ' ' VAL . 2.5 mp -130.93 148.12 33.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 C-N-CA 120.923 -0.311 . . . . 0.17999999999999999 110.532 -175.141 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.417 ' HG2' ' HB3' ' A' ' 11' ' ' ALA . 54.3 pttt -134.61 144.25 47.79 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.113 -0.699 . . . . 0.60999999999999999 109.113 174.209 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.541 ' HB2' ' CD1' ' A' ' 96' ' ' LEU . 67.4 ttt180 -91.0 132.57 35.91 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.196 0.522 . . . . 1.8700000000000001 111.583 -177.391 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.401 HD21 ' HB2' ' A' ' 11' ' ' ALA . 2.1 mm? -101.96 -35.53 8.94 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.116 -0.947 . . . . 0.89000000000000001 110.781 179.398 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.428 ' HB3' ' HB3' ' A' ' 9' ' ' ARG . . . . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.945 -0.55 . . . . 1.1000000000000001 109.841 179.191 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 62.2 mtt . . . . . 0 N--CA 1.48 1.031 0 CA-C-O 120.749 0.309 . . . . 7.2300000000000004 110.409 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 40.0 t -94.92 130.79 41.41 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.111 -0.495 . . . . 2.8799999999999999 110.371 177.452 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -112.64 -4.86 14.03 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.512 -0.551 . . . . 2.7999999999999998 109.512 175.172 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.402 ' HA ' ' O ' ' A' ' 80' ' ' PHE . 13.6 tptt -72.7 128.17 34.75 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.709 0.766 . . . . 1.1899999999999999 110.871 -178.283 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.62 HD23 ' N ' ' A' ' 9' ' ' ARG . 2.4 tt -136.55 157.02 47.76 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 114.522 -1.217 . . . . 1.1799999999999999 108.176 -178.052 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.62 ' N ' HD23 ' A' ' 8' ' ' LEU . 77.2 ttt180 -140.82 127.72 20.55 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 107.907 -1.146 . . . . 1.0600000000000001 107.907 173.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -140.95 157.88 44.73 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 120.037 -0.665 . . . . 0.22 112.496 -176.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.58 ' HA ' ' HA ' ' A' ' 76' ' ' ASP . . . -109.81 136.46 49.09 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.195 -0.912 . . . . 0.20000000000000001 109.599 177.094 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 11.2 p-80 -136.77 139.65 41.98 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.79 -0.364 . . . . 0.23000000000000001 110.949 -172.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.608 ' O ' ' HA ' ' A' ' 112' ' ' HIS . 6.6 tt -111.42 142.37 43.77 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.161 -1.052 . . . . 0.23999999999999999 108.161 176.002 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.542 HD13 ' NE2' ' A' ' 112' ' ' HIS . 22.1 tp -128.95 133.54 47.86 Favored 'General case' 0 C--N 1.323 -0.575 0 O-C-N 123.043 0.214 . . . . 0.27000000000000002 110.441 -176.336 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.504 HG23 HD13 ' A' ' 44' ' ' LEU . 53.5 t -119.07 133.53 65.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 O-C-N 123.589 0.556 . . . . 0.14999999999999999 109.978 175.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.523 ' HE3' HD21 ' A' ' 14' ' ' LEU . 34.2 mmtp -103.65 158.31 16.46 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.802 -0.635 . . . . 0.62 109.727 176.349 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.487 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 42.1 p90 -158.51 161.27 37.35 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.118 -0.492 . . . . 0.25 109.693 -177.049 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.1 t -50.84 108.69 0.25 Allowed 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 110.005 -0.369 . . . . 1.04 110.005 173.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 109.68 9.85 24.17 Favored Glycine 0 N--CA 1.446 -0.7 0 C-N-CA 120.323 -0.942 . . . . 0.53000000000000003 112.975 -177.18 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.421 ' C ' ' H ' ' A' ' 22' ' ' ASN . 50.6 p -85.32 21.82 1.64 Allowed 'General case' 0 C--O 1.236 0.352 0 CA-C-N 117.938 0.869 . . . . 0.69999999999999996 111.726 -176.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.457 ' NH1' ' HB3' ' A' ' 108' ' ' ASP . 97.3 mtt180 72.6 -34.98 0.31 Allowed 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.786 0.835 . . . . 3.4900000000000002 110.833 -178.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.421 ' H ' ' C ' ' A' ' 20' ' ' SER . 7.0 p30 -146.66 104.71 3.96 Favored Pre-proline 0 C--N 1.32 -0.686 0 N-CA-C 108.578 -0.897 . . . . 1.77 108.578 168.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -66.03 -156.7 0.03 OUTLIER 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 123.674 2.916 . . . . 1.71 113.2 -178.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.546 ' N ' HG22 ' A' ' 32' ' ' THR . 47.6 t 64.99 112.97 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-N 115.494 -0.775 . . . . 0.47999999999999998 111.165 -175.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.406 ' HB2' ' OD1' ' A' ' 67' ' ' ASP . 19.1 p -103.36 152.18 21.87 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.352 -0.385 . . . . 1.1200000000000001 110.015 178.293 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.55 ' CG ' ' HA ' ' A' ' 67' ' ' ASP . 38.5 mmt180 -67.58 -20.38 65.37 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 108.727 -0.842 . . . . 2.54 108.727 173.193 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.496 ' HG2' ' HD3' ' A' ' 65' ' ' ARG . 4.8 tmm_? -71.73 -36.22 70.41 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 114.621 -1.172 . . . . 1.77 110.791 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 69.3 p -97.67 -35.76 10.47 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.522 0.677 . . . . 0.67000000000000004 110.421 178.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 73.35 -6.7 14.4 Favored Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 114.718 -1.128 . . . . 0.81999999999999995 112.655 -178.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -121.68 -72.29 0.69 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.757 0.313 . . . . 2.1000000000000001 110.357 -178.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.6 m -147.8 146.26 29.08 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-O 121.0 0.429 . . . . 1.0800000000000001 111.21 -178.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.546 HG22 ' N ' ' A' ' 24' ' ' VAL . 14.6 t -125.48 11.82 8.03 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.8 0.81 . . . . 0.34000000000000002 109.49 174.58 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -68.94 -4.34 16.25 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.241 -0.89 . . . . 0.37 112.289 179.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -96.55 -23.86 16.33 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.037 0.446 . . . . 2.21 110.694 177.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.509 HG23 ' HB2' ' A' ' 39' ' ' ASP . 0.4 OUTLIER -93.85 136.34 25.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 109.389 -0.597 . . . . 0.31 109.389 177.505 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 75.0 p -95.0 179.99 5.03 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.359 -0.382 . . . . 0.39000000000000001 110.081 -174.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.498 ' O ' HG13 ' A' ' 41' ' ' ILE . 11.3 p90 -63.42 -28.13 69.77 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.262 -0.644 . . . . 1.53 109.262 175.372 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -73.74 -44.77 55.34 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.905 -0.589 . . . . 0.95999999999999996 110.362 178.186 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.509 ' HB2' HG23 ' A' ' 35' ' ' VAL . 43.9 m-20 -65.81 -32.42 73.94 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.484 0.659 . . . . 0.91000000000000003 109.693 176.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.487 ' HB2' ' HB3' ' A' ' 17' ' ' PHE . . . -68.4 -43.88 76.27 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.976 -1.011 . . . . 0.19 110.416 178.254 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.498 HG13 ' O ' ' A' ' 37' ' ' TYR . 95.1 mt -62.6 -37.82 79.93 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.409 0 N-CA-C 109.667 -0.494 . . . . 0.29999999999999999 109.667 174.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 55.9 tttp -65.94 -23.11 66.54 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 121.381 0.61 . . . . 2.3199999999999998 109.997 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -87.84 -50.27 6.56 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.33 -0.85 . . . . 1.02 109.549 -179.082 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.903 HD22 ' HB3' ' A' ' 111' ' ' LEU . 35.4 tp -62.61 -38.08 88.78 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.588 -0.733 . . . . 0.17000000000000001 110.41 -178.05 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.494 ' HG2' HG13 ' A' ' 104' ' ' ILE . 5.0 mm-40 -61.09 -31.35 71.03 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 115.957 -0.565 . . . . 0.87 112.399 -179.595 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -80.24 -40.85 26.22 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.631 -0.428 . . . . 1.3100000000000001 110.606 -179.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.422 ' O ' HG13 ' A' ' 51' ' ' ILE . 57.5 m95 -66.66 -45.32 79.31 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.139 0.422 . . . . 0.52000000000000002 112.139 177.036 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.571 ' HB3' HG21 ' A' ' 113' ' ' ILE . 93.4 p -63.99 -30.5 71.57 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.758 -0.46 . . . . 0.81999999999999995 109.758 176.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.491 ' HB2' ' O ' ' A' ' 45' ' ' GLN . 15.1 tt0 -65.16 -53.34 46.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.503 -0.772 . . . . 0.53000000000000003 110.381 175.402 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.618 ' HB3' HG22 ' A' ' 56' ' ' VAL . 97.1 mtt180 -65.39 -41.48 93.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.996 -0.547 . . . . 0.41999999999999998 111.657 -177.07 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.484 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 84.6 mt -61.25 -33.93 58.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.09 0.471 . . . . 0.20000000000000001 110.691 176.629 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -77.81 -41.91 35.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 0.27000000000000002 111.205 179.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 52.9 p -76.13 -29.81 57.96 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.252 -0.431 . . . . 0.34999999999999998 111.569 -176.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 103.21 9.99 37.64 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.78 -0.724 . . . . 0.29999999999999999 112.234 -179.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.403 ' HB2' ' HB3' ' A' ' 50' ' ' ARG . 39.2 mt-10 -64.51 -43.58 93.64 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.583 -0.525 . . . . 0.65000000000000002 109.583 176.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.618 HG22 ' HB3' ' A' ' 50' ' ' ARG . 11.7 m -138.49 149.79 24.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 108.968 -0.753 . . . . 0.19 108.968 170.12 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 12.0 m -81.69 162.08 23.14 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 109.468 -0.567 . . . . 0.96999999999999997 109.468 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -55.01 -43.44 73.63 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.843 -0.429 . . . . 0.22 109.843 -178.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -58.04 -46.32 85.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.537 -0.756 . . . . 1.72 111.443 179.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 41.4 mm-40 -59.4 -48.36 81.94 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-O 121.119 0.485 . . . . 2.0899999999999999 110.822 -178.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -68.78 -49.96 54.27 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.924 -0.58 . . . . 0.26000000000000001 110.866 -179.052 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -58.45 -55.37 35.97 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.629 0.603 . . . . 0.23999999999999999 112.629 -173.229 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.482 ' HA ' ' HA ' ' A' ' 71' ' ' TYR . 28.4 t -52.27 -28.01 17.21 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.684 0.624 . . . . 1.0 112.684 -175.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -100.01 -46.74 5.24 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.528 0.68 . . . . 0.60999999999999999 110.426 -179.155 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.496 ' HD3' ' HG2' ' A' ' 27' ' ' ARG . 31.3 mmt180 -94.21 -36.91 11.81 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.758 -1.11 . . . . 0.85999999999999999 113.944 -168.603 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.577 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 24.7 p -67.89 123.72 21.37 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.642 -0.423 . . . . 0.81999999999999995 110.651 -178.065 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.55 ' HA ' ' CG ' ' A' ' 26' ' ' ARG . 25.1 m-20 -83.77 -5.93 59.31 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.826 -0.625 . . . . 2.2799999999999998 110.676 179.5 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.51 ' SG ' ' HB2' ' A' ' 66' ' ' SER . 6.4 p -78.86 156.73 28.54 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.494 -0.776 . . . . 1.52 110.215 175.413 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -54.83 -20.33 18.45 Favored Glycine 0 C--N 1.331 0.284 0 CA-C-N 114.959 -1.018 . . . . 0.26000000000000001 114.501 -171.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.528 ' HB2' ' CA ' ' A' ' 75' ' ' GLY . 1.3 p -70.08 -1.49 10.08 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.675 0.62 . . . . 0.32000000000000001 112.675 179.422 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.482 ' HA ' ' HA ' ' A' ' 63' ' ' SER . 41.6 p90 -56.55 -33.6 66.27 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 109.54 -0.541 . . . . 0.54000000000000004 109.54 173.671 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -95.29 8.32 43.48 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.021 -0.536 . . . . 0.48999999999999999 111.158 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 11.0 m -122.59 -20.16 6.08 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.698 0.285 . . . . 0.70999999999999996 111.605 -176.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 107.57 14.85 16.75 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.74 -0.743 . . . . 0.54000000000000004 112.226 -178.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.528 ' CA ' ' HB2' ' A' ' 70' ' ' SER . . . 92.99 -19.73 50.25 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.69 -0.767 . . . . 0.34999999999999998 112.904 178.449 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.58 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 7.6 p-10 -98.36 144.71 27.46 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.584 0.706 . . . . 1.6499999999999999 111.492 -171.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.412 ' HB3' ' HE2' ' A' ' 80' ' ' PHE . 0.9 OUTLIER -100.35 175.72 5.61 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.504 -1.225 . . . . 0.93999999999999995 109.341 174.65 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -85.43 -148.0 10.13 Favored Glycine 0 C--N 1.315 -0.634 0 C-N-CA 120.709 -0.758 . . . . 0.44 111.981 -179.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -91.85 139.44 30.66 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.931 0.396 . . . . 3.8700000000000001 110.16 178.36 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.412 ' HE2' ' HB3' ' A' ' 77' ' ' LEU . 1.5 p90 -152.14 174.03 14.22 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.992 -0.549 . . . . 1.3100000000000001 109.746 -177.606 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 13.9 p -95.57 135.4 37.28 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.333 0.587 . . . . 1.1699999999999999 110.942 179.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 13.2 m -63.83 128.11 34.35 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.483 -0.78 . . . . 1.1899999999999999 110.585 -178.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 103.25 0.82 47.64 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.659 -0.782 . . . . 0.79000000000000004 112.395 -179.399 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -117.76 62.84 0.75 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.222 0.534 . . . . 1.55 111.152 -179.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 21.0 mmt -139.49 -123.9 0.12 Allowed 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.066 -0.716 . . . . 0.72999999999999998 109.066 173.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.414 ' HB2' ' CB ' ' A' ' 89' ' ' PHE . 19.9 mmt -110.68 151.54 27.59 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.263 -1.014 . . . . 1.3899999999999999 108.263 173.191 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.403 ' HB3' ' HD3' ' A' ' 88' ' ' PRO . 24.5 ttmm -55.55 -51.72 77.8 Favored Pre-proline 0 C--N 1.319 -0.754 0 N-CA-C 112.379 0.511 . . . . 2.3700000000000001 112.379 -174.108 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.403 ' HD3' ' HB3' ' A' ' 87' ' ' LYS . 86.2 Cg_endo -78.3 -22.9 9.27 Favored 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 121.474 1.449 . . . . 0.27000000000000002 111.72 -178.44 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.581 ' O ' HG23 ' A' ' 93' ' ' VAL . 33.1 t80 -70.89 -55.75 7.77 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.157 -0.929 . . . . 0.22 109.718 179.682 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -65.81 -34.83 79.08 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.606 -0.725 . . . . 2.1200000000000001 109.99 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.515 ' HA ' ' NE ' ' A' ' 94' ' ' ARG . 15.6 t70 -51.25 -35.83 39.06 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.492 -0.776 . . . . 0.60999999999999999 110.7 173.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.567 ' O ' ' HG ' ' A' ' 96' ' ' LEU . . . -82.44 -37.15 25.85 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.072 -0.513 . . . . 0.22 111.032 179.111 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.581 HG23 ' O ' ' A' ' 89' ' ' PHE . 15.2 t -62.75 -40.97 90.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-O 121.229 0.538 . . . . 0.25 110.597 -177.168 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.515 ' NE ' ' HA ' ' A' ' 91' ' ' ASP . 37.7 ptt180 -74.8 -15.41 60.75 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.822 -0.626 . . . . 2.5899999999999999 110.566 178.26 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -95.64 14.42 23.06 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.026 -0.533 . . . . 0.46999999999999997 111.169 -174.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.634 ' HB2' ' HB2' ' A' ' 100' ' ' ASP . 1.4 pp -149.74 152.71 35.71 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.83 -0.623 . . . . 0.28000000000000003 110.307 177.005 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.438 ' HG3' ' H ' ' A' ' 98' ' ' ILE . 21.7 tptm -102.22 175.63 5.46 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.132 -0.692 . . . . 1.6100000000000001 109.132 179.536 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.459 ' HA ' ' HG2' ' A' ' 116' ' ' ARG . 70.7 mt -46.24 114.56 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.196 0.522 . . . . 0.90000000000000002 111.579 176.049 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 102.1 -15.96 56.06 Favored Glycine 0 CA--C 1.522 0.48 0 CA-C-N 115.649 -0.705 . . . . 0.46000000000000002 113.562 178.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.634 ' HB2' ' HB2' ' A' ' 96' ' ' LEU . 53.9 m-20 -89.08 141.19 28.71 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 117.346 0.573 . . . . 0.46000000000000002 110.348 -177.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 8.9 mt -112.68 147.99 16.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.18 -0.464 . . . . 0.23000000000000001 110.462 -176.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 99.3 p -89.65 160.1 42.26 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 116.256 -0.429 . . . . 0.92000000000000004 110.643 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -74.23 176.36 9.7 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.324 2.016 . . . . 0.34000000000000002 111.196 171.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.882 HG23 HD23 ' A' ' 44' ' ' LEU . 23.9 mm -50.47 106.38 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 O-C-N 123.217 0.323 . . . . 0.20000000000000001 111.541 174.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.4 p -112.92 123.02 68.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 109.794 -0.447 . . . . 1.04 109.794 175.084 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -86.19 151.38 23.69 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.14 0.495 . . . . 0.55000000000000004 110.563 -179.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 6.8 p -126.78 -172.72 2.7 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.51 -0.768 . . . . 0.37 109.984 178.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.457 ' HB3' ' NH1' ' A' ' 21' ' ' ARG . 36.3 m-20 -62.36 -46.73 87.35 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.746 0.307 . . . . 2.1600000000000001 110.501 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 22.5 t -80.07 -59.43 2.72 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.836 -0.346 . . . . 1.0900000000000001 110.796 -178.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -152.05 -130.4 1.6 Allowed Glycine 0 N--CA 1.443 -0.884 0 C-N-CA 119.075 -1.536 . . . . 0.23999999999999999 113.649 -175.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.903 ' HB3' HD22 ' A' ' 44' ' ' LEU . 6.1 mp -116.56 147.79 41.49 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.283 -0.459 . . . . 0.19 111.372 -170.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . 0.608 ' HA ' ' O ' ' A' ' 13' ' ' LEU . 82.0 m-70 -143.48 152.96 42.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.419 0.628 . . . . 0.22 112.484 179.454 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.59 HG12 HD11 ' A' ' 44' ' ' LEU . 3.6 pt -133.42 138.17 51.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 107.604 -1.258 . . . . 0.17000000000000001 107.604 159.579 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 2.8 mp -128.42 147.52 32.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 C-N-CA 120.768 -0.373 . . . . 0.17999999999999999 110.386 -175.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.448 ' HG2' ' HB3' ' A' ' 11' ' ' ALA . 33.4 pttt -132.11 144.63 50.85 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.664 -0.865 . . . . 0.60999999999999999 108.664 172.437 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.537 ' HD3' HD21 ' A' ' 8' ' ' LEU . 5.5 ttp180 -82.79 135.03 35.09 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.302 0.572 . . . . 1.8700000000000001 110.902 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -101.83 -38.33 7.89 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.996 -1.002 . . . . 0.89000000000000001 109.768 -179.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.456 ' HB3' ' HB3' ' A' ' 9' ' ' ARG . . . . . . . . 0 C--O 1.249 1.036 0 CA-C-N 115.544 -0.753 . . . . 1.1000000000000001 109.735 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 79.1 mmm . . . . . 0 N--CA 1.482 1.157 0 N-CA-C 111.528 0.196 . . . . 7.2300000000000004 111.528 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.3 m -78.81 -35.35 44.34 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.388 0.613 . . . . 2.8799999999999999 109.59 177.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.582 ' O ' ' HA ' ' A' ' 81' ' ' SER . 0.0 OUTLIER -93.98 -42.18 9.18 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.125 -0.943 . . . . 2.7999999999999998 109.899 178.989 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -73.0 103.59 3.83 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 121.47 0.653 . . . . 1.1899999999999999 110.657 177.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.505 HD23 HG12 ' A' ' 93' ' ' VAL . 11.4 tp -103.73 175.34 5.51 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 114.665 -1.152 . . . . 1.1799999999999999 109.953 -174.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.494 ' HB3' ' HB3' ' A' ' 118' ' ' ALA . 53.8 ttt180 -146.08 132.49 19.65 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.567 -0.531 . . . . 1.0600000000000001 109.567 177.323 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.532 ' N ' ' HZ ' ' A' ' 80' ' ' PHE . . . -149.3 154.43 39.0 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.054 0.454 . . . . 0.22 111.69 -179.149 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.432 ' HB3' ' HG2' ' A' ' 115' ' ' LYS . . . -101.83 131.85 47.93 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.517 -0.765 . . . . 0.20000000000000001 108.95 175.413 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 29.6 p-80 -133.01 146.69 51.99 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.029 0.443 . . . . 0.23000000000000001 111.719 -172.011 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.555 HD23 ' N ' ' A' ' 14' ' ' LEU . 5.7 tt -117.46 144.65 44.81 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.478 -0.934 . . . . 0.23999999999999999 108.478 177.407 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.6 HD13 ' NE2' ' A' ' 112' ' ' HIS . 26.0 tp -131.03 119.91 22.69 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.64 0.257 . . . . 0.27000000000000002 110.675 -177.391 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.528 HG23 HD13 ' A' ' 44' ' ' LEU . 61.2 t -108.12 129.37 62.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 109.776 -0.453 . . . . 0.14999999999999999 109.776 176.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.477 ' HE3' HD21 ' A' ' 14' ' ' LEU . 31.5 mmtp -105.87 149.99 26.04 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.089 -0.505 . . . . 0.62 110.022 178.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.5 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 43.1 p90 -145.88 162.54 37.5 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.331 -0.395 . . . . 0.25 110.863 -176.451 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.481 ' HB3' ' HA ' ' A' ' 33' ' ' ALA . 34.9 p -51.87 113.18 0.93 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.037 -0.529 . . . . 1.04 111.129 177.272 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 95.5 8.58 58.41 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.587 -0.816 . . . . 0.53000000000000003 113.536 178.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.615 ' HB2' ' O ' ' A' ' 109' ' ' SER . 80.4 p -86.7 33.5 0.65 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 117.264 0.532 . . . . 0.69999999999999996 110.921 -177.557 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.432 ' HB3' ' O ' ' A' ' 20' ' ' SER . 66.8 ttt180 71.25 -34.82 0.31 Allowed 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.245 0.618 . . . . 3.4900000000000002 111.122 -176.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.459 ' H ' ' C ' ' A' ' 20' ' ' SER . 33.2 m-80 -133.63 91.77 25.04 Favored Pre-proline 0 C--N 1.327 -0.398 0 N-CA-C 109.245 -0.65 . . . . 1.77 109.245 176.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.509 ' C ' HG22 ' A' ' 32' ' ' THR . 72.7 Cg_endo -80.47 57.72 6.65 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 122.258 1.972 . . . . 1.71 112.774 -176.308 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.53 ' N ' HG22 ' A' ' 32' ' ' THR . 48.5 t -143.7 118.67 4.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 109.418 -0.586 . . . . 0.47999999999999998 109.418 178.074 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 40.2 t -104.85 150.34 24.92 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 110.037 -0.357 . . . . 1.1200000000000001 110.037 178.095 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.571 ' HG2' ' HA ' ' A' ' 67' ' ' ASP . 5.2 mmp_? -66.07 -8.35 22.9 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.727 0.299 . . . . 2.54 110.823 173.176 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.473 ' HD2' ' HD2' ' A' ' 65' ' ' ARG . 50.5 mtp180 -69.26 -50.68 44.77 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 121.555 0.693 . . . . 1.77 110.018 172.38 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 39.8 p -94.66 -33.62 12.9 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 115.154 -0.93 . . . . 0.67000000000000004 110.837 -172.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 80.31 -32.56 2.3 Favored Glycine 0 N--CA 1.451 -0.308 0 CA-C-N 115.813 -0.63 . . . . 0.81999999999999995 112.042 -178.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -92.56 -69.85 0.72 Allowed 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 122.576 0.35 . . . . 2.1000000000000001 110.717 -177.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.434 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 5.5 p -154.79 155.56 34.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.602 -0.272 . . . . 1.0800000000000001 110.922 177.207 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.53 HG22 ' N ' ' A' ' 24' ' ' VAL . 8.9 t -118.82 34.87 5.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 122.309 1.052 . . . . 0.34000000000000002 109.388 177.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.481 ' HA ' ' HB3' ' A' ' 18' ' ' SER . . . -76.58 -5.25 46.93 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.695 -1.139 . . . . 0.37 112.901 -173.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -94.8 -24.75 16.93 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.032 0.444 . . . . 2.21 110.848 -179.076 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.487 HG23 ' HB2' ' A' ' 39' ' ' ASP . 0.2 OUTLIER -95.72 135.89 28.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.941 -0.572 . . . . 0.31 109.816 179.87 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 67.0 p -96.34 178.42 5.37 Favored 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 109.952 -0.388 . . . . 0.39000000000000001 109.952 -175.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.454 ' O ' HG13 ' A' ' 41' ' ' ILE . 13.3 p90 -63.99 -27.89 69.44 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.224 -0.658 . . . . 1.53 109.224 176.467 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -70.73 -47.17 61.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.779 -0.646 . . . . 0.95999999999999996 110.204 177.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.487 ' HB2' HG23 ' A' ' 35' ' ' VAL . 47.1 m-20 -67.87 -29.59 68.75 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.401 0.62 . . . . 0.91000000000000003 109.752 178.233 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.5 ' HB2' ' HB3' ' A' ' 17' ' ' PHE . . . -70.35 -43.96 69.11 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.007 -0.997 . . . . 0.19 110.583 177.499 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.454 HG13 ' O ' ' A' ' 37' ' ' TYR . 80.0 mt -62.24 -37.35 78.34 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 N-CA-C 109.549 -0.537 . . . . 0.29999999999999999 109.549 173.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -62.19 -25.46 67.79 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.784 -0.644 . . . . 2.3199999999999998 110.174 177.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -84.82 -53.41 5.35 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.477 -0.783 . . . . 1.02 109.405 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.92 HD22 ' HB3' ' A' ' 111' ' ' LEU . 23.9 tp -62.01 -36.27 81.02 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.145 -0.934 . . . . 0.17000000000000001 110.587 -175.031 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.537 ' O ' ' HB2' ' A' ' 49' ' ' GLN . 0.0 OUTLIER -68.53 -24.71 64.67 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 112.348 0.499 . . . . 0.87 112.348 -177.909 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -80.43 -45.69 17.19 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.95 -0.389 . . . . 1.3100000000000001 109.95 178.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.436 ' NE1' ' HG3' ' A' ' 65' ' ' ARG . 52.9 m95 -65.69 -46.55 78.62 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.138 -0.483 . . . . 0.52000000000000002 111.207 177.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.522 ' HB3' HG21 ' A' ' 113' ' ' ILE . 92.2 p -64.01 -24.26 67.65 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.807 0.337 . . . . 0.81999999999999995 110.166 178.469 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.537 ' HB2' ' O ' ' A' ' 45' ' ' GLN . 10.9 tt0 -73.28 -56.67 4.76 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-N 116.11 -0.496 . . . . 0.53000000000000003 110.034 175.284 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.607 ' HB3' HG22 ' A' ' 56' ' ' VAL . 97.0 mtt180 -60.79 -42.4 97.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.473 -0.785 . . . . 0.41999999999999998 111.401 -177.041 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.448 HG22 HD13 ' A' ' 101' ' ' ILE . 98.0 mt -62.07 -40.17 86.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 120.823 0.344 . . . . 0.20000000000000001 110.613 177.648 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.39 -44.65 74.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.234 -0.439 . . . . 0.27000000000000002 111.373 -178.395 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 32.3 p -77.39 -31.02 53.95 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.842 0.354 . . . . 0.34999999999999998 111.38 -177.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 109.19 10.23 24.41 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.658 -0.782 . . . . 0.29999999999999999 112.548 179.353 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.463 ' HB2' ' HB3' ' A' ' 50' ' ' ARG . 45.5 mt-10 -60.17 -46.93 88.02 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.211 0.529 . . . . 0.65000000000000002 109.867 175.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.607 HG22 ' HB3' ' A' ' 50' ' ' ARG . 11.1 m -133.24 158.83 43.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.714 -0.676 . . . . 0.19 109.315 172.096 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 17.8 m -85.95 155.22 20.99 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 109.247 -0.649 . . . . 0.96999999999999997 109.247 178.31 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -52.39 -42.63 64.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.301 0.572 . . . . 0.22 109.783 -177.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.517 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 39.2 mt-10 -55.08 -41.73 71.9 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.811 -1.086 . . . . 1.72 112.044 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -65.94 -47.2 75.47 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-O 120.712 0.291 . . . . 2.0899999999999999 111.112 -174.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -69.48 -43.31 73.45 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.343 -0.39 . . . . 0.26000000000000001 110.784 -178.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.66 -51.3 69.97 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.105 -0.498 . . . . 0.23999999999999999 111.813 -176.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.561 ' HA ' ' O ' ' A' ' 71' ' ' TYR . 40.4 m -51.26 -27.44 9.21 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.939 0.718 . . . . 1.0 112.939 -177.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -98.55 -46.7 5.64 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.893 0.854 . . . . 0.60999999999999999 110.936 -179.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.473 ' HD2' ' HD2' ' A' ' 27' ' ' ARG . 37.4 mmt180 -94.97 -37.26 11.23 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 114.398 -1.274 . . . . 0.85999999999999999 113.713 -166.133 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.47 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 60.0 p -65.64 117.5 8.18 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.305 -0.558 . . . . 0.81999999999999995 110.065 -178.35 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.571 ' HA ' ' HG2' ' A' ' 26' ' ' ARG . 24.0 t70 -73.84 -15.82 61.15 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.345 0.593 . . . . 2.2799999999999998 111.089 179.33 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 46.2 t -77.37 160.84 28.49 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.307 0.575 . . . . 1.52 109.939 179.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -57.1 -18.0 25.55 Favored Glycine 0 C--N 1.328 0.134 0 CA-C-N 114.691 -1.14 . . . . 0.26000000000000001 114.425 -170.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.502 ' HB2' ' CA ' ' A' ' 75' ' ' GLY . 3.0 p -70.28 -0.11 7.42 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.861 0.689 . . . . 0.32000000000000001 112.861 179.198 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.561 ' O ' ' HA ' ' A' ' 63' ' ' SER . 39.2 p90 -60.29 -27.57 67.4 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 118.395 0.543 . . . . 0.54000000000000004 109.973 175.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -94.43 5.37 52.01 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.246 0.545 . . . . 0.48999999999999999 110.223 178.059 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.5 m -124.67 0.63 8.15 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.666 -0.697 . . . . 0.70999999999999996 111.005 -176.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.517 ' O ' ' HA ' ' A' ' 59' ' ' GLU . . . 75.2 29.62 60.1 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.724 -0.75 . . . . 0.54000000000000004 112.316 -177.388 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.502 ' CA ' ' HB2' ' A' ' 70' ' ' SER . . . 84.4 -3.59 85.98 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 121.01 -0.614 . . . . 0.34999999999999998 112.317 179.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -84.57 140.8 31.15 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.667 0.27 . . . . 1.6499999999999999 111.56 -169.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.449 HD12 ' HA ' ' A' ' 77' ' ' LEU . 0.5 OUTLIER -120.94 163.17 18.65 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.775 -0.648 . . . . 0.93999999999999995 110.493 172.118 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -79.01 -117.05 0.23 Allowed Glycine 0 C--N 1.31 -0.891 0 CA-C-N 114.964 -1.016 . . . . 0.44 113.44 -177.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 37.0 p90 -116.15 141.06 48.63 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.864 0.364 . . . . 3.8700000000000001 110.95 -176.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.532 ' HZ ' ' N ' ' A' ' 10' ' ' ALA . 3.5 p90 -158.23 129.56 6.56 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.084 -0.507 . . . . 1.3100000000000001 111.014 -178.482 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.582 ' HA ' ' O ' ' A' ' 6' ' ' GLU . 82.2 p -74.31 155.33 38.32 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.308 -0.627 . . . . 1.1699999999999999 109.308 178.185 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 9.3 m -59.77 114.38 2.74 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.144 -0.48 . . . . 1.1899999999999999 110.346 -178.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 114.05 1.49 23.81 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.685 -0.769 . . . . 0.79000000000000004 112.509 -176.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -90.84 15.22 11.69 Favored 'General case' 0 C--N 1.33 -0.281 0 O-C-N 122.593 -0.357 . . . . 1.55 111.5 178.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 26.2 mmt -126.84 -126.99 0.23 Allowed 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 121.116 0.484 . . . . 0.72999999999999998 111.147 -176.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 54.7 mtt -123.19 149.26 44.87 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.09 -1.078 . . . . 1.3899999999999999 108.09 179.005 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 64.6 tttp -49.82 -54.98 26.61 Favored Pre-proline 0 CA--C 1.541 0.618 0 N-CA-C 112.52 0.563 . . . . 2.3700000000000001 112.52 -175.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.433 ' HG2' HG22 ' A' ' 107' ' ' THR . 82.8 Cg_endo -76.02 -22.47 13.06 Favored 'Trans proline' 0 C--N 1.356 0.965 0 C-N-CA 121.798 1.665 . . . . 0.27000000000000002 112.321 -176.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.644 ' O ' HG23 ' A' ' 93' ' ' VAL . 38.7 t80 -73.3 -56.22 5.37 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.402 -0.817 . . . . 0.22 109.504 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.407 ' OE2' ' HD3' ' A' ' 94' ' ' ARG . 1.5 tm-20 -63.87 -33.55 75.94 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.595 -0.729 . . . . 2.1200000000000001 109.77 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.592 ' HA ' ' NE ' ' A' ' 94' ' ' ARG . 18.7 t70 -52.47 -37.74 57.78 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.237 -0.892 . . . . 0.60999999999999999 111.104 175.093 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.576 ' O ' ' HG ' ' A' ' 96' ' ' LEU . . . -81.76 -36.55 28.4 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.428 -0.351 . . . . 0.22 110.895 178.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.644 HG23 ' O ' ' A' ' 89' ' ' PHE . 11.5 t -63.6 -41.25 91.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.267 0.556 . . . . 0.25 110.699 -177.207 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.592 ' NE ' ' HA ' ' A' ' 91' ' ' ASP . 30.7 ptt180 -76.57 -18.55 58.6 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.776 -0.647 . . . . 2.5899999999999999 110.52 178.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -82.95 -5.91 59.25 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.923 -0.58 . . . . 0.46999999999999997 111.441 -172.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.617 ' HB2' ' HB2' ' A' ' 100' ' ' ASP . 0.5 OUTLIER -133.45 160.51 37.19 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.18 0.514 . . . . 0.28000000000000003 111.244 -179.591 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.648 ' HG2' ' H ' ' A' ' 98' ' ' ILE . 33.6 tttp -102.33 178.42 4.6 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 115.656 -0.702 . . . . 1.6100000000000001 109.461 178.099 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.648 ' H ' ' HG2' ' A' ' 97' ' ' LYS . 8.2 mt -53.36 119.34 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.265 -0.425 . . . . 0.90000000000000002 111.138 178.346 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 102.1 -10.04 56.67 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.821 -0.704 . . . . 0.46000000000000002 113.057 178.065 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.617 ' HB2' ' HB2' ' A' ' 96' ' ' LEU . 61.5 m-20 -97.82 139.92 32.96 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 117.1 0.45 . . . . 0.46000000000000002 110.407 -177.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.478 HG12 ' HB3' ' A' ' 115' ' ' LYS . 9.5 mt -111.2 151.69 13.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.082 -0.508 . . . . 0.23000000000000001 110.499 -177.282 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.413 ' OG ' HD21 ' A' ' 96' ' ' LEU . 10.8 m -86.37 156.74 56.63 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 115.965 -0.561 . . . . 0.92000000000000004 110.887 -178.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -75.99 176.49 9.96 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 122.477 2.118 . . . . 0.34000000000000002 110.183 166.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.88 HG23 HD23 ' A' ' 44' ' ' LEU . 22.8 mm -52.05 108.45 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 CA-C-O 121.052 0.454 . . . . 0.20000000000000001 111.732 177.628 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 76.2 t -108.33 115.64 49.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.049 -0.523 . . . . 1.04 110.004 175.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -85.9 140.77 30.09 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 121.195 0.521 . . . . 0.55000000000000004 110.235 177.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.433 HG22 ' HG2' ' A' ' 88' ' ' PRO . 8.4 p -118.37 -172.2 2.22 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.488 -0.778 . . . . 0.37 110.817 -177.692 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -63.41 -37.58 87.84 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.545 0.212 . . . . 2.1600000000000001 111.027 179.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.615 ' O ' ' HB2' ' A' ' 20' ' ' SER . 8.4 t -92.9 -61.37 1.6 Allowed 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.786 -0.366 . . . . 1.0900000000000001 110.478 179.241 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -145.63 -130.68 2.22 Favored Glycine 0 N--CA 1.443 -0.892 0 C-N-CA 119.026 -1.559 . . . . 0.23999999999999999 113.795 -173.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.92 ' HB3' HD22 ' A' ' 44' ' ' LEU . 6.7 mp -118.54 146.35 44.63 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.289 -0.455 . . . . 0.19 111.139 -171.786 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . 0.6 ' NE2' HD13 ' A' ' 14' ' ' LEU . 80.6 m-70 -144.35 142.5 30.42 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.066 0.46 . . . . 0.22 112.061 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.715 HG12 HD11 ' A' ' 44' ' ' LEU . 3.4 pt -125.77 136.22 61.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 107.771 -1.196 . . . . 0.17000000000000001 107.771 159.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.427 HG21 HG22 ' A' ' 93' ' ' VAL . 3.1 mp -128.58 141.23 47.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 C-N-CA 120.891 -0.324 . . . . 0.17999999999999999 110.372 -176.317 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.478 ' HB3' HG12 ' A' ' 101' ' ' ILE . 38.8 pttt -124.69 139.05 54.21 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.927 -0.768 . . . . 0.60999999999999999 108.927 172.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 52.6 ttt180 -80.45 129.18 34.35 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.956 0.408 . . . . 1.8700000000000001 111.153 -176.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.46 ' HB2' ' HG2' ' A' ' 9' ' ' ARG . 3.5 mm? -100.99 -30.67 11.5 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.608 -0.724 . . . . 0.89000000000000001 110.575 -177.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.494 ' HB3' ' HB3' ' A' ' 9' ' ' ARG . . . . . . . . 0 C--O 1.248 0.992 0 CA-C-O 118.467 -0.777 . . . . 1.1000000000000001 110.012 178.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.41 ' N ' ' SD ' ' A' ' 4' ' ' MET . 1.5 mpt? . . . . . 0 N--CA 1.479 1.006 0 CA-C-O 120.77 0.319 . . . . 7.2300000000000004 110.231 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 6.3 m -92.22 -65.4 1.01 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.3 -0.409 . . . . 2.8799999999999999 110.703 -178.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.434 ' O ' ' HA ' ' A' ' 81' ' ' SER . 14.7 pt-20 -80.05 -10.7 59.79 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.221 -0.445 . . . . 2.7999999999999998 111.031 -176.62 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 40.6 mmtm -78.93 114.88 18.24 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.342 0.591 . . . . 1.1899999999999999 110.693 176.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 10.5 tp -120.21 172.61 7.66 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.182 -0.917 . . . . 1.1799999999999999 109.133 -179.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.424 ' HG2' ' HB2' ' A' ' 117' ' ' LEU . 69.0 ttt180 -147.63 127.38 13.43 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.385 -0.598 . . . . 1.0600000000000001 109.385 177.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.546 ' O ' ' HB2' ' A' ' 77' ' ' LEU . . . -146.76 150.15 34.77 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.265 -0.574 . . . . 0.22 112.181 -177.484 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.421 ' HB3' ' HG2' ' A' ' 115' ' ' LYS . . . -103.01 134.41 46.5 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.065 -0.717 . . . . 0.20000000000000001 109.065 176.052 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.456 ' CE1' HD11 ' A' ' 77' ' ' LEU . 37.2 p-80 -136.18 151.32 49.61 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.098 0.475 . . . . 0.23000000000000001 112.05 -172.058 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.551 HD23 ' N ' ' A' ' 14' ' ' LEU . 4.7 tt -119.34 144.5 46.82 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.49 -0.929 . . . . 0.23999999999999999 108.49 175.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.598 HD13 ' NE2' ' A' ' 112' ' ' HIS . 28.9 tp -131.65 123.91 28.81 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.531 0.205 . . . . 0.27000000000000002 111.033 -176.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.552 HG23 HD13 ' A' ' 44' ' ' LEU . 71.1 t -113.82 138.03 44.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 109.87 -0.419 . . . . 0.14999999999999999 109.87 176.052 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.529 ' HE3' HD21 ' A' ' 14' ' ' LEU . 34.0 mmtp -111.29 158.8 18.59 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.876 -0.416 . . . . 0.62 109.876 177.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.457 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 38.4 p90 -149.03 162.58 39.64 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.427 -0.351 . . . . 0.25 110.306 -175.542 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.487 ' HB3' ' HA ' ' A' ' 33' ' ' ALA . 35.5 p -52.18 109.61 0.4 Allowed 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 120.929 0.395 . . . . 1.04 110.55 176.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 101.93 9.08 43.69 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.484 -0.865 . . . . 0.53000000000000003 112.947 -179.085 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.482 ' C ' ' H ' ' A' ' 22' ' ' ASN . 80.9 p -84.08 34.26 0.5 Allowed 'General case' 0 C--O 1.232 0.18 0 CA-C-N 117.29 0.545 . . . . 0.69999999999999996 111.223 -178.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.43 ' HB2' ' O ' ' A' ' 20' ' ' SER . 89.9 mtt180 73.03 -28.61 0.19 Allowed 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.521 0.728 . . . . 3.4900000000000002 110.895 -177.17 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.482 ' H ' ' C ' ' A' ' 20' ' ' SER . 3.0 p30 -150.07 104.39 3.17 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 115.919 -0.582 . . . . 1.77 110.175 172.425 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.427 ' C ' HG22 ' A' ' 32' ' ' THR . 6.8 Cg_exo -75.3 57.95 4.92 Favored 'Trans proline' 0 CA--C 1.532 0.403 0 C-N-CA 123.448 2.766 . . . . 1.71 113.368 -178.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.428 ' N ' HG22 ' A' ' 32' ' ' THR . 40.3 t -148.48 110.81 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 109.867 -0.42 . . . . 0.47999999999999998 109.867 176.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.471 ' HB3' ' HB2' ' A' ' 16' ' ' LYS . 17.1 p -104.41 154.57 19.69 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.831 -0.168 . . . . 1.1200000000000001 110.689 177.094 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.684 ' HB2' ' HA ' ' A' ' 67' ' ' ASP . 1.2 mpt_? -62.2 -13.6 29.32 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.031 0.443 . . . . 2.54 110.503 171.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.516 ' HG2' ' HA ' ' A' ' 65' ' ' ARG . 0.4 OUTLIER -80.59 -21.67 41.39 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.81 -0.632 . . . . 1.77 110.346 -179.689 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 36.3 p -115.35 -34.89 4.8 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.999 -0.546 . . . . 0.67000000000000004 110.79 -177.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 76.53 -33.11 1.38 Allowed Glycine 0 CA--C 1.517 0.207 0 CA-C-N 115.252 -0.886 . . . . 0.81999999999999995 113.065 176.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -99.59 -69.13 0.78 Allowed 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 110.124 -0.324 . . . . 2.1000000000000001 110.124 -178.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 42.9 m -154.57 152.76 30.42 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.095 -0.502 . . . . 1.0800000000000001 110.495 175.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.428 HG22 ' N ' ' A' ' 24' ' ' VAL . 10.5 t -119.4 30.88 6.87 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 122.17 0.986 . . . . 0.34000000000000002 108.903 175.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.487 ' HA ' ' HB3' ' A' ' 18' ' ' SER . . . -79.96 -5.39 55.57 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 114.898 -1.046 . . . . 0.37 111.364 -177.516 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -88.46 -25.68 22.49 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.413 0.625 . . . . 2.21 110.244 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.428 HG23 ' HB2' ' A' ' 39' ' ' ASP . 0.2 OUTLIER -100.14 137.48 27.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.442 -0.799 . . . . 0.31 109.895 -178.434 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 59.6 p -94.88 178.35 5.6 Favored 'General case' 0 CA--C 1.512 -0.487 0 N-CA-C 109.708 -0.478 . . . . 0.39000000000000001 109.708 -176.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.464 ' O ' HG13 ' A' ' 41' ' ' ILE . 10.1 p90 -63.11 -29.23 70.63 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.009 -0.676 . . . . 1.53 109.561 177.436 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -72.96 -44.13 61.48 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.058 -0.519 . . . . 0.95999999999999996 110.539 178.121 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.428 ' HB2' HG23 ' A' ' 35' ' ' VAL . 39.7 m-20 -69.72 -27.12 64.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.299 0.571 . . . . 0.91000000000000003 109.89 177.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.457 ' HB2' ' HB3' ' A' ' 17' ' ' PHE . . . -73.37 -45.75 53.08 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.303 -0.862 . . . . 0.19 110.683 176.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.493 ' CG1' HD21 ' A' ' 111' ' ' LEU . 80.5 mt -61.81 -36.39 73.43 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.369 0 N-CA-C 109.619 -0.512 . . . . 0.29999999999999999 109.619 175.246 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -57.78 -32.05 67.15 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 115.561 -0.745 . . . . 2.3199999999999998 110.468 176.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -87.37 -46.18 9.88 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.605 -0.725 . . . . 1.02 109.904 -175.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.895 HD22 ' HB3' ' A' ' 111' ' ' LEU . 34.6 tp -62.16 -37.41 85.11 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.019 -0.537 . . . . 0.17000000000000001 110.123 -178.551 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.519 ' O ' ' HB2' ' A' ' 49' ' ' GLN . 0.0 OUTLIER -64.72 -30.93 71.95 Favored 'General case' 0 C--O 1.225 -0.211 0 CA-C-N 116.271 -0.422 . . . . 0.87 111.779 179.581 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 59.4 mttm -72.08 -44.3 63.49 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.119 0.485 . . . . 1.3100000000000001 110.503 179.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 25.5 m95 -71.54 -43.34 66.59 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.088 -0.506 . . . . 0.52000000000000002 111.414 -179.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.474 ' HB3' HG21 ' A' ' 113' ' ' ILE . 93.6 p -65.04 -22.95 67.06 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.903 -0.406 . . . . 0.81999999999999995 109.903 175.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.519 ' HB2' ' O ' ' A' ' 45' ' ' GLN . 14.7 tt0 -71.55 -54.31 10.91 Favored 'General case' 0 C--O 1.224 -0.252 0 CA-C-N 116.047 -0.524 . . . . 0.53000000000000003 109.764 174.574 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.639 ' HB3' HG22 ' A' ' 56' ' ' VAL . 89.1 mtt180 -62.37 -41.69 98.83 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.903 -0.589 . . . . 0.41999999999999998 111.788 -177.59 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.44 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 82.1 mt -59.92 -40.01 81.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 120.998 0.427 . . . . 0.20000000000000001 110.425 176.49 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.9 -41.26 64.79 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.012 -0.54 . . . . 0.27000000000000002 111.523 179.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 66.5 p -76.13 -29.43 57.81 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.829 0.347 . . . . 0.34999999999999998 111.505 -176.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 107.06 4.49 35.76 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.615 -0.802 . . . . 0.29999999999999999 112.271 178.349 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.488 ' OE1' ' HG2' ' A' ' 50' ' ' ARG . 46.3 mt-10 -61.05 -49.69 76.36 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.134 0.492 . . . . 0.65000000000000002 110.176 178.221 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.639 HG22 ' HB3' ' A' ' 50' ' ' ARG . 15.8 m -131.49 154.62 40.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.695 -0.684 . . . . 0.19 109.268 173.193 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 22.8 p -85.41 165.76 16.94 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 109.554 -0.536 . . . . 0.96999999999999997 109.554 177.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -57.38 -41.9 81.11 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.978 -0.378 . . . . 0.22 109.978 -177.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.584 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 42.0 mt-10 -59.23 -46.56 88.15 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.76 -0.654 . . . . 1.72 111.623 -179.179 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -60.53 -44.61 95.87 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-O 120.92 0.391 . . . . 2.0899999999999999 111.0 -178.018 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -70.76 -49.57 45.29 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.246 -0.434 . . . . 0.26000000000000001 111.084 -178.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.41 -51.86 68.08 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.332 0.493 . . . . 0.23999999999999999 112.332 -174.424 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.491 ' HA ' ' O ' ' A' ' 71' ' ' TYR . 52.8 m -51.12 -24.09 3.75 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 113.041 0.756 . . . . 1.0 113.041 -178.083 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -104.18 -44.94 4.85 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.493 0.663 . . . . 0.60999999999999999 110.494 -179.018 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.516 ' HA ' ' HG2' ' A' ' 27' ' ' ARG . 16.3 mmt180 -90.81 -42.73 10.49 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 113.848 1.055 . . . . 0.85999999999999999 113.848 -170.353 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.444 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 72.7 p -64.3 124.89 22.9 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.044 0.449 . . . . 0.81999999999999995 111.28 -175.305 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.684 ' HA ' ' HB2' ' A' ' 26' ' ' ARG . 25.7 t70 -76.6 -16.05 59.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.543 -0.753 . . . . 2.2799999999999998 111.475 178.204 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 52.6 t -78.05 155.79 30.44 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.201 0.524 . . . . 1.52 110.15 -179.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -57.12 -18.1 26.1 Favored Glycine 0 N--CA 1.454 -0.138 0 CA-C-N 114.631 -1.168 . . . . 0.26000000000000001 113.638 -173.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 63.0 p -64.77 -7.7 12.04 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 112.035 0.383 . . . . 0.32000000000000001 112.035 176.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.491 ' O ' ' HA ' ' A' ' 63' ' ' SER . 25.2 p90 -57.88 -22.92 50.69 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.868 0.366 . . . . 0.54000000000000004 110.297 175.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -90.77 -0.23 57.64 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.06 0.457 . . . . 0.48999999999999999 110.674 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 16.3 m -126.34 14.38 7.72 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.888 -0.596 . . . . 0.70999999999999996 110.577 178.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.584 ' O ' ' HA ' ' A' ' 59' ' ' GLU . . . 70.75 27.33 72.56 Favored Glycine 0 CA--C 1.519 0.325 0 C-N-CA 120.839 -0.696 . . . . 0.54000000000000004 112.718 -178.708 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 82.3 -17.85 16.69 Favored Glycine 0 N--CA 1.454 -0.167 0 C-N-CA 121.034 -0.603 . . . . 0.34999999999999998 112.473 179.161 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -70.96 135.16 47.73 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-O 120.883 0.373 . . . . 1.6499999999999999 110.594 -176.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.546 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 19.2 mt -111.36 158.43 19.07 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.933 -0.576 . . . . 0.93999999999999995 110.291 176.408 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -81.84 -137.37 2.4 Favored Glycine 0 C--N 1.317 -0.507 0 CA-C-N 115.673 -0.694 . . . . 0.44 112.625 179.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 38.1 p90 -98.43 135.57 39.82 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.189 0.519 . . . . 3.8700000000000001 110.626 -177.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.43 ' HZ ' ' N ' ' A' ' 10' ' ' ALA . 2.0 p90 -151.5 164.6 36.44 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.921 -0.581 . . . . 1.3100000000000001 110.21 -178.572 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.434 ' HA ' ' O ' ' A' ' 6' ' ' GLU . 13.2 m -89.54 120.42 30.83 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 109.788 -0.449 . . . . 1.1699999999999999 109.788 178.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.5 p -55.36 118.85 4.79 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.932 -0.576 . . . . 1.1899999999999999 110.909 178.468 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 114.43 5.92 20.47 Favored Glycine 0 N--CA 1.447 -0.572 0 N-CA-C 111.538 -0.625 . . . . 0.79000000000000004 111.538 -176.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -105.04 -6.19 20.22 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.83 0.347 . . . . 1.55 110.803 -177.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 26.0 mmt -86.14 -97.48 0.07 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.252 0.549 . . . . 0.72999999999999998 110.873 -175.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 55.9 mtt -145.16 150.96 37.68 Favored 'General case' 0 CA--C 1.507 -0.694 0 N-CA-C 107.187 -1.412 . . . . 1.3899999999999999 107.187 176.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -55.85 -52.63 70.76 Favored Pre-proline 0 C--N 1.318 -0.797 0 CA-C-N 118.188 0.449 . . . . 2.3700000000000001 112.115 -174.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -74.03 -31.34 8.04 Favored 'Trans proline' 0 C--N 1.358 1.033 0 C-N-CA 121.466 1.444 . . . . 0.27000000000000002 111.891 -177.214 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.626 ' O ' HG23 ' A' ' 93' ' ' VAL . 29.7 t80 -65.74 -55.73 15.78 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.62 -0.718 . . . . 0.22 109.481 177.018 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -64.52 -34.6 78.6 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.338 -0.846 . . . . 2.1200000000000001 110.461 -177.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -56.99 -36.54 70.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.824 -0.625 . . . . 0.60999999999999999 110.516 175.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.436 ' O ' ' HG ' ' A' ' 96' ' ' LEU . . . -78.97 -28.26 43.54 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.192 -0.458 . . . . 0.22 110.981 178.356 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.626 HG23 ' O ' ' A' ' 89' ' ' PHE . 17.2 t -71.42 -36.48 61.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 121.267 0.556 . . . . 0.25 110.14 -177.55 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.511 ' C ' ' HD2' ' A' ' 94' ' ' ARG . 6.1 ppt_? -82.66 -9.23 59.47 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.918 -0.583 . . . . 2.5899999999999999 110.446 179.008 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.35 -2.66 58.78 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.989 -0.551 . . . . 0.46999999999999997 110.955 -177.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.567 ' HB2' ' HB2' ' A' ' 100' ' ' ASP . 0.7 OUTLIER -135.87 152.9 51.5 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.896 -0.593 . . . . 0.28000000000000003 110.442 178.906 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.607 ' HG2' ' H ' ' A' ' 98' ' ' ILE . 47.0 tttt -102.88 -174.13 2.48 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.634 -0.506 . . . . 1.6100000000000001 109.634 176.64 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.607 ' H ' ' HG2' ' A' ' 97' ' ' LYS . 10.4 mt -57.54 116.08 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 121.061 0.458 . . . . 0.90000000000000002 111.692 -176.387 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 98.23 3.83 57.62 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.813 -0.708 . . . . 0.46000000000000002 113.239 179.326 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.567 ' HB2' ' HB2' ' A' ' 96' ' ' LEU . 7.7 m-20 -104.67 141.76 35.87 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 117.196 0.498 . . . . 0.46000000000000002 110.811 178.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 8.3 mt -111.84 146.58 16.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.774 -0.648 . . . . 0.23000000000000001 109.737 -178.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 88.1 p -93.35 155.46 40.9 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 116.374 -0.376 . . . . 0.92000000000000004 110.292 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -74.23 175.54 10.81 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 122.125 1.883 . . . . 0.34000000000000002 111.131 171.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.851 HG23 HD23 ' A' ' 44' ' ' LEU . 20.3 mm -48.99 108.48 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 O-C-N 123.459 0.474 . . . . 0.20000000000000001 112.144 177.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.4 p -115.84 120.08 63.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 120.91 0.386 . . . . 1.04 110.125 175.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -85.42 152.45 23.21 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.141 0.496 . . . . 0.55000000000000004 110.964 -179.16 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 4.3 p -126.27 -172.51 2.64 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.434 -0.803 . . . . 0.37 110.237 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -60.78 -38.46 85.4 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.83 0.348 . . . . 2.1600000000000001 110.642 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.47 ' O ' ' HB2' ' A' ' 20' ' ' SER . 16.2 t -90.95 -60.63 1.86 Allowed 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 120.867 -0.333 . . . . 1.0900000000000001 110.694 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -150.55 -130.85 1.79 Allowed Glycine 0 N--CA 1.441 -1.019 0 C-N-CA 119.057 -1.544 . . . . 0.23999999999999999 114.084 -173.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.895 ' HB3' HD22 ' A' ' 44' ' ' LEU . 6.7 mp -116.07 146.2 42.39 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.184 -0.508 . . . . 0.19 111.844 -168.012 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . 0.598 ' NE2' HD13 ' A' ' 14' ' ' LEU . 85.0 m-70 -141.99 150.0 40.78 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.578 0.584 . . . . 0.22 112.578 178.422 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.571 HG12 HD11 ' A' ' 44' ' ' LEU . 3.3 pt -132.42 138.21 52.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 107.446 -1.316 . . . . 0.17000000000000001 107.446 159.379 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 2.2 mp -129.69 145.74 35.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 C-N-CA 120.755 -0.378 . . . . 0.17999999999999999 110.641 -175.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.449 ' HA ' ' O ' ' A' ' 100' ' ' ASP . 42.0 pttt -126.64 139.01 53.49 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.796 -0.816 . . . . 0.60999999999999999 108.796 171.365 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.45 ' HB2' ' CD1' ' A' ' 96' ' ' LEU . 60.7 ttt180 -83.63 125.12 31.5 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.174 0.512 . . . . 1.8700000000000001 110.86 -178.087 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.424 ' HB2' ' HG2' ' A' ' 9' ' ' ARG . 4.2 mm? -93.06 -31.96 14.65 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.487 -0.779 . . . . 0.89000000000000001 110.247 -179.114 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.865 0 CA-C-N 115.54 -0.755 . . . . 1.1000000000000001 109.962 179.747 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 27.9 ttt . . . . . 0 N--CA 1.48 1.064 0 CA-C-O 120.643 0.258 . . . . 7.2300000000000004 110.315 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 38.3 t -65.18 139.04 58.62 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.15 -0.477 . . . . 2.8799999999999999 110.212 179.108 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.494 ' H ' ' CD ' ' A' ' 6' ' ' GLU . 0.1 OUTLIER -95.87 -8.25 34.59 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.993 -0.549 . . . . 2.7999999999999998 109.942 179.455 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.456 ' HG3' ' HB2' ' A' ' 79' ' ' PHE . 10.8 mptt -81.63 115.96 21.15 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.838 0.827 . . . . 1.1899999999999999 110.82 -179.089 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.58 HD23 ' H ' ' A' ' 9' ' ' ARG . 1.8 tt -116.01 159.53 21.51 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 114.2 -1.364 . . . . 1.1799999999999999 108.001 -178.512 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.59 ' HB3' ' HB3' ' A' ' 118' ' ' ALA . 79.0 ttt180 -136.28 127.85 28.75 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.431 -0.581 . . . . 1.0600000000000001 109.431 174.274 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.425 ' N ' ' HZ ' ' A' ' 80' ' ' PHE . . . -150.05 152.17 34.41 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.093 0.473 . . . . 0.22 111.714 -179.244 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.417 ' HB3' ' HG2' ' A' ' 115' ' ' LYS . . . -101.87 136.78 41.12 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.458 -0.792 . . . . 0.20000000000000001 109.527 177.39 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 37.4 p-80 -136.45 149.1 48.07 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.964 0.412 . . . . 0.23000000000000001 111.286 -173.327 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.56 HD23 ' N ' ' A' ' 14' ' ' LEU . 6.2 tt -118.37 149.46 41.16 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.836 -0.802 . . . . 0.23999999999999999 108.836 177.275 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.569 ' O ' ' HA ' ' A' ' 66' ' ' SER . 29.6 tp -130.84 124.61 31.65 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.611 0.243 . . . . 0.27000000000000002 111.052 -179.228 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.546 HG23 HD13 ' A' ' 44' ' ' LEU . 85.1 t -111.34 138.03 41.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 109.405 -0.591 . . . . 0.14999999999999999 109.405 173.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.485 ' HB2' ' HB2' ' A' ' 25' ' ' SER . 24.9 mmtp -105.72 162.07 13.85 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.157 -0.474 . . . . 0.62 110.491 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.462 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 51.5 p90 -158.86 161.6 36.87 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.053 -0.521 . . . . 0.25 109.92 179.48 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.522 ' HB3' ' HA ' ' A' ' 33' ' ' ALA . 21.5 p -53.35 109.97 0.5 Allowed 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.347 -0.388 . . . . 1.04 111.026 178.576 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 104.46 10.36 33.71 Favored Glycine 0 N--CA 1.443 -0.86 0 C-N-CA 120.229 -0.986 . . . . 0.53000000000000003 113.371 178.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.661 ' HB2' ' O ' ' A' ' 109' ' ' SER . 39.8 p -81.49 46.24 0.94 Allowed 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 117.855 0.828 . . . . 0.69999999999999996 111.577 -174.065 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.402 ' HB3' ' O ' ' A' ' 20' ' ' SER . 56.2 ttt180 68.95 -37.01 0.35 Allowed 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.905 0.882 . . . . 3.4900000000000002 111.355 -177.213 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.488 ' H ' ' C ' ' A' ' 20' ' ' SER . 8.1 p30 -155.01 126.48 3.67 Favored Pre-proline 0 C--N 1.316 -0.866 0 N-CA-C 107.67 -1.233 . . . . 1.77 107.67 175.565 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -82.39 -156.11 0.07 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 122.302 2.001 . . . . 1.71 111.784 -175.106 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.615 ' N ' HG22 ' A' ' 32' ' ' THR . 57.5 t 60.07 114.12 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 123.423 0.689 . . . . 0.47999999999999998 111.692 -173.738 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.485 ' HB2' ' HB2' ' A' ' 16' ' ' LYS . 29.8 t -103.4 159.82 15.24 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.815 -0.63 . . . . 1.1200000000000001 109.722 177.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.589 ' HB2' ' HA ' ' A' ' 67' ' ' ASP . 5.5 mpt_? -75.33 -12.73 60.33 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 109.018 -0.734 . . . . 2.54 109.018 169.498 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.474 ' HG2' ' HD3' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -72.52 -49.75 30.67 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.249 -0.887 . . . . 1.77 109.195 174.066 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 55.6 p -85.39 -34.05 21.84 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.468 -0.787 . . . . 0.67000000000000004 111.249 -177.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 80.7 -34.73 2.29 Favored Glycine 0 C--N 1.322 -0.216 0 CA-C-N 115.314 -0.857 . . . . 0.81999999999999995 111.395 -176.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.556 ' O ' ' HA ' ' A' ' 24' ' ' VAL . 4.4 m-20 -114.56 -135.27 0.35 Allowed 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 108.349 -0.982 . . . . 2.1000000000000001 108.349 173.025 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -70.82 142.03 51.3 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 112.703 0.631 . . . . 1.0800000000000001 112.703 -171.261 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.615 HG22 ' N ' ' A' ' 24' ' ' VAL . 8.9 t -124.25 14.51 9.01 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.337 -0.847 . . . . 0.34000000000000002 109.461 175.219 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.522 ' HA ' ' HB3' ' A' ' 18' ' ' SER . . . -68.75 -4.35 15.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.302 -0.863 . . . . 0.37 111.565 177.587 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -88.73 -24.95 22.55 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.99 -0.55 . . . . 2.21 110.802 -178.053 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.77 HG23 ' HB3' ' A' ' 39' ' ' ASP . 0.1 OUTLIER -100.58 141.55 17.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.088 -0.505 . . . . 0.31 110.211 -179.126 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 40.7 p -98.1 174.75 6.38 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 110.212 -0.292 . . . . 0.39000000000000001 110.212 -176.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.516 ' O ' HG13 ' A' ' 41' ' ' ILE . 11.5 p90 -63.94 -26.85 68.77 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.101 -0.64 . . . . 1.53 109.507 177.713 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -71.04 -46.14 62.57 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.06 -0.518 . . . . 0.95999999999999996 110.526 178.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.77 ' HB3' HG23 ' A' ' 35' ' ' VAL . 2.7 t70 -70.0 -31.22 68.79 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.473 0.654 . . . . 0.91000000000000003 109.695 178.15 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.462 ' HB2' ' HB3' ' A' ' 17' ' ' PHE . . . -66.64 -41.97 87.43 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.232 -0.895 . . . . 0.19 110.347 175.658 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.516 HG13 ' O ' ' A' ' 37' ' ' TYR . 78.1 mt -64.63 -33.13 61.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 109.516 -0.549 . . . . 0.29999999999999999 109.516 173.517 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.521 ' HB3' ' O ' ' A' ' 39' ' ' ASP . 3.9 ttpm? -60.75 -28.32 68.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.298 0.571 . . . . 2.3199999999999998 109.993 176.212 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.457 ' HG3' ' CD1' ' A' ' 47' ' ' TRP . 6.2 tp10 -84.92 -52.88 5.69 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.403 -0.817 . . . . 1.02 109.487 -178.635 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.916 HD23 HG23 ' A' ' 104' ' ' ILE . 22.8 tp -64.61 -34.15 77.61 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.329 -0.851 . . . . 0.17000000000000001 110.762 -174.267 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.51 ' O ' ' HB2' ' A' ' 49' ' ' GLN . 4.7 mm-40 -70.41 -19.63 62.98 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.353 -0.385 . . . . 0.87 111.892 -178.481 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.425 ' HG3' ' O ' ' A' ' 42' ' ' LYS . 67.9 mttm -84.25 -46.95 11.29 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.741 -0.466 . . . . 1.3100000000000001 109.741 175.489 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.458 ' NE1' ' HG3' ' A' ' 65' ' ' ARG . 44.0 m95 -63.61 -48.05 78.9 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.144 -0.48 . . . . 0.52000000000000002 111.821 179.782 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.508 ' HB3' HG21 ' A' ' 113' ' ' ILE . 98.5 p -64.81 -20.53 66.44 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.507 -0.477 . . . . 0.81999999999999995 110.023 177.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.51 ' HB2' ' O ' ' A' ' 45' ' ' GLN . 11.8 tt0 -77.52 -54.72 6.08 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.183 -0.462 . . . . 0.53000000000000003 110.014 175.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.598 ' HB3' HG22 ' A' ' 56' ' ' VAL . 97.9 mtt180 -63.21 -41.5 99.15 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.637 -0.711 . . . . 0.41999999999999998 111.435 -176.627 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.483 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 98.3 mt -61.12 -33.59 56.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.159 0.504 . . . . 0.20000000000000001 110.48 176.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -79.75 -35.55 38.57 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.907 -0.588 . . . . 0.27000000000000002 111.444 -179.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 31.1 p -82.35 -28.98 31.23 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.811 0.338 . . . . 0.34999999999999998 111.602 -176.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 107.98 3.77 33.9 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.762 -0.732 . . . . 0.29999999999999999 112.375 179.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.448 ' HB2' ' HB3' ' A' ' 50' ' ' ARG . 36.8 mt-10 -61.79 -48.16 81.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.075 0.464 . . . . 0.65000000000000002 110.258 178.435 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.598 HG22 ' HB3' ' A' ' 50' ' ' ARG . 15.6 m -135.32 156.22 38.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 109.31 -0.626 . . . . 0.19 109.31 172.242 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.582 ' OG ' ' HG3' ' A' ' 60' ' ' GLU . 77.7 p -83.79 165.49 18.79 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.795 -0.446 . . . . 0.96999999999999997 109.795 178.035 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -57.7 -41.01 80.83 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.516 -0.55 . . . . 0.22 109.516 179.172 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.479 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 43.8 mt-10 -62.24 -41.35 98.34 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.062 -0.972 . . . . 1.72 111.962 -178.122 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.582 ' HG3' ' OG ' ' A' ' 57' ' ' SER . 41.2 mt-10 -60.76 -49.24 78.28 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.021 0.439 . . . . 2.0899999999999999 110.859 -179.659 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.14 -50.61 63.38 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.926 -0.579 . . . . 0.26000000000000001 111.073 -178.257 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -58.86 -52.1 67.19 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.351 0.5 . . . . 0.23999999999999999 112.351 -174.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.534 ' HA ' ' O ' ' A' ' 71' ' ' TYR . 20.2 m -51.5 -24.23 4.92 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 113.122 0.786 . . . . 1.0 113.122 -176.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -105.49 -44.12 4.78 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.583 0.706 . . . . 0.60999999999999999 110.615 -179.15 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.474 ' HD3' ' HG2' ' A' ' 27' ' ' ARG . 38.7 mmt-85 -90.92 -41.88 10.9 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 113.882 1.067 . . . . 0.85999999999999999 113.882 -170.131 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.569 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 75.9 p -64.17 122.7 17.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.055 0.455 . . . . 0.81999999999999995 111.615 -174.314 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.589 ' HA ' ' HB2' ' A' ' 26' ' ' ARG . 28.6 t70 -76.55 -9.33 58.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.618 -0.719 . . . . 2.2799999999999998 110.827 175.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.543 ' SG ' HD22 ' A' ' 14' ' ' LEU . 4.1 m -77.13 163.43 26.6 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.897 -0.592 . . . . 1.52 110.267 175.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -65.9 -16.28 63.71 Favored Glycine 0 CA--C 1.512 -0.142 0 CA-C-N 114.912 -1.04 . . . . 0.26000000000000001 113.203 -173.316 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.512 ' HB2' ' CA ' ' A' ' 75' ' ' GLY . 3.6 p -68.96 0.56 4.34 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 112.426 0.528 . . . . 0.32000000000000001 112.426 177.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.534 ' O ' ' HA ' ' A' ' 63' ' ' SER . 34.5 p90 -58.33 -26.47 63.14 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.137 0.494 . . . . 0.54000000000000004 110.154 175.515 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -95.29 -6.99 40.07 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.162 0.505 . . . . 0.48999999999999999 110.585 178.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.8 m -110.67 -0.02 17.31 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.835 -0.62 . . . . 0.70999999999999996 111.066 -175.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.479 ' O ' ' HA ' ' A' ' 59' ' ' GLU . . . 77.79 27.64 58.37 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.852 -0.689 . . . . 0.54000000000000004 112.218 -177.086 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.512 ' CA ' ' HB2' ' A' ' 70' ' ' SER . . . 81.94 -1.2 87.24 Favored Glycine 0 C--O 1.226 -0.373 0 C-N-CA 120.873 -0.679 . . . . 0.34999999999999998 111.85 -178.264 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -92.15 136.07 33.48 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 120.962 0.41 . . . . 1.6499999999999999 111.436 -169.215 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.6 mp -115.75 158.08 23.38 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.709 -0.678 . . . . 0.93999999999999995 109.548 172.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -85.35 -127.2 1.77 Allowed Glycine 0 C--N 1.308 -1.001 0 CA-C-N 114.944 -1.025 . . . . 0.44 112.255 -179.118 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.456 ' HB2' ' HG3' ' A' ' 7' ' ' LYS . 46.4 p90 -92.67 147.31 22.98 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.83 0.348 . . . . 3.8700000000000001 110.734 -177.694 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.446 ' CE1' ' HB3' ' A' ' 8' ' ' LEU . 2.3 p90 -163.59 147.25 10.32 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.098 -0.501 . . . . 1.3100000000000001 110.499 179.056 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 17.5 m -76.08 135.03 39.89 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.13 -0.486 . . . . 1.1699999999999999 110.577 179.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 16.0 m -61.03 114.64 3.21 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.939 -0.573 . . . . 1.1899999999999999 110.024 177.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.436 ' H ' ' HG3' ' A' ' 90' ' ' GLU . . . 112.58 -8.08 26.18 Favored Glycine 0 N--CA 1.447 -0.606 0 CA-C-N 115.79 -0.641 . . . . 0.79000000000000004 111.895 -177.522 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -101.14 47.01 0.92 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.655 0.741 . . . . 1.55 110.371 -177.296 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 21.6 mmt -135.82 -127.21 0.15 Allowed 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.87 -0.789 . . . . 0.72999999999999998 108.87 176.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 59.9 mtt -113.45 149.85 33.65 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.438 -0.949 . . . . 1.3899999999999999 108.438 174.028 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -53.3 -54.37 45.85 Favored Pre-proline 0 C--N 1.321 -0.646 0 N-CA-C 112.647 0.61 . . . . 2.3700000000000001 112.647 -174.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -74.61 -31.22 7.1 Favored 'Trans proline' 0 C--N 1.355 0.89 0 C-N-CA 121.387 1.391 . . . . 0.27000000000000002 111.667 -176.315 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.589 ' O ' HG23 ' A' ' 93' ' ' VAL . 42.9 t80 -66.03 -56.06 13.47 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.113 -0.949 . . . . 0.22 110.099 179.309 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.436 ' HG3' ' H ' ' A' ' 83' ' ' GLY . 5.6 tm-20 -64.61 -37.96 89.37 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.598 -0.728 . . . . 2.1200000000000001 110.218 -177.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.443 ' HA ' ' HD2' ' A' ' 94' ' ' ARG . 35.2 t70 -59.46 -26.93 65.64 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.874 -0.603 . . . . 0.60999999999999999 110.7 177.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -85.59 -21.39 28.52 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.495 -0.32 . . . . 0.22 111.408 176.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.589 HG23 ' O ' ' A' ' 89' ' ' PHE . 44.8 t -74.83 -47.9 35.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 121.253 0.549 . . . . 0.25 110.567 -173.737 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.443 ' HD2' ' HA ' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -78.49 1.79 21.18 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.195 -0.457 . . . . 2.5899999999999999 111.028 176.888 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -92.68 0.44 57.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.973 0.416 . . . . 0.46999999999999997 110.758 -179.485 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.589 ' HB2' ' HB2' ' A' ' 100' ' ' ASP . 0.4 OUTLIER -137.28 160.37 39.22 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.968 -0.56 . . . . 0.28000000000000003 110.627 177.876 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.482 ' HG3' ' H ' ' A' ' 98' ' ' ILE . 50.8 tptt -102.21 175.83 5.39 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.246 -0.65 . . . . 1.6100000000000001 109.246 179.433 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.482 ' H ' ' HG3' ' A' ' 97' ' ' LYS . 63.0 mt -57.71 114.66 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 120.97 0.414 . . . . 0.90000000000000002 110.725 177.797 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 104.76 -0.49 42.14 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.802 -0.714 . . . . 0.46000000000000002 112.528 -179.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.589 ' HB2' ' HB2' ' A' ' 96' ' ' LEU . 24.6 m-20 -105.17 137.45 42.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.797 0.298 . . . . 0.46000000000000002 110.522 179.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 12.7 mt -108.94 148.77 12.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.986 -0.552 . . . . 0.23000000000000001 109.902 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 95.7 p -91.28 156.05 43.95 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-N 116.469 -0.332 . . . . 0.92000000000000004 110.539 -179.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -69.69 174.08 9.97 Favored 'Trans proline' 0 C--O 1.233 0.271 0 C-N-CA 122.478 2.118 . . . . 0.34000000000000002 111.245 171.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.916 HG23 HD23 ' A' ' 44' ' ' LEU . 26.1 mm -51.67 100.78 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 O-C-N 123.314 0.383 . . . . 0.20000000000000001 111.447 176.025 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.5 p -104.76 118.34 51.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.2 0.524 . . . . 1.04 109.868 175.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -85.23 146.96 26.82 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.214 0.531 . . . . 0.55000000000000004 110.674 -179.427 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 18.5 p -124.49 -172.38 2.55 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.395 -0.82 . . . . 0.37 109.76 179.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -73.46 -29.43 62.53 Favored 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 120.967 -0.293 . . . . 2.1600000000000001 110.81 178.085 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.661 ' O ' ' HB2' ' A' ' 20' ' ' SER . 8.4 t -101.3 -9.31 21.33 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.1 0.407 . . . . 1.0900000000000001 112.1 -175.377 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 160.66 -127.47 1.78 Allowed Glycine 0 N--CA 1.437 -1.293 0 C-N-CA 119.871 -1.157 . . . . 0.23999999999999999 112.638 170.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.888 ' HB3' HD22 ' A' ' 44' ' ' LEU . 6.1 mp -120.9 144.11 48.6 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 114.981 -0.61 . . . . 0.19 110.846 -172.36 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . 0.543 ' HA ' ' O ' ' A' ' 13' ' ' LEU . 72.9 m-70 -143.06 151.72 41.09 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.262 0.553 . . . . 0.22 112.044 -179.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.633 HG12 HD11 ' A' ' 44' ' ' LEU . 2.8 pt -134.64 141.36 43.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 107.658 -1.238 . . . . 0.17000000000000001 107.658 161.126 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 1.8 mp -129.98 143.31 41.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 C-N-CA 120.773 -0.371 . . . . 0.17999999999999999 110.62 -176.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.425 ' HA ' ' O ' ' A' ' 100' ' ' ASP . 43.8 pttt -125.14 138.17 54.16 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.63 -0.878 . . . . 0.60999999999999999 108.63 172.136 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.441 ' HB2' ' CD1' ' A' ' 96' ' ' LEU . 61.3 ttt180 -85.64 136.39 33.39 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.079 0.466 . . . . 1.8700000000000001 111.268 -177.079 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 6.6 mp -115.25 -24.29 8.54 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.62 -0.718 . . . . 0.89000000000000001 111.508 -178.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.59 ' HB3' ' HB3' ' A' ' 9' ' ' ARG . . . . . . . . 0 C--O 1.244 0.774 0 CA-C-O 118.22 -0.895 . . . . 1.1000000000000001 109.882 175.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 98.2 mmm . . . . . 0 N--CA 1.479 1.009 0 N-CA-C 110.194 -0.299 . . . . 7.2300000000000004 110.194 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 57.4 m -139.87 169.84 16.98 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.169 -0.469 . . . . 2.8799999999999999 110.616 178.174 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -130.07 104.44 7.34 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.792 -0.64 . . . . 2.7999999999999998 109.865 176.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 24.3 tptt -149.76 134.07 17.33 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.281 0.563 . . . . 1.1899999999999999 110.004 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.667 HD23 ' N ' ' A' ' 9' ' ' ARG . 2.9 tt -139.29 155.92 47.4 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 115.065 -0.97 . . . . 1.1799999999999999 108.467 -177.449 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.667 ' N ' HD23 ' A' ' 8' ' ' LEU . 44.3 ttt180 -139.56 128.48 23.52 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 108.199 -1.038 . . . . 1.0600000000000001 108.199 173.422 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.43 ' O ' ' HB2' ' A' ' 77' ' ' LEU . . . -146.04 148.71 32.98 Favored 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 120.402 -0.519 . . . . 0.22 111.983 -177.106 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.42 ' HB3' ' HG2' ' A' ' 115' ' ' LYS . . . -102.44 137.15 41.07 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.428 -0.806 . . . . 0.20000000000000001 109.264 176.592 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 23.1 p-80 -137.37 152.68 49.95 Favored 'General case' 0 C--N 1.323 -0.587 0 C-N-CA 120.418 -0.513 . . . . 0.23000000000000001 111.872 -172.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.579 HD23 ' N ' ' A' ' 14' ' ' LEU . 5.4 tt -121.1 148.3 44.37 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.467 -0.938 . . . . 0.23999999999999999 108.467 177.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.612 HD21 ' HE3' ' A' ' 16' ' ' LYS . 27.4 tp -131.23 130.96 43.58 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 110.378 -0.23 . . . . 0.27000000000000002 110.378 -179.355 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.544 HG23 HD13 ' A' ' 44' ' ' LEU . 63.6 t -120.83 129.22 75.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 109.518 -0.549 . . . . 0.14999999999999999 109.518 173.241 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.612 ' HE3' HD21 ' A' ' 14' ' ' LEU . 32.1 mmtp -104.58 158.33 16.57 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.214 -0.448 . . . . 0.62 110.504 178.336 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -150.68 162.13 41.28 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.954 -0.566 . . . . 0.25 110.125 -175.07 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.463 ' HB3' ' C ' ' A' ' 33' ' ' ALA . 45.8 p -55.0 111.42 0.83 Allowed 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 110.117 -0.327 . . . . 1.04 110.117 175.209 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 104.24 9.84 35.47 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.074 -1.06 . . . . 0.53000000000000003 112.394 -177.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.475 ' HB2' ' O ' ' A' ' 109' ' ' SER . 79.5 p -92.98 24.21 3.82 Favored 'General case' 0 N--CA 1.453 -0.308 0 O-C-N 122.376 -0.485 . . . . 0.69999999999999996 110.791 -177.541 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 60.3 mtt180 71.79 -33.39 0.27 Allowed 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 123.225 0.61 . . . . 3.4900000000000002 111.406 -178.193 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.455 ' H ' ' C ' ' A' ' 20' ' ' SER . 38.5 m-80 -127.8 89.05 51.77 Favored Pre-proline 0 C--N 1.324 -0.541 0 N-CA-C 109.109 -0.7 . . . . 1.77 109.109 176.336 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.498 ' C ' HG22 ' A' ' 32' ' ' THR . 90.5 Cg_endo -79.84 45.46 1.96 Allowed 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 122.678 2.252 . . . . 1.71 112.82 -173.522 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.41 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 60.7 t -141.53 115.14 4.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 108.68 -0.859 . . . . 0.47999999999999998 108.68 178.796 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.473 ' HB2' ' OD1' ' A' ' 67' ' ' ASP . 15.9 p -100.84 158.35 16.04 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 110.173 -0.306 . . . . 1.1200000000000001 110.173 -178.04 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.485 ' HG2' ' HA ' ' A' ' 67' ' ' ASP . 18.3 mmm180 -72.97 -17.24 61.49 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 108.362 -0.977 . . . . 2.54 108.362 172.122 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 13.2 ttp180 -65.83 -48.64 70.97 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 114.463 -1.244 . . . . 1.77 110.054 177.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 33.3 p -96.35 -34.49 11.55 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.153 0.501 . . . . 0.67000000000000004 110.765 -178.078 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 85.91 -31.37 4.01 Favored Glycine 0 N--CA 1.45 -0.381 0 CA-C-N 115.752 -0.658 . . . . 0.81999999999999995 113.148 -179.375 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -101.24 -61.23 1.4 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.973 0.386 . . . . 2.1000000000000001 111.424 -178.128 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.41 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 10.3 p -154.77 149.62 26.68 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.986 0.422 . . . . 1.0800000000000001 111.674 178.798 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.498 HG22 ' C ' ' A' ' 23' ' ' PRO . 12.6 t -116.86 27.31 9.23 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 122.305 1.05 . . . . 0.34000000000000002 108.733 173.2 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.463 ' C ' ' HB3' ' A' ' 18' ' ' SER . . . -75.83 -4.43 40.68 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.598 -1.183 . . . . 0.37 112.162 -175.213 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -97.94 -19.8 17.84 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.943 0.401 . . . . 2.21 110.632 -178.263 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.505 HG23 ' HB2' ' A' ' 39' ' ' ASP . 0.2 OUTLIER -101.85 137.85 28.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 116.062 -0.517 . . . . 0.31 110.36 -178.667 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 61.8 p -96.91 177.9 5.47 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 109.531 -0.544 . . . . 0.39000000000000001 109.531 -178.257 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.472 ' HA ' ' HB3' ' A' ' 40' ' ' ALA . 0.1 OUTLIER -68.39 -21.26 64.7 Favored 'General case' 0 C--O 1.217 -0.616 0 C-N-CA 118.72 -1.192 . . . . 1.53 110.288 174.26 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -72.41 -41.98 65.63 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.931 -0.396 . . . . 0.95999999999999996 109.931 175.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.505 ' HB2' HG23 ' A' ' 35' ' ' VAL . 23.9 m-20 -71.04 -35.17 71.88 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.404 0.621 . . . . 0.91000000000000003 109.853 175.035 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.472 ' HB3' ' HA ' ' A' ' 37' ' ' TYR . . . -67.99 -48.25 66.29 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.098 -0.955 . . . . 0.19 110.613 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.437 ' CG1' HD21 ' A' ' 111' ' ' LEU . 69.8 mt -62.15 -36.83 76.44 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.462 0 N-CA-C 109.833 -0.432 . . . . 0.29999999999999999 109.833 175.661 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 59.6 tttp -59.86 -29.09 68.07 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.832 -0.622 . . . . 2.3199999999999998 109.891 178.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -88.91 -49.54 6.73 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.461 -0.791 . . . . 1.02 110.473 -178.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.928 HD23 HG23 ' A' ' 104' ' ' ILE . 33.9 tp -58.73 -36.42 74.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.969 -0.56 . . . . 0.17000000000000001 110.039 -177.503 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.456 ' O ' ' HB2' ' A' ' 49' ' ' GLN . 0.0 OUTLIER -66.92 -23.56 65.99 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-N 115.954 -0.566 . . . . 0.87 112.078 -179.692 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -85.01 -40.29 17.05 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 110.196 -0.298 . . . . 1.3100000000000001 110.196 179.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.413 ' O ' HG13 ' A' ' 51' ' ' ILE . 36.8 m95 -66.46 -47.87 71.73 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.96 -0.296 . . . . 0.52000000000000002 111.293 174.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.44 ' HB3' HG21 ' A' ' 113' ' ' ILE . 88.6 p -62.75 -28.24 69.83 Favored 'General case' 0 C--N 1.333 -0.128 0 C-N-CA 120.719 -0.392 . . . . 0.81999999999999995 110.062 177.449 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.456 ' HB2' ' O ' ' A' ' 45' ' ' GLN . 11.4 tt0 -66.74 -57.17 7.64 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.925 -0.58 . . . . 0.53000000000000003 110.323 173.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.622 ' HB3' HG22 ' A' ' 56' ' ' VAL . 86.2 mtt180 -61.14 -42.14 98.01 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.943 -0.571 . . . . 0.41999999999999998 111.58 -176.437 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.489 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 92.4 mt -61.51 -36.63 74.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 120.929 0.395 . . . . 0.20000000000000001 110.43 177.479 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -77.46 -35.45 53.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.068 -0.515 . . . . 0.27000000000000002 111.684 -179.476 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 51.1 p -80.49 -30.34 37.33 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.893 0.377 . . . . 0.34999999999999998 111.481 -177.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 108.55 4.43 32.37 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.76 -0.733 . . . . 0.29999999999999999 112.218 -179.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.42 ' HB2' ' HB3' ' A' ' 50' ' ' ARG . 40.0 mt-10 -61.49 -48.7 79.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.007 0.432 . . . . 0.65000000000000002 110.104 178.039 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.622 HG22 ' HB3' ' A' ' 50' ' ' ARG . 13.6 m -133.77 157.45 42.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 109.354 -0.61 . . . . 0.19 109.354 171.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 49.6 m -85.93 160.02 19.5 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 109.471 -0.566 . . . . 0.96999999999999997 109.471 177.211 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.424 ' HA ' HD13 ' A' ' 51' ' ' ILE . 2.7 t80 -53.66 -43.92 69.2 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.272 0.558 . . . . 0.22 109.948 -177.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.583 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 2.8 mp0 -56.96 -39.13 74.01 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.845 -1.071 . . . . 1.72 111.916 -178.307 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 31.5 mm-40 -65.39 -48.94 71.14 Favored 'General case' 0 CA--C 1.521 -0.16 0 CA-C-O 120.836 0.35 . . . . 2.0899999999999999 111.118 -177.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -68.94 -42.72 76.33 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.386 -0.37 . . . . 0.26000000000000001 111.108 -177.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.11 -53.82 52.22 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.331 -0.395 . . . . 0.23999999999999999 112.051 -175.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.519 ' HA ' ' O ' ' A' ' 71' ' ' TYR . 16.0 m -51.56 -21.8 2.79 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 113.149 0.796 . . . . 1.0 113.149 -177.342 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -104.99 -46.71 4.2 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.519 0.676 . . . . 0.60999999999999999 110.473 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' A' ' 65' ' ' ARG . 21.2 mmt180 -94.8 -36.11 11.81 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.745 -1.116 . . . . 0.85999999999999999 113.99 -168.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.499 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 54.4 p -63.23 116.81 5.79 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.031 0.443 . . . . 0.81999999999999995 110.479 -177.684 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.485 ' HA ' ' HG2' ' A' ' 26' ' ' ARG . 48.5 m-20 -82.15 0.72 39.6 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.772 -0.649 . . . . 2.2799999999999998 111.251 -178.657 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.565 ' SG ' HD22 ' A' ' 14' ' ' LEU . 1.7 m -78.42 173.67 12.1 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.869 -0.605 . . . . 1.52 109.978 172.159 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -69.28 -16.54 71.32 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.706 -0.759 . . . . 0.26000000000000001 112.026 179.533 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 67.2 p -65.98 -5.51 9.74 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 112.576 0.584 . . . . 0.32000000000000001 112.576 -179.046 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.519 ' O ' ' HA ' ' A' ' 63' ' ' SER . 30.4 p90 -60.36 -25.76 66.1 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.005 0.431 . . . . 0.54000000000000004 110.33 177.78 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -94.36 -2.58 51.85 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.239 0.542 . . . . 0.48999999999999999 110.448 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 7.0 m -116.84 9.36 13.85 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.832 -0.622 . . . . 0.70999999999999996 110.748 -178.1 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.583 ' O ' ' HA ' ' A' ' 59' ' ' GLU . . . 68.27 28.51 73.27 Favored Glycine 0 C--O 1.227 -0.288 0 C-N-CA 120.915 -0.66 . . . . 0.54000000000000004 112.039 -177.435 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 83.29 -21.2 8.78 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 121.145 -0.55 . . . . 0.34999999999999998 112.282 -178.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -72.68 136.81 45.7 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.787 0.327 . . . . 1.6499999999999999 111.192 -173.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.43 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 2.6 mp -116.17 166.79 11.62 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.955 -0.566 . . . . 0.93999999999999995 110.027 174.665 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -81.24 -148.52 6.16 Favored Glycine 0 C--N 1.314 -0.669 0 CA-C-N 115.393 -0.821 . . . . 0.44 113.138 -177.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -99.33 143.92 29.03 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.993 0.425 . . . . 3.8700000000000001 110.864 -179.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.411 ' HE2' ' HB3' ' A' ' 77' ' ' LEU . 0.9 OUTLIER -157.31 175.23 14.29 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.856 -0.611 . . . . 1.3100000000000001 109.815 -174.925 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 16.2 m -104.17 139.52 39.11 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.876 -0.787 . . . . 1.1699999999999999 108.876 175.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 48.0 m -61.96 126.96 29.18 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.076 0.465 . . . . 1.1899999999999999 110.812 -179.375 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 114.74 -4.25 22.87 Favored Glycine 0 N--CA 1.443 -0.898 0 CA-C-N 115.392 -0.822 . . . . 0.79000000000000004 111.276 -176.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -95.85 6.99 47.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.699 0.285 . . . . 1.55 111.363 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 25.0 mmt -104.16 -122.6 0.21 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.047 0.451 . . . . 0.72999999999999998 110.572 179.36 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 54.8 mtt -123.69 152.15 42.36 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 107.919 -1.141 . . . . 1.3899999999999999 107.919 175.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm -53.17 -53.99 49.64 Favored Pre-proline 0 C--N 1.319 -0.721 0 N-CA-C 112.249 0.463 . . . . 2.3700000000000001 112.249 -175.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.05 -30.68 10.54 Favored 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 121.457 1.438 . . . . 0.27000000000000002 111.836 -177.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.646 ' O ' HG23 ' A' ' 93' ' ' VAL . 26.3 t80 -67.36 -56.48 9.53 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.247 -0.888 . . . . 0.22 109.885 179.742 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -62.19 -35.32 78.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.535 -0.757 . . . . 2.1200000000000001 110.449 -178.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -61.12 -30.47 70.39 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.362 -0.836 . . . . 0.60999999999999999 110.905 178.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.465 ' O ' ' HG ' ' A' ' 96' ' ' LEU . . . -83.35 -26.84 30.16 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.851 0.357 . . . . 0.22 110.659 178.001 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.646 HG23 ' O ' ' A' ' 89' ' ' PHE . 27.4 t -70.43 -37.62 71.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.255 0.55 . . . . 0.25 110.165 -176.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.479 ' C ' ' HD2' ' A' ' 94' ' ' ARG . 6.2 ppt_? -78.92 -13.68 59.66 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.882 -0.599 . . . . 2.5899999999999999 110.735 178.657 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -84.23 -11.04 57.15 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.185 0.517 . . . . 0.46999999999999997 110.963 -175.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.583 ' HB2' ' HB2' ' A' ' 100' ' ' ASP . 0.9 OUTLIER -127.64 145.18 50.97 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.828 -0.624 . . . . 0.28000000000000003 110.761 179.713 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.424 ' HG3' ' H ' ' A' ' 98' ' ' ILE . 20.7 tptm -92.95 173.12 7.91 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 109.021 -0.733 . . . . 1.6100000000000001 109.021 178.754 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.463 ' HA ' ' HG2' ' A' ' 116' ' ' ARG . 72.1 mt -45.76 115.96 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.913 0.387 . . . . 0.90000000000000002 111.649 176.393 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 106.16 -12.27 44.47 Favored Glycine 0 CA--C 1.521 0.45 0 C-N-CA 120.946 -0.645 . . . . 0.46000000000000002 113.736 177.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.583 ' HB2' ' HB2' ' A' ' 96' ' ' LEU . 15.7 m-20 -97.95 148.98 22.91 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 117.566 0.683 . . . . 0.46000000000000002 111.144 -178.005 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 13.0 mt -115.83 149.08 18.15 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-N 115.951 -0.568 . . . . 0.23000000000000001 110.872 -174.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.411 ' HB2' ' H ' ' A' ' 114' ' ' ILE . 5.9 m -81.72 151.18 67.59 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 115.953 -0.567 . . . . 0.92000000000000004 110.806 -178.333 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -73.75 165.22 32.8 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 122.2 1.934 . . . . 0.34000000000000002 109.989 166.221 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.928 HG23 HD23 ' A' ' 44' ' ' LEU . 20.1 mm -46.47 108.54 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 O-C-N 123.32 0.387 . . . . 0.20000000000000001 111.956 178.292 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.3 p -115.32 117.59 56.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.193 -0.458 . . . . 1.04 110.157 176.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 16.8 mt-30 -85.25 147.24 26.67 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.055 0.455 . . . . 0.55000000000000004 110.07 178.105 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 8.8 p -121.38 -172.46 2.42 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.421 -0.808 . . . . 0.37 110.389 -177.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -59.86 -35.27 74.44 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.589 0.233 . . . . 2.1600000000000001 110.78 178.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.603 ' OG ' ' HE2' ' A' ' 16' ' ' LYS . 6.4 t -96.78 -60.93 1.49 Allowed 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.69 -0.404 . . . . 1.0900000000000001 110.884 -179.713 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -147.72 -135.02 2.57 Favored Glycine 0 N--CA 1.443 -0.884 0 C-N-CA 118.9 -1.619 . . . . 0.23999999999999999 113.733 -173.321 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.896 ' HB3' HD22 ' A' ' 44' ' ' LEU . 7.7 mp -113.83 146.34 40.11 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 114.962 -0.619 . . . . 0.19 111.232 -170.643 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . 0.538 ' HA ' ' O ' ' A' ' 13' ' ' LEU . 77.0 m-70 -144.16 150.14 37.58 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.144 0.497 . . . . 0.22 111.902 179.659 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.557 HG12 HD11 ' A' ' 44' ' ' LEU . 2.1 pt -134.57 137.58 51.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 107.715 -1.217 . . . . 0.17000000000000001 107.715 160.651 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.411 ' H ' ' HB2' ' A' ' 102' ' ' SER . 2.1 mp -128.1 145.96 34.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 C-N-CA 121.035 -0.266 . . . . 0.17999999999999999 110.735 -174.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.42 ' HG2' ' HB3' ' A' ' 11' ' ' ALA . 47.4 pttt -127.84 139.86 52.38 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.733 -0.84 . . . . 0.60999999999999999 108.733 172.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.483 ' HD3' HD21 ' A' ' 8' ' ' LEU . 4.7 ttp180 -83.11 133.92 35.03 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.12 -0.632 . . . . 1.8700000000000001 110.868 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -103.04 -36.0 8.33 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.87 -1.059 . . . . 0.89000000000000001 109.729 -178.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.475 ' HB3' ' HB3' ' A' ' 9' ' ' ARG . . . . . . . . 0 C--O 1.245 0.855 0 CA-C-O 117.992 -1.004 . . . . 1.1000000000000001 109.569 178.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 22.3 ptt? . . . . . 0 N--CA 1.481 1.088 0 N-CA-C 111.523 0.194 . . . . 7.2300000000000004 111.523 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 17.5 p -80.05 -16.22 55.52 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 112.111 0.411 . . . . 2.8799999999999999 112.111 -174.013 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.523 ' O ' ' HA ' ' A' ' 81' ' ' SER . 0.4 OUTLIER -88.54 1.05 55.64 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.876 -0.329 . . . . 2.7999999999999998 110.688 -178.513 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -71.81 114.78 10.26 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.281 0.562 . . . . 1.1899999999999999 109.95 176.425 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.655 HD23 ' H ' ' A' ' 9' ' ' ARG . 0.4 OUTLIER -124.04 164.37 19.52 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.046 -0.979 . . . . 1.1799999999999999 109.529 -174.63 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.655 ' H ' HD23 ' A' ' 8' ' ' LEU . 58.4 ttt180 -145.35 128.85 17.0 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.395 -0.594 . . . . 1.0600000000000001 109.395 175.539 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.432 ' N ' ' HZ ' ' A' ' 80' ' ' PHE . . . -146.35 153.74 40.86 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.12 0.486 . . . . 0.22 112.036 -179.456 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.41 ' HB3' ' HG2' ' A' ' 115' ' ' LYS . . . -106.81 133.03 52.1 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.457 -0.792 . . . . 0.20000000000000001 109.089 176.573 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 38.0 p-80 -137.06 155.65 49.39 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.366 0.506 . . . . 0.23000000000000001 112.366 -170.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.577 HD23 ' N ' ' A' ' 14' ' ' LEU . 5.3 tt -123.13 147.25 46.99 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.694 -0.854 . . . . 0.23999999999999999 108.694 176.377 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.577 ' N ' HD23 ' A' ' 13' ' ' LEU . 23.6 tp -131.64 124.4 29.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.486 0.184 . . . . 0.27000000000000002 111.126 -178.677 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.527 HG23 HD13 ' A' ' 44' ' ' LEU . 58.9 t -112.85 142.03 26.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 109.787 -0.449 . . . . 0.14999999999999999 109.787 175.577 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.429 ' HE3' HD21 ' A' ' 14' ' ' LEU . 31.2 mmtp -114.39 156.36 24.62 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.789 -0.448 . . . . 0.62 109.789 178.306 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.409 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 41.7 p90 -149.96 162.74 39.77 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.513 -0.312 . . . . 0.25 110.26 -176.087 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.474 ' HB3' ' C ' ' A' ' 33' ' ' ALA . 54.0 p -52.06 112.88 0.86 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.786 0.327 . . . . 1.04 111.111 179.046 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 99.63 10.37 47.34 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.327 -0.939 . . . . 0.53000000000000003 113.007 179.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.521 ' C ' ' H ' ' A' ' 22' ' ' ASN . 33.0 p -76.29 23.07 0.15 Allowed 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 117.459 0.63 . . . . 0.69999999999999996 112.462 -174.438 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 86.1 mtt180 69.55 -35.28 0.31 Allowed 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.708 0.803 . . . . 3.4900000000000002 110.355 -175.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.521 ' H ' ' C ' ' A' ' 20' ' ' SER . 13.2 m-80 -140.13 102.25 6.85 Favored Pre-proline 0 N--CA 1.445 -0.717 0 N-CA-C 108.08 -1.082 . . . . 1.77 108.08 174.046 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -68.31 -159.27 0.05 OUTLIER 'Trans proline' 0 CA--C 1.531 0.371 0 C-N-CA 122.894 2.396 . . . . 1.71 111.821 179.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.523 ' N ' HG22 ' A' ' 32' ' ' THR . 16.5 t 62.25 107.16 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-N 115.487 -0.779 . . . . 0.47999999999999998 111.976 178.202 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.417 ' HB3' ' HB2' ' A' ' 16' ' ' LYS . 59.3 p -103.72 155.88 18.24 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.644 -0.502 . . . . 1.1200000000000001 109.644 175.425 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.516 ' HB2' ' HA ' ' A' ' 67' ' ' ASP . 4.7 mpt_? -66.33 -7.85 21.54 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.123 0.487 . . . . 2.54 110.486 174.509 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.484 ' HG2' ' HD3' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -85.54 -27.23 25.71 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.421 -0.808 . . . . 1.77 110.237 178.887 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 26.8 p -108.31 -35.53 6.5 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.873 -0.603 . . . . 0.67000000000000004 111.193 -176.005 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 80.41 -33.98 2.26 Favored Glycine 0 CA--C 1.519 0.304 0 CA-C-N 115.443 -0.799 . . . . 0.81999999999999995 113.483 175.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.439 ' O ' HG22 ' A' ' 24' ' ' VAL . 15.0 t70 -105.13 -66.19 0.99 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.911 0.355 . . . . 2.1000000000000001 110.635 179.44 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 19.2 m -152.3 150.89 30.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.111 0.481 . . . . 1.0800000000000001 111.155 -179.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.523 HG22 ' N ' ' A' ' 24' ' ' VAL . 8.9 t -123.62 19.03 9.56 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 122.005 0.907 . . . . 0.34000000000000002 109.347 178.012 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.474 ' C ' ' HB3' ' A' ' 18' ' ' SER . . . -67.35 -5.26 13.61 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.066 -0.97 . . . . 0.37 112.364 177.449 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -92.39 -24.34 18.91 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.889 0.376 . . . . 2.21 111.111 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.444 HG13 ' OG1' ' A' ' 32' ' ' THR . 0.2 OUTLIER -101.78 137.15 30.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 116.138 -0.483 . . . . 0.31 109.965 -179.573 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 77.1 p -94.04 177.48 5.96 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 116.289 -0.414 . . . . 0.39000000000000001 110.054 -173.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.53 ' O ' HG13 ' A' ' 41' ' ' ILE . 15.4 p90 -63.37 -30.53 71.65 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 119.917 -0.713 . . . . 1.53 109.435 176.408 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -69.46 -47.78 62.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.081 -0.509 . . . . 0.95999999999999996 110.595 178.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 39.5 m-20 -70.38 -27.84 64.63 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.98 -0.555 . . . . 0.91000000000000003 110.26 179.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.409 ' HB2' ' HB3' ' A' ' 17' ' ' PHE . . . -74.31 -39.06 63.12 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.495 -0.775 . . . . 0.19 110.329 177.73 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.53 HG13 ' O ' ' A' ' 37' ' ' TYR . 80.6 mt -64.46 -36.71 78.05 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 109.524 -0.547 . . . . 0.29999999999999999 109.524 174.133 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.45 ' O ' ' HG3' ' A' ' 46' ' ' LYS . 26.3 mtpp -64.12 -25.0 67.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.942 0.401 . . . . 2.3199999999999998 110.485 175.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.45 ' HG3' ' NE1' ' A' ' 47' ' ' TRP . 6.9 tt0 -83.88 -51.76 6.92 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.892 -0.595 . . . . 1.02 109.823 -179.188 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.912 HD22 ' HB3' ' A' ' 111' ' ' LEU . 34.0 tp -60.69 -38.76 86.07 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.786 -0.643 . . . . 0.17000000000000001 110.479 -179.744 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.491 ' O ' ' HB2' ' A' ' 49' ' ' GLN . 5.0 mm-40 -61.51 -38.28 86.8 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.189 -0.459 . . . . 0.87 112.146 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.45 ' HG3' ' O ' ' A' ' 42' ' ' LYS . 68.3 mttm -72.78 -38.68 67.19 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.672 0.273 . . . . 1.3100000000000001 111.083 -177.723 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.45 ' NE1' ' HG3' ' A' ' 43' ' ' GLU . 9.8 m95 -70.83 -45.85 63.81 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.885 -0.326 . . . . 0.52000000000000002 110.863 178.06 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.463 ' HB3' HG21 ' A' ' 113' ' ' ILE . 89.1 p -64.36 -28.3 69.61 Favored 'General case' 0 CA--C 1.528 0.122 0 N-CA-C 110.073 -0.343 . . . . 0.81999999999999995 110.073 177.356 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.491 ' HB2' ' O ' ' A' ' 45' ' ' GLN . 12.5 tt0 -64.68 -52.05 59.3 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 116.018 -0.537 . . . . 0.53000000000000003 109.952 175.368 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.639 ' HB3' HG22 ' A' ' 56' ' ' VAL . 84.4 mtt180 -61.05 -46.73 89.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.548 -0.751 . . . . 0.41999999999999998 111.205 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.465 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 85.3 mt -56.69 -43.67 79.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.291 -0.413 . . . . 0.20000000000000001 110.872 177.185 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.68 -42.62 81.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.117 -0.492 . . . . 0.27000000000000002 111.927 -179.339 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 51.3 p -77.7 -30.39 51.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.934 0.397 . . . . 0.34999999999999998 111.367 -177.187 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 108.68 8.96 27.6 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.564 -0.827 . . . . 0.29999999999999999 112.242 179.006 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.504 ' OE1' ' HG2' ' A' ' 50' ' ' ARG . 48.6 mt-10 -60.84 -49.37 77.77 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.096 0.475 . . . . 0.65000000000000002 109.913 176.657 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.639 HG22 ' HB3' ' A' ' 50' ' ' ARG . 31.4 m -134.44 154.68 37.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.719 -0.673 . . . . 0.19 109.41 173.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.435 ' OG ' ' HG2' ' A' ' 60' ' ' GLU . 19.8 p -79.44 161.83 25.86 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 110.042 -0.355 . . . . 0.96999999999999997 110.042 176.569 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -55.04 -38.4 67.92 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.377 0.608 . . . . 0.22 109.548 178.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -59.2 -43.45 92.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.885 -1.052 . . . . 1.72 111.828 -179.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.435 ' HG2' ' OG ' ' A' ' 57' ' ' SER . 12.1 mm-40 -64.48 -42.09 96.1 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-O 121.016 0.436 . . . . 2.0899999999999999 110.85 -178.589 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.429 ' O ' ' HG2' ' A' ' 65' ' ' ARG . . . -70.01 -55.85 8.51 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.896 -0.593 . . . . 0.26000000000000001 110.455 179.611 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -54.63 -52.96 60.61 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.513 0.56 . . . . 0.23999999999999999 112.513 -174.041 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.483 ' HA ' ' O ' ' A' ' 71' ' ' TYR . 20.8 t -52.0 -27.95 15.26 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.695 0.628 . . . . 1.0 112.695 -175.633 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -105.28 -44.19 4.81 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.492 0.663 . . . . 0.60999999999999999 110.894 -177.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.484 ' HD3' ' HG2' ' A' ' 27' ' ' ARG . 16.6 mmt180 -83.59 -44.4 14.64 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.944 -1.026 . . . . 0.85999999999999999 113.114 -171.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.449 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 77.6 p -65.21 120.04 11.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.128 0.49 . . . . 0.81999999999999995 111.429 -173.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.516 ' HA ' ' HB2' ' A' ' 26' ' ' ARG . 19.6 t70 -70.81 -16.9 62.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.48 -0.782 . . . . 2.2799999999999998 110.885 177.132 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.473 ' O ' ' HD2' ' A' ' 71' ' ' TYR . 53.7 t -77.99 154.96 31.05 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.259 0.552 . . . . 1.52 109.931 178.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -58.94 -12.37 14.83 Favored Glycine 0 C--O 1.234 0.148 0 CA-C-N 114.66 -1.155 . . . . 0.26000000000000001 113.714 -173.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 52.3 p -64.72 -8.07 13.29 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 111.771 0.285 . . . . 0.32000000000000001 111.771 176.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.483 ' O ' ' HA ' ' A' ' 63' ' ' SER . 51.1 p90 -57.59 -25.38 59.95 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.932 0.396 . . . . 0.54000000000000004 110.596 176.631 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -93.98 3.35 55.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.058 0.456 . . . . 0.48999999999999999 111.035 -179.382 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 9.0 m -126.78 14.42 7.47 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.099 -0.5 . . . . 0.70999999999999996 110.772 179.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 67.97 24.7 74.44 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 121.063 -0.589 . . . . 0.54000000000000004 112.54 -178.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 86.91 -17.2 42.57 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 121.16 -0.543 . . . . 0.34999999999999998 112.219 -179.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -74.55 136.79 42.12 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.733 0.302 . . . . 1.6499999999999999 110.682 -176.01 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.419 ' O ' ' HG3' ' A' ' 9' ' ' ARG . 2.4 mp -113.46 157.88 21.39 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 116.248 -0.433 . . . . 0.93999999999999995 110.055 173.218 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -76.19 -107.03 0.13 Allowed Glycine 0 C--N 1.309 -0.953 0 CA-C-N 115.226 -0.897 . . . . 0.44 113.504 -175.497 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 9.1 p90 -120.87 149.0 43.28 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.716 0.293 . . . . 3.8700000000000001 110.796 -178.12 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.432 ' HZ ' ' N ' ' A' ' 10' ' ' ALA . 3.8 p90 -166.27 161.32 16.66 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.547 -0.538 . . . . 1.3100000000000001 109.547 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.523 ' HA ' ' O ' ' A' ' 6' ' ' GLU . 73.0 p -105.11 125.45 50.99 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 109.292 -0.632 . . . . 1.1699999999999999 109.292 176.337 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 11.0 p -44.69 122.09 3.0 Favored 'General case' 0 C--O 1.234 0.288 0 O-C-N 123.79 0.681 . . . . 1.1899999999999999 111.618 -178.048 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 114.42 10.46 13.22 Favored Glycine 0 N--CA 1.446 -0.655 0 CA-C-N 115.824 -0.626 . . . . 0.79000000000000004 111.662 -177.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -109.23 -5.48 15.9 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 111.481 0.178 . . . . 1.55 111.481 179.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 26.2 mmt -95.15 -105.05 0.15 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.285 0.564 . . . . 0.72999999999999998 111.085 -175.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.458 ' HB2' ' HB3' ' A' ' 89' ' ' PHE . 44.1 mtt -138.12 148.81 45.33 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 107.381 -1.34 . . . . 1.3899999999999999 107.381 177.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.418 ' HB3' ' HD3' ' A' ' 88' ' ' PRO . 64.6 tttp -51.16 -54.55 36.75 Favored Pre-proline 0 C--N 1.32 -0.685 0 N-CA-C 112.472 0.545 . . . . 2.3700000000000001 112.472 -175.496 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.552 ' HG2' HG22 ' A' ' 107' ' ' THR . 86.5 Cg_endo -75.67 -29.7 6.96 Favored 'Trans proline' 0 C--N 1.356 0.965 0 C-N-CA 121.664 1.576 . . . . 0.27000000000000002 111.997 -177.557 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.595 ' O ' HG23 ' A' ' 93' ' ' VAL . 12.4 t80 -66.32 -56.42 11.23 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.722 -0.672 . . . . 0.22 109.428 178.466 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.534 ' O ' ' HD3' ' A' ' 94' ' ' ARG . 4.2 tp10 -61.4 -36.14 79.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.16 -0.927 . . . . 2.1200000000000001 109.812 -179.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.765 ' HA ' ' NE ' ' A' ' 94' ' ' ARG . 27.2 t70 -54.44 -43.73 71.85 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 115.155 -0.929 . . . . 0.60999999999999999 110.77 177.529 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.67 ' O ' ' HG ' ' A' ' 96' ' ' LEU . . . -71.5 -34.4 70.09 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.022 -0.536 . . . . 0.22 110.765 179.617 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.595 HG23 ' O ' ' A' ' 89' ' ' PHE . 28.4 t -60.86 -49.53 84.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.406 -0.361 . . . . 0.25 111.219 -176.06 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.765 ' NE ' ' HA ' ' A' ' 91' ' ' ASP . 0.1 OUTLIER -75.91 -16.66 59.99 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.516 -0.474 . . . . 2.5899999999999999 110.479 179.463 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -78.34 -13.51 59.82 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.065 -0.516 . . . . 0.46999999999999997 111.439 -176.032 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.67 ' HG ' ' O ' ' A' ' 92' ' ' ALA . 0.4 OUTLIER -123.21 159.6 28.34 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.174 0.511 . . . . 0.28000000000000003 111.137 178.052 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.487 ' HE3' HD13 ' A' ' 98' ' ' ILE . 54.5 tptt -102.27 176.78 5.07 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.321 -0.854 . . . . 1.6100000000000001 109.321 178.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.487 HD13 ' HE3' ' A' ' 97' ' ' LYS . 1.1 mp -47.43 119.97 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 C-N-CA 123.423 0.689 . . . . 0.90000000000000002 111.298 178.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 92.92 -10.53 73.75 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 121.002 -0.618 . . . . 0.46000000000000002 113.071 176.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.59 ' HB2' ' HB2' ' A' ' 96' ' ' LEU . 23.1 m-20 -85.64 131.68 34.3 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 117.115 0.457 . . . . 0.46000000000000002 110.301 -178.418 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 8.7 mt -104.52 143.64 15.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.073 -0.512 . . . . 0.23000000000000001 109.779 179.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 89.2 p -88.22 148.49 42.86 Favored Pre-proline 0 C--N 1.318 -0.799 0 CA-C-N 116.341 -0.39 . . . . 0.92000000000000004 110.402 -178.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -70.1 163.73 37.47 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 122.032 1.821 . . . . 0.34000000000000002 110.615 170.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.862 HG23 HD23 ' A' ' 44' ' ' LEU . 21.5 mm -39.64 100.33 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 N-CA-C 112.959 0.726 . . . . 0.20000000000000001 112.959 179.318 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 1.8 p -104.69 118.13 51.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.979 -0.555 . . . . 1.04 109.798 175.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -85.8 145.52 27.18 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.266 0.555 . . . . 0.55000000000000004 110.801 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.552 HG22 ' HG2' ' A' ' 88' ' ' PRO . 6.1 p -117.28 -172.82 2.29 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.309 -0.86 . . . . 0.37 110.161 179.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -65.63 -35.39 80.67 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 121.011 -0.275 . . . . 2.1600000000000001 110.363 177.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.423 ' O ' ' HB2' ' A' ' 20' ' ' SER . 4.8 t -92.33 -60.96 1.71 Allowed 'General case' 0 N--CA 1.443 -0.778 0 C-N-CA 120.254 -0.578 . . . . 1.0900000000000001 110.606 -179.125 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -145.03 -131.98 2.44 Favored Glycine 0 N--CA 1.44 -1.077 0 C-N-CA 119.015 -1.564 . . . . 0.23999999999999999 113.793 -174.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.912 ' HB3' HD22 ' A' ' 44' ' ' LEU . 6.0 mp -121.53 147.99 45.08 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 114.917 -0.641 . . . . 0.19 111.08 -170.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . 0.5 ' HA ' ' O ' ' A' ' 13' ' ' LEU . 85.4 m-70 -143.25 148.97 37.25 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.313 0.577 . . . . 0.22 112.254 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.659 HG12 HD11 ' A' ' 44' ' ' LEU . 2.5 pt -131.05 135.04 60.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 107.491 -1.3 . . . . 0.17000000000000001 107.491 160.055 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 3.0 mp -130.2 142.79 42.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 C-N-CA 120.866 -0.334 . . . . 0.17999999999999999 110.439 -175.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.483 ' HA ' ' O ' ' A' ' 100' ' ' ASP . 40.9 pttt -123.21 139.18 54.32 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.622 -0.881 . . . . 0.60999999999999999 108.622 172.359 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.521 ' HB2' ' CD1' ' A' ' 96' ' ' LEU . 57.1 ttt180 -83.74 131.74 34.9 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.155 0.502 . . . . 1.8700000000000001 111.052 -177.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.459 ' HB2' ' HG2' ' A' ' 9' ' ' ARG . 4.3 mm? -98.9 -41.11 7.75 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.259 -0.882 . . . . 0.89000000000000001 109.832 179.004 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.4 ' HB3' ' HB3' ' A' ' 9' ' ' ARG . . . . . . . . 0 C--O 1.246 0.899 0 CA-C-O 118.622 -0.704 . . . . 1.1000000000000001 110.409 179.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 N--CA 1.479 0.998 0 N-CA-C 110.323 -0.251 . . . . 7.2300000000000004 110.323 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 25.1 t 61.96 82.91 0.16 Allowed 'General case' 0 C--O 1.233 0.214 0 O-C-N 123.638 0.586 . . . . 2.8799999999999999 110.689 -178.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.623 ' O ' ' HA ' ' A' ' 81' ' ' SER . 12.3 pt-20 -103.88 -25.75 12.94 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.41 -0.589 . . . . 2.7999999999999998 109.41 177.29 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.52 ' HA ' ' O ' ' A' ' 80' ' ' PHE . 73.1 mmtt -75.06 134.46 41.36 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 115.81 -0.632 . . . . 1.1899999999999999 111.034 -177.567 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.643 HD23 ' N ' ' A' ' 9' ' ' ARG . 3.2 tt -140.58 154.19 46.39 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 114.921 -1.036 . . . . 1.1799999999999999 108.284 -177.256 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.643 ' N ' HD23 ' A' ' 8' ' ' LEU . 26.5 ttt180 -133.64 132.93 41.34 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.348 -0.982 . . . . 1.0600000000000001 108.348 172.494 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -147.06 150.44 35.07 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.459 -0.496 . . . . 0.22 111.975 -174.094 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.623 ' HA ' ' HA ' ' A' ' 76' ' ' ASP . . . -108.45 133.74 52.2 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-N 115.698 -0.683 . . . . 0.20000000000000001 109.8 177.544 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 45.8 p-80 -138.73 145.09 39.84 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 120.93 0.395 . . . . 0.23000000000000001 111.108 -172.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.562 ' O ' ' HA ' ' A' ' 112' ' ' HIS . 6.6 tt -112.82 142.92 44.91 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.251 -1.018 . . . . 0.23999999999999999 108.251 176.339 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.618 HD13 ' NE2' ' A' ' 112' ' ' HIS . 29.3 tp -128.97 118.41 22.56 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.739 0.304 . . . . 0.27000000000000002 111.021 -175.763 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.519 HG23 HD13 ' A' ' 44' ' ' LEU . 46.3 t -107.88 134.19 50.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 109.501 -0.555 . . . . 0.14999999999999999 109.501 176.348 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.475 ' HE3' HD21 ' A' ' 14' ' ' LEU . 32.7 mmtp -109.45 152.41 25.43 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.754 -0.462 . . . . 0.62 109.754 178.309 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.451 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 47.0 p90 -143.37 162.51 35.55 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.515 -0.311 . . . . 0.25 110.533 -176.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.414 ' HB3' ' HA ' ' A' ' 33' ' ' ALA . 19.9 p -52.08 113.44 1.02 Allowed 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.276 -0.42 . . . . 1.04 111.14 177.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 95.29 10.04 57.45 Favored Glycine 0 C--N 1.334 0.429 0 C-N-CA 120.761 -0.733 . . . . 0.53000000000000003 113.318 179.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.664 ' HB2' ' O ' ' A' ' 109' ' ' SER . 85.6 p -90.0 35.05 0.84 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 117.368 0.584 . . . . 0.69999999999999996 111.523 -175.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.464 ' HB3' ' O ' ' A' ' 20' ' ' SER . 73.7 ttt180 71.82 -34.26 0.29 Allowed 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 120.995 0.426 . . . . 3.4900000000000002 111.16 -179.092 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.451 ' H ' ' C ' ' A' ' 20' ' ' SER . 45.7 m-80 -132.81 93.59 23.4 Favored Pre-proline 0 C--N 1.327 -0.385 0 N-CA-C 109.409 -0.589 . . . . 1.77 109.409 176.069 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.555 ' C ' HG22 ' A' ' 32' ' ' THR . 95.4 Cg_endo -80.83 49.16 3.14 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 122.507 2.138 . . . . 1.71 112.959 -176.326 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.482 ' N ' HG22 ' A' ' 32' ' ' THR . 47.3 t -147.26 117.0 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 N-CA-C 108.759 -0.83 . . . . 0.47999999999999998 108.759 178.052 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 41.2 t -105.89 154.23 20.85 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 110.203 -0.295 . . . . 1.1200000000000001 110.203 177.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.623 ' HB2' ' HA ' ' A' ' 67' ' ' ASP . 6.6 mpt_? -69.01 -5.27 20.7 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.087 0.47 . . . . 2.54 110.422 171.363 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.605 ' HG3' ' CD ' ' A' ' 65' ' ' ARG . 18.3 ttp180 -78.21 -29.58 48.41 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.654 -0.703 . . . . 1.77 109.623 175.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 71.6 p -115.28 -33.78 5.2 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.753 -0.658 . . . . 0.67000000000000004 111.454 -174.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 81.55 -36.39 2.44 Favored Glycine 0 CA--C 1.52 0.371 0 CA-C-N 115.977 -0.556 . . . . 0.81999999999999995 112.905 178.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -95.03 -65.99 0.94 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.801 0.334 . . . . 2.1000000000000001 110.625 -178.059 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 13.7 p -153.94 156.26 37.16 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.949 0.404 . . . . 1.0800000000000001 110.932 178.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.555 HG22 ' C ' ' A' ' 23' ' ' PRO . 14.8 t -120.07 28.63 7.96 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 122.076 0.941 . . . . 0.34000000000000002 109.146 174.054 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.414 ' HA ' ' HB3' ' A' ' 18' ' ' SER . . . -75.78 -5.7 47.09 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.92 -1.036 . . . . 0.37 111.422 -178.085 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -93.82 -25.72 17.24 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.902 -0.59 . . . . 2.21 111.095 -179.042 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.523 HG23 ' HB2' ' A' ' 39' ' ' ASP . 0.2 OUTLIER -98.61 138.77 22.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 116.135 -0.484 . . . . 0.31 109.76 -178.663 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 72.8 p -94.76 176.77 6.14 Favored 'General case' 0 CA--C 1.513 -0.474 0 N-CA-C 109.84 -0.43 . . . . 0.39000000000000001 109.84 -174.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.46 ' O ' HG13 ' A' ' 41' ' ' ILE . 4.1 p90 -63.88 -27.17 68.97 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 119.897 -0.721 . . . . 1.53 109.099 175.534 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -72.75 -46.78 51.66 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.956 -0.565 . . . . 0.95999999999999996 110.301 178.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.523 ' HB2' HG23 ' A' ' 35' ' ' VAL . 42.1 m-20 -64.68 -33.52 76.14 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 121.375 0.607 . . . . 0.91000000000000003 109.633 177.108 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.451 ' HB2' ' HB3' ' A' ' 17' ' ' PHE . . . -68.8 -45.73 70.52 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.985 -1.007 . . . . 0.19 110.64 179.311 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.487 ' CG1' HD21 ' A' ' 111' ' ' LEU . 70.1 mt -62.55 -37.68 79.51 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.345 0 N-CA-C 109.704 -0.48 . . . . 0.29999999999999999 109.704 174.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.446 ' O ' ' HG3' ' A' ' 46' ' ' LYS . 27.8 ttpt -63.73 -22.88 67.13 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.902 -0.59 . . . . 2.3199999999999998 110.126 179.343 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.44 ' HG3' ' CD1' ' A' ' 47' ' ' TRP . 8.7 tp10 -85.45 -54.52 4.52 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.662 -0.699 . . . . 1.02 109.309 179.506 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.947 HD22 ' HB3' ' A' ' 111' ' ' LEU . 29.6 tp -59.81 -36.25 76.38 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.859 -1.064 . . . . 0.17000000000000001 110.55 -174.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.441 ' HA ' HD11 ' A' ' 104' ' ' ILE . 3.9 mm-40 -64.2 -35.82 82.04 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.811 -0.632 . . . . 0.87 112.265 -179.353 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.446 ' HG3' ' O ' ' A' ' 42' ' ' LYS . 95.0 mttt -70.62 -47.42 60.16 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.153 0.501 . . . . 1.3100000000000001 109.801 178.582 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.492 ' NE1' ' HG3' ' A' ' 65' ' ' ARG . 51.3 m95 -61.9 -47.59 84.27 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.8 -0.636 . . . . 0.52000000000000002 111.687 179.199 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.564 ' HB3' HG21 ' A' ' 113' ' ' ILE . 97.5 p -64.32 -22.71 67.04 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.954 0.407 . . . . 0.81999999999999995 110.15 178.251 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -74.17 -57.37 4.0 Favored 'General case' 0 C--O 1.224 -0.261 0 CA-C-N 116.1 -0.5 . . . . 0.53000000000000003 110.063 174.083 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.658 ' HB3' HG22 ' A' ' 56' ' ' VAL . 96.9 mtt180 -61.6 -42.58 99.08 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.624 -0.716 . . . . 0.41999999999999998 111.46 -174.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 98.3 mt -60.39 -35.59 63.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.003 -0.544 . . . . 0.20000000000000001 110.739 177.123 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -79.73 -41.32 26.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.086 -0.506 . . . . 0.27000000000000002 111.32 -179.002 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 58.3 p -74.6 -29.96 61.51 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.21 -0.45 . . . . 0.34999999999999998 111.641 -176.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 107.73 4.87 34.1 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.749 -0.738 . . . . 0.29999999999999999 112.14 -178.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.417 ' HB2' ' HB3' ' A' ' 50' ' ' ARG . 38.3 mt-10 -61.92 -47.23 85.85 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.847 0.356 . . . . 0.65000000000000002 110.049 178.443 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.658 HG22 ' HB3' ' A' ' 50' ' ' ARG . 14.3 m -136.57 165.26 29.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.963 -0.562 . . . . 0.19 109.652 172.212 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 54.5 p -86.15 165.7 16.36 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.945 -0.391 . . . . 0.96999999999999997 109.945 176.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -58.89 -39.4 81.35 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.248 -0.649 . . . . 0.22 109.248 176.366 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -54.35 -54.88 34.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.633 -1.167 . . . . 1.72 111.959 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -56.59 -44.29 80.91 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.09 -0.505 . . . . 2.0899999999999999 111.621 -176.009 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -68.83 -45.9 69.95 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.798 0.332 . . . . 0.26000000000000001 110.816 -179.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.44 -53.52 55.41 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.119 -0.491 . . . . 0.23999999999999999 111.957 -175.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 50.0 m -53.33 -21.33 5.5 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 113.293 0.849 . . . . 1.0 113.293 -176.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -105.22 -46.1 4.32 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.439 0.637 . . . . 0.60999999999999999 110.718 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.605 ' CD ' ' HG3' ' A' ' 27' ' ' ARG . 24.7 mmt180 -93.97 -42.92 8.79 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 114.855 -1.066 . . . . 0.85999999999999999 113.65 -168.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.51 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 80.2 p -64.33 121.77 15.1 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.994 0.426 . . . . 0.81999999999999995 111.437 -174.38 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.623 ' HA ' ' HB2' ' A' ' 26' ' ' ARG . 25.0 t70 -73.63 -17.24 61.19 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.66 -0.7 . . . . 2.2799999999999998 111.568 178.624 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.416 ' O ' ' HD1' ' A' ' 71' ' ' TYR . 52.2 t -76.91 155.87 32.49 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.178 0.513 . . . . 1.52 109.926 -179.145 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -58.82 -12.44 14.6 Favored Glycine 0 N--CA 1.454 -0.112 0 CA-C-N 114.81 -1.087 . . . . 0.26000000000000001 113.621 -173.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.437 ' HB3' ' CD1' ' A' ' 77' ' ' LEU . 52.7 p -70.14 -7.82 44.72 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 116.579 0.19 . . . . 0.32000000000000001 111.207 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.416 ' HD1' ' O ' ' A' ' 68' ' ' CYS . 35.0 p90 -56.08 -29.62 60.81 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.861 0.362 . . . . 0.54000000000000004 110.21 175.723 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -90.45 2.85 55.27 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.372 -0.377 . . . . 0.48999999999999999 111.673 -174.063 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 30.0 m -125.39 -15.16 6.25 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.762 0.315 . . . . 0.70999999999999996 111.447 -179.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 107.22 24.14 6.66 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.524 -0.846 . . . . 0.54000000000000004 112.507 -179.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 91.34 -27.57 9.27 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.796 -0.716 . . . . 0.34999999999999998 113.063 176.124 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.623 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 7.5 p-10 -79.89 141.56 36.01 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-O 121.561 0.696 . . . . 1.6499999999999999 111.204 -176.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.472 HD12 ' HA ' ' A' ' 77' ' ' LEU . 0.6 OUTLIER -106.13 176.0 5.31 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 114.755 -1.111 . . . . 0.93999999999999995 109.604 177.187 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -83.88 -150.28 10.51 Favored Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 120.871 -0.68 . . . . 0.44 111.856 178.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.447 ' HA ' ' O ' ' A' ' 8' ' ' LEU . 21.3 p90 -94.15 145.91 24.36 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.101 0.477 . . . . 3.8700000000000001 111.214 -178.481 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.61 ' CE1' ' HB3' ' A' ' 8' ' ' LEU . 2.6 p90 -152.16 172.18 16.77 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.315 -0.995 . . . . 1.3100000000000001 108.315 179.031 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.623 ' HA ' ' O ' ' A' ' 6' ' ' GLU . 89.0 p -103.71 142.27 34.63 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 109.139 -0.689 . . . . 1.1699999999999999 109.139 174.382 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 10.1 m -52.38 122.76 9.37 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.704 -0.68 . . . . 1.1899999999999999 111.615 -173.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.456 ' H ' ' HG3' ' A' ' 90' ' ' GLU . . . 114.69 -12.7 20.64 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.892 -0.67 . . . . 0.79000000000000004 112.998 179.371 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -90.59 45.19 1.24 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 117.013 0.406 . . . . 1.55 111.665 -177.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 26.2 mmt -137.66 -108.28 0.19 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.043 0.449 . . . . 0.72999999999999998 110.297 178.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 59.5 mtt -140.26 150.68 44.38 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.278 -1.008 . . . . 1.3899999999999999 108.278 176.034 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -50.38 -54.27 36.44 Favored Pre-proline 0 C--N 1.322 -0.589 0 N-CA-C 112.682 0.623 . . . . 2.3700000000000001 112.682 -175.478 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.472 ' HG2' HG22 ' A' ' 107' ' ' THR . 84.5 Cg_endo -76.23 -27.45 8.09 Favored 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 121.63 1.553 . . . . 0.27000000000000002 112.036 -176.402 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.635 ' O ' HG23 ' A' ' 93' ' ' VAL . 24.2 t80 -70.06 -55.86 8.42 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.214 -0.903 . . . . 0.22 109.719 -179.422 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.456 ' HG3' ' H ' ' A' ' 83' ' ' GLY . 3.5 tm-20 -66.24 -34.78 78.78 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.392 -0.822 . . . . 2.1200000000000001 110.246 -177.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.49 ' HA ' ' NE ' ' A' ' 94' ' ' ARG . 19.6 t70 -54.64 -36.24 64.32 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.63 -0.713 . . . . 0.60999999999999999 110.86 175.021 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.561 ' O ' ' HG ' ' A' ' 96' ' ' LEU . . . -80.79 -35.47 33.07 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.213 -0.448 . . . . 0.22 110.958 179.172 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.635 HG23 ' O ' ' A' ' 89' ' ' PHE . 21.0 t -62.12 -44.55 99.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.303 0.573 . . . . 0.25 110.625 -178.178 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.49 ' NE ' ' HA ' ' A' ' 91' ' ' ASP . 38.1 ptt180 -73.87 -12.73 60.76 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.714 -0.676 . . . . 2.5899999999999999 110.564 179.279 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -95.11 6.16 49.83 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.067 -0.515 . . . . 0.46999999999999997 111.689 -173.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.561 ' HG ' ' O ' ' A' ' 92' ' ' ALA . 0.7 OUTLIER -141.26 146.87 37.36 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.425 -0.352 . . . . 0.28000000000000003 110.719 177.226 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.419 ' HG3' ' N ' ' A' ' 98' ' ' ILE . 55.2 tptt -88.89 168.95 12.0 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.372 -0.603 . . . . 1.6100000000000001 109.372 178.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.441 ' HA ' ' HG2' ' A' ' 116' ' ' ARG . 70.7 mt -45.54 115.96 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 121.137 0.494 . . . . 0.90000000000000002 111.649 175.737 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 99.63 -4.62 58.1 Favored Glycine 0 N--CA 1.45 -0.416 0 CA-C-N 115.779 -0.646 . . . . 0.46000000000000002 113.324 177.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.533 ' HB2' ' HB2' ' A' ' 96' ' ' LEU . 66.4 m-20 -100.22 144.57 29.09 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 117.099 0.449 . . . . 0.46000000000000002 110.331 179.511 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 8.8 mt -116.03 147.95 19.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.19 -0.459 . . . . 0.23000000000000001 110.562 -174.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 92.5 p -92.5 155.54 42.13 Favored Pre-proline 0 C--N 1.322 -0.588 0 CA-C-N 116.041 -0.527 . . . . 0.92000000000000004 110.612 -179.324 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -71.64 171.63 15.98 Favored 'Trans proline' 0 C--O 1.235 0.345 0 C-N-CA 122.323 2.016 . . . . 0.34000000000000002 111.393 171.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.931 HG23 HD23 ' A' ' 44' ' ' LEU . 22.7 mm -47.62 112.68 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 O-C-N 123.381 0.426 . . . . 0.20000000000000001 111.986 178.514 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.1 p -117.59 118.67 59.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.004 0.431 . . . . 1.04 110.258 176.257 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -85.44 141.65 29.8 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.2 0.524 . . . . 0.55000000000000004 110.373 178.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.472 HG22 ' HG2' ' A' ' 88' ' ' PRO . 7.5 p -115.94 -172.52 2.18 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.461 -0.791 . . . . 0.37 110.637 -178.263 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -58.21 -42.64 86.64 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.903 0.383 . . . . 2.1600000000000001 110.374 178.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.664 ' O ' ' HB2' ' A' ' 20' ' ' SER . 7.8 t -90.68 -61.62 1.63 Allowed 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 116.112 -0.494 . . . . 1.0900000000000001 110.652 -178.476 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -146.62 -133.14 2.42 Favored Glycine 0 N--CA 1.442 -0.941 0 C-N-CA 118.946 -1.597 . . . . 0.23999999999999999 113.499 -172.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.947 ' HB3' HD22 ' A' ' 44' ' ' LEU . 7.6 mp -115.58 145.92 42.23 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.199 -0.501 . . . . 0.19 111.408 -170.625 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . 0.618 ' NE2' HD13 ' A' ' 14' ' ' LEU . 75.4 m-70 -142.06 152.2 43.1 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.392 0.615 . . . . 0.22 112.374 178.611 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.66 HG12 HD11 ' A' ' 44' ' ' LEU . 2.8 pt -134.01 140.73 45.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 107.317 -1.364 . . . . 0.17000000000000001 107.317 158.388 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.409 HG21 HG22 ' A' ' 93' ' ' VAL . 2.2 mp -130.76 148.33 33.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 C-N-CA 120.656 -0.418 . . . . 0.17999999999999999 110.657 -175.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.443 ' HG2' ' HB3' ' A' ' 11' ' ' ALA . 35.6 pttt -132.41 141.3 48.8 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.451 -0.944 . . . . 0.60999999999999999 108.451 171.459 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.546 ' HD3' HD21 ' A' ' 8' ' ' LEU . 5.6 ttp180 -81.47 135.72 35.63 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.198 0.523 . . . . 1.8700000000000001 110.768 -178.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -104.75 -31.87 9.13 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.258 -0.883 . . . . 0.89000000000000001 110.561 -178.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.496 ' HB3' ' HB3' ' A' ' 9' ' ' ARG . . . . . . . . 0 C--O 1.246 0.915 0 CA-C-O 118.445 -0.788 . . . . 1.1000000000000001 110.579 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 70.5 mtm . . . . . 0 N--CA 1.48 1.037 0 CA-C-O 120.841 0.353 . . . . 7.2300000000000004 110.446 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 28.4 p -90.11 -53.94 4.25 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.358 -0.383 . . . . 2.8799999999999999 110.884 -179.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.471 ' HG3' ' HD3' ' A' ' 7' ' ' LYS . 13.1 pt-20 -83.91 -21.67 31.81 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.175 -0.466 . . . . 2.7999999999999998 110.527 -178.054 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.629 ' HA ' ' O ' ' A' ' 80' ' ' PHE . 5.9 mptt -73.82 115.65 13.5 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.566 0.698 . . . . 1.1899999999999999 111.707 -176.734 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.693 HD23 ' H ' ' A' ' 9' ' ' ARG . 1.5 tt -117.59 160.75 20.75 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 114.494 -1.23 . . . . 1.1799999999999999 107.886 178.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.693 ' H ' HD23 ' A' ' 8' ' ' LEU . 70.4 ttt180 -131.24 132.17 44.43 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 109.42 -0.585 . . . . 1.0600000000000001 109.42 172.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -150.45 150.27 31.11 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.933 0.397 . . . . 0.22 111.824 -175.404 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.407 ' HB3' ' HG2' ' A' ' 115' ' ' LYS . . . -108.54 136.04 48.8 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.732 -0.667 . . . . 0.20000000000000001 109.51 177.481 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 35.9 p-80 -138.83 157.24 46.42 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.088 0.471 . . . . 0.23000000000000001 111.852 -171.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.561 HD23 ' N ' ' A' ' 14' ' ' LEU . 4.8 tt -124.34 146.92 48.54 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.584 -0.895 . . . . 0.23999999999999999 108.584 176.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.561 ' N ' HD23 ' A' ' 13' ' ' LEU . 28.7 tp -131.51 120.66 23.26 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.512 0.196 . . . . 0.27000000000000002 111.028 -178.217 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.581 HG23 HD13 ' A' ' 44' ' ' LEU . 65.2 t -109.32 138.91 34.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 109.874 -0.417 . . . . 0.14999999999999999 109.874 176.417 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.485 ' HE2' ' OG ' ' A' ' 109' ' ' SER . 33.8 mmtp -112.04 154.4 25.42 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.731 -0.47 . . . . 0.62 109.731 176.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.497 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 41.4 p90 -144.26 162.53 36.15 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.267 -0.424 . . . . 0.25 110.351 -176.054 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.517 ' HB3' ' HA ' ' A' ' 33' ' ' ALA . 29.0 p -53.44 108.12 0.31 Allowed 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.046 0.45 . . . . 1.04 110.699 179.144 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 101.32 7.95 48.05 Favored Glycine 0 CA--C 1.522 0.502 0 C-N-CA 120.823 -0.704 . . . . 0.53000000000000003 113.208 -179.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.643 ' HB2' ' O ' ' A' ' 109' ' ' SER . 89.5 p -85.03 49.44 1.74 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 117.33 0.565 . . . . 0.69999999999999996 111.156 -177.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 71.66 -32.99 0.26 Allowed 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.631 0.772 . . . . 3.4900000000000002 110.954 -177.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.487 ' H ' ' C ' ' A' ' 20' ' ' SER . 4.8 p30 -151.97 118.04 3.12 Favored Pre-proline 0 C--N 1.321 -0.673 0 N-CA-C 109.095 -0.706 . . . . 1.77 109.095 174.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.495 ' C ' HG22 ' A' ' 32' ' ' THR . 95.0 Cg_endo -85.39 55.8 4.12 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.52 2.147 . . . . 1.71 113.135 -175.735 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.46 ' N ' HG22 ' A' ' 32' ' ' THR . 25.5 t -146.21 116.4 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 109.577 -0.527 . . . . 0.47999999999999998 109.577 176.197 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.45 ' HB3' ' HB2' ' A' ' 16' ' ' LYS . 66.3 p -104.1 159.24 15.84 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.926 -0.398 . . . . 1.1200000000000001 109.926 175.679 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.52 ' HG2' ' HA ' ' A' ' 67' ' ' ASP . 6.3 mmp_? -71.48 -7.17 45.74 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.397 0.618 . . . . 2.54 109.691 172.066 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.506 ' CG ' ' HD2' ' A' ' 65' ' ' ARG . 3.7 tmm_? -81.06 -36.18 30.81 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.279 -0.873 . . . . 1.77 110.054 178.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 61.8 p -101.71 -34.81 9.32 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.296 0.57 . . . . 0.67000000000000004 110.789 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 85.67 -43.85 3.29 Favored Glycine 0 N--CA 1.45 -0.383 0 CA-C-N 115.738 -0.665 . . . . 0.81999999999999995 112.986 177.241 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -93.0 -63.77 1.18 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.764 0.316 . . . . 2.1000000000000001 110.248 -177.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 19.8 m -153.12 151.67 30.42 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.365 -0.38 . . . . 1.0800000000000001 110.652 176.216 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.495 HG22 ' C ' ' A' ' 23' ' ' PRO . 12.1 t -115.09 34.36 4.9 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 122.19 0.995 . . . . 0.34000000000000002 108.915 176.234 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.517 ' HA ' ' HB3' ' A' ' 18' ' ' SER . . . -80.49 -6.09 57.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 114.946 -1.025 . . . . 0.37 112.102 -172.563 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -94.13 -23.83 17.79 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.38 0.609 . . . . 2.21 110.528 -178.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.4 HG23 ' HB2' ' A' ' 39' ' ' ASP . 0.2 OUTLIER -98.19 135.78 31.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.702 -0.681 . . . . 0.31 110.103 -179.135 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 71.0 p -95.83 179.46 5.1 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.024 -0.535 . . . . 0.39000000000000001 109.95 -175.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.51 ' O ' HG13 ' A' ' 41' ' ' ILE . 13.6 p90 -62.92 -31.11 72.12 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.006 -0.678 . . . . 1.53 109.468 176.335 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -71.89 -46.34 58.09 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-N 116.044 -0.525 . . . . 0.95999999999999996 110.596 178.535 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.4 ' HB2' HG23 ' A' ' 35' ' ' VAL . 28.8 m-20 -67.25 -27.78 67.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.245 0.545 . . . . 0.91000000000000003 109.87 177.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.497 ' HB2' ' HB3' ' A' ' 17' ' ' PHE . . . -71.07 -43.05 68.57 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.513 -0.767 . . . . 0.19 110.366 176.48 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.51 HG13 ' O ' ' A' ' 37' ' ' TYR . 86.5 mt -64.78 -37.08 79.24 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.414 0 N-CA-C 109.494 -0.558 . . . . 0.29999999999999999 109.494 174.358 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.404 ' O ' ' HG3' ' A' ' 46' ' ' LYS . 62.2 tttp -61.49 -28.25 69.17 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.599 -0.728 . . . . 2.3199999999999998 110.209 177.522 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 58.8 tt0 -88.08 -48.23 7.9 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.663 -0.699 . . . . 1.02 110.082 -178.388 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.885 HD23 HG23 ' A' ' 104' ' ' ILE . 32.2 tp -61.15 -36.58 80.17 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.871 -0.604 . . . . 0.17000000000000001 110.021 -179.256 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.46 ' HG2' HG13 ' A' ' 104' ' ' ILE . 4.4 mm-40 -64.08 -36.21 83.26 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-N 115.96 -0.564 . . . . 0.87 111.97 178.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.404 ' HG3' ' O ' ' A' ' 42' ' ' LYS . 98.1 mttt -69.23 -46.3 67.71 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.843 -0.343 . . . . 1.3100000000000001 110.461 179.653 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.4 ' O ' HG13 ' A' ' 51' ' ' ILE . 54.0 m95 -66.0 -46.14 79.06 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.475 -0.33 . . . . 0.52000000000000002 111.188 177.55 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 44.7 t -57.77 -35.27 70.53 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.881 -0.414 . . . . 0.81999999999999995 109.881 175.006 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.449 ' HB2' ' O ' ' A' ' 45' ' ' GLN . 13.0 tt0 -65.6 -55.98 14.69 Favored 'General case' 0 C--O 1.225 -0.233 0 CA-C-N 115.915 -0.584 . . . . 0.53000000000000003 110.488 176.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.634 ' HB3' HG22 ' A' ' 56' ' ' VAL . 93.5 mtt180 -62.15 -42.31 99.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.097 -0.501 . . . . 0.41999999999999998 111.609 -176.235 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.428 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 98.3 mt -60.24 -35.21 60.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.012 0.434 . . . . 0.20000000000000001 110.657 176.474 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -79.99 -38.89 31.22 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.943 -0.571 . . . . 0.27000000000000002 111.542 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 65.2 p -76.68 -29.99 56.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.72 0.295 . . . . 0.34999999999999998 111.456 -176.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 106.38 10.31 29.67 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.539 -0.839 . . . . 0.29999999999999999 112.141 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.424 ' HB2' ' HB3' ' A' ' 50' ' ' ARG . 41.4 mt-10 -67.1 -52.16 45.36 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.047 0.451 . . . . 0.65000000000000002 110.011 176.696 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.634 HG22 ' HB3' ' A' ' 50' ' ' ARG . 15.8 m -132.04 156.06 42.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.925 -0.58 . . . . 0.19 109.748 175.145 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 50.5 m -86.27 159.34 19.47 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.575 -0.528 . . . . 0.96999999999999997 109.575 178.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -52.41 -43.44 64.81 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.027 0.442 . . . . 0.22 110.249 -176.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.591 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 39.9 mt-10 -56.82 -43.49 81.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.236 -0.893 . . . . 1.72 112.105 -179.013 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -60.86 -46.34 90.95 Favored 'General case' 0 CA--C 1.521 -0.141 0 CA-C-O 120.958 0.408 . . . . 2.0899999999999999 110.587 -177.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -69.15 -51.1 41.64 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.048 -0.523 . . . . 0.26000000000000001 110.921 -179.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.78 -52.11 66.86 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.741 0.645 . . . . 0.23999999999999999 112.741 -173.231 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.507 ' HA ' ' O ' ' A' ' 71' ' ' TYR . 20.4 m -51.5 -25.47 6.64 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 112.859 0.688 . . . . 1.0 112.859 -176.726 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -105.36 -46.25 4.26 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.63 0.728 . . . . 0.60999999999999999 110.673 -177.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.506 ' HD2' ' CG ' ' A' ' 27' ' ' ARG . 27.8 mmt180 -88.26 -41.03 13.19 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.872 -1.058 . . . . 0.85999999999999999 113.54 -169.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.513 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 59.6 p -64.79 127.2 30.58 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.68 -0.408 . . . . 0.81999999999999995 111.14 -176.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.52 ' HA ' ' HG2' ' A' ' 26' ' ' ARG . 33.6 t70 -80.15 -10.84 59.78 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.424 0.631 . . . . 2.2799999999999998 111.157 179.091 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 44.8 t -77.56 163.04 26.64 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.94 -0.573 . . . . 1.52 109.688 179.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -61.26 -16.45 49.09 Favored Glycine 0 N--CA 1.454 -0.146 0 CA-C-N 115.642 -0.708 . . . . 0.26000000000000001 112.598 -176.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 61.8 p -65.51 -7.63 15.41 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 112.021 0.378 . . . . 0.32000000000000001 112.021 177.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.507 ' O ' ' HA ' ' A' ' 63' ' ' SER . 14.1 p90 -60.96 -23.64 65.48 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 109.479 -0.563 . . . . 0.54000000000000004 109.479 175.466 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -95.09 5.97 50.37 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.084 0.469 . . . . 0.48999999999999999 110.613 178.003 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 6.2 m -126.02 3.24 7.26 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.097 -0.501 . . . . 0.70999999999999996 110.823 -179.084 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.591 ' O ' ' HA ' ' A' ' 59' ' ' GLU . . . 73.16 25.43 73.34 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.812 -0.708 . . . . 0.54000000000000004 112.047 -175.731 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 83.66 -20.31 12.22 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 121.202 -0.523 . . . . 0.34999999999999998 111.809 -177.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -73.36 133.13 43.72 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.294 -0.453 . . . . 1.6499999999999999 110.672 -175.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.5 mp -115.78 164.1 14.87 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-O 121.307 0.575 . . . . 0.93999999999999995 110.009 175.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -82.5 -154.95 15.97 Favored Glycine 0 C--N 1.305 -1.169 0 CA-C-N 114.964 -1.016 . . . . 0.44 111.808 176.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.631 ' HA ' ' O ' ' A' ' 8' ' ' LEU . 93.3 m-85 -84.17 147.77 27.12 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.037 0.446 . . . . 3.8700000000000001 110.933 -179.478 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.629 ' O ' ' HA ' ' A' ' 7' ' ' LYS . 14.9 p90 -147.8 165.63 29.99 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.647 -0.871 . . . . 1.3100000000000001 108.647 -177.237 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -90.5 149.98 21.97 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 109.645 -0.502 . . . . 1.1699999999999999 109.645 -178.498 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.6 p -58.77 111.7 1.37 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.838 0.351 . . . . 1.1899999999999999 110.629 177.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 99.64 18.11 24.14 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.672 -0.775 . . . . 0.79000000000000004 112.514 -177.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -101.08 18.07 20.74 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.061 0.458 . . . . 1.55 110.98 -178.162 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 26.3 mmt -124.51 -105.31 0.35 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.885 0.374 . . . . 0.72999999999999998 111.057 -177.045 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 82.7 mmm -141.26 152.6 44.66 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.133 -1.062 . . . . 1.3899999999999999 108.133 175.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.431 ' HB3' ' HD3' ' A' ' 88' ' ' PRO . 23.8 ttmm -50.77 -56.39 19.63 Favored Pre-proline 0 C--N 1.321 -0.642 0 N-CA-C 112.701 0.63 . . . . 2.3700000000000001 112.701 -175.707 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.431 ' HD3' ' HB3' ' A' ' 87' ' ' LYS . 85.1 Cg_endo -77.44 -27.85 6.05 Favored 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 121.48 1.453 . . . . 0.27000000000000002 111.928 -176.163 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.683 ' O ' HG23 ' A' ' 93' ' ' VAL . 14.5 t80 -67.98 -56.81 7.6 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.187 -0.915 . . . . 0.22 109.854 -179.325 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -65.25 -38.21 89.62 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.502 -0.772 . . . . 2.1200000000000001 110.143 -178.132 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -57.03 -34.28 68.05 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.475 -0.784 . . . . 0.60999999999999999 110.617 177.17 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -78.91 -26.84 43.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 0.22 110.707 177.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.683 HG23 ' O ' ' A' ' 89' ' ' PHE . 35.5 t -72.28 -36.94 57.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.332 0.587 . . . . 0.25 109.977 -178.577 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.438 ' C ' ' HD2' ' A' ' 94' ' ' ARG . 2.0 ppt_? -83.08 -2.74 56.17 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.844 -0.617 . . . . 2.5899999999999999 110.246 179.237 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -97.43 9.69 41.7 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.093 -0.503 . . . . 0.46999999999999997 111.339 -177.386 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.531 ' HB2' ' HB2' ' A' ' 100' ' ' ASP . 0.4 OUTLIER -144.24 151.11 38.99 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.31 0.576 . . . . 0.28000000000000003 111.461 178.684 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.526 ' HE2' HD13 ' A' ' 98' ' ' ILE . 22.5 tptm -91.34 172.25 8.66 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.253 -0.885 . . . . 1.6100000000000001 109.402 177.011 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.526 HD13 ' HE2' ' A' ' 97' ' ' LYS . 1.3 mp -46.73 120.59 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 C-N-CA 123.344 0.658 . . . . 0.90000000000000002 110.85 176.689 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 97.72 -9.37 64.16 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.761 -0.733 . . . . 0.46000000000000002 113.28 176.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.531 ' HB2' ' HB2' ' A' ' 96' ' ' LEU . 12.1 m-20 -93.11 141.84 27.96 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 117.133 0.466 . . . . 0.46000000000000002 111.055 -177.802 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 9.4 mt -111.4 146.15 16.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.707 -0.679 . . . . 0.23000000000000001 109.668 -179.141 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 97.8 p -89.42 152.45 47.5 Favored Pre-proline 0 C--N 1.319 -0.755 0 CA-C-N 116.361 -0.382 . . . . 0.92000000000000004 110.422 -179.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -69.18 166.79 25.68 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 122.35 2.033 . . . . 0.34000000000000002 111.111 171.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.885 HG23 HD23 ' A' ' 44' ' ' LEU . 29.0 mm -46.07 105.09 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 O-C-N 123.562 0.539 . . . . 0.20000000000000001 112.05 178.693 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.0 p -111.52 121.18 63.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.253 -0.43 . . . . 1.04 110.196 177.445 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -85.57 156.47 20.72 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.228 0.537 . . . . 0.55000000000000004 110.92 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 2.8 p -130.09 -173.17 2.97 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.383 -0.826 . . . . 0.37 110.019 177.357 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -56.51 -49.1 75.73 Favored 'General case' 0 C--N 1.328 -0.341 0 O-C-N 123.213 0.32 . . . . 2.1600000000000001 110.887 177.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.643 ' O ' ' HB2' ' A' ' 20' ' ' SER . 8.3 t -84.14 -60.69 2.02 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 116.212 -0.449 . . . . 1.0900000000000001 110.638 -177.139 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -146.76 -132.71 2.36 Favored Glycine 0 N--CA 1.441 -1.004 0 C-N-CA 118.921 -1.609 . . . . 0.23999999999999999 113.982 -173.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.883 ' HB3' HD22 ' A' ' 44' ' ' LEU . 6.8 mp -118.77 150.41 39.85 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.964 -0.618 . . . . 0.19 111.377 -169.543 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . 0.561 ' HA ' ' O ' ' A' ' 13' ' ' LEU . 85.3 m-70 -144.58 150.15 36.99 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.205 0.526 . . . . 0.22 111.995 179.625 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.632 HG12 HD11 ' A' ' 44' ' ' LEU . 1.4 pt -134.25 137.02 52.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 107.514 -1.291 . . . . 0.17000000000000001 107.514 160.27 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.468 HG21 HG22 ' A' ' 93' ' ' VAL . 2.8 mp -130.53 144.77 36.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 C-N-CA 120.87 -0.332 . . . . 0.17999999999999999 110.826 -175.021 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.472 ' HA ' ' O ' ' A' ' 100' ' ' ASP . 43.2 pttt -126.18 142.53 51.49 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.116 -0.698 . . . . 0.60999999999999999 109.116 173.229 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.462 ' HB2' ' CD1' ' A' ' 96' ' ' LEU . 68.4 ttt180 -84.8 129.03 34.88 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.282 0.563 . . . . 1.8700000000000001 111.338 -178.309 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.407 ' HB2' ' HG2' ' A' ' 9' ' ' ARG . 4.2 mm? -97.34 -39.53 9.17 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.187 -0.915 . . . . 0.89000000000000001 110.4 -179.568 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.243 0.712 0 CA-C-O 118.374 -0.822 . . . . 1.1000000000000001 110.305 -179.332 . . . . . . . . 0 0 . 1 stop_ save_